geneId,uniqueDiseases,uniqueTherapeuticAreas,maxEQTLColoc,maxPQTLColoc,maxVEP,maxDistanceTSS,minEffectiveSampleSize,maxEffectiveSampleSize,earliestPublicationDate,cancerOrBenignTumor,infectiousDisease,pregnancyOrPerinatalDisease,disorderOfVisualSystem,cardiovascularDisease,pancreasDisease,gastrointestinalDisease,reproductiveSystemOrBreastDisease,integumentarySystemDisease,endocrineSystemDisease,respiratoryOrThoracicDisease,urinarySystemDisease,musculoskeletalOrConnectiveTissueDisease,disorderOfEar,immuneSystemDisease,hematologicDisease,nervousSystemDisease,psychiatricDisorder,nutritionalOrMetabolicDisease,geneticFamilialOrCongenitalDisease,injuryPoisoningOrOtherComplication,signOrSymptom,other,totalStudies,approvedSymbol,lofConstraint,misConstraint,synConstraint,pathwayCount,tissueSpecificity,tissueDistribution,Term,ID
ENSG00000147883,148,21,1,0,0,1,1622.2610172620696,1424218.0900670097,2007-04-26,90,1,2,76,184,84,4,25,4,2,4,6,1,0,2,1,7,0,5,17,1,1,60,577,CDKN2B,-0.83599997,-1.2127,-0.25674,5,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-2173796;R-HSA-2173793
ENSG00000175164,105,20,1,1,1,1,1249.6223436551306,1424218.0900670097,2009-03-10,15,43,1,13,125,15,26,3,2,7,10,0,6,1,5,8,1,0,7,10,0,2,71,371,ABO,-0.416,0.14459,-0.36479,0,0.5,0.0,,
ENSG00000140718,126,19,1,0,0,1,1059.622641509434,1470466.6505612188,2007-04-26,17,11,3,4,43,55,0,0,10,1,15,21,49,0,1,2,11,4,27,12,6,0,47,339,FTO,0.075999975,1.2714,1.0589,1,-1.0,-1.0,DNA Damage Reversal,R-HSA-73942
ENSG00000111252,87,17,1,1,1,1,5504.0130519525,756470.9740366563,2009-05-10,15,5,3,9,44,13,5,0,1,18,8,5,18,0,7,0,2,0,1,21,0,0,18,193,SH2B3,-0.35000002,-3.1608,-2.2235,3,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9006934
ENSG00000130203,107,16,1,1,1,1,613.7793103448275,1778690.168860174,2013-04-04,2,10,0,9,82,18,8,0,0,0,8,1,12,0,0,0,73,1,12,37,1,4,76,354,APOE,-0.319,-1.1323,-1.0559,12,0.75,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Receptor Tyrosine Kinases;Chylomicron assembly;Chylomicron remodeling;HDL remodeling;Plasma lipoprotein remodeling;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9006934;R-HSA-8963888;R-HSA-8963901;R-HSA-8964058;R-HSA-8963899;R-HSA-597592
ENSG00000166949,82,16,1,0,1,1,6762.688254947314,1470466.6505612188,2010-09-23,10,2,0,0,19,3,1,1,3,2,76,4,34,0,5,0,2,0,0,23,0,3,18,206,SMAD3,0.627,4.3603,-0.12651,22,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;TGFBR1 KD Mutants in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;RUNX3 regulates CDKN1A transcription;Diseases of signal transduction by growth factor receptors and second messengers;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Loss of Function of SMAD2/3 in Cancer;Loss of Function of TGFBR1 in Cancer;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Post-translational protein modification;FOXO-mediated transcription of cell cycle genes;Transcriptional regulation by RUNX3;Formation of definitive endoderm,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-3656532;R-HSA-3304356;R-HSA-8941855;R-HSA-5663202;R-HSA-2173796;R-HSA-3304349;R-HSA-3656534;R-HSA-2173793;R-HSA-597592;R-HSA-9617828;R-HSA-8878159;R-HSA-9823730
ENSG00000138821,66,15,1,0,1,1,15866.724081734988,1990918.947961699,2014-07-22,1,3,0,0,2,0,3,2,2,0,10,0,33,0,0,0,20,3,5,10,3,6,16,119,SLC39A8,0.398,1.1838,-0.33104,1,0.5,0.0,Zinc transporters,R-HSA-435354
ENSG00000181915,46,15,1,0,1,1,1922.5002600104003,1778690.168860174,2007-04-15,11,1,0,1,7,3,2,0,18,1,10,2,8,0,2,0,6,0,0,35,0,0,8,115,ADO,-0.47599995,-0.74926,-1.9151,1,-1.0,-1.0,,
ENSG00000148737,75,15,1,0,0,1,1375.764534883721,1778690.168860174,2007-04-26,22,5,6,20,19,129,1,0,2,0,0,24,12,0,0,2,10,0,4,5,0,0,25,286,TCF7L2,0.526,1.4156,-2.5135,11,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Regulation of MITF-M-dependent genes involved in cell cycle and proliferation;Formation of the beta-catenin:TCF transactivating complex;Transcriptional regulation by RUNX3;Binding of TCF/LEF:CTNNB1 to target gene promoters;RUNX3 regulates WNT signaling;Formation of definitive endoderm,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-9825892;R-HSA-201722;R-HSA-8878159;R-HSA-4411364;R-HSA-8951430;R-HSA-9823730
ENSG00000134242,71,15,1,0,1,0,937.7148182665424,466632.7979326389,2007-06-06,13,0,0,7,1,30,2,0,7,32,0,14,50,0,8,1,0,0,3,16,1,0,4,189,PTPN22,0.055999994,1.2355,0.0067992,2,0.5,0.0,Immune System;Phosphorylation of CD3 and TCR zeta chains,R-HSA-168256;R-HSA-202427
ENSG00000176920,43,15,1,0,1,1,4235.94939871935,493614.39488360845,2012-11-01,2,13,0,0,4,4,15,0,0,2,3,3,1,0,2,4,2,0,6,15,0,0,9,85,FUT2,-0.71000004,1.0674,0.68097,3,0.5,0.0,,
ENSG00000112715,47,14,0,0,1,1,6375.502972651605,1778690.168860174,2011-02-06,5,3,0,10,13,17,1,0,0,17,0,4,14,0,1,0,2,0,2,23,0,0,10,122,VEGFA,0.39,0.20402,-0.45845,10,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Interleukin-4 and Interleukin-13 signaling;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-6785807;R-HSA-8864260
ENSG00000125347,43,14,1,0,0,1,10351.48329956029,562534.7696387965,2010-11-21,3,3,0,0,3,1,1,0,4,1,50,3,2,0,4,0,0,0,1,22,0,0,3,101,IRF1,0.46899998,3.1942,0.98151,4,0.5,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000132170,20,14,1,0,0,1,13198.590886237946,1424218.0900670097,2012-09-01,0,0,0,2,1,32,1,0,0,1,1,2,2,0,1,1,2,0,1,3,0,0,3,53,PPARG,0.37199998,3.1059,0.20266,8,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-597592
ENSG00000164512,39,14,1,0,0,1,2209.8301559792026,1424218.0900670097,2010-05-09,1,0,0,30,4,40,1,1,2,1,0,4,43,0,7,0,3,0,0,7,0,0,3,147,ANKRD55,0.157,0.86195,1.3064,0,0.5,0.5,,
ENSG00000038532,42,14,1,0,0,1,1505.218309859155,574782.4268116049,2007-06-06,9,1,0,1,0,13,4,0,13,0,50,9,2,0,10,0,0,0,1,5,0,1,11,130,CLEC16A,0.361,0.71805,-2.2748,0,-1.0,-1.0,,
ENSG00000145012,59,14,1,0,0,1,1993.0086797624485,1424218.0900670097,2008-03-02,35,0,0,11,0,19,1,0,6,19,47,3,2,0,5,0,4,0,0,21,0,1,4,178,LPP,0.23500001,-1.1411,-0.89062,0,-1.0,-1.0,,
ENSG00000107249,33,13,1,0,0,1,1270.7887323943662,1990918.947961699,2009-05-10,2,0,2,4,2,37,0,0,0,16,10,0,20,0,1,0,3,0,0,3,0,1,4,105,GLIS3,0.14700001,-4.5377,-3.9016,0,0.5,0.0,,
ENSG00000118971,34,13,1,0,0,1,6148.286988658086,1424218.0900670097,2012-12-23,30,1,2,5,2,53,0,0,0,2,0,3,1,0,0,0,3,0,1,2,0,0,3,108,CCND2,0.615,2.8824,0.49464,4,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000134954,31,13,1,0,0,1,1036.6540600667408,1424218.0900670097,2009-10-18,4,0,0,8,2,25,0,0,11,0,13,17,13,0,3,0,2,0,1,14,0,0,10,123,ETS1,0.607,2.6084,0.35347,1,0.5,-1.0,,
ENSG00000137265,62,13,1,0,1,1,1494.9871332990222,431284.57934287674,2008-08-31,99,0,0,1,0,1,0,0,21,7,4,2,6,0,2,0,0,0,2,11,4,0,3,163,IRF4,0.617,2.9149,-0.17616,5,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-6785807
ENSG00000153814,42,13,1,0,0,1,2201.586503948313,1990918.947961699,2008-03-30,21,0,0,6,1,41,1,0,0,1,18,6,11,0,3,0,2,0,0,5,0,0,9,125,JAZF1,0.56200004,2.5362,0.12797,0,0.5,-1.0,,
ENSG00000120071,33,13,1,0,1,1,3154.6966051857794,1470466.6505612188,2014-05-19,7,5,0,2,5,1,1,0,0,0,3,2,5,0,0,0,3,0,0,8,1,0,6,49,KANSL1,0.675,0.89624,-1.4453,2,-1.0,0.0,Gene expression (Transcription),R-HSA-74160
ENSG00000084734,38,13,1,0,1,1,1335.4481927710845,1424218.0900670097,2010-07-25,3,0,5,3,0,23,7,4,0,0,0,5,40,0,0,0,1,1,9,25,0,0,12,138,GCKR,-0.13800001,0.16673,0.27523,2,1.0,0.5,Disease,R-HSA-1643685
ENSG00000112182,46,13,1,0,1,1,8063.55842573413,574782.4268116049,2008-11-02,31,1,0,0,0,9,1,0,7,23,51,3,2,0,6,0,0,0,0,11,0,1,6,152,BACH2,0.83599997,3.446,0.37633,0,0.75,0.0,,
ENSG00000149294,35,13,1,1,0,1,1173.5007132667617,1778690.168860174,2021-01-21,4,3,0,0,1,2,3,0,1,0,0,1,2,0,0,0,18,1,0,3,0,6,7,52,NCAM1,0.783,3.9385,1.1296,6,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738
ENSG00000091831,59,12,1,0,0,1,606.6666666666666,1424218.0900670097,2012-09-13,35,2,0,0,3,1,0,15,0,0,2,0,11,0,0,0,10,0,0,5,5,2,14,105,ESR1,0.544,2.4607,0.21561,15,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;RUNX1 regulates estrogen receptor mediated transcription;Post-translational protein modification;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202;R-HSA-8931987;R-HSA-597592;R-HSA-8864260
ENSG00000108175,43,12,1,0,0,1,6080.768276597768,1424218.0900670097,2009-11-15,46,0,0,2,3,30,2,0,3,1,0,3,2,0,2,0,4,0,0,31,0,0,0,129,ZMIZ1,0.78,4.147,0.083924,0,-1.0,-1.0,,
ENSG00000171522,38,12,1,0,0,1,1376.5857627118644,473900.221403792,2007-03-05,19,2,0,0,0,2,6,0,2,1,3,1,3,0,7,0,0,0,0,50,0,0,3,99,PTGER4,0.454,2.5528,0.42473,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000173175,14,12,1,0,0,1,1173.5007132667617,1424218.0900670097,2017-09-04,0,1,1,2,1,31,1,0,0,0,3,0,0,0,1,0,2,0,1,1,0,0,1,46,ADCY5,0.674,4.4785,0.23109,16,0.5,0.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000186868,27,12,1,0,1,1,1064.6275499474239,756470.9740366563,2010-11-02,4,4,0,1,11,0,0,0,2,0,1,0,2,0,0,0,4,0,0,7,1,2,3,42,MAPT,0.277,2.4904,0.20612,3,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000187323,50,12,1,0,0,1,4294.233261840138,1778690.168860174,2018-08-13,0,1,0,4,1,1,1,0,0,0,2,0,8,0,0,0,30,0,2,6,0,7,5,68,DCC,0.58599997,0.97556,-0.67217,7,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000293584,24,12,0,0,0,1,5212.488325165754,1424218.0900670097,2013-12-01,4,2,0,2,0,6,2,0,1,0,6,1,3,0,1,0,0,0,0,2,0,0,4,34,ENSG00000293584,,,,0,,,,
ENSG00000078403,41,12,1,0,0,1,6067.527905738457,1778690.168860174,2015-01-12,15,0,0,1,5,0,5,3,0,0,7,0,7,0,0,0,4,0,3,3,0,2,13,68,MLLT10,0.709,1.8885,-0.70851,0,0.5,-1.0,,
ENSG00000113302,25,12,0,1,0,1,1173.5007132667617,433862.5685735124,2008-06-29,3,2,0,0,0,4,2,0,20,1,0,3,10,0,2,0,1,0,0,96,0,0,2,146,IL12B,0.0009999871,1.2491,0.85791,4,0.5,1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000115267,24,12,1,0,1,1,1429.811906816221,381165.6245253304,2007-06-06,2,2,0,0,1,6,0,0,4,9,1,0,1,0,1,0,1,0,1,23,0,0,0,52,IFIH1,-0.40600002,-0.4273,-0.49606,12,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000134460,47,12,1,1,0,1,2209.8301559792026,574782.4268116049,2010-04-21,4,2,0,0,0,14,4,0,26,21,25,2,15,0,10,0,0,0,0,18,0,0,10,151,IL2RA,0.09399998,0.90473,-0.21338,4,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147;R-HSA-8877330
ENSG00000142599,19,12,1,0,0,1,15866.724081734988,1122672.658801146,2015-07-21,0,2,0,2,0,0,0,0,2,1,16,1,1,0,3,0,16,0,0,0,1,1,2,48,RERE,0.541,0.18278,-3.4833,0,-1.0,-1.0,,
ENSG00000196821,18,12,1,0,0,1,11252.882952659449,756470.9740366563,2017-12-06,1,0,0,0,2,2,0,0,0,3,0,1,1,0,1,0,2,0,0,2,1,3,4,23,ILRUN,0.81200004,3.3156,0.99091,0,0.5,-1.0,,
ENSG00000073605,36,12,1,0,1,1,1796.3636363636363,562534.7696387965,2007-07-26,9,5,0,0,3,4,0,0,0,1,64,2,4,0,4,0,0,0,0,11,0,1,5,113,GSDMB,-0.029999971,0.79983,0.93846,0,0.5,0.0,,
ENSG00000096395,19,12,0,0,0,1,3170.6458170445662,727796.3668420183,2011-09-08,2,1,0,5,1,2,1,0,0,2,0,0,8,0,0,0,1,0,0,8,0,4,1,36,MLN,-0.63,-0.14513,-1.1461,2,1.0,1.0,Signal Transduction,R-HSA-162582
ENSG00000096433,22,12,1,0,0,1,5020.480367868098,1778690.168860174,2018-08-13,0,7,0,0,1,6,0,0,1,1,3,1,8,0,1,0,1,0,0,4,0,0,3,37,ITPR3,0.32999998,5.2792,2.5235,15,-1.0,0.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000100344,45,12,0,0,1,1,1104.4585218702866,1424218.0900670097,2012-06-14,24,0,0,3,6,5,48,3,0,0,0,0,16,0,0,4,3,0,2,6,0,0,21,141,PNPLA3,-0.23899996,-0.25152,-0.61782,1,1.0,0.5,Acyl chain remodeling of DAG and TAG,R-HSA-1482883
ENSG00000105397,27,12,1,0,1,1,4577.112081236758,756470.9740366563,2009-12-06,3,23,0,0,1,10,2,0,6,6,4,10,30,0,5,0,0,0,0,34,0,0,0,134,TYK2,0.374,2.042,0.1738,20,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;MAPK1 (ERK2) activation;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-112411;R-HSA-6785807
ENSG00000114861,51,12,1,0,0,1,2395.7541411865996,1778690.168860174,2016-01-29,47,0,0,0,2,2,6,2,7,0,3,0,1,0,2,0,10,0,0,7,0,0,10,99,FOXP1,0.72099996,2.6573,-1.3166,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000115970,30,12,1,0,1,1,1225.1182294700059,645988.1975077938,2008-03-30,30,0,1,2,7,15,0,1,0,2,1,2,0,0,0,1,0,0,0,13,0,0,4,79,THADA,-0.17799997,-4.3399,-2.8973,1,-1.0,-1.0,,
ENSG00000120088,25,12,0,0,0,1,579.6775973030954,575147.0632428399,2009-11-15,4,5,0,1,6,1,0,0,0,2,0,2,0,0,0,0,2,0,2,5,1,0,1,32,CRHR1,0.34500003,2.9324,1.1763,2,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000125398,30,12,1,0,0,1,3110.913138146162,1424218.0900670097,2018-02-08,6,0,0,0,1,1,2,0,2,5,0,6,8,1,1,0,0,0,0,1,0,0,18,52,SOX9,0.846,1.6558,-1.417,7,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000149948,28,12,0,0,0,1,5148.813701236917,1470466.6505612188,2010-06-27,2,0,0,5,3,35,0,0,1,11,1,4,6,0,0,0,2,0,0,4,0,0,4,78,HMGA2,-0.68799996,-0.17393,-1.4073,1,0.5,0.5,,
ENSG00000153094,37,12,1,0,0,1,1978.0625865411243,1424218.0900670097,2013-12-01,22,3,0,0,1,10,2,0,1,0,20,1,4,1,0,0,0,0,0,3,0,0,4,72,BCL2L11,-0.23000002,-0.85136,-0.85946,8,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-8878159
ENSG00000182095,46,12,1,0,1,1,3434.615477124845,381165.6245253304,2021-11-04,0,1,0,2,0,2,3,0,5,6,1,0,8,0,3,0,0,0,0,26,0,1,8,66,TNRC18,0.444,-7.5215,-10.583,0,-1.0,-1.0,,
ENSG00000182185,32,12,0,0,0,1,2209.8301559792026,562534.7696387965,2011-03-13,9,3,0,5,2,0,0,0,1,5,25,2,6,0,3,0,0,0,0,7,0,0,3,71,RAD51B,-0.24699998,0.73464,-0.097242,10,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000197249,36,12,1,1,1,1,3114.677466385874,782476.8109259979,2012-07-19,6,0,1,0,9,0,8,0,0,0,13,0,5,0,2,0,1,0,2,16,0,1,12,76,SERPINA1,-0.13399994,-0.16272,0.0067797,6,1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000198734,45,12,1,0,1,1,3497.8652617778025,672632.4785173276,2013-05-05,5,0,0,1,55,0,0,2,2,0,1,0,1,0,2,8,0,0,0,1,0,4,41,123,F5,0.296,2.7865,1.015,6,0.75,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000204842,44,12,1,0,0,1,1455.4894671623297,804063.9714459113,2012-05-06,3,0,0,4,30,4,2,0,1,5,3,0,13,0,3,0,0,0,0,4,0,0,13,85,ATXN2,0.681,2.5897,0.24417,0,-1.0,-1.0,,
ENSG00000065060,19,11,1,0,1,1,3902.1881946159547,1778690.168860174,2012-12-27,2,0,0,0,2,0,0,0,0,2,1,8,3,0,0,0,1,0,1,2,0,1,3,26,BLTP3A,0.32099998,2.5595,2.0442,0,-1.0,-1.0,,
ENSG00000070366,42,11,1,0,1,1,4074.958527607362,1470466.6505612188,2012-09-09,3,1,0,6,33,0,2,0,0,0,1,0,18,0,0,0,8,0,0,1,2,0,17,92,SMG6,0.445,0.70311,-1.0055,1,-1.0,-1.0,,
ENSG00000173531,27,11,1,1,1,1,2303.867283111232,1470466.6505612188,2008-06-29,8,0,0,0,3,0,5,0,2,0,1,0,3,0,1,0,4,0,0,20,0,1,1,49,MST1,0.049000025,1.5116,0.77803,1,1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000275342,15,11,1,0,0,1,12511.068286850166,444537.33605315426,2017-07-17,1,1,0,0,2,1,0,0,0,11,2,3,0,0,1,0,1,0,0,3,0,0,1,27,PRAG1,-0.29499996,-5.2929,-3.8829,1,0.5,0.0,,
ENSG00000053918,18,11,0,0,1,1,665.2820816085157,1424218.0900670097,2008-08-17,7,0,1,9,2,92,0,0,0,0,1,4,1,0,0,0,4,0,1,0,0,0,1,123,KCNQ1,0.08499998,0.91213,-2.1794,3,0.5,0.0,,
ENSG00000079308,26,11,1,0,1,1,1562.6148003222465,1424218.0900670097,2017-02-14,20,0,0,3,11,2,4,1,0,6,4,0,0,0,1,0,0,0,0,3,0,0,1,56,TNS1,0.554,0.97811,0.23568,0,-1.0,-1.0,,
ENSG00000130940,30,11,1,0,1,1,959.7167584579072,756470.9740366563,2018-03-12,2,0,0,1,36,0,1,0,0,2,1,0,1,0,2,0,0,0,4,7,0,0,26,83,CASZ1,0.71500003,2.0333,0.00059885,0,0.5,0.0,,
ENSG00000134824,44,11,1,0,0,1,21479.205904930615,633132.2332759313,2017-01-24,9,0,0,0,4,4,2,0,1,1,15,0,2,0,0,0,7,0,0,9,0,0,4,58,FADS2,0.58500004,4.1372,1.0803,2,0.5,-1.0,,
ENSG00000145996,31,11,1,0,0,1,690.0730593607306,1424218.0900670097,2007-04-26,16,0,6,2,2,77,0,0,0,0,0,2,0,0,1,0,4,0,1,19,0,0,3,133,CDKAL1,0.357,0.92839,0.17079,1,-1.0,-1.0,,
ENSG00000150347,25,11,1,0,0,1,1101.254193548387,1424218.0900670097,2009-08-16,10,0,0,2,2,7,0,0,0,13,0,5,19,0,2,0,4,0,0,1,0,0,5,70,ARID5B,0.78900003,3.0454,1.0651,1,0.5,-1.0,,
ENSG00000158321,21,11,1,0,0,1,10835.003904419804,1424218.0900670097,2012-05-31,0,0,0,2,4,21,0,1,0,0,2,1,2,0,0,0,5,0,2,4,0,0,5,49,AUTS2,0.768,1.8752,-0.95394,1,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000164362,84,11,1,0,1,1,1168.9991445680068,782476.8109259979,2009-07-05,243,0,0,0,4,0,1,0,5,7,7,2,2,0,2,0,0,0,0,13,0,0,10,296,TERT,0.407,3.0616,-2.5415,3,,,Signal Transduction;Developmental Biology;Formation of the beta-catenin:TCF transactivating complex,R-HSA-162582;R-HSA-1266738;R-HSA-201722
ENSG00000197728,26,11,1,0,0,1,1455.4894671623297,562534.7696387965,2011-07-31,1,0,0,0,0,7,0,0,3,6,18,1,2,0,2,0,1,0,0,2,0,0,2,45,RPS26,0.68,2.7399,-0.36271,18,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000240505,17,11,0,1,1,1,6528.193096288606,382631.1172224132,2013-08-18,8,2,0,0,0,0,2,0,0,0,3,1,0,3,2,1,0,0,2,3,0,0,3,30,TNFRSF13B,-0.794,-0.31749,-0.72048,1,0.75,0.5,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000069667,34,11,1,0,0,1,455.18696069031637,633132.2332759313,2014-07-22,1,0,0,1,2,1,1,0,0,0,40,0,0,0,1,0,12,0,0,10,0,1,6,76,RORA,0.793,2.3246,-0.75151,10,0.5,-1.0,Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147;R-HSA-597592;R-HSA-6785807
ENSG00000110367,20,11,1,0,0,1,2696.97232079489,1122672.658801146,2011-02-24,4,1,0,2,0,0,0,0,2,0,2,1,3,0,1,0,1,0,0,2,0,0,2,21,DDX6,0.872,4.2783,0.32529,1,-1.0,-1.0,,
ENSG00000111275,23,11,1,0,1,1,608.526600541028,1424218.0900670097,2009-08-18,7,0,0,0,9,1,0,0,0,0,2,0,9,0,1,0,2,1,1,1,0,0,5,39,ALDH2,0.010999978,1.6597,-0.37307,4,0.5,-1.0,,
ENSG00000119866,28,11,1,0,0,1,17601.10520641419,1778690.168860174,2010-06-27,12,5,0,3,1,25,0,0,0,0,0,1,1,0,0,0,11,0,0,6,0,4,7,76,BCL11A,0.875,3.6173,0.3729,4,0.5,0.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000123384,28,11,1,0,0,1,1458.170321264661,464892.4593283075,2011-06-12,2,0,0,1,40,0,0,0,2,0,1,0,1,0,1,0,1,0,0,2,0,1,7,59,LRP1,0.88199997,12.037,3.5169,2,0.5,-1.0,,
ENSG00000138378,33,11,1,0,1,1,509.27868852459017,381165.6245253304,2008-01-20,7,2,0,5,2,1,0,0,0,18,0,37,33,0,4,0,0,0,0,21,0,0,3,133,STAT4,0.49699998,3.2053,0.59407,6,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000139531,23,11,1,1,0,1,2209.8301559792026,360837.067725683,2007-06-07,6,1,0,2,0,5,0,0,2,1,16,0,5,0,3,0,0,0,0,4,0,0,2,47,SUOX,-0.12800002,1.2698,2.059,1,-1.0,-1.0,,
ENSG00000162594,32,11,1,1,1,1,1233.0624505928854,381165.6245253304,2007-03-05,1,0,0,2,0,3,10,0,8,1,0,1,14,0,4,0,0,0,0,104,0,0,2,150,IL23R,0.26099998,1.5917,1.0305,2,0.5,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000166603,24,11,0,0,1,1,2795.536480686695,1424218.0900670097,2009-01-18,0,2,0,1,6,27,3,0,2,0,0,0,9,0,0,0,1,0,19,1,0,0,6,77,MC4R,-0.34099996,0.31113,-0.04436,3,0.75,0.5,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000168769,34,11,1,0,1,1,3747.57310565635,1778690.168860174,2009-09-20,42,0,0,0,1,3,2,0,1,0,11,0,5,0,1,0,5,0,0,3,0,0,4,78,TET2,-0.997,0.33568,1.3445,2,0.5,0.0,Developmental Biology;Gene expression (Transcription),R-HSA-1266738;R-HSA-74160
ENSG00000169047,19,11,1,0,0,1,4829.761896437188,804063.9714459113,2012-09-01,1,0,0,2,5,21,1,0,0,0,0,3,1,0,0,0,2,0,1,2,0,0,4,43,IRS1,0.32599998,1.1712,0.23413,18,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;HCMV Late Events;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-9610379;R-HSA-9006934;R-HSA-5663202
ENSG00000169519,26,11,1,0,0,1,51306.385885072414,1076472.0138856068,2018-11-26,0,0,0,1,3,0,1,1,0,0,1,0,2,0,0,0,12,0,2,1,0,1,6,31,METTL15,-0.21399999,0.81886,0.079822,0,-1.0,-1.0,,
ENSG00000182568,26,11,1,0,0,1,9770.187636657778,1778690.168860174,2010-11-21,2,0,0,0,2,2,0,0,6,1,2,1,0,0,2,0,11,0,0,6,0,0,4,39,SATB1,0.791,4.7431,0.56286,2,0.75,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000185650,28,11,1,0,0,1,7933.736701823757,562534.7696387965,2009-05-10,25,0,0,3,3,5,0,0,1,1,7,0,3,0,2,0,0,0,0,9,0,0,6,65,ZFP36L1,0.464,2.5976,-0.82291,1,-1.0,-1.0,,
ENSG00000186047,27,11,1,0,0,1,16208.587263816955,1470466.6505612188,2018-11-08,20,0,0,2,2,15,0,0,0,1,2,0,6,0,1,0,0,0,0,4,0,2,13,68,DLEU7,-0.90199995,-1.5756,-0.93928,0,1.0,1.0,,
ENSG00000205189,27,11,1,0,0,1,1702.4,1424218.0900670097,2013-12-30,13,0,0,1,1,1,0,0,11,0,38,0,0,0,4,0,1,0,0,1,0,1,6,78,ZBTB10,0.374,-0.13009,-3.0025,0,-1.0,-1.0,,
ENSG00000215817,37,11,1,0,0,1,2354.946760250557,1470466.6505612188,2018-07-27,0,0,0,8,4,11,9,0,0,0,3,0,31,0,1,0,1,0,2,4,0,0,40,114,ZC3H11B,0.25300002,2.0605,1.5444,0,1.0,1.0,,
ENSG00000075884,28,10,1,0,0,1,4917.108320036471,1778690.168860174,2017-06-06,0,0,0,0,4,0,22,0,0,0,2,2,1,0,0,0,3,3,0,2,0,1,9,49,ARHGAP15,-0.13399994,0.2856,0.27912,2,0.75,-1.0,Signal Transduction,R-HSA-162582
ENSG00000089225,32,10,0,0,0,1,525.0788381742739,672632.4785173276,2013-04-01,13,0,0,0,42,0,4,6,0,0,1,0,2,0,0,0,2,0,0,6,0,2,9,87,TBX5,0.73300004,1.6232,-0.64064,3,0.5,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000128604,32,10,1,0,0,1,1224.8497854077252,384314.83364002535,2008-01-20,16,3,0,6,0,0,2,0,2,0,0,27,27,0,3,0,0,0,0,24,0,0,4,114,IRF5,0.464,2.4893,0.34224,3,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000136573,20,10,1,0,0,1,1316.6666666666667,466632.7979326389,2008-01-20,3,1,0,1,0,0,4,0,0,1,0,23,16,0,0,0,1,0,0,11,0,0,3,64,BLK,-0.29499996,-2.5547,-2.3353,2,0.75,0.5,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000137507,36,10,1,0,0,1,1913.3228840125391,562534.7696387965,2008-06-29,6,1,0,2,0,0,2,0,23,0,72,0,0,0,8,0,0,0,0,26,0,1,13,154,LRRC32,0.297,1.0292,0.86657,0,-1.0,-1.0,,
ENSG00000163638,15,10,1,0,0,1,10023.250789889415,1424218.0900670097,2008-03-30,5,1,0,1,0,11,0,0,0,0,2,1,2,0,0,0,0,0,1,4,0,0,1,29,ADAMTS9,0.531,1.5284,-1.1882,3,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000171105,19,10,1,0,0,1,4575.628131795794,1424218.0900670097,2012-08-12,1,0,0,0,9,10,1,0,0,26,0,0,7,0,0,0,0,0,1,6,1,0,2,64,INSR,0.444,5.4734,0.4161,6,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000181634,19,10,1,0,0,1,985.590015128593,258213.8601133611,2008-06-29,3,3,0,0,0,1,0,0,0,2,1,4,1,0,1,0,0,0,0,39,0,0,2,57,TNFSF15,0.014999986,0.31414,-0.12838,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000077092,17,10,0,0,0,1,13045.478778177418,1778690.168860174,2019-02-25,2,0,1,14,0,3,2,0,0,0,5,0,0,0,0,0,3,0,7,1,0,0,5,43,RARB,0.523,3.1336,-0.40864,3,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000079691,20,10,0,0,0,1,2568.3760200548704,574782.4268116049,2011-11-06,0,0,0,6,1,2,2,0,0,0,0,1,2,0,0,0,1,0,3,4,0,0,8,30,CARMIL1,0.394,2.0427,0.40592,1,-1.0,0.0,,
ENSG00000118503,21,10,1,0,1,1,1195.9378109452737,562534.7696387965,2007-11-04,0,1,0,1,0,3,0,0,4,0,9,26,21,0,3,0,0,0,0,24,0,0,4,96,TNFAIP3,0.791,2.6717,1.5073,6,0.5,-1.0,Signal Transduction;Immune System;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-597592
ENSG00000135272,19,10,1,0,1,1,40486.1226680631,1990918.947961699,2021-06-29,0,1,0,0,3,0,0,0,0,0,3,0,7,0,1,0,7,1,0,1,0,1,5,30,MDFIC,-0.50100005,-0.70486,0.069987,0,-1.0,-1.0,,
ENSG00000142700,18,10,0,0,1,1,19827.24327071012,437137.9986908925,2017-06-09,5,0,0,0,4,5,0,0,0,1,0,0,2,0,0,0,0,0,1,1,1,1,3,24,DMRTA2,-0.23599994,-2.213,-4.7169,0,0.5,0.5,,
ENSG00000149485,26,10,1,0,0,1,2651.987951807229,562534.7696387965,2014-09-07,6,1,0,0,5,0,0,0,1,1,6,0,1,0,0,0,0,0,0,4,0,1,5,31,FADS1,0.572,3.4415,0.23049,3,-1.0,-1.0,,
ENSG00000164093,41,10,0,0,0,1,1959.2518901711103,756470.9740366563,2007-07-01,1,0,0,12,216,0,4,0,0,0,4,0,0,0,0,10,2,0,0,34,2,0,29,314,PITX2,0.59000003,2.2361,0.78279,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8864260
ENSG00000169194,25,10,1,0,1,1,2758.3907212758245,562534.7696387965,2009-01-25,2,1,0,0,0,2,0,0,22,0,33,0,1,0,2,0,0,0,0,14,0,1,7,85,IL13,-0.36399996,0.54219,0.46894,2,1.0,1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-18 signaling;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9012546;R-HSA-6785807
ENSG00000173068,37,10,1,0,0,1,2047.7477081041438,1424218.0900670097,2009-08-02,60,0,0,6,3,1,0,0,1,0,2,0,6,0,0,0,2,0,0,1,0,0,14,96,BNC2,0.635,0.84672,-0.95407,0,0.5,0.0,,
ENSG00000175354,23,10,1,0,0,1,2209.8301559792026,574782.4268116049,2007-06-06,1,0,0,0,0,13,1,0,4,7,0,1,15,0,4,0,0,0,0,30,0,0,1,77,PTPN2,0.38200003,1.7163,0.039378,4,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9006934
ENSG00000183765,60,10,1,0,1,1,4074.958527607362,521818.7070055739,2012-09-09,65,0,0,18,0,0,1,5,0,2,1,0,3,0,0,2,0,0,0,5,0,0,9,111,CHEK2,-0.39900005,-0.016674,1.2863,8,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-75035
ENSG00000184937,32,10,1,0,0,1,3053.277947180733,461914.58891516324,2012-02-05,18,1,1,0,6,3,5,15,0,0,0,0,1,0,0,0,0,0,0,2,0,0,40,92,WT1,0.747,1.4207,-1.313,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000185294,24,10,0,0,1,1,564.7745556594948,523652.45223581506,2011-02-01,3,6,0,2,1,0,0,0,0,0,4,4,3,0,0,0,7,0,0,5,0,0,2,37,SPPL2C,-0.12100005,0.30519,0.49912,0,1.0,0.5,,
ENSG00000185811,23,10,1,0,0,1,513.2780765580512,382631.1172224132,2008-06-29,16,0,0,0,0,1,1,0,5,0,4,13,1,0,3,0,0,0,0,18,0,0,3,65,IKZF1,0.68,3.4314,0.39099,1,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000198740,34,10,1,0,0,1,6712.63652527305,521818.7070055739,2013-04-01,10,2,0,3,18,0,0,0,8,0,31,0,2,0,1,0,7,0,0,0,0,0,14,96,ZNF652,0.527,2.3916,0.80824,0,-1.0,0.0,,
ENSG00000008196,30,10,0,0,0,1,7794.273577144567,1470466.6505612188,2018-07-27,0,0,0,8,4,12,0,0,0,0,0,9,9,0,0,0,3,0,7,2,0,2,2,58,TFAP2B,0.647,1.6348,0.19786,5,0.5,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Post-translational protein modification;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-597592;R-HSA-8864260
ENSG00000020633,27,10,1,0,1,1,8994.718522284358,562534.7696387965,2011-07-10,1,0,0,0,3,2,0,0,10,4,12,0,5,0,5,0,0,0,0,23,0,0,6,71,RUNX3,0.302,1.1651,-1.3177,10,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX3 regulates CDKN1A transcription;RUNX3 Regulates Immune Response and Cell Migration;Formation of the beta-catenin:TCF transactivating complex;Transcriptional regulation by RUNX3;Binding of TCF/LEF:CTNNB1 to target gene promoters;RUNX3 regulates WNT signaling,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8941855;R-HSA-8949275;R-HSA-201722;R-HSA-8878159;R-HSA-4411364;R-HSA-8951430
ENSG00000073792,15,10,1,0,0,1,690.0730593607306,1424218.0900670097,2007-04-26,3,0,1,6,1,63,0,0,0,3,0,4,0,0,0,0,4,0,1,2,0,0,0,88,IGF2BP2,0.675,3.0213,0.16825,1,-1.0,0.0,,
ENSG00000077498,43,10,1,0,1,1,3640.455608057697,1778690.168860174,2009-07-05,70,0,0,5,0,1,0,1,15,0,0,0,2,0,0,0,12,0,0,6,6,0,5,123,TYR,-0.34599996,-0.8461,-0.75169,2,1.0,1.0,Developmental Biology,R-HSA-1266738
ENSG00000081237,22,10,1,0,1,1,14698.010216795416,562534.7696387965,2016-07-11,1,0,0,0,0,0,0,0,1,6,16,3,6,0,3,0,0,0,0,4,0,1,1,42,PTPRC,0.657,1.9632,0.77258,3,0.5,-1.0,Immune System;Developmental Biology;Phosphorylation of CD3 and TCR zeta chains,R-HSA-168256;R-HSA-1266738;R-HSA-202427
ENSG00000085276,24,10,0,0,0,1,1752.5653533458412,756470.9740366563,2010-05-30,9,1,2,10,19,0,6,0,0,0,14,0,2,0,0,0,0,0,0,3,0,0,1,67,MECOM,0.839,2.4195,0.80606,3,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000102837,26,10,0,1,0,1,103081.39001430024,1778690.168860174,2016-08-01,0,1,0,0,0,5,3,0,0,0,3,1,0,0,0,0,21,0,1,1,0,2,4,42,OLFM4,-0.16299999,0.80618,-0.15278,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000104447,28,10,1,0,0,1,11608.613380386345,1424218.0900670097,2018-05-08,16,0,0,3,1,11,3,0,6,0,0,0,1,0,0,0,3,0,0,3,0,0,3,50,TRPS1,0.886,2.597,0.92413,0,1.0,-1.0,,
ENSG00000107485,34,10,1,0,0,1,725.727950310559,562534.7696387965,2013-08-30,19,0,0,0,0,1,0,1,6,2,43,0,7,0,7,0,0,0,0,4,0,0,3,93,GATA3,0.624,1.3283,-1.7684,6,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Signaling by Interleukins;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-449147;R-HSA-597592;R-HSA-6785807
ENSG00000117560,17,10,0,0,0,1,17257.066666666666,360837.067725683,2011-11-06,0,0,0,3,1,2,0,0,8,0,8,1,1,0,2,0,0,0,0,4,0,0,1,31,FASLG,0.394,1.1044,0.58368,10,0.5,0.5,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-6785807
ENSG00000117586,16,10,1,0,0,1,2240.9147424511543,360837.067725683,2009-10-18,0,1,0,1,0,0,0,0,4,0,11,16,4,0,1,0,1,0,0,2,0,0,6,47,TNFSF4,0.00999999,1.1459,0.92483,1,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000119408,23,10,1,0,0,1,25245.96296044253,562534.7696387965,2019-07-30,2,1,0,0,0,0,2,0,0,5,16,0,1,0,1,0,1,0,0,3,0,0,2,34,NEK6,0.032000005,1.9239,-0.10481,3,0.5,-1.0,,
ENSG00000124562,17,10,1,0,0,1,5020.480367868098,1129585.974638378,2018-08-13,2,0,0,0,4,0,0,0,0,1,0,2,6,0,0,0,4,0,2,4,0,1,5,31,SNRPC,0.096000016,1.8882,0.05946,1,-1.0,-1.0,,
ENSG00000124782,29,10,1,0,1,1,1898.2549302549303,1470466.6505612188,2018-08-09,4,0,0,2,2,28,0,0,0,0,3,0,27,0,1,0,1,0,0,2,0,0,11,81,RREB1,0.634,-1.9338,-4.7151,0,-1.0,-1.0,,
ENSG00000125798,17,10,1,0,0,1,2344.979769824783,1424218.0900670097,2016-05-16,1,0,2,0,1,3,0,0,0,19,0,0,1,0,1,0,0,0,1,4,0,0,2,35,FOXA2,0.482,-0.91998,-1.5673,6,0.5,0.5,Developmental Biology;Formation of definitive endoderm,R-HSA-1266738;R-HSA-9823730
ENSG00000128573,34,10,1,0,0,1,40569.14132202889,1990918.947961699,2018-08-13,0,0,0,1,2,0,3,0,0,0,1,0,17,0,0,0,20,2,0,1,0,13,5,65,FOXP2,0.843,3.1178,-0.51476,0,0.5,0.0,,
ENSG00000133103,19,10,1,0,1,1,2209.8301559792026,562534.7696387965,2013-12-25,21,1,0,0,2,0,0,0,0,0,10,1,15,0,3,0,2,0,0,2,0,0,5,62,COG6,-0.05700004,0.20587,-0.58911,3,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000138795,15,10,1,0,0,1,4767.159193524651,427337.4491868293,2013-06-16,1,0,0,0,6,0,0,0,1,1,1,1,2,0,1,0,0,0,1,2,0,0,0,17,LEF1,0.541,2.1888,0.4635,16,1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Regulation of MITF-M-dependent genes involved in cell cycle and proliferation;Formation of the beta-catenin:TCF transactivating complex;Transcriptional regulation by RUNX3;Binding of TCF/LEF:CTNNB1 to target gene promoters;RUNX3 regulates WNT signaling,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9825892;R-HSA-201722;R-HSA-8878159;R-HSA-4411364;R-HSA-8951430
ENSG00000140836,33,10,1,0,1,1,2274.83989021043,1424218.0900670097,2009-07-13,4,0,0,0,65,6,4,0,0,0,2,1,0,0,0,0,5,0,2,3,0,0,4,96,ZFHX3,0.811,-0.17206,-3.0289,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX3 regulates CDKN1A transcription;Transcriptional regulation by RUNX3,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8941855;R-HSA-8878159
ENSG00000150637,13,10,1,1,1,1,4800.0,574782.4268116049,2007-06-06,2,0,0,0,0,6,1,0,0,4,1,2,2,0,1,0,0,0,0,3,0,0,1,23,CD226,-0.011999965,0.67634,0.34746,1,0.75,0.0,Immune System,R-HSA-168256
ENSG00000151353,23,10,0,0,0,1,4713.845260560313,1470466.6505612188,2012-04-08,1,1,0,0,5,16,0,0,3,0,1,0,13,0,0,0,1,0,13,0,0,0,4,58,TMEM18,-0.19799995,-0.33723,-1.1294,0,-1.0,-1.0,,
ENSG00000152804,22,10,1,0,0,1,2334.9276231263384,1424218.0900670097,2007-04-26,0,0,1,2,2,48,0,0,0,0,11,2,0,0,2,0,2,0,0,2,0,0,3,75,HHEX,0.347,0.096694,-0.94914,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000154822,18,10,1,0,0,1,2209.8301559792026,1076472.0138856068,2013-12-25,2,0,0,0,1,1,5,0,0,0,2,0,6,0,0,0,5,1,0,10,0,0,1,34,PLCL2,0.909,5.1126,1.1303,0,0.5,0.0,,
ENSG00000164180,25,10,1,0,0,1,1493.7220461747397,1778690.168860174,2016-08-01,0,1,0,8,4,2,2,0,0,0,0,0,0,0,0,0,20,1,3,2,0,0,2,45,TMEM161B,0.20999998,1.8001,1.1806,0,-1.0,-1.0,,
ENSG00000170927,12,10,1,0,1,1,7794.273577144567,1424218.0900670097,2018-06-11,2,0,0,30,3,2,0,0,0,0,0,1,1,0,0,0,2,0,1,2,0,0,1,45,PKHD1,0.21700001,1.7677,1.8406,0,0.75,0.5,,
ENSG00000172575,24,10,1,0,0,1,2209.8301559792026,1778690.168860174,2012-09-06,1,0,0,0,4,21,0,0,0,11,0,5,14,0,3,0,9,0,0,7,0,0,1,76,RASGRP1,0.462,3.0281,0.797,6,0.5,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000173334,39,10,0,0,0,1,576.1087314662274,782476.8109259979,2008-06-29,7,0,0,0,28,1,14,0,6,0,0,0,1,0,1,0,0,0,7,28,0,0,28,121,TRIB1,0.15499997,-0.28706,-1.4925,1,0.5,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000175806,18,10,1,0,0,1,18146.19789076567,765591.3646788632,2016-08-12,2,0,0,0,2,3,3,0,0,1,0,1,1,0,0,0,7,0,0,2,0,0,3,25,MSRA,-0.97599995,-4.2767,-2.6877,1,0.5,0.0,,
ENSG00000177468,18,10,0,0,0,1,5020.480367868098,448058.917711015,2008-09-14,1,1,0,0,1,0,1,1,0,0,2,0,16,0,2,0,0,0,0,21,0,0,1,47,OLIG3,-0.398,-0.79948,-1.2445,0,,,,
ENSG00000178568,19,10,1,1,0,1,1917.911348018195,1778690.168860174,2015-09-29,6,0,0,1,6,9,0,1,0,0,1,1,2,0,0,0,4,0,0,7,0,0,0,38,ERBB4,0.643,2.8306,0.13765,20,0.5,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000196616,29,10,0,1,1,1,608.526600541028,1424218.0900670097,2009-08-18,11,0,0,0,1,1,5,0,0,0,0,0,11,0,0,0,7,11,3,0,1,0,13,64,ADH1B,-0.013000011,0.80857,0.18902,1,0.5,0.0,,
ENSG00000196628,45,10,0,0,0,1,1961.9637827131714,1778690.168860174,2009-07-01,2,0,0,23,0,9,1,0,0,0,0,1,4,0,0,0,29,0,0,13,0,2,9,93,TCF4,0.904,4.5772,1.4795,3,-1.0,-1.0,Signal Transduction;Developmental Biology;Formation of the beta-catenin:TCF transactivating complex,R-HSA-162582;R-HSA-1266738;R-HSA-201722
ENSG00000203760,18,10,1,0,0,1,7543.35234676665,1424218.0900670097,2009-05-10,3,1,0,3,4,24,0,0,0,0,0,0,0,0,0,0,1,2,2,1,0,0,1,42,CENPW,0.45,0.010407,0.21892,1,0.5,-1.0,,
ENSG00000089169,14,9,1,0,0,1,5934.5695905238435,280228.4034560385,2015-04-01,4,0,0,0,5,3,0,0,0,2,1,0,3,0,0,0,1,0,0,1,0,0,2,22,RPH3A,0.361,1.6481,0.61954,0,1.0,0.0,,
ENSG00000100393,20,9,1,0,1,1,15866.724081734988,1778690.168860174,2014-07-22,0,0,0,0,2,1,2,0,0,0,1,0,2,0,0,0,23,0,2,1,0,0,1,35,EP300,0.83599997,2.6711,-3.7529,59,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Zygotic genome activation (ZGA);Diseases of signal transduction by growth factor receptors and second messengers;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Formation of the beta-catenin:TCF transactivating complex;Post-translational protein modification;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-9819196;R-HSA-5663202;R-HSA-2173796;R-HSA-2173793;R-HSA-201722;R-HSA-597592;R-HSA-8864260;R-HSA-8878159
ENSG00000111540,15,9,1,0,0,1,2233.925729442971,405722.3511294316,2019-03-28,2,0,0,1,0,1,0,0,1,2,9,0,1,0,1,0,0,0,0,2,0,0,0,20,RAB5B,0.467,2.3823,0.67914,6,-1.0,-1.0,Immune System;Disease;TBC/RABGAPs;Rab regulation of trafficking;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-8854214;R-HSA-9007101;R-HSA-597592
ENSG00000114054,17,9,1,0,0,1,55416.28042655659,1470466.6505612188,2017-12-06,1,0,0,0,13,2,0,0,0,0,0,0,4,0,0,0,4,0,2,1,0,1,2,30,PCCB,0.157,-0.96306,-0.68668,4,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000135100,24,9,0,0,1,1,4991.807042932947,1424218.0900670097,2017-07-17,0,2,0,1,16,24,6,0,0,0,0,0,0,0,0,0,1,0,3,11,0,0,7,71,HNF1A,0.523,2.0902,0.14206,1,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000140968,27,9,1,0,0,1,1017.6823425022183,381165.6245253304,2009-06-14,11,1,0,0,0,0,7,0,0,1,0,16,10,0,3,0,0,0,0,29,0,0,4,82,IRF8,0.538,1.3131,-1.8765,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000141376,24,9,0,0,0,1,2989.6745085401226,1470466.6505612188,2015-05-13,2,0,0,8,4,0,0,0,0,4,0,17,25,0,0,3,0,0,0,4,0,0,5,72,BCAS3,0.42000002,2.837,0.55408,0,-1.0,-1.0,,
ENSG00000152518,19,9,1,0,1,1,19513.669354013397,1424218.0900670097,2015-09-29,8,0,0,3,8,19,1,0,0,0,0,2,0,0,1,1,0,0,0,6,0,0,0,49,ZFP36L2,-0.51199996,-5.3805,-8.2522,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000173281,18,9,0,0,0,1,31935.015289867086,1470466.6505612188,2018-07-27,0,0,0,0,2,4,4,0,0,0,1,1,9,0,0,0,2,0,0,0,1,0,5,29,PPP1R3B,0.09200001,-1.3712,-0.88802,0,0.5,-1.0,,
ENSG00000175161,22,9,1,0,0,1,636.1886490807354,1778690.168860174,2012-10-09,0,1,0,23,1,0,3,0,0,0,1,0,3,0,0,0,7,1,0,0,0,0,7,47,CADM2,0.48400003,2.0293,-1.4218,1,0.75,0.0,,
ENSG00000182511,40,9,1,1,0,1,15866.724081734988,1778690.168860174,2014-07-22,2,0,3,0,42,0,0,0,0,0,0,0,7,0,0,0,22,4,2,4,0,0,18,104,FES,0.038999975,1.1694,-0.85046,4,0.5,-1.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000183579,22,9,1,0,0,1,4852.554753131909,1424218.0900670097,2014-08-03,10,0,0,2,4,3,0,1,0,0,0,0,3,0,1,1,0,0,0,1,0,0,0,26,ZNRF3,0.49699998,0.41822,-2.3339,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000184730,19,9,1,1,1,1,15443.951531069062,381165.6245253304,2010-11-21,1,0,0,0,0,6,0,0,0,5,0,1,1,0,2,0,0,0,1,6,0,0,3,26,APOBR,0.00999999,-1.6767,-1.4987,1,0.75,0.0,,
ENSG00000196782,15,9,1,0,0,1,94665.79117035728,1424218.0900670097,2019-09-16,3,0,0,0,1,6,1,0,0,0,1,0,0,0,0,0,5,0,0,2,0,2,3,24,MAML3,0.673,1.7801,1.6338,11,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-8878159
ENSG00000198821,18,9,1,0,0,1,6360.046069371903,562534.7696387965,2010-04-11,1,0,0,0,0,0,0,0,1,3,24,0,1,0,4,0,0,0,0,3,0,1,5,43,CD247,0.36699998,0.37572,0.71592,12,0.75,0.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000224578,16,9,0,0,0,1,15258.981958714061,427337.4491868293,2018-08-13,7,0,0,10,3,0,0,7,0,3,0,0,3,0,0,0,1,0,0,2,0,0,2,38,HNRNPA1L3,-0.04100001,-0.18198,-0.99219,0,-1.0,0.0,,
ENSG00000263001,13,9,1,0,0,1,829.0581257413997,1424218.0900670097,2013-10-06,0,0,0,2,11,5,0,0,0,0,1,5,2,0,1,0,0,0,0,7,0,0,1,35,GTF2I,0.805,3.8165,1.1258,0,-1.0,-1.0,,
ENSG00000001617,14,9,1,1,1,1,29803.01405728205,1424218.0900670097,2020-01-20,0,0,0,2,0,1,0,0,0,0,1,0,0,0,1,0,3,0,1,1,0,2,2,14,SEMA3F,0.584,2.9824,1.8727,0,0.5,-1.0,,
ENSG00000010310,15,9,1,0,1,1,50011.025410338545,765591.3646788632,2017-09-04,0,0,0,0,1,24,0,0,0,0,2,3,1,0,0,0,2,0,8,2,0,0,1,44,GIPR,-0.638,-1.1764,-0.19129,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000078098,12,9,0,0,0,1,1455.4894671623297,309256.4614031486,2012-05-06,0,0,0,0,1,4,0,0,2,5,1,3,1,0,0,0,0,0,0,8,0,0,1,26,FAP,0.10799998,0.11244,-0.87109,0,0.5,0.0,,
ENSG00000107957,28,9,1,0,0,1,2010.4597478176527,562534.7696387965,2017-04-17,9,0,0,4,42,0,1,0,0,0,2,0,1,0,0,0,0,0,2,4,0,0,15,80,SH3PXD2A,0.624,1.7597,0.91413,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000115738,17,9,0,0,0,1,26841.183331692897,1424218.0900670097,2016-05-16,4,0,0,2,0,1,0,0,3,2,36,0,0,0,4,0,0,0,0,0,0,1,7,60,ID2,0.24199998,0.56729,-2.1146,1,0.5,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000116793,14,9,1,0,0,1,1997.3320313646393,756470.9740366563,2010-05-09,1,2,0,0,2,2,0,0,2,7,0,0,8,0,0,0,0,0,0,2,0,0,1,27,PHTF1,0.007000029,1.0583,0.75206,0,-1.0,-1.0,,
ENSG00000117114,18,9,1,0,0,1,2314.313784461153,1424218.0900670097,2015-08-24,1,0,0,0,2,2,0,0,0,1,0,1,1,0,2,0,0,0,0,5,0,0,1,16,ADGRL2,0.699,2.6759,1.7646,0,-1.0,0.0,,
ENSG00000118557,19,9,1,0,1,1,59800.922943370155,1076472.0138856068,2019-11-01,2,0,0,0,2,0,0,0,0,0,1,0,1,0,0,0,8,0,2,1,0,1,1,19,PMFBP1,-0.029999971,0.32096,-0.31369,0,0.5,0.0,,
ENSG00000125845,29,9,1,0,1,1,9987.340557506195,1990918.947961699,2018-06-11,21,1,0,19,4,0,2,0,0,7,0,0,8,0,0,0,0,0,0,6,0,0,1,69,BMP2,0.787,1.468,-0.50332,4,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000130584,18,9,1,0,0,1,9770.187636657778,1470466.6505612188,2018-08-13,6,0,0,0,4,8,1,0,0,0,3,0,2,0,0,0,0,0,0,5,0,1,1,31,ZBTB46,0.621,2.2602,-0.86552,0,0.5,-1.0,,
ENSG00000134825,24,9,1,0,0,1,6263.050060459492,1424218.0900670097,2010-11-21,6,0,0,0,7,3,1,0,2,0,3,0,0,0,0,0,4,0,0,5,0,0,3,34,TMEM258,-0.696,0.82686,0.068141,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000138688,19,9,1,0,1,1,4126.197669400086,1778690.168860174,2009-05-10,0,0,0,0,0,3,1,0,4,0,11,1,0,0,1,0,9,0,0,8,0,0,1,39,BLTP1,0.421,7.6887,2.3668,0,-1.0,-1.0,,
ENSG00000168071,18,9,1,0,1,1,1661.1500701262273,381165.6245253304,2010-11-21,12,1,0,0,0,1,1,0,0,1,0,0,9,0,2,0,0,0,0,11,0,0,1,39,CCDC88B,-0.008999944,-0.27703,-1.5127,0,0.5,0.0,,
ENSG00000168685,29,9,1,1,1,1,2880.672210672211,562534.7696387965,2012-10-01,6,0,0,0,0,2,0,0,12,4,30,1,0,0,8,0,0,0,0,3,0,0,8,74,IL7R,0.018999994,-1.169,-0.47684,3,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000172260,27,9,1,0,0,1,4713.845260560313,1778690.168860174,2013-04-07,0,0,0,0,0,4,0,1,0,0,1,0,6,0,0,0,27,0,9,3,0,1,4,56,NEGR1,0.571,1.4736,-0.54833,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000172818,25,9,1,0,0,1,4130.052768088722,1990918.947961699,2011-12-25,0,0,0,1,4,0,0,0,13,0,21,15,11,0,1,0,0,0,0,2,0,0,9,77,OVOL1,0.12900001,1.6277,0.97192,0,0.5,0.0,,
ENSG00000180592,16,9,0,0,0,1,5399.18558963428,782476.8109259979,2021-06-29,3,0,0,1,4,0,1,0,0,0,1,0,0,0,0,1,0,0,1,2,0,0,3,17,SKIDA1,0.40100002,0.11238,-2.5216,0,-1.0,0.5,,
ENSG00000053900,16,9,1,0,1,1,17601.10520641419,1778690.168860174,2019-01-21,0,2,0,0,4,1,0,0,0,0,1,0,6,0,0,0,2,0,4,0,0,1,1,22,ANAPC4,0.24299997,2.5443,1.2364,18,-1.0,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000064655,12,9,1,0,0,1,11608.613380386345,1424218.0900670097,2018-07-27,0,0,0,3,0,6,1,0,0,0,3,0,4,0,1,0,2,0,0,1,0,0,3,24,EYA2,0.353,1.1942,0.87867,1,0.5,0.0,,
ENSG00000075426,15,9,1,0,0,1,21082.402979080252,358386.30063935445,2012-11-01,3,1,0,2,2,0,0,0,4,0,2,0,1,0,0,0,0,0,0,6,0,0,3,24,FOSL2,0.72099996,1.9721,0.5242,0,-1.0,-1.0,,
ENSG00000109320,19,9,1,1,0,1,3511.742535866615,418004.04054809693,2012-11-01,3,0,0,0,1,0,2,0,0,1,7,1,0,0,1,0,0,0,0,3,0,0,4,23,NFKB1,0.822,3.9758,0.47587,27,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147
ENSG00000111245,18,9,1,0,0,1,2124.717330861909,574782.4268116049,2013-01-31,3,0,0,0,11,3,0,0,0,10,1,0,7,0,0,0,0,0,1,1,0,0,9,46,MYL2,-0.15699995,1.1174,0.14214,1,0.75,0.0,,
ENSG00000111249,26,9,1,0,0,1,1532.498589960519,931858.935708564,2016-11-29,11,1,0,0,23,1,0,0,0,3,4,0,14,0,0,0,0,0,0,1,0,0,16,74,CUX2,0.617,2.1579,-0.10954,0,0.5,0.5,,
ENSG00000111321,15,9,1,0,0,1,8994.718522284358,382631.1172224132,2011-07-10,0,2,0,0,0,0,2,0,0,0,3,0,1,2,2,0,0,0,0,8,1,0,2,23,LTBR,0.499,1.7723,-0.013704,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000112787,12,9,1,0,1,1,17601.10520641419,1424218.0900670097,2018-06-11,10,6,1,0,1,7,0,0,0,0,0,1,2,0,0,0,0,0,0,1,0,0,1,30,FBRSL1,0.116999984,-4.1529,-4.3418,0,-1.0,-1.0,,
ENSG00000113916,16,9,0,0,0,1,860.589000591366,714039.8414241908,2013-06-09,3,0,0,1,0,1,0,0,0,1,4,0,3,0,1,0,0,0,0,1,0,0,4,19,BCL6,0.779,3.4167,0.77009,3,0.5,-1.0,Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147;R-HSA-6785807
ENSG00000115290,16,9,1,0,1,1,12952.27698009484,1424218.0900670097,2011-08-28,0,0,0,3,3,31,0,0,0,0,0,2,1,0,0,0,3,0,1,3,0,0,3,50,GRB14,0.060000002,-0.56274,-0.31207,1,0.5,0.0,,
ENSG00000115380,32,9,1,1,1,1,2354.946760250557,1990918.947961699,2015-12-21,0,0,0,8,1,0,21,8,0,0,2,0,7,0,1,0,0,0,0,6,0,0,47,101,EFEMP1,0.627,2.7165,-0.12598,1,-1.0,0.0,,
ENSG00000115392,18,9,0,0,0,1,25967.06754524981,1778690.168860174,2018-02-26,0,0,0,0,2,5,0,0,0,0,6,0,3,0,0,0,5,1,5,1,0,0,2,30,FANCL,-0.444,-0.81485,-1.1704,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000115604,22,9,1,1,0,1,1993.0086797624485,562534.7696387965,2008-03-02,5,1,0,0,0,0,0,0,7,0,13,1,0,0,1,0,0,0,0,5,0,1,7,41,IL18R1,-0.15499997,1.2767,-0.016361,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-18 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9012546
ENSG00000119919,26,9,1,0,0,1,4383.801963294921,381165.6245253304,2007-06-06,3,0,0,0,0,1,2,0,2,11,0,1,3,0,2,0,0,0,0,55,0,0,0,80,NKX2-3,0.439,-1.1574,-2.7139,0,0.75,0.5,,
ENSG00000130876,26,9,1,0,0,1,1586.874773139746,562534.7696387965,2009-11-15,5,1,0,0,0,0,0,0,4,0,41,0,1,0,3,0,0,0,1,19,0,0,6,81,SLC7A10,0.227,1.5409,-0.23561,2,0.75,0.5,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000131196,20,9,1,0,1,1,53169.84323478868,1470466.6505612188,2019-05-31,0,0,0,0,3,1,0,0,0,2,0,5,10,0,1,0,0,0,0,1,2,0,5,30,NFATC1,0.53900003,-0.497,-2.179,4,0.5,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000131323,19,9,1,0,1,1,11231.262381898725,1424218.0900670097,2019-03-28,0,0,0,0,0,3,0,0,3,0,4,1,1,0,1,0,3,0,0,2,0,0,8,26,TRAF3,0.679,4.4189,0.93546,12,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000134962,9,9,1,0,0,1,47283.957661805514,1424218.0900670097,2021-06-14,0,0,0,0,1,1,0,0,1,1,0,0,3,0,0,0,0,2,1,1,0,0,2,13,KLB,0.356,2.2545,-0.27722,11,0.75,0.5,Signal Transduction;Disease;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202
ENSG00000135541,14,9,1,0,0,1,4693.289751970775,562534.7696387965,2011-08-11,2,0,0,0,0,0,0,0,2,3,7,2,1,0,3,0,0,0,0,1,0,0,2,23,AHI1,-0.069000006,-0.22863,-0.59835,1,-1.0,-1.0,,
ENSG00000136634,19,9,1,1,0,1,1336.2225519287833,574782.4268116049,2009-05-10,0,0,0,0,3,6,3,0,2,0,0,4,2,0,1,0,0,0,0,31,0,0,3,55,IL10,0.28899997,1.4128,-0.12417,6,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;CD163 mediating an anti-inflammatory response;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-9662834;R-HSA-6785807
ENSG00000136997,50,9,1,0,0,1,2116.2480995162405,1424218.0900670097,2008-09-14,58,0,0,0,0,7,0,0,0,6,12,1,3,0,8,0,0,0,0,4,0,0,3,102,MYC,0.872,1.5259,-0.15241,20,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Formation of the beta-catenin:TCF transactivating complex;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Transcriptional regulation by RUNX3;Binding of TCF/LEF:CTNNB1 to target gene promoters;RUNX3 regulates WNT signaling,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202;R-HSA-2173796;R-HSA-2173793;R-HSA-201722;R-HSA-597592;R-HSA-6785807;R-HSA-8864260;R-HSA-8878159;R-HSA-4411364;R-HSA-8951430
ENSG00000137834,16,9,1,0,0,1,13785.673050095118,645988.1975077938,2018-08-13,11,0,0,4,6,0,0,0,0,1,0,0,1,0,1,0,1,0,0,5,0,0,3,33,SMAD6,-0.99600005,-7.5875,-5.6215,2,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000143537,12,9,1,0,1,1,2314.313784461153,521818.7070055739,2022-11-09,2,1,0,3,1,0,0,0,0,0,0,1,1,0,1,0,0,0,0,2,0,0,3,15,ADAM15,0.17400002,1.5426,1.5531,2,-1.0,-1.0,,
ENSG00000143631,24,9,0,0,1,1,1647.8991596638655,562534.7696387965,2011-06-13,2,8,0,1,0,0,0,0,35,0,36,0,0,0,4,0,0,0,0,2,0,1,10,99,FLG,-0.93200004,-15.697,-10.291,2,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000143921,30,9,1,0,1,1,4518.532006719214,782476.8109259979,2016-04-16,1,0,0,0,18,4,21,0,0,1,0,0,0,0,0,0,0,0,8,49,0,1,36,139,ABCG8,-0.329,-2.6097,-2.2818,4,0.75,0.5,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000145777,25,9,1,0,0,1,663.1907192575406,576248.3784369711,2010-03-07,5,2,0,2,1,0,1,0,0,0,78,0,0,0,3,0,0,0,0,0,0,2,5,99,TSLP,-0.42900002,-0.54897,-1.457,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000146374,30,9,1,1,0,1,20703.900806847647,1424218.0900670097,2012-11-01,3,0,0,0,9,14,1,3,0,0,0,0,3,0,0,0,0,0,0,10,18,0,6,67,RSPO3,0.24900001,0.9221,0.2828,2,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000151422,17,9,1,0,0,1,3534.485612498504,279825.00883385167,2020-01-20,2,1,0,2,6,0,0,0,0,0,1,0,2,0,1,0,1,0,0,0,0,0,2,18,FER,0.277,0.73228,0.086644,1,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000162426,12,9,1,0,0,1,3640.455608057697,545791.5007333605,2010-04-21,1,1,0,0,2,0,3,0,1,0,3,0,0,0,2,0,1,0,0,4,0,0,0,18,SLC45A1,0.305,2.746,0.60831,0,0.5,0.0,,
ENSG00000163599,26,9,1,0,1,1,2209.8301559792026,574782.4268116049,2008-11-02,14,0,0,1,0,11,0,0,0,35,0,1,17,0,5,0,0,0,1,4,0,0,0,89,CTLA4,0.78900003,2.0899,0.57771,3,1.0,0.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-8877330
ENSG00000165029,17,9,1,0,1,1,1970.2283105022832,1424218.0900670097,2012-03-07,0,0,0,57,4,1,1,0,0,0,0,0,2,0,0,0,1,0,1,3,0,0,2,72,ABCA1,0.43699998,3.076,1.3522,4,-1.0,-1.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000172201,16,9,0,0,0,1,12358.468814746017,1424218.0900670097,2012-10-28,2,0,0,0,1,3,0,11,0,0,6,0,1,0,0,0,2,1,0,2,0,0,0,29,ID4,-0.93700004,-2.1926,-4.1665,2,0.5,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000176399,13,9,1,0,0,1,2988.7457407106926,575147.0632428399,2015-04-10,4,0,0,1,0,2,2,1,1,0,0,0,0,0,0,0,5,0,0,2,0,0,3,21,DMRTA1,-0.27900004,-2.9594,-2.6588,0,0.5,0.0,,
ENSG00000176635,19,9,0,0,0,1,6482.24749962681,521818.7070055739,2009-05-10,3,0,0,0,1,7,2,0,0,9,2,0,0,0,3,0,0,0,0,12,0,0,1,40,HORMAD2,-0.52400005,0.6642,-0.01761,0,1.0,0.5,,
ENSG00000179295,20,9,0,0,0,1,1823.3048648891686,468121.8445229682,2019-07-08,5,0,0,1,11,1,0,0,0,3,1,0,7,0,0,0,0,0,0,1,0,0,8,38,PTPN11,0.844,4.9526,1.5513,52,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;MAPK1 (ERK2) activation,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202;R-HSA-112411
ENSG00000186075,27,9,1,0,1,1,1224.8497854077252,438447.5304388146,2008-06-29,4,5,0,0,3,0,2,0,0,0,10,0,8,0,2,0,0,0,0,13,0,0,4,51,ZPBP2,-0.22800004,0.4603,0.12018,0,1.0,1.0,,
ENSG00000188641,19,9,1,0,1,1,15866.724081734988,1778690.168860174,2011-09-18,1,0,1,0,0,1,2,0,0,0,1,0,0,0,0,0,21,0,0,4,0,3,1,35,DPYD,-0.09000003,0.10047,0.22542,1,0.5,-1.0,Metabolism of nucleotides,R-HSA-15869
ENSG00000198670,58,9,0,1,1,1,5278.553937484916,756470.9740366563,2011-03-06,2,0,0,0,215,1,0,0,0,0,1,0,0,0,0,0,0,0,13,15,1,3,76,327,LPA,-0.18299997,-1.5017,-2.7146,1,1.0,0.5,Plasma lipoprotein remodeling,R-HSA-8963899
ENSG00000213996,21,9,1,0,1,1,5614.037386505252,1424218.0900670097,2018-08-13,7,0,0,0,1,3,18,0,0,0,0,0,1,0,0,1,0,0,4,9,0,0,10,54,TM6SF2,0.037,0.19852,0.063051,0,0.75,0.5,,
ENSG00000021645,15,8,0,0,0,1,1059.622641509434,1778690.168860174,2011-04-28,0,0,0,2,1,11,0,0,0,0,1,1,2,0,0,0,4,0,5,0,0,0,0,27,NRXN3,0.681,4.1824,0.047825,1,0.5,0.0,,
ENSG00000051825,19,8,1,0,1,1,15866.724081734988,633132.2332759313,2014-07-22,2,0,0,0,0,1,1,0,0,0,3,0,5,0,0,0,13,0,0,2,0,0,1,28,MPHOSPH9,0.30299997,1.8072,1.5512,0,0.5,-1.0,,
ENSG00000064651,16,8,1,0,0,1,15223.454539395489,1424218.0900670097,2018-08-13,0,8,0,0,5,1,0,3,2,0,0,0,2,0,3,0,0,0,0,0,0,0,18,42,SLC12A2,0.27899998,0.50869,-2.5289,1,0.5,-1.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000078328,22,8,0,0,0,1,1548.7309644670052,1778690.168860174,2016-05-16,0,0,0,1,2,1,0,0,0,0,0,0,1,0,1,0,18,0,0,6,0,0,12,42,RBFOX1,0.689,-1.3748,-3.6732,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000080644,34,8,1,0,0,1,6876.374591763159,633132.2332759313,2008-11-02,11,2,0,0,13,0,1,0,0,0,30,0,0,0,0,0,11,0,0,1,0,0,5,74,CHRNA3,-0.06500006,1.6569,-0.43743,3,0.75,0.5,,
ENSG00000092969,31,8,1,0,0,1,8671.61743288773,645988.1975077938,2014-02-07,12,0,0,0,9,0,0,0,4,19,3,0,0,0,1,0,0,0,0,11,0,0,9,68,TGFB2,0.537,2.3626,0.45081,5,-1.0,0.0,Signal Transduction;TGFBR3 regulates TGF-beta signaling,R-HSA-162582;R-HSA-9839389
ENSG00000100154,23,8,1,0,1,1,1917.911348018195,616612.9124297705,2017-08-01,37,1,0,5,0,0,0,1,0,1,0,0,3,0,0,0,0,0,0,6,0,0,3,57,TTC28,0.61399996,3.4708,2.1987,0,-1.0,0.0,,
ENSG00000103449,12,8,0,0,0,1,15258.981958714061,1778690.168860174,2019-06-24,0,0,0,0,1,0,1,0,0,2,1,0,0,0,0,0,3,0,0,2,3,0,3,16,SALL1,0.772,2.1498,0.60964,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000105329,25,8,1,1,1,1,40125.126089953985,1470466.6505612188,2017-12-06,0,0,0,4,23,6,0,0,0,0,0,1,8,0,0,0,3,0,0,1,0,0,15,61,TGFB1,0.31800002,0.77536,-0.44888,21,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;TGFBR1 KD Mutants in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;TGFBR3 regulates TGF-beta signaling;RUNX3 regulates CDKN1A transcription;Diseases of signal transduction by growth factor receptors and second messengers;Loss of Function of SMAD2/3 in Cancer;Loss of Function of TGFBR1 in Cancer;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-3656532;R-HSA-3304356;R-HSA-9839389;R-HSA-8941855;R-HSA-5663202;R-HSA-3304349;R-HSA-3656534;R-HSA-597592;R-HSA-6785807;R-HSA-8878159
ENSG00000117707,15,8,0,0,0,1,2397.122003085852,1424218.0900670097,2017-09-04,0,0,0,4,3,25,0,0,0,0,0,1,0,0,1,0,1,0,0,4,0,0,4,43,PROX1,0.778,3.4995,0.79933,0,1.0,0.0,,
ENSG00000118922,13,8,1,0,0,1,606.6666666666666,645988.1975077938,2016-02-08,0,1,0,0,3,0,1,1,0,1,3,0,0,0,0,0,5,0,0,3,0,0,0,18,KLF12,0.602,2.2386,0.17332,0,-1.0,0.0,,
ENSG00000119522,12,8,1,0,0,1,636.1886490807354,1424218.0900670097,2010-12-12,0,0,0,1,1,3,0,4,0,0,0,0,1,0,0,0,4,0,0,10,0,0,3,27,DENND1A,0.407,0.95655,-0.18506,1,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000121068,19,8,1,0,0,1,22775.087177885365,598869.4096893278,2017-07-17,0,0,0,2,9,0,0,0,0,1,0,5,9,0,0,0,0,0,3,2,0,0,2,33,TBX2,0.16799998,-1.8211,-3.988,1,0.5,0.0,Developmental Biology;Regulation of MITF-M-dependent genes involved in cell cycle and proliferation,R-HSA-1266738;R-HSA-9825892
ENSG00000129933,16,8,1,0,0,1,1899.55472404116,895916.2144062951,2013-08-25,8,0,0,2,1,5,9,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,5,32,MAU2,0.825,4.8573,-0.27687,1,-1.0,-1.0,,
ENSG00000130208,20,8,1,1,0,1,2095.3852392538524,464892.4593283075,2013-10-27,4,1,0,0,6,1,0,0,0,0,0,0,0,0,0,0,4,0,3,5,0,0,5,29,APOC1,-0.48300004,-0.74857,0.72809,3,1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000135111,27,8,0,0,0,1,2373.1792752244437,756470.9740366563,2018-06-11,11,1,0,0,24,0,0,5,0,1,1,0,0,0,0,0,0,0,0,1,0,0,4,48,TBX3,0.532,0.036562,-2.3154,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000136158,19,8,0,0,0,1,1225.1182294700059,1424218.0900670097,2010-09-16,0,1,0,2,0,31,0,0,0,1,0,0,2,0,0,0,6,0,0,2,0,0,6,51,SPRY2,0.31599998,1.3515,-0.13658,2,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000140564,32,8,1,1,0,1,15866.724081734988,1778690.168860174,2014-07-22,2,0,1,0,29,0,0,0,0,0,0,0,7,0,0,0,18,3,0,1,0,0,13,74,FURIN,0.7,2.2296,-1.0448,21,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;Signaling by Receptor Tyrosine Kinases;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;CD163 mediating an anti-inflammatory response;Plasma lipoprotein remodeling;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-9006934;R-HSA-2173796;R-HSA-2173793;R-HSA-9662834;R-HSA-8963899;R-HSA-597592
ENSG00000141279,13,8,1,0,0,1,3943.4948096885814,461914.58891516324,2013-07-01,0,0,0,5,2,0,1,0,0,1,0,0,1,0,3,0,2,0,0,0,0,0,2,17,NPEPPS,0.701,4.731,1.545,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000143507,17,8,1,0,1,1,595.0848708487085,414433.58532016096,2010-08-15,19,0,0,1,1,0,1,0,8,0,1,0,0,0,2,0,0,0,0,0,0,0,5,38,DUSP10,0.296,1.41,0.34236,3,0.5,0.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000143867,15,8,0,0,0,1,11608.613380386345,414433.58532016096,2021-09-30,1,0,0,7,2,0,5,1,0,0,0,0,0,0,0,0,1,0,0,6,0,0,8,31,OSR1,0.53400004,1.8831,-0.11677,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000148655,13,8,1,0,0,1,3662.2204953861096,1778690.168860174,2018-06-11,0,0,0,2,10,9,0,0,0,0,5,0,5,0,0,0,4,0,0,6,0,0,1,42,LRMDA,0.041999996,0.19713,-0.53908,0,0.5,-1.0,,
ENSG00000149177,19,8,1,0,0,1,11798.46653227782,414433.58532016096,2020-01-20,1,1,0,4,9,0,0,0,0,0,1,0,2,0,0,1,0,0,0,0,0,0,4,23,PTPRJ,-0.042999983,1.3847,1.0609,4,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Phosphorylation of CD3 and TCR zeta chains;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-202427;R-HSA-9006934
ENSG00000160712,23,8,1,1,1,1,2209.8301559792026,562534.7696387965,2013-07-01,1,1,0,0,28,0,0,0,10,0,8,0,6,0,1,0,0,0,0,0,0,0,6,61,IL6R,0.035000026,1.357,-0.3145,6,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;MAPK1 (ERK2) activation;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-112411;R-HSA-6785807
ENSG00000162341,17,8,1,0,1,1,11252.882952659449,1424218.0900670097,2018-05-08,11,0,0,0,0,2,2,0,0,0,3,3,0,0,0,0,0,0,1,0,2,0,3,27,TPCN2,0.023000002,-0.069799,0.19659,1,-1.0,-1.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000163281,14,8,0,0,0,1,61498.92173410762,1424218.0900670097,2018-10-08,0,0,0,2,5,18,0,0,0,0,1,2,0,0,0,0,3,0,8,1,0,0,0,40,GNPDA2,-0.40600002,0.95942,0.52413,1,-1.0,-1.0,,
ENSG00000169903,11,8,1,0,0,1,5190.694512845809,1424218.0900670097,2018-08-13,1,0,0,0,2,3,5,0,0,3,0,0,2,0,0,0,0,0,0,23,0,0,8,47,TM4SF4,-0.54499996,0.45404,-0.65617,0,0.75,0.5,,
ENSG00000171634,11,8,1,0,1,1,2302.4421471172964,1424218.0900670097,2012-07-15,2,0,0,0,2,5,1,0,0,0,0,0,1,0,0,0,3,0,0,0,0,3,1,18,BPTF,0.90999997,5.0945,0.93664,0,-1.0,-1.0,,
ENSG00000172572,20,8,1,0,0,1,3823.6404948245395,1424218.0900670097,2014-07-27,4,0,0,0,29,6,1,0,0,0,0,2,6,0,0,0,0,0,0,1,0,0,4,53,PDE3A,0.23699999,-0.62454,-2.2423,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000172995,13,8,1,0,0,1,58427.61478235146,1470466.6505612188,2020-06-15,0,1,0,0,2,5,0,0,0,0,2,0,2,0,0,0,1,0,2,0,0,0,2,17,ARPP21,0.28899997,0.14565,0.442,0,1.0,0.0,,
ENSG00000196526,11,8,1,0,0,1,2885.810854728632,634722.4486407059,2014-08-31,0,0,0,46,2,1,2,0,0,0,3,0,2,0,0,0,0,0,0,1,0,0,1,58,AFAP1,0.08200002,-1.3475,-1.7766,0,-1.0,0.0,,
ENSG00000198369,14,8,1,1,0,1,2181.616730755394,1424218.0900670097,2012-12-01,0,0,0,0,0,6,0,0,0,0,2,3,9,0,2,0,1,0,0,7,0,0,1,31,SPRED2,-0.36099994,0.71085,0.28941,3,-1.0,-1.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000212993,54,8,1,0,1,1,1848.986479177934,521818.7070055739,2007-04-01,264,0,0,0,0,1,0,2,0,17,0,0,0,0,1,0,0,0,0,1,4,0,10,300,POU5F1B,-0.29299998,-0.62957,-1.9752,0,0.5,0.5,,
ENSG00000004864,28,8,1,0,0,1,23238.11336553945,1470466.6505612188,2018-08-13,0,0,0,0,0,1,5,0,0,0,0,0,16,0,0,0,1,0,0,6,3,6,4,42,SLC25A13,0.06300002,1.1534,1.4654,3,1.0,-1.0,,
ENSG00000023516,17,8,1,0,0,1,11608.613380386345,1470466.6505612188,2021-04-08,0,0,0,0,0,1,0,0,1,0,1,2,12,0,0,0,0,0,0,8,2,0,1,28,AKAP11,0.681,0.883,0.9752,0,-1.0,-1.0,,
ENSG00000049656,51,8,1,0,0,1,2213.1795472287276,482893.2730520582,2008-11-02,106,1,0,0,0,0,1,1,4,0,0,1,0,0,0,0,0,0,0,0,0,2,7,123,CLPTM1L,0.263,0.73808,-1.178,0,-1.0,-1.0,,
ENSG00000101384,20,8,1,0,0,1,4588.605424593327,500292.45069431677,2014-05-26,6,0,0,2,22,0,0,0,1,0,1,0,6,0,0,0,0,0,0,6,0,0,3,47,JAG1,0.78900003,5.2977,1.1461,12,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-8878159
ENSG00000105662,14,8,1,0,0,1,20850.43936444706,1424218.0900670097,2018-08-13,2,0,0,0,2,9,9,0,0,0,0,2,0,0,0,0,0,0,2,4,0,0,4,34,CRTC1,0.583,2.0702,-1.117,4,0.5,-1.0,,
ENSG00000105705,17,8,1,0,1,1,1789.3037336024217,575072.4476732898,2011-02-23,4,0,0,0,1,5,5,0,0,0,0,0,2,0,0,0,8,0,0,2,0,0,1,28,SUGP1,0.398,1.404,0.2686,1,-1.0,-1.0,,
ENSG00000112273,27,8,0,0,0,1,6796.671949604783,756470.9740366563,2017-07-17,2,0,0,0,34,0,0,0,0,0,1,0,4,0,2,0,0,0,0,2,1,0,4,50,HDGFL1,,-1.9439,-2.1085,0,1.0,1.0,,
ENSG00000115896,23,8,1,0,1,1,2010.4597478176527,1778690.168860174,2010-11-21,0,0,0,0,1,0,0,0,0,0,5,2,5,0,3,0,5,0,0,3,0,0,3,27,PLCL1,0.337,1.6911,0.010082,0,0.5,0.0,,
ENSG00000123096,17,8,1,0,0,1,2249.4672199170122,1424218.0900670097,2011-10-18,9,0,0,0,11,8,0,1,0,0,1,1,0,0,0,0,0,0,0,1,0,0,4,36,SSPN,-0.56500006,-0.37509,-1.2397,1,0.5,0.0,,
ENSG00000130204,21,8,1,0,0,1,1140.321402214022,598869.4096893278,2009-09-06,0,0,0,0,4,1,0,0,0,0,2,0,1,0,0,0,17,0,2,3,0,0,5,35,TOMM40,0.544,1.8687,-0.75453,2,-1.0,-1.0,,
ENSG00000133812,13,8,1,0,1,1,2201.586503948313,1424218.0900670097,2017-12-22,1,0,0,0,6,3,0,1,0,0,0,0,2,0,1,0,0,0,0,1,0,0,6,21,SBF2,0.40899998,2.2041,1.0975,2,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000138083,12,8,1,0,0,1,29803.01405728205,1424218.0900670097,2020-01-20,0,0,0,3,0,3,0,0,0,0,1,0,0,0,0,0,2,1,0,2,0,1,3,16,SIX3,0.61300004,1.5772,-1.6975,0,0.5,0.5,,
ENSG00000145901,16,8,1,0,1,1,636.1886490807354,332375.5317723021,2009-10-18,0,1,0,0,0,2,0,0,5,0,0,15,5,0,0,0,4,0,0,27,0,0,2,61,TNIP1,0.627,1.2722,0.49591,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000146674,13,8,1,1,1,1,3400.4411583487367,367949.31877243903,2014-08-10,3,0,0,1,0,0,0,0,0,0,0,0,2,0,2,0,1,0,0,12,0,2,2,25,IGFBP3,0.13200003,-0.93106,-2.1888,3,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000148572,10,8,1,0,0,1,30422.437768133965,1424218.0900670097,2017-10-09,0,0,0,0,6,4,0,3,1,0,0,0,1,0,0,2,4,0,0,2,0,0,0,23,NRBF2,0.264,1.2623,0.79005,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000152219,14,8,1,0,0,1,16009.533384557282,574170.6270919729,2021-11-04,3,0,0,0,1,0,0,3,0,0,1,0,2,0,0,0,0,0,3,1,0,0,3,17,ARL14EP,0.17699999,1.407,0.56424,0,-1.0,-1.0,,
ENSG00000156395,30,8,0,0,0,1,22650.1728716785,1778690.168860174,2016-08-01,0,0,1,0,5,0,0,0,0,0,2,0,1,0,0,0,30,1,0,2,0,0,4,46,SORCS3,0.485,1.5908,-1.5456,0,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000162613,11,8,1,0,0,1,17601.10520641419,1778690.168860174,2017-05-24,1,1,0,0,3,0,0,0,0,0,0,0,1,0,0,0,1,0,3,2,0,0,1,13,FUBP1,0.723,1.9435,-0.52952,0,-1.0,-1.0,,
ENSG00000163083,17,8,0,1,1,1,4634.000517221562,1424218.0900670097,2013-04-01,22,0,0,2,0,3,0,7,0,0,0,0,5,0,0,0,1,0,0,1,0,0,3,44,INHBB,0.44199997,0.59451,-1.9918,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000166888,14,8,1,0,0,1,17116.666666666668,562534.7696387965,2016-05-16,1,0,0,0,0,0,0,0,3,0,46,0,1,0,5,0,1,0,0,0,0,1,4,62,STAT6,0.485,3.3501,0.49932,3,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9006934;R-HSA-6785807
ENSG00000169344,22,8,0,1,0,1,694.5559821620203,427337.4491868293,2009-05-10,0,2,0,0,8,1,0,0,0,2,0,62,1,0,0,2,0,0,0,0,0,0,2,80,UMOD,-0.24100006,0.49359,-1.7352,1,1.0,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000169554,23,8,1,0,0,1,1586.874773139746,1424218.0900670097,2012-09-04,6,1,0,0,20,4,0,0,0,0,0,2,0,0,0,0,2,0,0,2,0,0,2,39,ZEB2,0.886,5.6355,1.246,3,0.5,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000169684,31,8,1,0,1,1,3627.2944702864156,409235.3089791163,2008-04-03,28,3,0,0,15,0,1,0,0,0,31,0,0,0,0,0,1,0,0,0,0,1,3,83,CHRNA5,0.046000004,1.7263,0.64854,2,-1.0,0.0,,
ENSG00000171988,13,8,1,0,1,1,13658.782960109247,1778690.168860174,2018-08-13,0,0,0,0,4,1,2,1,0,0,0,0,3,0,0,0,2,0,0,2,0,0,2,17,JMJD1C,0.843,2.0931,0.1797,1,-1.0,-1.0,,
ENSG00000178562,15,8,1,0,0,1,3511.742535866615,562534.7696387965,2011-11-06,3,0,0,0,0,0,3,0,0,5,9,1,6,0,4,0,0,0,0,9,0,0,0,40,CD28,0.366,0.92709,0.051539,7,0.75,0.0,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202
ENSG00000178573,28,8,1,0,0,1,2521.196518187979,521818.7070055739,2009-01-18,17,0,0,0,0,0,0,0,0,31,0,3,11,0,2,0,0,0,3,4,0,0,4,75,MAF,0.148,-0.25296,-3.1037,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000180902,20,8,1,0,1,1,1871.6973317403424,562534.7696387965,2016-05-16,1,1,0,2,0,0,0,0,5,0,52,0,0,0,5,0,0,0,0,0,0,1,7,74,D2HGDH,0.09100002,0.52596,-0.66263,1,-1.0,-1.0,,
ENSG00000181751,16,8,1,0,0,1,2209.8301559792026,1778690.168860174,2013-12-25,0,0,0,2,0,5,0,0,0,11,0,2,8,0,1,0,2,0,0,3,0,0,0,34,MACIR,0.39,0.96045,0.40502,0,0.5,-1.0,,
ENSG00000184588,22,8,0,0,0,1,13000.861104796544,1778690.168860174,2018-08-16,0,0,0,0,2,1,0,1,0,0,0,1,0,0,0,0,17,4,0,3,0,0,5,34,PDE4B,0.626,3.0266,0.13476,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000189056,10,8,1,0,0,1,606.6666666666666,1470466.6505612188,2018-08-13,0,1,0,3,0,3,1,0,0,0,0,0,2,0,0,0,3,0,0,3,0,1,0,17,RELN,0.724,4.2857,0.97374,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000204103,28,8,1,0,0,1,1225.1182294700059,464892.4593283075,2011-07-06,5,0,0,0,2,0,0,0,0,6,0,0,16,0,1,0,0,0,3,7,0,0,21,61,MAFB,0.531,1.4486,-0.22643,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000004534,11,8,1,0,0,1,72258.6642662147,562534.7696387965,2018-08-13,2,0,0,0,1,4,1,0,0,0,1,0,4,0,0,0,0,0,0,0,0,1,1,15,RBM6,0.787,2.9854,1.4833,0,-1.0,-1.0,,
ENSG00000026508,10,8,1,0,0,1,1455.4894671623297,381165.6245253304,2012-05-06,7,0,0,0,0,1,0,0,1,12,0,7,0,0,1,0,0,0,0,1,0,0,1,31,CD44,0.34600002,0.90454,0.16881,6,0.5,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000048052,18,8,1,0,0,1,1173.5007132667617,1424218.0900670097,2012-02-05,1,0,0,0,10,5,0,0,1,0,0,0,8,1,0,0,0,0,0,3,0,0,6,35,HDAC9,0.623,1.4838,-0.83153,4,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000065675,14,8,1,0,0,1,27304.161593733363,562534.7696387965,2019-03-28,0,0,0,0,1,0,0,0,6,1,12,0,5,0,1,0,0,0,0,2,0,0,4,32,PRKCQ,0.42900002,3.2331,0.90732,9,0.75,0.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000069399,12,8,1,0,0,1,7841.608792317604,714039.8414241908,2013-10-27,0,0,0,0,0,0,1,0,0,0,6,0,3,0,0,0,5,0,3,11,0,1,2,32,BCL3,0.29799998,-0.94572,-2.8012,0,0.5,-1.0,,
ENSG00000087448,17,8,1,0,0,0,11740.48316175581,1424218.0900670097,2012-09-01,1,1,0,2,0,20,0,0,0,0,0,0,18,0,0,0,2,0,0,1,0,0,3,48,KLHL42,-0.32200003,1.4136,-0.34937,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000101096,19,8,1,0,0,1,15223.454539395489,1424218.0900670097,2018-08-13,1,0,0,0,7,7,0,0,0,0,2,0,7,0,3,0,0,0,0,2,0,0,15,44,NFATC2,0.635,1.1591,-0.56919,4,-1.0,0.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-8877330
ENSG00000103522,18,8,1,0,0,1,3511.742535866615,562534.7696387965,2017-04-20,3,0,0,0,0,0,0,0,2,2,14,0,4,0,2,0,0,0,1,3,0,0,0,31,IL21R,0.36900002,1.4081,0.20406,1,0.75,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000106633,12,8,1,0,0,1,7914.993941688755,895916.2144062951,2012-03-07,0,0,1,0,1,10,2,0,0,0,0,0,1,0,0,0,0,0,8,2,0,0,6,31,GCK,0.134,2.7902,0.16778,6,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685
ENSG00000109323,14,8,1,0,1,1,5426.200199914322,360837.067725683,2011-03-13,5,0,0,0,3,0,0,0,1,0,1,1,0,1,1,0,0,0,0,0,0,0,4,17,MANBA,0.17400002,0.063106,0.21104,2,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000109471,16,8,0,0,0,1,1993.0086797624485,960369.5592648841,2008-03-02,0,0,0,0,0,1,2,0,5,0,18,0,0,0,8,0,2,0,0,7,0,0,3,46,IL2,0.35500002,1.154,-0.093398,4,,,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147;R-HSA-8877330
ENSG00000115602,24,8,1,1,1,1,5002.767245657568,562534.7696387965,2012-09-28,0,4,0,2,0,0,0,0,4,0,79,0,0,0,4,0,0,0,1,0,0,3,4,101,IL1RL1,-0.062999964,-0.90161,-0.61396,3,0.75,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000123080,14,8,1,0,0,1,2642.0996026490066,645988.1975077938,2014-02-09,2,0,0,1,5,8,0,2,0,1,0,0,0,0,0,0,0,0,0,4,0,0,3,26,CDKN2C,0.060000002,1.5054,0.7997,4,0.5,-1.0,,
ENSG00000124766,26,8,0,0,0,1,11608.613380386345,521818.7070055739,2012-11-01,36,0,0,0,0,3,0,0,0,7,3,0,2,0,2,0,0,0,0,21,0,0,1,75,SOX4,0.27999997,-1.1983,-5.3473,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000133794,18,8,1,0,0,1,16067.419085829399,1990918.947961699,2017-12-06,0,0,0,0,5,2,0,0,0,0,2,0,15,0,0,0,2,0,0,1,0,2,3,32,BMAL1,0.75,3.6392,1.2349,9,-1.0,-1.0,,
ENSG00000136244,19,8,1,0,0,1,1492.3520749665329,562534.7696387965,2015-01-20,0,1,0,0,18,0,0,0,1,0,12,0,2,0,1,0,0,0,0,1,0,0,1,37,IL6,0.11900002,-0.2423,-0.037528,11,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Interleukins;CD163 mediating an anti-inflammatory response;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9662834;R-HSA-597592;R-HSA-6785807
ENSG00000136944,18,8,0,0,0,1,11679.569250778799,1424218.0900670097,2018-06-11,1,0,0,40,0,1,1,0,0,0,0,0,18,0,0,0,0,0,3,1,0,0,7,72,LMX1B,0.59099996,1.8923,-0.17216,0,1.0,0.5,,
ENSG00000138193,22,8,1,0,1,1,4074.958527607362,562534.7696387965,2011-06-05,4,0,4,13,22,0,0,0,0,0,1,0,1,0,0,0,0,0,0,3,0,0,2,50,PLCE1,0.436,3.1225,2.2115,1,-1.0,0.0,,
ENSG00000140807,14,8,0,0,0,1,5352.214117296449,78751.06843456876,2015-08-24,1,0,0,0,0,1,1,0,0,1,0,1,1,0,1,0,0,0,0,8,0,0,0,15,NKD1,0.292,0.61964,-0.34706,0,-1.0,0.0,,
ENSG00000143353,16,8,1,0,0,1,17710.3869470848,598869.4096893278,2018-08-13,2,0,0,9,1,0,7,0,2,0,0,0,2,0,0,0,0,0,0,6,0,0,7,36,LYPLAL1,-0.801,-1.6579,-0.97994,0,-1.0,-1.0,,
ENSG00000143971,13,8,1,0,1,1,1492.3520749665329,1424218.0900670097,2018-02-08,1,1,0,0,3,3,0,6,0,0,1,0,0,0,0,0,0,0,0,5,0,0,2,22,ETAA1,0.15100002,0.029236,0.25859,0,-1.0,-1.0,,
ENSG00000151474,9,8,0,0,0,1,606.6666666666666,433862.5685735124,2019-06-07,4,1,0,1,0,1,0,0,0,0,0,2,2,0,0,0,2,0,0,0,0,0,3,16,FRMD4A,0.544,-1.0981,-2.2456,0,0.5,-1.0,,
ENSG00000152217,19,8,1,0,0,1,1173.5007132667617,551389.5206213495,2019-11-01,3,0,0,0,3,2,0,0,0,0,0,0,3,0,0,0,8,0,0,3,0,1,5,28,SETBP1,0.857,1.8562,-0.098616,0,-1.0,0.0,,
ENSG00000153093,23,8,0,0,1,1,1494.9871332990222,414433.58532016096,2008-08-31,12,0,0,6,0,0,1,0,6,0,0,0,4,0,2,0,0,0,0,8,0,0,1,40,ACOXL,-0.23899996,0.8373,1.0717,1,0.5,0.5,,
ENSG00000157150,10,8,1,1,0,1,18319.91238877481,467606.0891342802,2020-12-08,1,0,0,0,0,1,0,0,0,5,0,0,1,0,1,1,0,0,0,2,0,0,1,13,TIMP4,-0.39699996,-0.33195,-1.0294,0,0.5,0.0,,
ENSG00000158636,14,8,1,0,0,1,2068.9726415094337,1424218.0900670097,2012-12-01,7,0,0,0,0,5,3,0,0,0,9,0,0,0,1,0,0,0,0,2,0,1,1,29,EMSY,0.73800004,3.2168,0.46223,0,-1.0,-1.0,,
ENSG00000160185,14,8,1,0,0,1,2209.8301559792026,574782.4268116049,2009-05-10,0,0,0,0,0,9,0,0,1,8,1,0,6,0,2,0,0,0,0,3,0,0,1,31,UBASH3A,-0.037999988,0.28864,-0.075925,0,1.0,0.5,,
ENSG00000162407,26,8,1,0,0,1,14260.80332304409,756470.9740366563,2013-11-21,0,0,0,1,47,0,0,1,0,0,0,1,1,0,0,0,0,0,2,2,0,0,15,70,PLPP3,0.597,1.9964,0.50874,1,-1.0,-1.0,,
ENSG00000162670,15,8,0,0,0,1,286678.73247515375,1778690.168860174,2020-09-21,0,0,0,0,1,0,0,1,0,0,0,0,2,0,0,0,7,0,3,1,0,1,1,17,BRINP3,0.63600004,0.3075,-0.87748,0,0.5,0.0,,
ENSG00000164113,16,8,0,0,0,1,9269.724378777702,1778690.168860174,2015-04-01,0,0,0,2,0,2,1,0,1,0,12,0,0,0,0,0,3,0,0,5,0,0,3,29,ADAD1,0.222,1.3454,-0.35922,0,1.0,1.0,,
ENSG00000164330,22,8,1,0,0,1,14790.180826912794,1424218.0900670097,2013-04-01,14,0,2,0,15,5,0,0,0,0,0,0,5,0,1,0,0,0,0,7,0,0,15,64,EBF1,0.736,3.5096,-0.023276,2,0.5,0.0,Developmental Biology;Olfactory Signaling Pathway,R-HSA-1266738;R-HSA-381753
ENSG00000165895,10,8,1,0,0,1,1173.5007132667617,500292.45069431677,2017-12-06,1,0,2,0,17,1,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,2,26,ARHGAP42,0.334,2.7685,0.22717,5,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000166033,31,8,1,0,1,1,1116.1902136457616,410642.56898295006,2010-04-12,1,5,0,21,5,0,0,0,0,0,0,0,2,0,0,0,0,0,0,32,0,3,10,79,HTRA1,0.12699997,0.69245,-1.2907,1,0.5,0.0,,
ENSG00000168610,12,8,1,1,0,1,4386.372160115398,464892.4593283075,2008-06-29,0,1,0,0,0,1,1,0,5,0,1,0,0,0,1,0,0,0,0,21,0,0,1,32,STAT3,0.89100003,7.3843,1.2281,38,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202;R-HSA-6785807
ENSG00000171621,20,8,1,0,0,1,15223.454539395489,322220.1169395476,2019-03-28,0,0,0,0,10,0,1,0,2,0,4,0,1,0,1,0,0,0,0,1,0,0,12,32,SPSB1,0.35799998,2.7275,-0.030294,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000172493,10,8,1,0,0,1,2821.1873684210527,292977.1806919819,2012-01-26,0,0,0,1,0,0,1,0,2,0,0,2,6,0,1,0,0,0,0,3,0,0,1,17,AFF1,0.51,0.53163,-0.59001,0,-1.0,-1.0,,
ENSG00000176697,18,8,1,0,1,1,59742.17313930438,1424218.0900670097,2018-08-13,0,2,0,0,3,4,7,0,0,0,1,0,3,0,0,0,7,0,8,0,0,0,0,35,BDNF,0.767,2.7789,1.3589,14,0.5,0.5,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000177311,18,8,1,0,1,1,9770.187636657778,1424218.0900670097,2019-07-30,7,0,0,0,2,4,0,0,1,0,6,0,0,0,1,0,0,0,0,8,0,0,4,33,ZBTB38,0.611,4.4313,1.6304,0,-1.0,-1.0,,
ENSG00000179588,20,8,1,0,1,1,3288.4396493594068,1424218.0900670097,2015-10-27,7,0,0,0,3,2,0,0,1,0,0,2,0,0,1,0,0,0,0,2,0,0,6,24,ZFPM1,-0.11399996,-8.2316,-9.2585,2,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000181722,11,8,1,0,0,1,2789.433363830436,1424218.0900670097,2011-10-30,4,0,0,0,1,6,0,1,0,0,0,0,2,0,0,0,3,0,0,4,0,0,1,22,ZBTB20,0.7,3.9575,0.26763,0,-1.0,0.0,,
ENSG00000183527,22,8,1,0,0,1,1380.9855975087582,384314.83364002535,2008-08-31,0,0,0,1,1,0,6,0,1,0,0,0,9,0,0,0,1,0,0,36,0,0,1,56,PSMG1,0.074,-0.26506,-0.51897,1,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000185104,18,8,0,0,0,1,2642.0996026490066,1424218.0900670097,2016-01-05,4,0,0,0,9,10,0,1,0,2,1,0,0,0,0,0,0,0,0,4,0,0,1,32,FAF1,0.55,1.6552,0.90959,0,-1.0,-1.0,,
ENSG00000189292,14,8,0,0,0,1,61498.92173410762,574170.6270919729,2018-10-08,0,1,0,0,2,1,1,0,2,0,0,0,3,0,0,0,0,0,6,0,0,0,5,21,ALKAL2,-0.29700005,-2.2503,-3.6789,2,0.5,0.0,,
ENSG00000198553,16,8,1,0,0,1,7740.251277929256,645988.1975077938,2015-09-22,7,0,0,0,2,1,0,1,0,0,2,0,0,0,4,0,0,0,0,5,0,0,1,23,KCNRG,-0.49600005,0.58043,1.2605,0,1.0,0.5,,
ENSG00000212710,20,8,0,0,0,1,2201.586503948313,482893.2730520582,2010-04-04,7,1,0,0,23,0,4,0,0,0,0,0,0,0,0,0,2,0,0,1,0,2,3,43,CTAGE1,,-0.94524,-0.58593,0,1.0,1.0,,
ENSG00000225968,25,8,0,0,0,1,1500.8351648351647,1076472.0138856068,2013-05-12,16,0,0,0,5,1,2,0,0,0,0,0,0,0,0,0,8,0,0,1,0,2,3,38,ELFN1,-0.84099996,-0.95313,-3.2138,0,0.5,0.0,,
ENSG00000254093,15,8,1,0,0,1,17019.2658782304,714039.8414241908,2017-07-17,0,0,0,0,2,0,0,0,0,0,0,1,5,0,0,0,1,0,1,2,0,1,4,17,PINX1,-0.921,-2.414,-1.8207,0,-1.0,-1.0,,
ENSG00000258839,30,8,1,0,1,1,4258.020870037778,431284.57934287674,2011-06-23,93,0,0,4,0,1,0,0,25,0,0,0,1,0,0,0,0,0,0,1,12,0,2,139,MC1R,-0.93299997,-1.9869,-2.4505,3,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000002822,30,7,1,0,1,1,4607.305208781748,1778690.168860174,2012-06-12,5,0,0,0,1,3,0,0,0,0,0,0,1,0,0,0,27,0,0,5,0,0,7,49,MAD1L1,-0.22800004,-0.61726,-2.2872,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000014914,16,7,1,0,1,1,19875.020792566687,464892.4593283075,2015-04-01,2,0,0,5,3,0,0,0,0,0,1,0,7,0,0,0,0,0,0,2,0,0,3,23,MTMR11,0.0009999871,1.2699,0.31418,0,0.5,0.0,,
ENSG00000030110,16,7,1,0,0,1,1935.4272517321017,1424218.0900670097,2009-05-31,8,1,0,0,0,5,0,0,0,0,1,0,1,0,0,2,0,0,0,4,0,0,0,22,BAK1,-0.19700003,1.8787,1.2639,3,-1.0,-1.0,,
ENSG00000043143,12,7,1,0,0,1,8947.668693718733,1424218.0900670097,2017-09-04,12,0,0,0,0,9,0,0,0,0,0,1,3,0,0,0,1,0,0,1,0,0,1,28,JADE2,0.75,3.1942,0.69358,1,-1.0,-1.0,,
ENSG00000064419,14,7,1,0,0,1,1496.8768710767745,381165.6245253304,2008-01-20,2,0,0,1,0,0,0,0,0,2,0,5,8,0,2,0,0,0,0,6,0,0,0,26,TNPO3,0.34600002,3.4263,1.6581,0,-1.0,-1.0,,
ENSG00000072041,9,7,0,0,0,1,4130.052768088722,1129585.974638378,2015-11-06,0,0,0,0,1,0,0,0,1,0,1,0,0,1,1,0,3,0,0,0,0,0,2,10,SLC6A15,0.40399998,1.7844,-0.84526,2,0.5,0.5,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000073584,15,7,1,0,0,1,16417.447913521348,360837.067725683,2009-05-10,0,0,0,1,0,2,0,0,11,0,19,0,0,0,5,0,0,0,0,2,0,0,10,50,SMARCE1,0.68200004,2.7817,0.66376,8,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000089127,7,7,1,1,1,1,11170.467958564675,192848.64833759028,2020-05-13,1,15,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,1,0,0,1,21,OAS1,0.18300003,0.54377,1.3968,3,0.5,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000099810,21,7,1,0,1,1,3070.816578575999,502231.5406594711,2011-10-09,31,1,0,0,8,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,5,48,MTAP,-0.48899996,0.0070921,-0.71329,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000102243,12,7,0,0,0,1,15443.951531069062,21897.542503344637,2015-08-24,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,0,0,2,0,0,0,8,VGLL1,,,,0,1.0,0.0,,
ENSG00000112685,11,7,1,0,0,1,24375.86003419404,414433.58532016096,2018-06-11,6,0,0,18,1,0,0,0,2,0,1,0,0,0,0,0,0,0,0,6,0,0,1,35,EXOC2,0.374,2.5178,0.17138,3,-1.0,-1.0,VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620916;R-HSA-5620920
ENSG00000112699,15,7,0,0,0,1,2885.810854728632,1424218.0900670097,2014-08-31,4,0,0,28,7,1,0,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,2,46,GMDS,0.28100002,0.4976,-0.43602,1,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000115138,10,7,1,1,1,1,4298.5808824872865,500292.45069431677,2010-11-21,3,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,1,1,0,3,0,0,2,13,POMC,-0.796,-1.6085,-0.77339,13,1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);G-protein activation;Disease;Signaling by Interleukins;Metabolism of steroids;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-202040;R-HSA-1643685;R-HSA-449147;R-HSA-8957322;R-HSA-6785807
ENSG00000120659,14,7,1,1,1,1,9724.911607071434,257615.15548119982,2010-11-21,3,1,0,0,0,0,0,0,2,8,4,0,3,0,0,0,0,0,0,4,0,0,0,25,TNFSF11,0.397,0.85948,-1.2047,4,0.5,0.5,Cytokine Signaling in Immune system;Immune System;Developmental Biology,R-HSA-1280215;R-HSA-168256;R-HSA-1266738
ENSG00000124126,11,7,1,0,0,1,606.6666666666666,448058.917711015,2015-07-07,12,1,2,1,5,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,24,PREX1,0.732,4.4885,0.73934,12,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000125970,24,7,1,1,1,1,10309.711437247712,1424218.0900670097,2012-09-13,59,0,0,0,0,4,0,0,8,0,0,0,1,0,0,0,0,0,0,3,3,0,1,79,RALY,0.26599997,1.4525,-0.12167,0,-1.0,-1.0,,
ENSG00000128731,31,7,1,0,1,1,924.2353892821031,431284.57934287674,2018-05-08,23,0,0,16,0,0,0,0,12,0,0,0,1,0,0,0,0,0,0,8,1,0,4,65,HERC2,0.75699997,7.8352,1.2628,6,-1.0,0.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000138111,9,7,1,0,0,1,1111.893899204244,1470466.6505612188,2018-07-16,1,1,0,0,0,0,0,0,0,0,3,0,1,0,0,0,1,0,0,1,0,0,1,9,MFSD13A,0.15499997,1.2809,0.80276,0,0.5,0.0,,
ENSG00000138675,26,7,1,1,0,1,8514.894924143098,756470.9740366563,2017-07-17,0,0,5,0,47,0,0,0,0,0,0,5,2,0,0,0,0,0,1,10,0,0,5,75,FGF5,-0.41799998,-0.014249,-1.3051,31,0.5,0.5,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000138696,18,7,1,0,0,1,2029.2825768667642,672632.4785173276,2009-09-20,17,0,0,0,5,0,5,0,0,0,0,0,1,0,0,0,1,0,0,2,0,0,8,39,BMPR1B,0.669,1.2676,-0.73983,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000142224,14,7,1,0,0,1,1336.2225519287833,169088.90478978804,2010-07-11,0,0,0,0,3,1,2,0,2,0,0,1,0,0,0,0,0,0,0,13,0,0,4,26,IL19,-0.125,0.63115,0.38469,1,0.75,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000145536,14,7,1,1,1,1,18863.307985083233,313882.50400013494,2018-05-21,0,0,0,0,0,0,2,3,0,0,1,0,0,0,1,1,0,0,0,1,0,0,14,23,ADAMTS16,0.20599997,-0.20053,-1.4164,3,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000146555,17,7,1,0,1,1,8479.376416968564,1778690.168860174,2017-09-07,0,1,0,0,0,0,0,0,0,0,2,0,5,0,0,0,7,0,0,2,0,3,4,24,SDK1,0.231,-3.4968,-4.9524,1,0.5,0.0,,
ENSG00000151006,16,7,1,1,1,1,8844.888938597473,442877.006007271,2015-11-28,0,5,0,0,1,2,1,0,1,0,4,0,0,0,0,0,0,0,0,7,0,0,0,21,PRSS53,-0.19799995,0.37772,0.5153,0,0.5,0.5,,
ENSG00000155313,12,7,0,0,0,1,7741.739669934235,407080.5516610372,2008-06-29,0,0,0,0,0,0,2,0,0,3,1,1,1,0,1,0,0,0,0,23,0,0,0,32,USP25,0.365,1.3384,0.56305,1,0.5,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000157554,19,7,1,0,0,1,1173.5007132667617,356440.71671986027,2016-11-29,4,0,0,2,7,1,0,0,0,0,0,0,13,0,3,0,0,0,0,0,0,0,7,37,ERG,0.76600003,2.9353,0.7573,0,-1.0,0.0,,
ENSG00000162927,14,7,1,0,0,0,2222.3233132932532,645988.1975077938,2010-03-14,0,0,0,0,1,1,1,0,4,0,0,0,0,0,3,0,0,0,0,22,0,0,1,33,PUS10,-0.072999954,-0.76423,-0.1315,0,-1.0,-1.0,,
ENSG00000163362,14,7,1,0,1,1,15186.98390755667,237176.1991038335,2011-02-06,2,0,0,0,0,0,1,0,1,0,0,0,3,0,3,0,3,0,0,18,0,0,0,31,INAVA,0.15899998,-0.25561,0.29918,0,0.5,0.0,,
ENSG00000164691,17,7,1,0,0,1,2209.8301559792026,322220.1169395476,2010-11-21,0,0,0,0,0,1,0,0,13,2,0,0,8,0,3,0,0,0,0,27,0,0,3,57,TAGAP,0.272,2.0272,0.70743,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000165915,11,7,1,0,0,1,1321.7688442211056,727796.3668420183,2020-12-08,5,0,0,2,2,2,0,0,0,0,0,0,0,0,0,0,6,0,1,0,0,0,2,20,SLC39A13,0.338,1.8851,0.5535,0,-1.0,-1.0,,
ENSG00000169599,16,7,1,1,1,1,13883.57970142381,356440.71671986027,2018-08-13,1,0,0,0,0,0,1,0,0,0,0,0,13,0,0,0,3,0,0,1,0,3,4,26,NFU1,-0.544,-0.020341,-0.89184,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000173064,16,7,0,0,0,1,4070.0998003992017,269829.0934099178,2011-06-05,4,0,0,0,7,0,0,0,0,5,1,0,6,0,0,0,0,0,0,3,0,0,9,35,HECTD4,0.708,8.633,2.7818,0,0.5,-1.0,,
ENSG00000174125,19,7,1,1,1,1,18135.990566037737,562534.7696387965,2013-12-30,0,3,0,2,0,0,0,0,3,0,29,0,0,0,4,0,0,0,0,0,0,1,4,46,TLR1,-0.34800005,0.35094,0.84718,8,0.5,0.0,Immune System;Defensins;Disease;Antimicrobial peptides,R-HSA-168256;R-HSA-1461973;R-HSA-1643685;R-HSA-6803157
ENSG00000182481,9,7,1,0,0,1,47078.309899184205,498258.534626183,2019-07-08,0,0,0,0,2,3,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,2,1,11,KPNA2,0.29500002,1.8199,0.18167,8,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;NS1 Mediated Effects on Host Pathways;Disease;ISG15 antiviral mechanism,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-168276;R-HSA-1643685;R-HSA-1169408
ENSG00000196498,18,7,1,0,1,1,26841.183331692897,1470466.6505612188,2021-11-04,1,0,0,0,5,0,0,0,0,0,2,0,3,0,0,0,0,0,0,1,0,2,3,17,NCOR2,0.552,-0.76706,-4.1012,18,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-2173793;R-HSA-597592
ENSG00000197208,10,7,1,0,1,1,3369.430422532613,414433.58532016096,2017-01-09,3,0,0,1,3,0,0,0,2,0,1,0,1,0,0,0,0,0,0,2,0,0,0,13,SLC22A4,0.018000007,1.5211,1.4972,1,0.5,0.0,Organic cation transport,R-HSA-549127
ENSG00000204084,14,7,1,0,0,1,41299.82664585649,360605.992793193,2013-12-25,2,0,0,0,7,0,0,0,0,5,0,1,3,0,0,0,0,0,0,1,0,0,2,21,INPP5B,0.04100001,1.6232,0.94739,2,-1.0,-1.0,,
ENSG00000213047,12,7,1,0,0,1,5426.200199914322,960369.5592648841,2010-11-21,5,0,0,1,0,0,0,1,1,0,0,0,0,0,2,0,6,0,0,10,0,0,0,26,DENND1B,0.20200002,1.113,0.29963,1,-1.0,0.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000243509,11,7,0,1,0,1,8143.099031885603,467606.0891342802,2017-01-09,4,1,0,0,0,1,0,0,6,0,0,0,0,0,1,0,0,0,0,3,0,1,0,17,TNFRSF6B,-0.857,-2.7684,-4.287,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000009950,11,7,1,0,1,1,7914.993941688755,1424218.0900670097,2012-03-07,1,0,0,0,1,1,0,0,0,0,0,0,11,0,0,0,0,0,1,10,0,0,1,26,MLXIPL,0.116,-0.36507,-1.34,4,1.0,0.0,,
ENSG00000030419,11,7,1,0,0,1,13219.952617929488,1424218.0900670097,2015-10-26,3,0,0,9,0,2,0,0,0,1,0,2,0,0,0,0,0,0,0,1,0,0,2,20,IKZF2,0.5,1.7332,0.070331,0,0.5,0.0,,
ENSG00000041982,14,7,1,1,0,1,5002.767245657568,1778690.168860174,2015-02-02,0,1,0,0,3,0,0,0,0,0,1,0,25,0,2,0,1,0,0,0,0,0,15,48,TNC,0.39200002,1.3748,2.3563,5,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000057657,17,7,1,0,0,1,2240.9147424511543,1778690.168860174,2008-06-29,3,0,0,0,0,0,0,0,0,0,1,10,2,0,0,0,1,0,0,26,0,0,2,45,PRDM1,0.686,2.4386,1.2502,3,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9006934
ENSG00000061273,13,7,1,0,0,1,13166.73562422059,562534.7696387965,2012-11-01,1,0,0,0,3,0,1,0,0,0,12,0,0,0,2,0,0,0,0,1,0,0,10,30,HDAC7,0.656,2.0121,-0.93576,6,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000066468,28,7,1,0,0,1,6275.684210526316,645988.1975077938,2010-05-09,84,1,0,0,2,2,0,0,0,0,0,0,14,0,0,0,0,0,0,0,0,2,5,110,FGFR2,0.722,4.4473,0.55432,18,1.0,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000081059,14,7,1,0,0,1,13219.952617929488,382631.1172224132,2015-10-26,0,0,0,0,0,0,0,0,0,8,3,6,4,0,3,0,0,0,0,2,0,0,2,28,TCF7,0.376,-1.2029,-1.9621,9,1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Regulation of MITF-M-dependent genes involved in cell cycle and proliferation;Formation of the beta-catenin:TCF transactivating complex;Transcriptional regulation by RUNX3;Binding of TCF/LEF:CTNNB1 to target gene promoters;RUNX3 regulates WNT signaling,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9825892;R-HSA-201722;R-HSA-8878159;R-HSA-4411364;R-HSA-8951430
ENSG00000085978,14,7,1,0,1,1,1922.5002600104003,1424218.0900670097,2007-04-15,1,0,0,0,0,3,0,0,0,1,0,2,1,0,1,0,0,0,0,15,0,0,0,24,ATG16L1,0.45499998,2.7578,-0.45655,1,-1.0,-1.0,,
ENSG00000100330,10,7,1,0,1,1,4293.955119214586,765591.3646788632,2011-07-03,1,0,0,1,0,2,2,0,0,0,0,0,1,0,0,0,0,0,0,5,0,0,2,14,MTMR3,0.698,3.0967,0.57031,2,0.5,-1.0,,
ENSG00000100342,15,7,1,1,1,1,451.92838274141474,90019.60981047938,2010-07-28,0,0,0,1,1,0,0,0,0,1,0,16,0,0,0,1,0,0,3,0,0,0,5,28,APOL1,-0.67999995,-0.29624,-0.048755,3,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000101017,13,7,1,1,0,1,1592.9531521110468,1778690.168860174,2008-09-14,1,0,0,0,0,0,0,0,0,5,0,1,11,0,2,0,3,0,0,7,0,0,0,30,CD40,0.323,2.0303,0.27987,3,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000103241,13,7,1,0,0,1,2699.1085295016815,1424218.0900670097,2012-09-09,7,0,0,8,1,1,4,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,23,FOXF1,0.315,0.30525,-2.9294,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000105855,17,7,1,0,0,1,22665.336221989495,562534.7696387965,2017-10-30,3,0,0,0,0,0,0,0,0,1,21,0,3,0,2,0,0,0,0,2,0,0,3,35,ITGB8,0.38599998,0.99753,0.46306,3,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000106070,13,7,1,0,0,1,11608.613380386345,1424218.0900670097,2018-08-29,5,0,0,0,0,4,0,0,0,0,0,0,2,0,0,0,2,0,0,1,1,0,2,17,GRB10,0.635,2.5464,0.37478,7,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-9006934
ENSG00000120262,31,7,1,0,1,1,2456.3560870795322,358386.30063935445,2009-02-15,38,0,0,0,1,0,0,15,0,0,0,0,3,0,0,0,0,0,0,7,4,0,6,74,CCDC170,-0.15799999,0.075568,0.4564,0,0.5,0.0,,
ENSG00000134987,17,7,1,0,0,1,2068.9726415094337,562534.7696387965,2013-12-30,3,1,0,0,0,0,3,0,0,0,39,0,0,0,3,0,0,0,0,1,0,0,5,55,WDR36,0.29400003,-0.88519,-0.76391,2,-1.0,0.0,rRNA processing,R-HSA-72312
ENSG00000136267,14,7,1,0,0,1,7914.993941688755,1778690.168860174,2012-03-07,0,0,0,4,8,40,0,1,0,0,0,0,0,0,0,0,3,0,3,0,0,0,1,60,DGKB,0.245,0.95957,-1.769,1,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000141052,11,7,1,0,0,1,576.1087314662274,672632.4785173276,2018-06-11,9,0,0,0,10,0,0,1,0,0,0,1,0,0,1,0,0,0,0,3,0,0,2,27,MYOCD,0.605,1.1718,0.58188,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000146535,12,7,1,0,0,1,6067.527905738457,645988.1975077938,2011-02-06,0,2,0,0,1,0,0,0,0,2,1,0,0,0,2,0,0,0,0,10,0,0,1,19,GNA12,0.44099998,1.3565,-2.1493,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000157557,14,7,1,0,0,1,38913.031770896094,1424218.0900670097,2018-08-29,4,0,0,0,1,1,0,0,0,0,0,0,4,0,0,0,0,0,0,4,7,0,1,22,ETS2,0.566,2.9027,0.6875,1,-1.0,-1.0,,
ENSG00000157870,12,7,1,0,0,1,2209.8301559792026,381165.6245253304,2011-02-06,0,0,0,0,0,0,1,0,0,2,4,0,5,0,5,0,0,0,0,2,0,0,3,22,PRXL2B,-0.847,-0.98658,-0.99319,1,0.5,0.0,Arachidonate metabolism,R-HSA-2142753
ENSG00000158517,9,7,1,0,0,1,13146.170818899478,381165.6245253304,2021-11-04,0,0,0,1,1,2,1,0,0,0,0,0,2,0,2,0,0,0,0,2,0,0,0,11,NCF1,0.38300002,2.5881,1.9569,8,0.5,0.0,Signal Transduction;Immune System;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-9006934
ENSG00000159216,22,7,1,0,0,1,2209.8301559792026,645988.1975077938,2011-06-05,10,0,0,3,5,0,0,0,0,0,34,0,8,0,0,0,0,0,0,4,0,0,2,66,RUNX1,0.36699998,1.4853,-0.50331,20,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;RUNX1 regulates estrogen receptor mediated transcription;Organic cation transport;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-8931987;R-HSA-549127;R-HSA-8877330;R-HSA-8878159
ENSG00000163660,12,7,0,0,0,1,46059.65662231034,1778690.168860174,2020-10-05,0,0,1,0,7,1,1,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,3,15,CCNL1,0.62,2.7574,-0.70323,0,-1.0,-1.0,,
ENSG00000166833,9,7,0,0,1,1,576.1087314662274,414433.58532016096,2022-02-07,0,0,0,1,0,0,0,0,0,0,0,1,2,0,1,0,1,0,0,1,0,0,1,8,NAV2,0.712,2.9877,0.099667,0,0.5,0.0,,
ENSG00000167085,10,7,0,0,0,1,14145.711748532529,469202.8533735097,2017-12-06,1,0,0,0,7,0,0,0,0,0,6,0,0,0,0,0,1,0,0,1,0,1,1,18,PHB1,0.33600003,3.0569,0.13987,5,-1.0,-1.0,,
ENSG00000170340,15,7,1,0,0,1,1968.6551410373067,381165.6245253304,2010-01-10,0,0,0,1,0,1,0,0,3,4,0,0,9,0,3,0,0,0,0,11,0,0,0,32,B3GNT2,0.32700002,1.6365,0.31993,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000171791,23,7,1,0,0,1,2340.854005693371,1424218.0900670097,2013-06-16,15,0,0,0,0,14,3,0,0,0,2,0,2,0,0,0,0,0,0,2,0,0,5,43,BCL2,0.63199997,1.5997,-0.28442,8,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-449147;R-HSA-6785807
ENSG00000173273,7,7,1,0,0,1,28863.30790298137,765591.3646788632,2019-06-24,1,1,0,0,1,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,8,TNKS,0.361,-0.27589,-3.4717,5,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000175426,15,7,0,1,1,1,40855.314577620855,1470466.6505612188,2020-05-06,0,0,4,0,6,5,0,0,0,0,1,0,5,0,0,0,0,0,4,0,0,0,1,26,PCSK1,0.291,2.0983,-0.020154,5,0.5,0.0,,
ENSG00000179088,12,7,1,0,0,1,17238.436176402993,1424218.0900670097,2020-06-24,0,0,0,0,0,1,0,0,3,4,0,1,0,0,1,0,0,0,6,1,0,0,0,17,C12orf42,-0.781,-0.066459,0.37997,0,1.0,0.5,,
ENSG00000185651,11,7,1,0,0,1,2240.9147424511543,645988.1975077938,2009-10-18,0,1,0,0,1,0,0,0,0,0,0,11,4,0,1,0,0,0,0,16,0,0,1,35,UBE2L3,0.697,3.807,1.4989,6,-1.0,-1.0,Signal Transduction;Immune System;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-8866652;R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000188064,17,7,0,0,0,1,1553.7438322851153,1424218.0900670097,2011-07-06,12,0,0,2,0,2,0,2,0,0,0,0,31,0,0,0,4,0,0,0,0,0,9,62,WNT7B,0.23900002,1.4421,-1.0349,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000213066,19,7,1,1,0,1,2507.7659073055775,1424218.0900670097,2008-06-29,7,0,0,0,0,1,0,0,4,5,0,0,3,0,0,0,0,0,0,11,0,0,1,32,CEP43,-0.16299999,-0.69879,-0.89301,9,0.5,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000010818,10,7,0,0,0,1,7829.805429864254,1424218.0900670097,2019-02-04,0,0,0,0,2,10,0,0,0,0,1,0,0,0,1,0,8,0,0,2,0,0,1,25,HIVEP2,0.886,3.8277,0.22162,0,-1.0,-1.0,,
ENSG00000016082,9,7,0,0,0,1,741.4421768707483,1778690.168860174,2015-03-12,3,0,0,0,1,1,2,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,2,13,ISL1,0.765,2.6662,-0.14518,3,0.5,0.0,Developmental Biology;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-9010553
ENSG00000019485,14,7,1,0,0,1,7098.679736796403,295550.4496098593,2018-10-26,0,0,0,0,0,1,0,0,0,14,1,0,0,0,0,0,0,0,1,4,1,0,1,23,PRDM11,0.71000004,4.2299,1.3075,0,-1.0,-1.0,,
ENSG00000020256,11,7,1,0,0,1,17115.61307125707,1778690.168860174,2017-06-12,1,0,0,0,3,6,0,0,0,0,3,0,2,0,0,0,3,0,1,0,0,0,0,19,ZFP64,0.564,1.9838,-0.19125,0,-1.0,-1.0,,
ENSG00000021826,12,7,0,0,1,1,1493.7220461747397,1470466.6505612188,2017-02-27,0,0,0,3,1,0,1,0,0,0,0,3,6,0,0,0,2,0,0,3,0,0,0,19,CPS1,0.236,1.7456,0.65953,1,1.0,0.0,,
ENSG00000028116,19,7,0,0,1,1,3015.13906224996,1122672.658801146,2012-09-04,0,0,0,0,1,0,0,0,0,0,0,0,5,0,0,0,32,2,0,6,0,1,2,49,VRK2,-0.13800001,-1.3952,-0.46769,7,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000056972,11,7,1,0,1,1,1337.2360939431396,309256.4614031486,2010-10-17,1,0,0,0,1,2,0,0,1,0,0,0,4,0,1,0,0,0,0,28,0,0,0,38,TRAF3IP2,0.22899997,2.1434,0.80757,0,-1.0,-1.0,,
ENSG00000060718,25,7,1,0,1,1,4899.965668950595,1990918.947961699,2012-08-26,0,0,0,12,0,1,0,0,0,0,0,0,36,0,0,0,5,0,0,3,0,2,12,71,COL11A1,0.651,1.0145,-1.0206,7,0.5,0.5,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000065243,12,7,1,0,0,1,47336.27089212796,1778690.168860174,2019-04-02,0,0,0,0,2,0,0,0,0,0,2,1,0,2,0,0,3,0,0,0,0,1,2,13,PKN2,0.572,2.713,-0.082107,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000070961,22,7,1,0,0,1,4654.903581267217,1470466.6505612188,2012-07-01,7,1,2,0,36,0,0,0,0,0,0,0,4,0,0,0,1,0,0,0,0,0,4,55,ATP2B1,0.828,7.0115,1.4576,4,0.5,-1.0,,
ENSG00000077238,15,7,1,1,1,1,16929.520201624895,562534.7696387965,2018-08-13,2,2,0,0,0,0,0,0,1,0,69,0,1,0,0,0,0,0,0,0,0,2,3,80,IL4R,0.397,1.2261,1.0353,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000079689,8,7,0,0,0,1,11056.124104522269,1129585.974638378,2020-12-11,0,0,0,0,2,1,1,0,0,1,0,0,1,0,0,0,1,0,0,0,0,0,2,9,SCGN,-0.375,0.28811,0.077009,0,0.5,0.0,,
ENSG00000081985,14,7,1,0,0,1,1224.8497854077252,215157.94798738702,2009-05-20,10,0,0,0,3,0,1,0,0,1,0,4,6,0,0,0,0,0,0,16,0,0,0,41,IL12RB2,-0.013000011,1.2949,0.68534,2,0.5,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000089022,12,7,1,0,0,1,8646.194612455462,327782.2658449885,2015-12-21,2,0,0,0,1,1,0,0,0,0,7,0,2,0,0,0,0,0,0,1,0,0,3,17,MAPKAPK5,0.39600003,1.8547,0.46858,3,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000091164,10,7,1,0,0,1,15603.785966148887,235397.69820205137,2017-10-09,0,0,0,5,1,0,0,0,0,0,0,0,2,0,1,0,4,0,0,2,0,0,1,16,TXNL1,0.323,1.8161,0.56307,7,-1.0,-1.0,Signal Transduction;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9013422;R-HSA-9706574
ENSG00000096968,16,7,1,0,1,1,1169.63707493229,562534.7696387965,2008-06-29,9,0,0,0,0,0,2,0,0,0,3,1,0,0,0,1,0,0,0,18,0,0,5,39,JAK2,0.15200001,-0.029992,-0.55164,38,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;MAPK1 (ERK2) activation;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202;R-HSA-112411;R-HSA-6785807
ENSG00000101489,15,7,1,0,0,1,14959.796450585092,1122672.658801146,2019-02-04,0,0,0,0,2,0,2,0,0,0,2,0,0,0,0,0,16,3,0,1,0,2,0,28,CELF4,0.454,2.8751,-0.15791,0,0.5,0.0,,
ENSG00000101665,38,7,0,0,0,1,1889.5238095238096,645988.1975077938,2007-10-14,53,0,0,0,12,0,3,1,0,0,0,0,0,0,0,0,0,0,2,5,0,0,6,82,SMAD7,0.561,0.87584,-2.6957,7,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-2173796;R-HSA-2173793;R-HSA-597592
ENSG00000102882,9,7,1,1,0,1,11635.351260982607,574170.6270919729,2023-01-18,1,0,0,0,0,0,1,0,0,0,2,0,1,0,1,0,0,0,4,0,0,0,1,11,MAPK3,0.065,2.018,0.17864,59,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);ERKs are inactivated;Disease;Response of Mtb to phagocytosis;Signaling by Interleukins;Infection with Mycobacterium tuberculosis;Cytochrome c-mediated apoptotic response;Activation of the AP-1 family of transcription factors;Gastrin-CREB signalling pathway via PKC and MAPK;RNA Polymerase I Promoter Opening;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;ISG15 antiviral mechanism;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-202670;R-HSA-1643685;R-HSA-9637690;R-HSA-449147;R-HSA-9635486;R-HSA-111461;R-HSA-450341;R-HSA-881907;R-HSA-73728;R-HSA-73864;R-HSA-73854;R-HSA-1169408;R-HSA-9006934;R-HSA-5663202;R-HSA-2173796;R-HSA-2173793
ENSG00000105656,11,7,1,0,0,1,13883.57970142381,502231.5406594711,2017-12-06,1,0,0,0,10,0,0,0,2,0,0,0,5,0,1,0,0,0,0,1,0,0,3,23,ELL,0.53400004,0.16474,-1.355,13,-1.0,-1.0,Generic Transcription Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Pausing and recovery of HIV elongation;Tat-mediated HIV elongation arrest and recovery;HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;RNA polymerase II transcribes snRNA genes;HIV Life Cycle;Late Phase of HIV Life Cycle;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-212436;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-167290;R-HSA-167243;R-HSA-167287;R-HSA-167238;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-6807505;R-HSA-162587;R-HSA-162599;R-HSA-6781827
ENSG00000105989,11,7,1,0,0,1,8479.376416968564,355284.1215006515,2012-11-01,12,0,0,0,1,0,0,2,0,0,3,0,9,0,0,0,0,0,0,1,0,0,2,30,WNT2,0.48900002,1.9654,0.83855,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000109684,13,7,1,0,0,1,636.1886490807354,381165.6245253304,2012-10-09,0,0,0,0,0,0,0,0,0,13,0,1,8,0,1,0,5,0,0,1,0,0,1,30,CLNK,-0.30799997,-0.042842,-1.113,0,0.5,0.5,,
ENSG00000110092,23,7,1,0,0,1,3996.48,1424218.0900670097,2010-05-09,37,0,0,4,1,14,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,59,CCND1,0.39099997,1.2714,-0.93749,17,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of MITF-M-dependent genes involved in cell cycle and proliferation;Interleukin-4 and Interleukin-13 signaling;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9825892;R-HSA-6785807;R-HSA-8878159
ENSG00000110693,14,7,1,0,0,1,22650.1728716785,756470.9740366563,2018-08-13,2,0,0,0,5,0,0,0,0,0,0,0,5,0,0,0,2,0,0,1,0,1,1,17,SOX6,0.835,3.2951,0.85291,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000116016,10,7,1,0,0,1,606.6666666666666,645988.1975077938,2010-12-05,10,1,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,2,17,EPAS1,0.634,0.22063,-1.1221,7,0.5,-1.0,,
ENSG00000117360,8,7,1,0,0,1,30268.2752942673,1910759.9043975426,2018-08-13,1,0,0,0,1,0,0,0,0,0,0,0,3,0,0,0,1,0,0,1,0,2,2,11,PRPF3,0.913,5.0043,1.0757,1,-1.0,-1.0,,
ENSG00000118007,22,7,1,0,0,1,68837.80679818468,633132.2332759313,2014-07-22,0,0,0,0,3,0,2,0,0,0,0,0,3,0,0,0,10,0,0,2,0,1,5,26,STAG1,0.841,4.1712,0.12305,7,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000118245,19,7,0,0,0,1,3624.878124194795,367949.31877243903,2007-05-27,40,0,0,0,3,0,0,1,0,0,0,0,5,0,0,0,2,0,0,6,0,0,2,59,TNP1,0.227,0.34047,0.49999,0,1.0,0.5,,
ENSG00000119772,20,7,1,0,0,1,17831.529851792977,1424218.0900670097,2010-11-21,4,0,0,0,3,1,0,0,0,0,0,0,3,0,3,0,0,0,0,3,0,0,4,21,DNMT3A,-0.998,1.997,1.1808,6,-1.0,-1.0,Gene expression (Transcription);Disease;Post-translational protein modification,R-HSA-74160;R-HSA-1643685;R-HSA-597592
ENSG00000121966,12,7,0,0,0,1,1343.4903047091414,328052.24452619,2016-03-22,2,0,1,0,1,0,0,0,3,0,2,0,2,0,1,0,0,0,0,0,0,0,0,12,CXCR4,0.486,2.6131,1.0761,7,0.5,-1.0,Signal Transduction;Developmental Biology;Disease;HIV Life Cycle;Formation of definitive endoderm,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-162587;R-HSA-9823730
ENSG00000124203,21,7,1,0,1,1,12542.479619943082,500292.45069431677,2012-11-01,0,0,4,0,17,0,0,0,0,0,1,1,0,0,1,0,0,0,0,10,0,0,4,38,ZNF831,0.17799997,-0.5355,-0.83931,0,0.5,0.5,,
ENSG00000129187,12,7,0,0,0,1,4847.839591114606,15443.951531069062,2015-08-24,2,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,0,0,1,0,0,0,8,DCTD,-0.924,0.3003,0.91052,1,-1.0,-1.0,Interconversion of nucleotide di- and triphosphates;Metabolism of nucleotides,R-HSA-499943;R-HSA-15869
ENSG00000130592,19,7,1,1,1,1,959.7167584579072,756470.9740366563,2011-02-06,13,1,0,0,16,0,0,0,1,2,0,0,0,0,0,0,0,0,2,4,0,0,0,39,LSP1,-0.037999988,-0.024965,-0.29664,0,0.5,0.0,,
ENSG00000132466,8,7,0,0,0,1,67624.25227505878,521818.7070055739,2023-01-18,3,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,1,1,0,0,2,10,ANKRD17,0.88199997,7.0131,1.0585,0,-1.0,-1.0,,
ENSG00000133392,10,7,0,0,1,1,29713.571045654095,756470.9740366563,2021-04-22,1,0,0,0,4,0,1,3,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,12,MYH11,0.623,3.4316,-0.21595,7,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000137033,26,7,0,1,1,1,3198.048859934853,562534.7696387965,2010-09-23,6,2,0,0,0,0,0,0,0,0,101,0,0,0,6,0,0,0,0,1,0,3,9,128,IL33,-0.684,-0.60998,-0.84618,4,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-597592
ENSG00000137309,10,7,1,0,0,1,9758.376437427909,1424218.0900670097,2018-08-13,2,0,0,0,3,5,1,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,1,15,HMGA1,0.565,1.0407,-0.49001,7,0.5,-1.0,Disease;Interactions of Vpr with host cellular proteins;Vpr-mediated nuclear import of PICs;HIV Life Cycle,R-HSA-1643685;R-HSA-176033;R-HSA-180910;R-HSA-162587
ENSG00000137869,18,7,1,0,0,1,6836.6103560984,1470466.6505612188,2016-05-02,6,1,0,0,1,0,0,0,0,0,0,0,14,0,0,0,1,0,0,4,0,0,6,33,CYP19A1,0.20700002,1.2112,0.73527,3,1.0,0.0,Disease;Metabolism of steroids,R-HSA-1643685;R-HSA-8957322
ENSG00000138771,10,7,1,0,1,1,37912.391866997306,782476.8109259979,2017-12-06,2,0,0,0,4,2,1,0,0,0,0,4,0,0,0,0,0,0,2,2,0,0,0,17,SHROOM3,0.552,0.8748,0.051565,0,-1.0,0.0,,
ENSG00000140332,12,7,0,0,0,1,75639.5973879004,1076472.0138856068,2018-02-26,3,0,0,1,3,0,0,0,0,0,3,0,0,0,0,0,4,0,0,1,1,0,0,16,TLE3,0.724,3.1232,-0.64545,5,0.5,-1.0,Signal Transduction;Formation of the beta-catenin:TCF transactivating complex,R-HSA-162582;R-HSA-201722
ENSG00000141655,16,7,1,1,0,1,1173.5007132667617,1470466.6505612188,2010-05-02,0,0,0,0,0,1,0,0,2,0,7,0,5,0,3,0,0,0,0,7,0,0,5,30,TNFRSF11A,0.12099999,0.28632,-0.26848,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000142611,20,7,0,0,1,1,2010.4597478176527,500292.45069431677,2011-06-12,0,0,0,5,23,0,0,0,0,0,1,0,1,0,0,0,2,0,0,3,0,0,8,43,PRDM16,0.696,1.5748,-0.13659,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000143156,21,7,1,0,0,1,8336.67534947153,500292.45069431677,2018-08-13,4,0,0,0,5,0,0,4,1,0,0,0,1,0,0,7,0,0,0,0,0,0,10,32,NME7,-0.19700003,0.57874,0.22868,2,-1.0,-1.0,,
ENSG00000143207,9,7,1,0,0,1,383158.3001114715,1122672.658801146,2019-02-04,0,1,0,0,2,0,2,1,0,0,0,0,0,0,0,0,8,0,0,0,0,1,1,16,COP1,0.44300002,-0.35153,-1.6111,2,-1.0,-1.0,,
ENSG00000144218,12,7,1,0,0,1,2209.8301559792026,765591.3646788632,2012-12-01,0,0,0,0,0,4,0,0,0,0,1,2,11,0,1,0,0,0,0,4,0,0,4,27,AFF3,0.68200004,2.2654,0.024574,0,-1.0,0.0,,
ENSG00000145022,11,7,0,0,0,0,15443.951531069062,15443.951531069062,2015-08-24,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,0,0,1,0,0,0,7,TCTA,-0.439,0.068308,0.36121,0,-1.0,-1.0,,
ENSG00000148120,12,7,1,0,0,1,2954.9908814589667,756470.9740366563,2012-04-29,0,0,0,0,28,0,0,2,0,0,0,1,1,0,0,0,1,0,0,5,0,1,0,39,AOPEP,0.021000028,0.58132,0.72417,0,-1.0,-1.0,,
ENSG00000148513,11,7,0,0,0,1,15443.951531069062,15443.951531069062,2015-08-24,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,0,0,1,0,0,0,7,ANKRD30A,-0.29499996,-1.4742,-1.7334,0,1.0,0.5,,
ENSG00000151320,16,7,1,0,1,1,17634.65533758174,756470.9740366563,2016-05-16,1,0,0,0,23,2,0,0,0,0,1,0,0,0,0,0,2,0,3,0,0,0,2,34,AKAP6,0.633,1.1311,1.1811,0,0.75,0.0,,
ENSG00000151623,13,7,1,0,1,1,18319.91238877481,381165.6245253304,2016-05-16,4,0,0,0,5,1,0,0,0,18,1,0,0,0,1,0,0,0,0,2,0,0,0,32,NR3C2,0.732,2.9983,0.47482,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000153064,9,7,1,0,1,1,11252.882952659449,384314.83364002535,2012-11-01,0,1,0,0,0,0,0,0,0,0,0,9,2,1,0,0,1,0,0,3,0,0,1,18,BANK1,-0.15600002,-0.49936,-0.71495,0,0.75,0.0,,
ENSG00000156113,12,7,1,0,0,1,3400.4411583487367,714039.8414241908,2014-08-10,0,0,0,1,1,2,0,0,0,0,0,0,4,0,0,0,1,0,0,2,0,0,5,16,KCNMA1,0.669,6.5284,0.5146,4,0.5,0.0,,
ENSG00000162104,9,7,1,0,0,1,65794.6850968381,574170.6270919729,2017-10-23,1,0,0,0,5,0,0,0,0,1,0,0,1,0,1,0,0,0,5,1,0,0,0,15,ADCY9,0.397,1.9141,-1.9139,14,0.5,-1.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000162599,22,7,0,0,0,1,2549.1573998257613,756470.9740366563,2018-12-20,0,0,0,1,2,0,0,0,0,22,0,0,2,0,0,0,4,0,0,8,0,0,6,45,NFIA,0.825,3.628,0.44515,2,-1.0,-1.0,Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000163064,13,7,0,0,0,1,6375.455618665776,191895.42310022408,2015-10-26,2,0,0,0,0,0,0,0,3,0,0,1,1,0,0,0,0,0,0,3,6,0,1,17,EN1,0.27600002,-0.61377,-2.533,0,0.75,0.5,,
ENSG00000164056,10,7,0,0,0,1,14416.617514965152,672632.4785173276,2018-12-12,2,0,0,0,3,0,5,0,1,0,0,0,1,0,0,0,0,0,0,2,0,0,2,16,SPRY1,-0.22399998,-0.64648,-0.13021,1,0.5,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000164307,19,7,1,1,1,1,2491.407942238267,500292.45069431677,2010-01-10,0,0,0,7,3,1,0,0,0,0,0,0,10,0,1,0,0,0,0,6,0,0,5,33,ERAP1,0.052999973,1.8456,0.64093,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000164756,11,7,1,0,1,1,14440.44839102838,1424218.0900670097,2010-06-27,0,0,2,4,0,53,0,0,0,0,0,2,0,0,0,0,4,0,1,1,0,0,0,67,SLC30A8,0.078999996,0.5869,0.7723,2,1.0,0.5,Zinc transporters,R-HSA-435354
ENSG00000164761,11,7,1,1,0,1,20828.67089766055,381165.6245253304,2019-03-28,2,0,0,0,0,0,0,0,0,2,1,0,1,0,1,0,0,0,0,6,2,0,0,15,TNFRSF11B,0.45700002,1.1201,0.20113,1,0.75,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000166037,15,7,0,0,0,0,1455.4894671623297,381165.6245253304,2012-05-06,2,0,0,0,1,0,0,0,1,15,0,0,2,0,3,0,0,0,0,2,0,0,0,26,CEP57,0.26,0.050453,-0.41337,7,-1.0,-1.0,,
ENSG00000168056,13,7,1,1,1,1,11608.613380386345,1424218.0900670097,2018-10-29,2,0,0,10,0,2,0,0,0,0,0,0,7,0,0,0,2,0,0,4,0,0,2,29,LTBP3,0.176,0.90009,-2.128,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000168811,10,7,1,0,0,1,1224.8497854077252,169088.90478978804,2008-03-02,12,0,0,1,2,0,0,0,0,0,0,4,0,0,2,0,0,0,0,8,0,0,2,31,IL12A,-0.13199997,0.93039,0.83942,4,0.5,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000169340,17,7,1,0,1,1,12120.972557134543,515513.2178404211,2016-01-21,0,2,0,0,3,2,0,0,0,1,0,38,0,0,0,1,0,0,0,0,0,0,2,49,PDILT,0.008000016,0.28112,0.26025,0,1.0,0.5,,
ENSG00000173093,9,7,0,0,0,1,10637.67957090616,144712.0807038357,2021-09-30,2,0,0,0,1,0,0,0,0,2,0,0,2,0,1,0,0,0,0,1,0,0,3,12,CCDC63,-0.051,1.1385,0.94075,0,1.0,0.5,,
ENSG00000174943,8,7,1,0,0,1,58427.61478235146,427337.4491868293,2014-07-22,0,0,0,0,2,0,0,0,0,0,2,0,2,0,0,0,3,0,1,0,1,0,1,12,KCTD13,0.287,2.2521,0.88563,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000176681,9,7,1,0,0,1,22691.275708596862,756470.9740366563,2015-03-17,2,0,0,0,1,0,0,0,0,3,0,0,1,0,0,0,3,0,0,1,0,0,1,12,LRRC37A,-0.42400002,2.6267,2.2264,0,0.5,0.0,,
ENSG00000177508,12,7,1,0,0,1,3923.397438503761,1424218.0900670097,2013-03-03,9,0,0,0,0,1,1,0,0,0,0,0,4,0,0,0,0,0,2,3,0,0,1,21,IRX3,-0.003000021,-1.7725,-3.5706,0,0.5,0.0,,
ENSG00000184719,15,7,0,0,0,1,16417.447913521348,521818.7070055739,2009-05-10,8,0,0,0,0,6,0,5,0,0,0,1,0,0,0,0,0,0,0,1,0,1,2,24,RNLS,-0.20599997,0.45731,0.30381,1,-1.0,-1.0,,
ENSG00000185338,12,7,1,0,0,1,8565.645362637362,237176.1991038335,2012-04-06,3,0,0,0,0,0,1,0,1,0,1,0,0,0,1,0,0,0,0,12,0,0,1,20,SOCS1,-0.47300005,-2.7673,-4.3144,12,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9006934;R-HSA-6785807
ENSG00000185499,14,7,1,0,0,1,20116.397853009086,341207.7500533011,2017-01-09,4,1,0,0,0,0,7,0,0,0,0,1,8,0,0,0,0,0,0,4,0,0,4,29,MUC1,0.036000013,-1.0418,-1.4956,7,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-597592;R-HSA-6785807
ENSG00000187609,15,7,1,0,1,1,18906.903981197203,1076472.0138856068,2019-06-01,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,7,0,0,1,0,3,3,17,EXD3,-0.37300003,-2.1106,-2.7774,0,-1.0,0.0,,
ENSG00000189283,11,7,0,0,0,1,15866.724081734988,1122672.658801146,2016-05-16,0,0,0,0,1,1,1,0,0,0,0,0,0,2,0,0,9,0,1,0,0,0,2,17,FHIT,-0.57000005,-1.358,-0.51931,0,1.0,-1.0,,
ENSG00000196588,15,7,1,0,0,1,15866.724081734988,394357.452283155,2013-04-01,15,0,0,0,2,0,1,0,0,0,0,0,0,0,1,0,3,0,0,1,0,0,2,25,MRTFA,0.611,-0.061525,-3.0624,2,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000197375,19,7,1,0,1,1,7741.739669934235,562534.7696387965,2008-06-29,4,3,0,0,2,0,0,0,5,0,7,0,0,0,0,0,0,0,0,8,0,0,3,32,SLC22A5,0.037,0.86805,0.7013,3,0.5,0.0,Disease;Organic cation transport;Carnitine shuttle,R-HSA-1643685;R-HSA-549127;R-HSA-200425
ENSG00000197915,17,7,0,0,1,1,1647.8991596638655,562534.7696387965,2015-01-08,1,5,0,0,0,0,0,0,10,0,11,0,0,0,2,0,0,0,0,2,0,0,3,34,HRNR,-0.951,-7.1812,-4.0771,1,,,Immune System,R-HSA-168256
ENSG00000197959,13,7,1,0,0,1,7118.174881239361,1424218.0900670097,2020-06-15,6,0,0,3,2,3,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,21,DNM3,0.311,2.3973,-0.37823,5,0.5,0.0,Signal Transduction;Immune System;Developmental Biology;Recycling pathway of L1;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-437239;R-HSA-9006934
ENSG00000205592,12,7,0,0,1,1,15443.951531069062,78751.06843456876,2010-11-21,1,0,0,0,0,1,0,0,0,1,0,1,1,0,1,0,0,0,0,8,0,0,0,14,MUC19,,2.851,2.7555,0,0.75,0.5,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000213626,9,7,1,0,0,1,2209.8301559792026,295550.4496098593,2011-02-24,0,1,0,0,2,0,0,0,0,0,1,4,6,0,2,0,0,0,0,0,0,0,5,21,LBH,-0.07099998,0.88419,-0.084562,0,-1.0,-1.0,,
ENSG00000256762,11,7,0,0,1,1,3328.0781640536243,448058.917711015,2011-06-19,0,1,0,0,2,1,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,4,11,STH,-0.954,0.7855,1.796,0,0.5,1.0,,
ENSG00000275410,22,7,0,0,0,1,3711.688577586207,1424218.0900670097,2007-07-01,120,0,0,3,0,41,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,1,1,170,HNF1B,0.76100004,2.0791,-0.70235,6,0.5,0.0,Developmental Biology;Regulation of gene expression in early pancreatic precursor cells,R-HSA-1266738;R-HSA-210747
ENSG00000284779,11,7,0,0,0,1,1505.218309859155,15443.951531069062,2007-07-15,1,0,0,0,0,2,0,0,0,1,0,1,1,0,1,0,0,0,0,1,0,0,0,8,ENSG00000284779,-0.697,-0.31564,-0.24932,0,,,,
ENSG00000011523,11,6,1,0,1,1,25445.331593824743,765591.3646788632,2017-04-17,1,0,0,1,22,11,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,38,CEP68,0.37300003,0.45771,-0.043008,0,-1.0,-1.0,,
ENSG00000038295,6,6,1,0,0,1,2551.671904944423,235397.69820205137,2013-05-28,0,0,0,0,2,2,0,0,0,0,0,0,1,0,2,0,1,0,0,0,0,0,2,10,TLL1,0.533,1.7387,-0.26006,4,0.5,0.0,,
ENSG00000041357,14,6,1,0,0,1,8440.605502818025,598869.4096893278,2017-06-12,6,1,0,0,2,0,0,0,0,0,3,0,1,0,0,0,1,0,0,0,0,0,0,14,PSMA4,0.59099996,2.8455,0.41038,62,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000065029,8,6,1,0,1,1,24267.559108327496,1424218.0900670097,2011-11-06,0,0,0,0,0,2,0,0,0,0,1,2,3,0,0,0,0,0,0,1,0,0,2,11,ZNF76,-0.19700003,0.92353,1.1882,0,-1.0,-1.0,,
ENSG00000078142,8,6,0,0,0,1,85474.33432267047,1076472.0138856068,2021-01-21,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,3,0,2,0,0,1,1,10,PIK3C3,-0.003000021,1.8019,0.13953,11,-1.0,-1.0,Signal Transduction;Immune System;Synthesis of PIPs at the Golgi membrane;Disease;Translation of Replicase and Assembly of the Replication Transcription Complex_9679504;Translation of Replicase and Assembly of the Replication Transcription Complex_9694676;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1660514;R-HSA-1643685;R-HSA-9679504;R-HSA-9694676;R-HSA-9006934
ENSG00000086205,7,6,1,0,1,1,48565.66499166897,1424218.0900670097,2022-10-12,0,0,0,1,5,2,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,11,FOLH1,0.199,3.3627,1.5308,1,0.5,0.0,,
ENSG00000087460,9,6,1,0,0,1,12620.35781065477,765591.3646788632,2018-10-08,0,0,0,0,5,3,7,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,2,19,GNAS,0.698,4.8425,-0.76227,13,-1.0,-1.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000087494,16,6,0,0,0,1,14697.947851329636,367949.31877243903,2013-04-01,21,0,0,3,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,1,0,0,5,34,PTHLH,0.44199997,0.32316,0.12661,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000100311,11,6,1,0,0,1,5426.200199914322,378712.0243337037,2010-11-21,1,0,0,5,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,15,0,0,1,24,PDGFB,0.527,0.82769,-0.18554,8,-1.0,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000100599,10,6,1,0,1,1,3466.7409637187616,562534.7696387965,2015-04-01,4,0,0,0,0,0,0,1,0,0,8,0,1,0,0,0,1,0,0,1,0,0,0,16,RIN3,0.13700002,1.2056,0.1779,1,0.5,0.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000100906,15,6,1,0,0,1,6131.4565483476135,322220.1169395476,2010-10-17,0,0,0,0,0,2,0,0,1,0,7,0,2,0,0,0,0,0,0,26,0,0,4,42,NFKBIA,0.5,0.66475,-1.8262,14,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-597592
ENSG00000101323,16,6,0,0,0,1,3823.6404948245395,473900.221403792,2012-12-23,21,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,2,0,0,2,0,0,1,29,HAO1,-0.21899998,-0.0041752,0.17498,2,1.0,0.5,Peroxisomal protein import,R-HSA-9033241
ENSG00000103460,26,6,0,0,0,1,2298.97385620915,1778690.168860174,2007-05-27,56,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,21,0,0,6,0,0,1,86,TOX3,0.53,0.61112,-0.67992,0,0.5,0.0,,
ENSG00000104313,7,6,1,0,0,1,3400.4411583487367,1424218.0900670097,2014-08-10,0,0,0,1,1,4,2,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,11,EYA1,0.709,1.3988,0.29229,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000107566,9,6,0,0,1,1,28863.30790298137,1424218.0900670097,2020-06-15,1,0,0,0,0,4,4,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,3,15,ERLIN1,-0.049000025,1.5345,-0.78054,2,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000107679,8,6,1,0,1,1,31971.308488731265,1424218.0900670097,2017-05-31,0,0,0,2,0,10,1,0,0,3,0,0,0,0,0,0,0,0,0,1,0,0,2,19,PLEKHA1,0.04400003,0.21443,0.76759,1,-1.0,-1.0,,
ENSG00000108375,11,6,1,1,1,1,3142.70544462942,521818.7070055739,2022-04-04,2,0,1,0,4,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,6,15,RNF43,0.36799997,2.7099,1.2059,2,0.5,0.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000113161,14,6,1,0,0,1,21602.64405680352,895916.2144062951,2018-08-13,0,0,0,0,3,2,1,0,0,0,0,0,0,0,0,0,0,0,3,7,0,0,8,24,HMGCR,0.553,4.235,0.94001,4,0.5,-1.0,Developmental Biology;Cholesterol biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-1266738;R-HSA-191273;R-HSA-8957322;R-HSA-1655829
ENSG00000117971,8,6,1,0,0,1,7199.506564314878,539013.8231881644,2017-12-06,1,0,0,0,2,0,0,1,0,0,2,0,0,0,0,0,2,0,0,0,0,0,3,11,CHRNB4,0.22799999,1.7163,-0.007388,4,0.5,0.5,Immune System,R-HSA-168256
ENSG00000124181,8,6,1,1,0,1,122088.395356851,634722.4486407059,2018-08-13,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,2,8,PLCG1,0.496,3.7025,-0.12679,35,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Role of second messengers in netrin-1 signaling;ISG15 antiviral mechanism;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-418890;R-HSA-1169408;R-HSA-9006934;R-HSA-5663202
ENSG00000125618,14,6,1,0,0,1,4634.000517221562,1778690.168860174,2020-09-04,7,0,0,0,1,0,0,8,0,2,0,0,0,0,0,0,3,0,0,0,0,0,2,23,PAX8,0.58500004,0.63944,-1.2739,2,0.75,0.0,Developmental Biology,R-HSA-1266738
ENSG00000127528,8,6,1,0,1,1,12604.830849636273,295550.4496098593,2018-09-13,3,0,0,0,1,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,2,9,KLF2,-0.11899996,-2.7144,-4.9361,0,-1.0,0.0,,
ENSG00000128918,12,6,1,0,1,1,2469.75,598869.4096893278,2014-04-13,2,0,0,0,1,0,4,0,0,0,0,0,17,0,0,0,0,0,0,0,0,2,2,28,ALDH1A2,0.41900003,1.327,-1.5143,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000134259,22,6,1,0,1,1,4520.7839403316675,1470466.6505612188,2017-12-06,0,0,0,0,9,0,0,3,0,0,0,0,15,0,0,0,1,0,0,2,0,0,16,46,NGF,0.32999998,1.243,-0.1063,19,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000134363,6,6,1,1,0,1,17710.3869470848,1424218.0900670097,2018-12-12,1,0,0,0,1,1,0,0,1,0,0,0,2,0,0,0,0,0,0,3,0,0,0,9,FST,0.74,2.7539,0.87999,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000134532,33,6,0,0,0,1,2464.7717968157694,1470466.6505612188,2011-12-25,0,0,0,0,3,0,0,0,0,0,0,0,46,0,0,0,10,0,0,1,0,13,10,83,SOX5,0.796,3.8086,0.06415,0,0.5,0.0,,
ENSG00000134871,32,6,1,0,1,1,2532.481590574374,756470.9740366563,2015-09-07,6,0,0,8,81,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,23,120,COL4A2,0.38200003,2.4069,-0.099654,14,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000138075,21,6,1,0,1,1,5627.692920383277,464892.4593283075,2016-04-16,0,0,0,0,3,2,10,0,0,0,0,0,0,0,0,0,0,0,4,24,0,0,14,57,ABCG5,-0.21899998,-1.0834,-1.7539,4,0.75,0.5,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000139233,9,6,0,0,0,1,14136.290802453483,1778690.168860174,2018-08-13,2,1,0,0,7,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,14,LLPH,-0.075999975,0.34358,0.80135,0,-1.0,-1.0,,
ENSG00000139304,7,6,0,0,1,1,7210.189329942696,287644.60739043093,2020-06-15,0,0,0,0,1,1,0,0,0,0,0,0,0,6,0,0,3,0,0,0,0,1,2,14,PTPRQ,0.059000015,-0.21493,0.17913,0,0.5,0.5,,
ENSG00000146215,10,6,1,0,1,1,37912.391866997306,562534.7696387965,2019-09-26,0,0,0,0,2,0,0,0,0,0,2,0,7,0,0,0,4,0,1,0,0,0,4,20,CRIP3,-0.036000013,-0.012232,0.34913,0,0.5,0.0,,
ENSG00000148219,21,6,0,0,0,1,15105.25930955241,1424218.0900670097,2013-06-23,4,0,0,0,9,2,0,0,0,0,0,0,17,0,0,0,13,0,0,0,0,0,12,57,ASTN2,0.527,1.3528,-0.54935,0,-1.0,-1.0,,
ENSG00000151276,6,6,0,0,0,1,890.6902263942574,1129585.974638378,2017-02-28,0,0,1,1,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,6,MAGI1,0.50600004,0.90507,-0.52874,0,-1.0,0.0,,
ENSG00000151612,17,6,0,0,0,1,4991.807042932947,521818.7070055739,2020-10-05,7,0,0,0,12,0,2,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,2,26,ZNF827,0.803,2.964,0.94113,0,-1.0,0.0,,
ENSG00000153107,10,6,0,0,0,1,11608.613380386345,322220.1169395476,2019-03-28,0,0,0,1,0,0,0,0,8,0,4,0,0,0,2,0,0,0,0,2,0,0,6,23,ANAPC1,0.727,5.2641,3.4036,18,-1.0,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000153815,9,6,1,0,0,1,62627.34914844415,1424218.0900670097,2017-05-31,0,0,0,0,9,14,1,0,0,0,0,0,2,0,0,0,0,0,0,2,0,1,0,29,CMIP,0.811,1.5063,-2.7693,0,-1.0,-1.0,,
ENSG00000154478,7,6,0,0,0,1,1173.5007132667617,1424218.0900670097,2020-06-15,0,0,0,0,2,4,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,10,GPR26,-0.29999995,1.0433,-1.1352,0,1.0,1.0,,
ENSG00000157837,10,6,1,0,0,1,36645.767033906064,1122672.658801146,2017-10-30,0,0,0,0,0,5,0,0,0,0,11,2,0,0,1,0,5,0,0,0,0,0,3,27,SPPL3,0.751,3.8659,-0.46587,0,-1.0,-1.0,,
ENSG00000159110,6,6,1,0,1,1,11170.467958564675,519652.4132779146,2020-05-13,0,35,0,0,0,0,0,0,0,0,2,1,3,0,0,0,1,0,0,1,0,0,0,43,IFNAR2,0.23900002,0.58779,0.35865,5,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease,R-HSA-1280215;R-HSA-168256;R-HSA-1643685
ENSG00000167207,11,6,1,0,1,1,1094.9990867579909,301203.06999851385,2006-10-26,0,2,0,0,0,0,5,0,0,0,6,0,1,0,0,0,0,0,0,34,0,0,2,50,NOD2,-0.032999992,0.92884,0.1242,7,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-597592
ENSG00000168702,8,6,0,0,0,1,7794.273577144567,1778690.168860174,2020-01-31,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,2,3,9,LRP1B,0.581,3.3496,-1.1709,0,0.5,0.0,,
ENSG00000168928,10,6,1,0,0,1,9436.778118284266,1424218.0900670097,2015-12-21,1,3,0,0,2,29,0,0,0,0,0,0,0,0,0,0,1,0,0,4,0,0,0,40,CTRB2,-0.16799998,-1.1148,-1.6867,2,1.0,0.0,,
ENSG00000171940,12,6,1,0,0,1,5148.813701236917,521818.7070055739,2012-08-12,5,0,0,0,0,0,0,0,2,0,7,0,0,0,4,0,0,0,0,1,0,0,3,22,ZNF217,0.763,1.7698,-1.0011,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000174482,11,6,0,0,0,1,2582.84346254169,1424218.0900670097,2018-10-08,0,0,0,2,2,11,0,0,0,0,0,1,0,0,0,0,5,0,4,0,0,0,0,25,LINGO2,0.286,0.66472,-0.49948,0,0.5,0.5,,
ENSG00000175445,29,6,1,1,1,1,5958.792867461649,1424218.0900670097,2012-03-07,0,0,0,0,41,6,1,0,0,0,0,0,0,0,0,0,0,0,4,19,0,0,20,91,LPL,-0.07500005,-0.35897,-0.5037,5,0.5,0.0,Developmental Biology;Gene expression (Transcription);Chylomicron remodeling;Plasma lipoprotein remodeling,R-HSA-1266738;R-HSA-74160;R-HSA-8963901;R-HSA-8963899
ENSG00000175600,15,6,1,0,0,1,7519.533660572241,765591.3646788632,2013-06-23,8,0,0,0,21,2,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,2,36,SUGCT,-0.14499998,-0.45968,0.0076154,0,0.5,0.0,,
ENSG00000181577,15,6,1,0,0,1,6176.301664532651,294387.2978738704,2015-01-28,2,0,0,0,0,1,0,0,0,13,0,0,1,0,0,0,0,0,0,6,0,0,2,25,LINC03040,,,,0,,,,
ENSG00000182985,12,6,1,0,0,1,52041.91017278707,572390.9560934792,2019-07-15,0,0,0,0,2,0,0,0,0,3,0,0,2,0,0,0,7,0,2,2,0,0,0,18,CADM1,0.578,2.8456,-1.0711,2,0.5,0.0,,
ENSG00000184349,7,6,1,0,0,1,576.1087314662274,1778690.168860174,2018-07-30,1,0,1,0,4,1,0,0,0,0,0,0,0,0,1,0,5,0,0,0,0,0,0,13,EFNA5,0.524,1.2368,-0.13286,3,-1.0,0.0,Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-1266738;R-HSA-3928665
ENSG00000185507,7,6,1,0,1,1,2201.6879293424927,381165.6245253304,2008-01-20,0,1,0,0,0,0,0,0,0,3,0,10,1,0,1,0,0,0,0,1,0,0,0,17,IRF7,-0.76600003,-3.5878,-4.7919,9,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Disease,R-HSA-1280215;R-HSA-168256;R-HSA-1643685
ENSG00000186088,8,6,1,0,1,1,2271.2278340632697,765591.3646788632,2017-10-30,0,0,0,1,0,1,0,0,0,0,3,0,0,0,1,0,0,0,0,1,0,0,3,10,GSAP,-0.20000005,-0.33019,-0.58677,0,-1.0,-1.0,,
ENSG00000186509,9,6,0,0,0,1,3339.9291648862936,1424218.0900670097,2016-05-16,0,0,0,0,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,1,8,OR9Q1,-0.31799996,0.44118,0.1597,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000187741,12,6,1,0,1,1,1455.4894671623297,235397.69820205137,2012-05-06,6,0,0,1,1,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,11,FANCA,-0.34399998,-6.4686,-5.6922,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000196739,14,6,1,0,0,1,61488.78712764537,1990918.947961699,2018-10-29,0,0,0,0,1,2,0,0,0,0,0,0,32,0,1,0,0,0,0,0,0,3,7,46,COL27A1,0.46100003,1.2258,-0.52873,5,0.5,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000198373,17,6,1,0,0,1,24006.171773641356,502231.5406594711,2018-08-13,0,0,0,0,13,0,3,0,0,0,0,0,11,0,0,0,1,0,0,7,0,0,4,39,WWP2,0.42799997,2.5087,0.33045,5,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000198380,16,6,1,0,0,1,13883.57970142381,415452.66715166246,2018-08-13,1,0,0,0,0,0,1,0,0,0,0,0,16,0,0,0,2,0,0,2,0,4,0,26,GFPT1,0.28399998,4.3554,0.57834,3,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000203896,8,6,1,0,0,1,17831.529851792977,1424218.0900670097,2010-11-21,4,1,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,0,6,0,0,0,14,LIME1,-0.96099997,-2.0317,-1.3629,0,1.0,0.0,,
ENSG00000205517,16,6,1,0,1,1,12542.479619943082,500292.45069431677,2017-12-06,0,0,5,0,23,0,0,0,0,1,1,0,0,0,0,0,0,0,0,7,0,0,1,38,RGL3,-0.176,-1.7807,-1.2836,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000253276,17,6,1,0,0,1,31711.504552099814,500292.45069431677,2018-09-13,2,0,0,0,11,0,0,0,0,0,0,5,0,0,0,0,1,0,0,1,0,0,8,28,CCDC71L,-0.748,-1.6133,-3.0169,0,-1.0,0.0,,
ENSG00000266265,25,6,1,0,0,1,4852.554753131909,1470466.6505612188,2010-06-27,26,0,0,0,4,15,0,0,0,0,0,0,7,0,0,0,0,0,0,5,0,0,3,60,KLF14,-0.72800004,-2.8765,-3.0625,0,0.5,0.5,,
ENSG00000284713,16,6,1,0,0,1,7457.218313253012,521818.7070055739,2009-09-20,28,0,0,0,2,3,0,0,0,0,0,0,0,0,0,0,1,0,0,10,0,0,2,46,SMIM38,,,,0,1.0,0.5,,
ENSG00000006704,6,6,0,0,0,1,4179.1530052660255,1122672.658801146,2016-07-11,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,0,1,0,0,1,0,0,1,6,GTF2IRD1,0.691,3.8988,1.2939,0,0.5,0.0,,
ENSG00000041353,13,6,1,0,0,1,15603.785966148887,1122672.658801146,2019-02-04,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,10,1,0,1,0,0,1,15,RAB27B,0.037,0.024399,-0.27993,3,0.5,0.0,Rab regulation of trafficking;Post-translational protein modification,R-HSA-9007101;R-HSA-597592
ENSG00000049192,6,6,1,0,1,1,31676.163230680246,397765.9672627851,2023-01-18,0,0,0,1,1,0,1,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,1,7,ADAMTS6,0.772,4.2154,0.82479,2,0.5,0.5,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000054282,11,6,1,1,1,1,9539.551199137346,367949.31877243903,2014-07-22,5,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,6,0,0,0,0,0,2,16,SDCCAG8,0.157,0.93068,1.1739,7,-1.0,-1.0,,
ENSG00000055208,10,6,0,0,0,1,13883.57970142381,645988.1975077938,2018-06-11,5,0,0,0,10,0,0,1,0,0,0,0,4,0,0,0,0,0,0,1,0,0,2,23,TAB2,0.883,3.2248,0.11019,16,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Alpha-protein kinase 1 signaling pathway;IRAK2 mediated activation of TAK1 complex;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9645460;R-HSA-937042;R-HSA-1643685;R-HSA-449147;R-HSA-9006934
ENSG00000064999,8,6,0,0,0,1,2600.6022324354553,598869.4096893278,2021-02-03,0,0,0,0,0,2,0,0,2,0,0,2,2,0,1,0,0,0,0,2,0,0,0,11,ANKS1A,0.45099998,3.302,0.26213,0,-1.0,-1.0,,
ENSG00000067208,7,6,1,1,1,1,11635.351260982607,1424218.0900670097,2011-08-11,1,0,0,0,1,1,0,0,1,0,1,0,0,0,5,0,0,0,0,0,0,0,0,10,EVI5,0.259,1.002,0.64697,0,-1.0,-1.0,,
ENSG00000068078,16,6,1,1,1,1,24531.437185293667,1424218.0900670097,2018-10-08,2,0,0,0,0,13,0,0,0,0,0,0,5,0,0,0,0,0,0,3,0,2,3,28,FGFR3,0.542,1.1956,-3.0724,16,0.5,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000095015,21,6,1,0,1,1,8376.86909770921,895916.2144062951,2010-05-09,33,0,0,0,3,13,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,3,56,MAP3K1,0.645,1.4665,-1.048,5,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000100991,12,6,1,0,0,1,17243.0319680403,235397.69820205137,2021-04-08,4,0,0,0,6,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,5,18,TRPC4AP,0.436,1.6305,-0.29466,1,-1.0,-1.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000102554,20,6,1,0,0,1,2628.763122476447,562534.7696387965,2010-08-01,45,0,0,4,0,0,0,0,4,0,7,0,0,0,0,0,0,0,0,1,0,0,5,66,KLF5,0.481,0.21757,-0.9898,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000103335,10,6,1,0,1,1,15223.454539395489,1470466.6505612188,2018-08-13,0,0,0,0,6,0,0,0,0,1,0,0,4,0,2,0,0,0,0,0,0,1,22,36,PIEZO1,-0.16999996,-10.0,-12.934,3,-1.0,0.0,,
ENSG00000104044,24,6,0,0,1,1,5269.58845172284,408814.07183661876,2015-08-03,51,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,10,5,0,1,72,OCA2,0.13099998,0.96565,0.57116,1,1.0,0.0,,
ENSG00000108788,11,6,1,0,1,1,30532.071889750743,1424218.0900670097,2017-01-09,1,0,0,0,4,12,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,2,22,MLX,0.306,0.61771,0.17806,1,-1.0,-1.0,,
ENSG00000113361,13,6,0,1,0,1,90049.68162979394,1122672.658801146,2019-06-01,0,2,0,0,0,0,1,0,0,0,0,0,1,0,0,0,7,0,0,0,0,3,1,15,CDH6,0.48900002,3.021,0.45211,1,0.5,0.0,,
ENSG00000118513,6,6,0,0,0,1,4029.528292143121,215157.94798738702,2021-11-04,1,0,0,0,0,0,0,0,0,2,0,1,0,0,1,0,0,0,0,1,0,0,1,7,MYB,0.55700004,3.0727,0.9721,5,0.75,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000121621,10,6,0,0,1,0,29803.01405728205,1910759.9043975426,2020-01-20,0,0,0,2,3,1,0,0,0,0,4,0,3,0,0,0,4,0,0,0,0,0,0,17,KIF18A,0.272,0.68702,-0.51285,9,0.75,0.5,Signal Transduction;Immune System;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-162582;R-HSA-168256;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000122691,30,6,1,0,0,1,2201.586503948313,502231.5406594711,2012-05-31,2,0,0,0,57,0,0,0,3,0,0,0,0,2,0,0,0,0,0,6,0,0,18,88,TWIST1,-0.45099998,-0.22258,-2.6565,4,0.5,0.0,Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-6785807
ENSG00000124762,40,6,1,0,0,1,3953.154495309038,756470.9740366563,2012-05-27,17,0,0,0,59,0,0,0,0,0,1,0,3,0,0,0,0,0,0,1,0,0,14,95,CDKN1A,-0.49199998,0.82899,0.28026,26,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Regulation of MITF-M-dependent genes involved in cell cycle and proliferation;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;FOXO-mediated transcription of cell cycle genes;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-9825892;R-HSA-597592;R-HSA-6785807;R-HSA-8864260;R-HSA-9617828;R-HSA-8878159
ENSG00000124788,9,6,1,0,0,1,14698.010216795416,645988.1975077938,2016-07-11,1,0,0,0,16,0,0,0,0,0,1,1,0,0,1,0,0,0,0,1,0,0,0,21,ATXN1,0.736,1.3447,-0.48138,0,-1.0,-1.0,,
ENSG00000125755,13,6,1,0,1,1,14416.617514965152,562534.7696387965,2017-12-06,0,0,0,0,3,0,2,0,0,0,8,0,0,0,0,0,2,0,0,1,0,0,3,19,SYMPK,0.514,2.741,-1.1379,5,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature Transcript to Cytoplasm,R-HSA-73857;R-HSA-74160;R-HSA-159231;R-HSA-159234;R-HSA-72202
ENSG00000132669,7,6,1,0,1,1,7405.70837168126,360605.992793193,2016-06-20,0,0,0,1,5,0,0,0,0,0,0,0,1,0,0,0,1,0,0,3,0,0,1,12,RIN2,0.36299998,0.89466,-0.024069,1,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000136826,21,6,0,0,0,1,11956.806484439921,1470466.6505612188,2013-04-01,23,0,0,0,7,0,0,0,0,2,0,0,13,0,0,0,0,0,0,1,0,0,5,51,KLF4,0.302,-1.7631,-3.8445,4,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);FOXO-mediated transcription of cell cycle genes,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9617828
ENSG00000138829,13,6,1,1,0,1,5538.547795606575,1470466.6505612188,2018-08-13,0,0,0,0,8,0,0,0,0,1,0,0,9,0,0,0,0,0,1,1,0,0,4,24,FBN2,0.68799996,3.2951,0.022749,3,1.0,0.5,,
ENSG00000140382,8,6,1,0,0,1,16064.925920375643,1424218.0900670097,2011-08-28,0,0,0,2,1,22,0,0,0,0,0,1,0,0,0,0,2,0,0,1,0,0,0,29,HMG20A,0.41799998,1.7472,0.83459,0,-1.0,-1.0,,
ENSG00000143995,15,6,0,0,0,1,1289.474816625917,1778690.168860174,2007-07-18,10,0,0,8,0,1,0,0,0,0,0,0,3,0,0,0,53,0,0,0,0,0,3,78,MEIS1,0.772,3.1619,0.26917,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000145675,14,6,1,0,0,1,46282.676044693806,1424218.0900670097,2018-10-08,7,0,0,0,0,4,0,0,0,0,0,0,11,0,0,0,1,0,0,4,0,0,3,30,PIK3R1,0.63699996,3.4447,0.98013,77,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Regulation of signaling by CBL;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-912631;R-HSA-9006934;R-HSA-5663202;R-HSA-6785807
ENSG00000146477,23,6,1,0,0,1,3452.4952599827634,1424218.0900670097,2008-02-10,19,0,0,0,24,8,6,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,6,65,SLC22A3,-0.24399996,-0.4441,-1.9246,2,0.5,0.0,Organic cation transport,R-HSA-549127
ENSG00000146592,13,6,1,0,0,1,19875.020792566687,645988.1975077938,2018-06-11,0,0,0,2,5,0,0,0,4,0,0,0,6,0,0,0,0,0,0,2,0,0,3,22,CREB5,0.579,1.6764,0.38042,0,-1.0,0.0,,
ENSG00000147697,29,6,0,0,0,1,687.2396535129933,1470466.6505612188,2009-07-05,30,0,0,0,1,0,0,0,0,0,0,0,28,0,0,0,0,0,0,3,0,10,8,80,GSDMC,-0.14999998,-0.49517,-0.49712,0,0.5,0.5,,
ENSG00000147889,15,6,1,0,1,1,8369.05237229488,804063.9714459113,2012-09-01,11,0,0,1,3,5,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,24,CDKN2A,0.20899999,-1.3314,-1.2112,21,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Regulation of MITF-M-dependent genes involved in cell cycle and proliferation;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-9825892;R-HSA-597592;R-HSA-8878159
ENSG00000148926,13,6,1,1,0,1,42939.405891994706,672632.4785173276,2021-04-22,0,0,0,0,5,0,1,1,0,0,0,0,3,0,1,0,0,0,0,0,0,0,5,16,ADM,0.41900003,0.33158,0.40732,3,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000149295,21,6,1,0,0,1,15866.724081734988,1122672.658801146,2014-07-22,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,28,2,0,2,0,0,4,38,DRD2,0.628,3.3779,0.6601,1,0.75,0.0,Signal Transduction;Amine ligand-binding receptors,R-HSA-162582;R-HSA-375280
ENSG00000149972,12,6,1,0,0,1,1946.2731006160163,1778690.168860174,2019-07-08,1,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,7,0,0,1,0,0,1,13,CNTN5,0.26999998,-0.8051,-0.3302,1,0.5,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000150361,7,6,0,0,0,1,3628.3346187140946,1778690.168860174,2020-08-01,0,3,0,0,0,0,1,0,0,0,2,0,1,0,1,0,1,0,0,0,0,0,0,9,KLHL1,0.24900001,0.033302,-0.61898,0,1.0,0.5,,
ENSG00000151418,9,6,0,0,0,1,28923.750134754748,1778690.168860174,2012-12-01,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,2,0,0,1,0,1,3,9,ATP6V1G3,-0.80999994,0.53235,-0.29707,5,1.0,0.5,Signal Transduction;Transferrin endocytosis and recycling;Immune System;Iron uptake and transport;Amino acids regulate mTORC1;Cellular response to starvation;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-917977;R-HSA-168256;R-HSA-917937;R-HSA-9639288;R-HSA-9711097;R-HSA-9006934
ENSG00000153774,25,6,1,0,0,1,9003.713615521008,756470.9740366563,2016-06-20,1,0,0,1,33,0,0,0,0,0,7,0,3,0,0,0,0,0,0,0,0,0,10,55,CFDP1,-0.100000024,-1.3646,-2.2279,0,-1.0,-1.0,,
ENSG00000154975,12,6,0,0,0,1,1173.5007132667617,1778690.168860174,2019-09-16,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,6,0,0,4,0,4,1,18,CA10,0.31800002,1.3066,-0.48947,0,0.5,0.5,,
ENSG00000156103,6,6,1,1,0,1,1173.5007132667617,353105.3286394775,2012-12-01,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,6,0,0,1,0,0,1,11,MMP16,0.701,3.6992,0.63674,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000156218,11,6,1,0,1,1,29134.639381717512,765591.3646788632,2019-02-25,0,0,0,0,0,1,1,0,0,0,9,0,3,0,0,0,0,0,0,0,2,0,1,17,ADAMTSL3,0.30800003,1.6692,1.0412,2,-1.0,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000156515,11,6,0,0,0,1,16195.03870269788,575147.0632428399,2021-08-24,0,0,0,0,0,2,2,0,0,0,0,0,2,0,0,0,0,0,2,2,0,0,4,14,HK1,0.61300004,5.1677,1.4281,3,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000163823,7,6,1,0,0,1,2491.407942238267,493614.39488360845,2010-02-28,0,5,0,0,2,0,0,0,1,0,0,3,0,0,0,0,0,0,1,5,0,0,0,17,CCR1,-0.931,1.8322,-0.5448,3,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000164161,16,6,0,0,0,1,8671.61743288773,1424218.0900670097,2014-02-07,2,0,0,0,0,2,2,0,0,0,28,0,6,0,0,0,0,0,0,0,0,0,4,44,HHIP,0.707,1.1625,0.61427,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000164175,26,6,0,0,1,1,4056.232884097035,431284.57934287674,2016-01-29,53,0,0,0,0,0,0,0,14,0,0,0,1,0,0,0,0,0,0,3,5,0,3,79,SLC45A2,-0.021999955,-0.15802,-0.65729,1,0.5,0.5,,
ENSG00000164442,8,6,0,0,0,1,46437.13674418605,1424218.0900670097,2018-10-08,1,0,0,0,0,7,1,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,2,13,CITED2,0.412,-1.0202,-2.6072,4,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8864260
ENSG00000166165,7,6,1,0,0,1,11608.613380386345,427337.4491868293,2022-12-10,1,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,1,0,1,8,CKB,0.27600002,0.92483,-1.5011,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000169592,14,6,1,0,0,0,15866.724081734988,1778690.168860174,2017-05-22,0,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,12,0,1,1,0,0,1,19,INO80E,-0.28199995,-1.7213,-2.0306,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000169946,14,6,0,0,0,1,8798.945480071758,1424218.0900670097,2017-04-01,3,0,0,0,13,1,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,8,28,ZFPM2,0.726,1.3508,0.10587,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000171132,10,6,1,0,0,1,19719.099998411362,461914.58891516324,2017-12-06,0,0,0,5,6,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,1,0,3,18,PRKCE,0.722,4.9304,-0.030254,5,0.5,-1.0,Signal Transduction;Immune System;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-9006934
ENSG00000171316,7,6,0,0,0,1,12303.942932114907,1778690.168860174,2022-07-14,2,0,0,0,0,0,0,0,7,1,0,0,0,0,0,0,1,0,0,1,0,0,1,13,CHD7,0.89100003,3.9606,0.28497,0,0.5,0.0,,
ENSG00000177432,8,6,0,0,0,1,89519.16315227402,1424218.0900670097,2020-06-15,0,0,0,2,1,3,0,0,0,0,0,0,5,0,1,0,0,0,0,0,0,0,2,14,NAP1L5,-0.88399994,0.031314,-0.86685,0,0.5,-1.0,,
ENSG00000182010,10,6,1,0,1,1,5478.894949850431,381165.6245253304,2012-09-13,1,0,0,0,0,0,0,0,0,15,0,1,12,0,1,0,0,0,0,1,0,0,0,31,RTKN2,-0.44700003,-0.22831,0.47028,0,1.0,0.0,,
ENSG00000182247,7,6,1,0,0,1,38886.589732507324,1424218.0900670097,2012-09-01,6,0,1,2,0,45,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,56,UBE2E2,0.508,1.7121,-1.273,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000187098,12,6,0,0,1,1,1173.5007132667617,394357.452283155,2020-04-27,9,0,0,0,1,1,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,3,17,MITF,0.518,1.0386,-0.13255,10,-1.0,-1.0,Developmental Biology;Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy;Regulation of MITF-M-dependent genes involved in cell cycle and proliferation;Post-translational protein modification,R-HSA-1266738;R-HSA-9857377;R-HSA-9825892;R-HSA-597592
ENSG00000198758,10,6,0,0,0,1,1636.6024808033078,473900.221403792,2010-05-02,5,0,0,0,0,0,1,0,2,1,0,0,1,0,0,0,0,0,0,2,0,0,0,12,EPS8L3,-0.052000046,0.56071,0.52415,0,0.75,0.5,,
ENSG00000198963,9,6,0,0,0,1,33892.13656698846,1778690.168860174,2015-12-21,0,2,0,1,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,4,0,0,2,11,RORB,0.74300003,3.6678,-0.33344,2,1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000254636,22,6,1,0,1,1,1116.1902136457616,378712.0243337037,2010-04-12,0,0,0,21,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,24,0,1,8,57,ARMS2,-0.81500006,1.0534,0.29868,0,0.5,0.5,,
ENSG00000049323,13,6,1,0,1,1,5567.300805970055,1470466.6505612188,2018-10-29,0,0,0,2,0,1,3,0,0,0,0,0,14,0,0,0,0,0,0,7,0,0,2,29,LTBP1,0.269,-0.67965,-2.8717,4,0.5,0.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000064989,9,6,1,0,0,1,47408.95172709719,882833.0320407465,2017-12-06,1,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,2,11,CALCRL,0.29900002,1.9565,0.33165,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000065000,7,6,1,0,1,1,25967.06754524981,598869.4096893278,2022-04-08,2,0,0,0,1,0,0,0,0,0,0,0,5,0,0,0,1,0,0,1,0,0,1,11,AP3D1,0.55700004,1.8755,-2.0419,0,-1.0,-1.0,,
ENSG00000066382,16,6,1,0,0,1,97181.90375256384,1470466.6505612188,2019-01-21,0,0,0,0,6,1,0,0,0,0,0,10,13,0,0,0,4,0,0,0,0,0,2,36,MPPED2,0.655,1.9437,0.58236,0,0.5,0.0,,
ENSG00000069275,6,6,1,0,0,1,37368.38182683358,645988.1975077938,2014-07-27,1,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,1,0,1,5,0,0,0,12,NUCKS1,0.71500003,1.9695,0.19197,0,-1.0,-1.0,,
ENSG00000075413,11,6,1,0,0,1,28863.30790298137,598869.4096893278,2020-04-27,2,0,0,0,4,1,0,0,0,0,0,0,6,0,0,0,0,0,0,0,1,0,2,16,MARK3,0.26999998,1.6367,0.88638,10,-1.0,-1.0,Signal Transduction;Developmental Biology;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-5663202
ENSG00000083799,7,6,1,0,0,1,2506.878320343566,190631.40295152203,2011-10-23,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,8,0,0,1,13,CYLD,0.675,4.7125,1.1247,6,0.5,-1.0,Signal Transduction;Immune System;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-597592
ENSG00000087237,19,6,1,0,1,1,6176.301664532651,464892.4593283075,2011-06-10,0,3,0,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,4,15,0,0,4,40,CETP,-0.013000011,0.4353,0.27756,3,0.75,0.0,Signal Transduction;HDL remodeling;Plasma lipoprotein remodeling,R-HSA-162582;R-HSA-8964058;R-HSA-8963899
ENSG00000090104,6,6,1,0,0,1,1993.0086797624485,233499.4066209918,2008-03-02,0,0,0,0,0,1,0,0,1,0,0,1,0,0,3,0,0,0,0,5,0,0,1,12,RGS1,0.18900001,-0.0083634,-0.0045833,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000090905,9,6,1,0,1,1,39476.809958350466,1424218.0900670097,2019-04-02,0,0,0,0,1,1,0,0,0,0,2,0,4,0,0,0,1,0,0,0,0,0,3,12,TNRC6A,0.74300003,1.967,0.27419,21,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Transcriptional regulation by small RNAs;Gene Silencing by RNA,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-5578749;R-HSA-211000
ENSG00000091656,13,6,1,0,0,1,10352.610157160763,1778690.168860174,2015-04-09,28,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,1,35,ZFHX4,0.756,1.3762,-0.42099,0,-1.0,0.0,,
ENSG00000092621,11,6,1,0,0,1,1493.7220461747397,384314.83364002535,2017-02-27,0,0,0,3,0,1,0,0,0,0,0,0,8,0,1,0,7,0,0,0,0,0,2,22,PHGDH,-0.15499997,1.2168,0.87663,1,-1.0,-1.0,,
ENSG00000100116,14,6,1,0,1,1,11515.948996192528,714039.8414241908,2021-02-24,2,0,0,8,2,0,0,0,0,0,0,3,6,0,0,0,0,0,0,0,0,0,4,25,GCAT,-0.04400003,0.12555,0.3081,0,0.5,-1.0,,
ENSG00000101144,10,6,1,0,0,1,16064.020235975437,521818.7070055739,2021-02-25,2,0,0,0,0,0,1,0,2,2,0,0,0,0,0,0,0,0,0,1,0,0,4,12,BMP7,0.477,1.806,-0.22481,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000102908,13,6,1,0,0,1,22803.782307526988,765591.3646788632,2018-07-27,0,0,0,0,11,11,0,0,0,0,0,0,8,0,0,0,1,0,0,1,0,0,2,34,NFAT5,0.765,3.5972,1.0058,0,-1.0,0.0,,
ENSG00000103196,10,6,1,1,0,1,42797.80710480359,313882.50400013494,2018-08-13,0,0,0,0,3,0,8,2,0,0,0,0,0,0,1,0,0,0,0,2,0,0,13,29,CRISPLD2,0.12900001,-2.0633,-1.8966,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000103811,14,6,1,1,1,1,6387.911270008938,279825.00883385167,2008-11-02,4,0,0,0,4,7,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,4,22,CTSH,-0.26699996,0.11121,-0.99699,3,0.5,-1.0,Immune System;Surfactant metabolism,R-HSA-168256;R-HSA-5683826
ENSG00000105974,13,6,1,0,0,1,4875.494439834025,756470.9740366563,2010-09-12,0,0,0,22,42,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,68,CAV1,0.032999992,0.82289,0.88388,26,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;FOXO-mediated transcription of cell cycle genes,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-9617828
ENSG00000105976,11,6,1,0,0,1,121238.60518192011,498258.534626183,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,1,2,0,0,0,0,0,0,1,0,1,5,12,MET,0.554,2.9693,0.52691,19,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Sema4D mediated inhibition of cell attachment and migration;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Regulation of MITF-M-dependent genes involved in cell cycle and proliferation,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-416550;R-HSA-9006934;R-HSA-5663202;R-HSA-9825892
ENSG00000106460,18,6,1,0,1,1,1146.0,1778690.168860174,2018-04-16,0,0,0,0,3,6,0,0,0,0,1,0,0,0,0,0,32,0,0,2,0,0,1,45,TMEM106B,0.18699998,0.96835,-0.67334,0,-1.0,-1.0,,
ENSG00000106617,13,6,0,0,0,1,25415.17921452856,448058.917711015,2016-01-21,0,0,0,3,6,0,0,0,0,0,0,18,8,0,0,2,0,0,0,0,0,0,4,41,PRKAG2,0.41799998,2.2529,-0.33225,10,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;MTOR signalling;Carnitine shuttle,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-165159;R-HSA-200425
ENSG00000106683,7,6,1,0,0,1,29370.302598064187,155552.2805078301,2018-08-13,0,0,0,0,1,0,3,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,8,LIMK1,0.662,2.4135,0.10228,6,1.0,-1.0,Signal Transduction;Immune System;Developmental Biology,R-HSA-162582;R-HSA-168256;R-HSA-1266738
ENSG00000107954,11,6,1,0,1,1,11483.587356620728,756470.9740366563,2017-04-17,1,0,0,0,48,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,53,NEURL1,-0.036000013,-0.44985,-2.0038,6,0.5,0.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000109501,11,6,1,0,1,1,1375.764534883721,1424218.0900670097,2009-09-06,0,2,0,3,1,30,0,0,0,0,0,2,0,0,0,0,4,0,0,0,0,0,0,42,WFS1,-0.64,-5.7089,-7.4795,3,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000109787,16,6,0,0,0,1,1233.0624505928854,500292.45069431677,2013-07-14,0,0,0,0,7,1,0,0,0,0,3,0,3,0,0,0,0,0,0,17,0,0,3,34,KLF3,0.531,2.2243,1.2408,0,-1.0,-1.0,,
ENSG00000111328,8,6,1,0,0,1,53369.71648873449,1990918.947961699,2016-05-16,2,0,0,0,0,1,0,0,0,0,1,0,4,0,1,0,0,0,0,0,0,0,1,10,CDK2AP1,-0.52199996,1.3067,-0.26147,0,0.5,-1.0,,
ENSG00000112531,9,6,1,0,0,1,5854.797308952907,1424218.0900670097,2016-03-07,0,0,0,0,2,5,0,0,0,0,0,0,2,0,0,0,1,0,0,6,0,0,3,19,QKI,0.551,3.6009,-1.9233,1,0.5,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000115085,11,6,1,0,1,1,9810.646336429862,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,5,0,0,1,0,2,0,1,0,0,2,0,0,1,12,ZAP70,0.376,1.8386,-0.42637,4,0.5,0.0,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202
ENSG00000119401,18,6,0,0,0,1,15105.25930955241,1424218.0900670097,2013-06-23,5,0,0,0,9,2,0,0,0,0,0,0,11,0,0,0,1,0,0,0,0,0,10,38,TRIM32,0.26999998,1.7542,0.88128,2,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000120885,14,6,1,0,0,1,1321.7688442211056,539013.8231881644,2009-09-06,0,0,0,0,2,0,0,0,0,0,3,0,0,0,0,0,26,1,0,1,0,0,3,36,CLU,0.28399998,1.7407,0.42253,4,0.5,-1.0,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000121297,15,6,1,0,0,1,25209.39839469752,1424218.0900670097,2016-05-16,12,0,0,0,0,4,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,2,6,26,TSHZ3,0.737,2.1019,0.12918,0,0.5,-1.0,,
ENSG00000123104,7,6,1,0,0,1,341.12987769365174,645988.1975077938,2014-09-25,1,0,0,2,4,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,10,ITPR2,0.27600002,4.4861,0.3923,14,0.5,-1.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000123700,9,6,1,0,0,1,260.62953995157386,645988.1975077938,2012-08-05,0,0,0,0,8,0,1,0,0,1,0,0,0,0,2,0,0,0,0,4,0,0,10,26,KCNJ2,0.34899998,3.9425,0.49202,5,0.5,0.0,Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Inwardly rectifying K+ channels,R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-1296065
ENSG00000123908,8,6,1,0,0,1,56455.913944919754,404399.6052088398,2018-06-11,0,0,0,0,3,0,0,0,3,4,0,0,0,0,1,0,3,0,0,1,0,0,0,15,AGO2,0.898,6.9835,0.90651,21,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);MicroRNA (miRNA) biogenesis;Disease;Transcriptional regulation by small RNAs;Gene Silencing by RNA;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-203927;R-HSA-1643685;R-HSA-5578749;R-HSA-211000;R-HSA-5663202
ENSG00000125965,12,6,1,0,1,1,2506.318335752298,714039.8414241908,2018-03-20,2,0,0,0,3,0,0,0,0,0,0,0,15,0,0,0,0,0,0,1,0,4,4,29,GDF5,0.29000002,1.0668,-0.87475,1,1.0,0.5,,
ENSG00000128052,18,6,1,1,1,1,5778.567426027213,355284.1215006515,2017-05-24,9,1,0,0,0,0,0,17,0,0,0,0,7,0,0,0,0,0,0,1,0,0,2,37,KDR,0.672,2.3819,0.27541,7,-1.0,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000128654,7,6,0,0,0,1,13838.006498684637,180089.50342935527,2021-11-04,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,1,0,2,9,MTX2,-0.103000045,-0.070457,-0.65551,2,-1.0,-1.0,Cristae formation,R-HSA-8949613
ENSG00000129038,17,6,1,0,1,1,298.4535019588975,414433.58532016096,2007-08-09,0,0,0,33,9,0,0,0,0,0,1,0,0,0,1,0,0,0,0,7,0,0,5,56,LOXL1,-0.06500006,-1.249,-2.4414,2,-1.0,0.0,,
ENSG00000130589,9,6,1,0,1,1,21897.542503344637,260210.21963428933,2023-01-18,1,1,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,4,0,0,0,9,HELZ2,0.007000029,-1.4507,-2.8862,10,-1.0,0.0,Developmental Biology;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-1266738;R-HSA-8957322;R-HSA-1655829
ENSG00000131808,21,6,0,1,0,1,857.1943661971831,197775.78125685986,2015-09-29,4,0,0,0,1,0,0,16,0,0,0,0,0,0,0,0,1,0,0,5,0,0,11,38,FSHB,-0.16299999,0.37596,0.1228,3,1.0,1.0,Signal Transduction,R-HSA-162582
ENSG00000132394,22,6,1,0,0,1,3400.4411583487367,562534.7696387965,2009-09-20,19,0,0,0,0,0,0,5,0,0,10,0,0,0,1,0,0,0,0,1,0,0,4,40,EEFSEC,-0.34500003,0.57989,-0.69248,1,-1.0,0.0,,
ENSG00000132874,10,6,0,0,0,1,10835.003904419804,1424218.0900670097,2012-05-31,3,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,4,13,SLC14A2,-0.008000016,0.18451,0.24498,1,0.5,0.5,,
ENSG00000132970,8,6,1,0,0,1,116388.33957200912,383158.3001114715,2021-09-30,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,1,0,0,2,0,0,2,8,WASF3,0.64,1.5312,0.76643,5,0.5,0.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000133059,10,6,1,0,1,1,27705.23321776723,718784.6890415357,2018-10-08,4,0,0,0,2,3,1,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,14,DSTYK,0.555,2.848,0.28614,0,-1.0,-1.0,,
ENSG00000134262,10,6,1,0,0,1,33670.70607708678,574782.4268116049,2015-04-01,4,0,0,0,2,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,1,10,AP4B1,0.22299999,0.49189,0.61529,2,-1.0,-1.0,Lysosome Vesicle Biogenesis,R-HSA-432720
ENSG00000135148,12,6,0,0,0,1,5504.0130519525,269829.0934099178,2021-09-30,3,0,0,0,4,0,0,0,0,4,1,0,2,0,0,0,0,0,0,0,0,0,5,19,TRAFD1,0.251,1.577,1.5349,0,-1.0,-1.0,,
ENSG00000135426,13,6,0,0,1,1,32555.310754135273,381165.6245253304,2019-03-28,0,0,0,1,0,0,0,0,4,0,14,0,1,0,2,0,0,0,0,0,0,0,2,24,TESPA1,0.23699999,0.35254,0.32795,0,0.75,0.0,,
ENSG00000136828,8,6,1,0,0,1,3413.036507531274,1122672.658801146,2019-11-18,0,0,0,2,2,0,0,0,0,0,0,0,6,0,0,0,4,0,0,1,0,0,2,17,RALGPS1,0.64199996,3.225,1.3331,0,-1.0,-1.0,,
ENSG00000137642,9,6,0,0,1,1,1321.7688442211056,645988.1975077938,2013-10-27,0,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,1,0,1,0,0,4,23,SORL1,0.45499998,2.8426,1.1868,1,-1.0,-1.0,,
ENSG00000138031,10,6,1,0,1,1,13286.695551704217,381165.6245253304,2012-04-08,0,2,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,5,7,0,0,2,19,ADCY3,0.305,3.196,-0.59553,15,-1.0,-1.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000138386,8,6,1,0,0,1,5426.200199914322,448058.917711015,2011-03-13,4,0,0,0,1,0,0,0,0,0,0,1,3,0,0,0,1,0,0,2,0,0,0,12,NAB1,0.347,1.6701,0.7586,2,-1.0,-1.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000138592,11,6,1,1,1,1,50161.278626555366,1990918.947961699,2018-11-28,0,0,0,0,1,0,0,0,0,0,4,0,15,0,2,0,1,0,0,0,0,0,4,27,USP8,0.72,2.9342,1.586,4,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-9006934;R-HSA-597592
ENSG00000138684,14,6,0,0,0,1,2011.4836363636364,382631.1172224132,2007-06-10,1,0,0,2,0,1,0,0,0,1,4,0,0,0,0,0,0,0,0,16,0,0,0,25,IL21,0.55,1.6323,1.903,1,1.0,1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000140386,6,6,1,0,1,1,16954.933657438592,512656.0695323204,2023-01-18,0,0,0,0,0,0,3,0,0,0,1,0,1,0,0,0,0,0,1,2,0,0,1,9,SCAPER,0.334,2.2837,-0.74391,0,0.5,-1.0,,
ENSG00000140396,7,6,1,0,0,1,12724.75719835148,645988.1975077938,2020-12-03,5,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,1,10,NCOA2,0.78900003,3.6782,1.0624,20,-1.0,-1.0,Signal Transduction;Developmental Biology;Gene expression (Transcription);Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Synthesis of bile acids and bile salts;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Bile acid and bile salt metabolism;Post-translational protein modification,R-HSA-162582;R-HSA-1266738;R-HSA-74160;R-HSA-5625886;R-HSA-192105;R-HSA-8957322;R-HSA-1655829;R-HSA-194068;R-HSA-597592
ENSG00000143228,12,6,1,0,0,1,44660.84794838759,633132.2332759313,2019-12-01,2,0,0,0,0,0,1,0,0,0,0,0,5,0,0,0,3,0,0,1,0,0,1,13,NUF2,0.010999978,0.70389,0.42599,6,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000145242,8,6,0,0,0,1,11879.507365909985,557593.503930131,2021-08-24,0,1,0,0,6,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,1,0,1,12,EPHA5,0.28899997,0.71188,-1.643,3,1.0,0.5,Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-1266738;R-HSA-3928665
ENSG00000147324,8,6,1,0,0,1,22650.1728716785,765591.3646788632,2019-02-25,0,0,0,1,1,1,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,2,8,MFHAS1,0.14099997,-4.3591,-6.8592,0,-1.0,-1.0,,
ENSG00000147862,9,6,0,0,0,1,606.6666666666666,1778690.168860174,2015-01-08,0,1,0,3,0,2,0,0,0,0,0,0,0,0,0,0,3,0,0,2,0,0,2,13,NFIB,0.7,2.2398,-1.4961,2,-1.0,0.0,Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000148143,11,6,1,0,1,1,3211.7688524050027,521818.7070055739,2015-08-03,10,0,0,0,2,0,0,0,2,3,1,0,0,0,0,0,0,0,0,1,0,0,0,19,ZNF462,0.918,5.1124,0.55531,0,-1.0,0.0,,
ENSG00000148842,16,6,1,0,0,1,9098.842759071593,1122672.658801146,2010-04-04,1,0,0,0,11,0,0,0,0,0,0,0,2,0,1,0,5,0,0,0,0,0,1,21,CNNM2,0.68799996,5.0163,-1.3205,0,0.5,-1.0,,
ENSG00000150907,19,6,1,0,1,1,3505.4942792099973,397765.9672627851,2011-02-06,21,0,0,0,0,0,0,0,0,2,2,0,6,0,0,0,0,0,0,10,0,0,8,49,FOXO1,0.652,0.59544,-2.2901,11,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling;FOXO-mediated transcription of cell cycle genes,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-6785807;R-HSA-9617828
ENSG00000151322,20,6,1,0,0,1,17634.65533758174,1778690.168860174,2016-05-16,2,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,9,0,6,1,0,0,3,28,NPAS3,0.714,0.76284,-2.3678,0,0.5,0.0,,
ENSG00000151465,8,6,1,0,0,1,2554.034444851594,394357.452283155,2010-09-16,0,0,0,1,3,40,0,0,0,0,7,3,0,0,0,0,1,0,0,0,0,0,0,55,CDC123,-0.013000011,0.80762,-0.3873,0,-1.0,-1.0,,
ENSG00000152254,7,6,0,0,1,1,7914.993941688755,1424218.0900670097,2012-03-07,0,0,2,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,7,2,0,0,2,16,G6PC2,-0.679,0.060917,0.087664,1,0.75,0.5,Gluconeogenesis,R-HSA-70263
ENSG00000153944,8,6,0,0,0,1,5209.980115614254,323648.5577791949,2019-11-18,2,0,0,2,0,0,0,0,0,2,0,0,1,0,0,0,3,0,0,1,0,0,0,11,MSI2,0.353,2.3636,0.15337,1,0.5,-1.0,Signal Transduction;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9706574
ENSG00000154237,9,6,0,0,1,1,26561.371714038676,275021.63051358337,2021-11-04,1,0,0,0,0,1,1,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,3,9,LRRK1,0.36900002,2.8603,-0.295,0,-1.0,0.0,,
ENSG00000155849,12,6,1,0,0,1,16461.04650907092,381165.6245253304,2012-12-01,2,0,0,0,0,0,0,0,1,2,0,0,2,0,3,0,0,0,0,11,0,0,0,21,ELMO1,0.657,4.0945,0.51228,5,0.5,-1.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000157933,6,6,1,0,1,1,65343.824011592886,1424218.0900670097,2022-10-12,0,1,0,0,1,2,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,7,SKI,0.19099998,-1.1759,-5.7393,2,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-2173793
ENSG00000160685,15,6,1,0,1,1,70321.24039683424,521818.7070055739,2016-07-17,11,0,0,0,2,0,0,0,0,0,0,0,4,0,1,0,0,0,0,1,0,0,2,21,ZBTB7B,0.51,2.7131,1.181,0,-1.0,-1.0,,
ENSG00000162924,12,6,1,0,0,1,1851.3940005041593,309256.4614031486,2009-06-07,0,0,0,0,0,2,0,0,4,0,0,1,10,0,1,0,0,0,0,23,0,0,0,41,REL,0.584,1.7567,0.48345,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000164867,28,6,1,0,0,1,33474.53224293741,756470.9740366563,2015-09-07,0,0,0,0,43,0,0,0,0,0,1,0,2,0,1,0,0,0,0,3,0,0,9,59,NOS3,0.100000024,1.4882,-0.47993,9,0.5,0.0,Signal Transduction;Immune System;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-9006934
ENSG00000164989,9,6,1,0,1,1,3750.4,756470.9740366563,2022-10-20,2,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,1,2,9,CCDC171,-0.25,-3.182,-2.1438,0,0.5,0.0,,
ENSG00000165476,10,6,1,0,0,1,31065.503241862327,645988.1975077938,2018-06-11,0,0,0,0,5,2,1,0,0,0,0,0,3,0,0,0,0,0,0,5,0,0,3,19,REEP3,-0.18400002,0.38896,-0.21197,0,-1.0,-1.0,,
ENSG00000165995,6,6,1,0,0,1,31519.426313660828,500292.45069431677,2013-08-25,0,0,1,0,7,0,6,0,0,0,2,0,0,0,0,0,3,0,0,0,0,0,1,20,CACNB2,0.23000002,-0.71303,-0.8498,8,-1.0,0.0,"Presynaptic depolarization and calcium channel opening;Developmental Biology;Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-112308;R-HSA-1266738;R-HSA-400042
ENSG00000166923,26,6,1,0,0,1,3400.4411583487367,672632.4785173276,2014-04-15,49,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,58,GREM1,0.144,1.3876,0.052068,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000168036,17,6,1,0,0,1,30508.10029756623,473900.221403792,2015-07-07,7,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,5,4,0,2,21,CTNNB1,0.861,5.7223,1.1102,38,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Regulation of MITF-M-dependent genes involved in cell cycle and proliferation;Formation of the beta-catenin:TCF transactivating complex;Transcriptional regulation by RUNX3;Binding of TCF/LEF:CTNNB1 to target gene promoters;RUNX3 regulates WNT signaling;Formation of definitive endoderm,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202;R-HSA-9825892;R-HSA-201722;R-HSA-8878159;R-HSA-4411364;R-HSA-8951430;R-HSA-9823730
ENSG00000168918,8,6,1,1,1,1,1321.7688442211056,340825.7076940272,2019-07-30,0,0,0,0,0,0,1,0,2,0,1,0,0,0,0,0,6,0,0,1,0,0,2,13,INPP5D,0.621,3.5253,0.25392,6,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000168944,10,6,1,0,1,1,6697.381489027931,1424218.0900670097,2018-09-13,2,0,0,0,5,4,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,2,15,CEP120,0.06999999,-0.44298,0.079674,0,-1.0,-1.0,,
ENSG00000169220,20,6,1,0,0,1,3225.687880597015,384314.83364002535,2012-03-01,0,0,0,0,0,0,0,0,7,0,0,26,3,0,3,0,0,0,0,7,0,0,2,48,RGS14,0.263,0.096157,0.70907,1,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000170145,7,6,1,0,0,1,13166.73562422059,718784.6890415357,2013-06-01,1,0,0,0,1,0,1,0,0,0,8,0,0,0,1,0,0,0,0,0,0,1,0,13,SIK2,0.58599997,3.1982,1.1135,0,-1.0,-1.0,,
ENSG00000170604,10,6,0,0,0,1,53233.7642464279,338763.57771536184,2018-08-13,0,0,0,0,0,0,1,0,0,0,0,0,5,0,0,0,2,0,0,5,0,1,2,16,IRF2BP1,0.462,1.4345,-2.0991,0,-1.0,-1.0,,
ENSG00000170961,7,6,1,0,0,1,21014.7618737575,1424218.0900670097,2018-08-13,2,0,0,3,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,12,HAS2,0.57,4.4235,0.56817,1,0.5,0.0,,
ENSG00000171044,8,6,1,0,0,1,5432.024354745645,1470466.6505612188,2018-08-13,0,0,0,0,1,3,1,0,0,0,2,0,5,0,0,0,1,0,0,0,0,0,0,13,XKR6,0.361,-0.15042,-4.1515,0,-1.0,0.5,,
ENSG00000171303,16,6,1,0,0,1,33209.14092714464,756470.9740366563,2018-08-13,0,0,0,0,21,0,0,0,0,0,2,0,1,0,0,0,1,0,3,0,0,0,4,32,KCNK3,0.17400002,1.7248,-1.3702,2,1.0,0.0,,
ENSG00000171368,9,6,1,0,0,1,42518.059957017445,1470466.6505612188,2021-04-22,0,0,0,0,2,0,1,0,0,1,0,5,2,0,0,0,0,0,0,1,0,0,0,12,TPPP,0.245,0.75567,-0.78735,0,1.0,0.0,,
ENSG00000172179,16,6,0,0,0,1,989.636803874092,367949.31877243903,2008-05-09,22,0,0,0,4,0,0,0,0,0,1,0,0,0,1,0,0,0,0,7,0,0,5,40,PRL,-0.439,1.1387,0.10281,3,1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000174749,8,6,1,0,0,1,35002.83947832971,1778690.168860174,2016-05-16,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,1,0,4,14,FAM241A,-0.19200003,0.039351,-0.73912,0,-1.0,0.0,,
ENSG00000175745,11,6,0,0,0,1,95776.89591443514,1424218.0900670097,2019-11-01,1,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,5,0,0,1,0,0,1,11,NR2F1,0.867,4.6926,-0.28185,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000176678,19,6,0,0,0,1,7366.095640042161,672632.4785173276,2019-05-14,5,0,0,7,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,9,35,FOXL1,-0.84000003,-1.3059,-1.9011,0,-1.0,0.0,,
ENSG00000176909,14,6,1,0,0,1,15183.279312299912,426392.4103859523,2010-11-21,1,0,0,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,3,5,0,0,7,20,MAMSTR,-0.49199998,-1.1871,-1.7071,0,0.75,0.0,,
ENSG00000178919,21,6,1,0,0,1,764.0560607681609,645988.1975077938,2009-02-06,20,0,0,0,1,0,0,0,0,44,0,0,0,0,2,0,0,0,0,5,0,0,1,73,FOXE1,-0.926,-2.0319,-2.4536,0,1.0,0.5,,
ENSG00000179399,8,6,1,0,0,1,2209.8301559792026,1778690.168860174,2013-01-07,1,0,0,1,0,11,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,2,17,GPC5,-0.123000026,-0.2356,-0.61528,13,0.5,0.5,Signal Transduction;Disease;Release of Hh-Np from the secreting cell;Glycosaminoglycan-protein linkage region biosynthesis;HS-GAG biosynthesis;Hedgehog ligand biogenesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-162582;R-HSA-1643685;R-HSA-5362798;R-HSA-1971475;R-HSA-2022928;R-HSA-5358346;R-HSA-1638091
ENSG00000180210,21,6,1,1,1,1,11014.04703420302,235397.69820205137,2015-03-12,0,0,0,0,48,0,0,0,0,0,1,0,0,0,1,8,0,0,0,1,0,0,27,86,F2,0.448,2.7726,1.0194,14,1.0,1.0,Signal Transduction;Immune System;Disease;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000180530,14,6,1,0,1,1,19965.24128263536,718784.6890415357,2013-04-01,11,0,0,0,5,0,0,0,0,0,0,1,0,0,0,0,4,0,0,1,0,0,2,24,NRIP1,0.51100004,-0.18568,-0.19951,7,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000182612,18,6,1,0,1,1,11026.887550854353,282369.4803133209,2015-12-21,1,3,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,1,0,9,27,TSPAN10,-0.454,-1.4789,-1.9853,0,0.5,1.0,,
ENSG00000184381,10,6,1,0,0,1,4419.5476539589445,515513.2178404211,2009-07-05,9,0,0,0,1,1,1,0,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,15,PLA2G6,0.027999997,1.5252,0.52826,5,-1.0,-1.0,Immune System;Acyl chain remodelling of PC;Acyl chain remodelling of PE;Golgi-to-ER retrograde transport,R-HSA-168256;R-HSA-1482788;R-HSA-1482839;R-HSA-8856688
ENSG00000185052,7,6,1,0,0,1,1173.5007132667617,278498.5074409075,2016-05-16,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,10,0,0,1,15,SLC24A3,0.571,2.7368,-0.47644,1,-1.0,0.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000185305,8,6,1,0,0,1,37912.391866997306,1424218.0900670097,2014-02-09,1,0,0,0,1,11,2,0,0,0,0,0,2,0,0,0,0,0,2,0,0,0,0,19,ARL15,-0.30400002,0.43707,-0.5763,0,-1.0,-1.0,,
ENSG00000185920,14,6,1,0,1,1,5414.650230111769,1470466.6505612188,2017-02-24,4,0,0,0,1,1,0,0,0,0,0,0,8,0,0,0,3,0,0,0,0,0,4,21,PTCH1,0.854,3.1493,-0.19741,6,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000187391,9,6,1,0,0,1,2201.586503948313,1778690.168860174,2017-12-22,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,5,0,0,1,0,1,1,11,MAGI2,0.63100004,1.8607,-0.051562,1,0.5,0.0,,
ENSG00000196428,11,6,0,0,1,1,2201.586503948313,1424218.0900670097,2017-12-22,5,0,0,5,4,9,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,26,TSC22D2,0.779,-0.07808,-1.5438,0,-1.0,-1.0,,
ENSG00000197361,10,6,1,0,0,1,31340.65440454944,1076472.0138856068,2018-10-08,0,0,0,0,1,5,0,0,0,0,0,0,0,0,1,0,6,0,0,1,0,0,1,15,FBXL22,-0.73599994,-1.9638,-0.89301,2,0.5,0.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000197943,14,6,1,0,1,1,1321.7688442211056,394357.452283155,2017-01-09,0,0,0,0,22,1,0,0,0,0,0,0,0,0,0,1,11,0,0,4,0,0,8,47,PLCG2,0.53900003,-0.641,-3.3329,15,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685
ENSG00000198589,7,6,1,0,1,1,22008.059288087163,301203.06999851385,2018-08-13,1,0,0,0,1,0,3,0,0,0,0,0,0,0,0,0,0,1,0,9,0,0,3,18,LRBA,0.485,1.3655,-0.010617,0,-1.0,-1.0,,
ENSG00000203740,13,6,1,0,1,1,11798.46653227782,645988.1975077938,2017-04-17,0,0,0,0,45,0,0,0,0,0,2,0,0,0,0,9,2,0,0,2,0,0,4,64,NTMT2,-0.19599998,0.58024,0.11773,0,0.5,1.0,,
ENSG00000214435,14,6,1,0,0,1,31519.426313660828,633132.2332759313,2013-08-25,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,0,1,2,0,1,2,16,AS3MT,-0.26,1.2991,0.87634,1,0.5,0.0,Phase II - Conjugation of compounds,R-HSA-156580
ENSG00000220948,6,6,0,0,0,1,49724.14538298504,1470466.6505612188,2023-01-18,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,1,6,TRIM51G,-0.32500005,-1.2297,-0.57748,0,,,,
ENSG00000221818,16,6,0,0,0,1,1173.5007132667617,765591.3646788632,2013-04-01,6,0,0,0,5,5,1,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,21,47,EBF2,0.606,1.4447,-0.40691,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000239697,7,6,1,1,0,1,10736.940639920189,427337.4491868293,2018-07-30,0,0,0,1,6,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,11,TNFSF12,0.028999984,-0.66456,-1.0674,2,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000244734,10,6,0,0,1,1,11593.92185913336,397309.7797528111,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,7,3,0,0,3,0,0,0,1,0,0,2,18,HBB,-0.964,0.77937,-1.4054,9,1.0,-1.0,Immune System;Disease;Late endosomal microautophagy;Chaperone Mediated Autophagy,R-HSA-168256;R-HSA-1643685;R-HSA-9615710;R-HSA-9613829
ENSG00000248905,12,6,1,0,1,1,12694.32595646462,521818.7070055739,2018-08-13,7,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,1,0,0,2,0,0,6,19,FMN1,-0.0019999743,-0.21366,-0.34482,0,0.5,0.0,,
ENSG00000250317,13,6,0,0,0,1,16417.447913521348,574782.4268116049,2009-05-10,0,0,0,0,0,4,0,0,0,9,0,0,14,0,1,0,0,0,0,2,0,0,2,32,SMIM20,0.09200001,0.094954,-0.82408,1,-1.0,-1.0,Complex IV assembly,R-HSA-9864848
ENSG00000258366,27,6,1,0,1,1,1371.734835355286,521818.7070055739,2009-07-05,31,0,0,0,0,0,0,0,13,0,8,0,0,0,3,0,0,0,0,5,0,0,9,69,RTEL1,0.339,-1.5797,-4.6092,3,-1.0,0.0,,
ENSG00000263528,9,6,1,0,0,1,11252.882952659449,251325.91086204,2016-07-11,2,0,0,0,0,0,0,0,0,0,1,4,3,0,0,0,0,0,0,3,0,0,2,15,IKBKE,0.34100002,2.807,0.12783,13,0.5,0.0,Signal Transduction;Immune System;Disease;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000268480,8,6,0,0,1,0,12591.910995156913,225599.91693237546,2011-12-25,0,0,0,1,0,0,0,6,11,0,2,0,0,0,0,0,0,0,0,1,0,0,1,22,NFILZ,,,,0,0.5,1.0,,
ENSG00000000971,17,5,1,1,1,1,1819.0502684236212,378712.0243337037,2010-04-12,0,2,0,34,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,0,0,1,70,CFH,0.57,1.4706,-0.57543,1,1.0,-1.0,Immune System,R-HSA-168256
ENSG00000008083,5,5,0,0,0,1,28389.49814649323,1778690.168860174,2016-07-01,1,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,JARID2,0.798,3.2608,-1.1486,1,0.5,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000019144,8,5,1,0,0,1,1082.8553287981858,562534.7696387965,2009-07-05,11,0,0,0,0,0,0,0,0,0,1,0,4,0,1,0,5,0,0,0,0,0,0,22,PHLDB1,0.39600003,1.7574,1.216,0,-1.0,0.0,,
ENSG00000049618,9,5,1,0,0,1,60158.36477334322,1424218.0900670097,2018-08-13,0,0,0,0,0,1,1,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,3,8,ARID1B,0.795,0.81072,-2.9392,6,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000064666,5,5,1,0,0,1,33224.221295945434,562534.7696387965,2022-10-12,1,3,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,3,0,0,0,9,CNN2,-0.006000042,0.22808,0.109,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000071575,10,5,0,0,0,1,54703.55383629191,433862.5685735124,2018-08-13,0,0,0,6,0,0,0,0,0,13,0,0,0,0,1,0,2,0,0,4,0,0,0,26,TRIB2,0.777,2.7818,0.43107,0,-1.0,-1.0,,
ENSG00000072818,9,5,1,0,1,1,11664.35640110979,381165.6245253304,2018-08-13,0,0,0,0,0,2,0,0,0,12,0,3,0,0,1,0,0,0,0,1,0,0,0,19,ACAP1,0.421,2.9491,0.47265,0,0.5,0.0,,
ENSG00000073060,17,5,1,0,0,1,28221.648477075985,756470.9740366563,2017-06-09,3,0,0,0,28,0,0,0,0,0,0,3,0,0,0,0,0,0,2,0,0,0,3,39,SCARB1,0.29000002,1.9517,0.83169,2,1.0,0.0,,
ENSG00000073282,16,5,1,0,1,1,2201.7501988862373,431284.57934287674,2010-09-26,29,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,2,0,0,1,34,TP63,0.704,3.5197,0.32035,9,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000077044,9,5,1,0,0,1,33287.94734762397,765591.3646788632,2019-02-04,0,0,0,0,1,7,0,0,0,0,0,9,0,0,1,0,0,0,0,0,0,0,2,20,DGKD,0.453,2.3324,-0.80832,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000088970,13,5,1,0,1,1,1898.2549302549303,671426.4432757655,2019-12-01,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,0,0,1,9,KIZ,-0.227,-0.17666,0.046557,0,-1.0,-1.0,,
ENSG00000099246,10,5,0,0,0,1,47336.27089212796,415452.66715166246,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,0,6,2,0,0,0,0,0,0,1,1,1,11,RAB18,0.463,1.0956,-0.58523,4,-1.0,-1.0,Immune System;Golgi-to-ER retrograde transport;Rab regulation of trafficking;Post-translational protein modification,R-HSA-168256;R-HSA-8856688;R-HSA-9007101;R-HSA-597592
ENSG00000100156,8,5,1,0,1,1,18475.74586768385,213435.01458839694,2015-12-21,1,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,0,0,0,10,SLC16A8,-0.94200003,-4.602,-5.1571,2,0.5,0.5,,
ENSG00000100321,6,5,1,0,0,1,2209.8301559792026,381165.6245253304,2012-08-29,4,0,0,0,0,0,0,0,0,0,0,1,13,0,2,0,0,0,0,2,0,0,0,22,SYNGR1,0.09899998,0.13992,0.25774,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000100365,7,5,1,0,0,1,19965.24128263536,233499.4066209918,2019-09-01,0,0,0,0,0,0,0,0,2,0,1,0,0,0,1,0,0,0,0,7,0,0,1,12,NCF4,-0.004999995,0.52693,-0.65281,8,0.5,0.0,Signal Transduction;Immune System;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-9006934
ENSG00000101019,26,5,1,0,1,1,10806.40677999821,1470466.6505612188,2018-03-20,7,0,0,0,7,0,0,0,0,0,0,0,21,0,0,0,0,0,0,0,2,0,11,48,UQCC1,-0.13999999,0.1872,0.80417,1,-1.0,-1.0,,
ENSG00000101076,10,5,1,0,1,1,4518.532006719214,1424218.0900670097,2011-08-28,0,0,0,0,0,42,3,0,0,0,0,0,6,0,0,0,0,0,0,11,0,0,4,66,HNF4A,0.561,2.7153,-0.15613,3,0.75,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000101204,12,5,1,0,0,1,25352.520712885682,539013.8231881644,2018-08-13,8,0,0,0,1,0,0,0,0,0,14,0,0,0,0,0,3,0,0,0,0,0,1,27,CHRNA4,0.16600001,0.18604,-0.97797,3,0.5,0.5,,
ENSG00000101246,9,5,1,0,0,1,3266.869416460749,521818.7070055739,2008-08-31,6,2,0,0,0,0,1,0,3,0,0,0,0,0,0,0,0,0,0,2,0,0,0,14,ARFRP1,0.065,0.53676,-0.86105,1,-1.0,-1.0,,
ENSG00000103591,9,5,1,0,1,1,97691.2238787727,444537.33605315426,2019-03-28,0,0,0,0,1,0,0,0,0,0,9,0,0,0,1,0,0,0,0,0,0,1,2,14,AAGAB,-0.15600002,-1.0037,-0.0089872,0,-1.0,-1.0,,
ENSG00000103599,8,5,1,0,0,1,7794.273577144567,1778690.168860174,2021-03-01,0,0,0,0,1,0,0,0,0,0,9,0,0,0,0,0,1,0,0,1,0,0,1,13,IQCH,0.139,1.777,1.2643,0,0.5,0.0,,
ENSG00000106392,5,5,1,0,0,1,121238.60518192011,1778690.168860174,2018-08-13,0,0,0,0,4,1,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,8,C1GALT1,0.411,0.39462,-1.1358,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000106638,6,5,1,0,0,1,2866.7577092511015,1778690.168860174,2016-09-07,0,0,0,0,0,2,0,0,0,0,0,0,5,0,0,0,1,0,1,0,0,0,1,10,TBL2,-0.05400002,1.3061,0.034531,0,0.5,0.0,,
ENSG00000108179,7,5,0,0,0,1,29890.37750380142,498258.534626183,2018-07-27,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,1,1,6,PPIF,-0.725,-0.8507,-0.71888,0,-1.0,-1.0,,
ENSG00000110921,6,5,1,0,0,1,1173.5007132667617,396735.32121509424,2021-09-30,0,0,0,0,2,1,0,0,0,0,0,0,4,0,0,0,3,0,0,1,0,0,0,11,MVK,0.014999986,2.0515,1.4077,2,0.5,-1.0,Cholesterol biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-191273;R-HSA-8957322;R-HSA-1655829
ENSG00000111913,8,5,0,0,0,1,2568.3760200548704,286678.73247515375,2013-12-25,0,0,0,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,3,3,0,0,1,12,RIPOR2,0.49800003,2.8255,1.8119,2,0.5,0.0,,
ENSG00000113719,7,5,1,0,0,1,10257.256188118812,235397.69820205137,2021-12-06,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,2,0,0,4,0,0,1,10,ERGIC1,0.31699997,2.1287,1.7213,0,-1.0,-1.0,,
ENSG00000113810,6,5,1,0,1,1,20139.580688207345,1424218.0900670097,2018-12-20,2,0,0,0,0,2,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,7,SMC4,0.22500002,0.88772,-0.98198,2,0.5,0.0,Condensation of Prophase Chromosomes,R-HSA-2299718
ENSG00000116833,12,5,1,0,0,1,4506.554666091045,521818.7070055739,2012-11-01,6,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,1,19,NR5A2,0.38099998,1.7368,0.28054,4,0.75,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Regulation of gene expression in early pancreatic precursor cells;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-210747;R-HSA-597592
ENSG00000117569,17,5,1,0,0,1,11506.226732433088,1778690.168860174,2019-11-18,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,11,0,3,1,0,0,1,19,PTBP2,0.58000004,3.4464,0.46744,0,-1.0,-1.0,,
ENSG00000118777,14,5,1,0,1,1,1072.1893201327084,384314.83364002535,2011-10-09,0,0,0,0,0,0,0,0,0,0,0,8,121,0,0,0,0,0,0,2,1,0,1,133,ABCG2,-0.30799997,0.50878,0.98433,9,0.5,0.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000122025,8,5,1,1,0,1,9387.521501785945,381165.6245253304,2018-08-13,1,0,0,0,0,0,0,0,0,10,0,0,1,0,1,0,0,0,0,3,0,0,0,16,FLT3,0.532,1.5509,0.8274,27,0.5,0.5,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000123106,15,5,1,0,1,1,3823.6404948245395,221804.66439828966,2014-07-27,6,0,0,0,0,0,1,0,0,0,0,0,5,0,0,0,0,0,0,2,0,0,5,19,CCDC91,-0.08399999,0.094366,-0.12024,0,-1.0,-1.0,,
ENSG00000124783,8,5,1,0,0,1,7118.174881239361,1778690.168860174,2014-02-09,1,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,2,8,SSR1,0.34600002,1.0795,0.46633,2,-1.0,-1.0,Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-72766;R-HSA-1799339
ENSG00000125378,14,5,1,0,1,1,3830.8097102584184,473900.221403792,2008-11-16,12,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,1,0,4,22,BMP4,0.742,1.7532,0.91375,11,0.5,0.0,Developmental Biology;Post-translational protein modification,R-HSA-1266738;R-HSA-597592
ENSG00000127666,10,5,1,0,0,1,54703.55383629191,381165.6245253304,2018-08-13,15,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,0,0,0,1,0,0,2,29,TICAM1,-0.80200005,0.34765,-0.76489,17,0.5,0.0,Immune System;Disease;IKK complex recruitment mediated by RIP1,R-HSA-168256;R-HSA-1643685;R-HSA-937041
ENSG00000130164,33,5,1,0,1,1,5277.165086999576,756470.9740366563,2013-09-17,0,0,0,0,70,0,0,0,0,0,0,0,1,0,0,0,0,0,10,21,0,0,39,141,LDLR,-0.09099996,0.60522,0.056437,5,0.5,-1.0,,
ENSG00000130700,8,5,0,0,1,1,2009.8265895953757,645988.1975077938,2018-11-08,4,0,0,2,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,15,GATA5,-0.62899995,-3.1449,-4.1545,1,0.5,0.0,,
ENSG00000131507,14,5,1,0,0,1,17831.529851792977,562534.7696387965,2010-11-21,0,0,0,0,0,0,0,0,0,0,30,0,1,0,2,0,0,0,0,10,0,0,3,46,NDFIP1,0.41799998,1.3203,0.067972,0,-1.0,-1.0,,
ENSG00000132911,11,5,0,0,1,1,3548.6052707235267,633132.2332759313,2014-07-22,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,9,0,0,1,0,0,1,13,NMUR2,-0.32700002,0.12467,0.19999,3,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000135547,7,5,1,0,0,1,975.1366503153469,765591.3646788632,2013-07-21,5,0,0,0,4,3,0,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,17,HEY2,-0.29200006,-0.28493,-1.2094,7,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000136381,13,5,1,0,0,1,8420.791106786926,323648.5577791949,2021-08-03,0,2,0,0,2,0,0,0,0,0,13,0,0,0,0,0,1,0,0,0,0,0,5,23,IREB2,0.611,2.8507,0.98991,1,-1.0,-1.0,Iron uptake and transport,R-HSA-917937
ENSG00000136560,8,5,1,0,0,1,95776.89591443514,1778690.168860174,2021-05-27,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,5,0,0,1,0,0,1,10,TANK,0.55799997,1.5977,1.0713,5,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000137809,6,5,1,1,1,1,1173.5007132667617,355284.1215006515,2017-09-07,6,0,0,0,0,1,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,0,1,12,ITGA11,0.15200001,1.2904,-0.90656,1,0.5,0.0,,
ENSG00000138035,7,5,0,0,0,1,17767.670397191134,1470466.6505612188,2018-06-11,0,0,0,19,0,0,1,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,1,24,PNPT1,0.36,0.28809,-0.83579,1,-1.0,-1.0,,
ENSG00000138621,7,5,1,0,0,1,13219.952617929488,322220.1169395476,2015-10-26,0,0,0,0,0,0,1,0,0,0,1,2,0,0,0,0,0,0,0,2,0,0,2,8,PPCDC,-0.319,0.74667,0.93624,1,-1.0,-1.0,Vitamin B5 (pantothenate) metabolism,R-HSA-199220
ENSG00000138640,9,5,1,1,1,1,3721.3983572895277,438004.58573217486,2013-04-14,4,0,0,0,0,0,0,0,0,0,16,0,1,0,0,0,0,0,0,1,0,0,1,23,FAM13A,0.254,1.6327,0.32017,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000139174,6,5,0,0,0,1,22938.587937312015,765591.3646788632,2016-05-16,4,0,0,2,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,10,PRICKLE1,0.72099996,2.8992,1.2093,1,-1.0,0.0,Signal Transduction;Asymmetric localization of PCP proteins,R-HSA-162582;R-HSA-4608870
ENSG00000141510,42,5,1,0,0,1,3400.9387113875905,672632.4785173276,2011-09-25,70,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,10,84,TP53,0.551,1.1539,0.95837,45,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Zygotic genome activation (ZGA);RUNX3 regulates CDKN1A transcription;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9819196;R-HSA-8941855;R-HSA-5663202;R-HSA-597592;R-HSA-6785807;R-HSA-8878159
ENSG00000143013,10,5,1,0,0,1,22540.468794299068,521818.7070055739,2016-05-16,10,0,0,5,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,20,LMO4,0.66999996,2.6121,-0.263,0,0.5,-1.0,,
ENSG00000145723,7,5,1,0,1,1,124837.11004999638,433862.5685735124,2018-10-08,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,1,0,0,1,0,0,1,6,GIN1,-0.085999966,0.58686,0.78559,0,-1.0,0.0,,
ENSG00000149179,12,5,1,0,0,1,11798.46653227782,1424218.0900670097,2021-11-04,0,0,0,0,10,1,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,6,20,CSTPP1,0.003000021,0.47659,-0.17749,0,-1.0,-1.0,,
ENSG00000150051,7,5,1,0,0,1,47408.95172709719,521818.7070055739,2022-03-24,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,2,8,MKX,0.425,0.026042,-0.013099,0,0.5,0.0,,
ENSG00000152127,5,5,1,0,0,1,27362.822584081572,334911.3573752668,2017-10-09,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,5,0,1,1,0,0,0,10,MGAT5,0.58500004,3.187,1.0565,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000153071,6,5,0,0,0,1,2628.763122476447,97181.90375256384,2011-12-11,1,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,1,0,0,1,6,DAB2,0.521,1.4104,0.4236,4,0.5,-1.0,Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-157858;R-HSA-190828
ENSG00000153162,16,5,1,1,1,1,12057.918844765343,1470466.6505612188,2020-12-15,0,0,0,0,0,0,1,0,0,0,2,0,14,0,0,0,0,0,0,0,1,0,10,28,BMP6,0.477,-0.68506,-1.67,0,0.5,0.0,,
ENSG00000157823,7,5,1,0,0,1,16064.925920375643,1424218.0900670097,2011-08-28,1,0,0,3,0,19,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,25,AP3S2,-0.30400002,0.12023,0.27911,0,-1.0,-1.0,,
ENSG00000159210,5,5,1,0,0,1,195005.6685718255,713911.8939045856,2018-07-27,0,0,0,0,1,3,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,1,8,SNF8,0.14700001,1.3953,0.21754,2,-1.0,-1.0,Endosomal Sorting Complex Required For Transport (ESCRT);Disease;HCMV Late Events,R-HSA-917729;R-HSA-1643685;R-HSA-9610379
ENSG00000161888,8,5,1,0,0,1,50087.52781663962,672632.4785173276,2020-10-05,0,0,0,0,3,0,0,0,0,1,0,0,2,0,0,0,0,0,0,2,0,0,3,11,SPC24,-0.844,-1.6263,-1.1777,6,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000161896,7,5,1,0,1,1,9269.724378777702,185805.42963097955,2010-05-09,0,0,0,0,0,0,1,0,0,1,3,0,2,0,0,0,0,0,0,2,0,0,0,9,IP6K3,-0.027999997,1.0202,0.63484,1,0.75,0.0,,
ENSG00000162882,9,5,1,0,1,1,3400.4411583487367,521818.7070055739,2014-08-10,6,0,0,1,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,14,HAAO,-0.544,-1.231,-1.2269,1,1.0,0.0,,
ENSG00000164588,7,5,1,0,0,1,80746.41870861933,713911.8939045856,2014-07-22,3,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,12,0,0,0,0,0,2,19,HCN1,0.671,3.2532,-2.4929,1,1.0,0.5,,
ENSG00000164733,7,5,1,1,0,1,1321.7688442211056,340825.7076940272,2016-12-15,0,1,0,0,0,2,0,0,0,0,2,0,0,0,0,0,3,0,0,3,0,0,0,11,CTSB,-0.75600004,-5.2014,-6.0243,5,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000167491,9,5,1,0,0,1,37457.27990395809,575147.0632428399,2016-07-17,2,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,10,GATAD2A,0.70500004,1.8452,-0.41655,9,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Regulation of endogenous retroelements by KRAB-ZFP proteins;Disease;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-427389;R-HSA-9843940;R-HSA-1643685;R-HSA-73762;R-HSA-73864;R-HSA-73854
ENSG00000167600,5,5,0,0,0,1,2784.605232861827,1990918.947961699,2018-08-13,6,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,1,10,CYP2S1,0.007000029,1.3319,0.41189,3,0.75,0.0,,
ENSG00000168952,6,5,1,0,0,1,95905.57783546533,1424218.0900670097,2020-06-15,0,0,0,0,1,2,0,0,0,0,0,0,0,0,1,0,0,0,2,1,0,0,0,7,STXBP6,-0.11800003,0.76431,0.013066,0,-1.0,0.0,,
ENSG00000169926,5,5,1,0,0,1,2454.525067818748,1424218.0900670097,2014-07-13,0,0,0,0,2,1,1,2,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,11,KLF13,-0.786,-2.095,-3.4043,0,-1.0,-1.0,,
ENSG00000170417,7,5,1,0,0,1,4305.167942827973,298504.9722193353,2021-09-07,0,0,0,0,0,0,2,0,0,0,1,0,2,0,0,0,0,0,0,0,0,1,2,8,TMEM182,-0.09200001,0.22899,-0.035335,0,0.75,0.0,,
ENSG00000170485,5,5,0,0,0,1,17981.04225579704,381165.6245253304,2018-08-13,0,0,0,0,0,0,0,2,0,1,2,0,0,0,1,0,0,0,0,1,0,0,0,7,NPAS2,0.662,3.1334,0.87543,6,-1.0,0.0,,
ENSG00000171056,9,5,1,0,0,1,1173.5007132667617,376569.5597064443,2018-07-27,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,4,11,SOX7,-0.37300003,-2.9593,-3.1657,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000172216,8,5,0,0,0,1,28292.123952140868,1424218.0900670097,2018-10-08,0,0,0,1,0,9,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,4,17,CEBPB,-0.67700005,-2.9753,-4.0509,8,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);PERK regulates gene expression;Disease;ATF4 activates genes in response to endoplasmic reticulum  stress;Cellular response to starvation;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-381042;R-HSA-1643685;R-HSA-380994;R-HSA-9711097;R-HSA-5663202
ENSG00000174437,9,5,0,0,0,1,19965.24128263536,715125.8126650311,2014-07-22,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,9,0,0,2,0,0,2,15,ATP2A2,0.795,7.0341,0.13271,4,0.75,-1.0,Signal Transduction,R-HSA-162582
ENSG00000177000,6,5,1,0,1,1,2201.586503948313,239405.90751969456,2017-12-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,6,MTHFR,0.14099997,2.024,0.35912,1,-1.0,-1.0,Metabolism of folate and pterines,R-HSA-196757
ENSG00000178623,12,5,1,0,1,1,3760.5598526703498,381165.6245253304,2011-02-06,0,0,0,0,0,0,2,0,0,0,0,0,1,0,1,0,2,0,0,33,0,0,0,39,GPR35,-0.893,0.87148,-0.48107,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000182224,5,5,1,0,0,1,47408.95172709719,500292.45069431677,2018-08-13,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,1,7,CYB5D1,-0.58000004,0.95015,-0.071543,0,-1.0,-1.0,,
ENSG00000182240,7,5,1,0,0,1,28281.469392655894,1778690.168860174,2022-01-04,0,0,0,0,1,4,0,0,0,0,0,0,0,0,0,0,2,0,0,3,0,0,2,12,BACE2,0.426,0.73575,-0.17103,0,0.5,0.0,,
ENSG00000182346,8,5,0,0,0,1,636.1886490807354,235397.69820205137,2012-10-09,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,9,13,DAOA,-0.45700002,-1.2421,-0.87537,0,,,,
ENSG00000182732,12,5,1,0,0,1,15866.724081734988,633132.2332759313,2014-07-22,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,12,0,0,1,2,0,0,18,RGS6,0.33600003,1.8256,0.24264,2,0.5,0.0,Signal Transduction;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,R-HSA-162582;R-HSA-6814122
ENSG00000183508,7,5,1,0,0,1,69427.89754098361,1424218.0900670097,2020-06-15,0,0,1,0,0,7,0,0,0,0,0,0,0,0,0,1,1,0,0,2,0,0,0,12,TENT5C,0.552,2.5857,0.2577,0,0.5,0.0,,
ENSG00000184058,8,5,1,0,0,1,19875.020792566687,521818.7070055739,2019-08-15,7,0,0,0,0,0,0,0,0,0,1,0,1,3,0,0,0,0,0,0,0,0,1,13,TBX1,0.297,-1.2286,-3.6039,1,0.75,0.0,Developmental Biology,R-HSA-1266738
ENSG00000185002,8,5,0,0,1,1,4314.782048701952,1424218.0900670097,2010-08-01,35,0,1,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,42,RFX6,0.30800003,0.91599,1.1006,1,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000185668,5,5,1,0,1,1,58392.07057732553,1778690.168860174,2013-12-25,0,0,0,0,1,0,0,0,0,2,1,0,6,0,0,0,1,0,0,0,0,0,0,11,POU3F1,-0.014999986,-0.23233,-3.1609,3,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000196581,6,5,0,0,0,1,852.7116564417178,1778690.168860174,2015-09-22,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,2,0,0,1,0,0,1,7,AJAP1,0.624,-0.92316,-2.0107,0,0.5,0.5,,
ENSG00000198945,8,5,1,0,1,1,13298.635084734673,1424218.0900670097,2016-06-17,3,0,0,0,0,2,0,0,0,0,0,3,0,0,1,0,0,0,0,0,0,0,1,10,L3MBTL3,0.674,1.4143,0.13983,0,-1.0,-1.0,,
ENSG00000213246,7,5,1,0,0,1,63200.72664467542,328593.8949890692,2019-07-01,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,2,0,0,3,9,SUPT4H1,-0.047999978,1.3356,0.079495,15,-1.0,-1.0,Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;Generic Transcription Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;Gene expression (Transcription);Abortive elongation of HIV-1 transcript in the absence of Tat;Disease;Pausing and recovery of HIV elongation;Tat-mediated HIV elongation arrest and recovery;HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;RNA polymerase II transcribes snRNA genes;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-113418;R-HSA-167158;R-HSA-212436;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-74160;R-HSA-167242;R-HSA-1643685;R-HSA-167290;R-HSA-167243;R-HSA-167287;R-HSA-167238;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-6807505;R-HSA-162587;R-HSA-162599
ENSG00000213588,7,5,0,0,0,1,7379.113053190667,406587.2658730814,2018-08-13,1,1,0,0,0,0,0,0,0,0,3,0,4,0,0,0,0,0,0,1,0,0,0,10,ZBTB9,0.07200003,1.6808,0.64732,0,-1.0,0.0,,
ENSG00000218819,13,5,0,0,0,1,15183.279312299912,1778690.168860174,2018-08-13,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,1,0,3,8,0,0,12,32,TDRD15,,,,0,1.0,1.0,,
ENSG00000225366,9,5,0,0,0,1,31676.163230680246,672632.4785173276,2021-04-22,0,0,0,1,2,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,4,11,CRIPTO3,,,,2,,,,
ENSG00000244405,9,5,1,0,0,1,164183.63392685485,575147.0632428399,2023-03-27,0,0,0,0,0,1,0,0,0,0,4,0,1,0,0,0,0,0,4,0,0,0,1,11,ETV5,0.767,3.0847,1.029,0,-1.0,-1.0,,
ENSG00000255974,23,5,1,0,0,1,15680.736809263815,464892.4593283075,2017-06-12,23,2,0,0,1,0,0,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,7,48,CYP2A6,0.12099999,-0.045596,-0.081915,2,1.0,0.5,,
ENSG00000260811,8,5,0,0,0,1,2607.4636857838914,765591.3646788632,2019-08-16,0,0,0,1,8,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,14,OR4C45,,0.50823,0.98032,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000277481,7,5,1,0,1,1,8256.753829078802,282369.4803133209,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,2,6,PKD1L3,-0.36399996,-3.635,-3.2889,0,0.5,1.0,,
ENSG00000017427,9,5,0,0,0,1,17224.294436185013,143284.77790855977,2020-05-13,5,4,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,12,IGF1,0.325,2.1757,-0.070415,6,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000036828,9,5,0,0,1,1,12374.366848021016,765591.3646788632,2019-02-04,0,0,0,0,0,7,0,0,0,2,3,6,0,0,0,0,0,0,0,0,0,0,2,20,CASR,0.531,4.8379,0.85468,3,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000048405,11,5,1,0,1,1,12620.35781065477,765591.3646788632,2020-05-06,0,0,0,0,0,4,7,0,0,0,0,0,0,0,0,0,0,0,0,7,0,1,3,22,ZNF800,0.64199996,2.2295,0.37342,0,0.5,-1.0,,
ENSG00000055955,11,5,1,1,1,1,7780.136143958869,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,4,0,0,0,3,0,0,2,0,0,3,13,ITIH4,0.16600001,1.862,0.44401,1,1.0,0.0,,
ENSG00000069702,12,5,0,1,0,1,7086.73896159931,765591.3646788632,2019-09-01,0,0,0,0,5,1,0,0,0,0,4,0,0,0,3,0,0,0,0,0,0,0,7,20,TGFBR3,0.36400002,2.4534,0.83215,10,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases;TGFBR3 regulates TGF-beta signaling,R-HSA-162582;R-HSA-9006934;R-HSA-9839389
ENSG00000069869,8,5,1,0,0,1,595.0848708487085,143413.24457139417,2010-08-15,2,0,0,1,0,0,0,0,6,0,0,0,7,0,0,0,0,0,0,0,0,0,1,17,NEDD4,0.14200002,1.0335,1.3247,5,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Downregulation of ERBB4 signaling;ISG15 antiviral mechanism;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1253288;R-HSA-1169408;R-HSA-9006934
ENSG00000070193,10,5,0,0,0,1,5414.650230111769,562534.7696387965,2017-02-24,3,0,0,0,0,0,2,0,0,0,4,0,0,0,0,0,0,0,0,3,0,0,4,16,FGF10,0.73300004,1.4724,-0.54479,23,-1.0,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000073849,8,5,1,0,0,1,4074.958527607362,1424218.0900670097,2012-09-01,1,4,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,24,ST6GAL1,0.26700002,1.3814,0.049881,6,0.75,-1.0,Translation of Structural Proteins_9683701;Disease;Post-translational protein modification,R-HSA-9683701;R-HSA-1643685;R-HSA-597592
ENSG00000073861,9,5,0,0,0,1,36645.767033906064,381165.6245253304,2019-03-28,0,0,0,0,0,0,0,0,1,10,6,0,0,0,1,0,0,0,0,1,0,0,0,19,TBX21,0.61899996,1.0994,-0.26821,0,0.75,0.5,,
ENSG00000075292,8,5,1,0,1,1,4917.108320036471,1076472.0138856068,2017-06-12,1,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,9,ZNF638,0.751,-0.17164,-0.60663,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000075420,10,5,1,0,1,1,5495.191484272216,1424218.0900670097,2016-04-04,0,1,0,25,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,36,FNDC3B,0.83599997,2.7826,0.74061,0,-1.0,-1.0,,
ENSG00000079999,6,5,0,0,0,1,38092.548464040476,160010.51072069994,2019-09-01,0,2,0,0,0,0,0,0,0,0,0,2,1,0,1,0,0,0,0,2,0,0,0,8,KEAP1,0.40499997,4.2976,0.44959,6,0.5,-1.0,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000086015,10,5,1,0,1,1,162367.55694122918,1424218.0900670097,2020-05-06,4,0,0,0,0,3,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,4,14,MAST2,0.42400002,2.1038,0.8864,0,0.5,-1.0,,
ENSG00000091583,8,5,1,1,1,1,8389.22186817101,464892.4593283075,2023-01-18,0,0,0,0,4,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,0,0,1,9,APOH,-0.54200006,0.52703,0.32496,1,1.0,0.5,,
ENSG00000095739,7,5,1,0,0,1,42359.490817992155,1424218.0900670097,2021-06-14,0,0,0,1,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,3,0,0,3,10,BAMBI,-0.30200005,-1.0834,-1.4133,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000099282,14,5,1,0,0,1,11806.630615232236,235397.69820205137,2015-03-12,0,0,0,0,26,0,0,0,0,0,1,0,0,0,1,2,0,0,0,0,0,0,15,45,TSPAN15,0.09399998,1.0938,-0.42506,1,-1.0,-1.0,,
ENSG00000100354,9,5,1,0,0,1,18495.732809430254,1424218.0900670097,2018-09-07,17,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,26,TNRC6B,0.668,2.9401,0.38961,20,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Gene Silencing by RNA,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-211000
ENSG00000100485,6,5,0,0,1,1,107949.90929360976,1424218.0900670097,2018-08-13,0,0,0,2,2,1,0,0,0,0,0,3,2,0,0,0,0,0,0,0,0,0,0,10,SOS2,0.58500004,1.6667,0.4874,5,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Activation of RAC1;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-428540;R-HSA-449147
ENSG00000102678,6,5,0,0,0,1,12315.440661331722,1424218.0900670097,2020-05-06,0,0,0,16,3,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,23,FGF9,0.582,2.1479,0.36979,38,0.5,0.0,Signal Transduction;Developmental Biology;Disease;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202
ENSG00000104756,5,5,1,0,0,1,24683.73068559002,1424218.0900670097,2021-09-30,1,0,0,0,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,7,KCTD9,0.556,3.7994,0.83587,0,-1.0,-1.0,,
ENSG00000105877,7,5,1,0,0,1,2253.2118120381815,521818.7070055739,2011-11-27,9,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,1,14,DNAH11,0.088,-6.7134,-5.6458,0,1.0,0.5,,
ENSG00000109917,23,5,1,0,1,1,1335.4481927710845,782476.8109259979,2010-07-25,0,0,0,0,24,0,1,0,0,0,0,0,0,0,0,0,0,0,7,14,0,0,13,59,ZPR1,0.185,0.73285,0.70063,0,-1.0,-1.0,,
ENSG00000111271,7,5,0,0,1,1,1756.5428571428572,381165.6245253304,2018-03-12,0,0,0,0,1,0,0,0,0,0,1,0,3,0,1,0,0,0,0,0,0,0,3,9,ACAD10,-0.049999952,1.4698,1.1698,1,-1.0,-1.0,,
ENSG00000112541,9,5,1,0,0,1,7098.679736796403,1424218.0900670097,2016-05-16,0,0,0,0,3,1,0,0,0,20,0,0,0,0,1,0,0,0,0,1,0,0,0,26,PDE10A,0.573,4.0387,0.59888,2,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000112679,8,5,0,0,0,1,1380.9855975087582,322220.1169395476,2018-11-29,1,0,0,0,0,0,0,0,1,0,0,5,0,0,0,0,0,0,0,9,0,0,1,17,DUSP22,-0.40699995,-1.2408,-2.7744,0,-1.0,-1.0,,
ENSG00000114423,7,5,1,0,0,1,33910.05821821659,260631.24114204012,2018-08-13,0,0,0,0,0,0,0,0,3,12,0,0,1,0,1,0,0,0,0,1,0,0,0,18,CBLB,0.594,1.8747,0.35652,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000115306,8,5,1,0,0,1,19318.919999180947,551389.5206213495,2018-08-29,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,2,0,1,12,SPTBN1,0.841,5.9038,-1.7393,10,-1.0,-1.0,Signal Transduction;Developmental Biology;Disease;Interaction between L1 and Ankyrins;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-445095;R-HSA-5663202;R-HSA-597592
ENSG00000115504,8,5,0,0,1,1,31535.173607928213,672632.4785173276,2020-09-04,10,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,17,EHBP1,0.44300002,1.6875,0.42559,0,-1.0,-1.0,,
ENSG00000115607,11,5,1,0,0,1,9432.693221905714,444537.33605315426,2010-02-28,3,0,0,1,0,0,0,0,10,0,7,0,0,0,0,0,0,0,0,12,0,0,0,33,IL18RAP,0.16100001,0.86894,0.27396,1,0.75,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-18 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9012546
ENSG00000116117,6,5,0,0,0,1,2560.851236868858,1424218.0900670097,2016-02-08,0,0,0,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,7,PARD3B,0.088,-0.78129,-0.45706,0,-1.0,0.0,,
ENSG00000116132,12,5,1,0,0,1,11798.46653227782,645988.1975077938,2012-04-29,0,0,0,1,46,0,0,0,0,0,1,0,0,0,0,2,1,0,0,0,0,0,0,51,PRRX1,0.42900002,1.192,-0.9744,0,-1.0,0.0,,
ENSG00000116991,5,5,1,0,0,1,21999.70749904969,263416.51565448404,2014-07-27,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,3,1,0,1,7,SIPA1L2,0.588,2.3517,0.52517,0,-1.0,-1.0,,
ENSG00000118094,6,5,1,0,0,1,2240.9147424511543,337860.4854363166,2009-10-18,1,0,0,0,0,0,0,0,0,0,0,2,2,0,0,0,1,0,0,2,0,0,0,8,TREH,-0.19000006,-0.66573,-1.3473,1,1.0,0.5,Digestion and absorption;Digestion,R-HSA-8963743;R-HSA-8935690
ENSG00000119042,14,5,1,0,0,1,4755.152728604566,323648.5577791949,2014-07-22,5,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,10,0,0,11,0,0,2,31,SATB2,0.923,5.5263,-0.95226,2,0.75,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000119640,7,5,1,1,0,0,11608.613380386345,295912.38030484633,2017-12-06,3,1,0,0,2,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,10,ACYP1,-0.301,1.0091,0.44564,0,-1.0,-1.0,,
ENSG00000121989,5,5,1,0,0,1,28292.123952140868,521818.7070055739,2022-02-02,2,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,1,7,ACVR2A,0.778,4.7321,0.95001,5,-1.0,-1.0,Signal Transduction;Developmental Biology;Regulation of signaling by NODAL,R-HSA-162582;R-HSA-1266738;R-HSA-1433617
ENSG00000123066,8,5,1,0,0,1,101791.22293364709,1470466.6505612188,2019-02-25,4,0,0,0,2,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,9,MED13L,0.959,6.2997,0.90269,3,-1.0,-1.0,Developmental Biology;Disease,R-HSA-1266738;R-HSA-1643685
ENSG00000124479,8,5,1,0,0,1,1412.4338624338625,500292.45069431677,2021-09-30,0,0,0,3,6,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,5,17,NDP,,,,0,0.5,0.0,,
ENSG00000124813,9,5,1,0,0,1,11608.613380386345,397765.9672627851,2019-01-21,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,1,0,0,1,1,0,4,15,RUNX2,0.648,1.7904,0.18875,9,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX2 regulates genes involved in cell migration,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8941332
ENSG00000125304,7,5,0,0,0,1,55635.00408218119,444537.33605315426,2019-03-28,0,0,0,0,0,2,0,0,0,0,4,0,0,0,0,0,0,0,0,1,0,1,2,10,TM9SF2,0.74399996,3.2829,0.71233,0,-1.0,-1.0,,
ENSG00000127152,17,5,1,0,0,1,17702.698630315714,1778690.168860174,2014-07-22,3,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,10,0,0,1,0,0,0,16,BCL11B,0.538,1.293,-4.0973,2,0.75,0.0,,
ENSG00000127324,6,5,1,1,1,1,10023.250789889415,1424218.0900670097,2008-03-30,1,0,0,0,0,9,0,0,1,0,5,0,0,0,0,0,0,0,0,1,0,0,0,17,TSPAN8,0.088,0.31009,0.065338,0,0.5,0.0,,
ENSG00000127329,5,5,0,0,1,1,4138.14345291562,355284.1215006515,2023-01-18,3,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,7,PTPRB,0.53400004,3.2973,1.3057,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000128342,8,5,1,0,0,1,2201.586503948313,143413.24457139417,2017-12-22,2,0,0,1,1,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,8,LIF,-0.074,0.82733,0.1975,3,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000131668,8,5,1,0,1,1,4245.506600377164,357868.436022711,2018-08-13,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,1,0,1,7,12,BARX1,-0.26600003,-0.98399,-2.4568,0,1.0,0.5,,
ENSG00000133466,11,5,1,0,1,1,2909.767697594502,381165.6245253304,2010-04-21,0,0,0,0,0,3,0,0,1,15,0,0,0,0,1,0,0,0,0,1,0,0,0,21,C1QTNF6,-0.25600004,1.3584,1.3291,0,0.5,0.0,,
ENSG00000134198,15,5,0,0,0,1,9008.784118129615,598869.4096893278,2013-06-23,0,0,0,0,16,0,0,0,0,0,0,0,3,0,1,0,1,0,0,0,0,0,7,28,TSPAN2,-0.19500005,-0.19553,-0.96145,0,0.5,0.0,,
ENSG00000134986,9,5,1,0,0,1,36159.555758564435,1778690.168860174,2017-01-09,0,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,1,10,NREP,-0.829,-0.333,0.23795,0,0.5,-1.0,,
ENSG00000136153,7,5,1,0,1,1,8442.826596069646,414433.58532016096,2011-09-29,1,0,0,16,0,1,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,23,LMO7,0.356,0.52036,0.023797,3,0.5,-1.0,Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000137040,9,5,0,0,1,1,32555.310754135273,562534.7696387965,2017-10-30,0,1,0,1,0,0,0,0,0,0,17,0,0,0,1,0,0,0,0,0,0,1,0,21,RANBP6,0.53499997,-0.29388,-0.70817,0,-1.0,-1.0,,
ENSG00000138311,18,5,1,0,0,1,4127.996124031008,1470466.6505612188,2010-05-09,26,0,0,0,0,0,0,2,0,0,0,0,1,0,0,0,1,0,0,0,0,0,2,32,ZNF365,0.14700001,1.2594,0.63044,0,0.75,0.0,,
ENSG00000138622,9,5,0,0,0,1,576.1087314662274,645988.1975077938,2012-04-29,0,0,0,0,25,2,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,30,HCN4,0.42900002,1.2903,-1.9582,1,0.75,0.5,,
ENSG00000139318,10,5,0,0,1,1,11506.226732433088,1778690.168860174,2018-11-26,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,7,1,0,0,0,0,4,14,DUSP6,0.55,1.0269,-1.0739,4,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;ERKs are inactivated;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-202670;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202
ENSG00000140945,13,5,1,0,0,1,13468.40052574979,1778690.168860174,2017-01-09,0,0,0,0,22,0,0,0,0,0,0,0,2,0,0,0,3,0,0,1,0,0,4,32,CDH13,0.544,-0.93707,-3.1743,1,0.5,0.0,,
ENSG00000142798,8,5,1,1,0,1,78906.83616868555,645988.1975077938,2018-07-30,0,0,0,0,7,0,0,0,0,0,1,0,2,0,0,0,0,0,0,1,0,0,2,13,HSPG2,0.397,3.4262,0.89339,20,-1.0,0.0,Disease;Glycosaminoglycan-protein linkage region biosynthesis;HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1643685;R-HSA-1971475;R-HSA-2022928;R-HSA-1638091
ENSG00000143153,14,5,1,0,0,1,4294.233261840138,502231.5406594711,2017-12-06,0,0,0,5,9,0,0,0,0,0,0,0,0,0,0,7,0,0,0,4,0,0,4,29,ATP1B1,0.805,3.0715,-0.010643,4,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000143226,15,5,1,1,1,1,1072.3175572519083,334911.3573752668,2009-11-15,0,0,0,0,0,0,3,0,0,0,0,5,5,0,0,0,2,0,0,36,0,0,0,51,FCGR2A,0.07800001,1.9922,0.64745,5,0.5,-1.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000143365,12,5,1,0,0,1,21897.542503344637,322220.1169395476,2012-11-01,0,0,0,0,0,0,1,0,2,0,2,0,0,0,0,0,0,0,0,16,0,0,2,23,RORC,0.649,2.8954,-0.57056,6,0.5,0.0,Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins;RUNX3 Regulates Immune Response and Cell Migration;Interleukin-4 and Interleukin-13 signaling;Transcriptional regulation by RUNX3,R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147;R-HSA-8949275;R-HSA-6785807;R-HSA-8878159
ENSG00000144810,13,5,1,0,0,1,26264.552756469657,414433.58532016096,2015-12-21,0,3,0,7,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,7,25,COL8A1,0.31599998,2.3762,0.2822,5,-1.0,0.0,,
ENSG00000147650,8,5,0,0,0,1,606.6666666666666,1424218.0900670097,2012-04-26,0,1,0,1,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,12,LRP12,0.709,2.4437,0.60587,1,-1.0,-1.0,,
ENSG00000150471,8,5,0,0,1,1,4717.2370452039695,415452.66715166246,2018-09-17,0,0,0,3,1,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,0,2,0,10,ADGRL3,0.549,2.4878,0.23898,0,0.5,0.0,,
ENSG00000151690,5,5,1,0,0,1,9724.911607071434,215157.94798738702,2020-10-26,1,0,0,0,0,0,0,0,0,1,0,2,1,0,0,0,0,0,0,1,0,0,0,6,MFSD6,0.39,3.1296,1.4144,0,-1.0,-1.0,,
ENSG00000152661,9,5,0,0,0,1,19462.919455293995,645988.1975077938,2016-06-20,0,0,0,3,17,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,7,29,GJA1,0.478,3.3847,-0.075573,11,-1.0,0.0,Signal Transduction;Disease;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-162582;R-HSA-1643685;R-HSA-157858;R-HSA-190828
ENSG00000152954,10,5,0,0,0,1,6796.671949604783,1778690.168860174,2021-09-30,0,0,0,2,0,0,0,0,0,0,0,0,8,0,0,0,1,0,0,5,0,0,2,18,NRSN1,-0.19700003,0.87133,1.116,0,0.75,0.5,,
ENSG00000153015,13,5,1,0,1,1,1468.3535353535353,1470466.6505612188,2015-12-21,1,0,0,0,1,0,10,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,12,29,CWC27,-0.181,0.75484,0.64084,1,-1.0,-1.0,,
ENSG00000153574,7,5,1,0,0,1,21408.6965896625,381165.6245253304,2021-07-21,3,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,0,0,1,0,0,0,7,RPIA,-0.019000053,0.15543,-0.53952,3,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000155657,12,5,1,0,1,1,21781.337520231158,1424218.0900670097,2018-01-04,0,0,0,0,23,3,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,1,30,TTN,0.521,7.0514,7.0041,2,0.5,0.0,,
ENSG00000156466,7,5,1,0,0,1,134159.95265752633,1424218.0900670097,2020-06-15,0,0,0,0,0,2,1,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,3,9,GDF6,0.658,0.087295,-1.1127,0,0.5,0.5,,
ENSG00000160584,5,5,0,0,0,1,19262.941432762796,562534.7696387965,2022-10-12,0,0,0,0,2,0,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,6,SIK3,0.732,3.9417,-0.041941,0,-1.0,-1.0,,
ENSG00000162552,18,5,1,0,0,1,5409.126569775645,187674.40497870417,2012-10-28,13,0,0,0,0,0,0,20,0,0,0,0,1,0,0,0,0,0,0,2,0,0,5,41,WNT4,0.306,2.0238,0.52019,7,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000163602,6,5,1,0,0,1,50072.877304794354,360837.067725683,2017-10-30,0,0,0,0,0,0,0,0,1,0,3,1,0,0,1,0,0,0,0,0,0,0,2,8,RYBP,0.828,2.2878,-0.28797,2,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8953750
ENSG00000163935,6,5,1,0,0,1,25415.17921452856,384314.83364002535,2012-11-01,2,0,0,0,1,0,0,0,0,0,0,0,19,0,0,0,0,0,0,1,0,0,1,24,SFMBT1,0.598,3.196,1.3495,0,0.5,-1.0,,
ENSG00000165409,10,5,1,0,1,1,2957.836375929682,269829.0934099178,2011-08-14,0,0,0,0,0,0,0,0,0,28,0,0,0,0,0,0,0,0,1,2,1,0,1,33,TSHR,-0.011999965,1.3233,0.51781,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000166035,9,5,1,0,0,1,2489.748511904762,213435.01458839694,2010-04-12,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,15,0,0,1,22,LIPC,-0.102,-0.40472,-0.41034,2,1.0,0.5,Plasma lipoprotein remodeling,R-HSA-8963899
ENSG00000167258,8,5,1,0,0,1,67341.17475659713,1424218.0900670097,2017-12-22,0,0,0,0,4,4,0,0,0,0,1,2,1,0,0,0,0,0,0,0,0,0,0,12,CDK12,0.79,2.6395,0.21512,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000167522,11,5,0,0,0,1,28498.101402717097,515513.2178404211,2018-10-08,9,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,16,ANKRD11,0.86800003,-1.0567,-5.6689,0,-1.0,-1.0,,
ENSG00000168488,8,5,1,0,0,1,6934.665266596663,575147.0632428399,2009-11-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,3,2,0,0,1,8,ATXN2L,0.703,0.89079,-2.2723,0,-1.0,-1.0,,
ENSG00000168743,8,5,1,0,0,1,17601.10520641419,562534.7696387965,2019-02-25,0,1,0,1,4,0,0,0,0,0,19,0,0,0,0,0,0,0,0,0,0,0,1,26,NPNT,0.055999994,0.56177,0.55583,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000169184,6,5,0,0,1,1,3624.878124194795,598869.4096893278,2015-08-24,1,0,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,1,0,1,0,0,0,7,MN1,0.518,-2.2255,-3.8415,0,0.5,0.0,,
ENSG00000169435,6,5,1,0,1,1,155978.81883421048,521818.7070055739,2021-01-04,10,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,1,1,0,0,1,16,RASSF6,-0.52199996,-0.51895,-0.99569,0,0.5,0.0,,
ENSG00000170035,6,5,1,0,0,1,12753.975004907414,1424218.0900670097,2010-02-28,0,0,0,0,3,3,0,1,0,0,0,0,1,0,0,0,0,0,0,5,0,0,0,13,UBE2E3,0.58500004,3.3307,0.4306,2,-1.0,-1.0,Immune System;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Protein ubiquitination;Post-translational protein modification,R-HSA-168256;R-HSA-8866652;R-HSA-8852135;R-HSA-597592
ENSG00000172301,5,5,1,0,0,1,232586.34864014547,521818.7070055739,2020-10-05,3,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,7,COPRS,0.026000023,-0.20784,0.024329,1,-1.0,-1.0,,
ENSG00000172927,17,5,1,0,1,1,3747.57310565635,645988.1975077938,2008-02-10,49,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,2,56,MYEOV,-0.71800005,0.31509,-0.26262,0,0.5,0.5,,
ENSG00000173171,14,5,1,0,1,1,4080.9772916381407,407080.5516610372,2015-06-22,15,1,0,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,0,0,0,3,24,MTX1,0.10100001,-1.193,-1.5647,3,-1.0,-1.0,Signal Transduction;Cristae formation,R-HSA-162582;R-HSA-8949613
ENSG00000174306,7,5,0,0,1,1,72982.48880358285,1424218.0900670097,2020-06-15,0,0,0,0,2,4,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,11,ZHX3,0.57,2.2405,1.5481,0,-1.0,-1.0,,
ENSG00000176887,7,5,0,0,0,1,6600.972478682,1424218.0900670097,2021-09-30,5,0,0,0,2,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,10,SOX11,-0.148,1.4861,-2.9078,0,0.5,1.0,,
ENSG00000178342,11,5,1,0,0,1,5267.085132525891,1778690.168860174,2013-10-19,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,12,0,0,1,0,2,1,18,KCNG2,-0.93799996,-2.5048,-4.7712,2,0.5,1.0,,
ENSG00000178951,7,5,1,0,0,1,101670.29565171694,382631.1172224132,2023-01-18,0,1,0,0,0,0,1,0,7,0,2,0,0,0,1,0,0,0,0,0,0,0,0,12,ZBTB7A,0.12199998,1.8718,-1.8125,0,-1.0,-1.0,,
ENSG00000180176,9,5,1,0,0,1,1194.3085904920767,1424218.0900670097,2009-05-10,20,0,0,5,0,25,0,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,53,TH,-0.26999998,-1.0314,-1.6511,1,0.75,0.5,Metabolism of amine-derived hormones,R-HSA-209776
ENSG00000182263,13,5,1,0,0,1,5789.2810075520965,500292.45069431677,2017-12-06,1,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,5,0,1,0,0,0,4,28,FIGN,0.724,1.5445,-0.76039,0,-1.0,0.0,,
ENSG00000182704,7,5,1,0,0,1,646.3304347826087,515513.2178404211,2017-09-01,0,0,0,0,0,1,0,1,0,0,0,0,2,0,0,0,0,0,0,1,0,1,0,6,TSKU,0.088,1.2313,0.56903,0,0.5,-1.0,,
ENSG00000184986,10,5,0,0,0,1,784.2751842751843,381165.6245253304,2020-10-15,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,3,0,0,7,0,0,0,13,TMEM121,-0.15699995,-0.47215,-2.3813,0,0.5,0.0,,
ENSG00000185313,9,5,0,0,1,1,975.1366503153469,645988.1975077938,2013-07-21,0,0,0,0,16,0,1,0,0,0,1,0,0,0,0,0,0,0,0,7,0,0,1,26,SCN10A,-0.05799997,0.16322,-0.6031,2,,,Developmental Biology;Interaction between L1 and Ankyrins,R-HSA-1266738;R-HSA-445095
ENSG00000188266,7,5,0,0,0,1,17996.405880815684,756470.9740366563,2021-09-30,1,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,2,6,HYKK,0.050000012,1.3198,0.24926,1,-1.0,0.0,,
ENSG00000197386,5,5,1,0,1,1,882.744118501307,1424218.0900670097,2018-10-08,1,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,4,0,0,1,0,0,0,9,HTT,0.647,3.723,-0.061857,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000198756,11,5,1,0,1,1,46282.676044693806,1470466.6505612188,2019-01-21,0,0,0,0,0,3,0,0,0,0,0,0,42,1,0,0,0,0,0,0,0,1,12,59,COLGALT2,0.19999999,0.66462,0.061303,1,0.5,0.0,,
ENSG00000198900,7,5,1,0,0,1,69915.00897904889,275021.63051358337,2018-08-13,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,2,1,0,0,1,7,TOP1,0.878,5.364,1.3289,1,-1.0,-1.0,SUMOylation of DNA replication proteins;Post-translational protein modification,R-HSA-4615885;R-HSA-597592
ENSG00000225614,6,5,0,0,0,1,7794.273577144567,598869.4096893278,2021-03-01,0,0,0,0,2,0,0,0,0,0,0,0,5,0,0,0,0,0,0,1,2,0,2,12,ZNF469,-0.71099997,-4.0028,-3.939,0,0.5,0.5,,
ENSG00000254647,14,5,1,0,0,1,2976.1223128139563,575147.0632428399,2011-08-04,0,0,0,8,0,22,0,0,0,0,0,3,0,0,2,0,1,0,0,0,0,0,0,36,INS,-0.19500005,0.85977,-0.55107,14,1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9006934;R-HSA-597592
ENSG00000266028,5,5,1,0,0,0,13883.57970142381,1424218.0900670097,2018-08-13,1,0,0,0,0,3,0,0,0,0,1,0,4,0,0,0,0,0,0,0,0,0,1,10,SRGAP2,0.444,2.1394,0.92373,8,0.5,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000002745,12,5,1,0,0,1,12039.527202924084,355284.1215006515,2018-08-13,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,25,0,1,32,WNT16,0.19599998,0.25549,0.31378,2,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000003137,6,5,0,0,1,1,14145.711748532529,562534.7696387965,2014-07-22,0,1,0,0,0,0,0,0,0,0,5,0,1,0,1,0,1,0,0,0,0,0,0,9,CYP26B1,0.629,1.2829,-0.23942,3,0.5,0.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000004846,11,5,1,0,0,1,48209.08438856935,562534.7696387965,2017-10-30,0,0,0,0,1,0,0,0,0,0,23,0,0,0,3,0,0,0,0,1,0,0,4,32,ABCB5,-0.17799997,-2.0603,-1.6446,1,1.0,0.5,,
ENSG00000006468,8,5,1,0,0,1,98744.41493028583,1424218.0900670097,2019-02-04,0,0,0,3,0,12,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,18,ETV1,0.342,0.51117,-0.82331,0,0.5,0.0,,
ENSG00000007237,6,5,1,0,0,1,12315.440661331722,521818.7070055739,2018-06-11,2,0,0,47,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,52,GAS7,0.32599998,2.4181,-0.061855,0,1.0,-1.0,,
ENSG00000013725,5,5,1,1,1,1,6455.576662143826,322220.1169395476,2009-06-14,0,0,0,0,0,1,0,0,0,1,0,0,0,0,4,0,0,0,0,3,0,0,1,10,CD6,-0.029999971,0.41164,-0.50697,0,0.5,0.0,,
ENSG00000026297,15,5,1,1,1,1,1233.0624505928854,381165.6245253304,2011-08-14,14,0,0,0,0,0,0,0,0,14,0,0,6,0,1,0,0,0,0,6,0,0,0,41,RNASET2,-0.22399998,0.026739,-0.34661,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000044524,10,5,1,0,1,1,42398.05428047667,1424218.0900670097,2018-07-30,1,0,0,0,11,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,16,EPHA3,0.49199998,0.84553,-0.37896,3,0.5,0.0,Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-1266738;R-HSA-3928665
ENSG00000054598,8,5,0,0,0,1,7053.66653679005,672632.4785173276,2015-01-08,0,0,0,41,7,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,0,0,1,53,FOXC1,-0.27600002,-3.6444,-6.2815,2,1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000056558,8,5,1,0,1,1,2010.4597478176527,381165.6245253304,2007-09-05,0,0,0,0,0,0,0,0,0,0,4,1,4,0,2,0,0,0,0,0,0,0,2,13,TRAF1,0.255,1.0151,0.73148,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000057663,7,5,0,0,0,1,17019.2658782304,562534.7696387965,2016-07-01,2,0,0,0,0,0,0,0,0,0,5,2,2,0,0,0,0,0,0,1,0,0,0,12,ATG5,0.26099998,2.2908,0.51452,4,-1.0,-1.0,Immune System;Receptor Mediated Mitophagy,R-HSA-168256;R-HSA-8934903
ENSG00000064225,5,5,1,0,0,1,29176.435594166323,381165.6245253304,2019-06-07,4,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,1,0,0,0,8,ST3GAL6,0.037,1.0265,0.61168,4,0.5,0.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000064393,5,5,1,0,0,1,11843.109477001575,381165.6245253304,2021-11-04,0,0,0,0,1,0,0,0,1,1,0,0,0,0,1,0,0,0,0,1,0,0,0,5,HIPK2,0.667,3.1629,0.23344,6,1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000065361,5,5,1,1,0,1,4800.0,574782.4268116049,2007-06-06,0,0,0,0,0,6,0,0,0,0,1,0,1,0,0,0,1,0,0,1,0,0,0,10,ERBB3,0.305,3.3038,2.0495,15,-1.0,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000065613,12,5,1,0,1,1,9539.551199137346,367949.31877243903,2021-09-30,8,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,2,14,SLK,0.38700002,3.0384,1.4295,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000067606,5,5,1,0,0,1,85474.33432267047,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,1,5,PRKCZ,0.42400002,2.9346,-0.49488,5,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000070831,13,5,1,0,0,1,16009.533384557282,355284.1215006515,2018-09-07,10,0,0,0,0,0,2,15,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,30,CDC42,0.389,2.9049,0.2892,28,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;G-protein beta:gamma signalling;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-397795;R-HSA-9006934
ENSG00000072110,5,5,1,0,0,1,145320.08042080907,765591.3646788632,2020-06-15,0,0,0,0,1,2,0,0,0,1,0,0,0,0,0,0,3,0,0,1,0,0,0,8,ACTN1,0.669,5.2049,1.5859,7,0.5,-1.0,Signal Transduction;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9706574
ENSG00000072682,8,5,1,0,0,1,6918.109956479261,284806.9010892102,2016-12-29,1,0,0,0,3,0,0,0,1,0,2,0,0,0,0,0,0,0,0,1,0,0,0,8,P4HA2,0.15899998,1.3154,1.0555,1,-1.0,-1.0,,
ENSG00000073712,13,5,1,0,0,1,1226.6884540988854,521818.7070055739,2013-04-01,13,0,0,14,1,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,1,36,FERMT2,0.696,2.3044,0.43229,3,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000074410,5,5,1,1,0,1,190279.23963861223,341207.7500533011,2019-06-24,0,0,0,0,0,0,2,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,3,8,CA12,0.032000005,0.45595,-0.3967,1,0.5,0.0,,
ENSG00000075035,10,5,0,0,1,1,55416.28042655659,1470466.6505612188,2018-10-08,0,0,0,0,0,10,0,1,0,0,0,0,13,0,0,0,5,0,0,0,0,0,2,31,WSCD2,0.347,2.3297,0.61886,0,1.0,0.0,,
ENSG00000076685,10,5,1,0,0,1,4607.305208781748,713911.8939045856,2012-06-12,0,0,0,0,11,1,0,0,0,0,0,0,1,0,0,0,5,0,0,0,0,0,3,21,NT5C2,-0.12800002,2.4647,0.12013,3,-1.0,-1.0,Purine catabolism;Metabolism of nucleotides,R-HSA-74259;R-HSA-15869
ENSG00000078114,8,5,0,0,1,1,2415.901095813431,645988.1975077938,2015-06-01,1,0,0,0,9,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,1,14,NEBL,-0.036000013,-0.093948,-0.24906,0,1.0,0.0,,
ENSG00000081189,15,5,1,0,0,1,8504.16066643711,1424218.0900670097,2014-07-22,0,0,0,1,0,3,0,0,0,0,0,0,1,0,0,0,11,0,0,0,0,0,5,21,MEF2C,0.788,4.8294,1.624,7,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-449147;R-HSA-9006934
ENSG00000086289,11,5,1,0,0,1,2630.136511375948,356440.71671986027,2011-07-06,5,0,0,1,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,0,1,0,5,29,EPDR1,-0.62600005,-1.7141,-1.6223,0,0.5,-1.0,,
ENSG00000087510,8,5,0,0,0,1,2314.313784461153,197485.87952538437,2021-11-04,0,0,0,2,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,10,TFAP2C,0.583,1.3295,-0.95998,8,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Post-translational protein modification;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-597592;R-HSA-8864260
ENSG00000088926,20,5,1,1,0,1,2037.010062290369,500292.45069431677,2013-05-05,0,0,0,0,61,0,0,0,0,0,2,0,0,0,1,3,0,0,0,0,0,0,32,99,F11,-0.14499998,0.84839,0.49262,2,1.0,0.5,Disease,R-HSA-1643685
ENSG00000089009,6,5,0,0,0,1,38916.5112034063,1778690.168860174,2018-03-12,0,0,0,0,3,0,0,0,0,1,0,0,1,0,0,0,2,0,0,2,0,0,0,9,RPL6,0.824,1.2551,0.4145,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000090530,9,5,1,0,0,1,5795.555913631969,356440.71671986027,2010-10-24,6,0,0,0,0,0,0,0,1,0,0,0,6,0,0,0,0,0,0,2,0,0,3,18,P3H2,-0.24899995,-1.6098,-1.4438,1,-1.0,0.0,,
ENSG00000090975,6,5,0,0,0,1,38092.548464040476,1778690.168860174,2014-02-09,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,1,5,PITPNM2,0.64,4.3256,0.4821,1,1.0,-1.0,,
ENSG00000092607,8,5,0,0,1,1,15911.334729431392,598869.4096893278,2021-11-04,0,0,0,1,0,0,0,0,0,0,1,0,8,0,0,0,0,0,0,4,0,0,3,17,TBX15,0.52900004,1.1753,-0.084833,0,0.5,0.0,,
ENSG00000095596,8,5,1,0,0,1,40529.80534846739,414433.58532016096,2018-07-27,0,0,0,10,0,0,0,0,0,0,1,0,0,0,0,0,3,0,0,2,0,0,3,19,CYP26A1,-0.42700005,-0.24131,-0.025936,2,1.0,1.0,Signal Transduction,R-HSA-162582
ENSG00000095637,5,5,1,0,0,1,143284.77790855977,427337.4491868293,2023-01-18,1,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,6,SORBS1,0.31,1.7339,0.49789,1,-1.0,-1.0,,
ENSG00000096401,20,5,0,0,0,1,3823.6404948245395,1990918.947961699,2014-07-27,0,0,0,0,0,0,0,0,0,0,0,0,23,0,0,0,6,0,0,3,0,1,4,37,CDC5L,0.74,2.7719,0.70557,1,-1.0,-1.0,,
ENSG00000100211,5,5,1,0,0,0,104829.95456615865,381165.6245253304,2018-11-30,1,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,5,CBY1,-0.13900006,0.38535,0.30172,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000100325,6,5,1,0,1,1,12129.582986241576,1424218.0900670097,2021-07-22,0,0,0,1,1,3,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,7,ASCC2,0.407,1.5957,0.62744,1,-1.0,-1.0,DNA Damage Reversal,R-HSA-73942
ENSG00000100345,13,5,1,0,1,0,8785.223357377507,407080.5516610372,2023-02-01,2,0,0,0,0,0,0,0,0,0,0,12,0,0,0,1,0,0,2,0,0,0,4,21,MYH9,0.841,6.1402,0.83696,13,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Disease;Diseases of signal transduction by growth factor receptors and second messengers;CD163 mediating an anti-inflammatory response,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-5663202;R-HSA-9662834
ENSG00000100376,8,5,1,0,1,1,180089.50342935527,521818.7070055739,2019-06-24,2,0,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,4,11,FAM118A,0.15200001,0.85217,0.36924,0,-1.0,-1.0,,
ENSG00000101000,20,5,1,1,1,1,11905.323060471395,394357.452283155,2016-02-09,5,0,0,0,20,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,15,42,PROCR,-0.26,0.64459,0.28888,2,0.5,0.0,,
ENSG00000101216,13,5,1,0,0,1,13144.133106414256,562534.7696387965,2021-07-21,11,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,1,17,GMEB2,0.63199997,1.3713,-0.57119,0,-1.0,-1.0,,
ENSG00000101464,13,5,0,0,0,1,10352.610157160763,322107.4898639223,2018-08-13,19,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,2,0,3,26,PIGU,0.325,0.47385,-0.74341,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000101751,8,5,1,0,0,1,16461.04650907092,521818.7070055739,2015-01-08,3,0,0,0,0,0,0,0,3,0,6,0,0,0,0,0,0,0,0,8,0,0,1,21,POLI,-0.719,-0.87726,-0.62888,2,-1.0,-1.0,,
ENSG00000103257,7,5,1,0,0,1,490.7337909992372,1990918.947961699,2018-11-01,0,0,0,1,0,1,0,0,0,0,1,0,3,0,0,0,1,0,0,0,0,0,0,7,SLC7A5,0.39099997,1.5011,-1.6477,3,0.5,-1.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000104388,9,5,1,0,0,1,17601.10520641419,381165.6245253304,2020-06-24,0,2,0,0,0,0,0,0,0,3,0,0,1,0,1,0,0,0,0,3,0,0,0,10,RAB2A,-0.024000049,2.5947,0.35064,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000104760,5,5,0,1,1,1,13778.506917702927,1424218.0900670097,2023-01-18,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,3,0,0,1,7,FGL1,-0.753,-3.6848,-2.6029,0,1.0,0.5,,
ENSG00000105810,14,5,1,0,0,1,606.6666666666666,756470.9740366563,2018-03-12,0,1,0,0,18,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,3,25,CDK6,0.588,3.1383,0.38451,9,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000106636,6,5,1,0,0,1,40855.314577620855,1424218.0900670097,2018-07-27,0,0,1,0,0,7,2,0,0,0,0,0,0,0,0,0,0,0,2,2,0,0,0,14,YKT6,0.36400002,1.5456,0.70093,8,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000106952,8,5,1,1,0,1,3511.742535866615,381165.6245253304,2016-08-25,1,1,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,10,0,0,0,15,TNFSF8,0.486,1.0968,0.30947,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000107105,11,5,1,0,0,1,4917.108320036471,1778690.168860174,2018-03-08,0,0,0,0,0,3,0,0,0,0,11,0,1,0,0,0,9,0,0,0,0,0,3,27,ELAVL2,0.751,0.56236,-1.2748,0,0.75,0.5,,
ENSG00000107611,8,5,1,0,1,1,17416.80601016872,426392.4103859523,2019-04-01,0,0,0,0,1,0,0,0,0,0,0,0,5,0,0,9,0,0,16,0,0,0,3,34,CUBN,0.24400002,1.0005,0.24173,5,1.0,0.0,Disease;Metabolism of steroids,R-HSA-1643685;R-HSA-8957322
ENSG00000107863,5,5,1,0,0,1,83710.65550453523,1778690.168860174,2022-07-14,0,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,0,0,1,10,ARHGAP21,0.73899996,4.193,1.7675,13,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000107960,41,5,1,0,1,1,7304.509669072407,521818.7070055739,2015-08-03,73,0,0,0,13,0,0,0,0,6,0,0,0,0,0,0,0,0,0,1,0,0,5,98,STN1,0.024999976,1.2158,0.82619,2,-1.0,-1.0,,
ENSG00000108557,9,5,1,0,1,1,46601.3671671619,895916.2144062951,2013-11-21,2,0,0,0,5,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,13,RAI1,0.871,2.4299,-1.2437,2,-1.0,-1.0,,
ENSG00000109667,9,5,1,0,1,1,932.622440120525,384314.83364002535,2012-12-23,0,0,0,0,1,0,0,0,0,0,0,1,96,0,0,0,0,0,0,3,1,0,0,102,SLC2A9,-0.021999955,0.036295,-1.4668,2,0.5,0.0,Disease;Cellular hexose transport,R-HSA-1643685;R-HSA-189200
ENSG00000109819,8,5,0,0,0,1,10983.062958035911,323648.5577791949,2015-07-21,1,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,5,17,PPARGC1A,0.62,1.5219,0.25614,13,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-597592
ENSG00000110080,10,5,1,0,0,1,39406.19595155135,464892.4593283075,2021-12-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,3,0,0,3,13,ST3GAL4,0.23799998,2.4055,1.5063,9,-1.0,-1.0,Signal Transduction;Translation of Structural Proteins_9683701;Disease;Post-translational protein modification,R-HSA-162582;R-HSA-9683701;R-HSA-1643685;R-HSA-597592
ENSG00000110243,24,5,0,1,1,1,1335.4481927710845,782476.8109259979,2010-07-25,0,0,0,0,29,0,1,0,0,0,0,0,0,0,0,0,0,0,13,14,0,0,16,73,APOA5,-0.14600003,0.62785,0.52561,5,1.0,0.5,Chylomicron remodeling;Plasma lipoprotein remodeling;Post-translational protein modification,R-HSA-8963901;R-HSA-8963899;R-HSA-597592
ENSG00000111077,10,5,1,0,0,1,12542.479619943082,500292.45069431677,2021-11-04,0,0,4,0,4,0,0,0,0,0,0,0,6,0,0,0,0,0,0,1,0,0,2,17,TNS2,0.388,1.337,0.54938,0,-1.0,0.0,,
ENSG00000111331,5,5,1,0,1,1,17224.294436185013,278739.419613982,2020-05-13,0,18,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,22,OAS3,-0.11199999,1.3843,0.80248,3,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000111404,6,5,0,0,0,1,19875.020792566687,500292.45069431677,2019-08-15,0,0,2,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,2,9,RERGL,-0.25399995,-0.21311,0.40916,0,-1.0,0.0,,
ENSG00000112062,7,5,0,0,0,1,3860.5077949574647,34592.48870785933,2023-01-18,0,0,0,1,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,1,0,0,1,7,MAPK14,0.436,2.9352,0.408,17,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;ADP signalling through P2Y purinoceptor 1;Gene expression (Transcription);Signal amplification;p38MAPK events;Disease;Signaling by Interleukins;Activation of the AP-1 family of transcription factors;Signaling by Receptor Tyrosine Kinases;CD163 mediating an anti-inflammatory response,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-418592;R-HSA-74160;R-HSA-392518;R-HSA-171007;R-HSA-1643685;R-HSA-449147;R-HSA-450341;R-HSA-9006934;R-HSA-9662834
ENSG00000112164,10,5,1,0,1,1,18665.604164523163,756470.9740366563,2019-02-04,0,0,1,0,2,14,0,0,0,0,0,0,0,0,0,0,1,0,4,0,0,0,0,22,GLP1R,0.50600004,1.8009,-0.092866,3,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000112319,11,5,1,0,1,1,4762.032136009875,645988.1975077938,2020-06-08,1,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,0,0,3,0,0,6,24,EYA4,0.464,1.2878,0.41731,1,0.5,0.0,,
ENSG00000112339,12,5,1,0,0,1,4770.822126363867,562534.7696387965,2012-12-01,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,6,0,0,0,3,0,0,4,16,HBS1L,0.213,0.83841,0.63784,1,-1.0,-1.0,,
ENSG00000112837,8,5,1,0,0,1,22534.2747592156,714039.8414241908,2019-03-04,0,0,0,0,0,0,0,0,0,0,1,0,4,0,1,0,0,0,0,4,0,0,2,12,TBX18,0.44,-0.73569,-0.80825,0,0.5,0.0,,
ENSG00000113282,7,5,0,0,0,1,72982.48880358285,500292.45069431677,2021-11-04,0,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,2,11,CLINT1,0.581,1.9476,1.0953,1,-1.0,-1.0,,
ENSG00000114439,5,5,1,0,0,1,171880.2916512608,437137.9986908925,2021-11-04,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,1,6,BBX,0.64100003,1.7997,0.8686,0,-1.0,-1.0,,
ENSG00000115850,9,5,1,1,1,1,4070.116983229079,376569.5597064443,2023-01-18,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,2,0,0,2,7,LCT,0.38,4.9902,2.5244,2,1.0,0.5,Digestion and absorption;Digestion;Disease,R-HSA-8963743;R-HSA-8935690;R-HSA-1643685
ENSG00000116183,7,5,0,0,0,1,122549.0830919942,427337.4491868293,2023-01-18,1,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,6,PAPPA2,0.45099998,2.1482,1.6486,1,1.0,0.5,,
ENSG00000116285,11,5,1,0,0,1,18290.737976096676,382631.1172224132,2017-01-09,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,13,0,0,1,17,ERRFI1,-0.08800006,1.7764,0.71292,0,0.5,-1.0,,
ENSG00000117479,20,5,1,0,0,1,11014.04703420302,203570.3035915171,2018-08-13,1,0,0,0,14,0,0,1,0,0,0,0,0,0,0,5,0,0,0,0,0,0,12,33,SLC19A2,0.148,0.8925,0.30214,1,0.5,-1.0,,
ENSG00000118200,5,5,1,0,0,1,1721.5740365111562,205425.60717824215,2011-11-24,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,5,CAMSAP2,0.804,3.773,2.2992,0,-1.0,0.0,,
ENSG00000118655,9,5,1,0,1,1,33670.70607708678,574782.4268116049,2015-04-01,4,0,0,0,2,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,9,DCLRE1B,0.45499998,0.96227,0.46428,1,-1.0,0.0,,
ENSG00000118946,9,5,1,1,0,1,21613.238490185555,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,4,0,3,1,0,0,2,13,PCDH17,0.575,1.7403,0.083007,0,0.5,0.0,,
ENSG00000119242,10,5,1,0,1,1,18547.897677202665,1778690.168860174,2017-07-17,0,0,0,0,7,10,0,0,0,0,0,0,0,0,0,0,3,0,0,2,0,0,1,23,CCDC92,0.26200002,0.79759,0.29617,0,0.5,-1.0,,
ENSG00000119771,7,5,1,0,0,1,34705.12345097053,498258.534626183,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,2,2,7,KLHL29,0.602,3.3809,0.021807,0,-1.0,0.0,,
ENSG00000120008,10,5,1,0,0,1,2456.6716166716164,1424218.0900670097,2018-08-13,19,0,0,1,2,18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41,WDR11,0.38300002,2.3248,1.8153,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000120162,12,5,1,0,0,1,2708.210557554624,155552.2805078301,2009-09-06,4,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,19,0,0,1,0,0,5,30,MOB3B,0.33099997,0.92031,-0.24201,0,0.5,0.0,,
ENSG00000120278,8,5,1,0,1,1,6067.527905738457,448058.917711015,2017-12-06,0,1,0,2,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,2,16,PLEKHG1,0.41000003,1.9951,1.1333,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000120899,6,5,1,0,0,1,1380.9855975087582,360605.992793193,2018-11-29,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,1,7,PTK2B,0.43800002,2.6933,0.17531,4,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9006934
ENSG00000122863,16,5,1,0,1,1,6888.642955845345,421288.2605201189,2019-06-01,0,0,0,0,0,0,0,0,0,0,0,0,15,0,0,0,2,0,0,0,1,9,4,31,CHST3,-0.11899996,-0.98194,-1.94,2,-1.0,0.0,Disease,R-HSA-1643685
ENSG00000122870,8,5,1,0,0,1,23745.54994600492,384314.83364002535,2018-06-11,0,0,0,20,0,0,0,0,0,0,0,4,15,0,0,1,0,0,0,0,0,0,3,43,BICC1,0.459,1.2448,-0.59423,0,0.5,0.0,,
ENSG00000122970,6,5,0,0,0,1,18539.65427935839,1122672.658801146,2018-01-31,1,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,2,7,IFT81,-0.05400002,0.81268,0.13891,1,-1.0,-1.0,Intraflagellar transport,R-HSA-5620924
ENSG00000124678,16,5,1,0,0,1,6796.671949604783,356440.71671986027,2019-03-28,0,0,0,1,0,0,0,0,0,0,2,0,8,0,0,0,0,0,0,4,0,0,6,21,TCP11,0.051999986,1.479,0.43177,0,1.0,1.0,,
ENSG00000125629,6,5,1,0,0,1,15223.454539395489,464892.4593283075,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,5,10,INSIG2,0.374,2.1015,0.34109,1,-1.0,-1.0,Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-8957322;R-HSA-1655829
ENSG00000128536,9,5,1,0,1,1,3198.048859934853,645988.1975077938,2013-11-17,0,1,0,0,2,0,0,0,0,0,6,0,0,4,0,0,0,0,0,0,0,0,1,14,CDHR3,-0.08700001,0.67832,0.29158,0,0.75,0.0,,
ENSG00000128915,8,5,0,0,0,1,14145.711748532529,444537.33605315426,2017-10-30,0,0,0,0,0,0,0,0,1,0,10,0,0,0,1,0,0,0,0,1,0,0,1,14,ICE2,0.004000008,-1.1319,0.53354,1,0.5,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000129353,15,5,1,0,1,1,11806.630615232236,714039.8414241908,2013-11-01,0,0,0,0,20,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,8,31,SLC44A2,0.21499997,1.9128,0.46131,3,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000130921,9,5,1,0,0,1,116566.20935579021,1910759.9043975426,2018-07-16,0,0,0,0,0,2,0,0,1,0,4,0,9,0,0,0,0,0,0,0,0,0,1,17,MTRFR,-0.22399998,0.2956,0.37252,0,0.5,-1.0,Translation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5368287;R-HSA-9937383
ENSG00000131620,6,5,0,0,0,1,20209.09625085965,301203.06999851385,2018-09-03,2,0,0,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,10,ANO1,0.38200003,2.4386,-0.10763,2,0.5,0.0,Disease,R-HSA-1643685
ENSG00000133105,11,5,1,0,0,1,766.3865546218487,756470.9740366563,2021-11-04,1,0,0,0,3,0,0,0,0,9,0,0,0,0,0,0,0,0,2,0,0,0,3,18,RXFP2,-0.09500003,1.6576,-0.20331,2,,,Signal Transduction,R-HSA-162582
ENSG00000133110,5,5,0,0,0,1,26561.371714038676,235397.69820205137,2023-01-18,1,0,0,0,2,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,3,9,POSTN,0.20300001,0.99803,-0.081876,0,0.5,0.0,,
ENSG00000134222,35,5,1,0,0,1,4653.444078947368,756470.9740366563,2007-07-18,0,0,0,0,75,1,0,0,0,0,0,0,0,0,0,0,0,0,4,13,0,0,30,123,PSRC1,-0.27999997,-0.012359,0.14917,0,0.75,0.0,,
ENSG00000134243,35,5,1,1,0,0,4653.444078947368,756470.9740366563,2007-07-18,0,0,0,0,70,1,0,0,0,0,0,0,0,0,0,0,0,0,4,13,0,0,29,117,SORT1,0.44700003,1.6434,0.40714,1,0.5,-1.0,,
ENSG00000134294,6,5,0,0,0,1,74806.7436355004,355284.1215006515,2019-10-24,7,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,2,12,SLC38A2,0.69200003,1.3661,0.44514,2,-1.0,-1.0,Glutamate Neurotransmitter Release Cycle;Transport of inorganic cations/anions and amino acids/oligopeptides;Neurotransmitter release cycle,R-HSA-210500;R-HSA-425393;R-HSA-112310
ENSG00000134324,6,5,0,0,0,1,13883.57970142381,355284.1215006515,2018-08-13,4,0,0,2,0,0,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,0,1,11,LPIN1,0.21600002,1.5605,0.65147,5,0.5,-1.0,Gene expression (Transcription);Depolymerization of the Nuclear Lamina,R-HSA-74160;R-HSA-4419969
ENSG00000134369,12,5,1,0,0,1,4195.089802267157,515513.2178404211,2020-06-15,0,0,0,0,7,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,3,13,NAV1,0.853,5.6562,2.0351,0,-1.0,-1.0,,
ENSG00000134453,9,5,1,0,0,1,1173.5007132667617,381165.6245253304,2009-05-10,0,0,0,0,0,2,0,0,1,2,0,0,0,0,2,0,0,0,0,2,0,0,0,9,RBM17,0.849,3.2657,0.52497,1,-1.0,-1.0,,
ENSG00000134538,5,5,0,0,1,1,12932.672326971864,500292.45069431677,2023-01-18,0,0,0,0,1,1,0,0,0,0,0,0,3,0,0,0,0,0,1,0,0,0,1,7,SLCO1B1,-0.42499995,-0.43705,-0.14644,5,1.0,1.0,"Atorvastatin ADME;Disease;Transport of vitamins, nucleosides, and related molecules;Metabolism of steroids;Bile acid and bile salt metabolism",R-HSA-9754706;R-HSA-1643685;R-HSA-425397;R-HSA-8957322;R-HSA-194068
ENSG00000134575,6,5,1,0,1,1,7914.993941688755,267702.03251961316,2012-03-07,0,1,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,6,ACP2,0.19599998,1.3402,0.76917,0,-1.0,-1.0,,
ENSG00000134640,9,5,0,0,0,1,1173.5007132667617,1424218.0900670097,2010-06-27,0,0,13,0,0,29,1,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,3,51,MTNR1B,-0.91700006,0.25497,-0.44364,2,0.5,1.0,Signal Transduction,R-HSA-162582
ENSG00000135362,10,5,1,0,1,1,6712.63652527305,381165.6245253304,2013-06-02,0,0,0,0,0,0,0,0,12,0,7,0,0,0,3,0,0,0,0,7,0,0,4,33,PRR5L,0.232,1.387,0.16484,0,0.5,0.0,,
ENSG00000135925,7,5,0,0,1,1,7731.604602670207,258456.3496858129,2018-01-01,4,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,6,0,0,3,15,WNT10A,-0.48399997,-0.80357,-0.84833,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000136040,8,5,0,0,0,1,29176.435594166323,562534.7696387965,2020-01-20,0,0,0,0,1,0,0,0,6,0,9,0,0,0,0,0,0,0,0,1,0,0,3,20,PLXNC1,0.421,2.8103,-1.1852,1,-1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000136378,17,5,1,0,1,1,14260.80332304409,502231.5406594711,2011-03-06,0,0,0,0,42,0,0,0,0,0,3,8,0,0,0,0,0,0,0,1,0,0,18,72,ADAMTS7,0.23900002,1.0363,-0.91937,2,1.0,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000136630,10,5,0,0,1,1,35002.83947832971,464892.4593283075,2018-09-03,0,0,0,0,3,0,3,0,0,0,0,0,0,0,0,0,0,0,0,8,1,0,5,20,HLX,0.58500004,-0.13308,-0.99341,0,0.5,0.0,,
ENSG00000136861,12,5,1,0,0,1,1173.5007132667617,1778690.168860174,2016-05-16,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,0,1,0,0,3,3,13,CDK5RAP2,0.30800003,1.1451,1.0513,7,-1.0,-1.0,,
ENSG00000136869,7,5,0,0,0,1,22650.1728716785,1778690.168860174,2019-02-04,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,9,0,1,0,0,0,1,15,TLR4,0.14200002,1.0096,0.67747,17,-1.0,-1.0,Immune System;Disease;IKK complex recruitment mediated by RIP1,R-HSA-168256;R-HSA-1643685;R-HSA-937041
ENSG00000137573,8,5,1,0,0,1,2630.136511375948,140221.1343160441,2011-07-06,7,0,0,0,0,0,0,0,0,8,0,0,23,0,0,0,0,0,0,2,0,0,5,45,SULF1,0.52900004,2.221,1.0011,0,-1.0,0.0,,
ENSG00000137818,7,5,0,0,0,1,1173.5007132667617,180089.50342935527,2008-08-31,12,0,0,0,0,1,0,0,0,0,0,1,13,0,0,0,0,0,0,2,0,0,0,29,RPLP1,-0.003000021,-0.53481,-0.27329,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000137825,9,5,1,0,0,1,53369.71648873449,360837.067725683,2017-10-30,0,0,0,1,0,0,0,0,3,0,7,0,0,0,1,0,0,0,0,0,0,0,4,16,ITPKA,0.27600002,0.80144,-1.6126,1,0.5,0.0,,
ENSG00000138036,8,5,1,0,0,1,13756.062794259458,178948.78717378277,2017-12-06,0,0,1,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,2,16,DYNC2LI1,-0.027999997,-0.85502,0.46628,1,-1.0,-1.0,Intraflagellar transport,R-HSA-5620924
ENSG00000139428,5,5,1,0,1,1,25903.3352616996,521818.7070055739,2021-09-30,1,0,0,0,3,0,0,0,0,0,0,0,3,0,0,0,0,0,0,2,0,0,1,10,MMAB,0.12599999,0.29256,0.10317,2,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000140285,14,5,1,1,0,1,1858.1047358594756,562534.7696387965,2018-08-13,3,0,0,0,0,0,0,0,0,23,3,0,0,0,0,0,0,0,0,5,0,0,1,35,FGF7,0.357,1.1968,-0.0066107,14,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000140506,5,5,1,0,0,1,24267.559108327496,427337.4491868293,2011-11-06,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,5,LMAN1L,-0.278,0.64658,-0.49053,2,0.75,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000140937,7,5,1,0,1,1,29803.01405728205,714039.8414241908,2020-01-20,0,0,0,8,1,0,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,12,CDH11,0.751,2.2578,0.35547,5,0.5,0.0,,
ENSG00000142606,7,5,1,0,1,1,9269.724378777702,258213.8601133611,2011-11-06,0,0,0,0,0,0,1,0,0,2,0,0,5,0,1,0,0,0,0,3,0,0,0,12,MMEL1,-0.027999997,0.31427,0.48416,0,0.5,0.0,,
ENSG00000142949,12,5,1,0,0,1,15866.724081734988,633132.2332759313,2014-07-22,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,19,1,0,1,0,0,2,24,PTPRF,0.652,4.0637,0.26172,3,-1.0,-1.0,Signal Transduction;Receptor-type tyrosine-protein phosphatases;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-388844;R-HSA-9006934
ENSG00000143126,35,5,1,1,1,1,4653.444078947368,756470.9740366563,2007-07-18,0,0,0,0,67,1,0,0,0,0,0,0,0,0,0,0,0,0,4,13,0,0,32,117,CELSR2,0.604,3.9105,-0.13786,0,0.5,0.0,,
ENSG00000143772,6,5,1,0,1,1,21168.40842438638,562534.7696387965,2017-09-11,0,0,0,0,0,0,1,0,0,0,3,0,0,0,1,0,0,0,0,6,0,0,1,12,ITPKB,0.65999997,-0.12417,-1.4343,1,0.5,0.0,,
ENSG00000143869,16,5,1,0,0,1,17587.419683666812,672632.4785173276,2016-08-12,18,0,0,0,14,1,8,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51,GDF7,-0.72599995,-2.2016,-2.9207,0,0.5,0.0,,
ENSG00000144152,5,5,1,0,0,1,3602.2757558061817,235397.69820205137,2017-11-23,0,0,0,0,3,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,1,0,4,11,FBLN7,-0.03400004,0.43365,-0.56672,0,-1.0,0.0,,
ENSG00000144560,10,5,1,0,1,1,85439.42346498996,598869.4096893278,2019-02-25,0,0,0,0,4,0,0,0,0,0,1,0,6,0,0,0,0,0,0,1,0,0,4,16,VGLL4,0.18199998,0.10415,-2.4664,0,-1.0,-1.0,,
ENSG00000145241,7,5,0,0,0,1,29713.571045654095,756470.9740366563,2022-06-28,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,2,6,CENPC,0.11400002,0.48879,0.35385,7,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000145349,11,5,1,0,0,1,5212.488325165754,756470.9740366563,2013-12-01,1,0,0,0,13,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,0,0,1,20,CAMK2D,0.553,1.1744,0.27837,20,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000145431,9,5,1,0,0,1,25209.39839469752,1424218.0900670097,2018-08-13,4,0,0,0,0,7,5,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,4,21,PDGFC,0.661,1.2943,0.17168,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000145725,9,5,1,0,1,0,72258.6642662147,1424218.0900670097,2018-07-27,0,0,0,1,0,16,0,0,0,0,0,0,3,0,0,0,1,0,0,0,0,0,2,23,PPIP5K2,0.02700001,4.0981,0.34929,1,-1.0,-1.0,,
ENSG00000145934,15,5,1,0,0,1,12603.236825665355,1778690.168860174,2018-04-26,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,8,0,1,1,0,0,5,16,TENM2,0.742,4.3532,1.698,0,1.0,0.5,,
ENSG00000147454,7,5,1,0,1,1,6902.107588581265,278190.43024910334,2018-03-02,7,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,11,SLC25A37,0.14099997,1.0913,-1.0501,1,0.5,-1.0,Mitochondrial iron-sulfur cluster biogenesis,R-HSA-1362409
ENSG00000149131,7,5,1,1,1,1,65343.824011592886,448058.917711015,2014-07-22,0,1,0,0,1,0,0,0,0,0,7,0,0,0,0,0,3,0,0,0,0,0,1,13,SERPING1,0.722,1.8596,0.85038,4,0.5,-1.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000151090,7,5,1,0,0,1,13369.750398006507,645988.1975077938,2018-04-02,6,0,0,0,8,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,17,THRB,0.57,3.7158,0.20924,2,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000151332,14,5,0,0,0,1,764.0560607681609,382631.1172224132,2009-02-06,10,0,0,0,0,0,0,0,0,25,1,0,0,0,2,0,0,0,0,8,0,0,0,46,MBIP,-0.06700003,0.56298,0.29082,2,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000151617,31,5,1,0,1,1,2548.6132437619963,502231.5406594711,2012-01-27,0,1,0,0,83,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,0,0,25,114,EDNRA,0.576,3.9853,0.71921,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000152377,5,5,0,0,0,1,25967.06754524981,645988.1975077938,2017-10-30,0,0,0,0,2,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,6,SPOCK1,0.41399997,0.92197,0.045547,0,0.5,0.0,,
ENSG00000152894,10,5,0,0,0,0,13217.328579372608,562534.7696387965,2011-11-06,1,0,0,0,0,0,0,0,0,0,17,0,0,0,2,0,0,0,0,4,0,0,3,27,PTPRK,0.49,3.3998,0.071193,1,-1.0,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000153006,9,5,0,0,1,0,1468.3535353535353,270756.050710225,2016-03-29,1,0,0,0,0,0,5,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,3,11,SREK1IP1,0.06300002,0.37615,-0.36328,0,-1.0,-1.0,,
ENSG00000153250,5,5,1,0,0,1,61498.92173410762,1424218.0900670097,2018-07-27,1,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,1,0,3,0,0,0,0,9,RBMS1,0.589,2.8234,0.12793,0,-1.0,-1.0,,
ENSG00000154556,5,5,1,0,0,1,86869.04450932604,1778690.168860174,2020-06-15,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,2,6,SORBS2,0.40100002,0.29476,0.28796,0,0.5,0.0,,
ENSG00000155158,6,5,1,0,0,1,365.92946130900157,301203.06999851385,2018-08-13,1,0,0,2,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,3,16,TTC39B,-0.153,-1.533,-1.4182,0,-1.0,-1.0,,
ENSG00000155761,10,5,1,0,0,1,2149.6485623003196,356440.71671986027,2013-05-26,0,0,0,0,0,0,0,0,0,0,0,0,8,0,1,0,0,0,0,5,1,0,4,19,SPAG17,0.30800003,1.2107,1.6293,0,0.5,0.0,,
ENSG00000155846,11,5,0,0,0,1,3961.1185899621164,322107.4898639223,2015-10-26,9,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,1,0,2,15,PPARGC1B,0.556,0.97805,0.064215,5,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000156006,9,5,0,0,0,1,5795.555913631969,464892.4593283075,2010-10-24,8,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,0,0,3,0,0,3,19,NAT2,-0.93799996,-1.4797,-0.25341,2,0.75,0.5,Phase II - Conjugation of compounds,R-HSA-156580
ENSG00000156413,7,5,0,0,1,1,13035.0221976327,227934.29698436207,2015-12-21,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,4,0,0,1,13,FUT6,-0.84099996,0.8856,1.0445,1,0.5,0.0,,
ENSG00000158019,8,5,0,0,0,1,29803.01405728205,355284.1215006515,2019-10-24,5,0,0,3,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,2,14,BABAM2,0.24699998,1.8344,0.14544,5,1.0,-1.0,,
ENSG00000158805,9,5,1,0,1,1,4186.354720520305,1990918.947961699,2018-05-08,6,0,0,1,0,2,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,11,ZNF276,-0.15699995,-3.0463,-4.6467,0,-1.0,-1.0,,
ENSG00000159217,11,5,0,0,0,1,84563.14597380339,1778690.168860174,2018-10-08,0,0,0,1,4,9,0,0,0,0,0,0,0,0,0,0,2,0,2,0,0,0,0,18,IGF2BP1,0.811,4.4234,0.31986,2,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000159314,8,5,1,0,1,1,2047.7477081041438,645988.1975077938,2013-03-27,1,0,0,0,1,0,0,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,4,11,ARHGAP27,0.291,-0.12875,-1.1258,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000159788,6,5,1,0,0,1,70325.27750501591,415452.66715166246,2018-08-13,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,2,6,RGS12,0.30400002,1.0082,-0.18449,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000160360,9,5,1,0,1,1,34004.8644513982,1424218.0900670097,2016-01-28,0,0,1,3,2,25,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,37,GPSM1,0.021000028,-0.7248,-0.56091,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000160856,8,5,1,1,1,1,2209.8301559792026,269829.0934099178,2011-08-14,0,0,0,0,0,0,0,0,0,8,0,1,4,0,1,0,0,0,0,1,0,0,0,15,FCRL3,-0.337,-0.448,-0.33022,0,1.0,0.5,,
ENSG00000161270,8,5,0,0,1,1,3018.671118530885,29263.143028452196,2020-06-14,0,0,0,0,1,0,2,0,0,0,0,4,0,0,0,0,0,0,0,1,0,0,2,10,NPHS1,0.12900001,1.0229,0.15124,1,0.75,0.5,,
ENSG00000162434,6,5,1,0,0,1,17601.10520641419,322220.1169395476,2019-09-01,0,3,0,0,0,0,0,0,0,2,0,0,1,0,1,0,0,0,0,0,0,0,1,8,JAK1,0.832,5.8688,0.92051,29,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;ISG15 antiviral mechanism;MAPK1 (ERK2) activation;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-1169408;R-HSA-112411;R-HSA-6785807
ENSG00000163125,7,5,1,0,0,1,28863.30790298137,1778690.168860174,2022-07-14,3,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,2,0,0,0,0,0,1,9,RPRD2,0.855,2.5402,0.20191,1,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000163131,16,5,1,1,1,1,5803.823646071701,431284.57934287674,2011-10-09,23,0,0,0,2,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,28,CTSS,0.33600003,2.6897,1.0448,6,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000163235,19,5,1,0,0,1,46282.676044693806,1990918.947961699,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,1,1,2,6,64,TGFA,0.004000008,0.56391,0.32668,19,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202;R-HSA-597592;R-HSA-8864260
ENSG00000163600,5,5,0,0,0,1,5617.422898742555,298389.02809443185,2018-08-13,1,0,0,0,0,0,1,0,0,4,1,0,4,0,0,0,0,0,0,0,0,0,0,11,ICOS,-0.273,0.85099,-0.25255,5,0.75,0.5,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202
ENSG00000163634,13,5,1,0,0,1,33670.70607708678,633132.2332759313,2014-07-22,1,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,5,0,0,4,0,0,0,13,THOC7,0.13200003,1.2914,0.060367,3,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm,R-HSA-73857;R-HSA-74160;R-HSA-159236;R-HSA-72202
ENSG00000164209,14,5,1,0,0,1,7523.79687373451,360837.067725683,2011-11-01,0,0,0,1,0,0,0,0,3,0,15,0,0,0,3,0,0,0,0,0,0,0,4,26,SLC25A46,-0.375,-0.7483,-1.5624,0,-1.0,-1.0,,
ENSG00000164400,6,5,0,0,0,1,13129.29816360601,161092.74087321138,2012-03-25,0,0,0,0,0,0,0,0,1,0,2,0,1,0,0,0,0,0,0,1,0,0,2,7,CSF2,0.38099998,1.0817,0.38305,5,0.5,1.0,,
ENSG00000164611,9,5,0,0,0,1,13219.952617929488,322220.1169395476,2015-10-26,0,0,0,0,0,0,0,0,0,0,7,9,1,0,0,0,0,0,0,1,0,0,3,21,PTTG1,0.32700002,1.1924,0.72741,3,0.5,-1.0,,
ENSG00000164749,14,5,1,0,1,1,20981.396731054978,1424218.0900670097,2013-04-01,12,0,0,0,4,1,0,0,0,0,2,0,10,0,0,0,0,0,0,0,0,0,0,29,HNF4G,0.579,0.93747,0.096444,2,1.0,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000164916,7,5,1,0,0,1,14145.711748532529,1424218.0900670097,2020-06-15,1,0,0,0,2,2,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,9,FOXK1,0.33600003,0.16343,-2.6089,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000165323,8,5,0,0,1,1,1173.5007132667617,163479.85522876077,2018-08-13,1,0,0,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,1,17,FAT3,0.653,2.6281,-0.20742,0,0.5,0.5,,
ENSG00000165496,8,5,0,0,0,1,140299.9470244188,1424218.0900670097,2020-06-15,0,0,0,0,1,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,3,9,RPL10L,-0.36099994,-0.34277,-0.75555,13,1.0,0.5,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000165966,6,5,1,0,0,1,3154.6966051857794,1778690.168860174,2014-05-19,0,0,0,0,1,6,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,10,PDZRN4,0.106000006,-1.3768,-1.4126,0,0.5,0.0,,
ENSG00000166167,5,5,1,0,0,1,46839.688475798255,286746.1002745869,2023-01-18,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2,6,BTRC,0.357,2.0569,0.66377,21,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Dectin-1 mediated noncanonical NF-kB signaling;NIK-->noncanonical NF-kB signaling;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-5607761;R-HSA-5676590;R-HSA-597592
ENSG00000166450,7,5,1,1,0,1,595.0848708487085,718784.6890415357,2010-08-15,4,0,0,0,1,0,0,0,4,0,0,0,3,0,0,0,0,0,0,0,0,0,1,13,PRTG,0.315,-0.15684,-1.1198,0,0.5,0.0,,
ENSG00000166682,7,5,1,1,1,1,53182.30026560605,521818.7070055739,2022-07-25,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,1,0,0,1,7,TMPRSS5,-0.319,-1.3911,-1.4315,0,0.75,0.0,,
ENSG00000166971,5,5,0,0,0,1,279992.27535235474,576962.439213685,2023-01-18,0,0,0,0,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,3,0,1,1,10,AKTIP,0.388,2.0383,1.594,0,-1.0,-1.0,,
ENSG00000167081,8,5,1,0,0,1,40865.098404951204,576962.439213685,2018-08-13,0,0,0,0,0,0,4,0,0,0,6,0,0,0,0,0,2,0,0,2,0,0,3,17,PBX3,0.644,2.5783,-0.42807,0,0.5,-1.0,,
ENSG00000168297,5,5,1,0,1,1,2201.6879293424927,301203.06999851385,2008-01-20,1,0,0,0,0,1,1,0,0,0,0,3,0,0,0,0,0,0,0,2,0,0,0,8,PXK,0.412,0.77803,0.01336,0,0.5,-1.0,,
ENSG00000169398,14,5,1,0,0,1,26561.371714038676,645988.1975077938,2018-07-30,1,0,0,0,12,0,0,0,0,0,1,0,5,0,0,0,3,0,0,0,0,0,0,22,PTK2,0.601,3.7869,0.77789,17,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000169508,8,5,1,0,0,1,32254.717802479194,562534.7696387965,2012-11-01,1,0,0,0,0,0,0,0,0,2,7,0,0,0,1,0,0,0,0,6,0,0,0,17,GPR183,0.24199998,1.7049,0.17687,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000169783,6,5,1,0,0,1,1752.8944032366824,1076472.0138856068,2009-02-01,2,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,9,LINGO1,0.45,3.5632,0.37747,1,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000170419,5,5,0,0,0,1,606.6666666666666,1778690.168860174,2018-11-09,1,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,1,15,VSTM2A,0.25300002,0.72653,-0.57237,0,0.5,0.5,,
ENSG00000170525,5,5,1,0,0,1,8063.55842573413,381165.6245253304,2008-11-02,2,0,0,0,0,1,0,0,0,4,0,0,5,0,1,0,0,0,0,0,0,0,0,13,PFKFB3,0.38200003,2.0524,-0.38704,1,0.5,-1.0,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",R-HSA-9634600
ENSG00000170549,8,5,1,0,0,1,689.130986728217,1778690.168860174,2010-11-25,0,0,0,0,6,1,0,0,0,0,2,0,0,0,0,0,2,0,0,4,0,0,0,15,IRX1,-0.125,-1.8476,-2.0669,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000170606,8,5,1,0,0,1,78398.053695655,1424218.0900670097,2021-11-04,5,0,0,0,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,11,HSPA4,0.684,1.3344,-0.046901,1,-1.0,-1.0,,
ENSG00000170776,10,5,1,0,1,1,8143.099031885603,279825.00883385167,2019-11-11,2,0,0,0,3,0,0,0,0,0,0,0,4,0,1,0,0,0,0,0,0,0,5,15,AKAP13,0.638,-0.68831,-0.98769,5,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000171124,8,5,1,1,1,1,3355.110147235327,301203.06999851385,2018-11-30,5,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,3,18,FUT3,-0.94200003,1.2581,0.54936,2,0.5,0.0,Reactions specific to the complex N-glycan synthesis pathway;Post-translational protein modification,R-HSA-975578;R-HSA-597592
ENSG00000171456,5,5,0,0,0,1,160010.51072069994,1424218.0900670097,2018-01-31,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,1,5,ASXL1,0.08200002,1.9316,0.76475,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000173145,8,5,1,0,1,1,4025.9751614505712,427337.4491868293,2011-10-16,1,1,0,1,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,13,NOC3L,-0.08000004,0.76611,0.29504,0,-1.0,-1.0,,
ENSG00000173578,5,5,1,0,0,1,22153.58593435135,381165.6245253304,2020-05-13,0,7,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,1,0,0,1,12,XCR1,-0.72800004,1.554,0.45823,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000174282,7,5,1,0,1,1,81243.5903011504,756470.9740366563,2020-04-15,2,0,0,0,3,0,1,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,9,ZBTB4,0.615,1.6834,-0.40961,0,-1.0,-1.0,,
ENSG00000175003,13,5,1,0,1,1,3747.57310565635,521818.7070055739,2009-09-20,14,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,2,6,0,0,8,36,SLC22A1,-0.18799996,0.85529,-0.5706,6,1.0,0.5,Neurotransmitter release cycle;Organic cation transport,R-HSA-112310;R-HSA-549127
ENSG00000175029,8,5,1,0,0,1,70264.86172946295,551389.5206213495,2021-01-04,6,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,9,0,0,0,0,0,4,22,CTBP2,0.478,1.6895,-0.040734,3,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000175595,12,5,0,0,1,1,15866.724081734988,1122672.658801146,2014-07-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,0,0,1,2,0,1,27,ERCC4,0.015999973,-0.57103,-1.0214,5,0.5,-1.0,Formation of Incision Complex in GG-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-5696395;R-HSA-6782135;R-HSA-6781827
ENSG00000176165,8,5,0,0,0,1,606.6666666666666,574170.6270919729,2019-11-18,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,4,0,2,0,0,0,1,10,FOXG1,0.64,3.7963,-1.4043,2,1.0,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription of cell cycle genes,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9617828
ENSG00000178538,7,5,1,0,0,1,9758.376437427909,1778690.168860174,2014-07-22,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,12,0,0,3,0,0,1,18,CA8,0.302,1.5581,0.92236,0,0.5,0.0,,
ENSG00000178882,10,5,0,0,0,1,46282.676044693806,1470466.6505612188,2018-10-29,1,0,0,3,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,0,0,1,4,23,RFLNA,-0.809,0.24792,-0.59801,0,1.0,0.0,,
ENSG00000179195,9,5,1,0,0,1,62627.34914844415,1424218.0900670097,2020-06-15,0,0,0,0,3,7,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,1,14,ZNF664,0.096000016,2.8571,-0.43427,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000180251,9,5,1,0,1,1,6712.63652527305,562534.7696387965,2013-06-02,1,0,0,0,0,0,0,0,3,0,7,0,0,0,0,0,1,0,0,5,0,0,0,17,SLC9A4,-0.062999964,-0.55569,-0.084088,1,1.0,0.5,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000181418,8,5,0,0,0,1,40939.08484366117,175016.11286382115,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,1,0,0,4,1,0,1,10,DDN,-0.16600001,-0.028724,-0.6844,0,0.75,0.5,,
ENSG00000182752,7,5,0,0,1,1,78906.83616868555,1470466.6505612188,2021-04-22,3,0,0,0,1,1,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,1,12,PAPPA,0.533,2.8169,-0.52468,1,1.0,0.0,,
ENSG00000183011,6,5,1,0,0,1,258213.8601133611,415452.66715166246,2021-11-04,0,1,0,0,2,0,0,0,0,1,0,0,4,0,0,0,0,0,0,0,0,1,0,9,NAA38,-0.732,-0.058182,-0.92702,1,-1.0,-1.0,,
ENSG00000183117,14,5,0,0,0,1,1649.8973703106751,1778690.168860174,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,1,4,0,0,0,12,0,0,1,0,0,1,19,CSMD1,0.41399997,-12.425,-13.699,0,0.75,0.5,,
ENSG00000183230,7,5,1,0,0,1,36733.9862649063,1129585.974638378,2021-02-09,0,0,0,0,7,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,11,CTNNA3,0.125,-0.48097,-1.0516,0,0.75,0.5,,
ENSG00000183655,6,5,1,0,0,1,2042.6733870967741,574261.7466389402,2017-10-20,2,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,1,7,KLHL25,-0.72599995,-1.4326,-0.82473,2,-1.0,0.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000184226,6,5,1,1,0,1,21201.639474894007,1778690.168860174,2016-05-16,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,9,0,0,0,0,0,1,13,PCDH9,0.59099996,2.8478,0.63094,0,1.0,0.0,,
ENSG00000184640,5,5,1,0,0,1,1173.5007132667617,515513.2178404211,2020-06-15,0,0,0,0,3,2,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,1,9,SEPTIN9,0.61,1.9809,-0.047547,0,-1.0,-1.0,,
ENSG00000184647,6,5,0,0,0,1,20850.43936444706,351483.8320914214,2019-11-18,1,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,3,0,0,0,0,0,1,7,PRSS55,-0.962,-3.5223,-2.8411,0,1.0,1.0,,
ENSG00000184661,6,5,1,0,1,1,6067.527905738457,251325.91086204,2021-09-30,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,7,12,CDCA2,0.16000003,0.14446,-0.34906,0,0.75,0.5,,
ENSG00000185627,11,5,1,0,0,1,5521.30125120308,482893.2730520582,2018-05-12,13,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,19,PSMD13,0.754,1.4648,-0.58904,62,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000185760,15,5,0,0,0,1,11026.887550854353,1778690.168860174,2018-02-26,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,5,0,0,1,0,0,8,18,KCNQ5,0.583,3.1393,-0.26339,1,0.5,0.5,,
ENSG00000186207,9,5,0,0,0,1,2988.7457407106926,296732.5758623771,2013-07-25,0,2,0,0,0,0,0,0,6,0,3,0,0,0,0,0,0,0,0,0,0,1,3,15,LCE5A,-0.91400003,0.40259,0.45374,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000187486,6,5,1,0,1,1,2334.9276231263384,1424218.0900670097,2007-04-26,0,0,0,1,2,26,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,32,KCNJ11,-0.074,2.8591,0.80539,6,0.5,0.0,Disease;Inwardly rectifying K+ channels,R-HSA-1643685;R-HSA-1296065
ENSG00000187546,6,5,0,0,0,1,42065.48568206028,235397.69820205137,2021-09-29,0,0,0,0,1,0,0,0,0,0,0,0,2,0,1,0,1,0,0,0,0,0,1,6,AGMO,-0.561,-2.552,-2.5169,1,1.0,0.5,,
ENSG00000188404,10,5,1,1,1,1,1173.5007132667617,303059.79257468163,2018-07-30,0,0,0,0,9,1,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,5,18,SELL,-0.16499996,-0.34695,-0.65732,3,0.75,0.0,Immune System,R-HSA-168256
ENSG00000188779,10,5,1,0,0,1,1289.474816625917,765591.3646788632,2007-07-18,0,0,0,0,3,3,0,0,0,0,0,0,0,0,0,0,15,0,6,1,0,0,0,28,SKOR1,0.195,-1.0498,-2.1664,0,1.0,0.5,,
ENSG00000188803,6,5,0,0,0,1,852.7116564417178,1778690.168860174,2022-07-14,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,4,8,SHISA6,0.315,0.62574,-1.7068,0,0.5,0.0,,
ENSG00000196284,12,5,1,0,0,1,7422.186296783451,1470466.6505612188,2018-10-29,0,0,0,1,0,0,0,0,0,0,0,0,14,0,0,0,1,0,0,2,0,0,5,23,SUPT3H,-0.342,0.027535,0.49587,1,-1.0,0.0,,
ENSG00000196502,8,5,1,1,1,1,18873.32760967438,171699.39272110126,2011-08-04,3,0,0,0,0,1,0,0,0,0,2,0,1,0,0,0,0,0,0,3,0,0,0,10,SULT1A1,-0.33000004,0.75576,0.58725,2,0.5,-1.0,Cytosolic sulfonation of small molecules;Phase II - Conjugation of compounds,R-HSA-156584;R-HSA-156580
ENSG00000196586,6,5,1,0,0,1,162367.55694122918,645988.1975077938,2021-01-04,6,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,2,12,MYO6,0.518,2.6145,0.738,5,-1.0,0.0,Signal Transduction;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-162582;R-HSA-9013422;R-HSA-9706574;R-HSA-157858;R-HSA-190828
ENSG00000196712,6,5,1,0,0,1,142818.1224245443,1778690.168860174,2019-01-21,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,1,0,0,1,0,0,1,7,NF1,0.551,8.4243,2.0349,2,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000197724,9,5,1,0,0,1,155987.83221129785,840741.6029688244,2020-11-10,0,1,0,0,0,0,2,1,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,9,PHF2,0.671,3.5968,0.39471,1,-1.0,-1.0,,
ENSG00000197826,6,5,0,0,0,1,88247.21228328612,410642.56898295006,2021-11-04,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,2,6,CFAP299,-0.35800004,0.19862,-0.61832,0,0.75,0.5,,
ENSG00000198846,7,5,1,0,0,1,11750.664703246046,1122672.658801146,2014-09-18,0,1,0,1,0,0,0,0,0,0,0,0,4,0,0,0,2,0,0,0,0,0,9,17,TOX,0.674,1.7773,1.0491,0,1.0,0.0,,
ENSG00000204120,9,5,1,0,1,1,11380.153347883632,502231.5406594711,2014-07-22,3,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,1,17,GIGYF2,0.85,1.9919,0.52,0,-1.0,-1.0,,
ENSG00000205269,8,5,1,0,0,1,21201.639474894007,141293.18354755783,2020-04-27,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,7,TMEM170B,0.023999989,0.68628,-0.053235,0,0.5,0.0,,
ENSG00000205683,11,5,1,0,0,1,4847.839591114606,645988.1975077938,2017-06-09,9,0,0,1,5,0,0,0,0,0,0,0,5,0,0,0,0,0,0,2,0,0,0,22,DPF3,0.509,1.4757,-0.15469,4,0.5,0.5,Developmental Biology;Gene expression (Transcription),R-HSA-1266738;R-HSA-74160
ENSG00000206538,5,5,0,0,0,1,4314.782048701952,1424218.0900670097,2010-08-01,16,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,22,VGLL3,0.065999985,-0.56028,-1.4144,0,0.5,0.0,,
ENSG00000213949,7,5,1,0,0,1,107949.90929360976,1424218.0900670097,2018-10-08,0,0,0,4,1,11,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,18,ITGA1,0.22899997,0.55814,-0.16387,6,0.5,0.0,Developmental Biology;Platelet Adhesion to exposed collagen,R-HSA-1266738;R-HSA-75892
ENSG00000221955,6,5,1,0,0,1,18988.45997716481,1424218.0900670097,2018-10-08,0,3,0,0,0,5,2,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,13,SLC12A8,-0.10500002,0.80898,0.55401,0,0.5,0.0,,
ENSG00000223601,8,5,0,0,1,1,38054.41297287997,645988.1975077938,2018-11-08,8,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,0,2,0,14,EBLN1,-0.908,0.057841,-0.36534,0,1.0,1.0,,
ENSG00000237388,9,5,0,0,0,1,36731.93220755782,765591.3646788632,2020-06-15,0,0,0,1,6,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,12,OR4A47,-0.61899996,-2.0567,-2.0909,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000242120,8,5,0,0,0,1,26667.58037719927,1778690.168860174,2020-09-04,5,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,5,0,0,1,0,0,0,13,MDFIC2,,,,0,,,,
ENSG00000253958,8,5,1,0,0,1,13959.203480505423,521818.7070055739,2018-08-13,2,3,0,0,1,0,0,0,0,0,0,0,4,0,0,0,0,0,0,1,0,0,0,11,CLDN23,-0.96099997,-4.414,-4.5821,1,0.5,0.0,Tight junction interactions,R-HSA-420029
ENSG00000257923,13,5,0,0,0,1,23863.59437972775,500292.45069431677,2018-08-13,17,0,0,0,2,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,3,24,CUX1,0.723,3.1172,-0.53939,3,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000272395,12,5,0,0,1,1,1420.1181281235802,1129585.974638378,2015-06-15,8,8,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,22,IFNL4,,-1.9865,-1.6919,0,,,,
ENSG00000276644,7,5,0,0,0,1,11095.106184492126,433862.5685735124,2017-11-01,0,0,0,0,3,0,0,0,0,0,0,0,4,1,0,0,5,0,0,0,0,0,2,15,DACH1,0.629,1.1322,-1.1886,0,0.5,0.0,,
ENSG00000005108,13,4,1,0,0,1,4647.141171844279,414433.58532016096,2018-06-11,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,3,0,0,3,29,THSD7A,0.5,-1.4005,-3.8172,2,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000006071,5,4,1,0,1,1,2334.9276231263384,765591.3646788632,2007-04-26,0,0,0,2,0,24,0,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,30,ABCC8,0.171,2.8451,1.1937,3,0.75,0.0,Disease,R-HSA-1643685
ENSG00000010030,4,4,1,0,0,1,2209.8301559792026,124837.11004999638,2013-12-25,0,0,0,0,0,0,0,0,0,0,0,1,3,0,1,0,0,0,0,1,0,0,0,6,ETV7,-0.38399994,-0.026882,-0.79667,0,0.5,0.0,,
ENSG00000011478,4,4,1,0,0,1,162649.50652667845,464892.4593283075,2020-05-06,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,4,QPCTL,-0.28400004,0.4851,-0.10647,0,-1.0,0.0,,
ENSG00000012223,4,4,1,0,0,1,3413.036507531274,167055.73472660675,2021-04-27,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,1,4,LTF,-0.29400003,0.29287,-0.33693,5,0.75,0.0,Immune System;Disease;Infection with Mycobacterium tuberculosis;Antimicrobial peptides,R-HSA-168256;R-HSA-1643685;R-HSA-9635486;R-HSA-6803157
ENSG00000033800,6,4,1,0,0,1,35617.65636301977,1470466.6505612188,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,1,7,PIAS1,0.862,2.3837,-0.16706,8,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;SUMOylation of ubiquitinylation proteins;Formation of Incision Complex in GG-NER;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-3232142;R-HSA-5696395;R-HSA-597592
ENSG00000041515,6,4,0,0,0,1,49076.16312667074,1778690.168860174,2022-07-14,1,0,0,5,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,MYO16,0.42299998,-0.27074,-1.5323,0,0.5,0.5,,
ENSG00000048028,5,4,1,1,0,1,76540.27834079113,645988.1975077938,2020-12-08,8,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,12,USP28,0.13599998,1.4006,0.63132,1,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000054654,8,4,1,0,1,1,23785.106928449426,645988.1975077938,2012-04-29,3,0,0,0,23,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,28,SYNE2,0.48400003,1.1927,1.1031,1,0.5,-1.0,,
ENSG00000055957,8,4,1,1,1,1,17715.769585753842,323648.5577791949,2012-07-03,0,0,0,1,0,0,0,0,0,0,0,0,7,0,0,0,2,0,0,0,0,0,2,12,ITIH1,-0.069000006,0.19035,0.61158,0,1.0,0.5,,
ENSG00000060749,5,4,1,0,1,1,158370.2523752734,1424218.0900670097,2018-10-08,2,0,0,0,1,5,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,9,QSER1,0.651,2.3906,1.901,0,-1.0,0.0,,
ENSG00000062716,4,4,1,0,0,1,36204.236233123425,355284.1215006515,2013-11-01,1,0,0,0,3,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,2,8,VMP1,0.80799997,3.2569,0.91894,0,-1.0,-1.0,,
ENSG00000065609,11,4,1,0,0,1,75846.20940126595,1470466.6505612188,2015-07-21,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,12,0,0,1,0,0,1,15,SNAP91,0.583,0.3108,-0.58058,2,0.5,0.0,,
ENSG00000069011,15,4,1,0,0,1,6148.286988658086,473900.221403792,2011-02-06,26,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,3,40,PITX1,0.425,0.84465,-0.22349,0,0.5,0.0,,
ENSG00000072201,4,4,0,0,0,1,74806.7436355004,355284.1215006515,2019-10-24,9,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,12,LNX1,0.061999977,0.72847,0.97877,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000072310,4,4,1,0,0,1,406587.2658730814,804063.9714459113,2020-06-15,3,0,0,0,2,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,SREBF1,0.338,1.1274,-0.68919,8,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Cholesterol biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-191273;R-HSA-8957322;R-HSA-1655829
ENSG00000075891,6,4,0,0,0,1,260210.21963428933,1424218.0900670097,2021-11-04,0,0,0,0,2,2,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,7,PAX2,0.549,1.8762,-0.082431,4,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000078401,4,4,0,1,0,1,82912.80518893801,235397.69820205137,2019-05-14,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,5,EDN1,0.16000003,0.71523,0.59392,3,0.5,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000079101,4,4,0,0,0,1,17115.61307125707,113270.13715667646,2017-06-12,1,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,5,CLUL1,-0.06500006,1.2721,0.12794,0,1.0,0.0,,
ENSG00000079102,7,4,1,0,0,1,54522.89908382802,1778690.168860174,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,6,1,0,0,0,0,2,10,RUNX1T1,0.814,3.2555,0.2365,0,0.5,0.0,,
ENSG00000081019,4,4,0,0,0,1,53169.84323478868,381165.6245253304,2021-09-30,0,1,0,0,0,1,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,5,RSBN1,0.49299997,2.1571,-0.94948,0,-1.0,-1.0,,
ENSG00000081026,5,4,0,0,0,1,25544.587256126448,215157.94798738702,2012-12-01,0,0,0,0,0,2,0,0,0,3,0,0,3,0,0,0,0,0,0,1,0,0,0,9,MAGI3,0.528,2.2742,1.9334,0,0.5,0.0,,
ENSG00000081923,4,4,0,0,1,0,104829.95456615865,882833.0320407465,2018-11-30,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,4,ATP8B1,0.38,3.336,1.092,1,0.5,0.0,,
ENSG00000084092,5,4,0,0,0,1,144102.0022515395,645988.1975077938,2017-12-06,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,5,NOA1,0.13800001,-0.042063,-0.62384,0,-1.0,-1.0,,
ENSG00000087157,5,4,1,0,0,1,78906.83616868555,464892.4593283075,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,2,6,PGS1,0.0019999743,0.75971,-0.50516,1,-1.0,-1.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000087299,5,4,0,0,0,1,79352.0033386007,448058.917711015,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,1,6,L2HGDH,0.12800002,0.22597,0.18923,1,-1.0,-1.0,,
ENSG00000099260,16,4,0,0,0,1,2025.9684106614018,645988.1975077938,2018-03-07,0,0,0,0,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,1,2,28,PALMD,0.037,0.39999,-0.44318,0,0.5,0.0,,
ENSG00000099377,6,4,1,0,1,1,4260.201964816084,392116.8525067137,2010-10-17,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,9,HSD3B7,-0.411,1.2739,0.018665,3,1.0,-1.0,Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-193775;R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000101187,4,4,1,0,1,1,21014.7618737575,1424218.0900670097,2018-06-11,0,0,0,0,1,5,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,8,SLCO4A1,-0.059000015,0.2617,-1.2391,1,0.5,0.0,"Transport of vitamins, nucleosides, and related molecules",R-HSA-425397
ENSG00000101955,11,4,1,1,1,1,31676.163230680246,672632.4785173276,2021-04-22,0,0,0,0,4,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,19,SRPX,,,,0,0.5,0.0,,
ENSG00000106829,6,4,0,0,0,1,40100.67080961279,1778690.168860174,2012-09-01,7,0,0,0,0,14,0,0,0,0,0,0,0,0,0,0,4,0,0,1,0,0,0,26,TLE4,0.834,4.0796,0.6844,4,0.5,-1.0,Signal Transduction;Formation of the beta-catenin:TCF transactivating complex,R-HSA-162582;R-HSA-201722
ENSG00000107099,4,4,1,0,0,1,133918.94977035935,235397.69820205137,2020-04-27,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,4,DOCK8,0.37800002,-1.7115,-2.6596,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000107295,4,4,1,0,0,1,21201.639474894007,263416.51565448404,2016-05-16,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,9,SH3GL2,0.06300002,-0.037436,-1.4454,10,0.75,0.0,Signal Transduction;Immune System;Developmental Biology;Disease;Recycling pathway of L1;Lysosome Vesicle Biogenesis;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-437239;R-HSA-432720;R-HSA-9006934
ENSG00000107882,8,4,1,0,0,1,60298.15939406673,756470.9740366563,2019-07-30,5,0,0,0,3,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,13,SUFU,0.786,3.1286,1.0883,5,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000107902,6,4,1,0,0,1,5394.0067552353075,281258.82202219026,2016-10-03,3,0,0,4,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,2,11,LHPP,-0.263,-0.16678,-0.075452,1,1.0,-1.0,,
ENSG00000111961,7,4,1,0,0,1,54703.55383629191,414433.58532016096,2016-05-16,0,0,0,2,0,0,0,0,0,15,0,0,0,0,1,0,0,0,0,1,0,0,0,19,SASH1,0.588,2.0667,0.51649,0,-1.0,0.0,,
ENSG00000112033,17,4,0,0,0,1,6796.671949604783,714039.8414241908,2021-06-01,0,0,0,2,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,2,0,0,4,17,PPARD,0.689,3.0214,0.91237,3,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Carnitine shuttle,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-200425
ENSG00000112137,25,4,1,0,0,1,1458.170321264661,756470.9740366563,2009-02-08,0,0,0,0,86,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,22,111,PHACTR1,0.66400003,3.2031,-0.52497,0,0.5,0.0,,
ENSG00000112782,6,4,1,0,0,1,1173.5007132667617,306980.8575290048,2021-02-24,0,0,0,6,0,1,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,2,13,CLIC5,-0.23300004,-0.33465,-0.98415,2,0.5,0.0,,
ENSG00000113070,4,4,0,0,0,1,33128.51949613685,235397.69820205137,2017-02-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,4,HBEGF,0.263,1.4108,0.76536,31,0.5,-1.0,Signal Transduction;Disease;EGFR Transactivation by Gastrin;Gastrin-CREB signalling pathway via PKC and MAPK;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-2179392;R-HSA-881907;R-HSA-9006934;R-HSA-5663202
ENSG00000113448,5,4,1,0,0,1,4074.958527607362,183761.6081180644,2011-06-05,1,0,0,0,0,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,2,6,PDE4D,0.597,2.3461,-0.28164,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000113522,10,4,1,0,0,1,16461.04650907092,562534.7696387965,2015-01-08,0,0,0,0,0,0,0,0,4,0,21,0,0,0,0,0,0,0,0,1,0,0,2,28,RAD50,0.111,2.2921,-0.059356,20,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000115221,4,4,0,0,0,1,3546.2199888330542,672632.4785173276,2018-10-08,0,0,0,0,1,2,0,0,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,8,ITGB6,-0.19599998,-0.078171,-0.24116,5,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000115596,5,4,1,0,0,1,66438.21345734232,464892.4593283075,2021-12-06,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,7,WNT6,-0.69500005,-1.0228,-2.5821,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000115808,10,4,1,0,0,1,21117.402887671095,756470.9740366563,2019-06-07,2,0,0,1,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,14,STRN,0.314,-0.86388,-2.5527,7,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000116017,5,4,1,0,0,1,3511.742535866615,233499.4066209918,2017-04-20,1,0,0,0,0,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,0,2,10,ARID3A,0.55799997,0.66049,-2.0352,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000116688,4,4,1,0,0,1,576.1087314662274,205433.03502595585,2017-09-26,0,1,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,2,0,0,0,6,MFN2,0.398,3.2281,1.1836,3,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000116815,4,4,1,1,1,1,3511.742535866615,328052.24452619,2009-06-14,3,0,0,0,0,0,0,0,0,0,0,1,1,0,6,0,0,0,0,0,0,0,0,11,CD58,0.24400002,0.52747,-1.0761,2,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000118263,8,4,1,0,0,1,118061.55082048493,1778690.168860174,2019-02-04,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,1,0,0,0,1,19,KLF7,0.781,3.4057,0.18617,0,-1.0,-1.0,,
ENSG00000118407,9,4,1,0,0,1,35105.56848720713,1470466.6505612188,2018-08-13,0,0,0,0,3,0,0,0,0,0,0,0,19,0,0,0,1,0,0,0,0,0,4,27,FILIP1,0.28899997,1.7505,1.4009,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000118473,6,4,1,0,0,1,31631.612453732203,765591.3646788632,2018-05-08,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,2,8,SGIP1,0.569,1.4985,0.51647,2,1.0,0.0,,
ENSG00000118985,4,4,1,0,1,1,8690.328677769423,141293.18354755783,2015-05-26,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,7,ELL2,0.652,2.7409,0.68516,1,-1.0,-1.0,RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-6807505
ENSG00000123500,8,4,0,0,1,1,33410.38706087121,189845.9324918578,2022-03-24,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,3,8,COL10A1,0.14499998,0.015396,-0.00090376,6,0.5,0.5,,
ENSG00000123685,5,4,1,0,0,1,38092.548464040476,322220.1169395476,2019-07-30,0,0,0,0,0,0,0,0,2,0,1,0,0,0,1,0,0,0,0,0,0,0,2,6,BATF3,-0.09399998,0.19577,-0.5709,0,0.5,0.0,,
ENSG00000123977,7,4,1,0,0,1,53369.71648873449,562534.7696387965,2017-10-30,0,0,0,0,0,0,0,0,0,0,6,0,0,0,1,0,1,0,0,0,0,0,3,11,DAW1,-0.13300002,0.16508,-0.25837,0,0.75,0.5,,
ENSG00000124177,6,4,0,0,0,1,98271.38571086437,1122672.658801146,2023-01-18,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,6,CHD6,0.779,5.5396,1.8422,0,-1.0,-1.0,,
ENSG00000124507,6,4,0,0,0,1,19008.705439555517,381165.6245253304,2021-09-30,0,0,0,0,0,0,0,0,0,2,0,0,3,0,2,0,0,0,0,4,0,0,0,11,PACSIN1,0.575,2.0925,0.13788,1,0.75,0.0,,
ENSG00000127663,7,4,1,0,0,1,21185.827169557175,1778690.168860174,2020-06-15,0,0,0,0,3,2,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,10,KDM4B,0.629,2.9574,-1.5833,3,-1.0,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000128567,6,4,1,0,1,1,1173.5007132667617,500292.45069431677,2015-07-21,0,0,0,0,5,1,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,1,12,PODXL,0.39499998,0.99686,-0.44988,0,0.5,0.0,,
ENSG00000128585,8,4,1,0,0,1,4804.684371102268,427337.4491868293,2020-04-27,10,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,14,MKLN1,0.55700004,2.3976,0.13341,1,-1.0,-1.0,Regulation of pyruvate metabolism;Pyruvate metabolism,R-HSA-9861718;R-HSA-70268
ENSG00000130287,5,4,0,1,1,1,4990.168473045886,269602.2657190595,2021-09-30,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,6,NCAN,0.47000003,1.9143,0.88345,13,1.0,0.5,Developmental Biology;DS-GAG biosynthesis;Disease;Glycosaminoglycan-protein linkage region biosynthesis,R-HSA-1266738;R-HSA-2022923;R-HSA-1643685;R-HSA-1971475
ENSG00000131435,4,4,1,0,0,1,18648.955860206086,301203.06999851385,2021-02-19,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,3,0,0,1,7,PDLIM4,0.04400003,0.21741,0.5801,0,-1.0,0.0,,
ENSG00000132855,9,4,1,1,0,1,6719.363522343953,464892.4593283075,2018-08-13,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,8,0,0,4,16,ANGPTL3,-0.20899999,0.43204,0.0090477,2,1.0,0.5,Signal Transduction;Plasma lipoprotein remodeling,R-HSA-162582;R-HSA-8963899
ENSG00000134882,8,4,1,0,0,1,36645.767033906064,298504.9722193353,2018-08-13,1,0,0,0,0,0,0,0,1,0,12,0,0,0,0,0,0,0,0,3,0,0,0,17,UBAC2,0.14099997,1.7804,0.094195,0,-1.0,-1.0,,
ENSG00000135205,5,4,1,0,0,1,46282.676044693806,1424218.0900670097,2023-01-18,0,0,0,0,1,1,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,2,8,CCDC146,0.074,1.4943,0.36794,0,0.5,-1.0,,
ENSG00000135250,10,4,0,0,0,1,15866.724081734988,1424218.0900670097,2014-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,15,0,0,1,0,0,1,18,SRPK2,0.653,3.1506,1.1748,1,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000136014,12,4,0,0,0,1,22345.675520395987,1424218.0900670097,2013-04-01,19,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,24,USP44,-0.03400004,1.6962,0.40337,1,1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000136574,7,4,1,0,0,1,8798.945480071758,358386.30063935445,2018-07-30,0,0,0,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,1,13,GATA4,0.532,-1.4458,-4.3772,11,0.5,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Formation of definitive endoderm,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9823730
ENSG00000137073,5,4,1,0,1,1,1446.3843469898532,1424218.0900670097,2018-07-27,4,0,0,0,0,7,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,13,UBAP2,0.375,0.57496,0.35323,0,-1.0,-1.0,,
ENSG00000137221,5,4,0,1,0,0,60160.87852227129,383158.3001114715,2018-08-13,1,0,0,0,4,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,7,TJAP1,0.046000004,0.26717,0.92654,0,-1.0,-1.0,,
ENSG00000137801,4,4,1,0,0,1,141293.18354755783,1424218.0900670097,2020-06-15,0,0,0,0,0,3,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,6,THBS1,0.699,3.7973,2.4889,7,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-597592
ENSG00000137872,12,4,1,0,0,1,1107.372972972973,1778690.168860174,2016-12-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,1,0,1,0,0,3,20,SEMA6D,0.604,2.1587,0.33021,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000138028,7,4,1,1,0,1,17432.94084323745,498258.534626183,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,2,2,7,CGREF1,-0.36399996,1.5234,0.51616,0,0.5,0.0,,
ENSG00000139734,6,4,0,0,0,1,57022.52707482435,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,0,0,0,0,1,1,7,DIAPH3,0.111,0.64132,-0.52276,13,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000139990,6,4,1,0,0,1,275021.63051358337,1424218.0900670097,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,3,9,DCAF5,0.809,4.289,1.3932,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000140479,5,4,0,0,0,1,7972.209256466767,279825.00883385167,2023-01-18,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,5,PCSK6,0.09100002,0.48815,-0.44438,4,0.5,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases;Plasma lipoprotein remodeling,R-HSA-162582;R-HSA-1266738;R-HSA-9006934;R-HSA-8963899
ENSG00000141252,5,4,1,0,1,1,852.7116564417178,1424218.0900670097,2013-04-01,14,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,19,VPS53,0.227,1.8529,-0.088347,1,-1.0,-1.0,,
ENSG00000143603,7,4,1,0,0,1,3985.392616290502,645988.1975077938,2010-02-21,2,0,0,0,56,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,61,KCNN3,0.621,4.6144,1.1184,1,0.5,0.0,,
ENSG00000143702,9,4,1,1,0,1,11350.321701851115,367949.31877243903,2014-07-22,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,4,10,CEP170,0.73899996,5.9408,4.5654,0,0.75,-1.0,,
ENSG00000144712,10,4,1,0,1,1,57060.02774555957,1424218.0900670097,2018-06-11,0,0,0,0,25,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,28,CAND2,0.185,1.1012,-1.1132,0,0.5,0.0,,
ENSG00000144815,4,4,1,0,0,1,17601.10520641419,666962.7170055452,2022-02-03,0,10,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,13,NXPE3,0.195,1.3003,0.19844,0,0.5,-1.0,,
ENSG00000145779,8,4,1,0,0,1,23795.17752819986,1424218.0900670097,2019-07-30,0,1,0,0,0,1,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,4,17,TNFAIP8,-0.26400006,-0.40919,-0.22957,1,0.5,-1.0,,
ENSG00000146263,4,4,0,0,1,1,1640.7577512776832,119033.45662439712,2020-08-05,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,4,MMS22L,0.49400002,1.2772,0.019707,0,0.5,0.0,,
ENSG00000146285,4,4,1,0,1,1,636.1886490807354,381165.6245253304,2012-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,1,4,SCML4,-0.059000015,0.54169,0.59547,0,0.5,0.0,,
ENSG00000146411,7,4,1,0,0,1,31535.173607928213,521818.7070055739,2017-12-06,4,0,0,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,15,SLC2A12,0.16399997,1.6804,0.12522,1,1.0,0.0,Cellular hexose transport,R-HSA-189200
ENSG00000146648,8,4,1,1,0,1,1622.2610172620696,672632.4785173276,2015-10-01,4,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,9,EGFR,0.525,3.0635,0.08211,36,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Gastrin-CREB signalling pathway via PKC and MAPK;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-881907;R-HSA-9006934;R-HSA-5663202;R-HSA-8864260
ENSG00000151458,5,4,1,0,0,1,3552.1418674698793,431284.57934287674,2019-08-05,2,0,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,3,0,0,0,8,ANKRD50,0.561,2.6157,0.93653,0,-1.0,-1.0,,
ENSG00000152359,5,4,1,0,1,1,144102.0022515395,574170.6270919729,2018-10-08,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,1,0,3,0,0,0,0,7,POC5,0.004999995,-0.32677,-0.38381,0,-1.0,-1.0,,
ENSG00000152689,6,4,1,0,0,1,2240.9147424511543,1470466.6505612188,2009-10-18,0,0,0,2,0,0,0,0,0,0,0,4,7,0,0,0,0,0,0,0,0,0,1,14,RASGRP3,0.218,-0.10491,-0.1155,2,0.5,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000153993,4,4,0,0,1,1,8575.926394479586,197485.87952538437,2021-11-04,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,SEMA3D,-0.074,0.75203,0.35598,0,0.75,0.0,,
ENSG00000154188,5,4,0,0,0,1,18584.262095180744,414433.58532016096,2018-06-11,0,0,0,25,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,29,ANGPT1,0.58599997,2.0158,0.34742,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000154262,8,4,1,0,1,1,47723.36592392044,464892.4593283075,2021-04-08,0,0,0,0,2,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,0,0,9,17,ABCA6,-0.04100001,-0.3291,0.4385,2,0.5,0.0,Gene expression (Transcription),R-HSA-74160
ENSG00000154342,4,4,0,0,0,1,18394.608190187482,500292.45069431677,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,6,WNT3A,0.24000001,1.4187,0.6233,11,1.0,0.5,Signal Transduction;Developmental Biology;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-5663202
ENSG00000155090,4,4,1,0,0,1,122549.0830919942,323648.5577791949,2021-06-14,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,1,0,0,0,5,KLF10,0.18300003,1.4217,-0.53745,0,-1.0,-1.0,,
ENSG00000157766,18,4,1,1,1,1,8479.376416968564,714039.8414241908,2016-10-20,2,0,0,0,0,0,0,0,0,0,0,0,18,0,0,0,5,0,0,0,0,0,8,33,ACAN,0.623,0.32052,0.059226,7,0.5,0.5,Disease,R-HSA-1643685
ENSG00000159212,10,4,1,0,0,1,1173.5007132667617,645988.1975077938,2018-06-11,6,0,0,0,12,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,CLIC6,-0.44500005,-2.6278,-2.8439,0,0.75,0.0,,
ENSG00000159450,6,4,0,0,1,1,180089.50342935527,322220.1169395476,2019-07-30,0,0,0,0,0,0,0,0,1,0,3,0,0,0,0,0,0,0,0,1,0,0,3,8,TCHH,-0.811,-2.876,-1.9649,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000160145,5,4,1,0,0,1,29636.447349988324,222348.28067288152,2019-08-13,1,0,0,3,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,KALRN,0.769,6.1845,1.4696,8,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000160999,10,4,1,0,0,1,16953.71495683784,464892.4593283075,2021-08-24,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,4,9,SH2B2,-0.771,-3.4945,-3.4196,2,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000161405,5,4,1,0,1,1,14626.396888221647,444537.33605315426,2019-02-20,0,0,0,0,1,0,0,0,0,1,6,0,0,0,0,0,0,0,0,1,0,0,0,9,IKZF3,0.756,2.7482,0.90704,0,0.75,0.0,,
ENSG00000162687,8,4,0,0,0,1,13780.964387238024,378712.0243337037,2016-05-16,0,0,0,5,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,0,0,2,15,KCNT2,0.25599998,2.9246,-0.24644,0,0.5,0.5,,
ENSG00000162739,5,4,0,0,0,1,2909.767697594502,233499.4066209918,2013-04-29,0,0,0,0,0,0,0,0,4,2,0,0,2,0,0,0,0,0,0,0,0,0,1,9,SLAMF6,0.24299997,1.1656,0.13543,1,1.0,0.0,Immune System,R-HSA-168256
ENSG00000163104,5,4,0,0,1,1,6356.593451690605,765591.3646788632,2018-10-08,1,0,0,0,2,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,7,SMARCAD1,0.74300003,4.2157,0.65557,0,-1.0,-1.0,,
ENSG00000163171,4,4,1,0,0,1,2010.4597478176527,521818.7070055739,2019-01-18,1,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,5,CDC42EP3,0.44300002,0.28539,-0.42081,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000163817,4,4,0,0,1,1,2982.5449101796407,568904.23398157,2020-05-13,0,25,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,31,SLC6A20,-0.319,1.0396,-0.014019,4,0.75,0.5,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000163818,5,4,0,0,0,1,3204.775737980212,426681.33856181684,2020-05-13,0,47,0,0,0,1,0,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,0,53,LZTFL1,0.12599999,1.068,1.1323,1,-1.0,0.0,BBSome-mediated cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620922;R-HSA-5620920
ENSG00000164938,5,4,1,0,0,1,7794.273577144567,1424218.0900670097,2010-06-27,0,0,0,0,2,12,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,16,TP53INP1,0.09899998,0.69623,0.46275,2,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000165424,4,4,0,0,0,1,42359.490817992155,235397.69820205137,2023-01-18,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,4,ZCCHC24,0.19599998,0.82166,-1.0402,0,0.5,-1.0,,
ENSG00000166069,4,4,0,0,0,1,75639.5973879004,1424218.0900670097,2023-11-02,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,0,0,4,TMCO5A,-0.143,-0.54116,-0.72169,0,1.0,1.0,,
ENSG00000166896,8,4,1,0,0,1,61743.30847289418,960369.5592648841,2018-03-21,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,4,0,0,0,0,0,2,8,ATP23,-0.15999997,0.87172,0.66071,0,0.5,0.0,,
ENSG00000167323,7,4,1,0,0,1,14887.749217677738,203090.6413944402,2020-06-08,0,0,0,0,2,0,0,0,1,0,0,2,0,0,0,0,1,0,0,0,0,0,0,6,STIM1,0.525,2.5772,0.9542,3,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000167470,4,4,0,0,0,1,98271.38571086437,235397.69820205137,2023-01-18,2,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,5,MIDN,-0.042000055,-2.4445,-4.513,0,-1.0,-1.0,,
ENSG00000167930,7,4,1,0,1,1,4084.9844874249125,1424218.0900670097,2017-09-04,0,0,0,0,1,10,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,5,18,FAM234A,-0.120000005,-0.64134,-1.253,0,-1.0,-1.0,,
ENSG00000168038,7,4,0,0,1,1,5410.6446575953605,242123.900206037,2013-03-17,5,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,9,ULK4,0.05699998,-0.18097,0.81995,0,0.5,0.0,,
ENSG00000168875,5,4,0,0,0,1,2314.313784461153,521818.7070055739,2021-01-04,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,7,SOX14,0.27999997,1.5494,-0.33236,0,0.5,0.5,,
ENSG00000168959,11,4,0,0,0,1,2271.2278340632697,1122672.658801146,2018-04-16,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,0,0,1,0,0,0,22,GRM5,0.57,3.3113,-1.6021,3,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000169083,5,4,1,0,1,1,1196.9181969949916,500292.45069431677,2011-07-10,4,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,9,AR,,,,6,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000169242,7,4,1,0,1,1,82119.20087440887,281079.0730593847,2019-12-09,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,1,0,0,6,EFNA1,0.41000003,1.2176,0.85796,3,0.5,-1.0,Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-1266738;R-HSA-3928665
ENSG00000169282,4,4,1,0,0,1,4428.697810877906,433862.5685735124,2016-02-01,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,4,KCNAB1,0.24199998,1.6435,0.4203,1,0.5,-1.0,,
ENSG00000169760,6,4,1,0,0,1,433862.5685735124,1778690.168860174,2020-06-15,0,0,0,0,1,5,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,1,12,NLGN1,0.709,3.3933,0.72206,1,0.5,0.0,,
ENSG00000169914,8,4,1,0,0,1,1017.6823425022183,160010.51072069994,2010-03-14,0,0,0,0,0,0,2,0,1,0,0,0,1,0,0,0,0,0,0,23,0,0,0,27,OTUD3,0.16399997,-0.041235,-0.71947,2,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000171045,13,4,1,0,0,1,15866.724081734988,1424218.0900670097,2013-08-25,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,17,0,0,2,0,0,4,24,TSNARE1,-0.031999946,-0.89721,-1.1343,0,-1.0,-1.0,,
ENSG00000171174,14,4,1,1,0,1,25903.3352616996,633132.2332759313,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,4,2,0,0,0,7,0,0,2,0,0,0,15,RBKS,-0.27999997,0.79188,0.85576,1,0.5,-1.0,,
ENSG00000171700,5,4,1,0,0,1,143209.11815732162,804063.9714459113,2020-10-05,0,0,0,0,3,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,RGS19,0.21399999,0.90467,-0.29177,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000171843,5,4,0,0,0,1,48013.53134222642,645988.1975077938,2018-06-11,0,0,0,5,4,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,12,MLLT3,0.833,1.7362,-1.3609,3,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation,R-HSA-73857;R-HSA-74160;R-HSA-674695;R-HSA-112382;R-HSA-75955
ENSG00000173611,4,4,1,0,1,1,205739.47405036874,437137.9986908925,2021-11-04,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,1,0,4,SCAI,0.30299997,2.0494,0.10922,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000174527,5,4,1,0,1,1,22651.370408599323,1778690.168860174,2018-01-31,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,3,7,MYO1H,0.032000005,0.51985,0.36934,0,,,,
ENSG00000175643,5,4,1,0,0,1,5002.767245657568,381165.6245253304,2015-02-02,1,1,0,0,0,2,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,7,RMI2,-0.944,-2.4818,-2.6405,14,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000175946,4,4,0,0,0,1,28292.123952140868,545988.1005477115,2018-06-11,1,0,0,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,9,KLHL38,-0.26400006,-0.31854,-0.10831,0,0.5,0.5,,
ENSG00000176771,5,4,0,0,0,1,419.41887279771237,521818.7070055739,2023-01-18,4,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,7,NCKAP5,0.37199998,0.04715,0.32957,0,0.5,0.0,,
ENSG00000178209,6,4,1,0,1,1,74722.59037384245,672632.4785173276,2021-04-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,2,0,0,1,0,0,0,6,PLEC,0.274,-2.7548,-8.1278,3,0.5,-1.0,,
ENSG00000178773,7,4,1,0,1,1,3070.816578575999,399832.86333511875,2018-05-08,7,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,1,10,CPNE7,-0.52199996,-4.0008,-4.8221,1,0.5,0.0,,
ENSG00000179104,5,4,0,0,0,0,1173.5007132667617,545791.5007333605,2020-01-20,0,0,0,8,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,11,TMTC2,0.361,1.407,-0.067918,0,-1.0,0.0,,
ENSG00000179673,12,4,0,0,0,1,2314.313784461153,500292.45069431677,2022-09-30,0,0,0,0,8,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,0,0,1,13,RPRML,-0.82799995,-0.85963,-0.27521,0,1.0,0.5,,
ENSG00000179796,5,4,0,0,0,1,16421.798554291887,498258.534626183,2020-06-08,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,1,1,4,LRRC3B,0.53499997,2.9335,-0.19689,0,0.5,0.5,,
ENSG00000181273,5,4,0,0,1,1,4080.311851618988,306980.8575290048,2020-10-26,0,0,0,0,4,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,7,OR5AK2,,-0.98327,-2.1559,1,1.0,1.0,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000182175,5,4,0,0,0,1,21020.801882160395,1424218.0900670097,2020-05-06,0,1,0,0,0,8,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,12,RGMA,0.134,0.80532,-1.443,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000182179,5,4,1,0,0,1,95776.89591443514,895916.2144062951,2022-06-28,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,UBA7,0.116999984,2.1743,1.7096,6,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;ISG15 antiviral mechanism,R-HSA-1280215;R-HSA-168256;R-HSA-1169408
ENSG00000183032,7,4,0,0,0,1,3141.278019404483,521818.7070055739,2019-10-14,3,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,1,1,9,SLC25A21,-0.548,-0.21731,-0.39811,1,0.5,0.0,,
ENSG00000183354,4,4,0,0,0,0,90566.66054026398,115954.67083953728,2023-01-18,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,4,BRD10,0.43800002,-4.8581,-4.8131,0,-1.0,-1.0,,
ENSG00000183624,4,4,1,0,0,1,141293.18354755783,1424218.0900670097,2023-01-18,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,4,HMCES,0.06699997,0.89754,1.1889,0,-1.0,-1.0,,
ENSG00000183682,5,4,1,0,0,1,95135.53490956625,765591.3646788632,2020-05-06,0,0,0,3,0,4,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,10,BMP8A,-0.337,0.33642,0.3323,0,1.0,0.0,,
ENSG00000183715,4,4,0,0,0,1,85623.56961715431,323648.5577791949,2019-11-18,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,6,OPCML,0.46899998,1.9936,-0.090035,1,0.75,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000183873,10,4,1,0,1,1,2386.884226884227,545988.1005477115,2018-06-11,0,0,0,0,24,0,0,0,0,0,4,0,0,0,0,0,0,0,0,15,0,0,2,45,SCN5A,0.628,4.8452,1.5859,2,1.0,0.5,Developmental Biology;Interaction between L1 and Ankyrins,R-HSA-1266738;R-HSA-445095
ENSG00000185551,5,4,0,0,0,1,87545.45580019058,552272.0184005043,2016-05-16,1,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,7,NR2F2,0.803,4.2064,-0.77401,1,-1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000185559,5,4,1,1,0,1,3141.278019404483,1470466.6505612188,2019-10-14,2,0,0,0,0,12,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,17,DLK1,0.53900003,0.36075,0.18481,1,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000185630,5,4,1,0,0,1,11026.887550854353,482893.2730520582,2021-04-08,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,4,9,PBX1,0.788,4.3043,0.21309,3,-1.0,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000185666,9,4,1,0,0,1,2489.748511904762,213435.01458839694,2010-04-12,0,3,0,7,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,7,0,0,0,19,SYN3,0.277,1.3111,1.1068,2,0.5,0.5,Dopamine Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Neurotransmitter release cycle,R-HSA-212676;R-HSA-181429;R-HSA-112310
ENSG00000185950,5,4,0,0,1,1,20994.407005520654,765591.3646788632,2017-08-01,9,0,0,0,0,2,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,14,IRS2,0.060000002,-4.5631,-8.3588,20,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202
ENSG00000186575,4,4,1,0,0,1,55635.00408218119,205739.47405036874,2021-06-14,0,0,0,1,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,4,NF2,0.81299996,2.853,0.13707,2,-1.0,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000187045,5,4,0,0,1,0,14290.097546507552,397309.7797528111,2018-08-13,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,6,10,TMPRSS6,0.17900002,0.54545,0.26062,2,1.0,0.5,,
ENSG00000187672,11,4,1,0,1,1,16548.58403989127,714039.8414241908,2021-08-11,0,0,0,0,0,0,1,0,0,0,2,0,7,0,0,0,0,0,0,0,0,0,18,28,ERC2,0.524,2.6924,-0.21768,0,1.0,0.5,,
ENSG00000187678,10,4,1,0,0,1,1372.985358086807,1778690.168860174,2009-05-31,10,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,2,0,0,0,0,0,1,20,SPRY4,0.27600002,-0.021265,-0.065874,0,-1.0,0.0,,
ENSG00000196569,7,4,0,0,0,1,10353.132295719844,437137.9986908925,2019-12-09,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,1,12,18,LAMA2,0.199,1.2753,0.70064,7,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000196660,8,4,1,0,0,1,1763.8185248066402,189845.9324918578,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,5,1,0,0,0,0,0,0,1,0,0,2,9,SLC30A10,0.00999999,1.4538,-0.31809,1,0.75,0.5,,
ENSG00000197183,4,4,1,0,0,1,70029.51727197871,1778690.168860174,2021-07-22,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,1,0,7,NOL4L,0.81299996,3.075,-0.62673,0,0.5,-1.0,,
ENSG00000197696,13,4,1,0,1,1,15866.724081734988,1470466.6505612188,2017-05-22,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,8,0,0,1,0,0,0,13,NMB,-0.531,-1.023,-0.93962,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000198625,16,4,1,0,0,1,14697.947851329636,765591.3646788632,2013-04-01,31,0,0,0,2,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,37,MDM4,0.854,2.4789,0.37659,7,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000198822,12,4,1,0,0,1,606.6666666666666,633132.2332759313,2014-07-22,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,15,0,0,1,0,0,0,18,GRM3,0.50699997,3.2438,0.39112,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000198836,4,4,0,0,1,1,97623.65810915266,1122672.658801146,2019-06-24,0,0,0,0,0,0,1,0,0,0,5,0,0,0,0,0,1,0,0,0,0,0,2,9,OPA1,0.49699998,2.7012,0.52596,2,-1.0,-1.0,,
ENSG00000198901,6,4,1,0,0,1,26908.700469045143,1424218.0900670097,2010-06-27,1,0,0,1,0,16,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,19,PRC1,0.29500002,0.76721,0.057188,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000205482,10,4,1,0,0,1,100620.50186431198,1470466.6505612188,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,8,0,0,0,0,0,2,0,0,0,5,17,SPDYE18,0.436,2.5989,2.9651,0,0.5,0.5,,
ENSG00000215262,9,4,0,0,1,1,28292.123952140868,1424218.0900670097,2015-04-01,7,0,0,0,0,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,17,KCNU1,-0.03400004,0.72124,0.24412,1,1.0,1.0,Fertilization,R-HSA-1187000
ENSG00000222011,6,4,1,0,1,1,83633.19622783325,1778690.168860174,2018-09-03,0,0,0,0,1,8,3,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,13,FAM185A,0.089999974,2.1748,2.2429,0,-1.0,0.0,,
ENSG00000237515,11,4,0,0,0,1,11062.466206020174,1122672.658801146,2018-09-14,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,8,0,0,1,0,0,2,12,SHISA9,0.426,0.55546,-0.98296,0,0.5,0.5,,
ENSG00000240583,5,4,0,0,0,1,30508.10029756623,191895.42310022408,2018-12-31,0,0,0,0,0,0,0,0,0,0,0,5,1,0,0,0,0,0,0,4,2,0,0,12,AQP1,0.08499998,1.107,0.55117,5,0.5,0.0,,
ENSG00000241635,7,4,1,0,1,1,1391.7394382818031,178948.78717378277,2018-08-13,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,8,0,0,7,19,UGT1A1,-0.03999996,0.1863,1.0369,5,0.75,0.5,Disease;Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-1643685;R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000243156,4,4,1,0,0,1,60111.20110003438,464892.4593283075,2019-02-25,0,0,0,1,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,6,MICAL3,0.601,1.2374,-0.76509,0,-1.0,-1.0,,
ENSG00000249915,5,4,1,0,1,1,19131.320498549245,220320.9576294899,2023-01-18,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,PDCD6,0.153,0.52199,0.46275,0,-1.0,-1.0,,
ENSG00000251322,4,4,0,0,1,1,141293.18354755783,323648.5577791949,2022-04-08,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,1,5,SHANK3,0.554,-1.375,-7.1183,0,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000257017,12,4,1,1,0,1,22651.370408599323,464892.4593283075,2018-08-13,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,4,5,0,0,10,23,HP,-0.013000011,0.38521,0.57342,2,1.0,0.0,Immune System,R-HSA-168256
ENSG00000261701,8,4,1,0,0,1,22651.370408599323,394357.452283155,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,4,0,0,4,12,HPR,-0.569,-0.47351,-0.28252,1,1.0,0.0,,
ENSG00000272391,10,4,1,0,1,1,89519.16315227402,645988.1975077938,2021-11-04,0,0,0,0,6,0,0,0,0,0,0,0,3,0,1,0,0,0,5,0,0,0,0,15,POM121C,0.45700002,4.3323,2.5819,28,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000005020,4,4,1,0,0,1,16417.447913521348,381165.6245253304,2009-05-10,0,0,0,0,0,3,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,6,SKAP2,-0.50699997,0.15205,-0.89238,1,-1.0,-1.0,,
ENSG00000005059,5,4,1,0,1,1,26264.552756469657,159902.65410399486,2023-01-18,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,5,MCUB,-0.487,0.43288,1.1281,2,0.5,-1.0,Mitochondrial calcium ion transport,R-HSA-8949215
ENSG00000005102,5,4,0,0,0,1,5020.480367868098,48439.20423385324,2021-06-01,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,1,0,0,5,MEOX1,-0.14199996,-0.12193,-0.03008,0,0.5,0.0,,
ENSG00000005471,7,4,1,0,1,1,2589.2809887313706,301203.06999851385,2017-03-03,1,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,19,0,0,5,28,ABCB4,0.37699997,3.5556,1.8181,3,1.0,0.5,Disease,R-HSA-1643685
ENSG00000005483,7,4,1,0,0,1,26264.552756469657,1778690.168860174,2015-12-21,0,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,7,0,0,0,13,KMT2E,0.783,1.4433,-0.13129,0,-1.0,-1.0,,
ENSG00000006062,4,4,1,0,0,1,38092.548464040476,205433.03502595585,2019-09-01,0,0,0,0,0,1,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,4,MAP3K14,0.737,4.5145,0.87241,5,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Dectin-1 mediated noncanonical NF-kB signaling;NIK-->noncanonical NF-kB signaling,R-HSA-1280215;R-HSA-168256;R-HSA-5607761;R-HSA-5676590
ENSG00000007171,6,4,0,0,1,1,4260.201964816084,309256.4614031486,2010-10-17,0,0,0,0,0,2,0,0,1,0,0,0,3,0,0,0,0,0,0,22,0,0,0,28,NOS2,0.14200002,2.1743,0.86509,5,0.75,0.5,Cytokine Signaling in Immune system;Immune System;Disease;Response of Mtb to phagocytosis;Signaling by Interleukins;Suppression of phagosomal maturation;Infection with Mycobacterium tuberculosis;Peroxisomal protein import;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-9637690;R-HSA-449147;R-HSA-9637687;R-HSA-9635486;R-HSA-9033241;R-HSA-6785807
ENSG00000009413,5,4,0,0,1,1,1968.6551410373067,1424218.0900670097,2010-10-17,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,1,0,0,2,0,0,0,7,REV3L,0.73899996,3.9998,0.89878,3,0.5,0.0,,
ENSG00000027869,6,4,1,0,1,1,54703.55383629191,381165.6245253304,2018-08-13,0,0,0,0,0,0,0,0,0,7,0,0,1,0,2,0,0,0,0,1,0,0,0,11,SH2D2A,-0.07200003,-0.42161,-0.86002,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000049540,11,4,1,1,1,1,20209.09625085965,672632.4785173276,2018-08-13,0,0,0,2,4,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,30,ELN,0.30400002,1.2583,0.89203,3,-1.0,0.0,,
ENSG00000050344,7,4,1,0,0,1,4572.573599240266,1424218.0900670097,2010-12-12,0,0,0,0,0,1,0,14,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,17,NFE2L3,-0.80200005,-4.8501,-3.7645,0,0.5,0.0,,
ENSG00000054967,4,4,1,1,0,1,141293.18354755783,334911.3573752668,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,4,RELT,0.045000017,0.95198,0.13738,0,1.0,0.0,,
ENSG00000064201,4,4,1,0,0,1,7740.251277929256,464892.4593283075,2019-10-31,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,5,TSPAN32,-0.64900005,-1.9347,-1.0182,0,0.75,0.5,,
ENSG00000065989,7,4,1,0,1,1,16461.04650907092,383158.3001114715,2013-07-01,0,0,0,0,1,0,0,0,0,2,0,0,1,0,0,0,0,0,0,4,0,0,0,8,PDE4A,0.566,2.4761,0.83823,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000068650,10,4,1,0,0,0,3721.3983572895277,332092.8064672836,2013-04-14,13,4,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,19,ATP11A,0.40399998,1.8398,-0.33464,2,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000076344,5,4,0,0,0,1,9653.357890992871,102471.73707899301,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,1,0,0,4,RGS11,-0.523,-1.7549,-1.8486,2,0.75,0.0,Signal Transduction;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,R-HSA-162582;R-HSA-6814122
ENSG00000077514,10,4,1,0,0,1,17227.359990886307,598869.4096893278,2012-05-27,6,0,0,0,0,0,0,3,0,0,0,0,7,0,0,0,0,0,0,0,0,0,3,19,POLD3,0.59000003,0.4016,0.75171,17,-1.0,-1.0,Gap-filling DNA repair synthesis and ligation in TC-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-6782210;R-HSA-6782135;R-HSA-6781827
ENSG00000078596,4,4,1,0,0,1,2909.767697594502,381165.6245253304,2013-04-29,0,0,0,0,0,0,0,0,0,3,0,0,2,0,1,0,0,0,0,0,0,0,1,7,ITM2A,,,,0,0.5,-1.0,,
ENSG00000080298,5,4,0,0,0,1,2989.6745085401226,521818.7070055739,2015-05-13,2,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,1,0,0,0,6,RFX3,0.788,3.1833,-0.65488,0,0.5,-1.0,,
ENSG00000082175,6,4,1,0,0,1,13132.241573569341,756470.9740366563,2023-01-18,2,0,2,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,PGR,0.44599998,-0.87107,-2.1285,5,0.75,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9006934;R-HSA-597592
ENSG00000082781,6,4,1,1,1,1,52463.65429696694,464892.4593283075,2017-07-17,0,0,0,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,7,ITGB5,0.43199998,1.8247,0.89452,7,-1.0,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000086991,11,4,1,0,0,1,1971.161594513502,1122672.658801146,2018-09-04,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,0,6,NOX4,-0.018000007,-0.031018,-0.85823,3,1.0,0.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000087303,8,4,1,1,0,1,50087.52781663962,551389.5206213495,2021-06-09,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,7,0,0,0,0,0,2,12,NID2,0.35799998,0.3508,-0.1654,1,0.5,0.0,,
ENSG00000088538,7,4,1,0,0,1,4692.292484766418,399832.86333511875,2012-12-01,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,5,0,0,1,0,0,0,8,DOCK3,0.702,4.3974,1.1671,5,0.5,0.0,Signal Transduction;Activated NTRK2 signals through FYN;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9032500;R-HSA-9006934
ENSG00000088930,9,4,1,0,0,1,42862.82950677874,1778690.168860174,2021-01-21,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,10,0,0,0,0,0,1,15,XRN2,0.587,2.9244,1.0674,3,-1.0,-1.0,Nuclear RNA decay;rRNA processing,R-HSA-9930044;R-HSA-72312
ENSG00000089012,4,4,1,1,1,1,2464.7717968157694,574782.4268116049,2009-05-10,0,0,0,0,0,6,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,9,SIRPG,-0.362,-0.31563,-0.84887,2,1.0,0.5,,
ENSG00000089234,7,4,0,0,0,1,4381.4703947368425,410642.56898295006,2014-06-11,0,3,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,0,0,0,11,BRAP,0.23400003,2.0636,0.43133,5,0.5,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000091409,6,4,1,0,0,1,3747.57310565635,521818.7070055739,2009-09-20,22,0,0,0,3,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,6,33,ITGA6,0.48000002,2.5966,1.727,7,-1.0,-1.0,,
ENSG00000096060,8,4,1,0,0,1,15186.98390755667,269829.0934099178,2017-12-06,2,0,0,0,1,0,0,0,0,3,0,0,5,0,0,0,0,0,0,0,0,0,0,11,FKBP5,0.374,2.6576,1.0942,4,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000100106,10,4,1,0,1,1,22856.518078955905,551389.5206213495,2016-10-20,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,0,10,0,0,0,0,0,3,17,TRIOBP,0.13499999,1.2819,1.2711,2,-1.0,-1.0,,
ENSG00000100316,7,4,1,0,0,1,19008.705439555517,190279.23963861223,2017-01-09,1,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,13,0,0,0,16,RPL3,0.835,2.4544,-1.0515,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000100368,8,4,1,0,0,1,9770.187636657778,315325.55297640257,2021-08-26,0,0,0,0,0,0,0,0,12,0,0,0,1,0,0,0,0,0,0,6,0,0,2,21,CSF2RB,0.48900002,0.88803,-0.31594,6,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Surfactant metabolism;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-5683826;R-HSA-449147
ENSG00000100395,5,4,1,0,0,1,22650.1728716785,1424218.0900670097,2018-04-26,2,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,9,L3MBTL2,0.351,2.4282,0.81263,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6;Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8953750;R-HSA-597592
ENSG00000101040,7,4,0,0,0,1,107949.90929360976,1778690.168860174,2019-11-01,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,5,0,0,1,0,0,0,10,ZMYND8,0.66400003,5.0259,0.53637,0,-1.0,-1.0,,
ENSG00000103111,4,4,1,0,0,1,45087.73717492625,1778690.168860174,2022-07-14,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,1,7,MON1B,0.204,0.47723,-1.9889,1,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000104689,6,4,1,1,0,1,2009.8265895953757,213435.01458839694,2011-09-11,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,6,TNFRSF10A,-0.29200006,-1.3747,-1.1088,8,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000104885,8,4,1,0,0,1,4381.4703947368425,645988.1975077938,2014-06-11,0,0,0,0,7,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,10,DOT1L,0.679,1.3785,-3.7277,1,0.5,-1.0,,
ENSG00000108256,4,4,1,0,0,1,151416.12986435954,1424218.0900670097,2018-01-31,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,4,NUFIP2,0.801,0.47472,-0.17428,0,0.5,-1.0,,
ENSG00000108306,6,4,1,0,0,1,51964.39839555753,756470.9740366563,2017-12-22,0,0,0,0,1,0,0,0,0,0,5,2,0,0,0,0,1,0,0,0,0,0,0,9,FBXL20,0.625,3.2805,0.49703,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000108379,4,4,1,0,0,1,10529.240292414317,340825.7076940272,2021-05-04,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,5,WNT3,0.633,3.9295,0.3483,3,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000110497,9,4,0,0,0,1,3339.9291648862936,235397.69820205137,2021-01-25,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,1,9,AMBRA1,0.509,3.4449,0.8633,1,-1.0,-1.0,,
ENSG00000110777,5,4,1,0,0,1,2880.672210672211,207220.14223281175,2017-01-05,5,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,8,POU2AF1,0.273,0.81685,-1.0306,0,0.75,0.0,,
ENSG00000110848,6,4,0,0,0,1,16417.447913521348,381165.6245253304,2009-05-10,0,0,0,0,0,3,0,0,0,15,0,0,0,0,2,0,0,0,0,2,0,0,0,22,CD69,0.13999999,0.68431,1.2451,0,0.75,0.0,,
ENSG00000110958,5,4,1,0,0,1,138890.6106237268,482893.2730520582,2023-01-18,1,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,7,PTGES3,0.13200003,0.74005,0.14544,8,-1.0,-1.0,Signal Transduction;Disease;Arachidonate metabolism,R-HSA-162582;R-HSA-1643685;R-HSA-2142753
ENSG00000111241,5,4,0,0,0,1,54272.859706395815,360605.992793193,2016-05-16,0,0,0,0,9,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,14,FGF6,-0.16900003,0.31892,-0.35512,28,0.75,0.5,Signal Transduction;Disease;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202
ENSG00000112175,21,4,0,0,0,1,4428.676231326727,598869.4096893278,2018-08-13,11,0,0,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,0,0,0,7,29,BMP5,0.28899997,0.72929,-0.097072,0,1.0,0.0,,
ENSG00000112499,9,4,0,0,0,1,25711.44771721631,467606.0891342802,2017-12-06,1,0,0,0,4,1,0,0,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,20,SLC22A2,-0.116999984,0.26302,-0.79456,5,1.0,0.5,Neurotransmitter release cycle;Organic cation transport,R-HSA-112310;R-HSA-549127
ENSG00000112874,5,4,0,0,0,1,95135.53490956625,346772.3766627423,2018-07-27,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,4,NUDT12,-0.23899996,-0.37107,-0.65695,1,-1.0,0.0,,
ENSG00000113845,6,4,0,0,0,1,5426.200199914322,183579.49764748462,2011-03-13,7,0,0,0,0,0,0,0,0,2,0,2,0,0,3,0,0,0,0,0,0,0,0,14,TIMMDC1,-0.023000002,0.56925,0.18122,1,-1.0,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000114904,6,4,1,0,1,1,32311.00439997589,281258.82202219026,2017-01-10,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,3,0,0,0,0,0,1,7,NEK4,-0.15799999,0.75534,0.66357,0,0.5,-1.0,,
ENSG00000115461,9,4,1,0,0,1,6436.334040236144,381165.6245253304,2016-05-16,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,0,0,0,2,0,0,1,18,IGFBP5,-0.019000053,-0.43584,-1.7584,2,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000116852,7,4,1,0,0,1,7741.739669934235,381165.6245253304,2008-06-29,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,2,0,0,6,0,0,0,10,KIF21B,0.472,3.875,1.2256,2,0.5,0.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000117592,4,4,1,0,0,1,2209.8301559792026,141293.18354755783,2013-12-25,0,0,0,0,0,0,0,0,0,0,0,6,5,0,0,0,0,0,0,1,0,0,1,13,PRDX6,0.01999998,1.8517,1.0226,2,-1.0,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000117713,8,4,0,0,0,1,13658.782960109247,464892.4593283075,2021-04-08,0,0,0,0,0,1,0,0,0,0,0,0,7,0,0,0,0,0,0,6,0,0,1,15,ARID1A,0.85899997,2.4598,-3.0462,7,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000120690,5,4,1,0,0,1,1602.528216704289,1424218.0900670097,2010-11-02,0,0,0,0,0,1,0,0,0,0,0,2,0,0,1,0,0,0,0,3,0,0,0,7,ELF1,0.34399998,1.6083,0.8085,2,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000123810,8,4,1,0,1,1,6263.050060459492,360605.992793193,2014-05-18,3,0,0,0,5,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,3,12,B9D2,-0.518,0.78519,0.59563,7,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000125813,7,4,0,0,0,1,1196.9181969949916,286678.73247515375,2011-10-27,0,0,0,1,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,4,0,0,2,14,PAX1,0.13999999,-2.1968,-3.5189,0,1.0,0.5,,
ENSG00000125966,8,4,0,0,0,1,15437.104944684224,322107.4898639223,2018-08-13,6,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,10,MMP24,0.40499997,2.5899,0.45,1,1.0,0.0,,
ENSG00000126217,8,4,1,0,1,1,31935.015289867086,394357.452283155,2017-12-06,5,0,0,1,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,15,MCF2L,0.23000002,1.5934,-0.67231,8,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000126456,8,4,1,0,1,1,22938.587937312015,323648.5577791949,2018-02-26,8,0,0,0,0,0,0,0,0,3,0,1,0,0,0,0,4,0,0,0,0,0,0,16,IRF3,0.051,0.91408,0.27853,16,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;IRF3-mediated induction of type I IFN;Disease;ISG15 antiviral mechanism,R-HSA-1280215;R-HSA-168256;R-HSA-3270619;R-HSA-1643685;R-HSA-1169408
ENSG00000126860,7,4,1,0,0,1,195005.6685718255,1424218.0900670097,2021-04-22,0,0,0,0,1,4,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,9,EVI2A,-0.29700005,0.56939,0.75742,0,0.75,0.0,,
ENSG00000127415,7,4,1,1,1,0,1321.7688442211056,283145.34784240765,2011-02-01,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,1,7,0,0,11,IDUA,-0.34399998,-3.2406,-4.5209,3,-1.0,0.0,Disease;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1643685;R-HSA-1638091
ENSG00000127419,5,4,1,0,1,1,6306.411000302206,1470466.6505612188,2011-02-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,9,1,0,0,12,TMEM175,-0.29499996,-0.34595,-1.0058,0,-1.0,-1.0,,
ENSG00000129810,5,4,0,0,0,1,132101.59514050526,1778690.168860174,2021-08-24,0,0,0,0,0,0,0,0,0,0,2,0,2,0,0,0,3,0,0,0,0,0,1,8,SGO1,-0.036000013,-0.14857,0.75853,7,0.5,0.5,Signal Transduction;Cyclin A/B1/B2 associated events during G2/M transition,R-HSA-162582;R-HSA-69273
ENSG00000130222,6,4,1,0,0,1,2958.3920643328356,562534.7696387965,2017-02-24,6,0,0,0,1,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,14,GADD45G,0.15100002,1.6012,0.13258,0,0.5,-1.0,,
ENSG00000130383,4,4,0,1,0,0,63367.23432105128,227934.29698436207,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,4,FUT5,-0.814,1.2836,0.43597,1,,,,
ENSG00000130449,12,4,0,0,0,1,15866.724081734988,633132.2332759313,2014-07-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,0,0,2,0,0,2,18,ZSWIM6,0.854,3.2892,-0.45568,0,-1.0,-1.0,,
ENSG00000133121,5,4,1,0,1,1,9098.842759071593,275021.63051358337,2010-04-04,2,0,0,0,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,9,STARD13,0.29400003,0.79424,-0.014408,4,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000133818,4,4,1,0,0,1,21724.94108458234,282360.54876783554,2019-09-01,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,1,6,RRAS2,-0.24600005,0.74888,-1.2224,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000134250,7,4,1,1,0,1,24013.64248317128,1424218.0900670097,2018-07-27,0,1,0,1,0,14,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,18,NOTCH2,0.849,6.0469,1.594,8,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000134802,4,4,1,0,0,1,2222.3233132932532,427337.4491868293,2012-03-08,0,0,0,0,2,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,5,SLC43A3,0.19599998,1.3159,0.63768,0,0.5,0.0,,
ENSG00000135365,4,4,0,0,0,1,11798.46653227782,1129585.974638378,2022-07-14,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,4,PHF21A,0.851,3.1353,0.7194,3,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000135437,10,4,1,0,0,1,5012.50123226096,326545.22790564946,2015-12-21,0,3,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,10,25,RDH5,-0.29999995,1.0359,0.554,3,0.5,0.0,Signal Transduction;Disease;The canonical retinoid cycle in rods (twilight vision),R-HSA-162582;R-HSA-1643685;R-HSA-2453902
ENSG00000135862,13,4,1,1,1,1,15603.785966148887,765591.3646788632,2018-12-03,12,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,18,LAMC1,0.736,2.4423,0.84736,11,0.5,-1.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-597592
ENSG00000135945,4,4,1,0,1,1,47450.88644524237,355284.1215006515,2021-09-30,7,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,10,REV1,0.639,1.9378,0.36061,4,-1.0,-1.0,,
ENSG00000136059,10,4,1,0,1,1,10699.7425376247,1470466.6505612188,2018-08-13,5,0,0,0,0,0,0,0,9,0,0,0,3,0,0,0,0,0,0,0,0,0,3,20,VILL,-0.10699999,0.82258,0.6998,0,0.75,-1.0,,
ENSG00000136280,5,4,1,0,1,0,52982.28647069224,765591.3646788632,2020-06-15,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,CCM2,0.24699998,1.787,1.1119,0,0.5,-1.0,,
ENSG00000136379,11,4,1,0,0,1,132101.59514050526,756470.9740366563,2018-07-30,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,2,16,ABHD17C,0.08099997,2.0635,-2.4678,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000136842,4,4,0,0,0,1,18146.19789076567,56432.02918263991,2016-08-12,1,0,0,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,7,TMOD1,0.40600002,1.2237,0.098874,1,0.5,-1.0,,
ENSG00000136930,4,4,1,0,1,1,205739.47405036874,645988.1975077938,2018-06-11,1,0,0,0,2,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,6,PSMB7,0.573,1.2112,0.067632,63,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000138071,6,4,1,0,0,1,28923.750134754748,394357.452283155,2012-12-01,1,0,0,0,3,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,6,ACTR2,0.823,4.5219,0.76009,6,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Disease,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685
ENSG00000138131,7,4,1,0,1,1,31432.8010828736,374021.10061973665,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,2,8,LOXL4,0.055999994,0.78563,1.5195,2,-1.0,0.0,,
ENSG00000139832,5,4,1,0,0,1,11608.613380386345,269829.0934099178,2022-08-20,0,0,0,1,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,1,0,0,1,9,RAB20,-0.742,0.93106,0.4548,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000139865,6,4,1,0,1,1,168625.47543722787,521818.7070055739,2016-05-16,5,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,0,1,0,0,0,10,TTC6,0.055000007,-0.59237,0.41787,0,0.5,0.5,,
ENSG00000140009,12,4,1,0,0,1,7131.187449283203,1076472.0138856068,2015-10-07,7,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,0,17,ESR2,-0.0019999743,-0.14268,-1.3346,6,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000141452,5,4,1,0,0,1,85474.33432267047,1424218.0900670097,2020-06-15,0,0,0,0,2,8,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,0,0,14,RMC1,0.42900002,1.5823,-0.21046,0,-1.0,-1.0,,
ENSG00000142082,6,4,1,0,0,1,12275.104837774083,394357.452283155,2019-09-05,8,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,14,SIRT3,-0.17299998,-1.4335,-1.2178,5,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Maturation of TCA enzymes and regulation of TCA cycle;Citric acid cycle (TCA cycle),R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9854311;R-HSA-71403
ENSG00000144677,7,4,1,0,0,1,20914.712631588172,388224.22818880016,2018-08-13,2,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,2,0,0,0,0,2,0,10,CTDSPL,0.63100004,2.106,1.1973,0,-1.0,-1.0,,
ENSG00000144802,7,4,0,0,1,1,10519.047635337382,381165.6245253304,2015-05-05,0,2,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,11,0,0,0,16,NFKBIZ,0.62,0.68869,-0.83941,0,1.0,-1.0,,
ENSG00000145819,11,4,0,0,0,1,52982.28647069224,645988.1975077938,2017-12-06,0,0,0,0,8,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,5,15,ARHGAP26,0.50699997,2.9664,-0.031336,10,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000145919,5,4,0,0,0,1,189845.9324918578,521818.7070055739,2023-01-18,2,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,6,BOD1,-0.33500004,0.55498,-1.2955,1,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000147677,24,4,0,0,0,1,1848.986479177934,1778690.168860174,2008-03-30,35,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,7,0,0,0,44,EIF3H,0.20099998,1.6424,-0.17521,6,-1.0,-1.0,Translation,R-HSA-72766
ENSG00000147905,5,4,1,0,0,1,94665.79117035728,1424218.0900670097,2019-11-01,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,5,0,1,0,0,0,0,8,ZCCHC7,-0.027999997,1.1591,0.4467,1,-1.0,-1.0,Nuclear RNA decay,R-HSA-9930044
ENSG00000149187,6,4,1,0,0,1,25495.37001303781,427337.4491868293,2018-10-08,0,0,0,0,5,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,8,CELF1,0.753,3.8793,-0.13287,0,-1.0,-1.0,,
ENSG00000149716,5,4,1,0,0,1,107949.90929360976,384314.83364002535,2021-09-30,1,0,0,2,0,2,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,10,LTO1,-0.878,-0.29241,-0.22648,0,-1.0,-1.0,,
ENSG00000150995,7,4,1,0,0,1,22345.675520395987,355284.1215006515,2013-04-01,14,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,18,ITPR1,0.675,6.2207,0.39462,15,-1.0,-1.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000151067,13,4,1,0,0,1,5892.720190233379,1076472.0138856068,2013-08-25,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,24,0,0,3,0,0,0,29,CACNA1C,0.814,7.2836,0.066422,5,0.5,0.0,"Developmental Biology;Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-1266738;R-HSA-400042
ENSG00000151229,5,4,1,0,1,1,2942.6911323718405,275021.63051358337,2016-12-22,0,0,1,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0,4,0,0,0,9,SLC2A13,0.265,0.34388,-1.453,1,0.5,0.0,,
ENSG00000151338,5,4,1,0,0,1,19162.51676090521,351924.78376246523,2019-06-01,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,4,MIPOL1,-0.45200002,0.17034,0.0084079,0,-1.0,0.0,,
ENSG00000151778,6,4,0,0,0,1,8479.376416968564,149644.92262336772,2017-09-07,1,0,0,0,0,0,0,0,0,0,1,0,8,0,0,0,1,0,0,0,0,0,0,11,SERP2,-0.84000003,0.16726,-1.2767,0,0.5,0.0,,
ENSG00000152601,5,4,1,0,0,1,2815.3867141162514,765591.3646788632,2012-02-05,4,0,0,0,0,5,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,13,MBNL1,0.68299997,3.359,0.54268,0,-1.0,-1.0,,
ENSG00000154252,5,4,0,0,0,1,53369.71648873449,207220.14223281175,2019-03-28,0,0,0,0,0,0,0,0,1,0,2,0,0,0,1,0,0,0,0,0,0,0,1,5,GAL3ST2,-0.849,-2.0439,-2.0467,0,1.0,1.0,,
ENSG00000154736,5,4,1,0,0,1,36494.548446257475,110317.46949935023,2022-06-23,0,0,0,0,0,0,1,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,6,ADAMTS5,0.18199998,0.66177,-0.26245,3,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000155093,4,4,0,0,0,0,636.1886490807354,54522.89908382802,2012-10-09,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,1,4,PTPRN2,0.18900001,-1.7635,-1.4335,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000158092,8,4,1,0,0,1,14417.426808127037,521818.7070055739,2017-01-23,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,6,NCK1,0.27999997,1.8715,-0.021836,14,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000158186,12,4,1,0,0,1,2517.7079365079367,1424218.0900670097,2009-02-08,0,0,0,0,19,5,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,4,30,MRAS,0.556,2.6024,0.40816,3,0.5,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000158955,5,4,1,0,0,1,15223.454539395489,235397.69820205137,2023-01-18,0,0,0,2,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,7,WNT9B,0.31699997,0.67002,-0.08288,3,0.5,0.5,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000160563,6,4,1,0,0,1,95776.89591443514,1778690.168860174,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,1,6,MED27,-0.08200002,1.7299,1.2199,5,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685
ENSG00000160783,5,4,1,0,1,1,5691.114246503779,410642.56898295006,2018-03-12,1,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,10,PMF1,-0.23099995,0.053932,0.31399,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000160785,5,4,1,0,0,1,11343.053400273848,147590.44123967979,2017-06-12,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,7,SLC25A44,0.144,2.0216,0.82143,1,-1.0,-1.0,,
ENSG00000162437,6,4,0,0,0,1,18475.74586768385,381165.6245253304,2017-03-27,2,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,5,RAVER2,0.185,0.37607,-0.44606,0,-1.0,-1.0,,
ENSG00000162747,5,4,1,1,1,1,1177.0449205252246,307158.2364521972,2013-07-03,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,2,0,0,2,6,FCGR3B,-0.46599996,1.1036,0.56357,2,0.5,0.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000164402,5,4,1,1,0,1,6011.059316454181,185805.42963097955,2021-08-26,0,0,0,1,0,0,0,0,2,0,3,0,0,0,0,0,0,0,1,0,0,0,0,7,SEPTIN8,0.41000003,1.5699,0.7925,0,1.0,-1.0,,
ENSG00000165609,5,4,1,0,0,0,3711.688577586207,1424218.0900670097,2012-09-06,0,0,0,1,2,19,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,23,NUDT5,0.023999989,0.75962,0.83924,1,-1.0,-1.0,Purine catabolism;Metabolism of nucleotides,R-HSA-74259;R-HSA-15869
ENSG00000166225,4,4,1,0,0,1,35604.990553220465,598869.4096893278,2023-01-18,0,0,0,0,1,0,0,0,0,1,0,0,2,0,0,0,0,0,0,1,0,0,0,5,FRS2,0.60800004,1.5347,0.63472,28,-1.0,-1.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000166444,5,4,1,0,1,1,52982.28647069224,718784.6890415357,2021-09-30,0,0,0,0,4,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,7,DENND2B,0.627,2.3239,0.33668,1,-1.0,-1.0,,
ENSG00000166510,9,4,1,0,0,1,3063.1079686575436,727796.3668420183,2013-08-25,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,1,0,0,3,14,CCDC68,0.07700002,0.63735,-0.24683,0,0.5,0.0,,
ENSG00000167914,5,4,1,0,1,1,3734.771139135828,71250.58603271045,2010-09-23,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,1,0,0,2,6,GSDMA,-0.24100006,0.090715,0.53033,0,1.0,0.5,,
ENSG00000168264,7,4,0,0,0,1,40455.65678857565,464892.4593283075,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,5,0,0,1,9,IRF2BP2,0.291,-4.373,-6.851,0,-1.0,-1.0,,
ENSG00000168421,4,4,1,0,0,1,46536.46918214105,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,1,0,0,0,4,RHOH,0.157,2.4827,-0.43277,1,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000168906,9,4,0,0,0,1,52982.28647069224,756470.9740366563,2017-12-06,3,1,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,21,MAT2A,0.842,4.6782,-1.2176,1,0.5,-1.0,Phase II - Conjugation of compounds,R-HSA-156580
ENSG00000168958,12,4,1,0,0,1,4588.845427996078,427337.4491868293,2021-09-30,0,0,0,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,12,MFF,0.37699997,0.54745,1.5061,0,-1.0,-1.0,,
ENSG00000169228,5,4,1,0,0,1,144712.0807038357,1424218.0900670097,2022-10-12,0,0,0,0,0,1,0,0,0,0,0,2,1,0,0,0,0,0,0,1,0,0,0,5,RAB24,0.56299996,1.8935,-0.26997,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000169567,6,4,1,0,0,1,15223.454539395489,286678.73247515375,2012-11-01,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,7,0,0,1,10,HINT1,-0.778,0.50384,1.0964,3,-1.0,-1.0,Developmental Biology;Regulation of MITF-M-dependent genes involved in cell cycle and proliferation,R-HSA-1266738;R-HSA-9825892
ENSG00000169764,4,4,0,0,0,1,141293.18354755783,406587.2658730814,2023-01-18,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,4,UGP2,0.009000003,2.3248,0.095174,2,0.5,-1.0,Glycogen metabolism;Glycogen synthesis;Glucuronidation;Phase II - Conjugation of compounds,R-HSA-8982491;R-HSA-3322077;R-HSA-156588;R-HSA-156580
ENSG00000170017,4,4,0,0,0,1,20455.424315535507,433862.5685735124,2019-11-22,1,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,ALCAM,0.526,1.751,0.3803,1,1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000170162,8,4,1,0,0,1,64537.09582160982,645988.1975077938,2021-09-30,0,0,0,0,7,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,8,17,VGLL2,-0.21899998,-2.6411,-2.6286,0,1.0,0.5,,
ENSG00000170185,5,4,1,0,0,1,4186.706368899917,427337.4491868293,2011-07-31,0,0,0,0,4,0,0,0,0,0,1,4,4,0,0,0,0,0,0,0,0,0,0,13,USP38,0.35900003,1.4786,0.52335,0,0.5,0.0,,
ENSG00000170266,14,4,1,1,0,1,4970.162871968654,562534.7696387965,2012-10-07,0,1,0,0,0,0,0,0,14,0,38,0,0,0,0,0,0,0,0,0,0,0,5,58,GLB1,0.061999977,1.1365,0.41777,7,-1.0,-1.0,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000170390,4,4,1,0,0,1,4428.697810877906,69925.93241087522,2016-02-01,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,DCLK2,0.47500002,1.121,-1.0616,0,0.5,0.0,,
ENSG00000170396,13,4,1,0,0,1,15866.724081734988,1778690.168860174,2012-12-01,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,15,0,0,2,0,0,6,24,ZNF804A,0.63,-0.12664,-0.36483,0,0.5,0.5,,
ENSG00000170430,5,4,1,0,0,1,14829.593216825258,205739.47405036874,2022-03-24,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,2,0,0,1,0,0,0,5,MGMT,-0.413,-0.072977,-0.4265,1,0.5,-1.0,DNA Damage Reversal,R-HSA-73942
ENSG00000170777,5,4,1,0,1,1,40125.126089953985,562534.7696387965,2021-09-30,0,0,0,0,0,0,0,0,0,0,7,1,0,0,0,0,0,0,0,0,0,1,1,10,TPD52L3,-0.80200005,-1.0845,-0.52042,0,1.0,1.0,,
ENSG00000170962,7,4,0,1,0,1,17257.066666666666,279825.00883385167,2021-04-08,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,7,PDGFD,0.074,0.44104,0.013112,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000171557,17,4,0,0,0,1,2324.6716622691292,500292.45069431677,2013-05-05,0,0,0,0,41,0,0,0,0,0,1,0,0,0,0,4,0,0,0,0,0,0,24,70,FGG,0.445,1.5174,0.39477,20,1.0,0.0,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000171729,4,4,0,0,0,1,1173.5007132667617,360605.992793193,2015-10-26,0,0,0,0,2,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,5,TMEM51,0.12900001,1.2873,0.097819,0,-1.0,0.0,,
ENSG00000172057,4,4,1,0,0,0,2880.672210672211,381165.6245253304,2012-05-05,3,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,0,2,0,0,0,9,ORMDL3,0.088,1.421,-0.49208,2,0.5,-1.0,Immune System;Sphingolipid de novo biosynthesis,R-HSA-168256;R-HSA-1660661
ENSG00000172803,4,4,1,0,0,1,45951.29495376284,367949.31877243903,2017-05-24,1,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,3,0,0,0,6,SNX32,-0.232,-0.50255,-1.22,0,1.0,0.5,,
ENSG00000173110,7,4,1,0,1,1,1380.9855975087582,307158.2364521972,2017-07-17,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,3,0,0,2,8,HSPA6,-0.883,1.1654,0.88992,5,0.5,0.0,Immune System,R-HSA-168256
ENSG00000173253,7,4,1,0,0,1,2630.136511375948,1424218.0900670097,2011-07-06,2,0,0,0,0,4,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,2,16,DMRT2,-0.27900004,-5.343,-4.187,0,0.75,0.0,,
ENSG00000173868,6,4,0,0,0,1,26841.183331692897,461914.58891516324,2018-08-13,0,0,0,1,3,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,8,PHOSPHO1,-0.311,-0.48027,-1.2314,2,1.0,0.0,,
ENSG00000174469,5,4,0,0,0,0,932.622440120525,498258.534626183,2022-06-27,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,5,CNTNAP2,0.27899998,0.26666,0.18283,0,0.75,0.5,,
ENSG00000175336,5,4,0,1,0,0,8844.888938597473,309256.4614031486,2015-11-28,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,7,0,0,0,10,APOF,-0.885,0.73449,0.60182,1,1.0,0.5,Plasma lipoprotein remodeling,R-HSA-8963899
ENSG00000178031,5,4,0,0,0,1,1594.2494117647059,521818.7070055739,2021-01-04,4,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,11,ADAMTSL1,0.25599998,-2.762,-3.6743,2,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000178199,6,4,1,0,0,1,8479.376416968564,295550.4496098593,2017-09-07,1,0,0,0,1,0,0,0,0,0,2,0,2,0,0,0,0,0,0,0,0,0,0,6,ZC3H12D,0.143,-1.2675,-1.6327,0,0.75,0.5,,
ENSG00000178279,4,4,0,0,1,1,8565.645362637362,315325.55297640257,2012-10-01,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,0,4,TNP2,-0.70799994,-0.83862,-0.96636,0,1.0,1.0,,
ENSG00000179630,6,4,1,0,1,1,1791.5069911962714,203321.91836345146,2008-06-29,0,3,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11,0,0,0,16,LACC1,-0.15799999,1.5853,0.47193,0,-1.0,0.0,,
ENSG00000181264,5,4,1,0,0,1,35617.65636301977,355399.3529808118,2018-08-13,0,0,0,6,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,10,TLCD5,-0.049999952,0.62626,0.68717,0,0.5,0.0,,
ENSG00000182168,5,4,1,0,1,1,13696.9199392042,1424218.0900670097,2020-06-15,0,0,0,0,1,9,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,12,UNC5C,0.35399997,1.6698,-0.27472,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000183431,6,4,1,0,0,1,82912.80518893801,461914.58891516324,2017-12-06,2,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,8,SF3A3,0.74,3.4804,0.40289,1,-1.0,-1.0,,
ENSG00000184939,4,4,1,0,0,1,26873.80285776456,235397.69820205137,2017-07-17,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,4,ZFP90,0.21100003,1.1187,-0.31307,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000185567,4,4,1,1,1,1,5640.466626325344,269829.0934099178,2020-12-03,0,0,0,0,0,0,0,0,0,2,0,2,4,0,0,0,0,0,0,1,0,0,0,9,AHNAK2,0.083000004,-5.931,-6.6278,0,0.5,0.0,,
ENSG00000186153,4,4,1,0,0,1,31303.173086766863,356440.71671986027,2019-09-01,0,0,0,0,1,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,4,WWOX,-0.82000005,-5.6664,-5.5948,3,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Receptor Tyrosine Kinases;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9006934;R-HSA-8864260
ENSG00000186510,11,4,1,0,1,1,8389.22186817101,756470.9740366563,2016-07-17,2,0,0,0,11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,16,CLCNKA,0.04100001,1.0649,0.19863,1,1.0,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000187736,5,4,1,0,0,1,42359.490817992155,598869.4096893278,2023-01-18,0,0,0,1,0,0,0,0,0,2,0,0,5,0,0,0,0,0,0,0,0,0,2,10,NHEJ1,0.18400002,0.97042,-0.41539,1,-1.0,-1.0,,
ENSG00000189431,5,4,0,0,0,1,17710.3869470848,249623.65852165114,2018-12-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,0,0,5,0,0,1,10,RASSF10,0.05400002,-1.5574,-2.1506,0,0.5,0.0,,
ENSG00000196396,12,4,1,0,0,1,12724.75719835148,143413.24457139417,2018-08-13,10,0,0,3,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,16,PTPN1,0.679,3.2208,1.1439,9,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-9006934
ENSG00000197548,5,4,1,0,0,1,143284.77790855977,1778690.168860174,2018-08-13,1,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,ATG7,0.014999986,1.2812,1.1293,4,-1.0,-1.0,Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-168256;R-HSA-1643685;R-HSA-5663202
ENSG00000197888,5,4,1,0,0,0,122088.395356851,147105.90765133628,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,1,0,0,1,5,UGT2B17,-0.04700005,1.7323,1.4897,3,0.75,0.5,Prednisone ADME;Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-9757110;R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000198286,6,4,0,0,0,1,4970.162871968654,295550.4496098593,2012-10-07,0,0,0,0,0,0,0,0,4,0,4,0,0,0,1,0,0,0,0,0,0,0,2,11,CARD11,0.63600004,3.7309,-1.3939,4,0.5,0.0,Immune System,R-HSA-168256
ENSG00000198324,8,4,0,0,0,1,5504.0130519525,545988.1005477115,2021-09-30,5,0,0,0,6,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,7,25,PHETA1,-0.94200003,-0.35229,-0.31951,0,-1.0,-1.0,,
ENSG00000198604,5,4,1,0,0,1,39707.309018073414,382631.1172224132,2019-07-17,4,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,7,BAZ1A,0.624,4.5449,1.5771,0,0.5,-1.0,,
ENSG00000198825,5,4,0,0,0,1,6306.411000302206,1424218.0900670097,2014-07-27,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,3,0,0,0,6,INPP5F,0.15600002,1.1799,-0.49181,1,0.5,-1.0,,
ENSG00000198860,8,4,1,0,1,1,46282.676044693806,1424218.0900670097,2019-01-21,2,0,0,0,0,3,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,4,16,TSEN15,-0.116000056,0.50103,0.21053,1,-1.0,-1.0,tRNA processing in the nucleus,R-HSA-6784531
ENSG00000204991,5,4,1,0,1,1,28498.101402717097,382631.1172224132,2022-04-08,3,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,1,0,0,7,SPIRE2,-0.34599996,-3.0978,-3.8503,0,0.5,0.0,,
ENSG00000205277,4,4,1,0,1,1,10529.240292414317,672632.4785173276,2018-08-13,0,0,0,0,5,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,9,MUC12,-0.11500001,1.4117,3.2787,6,1.0,0.5,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000214944,7,4,1,0,1,1,11231.262381898725,521818.7070055739,2021-06-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,3,0,0,1,15,ARHGEF28,0.10500002,-0.062638,-0.16226,4,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000215182,11,4,0,0,1,1,5458.8544283966285,562534.7696387965,2019-03-28,14,4,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,0,0,0,0,1,0,37,MUC5AC,-0.16799998,0.51701,-0.062162,6,1.0,0.5,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000215912,6,4,1,0,1,1,21584.376825785395,180089.50342935527,2011-08-11,1,0,0,0,0,0,0,0,0,0,0,0,6,0,1,0,0,0,0,4,0,0,0,12,TTC34,-0.467,-1.0219,-1.5049,0,0.5,0.5,,
ENSG00000228075,4,4,0,0,0,1,144102.0022515395,1424218.0900670097,2020-06-15,0,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,6,BOD1L2,-0.79700005,0.0047688,-0.75415,0,1.0,1.0,,
ENSG00000233608,4,4,1,0,0,1,10835.003904419804,1424218.0900670097,2012-05-31,2,0,0,0,0,1,0,0,0,0,3,0,0,0,0,0,0,0,0,4,0,0,0,10,TWIST2,0.286,0.22963,-0.55621,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000248144,7,4,1,0,0,1,46922.86439115351,151416.12986435954,2018-08-13,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,10,ADH1C,0.009000003,1.1398,0.060518,2,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000254470,4,4,1,0,0,1,14698.010216795416,141076.9910731678,2016-07-11,1,0,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,4,AP5B1,-0.42400002,-3.062,-4.5885,0,1.0,-1.0,,
ENSG00000002726,6,4,1,0,0,1,47738.39631923835,1424218.0900670097,2018-10-08,0,0,0,0,0,8,0,0,0,0,0,0,3,0,0,0,0,0,0,3,0,0,1,15,AOC1,-0.25300002,1.3093,0.86582,2,0.75,0.0,Immune System,R-HSA-168256
ENSG00000003756,6,4,1,0,0,1,76819.80313918999,765591.3646788632,2018-08-13,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,1,0,6,RBM5,0.798,5.2026,1.1753,1,-1.0,-1.0,,
ENSG00000007174,4,4,0,0,0,1,852.7116564417178,180344.38517486732,2022-07-13,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,4,DNAH9,0.22500002,1.7474,1.198,0,0.5,0.0,,
ENSG00000008441,6,4,0,0,0,1,27076.542115037268,141076.9910731678,2017-01-24,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,1,5,NFIX,0.908,5.3598,1.8042,2,0.5,-1.0,Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000009335,5,4,1,0,0,1,76819.80313918999,1424218.0900670097,2018-07-27,0,0,0,1,0,21,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,24,UBE3C,0.573,3.0512,-0.064336,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000010270,7,4,0,0,0,1,13883.57970142381,191895.42310022408,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,5,5,0,1,16,STARD3NL,0.25599998,1.2456,-0.40113,1,-1.0,-1.0,Pregnenolone biosynthesis;Metabolism of steroids,R-HSA-196108;R-HSA-8957322
ENSG00000010803,6,4,1,0,0,1,95776.89591443514,645988.1975077938,2018-07-30,0,0,0,0,7,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,10,SCMH1,0.34600002,3.1615,0.93076,8,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);SUMOylation of RNA binding proteins;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-4570464;R-HSA-597592
ENSG00000010810,6,4,1,0,0,1,4392.463820224719,381165.6245253304,2018-10-03,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0,1,0,0,4,0,0,0,8,FYN,0.78499997,5.241,0.901,44,-1.0,-1.0,Signal Transduction;Ephrin signaling;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Activated NTRK2 signals through FYN;Disease;Signaling by Interleukins;Platelet Adhesion to exposed collagen;Regulation of signaling by CBL;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-3928664;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-9032500;R-HSA-1643685;R-HSA-449147;R-HSA-75892;R-HSA-912631;R-HSA-3928665;R-HSA-9006934;R-HSA-5663202
ENSG00000011021,10,4,1,0,0,1,12542.479619943082,500292.45069431677,2018-08-13,0,0,4,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,3,21,CLCN6,0.213,2.0157,0.54802,2,-1.0,-1.0,Disease;Stimuli-sensing channels;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-2672351;R-HSA-5663202
ENSG00000011454,6,4,1,0,0,0,95135.53490956625,1778690.168860174,2022-07-14,0,0,0,0,0,1,0,0,0,0,0,1,4,0,0,0,2,0,0,0,0,0,0,8,RABGAP1,0.759,3.8213,0.20699,1,-1.0,-1.0,TBC/RABGAPs;Rab regulation of trafficking,R-HSA-8854214;R-HSA-9007101
ENSG00000013810,14,4,1,1,0,1,4349.584374369899,1990918.947961699,2010-03-28,7,0,0,0,0,0,0,0,0,0,0,0,22,0,0,0,0,0,0,1,0,0,10,40,TACC3,0.236,-0.24496,-1.8491,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000015413,5,4,0,1,1,1,8863.096741674168,466632.7979326389,2019-01-21,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,5,DPEP1,-0.505,-1.3812,-1.9166,3,0.75,0.0,Disease;Aflatoxin activation and detoxification;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonate metabolism,R-HSA-1643685;R-HSA-5423646;R-HSA-2142691;R-HSA-2142753
ENSG00000019186,9,4,1,0,0,1,24739.63081777544,322220.1169395476,2011-08-11,0,0,0,0,0,0,0,0,7,0,0,14,0,0,2,0,0,0,0,0,0,0,3,26,CYP24A1,-0.50699997,-1.134,0.18066,3,0.75,0.0,Disease;Vitamin D (calciferol) metabolism;Metabolism of steroids,R-HSA-1643685;R-HSA-196791;R-HSA-8957322
ENSG00000025156,9,4,0,0,0,1,57941.73301331828,645988.1975077938,2017-04-17,0,0,0,5,17,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,24,HSF2,0.59099996,1.549,0.41899,0,-1.0,-1.0,,
ENSG00000025434,5,4,1,0,0,1,7914.993941688755,314628.35415349517,2012-03-07,0,0,0,2,0,0,0,0,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,5,NR1H3,0.444,1.9533,0.1871,10,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000033867,8,4,1,0,1,1,20209.09625085965,756470.9740366563,2013-04-01,3,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,15,SLC4A7,0.44199997,2.119,0.085318,6,0.5,-1.0,Signal Transduction;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-162582;R-HSA-425393
ENSG00000042832,15,4,1,1,1,1,4558.688311952967,381165.6245253304,2016-05-16,4,0,0,0,0,0,0,0,0,43,0,0,0,0,2,0,0,0,0,8,0,0,0,57,TG,0.10799998,0.2623,-0.02058,0,1.0,0.0,,
ENSG00000043591,4,4,1,0,1,1,33209.14092714464,1424218.0900670097,2018-08-13,0,0,2,0,13,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,18,ADRB1,-0.939,-0.84844,-2.3533,2,0.5,0.0,Signal Transduction;Adrenoceptors;Amine ligand-binding receptors,R-HSA-162582;R-HSA-390696;R-HSA-375280
ENSG00000050730,4,4,0,0,0,1,38092.548464040476,233499.4066209918,2019-09-01,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,1,4,TNIP3,-0.0010000467,0.6907,0.31423,1,0.5,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000058063,6,4,0,0,0,1,6021.72810122829,572390.9560934792,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,1,4,0,0,1,11,ATP11B,0.478,2.1007,0.55176,2,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000064012,22,4,1,1,0,1,6455.028095238095,521818.7070055739,2011-10-09,48,0,0,0,0,0,0,0,1,1,0,0,2,0,0,0,0,0,0,0,0,0,0,52,CASP8,0.305,1.6719,0.79905,22,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147
ENSG00000064763,7,4,1,0,0,1,39406.19595155135,356440.71671986027,2020-05-18,3,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,1,0,0,3,14,FAR2,0.48400003,1.9811,0.24326,1,0.5,0.0,,
ENSG00000064932,7,4,1,0,0,1,17831.529851792977,1424218.0900670097,2010-11-21,3,0,0,0,0,1,0,0,0,0,4,0,0,0,0,0,0,0,0,10,0,0,0,18,SBNO2,-0.01699996,-4.0019,-7.7578,0,-1.0,0.0,,
ENSG00000065559,6,4,1,0,0,1,16208.587263816955,295550.4496098593,2020-04-15,0,0,0,0,1,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,12,16,MAP2K4,0.784,3.2263,-0.041687,5,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147
ENSG00000067182,5,4,1,1,0,1,3511.742535866615,240787.78738965438,2009-06-14,5,1,0,0,0,0,0,0,0,0,0,0,1,0,5,0,0,0,0,0,0,0,0,12,TNFRSF1A,0.61800003,1.5136,-0.95057,7,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000068745,5,4,1,0,0,1,71117.27631467933,521818.7070055739,2017-09-11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,3,0,0,1,6,IP6K2,0.615,3.318,0.25382,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000073969,6,4,1,0,0,1,11815.066044029352,263416.51565448404,2015-01-12,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,6,NSF,0.575,3.1116,1.3862,6,0.5,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000076003,8,4,1,0,0,1,4070.116983229079,376569.5597064443,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,1,0,0,2,6,MCM6,0.324,1.7972,0.52201,6,0.5,-1.0,Unwinding of DNA,R-HSA-176974
ENSG00000077549,11,4,1,0,0,1,2344.979769824783,645988.1975077938,2016-05-16,0,0,0,0,1,0,0,0,0,37,0,0,0,0,2,0,0,0,0,7,0,0,0,47,CAPZB,0.779,3.0868,1.1128,8,-1.0,-1.0,Signal Transduction;Immune System;Golgi-to-ER retrograde transport;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-8856688;R-HSA-597592
ENSG00000080546,8,4,1,0,1,1,118378.05897131584,521818.7070055739,2020-04-15,8,0,0,0,0,0,0,0,0,3,2,0,0,0,0,0,0,0,0,1,0,0,0,14,SESN1,0.29299998,1.5458,0.96772,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Amino acids regulate mTORC1;Cellular response to starvation,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9639288;R-HSA-9711097
ENSG00000081248,4,4,1,0,0,1,6796.671949604783,34592.48870785933,2018-01-01,1,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,4,CACNA1S,0.34899998,1.3387,0.28347,1,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000082438,5,4,1,0,0,1,72258.6642662147,294387.2978738704,2018-08-13,0,0,0,0,0,4,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,7,COBLL1,0.33600003,0.33578,0.89669,0,0.5,-1.0,,
ENSG00000083123,6,4,1,0,0,1,17426.74725331541,155552.2805078301,2019-08-15,0,0,0,0,0,1,4,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,8,BCKDHB,-0.20599997,0.0045109,-1.0351,7,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000083312,5,4,0,0,0,1,122749.39281265943,258213.8601133611,2023-01-18,0,0,0,0,1,0,0,0,0,1,0,3,0,0,0,0,0,0,0,1,0,0,0,6,TNPO1,0.848,4.9416,0.35627,3,-1.0,-1.0,Postmitotic nuclear pore complex (NPC) reformation;Intraflagellar transport,R-HSA-9615933;R-HSA-5620924
ENSG00000084674,17,4,1,0,1,1,7914.993941688755,464892.4593283075,2012-03-07,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,11,22,0,0,28,69,APOB,0.463,0.96416,0.84453,20,0.75,0.5,Immune System;Chylomicron assembly;Chylomicron remodeling;Plasma lipoprotein remodeling;Post-translational protein modification,R-HSA-168256;R-HSA-8963888;R-HSA-8963901;R-HSA-8963899;R-HSA-597592
ENSG00000086506,5,4,0,0,0,1,7947.16252759186,40939.08484366117,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,1,5,HBQ1,-0.939,-1.7612,-1.0968,0,0.75,0.5,,
ENSG00000088305,6,4,1,0,0,1,28863.30790298137,551389.5206213495,2012-11-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,1,7,DNMT3B,0.604,3.3349,1.3855,5,0.5,0.0,Gene expression (Transcription);Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;Post-translational protein modification,R-HSA-74160;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-597592
ENSG00000090316,5,4,1,0,0,1,17534.246691821227,515513.2178404211,2011-12-11,0,0,0,0,1,5,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,9,MAEA,0.297,2.763,-0.64188,1,-1.0,-1.0,Regulation of pyruvate metabolism;Pyruvate metabolism,R-HSA-9861718;R-HSA-70268
ENSG00000090621,5,4,1,0,0,1,28863.30790298137,1424218.0900670097,2016-05-18,1,0,0,0,1,5,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,9,PABPC4,0.689,3.3171,-0.7788,0,0.5,-1.0,,
ENSG00000091140,9,4,1,1,0,1,9619.2153471651,301203.06999851385,2011-02-06,1,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,20,0,0,0,24,DLD,0.273,1.5317,0.18114,13,0.5,-1.0,Signal Transduction;Disease;Citric acid cycle (TCA cycle);Regulation of pyruvate metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism,R-HSA-162582;R-HSA-1643685;R-HSA-71403;R-HSA-9861718;R-HSA-204174;R-HSA-70268
ENSG00000100605,11,4,1,0,0,1,12511.068286850166,718784.6890415357,2016-05-16,0,0,0,0,5,0,0,0,0,12,1,0,0,0,0,0,0,0,0,6,0,0,0,24,ITPK1,0.29000002,1.1036,-0.48579,3,0.5,-1.0,,
ENSG00000101166,6,4,1,0,0,1,39406.19595155135,448058.917711015,2023-01-18,0,0,0,0,2,0,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,2,8,PRELID3B,-0.037999988,1.327,0.89021,0,-1.0,-1.0,,
ENSG00000101311,19,4,0,0,0,1,3830.8097102584184,473900.221403792,2008-11-16,22,0,0,0,4,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,29,FERMT1,0.12900001,1.7509,1.0368,0,0.5,0.0,,
ENSG00000101868,9,4,1,0,0,1,56337.759367670486,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,0,2,1,7,POLA1,,,,10,-1.0,0.0,E2F mediated regulation of DNA replication;G1/S-Specific Transcription;Inhibition of replication initiation of damaged DNA by RB1/E2F1;Disease,R-HSA-113510;R-HSA-69205;R-HSA-113501;R-HSA-1643685
ENSG00000103479,6,4,1,0,1,1,93616.86016863462,268820.3463588091,2021-04-08,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,2,5,RBL2,0.398,1.6034,0.6074,9,-1.0,-1.0,Generic Transcription Pathway;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;RNA Polymerase II Transcription;Gene expression (Transcription);G1/S-Specific Transcription;FOXO-mediated transcription of cell cycle genes,R-HSA-212436;R-HSA-1362300;R-HSA-73857;R-HSA-74160;R-HSA-69205;R-HSA-9617828
ENSG00000103494,6,4,1,0,0,0,37103.599990958406,254373.32653042395,2020-05-06,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,6,9,RPGRIP1L,0.092999995,1.0197,0.74252,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000103932,4,4,1,0,0,1,260210.21963428933,334911.3573752668,2023-01-18,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,4,RPAP1,0.123000026,2.0138,0.89303,0,-1.0,-1.0,,
ENSG00000104081,5,4,1,0,0,1,2065.6571476154163,515513.2178404211,2016-03-09,5,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,8,BMF,0.21200001,0.69906,0.33115,2,0.5,-1.0,,
ENSG00000104093,7,4,0,0,1,1,95776.89591443514,1778690.168860174,2022-06-28,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,2,6,DMXL2,0.64,3.3184,0.30995,0,-1.0,-1.0,,
ENSG00000104237,5,4,0,0,0,1,13144.133106414256,65604.53261722306,2015-10-26,0,0,0,1,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,7,RP1,-0.44700003,0.35131,1.1677,0,1.0,0.5,,
ENSG00000104408,4,4,1,0,0,1,2630.136511375948,406587.2658730814,2011-07-06,1,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,1,0,0,1,0,0,0,8,EIF3E,0.17500001,3.1028,-0.51451,6,-1.0,-1.0,Translation,R-HSA-72766
ENSG00000104537,6,4,1,0,1,1,7263.279293455811,123012.11727811508,2017-10-23,3,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,1,0,0,0,0,0,2,16,ANXA13,0.04000002,0.022877,-0.13164,0,0.5,0.0,,
ENSG00000105963,6,4,1,0,0,1,19965.24128263536,562534.7696387965,2022-10-12,0,0,0,0,4,0,0,0,0,0,2,0,1,0,0,0,0,0,0,5,0,0,0,12,ADAP1,0.051,-1.2391,-5.0674,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000106038,6,4,0,0,0,1,39053.6332038119,756470.9740366563,2018-08-13,1,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,9,EVX1,-0.097,-1.6963,-2.1166,0,0.5,0.5,,
ENSG00000106049,9,4,1,0,0,1,12452.793604407574,521818.7070055739,2018-08-13,4,0,0,0,0,0,0,0,0,0,0,9,1,0,0,0,0,0,0,0,0,0,2,16,HIBADH,-0.12800002,-0.016545,-0.39455,1,-1.0,-1.0,,
ENSG00000106261,5,4,1,0,0,1,8142.9975274725275,200944.0765227402,2019-09-19,4,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,9,ZKSCAN1,0.587,2.8724,0.4206,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000106331,5,4,0,0,1,1,1594.1915802318488,254373.32653042395,2013-03-27,1,0,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,10,PAX4,-0.055999994,-0.27394,-0.092063,1,,,Developmental Biology,R-HSA-1266738
ENSG00000106546,12,4,0,0,0,1,28863.30790298137,355399.3529808118,2019-06-07,19,0,0,0,0,0,0,0,1,0,0,3,0,0,0,0,0,0,0,1,0,0,0,24,AHR,0.394,0.66328,-0.5122,5,-1.0,-1.0,,
ENSG00000107560,8,4,0,0,0,1,28863.30790298137,189557.6027707886,2018-05-08,5,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,14,RAB11FIP2,0.51699996,1.4351,-0.090494,1,-1.0,-1.0,,
ENSG00000108423,5,4,1,0,1,1,29811.1438239137,1424218.0900670097,2012-11-01,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,4,0,0,1,8,TUBD1,0.050000012,1.2065,0.71575,0,-1.0,-1.0,,
ENSG00000108424,4,4,1,0,0,1,141293.18354755783,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,1,0,0,1,5,KPNB1,0.881,6.7049,0.667,14,-1.0,-1.0,Cytokine Signaling in Immune system;Assembly of the ORC complex at the origin of replication;Immune System;Postmitotic nuclear pore complex (NPC) reformation;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;NS1 Mediated Effects on Host Pathways;Disease;Response of Mtb to phagocytosis;Suppression of phagosomal maturation;Infection with Mycobacterium tuberculosis;Metabolism of steroids;ISG15 antiviral mechanism;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-1280215;R-HSA-68616;R-HSA-168256;R-HSA-9615933;R-HSA-177243;R-HSA-180746;R-HSA-168271;R-HSA-168276;R-HSA-1643685;R-HSA-9637690;R-HSA-9637687;R-HSA-9635486;R-HSA-8957322;R-HSA-1169408;R-HSA-1655829
ENSG00000108924,4,4,1,0,0,1,36874.36292340531,384314.83364002535,2020-12-02,1,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,1,0,0,0,1,0,0,9,HLF,0.572,1.8213,0.45427,0,0.5,0.0,,
ENSG00000110448,4,4,1,1,1,1,6455.576662143826,322220.1169395476,2011-01-18,0,0,0,0,1,0,0,0,0,2,0,0,0,0,4,0,0,0,0,0,0,0,1,8,CD5,0.16500002,1.3463,0.97244,0,0.5,0.0,,
ENSG00000110696,4,4,1,0,0,1,191895.42310022408,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,1,0,0,5,C11orf58,0.555,1.5843,0.24523,0,-1.0,-1.0,,
ENSG00000111276,5,4,1,0,1,1,11252.882952659449,1424218.0900670097,2019-09-27,6,0,0,0,4,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,CDKN1B,0.19599998,-1.3002,-1.7923,16,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;FOXO-mediated transcription of cell cycle genes,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-9617828
ENSG00000111300,6,4,0,0,0,1,4707.0344827586205,236505.83325879707,2007-06-06,0,0,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,2,7,NAA25,0.65900004,3.8302,1.4068,0,-1.0,-1.0,,
ENSG00000111335,7,4,1,0,0,0,5504.0130519525,136288.48249759385,2021-09-30,4,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,4,11,OAS2,-0.08000004,0.87554,0.33849,4,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Disease,R-HSA-1280215;R-HSA-168256;R-HSA-1643685
ENSG00000111537,6,4,0,0,0,1,2902.7699290780142,355284.1215006515,2009-01-04,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,16,0,0,1,19,IFNG,-0.09500003,1.7952,-0.20277,5,0.75,0.5,Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147;R-HSA-8877330
ENSG00000112041,5,4,0,0,0,1,7899.584628811126,116089.30071075787,2020-06-24,0,0,0,0,0,1,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,5,TULP1,-0.019000053,-0.39346,-0.34999,0,1.0,0.5,,
ENSG00000112149,5,4,1,1,0,1,41299.82664585649,427337.4491868293,2020-12-11,0,0,0,0,1,0,0,0,0,0,0,1,5,0,0,0,0,0,0,2,0,0,0,9,CD83,-0.38300002,-0.10178,0.018352,0,0.5,-1.0,,
ENSG00000112232,4,4,0,0,0,1,20850.43936444706,253768.6150468714,2016-08-12,2,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6,KHDRBS2,0.116,-0.23577,-1.5037,1,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000112773,8,4,1,0,0,1,22345.675520395987,394357.452283155,2013-04-01,3,0,0,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,12,TENT5A,0.45499998,2.7975,-0.49219,0,0.75,-1.0,,
ENSG00000112799,8,4,0,0,1,1,28292.123952140868,251325.91086204,2021-08-11,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,13,LY86,-0.39499998,0.23725,0.091235,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000112877,5,4,1,0,1,1,7713.269928300295,598869.4096893278,2010-03-14,4,0,0,0,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,11,CEP72,-0.40900004,-0.67618,0.0075171,7,0.5,0.0,,
ENSG00000112996,11,4,0,0,1,1,6275.684210526316,1424218.0900670097,2011-01-24,29,0,0,1,0,4,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,MRPS30,-0.24300003,-0.53712,-1.1013,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000113231,11,4,1,0,0,1,7098.679736796403,381165.6245253304,2016-05-16,0,0,0,0,0,1,0,0,0,30,0,0,0,0,1,0,0,0,0,4,0,0,0,36,PDE8B,0.649,3.3877,-0.064964,1,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000113580,8,4,1,0,0,1,87748.84971094332,756470.9740366563,2018-06-11,0,0,0,0,17,0,0,0,0,1,2,0,0,0,0,0,0,0,0,1,0,0,0,21,NR3C1,0.706,3.0576,1.2636,8,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-597592
ENSG00000114251,5,4,1,0,0,1,50641.99826116222,189845.9324918578,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,4,WNT5A,0.56299996,1.2445,-0.33607,12,0.5,0.0,Signal Transduction;Killing mechanisms;WNT5:FZD7-mediated leishmania damping;Disease;WNT5A-dependent internalization of FZD4;Asymmetric localization of PCP proteins,R-HSA-162582;R-HSA-9664420;R-HSA-9673324;R-HSA-1643685;R-HSA-5099900;R-HSA-4608870
ENSG00000114491,5,4,1,0,0,1,29803.01405728205,464892.4593283075,2017-07-17,0,0,0,9,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,17,UMPS,0.265,1.3517,0.89665,1,-1.0,0.0,Nucleotide biosynthesis;Metabolism of nucleotides,R-HSA-8956320;R-HSA-15869
ENSG00000114790,11,4,1,0,1,1,2815.3867141162514,521818.7070055739,2012-02-05,1,0,0,0,9,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,17,ARHGEF26,0.139,-1.4023,-1.6194,4,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000114933,11,4,1,0,0,1,68483.49544336602,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,1,0,4,1,11,INO80D,0.649,3.4821,1.7339,2,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000115232,6,4,1,0,0,1,11209.69355605804,258213.8601133611,2017-01-09,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,8,0,0,1,11,ITGA4,0.397,1.253,-1.1256,5,0.75,0.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;RUNX3 Regulates Immune Response and Cell Migration;Transcriptional regulation by RUNX3,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-8949275;R-HSA-8878159
ENSG00000115339,6,4,1,1,0,1,71245.27443883417,1424218.0900670097,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,7,GALNT3,0.19599998,0.92811,-0.1441,3,0.5,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-597592
ENSG00000115464,7,4,1,0,0,1,11366.70347515427,427337.4491868293,2012-12-01,0,0,0,0,6,0,0,0,0,1,0,0,0,0,0,0,0,0,0,4,0,0,1,12,USP34,0.848,1.9038,-2.6364,2,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000115486,9,4,1,0,0,1,22540.468794299068,502231.5406594711,2015-09-07,9,0,0,0,14,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,27,GGCX,0.11199999,1.7017,0.22353,2,1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000115760,5,4,0,0,1,1,5390.708148148148,353105.3286394775,2021-11-04,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,2,5,BIRC6,0.787,2.4258,-1.944,2,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000116161,6,4,1,0,0,1,235397.69820205137,498258.534626183,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,2,5,CACYBP,-0.44099998,0.80172,0.33071,0,-1.0,-1.0,,
ENSG00000116604,8,4,1,0,0,1,6170.33304373009,498258.534626183,2012-06-10,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,3,17,MEF2D,0.71500003,2.7515,-0.22447,5,0.5,-1.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000117983,13,4,1,0,1,1,912.48959919672,237796.04123488106,2017-10-20,20,4,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,6,43,MUC5B,0.6,0.18731,-3.8728,6,1.0,0.0,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000118526,21,4,1,0,0,1,33474.53224293741,782476.8109259979,2011-03-06,0,0,0,0,49,0,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,29,82,TCF21,0.47000003,1.6645,0.93936,0,0.5,0.0,,
ENSG00000118689,7,4,0,0,0,1,4917.108320036471,464892.4593283075,2017-10-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,1,0,0,0,3,11,FOXO3,0.74,2.7292,0.015581,15,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling;FOXO-mediated transcription of cell cycle genes;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-6785807;R-HSA-9617828;R-HSA-8878159
ENSG00000118900,4,4,1,0,0,1,275248.1975391687,464892.4593283075,2021-11-04,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,5,UBN1,0.807,-1.2442,-2.9814,1,-1.0,-1.0,,
ENSG00000120055,4,4,1,0,0,1,87248.80974040499,355284.1215006515,2023-05-08,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,5,C10orf95,,-2.5754,-2.1191,0,0.5,0.0,,
ENSG00000120094,4,4,1,0,1,1,7794.273577144567,1778690.168860174,2021-03-01,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,4,HOXB1,0.251,0.78223,0.12798,1,,,Developmental Biology,R-HSA-1266738
ENSG00000120129,5,4,0,0,1,1,29811.1438239137,414433.58532016096,2021-11-16,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,1,7,DUSP1,0.30900002,0.17756,-2.6529,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000120337,7,4,0,0,0,1,7741.739669934235,442877.006007271,2008-06-29,0,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,7,0,0,1,12,TNFSF18,-0.324,-0.047347,0.40615,1,0.5,0.5,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000120658,11,4,1,0,0,1,87545.45580019058,633132.2332759313,2016-05-16,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,1,0,0,1,10,ENOX1,0.37300003,3.0798,1.0004,0,-1.0,0.0,,
ENSG00000120889,7,4,1,1,1,1,10114.784655272233,278190.43024910334,2023-01-18,7,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,13,TNFRSF10B,-0.075999975,-0.081284,-0.19125,8,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000121281,11,4,0,0,1,1,8160.912888142308,381165.6245253304,2017-01-09,0,0,0,0,0,0,1,0,0,4,0,0,0,0,2,0,0,0,0,14,0,0,0,21,ADCY7,0.26200002,2.3934,-0.64813,14,0.5,0.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000121552,4,4,1,0,1,1,23534.558919763418,1424218.0900670097,2022-02-07,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,4,CSTA,-0.21899998,-0.20959,0.37746,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000121807,5,4,1,0,0,1,9724.911607071434,519652.4132779146,2011-11-06,0,2,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,6,CCR2,-0.82500005,0.9264,0.14524,4,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Defensins;Signaling by Interleukins;Antimicrobial peptides,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1461973;R-HSA-449147;R-HSA-6803157
ENSG00000121858,6,4,1,1,0,1,48129.93320457106,521818.7070055739,2020-05-18,5,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,1,9,TNFSF10,0.19300002,0.11071,0.3449,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000123268,7,4,1,0,0,1,7751.696558653604,427337.4491868293,2010-10-24,6,0,0,0,3,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,14,ATF1,0.31699997,1.5874,0.69811,2,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9006934
ENSG00000123454,4,4,0,1,1,1,75715.46734074537,500292.45069431677,2023-01-18,0,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,7,DBH,0.06400001,0.35624,0.51931,1,1.0,0.5,Metabolism of amine-derived hormones,R-HSA-209776
ENSG00000123728,6,4,1,0,0,1,19526.19816296835,144744.15797648102,2019-10-24,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,6,RAP2C,,,,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000124493,4,4,0,0,0,1,2208.869002060642,135095.86576106868,2013-06-02,1,0,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,7,GRM4,0.51699996,3.8744,1.3449,3,1.0,1.0,Signal Transduction,R-HSA-162582
ENSG00000125730,10,4,0,1,1,1,2734.299212598425,378712.0243337037,2011-06-10,0,3,0,16,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,0,0,0,36,C3,0.459,4.4464,0.81706,10,1.0,-1.0,Signal Transduction;Immune System;Disease;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000126777,4,4,0,0,0,1,141293.18354755783,263416.51565448404,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,4,KTN1,0.232,-0.087865,-0.39934,9,-1.0,-1.0,Signal Transduction;RHO GTPases activate KTN1;Post-translational protein modification,R-HSA-162582;R-HSA-5625970;R-HSA-597592
ENSG00000127616,9,4,1,0,0,0,6040.069513406157,500292.45069431677,2009-02-08,0,1,0,0,9,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,13,SMARCA4,0.774,8.811,0.092531,13,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Formation of the non-canonical BAF (ncBAF) complex;Signaling by Interleukins;Formation of the beta-catenin:TCF transactivating complex,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9933947;R-HSA-449147;R-HSA-201722
ENSG00000127990,5,4,1,0,0,1,131525.74533408263,1129585.974638378,2019-11-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,1,5,SGCE,0.37199998,1.3845,0.5264,1,-1.0,0.0,,
ENSG00000130202,7,4,1,1,0,1,2310.3800086169754,645988.1975077938,2008-09-29,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,5,15,NECTIN2,0.342,1.5163,-0.14716,3,-1.0,-1.0,Immune System;Nectin/Necl  trans heterodimerization,R-HSA-168256;R-HSA-420597
ENSG00000130702,21,4,1,0,1,1,7751.696558653604,466632.7979326389,2010-10-24,22,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,25,LAMA5,0.22100002,-2.6755,-6.7705,8,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-6785807
ENSG00000131016,7,4,1,0,0,1,100075.58738100652,219793.50457789513,2020-04-27,2,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,3,7,AKAP12,0.504,1.388,1.3357,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000131470,5,4,1,0,1,1,49724.14538298504,381165.6245253304,2023-01-18,0,0,0,0,0,2,0,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,0,5,PSMC3IP,0.018999994,0.65805,0.90721,1,0.5,0.0,,
ENSG00000132406,5,4,1,0,0,1,11843.109477001575,205342.54344682425,2021-10-07,0,0,0,0,0,0,0,0,1,0,0,0,0,3,0,0,1,0,0,0,0,0,2,7,TMEM128,-0.55200005,-1.1996,-1.4052,0,-1.0,-1.0,,
ENSG00000132437,4,4,0,1,1,1,28923.750134754748,765591.3646788632,2012-12-01,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,4,DDC,0.07800001,1.0856,0.4658,2,0.5,0.0,Metabolism of amine-derived hormones,R-HSA-209776
ENSG00000133789,8,4,1,1,1,1,14639.784588829983,500292.45069431677,2017-07-17,0,0,0,0,9,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,2,14,SWAP70,0.41900003,1.487,-0.046308,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000133958,4,4,0,0,0,1,606.6666666666666,562534.7696387965,2020-12-11,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,4,UNC79,0.832,6.7522,2.3118,1,0.75,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000134107,5,4,0,0,0,1,38772.287745457244,215157.94798738702,2020-05-18,1,0,0,0,0,0,0,0,2,3,0,0,1,0,0,0,0,0,0,0,0,0,0,7,BHLHE40,0.781,0.92281,-0.55372,2,-1.0,-1.0,,
ENSG00000134249,5,4,0,0,1,1,32254.717802479194,442877.006007271,2012-11-01,0,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,5,ADAM30,-0.903,0.61184,-0.56086,1,1.0,1.0,Interaction With Cumulus Cells And The Zona Pellucida;Fertilization,R-HSA-2534343;R-HSA-1187000
ENSG00000134376,8,4,0,0,0,1,2267.5066522833513,169088.90478978804,2009-12-23,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,0,0,1,15,CRB1,0.22399998,0.63626,0.5787,0,1.0,0.5,,
ENSG00000134762,5,4,0,0,0,1,9855.14221891288,498258.534626183,2018-04-04,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,4,DSC3,-0.27100003,-0.72382,-1.0005,2,0.75,0.0,Developmental Biology,R-HSA-1266738
ENSG00000135472,7,4,1,0,0,1,28368.758914837086,1424218.0900670097,2019-07-05,0,0,0,0,2,8,0,0,0,0,0,0,1,0,0,0,0,0,7,0,0,0,0,18,FAIM2,0.24699998,1.676,0.38406,0,0.5,0.0,,
ENSG00000136104,6,4,1,0,0,1,25209.39839469752,482893.2730520582,2021-11-04,7,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,10,RNASEH2B,-0.40100002,-0.74038,0.41429,0,0.5,-1.0,,
ENSG00000136717,7,4,1,0,0,1,1321.7688442211056,427337.4491868293,2011-04-03,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,0,0,3,0,0,2,34,BIN1,0.18300003,1.3433,0.19722,1,0.75,-1.0,,
ENSG00000136824,12,4,1,0,0,1,36102.10446378434,367949.31877243903,2019-06-07,16,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,20,SMC2,0.592,0.97336,0.52661,2,0.5,-1.0,Condensation of Prophase Chromosomes,R-HSA-2299718
ENSG00000137266,5,4,0,0,0,1,7223.468925010245,95776.89591443514,2010-11-21,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,4,SLC22A23,0.37,1.4397,-0.4817,0,-1.0,-1.0,,
ENSG00000137656,12,4,1,0,1,1,2866.7577092511015,461914.58891516324,2016-09-07,0,0,0,0,9,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,16,BUD13,0.09100002,-0.12597,-0.16172,1,-1.0,-1.0,,
ENSG00000137831,4,4,0,0,1,1,90566.66054026398,500292.45069431677,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,4,UACA,0.167,0.68696,0.8585,2,0.5,-1.0,Signal Transduction;Cytochrome c-mediated apoptotic response,R-HSA-162582;R-HSA-111461
ENSG00000137941,9,4,1,0,1,1,95776.89591443514,1424218.0900670097,2019-07-01,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,3,0,0,0,0,0,4,11,TTLL7,0.436,3.0319,0.28017,1,0.5,0.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000138182,4,4,1,0,1,1,606.6666666666666,1424218.0900670097,2020-12-11,2,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,KIF20B,0.112999976,-0.73117,-0.46996,2,0.5,0.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000138468,7,4,1,0,1,1,5691.114246503779,562534.7696387965,2022-10-12,3,0,0,0,0,0,0,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,1,8,SENP7,0.49699998,1.8503,1.2617,0,-1.0,-1.0,,
ENSG00000138593,6,4,1,0,1,1,19827.24327071012,136665.8227530756,2017-06-12,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,11,SECISBP2L,0.51699996,2.0834,-0.012877,0,-1.0,-1.0,,
ENSG00000138777,4,4,1,0,0,1,38092.548464040476,521818.7070055739,2019-09-01,2,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,0,0,0,5,PPA2,-0.324,-0.42341,0.18535,2,-1.0,-1.0,tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-379726;R-HSA-72766
ENSG00000139083,5,4,1,0,0,1,21201.639474894007,355284.1215006515,2023-01-18,1,0,0,0,0,1,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,ETV6,0.56,2.2005,-0.15881,2,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000139117,4,4,0,0,0,1,47723.36592392044,1424218.0900670097,2021-04-08,0,0,0,0,1,1,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,6,CPNE8,0.036000013,0.49665,-0.85857,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000140262,6,4,1,0,1,1,29803.01405728205,1778690.168860174,2020-01-20,1,0,0,11,0,6,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,20,TCF12,0.39099997,0.31056,-0.33838,4,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9006934
ENSG00000140368,5,4,1,0,0,1,16954.933657438592,895916.2144062951,2022-11-04,0,0,0,0,1,2,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,6,PSTPIP1,-0.41999996,-1.6926,-2.5973,2,0.75,0.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000140443,5,4,1,0,0,1,40455.65678857565,1424218.0900670097,2018-06-11,2,0,0,0,5,3,0,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,22,IGF1R,0.607,4.6593,-0.84538,5,-1.0,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1643685;R-HSA-9006934
ENSG00000140455,4,4,1,0,0,1,195005.6685718255,960369.5592648841,2018-06-11,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,5,USP3,0.544,2.3331,0.4007,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000140948,8,4,1,0,0,1,2549.1573998257613,410642.56898295006,2016-05-16,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,4,17,ZCCHC14,0.68700004,0.98179,-3.4663,0,-1.0,-1.0,,
ENSG00000140995,18,4,1,0,0,1,2816.1549815498156,367949.31877243903,2016-01-29,17,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,2,0,0,1,27,DEF8,0.07200003,0.56367,-0.83969,0,-1.0,-1.0,,
ENSG00000141293,7,4,1,0,1,1,8116.851928965095,598869.4096893278,2013-04-01,6,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,11,SKAP1,-0.11399996,0.71934,0.33358,0,0.5,0.0,,
ENSG00000141458,4,4,1,0,1,1,61498.92173410762,756470.9740366563,2022-10-12,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,6,NPC1,0.324,1.7197,-0.14671,1,-1.0,-1.0,,
ENSG00000141564,4,4,1,0,0,0,1173.5007132667617,765591.3646788632,2017-12-22,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,5,RPTOR,0.795,5.9743,0.58712,8,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;mTORC1-mediated signalling;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;Amino acids regulate mTORC1;MTOR signalling;Cellular response to starvation,R-HSA-162582;R-HSA-212436;R-HSA-166208;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-9639288;R-HSA-165159;R-HSA-9711097
ENSG00000142039,12,4,1,0,0,1,11608.613380386345,1990918.947961699,2017-12-06,0,0,0,0,3,0,0,0,0,0,0,0,19,0,0,0,0,0,0,1,0,0,7,30,CCDC97,-0.14900005,1.0829,-0.7294,0,-1.0,-1.0,,
ENSG00000143452,6,4,1,0,1,1,18425.15713644852,427337.4491868293,2023-01-18,1,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,6,HORMAD1,0.25300002,0.56598,0.57852,0,1.0,0.5,,
ENSG00000143627,4,4,0,1,0,1,27912.017438396968,1424218.0900670097,2022-10-25,1,0,0,0,0,1,0,0,0,0,0,0,4,0,0,0,0,0,1,0,0,0,0,7,PKLR,0.09899998,1.6057,0.29485,5,0.5,0.5,Developmental Biology;Disease;Pyruvate metabolism,R-HSA-1266738;R-HSA-1643685;R-HSA-70268
ENSG00000143776,5,4,1,0,0,1,143413.24457139417,1424218.0900670097,2021-06-14,0,0,0,3,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,6,CDC42BPA,0.536,2.5563,0.86812,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000143951,4,4,1,0,0,1,4428.676231326727,521818.7070055739,2019-09-27,21,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,24,WDPCP,0.06099999,0.81657,0.1658,0,-1.0,-1.0,,
ENSG00000144229,4,4,1,0,0,1,3777.7471479602086,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,1,0,1,0,0,0,0,4,THSD7B,0.23699999,0.95834,-0.88883,2,1.0,0.5,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000144451,10,4,0,0,0,1,3534.485612498504,633132.2332759313,2019-12-01,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,1,6,SPAG16,-0.26100004,-0.82497,-0.55938,0,-1.0,-1.0,,
ENSG00000144460,8,4,0,0,0,0,26908.700469045143,407080.5516610372,2010-06-27,0,0,0,0,3,3,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,9,NYAP2,0.30299997,-0.41153,-0.57932,0,0.75,0.5,,
ENSG00000144857,11,4,1,1,0,1,1674.1244444444444,1424218.0900670097,2018-02-26,9,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,12,BOC,0.21100003,2.2833,0.7708,4,-1.0,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000145214,6,4,1,0,1,1,8476.999882033739,83896.55822718568,2012-03-01,0,0,0,0,0,1,0,0,0,0,0,4,1,0,0,0,0,0,0,4,0,0,0,10,DGKQ,-0.29400003,-2.6186,-4.5967,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000145332,8,4,1,0,0,1,17710.13395835839,208059.85546229704,2021-04-08,3,0,1,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,0,0,0,10,KLHL8,0.21899998,2.6968,1.1911,0,0.5,-1.0,,
ENSG00000145730,9,4,1,1,1,1,72258.6642662147,1778690.168860174,2018-07-27,0,0,0,2,0,22,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,1,31,PAM,0.13700002,1.2632,0.97668,0,0.5,-1.0,,
ENSG00000145850,7,4,1,1,0,1,66438.21345734232,464892.4593283075,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,4,0,0,4,10,TIMD4,-0.052000046,0.15222,-0.93888,0,0.75,0.0,,
ENSG00000146085,5,4,1,0,1,1,63367.23432105128,410642.56898295006,2022-09-30,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,0,0,3,0,0,0,1,9,MMUT,-0.17999995,1.0944,1.0944,4,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000147274,4,4,1,0,0,1,275021.63051358337,574261.7466389402,2022-08-01,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,4,RBMX,,,,7,-1.0,-1.0,Signal Transduction;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9013422;R-HSA-9706574
ENSG00000147592,5,4,1,0,0,1,41416.92752032799,672632.4785173276,2021-04-22,0,0,0,0,2,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,5,LACTB2,-0.38600004,0.4904,-0.12429,0,0.5,-1.0,,
ENSG00000147655,8,4,1,0,0,1,3823.6404948245395,521818.7070055739,2014-07-27,8,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,5,0,0,1,18,RSPO2,0.33200002,0.94147,-0.30662,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000148584,5,4,1,0,1,1,66438.21345734232,1424218.0900670097,2018-12-03,2,0,0,0,0,1,0,0,0,0,0,0,9,0,0,0,0,0,0,2,0,0,0,14,A1CF,0.17500001,1.2373,0.017838,2,1.0,0.5,,
ENSG00000149289,5,4,1,0,0,1,8844.888938597473,309256.4614031486,2015-11-28,0,1,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,13,0,0,0,17,ZC3H12C,0.611,2.7717,1.7881,0,-1.0,-1.0,,
ENSG00000150867,10,4,1,0,1,1,4908.781695658988,356440.71671986027,2013-08-30,8,0,0,0,0,0,0,0,0,1,0,0,4,0,0,0,0,0,0,0,0,0,2,15,PIP4K2A,0.37699997,1.2214,-0.0033592,4,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000150938,6,4,1,0,0,1,936.4488286066585,756470.9740366563,2022-02-07,1,0,0,0,3,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,CRIM1,0.624,0.60286,-1.602,0,0.5,-1.0,,
ENSG00000151414,5,4,1,0,1,1,15223.454539395489,235397.69820205137,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,4,9,NEK7,-0.044999957,1.3133,0.39283,3,0.5,-1.0,,
ENSG00000152034,9,4,0,0,0,1,24018.50271441657,756470.9740366563,2018-10-08,0,0,0,0,5,0,0,7,0,0,0,0,4,0,0,0,1,0,0,0,0,0,0,17,MCHR2,0.02700001,0.74508,0.24314,3,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000152128,8,4,1,0,0,1,606.6666666666666,263416.51565448404,2020-04-27,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,10,TMEM163,-0.024000049,1.0393,-0.44825,0,0.5,0.0,,
ENSG00000152315,4,4,1,0,0,1,69453.1498757531,433862.5685735124,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,2,0,2,0,0,0,0,0,2,9,KCNK13,0.061999977,0.9053,-0.59862,2,0.5,0.5,,
ENSG00000152767,5,4,1,0,0,1,11236.379024579468,405722.3511294316,2020-10-05,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,1,5,FARP1,0.45200002,0.45183,-0.035068,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000154175,4,4,1,0,0,1,69453.1498757531,235397.69820205137,2023-01-18,0,0,0,1,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,5,ABI3BP,0.055000007,0.56225,0.10761,0,-1.0,0.0,,
ENSG00000154639,13,4,1,0,0,1,78355.43324299547,1470466.6505612188,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,14,0,0,0,1,0,0,0,0,0,6,22,CXADR,0.24900001,2.0578,0.53939,2,0.5,0.0,Immune System,R-HSA-168256
ENSG00000156140,6,4,1,0,0,1,25778.35048791522,464892.4593283075,2020-10-05,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,2,6,ADAMTS3,0.32999998,0.95069,1.1185,3,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000156427,7,4,0,0,0,1,60111.20110003438,714039.8414241908,2019-01-21,0,0,0,0,0,0,0,0,0,0,3,0,7,0,0,0,0,0,0,0,0,1,3,14,FGF18,0.523,2.4404,0.20248,29,0.5,0.5,Signal Transduction;Disease;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202
ENSG00000156564,6,4,0,0,0,1,61498.92173410762,1778690.168860174,2018-10-08,0,0,0,0,1,4,0,0,0,0,0,0,0,0,0,0,2,0,5,0,0,0,0,12,LRFN2,0.269,0.81644,-1.9415,1,0.75,0.5,,
ENSG00000156689,4,4,1,0,0,1,17416.80601016872,279992.27535235474,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,1,4,GLYATL2,-0.65,-0.23555,0.042586,3,0.5,0.5,Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156580;R-HSA-9749641
ENSG00000157168,18,4,1,0,0,1,1422.4664310954063,384314.83364002535,2016-05-16,25,0,0,0,0,0,0,0,0,15,0,0,2,0,0,0,0,0,0,5,0,0,0,47,NRG1,0.603,0.94507,0.2071,20,0.5,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000157654,6,4,1,0,0,1,3773.7492453632494,427337.4491868293,2021-11-04,0,0,0,2,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,8,PALM2AKAP2,0.31699997,0.038053,0.66081,0,-1.0,0.0,,
ENSG00000157873,6,4,1,0,1,1,20302.198506576402,322220.1169395476,2012-11-01,1,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,2,0,0,1,7,TNFRSF14,0.17299998,0.45694,-0.24314,2,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000158113,9,4,1,0,0,1,11231.262381898725,322220.1169395476,2019-07-30,0,0,0,0,0,0,0,0,4,0,2,0,0,0,0,0,0,0,0,4,0,0,4,14,LRRC43,-0.24699998,-0.093045,-0.97248,0,0.5,0.0,,
ENSG00000158941,4,4,1,0,0,1,278498.5074409075,1778690.168860174,2020-06-15,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,CCAR2,0.712,0.82873,-2.2922,1,-1.0,-1.0,,
ENSG00000158985,6,4,1,0,0,1,57274.55741575397,562534.7696387965,2021-11-04,0,0,0,0,1,0,0,0,5,0,7,0,0,0,1,0,0,0,0,0,0,0,0,14,CDC42SE2,-0.40699995,0.79664,0.68359,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000159128,5,4,1,1,1,1,32254.717802479194,427337.4491868293,2012-11-01,0,0,0,0,1,0,0,0,0,0,0,0,3,0,1,0,0,0,0,6,0,0,0,11,IFNGR2,0.39,1.0428,0.35114,4,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease,R-HSA-1280215;R-HSA-168256;R-HSA-1643685
ENSG00000159640,9,4,1,1,1,1,1321.7688442211056,765591.3646788632,2018-08-13,0,0,0,0,5,2,0,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,3,22,ACE,0.120000005,-0.50314,-1.678,1,0.5,0.0,,
ENSG00000160161,4,4,0,0,0,1,5475.33700166113,521818.7070055739,2020-04-13,1,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,CILP2,-0.329,-1.641,-2.1536,0,0.5,0.5,,
ENSG00000160683,6,4,0,0,0,1,2209.8301559792026,38092.548464040476,2012-11-01,5,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,8,CXCR5,-0.28999996,2.8258,0.30129,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000161179,7,4,1,0,1,1,19008.705439555517,29624.432449478358,2011-02-24,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,3,0,0,1,7,YDJC,-0.926,-1.396,-1.7048,0,-1.0,0.0,,
ENSG00000161905,9,4,0,0,1,1,11380.153347883632,322220.1169395476,2018-08-13,8,0,0,0,0,0,0,0,0,0,7,0,0,0,2,0,0,0,0,0,0,0,6,23,ALOX15,-0.116999984,0.52454,0.17804,10,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Synthesis of Leukotrienes (LT) and Eoxins (EX);Signaling by Interleukins;Arachidonate metabolism;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-2142691;R-HSA-449147;R-HSA-2142753;R-HSA-6785807
ENSG00000161955,7,4,1,1,1,1,4293.955119214586,29997.958300125974,2011-12-25,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,8,TNFSF13,0.148,0.66607,0.54553,2,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;HuR (ELAVL1) binds and stabilizes mRNA,R-HSA-1280215;R-HSA-168256;R-HSA-450520
ENSG00000162302,6,4,1,0,1,1,5426.200199914322,355284.1215006515,2011-03-13,7,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,10,RPS6KA4,0.37300003,1.7931,-0.92268,1,0.5,-1.0,Developmental Biology;Recycling pathway of L1,R-HSA-1266738;R-HSA-437239
ENSG00000162337,4,4,0,0,1,1,41969.662606944315,191895.42310022408,2018-08-29,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6,3,0,1,11,LRP5,0.518,3.7149,1.2506,6,0.5,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000162576,5,4,1,1,0,0,42879.69557188197,251325.91086204,2023-01-18,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,2,5,MXRA8,-0.61099994,-3.2361,-4.2544,2,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000162598,4,4,0,0,1,1,123127.18790121445,360605.992793193,2019-02-25,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,4,C1orf87,-0.15499997,-0.083621,0.14031,0,1.0,0.5,,
ENSG00000162676,5,4,1,0,0,1,36204.236233123425,574170.6270919729,2013-11-01,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,1,0,0,0,0,4,GFI1,0.28500003,0.70931,-0.24767,1,0.75,0.0,Developmental Biology,R-HSA-1266738
ENSG00000162804,5,4,1,1,1,1,116388.33957200912,414433.58532016096,2023-01-18,0,0,0,2,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,5,SNED1,0.334,2.116,-0.17649,0,-1.0,-1.0,,
ENSG00000163110,6,4,1,0,1,1,51573.04760983911,521818.7070055739,2020-12-08,17,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,21,PDLIM5,0.092999995,0.55162,0.6631,1,0.75,-1.0,,
ENSG00000163344,4,4,1,1,0,1,95905.57783546533,220837.49604317299,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,4,PMVK,0.13099998,0.7558,-0.32185,2,-1.0,-1.0,Cholesterol biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-191273;R-HSA-8957322;R-HSA-1655829
ENSG00000163431,6,4,1,1,1,0,95776.89591443514,461914.58891516324,2017-12-06,0,0,0,0,4,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,7,LMOD1,0.621,2.0196,0.64069,1,0.5,0.0,,
ENSG00000163468,4,4,1,0,1,1,79958.75176875875,1470466.6505612188,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,2,5,CCT3,0.718,1.4302,1.2027,6,-1.0,-1.0,Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;BBSome-mediated cargo-targeting to cilium;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Cargo trafficking to the periciliary membrane,R-HSA-389957;R-HSA-389958;R-HSA-5620922;R-HSA-6814122;R-HSA-5620920
ENSG00000163513,5,4,1,0,0,1,6170.33304373009,360605.992793193,2012-06-10,2,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,9,TGFBR2,0.46899998,2.9468,0.11457,10,-1.0,-1.0,Signal Transduction;Disease;TGFBR1 KD Mutants in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;TGFBR3 regulates TGF-beta signaling;Diseases of signal transduction by growth factor receptors and second messengers;Loss of Function of SMAD2/3 in Cancer;Loss of Function of TGFBR1 in Cancer;Post-translational protein modification,R-HSA-162582;R-HSA-1643685;R-HSA-3656532;R-HSA-3304356;R-HSA-9839389;R-HSA-5663202;R-HSA-3304349;R-HSA-3656534;R-HSA-597592
ENSG00000163584,4,4,0,0,0,1,15223.454539395489,1129585.974638378,2022-07-14,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,3,6,RPL22L1,-0.79700005,0.30846,-0.28444,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000163687,6,4,0,0,1,1,3401.856738515132,116089.30071075787,2014-01-02,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,4,0,0,0,7,DNASE1L3,-0.12199998,0.33991,0.39569,0,0.75,0.0,,
ENSG00000163902,5,4,1,1,0,1,5691.114246503779,235397.69820205137,2018-08-13,5,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,14,RPN1,0.698,1.0452,-0.070007,3,-1.0,-1.0,Disease;Translation;SRP-dependent cotranslational protein targeting to membrane;Post-translational protein modification,R-HSA-1643685;R-HSA-72766;R-HSA-1799339;R-HSA-597592
ENSG00000163947,7,4,1,0,0,1,11608.613380386345,414433.58532016096,2021-02-24,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,4,0,0,1,11,ARHGEF3,0.40899998,1.9876,-0.1543,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000164308,6,4,1,1,1,1,9724.911607071434,427337.4491868293,2010-11-21,0,0,0,0,2,0,0,0,1,0,0,0,1,0,0,0,0,0,0,8,0,0,0,12,ERAP2,-0.28400004,0.15583,0.15633,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000164342,6,4,0,1,1,1,116089.30071075787,381165.6245253304,2020-06-24,2,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,0,0,0,1,0,0,0,13,TLR3,0.204,1.3402,0.61925,13,-1.0,0.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000164535,5,4,1,0,1,1,87248.80974040499,782476.8109259979,2023-01-18,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,5,DAGLB,-0.12100005,-1.8376,-1.2,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000165066,6,4,1,0,0,1,38886.589732507324,1778690.168860174,2016-01-28,0,0,0,1,0,20,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,24,NKX6-3,-0.24000001,-0.37791,-0.71316,0,0.75,0.5,,
ENSG00000165406,5,4,1,0,1,1,29220.636636952502,301203.06999851385,2014-09-14,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,3,14,MARCHF8,-0.0010000467,0.60326,0.71652,0,-1.0,-1.0,,
ENSG00000165899,5,4,0,0,1,0,7210.189329942696,287644.60739043093,2021-10-07,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,3,0,0,0,0,1,3,13,OTOGL,-0.069000006,-1.0765,-1.0614,1,0.75,0.5,,
ENSG00000166822,7,4,1,0,0,1,8479.376416968564,197485.87952538437,2017-09-07,0,0,0,0,4,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,8,TMEM170A,-0.90900004,-1.0313,-1.9455,0,-1.0,-1.0,,
ENSG00000167074,5,4,1,1,0,1,1455.4894671623297,562534.7696387965,2012-05-06,0,0,0,0,0,0,0,0,1,0,5,0,0,0,1,0,0,0,0,0,0,0,1,8,TEF,0.611,1.7296,-0.41688,0,-1.0,0.0,,
ENSG00000167080,4,4,0,0,1,1,32555.310754135273,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,1,4,B4GALNT2,-0.11199999,0.97131,0.43938,2,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000167165,6,4,1,1,1,1,19162.51676090521,134159.95265752633,2018-11-30,1,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,7,UGT1A6,0.075999975,0.15416,0.84361,3,0.75,0.0,Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000167232,5,4,1,0,1,1,16716.61368728359,287644.60739043093,2021-10-07,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,0,0,2,3,9,ZNF91,-0.13999999,1.5049,-0.10435,0,-1.0,-1.0,,
ENSG00000167553,5,4,1,0,1,1,13274.571243943194,521818.7070055739,2011-07-10,13,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1,16,TUBA1C,0.31199998,3.9863,1.3848,31,0.5,-1.0,Signal Transduction;Post-chaperonin tubulin folding pathway;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Prefoldin mediated transfer of substrate  to CCT/TriC;Gap junction assembly;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Disease;Aggrephagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Intraflagellar transport;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Recycling pathway of L1;Carboxyterminal post-translational modifications of tubulin;Gap junction trafficking and regulation;Kinesins;Gap junction trafficking;Post-translational protein modification,R-HSA-162582;R-HSA-389977;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-389957;R-HSA-190861;R-HSA-389958;R-HSA-1643685;R-HSA-9646399;R-HSA-9668328;R-HSA-5620924;R-HSA-8856688;R-HSA-6811434;R-HSA-437239;R-HSA-8955332;R-HSA-157858;R-HSA-983189;R-HSA-190828;R-HSA-597592
ENSG00000167653,14,4,1,1,0,1,3980.620486431807,301203.06999851385,2010-10-24,13,0,0,0,0,0,15,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,30,PSCA,-0.865,-0.78981,-0.1686,1,1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000167772,12,4,0,1,1,1,20307.85640079949,804063.9714459113,2017-12-06,0,0,0,0,11,3,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,6,25,ANGPTL4,-0.48099995,-0.4037,-0.8283,5,0.5,0.0,Developmental Biology;Gene expression (Transcription);Plasma lipoprotein remodeling,R-HSA-1266738;R-HSA-74160;R-HSA-8963899
ENSG00000168621,4,4,0,0,0,1,100857.20347685824,1424218.0900670097,2018-08-13,1,0,0,0,0,1,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,7,GDNF,0.27499998,0.89618,-0.12647,4,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000168884,5,4,1,0,0,1,50072.877304794354,124837.11004999638,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,1,4,TNIP2,-0.17400002,-1.12,-1.4775,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-597592
ENSG00000169031,15,4,1,0,1,1,4588.845427996078,111599.28184123649,2019-09-19,0,0,0,10,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,3,0,0,6,24,COL4A3,0.291,2.4627,1.3399,13,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000169174,23,4,1,1,1,1,6040.069513406157,502231.5406594711,2009-02-08,0,0,0,0,43,0,0,0,0,0,0,0,0,0,0,0,0,0,10,20,0,0,36,109,PCSK9,-0.25,0.58699,0.12791,4,1.0,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000169231,5,4,1,0,1,1,17601.10520641419,931858.935708564,2018-08-13,2,10,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,14,THBS3,0.25300002,2.5592,1.807,1,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000169436,7,4,0,0,0,1,11479.806667658058,73410.36533319784,2018-08-13,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,13,COL22A1,-0.004999995,-0.72286,-2.1974,2,1.0,0.0,,
ENSG00000169604,9,4,0,0,0,1,13883.57970142381,427337.4491868293,2018-08-13,2,0,0,7,3,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,15,ANTXR1,0.65400004,2.8739,-0.22095,1,-1.0,0.0,Disease,R-HSA-1643685
ENSG00000170175,4,4,1,0,0,1,64514.85721423125,329504.3397029431,2021-11-04,0,0,0,0,0,0,2,0,0,0,0,0,3,0,0,0,0,0,0,0,0,1,1,7,CHRNB1,-0.04700005,1.2258,0.5879,0,0.5,-1.0,,
ENSG00000170500,6,4,1,0,0,1,4917.108320036471,1470466.6505612188,2018-03-08,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,1,0,0,0,0,0,2,7,LONRF2,0.08399999,-0.25888,-2.1951,0,0.5,0.0,,
ENSG00000170615,7,4,0,0,1,1,155978.81883421048,404399.6052088398,2021-06-09,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,7,0,0,2,0,0,1,11,SLC26A5,0.23500001,2.0746,0.70838,1,,,,
ENSG00000170959,5,4,1,0,1,1,97181.90375256384,1990918.947961699,2021-05-27,0,0,0,1,1,0,0,0,0,0,0,0,3,0,0,0,2,0,0,0,0,0,0,7,DCDC1,-0.093000054,-0.3928,-0.12053,0,0.5,0.5,,
ENSG00000171055,5,4,1,0,1,1,69453.1498757531,672632.4785173276,2021-04-22,0,0,0,0,4,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,8,FEZ2,-0.896,-3.7795,-3.2859,0,-1.0,-1.0,,
ENSG00000171385,7,4,1,0,0,1,14044.7361070413,1424218.0900670097,2017-04-17,0,0,0,0,22,1,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,26,KCND3,0.697,4.8878,0.97721,2,0.5,0.0,,
ENSG00000171408,5,4,1,0,0,1,9633.181385755513,1129585.974638378,2020-01-20,0,0,0,10,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,1,13,PDE7B,0.208,1.2016,0.38961,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000171467,5,4,1,0,0,1,152668.76993812367,756470.9740366563,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,2,1,0,0,0,3,0,0,0,0,0,0,7,ZNF318,0.45499998,0.35232,-0.57815,0,-1.0,-1.0,,
ENSG00000172733,4,4,0,0,0,1,227570.98695011192,1778690.168860174,2018-07-27,0,0,0,0,4,5,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,13,PURG,0.675,1.3128,-0.19878,0,0.5,0.5,,
ENSG00000172890,4,4,1,0,1,1,13219.952617929488,426392.4103859523,2013-11-01,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,0,0,0,2,6,NADSYN1,-0.00999999,1.1789,-0.18989,1,-1.0,-1.0,,
ENSG00000172922,5,4,1,0,0,1,30311.18982428984,334911.3573752668,2019-05-31,0,0,0,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,2,0,0,1,8,RNASEH2C,-0.755,-1.4882,-0.57911,0,-1.0,-1.0,,
ENSG00000172987,4,4,1,0,0,1,144102.0022515395,360605.992793193,2016-06-20,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,6,HPSE2,0.16299999,0.61691,0.14122,1,0.5,0.0,Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1638091
ENSG00000173120,6,4,0,0,0,1,111071.83376541243,714039.8414241908,2021-01-04,3,0,0,0,0,0,0,0,2,0,0,0,4,0,0,0,0,0,0,0,0,0,2,11,KDM2A,0.943,6.9151,1.2304,1,-1.0,-1.0,,
ENSG00000173442,6,4,1,0,1,1,136288.48249759385,394357.452283155,2017-12-06,0,0,0,0,4,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,3,9,EHBP1L1,-0.062000036,-1.2209,-2.6126,0,0.5,0.0,,
ENSG00000174136,4,4,1,1,0,1,12724.75719835148,672632.4785173276,2021-04-22,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,5,RGMB,0.07499999,1.2398,0.44886,1,-1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000174177,5,4,1,0,1,1,1173.5007132667617,500292.45069431677,2018-08-13,0,0,0,0,2,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,13,CTU2,-0.53499997,-5.9994,-6.3968,1,-1.0,-1.0,,
ENSG00000174891,12,4,1,0,0,1,167055.73472660675,1122672.658801146,2018-04-26,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,0,0,1,0,0,1,14,RSRC1,-0.263,-0.1105,-0.76858,0,-1.0,-1.0,,
ENSG00000174945,4,4,1,0,0,1,11515.948996192528,515513.2178404211,2019-02-25,0,0,0,0,0,1,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,6,AMZ1,-0.88,-5.6773,-5.2894,0,1.0,1.0,,
ENSG00000175220,5,4,1,0,0,1,37366.49760007264,713911.8939045856,2019-11-18,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,5,ARHGAP1,0.399,1.5567,0.9078,13,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000176204,5,4,0,0,0,1,1173.5007132667617,1778690.168860174,2013-12-25,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,4,0,0,0,0,0,0,7,LRRTM4,0.30699998,1.4613,-0.82155,1,0.75,0.5,,
ENSG00000177352,5,4,1,0,1,1,161053.42428938235,756470.9740366563,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,1,0,5,CCDC71,-0.13499999,0.58486,-0.012601,0,-1.0,-1.0,,
ENSG00000177565,12,4,1,0,1,1,1586.874773139746,562534.7696387965,2019-03-28,1,0,0,0,0,0,0,0,1,0,16,0,0,0,0,0,5,0,0,0,0,0,0,23,TBL1XR1,0.826,5.2951,-0.30009,20,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-8957322;R-HSA-1655829;R-HSA-5663202
ENSG00000177951,6,4,1,0,0,1,11117.043488061146,239970.53614968536,2018-08-13,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,8,BET1L,-0.66199994,0.017128,-0.13083,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000178053,7,4,1,0,0,1,5602.666666666667,1778690.168860174,2016-08-01,1,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,7,MLF1,-0.25800002,0.50925,0.937,0,0.5,-1.0,,
ENSG00000179348,4,4,1,0,1,1,13785.673050095118,521818.7070055739,2018-08-13,13,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,21,GATA2,0.66499996,1.7347,-1.0437,3,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000179562,6,4,1,0,0,1,17534.246691821227,254373.32653042395,2011-12-11,0,0,0,0,0,4,3,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,9,GCC1,0.27600002,1.3004,0.50261,1,-1.0,-1.0,,
ENSG00000179603,4,4,0,0,0,1,1173.5007132667617,405722.3511294316,2019-09-16,0,0,0,1,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,7,GRM8,0.31300002,1.3658,0.56732,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000181143,5,4,1,1,0,1,3767.3530221234255,562534.7696387965,2019-03-28,0,1,0,0,0,0,0,0,0,0,12,0,0,0,0,0,1,0,0,0,0,0,1,15,MUC16,0.213,-4.9527,-3.0519,6,0.75,0.5,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000181449,6,4,0,0,0,1,57530.63913504606,311608.0072964156,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,11,0,0,3,16,SOX2,0.698,2.9769,-0.26656,12,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-449147;R-HSA-6785807
ENSG00000182255,6,4,0,0,0,1,63200.72664467542,1076472.0138856068,2019-06-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,1,2,7,KCNA4,0.727,2.7238,-0.6455,1,0.5,0.5,,
ENSG00000182446,4,4,1,0,0,1,14656.210545721095,274828.8365545636,2021-06-14,2,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,10,NPLOC4,0.574,2.6541,-0.93339,3,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000182621,4,4,1,0,0,1,66821.18426408028,358386.30063935445,2018-08-13,0,1,0,0,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,8,PLCB1,0.643,3.7087,-0.012392,8,0.5,-1.0,Signal Transduction;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Presynaptic function of Kainate receptors;G beta:gamma signalling through PLC beta;Free fatty acids regulate insulin secretion;Acetylcholine regulates insulin secretion;Activation of kainate receptors upon glutamate binding;G-protein beta:gamma signalling,R-HSA-162582;R-HSA-434316;R-HSA-500657;R-HSA-418217;R-HSA-400451;R-HSA-399997;R-HSA-451326;R-HSA-397795
ENSG00000183137,5,4,0,0,0,0,22541.66311868015,298504.9722193353,2013-04-01,4,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,7,CEP57L1,0.051,1.483,0.89995,0,-1.0,-1.0,,
ENSG00000183166,7,4,0,0,0,1,53182.30026560605,323648.5577791949,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,0,1,2,8,CALN1,0.102,1.2337,-1.0145,0,0.5,0.5,,
ENSG00000183475,5,4,0,0,0,1,101825.50588235294,414433.58532016096,2023-01-18,0,0,0,6,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,9,ASB7,0.723,4.2943,-0.40492,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000183621,5,4,1,0,0,1,38092.548464040476,124837.11004999638,2019-09-01,2,0,0,0,0,0,0,0,0,0,0,0,6,0,1,0,0,0,0,0,0,0,1,10,ZNF438,0.11799997,0.55806,0.5505,0,-1.0,-1.0,,
ENSG00000183742,4,4,0,0,0,1,46437.13674418605,521818.7070055739,2023-01-18,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,5,MACC1,-0.29900002,-0.83645,0.039074,0,0.5,0.0,,
ENSG00000183955,7,4,1,0,0,1,69915.00897904889,281258.82202219026,2022-10-12,0,0,0,0,0,0,0,1,0,0,2,0,3,0,0,0,0,0,0,0,0,0,2,8,KMT5A,0.686,2.2717,0.5366,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Condensation of Prophase Chromosomes,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-2299718
ENSG00000184220,5,4,0,0,0,1,72982.48880358285,397765.9672627851,2023-01-18,0,0,0,1,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,1,5,CMSS1,-0.021000028,0.42162,1.1241,0,-1.0,-1.0,,
ENSG00000184304,6,4,1,0,0,1,80746.41870861933,1424218.0900670097,2014-07-22,0,0,0,0,2,5,0,0,0,0,0,2,0,0,0,0,3,0,0,0,0,0,0,12,PRKD1,0.23799998,0.97306,-0.30835,1,-1.0,0.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000184305,4,4,0,0,0,1,40728.325602713354,1076472.0138856068,2020-06-15,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,5,CCSER1,0.41000003,-0.14238,-0.64954,0,0.5,0.5,,
ENSG00000184374,5,4,0,0,0,1,30508.10029756623,120940.93870730935,2019-06-07,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,5,COLEC10,-0.08200002,0.24254,-0.042065,2,1.0,0.5,Immune System,R-HSA-168256
ENSG00000184677,12,4,0,0,0,1,2630.136511375948,473900.221403792,2011-02-06,5,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,15,0,0,1,31,ZBTB40,0.397,2.7088,1.9045,0,-1.0,-1.0,,
ENSG00000184903,11,4,1,0,0,1,1173.5007132667617,1778690.168860174,2018-02-26,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,8,0,0,1,0,0,0,11,IMMP2L,-0.758,-0.32016,0.45707,0,-1.0,-1.0,,
ENSG00000185013,5,4,1,0,1,1,100857.20347685824,182108.85640724926,2018-08-13,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,7,NT5C1B,0.04699999,0.027955,0.11853,1,1.0,0.5,Purine catabolism;Metabolism of nucleotides,R-HSA-74259;R-HSA-15869
ENSG00000185022,11,4,1,0,0,1,5269.58845172284,1424218.0900670097,2022-06-23,11,0,0,0,0,1,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,MAFF,-0.95299995,0.087296,-1.0859,1,-1.0,-1.0,,
ENSG00000185053,10,4,0,0,0,1,95776.89591443514,1778690.168860174,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,1,0,0,0,6,0,0,0,0,0,2,13,SGCZ,-0.33200002,-3.7968,-3.2746,1,0.5,1.0,,
ENSG00000185658,10,4,1,0,1,1,87748.84971094332,756470.9740366563,2021-08-24,0,0,0,0,10,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,13,BRWD1,0.553,3.3693,0.16006,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000186205,4,4,0,0,1,1,51869.929302754055,384314.83364002535,2023-01-18,3,0,0,0,0,0,5,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,11,MTARC1,-0.23000002,-0.41553,-0.80862,1,0.5,-1.0,,
ENSG00000186645,8,4,1,0,0,1,61498.92173410762,1470466.6505612188,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,7,0,0,0,0,0,5,0,0,0,3,17,SPDYE17,,,,0,,,,
ENSG00000186687,4,4,1,0,0,1,62507.19385670474,235397.69820205137,2021-09-30,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,4,7,LYRM7,-0.89199996,-1.1113,-0.31643,1,0.5,-1.0,,
ENSG00000186767,6,4,0,0,0,1,58392.07057732553,298878.49542603496,2013-12-25,1,0,0,0,2,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,7,SPIN4,,,,0,-1.0,0.0,,
ENSG00000186889,5,4,1,0,0,1,2222.3233132932532,278190.43024910334,2012-03-08,15,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,19,TMEM17,-0.29499996,-0.25519,-0.58951,0,-1.0,0.0,,
ENSG00000187091,9,4,1,0,1,1,10699.7425376247,1470466.6505612188,2018-08-13,5,0,0,0,0,0,0,0,8,0,0,0,3,0,0,0,0,0,0,0,0,0,3,19,PLCD1,0.046000004,1.9691,1.7941,1,-1.0,-1.0,,
ENSG00000187446,4,4,1,0,0,1,51964.39839555753,219793.50457789513,2019-10-24,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,4,CHP1,0.30900002,1.8604,-0.17147,1,-1.0,-1.0,Hyaluronan degradation,R-HSA-2160916
ENSG00000187498,20,4,1,1,0,1,6356.593451690605,502231.5406594711,2015-09-07,1,0,0,4,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,89,COL4A1,0.76199996,4.9877,-0.081603,14,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000187664,6,4,0,0,0,1,15491.517664847557,314267.0072815654,2023-01-18,0,0,0,1,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,6,HAPLN4,-0.08399999,-0.99488,-1.2906,0,0.75,0.5,,
ENSG00000187720,9,4,1,0,0,1,6356.593451690605,414433.58532016096,2017-02-06,0,0,0,2,1,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,3,18,THSD4,0.273,-0.055119,0.1433,2,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000188389,5,4,1,1,0,1,9080.538589728061,562534.7696387965,2019-03-28,0,0,0,0,0,0,0,0,2,0,5,0,0,0,0,0,0,0,0,1,0,0,1,9,PDCD1,0.10900003,1.421,-0.021219,2,0.5,0.5,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000188467,9,4,0,0,1,1,4418.329808439475,431284.57934287674,2023-01-18,11,0,0,5,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,19,SLC24A5,-0.16199994,0.82507,0.080507,2,1.0,0.5,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000188738,5,4,0,0,1,1,21201.639474894007,95776.89591443514,2022-06-28,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,FSIP2,0.218,2.1642,2.5075,0,0.75,0.5,,
ENSG00000188897,8,4,1,0,1,1,104829.95456615865,360837.067725683,2017-10-30,0,0,0,0,0,0,1,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,2,6,ENSG00000188897,-0.75399995,-5.401,-4.6457,0,0.5,0.0,,
ENSG00000188981,4,4,1,0,0,1,58427.61478235146,338763.57771536184,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,1,0,0,1,0,5,MSANTD1,0.26700002,-0.11522,-0.57282,0,0.5,0.5,,
ENSG00000189079,4,4,0,0,0,1,190279.23963861223,765591.3646788632,2020-06-15,0,0,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,4,ARID2,0.776,4.4902,-0.41966,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000196141,9,4,1,0,0,1,32996.93546153374,756470.9740366563,2018-06-11,0,0,0,0,23,0,0,0,0,0,1,0,0,0,0,0,6,0,0,1,0,0,0,31,SPATS2L,0.278,1.089,0.42099,0,-1.0,-1.0,,
ENSG00000196296,5,4,1,0,0,1,46536.46918214105,1424218.0900670097,2020-06-15,0,2,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,7,ATP2A1,0.11900002,2.9172,1.2638,4,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000196352,8,4,1,0,0,1,19943.263992703425,378712.0243337037,2022-07-13,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,4,8,CD55,-0.23399997,0.32192,-0.62013,4,-1.0,-1.0,Signal Transduction;Immune System;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-597592
ENSG00000196353,6,4,1,0,0,1,118061.55082048493,1424218.0900670097,2020-06-15,0,0,0,0,1,6,0,0,0,0,1,0,0,0,0,0,0,0,4,0,0,0,0,12,CPNE4,0.45999998,3.2422,0.45748,0,0.75,0.5,,
ENSG00000196391,4,4,1,0,1,1,38092.548464040476,124837.11004999638,2019-09-01,0,0,0,0,1,0,0,0,0,0,0,0,2,0,1,0,0,0,0,1,0,0,0,5,ZNF774,-0.645,0.29163,1.072,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000196576,6,4,1,1,1,1,133918.94977035935,367949.31877243903,2020-04-27,3,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,7,PLXNB2,0.45499998,3.4743,-1.8572,0,-1.0,-1.0,,
ENSG00000196620,6,4,1,0,0,1,122088.395356851,464892.4593283075,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,1,0,0,2,6,UGT2B15,-0.102,-0.42532,-0.60178,3,0.75,0.5,Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000196748,4,4,0,0,0,1,83932.6290685273,464892.4593283075,2020-12-11,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,4,CLPSL2,-0.35599995,-0.58415,-2.0203,0,1.0,0.5,,
ENSG00000196990,7,4,0,0,0,1,54250.06986981613,539013.8231881644,2018-08-13,2,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,3,0,0,0,0,0,1,8,FAM163B,-0.56500006,-0.33854,-0.63143,0,1.0,0.5,,
ENSG00000197134,5,4,1,0,0,1,32705.240805002948,383158.3001114715,2019-02-04,3,0,0,0,1,7,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,12,ZNF257,-0.63399994,1.2621,1.3208,2,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of endogenous retroelements by KRAB-ZFP proteins,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9843940
ENSG00000197457,10,4,1,0,0,1,22540.468794299068,433862.5685735124,2020-04-27,10,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,13,STMN3,-0.847,-1.2883,-2.2122,0,0.5,-1.0,,
ENSG00000197461,7,4,1,0,0,1,13883.57970142381,180089.50342935527,2018-08-13,2,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,3,0,0,2,14,PDGFA,0.63600004,0.73223,-1.2473,9,0.5,-1.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000197635,7,4,1,0,0,1,74207.71608321255,323648.5577791949,2020-04-15,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,3,0,0,0,0,0,3,9,DPP4,0.09899998,0.6449,-0.017774,2,0.5,0.0,,
ENSG00000197757,4,4,1,0,0,1,93132.96870045633,500292.45069431677,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,6,HOXC6,0.32999998,1.391,0.71008,0,0.5,0.0,,
ENSG00000197872,11,4,1,0,0,1,2201.7501988862373,1470466.6505612188,2017-01-04,5,0,0,0,0,5,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,7,18,CYRIA,0.385,2.6696,0.94455,0,0.5,-1.0,,
ENSG00000198056,5,4,1,0,1,1,47450.88644524237,1424218.0900670097,2020-06-08,4,0,0,0,0,3,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,11,PRIM1,0.176,1.2394,-0.48029,9,0.5,-1.0,E2F mediated regulation of DNA replication;Inhibition of replication initiation of damaged DNA by RB1/E2F1;Disease,R-HSA-113510;R-HSA-113501;R-HSA-1643685
ENSG00000198121,5,4,1,0,1,1,21014.7618737575,205425.60717824215,2018-12-03,1,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,4,LPAR1,0.611,3.213,0.59658,3,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000198408,6,4,0,1,0,1,25967.06754524981,232656.1405260205,2018-06-11,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,1,7,OGA,0.68,3.5563,-0.75682,0,-1.0,-1.0,,
ENSG00000198561,10,4,1,0,0,1,64507.782812759775,1076472.0138856068,2019-02-04,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,6,1,0,1,0,0,0,11,CTNND1,0.81299996,2.7344,0.80449,6,-1.0,-1.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1643685;R-HSA-9006934
ENSG00000198646,6,4,1,0,0,1,48007.02989015681,782476.8109259979,2017-12-06,0,0,0,0,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,7,NCOA6,0.64100003,3.0424,1.1942,14,-1.0,-1.0,Developmental Biology;Gene expression (Transcription);Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-1266738;R-HSA-74160;R-HSA-8957322;R-HSA-1655829
ENSG00000198719,6,4,0,1,0,1,25056.289178133135,223386.61486493575,2011-09-29,0,0,0,10,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,14,DLL1,0.764,1.5314,-2.173,12,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000203747,4,4,0,0,1,1,1177.0449205252246,207559.43508869337,2013-07-03,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,4,FCGR3A,-0.011999965,0.84666,0.57475,6,0.5,-1.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000203963,6,4,1,0,0,1,2506.878320343566,58331.23271678036,2011-10-23,0,2,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,2,0,0,1,10,C1orf141,-0.895,0.067271,0.25611,0,0.5,0.5,,
ENSG00000204381,6,4,1,0,0,1,76983.04900783773,322220.1169395476,2018-05-21,0,0,0,0,0,0,0,0,1,0,4,0,0,0,2,0,0,0,0,0,0,0,3,10,LAYN,-0.08200002,-0.022461,0.30978,0,-1.0,0.0,,
ENSG00000205403,9,4,1,1,1,0,2489.748511904762,378712.0243337037,2010-04-12,0,3,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,1,24,CFI,-0.075999975,0.28073,-0.20028,1,1.0,0.0,Immune System,R-HSA-168256
ENSG00000213221,5,4,1,0,0,1,18574.759037493004,136025.05987988086,2013-07-01,0,2,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,6,DNLZ,-0.95500004,-1.5426,-2.0246,0,-1.0,0.0,,
ENSG00000214078,5,4,1,0,1,1,8224.790081005125,282369.4803133209,2020-02-11,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,5,CPNE1,-0.011999965,0.67652,1.2568,2,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000214595,5,4,1,0,0,1,48345.89330777902,220320.9576294899,2018-11-28,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,1,6,EML6,0.274,-2.9156,-3.789,0,0.5,0.0,,
ENSG00000221843,4,4,0,0,0,1,21939.796916619583,294387.2978738704,2020-05-06,0,0,1,0,0,4,0,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,9,SPATA31H1,-0.78900003,2.4229,1.4687,0,0.75,0.5,,
ENSG00000226124,10,4,1,0,0,1,114817.16866287061,645988.1975077938,2018-10-03,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,4,0,0,1,0,0,0,7,FTCDNL1,,,,0,-1.0,0.0,,
ENSG00000233276,5,4,1,0,0,1,78751.06843456876,715125.8126650311,2021-11-02,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,2,0,0,1,5,GPX1,-0.38,0.13169,-0.76477,4,-1.0,-1.0,Arachidonate metabolism,R-HSA-2142753
ENSG00000241058,10,4,0,0,0,1,46059.65662231034,633132.2332759313,2018-08-13,0,0,2,0,5,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,0,11,NSUN6,-0.546,-1.2071,-0.076774,1,0.5,-1.0,,
ENSG00000260456,5,4,0,0,0,1,6067.527905738457,356440.71671986027,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,2,0,0,2,8,C16orf95,-0.694,-1.72,-1.0774,0,1.0,0.0,,
ENSG00000266472,5,4,1,0,0,1,916.5288107887209,1990918.947961699,2015-10-19,0,0,0,0,3,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,6,MRPS21,-0.60899997,0.49839,0.13097,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000273540,5,4,0,0,0,1,279825.00883385167,498258.534626183,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,1,4,AGBL1,-0.31299996,-2.6251,-1.8073,1,0.75,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000293569,5,4,0,0,0,1,2325.5337209302324,39507.00295325707,2011-05-29,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,4,ENSG00000293569,,,,0,,,,
ENSG00000000457,3,3,0,0,1,1,14424.741402471152,303059.79257468163,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,5,SCYL3,0.334,1.446,1.0769,0,-1.0,-1.0,,
ENSG00000005243,3,3,1,0,0,1,155978.81883421048,189845.9324918578,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,3,COPZ2,-0.36699998,-0.11289,0.42463,2,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000006016,3,3,1,0,0,1,178948.78717378277,256331.89034791503,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,3,CRLF1,-0.044999957,0.52571,-0.24105,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000007341,4,3,1,0,0,1,1764.0167799089645,180344.38517486732,2020-01-20,1,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,ST7L,0.037999988,1.7886,0.81116,0,1.0,-1.0,,
ENSG00000019505,4,3,1,0,0,1,35292.77048385347,1778690.168860174,2019-11-18,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,4,0,0,0,0,0,0,7,SYT13,0.22299999,0.78116,-0.26832,0,0.5,0.0,,
ENSG00000031081,4,3,0,0,0,0,11252.882952659449,38054.41297287997,2011-11-06,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,4,ARHGAP31,0.62,2.7098,1.6132,4,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000032219,4,3,1,0,1,1,259002.9318385734,1424218.0900670097,2020-06-15,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,5,ARID4A,0.661,1.6165,0.45161,2,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000043355,4,3,0,0,0,1,63200.72664467542,326545.22790564946,2022-07-13,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,6,ZIC2,0.48000002,0.46995,-3.5961,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000054793,4,3,1,0,0,1,89519.16315227402,414433.58532016096,2021-11-04,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,2,5,ATP9A,0.54499996,4.5023,-0.19705,1,0.5,-1.0,,
ENSG00000054938,7,3,1,1,0,1,45736.28457081111,110317.46949935023,2019-05-14,6,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,8,CHRDL2,0.0059999824,0.75831,0.33138,0,0.5,0.0,,
ENSG00000061492,5,3,1,0,0,1,55315.825152625155,1424218.0900670097,2017-04-17,0,0,0,0,9,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,WNT8A,-0.052000046,1.5214,0.44839,4,,,Signal Transduction,R-HSA-162582
ENSG00000064787,7,3,1,0,0,1,11330.61429528453,521818.7070055739,2021-01-04,6,0,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,1,0,0,0,0,18,BCAS1,0.14499998,0.13098,0.32698,0,1.0,0.0,,
ENSG00000070718,3,3,1,0,0,1,64245.57828610605,306980.8575290048,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,AP3M2,0.14200002,1.8602,0.11239,0,-1.0,-1.0,,
ENSG00000072694,3,3,1,1,0,1,5640.466626325344,28863.30790298137,2021-02-03,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,3,FCGR2B,0.004999995,1.4391,1.3262,1,1.0,-1.0,Immune System,R-HSA-168256
ENSG00000074370,4,3,1,0,0,1,260210.21963428933,713911.8939045856,2022-11-03,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,ATP2A3,0.241,2.0809,-0.14466,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000078747,4,3,1,0,0,0,26667.58037719927,260210.21963428933,2020-09-04,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,ITCH,0.657,4.361,0.58067,10,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Downregulation of ERBB4 signaling;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-1253288;R-HSA-9006934
ENSG00000079263,9,3,1,0,0,1,1494.9871332990222,135108.48254553688,2008-08-31,11,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,5,0,0,0,18,SP140,0.255,2.2313,0.72741,0,0.75,0.0,,
ENSG00000082641,4,3,1,0,0,1,3769.2547642928785,515513.2178404211,2012-09-04,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,0,5,NFE2L1,0.583,2.2227,0.14092,0,0.5,-1.0,,
ENSG00000083307,4,3,0,0,0,1,68837.80679818468,203090.6413944402,2020-05-18,1,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,4,GRHL2,0.633,2.2946,0.14845,0,0.5,0.0,,
ENSG00000084731,4,3,1,0,0,1,42362.45324254164,765591.3646788632,2018-06-11,1,0,0,0,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,KIF3C,0.73399997,3.5249,1.4287,4,1.0,0.0,Immune System;Intraflagellar transport;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-168256;R-HSA-5620924;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000085831,5,3,0,0,0,1,29890.37750380142,228220.5662976458,2023-01-18,1,0,0,0,3,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,6,TTC39A,0.25,2.1883,0.5467,0,0.5,0.0,,
ENSG00000086062,4,3,1,1,0,1,130873.95073828615,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,6,1,0,0,0,0,0,0,0,0,2,9,B4GALT1,0.26099998,0.89855,-0.77764,8,-1.0,-1.0,Signal Transduction;Interaction With Cumulus Cells And The Zona Pellucida;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Immune System;Fertilization;Disease;Post-translational protein modification,R-HSA-162582;R-HSA-2534343;R-HSA-3656244;R-HSA-168256;R-HSA-1187000;R-HSA-1643685;R-HSA-597592
ENSG00000087128,4,3,0,0,1,1,286678.73247515375,374021.10061973665,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,4,TMPRSS11E,-0.059000015,0.062265,0.77591,0,0.75,0.5,,
ENSG00000088179,3,3,1,0,0,1,13883.57970142381,36494.548446257475,2018-08-13,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,5,PTPN4,0.504,2.322,1.2929,3,-1.0,-1.0,Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins,R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147
ENSG00000090661,3,3,1,0,0,1,134703.04231665854,384314.83364002535,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,1,0,0,0,4,CERS4,-0.472,-0.91299,-0.76197,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000093217,5,3,0,0,1,1,20914.712631588172,138890.6106237268,2018-08-13,2,0,0,0,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,XYLB,-0.054999948,0.056983,0.28809,1,0.5,0.0,,
ENSG00000095383,4,3,1,0,1,1,190279.23963861223,275021.63051358337,2023-01-18,0,0,0,0,0,2,0,0,0,3,0,0,0,0,0,0,0,0,0,1,0,0,0,6,TBC1D2,0.204,1.5579,0.90205,1,-1.0,-1.0,TBC/RABGAPs;Rab regulation of trafficking,R-HSA-8854214;R-HSA-9007101
ENSG00000100359,3,3,1,0,0,1,137776.79053446153,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,3,SGSM3,-0.17499995,-0.036296,-1.6552,0,-1.0,-1.0,,
ENSG00000100364,7,3,1,0,0,1,114942.80121356022,1470466.6505612188,2018-05-08,7,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,10,KIAA0930,0.16299999,1.7201,-1.3655,0,0.5,-1.0,,
ENSG00000100890,4,3,1,0,0,1,76062.08958444146,233499.4066209918,2021-08-26,1,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,2,9,PRORP,0.0009999871,1.1135,1.0094,3,-1.0,-1.0,rRNA processing in the mitochondrion;rRNA processing,R-HSA-8868766;R-HSA-72312
ENSG00000101162,3,3,0,0,1,1,39406.19595155135,107200.17738606388,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,0,0,1,8,TUBB1,-0.58599997,0.8784,0.8655,31,0.5,0.5,Signal Transduction;Post-chaperonin tubulin folding pathway;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Prefoldin mediated transfer of substrate  to CCT/TriC;Gap junction assembly;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Disease;Aggrephagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Intraflagellar transport;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Recycling pathway of L1;Carboxyterminal post-translational modifications of tubulin;Gap junction trafficking and regulation;Kinesins;Gap junction trafficking;Post-translational protein modification,R-HSA-162582;R-HSA-389977;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-389957;R-HSA-190861;R-HSA-389958;R-HSA-1643685;R-HSA-9646399;R-HSA-9668328;R-HSA-5620924;R-HSA-8856688;R-HSA-6811434;R-HSA-437239;R-HSA-8955332;R-HSA-157858;R-HSA-983189;R-HSA-190828;R-HSA-597592
ENSG00000101367,3,3,1,0,0,1,36711.14417421714,466632.7979326389,2018-12-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,MAPRE1,0.624,2.4297,0.038828,14,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000101445,9,3,1,0,0,1,15866.724081734988,633132.2332759313,2014-07-22,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,9,0,0,1,0,0,0,11,PPP1R16B,0.61899996,2.8278,1.4497,0,0.5,0.0,,
ENSG00000101890,4,3,0,0,0,1,25400.368448108824,187203.10687937262,2020-06-08,4,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,7,GUCY2F,,,,1,1.0,1.0,,
ENSG00000102572,3,3,1,0,0,1,115123.9652207147,1424218.0900670097,2019-02-04,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,0,8,STK24,0.468,2.4823,0.73698,2,-1.0,-1.0,,
ENSG00000102755,5,3,0,0,0,1,18394.608190187482,394357.452283155,2017-12-06,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,3,12,FLT1,0.621,2.959,0.032683,2,1.0,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000103035,4,3,0,0,0,1,145320.08042080907,433862.5685735124,2023-01-18,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,3,0,0,0,0,0,0,5,PSMD7,0.324,1.5979,-1.2268,62,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000103126,3,3,1,0,0,1,40939.08484366117,191895.42310022408,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,5,1,0,0,8,AXIN1,0.43699998,0.20333,-1.4556,18,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);APC truncation mutants have impaired AXIN binding;Truncations of AMER1 destabilize the destruction complex;AXIN missense mutants destabilize the destruction complex;Signaling by AMER1 mutants;Signaling by APC mutants;Signaling by AXIN mutants;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-5467337;R-HSA-5467348;R-HSA-5467340;R-HSA-4839748;R-HSA-4839744;R-HSA-4839735;R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000105675,3,3,1,0,0,1,17541.24297681336,178948.78717378277,2021-04-08,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,4,ATP4A,0.19199997,3.4721,0.31081,1,1.0,0.5,,
ENSG00000105717,4,3,0,0,0,1,6628.429524120093,165311.73772118514,2018-08-13,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,PBX4,-0.078999996,0.43632,-0.62556,0,0.5,0.5,,
ENSG00000105849,3,3,0,0,0,1,180344.38517486732,551389.5206213495,2022-02-02,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,1,3,POLR1F,-0.36,-0.1457,-0.12019,5,-1.0,-1.0,RNA Polymerase I Transcription Termination;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance,R-HSA-73863;R-HSA-74160;R-HSA-73772;R-HSA-5250941;R-HSA-427413;R-HSA-73762;R-HSA-73864;R-HSA-73854
ENSG00000106066,11,3,1,1,1,1,22902.966768273185,431284.57934287674,2018-05-08,24,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,2,0,0,0,32,CPVL,0.027999997,0.52226,0.8477,0,0.5,0.0,,
ENSG00000107104,7,3,1,0,0,1,27913.33943605074,355284.1215006515,2018-08-13,23,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,3,27,KANK1,-0.14900005,-5.0552,-3.699,2,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000107562,9,3,0,0,0,1,4428.697810877906,502231.5406594711,2009-02-08,0,1,0,0,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,30,CXCL12,-0.06700003,-0.53508,-0.92184,5,-1.0,-1.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000107742,3,3,1,0,0,1,205425.60717824215,598869.4096893278,2019-06-01,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,1,0,4,SPOCK2,0.100000024,0.22337,-0.12722,0,0.5,-1.0,,
ENSG00000108342,4,3,0,0,0,1,26020.4828907398,95905.57783546533,2023-05-17,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,2,6,CSF3,-0.23699999,0.93431,-0.82169,4,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000108828,3,3,1,0,0,1,76460.46239913636,718784.6890415357,2022-08-01,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,VAT1,-0.01999998,1.5325,0.28271,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000109625,3,3,1,1,0,1,5602.666666666667,235397.69820205137,2017-05-18,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,CPZ,-0.96599996,-6.6902,-5.1274,0,0.5,0.0,,
ENSG00000110400,4,3,0,0,0,1,383158.3001114715,498258.534626183,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,4,NECTIN1,0.34100002,1.9613,0.89533,2,0.5,-1.0,Nectin/Necl  trans heterodimerization,R-HSA-420597
ENSG00000110492,9,3,0,0,0,0,103877.27822338727,633132.2332759313,2017-10-09,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,0,0,1,0,0,0,7,MDK,-0.69799995,-0.025016,-0.8712,3,0.5,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000110665,4,3,1,0,0,1,6455.028095238095,464892.4593283075,2013-06-16,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,C11orf21,-0.82799995,0.15041,0.4425,0,0.75,0.0,,
ENSG00000110880,3,3,1,0,0,1,464892.4593283075,718784.6890415357,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,CORO1C,0.62,2.9409,1.169,0,-1.0,-1.0,,
ENSG00000110975,4,3,0,0,0,1,195005.6685718255,1424218.0900670097,2020-06-15,0,0,0,0,1,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,SYT10,0.18599999,0.87125,0.17957,2,0.5,1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000111344,5,3,0,0,0,1,5504.0130519525,203090.6413944402,2021-09-30,2,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,6,RASAL1,0.01999998,0.3923,0.10975,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000111596,4,3,1,0,0,1,17115.61307125707,714039.8414241908,2017-06-12,1,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,CNOT2,0.78900003,3.2082,0.73996,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Deadenylation of mRNA;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-429947;R-HSA-1266738;R-HSA-74160
ENSG00000112214,8,3,1,0,1,1,25788.156322680115,360605.992793193,2013-06-23,0,0,0,0,22,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,26,FHL5,-0.40600002,0.50675,0.326,0,0.5,0.0,,
ENSG00000112992,3,3,1,0,0,1,11820.981159685385,132810.11396011396,2022-07-26,1,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,7,NNT,0.412,2.1843,1.1675,1,0.5,-1.0,Citric acid cycle (TCA cycle),R-HSA-71403
ENSG00000113263,3,3,1,0,1,1,108784.9761126256,183579.49764748462,2019-10-24,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,3,ITK,0.356,2.3278,-0.5042,2,1.0,0.5,Immune System,R-HSA-168256
ENSG00000113389,7,3,1,0,0,1,12542.479619943082,448058.917711015,2018-08-13,0,0,4,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,18,NPR3,0.07999998,0.5766,0.0078059,0,0.5,0.0,,
ENSG00000113600,6,3,0,1,1,1,31971.308488731265,250587.75487558788,2015-12-21,0,0,0,6,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,9,C9,-0.22300005,-0.66282,0.11928,2,1.0,0.5,Immune System,R-HSA-168256
ENSG00000113638,3,3,1,0,0,1,8899.182776992497,111054.97262387123,2019-08-05,3,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,6,TTC33,-0.13199997,0.59972,-0.029523,0,-1.0,0.0,,
ENSG00000113889,5,3,0,0,1,1,455.18696069031637,168116.01355658393,2012-10-09,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,6,KNG1,0.425,0.92609,0.49566,7,1.0,0.5,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000114302,5,3,1,1,0,1,66821.18426408028,384314.83364002535,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,2,0,0,0,0,0,0,5,PRKAR2A,0.254,0.92442,0.35595,13,0.5,-1.0,Signal Transduction;CREB1 phosphorylation through the activation of Adenylate Cyclase;Developmental Biology;Disease,R-HSA-162582;R-HSA-442720;R-HSA-1266738;R-HSA-1643685
ENSG00000114902,4,3,1,0,0,1,94951.97167384504,453046.0257943742,2018-10-03,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,1,0,0,0,4,SPCS1,0.009000003,0.38027,-0.20401,5,-1.0,-1.0,Disease;Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-1643685;R-HSA-72766;R-HSA-1799339
ENSG00000115705,7,3,1,0,1,1,12523.167863773606,381165.6245253304,2016-05-16,0,0,0,0,0,0,0,0,0,18,0,0,0,0,1,0,0,0,0,3,0,0,0,22,TPO,0.032000005,0.32831,-0.27418,1,1.0,0.0,Metabolism of amine-derived hormones,R-HSA-209776
ENSG00000115963,3,3,0,0,0,1,1991.9458375125375,38092.548464040476,2012-01-04,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,RND3,0.467,1.4522,-0.15454,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000116580,4,3,0,0,1,1,21147.42176870748,931858.935708564,2020-10-01,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,GON4L,0.51,3.3823,1.62,0,-1.0,-1.0,,
ENSG00000116785,4,3,1,0,0,1,1725.7049053688684,378712.0243337037,2010-08-08,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,6,CFHR3,-0.30200005,1.502,0.89662,1,1.0,1.0,Immune System,R-HSA-168256
ENSG00000116985,3,3,1,0,0,1,260210.21963428933,672632.4785173276,2021-04-22,0,0,0,0,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,BMP8B,-0.29700005,1.1878,0.12574,0,-1.0,0.0,,
ENSG00000117020,6,3,1,0,0,1,1871.6973317403424,1778690.168860174,2017-03-27,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,1,11,AKT3,0.518,4.235,-0.90163,27,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);G beta:gamma signalling through PI3Kgamma;RUNX2 regulates genes involved in cell migration;Disease;G-protein beta:gamma signalling;Rab regulation of trafficking;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-392451;R-HSA-8941332;R-HSA-1643685;R-HSA-397795;R-HSA-9007101;R-HSA-9006934;R-HSA-5663202
ENSG00000117280,3,3,1,0,0,1,2839.268167569108,1424218.0900670097,2009-11-15,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,7,RAB29,0.21200001,1.4959,0.70118,1,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000118482,4,3,0,0,0,1,131525.74533408263,1076472.0138856068,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,1,4,PHF3,0.699,0.79829,0.074592,0,-1.0,-1.0,,
ENSG00000118515,3,3,1,0,0,1,86869.04450932604,235397.69820205137,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,4,SGK1,0.28399998,2.1269,-0.37394,5,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Stimuli-sensing channels;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-2672351;R-HSA-9006934
ENSG00000119147,6,3,1,0,1,1,46282.676044693806,1470466.6505612188,2021-08-24,0,0,0,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,1,0,0,4,20,ECRG4,-0.525,-0.4352,-0.90003,0,0.5,0.0,,
ENSG00000119927,3,3,1,0,1,1,60313.16706022933,170747.68362649818,2024-04-17,3,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,8,GPAM,0.25300002,1.3848,-0.33578,6,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Synthesis of PA;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);RUNX1 regulates estrogen receptor mediated transcription,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1483166;R-HSA-8957322;R-HSA-1655829;R-HSA-8931987
ENSG00000120158,3,3,1,0,0,1,39406.19595155135,100358.73833384078,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,3,6,RCL1,0.17199999,-1.2468,-1.1967,2,0.5,-1.0,rRNA processing,R-HSA-72312
ENSG00000120254,3,3,0,0,0,1,2020.2928746928746,270267.2992956902,2010-09-23,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,MTHFD1L,0.144,1.2196,0.74064,1,-1.0,0.0,Metabolism of folate and pterines,R-HSA-196757
ENSG00000120341,8,3,0,0,1,1,17426.74725331541,1424218.0900670097,2018-10-08,0,0,0,0,0,6,0,0,0,0,0,0,3,0,0,0,0,0,14,0,0,0,0,23,SEC16B,-0.12699997,-0.42015,-0.53686,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000120708,3,3,1,1,0,1,141293.18354755783,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,TGFBI,0.144,0.59018,0.020023,1,0.5,-1.0,,
ENSG00000121380,3,3,0,0,0,1,21201.639474894007,141293.18354755783,2023-01-18,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,BCL2L14,0.04000002,0.55859,0.78728,1,0.5,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000121594,3,3,1,0,0,1,1455.4894671623297,38944.05949995025,2012-05-06,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,0,0,0,0,2,0,0,0,5,CD80,0.18199998,1.4654,0.34031,8,0.5,0.5,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-5663202
ENSG00000121964,3,3,0,0,0,1,31519.426313660828,323648.5577791949,2013-08-25,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,2,7,GTDC1,-0.49199998,0.59317,0.070849,0,-1.0,-1.0,,
ENSG00000122786,7,3,1,0,1,1,17853.333333333332,197485.87952538437,2018-08-13,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,11,CALD1,0.502,1.2584,1.0217,1,0.5,-1.0,,
ENSG00000123095,3,3,0,0,0,1,162367.55694122918,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,BHLHE41,-0.21899998,-2.2157,-4.133,1,0.5,0.0,,
ENSG00000124429,3,3,0,0,1,0,141293.18354755783,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,POF1B,,,,0,0.5,0.0,,
ENSG00000124614,3,3,1,0,0,1,24407.480025615696,381165.6245253304,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,4,RPS10,0.735,2.1838,0.50027,18,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000124664,3,3,1,0,1,1,24267.559108327496,278190.43024910334,2011-11-06,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,4,SPDEF,0.422,1.1726,-0.54614,0,0.5,0.0,,
ENSG00000125166,3,3,0,0,0,1,5056.7621594471,11815.066044029352,2015-01-12,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,GOT2,0.40899998,1.7443,0.97636,5,0.75,-1.0,,
ENSG00000125245,5,3,1,0,0,1,53369.71648873449,269829.0934099178,2019-03-28,1,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,0,0,0,0,0,0,8,GPR18,-0.23800004,0.94582,0.13591,2,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000125255,3,3,0,0,1,1,104829.95456615865,384314.83364002535,2018-11-30,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,5,0,0,0,8,SLC10A2,-0.464,-1.0034,-0.79626,1,1.0,0.5,Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-8957322;R-HSA-194068
ENSG00000125637,5,3,1,0,0,1,9658.639391362309,230316.30849350386,2017-03-27,3,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,PSD4,0.34399998,0.83514,0.19817,0,0.5,0.0,,
ENSG00000127124,3,3,1,0,0,1,63200.72664467542,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,HIVEP3,0.583,2.4535,0.71972,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000127418,4,3,1,0,0,1,20703.900806847647,645988.1975077938,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,5,0,0,8,FGFRL1,-0.16199994,-0.92774,-2.8261,1,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000129244,3,3,0,1,0,1,11105.796116504855,183937.6490790624,2014-08-17,1,0,0,0,0,1,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,ATP1B2,0.47399998,1.483,0.37378,4,0.75,-1.0,Disease,R-HSA-1643685
ENSG00000129514,5,3,0,0,0,1,41642.5373617829,521818.7070055739,2023-01-18,5,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,7,FOXA1,0.425,-0.11277,-1.7475,2,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000130518,4,3,1,0,0,1,78751.06843456876,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,2,0,0,0,4,IQCN,0.11400002,1.2931,1.2531,0,1.0,0.0,,
ENSG00000130762,5,3,0,0,0,1,28821.88430161129,410642.56898295006,2021-04-08,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,11,ARHGEF16,-0.018000007,0.28551,-0.2275,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000131941,12,3,1,0,1,1,3830.8097102584184,473900.221403792,2008-11-16,14,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,16,RHPN2,0.315,2.3533,1.8331,3,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000132475,4,3,1,0,0,1,135108.48254553688,219793.50457789513,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,4,H3-3B,0.515,4.0047,-3.3692,32,0.5,-1.0,,
ENSG00000132693,9,3,1,1,0,1,28863.30790298137,438447.5304388146,2022-12-10,1,14,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,CRP,-0.93200004,-0.30172,-0.66532,1,1.0,0.5,Immune System,R-HSA-168256
ENSG00000132872,3,3,0,0,0,1,25245.96296044253,415452.66715166246,2023-01-18,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,3,SYT4,0.681,0.51842,-0.35598,0,1.0,0.0,,
ENSG00000133069,4,3,1,0,0,1,13883.57970142381,270267.2992956902,2018-08-13,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,2,5,TMCC2,0.51600003,2.9305,1.2971,0,0.75,0.0,,
ENSG00000133131,7,3,0,0,0,1,2351.3270306772138,135095.86576106868,2012-11-11,0,0,0,0,0,6,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,8,MORC4,,,,0,0.5,-1.0,,
ENSG00000133805,3,3,1,1,0,1,66821.18426408028,183427.12489668437,2023-10-03,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,3,AMPD3,0.18300003,2.0819,0.9718,2,0.5,-1.0,Immune System;Nucleotide salvage;Metabolism of nucleotides,R-HSA-168256;R-HSA-8956321;R-HSA-15869
ENSG00000133961,3,3,1,0,0,1,81805.8846123197,275021.63051358337,2023-01-18,1,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NUMB,0.35399997,1.5625,0.28009,5,-1.0,-1.0,Signal Transduction;Developmental Biology;Recycling pathway of L1,R-HSA-162582;R-HSA-1266738;R-HSA-437239
ENSG00000134046,3,3,0,0,0,1,229954.37886203246,232586.34864014547,2021-01-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,3,MBD2,0.46100003,0.28894,-1.3981,2,-1.0,-1.0,Gene expression (Transcription);Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase I Promoter Opening;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance,R-HSA-74160;R-HSA-5250941;R-HSA-427413;R-HSA-73728;R-HSA-73864;R-HSA-73854
ENSG00000134215,7,3,1,0,0,1,6482.24749962681,381165.6245253304,2012-04-06,0,0,0,0,0,0,0,0,0,23,0,0,0,0,1,0,0,0,0,4,0,0,0,28,VAV3,0.15799999,1.0975,0.39244,17,0.5,0.0,Signal Transduction;Immune System;Developmental Biology;Azathioprine ADME;Disease;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-9748787;R-HSA-1643685;R-HSA-3928665;R-HSA-9006934
ENSG00000134323,9,3,0,0,0,1,17979.386203078288,765591.3646788632,2015-04-09,25,0,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,29,MYCN,0.689,0.08095,-2.2322,2,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000134569,3,3,0,0,0,1,26219.529008428708,102866.95819249244,2019-08-16,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,8,LRP4,0.499,5.2226,1.6053,1,0.5,0.0,,
ENSG00000135926,5,3,1,0,1,1,6070.704428815815,178948.78717378277,2012-11-01,4,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,8,TMBIM1,-0.11399996,0.36954,-0.68186,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000136205,15,3,1,0,0,1,43372.03071242184,521818.7070055739,2014-09-14,30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,37,TNS3,0.573,1.2787,-0.75178,1,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000136732,5,3,1,0,0,1,72318.77242389097,645988.1975077938,2018-07-30,1,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,7,GYPC,-0.775,-1.0533,-0.42181,1,0.5,-1.0,,
ENSG00000137038,4,3,0,0,0,1,11696.545114925451,1424218.0900670097,2020-06-15,0,0,0,0,0,3,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,6,DMAC1,-0.842,-1.6454,-1.5611,1,-1.0,-1.0,,
ENSG00000137090,8,3,0,0,0,1,866.7994237927694,355284.1215006515,2010-06-13,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,25,DMRT1,0.56799996,-2.3223,-2.948,1,1.0,1.0,Developmental Biology,R-HSA-1266738
ENSG00000137871,4,3,1,0,1,1,46735.522883704674,260210.21963428933,2018-06-11,2,0,0,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,ZNF280D,0.501,1.0641,-0.2046,0,-1.0,-1.0,,
ENSG00000138061,11,3,1,0,1,1,3263.956597558613,270058.9149022027,2015-08-03,23,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,26,CYP1B1,-0.08899999,-2.0908,-2.1681,4,-1.0,0.0,Disease;Arachidonate metabolism,R-HSA-1643685;R-HSA-2142753
ENSG00000138095,3,3,1,0,0,1,39464.144511075756,1778690.168860174,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,1,0,0,0,4,LRPPRC,0.19199997,-1.9032,-2.1366,1,-1.0,-1.0,,
ENSG00000138160,5,3,0,0,0,1,14440.44839102838,294387.2978738704,2019-03-28,0,0,0,0,0,6,0,0,0,0,3,0,0,0,0,0,0,0,0,2,0,0,0,11,KIF11,0.816,2.7188,0.47097,3,0.5,0.0,Immune System;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-168256;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000138246,3,3,1,0,0,1,122069.83349127392,384314.83364002535,2017-12-06,0,0,0,0,1,0,0,0,0,0,2,0,2,0,0,0,0,0,0,0,0,0,0,5,DNAJC13,0.73300004,3.394,1.2701,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000138380,10,3,1,0,1,1,23549.541220353076,461914.58891516324,2016-05-16,0,1,0,0,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,22,CARF,0.218,1.1749,1.0203,0,-1.0,-1.0,,
ENSG00000138587,3,3,0,0,0,1,279825.00883385167,1424218.0900670097,2023-01-18,2,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,MNS1,-0.032999992,-0.29996,-0.41903,0,0.5,0.0,,
ENSG00000138653,3,3,0,0,0,1,281079.0730593847,433862.5685735124,2023-01-18,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,4,NDST4,0.227,0.99963,-0.21891,1,,,HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-2022928;R-HSA-1638091
ENSG00000139329,4,3,0,0,1,1,26561.371714038676,72982.48880358285,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,4,LUM,-0.023000002,1.6049,-0.4053,7,0.5,0.0,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Defective ST3GAL3 causes MCT12 and EIEE15;Disease,R-HSA-3656244;R-HSA-3656243;R-HSA-1643685
ENSG00000140391,3,3,1,0,0,1,294387.2978738704,782476.8109259979,2021-09-30,0,0,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TSPAN3,0.291,1.0203,-1.2892,0,-1.0,-1.0,,
ENSG00000140505,7,3,0,0,0,1,213483.6843090745,1470466.6505612188,2018-08-13,0,0,0,0,3,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,1,10,CYP1A2,-0.35500002,0.41091,0.1772,7,1.0,0.5,Aflatoxin activation and detoxification;Phase II - Conjugation of compounds;Arachidonate metabolism,R-HSA-5423646;R-HSA-156580;R-HSA-2142753
ENSG00000141646,6,3,1,0,0,1,53369.71648873449,322220.1169395476,2019-03-28,0,0,0,0,2,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,7,SMAD4,0.773,4.9422,0.79666,21,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;RUNX3 regulates CDKN1A transcription;Diseases of signal transduction by growth factor receptors and second messengers;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Loss of Function of SMAD2/3 in Cancer;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Post-translational protein modification;FOXO-mediated transcription of cell cycle genes;Transcriptional regulation by RUNX3;Formation of definitive endoderm,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-8941855;R-HSA-5663202;R-HSA-2173796;R-HSA-3304349;R-HSA-2173793;R-HSA-597592;R-HSA-9617828;R-HSA-8878159;R-HSA-9823730
ENSG00000141664,3,3,1,0,0,1,54892.674160393246,200944.0765227402,2018-01-31,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,ZCCHC2,0.44300002,-0.33417,-2.1763,0,-1.0,-1.0,,
ENSG00000143185,7,3,0,0,0,1,45809.99756555466,190279.23963861223,2021-11-06,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,0,0,0,10,XCL2,-0.65699995,-0.031972,0.24432,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000143641,5,3,1,1,0,1,66438.21345734232,1778690.168860174,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,3,0,0,1,7,GALNT2,0.485,1.8886,-0.34716,2,-1.0,-1.0,Golgi-to-ER retrograde transport;Post-translational protein modification,R-HSA-8856688;R-HSA-597592
ENSG00000143970,4,3,0,0,0,1,281079.0730593847,384314.83364002535,2023-01-18,0,0,0,0,2,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,5,ASXL2,0.76100004,2.1146,0.44805,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000144285,5,3,1,0,1,1,3031.996829799881,101939.62799908599,2013-09-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,3,10,SCN1A,0.902,7.6177,1.7673,2,0.5,0.5,Developmental Biology;Interaction between L1 and Ankyrins,R-HSA-1266738;R-HSA-445095
ENSG00000144554,3,3,1,0,0,1,13116.6997137056,219793.50457789513,2023-01-18,2,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,FANCD2,0.22299999,1.7648,1.7645,2,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000144619,13,3,0,0,0,1,1173.5007132667617,633132.2332759313,2014-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,17,0,0,1,0,0,0,19,CNTN4,0.273,0.64317,-1.0412,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000145147,3,3,0,0,0,1,72982.48880358285,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,SLIT2,0.774,3.1241,-0.082669,9,-1.0,0.0,Developmental Biology;Activation of RAC1;Regulation of commissural axon pathfinding by SLIT and ROBO;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-428540;R-HSA-428542;R-HSA-9010553
ENSG00000145194,4,3,1,0,0,1,218846.39173691504,756470.9740366563,2024-07-19,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,2,0,0,0,0,5,ECE2,0.035000026,1.2304,0.48453,1,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000145354,5,3,1,0,0,1,28292.123952140868,645988.1975077938,2018-06-11,0,0,0,0,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,8,CISD2,0.56299996,1.3254,0.071953,0,0.5,-1.0,,
ENSG00000145623,5,3,0,0,0,1,58331.23271678036,397765.9672627851,2017-01-09,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,0,0,0,8,OSMR,0.073000014,1.1915,0.67021,1,-1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000145740,3,3,0,0,0,1,358386.30063935445,551389.5206213495,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,SLC30A5,0.32700002,1.5789,0.56383,2,-1.0,-1.0,Zinc transporters,R-HSA-435354
ENSG00000147854,3,3,0,0,0,1,57035.41574163062,86578.02523657946,2023-01-18,0,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,3,UHRF2,0.679,3.7567,-1.3022,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000148090,6,3,1,0,0,1,15223.454539395489,180089.50342935527,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,0,0,3,7,AUH,0.0059999824,-0.63377,-0.95218,2,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000148498,3,3,0,0,0,0,235397.69820205137,433862.5685735124,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,3,PARD3,0.39,0.84614,1.0033,2,-1.0,0.0,Signal Transduction;Tight junction interactions,R-HSA-162582;R-HSA-420029
ENSG00000148702,11,3,0,0,0,1,636.1886490807354,521818.7070055739,2012-10-09,3,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,5,12,HABP2,-0.413,-0.36751,-0.33458,0,1.0,0.5,,
ENSG00000149182,6,3,1,0,0,1,21724.94108458234,191895.42310022408,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,5,ARFGAP2,0.19999999,0.85046,0.25793,3,-1.0,-1.0,Signal Transduction;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-162582;R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000149564,9,3,0,1,0,0,15866.724081734988,633132.2332759313,2014-07-22,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,13,0,0,1,0,0,0,15,ESAM,-0.008999944,0.55466,0.15229,1,-1.0,-1.0,,
ENSG00000150281,5,3,0,1,0,1,3680.879332715477,353105.3286394775,2018-01-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,6,CTF1,-0.959,-2.2418,-2.574,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000151033,4,3,0,0,0,1,11608.613380386345,187674.40497870417,2020-06-15,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,6,LYZL2,-0.20099998,0.47335,0.42558,0,1.0,1.0,,
ENSG00000151929,10,3,1,1,1,1,4180.524301336573,756470.9740366563,2019-12-01,0,0,0,0,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,1,29,BAG3,0.462,-0.061263,0.32762,1,0.5,-1.0,,
ENSG00000152214,3,3,0,0,0,1,8476.999882033739,1424218.0900670097,2012-03-01,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,1,10,0,0,0,15,RIT2,-0.684,0.45823,-0.39789,1,1.0,0.5,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000152592,3,3,0,0,1,1,30311.18982428984,221280.45048451523,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,4,DMP1,-0.20899999,1.2873,1.0621,3,,,Post-translational protein modification,R-HSA-597592
ENSG00000153214,3,3,1,0,0,1,86869.04450932604,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,4,TMEM87B,-0.33099997,0.43036,-0.37454,0,-1.0,-1.0,,
ENSG00000153956,5,3,0,0,0,1,498258.534626183,1129585.974638378,2021-09-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,1,4,CACNA2D1,0.56299996,2.3712,-0.44289,1,0.5,0.0,Presynaptic depolarization and calcium channel opening,R-HSA-112308
ENSG00000154122,6,3,1,0,1,1,20287.111973223167,1424218.0900670097,2018-06-11,0,0,0,14,0,27,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,42,ANKH,0.537,3.5436,0.03267,1,-1.0,-1.0,Miscellaneous transport and binding events,R-HSA-5223345
ENSG00000154127,5,3,1,0,0,1,38092.548464040476,502231.5406594711,2019-09-01,0,0,0,0,6,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,8,UBASH3B,0.42000002,2.2416,0.57906,0,0.5,0.0,,
ENSG00000154240,3,3,0,0,0,1,180089.50342935527,645988.1975077938,2021-11-04,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,CEP112,0.089999974,0.8353,0.73823,0,0.5,-1.0,,
ENSG00000154743,4,3,1,0,0,1,20841.620346446787,804063.9714459113,2018-07-27,1,0,0,0,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,TSEN2,-0.21200001,-0.36979,0.43312,1,-1.0,0.0,tRNA processing in the nucleus,R-HSA-6784531
ENSG00000155052,9,3,0,0,0,1,1140.321402214022,1778690.168860174,2016-03-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,0,0,1,0,0,1,17,CNTNAP5,0.36799997,0.45905,-0.57461,0,0.75,0.5,,
ENSG00000155816,3,3,0,0,0,0,30508.10029756623,191895.42310022408,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,1,0,0,5,FMN2,0.49,-0.27361,-1.8592,0,0.5,0.0,,
ENSG00000155903,6,3,1,0,0,1,78751.06843456876,1470466.6505612188,2017-10-30,0,0,0,0,0,0,0,0,0,0,0,0,3,0,1,0,0,0,0,2,0,0,0,6,RASA2,-0.48399997,-0.64145,-0.81798,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000156110,5,3,1,0,0,1,189845.9324918578,466632.7979326389,2022-06-03,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,2,5,ADK,0.10699999,1.7207,0.57273,2,0.5,-1.0,Nucleotide salvage;Metabolism of nucleotides,R-HSA-8956321;R-HSA-15869
ENSG00000156510,4,3,1,0,0,1,11231.262381898725,77053.54729989004,2023-01-18,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,5,HKDC1,0.195,0.52093,0.73711,1,0.5,0.0,,
ENSG00000157036,4,3,0,0,0,1,2386.884226884227,35007.42267940216,2018-08-13,4,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,4,0,0,0,10,EXOG,-0.77199996,0.097776,1.1612,1,-1.0,-1.0,,
ENSG00000158717,5,3,1,0,0,1,1173.5007132667617,225499.30235578204,2018-05-08,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,RNF166,-0.29900002,-1.4708,-2.7465,0,0.5,-1.0,,
ENSG00000158869,7,3,1,0,0,1,51964.39839555753,562534.7696387965,2016-05-16,0,0,0,0,0,0,0,0,0,0,14,0,0,0,1,0,0,0,0,0,0,0,3,18,FCER1G,0.302,0.56168,0.52665,10,0.5,-1.0,Immune System;Platelet Adhesion to exposed collagen,R-HSA-168256;R-HSA-75892
ENSG00000159322,3,3,1,0,0,1,88771.02207231094,645988.1975077938,2024-01-19,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,ADPGK,0.06300002,0.49947,-0.81144,1,-1.0,-1.0,,
ENSG00000159363,3,3,1,0,0,0,15223.454539395489,235397.69820205137,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,7,ATP13A2,0.287,2.0755,0.93106,1,0.5,-1.0,,
ENSG00000160808,4,3,0,0,0,1,141076.9910731678,895916.2144062951,2020-05-18,1,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,MYL3,0.18900001,1.3298,0.49217,1,0.5,-1.0,,
ENSG00000162367,3,3,1,0,0,1,107949.90929360976,1424218.0900670097,2023-06-29,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,TAL1,0.009000003,-1.0407,-1.4781,2,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000163406,7,3,1,0,1,1,53369.71648873449,322220.1169395476,2019-03-28,0,0,0,0,0,0,0,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,3,8,SLC15A2,-0.153,0.29139,0.050926,0,0.5,0.0,,
ENSG00000163462,4,3,0,0,0,1,221280.45048451523,523652.45223581506,2023-07-29,2,1,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,6,TRIM46,0.646,4.1874,1.3318,1,1.0,0.5,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000163606,4,3,1,1,1,1,76062.08958444146,315325.55297640257,2020-04-15,0,0,0,0,0,0,0,0,3,0,2,0,0,0,0,0,0,0,0,0,0,0,1,6,CD200R1,-0.12399995,0.8811,0.76432,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000163623,4,3,1,0,0,1,19875.020792566687,1424218.0900670097,2019-02-04,0,0,0,0,0,13,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,15,NKX6-1,-0.021000028,-1.9705,-3.7454,5,0.5,0.5,Developmental Biology;Regulation of gene expression in early pancreatic precursor cells,R-HSA-1266738;R-HSA-210747
ENSG00000163635,10,3,1,0,1,1,99863.42410604075,1424218.0900670097,2018-02-26,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,4,0,0,1,0,0,0,13,ATXN7,0.74300003,-0.90971,-0.89445,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000164107,8,3,1,0,0,1,2274.83989021043,645988.1975077938,2017-04-17,0,0,0,0,20,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,7,29,HAND2,0.399,-0.26935,-2.4003,2,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000164114,6,3,0,0,0,1,87627.83156192786,500292.45069431677,2017-12-06,0,2,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,15,MAP9,-0.35899997,0.0092923,0.18997,0,0.5,0.0,,
ENSG00000164485,3,3,0,1,0,1,24739.63081777544,205433.03502595585,2011-08-11,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,0,0,0,0,0,0,0,2,6,IL22RA2,-0.42400002,0.30341,0.57318,1,0.75,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000164626,8,3,1,0,0,1,33287.94734762397,394357.452283155,2016-06-20,0,0,0,3,14,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,23,KCNK5,0.24900001,2.2926,0.25912,1,0.5,0.0,,
ENSG00000165030,3,3,0,0,0,1,15223.454539395489,235397.69820205137,2021-09-30,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,8,NFIL3,0.30400002,2.1216,0.56911,0,-1.0,-1.0,,
ENSG00000165060,3,3,1,0,0,1,109403.78480585825,309838.540915932,2021-07-22,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,5,FXN,0.19099998,-0.44136,-0.60317,4,-1.0,-1.0,Maturation of TCA enzymes and regulation of TCA cycle;Citric acid cycle (TCA cycle);Mitochondrial iron-sulfur cluster biogenesis,R-HSA-9854311;R-HSA-71403;R-HSA-1362409
ENSG00000165124,5,3,0,1,1,1,42359.490817992155,358386.30063935445,2017-12-06,0,0,0,2,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,SVEP1,0.49699998,1.9982,-0.48206,0,0.5,0.0,,
ENSG00000165495,4,3,0,0,0,1,1173.5007132667617,521818.7070055739,2016-05-16,4,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,6,PKNOX2,0.60899997,1.9015,-0.11706,0,0.5,0.0,,
ENSG00000165588,4,3,1,0,0,1,898.4958904109589,1076472.0138856068,2020-07-31,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,5,OTX2,0.676,1.6615,0.68949,2,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000165684,4,3,1,0,1,1,78751.06843456876,192594.63282947522,2023-01-18,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,4,SNAPC4,0.004999995,-2.5235,-3.7303,3,-1.0,0.0,RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription;RNA polymerase II transcribes snRNA genes,R-HSA-76046;R-HSA-76071;R-HSA-73857;R-HSA-74160;R-HSA-749476;R-HSA-74158;R-HSA-6807505
ENSG00000165923,5,3,0,0,0,1,23604.90768007222,756470.9740366563,2021-02-24,0,0,0,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,8,AGBL2,0.055999994,2.0835,1.268,1,0.5,0.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000166126,5,3,1,0,0,1,225895.43837715342,306980.8575290048,2022-12-14,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,3,AMN,-0.44599998,-2.732,-4.0719,4,0.75,0.0,Disease,R-HSA-1643685
ENSG00000166147,8,3,0,0,0,1,1458.170321264661,242123.900206037,2011-09-11,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,12,FBN1,0.895,8.1987,1.8863,7,0.5,0.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000166164,7,3,1,0,0,1,21897.542503344637,258213.8601133611,2017-01-09,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,0,0,0,0,5,0,0,0,12,BRD7,0.66400003,1.2633,1.0205,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000166166,5,3,1,0,0,1,18025.191197652486,713911.8939045856,2021-04-08,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,4,0,0,0,0,0,0,6,TRMT61A,-0.18299997,0.96232,-0.15957,1,-1.0,-1.0,,
ENSG00000166415,8,3,0,0,1,1,30786.942988595107,464892.4593283075,2019-05-31,0,0,0,0,0,0,1,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,4,16,WDR72,-0.08899999,-0.31313,0.28936,0,0.5,0.0,,
ENSG00000166428,3,3,1,0,1,1,11252.882952659449,124837.11004999638,2012-03-25,0,0,0,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,1,0,0,0,7,PLD4,-0.58299994,-1.7793,-0.30582,3,0.5,0.0,Immune System,R-HSA-168256
ENSG00000166501,4,3,1,1,0,1,2880.672210672211,160010.51072069994,2012-11-01,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,0,0,0,6,PRKCB,0.759,4.7871,-0.040536,10,0.5,0.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Depolymerization of the Nuclear Lamina;WNT5A-dependent internalization of FZD4;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-4419969;R-HSA-5099900;R-HSA-9006934
ENSG00000168314,4,3,1,0,0,1,3328.0781640536243,427337.4491868293,2011-06-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,4,0,0,0,7,MOBP,0.351,1.9277,1.0813,1,1.0,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000168461,5,3,0,0,0,1,8479.376416968564,42193.37905314073,2017-09-07,3,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,1,12,RAB31,-0.51600003,0.46784,-0.451,3,-1.0,-1.0,Immune System;Rab regulation of trafficking;Post-translational protein modification,R-HSA-168256;R-HSA-9007101;R-HSA-597592
ENSG00000168672,4,3,0,0,0,1,11391.28506861999,521818.7070055739,2019-09-27,13,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,LRATD2,-0.612,-0.27447,-0.68557,0,0.5,-1.0,,
ENSG00000168917,4,3,1,0,1,1,406587.2658730814,1470466.6505612188,2023-11-09,1,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,4,SLC35G2,-0.029000044,1.6019,1.0482,0,-1.0,0.0,,
ENSG00000169372,9,3,1,0,0,1,89519.16315227402,1990918.947961699,2019-01-21,0,0,0,0,1,0,0,0,0,0,0,0,21,0,0,0,0,0,0,0,0,0,4,26,CRADD,0.0009999871,0.68636,-0.27192,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000169855,4,3,1,0,0,1,21201.639474894007,360605.992793193,2022-02-03,0,0,0,0,1,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,ROBO1,0.144,1.5691,-1.3238,9,-1.0,0.0,Developmental Biology;Activation of RAC1;Regulation of commissural axon pathfinding by SLIT and ROBO;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-428540;R-HSA-428542;R-HSA-9010553
ENSG00000169856,4,3,1,0,0,1,52982.28647069224,1424218.0900670097,2018-10-08,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,7,ONECUT1,0.17699999,-0.14587,-1.24,5,0.75,0.5,Developmental Biology;Regulation of gene expression in early pancreatic precursor cells,R-HSA-1266738;R-HSA-210747
ENSG00000169994,6,3,1,0,1,0,56614.28807963426,168116.01355658393,2022-10-12,2,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,8,MYO7B,0.04400003,0.49486,-0.6409,0,1.0,0.5,,
ENSG00000170370,6,3,0,0,0,1,40455.65678857565,384314.83364002535,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,1,0,0,6,11,EMX2,0.501,0.93448,-0.60804,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000170579,6,3,0,0,0,1,1173.5007132667617,322220.1169395476,2021-11-04,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,3,6,DLGAP1,0.776,2.6632,-0.64481,1,1.0,0.0,,
ENSG00000170967,10,3,0,0,0,1,22651.370408599323,502231.5406594711,2015-09-07,0,0,0,0,31,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,46,DDI1,-0.337,0.69161,-0.23561,0,1.0,1.0,,
ENSG00000171681,6,3,1,0,0,1,68537.47953791295,756470.9740366563,2020-05-18,10,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,ATF7IP,0.706,2.3404,0.47443,3,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000171819,4,3,1,1,1,1,16954.933657438592,100711.28404230655,2023-01-18,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,5,ANGPTL7,-0.23099995,0.57375,0.26783,0,0.5,0.0,,
ENSG00000171858,6,3,1,0,0,1,14178.745544178992,301203.06999851385,2016-03-08,5,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,7,RPS21,0.10100001,1.1037,-1.3892,18,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000172171,10,3,1,0,0,1,68537.47953791295,1470466.6505612188,2020-09-04,5,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,6,18,TEFM,0.19199997,1.0247,0.48912,0,-1.0,-1.0,,
ENSG00000172456,9,3,1,0,0,1,6356.593451690605,448058.917711015,2022-06-28,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,8,FGGY,-0.20000005,0.83035,0.54491,0,0.5,-1.0,,
ENSG00000172789,7,3,0,0,0,1,45372.42965956089,765591.3646788632,2020-06-15,0,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,7,HOXC5,-0.44500005,-0.49573,-0.19412,0,0.5,0.5,,
ENSG00000173517,4,3,1,0,0,1,40100.67080961279,275021.63051358337,2012-09-01,1,0,0,1,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,PEAK1,0.478,1.5763,1.662,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000173641,9,3,1,0,0,1,5495.191484272216,428754.4911049721,2016-07-17,2,0,0,0,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,HSPB7,-0.50600004,0.052854,0.0737,0,0.75,0.0,,
ENSG00000173930,5,3,1,0,0,1,49127.555514088446,294387.2978738704,2021-09-30,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,5,SLCO4C1,-0.011000037,-0.17723,0.64633,2,1.0,0.5,"Immune System;Transport of vitamins, nucleosides, and related molecules",R-HSA-168256;R-HSA-425397
ENSG00000174004,8,3,1,0,0,1,53369.71648873449,562534.7696387965,2017-10-30,0,0,0,0,0,0,0,0,0,0,17,0,0,0,1,0,0,0,0,0,0,0,3,21,NRROS,0.09100002,0.92352,-0.67879,0,0.5,0.0,,
ENSG00000174123,7,3,1,0,1,1,32555.310754135273,295500.356444329,2018-05-21,0,0,0,0,0,0,0,0,0,0,11,0,0,0,2,0,0,0,0,0,0,0,1,14,TLR10,-0.83299994,0.41952,1.8653,3,1.0,0.5,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000174326,5,3,1,0,1,1,1071.147302417597,1424218.0900670097,2013-08-14,2,0,0,0,0,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,24,SLC16A11,-0.78199995,-2.0214,-2.4074,0,0.5,0.0,,
ENSG00000174448,4,3,1,0,0,1,70029.51727197871,295500.356444329,2019-07-30,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,2,5,STARD6,-0.13900006,0.5256,1.018,1,1.0,1.0,Pregnenolone biosynthesis;Metabolism of steroids,R-HSA-196108;R-HSA-8957322
ENSG00000174948,3,3,0,0,0,1,144102.0022515395,360605.992793193,2016-06-20,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,7,GPR149,-0.28499997,-0.30192,-0.67079,0,0.5,0.5,,
ENSG00000174953,4,3,1,0,0,1,21014.7618737575,380831.7787965888,2017-12-06,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,DHX36,0.599,2.316,-0.1649,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000175489,4,3,1,0,0,1,13132.241573569341,53182.30026560605,2017-07-17,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,4,LRRC25,0.43400002,1.2579,0.99881,0,0.75,0.0,,
ENSG00000177105,4,3,1,0,0,1,6762.688254947314,645988.1975077938,2021-09-07,0,0,0,0,2,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,RHOG,0.633,3.5322,-0.48901,7,0.5,-1.0,Signal Transduction;Immune System;Disease;RHO GTPases activate KTN1;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5625970;R-HSA-5663202
ENSG00000177947,5,3,0,0,1,1,7304.509669072407,188264.63129042363,2018-11-08,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,7,CIMAP1A,-0.477,-0.89103,-1.0798,0,1.0,1.0,,
ENSG00000178385,5,3,0,0,0,1,93139.63789601182,1424218.0900670097,2020-06-15,1,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,7,PLEKHM3,0.339,2.1636,0.76439,0,-1.0,0.0,,
ENSG00000178700,3,3,0,0,0,0,8899.182776992497,1424218.0900670097,2019-08-05,1,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,DHFR2,-0.32000005,0.89282,-0.49296,1,-1.0,-1.0,Metabolism of folate and pterines,R-HSA-196757
ENSG00000179915,4,3,1,0,0,1,606.6666666666666,1778690.168860174,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,5,NRXN1,0.68299997,1.2953,-3.1378,2,1.0,0.0,,
ENSG00000180660,3,3,0,0,0,1,100620.50186431198,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,3,MAB21L1,0.531,1.7606,-0.24747,0,0.75,0.5,,
ENSG00000180815,3,3,0,0,1,0,69427.89754098361,427337.4491868293,2023-01-18,0,0,1,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,MAP3K15,,,,0,0.75,0.5,,
ENSG00000180875,5,3,1,0,0,1,14308.219359325909,306980.8575290048,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,5,GREM2,-0.22399998,0.53415,0.32387,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000181019,4,3,0,0,0,1,83633.19622783325,1424218.0900670097,2021-11-04,0,0,0,0,1,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,NQO1,-0.23399997,1.4976,0.87383,2,0.5,0.0,Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines,R-HSA-350562;R-HSA-351202
ENSG00000182053,3,3,0,0,0,1,71329.99611279755,275021.63051358337,2022-10-12,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,5,TRIM49B,0.055000007,0.55273,-0.86727,0,,,,
ENSG00000182149,5,3,1,0,0,1,101825.50588235294,437137.9986908925,2021-11-04,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,4,IST1,0.07800001,-0.21272,-0.32192,2,-1.0,-1.0,Immune System;Sealing of the nuclear envelope (NE) by ESCRT-III,R-HSA-168256;R-HSA-9668328
ENSG00000182197,5,3,0,0,0,1,7199.101761070433,645988.1975077938,2023-01-18,0,0,0,0,4,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,EXT1,0.661,2.7372,0.7421,3,-1.0,-1.0,Disease;HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1643685;R-HSA-2022928;R-HSA-1638091
ENSG00000183049,3,3,1,0,0,1,10023.250789889415,254373.32653042395,2008-03-30,0,0,0,0,0,6,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,8,CAMK1D,0.635,3.1845,0.065502,0,0.5,0.0,,
ENSG00000183160,5,3,0,0,1,1,12315.440661331722,414433.58532016096,2023-01-18,0,0,0,5,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,2,10,TMEM119,-0.82299995,-0.5211,-0.26148,0,-1.0,0.0,,
ENSG00000184164,3,3,1,0,1,1,78016.97193351923,356440.71671986027,2022-02-07,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,1,5,CRELD2,-0.11899996,-0.19555,-1.0975,0,-1.0,-1.0,,
ENSG00000184216,4,3,1,0,1,1,3479.8716981132075,381165.6245253304,2013-12-25,0,0,0,0,0,0,0,0,0,0,0,4,5,0,1,0,0,0,0,0,0,0,0,10,IRAK1,,,,18,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;IRAK1 recruits IKK complex;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;Gene expression (Transcription);Disease;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-937039;R-HSA-975144;R-HSA-74160;R-HSA-1643685;R-HSA-449147
ENSG00000184378,19,3,1,0,0,1,8143.099031885603,367949.31877243903,2017-01-23,21,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,23,ACTRT3,-0.24199998,0.6078,0.70546,0,1.0,0.0,,
ENSG00000185009,5,3,1,0,0,1,162367.55694122918,466632.7979326389,2022-06-03,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,2,5,AP3M1,0.17699999,1.6463,0.25805,1,-1.0,-1.0,,
ENSG00000185352,6,3,0,0,0,1,167455.33102651383,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,0,0,0,0,0,1,7,HS6ST3,0.35900003,0.22412,-0.10768,1,1.0,0.0,HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-2022928;R-HSA-1638091
ENSG00000185477,3,3,0,0,0,1,4106.914803843126,156470.480665571,2022-10-07,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1,3,GPRIN3,-0.27499998,0.037269,0.47403,0,0.5,0.0,,
ENSG00000186081,11,3,1,1,1,1,10352.610157160763,431284.57934287674,2015-04-09,43,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,0,0,0,48,KRT5,0.462,1.0035,-0.046195,4,0.75,0.0,Developmental Biology,R-HSA-1266738
ENSG00000186998,5,3,1,0,0,1,22345.675520395987,155552.2805078301,2013-04-01,5,0,0,10,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,EMID1,0.0059999824,-0.38644,-1.3804,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000187118,4,3,0,0,0,1,3943.4948096885814,83896.55822718568,2011-08-11,2,0,0,0,0,0,0,0,0,0,0,2,0,0,5,0,0,0,0,0,0,0,0,9,CMC1,-0.906,0.17185,-0.92518,1,-1.0,-1.0,,
ENSG00000187140,3,3,0,0,0,1,21201.639474894007,133918.94977035935,2020-04-27,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,FOXD3,-0.88900006,-1.8375,-3.6828,2,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000187676,8,3,1,1,1,1,33892.13656698846,1778690.168860174,2015-12-21,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,0,0,6,0,0,0,20,B3GLCT,-0.10899997,-0.095709,-0.19256,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000188001,3,3,0,0,0,1,14698.010216795416,189385.65312252965,2016-07-11,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,3,TPRG1,-0.29499996,0.40335,-0.33199,0,0.5,0.0,,
ENSG00000188820,3,3,1,0,0,1,1570.5303430079155,87248.80974040499,2014-07-31,0,0,0,0,0,0,0,0,0,0,0,3,1,0,0,0,0,0,0,2,0,0,0,6,CALHM6,-0.96599996,-1.7918,-2.533,0,0.5,-1.0,,
ENSG00000188938,4,3,1,0,1,1,9104.994072995736,376569.5597064443,2020-11-10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,6,FAM120AOS,-0.176,0.22451,-0.46316,0,-1.0,-1.0,,
ENSG00000189319,5,3,1,0,0,1,33954.407278742765,406587.2658730814,2017-01-09,2,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,2,0,0,0,12,FAM53B,0.43199998,1.6333,-0.044846,0,-1.0,-1.0,,
ENSG00000189337,3,3,0,0,0,1,1173.5007132667617,44258.8831230259,2020-06-15,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,KAZN,0.314,1.2841,-0.98969,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000196132,5,3,1,0,0,1,18226.911277750685,433862.5685735124,2017-11-01,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,13,MYT1,0.74300003,3.8128,1.7823,0,1.0,0.5,,
ENSG00000197157,5,3,1,0,0,1,95776.89591443514,1778690.168860174,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,4,SND1,0.61399996,3.638,1.4493,1,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000197381,6,3,1,0,0,1,714039.8414241908,1778690.168860174,2021-05-27,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,3,0,0,0,0,0,0,6,ADARB1,0.677,3.7351,1.1224,2,0.5,-1.0,,
ENSG00000197702,3,3,0,0,0,1,143413.24457139417,189845.9324918578,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,PARVA,0.32099998,0.32741,-1.2679,3,-1.0,0.0,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,R-HSA-446388
ENSG00000198053,3,3,1,1,1,1,74722.59037384245,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,3,0,0,0,6,SIRPA,0.69,2.5376,0.16174,3,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000198870,3,3,0,0,0,1,60085.7648087202,931858.935708564,2023-07-29,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,STKLD1,-0.17900002,0.37227,-0.7435,0,1.0,1.0,,
ENSG00000198876,4,3,0,0,1,1,58154.03337969838,397765.9672627851,2021-09-30,2,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,7,DCAF12,0.302,2.2725,1.1085,0,-1.0,-1.0,,
ENSG00000203727,6,3,1,0,0,1,286746.1002745869,1778690.168860174,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,7,0,0,0,0,0,0,10,SAMD5,-0.76,-1.3319,-2.1134,0,-1.0,0.0,,
ENSG00000203786,6,3,1,0,1,1,12651.541733305481,112025.85662838118,2021-04-08,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,0,0,1,6,KPRP,-0.919,-0.46224,0.29886,1,1.0,0.5,,
ENSG00000204022,4,3,0,0,0,0,66821.18426408028,355284.1215006515,2021-01-04,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,5,LIPJ,-0.06799996,0.078565,-0.06687,1,1.0,1.0,Developmental Biology,R-HSA-1266738
ENSG00000204033,3,3,1,0,1,1,63200.72664467542,83896.55822718568,2022-07-13,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,4,LRIT2,-0.37899995,-1.1656,-0.41745,0,1.0,0.5,,
ENSG00000204291,5,3,1,1,0,1,60111.20110003438,322220.1169395476,2019-02-25,0,0,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,6,COL15A1,0.23699999,1.0432,0.48035,4,0.5,0.0,,
ENSG00000205213,3,3,1,0,1,1,180089.50342935527,383158.3001114715,2021-11-04,0,0,0,0,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2,0,0,0,6,LGR4,0.274,0.57168,-0.022474,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000213341,4,3,1,0,1,1,34310.1963031151,309256.4614031486,2018-07-27,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,5,CHUK,0.39,2.0823,0.41268,31,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;IKK complex recruitment mediated by RIP1;Dectin-1 mediated noncanonical NF-kB signaling;NIK-->noncanonical NF-kB signaling;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-937041;R-HSA-5607761;R-HSA-5676590;R-HSA-5663202
ENSG00000216490,4,3,1,1,1,1,11231.262381898725,294763.3750742061,2013-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,3,0,0,1,7,IFI30,-0.503,-0.5757,-1.5263,2,0.5,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000234409,3,3,1,0,0,1,101670.29565171694,360605.992793193,2022-02-03,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,CCDC188,-0.15100002,0.18942,0.012268,0,1.0,0.5,,
ENSG00000237651,4,3,1,0,0,1,29050.862407491317,228220.5662976458,2018-07-30,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,4,C2orf74,-0.13399994,0.33282,-0.15953,0,-1.0,-1.0,,
ENSG00000243317,3,3,1,0,0,1,2325.5337209302324,356440.71671986027,2011-05-29,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,3,STMP1,-0.551,0.16225,0.070372,0,-1.0,-1.0,,
ENSG00000244414,4,3,1,0,0,1,13780.964387238024,378712.0243337037,2021-04-23,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,10,CFHR1,-0.20799994,1.8632,1.1987,1,1.0,0.5,Immune System,R-HSA-168256
ENSG00000272325,4,3,1,0,0,1,9387.521501785945,258213.8601133611,2021-06-01,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,3,0,0,0,5,NUDT3,0.32099998,1.1606,-0.17005,1,-1.0,-1.0,,
ENSG00000273611,3,3,1,0,0,1,38092.548464040476,464892.4593283075,2019-09-01,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,ZNHIT3,-0.86899996,-0.69304,-0.75915,0,-1.0,-1.0,,
ENSG00000275591,4,3,0,0,0,1,141293.18354755783,672632.4785173276,2021-04-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,4,XKR5,-0.68799996,-4.5705,-3.5889,0,,,,
ENSG00000002919,4,3,1,0,0,1,46157.70518111334,1424218.0900670097,2018-08-09,1,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,SNX11,0.116,0.78728,0.67249,0,-1.0,-1.0,,
ENSG00000007372,10,3,1,0,0,1,353105.3286394775,1778690.168860174,2018-04-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,1,0,0,1,9,PAX6,0.774,3.2634,0.15537,5,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000008394,3,3,1,0,0,1,20850.43936444706,1778690.168860174,2020-09-09,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,MGST1,-0.17700005,0.32029,1.1183,3,0.5,0.0,Immune System;Glutathione conjugation;Aflatoxin activation and detoxification;Phase II - Conjugation of compounds,R-HSA-168256;R-HSA-156590;R-HSA-5423646;R-HSA-156580
ENSG00000008838,6,3,1,0,0,1,42341.12463940832,298504.9722193353,2020-10-27,1,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,1,0,0,0,0,0,0,8,MED24,0.23900002,2.6343,0.25861,5,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685
ENSG00000009709,5,3,0,0,0,1,1225.1182294700059,4843.708956477903,2012-08-05,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,5,PAX7,0.496,1.0115,-0.52333,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000015520,7,3,1,0,0,1,52982.28647069224,464892.4593283075,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,0,0,3,7,NPC1L1,0.045000017,2.0642,0.62867,1,0.75,0.5,Digestion and absorption,R-HSA-8963743
ENSG00000016864,4,3,1,0,0,0,15393.842325758538,156470.480665571,2010-01-17,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,2,4,GLT8D1,-0.26600003,0.49271,0.43524,0,-1.0,-1.0,,
ENSG00000023839,3,3,1,0,0,1,98918.68253887848,260631.24114204012,2021-06-14,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,3,ABCC2,0.014999986,1.0363,1.6072,6,0.5,0.0,Atorvastatin ADME;Disease,R-HSA-9754706;R-HSA-1643685
ENSG00000023902,5,3,1,0,0,1,49367.473680139236,406587.2658730814,2019-01-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,6,PLEKHO1,0.27100003,0.67233,-0.17974,0,0.5,-1.0,,
ENSG00000027697,3,3,1,1,0,1,8236.314851926074,275021.63051358337,2019-03-05,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,IFNGR1,0.11900002,1.0289,0.78453,4,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease,R-HSA-1280215;R-HSA-168256;R-HSA-1643685
ENSG00000030066,5,3,0,0,1,1,21724.94108458234,1424218.0900670097,2020-06-15,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,5,NUP160,0.40499997,1.0958,0.64341,35,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Postmitotic nuclear pore complex (NPC) reformation;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9615933;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000040275,15,3,0,0,1,1,4179.1530052660255,521818.7070055739,2021-09-30,18,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,22,SPDL1,-0.263,0.3419,-0.82401,6,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000042813,6,3,0,0,0,0,38092.548464040476,360837.067725683,2017-10-30,0,0,0,0,0,0,0,0,3,0,0,0,0,0,3,0,0,0,0,0,0,0,1,7,ZPBP,0.16000003,0.6698,-0.86079,0,1.0,0.5,,
ENSG00000047936,3,3,0,0,0,1,41471.88424680565,53488.43246868315,2022-08-01,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,ROS1,0.007000029,0.1768,-0.12569,0,0.75,0.5,,
ENSG00000048740,10,3,1,0,0,1,23329.022142685433,225895.43837715342,2019-06-07,11,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,19,CELF2,0.706,4.1462,-0.37279,0,0.5,-1.0,,
ENSG00000049883,3,3,1,0,0,1,88247.21228328612,1778690.168860174,2021-11-04,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,3,PTCD2,0.20300001,-0.80394,-0.65098,0,-1.0,-1.0,,
ENSG00000055118,5,3,1,0,0,1,138890.6106237268,645988.1975077938,2018-06-11,0,0,0,0,10,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,KCNH2,0.43199998,2.4976,-2.0417,2,0.5,0.0,,
ENSG00000061918,4,3,0,0,0,1,50161.278626555366,1424218.0900670097,2018-11-28,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,GUCY1B1,0.20200002,2.1796,-0.2654,2,-1.0,-1.0,,
ENSG00000064042,3,3,0,0,0,1,6697.381489027931,48345.89330777902,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,3,LIMCH1,0.232,1.8321,1.2499,0,0.5,0.0,,
ENSG00000066084,3,3,1,0,0,1,62507.19385670474,180089.50342935527,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,DIP2B,0.552,4.0735,1.2887,0,-1.0,-1.0,,
ENSG00000067560,3,3,1,0,0,1,52463.65429696694,319456.42855430726,2017-07-17,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,4,RHOA,0.56700003,4.5657,-0.25248,26,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;G beta:gamma signalling through PI3Kgamma;RHO GTPases activate KTN1;Sema4D mediated inhibition of cell attachment and migration;G-protein beta:gamma signalling;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-392451;R-HSA-5625970;R-HSA-416550;R-HSA-397795;R-HSA-9006934;R-HSA-597592
ENSG00000067798,5,3,1,0,0,1,365.92946130900157,313882.50400013494,2012-10-09,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,13,NAV3,0.574,2.1808,-0.56012,0,0.5,0.0,,
ENSG00000069493,4,3,1,0,1,1,38092.548464040476,260631.24114204012,2019-09-01,0,0,0,0,0,1,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,0,6,CLEC2D,-0.502,0.77627,0.056034,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000073417,3,3,1,0,1,1,33287.94734762397,108425.35980999071,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,1,0,0,0,4,PDE8A,0.36900002,0.062264,0.052599,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000074755,4,3,1,0,1,1,88825.27591578313,1424218.0900670097,2017-05-31,0,0,0,0,1,17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,ZZEF1,0.48299998,1.9932,-0.54893,0,-1.0,-1.0,,
ENSG00000076356,4,3,1,0,0,1,286746.1002745869,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,1,4,PLXNA2,0.47500002,4.3988,1.4115,4,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000078808,3,3,1,0,0,0,22938.587937312015,562534.7696387965,2021-02-03,0,0,0,0,0,0,0,0,0,1,2,1,0,0,0,0,0,0,0,0,0,0,0,4,SDF4,0.125,1.1757,-1.0985,0,-1.0,-1.0,,
ENSG00000081177,4,3,1,0,0,1,161378.55789591218,338763.57771536184,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,4,EXD2,0.21499997,1.6331,2.1604,0,-1.0,-1.0,,
ENSG00000081479,3,3,0,0,1,1,55894.896962213366,384314.83364002535,2019-04-01,2,0,0,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,2,16,LRP2,0.648,4.5356,1.6298,5,0.5,0.5,Transport of RCbl within the body;Vitamin D (calciferol) metabolism;Metabolism of steroids,R-HSA-9758890;R-HSA-196791;R-HSA-8957322
ENSG00000090612,3,3,0,0,1,1,321652.32418617036,718784.6890415357,2020-06-15,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,ZNF268,-0.411,-2.4461,-2.5096,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000091136,5,3,1,1,1,1,15603.785966148887,160010.51072069994,2020-05-13,0,2,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,8,LAMB1,0.399,1.1458,0.99841,11,-1.0,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-597592
ENSG00000091138,7,3,0,0,0,1,10007.78992071779,301203.06999851385,2017-01-09,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,16,0,0,3,21,SLC26A3,0.143,0.67282,0.19623,2,1.0,0.5,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000091732,12,3,1,0,1,1,52463.65429696694,782476.8109259979,2011-03-06,0,0,0,0,27,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,30,ZC3HC1,0.19,1.4423,1.0466,1,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000099308,5,3,1,0,1,1,95776.89591443514,384314.83364002535,2019-07-01,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,3,6,MAST3,0.53400004,3.5367,-0.25751,0,0.5,-1.0,,
ENSG00000099331,4,3,1,0,0,1,219793.50457789513,521818.7070055739,2021-01-04,6,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,11,MYO9B,0.57,3.7698,-0.24062,9,0.5,-1.0,Signal Transduction;Immune System;Developmental Biology;Disease,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685
ENSG00000100097,3,3,0,1,0,0,29803.01405728205,78906.83616868555,2020-01-20,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,LGALS1,-0.47899997,0.40896,0.21699,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000101333,3,3,1,0,0,1,74722.59037384245,427337.4491868293,2018-08-13,0,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,9,PLCB4,0.491,3.2834,0.19532,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000102683,6,3,0,0,0,1,138890.6106237268,1424218.0900670097,2018-06-11,0,0,0,0,8,4,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,SGCG,-0.21099997,0.10352,-0.6925,1,0.75,0.0,,
ENSG00000103489,4,3,0,0,0,1,6323.890827983723,1122672.658801146,2023-01-18,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,XYLT1,0.522,0.76248,-0.91391,1,-1.0,0.0,Glycosaminoglycan-protein linkage region biosynthesis,R-HSA-1971475
ENSG00000105738,3,3,1,0,0,1,4414.095816431457,551389.5206213495,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,4,SIPA1L3,0.44099998,1.6897,-0.18757,0,-1.0,-1.0,,
ENSG00000105856,5,3,1,0,0,1,138890.6106237268,1129585.974638378,2022-07-14,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,5,HBP1,0.32099998,1.0517,0.17396,0,-1.0,-1.0,,
ENSG00000105928,9,3,1,0,0,1,49367.473680139236,633132.2332759313,2019-11-01,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,0,8,GSDME,-0.14199996,-0.38884,0.22178,4,-1.0,0.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000105954,4,3,0,0,0,1,5854.333407114106,433862.5685735124,2022-12-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,4,7,NPVF,-0.737,-0.4399,0.87353,0,1.0,0.5,,
ENSG00000105971,7,3,1,0,1,1,3985.392616290502,545988.1005477115,2017-04-17,0,0,0,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,37,CAV2,0.061999977,-0.31579,0.76187,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000106571,3,3,0,0,0,1,76632.8325989884,464892.4593283075,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,GLI3,0.702,1.066,-0.86002,5,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000107186,4,3,1,0,0,1,7794.273577144567,180089.50342935527,2021-03-01,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,4,MPDZ,-0.13800001,-4.4177,-2.8744,0,0.5,0.0,,
ENSG00000107968,5,3,1,0,0,1,32254.717802479194,382631.1172224132,2012-11-01,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,8,0,0,0,10,MAP3K8,0.42000002,2.6901,-0.18146,2,1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000108219,8,3,1,0,0,1,1321.7688442211056,502231.5406594711,2012-11-01,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,3,0,0,5,0,0,0,16,TSPAN14,0.315,2.3465,0.19297,2,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000108465,3,3,1,0,0,1,13217.328579372608,356440.71671986027,2018-12-10,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,1,4,CDK5RAP3,0.035000026,1.475,1.1209,0,-1.0,-1.0,,
ENSG00000108691,4,3,1,0,0,1,29050.862407491317,90566.66054026398,2023-01-18,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,5,CCL2,-0.84000003,0.893,0.47195,5,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;PERK regulates gene expression;ATF4 activates genes in response to endoplasmic reticulum  stress;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-381042;R-HSA-380994;R-HSA-449147;R-HSA-6785807
ENSG00000108953,6,3,1,0,0,1,55416.28042655659,756470.9740366563,2017-10-09,0,0,0,0,8,0,0,0,0,0,1,0,0,0,0,0,5,0,0,0,0,0,0,14,YWHAE,0.825,4.0589,-0.33558,21,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Rab regulation of trafficking;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-9007101;R-HSA-75035
ENSG00000108984,8,3,1,0,0,1,46282.676044693806,1470466.6505612188,2021-08-24,0,0,0,0,1,0,0,0,0,0,0,0,22,0,0,0,0,0,0,0,0,0,7,30,MAP2K6,0.36299998,3.4521,0.5055,8,0.5,0.0,Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins,R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147
ENSG00000109606,5,3,0,0,0,1,1173.5007132667617,323648.5577791949,2016-10-20,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,0,0,3,0,0,0,8,DHX15,0.844,7.9376,0.32561,1,-1.0,-1.0,,
ENSG00000109758,8,3,1,1,1,1,66438.21345734232,782476.8109259979,2021-12-06,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,8,HGFAC,-0.64,-2.4994,-2.931,1,1.0,0.5,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000109920,3,3,1,0,1,1,47679.51344648143,1129585.974638378,2022-07-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,3,FNBP4,0.648,0.95189,-0.749,0,-1.0,-1.0,,
ENSG00000109956,3,3,1,0,0,1,107949.90929360976,521818.7070055739,2020-11-10,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,B3GAT1,0.251,1.0997,-2.0473,1,1.0,0.0,Glycosaminoglycan-protein linkage region biosynthesis,R-HSA-1971475
ENSG00000110077,6,3,1,0,1,1,6306.411000302206,340825.7076940272,2011-04-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,1,0,0,2,15,MS4A6A,-0.33099997,0.00098546,0.1553,0,-1.0,-1.0,,
ENSG00000111199,3,3,0,0,1,1,11056.124104522269,427337.4491868293,2021-09-30,0,0,0,0,1,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,0,5,TRPV4,0.176,3.5725,0.7299,2,0.5,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000112038,3,3,1,0,1,1,5212.488325165754,138299.18470865054,2013-12-01,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,9,OPRM1,-0.08200002,-0.03313,0.15401,6,0.5,0.5,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);G-protein activation;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-202040;R-HSA-449147;R-HSA-6785807
ENSG00000112139,4,3,1,1,1,1,18665.604164523163,1778690.168860174,2022-07-14,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,5,MDGA1,0.23299998,1.5591,-0.38991,1,1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000112486,5,3,1,0,0,1,2209.8301559792026,298389.02809443185,2010-05-09,4,0,0,0,0,0,0,0,0,1,0,0,17,0,0,0,0,0,0,0,0,0,0,22,CCR6,-0.538,2.7238,-0.0095478,3,1.0,0.5,Signal Transduction;Immune System;Defensins;Antimicrobial peptides,R-HSA-162582;R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000112697,4,3,0,0,0,1,162367.55694122918,645988.1975077938,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,4,TMEM30A,0.09399998,1.6748,0.96712,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000113369,5,3,0,0,0,1,6716.9009698128675,427337.4491868293,2018-11-09,4,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,7,ARRDC3,0.675,2.3798,1.3456,0,-1.0,-1.0,,
ENSG00000113520,4,3,1,0,0,1,33224.221295945434,144127.33793912127,2021-11-16,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,IL4,0.20300001,0.38685,-0.1033,2,,,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-18 signaling;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9012546;R-HSA-6785807
ENSG00000113578,3,3,0,0,0,1,100620.50186431198,394357.452283155,2020-10-05,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,FGF1,-0.04100001,1.1744,-0.55953,40,1.0,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000114316,3,3,0,0,0,1,409691.21276290494,496380.6986910653,2021-11-04,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,3,USP4,0.277,2.1405,1.3032,4,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000115159,7,3,1,0,1,1,95776.89591443514,565426.5954047199,2022-06-28,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,0,0,0,0,0,1,5,GPD2,0.204,1.9915,0.34443,2,-1.0,-1.0,Synthesis of PA,R-HSA-1483166
ENSG00000115419,4,3,1,0,0,1,11252.882952659449,205433.03502595585,2021-02-03,1,0,0,0,0,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,GLS,-0.23399997,-0.87192,-2.2188,3,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Glutamate Neurotransmitter Release Cycle;Neurotransmitter release cycle,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-210500;R-HSA-112310
ENSG00000115421,3,3,0,0,0,1,30049.94565242696,322220.1169395476,2020-04-15,0,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,1,4,PAPOLG,0.52900004,2.753,-0.2769,1,-1.0,0.0,Nuclear RNA decay,R-HSA-9930044
ENSG00000115677,3,3,1,0,0,0,189845.9324918578,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,HDLBP,0.717,5.1351,0.20077,1,-1.0,-1.0,,
ENSG00000116701,7,3,1,0,1,1,1699.9078179437677,83896.55822718568,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,8,3,0,0,0,0,0,0,4,0,0,0,15,NCF2,0.20099998,2.0213,1.5808,8,0.5,0.0,Signal Transduction;Immune System;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-9006934
ENSG00000116729,4,3,1,0,0,1,30508.10029756623,189845.9324918578,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,6,0,0,1,10,WLS,0.525,1.7298,0.30547,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000117461,3,3,1,0,1,1,337860.4854363166,598869.4096893278,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,3,PIK3R3,-0.53499997,-0.86908,1.1066,18,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Regulation of signaling by CBL;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-912631;R-HSA-9006934;R-HSA-5663202
ENSG00000118137,3,3,0,1,0,1,2815.3867141162514,269602.2657190595,2013-08-21,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,4,APOA1,-0.16799998,0.30209,-0.17802,17,1.0,0.0,Disease;HDL remodeling;Plasma lipoprotein remodeling;Post-translational protein modification,R-HSA-1643685;R-HSA-8964058;R-HSA-8963899;R-HSA-597592
ENSG00000118785,4,3,1,1,0,1,4043.9032887820995,175016.11286382115,2021-04-08,0,0,0,0,2,0,0,0,0,0,0,0,5,0,0,0,0,0,0,8,0,0,0,15,SPP1,-0.33500004,0.83275,0.1776,7,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Receptor Tyrosine Kinases;RUNX3 Regulates Immune Response and Cell Migration;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9006934;R-HSA-8949275;R-HSA-597592;R-HSA-8878159
ENSG00000119318,4,3,0,0,1,1,606.6666666666666,521818.7070055739,2020-12-11,5,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,7,RAD23B,0.776,2.0988,-0.50523,4,-1.0,-1.0,N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Formation of Incision Complex in GG-NER;Post-translational protein modification,R-HSA-532668;R-HSA-5696395;R-HSA-597592
ENSG00000119535,11,3,1,1,0,1,71250.58603271045,1778690.168860174,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,10,0,0,1,0,0,0,16,CSF3R,0.274,2.4079,1.7861,4,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Developmental Biology;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-449147
ENSG00000119681,4,3,1,1,0,1,7578.3765154275925,143413.24457139417,2021-02-24,0,0,0,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,17,LTBP2,0.40499997,1.1725,0.055627,2,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000119682,5,3,1,0,0,1,442877.006007271,1122672.658801146,2019-02-04,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,10,AREL1,0.26099998,2.2104,0.49277,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000119950,3,3,1,0,0,1,42362.45324254164,227934.29698436207,2024-08-05,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,MXI1,0.16100001,1.2083,-1.0323,0,-1.0,-1.0,,
ENSG00000120457,6,3,1,0,0,1,32996.93546153374,645988.1975077938,2018-06-11,0,0,0,0,16,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,18,KCNJ5,0.088,2.0231,0.47902,2,0.5,0.0,Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Inwardly rectifying K+ channels,R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-1296065
ENSG00000120616,4,3,1,0,0,1,104865.12229088554,356440.71671986027,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,1,0,0,2,7,EPC1,0.771,3.3837,0.72171,2,1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8953750
ENSG00000121440,5,3,0,0,0,1,307.7185080928923,498258.534626183,2020-07-31,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,5,PDZRN3,0.40899998,-2.3433,-3.8763,0,-1.0,0.0,,
ENSG00000121691,3,3,1,1,0,1,1173.5007132667617,343998.09227709647,2022-07-22,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,CAT,0.100000024,0.51938,0.79123,5,0.5,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Peroxisomal protein import,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-9033241
ENSG00000122194,19,3,0,1,1,1,6918.109956479261,502231.5406594711,2015-09-07,0,0,0,0,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,14,44,PLG,0.44099998,1.5082,0.71041,6,1.0,0.5,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000122641,5,3,0,0,0,1,25967.06754524981,1424218.0900670097,2022-10-12,0,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,7,INHBA,0.834,2.8589,-0.50211,5,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000124172,4,3,0,0,0,1,62627.34914844415,1424218.0900670097,2023-01-18,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,10,ATP5F1E,-0.65400004,-0.10093,0.11955,2,-1.0,-1.0,Formation of ATP by chemiosmotic coupling;Cristae formation,R-HSA-163210;R-HSA-8949613
ENSG00000124749,3,3,1,0,0,1,115672.19495323602,275021.63051358337,2023-01-18,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,COL21A1,-0.339,-0.39551,-1.5217,2,0.5,0.0,,
ENSG00000125520,4,3,1,0,1,1,22541.66311868015,406587.2658730814,2013-04-01,8,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,10,SLC2A4RG,0.021000028,-0.90933,-3.016,0,0.5,-1.0,,
ENSG00000126653,4,3,1,0,0,1,6356.593451690605,260210.21963428933,2020-10-27,0,0,0,0,1,2,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,5,NSRP1,0.41799998,0.9203,0.26517,1,-1.0,-1.0,,
ENSG00000128298,3,3,1,0,1,1,162367.55694122918,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,3,BAIAP2L2,-0.46800005,-1.9641,-2.3195,1,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000128815,3,3,1,0,1,1,1036.6540600667408,124837.11004999638,2010-02-12,1,0,0,0,0,0,0,0,0,0,0,16,3,0,0,0,0,0,0,0,0,0,0,20,WDFY4,0.472,1.5402,0.1547,0,0.5,0.0,,
ENSG00000128849,5,3,1,0,0,1,1173.5007132667617,414433.58532016096,2021-09-30,0,0,0,2,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,6,CGNL1,-0.085999966,-1.7122,-0.61819,0,0.5,0.0,,
ENSG00000129003,5,3,1,0,1,1,4392.463820224719,575147.0632428399,2014-07-27,0,0,0,8,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,23,VPS13C,0.143,-1.3143,-0.29449,0,-1.0,-1.0,,
ENSG00000129128,3,3,0,0,0,1,29803.01405728205,1076472.0138856068,2020-01-20,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,4,SPCS3,0.37699997,1.1162,-0.81391,5,-1.0,-1.0,Disease;Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-1643685;R-HSA-72766;R-HSA-1799339
ENSG00000129214,3,3,1,1,1,1,16516.60902750872,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,8,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,11,SHBG,-0.095999956,0.94071,0.000696,0,1.0,0.5,,
ENSG00000131080,4,3,0,1,1,1,260210.21963428933,464892.4593283075,2023-01-18,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,EDA2R,,,,1,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000131165,3,3,1,1,0,1,116388.33957200912,1470466.6505612188,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,3,CHMP1A,-0.044999957,-0.26423,-1.3481,1,-1.0,-1.0,Disease;HCMV Late Events,R-HSA-1643685;R-HSA-9610379
ENSG00000131724,4,3,1,1,0,1,61498.92173410762,294387.2978738704,2019-02-04,0,0,0,0,0,6,0,0,0,0,2,0,0,0,0,0,0,0,3,0,0,0,0,11,IL13RA1,,,,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000131759,3,3,0,0,0,0,776.63523573201,776.63523573201,2020-11-17,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,RARA,0.746,3.3912,0.21024,6,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-597592
ENSG00000131979,6,3,1,0,0,1,4392.463820224719,328052.24452619,2014-07-27,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,6,0,0,1,11,GCH1,0.10100001,0.62902,-1.6717,1,0.5,0.0,,
ENSG00000132535,3,3,1,0,0,0,112184.2204720767,500292.45069431677,2021-12-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,DLG4,0.849,4.8436,1.0482,14,0.75,-1.0,Signal Transduction;Activation of Ca-permeable Kainate Receptor;Ionotropic activity of kainate receptors;LGI-ADAM interactions;Developmental Biology;Activation of kainate receptors upon glutamate binding;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-451308;R-HSA-451306;R-HSA-5682910;R-HSA-1266738;R-HSA-451326;R-HSA-9006934
ENSG00000135069,4,3,0,0,0,1,1173.5007132667617,1424218.0900670097,2019-11-01,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,5,PSAT1,-0.30499995,0.97952,1.1077,1,0.5,0.0,Serine metabolism,R-HSA-977347
ENSG00000135903,3,3,1,0,0,1,52444.40424400289,1778690.168860174,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,4,0,0,2,8,PAX3,0.59099996,1.8017,-0.40543,3,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000136848,8,3,1,0,0,1,2288.8778073359817,464892.4593283075,2010-07-11,0,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,18,DAB2IP,0.593,1.5228,-2.0395,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000136859,4,3,1,0,0,1,42359.490817992155,356440.71671986027,2021-02-24,0,0,0,8,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,10,ANGPTL2,0.357,1.9108,0.35663,0,-1.0,0.0,,
ENSG00000137166,8,3,1,0,0,1,2302.4421471172964,521818.7070055739,2016-08-09,29,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,40,FOXP4,0.504,0.9111,-1.0806,0,-1.0,-1.0,,
ENSG00000137473,11,3,1,0,1,1,52982.28647069224,461914.58891516324,2023-01-18,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,5,13,TTC29,0.112999976,-0.17572,0.057626,0,0.75,0.5,,
ENSG00000137693,3,3,1,0,0,1,5148.813701236917,360605.992793193,2012-08-12,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,7,YAP1,0.788,1.3479,-0.71755,12,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Signaling by Receptor Tyrosine Kinases;Zygotic genome activation (ZGA);Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9006934;R-HSA-9819196;R-HSA-8878159
ENSG00000138081,3,3,1,0,0,1,239495.8061730764,1778690.168860174,2022-07-14,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,FBXO11,0.78499997,4.098,-2.8883,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000138101,7,3,1,0,0,1,14417.426808127037,765591.3646788632,2016-07-01,6,0,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,DTNB,0.06400001,0.78178,0.1719,1,0.5,-1.0,,
ENSG00000138166,4,3,0,0,1,1,1233.0624505928854,235397.69820205137,2013-07-14,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,7,0,0,0,10,DUSP5,-0.069000006,-1.4189,-2.6072,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000138439,3,3,1,0,0,1,7729.393499458288,515513.2178404211,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,7,FAM117B,0.236,0.11071,-1.8345,0,-1.0,0.0,,
ENSG00000138663,4,3,0,0,0,1,141293.18354755783,645988.1975077938,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,4,COPS4,0.696,3.2445,-0.27994,5,-1.0,-1.0,Signal Transduction;Formation of TC-NER Pre-Incision Complex;RHOBTB1 GTPase cycle;Transcription-Coupled Nucleotide Excision Repair (TC-NER);RHOBTB GTPase Cycle;Post-translational protein modification,R-HSA-162582;R-HSA-6781823;R-HSA-9013422;R-HSA-6781827;R-HSA-9706574;R-HSA-597592
ENSG00000138670,4,3,1,0,0,1,63200.72664467542,394357.452283155,2017-12-06,0,0,0,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,8,RASGEF1B,0.35900003,1.2326,1.1913,0,0.5,-1.0,,
ENSG00000139155,5,3,1,0,0,1,72148.96319633072,235397.69820205137,2023-01-18,4,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,SLCO1C1,-0.15100002,-0.92825,-0.46386,1,0.75,0.5,"Transport of vitamins, nucleosides, and related molecules",R-HSA-425397
ENSG00000139350,5,3,0,0,0,1,46959.34409726352,360605.992793193,2020-11-26,0,0,0,0,1,2,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,6,NEDD1,0.15799999,0.47722,0.23547,7,-1.0,-1.0,,
ENSG00000139910,5,3,1,0,0,1,95776.89591443514,433862.5685735124,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,0,0,0,0,0,1,6,NOVA1,0.622,2.481,-1.3543,0,0.5,0.0,,
ENSG00000140030,6,3,1,0,1,1,17831.529851792977,263416.51565448404,2010-11-21,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,11,0,0,0,13,GPR65,-0.93299997,0.51686,1.1562,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000140319,6,3,1,0,0,1,1555.3915044988491,448058.917711015,2012-02-12,3,0,0,0,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,SRP14,0.678,1.248,-0.57584,2,-1.0,-1.0,Immune System;Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-168256;R-HSA-72766;R-HSA-1799339
ENSG00000140474,3,3,1,0,1,1,145171.50087288846,267702.03251961316,2021-04-08,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,ULK3,-0.16100001,-0.33036,-0.98309,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000140538,6,3,1,1,0,1,49076.16312667074,132781.32332824613,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,0,0,0,0,1,5,NTRK3,0.653,2.6287,-1.5625,10,0.5,0.0,Signal Transduction;Disease;Receptor-type tyrosine-protein phosphatases;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-388844;R-HSA-9006934;R-HSA-5663202
ENSG00000140575,5,3,1,0,0,1,70127.81876237011,322220.1169395476,2019-07-30,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,1,0,0,3,8,IQGAP1,0.605,2.2286,-0.273,19,-1.0,-1.0,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202
ENSG00000140876,5,3,1,0,0,1,12050.555429421123,143413.24457139417,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2,6,NUDT7,-0.941,-1.1899,-0.90656,2,0.5,-1.0,Peroxisomal protein import,R-HSA-9033241
ENSG00000141441,3,3,0,0,0,1,28292.123952140868,86355.0747064496,2023-01-18,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,GAREM1,0.49299997,1.1886,0.12188,0,0.5,0.0,,
ENSG00000142156,4,3,1,0,1,1,59709.43958950876,333304.3295866077,2018-08-13,0,0,0,1,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,12,COL6A1,0.29400003,0.3978,-0.73388,8,0.5,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000142178,3,3,0,0,0,1,72148.96319633072,438004.58573217486,2019-04-02,3,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,SIK1,,,,1,-1.0,0.0,,
ENSG00000143322,4,3,1,0,0,1,7199.101761070433,1424218.0900670097,2020-06-15,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,5,ABL2,0.422,2.4001,0.39799,4,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738
ENSG00000143382,6,3,1,1,0,1,1458.170321264661,360605.992793193,2016-06-20,0,0,0,0,8,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,11,ADAMTSL4,0.07999998,0.93574,0.079394,2,-1.0,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000143469,3,3,1,0,0,1,2977.227192317412,895916.2144062951,2020-08-06,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,SYT14,0.44700003,2.8227,1.7849,0,0.5,0.5,,
ENSG00000143727,3,3,1,1,1,1,190279.23963861223,433862.5685735124,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,1,4,ACP1,-0.54700005,0.26275,-0.28177,0,-1.0,-1.0,,
ENSG00000144724,6,3,0,0,0,1,26561.371714038676,141293.18354755783,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,2,7,PTPRG,0.286,0.44516,0.40722,0,-1.0,0.0,,
ENSG00000144749,4,3,1,0,1,1,17634.65533758174,645988.1975077938,2017-03-27,1,0,0,0,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,LRIG1,0.35399997,-1.7609,-3.7585,3,0.5,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000145743,3,3,0,0,0,1,353105.3286394775,1122672.658801146,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,FBXL17,0.32200003,-2.6134,-4.9424,1,0.5,0.0,,
ENSG00000147459,3,3,1,0,0,1,100711.28404230655,147316.01557138463,2023-01-18,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,DOCK5,0.32099998,1.73,-0.0058555,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000148053,4,3,1,0,0,1,5570.255350886628,1122672.658801146,2019-11-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,1,4,NTRK2,0.877,5.2938,1.4506,14,0.5,0.0,Signal Transduction;Activated NTRK2 signals through FYN;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-9032500;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000148288,3,3,1,0,0,1,74722.59037384245,519652.4132779146,2023-02-10,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,4,GBGT1,-0.245,0.60901,0.71362,0,-1.0,-1.0,,
ENSG00000148308,4,3,0,0,0,1,4804.684371102268,107200.17738606388,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,6,GTF3C5,-0.052000046,0.60259,-0.38288,3,-1.0,-1.0,RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-76046;R-HSA-76061;R-HSA-76066;R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000148700,3,3,1,0,0,1,1224.1183406113537,133918.94977035935,2020-04-27,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,ADD3,0.605,0.99475,0.36514,3,-1.0,-1.0,Signal Transduction;Miscellaneous transport and binding events,R-HSA-162582;R-HSA-5223345
ENSG00000150244,4,3,0,0,0,1,31935.015289867086,168116.01355658393,2022-10-12,0,0,0,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,8,TRIM48,-0.579,-2.1096,-2.6937,1,,,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000150672,4,3,0,0,0,0,76832.90012167432,294763.3750742061,2017-09-11,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,5,DLG2,0.556,1.8693,0.05286,7,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000151208,4,3,1,0,0,1,90049.68162979394,383158.3001114715,2021-08-24,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,4,DLG5,0.667,2.9122,0.57287,5,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000152056,5,3,1,0,0,1,51964.39839555753,295550.4496098593,2019-03-28,0,0,0,0,0,0,0,0,0,0,3,2,0,0,0,0,0,0,0,1,0,0,0,6,AP1S3,0.18300003,1.0652,1.6332,4,0.5,0.0,Immune System;Disease;Lysosome Vesicle Biogenesis,R-HSA-168256;R-HSA-1643685;R-HSA-432720
ENSG00000152256,3,3,1,0,0,1,8879.64685213962,521818.7070055739,2017-01-09,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,9,PDK1,-0.268,-0.67004,-1.2316,3,-1.0,-1.0,Signal Transduction;Regulation of pyruvate metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism,R-HSA-162582;R-HSA-9861718;R-HSA-204174;R-HSA-70268
ENSG00000152430,4,3,1,0,0,0,36971.17314636357,109754.42426572418,2019-10-24,0,2,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,4,BOLL,0.19,0.71727,0.59654,0,1.0,0.5,,
ENSG00000152503,7,3,0,0,0,1,13217.328579372608,645988.1975077938,2018-07-30,0,0,0,0,12,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,15,TRIM36,0.25300002,-0.26848,-0.50452,1,0.75,0.0,Immune System,R-HSA-168256
ENSG00000152527,4,3,1,0,1,1,34004.8644513982,804063.9714459113,2017-01-09,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,5,PLEKHH2,0.181,-2.0004,-1.2698,0,-1.0,0.0,,
ENSG00000153246,3,3,1,1,1,1,1796.7214927436075,672632.4785173276,2011-02-22,0,0,0,0,1,0,0,0,0,0,0,13,0,0,0,0,0,1,0,0,0,0,0,15,PLA2R1,0.0,1.1544,0.052984,6,0.5,0.0,Acyl chain remodelling of PS;Acyl chain remodelling of PG;Acyl chain remodelling of PI;Synthesis of PA;Acyl chain remodelling of PC;Acyl chain remodelling of PE,R-HSA-1482801;R-HSA-1482925;R-HSA-1482922;R-HSA-1483166;R-HSA-1482788;R-HSA-1482839
ENSG00000153820,4,3,0,0,0,1,6149.559264013693,1424218.0900670097,2018-10-03,0,0,0,0,0,3,0,0,0,0,0,0,2,0,0,0,3,0,0,0,0,0,0,8,SPHKAP,0.41399997,0.55867,0.27256,0,0.75,0.5,,
ENSG00000153930,6,3,0,0,0,1,28481.446138431995,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,10,0,0,0,0,0,0,0,0,0,5,16,ANKFN1,0.259,-0.3748,0.038759,0,0.5,0.5,,
ENSG00000154229,7,3,1,1,0,1,5495.191484272216,756470.9740366563,2021-01-25,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,10,PRKCA,0.603,4.5421,-0.22175,20,0.5,0.0,Signal Transduction;Acetylcholine regulates insulin secretion;Developmental Biology;EGFR Transactivation by Gastrin;Depolymerization of the Nuclear Lamina;HuR (ELAVL1) binds and stabilizes mRNA;WNT5A-dependent internalization of FZD4;Gastrin-CREB signalling pathway via PKC and MAPK;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-399997;R-HSA-1266738;R-HSA-2179392;R-HSA-4419969;R-HSA-450520;R-HSA-5099900;R-HSA-881907;R-HSA-9006934
ENSG00000154721,3,3,1,0,0,0,205425.60717824215,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,3,JAM2,0.06999999,0.58471,-0.38271,2,0.5,0.0,,
ENSG00000155324,3,3,1,0,0,1,7600.005437861108,78398.053695655,2019-05-15,0,0,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,GRAMD2B,-0.22399998,0.76502,0.65162,0,-1.0,-1.0,,
ENSG00000155366,3,3,1,0,0,1,86992.9057658324,267702.03251961316,2022-09-15,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,RHOC,-0.024000049,2.1466,-0.14295,8,-1.0,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000155393,11,3,1,0,0,1,3288.4396493594068,355284.1215006515,2012-09-09,14,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,16,HEATR3,-0.15699995,0.35328,-1.1452,0,-1.0,-1.0,,
ENSG00000155749,12,3,1,0,1,1,12748.270862028934,367949.31877243903,2015-04-09,10,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,12,FLACC1,-0.20500004,0.97727,0.6455,0,0.5,0.0,,
ENSG00000155897,3,3,0,0,0,1,23238.11336553945,58995.33218928629,2020-01-31,2,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,ADCY8,0.41399997,2.0467,-0.22811,16,0.75,0.5,Signal Transduction;CREB1 phosphorylation through the activation of Adenylate Cyclase;Disease,R-HSA-162582;R-HSA-442720;R-HSA-1643685
ENSG00000156804,5,3,1,0,0,1,29803.01405728205,645988.1975077938,2018-06-11,1,0,0,14,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,FBXO32,0.45999998,2.3169,0.643,3,1.0,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000157404,3,3,0,1,0,1,2240.9147424511543,464892.4593283075,2018-03-01,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,3,KIT,0.76,4.1661,0.5569,20,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202;R-HSA-8864260
ENSG00000158169,4,3,0,0,0,1,16168.601665727347,765591.3646788632,2020-06-15,0,0,0,0,3,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,FANCC,-0.021999955,0.41238,-0.68071,3,0.5,0.0,Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000162618,3,3,0,0,0,1,5200.0606458032635,438447.5304388146,2021-06-01,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,ADGRL4,-0.44000006,-0.5177,-0.79807,0,0.5,0.0,,
ENSG00000162779,3,3,1,0,1,1,32056.464442383058,427337.4491868293,2019-11-18,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,AXDND1,0.018999994,0.11872,0.035144,0,1.0,1.0,,
ENSG00000162897,3,3,0,0,0,1,100075.58738100652,258213.8601133611,2023-01-18,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,3,FCAMR,-0.17200005,0.38249,-0.25351,1,0.75,0.5,,
ENSG00000162989,3,3,0,0,0,1,28821.88430161129,258456.3496858129,2019-06-24,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,6,KCNJ3,0.777,5.493,0.76247,2,0.5,0.0,Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Inwardly rectifying K+ channels,R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-1296065
ENSG00000163132,6,3,0,0,0,1,71387.66703162997,360837.067725683,2017-10-30,0,0,0,0,0,0,0,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,6,10,MSX1,-0.28900003,-1.4494,-2.2786,1,0.75,0.0,Developmental Biology,R-HSA-1266738
ENSG00000163510,4,3,0,0,0,1,95776.89591443514,521818.7070055739,2022-06-28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,CWC22,0.125,0.96759,0.47527,1,-1.0,-1.0,,
ENSG00000163596,13,3,1,0,0,1,6040.069513406157,1778690.168860174,2009-02-08,0,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,4,18,ICA1L,0.14200002,1.0951,1.4795,0,0.5,0.0,,
ENSG00000163673,10,3,1,0,0,1,14577.354388342934,633132.2332759313,2011-12-20,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,12,0,0,1,0,0,0,14,DCLK3,0.052999973,0.69994,-1.6327,0,0.5,0.5,,
ENSG00000164199,7,3,0,0,0,1,12410.70681955995,323648.5577791949,2020-04-27,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,9,ADGRV1,0.36299998,2.3256,1.0709,1,1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000164211,3,3,0,0,0,1,11366.70347515427,482893.2730520582,2018-11-08,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,9,STARD4,-0.648,0.57022,-0.092029,1,-1.0,-1.0,Pregnenolone biosynthesis;Metabolism of steroids,R-HSA-196108;R-HSA-8957322
ENSG00000164344,6,3,1,1,1,1,23297.025078966395,62629.11170662631,2019-01-19,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,8,KLKB1,0.026000023,0.65772,-0.40272,4,1.0,0.0,Disease,R-HSA-1643685
ENSG00000164398,3,3,1,0,0,1,21020.801882160395,225599.91693237546,2021-11-04,0,1,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,ACSL6,0.416,2.3193,-0.19327,1,0.5,0.0,Synthesis of very long-chain fatty acyl-CoAs;Fatty acyl-CoA biosynthesis,R-HSA-75876;R-HSA-75105
ENSG00000164649,4,3,1,0,0,1,2253.2118120381815,521818.7070055739,2011-11-27,10,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,CDCA7L,0.01700002,-0.6865,-0.84558,0,0.5,-1.0,,
ENSG00000164841,3,3,1,0,0,1,165565.7343481966,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,1,4,TMEM74,-0.07200003,0.46007,-0.11939,0,0.5,0.5,,
ENSG00000165916,4,3,1,0,0,1,59709.43958950876,356440.71671986027,2021-09-30,0,0,0,3,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,PSMC3,0.648,5.0225,0.69308,62,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000166275,4,3,1,0,0,1,15866.724081734988,165063.00332091324,2014-07-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,6,BORCS7,-0.48399997,-0.12554,-0.96428,0,-1.0,-1.0,,
ENSG00000166396,7,3,1,0,1,1,31832.908703542336,233499.4066209918,2019-03-28,0,0,0,0,0,0,0,0,2,0,9,0,0,0,0,0,0,0,0,0,0,0,2,13,SERPINB7,-0.049000025,-0.54549,0.21487,0,0.75,0.5,,
ENSG00000166780,3,3,1,0,0,1,17115.61307125707,1129585.974638378,2017-06-12,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,BMERB1,0.143,0.39186,-0.96367,0,0.5,-1.0,,
ENSG00000167191,6,3,1,0,0,1,89519.16315227402,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,3,0,0,0,0,0,2,14,GPRC5B,0.21499997,2.0329,0.24354,0,0.5,0.0,,
ENSG00000167261,3,3,1,1,0,1,21584.376825785395,207220.14223281175,2021-05-22,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,4,DPEP2,-0.08899999,0.46639,0.094027,3,0.5,0.0,Disease;Aflatoxin activation and detoxification;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonate metabolism,R-HSA-1643685;R-HSA-5423646;R-HSA-2142691;R-HSA-2142753
ENSG00000167941,8,3,1,0,0,1,30508.10029756623,191895.42310022408,2018-08-29,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,8,0,0,11,SOST,-0.63399994,-0.55315,-1.6453,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000168386,4,3,1,0,0,1,59060.02777333318,189385.65312252965,2020-05-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,5,FILIP1L,0.315,1.0806,1.2845,0,-1.0,0.0,,
ENSG00000169189,4,3,1,0,0,1,31137.07865241903,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,1,0,3,0,0,0,0,0,0,0,0,2,0,0,0,6,NSMCE1,0.15399998,0.82383,0.67064,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000169224,3,3,1,0,1,1,33910.05821821659,157563.09954473734,2021-09-30,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,2,0,0,0,2,0,0,0,11,GCSAML,-0.827,0.21608,1.1201,0,0.5,0.5,,
ENSG00000169347,6,3,1,0,1,1,17257.066666666666,1424218.0900670097,2019-02-04,0,0,0,0,0,12,0,0,0,0,0,0,2,0,0,0,0,0,2,0,0,0,0,16,GP2,-0.09099996,0.72783,-0.69206,2,1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000169836,4,3,0,0,0,1,48204.250315121484,552272.0184005043,2020-09-21,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,TACR3,-0.21000004,0.99959,0.1362,2,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000169896,5,3,1,0,1,1,1055.3059723939707,26873.80285776456,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,8,7,0,0,0,0,0,0,1,0,0,0,16,ITGAM,0.32200003,1.3471,0.20711,5,1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000170324,4,3,1,0,0,1,63200.72664467542,1424218.0900670097,2022-07-13,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,4,FRMPD2,0.05400002,-0.55022,-0.072397,0,1.0,0.5,,
ENSG00000170801,3,3,0,0,0,1,73985.70318108075,356440.71671986027,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,3,0,0,0,5,HTRA3,-0.385,-0.50125,-1.0471,0,0.5,0.0,,
ENSG00000170820,6,3,0,0,1,1,5148.813701236917,144744.15797648102,2012-08-12,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,4,FSHR,-0.07099998,-0.96401,-2.209,2,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000170946,4,3,1,0,0,1,7055.2570020983485,1990918.947961699,2014-07-15,0,0,0,1,1,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,5,DNAJC24,-0.51400006,0.64845,0.23993,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000171560,10,3,0,0,1,1,11905.323060471395,410642.56898295006,2018-03-12,0,0,0,0,15,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,20,FGA,-0.502,0.52576,-0.38201,21,1.0,0.0,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000171763,4,3,1,0,1,1,606.6666666666666,125558.52890364222,2020-12-11,0,1,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,AFG2B,-0.17999995,-0.61292,-1.8426,0,-1.0,-1.0,,
ENSG00000173166,3,3,0,0,0,1,188650.0849055397,557593.503930131,2019-01-21,0,0,0,0,0,0,1,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,4,RAPH1,0.622,0.69212,-0.40631,0,0.5,-1.0,,
ENSG00000173757,4,3,1,0,0,1,36645.767033906064,562534.7696387965,2019-04-26,0,0,0,0,0,0,0,0,0,0,8,0,0,0,2,0,0,0,0,0,0,0,1,11,STAT5B,0.723,5.1347,2.1209,20,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202
ENSG00000174343,6,3,0,0,0,1,2957.836375929682,381165.6245253304,2011-08-14,0,0,0,0,0,0,0,0,0,4,0,0,0,0,2,0,0,0,0,1,0,0,0,7,CHRNA9,0.11799997,0.28523,0.4059,2,,,,
ENSG00000174579,6,3,1,0,0,1,205425.60717824215,645988.1975077938,2017-12-06,0,0,0,0,5,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,7,MSL2,0.831,3.003,-0.68717,1,0.5,-1.0,,
ENSG00000175189,3,3,0,1,1,0,22803.782307526988,394357.452283155,2017-12-06,1,0,0,0,3,0,0,0,0,0,0,0,17,0,0,0,0,0,0,0,0,0,0,21,INHBC,-0.176,1.2476,1.2821,1,1.0,1.0,,
ENSG00000175920,7,3,0,0,0,1,16918.70929392283,464892.4593283075,2021-12-06,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,8,DOK7,-0.658,-4.997,-4.6737,0,0.5,0.0,,
ENSG00000176715,5,3,0,0,1,1,28498.101402717097,408814.07183661876,2021-09-30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,1,7,ACSF3,-0.71500003,-2.0014,-2.2741,1,-1.0,-1.0,Synthesis of very long-chain fatty acyl-CoAs;Fatty acyl-CoA biosynthesis,R-HSA-75876;R-HSA-75105
ENSG00000176845,8,3,1,0,0,1,32770.26657396631,473900.221403792,2018-08-13,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,13,METRNL,0.14999998,0.19412,-0.91787,0,0.5,-1.0,,
ENSG00000177182,3,3,1,0,0,1,338763.57771536184,415452.66715166246,2023-01-18,0,0,0,1,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,4,CLVS1,0.527,1.951,0.46773,1,0.5,0.5,Lysosome Vesicle Biogenesis,R-HSA-432720
ENSG00000177380,3,3,1,0,0,0,71913.46219676935,448058.917711015,2021-11-04,0,0,0,0,2,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,6,PPFIA3,0.736,5.0536,0.023361,6,0.5,0.0,Acetylcholine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Receptor-type tyrosine-protein phosphatases;Neurotransmitter release cycle,R-HSA-264642;R-HSA-210500;R-HSA-212676;R-HSA-181429;R-HSA-388844;R-HSA-112310
ENSG00000178078,4,3,1,0,1,1,115338.82014347943,183761.6081180644,2024-07-19,0,0,0,0,0,0,0,0,3,0,0,1,0,0,0,0,0,0,0,1,0,0,0,5,STAP2,-0.34300005,0.024568,-0.6814,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000178409,6,3,0,0,0,1,108425.35980999071,1424218.0900670097,2018-10-08,0,0,0,0,0,7,0,0,0,2,0,0,0,0,0,0,0,0,0,2,0,0,0,11,BEND3,0.661,2.9929,0.28945,0,-1.0,0.0,,
ENSG00000178828,8,3,0,0,0,1,2902.7699290780142,301203.06999851385,2009-01-04,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,39,0,0,0,42,RNF186,-0.873,0.31402,-0.58889,0,0.5,0.5,,
ENSG00000179165,3,3,0,0,0,0,36204.236233123425,83932.6290685273,2013-11-01,0,0,0,0,0,0,0,0,0,0,0,0,3,0,1,0,0,0,0,0,0,0,1,5,PXT1,-0.36300004,0.34546,0.44652,0,1.0,1.0,,
ENSG00000180263,7,3,1,0,0,1,27151.057170554835,502231.5406594711,2017-12-06,0,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,13,FGD6,0.30900002,2.6883,1.8391,0,-1.0,-1.0,,
ENSG00000180929,3,3,0,0,0,1,11879.507365909985,11879.507365909985,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,3,GPR62,-0.93799996,-1.5539,-1.7843,0,1.0,0.5,,
ENSG00000181004,3,3,0,0,0,1,98425.9553998263,157378.92113144128,2018-08-13,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,1,0,0,0,4,BBS12,-0.41900003,1.5921,0.53539,1,0.5,0.0,BBSome-mediated cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620922;R-HSA-5620920
ENSG00000181220,4,3,1,0,0,1,38092.548464040476,1424218.0900670097,2019-09-01,0,0,0,0,2,3,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,ZNF746,0.45,1.1353,-0.95144,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000181786,3,3,0,0,0,1,2784.605232861827,87360.012040253,2019-03-28,0,0,0,0,0,0,1,0,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,6,ACTL9,-0.57500005,-0.55083,-0.51416,0,1.0,1.0,,
ENSG00000182667,4,3,1,0,0,1,294763.3750742061,1778690.168860174,2019-07-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,3,5,NTM,0.508,1.583,0.10145,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000183072,10,3,1,0,0,1,4245.506600377164,756470.9740366563,2018-03-12,0,0,0,0,23,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,27,NKX2-5,0.679,0.35138,0.036867,3,1.0,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000183287,3,3,1,0,0,1,5283.497167082224,383158.3001114715,2023-01-18,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CCBE1,0.06699997,-0.014009,-1.0855,0,0.5,0.0,,
ENSG00000183454,9,3,1,0,0,1,15866.724081734988,633132.2332759313,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,0,0,1,0,0,1,17,GRIN2A,0.732,3.7232,-0.99497,7,1.0,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000183888,4,3,0,0,0,1,48013.53134222642,464892.4593283075,2023-01-18,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,SRARP,-0.9,0.24484,0.088005,0,0.5,0.5,,
ENSG00000183891,11,3,1,0,0,1,4654.903581267217,502231.5406594711,2012-07-01,0,0,0,0,28,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,39,TTC32,-0.655,-0.017951,-1.1496,0,-1.0,-1.0,,
ENSG00000184384,6,3,0,0,0,1,1173.5007132667617,122549.0830919942,2012-11-01,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,6,MAML2,0.69200003,0.6753,-0.67393,11,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-8878159
ENSG00000184557,9,3,0,0,0,1,78906.83616868555,1470466.6505612188,2020-04-15,0,0,0,0,0,0,0,0,0,0,2,0,11,0,0,0,0,0,0,0,0,0,3,16,SOCS3,0.035000026,1.8697,-0.46091,15,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147;R-HSA-597592;R-HSA-6785807
ENSG00000185591,3,3,1,0,0,1,650.6230088495576,427337.4491868293,2019-12-19,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,SP1,0.831,1.9581,-0.94886,10,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Metabolism of steroids;RNA polymerase II transcribes snRNA genes;Regulation of cholesterol biosynthesis by SREBP (SREBF);SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-8957322;R-HSA-6807505;R-HSA-1655829;R-HSA-2173796;R-HSA-2173793
ENSG00000185619,4,3,1,0,0,1,53182.30026560605,1424218.0900670097,2018-10-08,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,0,11,PCGF3,0.5,1.7889,-1.3034,0,-1.0,-1.0,,
ENSG00000185787,9,3,1,0,0,1,16954.933657438592,394357.452283155,2011-03-06,0,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,22,MORF4L1,0.729,2.6974,0.78906,1,-1.0,-1.0,,
ENSG00000186010,6,3,1,0,0,1,13312.090120192841,1778690.168860174,2014-07-22,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,8,0,0,0,0,0,0,13,NDUFA13,-0.301,-0.55777,-0.42203,3,-1.0,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000186104,3,3,1,0,0,1,28863.30790298137,426392.4103859523,2021-01-07,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,3,9,CYP2R1,-0.113000035,0.39152,-0.083039,3,-1.0,0.0,Disease;Vitamin D (calciferol) metabolism;Metabolism of steroids,R-HSA-1643685;R-HSA-196791;R-HSA-8957322
ENSG00000186260,4,3,0,0,0,1,59049.74494220139,190279.23963861223,2021-11-04,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,2,0,0,0,5,MRTFB,0.649,1.1111,0.18512,0,-1.0,-1.0,,
ENSG00000186591,3,3,1,0,0,1,86869.04450932604,235397.69820205137,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,4,UBE2H,0.756,3.9117,1.0393,2,-1.0,-1.0,Immune System;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Protein ubiquitination;Post-translational protein modification,R-HSA-168256;R-HSA-8866652;R-HSA-8852135;R-HSA-597592
ENSG00000186665,4,3,0,0,1,1,50366.5001531924,338763.57771536184,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,1,0,0,0,0,0,4,C17orf58,-0.48800004,0.55749,1.2305,0,0.5,-1.0,,
ENSG00000186834,3,3,0,1,0,1,47692.964985095256,322220.1169395476,2021-04-08,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,3,HEXIM1,0.852,1.9377,-0.77896,0,-1.0,-1.0,,
ENSG00000187079,8,3,1,0,0,1,66143.86334580673,598869.4096893278,2021-08-24,0,0,0,1,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,0,0,0,4,19,TEAD1,0.724,2.6967,-0.12663,3,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Transcriptional regulation by RUNX3,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-8878159
ENSG00000187605,3,3,0,0,0,1,3902.1881946159547,258673.33020768655,2012-12-27,0,0,0,0,0,0,0,0,0,0,0,3,3,0,0,0,0,0,0,1,0,0,0,7,TET3,0.787,3.5548,-1.0894,2,0.5,0.0,Developmental Biology;Gene expression (Transcription);Chromatin modifications during the maternal to zygotic transition (MZT),R-HSA-1266738;R-HSA-74160;R-HSA-9821002
ENSG00000189114,3,3,0,0,1,1,141553.2677895436,290494.30239723594,2021-10-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,0,1,5,BLOC1S3,-0.83599997,-1.3295,-1.1953,1,-1.0,-1.0,,
ENSG00000189403,3,3,1,0,0,1,180089.50342935527,1424218.0900670097,2018-10-08,0,0,0,0,0,3,0,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,7,HMGB1,0.832,3.3365,0.2466,11,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147
ENSG00000196482,3,3,0,0,0,1,87545.45580019058,1076472.0138856068,2016-05-16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,ESRRG,0.536,2.7657,0.29192,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000196781,4,3,1,0,0,1,72258.6642662147,1424218.0900670097,2017-09-04,0,0,0,2,0,32,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,35,TLE1,0.657,2.4987,-1.0553,4,-1.0,-1.0,Signal Transduction;Formation of the beta-catenin:TCF transactivating complex,R-HSA-162582;R-HSA-201722
ENSG00000196937,5,3,0,0,0,1,64867.9873639546,191895.42310022408,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,3,0,0,8,FAM3C,0.092999995,1.212,0.086095,1,-1.0,-1.0,,
ENSG00000197272,5,3,1,1,1,1,9770.187636657778,42695.388792574355,2012-11-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,0,0,0,5,IL27,0.29799998,0.32572,0.41271,1,1.0,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000197859,4,3,0,0,0,1,72982.48880358285,313882.50400013494,2022-03-24,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,5,ADAMTSL2,0.32099998,1.0796,-0.89423,2,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000198223,6,3,0,0,0,1,9539.63031657299,298504.9722193353,2023-01-18,1,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,1,11,CSF2RA,,,,6,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Surfactant metabolism;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-5683826;R-HSA-449147
ENSG00000198597,4,3,0,0,0,1,636.1886490807354,574170.6270919729,2012-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,2,0,0,0,1,10,ZNF536,0.755,2.0591,-1.0372,0,0.5,0.0,,
ENSG00000198807,12,3,1,0,0,1,22345.675520395987,1470466.6505612188,2013-04-01,12,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,2,23,PAX9,0.565,0.92775,0.065255,0,0.75,0.5,,
ENSG00000198837,4,3,1,0,1,1,72098.8014618248,406587.2658730814,2021-01-04,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,7,DENND4B,0.473,4.0283,1.0954,1,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000198929,4,3,1,0,0,1,5669.479986077271,44660.84794838759,2020-05-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,2,4,NOS1AP,0.505,2.0461,0.3399,0,1.0,0.0,,
ENSG00000198947,4,3,0,0,0,0,38970.013185525226,275021.63051358337,2021-03-23,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,5,DMD,,,,3,-1.0,0.0,,
ENSG00000198961,5,3,1,0,1,1,13883.57970142381,36494.548446257475,2018-08-13,2,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,1,10,PJA2,0.52,0.61825,-0.33754,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000203883,5,3,1,0,1,1,15223.454539395489,235397.69820205137,2018-08-13,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,13,SOX18,-0.48300004,-2.8079,-3.9078,0,0.5,0.0,,
ENSG00000204099,6,3,1,0,0,1,9080.538589728061,188650.0849055397,2021-09-30,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,5,0,0,0,8,NEU4,-0.538,-0.91763,-1.7682,2,1.0,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000204217,4,3,0,0,0,1,219793.50457789513,765591.3646788632,2020-06-15,0,0,0,0,2,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,BMPR2,0.624,3.2823,2.2254,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000205133,3,3,0,0,0,1,189845.9324918578,196178.71491042234,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,TRIQK,-0.81500006,0.14308,0.05727,0,-1.0,-1.0,,
ENSG00000205542,4,3,1,0,0,1,33224.221295945434,190279.23963861223,2019-03-28,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,4,TMSB4X,,,,1,-1.0,-1.0,,
ENSG00000214212,3,3,0,0,0,1,189809.5197599981,270359.2512882127,2022-11-02,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,3,C19orf38,0.23400003,0.99666,0.10944,0,1.0,0.0,,
ENSG00000215114,5,3,1,0,0,1,35269.470595523715,464892.4593283075,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,0,0,2,6,UBXN2B,0.014999986,-0.060136,-0.51181,0,-1.0,-1.0,,
ENSG00000217128,3,3,0,0,0,1,57274.55741575397,193771.21296110394,2021-06-08,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,1,0,0,0,3,FNIP1,0.606,2.6871,0.34725,1,-1.0,-1.0,Amino acids regulate mTORC1;Cellular response to starvation,R-HSA-9639288;R-HSA-9711097
ENSG00000221947,3,3,1,0,0,1,42193.37905314073,672632.4785173276,2021-04-22,0,0,0,0,2,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,XKR9,-0.31200004,-1.6553,-0.76038,0,0.5,0.5,,
ENSG00000229676,3,3,0,0,0,1,1115.4385201305768,464892.4593283075,2020-09-04,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,ZNF492,-0.255,2.2989,2.3371,1,0.5,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000230873,5,3,0,0,0,1,13217.328579372608,1076472.0138856068,2018-12-10,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,3,0,0,2,0,0,0,6,STMND1,-0.14600003,0.74745,0.49194,0,0.5,0.5,,
ENSG00000234616,7,3,1,0,0,1,1175.2703793381759,196816.54442141854,2015-12-23,13,0,0,0,0,0,19,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,33,JRK,-0.911,-0.55843,-0.25238,0,-1.0,-1.0,,
ENSG00000239268,6,3,0,0,0,1,47507.298118531595,1778690.168860174,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,12,0,0,0,0,1,0,14,LINC03051,,,,0,,,,
ENSG00000241399,3,3,1,1,0,1,183579.49764748462,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,3,CD302,-0.273,-0.21454,0.34797,0,0.5,-1.0,,
ENSG00000242252,4,3,0,1,0,1,53991.032093194284,367949.31877243903,2018-03-12,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,BGLAP,-0.79499996,0.34834,-0.68475,4,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000242366,3,3,0,0,0,1,9683.018934405887,464892.4593283075,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,5,UGT1A8,-0.08200002,-0.35707,-0.52934,2,0.5,0.5,Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000244754,4,3,1,0,0,1,606.6666666666666,394357.452283155,2017-12-06,1,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,N4BP2L2,-0.10399997,0.33925,1.2042,0,-1.0,-1.0,,
ENSG00000256269,3,3,1,1,0,1,394357.452283155,1424218.0900670097,2020-10-05,0,0,0,0,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,HMBS,0.454,1.3249,-0.50838,1,1.0,-1.0,Heme biosynthesis,R-HSA-189451
ENSG00000258817,4,3,0,0,0,1,29803.01405728205,227570.98695011192,2018-07-27,0,0,0,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,OR4C13,-0.939,-2.5258,-1.757,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000266074,4,3,1,0,0,1,48439.20423385324,258456.3496858129,2018-08-13,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,BAHCC1,-0.959,-3.1033,-2.446,0,0.5,0.0,,
ENSG00000278311,9,3,1,0,0,1,95776.89591443514,574170.6270919729,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,3,0,0,0,2,9,GGNBP2,0.799,3.18,0.16693,0,-1.0,-1.0,,
ENSG00000001626,3,3,0,0,0,1,25712.85968365041,205739.47405036874,2016-08-12,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,CFTR,-0.15199995,-1.0736,0.86225,11,0.5,0.0,Signal Transduction;Disease;Late endosomal microautophagy;Aggrephagy;Chaperone Mediated Autophagy;Post-translational protein modification,R-HSA-162582;R-HSA-1643685;R-HSA-9615710;R-HSA-9646399;R-HSA-9613829;R-HSA-597592
ENSG00000002933,3,3,1,0,1,1,67543.07751516618,275021.63051358337,2021-08-24,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,TMEM176A,-0.08800006,0.74292,-0.34071,0,0.5,-1.0,,
ENSG00000004399,3,3,1,0,1,1,107949.90929360976,895916.2144062951,2020-06-15,0,0,0,2,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,PLXND1,0.599,2.7074,-1.7653,3,-1.0,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000005844,5,3,1,1,0,1,32254.717802479194,382631.1172224132,2012-11-01,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,3,0,0,0,6,ITGAL,0.40499997,2.6298,1.0206,5,0.5,0.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX3 Regulates Immune Response and Cell Migration;Transcriptional regulation by RUNX3,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-8949275;R-HSA-8878159
ENSG00000005961,4,3,1,0,1,1,31340.65440454944,598869.4096893278,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,1,0,0,0,4,ITGA2B,0.23699999,1.3317,0.84086,15,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000006607,5,3,1,0,0,1,22541.66311868015,1470466.6505612188,2013-04-01,3,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,7,FARP2,-0.004999995,-0.17762,0.27246,2,-1.0,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000008197,5,3,0,0,1,1,49017.409866211325,572390.9560934792,2021-01-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,1,0,0,0,1,5,TFAP2D,0.611,0.94993,-0.56498,2,,,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8864260
ENSG00000008226,4,3,1,0,1,1,34731.86187768143,645988.1975077938,2018-07-30,1,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,DLEC1,0.18699998,0.67697,0.25772,0,0.5,0.5,,
ENSG00000011198,3,3,0,0,0,1,16461.04650907092,756470.9740366563,2015-01-08,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,4,ABHD5,0.07800001,0.70878,-0.55094,1,-1.0,-1.0,,
ENSG00000012983,3,3,1,0,1,1,13883.57970142381,36494.548446257475,2018-08-13,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,6,MAP4K5,0.236,0.66959,-0.5524,0,-1.0,-1.0,,
ENSG00000014123,4,3,1,0,0,1,90566.66054026398,574261.7466389402,2022-08-01,0,0,0,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,UFL1,0.100000024,0.17112,-0.37571,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000014641,3,3,1,1,0,1,22650.1728716785,562534.7696387965,2020-09-04,7,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,10,MDH1,0.32599998,0.48124,-0.46909,1,0.5,-1.0,,
ENSG00000023330,3,3,1,0,0,1,121238.60518192011,190631.40295152203,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,3,ALAS1,0.351,1.9652,0.39896,4,0.75,-1.0,Heme biosynthesis,R-HSA-189451
ENSG00000029559,4,3,1,0,0,1,11608.613380386345,415452.66715166246,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,1,0,5,IBSP,-0.15400004,0.80096,0.065819,2,0.5,1.0,,
ENSG00000030304,3,3,0,0,0,1,23229.874044851975,151416.12986435954,2023-10-16,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,MUSK,0.222,1.2742,0.51907,1,0.5,0.5,,
ENSG00000030582,6,3,1,1,0,1,727.4704124327556,340825.7076940272,2022-04-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,1,0,0,2,11,GRN,0.41000003,1.301,-0.085627,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000033122,4,3,0,0,0,1,10519.047635337382,498258.534626183,2015-05-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,3,LRRC7,0.797,3.5029,0.47372,7,0.5,0.5,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000034152,4,3,1,0,0,1,6356.593451690605,235397.69820205137,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,4,MAP2K3,0.007000029,0.93376,-1.5486,3,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147
ENSG00000034693,5,3,0,0,0,0,38913.031770896094,323648.5577791949,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,6,9,PEX3,0.027999997,1.0392,-0.099114,2,-1.0,-1.0,Class I peroxisomal membrane protein import,R-HSA-9603798
ENSG00000034971,4,3,0,1,1,0,12315.440661331722,414433.58532016096,2021-02-24,0,0,0,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,20,MYOC,-0.34300005,1.1937,0.64377,0,0.5,0.0,,
ENSG00000038219,3,3,1,0,0,1,3686.050910157416,47964.23150355728,2020-05-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,BOD1L1,0.588,0.90785,0.25979,1,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000038427,3,3,1,1,1,1,151416.12986435954,270756.050710225,2022-03-24,0,0,0,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,VCAN,0.777,2.6822,1.5297,13,0.5,0.0,DS-GAG biosynthesis;Disease;Glycosaminoglycan-protein linkage region biosynthesis;Post-translational protein modification,R-HSA-2022923;R-HSA-1643685;R-HSA-1971475;R-HSA-597592
ENSG00000050820,3,3,1,0,0,1,4852.554753131909,464892.4593283075,2014-08-03,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,BCAR1,0.222,-2.1285,-2.8238,4,-1.0,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000051180,3,3,0,0,0,1,32705.240805002948,155552.2805078301,2023-01-18,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,RAD51,0.533,3.6487,0.93002,13,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Transcriptional Regulation by E2F6,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-8953750
ENSG00000056487,3,3,0,0,0,1,205425.60717824215,469213.60545951413,2023-01-18,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,PHF21B,0.324,-0.90703,-2.1795,0,0.5,0.0,,
ENSG00000058404,3,3,1,0,1,1,17199.976915777446,333656.03575930354,2013-08-29,0,0,0,0,0,5,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,7,CAMK2B,0.55,3.3648,-1.1717,21,0.75,0.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000059691,12,3,1,0,0,1,88771.02207231094,727796.3668420183,2022-06-28,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,4,11,GATB,0.16100001,0.21003,-0.38378,0,-1.0,-1.0,,
ENSG00000060069,4,3,0,0,0,1,46282.676044693806,356440.71671986027,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,0,0,0,2,9,CTDP1,0.35000002,0.82764,-1.4517,14,-1.0,-1.0,Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;Generic Transcription Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Pausing and recovery of HIV elongation;Tat-mediated HIV elongation arrest and recovery;HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-113418;R-HSA-167158;R-HSA-212436;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-167290;R-HSA-167243;R-HSA-167287;R-HSA-167238;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-162587;R-HSA-162599
ENSG00000061455,7,3,0,0,1,1,20209.09625085965,718784.6890415357,2018-08-13,0,0,0,0,10,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,13,PRDM6,0.351,-1.0477,-2.2994,0,0.5,0.5,,
ENSG00000066405,4,3,0,0,0,1,195005.6685718255,498258.534626183,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,3,CLDN18,-0.17900002,1.1136,0.63844,1,0.75,0.5,Tight junction interactions,R-HSA-420029
ENSG00000068305,3,3,0,0,0,1,141293.18354755783,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,MEF2A,0.23799998,1.2515,-0.54021,2,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-449147;R-HSA-9006934
ENSG00000068784,4,3,1,0,0,1,189845.9324918578,672632.4785173276,2021-04-22,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,3,7,SRBD1,0.12800002,-1.4515,-2.1055,0,-1.0,-1.0,,
ENSG00000071909,4,3,1,0,0,1,12685.217791998773,360605.992793193,2021-11-04,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,MYO3B,-0.004999995,0.67024,0.81268,2,0.5,0.5,,
ENSG00000072274,5,3,1,1,0,1,97691.2238787727,1424218.0900670097,2019-03-28,0,0,0,1,0,5,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,9,TFRC,0.51100004,1.6437,-0.50525,18,-1.0,-1.0,Signal Transduction;Transferrin endocytosis and recycling;Iron uptake and transport,R-HSA-162582;R-HSA-917977;R-HSA-917937
ENSG00000072952,12,3,1,0,0,1,51964.39839555753,672632.4785173276,2016-05-16,0,0,0,0,13,0,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,4,28,IRAG1,0.26200002,0.82373,-0.59791,1,-1.0,-1.0,,
ENSG00000073711,4,3,0,0,0,1,197775.78125685986,1424218.0900670097,2018-07-30,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,PPP2R3A,0.10900003,0.1465,0.30287,0,0.75,0.0,,
ENSG00000073921,8,3,1,0,0,1,1321.7688442211056,1778690.168860174,2009-09-06,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,0,0,0,0,0,2,24,PICALM,0.353,1.074,-1.1234,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000074047,5,3,1,0,0,1,65127.395275883,765591.3646788632,2018-07-27,6,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,16,GLI2,0.63600004,0.50151,-0.81684,5,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000075624,5,3,0,0,0,1,21408.6965896625,160010.51072069994,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,3,0,0,0,5,ACTB,0.807,7.6921,-4.0454,41,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-597592
ENSG00000075711,3,3,1,0,0,1,5625.245517486242,78016.97193351923,2014-08-02,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,3,DLG1,0.509,1.5463,1.2817,10,-1.0,-1.0,Signal Transduction;Activation of Ca-permeable Kainate Receptor;Ionotropic activity of kainate receptors;Developmental Biology;Activation of kainate receptors upon glutamate binding,R-HSA-162582;R-HSA-451308;R-HSA-451306;R-HSA-1266738;R-HSA-451326
ENSG00000076864,4,3,1,0,0,1,106307.15058733243,1470466.6505612188,2021-09-30,0,0,0,0,1,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,6,RAP1GAP,0.407,1.3684,-1.0842,2,0.5,0.0,Immune System;Developmental Biology,R-HSA-168256;R-HSA-1266738
ENSG00000077063,5,3,1,0,0,1,29803.01405728205,1778690.168860174,2018-04-16,0,0,0,15,0,4,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,27,CTTNBP2,0.22600001,1.5571,0.19554,0,-1.0,0.0,,
ENSG00000078295,8,3,1,0,1,1,636.1886490807354,1778690.168860174,2012-10-09,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,1,11,ADCY2,0.671,4.9485,0.7363,14,0.75,0.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000080709,6,3,0,0,0,1,25001.14127082048,645988.1975077938,2018-06-11,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,13,KCNN2,0.339,1.5727,-1.7359,2,0.5,0.0,,
ENSG00000080854,11,3,0,0,0,1,15866.724081734988,1778690.168860174,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,0,0,7,0,0,1,23,IGSF9B,0.51699996,1.8227,-1.8389,0,-1.0,0.0,,
ENSG00000081138,4,3,1,0,1,1,353105.3286394775,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,5,CDH7,0.448,1.5816,0.048781,1,0.75,0.5,,
ENSG00000084093,7,3,1,0,1,1,45342.615436918815,461914.58891516324,2016-06-20,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,14,REST,0.84000003,1.2246,-0.54279,5,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-9006934
ENSG00000084636,4,3,1,0,1,1,75245.66341852833,1778690.168860174,2022-07-14,0,0,0,5,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,8,COL16A1,0.20599997,1.7469,0.9438,4,0.5,0.0,,
ENSG00000085274,23,3,1,0,0,1,5212.488325165754,278190.43024910334,2013-08-18,35,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,38,MYNN,0.44700003,2.4628,0.85526,0,-1.0,-1.0,,
ENSG00000085365,5,3,1,0,0,1,39406.19595155135,521433.73994041845,2019-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,1,4,SCAMP1,0.14200002,0.92157,0.020652,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000085377,3,3,0,0,0,1,7993.413494279795,180089.50342935527,2019-05-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,5,PREP,0.605,2.6603,0.26354,0,0.5,-1.0,,
ENSG00000085719,3,3,1,0,1,1,69453.1498757531,235397.69820205137,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,4,CPNE3,-0.38900006,-0.017964,0.084938,2,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000086300,4,3,0,0,0,1,12188.899060602089,1424218.0900670097,2023-01-18,0,0,0,0,3,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,SNX10,-0.518,1.1863,1.4251,0,0.5,0.0,,
ENSG00000088367,9,3,1,0,0,1,28863.30790298137,598869.4096893278,2019-06-07,7,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,11,EPB41L1,0.61399996,4.2506,2.4632,4,-1.0,0.0,,
ENSG00000088808,6,3,1,0,0,1,99863.42410604075,1424218.0900670097,2018-02-26,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,9,PPP1R13B,0.53400004,2.1284,0.6818,5,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000089094,3,3,1,0,0,1,175540.09121723313,1424218.0900670097,2018-08-13,0,0,0,1,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,KDM2B,0.73399997,4.6282,-0.067619,1,-1.0,-1.0,,
ENSG00000089116,3,3,0,0,0,1,281079.0730593847,1424218.0900670097,2023-01-18,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,LHX5,0.58000004,0.93355,-1.2234,0,0.75,0.5,,
ENSG00000090006,6,3,1,0,1,1,20209.09625085965,251325.91086204,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,6,LTBP4,0.26599997,-0.0002426,-1.4684,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000090339,6,3,1,1,1,0,106176.1187815965,281079.0730593847,2023-01-18,0,0,0,0,3,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,5,ICAM1,0.12400001,1.1327,0.5145,5,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000091879,4,3,1,0,0,1,53488.43246868315,672632.4785173276,2021-02-24,0,0,0,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,7,ANGPT2,0.394,-1.4366,-2.3929,1,-1.0,0.0,,
ENSG00000091972,5,3,0,1,0,1,21082.402979080252,109446.40450246628,2023-01-18,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,CD200,0.14999998,1.5288,-0.13412,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000095713,4,3,1,0,0,1,10720.290585255112,574261.7466389402,2021-11-04,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,4,CRTAC1,0.227,1.6615,0.50128,0,0.5,0.0,,
ENSG00000095951,3,3,1,0,1,1,271154.8062006991,562534.7696387965,2020-04-15,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,1,0,4,HIVEP1,0.769,1.5826,0.87527,0,-1.0,-1.0,,
ENSG00000099139,4,3,1,0,0,1,29803.01405728205,197485.87952538437,2020-01-20,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,PCSK5,0.27600002,2.5535,1.2742,2,0.5,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases;Plasma lipoprotein remodeling,R-HSA-162582;R-HSA-9006934;R-HSA-8963899
ENSG00000099250,3,3,0,0,0,1,56432.02918263991,765591.3646788632,2016-06-20,0,0,0,0,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,NRP1,0.592,1.8829,-0.13224,8,-1.0,-1.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000100249,3,3,0,0,0,1,29803.01405728205,141293.18354755783,2020-01-20,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,C22orf31,-0.44299996,0.50845,0.40647,0,0.75,0.5,,
ENSG00000100385,3,3,1,0,0,1,25228.351274787536,295550.4496098593,2010-09-23,2,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,5,IL2RB,0.388,0.5576,0.068051,4,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000100417,4,3,0,0,0,1,95776.89591443514,157277.57551067916,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,3,PMM1,-0.06700003,0.78498,0.56772,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000100503,3,3,1,0,0,0,26561.371714038676,180089.50342935527,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,3,NIN,0.38,1.2238,0.95856,0,0.5,-1.0,,
ENSG00000100523,3,3,0,0,0,1,5892.720190233379,156470.480665571,2021-02-24,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,6,DDHD1,0.35799998,0.71714,0.074893,1,0.5,-1.0,Synthesis of PA,R-HSA-1483166
ENSG00000100629,5,3,1,0,1,1,753.7042513863216,215157.94798738702,2018-10-08,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,1,0,1,11,CEP128,0.042999983,0.57206,-0.07817,0,0.5,0.0,,
ENSG00000100883,3,3,1,0,0,1,27926.150856558426,1424218.0900670097,2021-05-22,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,SRP54,0.696,3.754,0.18436,1,-1.0,-1.0,Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-72766;R-HSA-1799339
ENSG00000100916,8,3,0,0,0,1,3477.2237028636237,50087.52781663962,2017-02-14,4,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,2,0,0,0,8,BRMS1L,0.19199997,0.85957,0.42398,0,-1.0,-1.0,,
ENSG00000100979,8,3,1,1,1,1,17587.419683666812,502231.5406594711,2021-12-06,0,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,16,PLTP,-0.0019999743,0.88764,0.42326,2,-1.0,-1.0,Signal Transduction;HDL remodeling;Plasma lipoprotein remodeling,R-HSA-162582;R-HSA-8964058;R-HSA-8963899
ENSG00000100985,4,3,1,1,1,1,34004.8644513982,213435.01458839694,2017-01-09,0,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,10,MMP9,-0.20799994,0.33225,-0.34197,9,0.75,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Signaling by Interleukins;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-449147;R-HSA-3928665;R-HSA-9006934;R-HSA-6785807
ENSG00000101440,5,3,1,0,0,1,115338.82014347943,275021.63051358337,2023-01-18,3,0,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,ASIP,-0.794,-0.53971,-0.28957,0,0.75,0.0,,
ENSG00000101452,6,3,0,0,0,1,98271.38571086437,1129585.974638378,2021-02-24,7,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,9,DHX35,-0.008000016,0.87128,0.02176,1,-1.0,-1.0,,
ENSG00000101773,6,3,0,0,0,1,17587.419683666812,315753.8718331748,2023-01-18,4,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,9,RBBP8,0.018999994,0.83101,0.88791,17,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Transcriptional Regulation by E2F6,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-8953750
ENSG00000102924,3,3,1,0,0,1,70127.81876237011,1424218.0900670097,2019-07-30,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,4,CBLN1,0.305,2.2057,0.97848,0,1.0,0.0,,
ENSG00000102935,3,3,0,0,0,1,180089.50342935527,1076472.0138856068,2021-11-04,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,4,ZNF423,0.804,4.2914,-0.19268,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000102967,3,3,1,0,0,1,69925.93241087522,356440.71671986027,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,DHODH,-0.03400004,-0.11329,-0.21445,1,1.0,-1.0,Nucleotide biosynthesis;Metabolism of nucleotides,R-HSA-8956320;R-HSA-15869
ENSG00000103148,3,3,1,0,0,1,13731.993981048436,198317.64799485338,2022-06-10,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,5,NPRL3,0.347,0.39418,-0.98127,1,-1.0,-1.0,Amino acids regulate mTORC1;Cellular response to starvation,R-HSA-9639288;R-HSA-9711097
ENSG00000103351,4,3,1,0,1,1,272025.74568937684,1424218.0900670097,2018-10-08,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,5,CLUAP1,-0.23000002,-0.19851,-0.73326,1,-1.0,-1.0,,
ENSG00000103653,3,3,1,0,0,1,23977.88222946887,75715.46734074537,2019-10-31,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,4,CSK,0.778,4.7576,0.36455,13,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Phosphorylation of CD3 and TCR zeta chains;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-202427;R-HSA-9006934;R-HSA-5663202
ENSG00000103742,4,3,1,1,0,1,95776.89591443514,383158.3001114715,2022-06-28,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,IGDCC4,0.19099998,0.3637,-1.012,0,0.5,0.0,,
ENSG00000104043,3,3,1,0,1,1,100808.28156961637,283145.34784240765,2022-04-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,4,ATP8B4,-0.013000011,0.40299,0.51748,2,1.0,0.0,Immune System,R-HSA-168256
ENSG00000104047,5,3,0,0,0,1,123127.18790121445,562534.7696387965,2019-02-25,1,0,0,0,0,2,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,6,DTWD1,-0.283,0.0076073,0.4645,0,-1.0,-1.0,,
ENSG00000104324,3,3,1,1,0,1,132101.59514050526,515513.2178404211,2018-10-08,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,CPQ,-0.07700002,0.92115,1.1716,0,0.5,-1.0,,
ENSG00000104343,4,3,1,0,0,1,25778.35048791522,1778690.168860174,2022-07-14,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,5,UBE2W,-0.34899998,2.0435,0.2222,2,-1.0,-1.0,Immune System;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Protein ubiquitination;Post-translational protein modification,R-HSA-168256;R-HSA-8866652;R-HSA-8852135;R-HSA-597592
ENSG00000104365,4,3,1,0,0,1,83896.55822718568,598869.4096893278,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,1,3,0,1,0,0,0,0,0,0,0,0,5,IKBKB,0.528,3.3222,2.2352,29,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;IRAK1 recruits IKK complex;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;Disease;Signaling by Interleukins;IKK complex recruitment mediated by RIP1,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-937039;R-HSA-975144;R-HSA-1643685;R-HSA-449147;R-HSA-937041
ENSG00000104412,3,3,1,0,0,1,26561.371714038676,562534.7696387965,2022-10-12,1,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,4,EMC2,-0.84000003,-0.54987,-1.282,0,-1.0,-1.0,,
ENSG00000104427,3,3,1,0,0,1,28923.750134754748,130223.09311270775,2012-12-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0,0,0,4,ZC2HC1A,-0.09500003,-0.64223,-0.28127,0,-1.0,0.0,,
ENSG00000104490,5,3,1,0,0,1,1173.5007132667617,394357.452283155,2018-08-13,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,7,NCALD,0.12599999,1.7115,0.22846,1,0.5,-1.0,Activation of Ca-permeable Kainate Receptor;Ionotropic activity of kainate receptors;Activation of kainate receptors upon glutamate binding,R-HSA-451308;R-HSA-451306;R-HSA-451326
ENSG00000104936,4,3,1,0,0,1,21724.94108458234,782476.8109259979,2021-09-30,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,DMPK,0.32999998,-0.55874,-2.6092,1,-1.0,-1.0,,
ENSG00000105287,3,3,1,0,0,1,1494.9871332990222,55635.00408218119,2008-08-31,1,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,PRKD2,0.61899996,3.9947,0.15263,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000105357,4,3,0,0,1,0,96212.56699204071,278498.5074409075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,3,6,MYH14,0.353,1.4521,-0.33841,6,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000105372,4,3,1,0,0,1,31340.65440454944,219793.50457789513,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,3,6,RPS19,0.76100004,2.3157,-0.49634,18,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000105376,4,3,1,1,1,1,58331.23271678036,281079.0730593847,2017-01-09,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,4,ICAM5,0.32700002,2.1202,0.8225,2,1.0,0.5,Immune System,R-HSA-168256
ENSG00000105398,7,3,1,1,0,1,4518.532006719214,301203.06999851385,2018-08-13,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,4,19,SULT2A1,-0.61099994,1.0659,-0.35181,3,1.0,0.5,Cytosolic sulfonation of small molecules;Phase II - Conjugation of compounds,R-HSA-156584;R-HSA-156580
ENSG00000105538,3,3,1,0,1,1,16461.04650907092,56716.257154516876,2015-01-08,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,RASIP1,0.55,-0.53653,-2.3997,0,-1.0,0.0,,
ENSG00000105939,4,3,1,0,1,1,27926.150856558426,381165.6245253304,2019-09-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0,0,0,4,ZC3HAV1,0.40499997,2.3123,0.6641,1,0.5,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000105991,5,3,1,0,1,1,15013.867579594042,338763.57771536184,2019-09-01,0,0,0,0,0,0,0,1,0,0,0,0,2,0,2,0,0,0,0,0,0,0,0,5,HOXA1,-0.011999965,0.31438,-0.42364,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000106031,7,3,0,0,0,1,45372.42965956089,645988.1975077938,2018-11-28,1,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,12,HOXA13,0.518,-1.1312,-1.8795,0,0.5,0.5,,
ENSG00000106052,9,3,0,0,0,1,3400.4411583487367,521818.7070055739,2014-08-10,28,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,32,TAX1BP1,0.21399999,0.89166,-0.67129,2,-1.0,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000106462,4,3,1,0,0,1,7304.509669072407,645988.1975077938,2023-01-18,3,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,6,EZH2,0.728,5.1188,-0.51651,8,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Transcriptional Regulation by E2F6,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-8953750
ENSG00000106799,5,3,1,0,0,1,33892.13656698846,251932.6025865064,2015-12-21,0,3,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,4,0,0,0,11,TGFBR1,0.491,3.6549,-0.08184,10,-1.0,-1.0,Signal Transduction;Disease;TGFBR1 KD Mutants in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;TGFBR3 regulates TGF-beta signaling;Diseases of signal transduction by growth factor receptors and second messengers;Loss of Function of SMAD2/3 in Cancer;Loss of Function of TGFBR1 in Cancer;Post-translational protein modification,R-HSA-162582;R-HSA-1643685;R-HSA-3656532;R-HSA-3304356;R-HSA-9839389;R-HSA-5663202;R-HSA-3304349;R-HSA-3656534;R-HSA-597592
ENSG00000107862,5,3,1,0,0,1,32996.93546153374,228220.5662976458,2018-07-30,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,5,GBF1,0.35799998,4.1594,1.5536,4,-1.0,-1.0,VxPx cargo-targeting to cilium;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Cargo trafficking to the periciliary membrane;Post-translational protein modification,R-HSA-5620916;R-HSA-8856688;R-HSA-6811434;R-HSA-5620920;R-HSA-597592
ENSG00000108018,3,3,0,0,0,1,137776.79053446153,1778690.168860174,2022-07-14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,8,SORCS1,0.49400002,1.2799,-1.1665,0,0.5,0.0,,
ENSG00000108443,3,3,1,0,0,1,143284.77790855977,1424218.0900670097,2023-01-18,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,RPS6KB1,0.61300004,3.4368,0.72137,1,-1.0,-1.0,Signal Transduction;mTORC1-mediated signalling;MTOR signalling,R-HSA-162582;R-HSA-166208;R-HSA-165159
ENSG00000108840,4,3,1,0,1,1,94951.97167384504,598869.4096893278,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,1,0,0,4,HDAC5,0.729,3.875,0.17561,5,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000109452,5,3,0,0,0,1,89994.51225946742,448058.917711015,2023-01-18,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,INPP4B,0.361,0.72474,-0.20697,3,-1.0,-1.0,,
ENSG00000109689,4,3,0,0,0,1,15223.454539395489,427337.4491868293,2018-08-13,0,0,0,0,5,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,17,STIM2,0.49400002,0.32525,-0.85313,0,0.5,-1.0,,
ENSG00000109881,4,3,0,0,0,1,105281.95721639719,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,3,CCDC34,-0.08000004,-0.17928,0.38431,0,0.5,-1.0,,
ENSG00000109919,3,3,1,0,1,1,169114.71396884156,672632.4785173276,2021-04-22,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,MTCH2,0.24900001,1.8639,0.98456,0,-1.0,-1.0,,
ENSG00000110075,3,3,1,0,0,1,19537.33156770309,175016.11286382115,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,1,0,0,5,PPP6R3,0.519,2.3839,0.45044,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000110218,3,3,1,0,1,1,10268.412527615117,170747.68362649818,2020-06-24,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,3,PANX1,0.01700002,-0.035264,-0.44063,4,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000110244,3,3,0,0,1,1,141553.2677895436,1424218.0900670097,2021-12-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,APOA4,0.014999986,-0.34517,0.069172,5,1.0,0.5,Chylomicron assembly;Chylomicron remodeling;Plasma lipoprotein remodeling,R-HSA-8963888;R-HSA-8963901;R-HSA-8963899
ENSG00000110427,4,3,0,0,0,1,3202.857946868979,414433.58532016096,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,4,KIAA1549L,0.28899997,2.1183,1.2427,0,0.75,0.5,,
ENSG00000110514,4,3,1,0,1,1,29803.01405728205,407080.5516610372,2020-01-20,0,0,0,2,0,1,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,MADD,0.27499998,1.8667,0.80073,2,0.5,-1.0,Signal Transduction;Rab regulation of trafficking,R-HSA-162582;R-HSA-9007101
ENSG00000110583,3,3,0,0,0,1,161378.55789591218,500292.45069431677,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,3,NAA40,0.045000017,1.7038,-0.79842,0,-1.0,-1.0,,
ENSG00000110841,3,3,0,0,0,0,141293.18354755783,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,PPFIBP1,0.08899999,1.5784,1.5855,2,-1.0,-1.0,Disease;Receptor-type tyrosine-protein phosphatases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-388844;R-HSA-5663202
ENSG00000111145,4,3,1,0,0,1,5394.0067552353075,269829.0934099178,2016-10-03,1,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,3,0,0,0,7,ELK3,0.39200002,1.1297,-0.80003,0,-1.0,-1.0,,
ENSG00000111266,3,3,1,0,0,1,32254.717802479194,145320.08042080907,2012-11-01,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,4,DUSP16,0.49800003,1.6928,0.58377,4,-1.0,-1.0,Signal Transduction;Disease;Response of Mtb to phagocytosis;Infection with Mycobacterium tuberculosis;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9637690;R-HSA-9635486;R-HSA-5663202
ENSG00000111912,3,3,1,0,0,1,8798.945480071758,427337.4491868293,2022-02-24,0,0,0,0,2,0,0,0,0,0,0,0,4,0,0,0,0,0,0,1,0,0,0,7,NCOA7,0.48000002,1.437,0.75579,0,-1.0,-1.0,,
ENSG00000112195,3,3,0,0,1,1,6306.411000302206,1424218.0900670097,2022-06-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,3,TREML2,-0.36399996,0.80402,0.69051,1,0.5,0.5,Immune System,R-HSA-168256
ENSG00000112210,4,3,1,0,0,1,61908.58368613427,380831.7787965888,2017-12-06,0,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,6,RAB23,0.162,0.99039,0.035584,1,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000112280,3,3,1,1,0,1,132101.59514050526,1470466.6505612188,2024-03-31,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,3,COL9A1,0.111,0.12097,-1.5373,8,0.5,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000112306,4,3,0,0,0,1,11608.613380386345,356440.71671986027,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,1,5,RPS12,0.63600004,0.29938,-0.9524,18,-1.0,-1.0,Developmental Biology;Disease;Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;rRNA processing;Regulation of expression of SLITs and ROBOs;Mitochondrial translation;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Mitochondrial ribosome-associated quality control;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-72312;R-HSA-9010553;R-HSA-5368287;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-9937383;R-HSA-975956
ENSG00000112514,5,3,1,0,1,1,11261.194304597275,294387.2978738704,2021-09-30,0,0,0,1,0,3,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,7,CUTA,-0.35800004,0.20444,0.36696,0,-1.0,-1.0,,
ENSG00000112530,5,3,1,0,0,1,16007.105585235551,1778690.168860174,2021-01-28,0,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,5,PACRG,-0.301,1.0591,0.39843,0,0.5,0.0,,
ENSG00000112561,3,3,1,0,0,1,36494.548446257475,1424218.0900670097,2019-05-14,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,TFEB,0.533,1.3729,0.17103,2,0.5,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000112701,5,3,1,0,1,1,46282.676044693806,1424218.0900670097,2022-10-12,0,0,0,0,3,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,7,SENP6,0.678,0.53649,1.602,0,-1.0,-1.0,,
ENSG00000113083,4,3,1,0,1,1,7794.273577144567,251325.91086204,2017-07-17,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,5,LOX,0.49699998,-0.038187,-1.2222,2,0.5,0.0,,
ENSG00000113734,3,3,1,0,0,1,2815.3867141162514,414433.58532016096,2012-02-05,0,0,0,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,BNIP1,-0.23099995,0.39507,-0.66671,1,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic,R-HSA-8856688;R-HSA-6811434
ENSG00000113742,8,3,1,0,0,1,17831.529851792977,756470.9740366563,2010-11-21,0,0,0,0,12,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,0,0,0,16,CPEB4,0.713,3.4732,0.87014,0,-1.0,-1.0,,
ENSG00000113761,5,3,1,0,0,1,13406.534485141672,1129585.974638378,2018-08-13,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,11,ZNF346,-0.20899999,0.30014,-0.033662,0,-1.0,-1.0,,
ENSG00000114166,4,3,1,0,0,1,8645.883646541384,1778690.168860174,2016-07-23,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,5,KAT2B,0.53900003,1.7615,-0.58722,20,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-73762;R-HSA-73864;R-HSA-73854;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000114948,3,3,1,0,0,1,195666.44200393453,382631.1172224132,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,3,ADAM23,0.584,1.9745,0.04251,1,0.5,0.0,LGI-ADAM interactions;Developmental Biology,R-HSA-5682910;R-HSA-1266738
ENSG00000115009,6,3,1,1,0,1,19965.24128263536,360837.067725683,2017-01-09,0,0,0,0,0,0,0,0,0,0,8,0,0,0,1,0,0,0,0,9,0,0,0,18,CCL20,-0.849,0.55821,0.00064459,3,0.75,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000115234,4,3,0,0,0,1,12680.01763007691,410562.9666468075,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0,0,0,0,1,4,SNX17,0.29500002,1.3385,-0.60931,0,-1.0,-1.0,,
ENSG00000115239,4,3,1,0,0,0,4848.198413903923,714039.8414241908,2019-07-15,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,3,ASB3,0.0019999743,-1.2287,-1.2298,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000115295,3,3,0,0,0,1,20803.124897847996,258456.3496858129,2019-06-24,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,3,CLIP4,0.27999997,0.33423,0.56996,0,0.5,0.0,,
ENSG00000115368,3,3,1,0,0,1,107949.90929360976,672632.4785173276,2021-04-22,0,0,0,2,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,WDR75,0.444,1.1783,0.46831,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000115507,4,3,1,0,0,1,6824.02273314389,521818.7070055739,2008-02-10,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,30,OTX1,0.49199998,1.3955,0.37156,0,0.75,0.5,,
ENSG00000115590,4,3,1,1,0,1,19974.136110585117,65343.824011592886,2011-02-06,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,0,0,0,5,IL1R2,-0.38699996,-0.021329,-0.33915,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000115598,3,3,1,1,0,1,110500.54208463429,116566.20935579021,2023-01-18,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,1,4,IL1RL2,-0.24600005,0.053045,-0.81558,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000115884,6,3,1,1,0,1,72982.48880358285,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,0,0,0,2,9,SDC1,0.12099999,-0.26508,-1.5221,15,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Glycosaminoglycan-protein linkage region biosynthesis;HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-1971475;R-HSA-2022928;R-HSA-1638091
ENSG00000115956,4,3,1,0,1,1,38092.548464040476,196178.71491042234,2019-08-16,0,0,0,0,9,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,12,PLEK,0.19099998,0.50143,0.50569,1,1.0,0.0,,
ENSG00000116031,3,3,1,1,1,1,19485.115214960064,205433.03502595585,2021-09-30,0,0,0,0,0,0,0,0,2,0,2,0,0,0,0,0,1,0,0,0,0,0,0,5,CD207,-0.20500004,0.39426,-0.3953,1,1.0,0.0,Immune System,R-HSA-168256
ENSG00000116288,5,3,1,1,0,1,9770.187636657778,160010.51072069994,2011-02-06,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,1,7,PARK7,-0.024999976,0.36438,-0.51419,4,-1.0,-1.0,Late endosomal microautophagy;Aggrephagy;Chaperone Mediated Autophagy;Post-translational protein modification,R-HSA-9615710;R-HSA-9646399;R-HSA-9613829;R-HSA-597592
ENSG00000116539,5,3,0,0,0,1,5767.216111984002,645988.1975077938,2015-12-23,3,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,ASH1L,0.896,4.8029,2.1215,1,-1.0,-1.0,,
ENSG00000116678,3,3,1,1,0,1,3193.837030670892,1424218.0900670097,2013-04-07,0,0,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,6,LEPR,0.411,2.0667,1.1476,1,1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000116761,5,3,0,0,0,1,16548.58403989127,87248.80974040499,2021-02-25,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,6,CTH,-0.07799995,0.67056,0.87069,3,0.75,-1.0,,
ENSG00000117298,3,3,0,0,0,1,78728.4671948324,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,ECE1,0.518,2.4896,0.36254,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000117335,9,3,1,0,0,1,3031.996829799881,378712.0243337037,2014-10-26,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,11,CD46,0.23699999,0.75927,0.60747,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000117472,3,3,1,1,0,0,108079.44677357117,406587.2658730814,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,TSPAN1,-0.14199996,0.65449,0.31559,0,0.5,0.0,,
ENSG00000117475,5,3,1,0,0,0,138890.6106237268,281079.0730593847,2023-01-18,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,4,BLZF1,-0.14499998,0.75149,1.414,1,-1.0,-1.0,,
ENSG00000117676,3,3,1,0,1,1,464892.4593283075,718784.6890415357,2020-06-15,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,RPS6KA1,0.306,3.0216,1.0314,8,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;CREB phosphorylation;Signaling by Interleukins;Gastrin-CREB signalling pathway via PKC and MAPK;Recycling pathway of L1;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-199920;R-HSA-449147;R-HSA-881907;R-HSA-437239;R-HSA-9006934
ENSG00000118257,3,3,0,0,0,1,1173.5007132667617,13953.339315836178,2016-02-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,NRP2,0.43800002,2.2509,-0.16889,2,0.5,-1.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000118514,4,3,1,0,0,1,37221.07677995828,645988.1975077938,2018-08-13,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,8,ALDH8A1,-0.113000035,0.69298,0.7807,1,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000118690,6,3,0,0,0,1,39507.00295325707,298504.9722193353,2017-02-06,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,1,0,0,0,0,0,1,10,ARMC2,0.06400001,1.587,0.38595,0,0.5,-1.0,,
ENSG00000119403,4,3,1,0,0,1,2209.8301559792026,322220.1169395476,2011-02-24,0,0,0,0,0,0,0,0,1,0,0,0,5,0,0,0,0,0,0,0,0,0,2,8,PHF19,0.527,3.4308,1.2024,1,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000119487,5,3,1,0,0,1,42518.059957017445,337665.15408826765,2023-06-05,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,9,MAPKAP1,0.63100004,3.5846,1.3175,6,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000119509,4,3,1,0,0,1,40125.126089953985,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,0,0,0,0,2,6,INVS,0.059000015,2.0948,1.0844,0,-1.0,-1.0,,
ENSG00000119547,3,3,0,0,0,1,89067.8028724554,309838.540915932,2021-07-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,ONECUT2,0.323,-0.14593,-1.0169,0,0.5,0.5,,
ENSG00000120549,3,3,1,0,0,1,161092.74087321138,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,4,KIAA1217,0.38,1.5602,1.0783,0,0.5,0.0,,
ENSG00000120733,10,3,1,0,0,1,94951.97167384504,633132.2332759313,2019-12-01,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,5,KDM3B,0.883,6.2276,0.6028,1,-1.0,-1.0,,
ENSG00000120949,6,3,0,1,1,1,90413.10180725924,562534.7696387965,2019-07-30,0,0,0,0,0,0,0,0,1,0,16,0,0,0,0,0,0,0,0,0,0,0,3,20,TNFRSF8,0.464,1.0713,-0.62298,1,0.5,0.5,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000122877,4,3,0,0,0,1,1555.3915044988491,714039.8414241908,2012-02-12,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,4,EGR2,0.599,2.7999,-0.4769,4,0.5,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000123219,3,3,1,0,0,1,11555.03331839167,197485.87952538437,2022-08-01,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,4,CENPK,-0.643,-0.077043,0.14565,7,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000124160,4,3,0,0,0,1,34785.74493482017,1122672.658801146,2019-08-13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,4,0,0,0,0,0,0,6,NCOA5,0.679,1.8695,0.59006,0,-1.0,-1.0,,
ENSG00000124226,5,3,1,0,0,1,2235.282959215934,135108.48254553688,2014-05-29,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,7,0,0,0,9,RNF114,0.57,0.63375,-0.14641,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000125363,3,3,0,0,0,1,62507.19385670474,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,AMELX,,,,2,,,Post-translational protein modification,R-HSA-597592
ENSG00000125571,3,3,0,0,0,1,205433.03502595585,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,IL37,-0.67200005,0.017881,0.18809,2,1.0,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-18 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9012546
ENSG00000125746,4,3,1,0,0,1,11805.060290205021,1424218.0900670097,2018-08-13,1,0,0,1,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,EML2,0.15499997,0.78272,0.13788,0,-1.0,-1.0,,
ENSG00000125910,3,3,0,0,1,1,47692.964985095256,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,0,3,S1PR4,-0.89400005,-0.94567,-1.6207,2,0.5,0.0,Signal Transduction;Lysosphingolipid and LPA receptors,R-HSA-162582;R-HSA-419408
ENSG00000126214,4,3,1,0,0,1,113567.57166187582,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,1,0,0,0,0,0,5,KLC1,0.495,3.9339,0.42344,5,0.5,-1.0,Signal Transduction;Immune System;Disease;RHO GTPases activate KTN1;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5625970;R-HSA-8856688;R-HSA-6811434;R-HSA-983189;R-HSA-5663202
ENSG00000126461,4,3,0,0,0,1,187203.10687937262,298389.02809443185,2023-01-18,4,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,6,SCAF1,0.44700003,-2.735,-5.9177,0,-1.0,-1.0,,
ENSG00000126856,5,3,0,0,1,1,1321.7688442211056,340825.7076940272,2018-05-08,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,8,PRDM7,-0.0019999743,0.54266,0.98171,1,1.0,1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000128268,4,3,1,0,0,1,95776.89591443514,124837.11004999638,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,3,MGAT3,0.399,2.6355,-1.4717,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000128285,3,3,1,0,0,1,116388.33957200912,226155.40757232966,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,3,MCHR1,0.051,0.4375,-0.038299,4,0.5,0.5,Signal Transduction;BBSome-mediated cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-162582;R-HSA-5620922;R-HSA-5620920
ENSG00000128829,3,3,1,0,0,1,29441.841556737847,448058.917711015,2018-08-09,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,EIF2AK4,0.25,3.5338,1.1142,1,-1.0,-1.0,Cellular response to starvation,R-HSA-9711097
ENSG00000128908,4,3,1,0,0,1,183761.6081180644,574261.7466389402,2022-08-01,0,0,0,0,3,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,5,INO80,0.835,3.7724,-0.29443,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000129351,11,3,1,0,0,1,32757.942031942086,1990918.947961699,2019-01-21,0,0,0,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,0,0,2,3,30,ILF3,0.691,2.5872,-1.3507,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000129993,6,3,0,0,1,1,4804.684371102268,100272.30573726878,2021-09-30,4,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,6,CBFA2T3,0.042999983,-2.9988,-4.5751,0,0.5,0.0,,
ENSG00000130513,3,3,1,1,1,1,4824.132223654906,100932.72668060903,2018-03-21,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,4,GDF15,-0.72300005,-0.48975,-0.86254,0,0.5,0.0,,
ENSG00000130517,3,3,1,0,0,1,50161.278626555366,405722.3511294316,2018-11-28,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,5,PGPEP1,-0.25100005,0.73999,-0.17758,0,-1.0,-1.0,,
ENSG00000130635,4,3,0,0,0,1,3505.4942792099973,59773.57464796038,2021-03-01,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,10,COL5A1,0.911,4.1992,0.33687,13,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000130749,5,3,0,0,0,1,260210.21963428933,1424218.0900670097,2018-10-08,0,0,0,0,1,7,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,10,ZC3H4,0.82,0.40075,-3.5172,1,-1.0,-1.0,Nuclear RNA decay,R-HSA-9930044
ENSG00000130787,5,3,1,1,1,1,125299.9543761523,645988.1975077938,2019-12-01,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,0,0,0,9,HIP1R,-0.21500003,-1.0228,-2.689,2,-1.0,-1.0,,
ENSG00000130812,3,3,1,0,0,1,2981.0834902699307,383158.3001114715,2013-10-31,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,3,ANGPTL6,-0.33800006,-1.7503,-1.9395,0,1.0,0.5,,
ENSG00000131018,15,3,1,0,0,1,12591.910995156913,355284.1215006515,2018-08-13,24,0,0,0,0,0,0,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,66,SYNE1,0.436,3.3265,1.5392,1,0.5,-1.0,,
ENSG00000131042,4,3,1,1,1,1,4374.072533507439,340825.7076940272,2022-04-04,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,4,0,0,0,0,0,1,7,LILRB2,0.13700002,-0.53181,0.509,2,0.75,0.0,Immune System,R-HSA-168256
ENSG00000131149,3,3,1,0,0,1,190279.23963861223,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,3,GSE1,0.644,-5.4823,-7.2051,0,-1.0,-1.0,,
ENSG00000131242,3,3,1,0,0,1,7794.273577144567,521818.7070055739,2020-05-06,7,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,9,RAB11FIP4,0.464,2.1785,-0.87169,0,0.5,0.0,,
ENSG00000131374,7,3,0,0,0,1,80746.41870861933,500292.45069431677,2014-07-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,2,10,TBC1D5,0.13,0.85719,0.36914,0,-1.0,-1.0,,
ENSG00000131437,4,3,1,0,1,1,36645.767033906064,104792.02869450308,2018-05-21,0,0,0,0,0,0,0,0,1,0,2,0,0,0,1,0,0,0,0,0,0,0,0,4,KIF3A,0.701,3.6926,0.98932,7,0.5,-1.0,Signal Transduction;Immune System;Intraflagellar transport;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-162582;R-HSA-168256;R-HSA-5620924;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000131873,5,3,1,0,0,1,26561.371714038676,414433.58532016096,2023-01-18,2,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,CHSY1,0.643,0.87685,-1.5921,2,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000132549,3,3,0,0,0,1,43732.839609234245,223386.61486493575,2021-09-30,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,VPS13B,0.292,2.4646,1.1891,0,-1.0,-1.0,,
ENSG00000133606,4,3,1,0,1,1,279992.27535235474,421288.2605201189,2022-02-02,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2,1,5,MKRN1,0.69299996,1.6816,-1.0232,3,-1.0,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000134061,3,3,0,0,0,1,606.6666666666666,427337.4491868293,2020-12-11,0,1,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CD180,-0.88600004,1.0925,0.81741,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000134146,4,3,0,0,0,1,40153.0728800662,1424218.0900670097,2016-05-16,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,1,12,DPH6,-0.39900005,-0.80493,-0.84443,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000134184,4,3,0,0,0,1,8538.732458188144,468121.8445229682,2018-08-13,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,15,GSTM1,,,,3,0.5,0.0,Glutathione conjugation;Azathioprine ADME;Phase II - Conjugation of compounds,R-HSA-156590;R-HSA-9748787;R-HSA-156580
ENSG00000134245,13,3,1,0,0,1,3257.748638086632,756470.9740366563,2018-08-13,0,0,0,0,16,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,5,23,WNT2B,0.324,1.4399,-0.42295,2,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000134389,4,3,0,1,0,1,10220.829814713417,378712.0243337037,2023-01-18,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,7,CFHR5,-0.46599996,-0.69479,-0.1997,1,1.0,1.0,Immune System,R-HSA-168256
ENSG00000134443,5,3,0,1,1,1,118061.55082048493,1424218.0900670097,2018-10-08,0,0,0,0,1,8,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,12,GRP,-0.796,-0.9846,-1.1736,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000134574,3,3,1,0,0,1,25495.37001303781,112237.0074902361,2023-01-18,0,0,0,1,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,DDB2,0.28100002,2.2896,1.4927,6,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Formation of Incision Complex in GG-NER;Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-5696395;R-HSA-597592
ENSG00000134827,6,3,1,1,1,1,6190.2971786910875,426392.4103859523,2021-06-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,20,1,0,0,0,33,TCN1,-0.227,0.10919,0.77466,3,0.5,0.0,Immune System;Transport of RCbl within the body,R-HSA-168256;R-HSA-9758890
ENSG00000134917,9,3,1,1,0,1,11679.569250778799,448058.917711015,2020-01-20,0,0,0,10,13,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,24,ADAMTS8,-0.075999975,-0.68993,-1.6756,3,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000135211,3,3,0,0,0,0,1173.5007132667617,260631.24114204012,2022-07-22,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,3,TMEM60,0.18599999,0.96202,0.31183,0,-1.0,-1.0,,
ENSG00000136011,7,3,0,1,1,1,21005.64720402067,235397.69820205137,2023-01-18,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,8,STAB2,0.09399998,1.2202,0.61354,2,1.0,0.5,Hyaluronan degradation,R-HSA-2160916
ENSG00000136068,6,3,1,0,1,1,38944.05949995025,414433.58532016096,2023-02-20,0,0,0,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,8,FLNB,0.496,4.5491,2.0226,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;ISG15 antiviral mechanism,R-HSA-1280215;R-HSA-168256;R-HSA-1169408
ENSG00000136141,6,3,1,0,0,1,58392.07057732553,645988.1975077938,2013-12-25,0,0,0,0,4,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,7,LRCH1,0.522,1.8592,-0.26754,0,-1.0,-1.0,,
ENSG00000136240,4,3,1,0,0,1,78751.06843456876,1990918.947961699,2022-11-21,0,0,0,0,0,0,0,0,2,0,0,0,3,0,0,0,0,0,0,2,0,0,0,7,KDELR2,-0.31599998,-1.106,-1.5119,2,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000136383,4,3,1,0,0,1,5495.191484272216,258213.8601133611,2021-01-25,0,0,0,0,2,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,5,ALPK3,0.12599999,-0.20306,-0.54612,0,0.75,0.0,,
ENSG00000136631,9,3,1,0,0,1,75846.20940126595,633132.2332759313,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,1,8,VPS45,0.371,1.9567,1.1141,3,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000136689,3,3,1,1,0,1,38090.46465522045,286678.73247515375,2023-03-16,0,0,0,0,2,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,7,IL1RN,-0.50699997,0.44322,-0.81241,2,1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000136697,3,3,1,0,1,1,13219.952617929488,384314.83364002535,2015-10-26,0,0,0,0,1,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,4,IL1F10,-0.576,-0.10528,-0.5809,2,1.0,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000136770,11,3,1,0,0,1,22345.675520395987,242964.12552687144,2013-04-01,13,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,16,DNAJC1,0.038999975,-0.17781,-0.17101,0,-1.0,-1.0,,
ENSG00000136816,3,3,1,0,0,1,3777.7471479602086,521818.7070055739,2021-01-04,3,0,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,7,TOR1B,0.232,0.366,0.29487,1,-1.0,-1.0,,
ENSG00000137273,6,3,0,0,0,1,27094.55086624802,410642.56898295006,2018-03-12,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,15,FOXF2,-0.016000032,-1.0544,-1.985,0,0.5,0.0,,
ENSG00000137393,6,3,1,0,0,1,9216.225182566941,230312.26972227366,2018-07-30,0,0,0,0,3,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,2,14,RNF144B,-0.008999944,0.56443,0.16898,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000137478,4,3,0,0,0,1,1233.0624505928854,254373.32653042395,2013-07-14,0,0,0,0,0,2,0,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,0,6,FCHSD2,0.53400004,1.9349,1.2058,0,-1.0,-1.0,,
ENSG00000138039,3,3,1,0,0,1,1625.0884685784015,433862.5685735124,2010-12-12,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,3,LHCGR,-0.055999994,-0.025551,-0.32406,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000138107,4,3,1,0,0,1,11843.109477001575,545988.1005477115,2023-01-18,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,ACTR1A,0.663,4.1158,0.57826,11,-1.0,-1.0,Immune System;Golgi-to-ER retrograde transport;Post-translational protein modification,R-HSA-168256;R-HSA-8856688;R-HSA-597592
ENSG00000138442,5,3,0,0,1,1,76053.78010001863,410642.56898295006,2013-11-21,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,8,WDR12,0.09799999,0.54319,0.85843,1,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000138483,5,3,0,0,0,1,5831.6298337927,521818.7070055739,2018-05-21,8,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,11,CCDC54,-0.57299995,0.57347,0.43981,0,1.0,1.0,,
ENSG00000138600,3,3,1,0,0,1,60436.282913699004,100620.50186431198,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,SPPL2A,-0.074,0.038041,-0.3604,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000138669,7,3,1,0,0,1,110681.64879593803,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,3,0,0,0,0,0,1,10,PRKG2,0.521,3.1982,0.089839,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000138738,9,3,1,0,0,1,24848.65239573974,1470466.6505612188,2020-06-15,1,0,0,0,0,2,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,11,PRDM5,0.10100001,1.2589,0.15054,0,-1.0,0.0,,
ENSG00000138778,4,3,1,0,0,1,3288.4396493594068,272025.74568937684,2013-05-12,4,0,0,0,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,CENPE,0.549,1.8159,0.28117,9,0.5,0.5,Signal Transduction;Immune System;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic,R-HSA-162582;R-HSA-168256;R-HSA-8856688;R-HSA-6811434
ENSG00000139219,6,3,0,0,1,1,2010.4597478176527,1470466.6505612188,2014-09-14,5,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,10,COL2A1,0.81700003,5.3873,0.32968,13,0.75,0.5,Signal Transduction;Immune System;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-9006934
ENSG00000139269,3,3,0,0,0,1,377768.5830971079,1424218.0900670097,2023-07-19,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,INHBE,0.074,1.0099,0.10676,1,1.0,0.5,,
ENSG00000139364,3,3,0,0,0,1,1173.5007132667617,228168.37020113936,2022-07-22,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,TMEM132B,0.712,2.7991,1.0519,0,1.0,0.5,,
ENSG00000139515,4,3,0,0,0,1,4852.554753131909,196816.54442141854,2014-08-03,2,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,7,PDX1,-0.64199996,-1.1492,-2.0295,5,0.75,0.5,Developmental Biology;Regulation of gene expression in early pancreatic precursor cells,R-HSA-1266738;R-HSA-210747
ENSG00000139697,6,3,0,0,1,1,89519.16315227402,1990918.947961699,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,1,0,0,0,0,1,0,6,SBNO1,0.818,4.038,-0.64431,0,0.5,-1.0,,
ENSG00000140090,6,3,1,0,0,1,1321.7688442211056,340825.7076940272,2018-05-08,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,2,10,SLC24A4,0.13800001,1.2877,0.096722,2,0.75,0.5,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000140464,4,3,1,0,1,1,2325.5337209302324,1424218.0900670097,2011-05-29,4,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,10,PML,0.38700002,1.9612,0.29926,8,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);SUMOylation of ubiquitinylation proteins;Disease;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-3232142;R-HSA-1643685;R-HSA-597592
ENSG00000140577,4,3,1,0,0,1,32254.717802479194,160010.51072069994,2012-11-01,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,5,CRTC3,0.45599997,0.035863,-1.8678,3,-1.0,-1.0,,
ENSG00000140678,3,3,1,0,1,1,3765.848204687164,71370.26196812681,2008-01-20,0,1,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,3,0,0,0,7,ITGAX,0.15899998,0.73147,-0.31645,5,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000140848,3,3,0,0,0,1,141293.18354755783,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,CPNE2,0.22899997,2.0449,-0.020421,0,-1.0,-1.0,,
ENSG00000140873,3,3,0,0,1,1,11823.945078454788,414433.58532016096,2020-01-20,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,ADAMTS18,-0.054999948,-4.093,-4.2128,3,0.75,0.5,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000141002,6,3,1,0,0,1,16869.130815559005,351483.8320914214,2018-08-13,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,6,TCF25,0.328,-0.68507,-2.5666,0,-1.0,-1.0,,
ENSG00000141086,3,3,0,1,1,0,7914.993941688755,286678.73247515375,2012-03-07,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,3,CTRL,-0.37199998,0.52126,-0.49366,1,1.0,0.0,,
ENSG00000141101,4,3,1,0,1,1,23467.651805886748,104865.12229088554,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,5,NOB1,-0.23300004,-0.045274,-0.50398,1,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000141431,6,3,0,0,1,1,263416.51565448404,1778690.168860174,2019-11-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,0,8,ASXL3,0.771,1.2022,0.4421,0,-1.0,0.5,,
ENSG00000141505,4,3,0,1,0,1,141553.2677895436,464892.4593283075,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,1,4,ASGR1,-0.32299995,0.043016,0.9693,1,1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000141506,5,3,1,0,0,1,116089.30071075787,381165.6245253304,2020-06-24,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,0,0,0,1,0,0,0,5,PIK3R5,0.55799997,3.085,0.76589,9,1.0,0.0,Signal Transduction;Immune System;G beta:gamma signalling through PI3Kgamma;Disease;G-protein beta:gamma signalling;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-392451;R-HSA-1643685;R-HSA-397795;R-HSA-5663202
ENSG00000142002,4,3,1,0,0,1,3721.3983572895277,474830.9126255118,2013-04-14,2,28,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,33,DPP9,0.353,1.4404,-1.497,0,-1.0,-1.0,,
ENSG00000142173,6,3,1,0,1,1,64514.85721423125,1470466.6505612188,2021-11-04,0,0,0,0,0,0,2,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,2,12,COL6A2,0.10500002,-0.91252,-3.8897,8,-1.0,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000142192,6,3,0,0,1,1,1321.7688442211056,340825.7076940272,2021-06-07,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,2,14,APP,0.59000003,2.2633,0.39774,17,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Disease;Signaling by Interleukins;Lysosome Vesicle Biogenesis;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9609523;R-HSA-1643685;R-HSA-449147;R-HSA-432720;R-HSA-597592
ENSG00000142515,7,3,1,1,1,1,2803.232542372881,521818.7070055739,2014-04-21,41,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,46,KLK3,-0.06500006,0.58103,-0.17551,2,1.0,0.0,Signal Transduction;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,R-HSA-162582;R-HSA-5625886
ENSG00000142655,9,3,1,0,0,1,14697.947851329636,562534.7696387965,2013-04-01,12,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,1,0,0,0,19,PEX14,0.458,1.4954,0.22803,3,-1.0,-1.0,Class I peroxisomal membrane protein import;Peroxisomal protein import;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-9603798;R-HSA-9033241;R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000143196,6,3,0,0,0,1,97822.37358221927,551389.5206213495,2022-10-12,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,4,10,DPT,0.037,0.2318,0.086494,0,0.5,0.0,,
ENSG00000143384,4,3,1,0,0,1,78751.06843456876,406587.2658730814,2019-03-05,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,6,MCL1,0.605,-0.80627,-1.4202,2,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-6785807
ENSG00000143499,4,3,0,0,1,1,18944.728646379852,235397.69820205137,2016-11-29,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,8,SMYD2,-0.097,0.51669,-0.59135,2,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000143520,3,3,0,0,0,1,76983.04900783773,193771.21296110394,2018-05-21,0,1,0,0,0,0,0,0,0,0,3,0,0,0,2,0,0,0,0,0,0,0,0,6,FLG2,-0.934,1.0985,0.57407,1,1.0,0.5,Immune System,R-HSA-168256
ENSG00000143552,3,3,0,0,0,0,47480.26423551067,220837.49604317299,2021-04-08,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,NUP210L,0.579,3.9459,1.5544,0,1.0,1.0,,
ENSG00000144331,4,3,1,0,0,1,33410.38706087121,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,5,ZNF385B,0.24900001,1.0099,1.0167,0,0.5,0.0,,
ENSG00000144354,6,3,0,0,0,1,144744.15797648102,521818.7070055739,2021-01-04,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,8,CDCA7,0.324,1.8093,1.3342,0,0.5,0.0,,
ENSG00000144481,4,3,0,0,0,1,6170.33304373009,360605.992793193,2011-06-12,0,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,18,TRPM8,0.055000007,1.5081,0.51557,1,0.75,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000144535,3,3,0,0,0,0,15702.824330266134,1470466.6505612188,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,DIS3L2,0.532,1.4012,0.4193,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000144642,5,3,0,0,0,1,4849.620824090643,498258.534626183,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,5,RBMS3,0.411,0.76809,-0.072127,0,-1.0,0.0,,
ENSG00000144668,3,3,1,0,1,1,33678.58412439629,645988.1975077938,2018-08-13,3,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,ITGA9,0.445,1.4393,-0.11281,3,-1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000144681,5,3,1,0,0,1,7762.1257343089765,60298.15939406673,2019-09-19,0,0,0,0,0,0,0,0,0,0,2,2,0,0,0,0,0,0,0,1,0,0,0,5,STAC,-0.17999995,0.27558,-0.26933,0,0.5,0.0,,
ENSG00000145113,4,3,1,0,1,1,58357.815018992726,227934.29698436207,2024-03-18,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,MUC4,0.04699999,-6.5749,-5.0021,6,0.5,0.5,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000145321,3,3,1,1,1,1,28863.30790298137,426392.4103859523,2021-01-07,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,5,11,GC,-0.49199998,0.3083,-0.63277,1,1.0,0.5,Vitamin D (calciferol) metabolism;Metabolism of steroids,R-HSA-196791;R-HSA-8957322
ENSG00000145335,6,3,1,1,0,1,606.6666666666666,1778690.168860174,2009-11-15,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,32,0,0,0,39,SNCA,0.30900002,1.1478,-0.67771,2,0.75,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000145390,3,3,1,0,0,1,141293.18354755783,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,USP53,0.092999995,1.5966,1.6579,0,-1.0,0.0,,
ENSG00000145569,7,3,1,0,1,1,13114.86037139043,562534.7696387965,2017-10-30,0,0,0,0,0,0,0,0,1,0,17,0,0,0,2,0,0,0,0,0,0,0,0,20,OTULINL,-0.21200001,0.25887,-0.81302,0,0.5,0.0,,
ENSG00000145632,5,3,1,0,0,1,116566.20935579021,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,3,0,0,0,0,0,1,6,PLK2,0.52900004,3.0114,-0.96908,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;CD163 mediating an anti-inflammatory response,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-9662834
ENSG00000146122,3,3,1,0,0,1,3400.4411583487367,1424218.0900670097,2014-08-10,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,DAAM2,0.51199996,0.8738,0.47667,0,0.5,-1.0,,
ENSG00000146540,4,3,1,1,0,1,19965.24128263536,464892.4593283075,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,6,CHLSN,-0.32299995,-0.99456,-1.4051,0,-1.0,-1.0,,
ENSG00000146733,3,3,1,0,0,1,3332.1274147143445,134703.04231665854,2021-03-02,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,4,PSPH,-0.062999964,1.164,1.5656,1,-1.0,-1.0,Serine metabolism,R-HSA-977347
ENSG00000146830,3,3,1,0,0,1,116089.30071075787,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,5,GIGYF1,0.265,-1.3319,-4.2366,0,-1.0,-1.0,,
ENSG00000147138,7,3,1,0,1,1,8614.851322410133,258213.8601133611,2020-06-08,0,0,0,0,0,0,0,0,0,7,0,0,7,0,0,0,0,0,0,1,0,0,0,15,GPR174,,,,0,1.0,0.5,,
ENSG00000147874,7,3,1,0,1,1,9539.551199137346,1424218.0900670097,2018-10-08,7,0,0,0,2,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,HAUS6,-0.21099997,0.22219,0.14243,7,-1.0,-1.0,,
ENSG00000148204,3,3,0,0,0,1,96018.8961005241,132101.59514050526,2024-03-31,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,CRB2,-0.20200002,-2.058,-3.6491,0,0.5,0.5,,
ENSG00000148408,3,3,1,0,0,1,94951.97167384504,384314.83364002535,2021-05-17,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,4,CACNA1B,0.575,3.2473,-1.386,1,1.0,0.5,Presynaptic depolarization and calcium channel opening,R-HSA-112308
ENSG00000148795,4,3,0,0,0,1,14178.745544178992,280228.4034560385,2016-03-08,1,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6,CYP17A1,-0.24899995,1.3441,0.61711,3,1.0,0.0,Disease;Metabolism of steroids,R-HSA-1643685;R-HSA-8957322
ENSG00000149084,4,3,1,0,1,1,5399.18558963428,1424218.0900670097,2017-05-31,0,0,0,0,3,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,HSD17B12,-0.311,0.664,0.098918,2,-1.0,-1.0,Synthesis of very long-chain fatty acyl-CoAs;Fatty acyl-CoA biosynthesis;Metabolism of steroids,R-HSA-75876;R-HSA-75105;R-HSA-8957322
ENSG00000149091,6,3,0,0,0,1,21005.64720402067,358386.30063935445,2015-07-21,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,14,DGKZ,0.549,4.1145,0.22105,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000149600,5,3,1,0,0,1,32705.240805002948,521818.7070055739,2021-11-04,2,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,2,0,0,0,7,COMMD7,-0.14699996,0.5897,0.19576,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000150594,4,3,0,0,0,1,10277.394146948942,275021.63051358337,2023-01-18,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,9,ADRA2A,-0.783,-0.69193,-2.2402,6,0.5,0.0,"Signal Transduction;Adrenoceptors;Surfactant metabolism;Amine ligand-binding receptors;Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-162582;R-HSA-390696;R-HSA-5683826;R-HSA-375280;R-HSA-400042
ENSG00000150977,7,3,1,0,0,1,142818.1224245443,338763.57771536184,2019-01-21,0,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,2,0,5,RILPL2,-0.50699997,0.26792,-0.85194,0,0.5,-1.0,,
ENSG00000151148,4,3,1,0,0,1,22651.370408599323,280228.4034560385,2020-05-29,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,8,UBE3B,0.325,2.1522,1.076,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000151376,5,3,1,0,0,1,18584.262095180744,414433.58532016096,2019-02-25,0,0,0,18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,20,ME3,0.14700001,1.7518,0.21618,1,-1.0,-1.0,Pyruvate metabolism,R-HSA-70268
ENSG00000151490,5,3,0,0,0,1,28783.576939547238,427337.4491868293,2021-06-29,0,0,0,0,2,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,7,PTPRO,0.487,1.8918,-0.64234,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000151692,4,3,1,0,0,1,48439.20423385324,119412.5469599979,2020-12-03,1,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,RNF144A,0.45,1.1329,0.027697,1,0.5,-1.0,E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000151789,3,3,1,0,0,1,1173.5007132667617,645988.1975077938,2022-07-22,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ZNF385D,0.389,0.56758,-0.6241,0,0.5,0.0,,
ENSG00000151914,3,3,1,0,1,1,10328.003557136504,78398.053695655,2022-11-01,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,DST,0.703,3.9467,1.9832,7,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000152270,3,3,1,0,1,1,282360.54876783554,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,1,5,PDE3B,0.045000017,-1.0165,-2.7112,2,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000152684,4,3,1,0,1,1,107949.90929360976,1424218.0900670097,2018-10-08,0,0,0,4,0,9,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,14,PELO,-0.008000016,0.42656,0.40964,0,-1.0,-1.0,,
ENSG00000152785,5,3,1,0,1,1,19943.263992703425,320319.7525060048,2021-06-14,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,0,0,1,7,BMP3,0.16500002,-0.32632,-0.8441,0,0.5,0.5,,
ENSG00000153208,5,3,1,1,1,1,4755.152728604566,672632.4785173276,2019-09-01,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,6,MERTK,0.213,1.7698,1.602,1,0.5,-1.0,,
ENSG00000153233,4,3,1,0,0,1,2373.1792752244437,575147.0632428399,2018-07-27,2,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,7,PTPRR,0.36699998,1.0651,0.080572,0,0.5,0.5,,
ENSG00000153707,6,3,0,0,0,1,1817.661971830986,1778690.168860174,2008-07-27,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,22,0,0,0,0,0,0,24,PTPRD,0.796,-0.24895,-4.485,2,0.5,0.0,Receptor-type tyrosine-protein phosphatases,R-HSA-388844
ENSG00000153822,3,3,0,0,0,1,28292.123952140868,189385.65312252965,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,KCNJ16,-0.15699995,0.48391,0.89243,3,0.75,0.0,Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Inwardly rectifying K+ channels,R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-1296065
ENSG00000153904,4,3,1,0,0,1,100620.50186431198,322107.4898639223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,1,4,DDAH1,-0.13699996,-0.26103,-1.1062,1,0.5,0.0,,
ENSG00000154217,3,3,1,0,0,1,464892.4593283075,645988.1975077938,2023-01-18,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,PITPNC1,0.34100002,1.6258,0.27865,0,-1.0,-1.0,,
ENSG00000154723,5,3,0,0,0,0,78728.4671948324,283145.34784240765,2021-02-24,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,7,ATP5PF,-0.11800003,0.30746,0.42393,3,0.5,-1.0,Formation of ATP by chemiosmotic coupling;Cristae formation,R-HSA-163210;R-HSA-8949613
ENSG00000154928,4,3,1,0,0,1,11014.04703420302,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,1,0,0,0,0,0,0,4,EPHB1,0.559,3.0453,-0.2725,4,0.5,0.0,Ephrin signaling;Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-3928664;R-HSA-1266738;R-HSA-3928665
ENSG00000156127,4,3,0,0,0,1,38092.548464040476,205433.03502595585,2019-09-01,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,2,0,0,0,4,BATF,0.26099998,1.3218,0.052921,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000156234,3,3,0,0,0,1,14639.784588829983,382631.1172224132,2020-07-28,0,0,0,0,0,0,0,0,0,0,1,0,2,0,1,0,0,0,0,0,0,0,0,4,CXCL13,0.22299999,0.84774,0.80913,2,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000156687,11,3,0,0,0,1,79364.11071948418,1778690.168860174,2019-01-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,0,0,2,7,UNC5D,0.527,2.5107,0.20304,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000156931,3,3,1,0,1,1,3669.3510358914505,1470466.6505612188,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,1,0,0,0,4,VPS8,0.31199998,1.2427,-0.51208,0,-1.0,-1.0,,
ENSG00000157110,6,3,1,0,0,1,5691.114246503779,355284.1215006515,2021-09-30,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,19,RBPMS,0.26700002,0.66968,-0.40265,0,-1.0,-1.0,,
ENSG00000157152,4,3,1,0,1,1,18319.91238877481,275021.63051358337,2021-09-30,0,0,0,0,0,2,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,1,6,SYN2,0.46100003,0.61332,0.052906,2,1.0,0.0,Dopamine Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Neurotransmitter release cycle,R-HSA-212676;R-HSA-181429;R-HSA-112310
ENSG00000157322,7,3,1,0,1,1,106966.34210063417,714039.8414241908,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,1,12,CLEC18A,0.37,2.2204,2.3884,0,0.75,0.5,,
ENSG00000157335,4,3,0,0,0,1,117707.74532698281,356440.71671986027,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,4,CLEC18C,0.47100002,3.2661,2.7317,0,1.0,0.5,,
ENSG00000157570,4,3,0,0,0,1,2034.7189765458422,414433.58532016096,2011-10-30,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,TSPAN18,0.21899998,1.3525,0.0011956,0,0.5,0.0,,
ENSG00000157680,3,3,0,0,0,1,14959.796450585092,323648.5577791949,2017-10-09,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,7,DGKI,0.572,2.727,-0.11419,1,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000157869,12,3,0,0,0,1,2010.4597478176527,1470466.6505612188,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,32,0,0,0,0,0,0,4,0,0,10,46,RAB28,-0.33200002,-0.0034101,-0.39013,0,-1.0,-1.0,,
ENSG00000157985,3,3,1,0,0,1,2560.851236868858,139549.80122422232,2016-02-08,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,3,AGAP1,0.634,1.7898,-0.24053,0,0.5,0.0,,
ENSG00000158286,3,3,1,0,1,1,70780.16579822965,355284.1215006515,2023-01-18,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,RNF207,-0.27699995,-2.203,-1.1751,0,0.5,0.0,,
ENSG00000158445,10,3,0,0,0,1,94951.97167384504,633132.2332759313,2019-12-01,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,0,0,1,0,0,0,8,KCNB1,0.691,5.403,0.12823,2,1.0,0.0,,
ENSG00000158623,3,3,1,0,0,1,46601.3671671619,100620.50186431198,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,COPG2,-0.13199997,0.10904,-0.10301,2,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000159184,5,3,0,0,1,1,11391.28506861999,521818.7070055739,2020-12-08,16,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,19,HOXB13,-0.273,0.25265,-0.17054,0,0.75,0.5,,
ENSG00000159224,3,3,1,0,1,1,383158.3001114715,765591.3646788632,2020-06-15,1,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,GIP,-0.47800004,-0.18042,0.051552,3,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000159445,4,3,1,0,0,1,47480.26423551067,322220.1169395476,2021-04-08,0,0,0,0,0,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,6,THEM4,-0.569,0.34124,-0.28646,6,-1.0,-1.0,Signal Transduction;Immune System;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-9006934
ENSG00000159556,3,3,0,0,0,1,2977.227192317412,512656.0695323204,2020-08-06,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,3,ISL2,0.100000024,-0.26153,-1.0269,0,0.5,0.5,,
ENSG00000159692,4,3,0,0,0,1,38886.589732507324,1424218.0900670097,2016-01-28,0,0,1,1,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,CTBP1,0.467,2.2636,-2.6648,4,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000160224,3,3,0,0,1,1,2712.0995243322354,124837.11004999638,2011-04-19,0,0,0,0,0,1,0,0,0,0,0,0,6,0,0,0,0,0,1,0,0,0,0,8,AIRE,-0.16900003,-1.0396,-1.3697,0,0.5,1.0,,
ENSG00000160299,3,3,1,0,1,0,10079.256730844207,1424218.0900670097,2020-06-15,0,0,0,0,0,2,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,PCNT,0.05699998,-0.4558,-0.98326,10,1.0,0.0,Late endosomal microautophagy;Aggrephagy;Chaperone Mediated Autophagy,R-HSA-9615710;R-HSA-9646399;R-HSA-9613829
ENSG00000160321,3,3,1,0,0,1,137776.79053446153,427337.4491868293,2023-01-18,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,ZNF208,-0.28900003,-2.1054,-0.89167,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000160446,5,3,0,0,1,1,162874.72124856082,562534.7696387965,2017-10-30,0,0,0,0,0,0,0,0,0,0,6,0,0,0,2,0,0,0,0,0,0,0,2,10,ZDHHC12,-0.29999995,-0.46552,-1.0318,0,-1.0,0.0,,
ENSG00000160447,4,3,1,1,0,1,90413.10180725924,464892.4593283075,2019-10-24,0,0,0,0,0,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,1,5,PKN3,0.013000011,1.7033,0.72974,4,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000160691,4,3,1,0,1,0,4386.372160115398,1470466.6505612188,2016-08-25,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,0,0,1,6,SHC1,0.29500002,1.5908,0.38824,41,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Constitutive Signaling by Overexpressed ERBB2;Developmental Biology;Disease;Signaling by Interleukins;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9634285;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202
ENSG00000160710,4,3,1,0,1,1,45641.36785780183,301203.06999851385,2021-09-30,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,6,ADAR,0.551,3.4201,-0.030317,4,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000160867,3,3,1,1,1,1,89519.16315227402,464892.4593283075,2019-02-04,0,0,0,0,0,6,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,8,FGFR4,0.116,1.9115,-0.17673,14,0.5,0.0,Signal Transduction;Disease;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202
ENSG00000160870,3,3,1,0,0,1,57022.52707482435,384314.83364002535,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,4,CYP3A7,-0.03400004,1.1674,1.285,1,1.0,0.5,,
ENSG00000161040,3,3,1,0,0,0,100857.20347685824,294387.2978738704,2018-08-13,0,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,FBXL13,0.11900002,1.1396,1.3139,2,0.5,0.5,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000161180,5,3,1,0,0,0,13219.952617929488,68837.80679818468,2014-02-14,0,0,0,0,0,0,0,0,0,0,0,3,3,0,0,0,0,0,0,2,0,0,0,8,CCDC116,-0.15799999,0.40279,1.2209,0,1.0,0.5,,
ENSG00000161618,6,3,0,0,1,0,12846.890397545798,466632.7979326389,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,2,9,ALDH16A1,-0.18299997,-2.4012,-1.7594,0,-1.0,0.0,,
ENSG00000161847,3,3,0,0,0,0,33086.382515598,124837.11004999638,2018-12-20,0,2,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,6,RAVER1,0.110000014,-0.40812,-1.5871,0,-1.0,0.0,,
ENSG00000162604,4,3,0,0,0,1,21117.402887671095,143413.24457139417,2023-01-18,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,TM2D1,-0.09800005,0.30379,0.49935,0,-1.0,-1.0,,
ENSG00000162630,4,3,1,0,0,1,33410.38706087121,464892.4593283075,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,5,B3GALT2,0.413,1.8133,-0.47574,1,0.5,0.0,,
ENSG00000162702,3,3,0,0,0,1,63200.72664467542,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,6,ZNF281,0.897,1.7158,-1.0645,0,0.5,-1.0,,
ENSG00000162733,4,3,0,0,0,1,8479.376416968564,124531.34246675359,2017-09-07,1,0,0,2,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,8,DDR2,0.625,3.8315,0.45728,1,-1.0,0.0,,
ENSG00000162878,7,3,1,0,0,1,1225.1182294700059,197485.87952538437,2014-08-10,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,2,6,PKDCC,-0.14999998,-2.0231,-2.8933,0,0.5,0.0,,
ENSG00000162928,5,3,1,0,0,1,38092.548464040476,381165.6245253304,2019-09-01,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,0,0,0,0,0,0,0,1,5,PEX13,-0.15900004,-0.75296,-0.080662,3,-1.0,-1.0,Class I peroxisomal membrane protein import;Peroxisomal protein import;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-9603798;R-HSA-9033241;R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000163106,3,3,1,1,0,1,1500.8351648351647,645988.1975077938,2013-05-12,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,HPGDS,-0.92499995,0.10274,-0.21162,2,0.5,0.0,Glutathione conjugation;Phase II - Conjugation of compounds;Arachidonate metabolism,R-HSA-156590;R-HSA-156580;R-HSA-2142753
ENSG00000163491,12,3,1,0,1,1,18840.66477842686,327772.01590957545,2013-04-01,20,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,22,NEK10,0.003000021,-0.029939,0.15647,0,0.5,0.0,,
ENSG00000163492,9,3,0,0,1,1,8134.789801592449,298158.45127615496,2023-01-18,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,11,24,CCDC141,-0.052000046,-0.27709,-0.02473,0,1.0,0.0,,
ENSG00000163501,4,3,1,0,1,1,45589.72605179723,196816.54442141854,2023-01-18,0,0,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,5,IHH,0.45599997,2.0023,0.085941,9,0.5,0.5,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Release of Hh-Np from the secreting cell;Hedgehog ligand biogenesis;Hh mutants abrogate ligand secretion;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5362798;R-HSA-5358346;R-HSA-5387390;R-HSA-5663202
ENSG00000163508,10,3,0,0,1,1,3332.1274147143445,355284.1215006515,2013-10-22,11,0,0,1,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,15,EOMES,0.50699997,-0.15048,-1.8135,6,0.75,0.5,Developmental Biology;Formation of definitive endoderm,R-HSA-1266738;R-HSA-9823730
ENSG00000163518,3,3,0,0,0,0,2677.01402832708,95905.57783546533,2023-06-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,3,FCRL4,0.17900002,-0.12852,-0.15414,0,1.0,0.5,,
ENSG00000163710,3,3,1,0,0,1,78398.053695655,165565.7343481966,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,3,PCOLCE2,-0.062999964,0.2269,0.40028,1,0.5,0.0,,
ENSG00000163798,3,3,1,0,1,1,94665.79117035728,298504.9722193353,2023-01-18,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,3,SLC4A1AP,0.18599999,0.86435,0.38869,0,-1.0,-1.0,,
ENSG00000163803,3,3,0,0,0,0,3613.737329219921,239970.53614968536,2018-06-12,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,5,PLB1,-0.11399996,0.2285,-0.96379,2,1.0,0.0,Acyl chain remodelling of PC,R-HSA-1482788
ENSG00000163811,3,3,1,0,0,1,14697.947851329636,227752.06557835746,2016-04-27,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,3,WDR43,0.76,0.016715,-1.4879,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000163904,3,3,1,0,1,1,30811.772283944152,384314.83364002535,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,1,4,SENP2,0.746,2.2222,0.76405,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000163933,3,3,1,0,0,1,34004.8644513982,1470466.6505612188,2017-01-09,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,4,RFT1,0.106000006,0.77387,0.22478,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000163939,5,3,1,0,0,1,1173.5007132667617,1470466.6505612188,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,6,PBRM1,0.77,4.4177,1.334,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000163950,7,3,0,0,0,1,87030.31235300079,1470466.6505612188,2022-02-02,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,1,3,13,SLBP,-0.286,-1.685,-0.96436,3,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature Transcript to Cytoplasm,R-HSA-73857;R-HSA-74160;R-HSA-159230;R-HSA-159234;R-HSA-72202
ENSG00000164037,4,3,1,0,0,1,38092.548464040476,765591.3646788632,2019-09-01,0,0,0,0,0,3,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,5,SLC9B1,0.0,2.2277,1.676,1,1.0,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000164171,6,3,1,0,0,1,125821.84557838629,1470466.6505612188,2023-03-16,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,1,0,0,2,9,ITGA2,0.21100003,1.8089,0.59777,8,-1.0,0.0,Signal Transduction;Developmental Biology;Platelet Adhesion to exposed collagen;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-75892;R-HSA-9006934
ENSG00000164172,12,3,1,0,0,1,5531.601992882563,633132.2332759313,2014-06-13,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,1,0,0,6,0,0,0,10,MOCS2,-0.065999985,0.41632,-0.19667,1,-1.0,-1.0,,
ENSG00000164221,3,3,0,0,0,1,6356.593451690605,89519.16315227402,2023-01-18,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,CCDC112,0.125,-1.0043,-1.1592,0,0.5,-1.0,,
ENSG00000164332,5,3,0,0,0,1,3108.527807962371,144127.33793912127,2021-06-01,0,0,0,0,0,0,0,0,2,0,0,0,2,0,0,0,0,0,0,2,0,0,0,6,UBLCP1,0.0019999743,1.5739,0.1628,0,-1.0,-1.0,,
ENSG00000164379,4,3,0,0,0,1,16501.939666435188,410642.56898295006,2013-04-01,2,0,0,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,FOXQ1,-0.93799996,-4.7425,-5.3143,0,0.5,0.0,,
ENSG00000164465,5,3,1,0,0,1,17334.00194711458,672632.4785173276,2021-04-22,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,6,DCBLD1,0.058000028,0.38498,-0.35779,0,-1.0,0.0,,
ENSG00000164500,7,3,1,0,1,1,22938.587937312015,322220.1169395476,2019-06-07,9,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,11,SPMIP7,-0.35399997,0.52799,1.059,0,1.0,1.0,,
ENSG00000164574,5,3,0,0,0,1,15866.724081734988,1424218.0900670097,2017-05-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,2,0,0,0,0,5,GALNT10,0.31699997,0.98028,0.018569,1,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000164690,5,3,1,0,0,1,10227.197550504849,427337.4491868293,2023-01-18,1,0,0,0,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,SHH,0.50699997,0.50243,-2.8431,11,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Release of Hh-Np from the secreting cell;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Hh mutants abrogate ligand secretion;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-5362798;R-HSA-5358346;R-HSA-5362768;R-HSA-5387390;R-HSA-5663202
ENSG00000164741,5,3,0,0,0,1,8360.758176657433,645988.1975077938,2018-08-13,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,DLC1,0.526,-4.308,-4.2017,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000164853,4,3,0,0,0,1,16386.12478006288,407080.5516610372,2019-05-31,0,0,0,0,0,0,0,0,0,0,0,3,8,0,0,0,2,0,0,0,0,0,0,13,UNCX,-0.10500002,-3.1703,-5.5525,0,1.0,0.5,,
ENSG00000165061,4,3,0,0,0,1,21381.561783724817,326545.22790564946,2021-11-04,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,7,ZMAT4,0.065,0.74235,-0.4007,0,0.75,0.5,,
ENSG00000165322,3,3,0,0,0,1,29803.01405728205,355284.1215006515,2019-10-24,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,8,ARHGAP12,0.319,1.0082,1.0152,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000165379,8,3,1,0,0,1,21838.21022330194,1778690.168860174,2018-04-26,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,17,0,0,0,0,0,0,19,LRFN5,0.371,1.6525,-0.17613,0,0.5,0.0,,
ENSG00000165471,5,3,0,0,0,1,4412.925945857845,191895.42310022408,2018-08-29,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,8,0,0,10,MBL2,-0.5,-0.47355,-0.35617,3,1.0,1.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000165633,6,3,1,0,1,1,197485.87952538437,545988.1005477115,2023-01-18,0,0,0,0,4,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,VSTM4,0.28100002,0.27731,0.053674,0,-1.0,0.0,,
ENSG00000165661,4,3,1,0,1,0,156470.480665571,1778690.168860174,2022-07-14,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,5,QSOX2,0.009000003,0.62586,-0.075263,0,-1.0,-1.0,,
ENSG00000165671,3,3,0,0,1,1,134159.95265752633,765591.3646788632,2020-05-06,0,0,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,5,NSD1,0.856,5.7561,2.1855,1,-1.0,-1.0,,
ENSG00000165912,6,3,1,0,0,1,11798.46653227782,448058.917711015,2022-10-12,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,8,PACSIN3,0.153,0.67111,0.092115,1,0.75,0.0,,
ENSG00000166024,5,3,1,0,1,1,73985.70318108075,433862.5685735124,2021-09-30,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,6,R3HCC1L,-0.01999998,0.21755,0.3814,0,-1.0,-1.0,,
ENSG00000166025,3,3,0,0,1,1,45087.14211417935,189557.6027707886,2023-01-18,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,AMOTL1,0.41900003,1.2895,0.051453,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000166170,9,3,1,0,0,1,44366.618252427186,1076472.0138856068,2018-04-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,1,0,0,1,14,BAG5,-0.03999996,1.0333,0.38062,1,1.0,-1.0,,
ENSG00000166262,6,3,1,0,0,1,35292.77048385347,332092.8064672836,2024-01-05,3,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,0,0,0,8,FAM227B,-0.86899996,-0.42311,-1.192,0,-1.0,-1.0,,
ENSG00000166272,3,3,0,0,0,1,171880.2916512608,765591.3646788632,2020-06-15,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,WBP1L,0.218,1.3815,0.63283,0,-1.0,-1.0,,
ENSG00000166391,3,3,0,0,0,1,207220.14223281175,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,3,MOGAT2,-0.047999978,0.33276,0.63908,1,0.75,0.5,,
ENSG00000166575,7,3,1,0,0,1,18906.903981197203,414433.58532016096,2018-12-31,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,4,0,0,9,TMEM135,0.25700003,1.0284,-0.09537,0,-1.0,-1.0,,
ENSG00000166825,4,3,1,1,1,1,49127.555514088446,301203.06999851385,2018-11-30,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,4,ANPEP,0.29500002,1.3814,0.069454,2,0.75,0.0,Immune System;Metabolism of Angiotensinogen to Angiotensins,R-HSA-168256;R-HSA-2022377
ENSG00000166965,8,3,1,0,0,1,47964.23150355728,1424218.0900670097,2018-10-08,5,0,0,0,1,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,RCCD1,-0.69200003,-2.439,-2.9426,1,-1.0,0.0,Protein hydroxylation;Post-translational protein modification,R-HSA-9629569;R-HSA-597592
ENSG00000167004,3,3,1,0,0,1,141553.2677895436,882833.0320407465,2021-12-06,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,PDIA3,0.574,1.1721,0.67453,3,0.5,-1.0,Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Immune System;Post-translational protein modification,R-HSA-901042;R-HSA-532668;R-HSA-168256;R-HSA-597592
ENSG00000167173,4,3,1,0,1,1,143284.77790855977,397765.9672627851,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,5,C15orf39,0.342,0.83246,-0.00093032,0,0.5,-1.0,,
ENSG00000167193,3,3,1,0,0,1,93139.63789601182,448058.917711015,2023-01-18,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,CRK,0.663,2.0656,0.27482,10,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Regulation of signaling by CBL;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-912631;R-HSA-9006934
ENSG00000167208,4,3,1,0,0,1,1791.5069911962714,322220.1169395476,2009-12-16,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,6,SNX20,-0.45500004,-0.81186,-1.45,0,0.5,0.0,,
ENSG00000167283,3,3,1,0,0,0,153400.07480928372,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,1,0,0,0,0,0,0,4,ATP5MG,-0.12399995,0.41851,-0.35401,3,-1.0,-1.0,Formation of ATP by chemiosmotic coupling;Cristae formation,R-HSA-163210;R-HSA-8949613
ENSG00000167523,8,3,1,0,0,1,3815.989131101703,427337.4491868293,2021-02-06,7,0,0,0,2,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,12,SPATA33,-0.77199996,-1.5331,-1.258,0,1.0,-1.0,,
ENSG00000167528,4,3,1,0,1,1,82295.36127718941,714039.8414241908,2020-06-15,0,0,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,ZNF641,0.26599997,0.88589,1.2842,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000167701,3,3,1,0,1,0,28635.19181934661,132101.59514050526,2023-01-18,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,GPT,-0.6,-2.3265,-3.23,2,0.5,0.0,Pyruvate metabolism,R-HSA-70268
ENSG00000167910,7,3,0,0,0,1,4518.532006719214,301203.06999851385,2018-08-13,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,21,0,0,5,28,CYP7A1,0.18,0.083203,0.22935,5,1.0,1.0,Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000168079,6,3,1,1,1,1,42398.05428047667,168116.01355658393,2022-10-12,0,0,0,0,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,9,SCARA5,-0.39400005,-0.65039,-1.889,1,0.5,0.0,,
ENSG00000168268,4,3,1,0,1,1,95776.89591443514,213085.6895276826,2021-06-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,3,NT5DC2,0.21200001,1.0532,-0.18684,0,-1.0,-1.0,,
ENSG00000168395,3,3,1,0,0,1,64514.85721423125,137776.79053446153,2021-09-30,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,ING5,0.34600002,1.8033,-0.18818,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000168515,3,3,0,0,0,1,78906.83616868555,104865.12229088554,2023-01-18,0,2,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,5,SCGB1D1,-0.86899996,0.5329,-0.12429,0,0.5,1.0,,
ENSG00000168671,3,3,0,0,0,1,233499.4066209918,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,UGT3A2,-0.08000004,0.82556,0.067507,2,0.5,0.5,Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000168925,7,3,1,1,0,1,5916.919614951869,1424218.0900670097,2009-05-10,0,0,0,0,1,24,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,26,CTRB1,-0.90199995,-1.4694,-1.2192,2,1.0,0.0,,
ENSG00000168930,3,3,0,0,0,1,2527.185234452943,2527.185234452943,2021-12-01,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,3,TRIM49,0.031000018,2.39,1.3568,0,,,,
ENSG00000169218,3,3,0,0,0,1,59389.77313114188,180089.50342935527,2021-11-04,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,RSPO1,-0.004999995,1.1297,0.49634,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000169230,5,3,1,0,0,0,100620.50186431198,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,2,6,PRELID1,0.25,1.9931,1.4887,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000169972,3,3,1,0,0,1,32254.717802479194,306980.8575290048,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,1,4,PUSL1,-0.985,-4.7055,-5.1171,0,-1.0,-1.0,,
ENSG00000170242,3,3,1,0,1,1,190279.23963861223,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,3,USP47,0.68200004,2.7799,0.29593,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000170421,4,3,1,0,1,1,6852.019889502762,521818.7070055739,2011-07-08,24,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,26,KRT8,0.20999998,1.9436,1.4028,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000170509,6,3,1,0,0,1,6788.635053755645,172076.47010352428,2023-01-18,6,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,20,HSD17B13,-0.14999998,-0.062698,-0.32697,1,1.0,0.0,,
ENSG00000170571,3,3,0,0,0,1,98524.26480884294,323648.5577791949,2017-10-09,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,7,EMB,0.111,-0.36037,-0.70615,1,0.5,-1.0,,
ENSG00000170624,5,3,1,0,0,1,576.1087314662274,323648.5577791949,2022-03-28,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,3,0,0,0,0,0,0,5,SGCD,0.120000005,-0.11017,-0.18254,1,0.5,0.0,,
ENSG00000170873,6,3,1,0,0,1,21724.94108458234,756470.9740366563,2018-06-11,4,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,11,MTSS1,0.668,2.2992,1.0672,0,-1.0,-1.0,,
ENSG00000171222,5,3,1,0,1,1,53157.639291331456,249965.96240703977,2018-08-13,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,6,SCAND1,-0.946,-2.0608,-2.6356,0,-1.0,-1.0,,
ENSG00000171502,6,3,1,1,1,1,23467.651805886748,414433.58532016096,2020-01-20,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,11,COL24A1,0.04400003,0.46209,0.36294,5,0.5,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000171612,5,3,0,0,0,1,15223.454539395489,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,4,6,SLC25A33,0.25800002,2.4543,0.49853,0,0.5,-1.0,,
ENSG00000171735,4,3,0,0,0,1,344.7221238938053,433862.5685735124,2016-05-16,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,4,CAMTA1,0.773,4.7704,1.5723,0,-1.0,-1.0,,
ENSG00000171757,8,3,1,0,1,0,3721.3983572895277,158370.2523752734,2013-04-14,6,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,9,LRRC34,-0.15100002,0.56843,0.045746,0,0.5,0.5,,
ENSG00000171914,5,3,1,0,0,1,78355.43324299547,189845.9324918578,2021-08-24,2,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,4,13,TLN2,0.544,1.9885,-1.1588,0,0.5,-1.0,,
ENSG00000172164,3,3,0,0,0,1,13026.258393364305,1424218.0900670097,2020-06-08,3,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,SNTB1,0.013000011,-1.0484,-0.26947,1,0.5,-1.0,,
ENSG00000172238,5,3,0,0,0,1,88632.90640619362,124801.11117486731,2018-12-03,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,4,ATOH1,0.23299998,-0.25259,-0.60327,0,1.0,0.5,,
ENSG00000172379,5,3,1,0,0,1,125894.9248389576,645988.1975077938,2018-06-11,0,0,0,0,9,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,11,ARNT2,0.502,2.3501,-0.074948,6,1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000172461,3,3,0,0,0,1,19068.334286166748,466632.7979326389,2014-07-22,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,6,FUT9,0.236,2.145,-0.27982,1,0.75,0.5,,
ENSG00000172530,3,3,1,0,0,1,2324.6716622691292,515513.2178404211,2020-06-15,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,BANP,0.697,2.6533,-0.87833,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000172673,5,3,0,0,0,1,20302.198506576402,464892.4593283075,2012-11-01,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,5,THEMIS,0.106000006,-0.0050502,-0.19306,0,1.0,0.5,,
ENSG00000172977,3,3,1,0,0,1,13959.203480505423,171880.2916512608,2022-04-08,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,4,KAT5,0.40600002,3.7481,-2.0593,22,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Formation of the beta-catenin:TCF transactivating complex,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-201722
ENSG00000173327,3,3,1,0,0,0,17710.3869470848,221280.45048451523,2018-12-12,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,1,4,MAP3K11,0.20999998,0.52214,-1.4731,7,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000173402,5,3,1,1,0,1,58331.23271678036,437137.9986908925,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,2,0,1,0,7,DAG1,0.702,2.5564,0.28176,9,-1.0,-1.0,Matriglycan biosynthesis on DAG1;DAG1 glycosylations;Developmental Biology;Disease;Regulation of expression of SLITs and ROBOs;Post-translational protein modification,R-HSA-9939291;R-HSA-8931838;R-HSA-1266738;R-HSA-1643685;R-HSA-9010553;R-HSA-597592
ENSG00000173406,5,3,0,0,0,1,286746.1002745869,1778690.168860174,2022-07-14,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,7,DAB1,0.593,1.6851,0.80684,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000173597,4,3,1,0,0,1,47450.88644524237,464892.4593283075,2018-09-07,14,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,17,SULT1B1,-0.036000013,-0.063918,-1.4552,1,0.5,0.0,Cytosolic sulfonation of small molecules;Phase II - Conjugation of compounds,R-HSA-156584;R-HSA-156580
ENSG00000173728,5,3,0,0,0,1,137776.79053446153,498258.534626183,2023-01-18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,7,SPMIP3,-0.41700006,0.64891,0.14214,0,1.0,1.0,,
ENSG00000173821,4,3,1,0,1,1,2201.586503948313,360605.992793193,2016-05-16,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,9,RNF213,0.30800003,4.9553,1.2474,3,-1.0,-1.0,Immune System;Disease;Response of Mtb to phagocytosis;Infection with Mycobacterium tuberculosis;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-168256;R-HSA-1643685;R-HSA-9637690;R-HSA-9635486;R-HSA-5663202
ENSG00000173933,3,3,0,0,0,1,233499.4066209918,360605.992793193,2022-02-03,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,RBM4,0.577,2.0983,-0.14861,1,-1.0,-1.0,,
ENSG00000174137,5,3,1,0,0,1,53449.348719171874,598869.4096893278,2019-01-21,2,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,6,FAM53A,-0.77699995,-2.3573,-2.6412,0,0.5,0.0,,
ENSG00000174332,3,3,0,0,0,1,86992.9057658324,356440.71671986027,2021-02-24,0,0,0,5,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,7,GLIS1,0.39999998,-0.54636,-0.36508,0,0.5,0.5,,
ENSG00000174502,3,3,0,0,0,1,2033.6842105263158,3725.450516986706,2013-05-13,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,SLC26A9,0.356,1.4,-0.42181,1,0.75,0.5,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000174562,5,3,0,1,0,1,25249.54308571149,278190.43024910334,2018-08-13,3,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,1,11,KLK15,-0.426,-0.19018,-0.22483,0,0.5,0.5,,
ENSG00000174607,6,3,1,0,0,1,33997.53366911201,183761.6081180644,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,1,7,UGT8,0.56,2.4068,1.0556,1,1.0,0.0,,
ENSG00000174951,8,3,0,0,1,1,19965.24128263536,196816.54442141854,2021-09-30,0,0,0,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,0,5,0,0,0,10,FUT1,-0.89199996,0.74516,0.23471,2,0.5,0.0,,
ENSG00000175110,4,3,1,0,0,1,4195.089802267157,180089.50342935527,2021-09-30,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,0,0,2,7,MRPS22,0.073000014,0.40974,0.02723,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000175264,4,3,0,0,0,1,3339.9291648862936,383158.3001114715,2021-01-25,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,4,CHST1,0.30400002,1.9737,-0.10546,1,0.5,0.0,,
ENSG00000175707,3,3,0,0,0,1,71913.46219676935,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,5,KDF1,0.431,1.247,0.43786,0,-1.0,0.0,,
ENSG00000175727,4,3,1,0,0,1,25415.17921452856,384314.83364002535,2019-01-21,0,0,0,0,0,0,0,0,0,0,0,0,13,0,0,0,3,0,0,0,0,0,1,17,MLXIP,0.53900003,2.5604,-0.16714,0,0.5,-1.0,,
ENSG00000175792,7,3,1,0,0,1,38851.92581543917,521818.7070055739,2018-08-13,6,0,0,0,0,0,0,2,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,14,RUVBL1,0.831,4.3743,0.22423,7,-1.0,-1.0,Signal Transduction;Formation of the beta-catenin:TCF transactivating complex;Post-translational protein modification,R-HSA-162582;R-HSA-201722;R-HSA-597592
ENSG00000175879,3,3,0,0,0,1,55894.896962213366,230316.30849350386,2019-05-31,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,3,HOXD8,-0.153,-2.8013,-2.1444,0,0.5,0.0,,
ENSG00000176842,10,3,0,0,0,1,3400.4411583487367,521818.7070055739,2014-08-10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,1,0,0,14,IRX5,0.587,0.47481,-1.2179,0,0.5,0.0,,
ENSG00000177034,3,3,0,0,0,1,86869.04450932604,235397.69820205137,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,4,MTX3,0.049000025,-0.46346,-0.42756,0,-1.0,-1.0,,
ENSG00000177425,4,3,1,0,0,1,2314.313784461153,414433.58532016096,2019-07-08,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,5,PAWR,-0.94500005,-3.1902,-3.1198,0,-1.0,0.0,,
ENSG00000177469,3,3,0,0,0,1,34004.8644513982,804063.9714459113,2017-01-09,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,CAVIN1,-0.09200001,0.58859,0.1324,4,-1.0,-1.0,,
ENSG00000177595,6,3,1,0,1,1,7794.273577144567,200944.0765227402,2021-03-01,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,5,PIDD1,-0.23699999,-1.6597,-3.1145,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000177628,4,3,1,0,1,1,3009.517504539917,76832.90012167432,2014-07-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,0,0,1,11,GBA1,0.29299998,2.2965,0.61578,2,-1.0,-1.0,,
ENSG00000178175,6,3,1,0,0,1,2010.4597478176527,645988.1975077938,2019-01-18,0,0,0,3,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,7,ZNF366,0.399,0.49718,0.012517,0,-1.0,0.0,,
ENSG00000178177,3,3,0,0,1,1,263416.51565448404,1424218.0900670097,2020-06-15,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,LCORL,0.65900004,2.8645,2.5308,0,-1.0,-1.0,,
ENSG00000178645,4,3,0,0,0,1,19662.31571784985,521818.7070055739,2016-04-04,3,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,C10orf53,-0.571,-0.19301,-0.37806,0,1.0,1.0,,
ENSG00000178694,4,3,0,0,0,1,17243.0319680403,112184.2204720767,2022-10-12,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,NSUN3,0.20499998,0.48144,0.072451,0,-1.0,-1.0,,
ENSG00000178950,3,3,1,0,0,1,37368.38182683358,159189.58506586426,2016-05-16,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,0,0,5,GAK,0.31300002,0.50011,-2.5253,2,-1.0,-1.0,,
ENSG00000178997,5,3,0,0,0,1,65343.824011592886,358386.30063935445,2019-10-24,0,2,0,0,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,6,EXD1,-0.536,-0.67688,0.67039,0,1.0,1.0,,
ENSG00000179407,4,3,0,0,0,1,70123.15753486022,438004.58573217486,2019-04-02,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,4,DNAJB8,-0.786,-0.58372,0.40156,0,1.0,1.0,,
ENSG00000179526,5,3,0,0,1,1,1321.7688442211056,295550.4496098593,2020-01-20,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,6,0,0,0,0,0,1,10,SHARPIN,0.09799999,-1.0273,-2.3648,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000179833,3,3,0,0,0,1,190279.23963861223,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,3,SERTAD2,0.579,1.7214,0.2273,0,0.5,-1.0,,
ENSG00000179859,4,3,1,0,0,1,4946.6795233831535,521818.7070055739,2015-06-18,6,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,8,RNF227,,,,0,1.0,-1.0,,
ENSG00000180448,4,3,1,0,1,1,31340.65440454944,160010.51072069994,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,2,6,ARHGAP45,0.25,-1.2435,-4.2894,4,0.75,0.0,,
ENSG00000180611,3,3,1,0,0,1,13231.205953103572,381165.6245253304,2018-10-08,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,3,MB21D2,0.53900003,1.6443,0.33074,0,-1.0,-1.0,,
ENSG00000180828,10,3,0,0,1,1,72170.02447217306,498258.534626183,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,3,9,BHLHE22,-0.30999994,-2.4243,-4.9077,1,1.0,0.0,,
ENSG00000180957,12,3,0,0,0,1,3170.025142372042,521818.7070055739,2020-09-04,12,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,15,PITPNB,-0.80700004,0.99475,-0.36541,1,-1.0,-1.0,,
ENSG00000181191,8,3,1,0,1,1,80746.41870861933,671426.4432757655,2014-07-22,0,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,7,PJA1,,,,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000181222,4,3,1,0,0,1,86869.04450932604,521818.7070055739,2021-09-30,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,POLR2A,0.798,9.204,-2.6038,41,0.5,1.0,Signal Transduction;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;RNA Pol II CTD phosphorylation and interaction with CE;mRNA Capping;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;Generic Transcription Pathway;FGFR2 alternative splicing;mRNA Splicing - Minor Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;Formation of TC-NER Pre-Incision Complex;Developmental Biology;Inhibition of DNA recombination at telomere;Gene expression (Transcription);PIWI-interacting RNA (piRNA) biogenesis;Viral Messenger RNA Synthesis;MicroRNA (miRNA) biogenesis;Abortive elongation of HIV-1 transcript in the absence of Tat;Disease;Pausing and recovery of HIV elongation;Tat-mediated HIV elongation arrest and recovery;HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;Gap-filling DNA repair synthesis and ligation in TC-NER;Transcriptional regulation by small RNAs;Gene Silencing by RNA;RNA polymerase II transcribes snRNA genes;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-167160;R-HSA-77075;R-HSA-72086;R-HSA-113418;R-HSA-167158;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-212436;R-HSA-6803529;R-HSA-72165;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-6781823;R-HSA-1266738;R-HSA-9670095;R-HSA-74160;R-HSA-5601884;R-HSA-168325;R-HSA-203927;R-HSA-167242;R-HSA-1643685;R-HSA-167290;R-HSA-167243;R-HSA-167287;R-HSA-167238;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-6782210;R-HSA-5578749;R-HSA-211000;R-HSA-6807505;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-6781827;R-HSA-9006934;R-HSA-5663202
ENSG00000181541,3,3,0,0,0,1,1814.757548363768,427337.4491868293,2016-12-30,1,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,MAB21L2,0.273,3.1238,0.23819,0,1.0,0.0,,
ENSG00000182134,5,3,1,0,0,1,36159.555758564435,394357.452283155,2017-01-09,0,0,0,0,5,0,0,0,3,0,0,0,0,0,0,0,0,0,0,2,0,0,0,10,TDRKH,0.399,2.4663,1.364,1,0.5,-1.0,Gene expression (Transcription);PIWI-interacting RNA (piRNA) biogenesis;Gene Silencing by RNA,R-HSA-74160;R-HSA-5601884;R-HSA-211000
ENSG00000182196,5,3,1,0,0,1,55416.28042655659,515513.2178404211,2018-07-27,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,5,ARL6IP4,-0.27699995,-1.0075,-2.0756,0,-1.0,-1.0,,
ENSG00000182218,15,3,1,0,1,1,52463.65429696694,502231.5406594711,2017-07-17,0,0,0,0,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,44,HHIPL1,-0.116000056,-0.66185,-1.1835,0,0.5,0.0,,
ENSG00000182348,5,3,0,0,0,1,606.6666666666666,1778690.168860174,2017-11-01,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,0,0,1,0,0,0,13,ZNF804B,0.100000024,-0.26351,-0.68322,1,1.0,1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000182463,5,3,1,0,0,1,28292.123952140868,1424218.0900670097,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,7,TSHZ2,0.594,0.92101,-0.2203,0,-1.0,0.0,,
ENSG00000182512,3,3,0,0,0,1,932.622440120525,47832.98019165416,2022-06-27,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,2,0,0,0,5,GLRX5,-0.74100006,-1.8416,-1.4522,1,0.5,-1.0,Mitochondrial iron-sulfur cluster biogenesis,R-HSA-1362409
ENSG00000182771,3,3,0,0,0,1,68837.80679818468,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,5,GRID1,0.6,2.548,0.021878,0,0.5,0.5,,
ENSG00000183023,6,3,1,0,0,1,576.1087314662274,191895.42310022408,2018-12-31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,0,2,6,SLC8A1,0.63699996,2.4092,-0.95457,3,1.0,0.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000183153,3,3,0,0,1,1,69453.1498757531,235397.69820205137,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,4,GJD3,,-2.2448,-2.8994,1,0.5,0.0,Gap junction assembly;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-190861;R-HSA-157858;R-HSA-190828
ENSG00000183386,3,3,1,0,0,0,82912.80518893801,394357.452283155,2019-05-14,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,FHL3,0.16500002,1.1161,0.67118,0,0.75,0.0,,
ENSG00000183691,13,3,1,0,0,1,1225.1182294700059,714039.8414241908,2009-12-20,0,0,0,0,0,0,3,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,13,23,NOG,0.633,1.4066,-0.3929,2,0.5,0.5,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000183723,3,3,0,0,0,1,26561.371714038676,72982.48880358285,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,3,CMTM4,-0.13600004,0.23718,-0.55859,0,-1.0,-1.0,,
ENSG00000183762,3,3,1,0,1,1,180089.50342935527,235397.69820205137,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,3,KREMEN1,0.15200001,1.2623,0.81777,3,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000183908,5,3,0,0,0,1,3555.255856435903,235397.69820205137,2021-09-30,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,6,LRRC55,0.088,0.72635,-0.65977,0,0.5,0.5,,
ENSG00000183960,3,3,0,0,0,1,28821.88430161129,341207.7500533011,2019-06-24,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,6,KCNH8,0.19,1.7796,0.59629,1,0.75,0.5,,
ENSG00000184371,3,3,1,0,0,1,11608.613380386345,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,CSF1,0.662,0.49258,-0.52156,6,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Developmental Biology;Signaling by Interleukins;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-449147;R-HSA-597592
ENSG00000184500,7,3,0,1,1,1,13764.1487425546,112184.2204720767,2022-10-12,2,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,18,PROS1,0.47000003,1.9624,1.3362,8,0.5,0.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000184838,9,3,0,0,0,1,91172.20051337926,1778690.168860174,2021-02-05,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,13,1,0,0,0,0,0,15,PRR16,0.37800002,-0.6672,0.0017197,0,0.5,0.0,,
ENSG00000184956,3,3,0,0,1,1,3339.9291648862936,464892.4593283075,2021-01-25,0,0,0,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,MUC6,-0.19299996,0.74943,-0.62057,6,0.75,0.0,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000185033,7,3,1,0,0,1,3263.956597558613,397765.9672627851,2018-12-12,0,0,0,0,0,0,0,0,4,0,0,0,1,0,0,0,0,0,0,10,0,0,0,15,SEMA4B,0.116999984,-0.1317,-1.9347,0,0.5,-1.0,,
ENSG00000185345,5,3,1,0,0,1,24436.75553070369,1778690.168860174,2018-08-13,0,0,0,0,0,3,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,PRKN,-0.16999996,-0.4254,-0.71158,6,0.5,0.0,,
ENSG00000185737,3,3,0,0,1,0,83896.55822718568,1778690.168860174,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,3,NRG3,0.36400002,-0.10856,-0.70488,17,0.5,0.5,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000185800,4,3,1,0,0,1,123127.18790121445,461914.58891516324,2019-02-25,0,0,0,0,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,5,DMWD,0.35000002,0.83944,-2.9063,0,-1.0,-1.0,,
ENSG00000185909,7,3,1,0,0,1,91777.88428345599,1778690.168860174,2019-02-04,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,0,0,1,0,0,0,12,KLHDC8B,-0.016000032,1.4554,1.7788,0,0.5,-1.0,,
ENSG00000185926,5,3,0,0,0,1,29803.01405728205,448058.917711015,2019-08-16,0,0,0,1,5,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,OR4C46,-0.96800005,-4.876,-4.1393,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000185962,4,3,1,0,0,1,6712.63652527305,309256.4614031486,2012-12-01,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,8,0,0,0,11,LCE3A,-0.85800004,-0.27584,-0.0097581,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000186094,4,3,0,0,0,1,131525.74533408263,645988.1975077938,2018-07-30,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,8,AGBL4,-0.10699999,0.5861,-0.70658,1,0.5,0.5,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000186329,4,3,0,0,0,1,7794.273577144567,111599.28184123649,2021-03-01,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,5,TMEM212,-0.643,0.38676,0.55884,0,1.0,0.0,,
ENSG00000186472,9,3,1,0,1,1,86992.9057658324,1778690.168860174,2019-02-04,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,14,PCLO,0.809,0.49955,-1.2348,1,0.75,0.0,,
ENSG00000186577,4,3,0,0,0,1,5691.114246503779,303059.79257468163,2023-01-18,2,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SMIM29,0.19099998,0.12474,-0.10561,0,0.5,-1.0,,
ENSG00000186666,4,3,0,0,0,1,13286.695551704217,275021.63051358337,2012-04-08,0,0,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,5,BCDIN3D,-0.069000006,1.0548,1.1116,1,1.0,-1.0,Gene expression (Transcription);MicroRNA (miRNA) biogenesis;Gene Silencing by RNA,R-HSA-74160;R-HSA-203927;R-HSA-211000
ENSG00000186867,3,3,0,0,1,1,937.7148182665424,49724.14538298504,2015-04-27,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,3,QRFPR,-0.53199995,0.1451,0.13473,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000187398,6,3,0,0,0,1,15866.724081734988,1778690.168860174,2014-07-22,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,13,LUZP2,-0.227,-0.31829,-0.14427,0,0.75,0.5,,
ENSG00000188042,3,3,0,0,0,1,1173.5007132667617,433862.5685735124,2017-12-06,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,ARL4C,0.204,2.8692,0.11921,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000188076,8,3,0,0,0,1,13322.121683308418,355284.1215006515,2019-06-12,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,19,SCGB1C1,-0.265,1.8297,1.6851,0,0.5,0.5,,
ENSG00000188263,5,3,0,0,1,1,21897.542503344637,515513.2178404211,2017-01-09,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,7,0,0,0,9,IL17REL,-0.14100003,-0.8701,-1.1375,0,0.75,0.5,,
ENSG00000188483,7,3,0,0,1,1,95776.89591443514,298504.9722193353,2022-06-28,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,2,0,0,0,0,0,1,6,IER5L,0.15100002,-3.4405,-4.9011,0,-1.0,0.0,,
ENSG00000196090,3,3,0,0,0,0,405722.3511294316,1778690.168860174,2021-06-29,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,3,PTPRT,0.605,3.2219,-0.54263,0,0.5,0.5,,
ENSG00000196208,13,3,1,0,1,1,12358.468814746017,468121.8445229682,2012-10-28,24,0,0,0,0,0,0,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,54,GREB1,0.35500002,2.7704,-0.1889,1,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000196275,7,3,1,0,0,1,58331.23271678036,756470.9740366563,2017-01-09,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,8,GTF2IRD2,0.12900001,3.2472,3.1702,0,-1.0,-1.0,,
ENSG00000196372,3,3,1,0,0,1,141293.18354755783,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,ASB13,-0.686,-0.77866,-0.87009,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000196557,3,3,1,0,1,0,376569.5597064443,1424218.0900670097,2023-01-18,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,CACNA1H,-0.059000015,-7.6469,-12.87,3,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000197070,7,3,1,0,0,1,26841.183331692897,298504.9722193353,2019-04-26,0,0,0,0,0,0,0,0,4,0,9,0,0,0,0,0,0,0,0,0,0,0,2,15,ARRDC1,-0.19099998,-0.95064,-1.737,0,-1.0,-1.0,,
ENSG00000197124,4,3,1,0,0,1,9964.719723813545,1424218.0900670097,2021-09-30,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,ZNF682,-0.09800005,0.67692,0.97907,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000197408,5,3,0,0,1,1,550.1625195754307,78728.4671948324,2018-08-13,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,6,CYP2B6,-0.04400003,0.2815,0.1016,4,1.0,0.5,,
ENSG00000197410,3,3,1,0,1,1,633.8223938223938,249623.65852165114,2019-05-03,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,0,0,1,0,0,0,6,DCHS2,0.09100002,0.29745,-0.20108,0,0.5,0.5,,
ENSG00000197415,4,3,1,0,0,1,44271.67133520075,1122672.658801146,2022-07-26,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,VEPH1,-0.06799996,0.8436,1.9917,0,0.5,0.0,,
ENSG00000197467,3,3,0,0,0,1,62627.34914844415,275021.63051358337,2018-07-27,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,6,COL13A1,0.11400002,-0.13261,-2.1894,4,0.5,0.0,,
ENSG00000197980,4,3,1,0,0,1,28863.30790298137,207233.9114391144,2022-12-10,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,LEKR1,-0.21200001,0.19202,-0.49716,0,0.5,0.5,,
ENSG00000198108,6,3,1,0,0,1,78751.06843456876,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,2,0,2,0,0,0,0,0,0,5,0,0,0,9,CHSY3,0.10799998,0.087351,-2.0094,1,0.5,0.0,,
ENSG00000198353,4,3,1,0,0,1,47692.964985095256,756470.9740366563,2018-08-13,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,5,HOXC4,0.13700002,0.45901,-0.32253,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000198355,4,3,1,0,1,1,93616.86016863462,1424218.0900670097,2020-05-06,0,0,0,0,0,5,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,PIM3,-0.0019999743,-1.2655,-5.1454,0,-1.0,-1.0,,
ENSG00000198535,4,3,1,0,0,1,95135.53490956625,1424218.0900670097,2017-09-04,0,0,0,1,0,22,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,25,C2CD4A,-0.96300006,-3.912,-4.7491,0,0.5,0.5,,
ENSG00000198547,3,3,0,0,0,1,47283.957661805514,433862.5685735124,2021-11-04,0,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,6,C20orf203,-0.83500004,-0.78187,-0.67321,0,-1.0,1.0,,
ENSG00000198673,3,3,1,0,0,1,151416.12986435954,338763.57771536184,2023-01-18,0,0,0,0,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,TAFA2,0.17699999,1.6182,-0.51556,0,0.5,0.0,,
ENSG00000198795,3,3,0,0,0,1,180089.50342935527,1778690.168860174,2021-11-04,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,4,ZNF521,0.794,4.0944,0.016635,3,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000198873,10,3,1,1,0,1,3711.688577586207,410642.56898295006,2012-09-06,0,0,0,0,15,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,22,GRK5,0.39600003,2.4301,0.6453,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000198914,5,3,0,0,0,1,103877.27822338727,1424218.0900670097,2017-10-09,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,6,POU3F3,0.518,-0.10336,-3.8183,1,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000203724,3,3,0,0,0,1,83710.65550453523,1076472.0138856068,2022-12-23,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,0,0,0,7,C1orf53,-0.975,-2.8871,-2.8818,0,0.5,0.0,,
ENSG00000204006,5,3,0,0,0,1,8454.377496185232,545988.1005477115,2018-06-11,0,0,0,0,4,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,7,C1orf185,-0.674,0.3326,0.13274,0,1.0,1.0,,
ENSG00000204160,3,3,1,0,0,1,47507.298118531595,438004.58573217486,2019-04-02,0,0,0,0,2,0,0,0,0,0,1,0,4,0,0,0,0,0,0,0,0,0,0,7,ZDHHC18,0.089999974,1.347,0.45221,0,0.5,-1.0,,
ENSG00000204179,3,3,0,0,0,1,141293.18354755783,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,PTPN20,0.302,2.6472,2.2915,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000205693,5,3,1,1,0,1,46282.676044693806,575147.0632428399,2021-08-24,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,5,MANSC4,-0.44099998,1.2613,1.4298,0,0.5,0.5,,
ENSG00000205755,6,3,0,0,0,1,14145.711748532529,298504.9722193353,2023-01-18,1,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,9,CRLF2,,,,1,0.5,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000205835,3,3,0,0,0,1,1270.7887323943662,114027.3065785449,2013-04-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,4,GMNC,0.11799997,0.30209,-0.20023,0,0.5,0.5,,
ENSG00000213088,4,3,0,0,0,1,1565.572378585343,95905.57783546533,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,2,0,0,0,0,0,0,5,11,ACKR1,-0.84099996,-0.38415,-0.75933,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000213186,4,3,1,0,0,1,167055.73472660675,672632.4785173276,2020-06-15,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,TRIM59,0.325,0.23047,-0.028909,0,0.5,0.0,,
ENSG00000213658,4,3,1,0,0,1,30049.94565242696,645988.1975077938,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,2,0,0,0,0,5,LAT,0.526,1.3219,0.47755,7,0.5,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000221823,3,3,1,0,0,1,15223.454539395489,235397.69820205137,2018-08-13,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,13,PPP3R1,0.323,3.5914,0.71879,6,0.5,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000225190,3,3,0,0,0,1,21724.94108458234,329504.3397029431,2017-03-27,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,3,PLEKHM1,0.56700003,4.3929,3.3716,0,0.5,0.0,,
ENSG00000235162,3,3,0,0,0,1,10709.859958046933,48998.92396570104,2021-08-11,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,C12orf75,-0.85800004,-0.71835,-1.6137,0,0.5,-1.0,,
ENSG00000238083,4,3,0,1,0,0,9633.181385755513,115161.86934995181,2019-04-12,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,4,LRRC37A2,0.46600002,3.9426,2.8442,0,1.0,1.0,,
ENSG00000240849,6,3,0,0,0,0,28292.123952140868,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,2,5,PEDS1,0.33099997,2.4649,-0.030917,0,-1.0,-1.0,,
ENSG00000243943,3,3,0,0,0,1,25903.3352616996,467606.0891342802,2020-12-08,1,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,ZNF512,0.51100004,2.9851,0.59713,0,-1.0,-1.0,,
ENSG00000248746,3,3,1,0,1,0,189845.9324918578,409691.21276290494,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,3,ACTN3,0.055999994,-0.33789,0.1433,2,1.0,0.5,,
ENSG00000249709,4,3,1,0,1,1,106176.1187815965,466632.7979326389,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,5,ZNF564,0.052999973,1.3919,-0.48482,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000254656,4,3,0,0,1,1,12129.582986241576,444537.33605315426,2009-12-06,0,0,0,0,0,7,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,9,RTL1,-0.86899996,1.2606,0.98866,0,0.5,0.5,,
ENSG00000256980,3,3,0,0,0,1,10353.132295719844,239970.53614968536,2019-12-09,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,3,KHDC1L,-0.02699995,-0.57276,-0.7256,0,0.75,0.5,,
ENSG00000258873,5,3,1,0,0,1,2630.136511375948,42193.37905314073,2011-07-06,2,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,1,11,DUXA,-0.17999995,0.15107,-0.34692,1,,,Developmental Biology;Zygotic genome activation (ZGA),R-HSA-1266738;R-HSA-9819196
ENSG00000259571,5,3,0,0,0,1,76632.8325989884,545988.1005477115,2021-11-04,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,5,BLID,-0.885,-0.039859,0.24093,0,,,,
ENSG00000260314,3,3,0,1,1,1,12626.756968368305,141293.18354755783,2021-05-28,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,3,MRC1,,,,2,0.5,0.0,Immune System;Disease;Infection with Mycobacterium tuberculosis,R-HSA-168256;R-HSA-1643685;R-HSA-9635486
ENSG00000261236,4,3,1,0,0,1,8479.376416968564,26561.371714038676,2017-09-07,3,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,2,9,BOP1,0.08700001,-1.7854,-3.7443,1,0.5,-1.0,rRNA processing,R-HSA-72312
ENSG00000262246,3,3,1,0,1,1,103877.27822338727,1424218.0900670097,2017-10-09,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,CORO7,-0.08899999,-1.329,-2.1032,0,0.5,-1.0,,
ENSG00000262406,10,3,0,1,0,1,58079.51445419244,410642.56898295006,2022-09-30,0,0,0,0,14,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,2,19,MMP12,-0.515,0.7261,-0.40577,2,0.5,0.5,,
ENSG00000265808,6,3,1,0,0,1,10351.48329956029,160010.51072069994,2020-05-18,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,9,SEC22B,-0.829,0.097177,0.083572,4,-1.0,-1.0,Immune System;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-168256;R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000268500,3,3,1,0,1,1,5002.767245657568,256331.89034791503,2015-02-02,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,3,SIGLEC5,-0.15699995,0.68986,0.41331,2,0.75,0.5,Immune System,R-HSA-168256
ENSG00000270765,6,3,0,0,1,1,39662.38758270012,382631.1172224132,2023-01-18,0,0,0,0,0,0,0,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,1,6,GAS2L2,0.116,-0.19915,-0.27701,0,0.75,0.5,,
ENSG00000273749,3,3,0,0,1,0,141293.18354755783,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,3,CYFIP1,0.56,3.1531,0.42153,9,-1.0,-1.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000289051,3,3,0,0,0,0,135095.86576106868,294387.2978738704,2021-09-30,0,0,0,0,0,2,0,0,0,3,0,0,0,0,0,0,0,0,0,1,0,0,0,6,MLDHR,,,,0,,,,
ENSG00000000460,2,2,0,0,0,1,26219.529008428708,109001.36551434857,2022-10-12,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,4,FIRRM,0.11500001,1.4063,0.69609,3,0.5,0.0,,
ENSG00000004059,2,2,0,0,0,1,45589.72605179723,254373.32653042395,2020-05-06,0,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ARF5,0.315,2.2684,-0.6046,2,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000004975,2,2,1,0,1,1,106850.5808972156,337860.4854363166,2021-11-04,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,DVL2,0.28100002,1.0542,-0.80105,13,-1.0,-1.0,Signal Transduction;Killing mechanisms;WNT5:FZD7-mediated leishmania damping;Disease;WNT5A-dependent internalization of FZD4;Asymmetric localization of PCP proteins;Degradation of DVL,R-HSA-162582;R-HSA-9664420;R-HSA-9673324;R-HSA-1643685;R-HSA-5099900;R-HSA-4608870;R-HSA-4641258
ENSG00000005339,3,2,0,0,0,1,2033.7777777777778,645988.1975077938,2015-03-16,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,CREBBP,0.899,4.7763,-2.9844,53,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Diseases of signal transduction by growth factor receptors and second messengers;Formation of the beta-catenin:TCF transactivating complex;Post-translational protein modification;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-8957322;R-HSA-1655829;R-HSA-5663202;R-HSA-201722;R-HSA-597592;R-HSA-8864260;R-HSA-8878159
ENSG00000006432,6,2,1,0,1,1,16548.58403989127,1778690.168860174,2022-01-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,1,6,MAP3K9,0.32599998,1.6109,1.0585,0,0.5,0.0,,
ENSG00000006459,2,2,1,0,0,1,141076.9910731678,180089.50342935527,2020-05-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,KDM7A,0.595,1.1127,-0.99827,2,-1.0,0.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000007944,3,2,0,0,0,1,130807.0446049922,464892.4593283075,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,3,MYLIP,0.21399999,1.1612,0.39055,3,-1.0,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000008130,2,2,1,1,1,1,108079.44677357117,397765.9672627851,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,NADK,0.37199998,2.7168,-0.2033,1,-1.0,-1.0,,
ENSG00000010379,2,2,0,0,0,0,106176.1187815965,112184.2204720767,2023-01-18,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC6A13,-0.14900005,0.71137,0.48931,2,1.0,0.5,"GABA synthesis, release, reuptake and degradation;Neurotransmitter release cycle",R-HSA-888590;R-HSA-112310
ENSG00000011028,6,2,1,0,0,1,37566.48658985146,895916.2144062951,2022-02-03,0,0,0,0,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,MRC2,0.486,2.2845,-0.3617,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000011422,5,2,1,1,1,0,27408.031319588463,200944.0765227402,2023-01-18,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,8,PLAUR,0.08899999,0.80161,1.1529,3,1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000023171,9,2,1,0,0,1,1427.6729559748428,323648.5577791949,2008-08-31,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,26,GRAMD1B,0.283,1.1345,-0.8423,0,0.75,0.0,,
ENSG00000024526,3,2,0,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,DEPDC1,0.069000006,1.6297,1.7123,0,0.5,0.5,,
ENSG00000026652,3,2,0,0,0,1,95470.48963056858,159902.65410399486,2023-11-10,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,AGPAT4,0.53900003,3.0509,1.166,1,1.0,0.0,Synthesis of PA,R-HSA-1483166
ENSG00000028203,5,2,1,0,0,1,12358.468814746017,380831.7787965888,2012-10-28,0,0,0,0,1,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,VEZT,0.323,0.54753,0.021561,0,-1.0,-1.0,,
ENSG00000035115,2,2,1,0,0,1,320319.7525060048,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,SH3YL1,-0.28400004,0.32715,0.17986,0,-1.0,-1.0,,
ENSG00000035928,2,2,0,0,0,1,29595.74025786674,97691.2238787727,2019-03-28,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,2,RFC1,0.61300004,1.8896,0.83533,14,-1.0,-1.0,Gap-filling DNA repair synthesis and ligation in TC-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-6782210;R-HSA-6782135;R-HSA-6781827
ENSG00000036530,7,2,1,0,0,1,52463.65429696694,270267.2992956902,2017-07-17,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,8,CYP46A1,0.499,2.8689,-0.31041,2,1.0,0.0,Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-193775;R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000040341,3,2,1,0,0,1,133119.54945431868,562534.7696387965,2022-01-12,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,5,STAU2,0.521,1.8658,0.064921,0,-1.0,-1.0,,
ENSG00000048828,4,2,1,0,0,0,22650.1728716785,1778690.168860174,2021-04-15,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,7,FAM120A,0.778,5.0813,1.3223,0,-1.0,-1.0,,
ENSG00000049130,8,2,1,0,0,1,851.38127090301,114942.80121356022,2009-05-31,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,17,KITLG,0.41900003,1.5682,0.50205,7,-1.0,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000049245,2,2,1,0,0,1,190279.23963861223,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,VAMP3,0.026000023,0.36102,-0.28403,17,-1.0,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000051009,2,2,1,0,0,1,46958.1226038696,53923.32227513003,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,FHIP1B,0.533,2.0021,-1.131,0,-1.0,-1.0,,
ENSG00000054796,2,2,0,0,0,1,35604.990553220465,86537.94134095173,2024-07-19,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,2,SPO11,-0.26100004,1.0539,-0.62057,1,1.0,1.0,,
ENSG00000055130,3,2,1,0,0,1,37323.99073154585,160010.51072069994,2017-01-09,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,CUL1,0.706,6.4881,0.93937,32,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Signaling by Interleukins;Iron uptake and transport;Dectin-1 mediated noncanonical NF-kB signaling;NIK-->noncanonical NF-kB signaling;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-917937;R-HSA-5607761;R-HSA-5676590;R-HSA-5663202;R-HSA-597592
ENSG00000060491,2,2,0,0,0,1,162367.55694122918,220320.9576294899,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,OGFR,0.015999973,-0.3203,-0.8337,0,-1.0,-1.0,,
ENSG00000064547,8,2,1,0,0,1,633132.2332759313,633132.2332759313,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,LPAR2,0.023000002,1.0491,-0.032735,3,0.5,-1.0,Signal Transduction;Lysosphingolipid and LPA receptors,R-HSA-162582;R-HSA-419408
ENSG00000065413,3,2,0,0,0,1,36448.89503858875,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ANKRD44,0.635,2.8338,1.2694,0,0.5,-1.0,,
ENSG00000065618,7,2,0,0,1,1,20810.981317003367,355284.1215006515,2021-09-30,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,11,COL17A1,0.09100002,0.79988,0.58935,6,1.0,0.0,Immune System,R-HSA-168256
ENSG00000067715,3,2,1,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,SYT1,0.668,4.0092,1.5805,11,0.75,0.0,"GABA synthesis, release, reuptake and degradation;Acetylcholine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Neurotoxicity of clostridium toxins;Disease;Dopamine Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Neurotransmitter release cycle",R-HSA-888590;R-HSA-264642;R-HSA-210500;R-HSA-168799;R-HSA-1643685;R-HSA-212676;R-HSA-181429;R-HSA-112310
ENSG00000067842,2,2,1,0,0,0,135095.86576106868,427337.4491868293,2021-09-30,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ATP2B3,,,,3,1.0,0.5,,
ENSG00000068885,4,2,0,0,0,1,4804.684371102268,30371.21318531366,2023-01-18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,IFT80,0.26099998,1.5647,0.24364,1,-1.0,-1.0,Intraflagellar transport,R-HSA-5620924
ENSG00000070610,2,2,1,0,0,1,634722.4486407059,1424218.0900670097,2020-06-15,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,GBA2,0.227,1.9266,1.3038,1,-1.0,-1.0,,
ENSG00000071282,4,2,1,0,0,1,3624.878124194795,326545.22790564946,2015-08-24,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,7,LMCD1,0.027999997,0.72385,0.62125,1,0.5,0.0,Surfactant metabolism,R-HSA-5683826
ENSG00000072364,3,2,1,0,0,1,233499.4066209918,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,AFF4,0.886,3.6501,1.0644,3,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-73857;R-HSA-74160
ENSG00000072858,3,2,1,0,0,1,22541.66311868015,765591.3646788632,2013-04-01,13,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,SIDT1,-0.21700001,-0.42642,-0.43178,0,0.5,0.0,,
ENSG00000074527,2,2,1,1,1,1,112184.2204720767,384314.83364002535,2024-04-26,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,NTN4,0.467,1.943,1.1236,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000077458,4,2,0,0,0,1,295500.356444329,322220.1169395476,2019-07-30,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,3,FAM76B,0.48400003,1.0176,-1.4426,0,0.5,-1.0,,
ENSG00000077782,3,2,1,0,0,1,15866.724081734988,1424218.0900670097,2017-05-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,FGFR1,0.726,4.2752,0.0021697,22,-1.0,-1.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000078674,3,2,1,0,1,1,254373.32653042395,545988.1005477115,2020-05-06,0,0,0,0,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,PCM1,0.3,-6.7316,-4.5798,7,-1.0,-1.0,,
ENSG00000078725,3,2,0,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,BRINP1,0.68799996,2.005,-0.53492,0,1.0,0.0,,
ENSG00000078804,2,2,1,0,0,1,353105.3286394775,384314.83364002535,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,TP53INP2,-0.39,-1.3169,-1.3024,0,1.0,-1.0,,
ENSG00000078814,2,2,1,0,1,1,1939.0354957160343,26667.58037719927,2016-03-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,MYH7B,-0.014999986,-0.044392,-1.52,0,0.75,0.0,,
ENSG00000079337,2,2,1,0,0,1,143585.2019681512,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,3,RAPGEF3,0.046000004,0.79324,1.0666,4,-1.0,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000079482,2,2,0,0,0,1,275021.63051358337,718784.6890415357,2022-08-01,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,OPHN1,,,,10,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000079841,2,2,0,0,0,1,263416.51565448404,360605.992793193,2021-07-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,RIMS1,0.504,-0.0045548,-1.3554,6,1.0,0.5,"GABA synthesis, release, reuptake and degradation;Acetylcholine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Neurotransmitter release cycle",R-HSA-888590;R-HSA-264642;R-HSA-210500;R-HSA-212676;R-HSA-181429;R-HSA-112310
ENSG00000080166,2,2,1,0,0,1,114942.80121356022,1424218.0900670097,2018-05-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,DCT,-0.10099995,-0.0010125,0.14961,2,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000080802,2,2,0,0,0,1,108784.9761126256,1076472.0138856068,2021-05-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,3,CNOT4,0.764,3.1462,0.98131,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Deadenylation of mRNA;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-429947;R-HSA-1266738;R-HSA-74160
ENSG00000080845,3,2,0,0,0,1,77544.39441764928,464892.4593283075,2021-09-30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,DLGAP4,0.669,2.7239,0.66144,1,-1.0,-1.0,,
ENSG00000081014,3,2,1,0,0,1,157277.57551067916,598869.4096893278,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,4,AP4E1,0.42400002,0.36717,0.32464,2,-1.0,-1.0,Lysosome Vesicle Biogenesis,R-HSA-432720
ENSG00000083097,2,2,0,0,0,1,985.590015128593,284806.9010892102,2016-02-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,2,DOP1A,0.605,3.6898,1.8186,0,-1.0,-1.0,,
ENSG00000084453,3,2,1,0,1,1,6067.527905738457,11515.948996192528,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,4,SLCO1A2,-0.23899996,0.37842,0.55472,3,0.75,0.5,"Transport of vitamins, nucleosides, and related molecules;Metabolism of steroids;Bile acid and bile salt metabolism",R-HSA-425397;R-HSA-8957322;R-HSA-194068
ENSG00000085788,8,2,1,0,1,1,9495.008807985907,633132.2332759313,2011-10-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,1,0,0,0,11,DDHD2,0.24199998,1.7398,0.90128,1,-1.0,-1.0,Synthesis of PA,R-HSA-1483166
ENSG00000088298,3,2,1,0,0,1,28863.30790298137,102866.95819249244,2019-08-16,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,EDEM2,0.251,2.0111,0.16868,2,-1.0,-1.0,ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Disease;Post-translational protein modification,R-HSA-901032;R-HSA-901042;R-HSA-532668;R-HSA-1643685;R-HSA-597592
ENSG00000090263,8,2,1,0,0,0,49367.473680139236,633132.2332759313,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,3,MRPS33,-0.56500006,0.73694,0.013307,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000091436,3,2,1,0,0,1,151416.12986435954,672632.4785173276,2021-04-22,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,MAP3K20,0.431,1.8311,0.018017,0,0.5,-1.0,,
ENSG00000091844,4,2,1,0,0,1,22541.66311868015,1424218.0900670097,2013-04-01,13,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,RGS17,0.292,1.0738,-0.16501,3,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000096063,4,2,1,0,0,1,12129.582986241576,334911.3573752668,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,5,SRPK1,0.23699999,2.2039,0.52088,2,-1.0,-1.0,Replacement of protamines by nucleosomes in the male pronucleus;Developmental Biology;Disease,R-HSA-9821993;R-HSA-1266738;R-HSA-1643685
ENSG00000096696,6,2,1,0,0,1,2042.6733870967741,39507.00295325707,2013-04-14,10,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,16,DSP,0.55700004,2.6512,1.1215,6,0.5,0.0,Signal Transduction;Immune System;Developmental Biology,R-HSA-162582;R-HSA-168256;R-HSA-1266738
ENSG00000096996,2,2,1,1,0,1,12032.564048865619,169088.90478978804,2018-12-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,4,IL12RB1,0.13800001,0.57071,0.066842,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000100147,3,2,1,0,0,1,100370.13163171016,645988.1975077938,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,CCDC134,-0.40100002,0.8815,0.58716,0,-1.0,-1.0,,
ENSG00000100219,4,2,1,0,1,1,87515.7591699547,414433.58532016096,2023-01-18,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,XBP1,0.222,0.26437,-0.4143,3,0.5,-1.0,ATF6 (ATF6-alpha) activates chaperone genes;ATF6 (ATF6-alpha) activates chaperones,R-HSA-381183;R-HSA-381033
ENSG00000100234,4,2,0,0,0,1,2489.748511904762,414433.58532016096,2010-04-12,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,7,TIMP3,0.33999997,1.9483,-0.24444,1,-1.0,-1.0,,
ENSG00000100346,8,2,0,0,0,1,15866.724081734988,633132.2332759313,2015-07-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,0,0,1,0,0,0,12,CACNA1I,0.47500002,3.3072,-2.8617,2,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000100731,2,2,1,0,0,1,116547.04276487474,358386.30063935445,2018-10-03,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,PCNX1,0.592,2.0038,0.8082,0,-1.0,-1.0,,
ENSG00000101442,2,2,1,0,1,1,52982.28647069224,323648.5577791949,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,ACTR5,0.013999999,-0.16572,-0.93508,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000101746,2,2,0,0,0,1,727796.3668420183,1424218.0900670097,2022-07-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,NOL4,0.674,2.2829,0.27497,0,0.75,0.5,,
ENSG00000102230,2,2,0,0,0,1,279992.27535235474,279992.27535235474,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,PCYT1B,,,,1,0.5,0.0,,
ENSG00000102349,2,2,0,0,0,1,18866.71302373548,275021.63051358337,2023-01-18,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,KLF8,,,,0,0.5,0.0,,
ENSG00000103496,2,2,1,0,0,0,8614.851322410133,562534.7696387965,2020-06-08,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,2,STX4,0.16500002,1.4454,-0.10102,5,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000103510,2,2,1,0,0,0,47935.61449674282,236328.22905445524,2014-07-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,3,KAT8,0.148,2.9438,-1.1721,2,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000104059,2,2,1,0,0,1,61406.63987179962,960369.5592648841,2021-05-27,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,ENTREP2,-0.12399995,-0.56228,-1.3192,0,1.0,0.5,,
ENSG00000104331,2,2,0,0,0,1,104792.02869450308,104792.02869450308,2018-05-21,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,BPNT2,0.38099998,-0.43186,-0.89095,1,-1.0,-1.0,Cytosolic sulfonation of small molecules;Phase II - Conjugation of compounds,R-HSA-156584;R-HSA-156580
ENSG00000104901,2,2,1,1,1,0,38092.548464040476,50072.877304794354,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,DKKL1,-0.01699996,0.036301,0.89266,0,1.0,0.5,,
ENSG00000105655,3,2,1,0,0,1,22345.675520395987,141076.9910731678,2013-04-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,ISYNA1,-0.0039999485,0.38642,-1.9607,1,0.5,0.0,,
ENSG00000105778,2,2,0,0,0,0,1173.5007132667617,405722.3511294316,2021-06-29,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,AVL9,0.18900001,1.0786,-0.28776,0,-1.0,-1.0,,
ENSG00000105993,2,2,0,0,0,1,16461.04650907092,16461.04650907092,2015-01-08,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,DNAJB6,0.07999998,0.090043,-0.59912,4,-1.0,-1.0,,
ENSG00000106688,2,2,0,0,0,1,100620.50186431198,100620.50186431198,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,SLC1A1,-0.042999983,-0.74611,-1.392,3,0.5,0.0,Glutamate Neurotransmitter Release Cycle;Disease;Transport of inorganic cations/anions and amino acids/oligopeptides;Neurotransmitter release cycle,R-HSA-210500;R-HSA-1643685;R-HSA-425393;R-HSA-112310
ENSG00000106804,2,2,0,0,1,1,2288.8778073359817,718784.6890415357,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,C5,0.22100002,2.3738,1.8296,5,1.0,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000106976,2,2,1,1,0,1,75715.46734074537,1778690.168860174,2022-07-14,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,DNM1,0.583,5.0313,0.040702,8,1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Recycling pathway of L1;EPH-ephrin mediated repulsion of cells;Gap junction trafficking and regulation;Gap junction trafficking;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-437239;R-HSA-3928665;R-HSA-157858;R-HSA-190828;R-HSA-9006934
ENSG00000107651,3,2,1,0,0,1,159189.58506586426,765591.3646788632,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,7,SEC23IP,0.13499999,0.75147,0.66583,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000107669,2,2,1,0,0,1,13883.57970142381,36494.548446257475,2018-08-13,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,4,ATE1,0.31300002,0.26405,-0.57635,0,-1.0,-1.0,,
ENSG00000107771,3,2,0,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,CCSER2,0.411,0.71631,0.3217,0,-1.0,-1.0,,
ENSG00000107859,2,2,1,0,0,0,57060.02774555957,228220.5662976458,2018-08-13,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,PITX3,0.30900002,0.65794,-0.046066,0,0.5,0.5,,
ENSG00000108255,2,2,0,0,0,1,389039.02837669326,765591.3646788632,2018-04-26,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,CRYBA1,0.013000011,1.2062,-0.79681,0,,,,
ENSG00000108312,2,2,1,0,0,1,100857.20347685824,382631.1172224132,2018-08-13,0,0,0,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,UBTF,0.867,6.267,-0.95375,5,-1.0,-1.0,RNA Polymerase I Transcription Termination;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase I Promoter Opening;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance,R-HSA-73863;R-HSA-74160;R-HSA-73772;R-HSA-5250941;R-HSA-427413;R-HSA-73728;R-HSA-73762;R-HSA-73864;R-HSA-73854
ENSG00000108352,2,2,1,0,0,1,60436.282913699004,598869.4096893278,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,RAPGEFL1,0.30400002,1.5862,0.42125,0,0.5,-1.0,,
ENSG00000108582,2,2,1,0,0,1,54580.46858134564,464892.4593283075,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,CPD,0.37300003,1.9862,-0.74679,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000109572,4,2,1,0,0,1,15866.724081734988,263416.51565448404,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,1,0,0,0,6,CLCN3,0.65900004,5.2049,1.0776,1,-1.0,-1.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000109861,3,2,1,1,1,1,22669.576834673207,183944.18510175147,2021-02-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,CTSC,-0.051,-0.54589,-1.2373,4,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000110245,2,2,0,0,1,1,66438.21345734232,189783.09211041918,2021-10-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,APOC3,-0.67999995,0.24201,0.6376,4,1.0,0.0,Chylomicron assembly;Chylomicron remodeling;HDL remodeling;Plasma lipoprotein remodeling,R-HSA-8963888;R-HSA-8963901;R-HSA-8964058;R-HSA-8963899
ENSG00000110436,2,2,1,0,0,1,118492.7744519305,1424218.0900670097,2019-02-04,1,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,SLC1A2,0.431,3.0008,0.098769,3,1.0,0.0,Glutamate Neurotransmitter Release Cycle;Transport of inorganic cations/anions and amino acids/oligopeptides;Neurotransmitter release cycle,R-HSA-210500;R-HSA-425393;R-HSA-112310
ENSG00000110799,6,2,0,1,1,1,13764.1487425546,168116.01355658393,2019-08-16,0,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,24,VWF,0.361,3.5269,1.2551,23,-1.0,0.0,Signal Transduction;Disease;Platelet Adhesion to exposed collagen;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-75892;R-HSA-5663202
ENSG00000110906,3,2,1,0,0,1,136288.48249759385,394357.452283155,2020-10-05,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,4,KCTD10,0.42900002,3.1947,0.90394,0,-1.0,-1.0,,
ENSG00000111424,2,2,1,0,0,0,66575.78981395929,427337.4491868293,2021-02-06,1,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,VDR,0.286,2.1968,-0.69368,3,1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Vitamin D (calciferol) metabolism;Metabolism of steroids;Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-196791;R-HSA-8957322;R-HSA-597592
ENSG00000111605,2,2,1,0,0,1,187674.40497870417,427337.4491868293,2022-03-24,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,CPSF6,0.694,4.0786,0.1008,6,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000111785,6,2,1,0,0,1,87748.84971094332,756470.9740366563,2023-06-29,0,0,0,1,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,RIC8B,0.574,2.6156,1.3418,0,-1.0,-1.0,,
ENSG00000111799,2,2,0,0,1,1,3505.4942792099973,54376.19860110506,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,3,COL12A1,0.625,3.5739,0.0069892,4,-1.0,0.0,,
ENSG00000112039,2,2,0,0,1,0,20302.198506576402,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,FANCE,0.042999983,0.32308,0.69487,2,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000112167,3,2,1,0,0,1,26988.6968266269,196178.71491042234,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,SAYSD1,-0.633,-0.13293,0.18599,0,0.5,-1.0,,
ENSG00000112249,4,2,1,0,1,1,66821.18426408028,1076472.0138856068,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,5,0,0,0,0,0,0,6,ASCC3,0.323,3.3492,-0.1655,1,-1.0,-1.0,DNA Damage Reversal,R-HSA-73942
ENSG00000112977,4,2,1,0,0,1,19974.136110585117,160010.51072069994,2011-02-06,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,7,0,0,0,8,DAP,-0.28900003,0.5474,0.23008,0,-1.0,-1.0,,
ENSG00000113648,2,2,0,0,0,1,25209.39839469752,482893.2730520582,2018-11-08,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,8,MACROH2A1,0.846,3.8636,0.81346,0,-1.0,-1.0,,
ENSG00000113712,2,2,0,0,0,1,4074.958527607362,1778690.168860174,2011-06-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,CSNK1A1,0.65999997,4.9368,0.52456,15,-1.0,-1.0,Signal Transduction;APC truncation mutants have impaired AXIN binding;Truncations of AMER1 destabilize the destruction complex;AXIN missense mutants destabilize the destruction complex;Signaling by AMER1 mutants;Signaling by APC mutants;Signaling by AXIN mutants;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-5467337;R-HSA-5467348;R-HSA-5467340;R-HSA-4839748;R-HSA-4839744;R-HSA-4839735;R-HSA-1643685;R-HSA-5663202
ENSG00000113758,4,2,1,0,1,1,88771.02207231094,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,3,DBN1,0.653,0.24194,-0.43203,4,-1.0,-1.0,Signal Transduction;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9013422;R-HSA-9706574
ENSG00000115008,3,2,1,0,0,1,4520.7839403316675,89312.40641133794,2017-05-24,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,6,IL1A,0.07800001,0.37543,0.51737,7,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-6785807
ENSG00000115252,3,2,1,0,0,1,71913.46219676935,427337.4491868293,2021-02-03,0,0,0,0,7,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,14,PDE1A,0.14600003,0.55266,-0.60898,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000115540,3,2,0,0,0,1,248902.39286982678,322220.1169395476,2019-07-30,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,3,MOB4,0.714,2.4637,-0.16311,0,-1.0,-1.0,,
ENSG00000115594,3,2,1,1,0,1,19974.136110585117,384314.83364002535,2011-02-06,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,0,0,0,6,IL1R1,0.371,2.2471,-0.090605,3,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147
ENSG00000115825,3,2,1,0,0,1,606.6666666666666,259947.56530348706,2020-11-10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,PRKD3,0.31800002,0.9381,-0.73887,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000115919,2,2,1,0,0,1,96212.56699204071,311608.0072964156,2021-06-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,7,KYNU,-0.36399996,0.10945,0.78504,1,0.5,0.0,,
ENSG00000116273,3,2,1,0,0,1,358386.30063935445,1424218.0900670097,2020-06-15,0,0,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,PHF13,0.81700003,2.0609,-1.0092,0,-1.0,-1.0,,
ENSG00000116489,3,2,1,0,0,1,39406.19595155135,366584.236923103,2022-01-12,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,4,CAPZA1,0.671,1.2883,0.81835,8,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Golgi-to-ER retrograde transport;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-8856688;R-HSA-597592
ENSG00000116717,2,2,1,0,0,1,96212.56699204071,414433.58532016096,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,GADD45A,0.21899998,1.619,0.17694,2,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription of cell cycle genes,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9617828
ENSG00000116771,2,2,1,0,1,1,31268.56515673724,286678.73247515375,2022-10-12,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,5,AGMAT,-0.712,-0.78133,-0.75278,1,0.75,0.0,Metabolism of polyamines,R-HSA-351202
ENSG00000116786,3,2,1,0,1,0,575147.0632428399,1778690.168860174,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,PLEKHM2,-0.085999966,0.49005,-1.3139,0,0.5,-1.0,,
ENSG00000116874,2,2,1,0,0,1,97181.90375256384,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,3,WARS2,-0.09800005,0.66232,0.52717,1,-1.0,-1.0,tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-379726;R-HSA-72766
ENSG00000117450,2,2,0,0,0,1,17416.80601016872,322220.1169395476,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,1,4,PRDX1,-0.32200003,0.52088,-0.20493,4,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000117501,2,2,0,0,0,1,42359.490817992155,138626.81357188412,2022-10-12,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,MROH9,-0.22399998,-0.062829,-0.63726,0,0.5,0.5,,
ENSG00000117595,4,2,1,0,1,1,1225.1182294700059,3183.954613716002,2012-08-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,6,IRF6,0.786,3.8977,1.888,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000117614,2,2,0,0,0,1,180089.50342935527,382631.1172224132,2021-11-04,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,3,SYF2,0.12199998,0.78195,-0.0050603,1,-1.0,-1.0,,
ENSG00000117834,2,2,1,0,1,1,29890.37750380142,384314.83364002535,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,3,SLC5A9,0.018000007,1.1666,0.77437,1,1.0,0.5,Cellular hexose transport,R-HSA-189200
ENSG00000119139,2,2,1,0,0,1,134717.76666505725,360605.992793193,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,TJP2,0.17500001,0.63558,-0.005639,5,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000119508,2,2,0,0,0,1,40070.16862948424,225599.91693237546,2023-06-01,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,NR4A3,0.56299996,1.0269,-0.9485,2,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000119616,2,2,0,0,0,1,22650.1728716785,119459.84213494582,2021-04-15,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,FCF1,-0.016000032,0.63598,-0.47781,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000119655,3,2,1,1,0,1,29803.01405728205,765591.3646788632,2020-01-20,0,0,0,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,NPC2,-0.42200005,0.46551,-0.40618,2,1.0,-1.0,Immune System,R-HSA-168256
ENSG00000119669,5,2,1,0,0,1,32996.93546153374,645988.1975077938,2018-06-11,0,0,0,0,12,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,IRF2BPL,0.45599997,-1.7558,-6.4788,0,-1.0,-1.0,,
ENSG00000119699,2,2,1,0,0,1,124531.34246675359,151416.12986435954,2021-02-24,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TGFB3,0.751,2.8651,1.2811,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000120210,4,2,1,0,0,1,16265.178122897742,160062.83409140486,2021-04-08,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,0,0,0,7,INSL6,-0.944,-2.6796,-2.9056,0,0.75,0.5,,
ENSG00000120370,4,2,0,0,0,1,28662.872466831042,298878.49542603496,2018-06-11,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,GORAB,0.19800001,0.29956,-0.58663,0,-1.0,0.0,,
ENSG00000120451,8,2,1,0,0,1,15866.724081734988,633132.2332759313,2013-08-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,1,0,0,0,13,SNX19,0.116999984,0.60859,-0.81132,0,-1.0,-1.0,,
ENSG00000122180,2,2,0,0,0,1,16168.601665727347,545988.1005477115,2021-09-30,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,MYOG,0.28500003,0.59093,0.23504,2,0.75,0.5,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000122359,2,2,1,0,1,1,3173.217415100313,38772.287745457244,2015-09-15,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,1,10,ANXA11,-0.085999966,-0.24716,-0.16819,0,-1.0,-1.0,,
ENSG00000122484,2,2,0,0,0,1,167055.73472660675,298504.9722193353,2021-11-04,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,2,RPAP2,-0.21200001,1.8744,0.9512,1,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000122574,2,2,0,0,0,1,12670.749798140494,12670.749798140494,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,WIPF3,-0.16900003,-1.8025,-2.4012,5,0.5,0.0,Signal Transduction;Immune System;Disease,R-HSA-162582;R-HSA-168256;R-HSA-1643685
ENSG00000123297,5,2,1,0,0,1,4390.565692705228,415452.66715166246,2009-06-14,0,0,0,0,0,0,0,0,0,0,0,0,5,0,2,0,0,0,0,0,0,0,0,7,TSFM,-0.19700003,0.08862,-0.70536,1,-1.0,-1.0,Translation;Mitochondrial translation elongation;Mitochondrial translation,R-HSA-72766;R-HSA-5389840;R-HSA-5368287
ENSG00000123815,2,2,0,0,0,1,15680.736809263815,160010.51072069994,2021-09-30,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,2,COQ8B,0.07700002,1.1205,1.2226,1,-1.0,-1.0,,
ENSG00000124299,3,2,0,0,0,0,1594.2494117647059,1424218.0900670097,2011-12-11,0,0,1,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,PEPD,-0.13199997,0.2165,0.46702,0,0.5,-1.0,,
ENSG00000124827,4,2,0,0,1,1,23534.558919763418,81496.15268573073,2023-01-18,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,2,6,GCM2,-0.20500004,1.9513,0.67994,0,1.0,1.0,,
ENSG00000125084,2,2,0,0,1,1,75639.5973879004,175016.11286382115,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,0,0,0,5,WNT1,0.042999983,0.33644,0.21421,6,0.5,1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000125810,4,2,0,0,0,1,31935.015289867086,168116.01355658393,2019-11-01,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,10,CD93,-0.23699999,-0.76676,-1.557,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000125834,2,2,1,0,0,1,7794.273577144567,66575.78981395929,2021-02-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,STK35,0.232,1.0712,-3.2354,0,1.0,-1.0,,
ENSG00000125871,3,2,0,0,0,0,141553.2677895436,464892.4593283075,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,3,MGME1,0.06800002,0.67804,0.92302,1,-1.0,-1.0,,
ENSG00000125877,2,2,1,0,0,1,47935.61449674282,551389.5206213495,2014-07-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,3,ITPA,-0.15900004,0.5267,0.10847,2,-1.0,-1.0,Purine catabolism;Metabolism of nucleotides,R-HSA-74259;R-HSA-15869
ENSG00000126218,4,2,0,1,1,1,38139.653327239444,168116.01355658393,2022-10-12,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,11,F10,0.032000005,2.0575,0.62396,9,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000127080,3,2,1,0,0,1,78751.06843456876,1424218.0900670097,2023-05-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,IPPK,0.49400002,1.4967,-0.39631,2,-1.0,-1.0,,
ENSG00000127922,2,2,1,0,0,1,64867.9873639546,118061.55082048493,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,2,SEM1,0.24599999,-0.076905,-0.47773,72,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000127946,2,2,1,0,0,1,3678.822140221402,95491.56815792594,2016-05-01,0,1,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,HIP1,0.426,2.2954,0.70036,3,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000128250,3,2,1,0,1,1,69453.1498757531,219793.50457789513,2023-01-18,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,RFPL1,-0.34099996,1.0359,0.31991,0,1.0,0.5,,
ENSG00000128510,2,2,0,0,0,1,2010.4597478176527,75632.36795352261,2019-01-18,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,CPA4,-0.09399998,1.1781,-0.048501,0,0.5,0.0,,
ENSG00000128595,3,2,1,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,CALU,0.444,2.0353,1.2241,3,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000128652,5,2,1,0,0,1,4038.691897137312,180089.50342935527,2010-09-19,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,9,HOXD3,0.36299998,1.3548,0.49764,1,1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000128951,3,2,0,0,0,1,6356.593451690605,414433.58532016096,2022-10-12,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DUT,-0.684,-1.2104,-1.802,1,-1.0,-1.0,Disease;Interconversion of nucleotide di- and triphosphates;Metabolism of nucleotides,R-HSA-1643685;R-HSA-499943;R-HSA-15869
ENSG00000128965,3,2,1,0,0,1,160062.83409140486,461914.58891516324,2023-01-18,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,CHAC1,-0.42499995,0.39758,-1.0183,2,0.5,0.0,Glutathione conjugation;Phase II - Conjugation of compounds,R-HSA-156590;R-HSA-156580
ENSG00000129083,2,2,0,0,0,1,282360.54876783554,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,4,COPB1,0.731,2.5707,0.5375,3,-1.0,-1.0,Immune System;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-168256;R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000129910,2,2,1,0,0,1,15223.454539395489,275021.63051358337,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,CDH15,-0.40999997,-2.6625,-3.2986,2,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000130227,6,2,1,0,0,1,21724.94108458234,756470.9740366563,2018-06-11,0,0,0,0,14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,XPO7,0.81299996,5.4789,-1.2698,0,-1.0,-1.0,,
ENSG00000130363,2,2,1,0,1,1,11843.109477001575,124837.11004999638,2022-11-04,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,RSPH3,0.21600002,0.38297,0.53622,0,-1.0,-1.0,,
ENSG00000130427,2,2,1,1,0,1,19719.099998411362,397309.7797528111,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,EPO,0.181,0.85156,0.061532,6,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000130475,3,2,1,0,0,1,95413.07358079177,228688.0296088316,2017-12-06,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,FCHO1,0.501,1.6616,0.10253,2,0.5,0.0,,
ENSG00000130675,2,2,0,0,1,1,40855.314577620855,275021.63051358337,2020-05-06,0,0,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,MNX1,0.366,-1.1528,-2.2059,0,0.75,0.5,,
ENSG00000131408,2,2,1,0,1,1,17601.10520641419,278739.419613982,2022-08-03,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,8,NR1H2,0.09899998,0.56473,-1.7443,9,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000131558,4,2,1,0,0,1,49127.555514088446,1076472.0138856068,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,EXOC4,0.255,1.4637,0.19287,3,-1.0,-1.0,VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620916;R-HSA-5620920
ENSG00000131773,3,2,0,0,0,1,58480.4002699495,58480.4002699495,2023-01-18,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,KHDRBS3,-0.110000014,0.29524,-0.9847,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000132481,2,2,1,0,1,0,45951.29495376284,464892.4593283075,2017-05-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,3,TRIM47,-0.35099995,-1.0287,-1.7354,0,-1.0,0.0,,
ENSG00000132846,3,2,0,0,0,1,1173.5007132667617,1424218.0900670097,2010-06-27,0,0,0,0,0,15,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,16,ZBED3,-0.949,-4.6021,-4.5137,0,-1.0,-1.0,,
ENSG00000132854,2,2,0,0,0,1,15603.785966148887,27042.492063542606,2024-07-19,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,KANK4,0.171,0.84638,1.6003,0,0.5,0.0,,
ENSG00000133115,2,2,0,0,0,1,137776.79053446153,355284.1215006515,2023-02-01,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,STOML3,-0.30799997,0.030534,1.1282,1,1.0,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000133687,2,2,1,0,1,1,1173.5007132667617,323648.5577791949,2017-10-09,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,6,TMTC1,0.195,0.33976,-0.42893,0,-1.0,0.0,,
ENSG00000134516,3,2,0,0,0,1,191477.8325312717,229954.37886203246,2023-12-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,4,DOCK2,0.579,4.9199,1.0048,7,0.75,0.0,Signal Transduction;Immune System;Disease,R-HSA-162582;R-HSA-168256;R-HSA-1643685
ENSG00000134780,2,2,1,0,0,1,449855.9086123723,1122672.658801146,2019-02-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,5,DAGLA,0.695,5.1894,1.4264,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000135114,3,2,1,0,0,1,28863.30790298137,227570.98695011192,2018-07-27,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,OASL,-0.049000025,0.66267,0.55117,3,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000135315,2,2,0,0,0,1,183427.12489668437,183427.12489668437,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,CEP162,-0.10099995,-0.40864,-0.40874,1,-1.0,-1.0,,
ENSG00000135392,2,2,0,0,0,1,114439.41769154315,575147.0632428399,2024-07-19,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,DNAJC14,0.728,1.8483,-0.34259,0,-1.0,-1.0,,
ENSG00000135503,2,2,1,0,0,1,25967.06754524981,1076472.0138856068,2021-01-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,3,ACVR1B,0.597,4.548,0.3944,3,-1.0,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000135549,2,2,1,0,0,1,260210.21963428933,645988.1975077938,2023-01-18,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PKIB,-0.0019999743,0.057241,-0.015016,0,0.5,0.0,,
ENSG00000136045,2,2,1,0,0,1,61498.92173410762,328052.24452619,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,2,PWP1,0.167,1.2327,-0.22744,0,-1.0,-1.0,,
ENSG00000136270,2,2,0,0,0,1,12856.67036944375,197485.87952538437,2023-01-18,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TBRG4,0.17500001,1.3807,-0.33289,1,-1.0,-1.0,,
ENSG00000136542,2,2,0,0,0,1,40855.314577620855,185157.22384241043,2023-01-18,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GALNT5,-0.00999999,0.056389,-0.37423,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000137502,2,2,0,0,0,1,634722.4486407059,634722.4486407059,2022-10-12,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RAB30,0.351,2.563,0.89479,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000137764,3,2,1,0,0,1,21223.64451016636,1424218.0900670097,2023-01-18,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,7,MAP2K5,-0.20099998,0.77293,-0.36244,1,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000137819,2,2,1,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,PAQR5,0.21100003,0.9338,1.4633,0,0.5,0.0,,
ENSG00000137845,4,2,1,0,0,1,57692.51997622251,323648.5577791949,2019-02-28,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,6,ADAM10,0.724,3.9218,0.078292,16,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Disease;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-3928665;R-HSA-9006934;R-HSA-5663202;R-HSA-597592
ENSG00000138018,2,2,1,0,0,1,464892.4593283075,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,SELENOI,0.16799998,1.8533,0.76268,1,-1.0,-1.0,,
ENSG00000138092,2,2,0,0,0,1,38092.548464040476,160010.51072069994,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,2,CENPO,-0.13800001,0.39085,-0.68634,7,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000138175,3,2,1,1,0,1,49367.473680139236,366584.236923103,2019-11-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,4,ARL3,0.44300002,1.4109,0.59289,1,0.5,-1.0,Cargo trafficking to the periciliary membrane,R-HSA-5620920
ENSG00000138496,2,2,1,0,1,0,263416.51565448404,645988.1975077938,2023-12-28,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,PARP9,0.17900002,2.4856,1.2534,3,-1.0,-1.0,Translation of Structural Proteins_9683701;Disease,R-HSA-9683701;R-HSA-1643685
ENSG00000138639,3,2,1,0,0,1,30811.772283944152,645988.1975077938,2023-01-18,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,ARHGAP24,0.20300001,0.37425,-0.09853,3,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000138750,2,2,1,0,0,1,159189.58506586426,1424218.0900670097,2023-12-28,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,NUP54,0.389,1.6561,0.53894,29,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Postmitotic nuclear pore complex (NPC) reformation;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-9615933;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000138756,2,2,1,0,0,1,50072.877304794354,384314.83364002535,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,3,BMP2K,0.232,0.4489,0.24856,0,-1.0,0.0,,
ENSG00000138769,2,2,1,0,0,1,17115.61307125707,1424218.0900670097,2017-06-12,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CDKL2,-0.22300005,0.41554,0.98155,0,0.5,0.5,,
ENSG00000138942,2,2,1,0,0,1,269829.0934099178,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RNF185,-0.049000025,0.89073,0.63858,3,-1.0,-1.0,ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Disease;Post-translational protein modification,R-HSA-901032;R-HSA-901042;R-HSA-532668;R-HSA-1643685;R-HSA-597592
ENSG00000139370,2,2,1,0,1,1,2240.9147424511543,355284.1215006515,2009-10-18,1,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,8,SLC15A4,0.15399998,-0.93503,-2.2434,3,-1.0,-1.0,Immune System;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-168256;R-HSA-425393
ENSG00000139436,2,2,1,0,1,1,21939.796916619583,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,GIT2,0.29900002,1.6279,0.59717,8,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000139438,2,2,0,0,0,1,25903.3352616996,54391.03477538057,2021-09-30,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,FAM222A,0.25,-0.068334,-0.94499,0,0.5,0.0,,
ENSG00000139597,4,2,1,0,0,1,18425.15713644852,464892.4593283075,2018-08-13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,N4BP2L1,0.08200002,1.0125,0.30532,0,-1.0,-1.0,,
ENSG00000139618,18,2,1,0,1,1,5090.835605984854,367949.31877243903,2014-06-01,30,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,BRCA2,0.19700003,1.0218,1.5467,14,0.5,0.5,Disease,R-HSA-1643685
ENSG00000140416,3,2,0,0,0,1,5693.539194254021,189845.9324918578,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,3,TPM1,0.24299997,3.9463,-0.023493,2,0.5,-1.0,,
ENSG00000140465,2,2,0,0,0,1,104168.97660865163,217298.65879872965,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,2,CYP1A1,-0.472,0.68511,-0.25016,5,0.5,0.0,Arachidonate metabolism,R-HSA-2142753
ENSG00000140522,5,2,1,0,0,1,26264.552756469657,81805.8846123197,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,5,RLBP1,0.046000004,0.01579,0.20283,3,1.0,0.5,Disease;The canonical retinoid cycle in rods (twilight vision),R-HSA-1643685;R-HSA-2453902
ENSG00000140832,2,2,0,0,1,1,384314.83364002535,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,MARVELD3,-0.29400003,-1.0124,-0.96938,0,0.5,0.0,,
ENSG00000141837,3,2,0,0,0,1,45596.93743173501,360605.992793193,2022-02-03,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,5,CACNA1A,0.669,3.9533,-2.3545,2,1.0,0.5,,
ENSG00000142303,2,2,0,0,1,1,46346.11759039019,187674.40497870417,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,6,0,0,0,7,ADAMTS10,0.533,3.8057,0.52611,2,-1.0,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000142544,2,2,0,0,1,1,205425.60717824215,466632.7979326389,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,CTU1,-0.97800004,-4.2309,-5.4861,1,-1.0,0.0,,
ENSG00000142687,2,2,0,0,0,1,9551.80276784896,9551.80276784896,2013-06-10,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,2,KIAA0319L,0.39,2.4746,2.1957,0,-1.0,-1.0,,
ENSG00000143032,2,2,0,0,0,1,80065.63748488021,161053.42428938235,2022-07-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,2,BARHL2,0.371,0.89787,-0.76863,0,1.0,0.5,,
ENSG00000143179,2,2,1,0,0,1,11343.053400273848,42359.490817992155,2017-06-12,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,UCK2,0.579,2.3798,0.19092,1,-1.0,-1.0,Nucleotide salvage;Metabolism of nucleotides,R-HSA-8956321;R-HSA-15869
ENSG00000143297,2,2,1,0,0,1,44660.84794838759,95905.57783546533,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,FCRL5,-0.008999944,0.67923,0.48506,0,1.0,0.5,,
ENSG00000143321,2,2,1,1,1,0,43039.044982671156,521818.7070055739,2023-01-18,3,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,HDGF,0.604,1.9371,-0.76537,1,-1.0,-1.0,,
ENSG00000143437,2,2,0,0,0,0,51964.39839555753,112025.85662838118,2019-10-24,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,ARNT,0.61300004,2.9885,1.4841,7,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000143590,2,2,0,0,1,1,2314.313784461153,90049.68162979394,2021-08-24,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,EFNA3,-0.032999992,0.28434,-0.89944,3,0.5,0.0,Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-1266738;R-HSA-3928665
ENSG00000143919,2,2,1,0,0,0,134159.95265752633,353105.3286394775,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,CAMKMT,-0.643,-1.0178,-1.7017,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000143952,2,2,0,0,0,1,521818.7070055739,1778690.168860174,2022-07-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,VPS54,0.53499997,0.73671,0.82041,1,-1.0,-1.0,,
ENSG00000144278,3,2,0,0,0,1,11998.245559158242,92958.5298655546,2019-10-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,2,GALNT13,0.265,0.96192,0.15972,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000144711,2,2,1,0,0,1,1173.5007132667617,1470466.6505612188,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,IQSEC1,0.52900004,1.619,-0.80489,0,-1.0,-1.0,,
ENSG00000144791,2,2,0,0,0,1,36494.548446257475,426681.33856181684,2022-08-03,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,LIMD1,0.478,0.57318,0.69488,1,-1.0,-1.0,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,R-HSA-1234176
ENSG00000145087,2,2,0,0,0,1,4182.535003468676,4182.535003468676,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,STXBP5L,0.496,1.3884,-0.60091,0,0.5,0.5,,
ENSG00000145103,4,2,1,0,0,1,24523.50385931762,404399.6052088398,2021-06-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,5,ILDR1,-0.103000045,0.06617,0.25854,0,0.5,0.0,,
ENSG00000145425,2,2,1,0,0,1,219793.50457789513,521818.7070055739,2021-01-04,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,RPS3A,0.709,2.7806,-0.54874,18,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000146216,2,2,0,0,0,0,53182.30026560605,86431.73511208472,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,TTBK1,0.508,1.1886,-1.647,0,0.75,0.5,,
ENSG00000146243,3,2,1,0,0,1,358386.30063935445,756470.9740366563,2021-11-04,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,IRAK1BP1,-0.25600004,-0.029967,-0.29323,0,-1.0,0.0,,
ENSG00000146731,2,2,1,0,0,1,93711.85771992602,394357.452283155,2020-10-05,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,CCT6A,0.76600003,1.425,-0.6949,6,-1.0,-1.0,Signal Transduction;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-389957;R-HSA-389958;R-HSA-6814122;R-HSA-9706574
ENSG00000146828,2,2,0,0,1,1,23977.62337317567,23977.62337317567,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,SLC12A9,-0.0069999695,1.9726,-0.14289,0,-1.0,0.0,,
ENSG00000147443,2,2,0,0,1,1,3038.749948464234,225599.91693237546,2018-09-11,1,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,DOK2,-0.83800006,-2.3572,-1.9764,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000147676,2,2,1,0,0,1,104829.95456615865,301203.06999851385,2018-11-30,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,MAL2,-0.6,-0.70671,-1.0486,0,0.5,0.0,,
ENSG00000147853,2,2,0,0,0,1,74722.59037384245,100358.73833384078,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,3,AK3,-0.602,-2.8178,-2.4325,1,0.5,-1.0,,
ENSG00000148396,5,2,1,0,1,1,25713.037079860835,249965.96240703977,2016-07-18,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,7,SEC16A,0.379,-0.36162,-1.9852,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000148429,3,2,0,0,0,1,1321.7688442211056,340825.7076940272,2017-02-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,1,10,USP6NL,0.29299998,-0.93482,-1.125,1,-1.0,-1.0,,
ENSG00000149311,11,2,1,0,1,1,5691.114246503779,367949.31877243903,2011-10-09,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,21,ATM,0.153,2.5412,1.4616,28,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000150681,3,2,0,0,0,0,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,RGS18,-0.53900003,0.096204,0.1997,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000150722,2,2,1,0,0,1,144712.0807038357,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,PPP1R1C,-0.62899995,-0.19551,0.37783,0,1.0,0.5,,
ENSG00000150750,4,2,1,0,0,1,13748.238482016517,97181.90375256384,2023-01-18,3,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,POU2AF2,-0.365,-0.21071,0.54513,0,0.5,0.5,,
ENSG00000151240,3,2,0,0,0,1,48114.22515098965,278190.43024910334,2023-04-07,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,DIP2C,0.765,4.7898,-1.7484,0,-1.0,0.0,,
ENSG00000151304,2,2,0,0,0,1,41593.31020127409,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,SRFBP1,-0.25399995,-1.5562,-1.0453,0,-1.0,-1.0,,
ENSG00000151327,2,2,1,1,0,0,27926.150856558426,515513.2178404211,2020-06-15,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FAM177A1,-0.32000005,-0.22411,0.18827,0,-1.0,-1.0,,
ENSG00000151532,7,2,0,0,0,1,11803.379416282642,124801.11117486731,2014-08-08,12,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,VTI1A,0.13599998,0.44375,0.86659,2,-1.0,-1.0,,
ENSG00000151655,2,2,0,0,0,1,21201.639474894007,21201.639474894007,2023-03-22,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ITIH2,-0.20500004,0.80563,0.61373,2,1.0,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000151748,3,2,0,0,0,1,235397.69820205137,358386.30063935445,2021-11-04,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,SAV1,0.29299998,0.35624,0.45265,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000152422,2,2,0,0,0,0,4725.974479889043,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,XRCC4,-0.031999946,0.76448,0.47222,3,-1.0,-1.0,Disease;HIV Life Cycle;Post-translational protein modification,R-HSA-1643685;R-HSA-162587;R-HSA-597592
ENSG00000152763,2,2,1,0,1,1,31137.07865241903,322220.1169395476,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,DNAI4,0.13800001,0.090516,-0.49804,0,0.5,0.0,,
ENSG00000153237,4,2,1,0,0,1,18226.911277750685,1778690.168860174,2017-11-01,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,15,CCDC148,-0.20899999,0.036505,-0.23619,0,0.5,0.5,,
ENSG00000153879,2,2,1,0,0,1,135108.48254553688,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,CEBPG,-0.07200003,0.87529,0.508,3,-1.0,-1.0,PERK regulates gene expression;ATF4 activates genes in response to endoplasmic reticulum  stress;Cellular response to starvation,R-HSA-381042;R-HSA-380994;R-HSA-9711097
ENSG00000154001,2,2,1,0,0,0,100620.50186431198,100620.50186431198,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,PPP2R5E,0.807,4.2944,0.5362,23,-1.0,-1.0,Signal Transduction;Immune System;APC truncation mutants have impaired AXIN binding;Truncations of AMER1 destabilize the destruction complex;AXIN missense mutants destabilize the destruction complex;Signaling by AMER1 mutants;Signaling by APC mutants;Signaling by AXIN mutants;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-5467337;R-HSA-5467348;R-HSA-5467340;R-HSA-4839748;R-HSA-4839744;R-HSA-4839735;R-HSA-1643685;R-HSA-5663202
ENSG00000154305,9,2,1,0,1,1,6040.069513406157,756470.9740366563,2009-02-08,0,0,0,0,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,45,MIA3,0.449,1.7074,1.4304,3,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000154783,7,2,0,0,1,1,25464.040702316375,895916.2144062951,2017-12-06,0,0,0,0,15,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,FGD5,0.7,0.36678,-0.43746,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000155011,3,2,0,0,0,1,48114.22515098965,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,4,DKK2,0.379,0.55298,0.009635,3,0.5,0.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000155511,9,2,0,0,0,1,15866.724081734988,1778690.168860174,2013-08-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,2,0,0,0,0,0,16,GRIA1,0.552,4.3627,0.13556,8,0.75,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000155542,2,2,1,0,1,1,175540.09121723313,275021.63051358337,2023-01-18,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SETD9,-0.45500004,0.69699,0.38694,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000155719,5,2,1,0,0,1,208836.15741332836,545791.5007333605,2021-09-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,5,OTOA,0.17799997,1.398,1.1829,1,0.75,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000155760,4,2,0,0,0,1,105281.95721639719,191895.42310022408,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,3,FZD7,0.21899998,1.8809,-1.0945,4,-1.0,0.0,Signal Transduction;Killing mechanisms;WNT5:FZD7-mediated leishmania damping;Disease;Asymmetric localization of PCP proteins,R-HSA-162582;R-HSA-9664420;R-HSA-9673324;R-HSA-1643685;R-HSA-4608870
ENSG00000155926,3,2,1,0,0,1,190279.23963861223,260631.24114204012,2023-01-18,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,3,SLA,-0.032999992,0.42524,0.5219,1,0.75,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000156170,2,2,1,0,0,1,114439.41769154315,718784.6890415357,2022-08-01,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NDUFAF6,-0.566,-0.86475,-1.9762,1,-1.0,0.0,Complex I biogenesis,R-HSA-6799198
ENSG00000157193,2,2,1,1,1,0,316493.8060781965,316493.8060781965,2023-02-08,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,LRP8,0.476,2.8647,0.45618,2,0.5,0.0,,
ENSG00000157782,2,2,0,0,0,1,129773.77741504063,275021.63051358337,2021-11-04,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,CABP1,0.041999996,0.1397,-1.8151,1,1.0,0.0,,
ENSG00000157890,2,2,0,0,0,1,406587.2658730814,1076472.0138856068,2023-07-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,MEGF11,-0.16499996,-1.0224,0.10543,0,0.5,0.5,,
ENSG00000158301,3,2,0,0,1,0,89519.16315227402,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,1,6,GPRASP2,,,,0,-1.0,0.0,,
ENSG00000158480,3,2,1,0,0,1,11052.199934661876,108425.35980999071,2015-01-08,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,7,0,0,0,8,SPATA2,0.597,0.89482,0.50458,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000158545,2,2,0,0,0,1,49742.651617673284,338763.57771536184,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,ZC3H18,0.874,0.12458,-2.0261,1,-1.0,-1.0,Nuclear RNA decay,R-HSA-9930044
ENSG00000158747,3,2,1,1,0,1,2344.979769824783,190279.23963861223,2021-11-04,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,2,0,0,0,4,NBL1,0.021000028,0.9989,0.51524,0,0.5,-1.0,,
ENSG00000158987,3,2,1,0,0,1,34004.8644513982,298504.9722193353,2017-01-09,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,2,0,0,0,7,RAPGEF6,0.59000003,2.6309,-0.236,0,-1.0,-1.0,,
ENSG00000159164,2,2,1,1,0,1,141076.9910731678,765591.3646788632,2020-05-18,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SV2A,0.571,3.0316,1.3317,4,0.5,0.0,Neurotoxicity of clostridium toxins;Disease,R-HSA-168799;R-HSA-1643685
ENSG00000159197,15,2,0,0,0,1,1458.170321264661,502231.5406594711,2009-02-08,0,0,0,0,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,61,KCNE2,-0.63600004,0.65933,0.14342,2,1.0,0.5,,
ENSG00000159208,2,2,0,0,0,1,145011.35140303092,198739.68381728645,2018-01-31,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,CIART,0.394,0.85742,0.74526,0,-1.0,0.0,,
ENSG00000159339,4,2,1,1,1,1,2209.8301559792026,367949.31877243903,2008-10-12,6,0,0,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,0,0,0,0,19,PADI4,-0.011999965,0.25703,0.056965,1,0.75,0.5,,
ENSG00000159588,2,2,1,0,1,1,404399.6052088398,1470466.6505612188,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,2,CCDC17,-0.51900005,-0.93204,-1.658,0,1.0,0.5,,
ENSG00000159674,3,2,1,0,1,1,180344.38517486732,338763.57771536184,2022-02-02,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2,0,4,SPON2,-0.56299996,-1.6127,-1.5043,2,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000159873,4,2,1,0,0,1,5972.362784288149,414433.58532016096,2023-01-18,4,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,CCDC117,0.746,-1.0557,-0.82542,0,-1.0,-1.0,,
ENSG00000160226,2,2,1,0,1,1,32757.691667591258,645988.1975077938,2016-07-25,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,6,CFAP410,-0.45299995,-1.8237,-1.4303,0,-1.0,-1.0,,
ENSG00000160293,3,2,0,0,0,1,75245.66341852833,414433.58532016096,2023-01-18,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,VAV2,0.37699997,2.4757,-1.0388,21,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Azathioprine ADME;Disease;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-9748787;R-HSA-1643685;R-HSA-3928665;R-HSA-9006934
ENSG00000160801,2,2,1,0,0,1,384314.83364002535,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,PTH1R,0.333,1.9767,-0.42003,2,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000161091,3,2,0,0,1,0,19965.24128263536,133918.94977035935,2020-04-27,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,MFSD12,-0.804,-4.3038,-5.0626,0,-1.0,-1.0,,
ENSG00000161904,5,2,1,0,0,1,1233.0624505928854,1129585.974638378,2013-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,0,0,0,10,LEMD2,0.022000015,-1.1938,-2.9062,4,-1.0,-1.0,Sealing of the nuclear envelope (NE) by ESCRT-III;Depolymerization of the Nuclear Lamina,R-HSA-9668328;R-HSA-4419969
ENSG00000161960,2,2,1,0,0,0,47408.95172709719,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,EIF4A1,0.663,5.217,-1.7912,9,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Deadenylation of mRNA;Developmental Biology;Translation;ISG15 antiviral mechanism,R-HSA-1280215;R-HSA-168256;R-HSA-429947;R-HSA-1266738;R-HSA-72766;R-HSA-1169408
ENSG00000162493,2,2,0,0,0,1,61130.50361100096,111599.28184123649,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,3,PDPN,0.311,0.3922,0.16616,2,0.5,0.0,,
ENSG00000162738,2,2,0,0,0,1,8614.851322410133,83932.6290685273,2020-06-08,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,3,VANGL2,0.574,2.547,0.27292,5,0.5,0.0,Signal Transduction;Asymmetric localization of PCP proteins,R-HSA-162582;R-HSA-4608870
ENSG00000163072,2,2,0,0,0,1,16853.230163428838,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,3,NOSTRIN,-0.47399998,-0.43341,-0.44664,1,-1.0,0.0,,
ENSG00000163145,3,2,1,0,0,1,81243.5903011504,251325.91086204,2023-01-18,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,C1QTNF7,-0.120000005,1.039,0.12662,0,-1.0,0.0,,
ENSG00000163206,2,2,0,0,0,1,112025.85662838118,112345.61202884468,2021-01-07,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,SMCP,-0.89199996,0.23327,0.67205,0,1.0,0.5,,
ENSG00000163485,6,2,1,0,0,1,36645.767033906064,562534.7696387965,2016-05-16,0,0,0,0,1,0,0,0,0,0,21,0,0,0,0,0,0,0,0,0,0,0,0,22,ADORA1,0.402,2.5507,0.073813,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000163499,2,2,0,0,0,1,183937.6490790624,804063.9714459113,2018-10-08,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CRYBA2,-0.37199998,0.075643,0.58224,0,0.5,0.5,,
ENSG00000163515,2,2,0,0,1,1,215157.94798738702,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,2,RETNLB,-0.852,-0.16303,0.059228,0,1.0,0.5,,
ENSG00000163581,4,2,0,0,1,1,3442.049438202247,1424218.0900670097,2017-02-28,0,0,0,0,0,10,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,13,SLC2A2,0.14200002,1.5839,0.45838,5,1.0,0.5,Developmental Biology;Digestion and absorption;Disease;Cellular hexose transport,R-HSA-1266738;R-HSA-8963743;R-HSA-1643685;R-HSA-189200
ENSG00000163618,2,2,0,0,0,1,9140.849127733147,228168.37020113936,2023-02-15,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,3,CADPS,0.555,2.9899,-0.48118,0,0.5,0.0,,
ENSG00000163684,2,2,0,0,0,1,38702.75183793498,1424218.0900670097,2014-02-14,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,RPP14,-0.569,0.4798,0.065751,2,0.5,-1.0,Fatty acyl-CoA biosynthesis;rRNA processing;tRNA processing in the nucleus,R-HSA-75105;R-HSA-72312;R-HSA-6784531
ENSG00000163738,2,2,0,0,0,1,71250.58603271045,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0,0,0,3,MTHFD2L,-0.19000006,-0.87498,-0.75454,1,0.5,0.0,Metabolism of folate and pterines,R-HSA-196757
ENSG00000163785,2,2,1,0,0,1,75715.46734074537,448058.917711015,2021-11-04,0,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,RYK,0.543,1.5926,-0.021516,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000163882,2,2,0,0,0,1,74722.59037384245,80485.44657814708,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,2,POLR2H,0.35399997,1.5715,0.23461,53,-1.0,-1.0,Signal Transduction;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;RNA Pol II CTD phosphorylation and interaction with CE;mRNA Capping;RNA Polymerase III Transcription Initiation;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Initiation From Type 1 Promoter;Generic Transcription Pathway;RNA Polymerase III Transcription Initiation From Type 2 Promoter;FGFR2 alternative splicing;Immune System;mRNA Splicing - Minor Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;Formation of TC-NER Pre-Incision Complex;Developmental Biology;RNA Polymerase III Chain Elongation;Inhibition of DNA recombination at telomere;Gene expression (Transcription);PIWI-interacting RNA (piRNA) biogenesis;RNA Polymerase I Promoter Escape;Viral Messenger RNA Synthesis;MicroRNA (miRNA) biogenesis;Abortive elongation of HIV-1 transcript in the absence of Tat;Disease;Pausing and recovery of HIV elongation;Tat-mediated HIV elongation arrest and recovery;HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase II Pre-transcription Events;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;RNA Polymerase I Transcription Initiation;Gap-filling DNA repair synthesis and ligation in TC-NER;Transcriptional regulation by small RNAs;Gene Silencing by RNA;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;RNA polymerase II transcribes snRNA genes;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-167160;R-HSA-77075;R-HSA-72086;R-HSA-76046;R-HSA-113418;R-HSA-167158;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-76071;R-HSA-76061;R-HSA-212436;R-HSA-76066;R-HSA-6803529;R-HSA-168256;R-HSA-72165;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-73863;R-HSA-6781823;R-HSA-1266738;R-HSA-73780;R-HSA-9670095;R-HSA-74160;R-HSA-5601884;R-HSA-73772;R-HSA-168325;R-HSA-203927;R-HSA-167242;R-HSA-1643685;R-HSA-167290;R-HSA-167243;R-HSA-167287;R-HSA-167238;R-HSA-5250941;R-HSA-427413;R-HSA-674695;R-HSA-749476;R-HSA-74158;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-73762;R-HSA-6782210;R-HSA-5578749;R-HSA-211000;R-HSA-73864;R-HSA-73854;R-HSA-6807505;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-6781827;R-HSA-9006934;R-HSA-5663202
ENSG00000163884,2,2,0,0,0,1,84270.16077055593,384314.83364002535,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,3,0,0,0,7,KLF15,0.587,0.80165,-0.55256,1,0.5,0.0,,
ENSG00000163946,2,2,1,0,1,1,295550.4496098593,322220.1169395476,2020-04-15,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,2,TASOR,0.622,1.4137,0.21409,1,-1.0,-1.0,,
ENSG00000164022,2,2,1,0,0,0,180089.50342935527,562534.7696387965,2021-11-04,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,3,AIMP1,0.069000006,0.27475,0.34383,3,-1.0,-1.0,tRNA Aminoacylation;Developmental Biology;Cytosolic tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-1266738;R-HSA-379716;R-HSA-72766
ENSG00000164054,2,2,0,0,0,1,58331.23271678036,222348.28067288152,2017-01-09,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,SHISA5,-0.13999999,0.18953,0.083289,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000164116,7,2,1,0,0,1,4654.903581267217,500292.45069431677,2012-07-01,0,0,0,0,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,30,GUCY1A1,0.04100001,0.9377,0.42232,2,-1.0,-1.0,,
ENSG00000164266,5,2,0,1,1,1,5130.778833931584,72874.86198192068,2017-07-28,0,0,0,0,0,11,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,14,SPINK1,-0.029999971,0.17221,-0.26374,1,1.0,0.0,,
ENSG00000164305,2,2,1,0,0,1,1501.5536071373635,260210.21963428933,2021-03-26,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,CASP3,0.14099997,1.4892,1.0437,15,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Cytochrome c-mediated apoptotic response,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-111461
ENSG00000164597,2,2,1,0,0,0,394357.452283155,1778690.168860174,2020-10-05,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,COG5,-0.026000023,-0.53705,-0.19727,3,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000164651,5,2,0,0,0,1,22541.66311868015,521818.7070055739,2013-04-01,16,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,SP8,-0.13300002,-2.2788,-4.4471,0,1.0,1.0,,
ENSG00000164695,3,2,1,0,1,1,8116.851928965095,404399.6052088398,2013-04-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,CHMP4C,-0.393,-0.064782,-0.26281,9,0.5,0.0,Endosomal Sorting Complex Required For Transport (ESCRT);Budding and maturation of HIV virion;Disease;Late endosomal microautophagy;Translation of Replicase and Assembly of the Replication Transcription Complex_9679504;Sealing of the nuclear envelope (NE) by ESCRT-III;Translation of Replicase and Assembly of the Replication Transcription Complex_9694676;HIV Life Cycle;Late Phase of HIV Life Cycle;HCMV Late Events,R-HSA-917729;R-HSA-162588;R-HSA-1643685;R-HSA-9615710;R-HSA-9679504;R-HSA-9668328;R-HSA-9694676;R-HSA-162587;R-HSA-162599;R-HSA-9610379
ENSG00000164944,3,2,1,0,0,1,5414.650230111769,351924.78376246523,2017-02-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,VIRMA,0.561,3.6977,1.1049,0,-1.0,-1.0,,
ENSG00000164983,2,2,0,0,0,1,56073.79969618524,220837.49604317299,2021-07-08,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TMEM65,-0.875,-0.53646,-2.2542,0,-1.0,-1.0,,
ENSG00000165084,2,2,0,0,0,1,221304.1606010112,351924.78376246523,2019-06-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,1,6,C8orf34,-0.10399997,0.092148,-0.16615,0,0.5,0.0,,
ENSG00000165181,2,2,0,0,0,1,606.6666666666666,4428.697810877906,2016-02-01,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SHOC1,0.10799998,1.4144,1.9589,0,1.0,0.5,,
ENSG00000165219,3,2,1,0,0,1,201549.9575922349,512656.0695323204,2023-01-18,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,5,GAPVD1,0.65999997,2.3927,0.22323,2,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000165669,3,2,0,0,0,1,36448.89503858875,134130.21063635303,2023-01-18,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FAM204A,0.21600002,0.40131,0.75484,0,-1.0,-1.0,,
ENSG00000165714,2,2,1,0,0,1,78016.97193351923,562534.7696387965,2022-02-07,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,3,BORCS5,-0.10500002,0.44177,-0.63686,0,-1.0,-1.0,,
ENSG00000166407,3,2,0,0,0,1,4338.666666666667,433862.5685735124,2010-12-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,11,LMO1,0.05400002,0.66516,0.011386,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000166446,4,2,1,0,0,1,22345.675520395987,180089.50342935527,2013-04-01,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,12,CDYL2,0.287,-0.2093,-2.8012,0,0.5,0.0,,
ENSG00000167014,2,2,0,0,0,1,101825.50588235294,128346.64343021637,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,TERB2,-0.08899999,0.21569,0.091235,0,1.0,0.5,,
ENSG00000167103,2,2,1,0,0,0,19662.31571784985,274828.8365545636,2016-04-04,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,PIP5KL1,-0.724,-2.2667,-2.7403,0,-1.0,0.0,,
ENSG00000168010,2,2,0,0,1,1,50072.877304794354,101091.64372355297,2020-06-08,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,ATG16L2,-0.176,-0.22355,-1.3844,1,0.5,-1.0,,
ENSG00000168496,2,2,0,0,0,1,38751.153956846036,76632.8325989884,2023-01-18,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FEN1,-0.07099998,2.727,1.6795,6,0.5,-1.0,Disease;HIV Life Cycle,R-HSA-1643685;R-HSA-162587
ENSG00000169126,2,2,1,0,0,1,56337.759367670486,129783.42151918238,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,ODAD2,0.023000002,0.90537,0.93395,0,0.5,0.0,,
ENSG00000169469,2,2,0,0,1,1,16461.04650907092,16461.04650907092,2015-01-08,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,SPRR1B,-0.85800004,0.25655,0.17274,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000169717,3,2,0,0,0,1,54272.859706395815,394357.452283155,2020-10-05,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,ACTRT2,-0.30700004,0.55155,-0.76344,0,1.0,1.0,,
ENSG00000169740,9,2,0,0,0,1,52463.65429696694,502231.5406594711,2015-09-07,0,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,21,ZNF32,0.19599998,2.0587,0.49017,0,-1.0,-1.0,,
ENSG00000170464,3,2,1,0,0,1,56455.913944919754,756470.9740366563,2023-01-18,0,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,DNAJC18,0.0,1.869,1.1827,0,1.0,0.0,,
ENSG00000170605,2,2,0,0,0,1,51249.742722210474,205433.03502595585,2023-01-18,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,OR9K2,-0.80499995,-0.66936,0.47434,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000171448,2,2,1,0,0,1,765591.3646788632,1470466.6505612188,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,ZBTB26,0.41399997,3.7462,1.5461,0,-1.0,-1.0,,
ENSG00000171989,2,2,1,0,1,1,13883.57970142381,36494.548446257475,2018-08-13,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,5,LDHAL6B,-0.85899997,-0.54436,-1.2161,1,1.0,1.0,Pyruvate metabolism,R-HSA-70268
ENSG00000171992,3,2,1,0,0,1,281258.82202219026,281258.82202219026,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,SYNPO,0.421,0.62408,-0.32626,0,0.75,0.0,,
ENSG00000172209,2,2,1,0,0,0,232656.1405260205,464892.4593283075,2018-06-11,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,GPR22,0.338,2.4768,-0.65008,0,0.5,0.5,,
ENSG00000172264,4,2,1,0,1,1,86334.97261459603,376569.5597064443,2020-11-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,3,4,MACROD2,0.27600002,0.64634,0.34562,0,-1.0,0.0,,
ENSG00000172382,2,2,1,1,0,0,258213.8601133611,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PRSS27,-0.34300005,-0.70699,-0.88665,0,0.5,0.0,,
ENSG00000172765,2,2,0,0,0,0,31535.173607928213,89519.16315227402,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,TMCC1,0.564,4.3014,1.2316,0,-1.0,-1.0,,
ENSG00000173020,3,2,1,0,0,1,26569.585928193977,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,3,GRK2,0.71000004,4.1811,-0.59217,5,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000173465,3,2,1,0,0,1,10340.746973800697,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,ZNRD2,-0.02699995,0.062621,0.66331,0,-1.0,-1.0,,
ENSG00000173598,2,2,0,0,0,1,100620.50186431198,100620.50186431198,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,NUDT4,-0.776,-0.027053,-0.33561,1,-1.0,-1.0,,
ENSG00000173726,2,2,0,0,0,1,286678.73247515375,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,TOMM20,0.049000025,1.1908,0.14665,3,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000173805,3,2,1,0,1,1,4074.958527607362,196816.54442141854,2012-09-09,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HAP1,-0.30999994,-0.1706,-0.19029,0,0.5,0.0,,
ENSG00000174175,2,2,0,0,0,1,56614.28807963426,645988.1975077938,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,SELP,0.027999997,0.55351,-0.24559,2,-1.0,0.0,,
ENSG00000174442,4,2,1,0,1,1,17115.61307125707,521818.7070055739,2017-06-12,5,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,ZWILCH,-0.06099999,0.16491,-0.23566,6,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000174501,3,2,1,0,1,1,52830.887409864736,360605.992793193,2022-02-03,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,ANKRD36C,0.65999997,2.4268,2.1244,0,0.5,0.0,,
ENSG00000174529,3,2,1,0,1,1,26561.371714038676,42193.37905314073,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,TMEM81,,0.67252,-0.069825,0,0.5,0.0,,
ENSG00000174697,4,2,0,0,0,1,14440.44839102838,254373.32653042395,2013-08-14,0,0,0,0,0,9,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,LEP,-0.13900006,1.8295,-1.619,4,0.75,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000174876,2,2,0,1,0,0,258456.3496858129,258456.3496858129,2019-06-24,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,AMY1B,,,,1,1.0,0.5,,
ENSG00000175115,3,2,1,0,0,1,4713.845260560313,150669.89240227733,2013-04-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,3,PACS1,0.7,3.883,0.5349,1,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000175155,2,2,0,0,0,1,20393.928394796258,356440.71671986027,2023-11-28,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,2,YPEL2,0.628,2.3725,0.042207,0,0.5,-1.0,,
ENSG00000175548,2,2,0,0,0,1,5795.555913631969,114439.41769154315,2013-10-24,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ALG10B,-0.018000007,0.31936,0.85681,1,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000175662,2,2,1,0,0,0,218250.16474351365,1424218.0900670097,2021-02-03,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TOM1L2,0.38599998,1.0865,0.18646,0,-1.0,-1.0,,
ENSG00000175785,2,2,0,0,0,1,47832.98019165416,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,2,PRIMA1,-0.052999973,-0.36854,-1.3287,0,0.5,0.0,,
ENSG00000176046,2,2,1,0,0,1,16417.447913521348,23238.11336553945,2009-05-10,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,NUPR1,-0.75100005,0.7226,0.5963,0,0.5,-1.0,,
ENSG00000176142,2,2,0,0,1,1,3511.742535866615,83896.55822718568,2017-04-20,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,TMEM39A,0.42000002,2.7079,1.1977,0,-1.0,-1.0,,
ENSG00000176890,2,2,0,0,0,1,50087.52781663962,143284.77790855977,2023-01-18,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TYMS,0.11799997,1.5712,-1.3815,2,0.5,0.0,G1/S-Specific Transcription;Interconversion of nucleotide di- and triphosphates;Metabolism of nucleotides,R-HSA-69205;R-HSA-499943;R-HSA-15869
ENSG00000177283,4,2,0,0,0,1,497.96659528907924,156470.480665571,2016-08-01,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,FZD8,0.24699998,1.3249,-4.6128,4,0.5,0.0,Signal Transduction;Disease;Asymmetric localization of PCP proteins;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-4608870;R-HSA-5663202
ENSG00000177374,5,2,1,0,0,1,60546.60146904292,1990918.947961699,2018-08-13,0,0,0,0,5,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,8,HIC1,0.09899998,-1.9458,-5.8695,1,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000177511,2,2,0,0,0,1,4610.656076150852,15603.785966148887,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,ST8SIA3,0.265,2.2463,0.49373,2,0.5,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000177673,2,2,0,0,0,1,125392.97184483419,322107.4898639223,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,TEX44,-0.86899996,0.64724,0.45008,0,1.0,1.0,,
ENSG00000177710,3,2,1,0,1,1,1618.5431309904154,88771.02207231094,2021-08-14,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,3,SLC35G5,-0.21300006,-2.1364,-1.6118,0,0.5,1.0,,
ENSG00000177963,2,2,1,0,0,1,47450.88644524237,355284.1215006515,2021-09-30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,RIC8A,-0.006000042,0.5287,0.18509,0,-1.0,-1.0,,
ENSG00000177971,2,2,1,0,0,1,135095.86576106868,272025.74568937684,2018-10-08,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,IMP3,-0.95500004,-0.61081,-2.3272,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000178074,2,2,1,0,0,1,382631.1172224132,545988.1005477115,2023-01-18,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,C2orf69,0.086000025,1.2579,-0.50349,0,-1.0,-1.0,,
ENSG00000178202,12,2,1,1,1,1,5209.980115614254,521818.7070055739,2017-06-09,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,22,POGLUT3,-0.20099998,-0.45259,0.1849,0,-1.0,-1.0,,
ENSG00000179456,3,2,0,0,0,1,4203.226874852141,355284.1215006515,2022-01-24,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,6,ZBTB18,0.872,4.2554,-0.43898,0,0.5,-1.0,,
ENSG00000179674,2,2,0,0,0,1,1173.5007132667617,8747.760404864415,2015-09-22,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ARL14,-0.68200004,-0.69198,-0.58652,0,0.5,0.5,,
ENSG00000180104,2,2,1,0,0,1,3400.4411583487367,672632.4785173276,2014-08-10,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,EXOC3,0.525,1.4344,-0.5896,3,-1.0,-1.0,VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620916;R-HSA-5620920
ENSG00000180228,2,2,0,0,0,1,16461.04650907092,16461.04650907092,2015-01-08,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,PRKRA,0.069000006,1.0002,-0.41266,3,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Gene expression (Transcription);MicroRNA (miRNA) biogenesis;Gene Silencing by RNA,R-HSA-1280215;R-HSA-168256;R-HSA-74160;R-HSA-203927;R-HSA-211000
ENSG00000180318,2,2,0,0,0,1,12682.787696090549,12682.787696090549,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,ALX1,0.162,0.2872,0.29701,0,0.5,0.5,,
ENSG00000180336,2,2,0,0,0,1,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,MEIOC,0.781,2.5703,0.77477,0,1.0,0.5,,
ENSG00000180543,3,2,0,0,0,1,8710.508087253302,120940.93870730935,2010-08-29,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TSPYL5,,-1.5005,-2.4797,0,0.5,-1.0,,
ENSG00000182199,8,2,0,0,0,1,15866.724081734988,633132.2332759313,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,1,0,0,0,6,SHMT2,0.20599997,2.1221,0.5265,3,0.5,-1.0,Signal Transduction;Metabolism of folate and pterines,R-HSA-162582;R-HSA-196757
ENSG00000182327,2,2,0,0,0,1,208059.85546229704,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,GLTPD2,-0.729,-2.0621,-1.9346,0,1.0,0.5,,
ENSG00000182747,2,2,0,0,0,1,130268.25219927442,272025.74568937684,2018-10-08,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SLC35D3,-0.54499996,-0.43996,-2.4696,0,1.0,1.0,,
ENSG00000183484,2,2,1,0,0,1,135108.48254553688,225599.91693237546,2023-10-04,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,GPR132,-0.905,2.0812,0.3898,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000184144,4,2,1,1,0,1,200944.0765227402,1424218.0900670097,2020-06-15,0,0,0,0,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,CNTN2,0.458,3.3008,1.1595,3,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000184361,4,2,1,0,0,1,26841.183331692897,562534.7696387965,2019-07-30,0,0,0,0,0,0,0,0,1,0,14,0,0,0,0,0,0,0,0,0,0,0,0,15,SPATA32,-0.08099997,1.4515,1.4823,0,1.0,1.0,,
ENSG00000185070,3,2,1,1,0,1,87073.84469976889,645988.1975077938,2020-06-08,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,FLRT2,0.417,1.5939,-1.1571,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000185100,3,2,1,0,0,1,32705.240805002948,269829.0934099178,2023-01-18,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,0,0,0,4,ADSS1,-0.245,-0.1029,-0.33475,1,0.75,0.0,,
ENSG00000185339,5,2,1,1,1,1,46977.28346057821,282360.54876783554,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,10,0,0,0,0,15,TCN2,0.11199999,-1.4942,-2.0781,3,0.5,-1.0,Transport of RCbl within the body;Disease,R-HSA-9758890;R-HSA-1643685
ENSG00000185634,2,2,0,0,0,1,23238.11336553945,42150.86382443902,2020-01-31,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SHC4,0.283,0.47711,-0.42626,0,0.75,0.0,,
ENSG00000185742,2,2,0,0,0,1,137776.79053446153,158370.2523752734,2023-02-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,C11orf87,0.167,0.59657,0.2746,0,1.0,0.5,,
ENSG00000186197,4,2,1,0,0,1,116089.30071075787,258213.8601133611,2020-06-24,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,1,0,0,0,7,EDARADD,0.009000003,1.2558,0.47431,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000186340,6,2,1,1,0,1,38913.031770896094,672632.4785173276,2021-04-22,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,8,THBS2,0.554,3.1877,0.26649,3,-1.0,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-597592
ENSG00000186417,4,2,1,0,0,1,32757.942031942086,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,1,0,0,0,6,GLDN,-0.07799995,-1.2504,-2.2479,0,0.5,0.0,,
ENSG00000186487,2,2,0,0,0,1,3115.132220795892,323648.5577791949,2023-03-29,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,MYT1L,0.915,5.5286,1.5194,0,0.75,0.5,,
ENSG00000186564,3,2,0,0,0,1,180089.50342935527,427337.4491868293,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,5,FOXD2,-0.95500004,-1.804,-2.8038,0,0.5,0.5,,
ENSG00000187516,2,2,0,0,0,1,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,H2AP,,,,0,1.0,1.0,,
ENSG00000187772,5,2,1,0,0,1,103877.27822338727,1778690.168860174,2016-08-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,0,0,1,0,0,0,15,LIN28B,0.589,1.1594,-0.11502,0,1.0,0.5,,
ENSG00000187860,3,2,1,0,1,1,7702.451053582179,151416.12986435954,2014-01-01,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,CCDC157,-0.16499996,0.48912,0.96959,0,0.5,0.0,,
ENSG00000188306,3,2,0,0,0,0,28221.648477075985,42061.79578384488,2017-06-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,LRRIQ4,0.22500002,0.42374,0.48022,0,1.0,1.0,,
ENSG00000188315,4,2,0,0,1,1,22650.1728716785,95776.89591443514,2021-04-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,C3orf62,-0.17200005,0.54247,0.41632,0,-1.0,-1.0,,
ENSG00000188425,3,2,0,0,0,1,78728.4671948324,101032.95487940393,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,3,5,NANOS2,-0.14199996,0.62525,0.32054,0,1.0,1.0,,
ENSG00000188659,3,2,1,0,0,0,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,SAXO2,-0.449,0.93092,0.79412,0,0.75,0.0,,
ENSG00000188672,2,2,1,0,1,1,207220.14223281175,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,2,RHCE,0.31199998,2.1189,1.9358,1,1.0,0.0,,
ENSG00000188725,2,2,0,0,0,1,125299.9543761523,328593.8949890692,2019-07-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,3,SMIM15,-0.46300006,0.32566,0.26938,0,-1.0,-1.0,,
ENSG00000189007,3,2,0,0,0,1,20209.09625085965,191393.33333333334,2021-08-11,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,5,ADAT2,-0.32599998,0.80136,0.91708,1,-1.0,0.0,,
ENSG00000189045,2,2,1,0,1,1,360605.992793193,1424218.0900670097,2020-06-15,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ANKDD1B,-0.17299998,0.21988,-0.14436,0,0.5,0.5,,
ENSG00000189326,3,2,0,0,0,1,7372.5659126184055,7372.5659126184055,2016-09-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,SPANXN4,,,,0,1.0,1.0,,
ENSG00000196159,3,2,0,0,1,1,114027.3065785449,414433.58532016096,2023-06-29,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,FAT4,0.68299997,2.1425,1.3552,0,-1.0,0.0,,
ENSG00000196535,8,2,0,0,0,1,633132.2332759313,633132.2332759313,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,MYO18A,0.58599997,3.5331,1.8883,3,0.5,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000196950,2,2,1,0,0,1,294387.2978738704,1424218.0900670097,2021-09-30,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,SLC39A10,0.672,2.5007,1.1732,1,0.5,-1.0,Zinc transporters,R-HSA-435354
ENSG00000196968,2,2,1,0,0,0,228220.5662976458,295550.4496098593,2018-07-30,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,FUT11,-0.41199994,-1.332,-2.0566,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000197217,2,2,1,0,0,1,4447.295196209435,260631.24114204012,2024-07-19,0,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ENTPD4,0.09500003,0.36154,0.90357,1,-1.0,-1.0,Metabolism of nucleotides,R-HSA-15869
ENSG00000197226,2,2,0,0,0,1,5173.510782660749,5173.510782660749,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,TBC1D9B,0.111,0.90702,0.17801,0,-1.0,-1.0,,
ENSG00000197329,4,2,0,0,0,1,95776.89591443514,1129585.974638378,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,PELI1,0.44199997,2.047,0.22421,4,1.0,-1.0,Cytokine Signaling in Immune system;Immune System;IRAK1 recruits IKK complex;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-937039;R-HSA-975144;R-HSA-449147
ENSG00000197345,3,2,1,0,0,1,195005.6685718255,278498.5074409075,2023-01-18,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,MRPL21,0.036000013,0.27681,0.4314,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000197576,2,2,1,0,1,1,3400.4411583487367,251325.91086204,2014-08-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,HOXA4,-0.90199995,-1.8013,-2.3722,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000198354,2,2,0,0,0,1,143284.77790855977,433862.5685735124,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,DCAF12L2,,,,0,0.5,0.0,,
ENSG00000198648,3,2,1,0,0,1,6306.411000302206,521818.7070055739,2011-02-01,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,0,16,STK39,0.61899996,2.4598,-0.028218,0,-1.0,-1.0,,
ENSG00000198691,4,2,0,0,0,1,1225.1182294700059,5414.650230111769,2012-08-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,4,ABCA4,0.21399999,1.3815,0.32417,3,0.75,0.5,Disease,R-HSA-1643685
ENSG00000198700,3,2,0,0,0,1,22650.1728716785,1778690.168860174,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,IPO9,0.69,3.4198,0.68624,0,-1.0,-1.0,,
ENSG00000198890,4,2,0,0,0,1,2464.7717968157694,1778690.168860174,2011-12-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,0,0,1,0,0,0,20,PRMT6,-0.052000046,0.27969,-0.71622,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000204764,3,2,0,0,0,1,40153.0728800662,539013.8231881644,2020-11-25,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,RANBP17,-0.38,-0.18836,0.49636,0,-1.0,0.5,,
ENSG00000205002,2,2,0,0,0,1,1173.5007132667617,2690.0277610138805,2011-07-21,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,AARD,-0.719,-0.86864,0.057878,0,0.5,0.0,,
ENSG00000205531,2,2,1,1,0,1,19257.690392998462,384314.83364002535,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,NAP1L4,0.615,1.5164,-0.38292,0,-1.0,-1.0,,
ENSG00000205884,5,2,0,0,0,1,21781.337520231158,645988.1975077938,2018-08-13,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,5,DEFB136,-0.96800005,-0.89088,-1.007,2,1.0,1.0,Immune System;Defensins;Antimicrobial peptides,R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000211452,2,2,1,0,0,1,190279.23963861223,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,2,DIO1,0.075999975,1.1669,0.26843,1,0.75,0.5,Metabolism of amine-derived hormones,R-HSA-209776
ENSG00000214193,2,2,1,0,0,1,328052.24452619,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,SH3D21,-0.22099996,-0.12511,0.24786,0,0.5,0.0,,
ENSG00000214413,2,2,0,0,0,1,50072.877304794354,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,BBIP1,-0.69299996,0.2351,0.47314,1,0.5,-1.0,BBSome-mediated cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620922;R-HSA-5620920
ENSG00000219626,2,2,1,0,0,0,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,FAM228B,-0.375,0.49802,0.91599,0,-1.0,-1.0,,
ENSG00000226321,3,2,1,0,0,1,143413.24457139417,414433.58532016096,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,CROCC2,-0.21399999,-0.75107,-1.6994,0,0.5,0.5,,
ENSG00000226807,2,2,0,0,0,0,405722.3511294316,437137.9986908925,2021-06-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,2,MROH5,-0.553,-0.13581,-0.109,0,1.0,1.0,,
ENSG00000231213,2,2,0,0,0,1,13219.952617929488,410642.56898295006,2015-10-26,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,PLSCR5,-0.921,-1.163,-2.1009,0,,,,
ENSG00000233701,2,2,0,0,0,1,3235.5860731550038,9658.639391362309,2017-03-27,1,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,PRR23C,-0.94500005,-0.46011,-0.69107,0,,,,
ENSG00000233927,4,2,1,0,0,1,53362.65624943269,108816.31098183901,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,4,RPS28,0.09200001,1.9087,-0.79684,18,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000233932,5,2,0,0,0,1,5062.4538966212895,125392.97184483419,2023-01-18,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,CTXN2,-0.288,0.37258,0.044298,0,0.5,0.5,,
ENSG00000240563,2,2,0,0,1,1,913.5802469135803,118061.55082048493,2020-06-30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,L1TD1,-0.291,-1.18,-2.1464,0,0.75,0.5,,
ENSG00000243244,2,2,0,0,0,1,78906.83616868555,78906.83616868555,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,STON1,-0.523,-3.9236,-1.6345,2,-1.0,0.0,,
ENSG00000244045,4,2,1,0,0,0,33892.13656698846,213435.01458839694,2015-12-21,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,7,VMA12,-0.37399995,-0.075473,-0.89681,0,-1.0,-1.0,,
ENSG00000244122,2,2,0,0,0,1,23095.07516203479,23238.11336553945,2020-01-31,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,UGT1A7,0.049000025,0.14186,-0.35241,2,1.0,0.5,Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000244682,2,2,0,0,0,1,50072.877304794354,87248.80974040499,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,3,FCGR2C,,1.9098,0.96385,0,1.0,0.5,,
ENSG00000250305,4,2,0,0,0,1,8360.758176657433,94043.79902545024,2018-08-13,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,TRMT9B,-0.86,-5.4041,-2.6858,1,0.75,0.0,,
ENSG00000255690,2,2,0,0,0,1,116566.20935579021,225599.91693237546,2023-01-18,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,TRIL,-0.029000044,-1.4925,-2.9181,0,1.0,0.0,,
ENSG00000257315,2,2,0,0,0,0,141076.9910731678,180089.50342935527,2020-05-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,ZBED6,0.18199998,0.4123,-0.48245,0,-1.0,0.0,,
ENSG00000259009,2,2,0,0,0,1,4518.532006719214,282360.54876783554,2022-08-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,2,TPRX2,,,,1,,,Developmental Biology;Zygotic genome activation (ZGA),R-HSA-1266738;R-HSA-9819196
ENSG00000260325,2,2,1,0,1,1,56455.913944919754,215157.94798738702,2023-01-18,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,3,HSPB9,-0.888,0.48893,-0.02485,0,0.5,0.5,,
ENSG00000261371,7,2,1,0,0,1,54391.03477538057,502231.5406594711,2017-12-06,0,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,18,PECAM1,,,,7,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000262655,4,2,1,1,0,1,21724.94108458234,645988.1975077938,2021-09-30,0,0,0,0,4,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,6,SPON1,0.31300002,0.78426,-1.1037,2,-1.0,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000263155,4,2,0,0,1,1,138890.6106237268,281079.0730593847,2018-07-30,0,0,0,0,5,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,MYZAP,-0.11399996,-0.73997,-1.9105,0,1.0,0.0,,
ENSG00000274523,2,2,1,0,1,1,201549.9575922349,226101.35678720698,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,3,RCC1L,-0.024000049,-0.48234,-1.2137,0,-1.0,-1.0,rRNA modification in the mitochondrion;rRNA processing in the mitochondrion;rRNA processing,R-HSA-6793080;R-HSA-8868766;R-HSA-72312
ENSG00000276043,2,2,0,0,1,0,272025.74568937684,895916.2144062951,2018-10-08,0,0,0,0,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,UHRF1,0.829,5.1832,0.10914,2,0.75,0.0,Developmental Biology;Gene expression (Transcription);Chromatin modifications during the maternal to zygotic transition (MZT),R-HSA-1266738;R-HSA-74160;R-HSA-9821002
ENSG00000276747,8,2,0,0,0,1,10352.610157160763,227752.06557835746,2018-08-13,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,PADI6,0.004999995,0.36547,-1.2155,2,1.0,1.0,Developmental Biology,R-HSA-1266738
ENSG00000277149,3,2,0,0,0,0,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,TYW1B,-0.014999986,2.266,0.92765,0,0.5,0.0,,
ENSG00000285231,2,2,0,0,0,1,10965.091075927192,17259.1075111459,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,2,OOSP3,,,,0,,,,
ENSG00000285976,2,2,0,0,0,1,193771.21296110394,1424218.0900670097,2021-06-08,0,0,0,0,0,1,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,4,ENSG00000285976,,,,0,0.5,0.0,,
ENSG00000000003,2,2,0,0,1,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,TSPAN6,,,,0,-1.0,0.0,,
ENSG00000001036,2,2,0,0,0,1,38092.548464040476,160010.51072069994,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,2,FUCA2,-0.014999986,0.99621,-0.078367,3,0.5,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000001461,2,2,1,0,0,0,133918.94977035935,133918.94977035935,2020-04-27,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,NIPAL3,-0.09200001,1.5111,0.94945,1,0.5,-1.0,Miscellaneous transport and binding events,R-HSA-5223345
ENSG00000002587,2,2,0,0,0,1,13668.611881626193,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,3,HS3ST1,0.291,0.093919,-0.32213,1,0.5,0.0,HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-2022928;R-HSA-1638091
ENSG00000003436,2,2,1,0,0,0,47408.95172709719,187203.10687937262,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,TFPI,0.44199997,1.4962,0.98076,1,0.5,-1.0,,
ENSG00000004478,2,2,0,0,1,1,5892.720190233379,120710.69247609908,2024-07-19,0,0,0,0,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,FKBP4,0.265,0.97009,-0.5055,8,-1.0,-1.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000004487,2,2,1,0,0,0,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,KDM1A,0.362,3.796,-0.028337,8,-1.0,-1.0,Signal Transduction;Disease;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,R-HSA-162582;R-HSA-1643685;R-HSA-5625886
ENSG00000005379,3,2,0,0,0,1,67025.4366542422,464892.4593283075,2019-01-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,TSPOAP1,0.427,1.7126,1.1802,6,0.5,-1.0,Acetylcholine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Pregnenolone biosynthesis;Dopamine Neurotransmitter Release Cycle;Metabolism of steroids;Serotonin Neurotransmitter Release Cycle;Neurotransmitter release cycle,R-HSA-264642;R-HSA-210500;R-HSA-196108;R-HSA-212676;R-HSA-8957322;R-HSA-181429;R-HSA-112310
ENSG00000006025,3,2,1,0,0,1,14145.711748532529,562534.7696387965,2019-10-17,0,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,1,13,OSBPL7,0.29400003,2.551,0.15741,1,-1.0,-1.0,Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000007047,3,2,1,0,0,0,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,MARK4,0.639,2.9454,-0.42945,1,-1.0,-1.0,,
ENSG00000008438,3,2,0,0,0,1,78728.4671948324,101032.95487940393,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,4,PGLYRP1,-0.42499995,0.3383,1.0415,2,1.0,0.5,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000014257,2,2,1,0,0,1,133278.70877396542,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,ACP3,-0.078999996,0.3975,0.4388,1,1.0,0.0,Immune System,R-HSA-168256
ENSG00000019991,2,2,0,0,0,1,1475.7794086810652,521818.7070055739,2022-11-23,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,HGF,0.52900004,1.9628,0.62406,18,1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202;R-HSA-6785807
ENSG00000022267,9,2,1,0,0,1,52982.28647069224,279825.00883385167,2021-09-30,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,12,FHL1,,,,0,0.75,-1.0,,
ENSG00000023318,3,2,1,0,0,1,13116.6997137056,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,2,5,ERP44,0.18400002,1.6527,1.0728,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000023892,2,2,1,0,1,0,183579.49764748462,203321.91836345146,2020-04-15,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,2,DEF6,0.39,2.842,0.73628,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000026103,5,2,1,1,0,1,6455.028095238095,87248.80974040499,2013-06-16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,8,FAS,0.628,1.2561,0.32235,7,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000033170,2,2,1,1,0,1,20933.57944451354,384314.83364002535,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,2,FUT8,0.333,2.2516,-0.028291,2,-1.0,-1.0,Disease;Reactions specific to the complex N-glycan synthesis pathway;Post-translational protein modification,R-HSA-1643685;R-HSA-975578;R-HSA-597592
ENSG00000035403,2,2,1,0,0,1,89519.16315227402,106176.1187815965,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,VCL,0.53900003,4.2503,1.9453,13,-1.0,-1.0,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202
ENSG00000046653,2,2,1,0,0,1,64148.70787518679,86992.9057658324,2021-03-06,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,GPM6B,,,,0,0.75,0.0,,
ENSG00000047365,2,2,1,0,0,1,160010.51072069994,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,ARAP2,0.116,-0.68052,0.46347,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000048991,3,2,1,0,1,1,2892.8464232116057,269602.2657190595,2013-04-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,3,R3HDM1,0.61800003,2.2315,1.3115,0,0.5,-1.0,,
ENSG00000049249,3,2,0,0,0,1,281258.82202219026,281258.82202219026,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,TNFRSF9,0.10900003,0.36664,-0.70006,1,0.5,0.5,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000052850,3,2,0,0,0,1,5488.863526985218,180089.50342935527,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,5,ALX4,0.09799999,-0.26237,-1.144,0,0.5,0.5,,
ENSG00000054392,3,2,0,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,HHAT,0.21499997,0.29722,1.051,2,-1.0,0.0,Signal Transduction;Disease;Hedgehog ligand biogenesis;Hh mutants abrogate ligand secretion;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5358346;R-HSA-5387390;R-HSA-5663202
ENSG00000054523,2,2,1,0,0,1,57060.02774555957,125894.9248389576,2018-08-13,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,KIF1B,0.624,5.2587,1.7316,2,0.75,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000055044,2,2,1,0,0,1,144712.0807038357,190279.23963861223,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,3,NOP58,0.004999995,0.9266,-0.38407,3,-1.0,-1.0,SUMOylation of RNA binding proteins;rRNA processing;Post-translational protein modification,R-HSA-4570464;R-HSA-72312;R-HSA-597592
ENSG00000057294,3,2,0,0,0,1,32996.93546153374,645988.1975077938,2018-06-11,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,11,PKP2,-0.10500002,0.99086,0.36728,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000060237,6,2,1,0,1,0,26205.642998747087,355284.1215006515,2017-06-12,10,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,WNK1,0.773,4.67,0.90354,1,-1.0,-1.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000064687,4,2,1,0,1,1,1321.7688442211056,340825.7076940272,2011-04-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,1,16,ABCA7,-0.36800003,-3.5932,-4.1534,1,0.5,0.0,,
ENSG00000064726,2,2,1,0,0,1,123127.18790121445,1424218.0900670097,2019-02-25,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,BTBD1,-0.10500002,0.21024,-1.1863,2,0.5,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000065054,3,2,1,1,1,1,143413.24457139417,358386.30063935445,2021-10-18,0,0,0,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,NHERF2,-0.54200006,-1.6495,-3.2457,0,0.5,0.0,,
ENSG00000066248,8,2,1,0,0,0,633132.2332759313,633132.2332759313,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,NGEF,0.5,2.973,0.15856,6,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000066827,2,2,0,0,0,1,58995.33218928629,645988.1975077938,2023-11-09,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ZFAT,0.32099998,1.5974,-1.1544,0,0.5,0.0,,
ENSG00000067141,3,2,1,1,0,1,141293.18354755783,341207.7500533011,2019-06-24,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,6,NEO1,0.505,2.1628,0.96086,2,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000068796,3,2,1,0,0,1,448058.917711015,1778690.168860174,2019-02-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,7,KIF2A,0.38300002,2.6011,0.82127,9,-1.0,-1.0,Signal Transduction;Immune System;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-162582;R-HSA-168256;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000069956,4,2,0,0,1,1,183427.12489668437,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,5,MAPK6,0.53499997,1.6886,-0.55137,1,-1.0,-1.0,,
ENSG00000070444,2,2,1,0,0,1,1424218.0900670097,1778690.168860174,2022-07-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,MNT,0.38099998,-0.5038,-2.8713,0,-1.0,-1.0,,
ENSG00000070540,2,2,1,0,1,1,394357.452283155,1424218.0900670097,2020-10-05,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,WIPI1,-0.05700004,1.9015,0.94722,2,0.5,-1.0,,
ENSG00000071127,3,2,1,0,1,1,12846.890397545798,645988.1975077938,2018-06-11,0,0,0,0,3,0,0,0,0,0,0,0,31,0,0,0,0,0,0,0,0,0,0,34,WDR1,0.551,1.3005,-2.3166,1,-1.0,-1.0,,
ENSG00000072506,2,2,1,0,0,1,61498.92173410762,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,5,HSD17B10,,,,5,-1.0,-1.0,rRNA processing in the mitochondrion;rRNA processing,R-HSA-8868766;R-HSA-72312
ENSG00000073614,2,2,1,0,1,0,112184.2204720767,1424218.0900670097,2024-02-19,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,KDM5A,0.73,3.6096,-0.76174,2,0.5,-1.0,Developmental Biology;Chromatin modifications during the maternal to zygotic transition (MZT),R-HSA-1266738;R-HSA-9821002
ENSG00000074695,3,2,0,0,0,1,10855.136371158706,269829.0934099178,2023-01-18,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,0,0,0,4,LMAN1,0.31800002,0.38388,-0.16739,9,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000075151,2,2,1,0,0,1,180089.50342935527,376569.5597064443,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,EIF4G3,0.787,3.5699,0.47728,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;ISG15 antiviral mechanism,R-HSA-1280215;R-HSA-168256;R-HSA-1169408
ENSG00000075399,3,2,0,0,1,1,5491.379973178364,60436.282913699004,2021-11-04,2,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,VPS9D1,-0.39999998,-3.8551,-4.0303,0,-1.0,-1.0,,
ENSG00000075539,2,2,0,0,0,1,634722.4486407059,634722.4486407059,2022-10-12,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FRYL,0.566,3.3198,1.3239,0,0.5,-1.0,,
ENSG00000076554,3,2,1,0,0,1,12724.75719835148,521818.7070055739,2022-11-04,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,TPD52,0.171,0.76225,0.49173,1,0.5,-1.0,,
ENSG00000078269,3,2,1,0,1,1,134159.95265752633,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,2,0,0,0,7,SYNJ2,0.032000005,0.97993,0.79398,2,1.0,-1.0,,
ENSG00000078589,4,2,0,0,0,1,17820.993879369486,258213.8601133611,2021-09-30,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,0,4,P2RY10,,,,2,0.5,0.0,Signal Transduction;P2Y receptors;Nucleotide-like (purinergic) receptors,R-HSA-162582;R-HSA-417957;R-HSA-418038
ENSG00000078795,4,2,0,0,0,1,92716.58618343195,298878.49542603496,2018-07-30,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,PKD2L2,-0.110000014,0.72504,-0.20594,0,0.5,0.5,,
ENSG00000081052,7,2,1,0,1,1,96018.8961005241,213982.31715359434,2023-01-18,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,6,COL4A4,0.393,2.2347,0.80754,13,-1.0,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000082898,2,2,1,0,0,1,195005.6685718255,645988.1975077938,2018-06-11,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,XPO1,0.917,7.9498,0.056304,18,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Cyclin A/B1/B2 associated events during G2/M transition;Developmental Biology;Gene expression (Transcription);Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Disease;HuR (ELAVL1) binds and stabilizes mRNA;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-69273;R-HSA-1266738;R-HSA-74160;R-HSA-177243;R-HSA-165054;R-HSA-168333;R-HSA-168274;R-HSA-1643685;R-HSA-450520;R-HSA-162587;R-HSA-162599
ENSG00000083067,2,2,1,0,0,1,74358.55048688942,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,4,TRPM3,0.52,3.8396,1.501,1,1.0,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000085185,2,2,0,0,0,1,143284.77790855977,275021.63051358337,2023-01-18,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,BCORL1,,,,0,-1.0,0.0,,
ENSG00000085265,3,2,1,0,0,1,40855.314577620855,1778690.168860174,2022-07-14,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,FCN1,-0.48599994,0.15537,0.1354,4,0.75,0.0,Immune System,R-HSA-168256
ENSG00000085514,4,2,1,0,1,1,1321.7688442211056,340825.7076940272,2019-01-07,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,10,PILRA,-0.42499995,1.3117,0.54536,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000085721,2,2,0,0,0,1,195005.6685718255,572390.9560934792,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,RRN3,0.251,0.24968,-0.23684,2,-1.0,-1.0,Gene expression (Transcription);RNA Polymerase I Promoter Escape;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance,R-HSA-74160;R-HSA-73772;R-HSA-73762;R-HSA-73864;R-HSA-73854
ENSG00000085982,2,2,0,0,0,1,28923.750134754748,29134.639381717512,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,USP40,-0.08500004,0.22888,0.34374,0,-1.0,-1.0,,
ENSG00000087206,2,2,1,0,1,1,143284.77790855977,1778690.168860174,2022-07-14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,UIMC1,0.43400002,0.70243,0.721,5,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000088812,2,2,0,0,0,1,21201.639474894007,21201.639474894007,2023-03-22,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ATRN,0.605,2.9594,-0.077968,0,-1.0,-1.0,,
ENSG00000089159,2,2,0,0,0,1,14790.180826912794,36494.548446257475,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,PXN,0.17199999,0.97667,0.13296,7,-1.0,-1.0,Signal Transduction;Developmental Biology;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-446388;R-HSA-9006934
ENSG00000089250,4,2,0,0,0,1,22650.1728716785,1778690.168860174,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,5,NOS1,0.601,4.7323,1.0698,3,0.75,0.5,Immune System,R-HSA-168256
ENSG00000090382,2,2,0,1,1,1,167055.73472660675,383158.3001114715,2019-03-05,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,LYZ,-0.65199995,1.0666,0.19762,3,0.5,-1.0,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000090534,2,2,0,1,0,1,74722.59037384245,107200.17738606388,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,0,0,0,5,THPO,-0.116999984,1.4598,0.18821,1,1.0,0.0,,
ENSG00000095209,3,2,0,0,0,1,37244.11672614318,87515.7591699547,2018-04-04,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TMEM38B,-0.329,-0.13505,0.1555,0,0.5,-1.0,,
ENSG00000095261,2,2,1,0,0,1,334911.3573752668,482893.2730520582,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,PSMD5,0.078999996,0.81512,0.71479,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000095917,3,2,1,1,0,1,55992.89702693355,275021.63051358337,2023-01-18,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,TPSD1,-0.747,-2.4387,-1.7419,0,0.5,0.0,,
ENSG00000099194,3,2,1,0,0,1,96212.56699204071,278498.5074409075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,4,SCD,0.758,3.2877,1.1124,4,0.5,-1.0,Signal Transduction;Gene expression (Transcription);Fatty acyl-CoA biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-162582;R-HSA-74160;R-HSA-75105;R-HSA-8957322;R-HSA-1655829
ENSG00000099985,4,2,0,0,0,1,62762.391330626975,394357.452283155,2020-10-05,0,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,OSM,0.083000004,0.16097,0.34577,2,1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000100197,9,2,1,0,1,1,633132.2332759313,1778690.168860174,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,3,CYP2D6,-0.706,-1.3217,-2.8499,6,1.0,0.5,Aspirin ADME,R-HSA-9749641
ENSG00000100242,2,2,1,0,1,1,13785.673050095118,232586.34864014547,2019-09-27,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SUN2,0.24400002,1.6318,1.2415,1,-1.0,-1.0,,
ENSG00000100439,4,2,0,0,0,0,26561.371714038676,42193.37905314073,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,4,ABHD4,-0.037999988,1.427,0.48818,1,-1.0,-1.0,,
ENSG00000100626,2,2,1,1,0,1,16534.94713490521,756470.9740366563,2024-11-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,GALNT16,0.417,1.5646,0.76821,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000100934,3,2,1,0,1,1,93393.2908111381,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,3,SEC23A,0.292,2.0263,0.60057,6,-1.0,-1.0,Immune System;Disease;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-8957322;R-HSA-1655829;R-HSA-597592
ENSG00000101391,4,2,0,0,0,1,44692.894702471654,194667.2540182328,2021-07-21,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CDK5RAP1,-0.08000004,1.4725,0.48823,0,-1.0,-1.0,,
ENSG00000101460,6,2,1,0,0,1,3815.989131101703,179853.90625477568,2021-04-23,6,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,MAP1LC3A,-0.29299998,0.51405,-0.17819,3,-1.0,-1.0,Receptor Mediated Mitophagy,R-HSA-8934903
ENSG00000102974,2,2,1,0,0,1,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,CTCF,0.795,4.8464,-1.5239,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000103415,2,2,1,0,0,1,171880.2916512608,360605.992793193,2021-07-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,HMOX2,-0.08700001,0.3819,0.40001,5,-1.0,-1.0,Signal Transduction;Immune System;Iron uptake and transport,R-HSA-162582;R-HSA-168256;R-HSA-917937
ENSG00000104142,4,2,0,0,0,1,21408.6965896625,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,4,0,1,0,0,0,0,0,0,0,0,0,0,5,VPS18,0.566,1.686,0.84171,1,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000104312,2,2,1,0,0,1,1791.5069911962714,169088.90478978804,2009-12-16,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,RIPK2,0.468,1.5403,0.2442,9,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-597592
ENSG00000105281,2,2,1,0,0,1,56716.257154516876,286678.73247515375,2024-10-15,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,SLC1A5,-0.075999975,0.79239,-1.1496,6,-1.0,-1.0,Signal Transduction;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-162582;R-HSA-425393
ENSG00000105371,5,2,0,1,0,1,106176.1187815965,281079.0730593847,2023-01-18,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,ICAM4,-0.26100004,0.76389,0.27537,2,0.75,0.5,Immune System,R-HSA-168256
ENSG00000106178,2,2,1,1,0,1,1514.869451697128,198317.64799485338,2020-08-21,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,7,10,CCL24,-0.14600003,0.73906,-0.12254,0,0.75,0.0,,
ENSG00000106355,4,2,0,0,0,1,95776.89591443514,1778690.168860174,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,LSM5,-0.44099998,0.22187,0.083978,2,-1.0,-1.0,,
ENSG00000106536,3,2,1,0,0,1,29803.01405728205,376569.5597064443,2020-01-20,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,8,POU6F2,0.408,1.2327,0.57881,0,0.5,1.0,,
ENSG00000106631,2,2,1,0,0,1,55267.6400199672,294387.2978738704,2019-02-04,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,8,MYL7,-0.533,0.67787,0.46389,1,1.0,0.0,,
ENSG00000107201,2,2,0,1,1,1,11052.199934661876,309256.4614031486,2015-01-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,10,RIGI,0.014999986,1.629,1.1387,15,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-1169408;R-HSA-597592
ENSG00000108774,4,2,1,0,0,1,116089.30071075787,381165.6245253304,2020-06-24,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,0,5,RAB5C,0.59000003,1.5744,0.16978,7,-1.0,-1.0,Immune System;Disease;TBC/RABGAPs;Rab regulation of trafficking;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-8854214;R-HSA-9007101;R-HSA-597592
ENSG00000109670,4,2,1,0,0,1,38918.988387096775,1424218.0900670097,2012-09-01,0,0,0,2,0,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,FBXW7,0.819,4.5357,-0.031066,8,0.5,-1.0,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000109805,4,2,0,0,1,1,95776.89591443514,1778690.168860174,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,NCAPG,0.329,1.3938,1.2001,1,0.5,0.5,,
ENSG00000110315,3,2,1,0,0,1,190279.23963861223,263416.51565448404,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,3,RNF141,-0.14400005,0.93222,0.61564,0,-1.0,-1.0,,
ENSG00000110536,2,2,1,0,0,1,29803.01405728205,141293.18354755783,2020-01-20,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,PTPMT1,-0.031999946,-0.40436,-1.6808,1,-1.0,-1.0,,
ENSG00000110851,2,2,1,0,0,1,180089.50342935527,598869.4096893278,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,PRDM4,0.26599997,2.1843,0.76979,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000111341,4,2,1,0,1,1,5920.046363037069,714039.8414241908,2021-08-24,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,1,8,MGP,-0.63,0.23992,0.26443,0,-1.0,-1.0,,
ENSG00000111452,2,2,0,0,0,1,61813.08013553196,259814.8604210848,2022-10-12,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,ADGRD1,0.17400002,1.1242,0.063691,0,0.5,0.0,,
ENSG00000111581,2,2,0,0,0,1,137776.79053446153,143284.77790855977,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,NUP107,0.167,1.4595,1.2568,35,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Postmitotic nuclear pore complex (NPC) reformation;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9615933;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000111817,2,2,1,0,0,1,20302.198506576402,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,2,DSE,0.43699998,3.703,0.77377,1,-1.0,-1.0,DS-GAG biosynthesis,R-HSA-2022923
ENSG00000112079,2,2,0,0,0,1,19008.705439555517,39406.19595155135,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,4,STK38,0.361,2.3696,0.43166,2,-1.0,-1.0,Signal Transduction;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9013422;R-HSA-9706574
ENSG00000112242,4,2,0,0,0,1,56942.29853437452,83633.19622783325,2021-11-04,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,E2F3,0.607,1.375,0.072356,6,-1.0,-1.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000112584,2,2,1,0,0,1,124531.34246675359,1129585.974638378,2021-02-24,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,FAM120B,0.003000021,1.3572,0.36148,2,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000113100,3,2,0,0,1,1,49127.555514088446,1122672.658801146,2023-04-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,CDH9,0.422,1.4201,-1.2306,1,0.5,0.5,,
ENSG00000113430,6,2,1,0,0,1,4314.782048701952,521818.7070055739,2010-08-01,41,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,42,IRX4,-0.12899995,-2.8483,-2.4984,0,0.5,0.5,,
ENSG00000113552,3,2,1,0,0,1,53369.71648873449,444537.33605315426,2019-03-28,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,3,GNPDA1,-0.16900003,1.687,-0.26137,1,-1.0,-1.0,,
ENSG00000114850,2,2,1,0,0,1,11343.053400273848,162367.55694122918,2017-06-12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,SSR3,0.18400002,1.0778,-1.1145,1,-1.0,-1.0,Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-72766;R-HSA-1799339
ENSG00000115073,2,2,1,0,1,1,82912.80518893801,190279.23963861223,2019-05-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,ACTR1B,0.032000005,0.67004,0.024899,2,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000115524,5,2,1,0,0,1,15866.724081734988,1122672.658801146,2014-07-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,12,SF3B1,0.9,9.8404,1.4534,3,-1.0,-1.0,mRNA Splicing - Minor Pathway;Gene expression (Transcription),R-HSA-72165;R-HSA-74160
ENSG00000115539,3,2,0,0,0,1,3466.7409637187616,334911.3573752668,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,3,PDCL3,-0.23399997,1.0346,1.2597,0,-1.0,-1.0,,
ENSG00000115592,2,2,0,0,0,1,275021.63051358337,1424218.0900670097,2023-01-18,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,PRKAG3,0.10500002,0.2822,0.49884,8,1.0,0.5,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;MTOR signalling,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-165159
ENSG00000116106,2,2,1,0,0,1,2340.854005693371,433862.5685735124,2015-09-22,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,3,EPHA4,0.74399996,4.0297,0.83613,4,0.5,0.0,Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-1266738;R-HSA-3928665
ENSG00000116138,3,2,1,0,0,1,33020.37419502054,152074.501796497,2024-04-26,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,DNAJC16,0.06699997,1.4844,1.3885,0,-1.0,-1.0,,
ENSG00000116824,2,2,0,0,0,1,28923.750134754748,124837.11004999638,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,4,CD2,-0.143,0.27214,-0.18944,1,1.0,0.0,,
ENSG00000117036,2,2,0,0,0,1,50072.877304794354,521818.7070055739,2020-12-03,5,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,ETV3,0.553,2.8658,0.94292,0,-1.0,-1.0,,
ENSG00000118292,2,2,1,0,0,1,145011.35140303092,205433.03502595585,2020-04-15,0,0,0,0,0,0,0,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,C1orf54,-0.31599998,0.17742,-0.21298,0,-1.0,-1.0,,
ENSG00000118960,2,2,0,0,1,1,3602.2757558061817,78398.053695655,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,HS1BP3,-0.21200001,0.44928,0.94928,0,-1.0,-1.0,,
ENSG00000119523,2,2,0,0,0,0,33224.221295945434,166624.24147696298,2023-01-18,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,ALG2,-0.408,-0.93806,-1.2975,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000119596,2,2,0,0,0,1,405722.3511294316,409691.21276290494,2021-06-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,YLPM1,0.445,0.88473,-0.68927,0,-1.0,-1.0,,
ENSG00000119900,2,2,0,0,0,1,383158.3001114715,521818.7070055739,2023-01-18,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,OGFRL1,-0.306,0.12788,-0.5927,0,-1.0,-1.0,,
ENSG00000120306,4,2,1,0,0,1,95776.89591443514,1122672.658801146,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,CYSTM1,0.343,1.025,0.73822,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000120318,2,2,1,0,1,1,180344.38517486732,382631.1172224132,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,2,ARAP3,0.402,2.5014,0.54613,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000120833,2,2,1,0,0,1,205425.60717824215,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,SOCS2,0.092999995,0.17793,-0.21729,4,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-597592
ENSG00000120868,8,2,0,0,0,1,49367.473680139236,633132.2332759313,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,3,APAF1,0.33600003,2.2791,0.84309,8,0.5,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000121542,2,2,1,0,0,1,308753.52852769714,308753.52852769714,2022-06-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,SEC22A,0.265,0.10212,0.44539,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000121753,2,2,1,0,0,0,107949.90929360976,405722.3511294316,2021-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,ADGRB2,0.617,3.8435,-0.040472,0,1.0,0.0,,
ENSG00000121797,2,2,0,0,1,1,4374.072533507439,87248.80974040499,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,3,CCRL2,-0.939,-0.37356,-0.22806,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000122254,2,2,0,0,0,1,86834.45368293284,195666.44200393453,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,HS3ST2,0.04100001,1.4976,-0.71497,1,0.75,0.0,HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-2022928;R-HSA-1638091
ENSG00000122376,3,2,1,0,1,1,3019.871771386701,384314.83364002535,2020-04-01,0,0,0,0,0,0,0,0,0,0,0,6,14,0,0,0,0,0,0,0,0,0,0,20,SHLD2,0.33999997,2.6526,1.9838,0,-1.0,-1.0,,
ENSG00000122515,3,2,1,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,ZMIZ2,0.602,2.2493,0.97166,0,-1.0,-1.0,,
ENSG00000123178,2,2,1,0,0,1,466632.7979326389,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,SPRYD7,-0.021999955,0.53936,0.058262,0,-1.0,-1.0,,
ENSG00000123411,2,2,1,0,0,1,1505.218309859155,125132.86186732909,2008-01-15,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,3,IKZF4,0.60800004,3.0512,0.2048,0,-1.0,-1.0,,
ENSG00000124191,3,2,1,0,0,1,21479.205904930615,124801.11117486731,2018-02-17,4,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,TOX2,0.495,0.73733,-0.045812,0,0.5,-1.0,,
ENSG00000124780,3,2,1,0,1,1,135095.86576106868,1424218.0900670097,2020-05-06,0,0,0,0,0,6,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,8,KCNK17,-0.57299995,-0.54633,-0.21436,2,0.5,0.0,,
ENSG00000124795,2,2,1,0,0,1,281079.0730593847,281079.0730593847,2023-01-18,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,DEK,0.232,0.42422,-0.64912,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-8864260
ENSG00000125848,4,2,0,0,0,1,86334.97261459603,95776.89591443514,2020-11-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,FLRT3,0.41500002,2.5191,0.84653,2,0.5,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000126091,3,2,0,0,0,1,42862.82950677874,95776.89591443514,2021-01-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,4,ST3GAL3,0.427,2.6189,0.64225,10,0.5,-1.0,Signal Transduction;Defective ST3GAL3 causes MCT12 and EIEE15;Translation of Structural Proteins_9683701;Disease;Post-translational protein modification,R-HSA-162582;R-HSA-3656243;R-HSA-9683701;R-HSA-1643685;R-HSA-597592
ENSG00000126460,2,2,1,0,1,0,72098.8014618248,183579.49764748462,2021-09-30,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PRRG2,-0.29400003,-1.0001,-0.5421,0,0.5,0.0,,
ENSG00000126603,4,2,0,0,0,1,47408.95172709719,203090.6413944402,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,GLIS2,0.36299998,0.10964,-1.906,0,-1.0,0.0,,
ENSG00000127412,3,2,0,0,1,1,21836.040905626443,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,TRPV5,-0.0069999695,0.54849,-0.44019,1,0.75,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000128713,2,2,1,0,0,1,521818.7070055739,672632.4785173276,2021-04-22,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HOXD11,-0.42499995,-2.8035,-3.0149,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000129422,3,2,1,1,0,1,138626.81357188412,414433.58532016096,2020-05-06,0,0,0,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,MTUS1,-0.021999955,-5.7375,-3.4979,0,-1.0,0.0,,
ENSG00000129911,2,2,1,0,0,1,118061.55082048493,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,KLF16,-0.928,-2.0943,-3.4858,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000130158,2,2,0,0,0,0,48439.20423385324,52982.28647069224,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,DOCK6,0.13,0.83921,-0.10754,3,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000130167,2,2,0,0,0,1,65794.6850968381,106307.15058733243,2017-10-23,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TSPAN16,-0.17799997,0.81071,0.29248,0,1.0,0.5,,
ENSG00000130193,2,2,1,0,0,1,5916.696696380832,30182.28889075047,2021-09-30,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,THEM6,-0.94799995,-3.2758,-3.5022,0,-1.0,-1.0,,
ENSG00000130487,3,2,0,0,1,1,157962.97296027775,551389.5206213495,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,1,10,KLHDC7B,-0.949,-2.4403,-3.1333,0,0.5,0.5,,
ENSG00000130701,3,2,1,0,0,1,76460.46239913636,521818.7070055739,2021-01-04,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,RBBP8NL,-0.52,-2.1221,-2.8215,0,0.5,0.0,,
ENSG00000130724,3,2,1,0,0,0,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,CHMP2A,0.49199998,0.15314,-0.586,10,-1.0,-1.0,Disease;Late endosomal microautophagy;Translation of Replicase and Assembly of the Replication Transcription Complex_9679504;Sealing of the nuclear envelope (NE) by ESCRT-III;Translation of Replicase and Assembly of the Replication Transcription Complex_9694676;HIV Life Cycle;Late Phase of HIV Life Cycle;HCMV Late Events;Lysosome Vesicle Biogenesis,R-HSA-1643685;R-HSA-9615710;R-HSA-9679504;R-HSA-9668328;R-HSA-9694676;R-HSA-162587;R-HSA-162599;R-HSA-9610379;R-HSA-432720
ENSG00000130829,3,2,1,0,0,1,3711.688577586207,384314.83364002535,2010-06-27,0,0,0,0,0,14,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,16,DUSP9,,,,3,0.75,0.5,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000130856,2,2,1,0,0,1,406587.2658730814,1424218.0900670097,2020-06-15,2,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,ZNF236,0.673,4.9431,0.86981,0,-1.0,-1.0,,
ENSG00000131409,2,2,0,0,1,1,85474.33432267047,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,3,LRRC4B,-0.505,2.354,-1.0973,1,0.5,0.0,Receptor-type tyrosine-protein phosphatases,R-HSA-388844
ENSG00000131748,3,2,1,0,1,1,32555.310754135273,38054.41297287997,2023-01-18,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,STARD3,0.18800002,0.84142,0.65888,1,-1.0,-1.0,Pregnenolone biosynthesis;Metabolism of steroids,R-HSA-196108;R-HSA-8957322
ENSG00000132436,3,2,0,0,1,1,38054.41297287997,115954.67083953728,2024-04-15,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,FIGNL1,0.385,0.84812,-0.044739,2,-1.0,-1.0,,
ENSG00000132554,7,2,1,0,0,1,10352.610157160763,367949.31877243903,2014-01-08,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,26,RGS22,-0.014000058,1.0587,0.81519,1,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000132698,2,2,1,0,0,1,14775.77846934071,645988.1975077938,2011-02-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,RAB25,-0.25300002,0.93481,0.70266,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000132819,2,2,0,0,0,0,143284.77790855977,672632.4785173276,2021-04-22,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,RBM38,0.13200003,-0.37583,-0.70376,0,0.5,-1.0,,
ENSG00000132906,2,2,1,1,0,1,23193.038917495975,384314.83364002535,2022-10-12,2,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,6,CASP9,0.0059999824,-0.75831,-0.058003,9,-1.0,-1.0,Signal Transduction;Immune System;Disease;Cytochrome c-mediated apoptotic response;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-111461;R-HSA-5663202
ENSG00000133216,3,2,0,0,0,1,59060.02777333318,112237.0074902361,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,3,6,EPHB2,0.735,4.124,1.2326,5,0.5,0.0,Ephrin signaling;Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-3928664;R-HSA-1266738;R-HSA-3928665
ENSG00000133401,3,2,0,0,0,1,141293.18354755783,414433.58532016096,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,PDZD2,0.533,3.1542,2.0304,0,0.5,0.0,,
ENSG00000133454,2,2,0,0,1,1,8798.945480071758,645988.1975077938,2018-07-30,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,11,MYO18B,0.08899999,0.092879,-0.86554,0,0.5,0.5,,
ENSG00000133574,2,2,0,0,0,1,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,GIMAP4,-0.204,0.36038,0.11946,0,0.5,-1.0,,
ENSG00000133878,3,2,1,0,0,1,131525.74533408263,323648.5577791949,2018-09-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,2,6,DUSP26,0.023000002,1.5818,0.24478,0,0.75,0.0,,
ENSG00000133983,2,2,1,0,0,1,232586.34864014547,464892.4593283075,2021-01-04,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,COX16,-0.37300003,0.00043046,-0.51346,1,-1.0,-1.0,Complex IV assembly,R-HSA-9864848
ENSG00000134086,3,2,1,0,0,1,33020.37419502054,112184.2204720767,2024-04-26,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,VHL,0.013000011,-1.1373,-2.0401,7,-1.0,-1.0,Signal Transduction;Immune System;SUMOylation of ubiquitinylation proteins;Disease;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-3232142;R-HSA-1643685;R-HSA-1234176;R-HSA-597592
ENSG00000134291,2,2,1,0,0,1,278190.43024910334,356440.71671986027,2023-08-23,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,TMEM106C,-0.15499997,0.79048,0.15814,0,-1.0,-1.0,,
ENSG00000134365,3,2,1,1,0,1,31971.308488731265,378712.0243337037,2024-07-19,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,7,CFHR4,-0.204,0.58343,-0.34267,1,1.0,1.0,Immune System,R-HSA-168256
ENSG00000134644,2,2,0,0,0,1,286678.73247515375,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,PUM1,0.835,5.5922,1.5883,1,-1.0,-1.0,,
ENSG00000134853,3,2,1,0,0,1,30837.791010519606,151416.12986435954,2018-02-05,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PDGFRA,0.736,3.4194,1.2464,13,0.5,-1.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000135048,2,2,1,1,1,1,75978.4105377159,129783.42151918238,2023-01-18,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CEMIP2,0.412,1.4422,0.79977,0,0.5,-1.0,,
ENSG00000135473,3,2,0,0,0,0,31137.07865241903,309256.4614031486,2020-12-29,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,6,PAN2,0.40600002,4.8474,2.461,1,-1.0,-1.0,Deadenylation of mRNA,R-HSA-429947
ENSG00000135535,2,2,1,1,0,1,20139.580688207345,183579.49764748462,2021-09-30,4,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,6,CD164,-0.232,-1.6333,-2.418,0,-1.0,-1.0,,
ENSG00000135643,2,2,1,0,0,1,58331.23271678036,1129585.974638378,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,KCNMB4,0.601,2.1783,0.18069,2,0.5,0.0,,
ENSG00000135744,2,2,1,0,1,1,252346.18526092035,500292.45069431677,2018-08-13,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,AGT,-0.20200002,0.41574,0.52225,5,1.0,0.0,Signal Transduction;Metabolism of Angiotensinogen to Angiotensins,R-HSA-162582;R-HSA-2022377
ENSG00000135931,2,2,1,0,0,1,182481.56964523086,205342.54344682425,2021-10-07,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,ARMC9,0.024999976,1.2468,1.0271,0,0.5,0.0,,
ENSG00000135999,2,2,0,0,0,1,116547.04276487474,146036.54470217813,2018-10-03,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,EPC2,0.797,2.4978,-0.18502,0,-1.0,-1.0,,
ENSG00000136144,2,2,1,0,1,1,323648.5577791949,328052.24452619,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,2,RCBTB1,0.24900001,1.587,0.87861,0,-1.0,-1.0,,
ENSG00000136352,3,2,0,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,NKX2-1,0.478,0.57315,-1.4118,0,0.75,0.5,,
ENSG00000136531,2,2,1,0,1,1,5382.953735491254,54892.674160393246,2014-10-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,SCN2A,0.839,8.7269,1.0759,3,1.0,0.5,Developmental Biology;Interaction between L1 and Ankyrins,R-HSA-1266738;R-HSA-445095
ENSG00000136830,2,2,1,0,0,1,151706.1907321582,521818.7070055739,2022-11-07,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,NIBAN2,0.43699998,1.5287,0.24038,0,0.5,-1.0,,
ENSG00000136938,3,2,1,0,0,1,27926.150856558426,399832.86333511875,2021-05-22,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,ANP32B,0.63600004,1.919,0.38434,0,-1.0,-1.0,,
ENSG00000137288,3,2,1,0,0,1,5250.794672586016,124837.11004999638,2015-09-15,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,5,UQCC2,-0.398,0.9089,0.53819,1,-1.0,-1.0,,
ENSG00000137561,3,2,0,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,TTPA,-0.27600002,-0.1108,-1.2038,1,1.0,0.5,,
ENSG00000137563,3,2,1,0,0,0,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,GGH,-0.48800004,-1.1315,-1.3053,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000137672,2,2,0,0,0,1,13132.241573569341,126388.59884645446,2023-01-18,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,TRPC6,0.292,1.9131,0.074749,4,0.5,0.0,Signal Transduction;Developmental Biology;Role of second messengers in netrin-1 signaling;Stimuli-sensing channels,R-HSA-162582;R-HSA-1266738;R-HSA-418890;R-HSA-2672351
ENSG00000137707,3,2,0,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,BTG4,-0.07200003,0.88369,0.24157,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000137709,4,2,1,0,1,1,108425.35980999071,431284.57934287674,2024-07-19,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,4,0,0,0,6,POU2F3,0.42299998,1.2654,1.2141,0,1.0,0.5,,
ENSG00000137714,4,2,1,0,0,1,32441.284146482223,394357.452283155,2020-05-29,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,12,FDX1,-0.29299998,-0.24788,-0.33264,6,1.0,-1.0,Disease;Pregnenolone biosynthesis;Metabolism of steroids;Post-translational protein modification,R-HSA-1643685;R-HSA-196108;R-HSA-8957322;R-HSA-597592
ENSG00000137767,2,2,0,0,0,1,286746.1002745869,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,SQOR,0.027999997,-0.032087,-0.46951,1,0.5,-1.0,,
ENSG00000137960,2,2,0,0,0,1,28863.30790298137,32254.717802479194,2012-11-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,GIPC2,-0.91700006,-1.4105,-1.608,0,0.5,0.0,,
ENSG00000138069,2,2,1,0,0,1,32996.93546153374,228220.5662976458,2018-07-30,0,0,0,0,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,RAB1A,0.689,2.796,-0.070985,6,-1.0,-1.0,Golgi-to-ER retrograde transport;Rab regulation of trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-9007101;R-HSA-6811434;R-HSA-597592
ENSG00000138135,3,2,0,0,0,1,24013.64248317128,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,3,0,0,0,4,CH25H,-0.029000044,0.63862,-0.45919,1,0.5,0.0,Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000138136,3,2,0,0,0,1,2340.854005693371,355284.1215006515,2011-10-23,3,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,11,LBX1,0.24699998,0.51755,-0.37828,0,1.0,0.5,,
ENSG00000138152,2,2,1,0,0,1,52982.28647069224,81805.8846123197,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,BTBD16,-0.24600005,0.076694,0.25435,0,0.5,0.5,,
ENSG00000138190,3,2,1,0,1,1,124531.34246675359,414433.58532016096,2020-05-06,0,0,0,3,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,EXOC6,0.21200001,0.37893,-0.40393,3,1.0,-1.0,VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620916;R-HSA-5620920
ENSG00000138375,2,2,1,0,0,1,78906.83616868555,112237.0074902361,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,3,SMARCAL1,0.20499998,1.7809,1.2961,0,-1.0,-1.0,,
ENSG00000138735,2,2,1,0,1,1,219793.50457789513,270267.2992956902,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,PDE5A,0.296,1.5493,1.1112,3,-1.0,-1.0,Signal Transduction;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9013422;R-HSA-9706574
ENSG00000139133,2,2,0,0,0,1,263416.51565448404,415452.66715166246,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,3,ALG10,0.09899998,1.1777,0.70363,1,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000139343,2,2,1,0,0,1,104168.97660865163,123127.18790121445,2019-02-25,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,2,SNRPF,-0.17400002,1.1835,0.35958,7,-1.0,-1.0,mRNA Splicing - Minor Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;snRNP Assembly;Metabolism of non-coding RNA,R-HSA-72165;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-191859;R-HSA-194441
ENSG00000139613,7,2,0,0,1,0,72982.48880358285,466632.7979326389,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,4,8,SMARCC2,0.833,4.8274,0.51757,8,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Formation of the non-canonical BAF (ncBAF) complex,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9933947
ENSG00000139974,2,2,0,0,0,1,28061.17463598858,406587.2658730814,2023-11-09,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SLC38A6,-0.553,-0.41439,0.22303,0,-1.0,-1.0,,
ENSG00000140105,2,2,1,1,0,0,182720.23308494932,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,WARS1,0.544,2.7923,0.97027,1,0.5,-1.0,tRNA Aminoacylation;Cytosolic tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-379716;R-HSA-72766
ENSG00000140367,2,2,1,0,0,1,25415.17921452856,71913.46219676935,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,3,UBE2Q2,-0.26100004,0.38706,0.16272,2,-1.0,-1.0,Immune System;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Protein ubiquitination;Post-translational protein modification,R-HSA-168256;R-HSA-8866652;R-HSA-8852135;R-HSA-597592
ENSG00000140374,3,2,1,0,1,1,7174.748443718747,17634.65533758174,2015-10-01,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,ETFA,-0.16600001,0.7966,-0.29524,1,0.5,-1.0,,
ENSG00000140470,2,2,0,0,1,1,46346.11759039019,187674.40497870417,2019-03-04,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,0,0,0,8,ADAMTS17,0.03399998,-1.5379,-3.4616,2,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000140600,2,2,0,0,0,1,3877.389556121125,75457.10036559975,2020-10-27,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,3,SH3GL3,-0.43400002,0.41898,-0.20503,6,0.5,0.5,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1643685;R-HSA-9006934
ENSG00000140750,2,2,1,0,0,1,286678.73247515375,645988.1975077938,2024-10-15,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,ARHGAP17,0.24699998,0.88842,0.18698,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000140829,4,2,1,0,0,1,122069.83349127392,410562.9666468075,2017-12-06,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,DHX38,0.24800003,2.3268,-0.023623,4,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm,R-HSA-73857;R-HSA-74160;R-HSA-159236;R-HSA-72202
ENSG00000141338,3,2,1,0,1,1,52982.28647069224,464892.4593283075,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,ABCA8,-0.085999966,0.53784,1.1437,1,-1.0,0.0,,
ENSG00000141434,2,2,0,0,0,1,464892.4593283075,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,MEP1B,-0.22300005,1.2288,0.86181,0,1.0,0.5,,
ENSG00000141448,2,2,0,0,0,1,130012.43105053755,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,GATA6,0.473,-1.0918,-2.6218,6,0.5,0.0,Developmental Biology;Surfactant metabolism;Formation of definitive endoderm,R-HSA-1266738;R-HSA-5683826;R-HSA-9823730
ENSG00000141527,5,2,1,0,1,0,74849.51324866469,152547.21264052036,2024-07-19,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,4,0,0,0,11,CARD14,-0.222,-0.25379,-1.5954,0,0.5,0.0,,
ENSG00000141560,2,2,1,0,0,1,141293.18354755783,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,FN3KRP,-0.40900004,-0.37318,0.012148,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000141568,2,2,1,0,0,1,190279.23963861223,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,FOXK2,0.27899998,-1.3391,-3.6655,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000142657,2,2,0,0,0,0,86578.02523657946,86578.02523657946,2023-01-18,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,PGD,0.448,2.1229,0.49375,2,0.5,-1.0,,
ENSG00000142789,3,2,0,0,0,1,19965.24128263536,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,CELA3A,-0.20899999,0.066399,-0.38421,0,1.0,0.0,,
ENSG00000142871,2,2,0,0,0,1,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,CCN1,0.491,0.71569,0.068163,2,-1.0,0.0,,
ENSG00000143194,2,2,1,0,0,1,376569.5597064443,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,MAEL,-0.059999943,0.66115,0.21423,1,1.0,0.5,Gene expression (Transcription);PIWI-interacting RNA (piRNA) biogenesis;Gene Silencing by RNA,R-HSA-74160;R-HSA-5601884;R-HSA-211000
ENSG00000143355,2,2,0,0,0,1,116388.33957200912,226155.40757232966,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,LHX9,0.589,1.2313,0.32966,1,1.0,0.5,Developmental Biology;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-9010553
ENSG00000143379,2,2,0,0,0,1,122069.83349127392,195005.6685718255,2017-12-06,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SETDB1,0.71000004,5.1021,1.354,3,-1.0,-1.0,Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex;Gene expression (Transcription);Regulation of endogenous retroelements by KRAB-ZFP proteins,R-HSA-9843970;R-HSA-74160;R-HSA-9843940
ENSG00000143418,5,2,1,0,1,1,42061.79578384488,367949.31877243903,2020-04-27,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,8,CERS2,0.499,2.3616,-0.25489,1,0.5,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000143420,2,2,1,0,0,1,220837.49604317299,239242.60169290405,2024-07-19,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ENSA,0.20999998,1.6723,-0.21743,1,-1.0,-1.0,MASTL Facilitates Mitotic Progression,R-HSA-2465910
ENSG00000144115,6,2,1,0,1,1,6021.72810122829,249965.96240703977,2018-05-08,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,19,THNSL2,-0.12199998,1.4055,0.32495,0,-1.0,0.0,,
ENSG00000144227,3,2,0,0,0,1,211520.9786068896,399832.86333511875,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,2,NXPH2,0.467,0.77504,-1.1867,0,0.75,0.5,,
ENSG00000144283,5,2,1,0,0,0,18226.911277750685,727796.3668420183,2017-11-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,10,PKP4,0.24800003,1.631,0.71446,5,1.0,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000145029,3,2,0,0,0,1,34004.8644513982,160010.51072069994,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,0,0,0,3,NICN1,-0.03400004,0.98577,0.4218,1,-1.0,-1.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000145439,6,2,1,0,0,1,87545.45580019058,394357.452283155,2016-05-16,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,6,CBR4,-0.791,-0.029768,0.20859,1,-1.0,-1.0,Fatty acyl-CoA biosynthesis,R-HSA-75105
ENSG00000145685,3,2,1,0,0,1,11608.613380386345,427337.4491868293,2021-11-04,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,6,LHFPL2,0.255,1.4575,-0.5722,1,-1.0,-1.0,,
ENSG00000145703,3,2,1,1,1,1,21168.40842438638,406587.2658730814,2020-04-20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,IQGAP2,-0.006000042,1.7742,0.30424,5,0.5,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000145715,2,2,0,0,0,1,283145.34784240765,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,RASA1,0.7,3.6029,-0.043004,5,0.5,-1.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000146147,2,2,0,0,1,1,464892.4593283075,756470.9740366563,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,MLIP,-0.100000024,-0.42997,-0.50039,0,0.75,0.0,,
ENSG00000146151,2,2,0,0,0,1,112237.0074902361,156470.480665571,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,HMGCLL1,-0.29400003,-0.11729,0.22683,1,0.5,0.0,,
ENSG00000146197,2,2,0,0,0,1,11252.882952659449,562534.7696387965,2021-02-03,0,0,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,4,SCUBE3,0.598,3.1941,1.6498,1,1.0,0.0,,
ENSG00000146950,5,2,1,0,0,1,2800.060653309738,232586.34864014547,2012-05-27,9,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,SHROOM2,,,,0,0.5,0.0,,
ENSG00000147041,5,2,0,0,0,1,12682.787696090549,168446.94284777794,2023-01-18,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,SYTL5,,,,0,0.5,0.0,,
ENSG00000147601,2,2,1,0,0,1,405722.3511294316,1778690.168860174,2021-06-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,3,TERF1,0.39999998,0.30631,-0.00083223,14,-1.0,-1.0,"Depyrimidination;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine;Base-Excision Repair, AP Site Formation;Inhibition of DNA recombination at telomere",R-HSA-73928;R-HSA-110328;R-HSA-110329;R-HSA-73929;R-HSA-9670095
ENSG00000147894,4,2,1,0,0,1,32757.691667591258,433862.5685735124,2016-07-25,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,7,C9orf72,0.010999978,0.15902,-0.24997,0,-1.0,-1.0,,
ENSG00000148444,2,2,0,0,0,1,6460.9680945243545,338763.57771536184,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,2,COMMD3,-0.32700002,-0.84283,-1.0994,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000148481,2,2,0,0,0,1,39350.931204693305,85257.29281961471,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,MINDY3,0.26599997,0.30428,-0.34228,0,-1.0,-1.0,,
ENSG00000148660,5,2,1,0,0,1,10519.047635337382,765591.3646788632,2015-05-05,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,0,15,CAMK2G,0.59599996,3.0314,0.54266,21,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000148719,2,2,1,0,0,1,89519.16315227402,143284.77790855977,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,DNAJB12,0.491,1.3639,1.1138,0,-1.0,-1.0,,
ENSG00000149308,3,2,1,0,0,1,20139.580688207345,137776.79053446153,2021-11-04,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,NPAT,0.526,0.27369,0.50817,0,-1.0,-1.0,,
ENSG00000149503,5,2,1,0,1,1,97257.17815683526,521818.7070055739,2016-07-17,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,INCENP,0.46100003,1.913,0.35148,7,0.5,-1.0,Signal Transduction;SUMOylation of DNA replication proteins;Post-translational protein modification,R-HSA-162582;R-HSA-4615885;R-HSA-597592
ENSG00000149596,3,2,1,0,0,1,62627.34914844415,645988.1975077938,2018-08-13,0,0,0,0,5,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,JPH2,-0.051,-0.84463,-2.3796,0,0.5,0.0,,
ENSG00000149633,3,2,1,0,1,1,87545.45580019058,645988.1975077938,2016-05-16,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,KIAA1755,0.046000004,-0.22262,0.13107,0,-1.0,0.0,,
ENSG00000149679,3,2,1,0,1,1,13085.90106375065,1778690.168860174,2014-04-15,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,CABLES2,0.0,0.9245,0.13559,1,0.5,-1.0,,
ENSG00000150667,2,2,0,0,1,1,19820.64677492791,155552.2805078301,2023-01-18,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FSIP1,-0.36600006,0.18648,0.64439,0,0.75,0.5,,
ENSG00000151917,2,2,0,0,0,0,10328.003557136504,10328.003557136504,2022-11-01,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,BEND6,-0.08500004,0.36572,-0.10228,0,1.0,0.0,,
ENSG00000152061,3,2,1,0,0,1,100711.28404230655,1470466.6505612188,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,RABGAP1L,0.41399997,1.6279,0.10556,0,0.5,-1.0,,
ENSG00000152404,2,2,1,0,0,1,9140.849127733147,252346.18526092035,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,CWF19L2,-0.034999967,-0.64025,-0.11135,1,-1.0,-1.0,,
ENSG00000153404,3,2,0,0,1,1,157962.97296027775,506796.91138105374,2021-12-01,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,6,PLEKHG4B,-0.14699996,-1.0309,-0.81266,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000153976,3,2,0,0,0,1,26561.371714038676,36494.548446257475,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,4,HS3ST3A1,-0.76600003,-1.4441,-2.0935,1,0.5,0.0,HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-2022928;R-HSA-1638091
ENSG00000154134,2,2,1,0,0,1,1594.2494117647059,96018.8961005241,2023-09-30,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ROBO3,0.251,-0.51601,-1.1303,3,0.5,0.0,Developmental Biology;Regulation of commissural axon pathfinding by SLIT and ROBO;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-428542;R-HSA-9010553
ENSG00000154146,8,2,1,0,0,1,8896.769754346884,633132.2332759313,2009-07-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,1,0,0,0,13,NRGN,-0.53900003,0.26095,-0.38546,1,1.0,0.0,,
ENSG00000154438,2,2,0,0,0,1,13268.357482017771,44271.67133520075,2016-08-12,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ASZ1,-0.30400002,-0.11683,0.053095,1,1.0,1.0,Gene expression (Transcription);Gene Silencing by RNA,R-HSA-74160;R-HSA-211000
ENSG00000154856,2,2,0,1,0,1,180089.50342935527,286678.73247515375,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,4,APCDD1,0.41399997,1.0002,0.90413,0,0.5,0.0,,
ENSG00000155287,6,2,0,0,0,1,13085.90106375065,197485.87952538437,2014-04-15,8,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,SLC25A28,0.42400002,3.6142,-0.62103,1,-1.0,-1.0,Mitochondrial iron-sulfur cluster biogenesis,R-HSA-1362409
ENSG00000155545,2,2,0,0,0,1,45372.42965956089,260210.21963428933,2023-01-18,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MIER3,0.75,2.4988,1.4259,0,-1.0,-1.0,,
ENSG00000155980,2,2,1,0,1,1,87380.83817331228,182720.23308494932,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,3,KIF5A,0.685,5.0359,1.901,5,1.0,0.0,Signal Transduction;Immune System;RHO GTPases activate KTN1;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-162582;R-HSA-168256;R-HSA-5625970;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000156265,8,2,1,0,0,1,21724.94108458234,756470.9740366563,2017-12-06,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,14,MAP3K7CL,-0.29900002,0.56133,0.11105,0,0.5,-1.0,,
ENSG00000156273,2,2,1,0,0,1,2628.763122476447,672632.4785173276,2011-12-11,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,BACH1,0.16399997,1.2466,0.31097,4,0.5,-1.0,,
ENSG00000156535,6,2,0,1,1,1,15013.867579594042,355284.1215006515,2021-09-30,8,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,CD109,-0.09200001,-0.00159,0.40772,2,1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000156920,4,2,0,0,1,1,163479.85522876077,260210.21963428933,2023-01-18,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ADGRG4,,,,0,0.5,0.5,,
ENSG00000157111,3,2,1,0,1,1,25415.17921452856,384314.83364002535,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,0,0,0,0,0,18,TMEM171,-0.22899997,0.028943,0.7405,0,0.75,0.5,,
ENSG00000157227,7,2,1,0,1,1,4899.965668950595,42193.37905314073,2017-09-07,3,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,12,MMP14,0.68799996,2.7231,0.049544,5,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000157368,3,2,1,1,1,1,42359.490817992155,259947.56530348706,2021-06-07,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,IL34,-0.311,-1.1898,-1.215,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000157388,4,2,0,0,0,1,30123.495451561474,756470.9740366563,2018-08-13,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,10,CACNA1D,0.747,6.624,1.3228,4,-1.0,0.0,"Developmental Biology;Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-1266738;R-HSA-400042
ENSG00000157637,2,2,1,0,1,1,31474.871572433167,118061.55082048493,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,2,SLC38A10,0.15899998,0.22624,-0.60531,0,-1.0,-1.0,,
ENSG00000158417,2,2,1,0,0,1,6441.646984732354,188264.63129042363,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,EIF5B,0.61800003,3.6127,0.27041,1,-1.0,-1.0,Translation,R-HSA-72766
ENSG00000158477,2,2,0,0,0,1,44660.84794838759,95905.57783546533,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,CD1A,-0.64400005,-0.54671,-0.054358,1,1.0,0.5,Immune System,R-HSA-168256
ENSG00000158497,3,2,0,0,0,1,260210.21963428933,1470466.6505612188,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,HMHB1,-0.918,-0.22235,0.26777,0,0.5,0.5,,
ENSG00000158528,2,2,0,0,0,1,15843.748592591368,15843.748592591368,2023-01-18,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PPP1R9A,0.495,2.046,2.0133,0,-1.0,0.0,,
ENSG00000159167,3,2,0,0,0,1,71913.46219676935,384314.83364002535,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,0,0,0,0,8,STC1,0.44199997,2.1005,0.68285,0,-1.0,0.0,,
ENSG00000159199,2,2,1,0,0,1,804063.9714459113,895916.2144062951,2023-12-08,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ATP5MC1,0.277,1.614,0.87495,3,0.5,-1.0,Formation of ATP by chemiosmotic coupling;Cristae formation,R-HSA-163210;R-HSA-8949613
ENSG00000159248,4,2,1,0,0,1,10353.132295719844,326545.22790564946,2019-12-09,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,15,GJD2,0.20300001,2.7783,-0.21891,2,0.5,0.5,Gap junction assembly;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-190861;R-HSA-157858;R-HSA-190828
ENSG00000159261,5,2,0,0,0,1,5772.395160382667,384314.83364002535,2009-06-28,0,0,0,0,0,0,0,0,0,0,0,27,5,0,0,0,0,0,0,0,0,0,0,32,CLDN14,-0.745,0.80695,0.96463,1,0.75,0.5,Tight junction interactions,R-HSA-420029
ENSG00000159592,2,2,0,0,0,1,195005.6685718255,396735.32121509424,2022-06-03,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,GPBP1L1,0.38099998,0.17273,-1.0441,0,-1.0,-1.0,,
ENSG00000160124,2,2,1,0,0,0,23180.53404670798,122549.0830919942,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,MIX23,-0.016000032,0.58578,0.026466,0,-1.0,-1.0,,
ENSG00000160183,2,2,0,0,1,1,396735.32121509424,551389.5206213495,2022-06-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,TMPRSS3,-0.10599995,0.23772,-0.17814,0,0.5,0.0,,
ENSG00000160714,2,2,0,0,0,1,26020.4828907398,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,UBE2Q1,0.78900003,3.9538,-1.111,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000160746,5,2,1,0,1,1,132101.59514050526,225895.43837715342,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,4,ANO10,-0.24000001,1.0031,0.44505,2,-1.0,-1.0,Disease;Stimuli-sensing channels,R-HSA-1643685;R-HSA-2672351
ENSG00000160789,3,2,1,0,0,1,203090.6413944402,521818.7070055739,2023-01-18,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,LMNA,0.588,3.1003,0.88116,8,-1.0,-1.0,Disease;Depolymerization of the Nuclear Lamina;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-4419969;R-HSA-5663202
ENSG00000160803,3,2,0,0,0,1,6306.411000302206,322220.1169395476,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,4,UBQLN4,0.686,4.4017,1.2276,0,-1.0,-1.0,,
ENSG00000160882,2,2,1,0,0,1,327412.48125652794,1990918.947961699,2022-11-21,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,CYP11B1,0.07700002,-0.26072,-0.65,3,1.0,0.5,Disease;Metabolism of steroids,R-HSA-1643685;R-HSA-8957322
ENSG00000161649,3,2,0,1,1,1,66438.21345734232,410562.9666468075,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,2,5,CD300LG,-0.23300004,0.51675,0.25463,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000162267,10,2,1,1,1,1,15866.724081734988,671426.4432757655,2013-08-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,0,0,2,0,0,0,16,ITIH3,-0.023000002,1.0323,0.77442,1,1.0,0.0,,
ENSG00000162402,4,2,1,0,0,1,6697.381489027931,221604.72575627107,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,0,4,USP24,0.639,4.1357,-0.81845,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000162551,6,2,1,0,1,1,9771.128629905248,183761.6081180644,2015-08-14,0,0,0,0,2,0,0,0,0,0,0,30,0,0,0,0,0,0,0,0,0,0,0,32,ALPL,0.013000011,1.9112,0.78155,1,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000162664,3,2,0,0,0,1,3182.5825880914163,1778690.168860174,2018-04-26,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,ZNF326,0.34899998,1.4345,1.3753,0,0.5,-1.0,,
ENSG00000162706,2,2,0,0,0,1,26020.4828907398,295550.4496098593,2020-04-15,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,3,CADM3,0.61899996,1.5651,-0.034458,2,1.0,0.0,Nectin/Necl  trans heterodimerization,R-HSA-420597
ENSG00000162944,4,2,0,0,0,1,190631.40295152203,229954.37886203246,2022-10-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,2,0,0,0,5,RFTN2,0.02700001,0.87535,0.46607,0,0.5,0.0,,
ENSG00000162949,2,2,0,0,0,1,1173.5007132667617,3647.3244633670392,2020-04-10,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CAPN13,-0.12100005,-0.3675,-0.67539,1,0.5,0.0,,
ENSG00000162971,3,2,1,0,0,1,15866.724081734988,545988.1005477115,2015-07-21,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,4,TYW5,-0.16499996,0.47242,0.86609,1,-1.0,0.0,,
ENSG00000163050,2,2,1,0,0,1,57530.63913504606,311608.0072964156,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,1,9,COQ8A,0.0009999871,-0.50193,-0.31296,1,0.75,0.0,,
ENSG00000163166,5,2,0,0,0,1,13764.1487425546,28293.79213117525,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,IWS1,0.626,1.6745,0.96072,3,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation,R-HSA-73857;R-HSA-74160;R-HSA-674695;R-HSA-112382;R-HSA-75955
ENSG00000163453,2,2,0,0,0,1,4824.132223654906,132781.32332824613,2018-03-21,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,IGFBP7,-0.81200004,-1.6341,-2.4098,3,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000163512,2,2,0,0,0,1,263416.51565448404,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,AZI2,0.315,0.49081,0.94592,0,-1.0,-1.0,,
ENSG00000163788,6,2,0,0,0,1,3141.278019404483,1778690.168860174,2019-10-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,1,8,SNRK,0.809,4.3055,0.14554,0,-1.0,-1.0,,
ENSG00000163808,2,2,1,0,1,1,22794.303125024984,1122672.658801146,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,2,KIF15,0.10900003,2.316,0.99495,3,0.75,0.5,Immune System;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-168256;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000163820,2,2,1,0,1,1,13712.097086212076,278739.419613982,2020-05-13,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,8,FYCO1,0.153,1.5115,2.5637,0,0.5,-1.0,,
ENSG00000164062,2,2,1,0,0,1,71117.27631467933,229954.37886203246,2023-12-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,3,APEH,0.13,1.1763,0.67109,2,-1.0,-1.0,Immune System;Translation,R-HSA-168256;R-HSA-72766
ENSG00000164136,2,2,0,0,0,1,215157.94798738702,225599.91693237546,2023-10-04,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,IL15,-0.73599994,-0.28171,-0.021431,1,-1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000164151,4,2,0,0,0,1,81243.5903011504,251325.91086204,2018-08-13,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,6,ICE1,0.571,0.35472,0.13511,1,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000164743,2,2,0,0,0,1,85501.24197763791,1424218.0900670097,2022-08-01,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,C8orf48,,-3.6694,-1.8951,0,0.5,0.0,,
ENSG00000165272,2,2,1,0,0,1,17601.10520641419,225599.91693237546,2023-05-17,0,3,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,AQP3,0.162,2.1441,0.39993,3,0.5,-1.0,Passive transport by Aquaporins,R-HSA-432047
ENSG00000165383,2,2,0,0,1,1,2240.9147424511543,83932.6290685273,2009-10-18,0,0,0,0,0,0,0,0,0,0,0,3,1,0,0,0,0,0,0,0,0,0,0,4,LRRC18,-0.50600004,-0.56551,-0.79497,0,0.75,0.5,,
ENSG00000165568,2,2,0,0,0,1,2762.5939615736506,5625.245517486242,2014-08-02,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,AKR1E2,-0.30200005,-0.18634,1.08,1,1.0,0.0,Glycogen metabolism,R-HSA-8982491
ENSG00000165731,2,2,1,1,0,1,656.3454061796604,251325.91086204,2016-10-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,4,RET,0.76,2.6933,1.1228,5,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000165757,7,2,1,0,1,1,2784.7655765920827,502231.5406594711,2010-11-18,0,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,21,JCAD,0.504,1.0741,0.60418,0,-1.0,0.0,,
ENSG00000165775,6,2,1,0,0,0,23958.629374193897,23958.629374193897,2016-02-09,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,FUNDC2,,,,0,0.5,-1.0,,
ENSG00000165806,2,2,1,1,1,1,57530.63913504606,278498.5074409075,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,7,CASP7,0.007000029,1.127,0.84857,6,-1.0,-1.0,Cytochrome c-mediated apoptotic response,R-HSA-111461
ENSG00000165929,3,2,1,0,0,1,49338.897692059916,135593.17169557852,2022-10-12,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,7,TC2N,-0.16499996,0.40763,-0.096801,0,0.5,0.0,,
ENSG00000166323,12,2,1,0,0,1,11101.688409289527,482893.2730520582,2017-10-23,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,18,C11orf65,-0.669,0.23182,0.73823,0,1.0,0.5,,
ENSG00000166387,3,2,1,0,0,1,31535.173607928213,521818.7070055739,2020-04-27,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,10,PPFIBP2,-0.11099994,-0.8244,0.15155,1,-1.0,-1.0,Receptor-type tyrosine-protein phosphatases,R-HSA-388844
ENSG00000166747,2,2,1,0,0,1,205739.47405036874,286678.73247515375,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,2,AP1G1,0.887,3.005,-0.30999,4,-1.0,-1.0,Immune System;Disease;Lysosome Vesicle Biogenesis,R-HSA-168256;R-HSA-1643685;R-HSA-432720
ENSG00000167083,3,2,1,0,0,1,110500.54208463429,382631.1172224132,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,3,GNGT2,-0.651,0.87,-0.096558,28,1.0,0.0,"Signal Transduction;Presynaptic function of Kainate receptors;ADP signalling through P2Y purinoceptor 12;Thromboxane signalling through TP receptor;G beta:gamma signalling through PLC beta;Prostacyclin signalling through prostacyclin receptor;G beta:gamma signalling through BTK;ADP signalling through P2Y purinoceptor 1;G beta:gamma signalling through PI3Kgamma;Signal amplification;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Disease;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Activation of kainate receptors upon glutamate binding;Adrenaline,noradrenaline inhibits insulin secretion;G-protein beta:gamma signalling;Inwardly rectifying K+ channels",R-HSA-162582;R-HSA-500657;R-HSA-392170;R-HSA-428930;R-HSA-418217;R-HSA-392851;R-HSA-8964315;R-HSA-418592;R-HSA-392451;R-HSA-392518;R-HSA-202040;R-HSA-6814122;R-HSA-1643685;R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-451326;R-HSA-400042;R-HSA-397795;R-HSA-1296065
ENSG00000167325,2,2,1,0,0,1,43068.92285742159,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,RRM1,0.758,5.0504,0.69917,1,-1.0,-1.0,Interconversion of nucleotide di- and triphosphates;Metabolism of nucleotides,R-HSA-499943;R-HSA-15869
ENSG00000167363,3,2,1,0,0,1,333656.03575930354,575147.0632428399,2024-07-19,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,3,FN3K,-0.503,-0.69169,-0.89557,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000167468,3,2,1,0,0,1,33224.221295945434,190279.23963861223,2019-06-07,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,GPX4,-0.385,-1.7155,-2.7785,7,-1.0,-1.0,Arachidonate metabolism,R-HSA-2142753
ENSG00000167578,3,2,1,0,0,0,100620.50186431198,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,4,RAB4B,0.157,1.0279,0.56607,3,0.5,-1.0,Signal Transduction;Immune System;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-9006934;R-HSA-597592
ENSG00000167771,8,2,0,0,0,1,633132.2332759313,633132.2332759313,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,RCOR2,0.46100003,1.5323,-0.26685,0,0.5,0.0,,
ENSG00000168385,2,2,1,0,0,1,189845.9324918578,189845.9324918578,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,SEPTIN2,0.014999986,1.9501,-0.75868,1,-1.0,-1.0,,
ENSG00000168575,2,2,1,0,0,1,101670.29565171694,286678.73247515375,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,SLC20A2,0.356,3.2904,0.57063,2,0.5,-1.0,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000168646,2,2,0,0,0,1,117707.74532698281,180089.50342935527,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,AXIN2,0.603,-0.012915,-1.5461,6,-1.0,0.0,Signal Transduction;Formation of the beta-catenin:TCF transactivating complex;Post-translational protein modification,R-HSA-162582;R-HSA-201722;R-HSA-597592
ENSG00000168785,2,2,0,0,0,1,9508.245308881369,26857.199410645524,2021-04-08,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,TSPAN5,0.579,2.8719,0.66229,1,0.5,0.0,,
ENSG00000168936,5,2,1,0,0,1,101603.42051482818,1990918.947961699,2022-11-21,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,2,8,TMEM129,-0.801,-1.4273,-2.2828,1,-1.0,-1.0,E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000168938,2,2,1,0,1,1,156470.480665571,197485.87952538437,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,PPIC,-0.35399997,0.044583,-0.35875,0,-1.0,0.0,,
ENSG00000169375,2,2,1,0,0,1,254373.32653042395,294763.3750742061,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,SIN3A,0.86,5.1667,0.50596,14,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;Signaling by Receptor Tyrosine Kinases;Regulation of MITF-M-dependent genes involved in cell cycle and proliferation;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-9006934;R-HSA-9825892;R-HSA-597592
ENSG00000169925,2,2,1,0,0,1,88771.02207231094,1424218.0900670097,2024-01-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,BRD3,0.604,2.7612,-0.69125,0,-1.0,-1.0,,
ENSG00000170004,3,2,1,0,0,1,23649.721229928127,220837.49604317299,2020-09-04,5,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,CHD3,0.74300003,8.4269,0.50691,10,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Regulation of endogenous retroelements by KRAB-ZFP proteins;Disease;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-427389;R-HSA-9843940;R-HSA-1643685;R-HSA-73762;R-HSA-73864;R-HSA-73854;R-HSA-597592
ENSG00000170178,2,2,0,0,0,1,116388.33957200912,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,HOXD12,-0.684,-2.1464,-1.0184,0,0.5,0.5,,
ENSG00000170522,2,2,0,0,0,1,39406.19595155135,645988.1975077938,2023-12-08,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,ELOVL6,0.572,4.1115,1.0398,2,0.5,0.0,Synthesis of very long-chain fatty acyl-CoAs;Fatty acyl-CoA biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-75876;R-HSA-75105;R-HSA-8957322;R-HSA-1655829
ENSG00000170561,3,2,0,0,0,1,11014.04703420302,396735.32121509424,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,3,IRX2,-0.30499995,-3.3066,-4.4587,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000170633,4,2,1,0,0,1,75632.36795352261,275021.63051358337,2023-01-18,0,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,RNF34,0.522,2.2794,1.376,2,-1.0,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000170634,2,2,1,0,0,1,25129.86299666951,306980.8575290048,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,ACYP2,-0.72800004,-0.40844,-0.57606,0,0.5,-1.0,,
ENSG00000170921,4,2,1,0,0,1,2201.7501988862373,1778690.168860174,2017-01-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,3,6,TANC2,0.83,3.7492,1.0484,0,0.5,-1.0,,
ENSG00000170956,2,2,1,0,0,1,31340.65440454944,161092.74087321138,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,CEACAM3,-0.35899997,0.65998,-0.20767,2,1.0,0.5,Immune System,R-HSA-168256
ENSG00000171804,3,2,0,0,1,1,72098.8014618248,718784.6890415357,2022-08-01,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,WDR87,0.22899997,3.7286,1.9379,0,1.0,1.0,,
ENSG00000172020,2,2,0,0,0,1,6375.838537521578,86431.73511208472,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,GAP43,0.64199996,0.48505,0.11115,1,1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000172059,2,2,1,0,0,1,286678.73247515375,645988.1975077938,2024-10-15,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,KLF11,-0.07000005,-0.95656,-1.5085,0,-1.0,-1.0,,
ENSG00000172155,3,2,0,0,0,1,47480.26423551067,87360.012040253,2021-04-08,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,LCE1D,-0.86899996,1.0832,0.090927,1,1.0,1.0,Developmental Biology,R-HSA-1266738
ENSG00000172354,2,2,1,0,0,0,32254.717802479194,174661.93770086087,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,3,GNB2,0.628,3.0831,-1.9687,29,-1.0,-1.0,"Signal Transduction;Presynaptic function of Kainate receptors;ADP signalling through P2Y purinoceptor 12;Thromboxane signalling through TP receptor;G beta:gamma signalling through PLC beta;Prostacyclin signalling through prostacyclin receptor;G beta:gamma signalling through BTK;ADP signalling through P2Y purinoceptor 1;G beta:gamma signalling through PI3Kgamma;Signal amplification;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Disease;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Activation of kainate receptors upon glutamate binding;Adrenaline,noradrenaline inhibits insulin secretion;G-protein beta:gamma signalling;Inwardly rectifying K+ channels",R-HSA-162582;R-HSA-500657;R-HSA-392170;R-HSA-428930;R-HSA-418217;R-HSA-392851;R-HSA-8964315;R-HSA-418592;R-HSA-392451;R-HSA-392518;R-HSA-202040;R-HSA-6814122;R-HSA-1643685;R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-451326;R-HSA-400042;R-HSA-397795;R-HSA-1296065
ENSG00000172613,2,2,1,0,0,0,189845.9324918578,189845.9324918578,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,RAD9A,0.134,0.166,-1.4266,7,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000172650,6,2,0,0,1,1,21724.94108458234,281079.0730593847,2023-01-18,0,0,0,0,5,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,AGAP5,0.283,5.3654,4.6578,0,-1.0,-1.0,,
ENSG00000173114,8,2,0,0,0,1,15866.724081734988,633132.2332759313,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,1,0,0,0,11,LRRN3,0.44099998,1.6488,0.18584,0,0.5,0.0,,
ENSG00000173163,2,2,0,0,0,1,49724.14538298504,237176.1991038335,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,2,COMMD1,-0.116000056,-0.60025,-0.060281,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000173226,2,2,1,0,1,1,36204.236233123425,83896.55822718568,2013-11-01,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,3,IQCB1,0.111,0.89199,1.2669,1,-1.0,-1.0,,
ENSG00000173769,2,2,0,0,0,1,405722.3511294316,1778690.168860174,2021-06-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,3,TOPAZ1,0.453,1.1365,0.19664,0,1.0,1.0,,
ENSG00000173801,3,2,1,0,1,1,105873.71696731678,196816.54442141854,2021-11-04,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,JUP,0.467,2.0603,1.2196,15,0.5,-1.0,Signal Transduction;Immune System;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-9006934
ENSG00000174080,4,2,1,1,0,1,49367.473680139236,191477.8325312717,2021-01-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,0,4,CTSF,-0.296,-0.64111,-0.85051,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000174718,2,2,0,0,1,1,17115.61307125707,258213.8601133611,2017-06-12,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RESF1,0.43,-1.425,-0.68558,0,0.5,-1.0,,
ENSG00000174842,2,2,0,0,0,0,86578.02523657946,86578.02523657946,2023-01-18,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,GLMN,-0.70500004,0.47029,0.87893,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000174851,2,2,1,0,0,1,205512.54339369212,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,YIF1A,-0.18599999,0.5815,-0.22341,1,-1.0,-1.0,,
ENSG00000174963,2,2,1,0,0,1,182720.23308494932,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,4,ZIC4,0.17299998,-0.52831,-0.45747,0,1.0,0.5,,
ENSG00000175215,3,2,0,0,0,1,104168.97660865163,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,3,CTDSP2,0.48900002,1.8425,0.27786,1,-1.0,-1.0,,
ENSG00000175334,2,2,1,0,0,0,189845.9324918578,189845.9324918578,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,BANF1,0.714,2.2912,-0.36918,8,-1.0,-1.0,Disease;Interactions of Vpr with host cellular proteins;Vpr-mediated nuclear import of PICs;HIV Life Cycle,R-HSA-1643685;R-HSA-176033;R-HSA-180910;R-HSA-162587
ENSG00000175787,3,2,1,0,0,1,228220.5662976458,765591.3646788632,2018-07-30,0,0,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,ZNF169,-0.502,0.79689,-0.026379,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000176182,3,2,0,0,0,1,79958.75176875875,301203.06999851385,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,4,MYPOP,-0.724,-1.8256,-3.2496,0,-1.0,-1.0,,
ENSG00000176422,2,2,1,0,0,1,1173.5007132667617,384314.83364002535,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,SPRYD4,-0.07700002,0.35082,0.66535,0,0.5,-1.0,,
ENSG00000176463,3,2,1,0,0,1,143413.24457139417,1778690.168860174,2022-07-14,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,5,SLCO3A1,0.362,1.7741,-1.7738,1,0.5,-1.0,"Transport of vitamins, nucleosides, and related molecules",R-HSA-425397
ENSG00000176547,3,2,0,0,0,1,11798.46653227782,358386.30063935445,2021-11-04,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,OR4C3,-0.905,-1.4321,-1.993,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000176658,2,2,1,0,0,1,31104.940443685748,63200.72664467542,2022-07-13,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,3,MYO1D,0.213,1.287,0.017884,0,0.5,-1.0,,
ENSG00000177570,3,2,0,0,0,1,58995.33218928629,105281.95721639719,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,SAMD12,-0.07700002,0.36747,0.44669,0,-1.0,0.0,,
ENSG00000177875,2,2,0,0,0,1,634722.4486407059,634722.4486407059,2022-10-12,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CCDC184,-0.79999995,-0.18681,0.42694,0,0.5,0.0,,
ENSG00000177888,4,2,1,0,0,1,13780.964387238024,378712.0243337037,2021-04-23,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,11,ZBTB41,0.42299998,3.3398,0.2294,0,-1.0,-1.0,,
ENSG00000177954,2,2,1,0,0,1,65127.395275883,358386.30063935445,2021-09-30,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,RPS27,0.48000002,1.6674,-1.0485,24,-1.0,-1.0,Signal Transduction;Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000177989,2,2,1,0,0,1,32704.444432364853,38092.548464040476,2019-08-13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,3,CIMAP1B,-0.521,-2.3842,-2.2976,0,0.5,0.0,,
ENSG00000178257,2,2,0,0,0,1,11635.351260982607,58331.23271678036,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,2,PRM3,-0.911,-1.4796,-2.1095,0,1.0,0.5,,
ENSG00000178802,2,2,1,1,0,0,17587.419683666812,1990918.947961699,2022-11-21,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,MPI,-0.03999996,0.59212,1.2281,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000178952,4,2,1,0,0,1,87248.80974040499,574170.6270919729,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,3,TUFM,0.297,2.129,0.70311,2,-1.0,-1.0,Disease;Translation;Mitochondrial translation elongation;Mitochondrial translation,R-HSA-1643685;R-HSA-72766;R-HSA-5389840;R-HSA-5368287
ENSG00000179583,4,2,1,0,0,1,4134.815431828146,160010.51072069994,2011-11-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,5,CIITA,0.27100003,-0.86816,-2.0337,1,0.5,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000179776,3,2,0,0,0,1,123747.82788719954,203090.6413944402,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,CDH5,0.339,1.7147,-0.0038933,3,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000180316,2,2,0,0,0,1,19008.705439555517,20751.495140412953,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,PNPLA1,0.055000007,0.68966,0.1223,0,1.0,0.5,,
ENSG00000180720,3,2,0,0,0,1,11798.46653227782,15866.724081734988,2017-05-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,2,CHRM4,0.602,3.7955,-0.063194,2,0.5,0.5,Signal Transduction;Amine ligand-binding receptors,R-HSA-162582;R-HSA-375280
ENSG00000180772,3,2,1,0,0,1,27325.171231406224,251325.91086204,2022-01-12,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,4,AGTR2,,,,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000180999,3,2,0,0,0,1,89312.40641133794,137776.79053446153,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,C1orf105,0.08499998,-0.22668,0.2574,0,0.5,0.5,,
ENSG00000181163,2,2,1,0,0,1,197775.78125685986,219437.49527928562,2022-10-20,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,2,NPM1,0.68700004,1.4023,-1.1917,10,-1.0,-1.0,Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-177243;R-HSA-180746;R-HSA-1643685;R-HSA-5663202;R-HSA-597592;R-HSA-8864260
ENSG00000181284,3,2,0,0,1,1,127123.38472704956,137776.79053446153,2021-09-30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,TMEM102,-0.57299995,-0.17855,0.22047,0,-1.0,0.0,,
ENSG00000181555,3,2,1,0,0,1,50641.99826116222,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,SETD2,0.824,4.1571,1.7239,1,-1.0,-1.0,,
ENSG00000181610,2,2,0,0,0,1,32705.240805002948,286678.73247515375,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,MRPS23,-0.116999984,0.084179,-1.1298,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000181781,2,2,1,0,0,1,162367.55694122918,220320.9576294899,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,CIMAP1D,-0.941,-1.2781,-1.7008,0,0.75,0.5,,
ENSG00000181830,2,2,1,0,0,1,94665.79117035728,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,SLC35C1,0.33600003,0.848,-0.05033,3,0.5,-1.0,"Disease;Transport of vitamins, nucleosides, and related molecules;Post-translational protein modification",R-HSA-1643685;R-HSA-425397;R-HSA-597592
ENSG00000182103,3,2,0,0,0,1,18475.74586768385,1129585.974638378,2017-03-27,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,FAM181B,-0.85099995,-4.3249,-3.6648,0,1.0,0.5,,
ENSG00000182264,3,2,1,0,0,1,35269.470595523715,208059.85546229704,2021-09-30,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,IZUMO1,-0.34000003,1.5154,1.2605,1,1.0,0.5,Fertilization,R-HSA-1187000
ENSG00000182518,2,2,0,0,0,1,383158.3001114715,500292.45069431677,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,VCF2,,,,0,-1.0,-1.0,,
ENSG00000182831,3,2,1,0,0,1,86334.97261459603,1778690.168860174,2020-11-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,0,0,0,5,HAPSTR1,0.536,1.1192,-3.0189,0,0.5,-1.0,,
ENSG00000183304,3,2,0,0,0,1,129783.42151918238,182108.85640724926,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,FAM9A,,,,0,1.0,1.0,,
ENSG00000183395,5,2,0,0,0,1,28783.576939547238,521818.7070055739,2023-01-18,3,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,PMCH,0.014999986,0.62328,-0.49169,3,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000183463,3,2,1,0,1,1,45589.72605179723,196816.54442141854,2021-02-19,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,6,URAD,-0.91700006,-1.365,-1.583,0,1.0,0.5,,
ENSG00000183578,3,2,0,0,0,1,7794.273577144567,598869.4096893278,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,3,TNFAIP8L3,-0.23699999,0.86193,0.32184,1,0.5,0.0,,
ENSG00000183778,2,2,1,0,0,1,156924.83779214323,384314.83364002535,2024-08-05,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,B3GALT5,-0.86800003,1.1734,-0.14715,1,1.0,0.0,,
ENSG00000183813,3,2,0,0,0,1,38092.548464040476,70162.45524671457,2019-03-28,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,0,3,CCR4,0.19099998,1.2285,-1.2766,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000184012,3,2,1,0,1,1,29919.773016359526,521818.7070055739,2020-09-04,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,TMPRSS2,0.009000003,-0.02404,0.25277,3,0.5,0.0,Disease,R-HSA-1643685
ENSG00000184155,2,2,0,0,0,1,26020.4828907398,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,OR10J5,-0.95500004,0.053457,-1.1645,2,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000184156,2,2,0,0,0,1,58995.33218928629,1778690.168860174,2022-07-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,KCNQ3,0.542,2.3645,0.38284,2,1.0,0.5,Developmental Biology;Interaction between L1 and Ankyrins,R-HSA-1266738;R-HSA-445095
ENSG00000184185,2,2,1,0,0,1,72982.48880358285,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,KCNJ12,0.63100004,4.2814,1.2917,4,0.75,0.0,Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Inwardly rectifying K+ channels,R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-1296065
ENSG00000184347,2,2,0,0,0,1,16461.04650907092,645988.1975077938,2015-01-08,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,SLIT3,0.524,2.49,-0.22764,3,-1.0,0.0,Developmental Biology;Regulation of commissural axon pathfinding by SLIT and ROBO,R-HSA-1266738;R-HSA-428542
ENSG00000184471,2,2,1,0,0,1,183427.12489668437,183427.12489668437,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,C1QTNF8,-0.924,-3.5348,-2.9194,0,0.5,0.5,,
ENSG00000184995,4,2,0,0,0,1,57306.824110263355,269829.0934099178,2018-08-13,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,1,0,0,0,9,IFNE,-0.89100003,-0.703,-0.047802,0,0.5,0.5,,
ENSG00000185122,2,2,1,0,0,1,31120.920520971555,765591.3646788632,2018-10-08,0,0,0,0,0,5,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,7,HSF1,0.116,-0.37989,-2.7557,6,-1.0,-1.0,Aggrephagy,R-HSA-9646399
ENSG00000185274,3,2,0,0,0,1,1173.5007132667617,1778690.168860174,2022-07-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,GALNT17,0.39,2.8667,0.69998,1,0.5,0.0,,
ENSG00000185565,3,2,0,0,0,1,11181.989763105319,1778690.168860174,2022-07-14,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,4,LSAMP,0.66400003,2.236,0.8862,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000185662,2,2,0,0,0,1,116388.33957200912,356440.71671986027,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,4,SMIM23,-0.24000001,0.45095,0.30876,0,1.0,1.0,,
ENSG00000185917,2,2,1,0,1,1,75639.5973879004,360605.992793193,2022-02-03,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,SETD4,0.0059999824,1.015,0.82909,0,-1.0,-1.0,,
ENSG00000185933,2,2,0,0,0,0,78894.16685939343,327782.2658449885,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,CALHM1,-0.29299998,0.95572,0.41909,2,0.5,1.0,,
ENSG00000186073,5,2,1,0,0,1,286746.1002745869,1778690.168860174,2019-11-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,6,CDIN1,0.069000006,0.49871,0.12417,0,0.75,0.0,,
ENSG00000186583,2,2,0,0,0,0,34004.8644513982,340825.7076940272,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,4,SPATC1,-0.28199995,0.26673,-0.13785,0,1.0,0.5,,
ENSG00000186895,2,2,0,0,0,1,2560.851236868858,20209.09625085965,2016-02-08,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,FGF3,-0.81500006,-1.951,-1.9097,21,1.0,1.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000186951,4,2,0,0,0,1,144744.15797648102,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,PPARA,0.28899997,2.5308,0.42093,13,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-8957322;R-HSA-1655829;R-HSA-597592
ENSG00000187003,3,2,0,0,0,0,7794.273577144567,180089.50342935527,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,3,ACTL7A,-0.18200004,0.52133,-0.14403,0,1.0,1.0,,
ENSG00000187068,2,2,0,0,0,1,18419.5411898693,1424218.0900670097,2016-05-24,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,C3orf70,-0.26699996,-0.35444,-1.6293,0,0.5,0.0,,
ENSG00000187164,3,2,1,0,0,1,2033.7777777777778,161053.42428938235,2015-03-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,SHTN1,0.38099998,0.76286,0.5415,1,1.0,0.0,Developmental Biology;Recycling pathway of L1,R-HSA-1266738;R-HSA-437239
ENSG00000187510,3,2,0,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,PLEKHG7,-0.17999995,0.2936,0.016492,0,0.5,0.5,,
ENSG00000188338,4,2,1,0,0,1,144744.15797648102,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,SLC38A3,0.56700003,2.9003,0.94361,1,0.75,0.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000188352,2,2,0,0,1,1,155552.2805078301,1424218.0900670097,2020-06-15,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,FOCAD,0.041999996,-3.3503,-1.5486,0,0.5,-1.0,,
ENSG00000188501,3,2,0,0,0,1,51573.04760983911,521818.7070055739,2023-01-18,2,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,LCTL,-0.14600003,0.69763,0.31409,0,1.0,1.0,,
ENSG00000188624,2,2,0,0,0,1,94458.73018015742,101032.95487940393,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,IGFL3,-0.15900004,0.15319,0.56214,0,1.0,0.5,,
ENSG00000189299,2,2,1,0,0,1,195005.6685718255,294387.2978738704,2021-09-30,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,FOXR2,,,,0,1.0,1.0,,
ENSG00000196184,2,2,0,0,0,1,26020.4828907398,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,OR10J1,-0.939,-1.4345,-2.1894,1,1.0,1.0,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000196335,3,2,0,0,0,1,260210.21963428933,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,STK31,0.22100002,0.49458,-1.1042,0,1.0,0.5,,
ENSG00000196466,2,2,0,0,1,1,205425.60717824215,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,ZNF799,-0.052000046,0.48537,1.165,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000196549,2,2,0,0,0,1,427337.4491868293,500292.45069431677,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,MME,0.069000006,1.2436,0.59626,3,0.5,0.0,Immune System;Metabolism of Angiotensinogen to Angiotensins,R-HSA-168256;R-HSA-2022377
ENSG00000196914,3,2,1,0,1,1,18584.262095180744,414433.58532016096,2018-06-11,0,0,0,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,ARHGEF12,0.63100004,4.127,1.5803,7,-1.0,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000197852,2,2,0,0,0,1,437137.9986908925,482893.2730520582,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,INKA2,0.069000006,0.20977,0.24238,0,-1.0,0.0,,
ENSG00000197891,3,2,0,0,1,1,13668.611881626193,574170.6270919729,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,0,40,0,0,0,0,0,2,0,0,0,0,42,SLC22A12,-0.411,0.62845,-0.49144,2,1.0,1.0,Disease,R-HSA-1643685
ENSG00000197912,6,2,1,0,0,1,98271.38571086437,224333.96758339784,2020-04-27,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,8,SPG7,-0.54700005,-1.4984,-2.0036,2,-1.0,-1.0,Mitochondrial calcium ion transport,R-HSA-8949215
ENSG00000198276,2,2,0,0,0,1,205739.47405036874,207220.14223281175,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,UCKL1,-0.40499997,0.6349,-2.9947,1,-1.0,-1.0,Nucleotide salvage;Metabolism of nucleotides,R-HSA-8956321;R-HSA-15869
ENSG00000198576,5,2,1,0,0,1,3979.099342105263,196816.54442141854,2021-09-30,3,0,0,0,0,0,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,ARC,-0.393,0.32399,-1.6726,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000198626,2,2,0,0,0,1,25967.06754524981,270756.050710225,2023-08-31,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,RYR2,0.576,6.4389,-0.17198,2,1.0,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000198732,4,2,1,1,0,1,16534.94713490521,203570.3035915171,2021-10-04,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,10,SMOC1,0.39999998,1.0146,0.87648,0,0.5,0.0,,
ENSG00000198739,3,2,0,0,0,1,5344.438356164384,275021.63051358337,2016-10-20,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,LRRTM3,0.27899998,2.1299,0.65907,1,0.5,0.5,,
ENSG00000198788,3,2,0,0,0,1,3721.3983572895277,97623.65810915266,2013-04-14,2,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,4,MUC2,0.16900003,0.028424,-2.1216,0,1.0,0.5,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000198796,3,2,1,0,0,1,28635.19181934661,155496.87140784386,2021-08-24,0,0,0,0,0,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ALPK2,0.13800001,2.5584,0.9354,0,0.75,0.5,,
ENSG00000198934,2,2,0,0,0,1,26561.371714038676,26561.371714038676,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,MAGEE1,,,,0,1.0,0.0,,
ENSG00000204671,7,2,0,0,0,1,4949.809465233867,315325.55297640257,2023-01-18,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,2,9,IL31,-0.70500004,1.3147,0.24349,1,,,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000204983,4,2,0,0,0,1,2351.3270306772138,72874.86198192068,2012-11-11,0,0,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,PRSS1,-0.301,-1.5604,-1.0039,3,1.0,0.0,,
ENSG00000205089,2,2,1,0,1,1,15223.454539395489,91172.20051337926,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,3,CCNI2,-0.45099998,-0.89225,-2.1079,0,0.5,0.5,,
ENSG00000205336,2,2,1,1,0,1,13490.640854493924,521818.7070055739,2021-01-04,8,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,ADGRG1,0.12900001,1.4013,0.036295,0,0.5,-1.0,,
ENSG00000205359,3,2,0,0,0,1,31519.426313660828,1424218.0900670097,2013-08-25,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,SLCO6A1,-0.12800002,0.26334,-0.20401,0,1.0,1.0,,
ENSG00000205978,2,2,1,0,1,1,254373.32653042395,1424218.0900670097,2020-05-06,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,NYNRIN,0.30400002,1.9326,0.24891,0,-1.0,0.0,,
ENSG00000206557,3,2,0,0,0,1,107949.90929360976,414433.58532016096,2023-01-18,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,TRIM71,0.725,1.8668,-2.9179,1,1.0,1.0,Immune System,R-HSA-168256
ENSG00000211445,3,2,1,0,1,1,65215.33040479902,220320.9576294899,2020-10-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,5,GPX3,-0.44000006,0.38436,0.38043,1,0.5,-1.0,,
ENSG00000213413,3,2,1,0,1,1,124837.11004999638,307158.2364521972,2022-10-12,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,3,PVRIG,-0.25399995,-0.37608,-1.0333,0,1.0,0.5,,
ENSG00000213445,3,2,1,0,1,1,87627.83156192786,895916.2144062951,2020-10-05,0,0,0,0,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,SIPA1,0.06400001,-1.0743,-2.7941,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000219438,2,2,0,0,0,1,2628.763122476447,25967.06754524981,2011-12-11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,TAFA5,0.18,0.36197,-1.6453,0,1.0,0.0,,
ENSG00000227124,2,2,1,0,0,1,156470.480665571,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,ZNF717,-0.45000005,-2.3545,-2.0094,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000227268,2,2,0,0,0,0,135095.86576106868,358386.30063935445,2021-09-30,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,KLLN,-0.76199996,-2.3235,-2.1653,0,0.5,0.5,,
ENSG00000236334,2,2,0,0,0,1,42879.69557188197,116566.20935579021,2023-01-18,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,PPIAL4G,-0.66700006,0.41866,0.84439,0,0.5,0.5,,
ENSG00000237289,2,2,1,0,0,1,136665.8227530756,1424218.0900670097,2020-06-15,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CKMT1B,0.19999999,1.4415,1.8161,1,0.5,0.0,,
ENSG00000237763,2,2,0,1,0,0,258456.3496858129,258456.3496858129,2019-06-24,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,AMY1A,-0.903,0.97134,1.031,1,1.0,0.5,Digestion and absorption;Digestion,R-HSA-8963743;R-HSA-8935690
ENSG00000243477,3,2,0,1,0,0,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,NAA80,-0.123000026,0.087757,0.26731,0,0.5,-1.0,,
ENSG00000243978,3,2,1,0,0,0,155978.81883421048,269602.2657190595,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,0,0,0,3,RTL9,,,,0,1.0,0.5,,
ENSG00000244067,2,2,1,0,1,1,20307.85640079949,1424218.0900670097,2021-12-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,GSTA2,-0.635,-0.92109,-1.8955,3,0.75,0.5,Cytokine Signaling in Immune system;Immune System;Glutathione conjugation;Azathioprine ADME;Signaling by Interleukins;Phase II - Conjugation of compounds,R-HSA-1280215;R-HSA-168256;R-HSA-156590;R-HSA-9748787;R-HSA-449147;R-HSA-156580
ENSG00000251545,2,2,0,0,0,1,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,ENSG00000251545,,,,0,,,,
ENSG00000256235,2,2,1,0,0,1,16707.987957550526,38683.85723426901,2024-07-19,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,SMIM3,-0.94500005,0.02261,0.24447,0,0.5,-1.0,,
ENSG00000257727,2,2,1,0,0,0,77781.5808168603,718784.6890415357,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,CNPY2,-0.039000034,0.75635,0.48209,0,-1.0,-1.0,,
ENSG00000258597,2,2,0,0,0,1,21491.41203013235,81592.0104673446,2024-07-19,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,SERPINA2,,,,0,1.0,1.0,,
ENSG00000263639,5,2,1,1,0,1,2803.232542372881,521818.7070055739,2008-02-10,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,36,MSMB,-0.597,0.55162,0.36309,0,1.0,0.0,,
ENSG00000265107,4,2,1,0,0,1,125894.9248389576,545988.1005477115,2018-06-11,0,0,0,0,12,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,GJA5,0.23500001,1.5618,-0.045604,1,0.5,0.0,Gap junction assembly;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-190861;R-HSA-157858;R-HSA-190828
ENSG00000277893,2,2,0,0,0,1,180089.50342935527,384314.83364002535,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,3,SRD5A2,-0.717,-0.88175,-0.87398,1,0.75,0.5,Metabolism of steroids,R-HSA-8957322
ENSG00000278259,2,2,1,0,1,1,230316.30849350386,1424218.0900670097,2019-05-31,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,MYO19,-0.23599994,0.062998,-1.3392,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000003056,2,2,1,0,0,1,18665.604164523163,574782.4268116049,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,M6PR,0.15899998,1.1733,0.93156,5,-1.0,-1.0,Lysosome Vesicle Biogenesis,R-HSA-432720
ENSG00000003393,2,2,0,0,1,1,281079.0730593847,281079.0730593847,2023-01-18,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,ALS2,0.351,2.9747,1.0096,2,1.0,-1.0,Signal Transduction;Rab regulation of trafficking,R-HSA-162582;R-HSA-9007101
ENSG00000003400,3,2,1,0,1,1,16328.889997166336,278190.43024910334,2019-08-13,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,CASP10,-0.046000004,0.61351,0.72154,4,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000004848,4,2,0,0,0,1,205425.60717824215,466632.7979326389,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,5,ARX,,,,0,0.75,0.5,,
ENSG00000004897,3,2,0,0,0,1,2314.313784461153,383158.3001114715,2022-11-09,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,CDC27,0.62,1.4195,0.070202,18,-1.0,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000006453,2,2,1,0,0,1,221280.45048451523,384314.83364002535,2023-02-20,0,0,0,0,1,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,5,BAIAP2L1,0.33099997,0.37045,-0.83251,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000006576,2,2,1,0,0,1,260631.24114204012,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,4,PHTF2,-0.11500001,1.3624,0.79142,0,0.5,-1.0,,
ENSG00000007392,3,2,0,0,0,0,48276.34365519406,575147.0632428399,2024-07-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,4,LUC7L,0.17900002,1.7311,0.14107,0,-1.0,-1.0,,
ENSG00000008118,3,2,0,0,0,1,2282.7743876235495,433862.5685735124,2019-11-08,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,4,CAMK1G,0.38300002,1.5694,-0.033786,0,0.5,0.0,,
ENSG00000008300,2,2,0,0,1,1,21878.141822721598,218250.16474351365,2021-09-20,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,CELSR3,0.656,5.1027,1.6901,0,0.5,0.5,,
ENSG00000008869,4,2,0,0,0,1,203090.6413944402,765591.3646788632,2020-06-15,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,HEATR5B,0.231,1.9755,-0.89816,0,-1.0,-1.0,,
ENSG00000009954,2,2,1,0,0,1,11231.262381898725,230312.26972227366,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,4,BAZ1B,0.799,4.5608,-0.32115,2,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000011332,2,2,1,0,0,1,122549.0830919942,207233.9114391144,2024-07-19,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DPF1,0.58500004,2.6541,-0.082005,4,1.0,0.5,Developmental Biology;Gene expression (Transcription),R-HSA-1266738;R-HSA-74160
ENSG00000011485,2,2,1,0,0,1,32254.717802479194,169088.90478978804,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,4,PPP5C,0.544,3.0039,0.36532,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000014824,9,2,0,0,1,1,389039.02837669326,1778690.168860174,2018-04-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,1,0,0,0,6,SLC30A9,0.413,0.95592,-0.15834,0,-1.0,-1.0,,
ENSG00000018699,2,2,1,0,0,1,180089.50342935527,431284.57934287674,2021-11-04,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,TTC27,0.227,-0.47223,-0.69606,0,-1.0,-1.0,,
ENSG00000019102,2,2,0,1,0,1,171880.2916512608,316493.8060781965,2022-04-08,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,VSIG2,-0.278,-0.21428,-0.018165,0,1.0,0.0,,
ENSG00000021852,4,2,0,0,0,1,1090.4460111317255,1778690.168860174,2022-07-14,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,6,C8B,-0.17999995,-0.21839,-0.31376,2,1.0,0.5,Immune System,R-HSA-168256
ENSG00000027075,2,2,1,0,0,0,4713.845260560313,180089.50342935527,2013-04-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,2,PRKCH,0.533,2.4029,0.83971,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000028137,3,2,1,0,0,1,32555.310754135273,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,3,TNFRSF1B,0.36299998,1.0397,0.19198,5,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000029534,3,2,1,0,0,0,46730.28130799027,1424218.0900670097,2017-09-04,0,0,0,1,0,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,ANK1,0.701,3.8484,1.5058,5,0.75,0.0,Developmental Biology;Interaction between L1 and Ankyrins;Post-translational protein modification,R-HSA-1266738;R-HSA-445095;R-HSA-597592
ENSG00000031003,4,2,1,0,0,1,14044.7361070413,645988.1975077938,2018-06-11,0,0,0,0,15,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,16,FAM13B,0.41399997,1.5477,0.77878,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000031691,4,2,1,0,1,1,17416.80601016872,66245.61918163559,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,4,CENPQ,-0.03999996,0.41098,0.65992,7,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000035141,2,2,1,0,0,1,189845.9324918578,189845.9324918578,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,FAM136A,-0.627,-0.13669,0.44937,0,-1.0,-1.0,,
ENSG00000037749,3,2,0,0,0,0,108784.9761126256,1122672.658801146,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,0,0,0,0,0,4,MFAP3,0.342,1.1555,1.0058,1,-1.0,-1.0,,
ENSG00000037965,2,2,0,0,0,1,45342.615436918815,116388.33957200912,2022-10-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,2,HOXC8,0.12800002,0.10128,-0.39436,1,0.5,0.0,,
ENSG00000039139,2,2,0,0,0,1,1790.049338274219,7199.101761070433,2023-02-22,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DNAH5,0.236,2.1186,0.98966,0,0.5,0.5,,
ENSG00000039560,2,2,1,0,0,1,230312.26972227366,414433.58532016096,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,4,RAI14,0.482,2.4355,1.9289,0,-1.0,-1.0,,
ENSG00000047579,4,2,0,0,0,1,38106.7872841086,765591.3646788632,2019-06-07,2,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,DTNBP1,-0.103000045,-0.31502,-0.3073,1,0.5,-1.0,,
ENSG00000047648,3,2,1,0,0,0,48144.67157536577,232586.34864014547,2018-06-11,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,ARHGAP6,,,,2,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000048471,5,2,1,0,0,1,95776.89591443514,1129585.974638378,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,5,SNX29,0.052999973,-2.2062,-4.175,0,-1.0,-1.0,,
ENSG00000051108,2,2,0,0,0,1,26561.371714038676,26561.371714038676,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,HERPUD1,0.333,1.1981,0.73281,1,-1.0,-1.0,PERK regulates gene expression;ATF4 activates genes in response to endoplasmic reticulum  stress,R-HSA-381042;R-HSA-380994
ENSG00000051382,2,2,0,0,0,1,33954.407278742765,69925.93241087522,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,PIK3CB,0.681,3.3831,0.95476,32,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Regulation of signaling by CBL;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-912631;R-HSA-9006934;R-HSA-5663202
ENSG00000052126,2,2,1,0,0,1,466632.7979326389,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,PLEKHA5,0.63100004,0.84997,-0.18569,1,-1.0,-1.0,,
ENSG00000053254,3,2,0,0,0,1,23238.11336553945,1424218.0900670097,2020-01-31,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,FOXN3,0.627,2.3968,0.52707,0,-1.0,-1.0,,
ENSG00000054611,2,2,1,0,0,1,201549.9575922349,226101.35678720698,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,3,TBC1D22A,0.11900002,1.035,-0.63272,0,-1.0,-1.0,,
ENSG00000054803,3,2,0,1,0,1,6489.4621952607295,1778690.168860174,2022-07-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,CBLN4,0.049000025,1.4182,-0.54465,0,0.5,0.5,,
ENSG00000054983,4,2,1,0,0,1,19008.705439555517,160010.51072069994,2013-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,9,0,0,0,10,GALC,-0.019000053,-0.27925,-1.5003,1,-1.0,-1.0,,
ENSG00000055163,2,2,1,0,0,1,20307.85640079949,295550.4496098593,2020-01-20,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,1,0,0,0,5,CYFIP2,0.726,6.9395,0.74807,5,0.5,-1.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000055483,4,2,1,0,1,0,358386.30063935445,895916.2144062951,2021-11-04,0,0,0,0,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,USP36,0.35500002,0.18608,-0.67233,0,-1.0,-1.0,,
ENSG00000055917,3,2,0,0,0,1,72982.48880358285,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,3,PUM2,0.42400002,2.7577,0.19672,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000057252,4,2,1,0,0,1,10227.197550504849,78016.97193351923,2022-02-07,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,SOAT1,0.012000024,1.2669,0.15505,1,1.0,-1.0,,
ENSG00000057935,2,2,1,0,0,1,298504.9722193353,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,3,MTA3,0.38599998,-0.23497,-1.1386,8,0.5,-1.0,Signal Transduction;Developmental Biology;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Regulation of endogenous retroelements by KRAB-ZFP proteins;Disease;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance,R-HSA-162582;R-HSA-1266738;R-HSA-74160;R-HSA-427389;R-HSA-9843940;R-HSA-1643685;R-HSA-73762;R-HSA-73864;R-HSA-73854
ENSG00000058335,3,2,1,0,0,1,10353.132295719844,134717.76666505725,2019-12-09,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,6,RASGRF1,0.65,5.1518,1.5083,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000058673,2,2,1,0,0,0,141076.9910731678,180089.50342935527,2020-05-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,ZC3H11A,0.713,3.2512,1.6306,3,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm,R-HSA-73857;R-HSA-74160;R-HSA-159236;R-HSA-72202
ENSG00000058729,2,2,0,0,0,1,129783.42151918238,131870.09182409043,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,RIOK2,-0.008999944,1.4653,0.64526,1,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000058866,3,2,0,0,0,1,17650.005912143264,414433.58532016096,2018-06-11,0,0,0,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,29,DGKG,0.08499998,1.2253,1.0247,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000059378,3,2,1,0,0,1,69925.93241087522,394357.452283155,2017-12-06,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,7,PARP12,-0.021999955,0.17234,-1.6302,0,-1.0,-1.0,,
ENSG00000062038,4,2,1,0,0,1,27202.138632157865,521818.7070055739,2020-04-27,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,CDH3,0.17699999,0.71843,0.1985,1,0.5,0.0,,
ENSG00000062282,2,2,1,0,0,1,221280.45048451523,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,4,DGAT2,0.06999999,0.67584,-0.13193,3,0.75,0.0,Gene expression (Transcription);Acyl chain remodeling of DAG and TAG,R-HSA-74160;R-HSA-1482883
ENSG00000062822,5,2,0,0,0,1,138890.6106237268,645988.1975077938,2023-01-18,0,0,0,0,5,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,POLD1,0.12199998,1.3967,-1.5053,18,-1.0,0.0,Gap-filling DNA repair synthesis and ligation in TC-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-6782210;R-HSA-6782135;R-HSA-6781827
ENSG00000064703,3,2,0,0,1,1,203090.6413944402,765591.3646788632,2020-06-15,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DDX20,0.035000026,0.49168,0.030821,2,1.0,0.0,Disease;snRNP Assembly;Metabolism of non-coding RNA,R-HSA-1643685;R-HSA-191859;R-HSA-194441
ENSG00000064835,3,2,1,0,0,1,1173.5007132667617,521818.7070055739,2022-07-22,4,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,POU1F1,0.075999975,0.74965,-0.05095,0,1.0,1.0,,
ENSG00000065802,2,2,0,0,0,1,4435.36939554283,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,ASB1,0.049000025,1.1399,0.20571,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000066279,3,2,0,0,1,1,31971.308488731265,378712.0243337037,2020-08-26,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,7,ASPM,0.23400003,0.80711,0.024148,0,0.75,0.5,,
ENSG00000066336,2,2,0,0,0,1,107949.90929360976,358386.30063935445,2018-08-13,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SPI1,0.7,1.6476,-1.1107,2,0.75,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000066629,2,2,0,0,1,1,122069.83349127392,380831.7787965888,2017-12-06,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,EML1,0.64,3.3528,1.3678,0,-1.0,0.0,,
ENSG00000067082,3,2,1,0,0,1,131525.74533408263,328052.24452619,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,0,0,0,0,0,0,5,KLF6,0.892,2.7032,0.11493,0,0.5,-1.0,,
ENSG00000067221,4,2,1,0,0,1,69925.93241087522,270267.2992956902,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,STOML1,-0.08700001,1.1799,0.25388,0,0.5,-1.0,,
ENSG00000068028,2,2,1,0,1,1,25967.06754524981,55416.28042655659,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,RASSF1,-0.40900004,-0.27949,-0.71278,0,-1.0,-1.0,,
ENSG00000068383,2,2,1,0,1,1,286678.73247515375,384314.83364002535,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,INPP5A,0.644,1.9395,0.61592,1,-1.0,-1.0,,
ENSG00000068912,2,2,0,0,0,0,201549.9575922349,226101.35678720698,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,3,ERLEC1,0.05400002,0.28363,-0.7844,4,-1.0,-1.0,Signal Transduction;Disease;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Hh mutants abrogate ligand secretion;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5358346;R-HSA-5362768;R-HSA-5387390;R-HSA-5663202
ENSG00000069020,2,2,1,0,0,1,383158.3001114715,521818.7070055739,2023-01-18,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,MAST4,0.33999997,1.1639,-1.8746,0,-1.0,-1.0,,
ENSG00000070759,2,2,0,0,0,1,63367.23432105128,551389.5206213495,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,2,TESK2,0.13499999,1.5942,1.1074,0,-1.0,-1.0,,
ENSG00000071054,4,2,1,0,0,1,51964.39839555753,263416.51565448404,2017-09-11,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,2,0,0,0,5,MAP4K4,0.69200003,5.0873,-0.15597,1,0.5,-1.0,,
ENSG00000071082,3,2,1,0,0,1,29803.01405728205,143413.24457139417,2020-01-20,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,RPL31,0.783,2.0747,0.39119,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000072657,2,2,1,0,0,1,1765.939149399643,118061.55082048493,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,TRHDE,0.204,1.4841,-0.49946,0,0.5,0.0,,
ENSG00000073737,2,2,1,0,0,1,4518.532006719214,112184.2204720767,2022-08-17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,DHRS9,0.049000025,-0.45761,0.68827,2,0.5,0.0,Signal Transduction;The canonical retinoid cycle in rods (twilight vision),R-HSA-162582;R-HSA-2453902
ENSG00000074211,2,2,1,0,0,1,135095.86576106868,727796.3668420183,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,PPP2R2C,0.625,4.7391,-0.21904,0,0.5,0.0,,
ENSG00000074590,4,2,0,0,0,1,31104.940443685748,106674.19403831073,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,5,NUAK1,0.36299998,2.2117,0.40819,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000074603,3,2,0,0,0,0,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,DPP8,0.63199997,2.6409,-0.1897,0,-1.0,-1.0,,
ENSG00000074706,3,2,1,1,0,1,3730.789802911422,193771.21296110394,2019-10-24,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,3,IPCEF1,0.30699998,1.5932,1.0384,0,0.75,0.0,,
ENSG00000075213,3,2,0,0,0,1,6255.283599045708,187674.40497870417,2021-02-24,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,SEMA3A,0.547,2.3501,0.68975,3,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000075223,4,2,1,1,0,1,29803.01405728205,718784.6890415357,2018-06-11,0,0,0,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,SEMA3C,0.26200002,1.4097,0.6726,0,-1.0,0.0,,
ENSG00000075429,2,2,0,0,0,1,118684.63990752245,118684.63990752245,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,CACNG5,-0.036000013,0.66211,-0.045926,0,1.0,1.0,,
ENSG00000076242,2,2,1,0,0,1,50469.22952482314,215157.94798738702,2021-02-25,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MLH1,0.361,1.0943,0.20291,6,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000079313,2,2,1,0,1,1,1321.7688442211056,427337.4491868293,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,6,REXO1,0.384,-1.8743,-3.9014,0,-1.0,-1.0,,
ENSG00000079393,3,2,1,1,1,1,545988.1005477115,1778690.168860174,2021-05-27,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,5,DUSP13B,-0.40699995,0.64254,1.0426,0,0.5,0.5,,
ENSG00000079557,2,2,0,0,0,1,21602.64405680352,406587.2658730814,2013-04-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,AFM,-0.44000006,-0.42108,-0.12795,0,1.0,0.5,,
ENSG00000079805,2,2,0,0,0,1,54391.03477538057,71329.99611279755,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,DNM2,0.76100004,4.8688,-0.90238,11,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Recycling pathway of L1;Lysosome Vesicle Biogenesis;Gap junction trafficking and regulation;Gap junction trafficking;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-437239;R-HSA-432720;R-HSA-157858;R-HSA-190828;R-HSA-9006934
ENSG00000079819,2,2,1,0,0,1,42027.118313217856,180089.50342935527,2019-04-11,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,3,EPB41L2,0.486,1.2455,0.52551,1,0.5,-1.0,,
ENSG00000080608,3,2,0,0,0,1,570453.341025074,1778690.168860174,2019-02-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,8,PUM3,-0.36300004,-2.8844,-1.1276,0,-1.0,-1.0,,
ENSG00000082014,2,2,1,0,0,1,17285.31431524312,461914.58891516324,2016-07-01,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SMARCD3,0.628,3.7868,0.56495,18,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Formation of the non-canonical BAF (ncBAF) complex;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9933947;R-HSA-8957322;R-HSA-1655829
ENSG00000082458,2,2,0,0,0,1,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,DLG3,,,,10,-1.0,0.0,Signal Transduction;Activation of Ca-permeable Kainate Receptor;Ionotropic activity of kainate receptors;Developmental Biology;Activation of kainate receptors upon glutamate binding,R-HSA-162582;R-HSA-451308;R-HSA-451306;R-HSA-1266738;R-HSA-451326
ENSG00000083093,6,2,0,0,1,1,4567.77694548481,367949.31877243903,2011-02-01,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,PALB2,0.100000024,0.8204,0.87261,10,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000084110,6,2,1,0,0,1,53157.639291331456,189557.6027707886,2018-08-13,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,7,HAL,-0.21300006,0.49342,0.65252,1,0.75,0.5,,
ENSG00000084676,2,2,1,0,0,1,65794.6850968381,562534.7696387965,2017-10-23,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,3,NCOA1,0.702,2.5875,1.3038,22,-1.0,-1.0,Signal Transduction;Developmental Biology;Gene expression (Transcription);Synthesis of bile acids and bile salts;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Bile acid and bile salt metabolism;Post-translational protein modification,R-HSA-162582;R-HSA-1266738;R-HSA-74160;R-HSA-192105;R-HSA-8957322;R-HSA-1655829;R-HSA-194068;R-HSA-597592
ENSG00000084710,3,2,1,0,0,1,25056.289178133135,358386.30063935445,2011-09-29,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,EFR3B,0.25300002,3.9641,1.2901,0,0.5,0.0,,
ENSG00000084764,2,2,1,0,0,1,306980.8575290048,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,3,MAPRE3,0.837,2.8445,1.2762,0,0.5,-1.0,,
ENSG00000084774,2,2,0,0,0,0,43732.839609234245,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,CAD,0.59099996,5.7821,0.22596,1,-1.0,-1.0,Nucleotide biosynthesis;Metabolism of nucleotides,R-HSA-8956320;R-HSA-15869
ENSG00000085832,2,2,1,0,0,1,81496.15268573073,228220.5662976458,2018-07-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,EPS15,0.15100002,0.37095,0.79529,5,-1.0,-1.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1643685;R-HSA-9006934
ENSG00000086544,3,2,1,0,1,1,1501.5536071373635,160010.51072069994,2011-11-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,0,0,0,5,ITPKC,0.29299998,0.80673,0.54423,1,0.5,-1.0,,
ENSG00000087008,2,2,1,0,1,1,100711.28404230655,672632.4785173276,2021-04-22,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ACOX3,-0.11399996,-0.086507,-0.1781,2,-1.0,-1.0,Peroxisomal protein import,R-HSA-9033241
ENSG00000087053,7,2,0,0,0,1,100620.50186431198,1470466.6505612188,2021-08-24,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,5,14,MTMR2,0.100000024,1.6219,0.96361,4,-1.0,-1.0,,
ENSG00000087245,3,2,1,0,1,1,42193.37905314073,269000.70907194994,2021-12-01,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,3,MMP2,0.34600002,1.4267,-0.31938,8,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Signaling by Interleukins;EPH-ephrin mediated repulsion of cells;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-449147;R-HSA-3928665;R-HSA-6785807
ENSG00000088053,3,2,1,1,1,1,56614.28807963426,135593.17169557852,2019-08-16,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,GP6,-0.73399997,-0.28432,-0.5285,3,0.5,0.5,Platelet Adhesion to exposed collagen,R-HSA-75892
ENSG00000088756,3,2,1,0,0,1,162367.55694122918,396735.32121509424,2022-06-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,ARHGAP28,0.204,0.52529,0.39864,1,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000090447,4,2,0,0,1,1,59060.02777333318,521818.7070055739,2023-01-18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,6,TFAP4,0.644,1.203,-1.4158,0,-1.0,0.0,,
ENSG00000090857,4,2,1,0,0,1,281258.82202219026,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,5,PDPR,0.17400002,2.6992,1.0802,1,-1.0,-1.0,Regulation of pyruvate metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism,R-HSA-9861718;R-HSA-204174;R-HSA-70268
ENSG00000092020,3,2,1,0,0,1,30532.071889750743,155496.87140784386,2015-10-19,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,PPP2R3C,0.045000017,1.8007,-0.14506,0,-1.0,-1.0,,
ENSG00000092108,2,2,1,0,1,1,10257.256188118812,87380.83817331228,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,SCFD1,0.19099998,0.52264,-0.94311,2,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000092421,2,2,1,0,0,1,201549.9575922349,226101.35678720698,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,2,SEMA6A,0.663,-0.19497,-1.7766,1,0.5,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000093167,3,2,1,0,0,1,33678.58412439629,269829.0934099178,2021-11-04,2,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,5,LRRFIP2,-0.14400005,0.41253,0.18768,0,-1.0,-1.0,,
ENSG00000095752,6,2,0,0,1,1,60311.48086819863,1990918.947961699,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,4,16,IL11,-0.79700005,-1.7078,-2.25,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000095787,3,2,1,0,0,1,7223.468925010245,111599.28184123649,2019-03-19,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,WAC,0.752,0.89239,-0.44117,1,-1.0,-1.0,E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000096070,2,2,1,0,0,1,83932.6290685273,87248.80974040499,2020-12-11,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,BRPF3,0.74399996,4.3153,1.5134,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000096080,3,2,0,0,0,1,40455.65678857565,521818.7070055739,2022-10-12,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,MRPS18A,-0.41499996,-0.90582,-0.83067,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000100014,3,2,1,0,1,1,48088.08731084698,394357.452283155,2015-09-07,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,7,SPECC1L,0.566,3.206,0.59277,0,-1.0,-1.0,,
ENSG00000100150,3,2,0,0,0,1,5414.650230111769,355284.1215006515,2017-02-24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,DEPDC5,0.597,3.7429,1.1301,1,-1.0,-1.0,Amino acids regulate mTORC1;Cellular response to starvation,R-HSA-9639288;R-HSA-9711097
ENSG00000100201,2,2,1,0,0,1,38851.92581543917,301203.06999851385,2023-08-23,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,DDX17,0.748,4.3675,-0.0041533,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000100347,3,2,1,0,0,1,90049.68162979394,227570.98695011192,2018-07-27,0,0,0,0,0,1,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,SAMM50,0.12199998,0.92138,0.52297,3,0.5,-1.0,Signal Transduction;Cristae formation,R-HSA-162582;R-HSA-8949613
ENSG00000100399,2,2,1,0,1,1,87030.31235300079,309838.540915932,2021-07-22,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,CHADL,-0.41499996,-0.80665,-1.4604,0,1.0,0.0,,
ENSG00000100625,2,2,0,0,1,1,51573.04760983911,1424218.0900670097,2023-08-23,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SIX4,0.324,1.1565,-0.14812,0,0.75,0.0,,
ENSG00000100714,2,2,1,0,0,1,545988.1005477115,1122672.658801146,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,MTHFD1,0.49,2.9224,1.0139,1,1.0,-1.0,Metabolism of folate and pterines,R-HSA-196757
ENSG00000100749,2,2,1,0,0,1,6375.838537521578,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,3,VRK1,0.25300002,1.4104,0.68348,2,0.5,-1.0,,
ENSG00000101266,4,2,0,0,0,0,37099.31252818776,101032.95487940393,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,2,5,CSNK2A1,0.726,5.3272,1.7413,13,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Phosphorylation and nuclear translocation of the CRY:PER:kinase complex;Gene expression (Transcription);Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Disease;Receptor Mediated Mitophagy,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-9931530;R-HSA-74160;R-HSA-6814122;R-HSA-1643685;R-HSA-8934903
ENSG00000101421,3,2,1,0,0,1,47797.53772269011,93616.86016863462,2021-04-08,2,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,CHMP4B,0.792,2.8951,0.9067,9,-1.0,-1.0,Endosomal Sorting Complex Required For Transport (ESCRT);Budding and maturation of HIV virion;Disease;Late endosomal microautophagy;Translation of Replicase and Assembly of the Replication Transcription Complex_9679504;Sealing of the nuclear envelope (NE) by ESCRT-III;Translation of Replicase and Assembly of the Replication Transcription Complex_9694676;HIV Life Cycle;Late Phase of HIV Life Cycle;HCMV Late Events,R-HSA-917729;R-HSA-162588;R-HSA-1643685;R-HSA-9615710;R-HSA-9679504;R-HSA-9668328;R-HSA-9694676;R-HSA-162587;R-HSA-162599;R-HSA-9610379
ENSG00000101463,2,2,0,0,0,1,1173.5007132667617,192594.63282947522,2022-07-22,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,SYNDIG1,-0.24199998,0.53537,0.35834,0,0.5,0.0,,
ENSG00000101493,3,2,0,0,0,1,107949.90929360976,227752.06557835746,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,ZNF516,0.59000003,-0.52159,-3.0127,0,-1.0,-1.0,,
ENSG00000101938,3,2,1,1,0,1,97181.90375256384,180344.38517486732,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,3,CHRDL1,,,,3,0.5,0.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000102245,3,2,0,0,0,1,21408.6965896625,42879.69557188197,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,3,CD40LG,,,,3,0.75,0.5,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000102466,2,2,0,0,0,1,3398.9393113014553,1778690.168860174,2022-07-14,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,FGF14,0.518,1.8427,-0.87313,1,0.5,0.5,,
ENSG00000102471,2,2,1,0,0,1,155552.2805078301,197485.87952538437,2022-04-08,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,NDFIP2,-0.026000023,-1.1164,-1.5388,0,-1.0,-1.0,,
ENSG00000102531,2,2,0,0,1,1,118378.05897131584,1129585.974638378,2021-09-30,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,2,FNDC3A,0.74399996,2.1622,0.57142,0,-1.0,-1.0,,
ENSG00000102738,3,2,1,0,1,1,11101.688409289527,29811.1438239137,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,MRPS31,-0.027999997,0.4754,-0.043824,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000102743,4,2,1,0,1,1,19008.705439555517,356440.71671986027,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,11,0,0,0,12,SLC25A15,-0.026000023,1.3292,0.75442,1,0.5,-1.0,,
ENSG00000102780,4,2,1,0,0,1,3225.687880597015,252346.18526092035,2012-03-01,0,0,0,0,1,0,0,0,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,17,DGKH,0.311,2.7811,0.082562,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000102977,2,2,1,0,0,0,196178.71491042234,521818.7070055739,2023-01-18,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ACD,0.078999996,1.066,-0.60941,14,-1.0,-1.0,,
ENSG00000103174,2,2,1,0,0,1,2281.2733292458615,2281.2733292458615,2021-05-16,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,NAGPA,-0.49399996,-2.5032,-3.1964,0,-1.0,0.0,,
ENSG00000103227,3,2,1,0,0,1,17634.65533758174,515513.2178404211,2017-03-27,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,LMF1,-0.436,-2.549,-3.1249,1,-1.0,-1.0,Plasma lipoprotein remodeling,R-HSA-8963899
ENSG00000103502,2,2,1,0,0,1,279992.27535235474,279992.27535235474,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,CDIPT,-0.042000055,0.46478,-0.056248,1,-1.0,-1.0,,
ENSG00000103647,2,2,0,0,0,1,7211.241069373615,19257.690392998462,2024-02-23,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CORO2B,0.36699998,2.984,0.65987,0,0.5,0.0,,
ENSG00000103657,2,2,0,0,1,1,16548.58403989127,1424218.0900670097,2022-01-12,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,HERC1,0.66999996,5.2959,0.3551,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000103723,4,2,1,0,0,1,95776.89591443514,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,4,AP3B2,0.48000002,2.3169,0.47079,0,0.75,0.0,,
ENSG00000104321,2,2,0,0,0,1,4428.697810877906,50072.877304794354,2016-02-01,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,TRPA1,-0.062999964,1.0926,0.48399,1,0.5,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000104415,4,2,0,1,0,1,2909.767697594502,269829.0934099178,2013-04-29,0,0,0,0,0,0,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,0,6,CCN4,-0.15100002,0.24653,0.38726,0,0.5,0.0,,
ENSG00000104499,2,2,1,0,0,1,100620.50186431198,100620.50186431198,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,GML,-0.831,0.69684,0.39682,4,1.0,0.5,,
ENSG00000104613,2,2,1,0,0,1,1173.5007132667617,5974.89167562403,2018-04-09,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,INTS10,0.314,1.0098,-0.051594,1,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000104723,2,2,1,0,0,1,20218.32796048584,433862.5685735124,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,TUSC3,-0.30999994,-1.1313,-2.3468,3,-1.0,0.0,Miscellaneous transport and binding events;Disease;Post-translational protein modification,R-HSA-5223345;R-HSA-1643685;R-HSA-597592
ENSG00000104731,2,2,1,0,1,1,3141.278019404483,3979.099342105263,2019-10-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,KLHDC4,-0.74,-3.98,-3.3931,0,-1.0,-1.0,,
ENSG00000104763,4,2,1,0,0,1,55315.825152625155,645988.1975077938,2017-04-17,0,0,0,0,13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,ASAH1,-0.43499994,-2.8275,-1.7481,3,0.5,-1.0,Immune System;Developmental Biology,R-HSA-168256;R-HSA-1266738
ENSG00000104825,2,2,0,0,1,0,79958.75176875875,101032.95487940393,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,3,NFKBIB,0.16900003,0.97843,-0.40179,4,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000104870,2,2,1,0,0,1,562534.7696387965,1424218.0900670097,2022-10-12,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,FCGRT,0.29400003,0.28154,-0.82734,0,-1.0,-1.0,,
ENSG00000104892,2,2,1,0,0,1,469202.8533735097,469202.8533735097,2022-07-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,KLC3,-0.617,-3.2439,-4.079,4,0.5,0.0,Signal Transduction;Immune System;RHO GTPases activate KTN1;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-162582;R-HSA-168256;R-HSA-5625970;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000104897,4,2,0,0,0,1,151416.12986435954,403949.6773304188,2023-10-16,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,3,SF3A2,0.698,2.1471,-1.6256,1,-1.0,-1.0,,
ENSG00000105352,3,2,0,0,0,1,42341.12463940832,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,4,CEACAM4,-0.45200002,-0.48534,-0.81923,0,1.0,0.5,,
ENSG00000105393,2,2,1,0,0,0,3222.2904948099313,141293.18354755783,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,BABAM1,0.328,0.61036,-0.37442,5,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000105550,4,2,0,0,1,1,19965.24128263536,160010.51072069994,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,0,0,0,5,FGF21,-0.51,-0.361,0.3216,2,1.0,1.0,Plasma lipoprotein remodeling,R-HSA-8963899
ENSG00000105677,4,2,1,0,0,1,4518.532006719214,301203.06999851385,2021-04-08,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,6,TMEM147,-0.27499998,0.93749,-0.15728,0,-1.0,-1.0,,
ENSG00000105696,2,2,1,0,0,1,97181.90375256384,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,TMEM59L,-0.16499996,-0.4261,-1.5593,0,1.0,0.0,,
ENSG00000105737,4,2,0,0,0,1,54297.13859953472,101032.95487940393,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,4,GRIK5,0.408,3.1806,-0.48082,1,0.5,0.0,Activation of Ca-permeable Kainate Receptor;Ionotropic activity of kainate receptors;Activation of kainate receptors upon glutamate binding,R-HSA-451308;R-HSA-451306;R-HSA-451326
ENSG00000105866,5,2,1,0,0,1,94951.97167384504,1778690.168860174,2021-05-17,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,7,SP4,0.661,-0.49685,-1.3918,0,-1.0,0.0,,
ENSG00000105889,3,2,1,0,0,1,48439.20423385324,90413.10180725924,2019-10-24,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,STEAP1B,0.23000002,0.77225,0.91791,0,0.5,0.5,,
ENSG00000105926,4,2,1,0,0,1,150669.89240227733,1122672.658801146,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,4,PALS2,0.362,1.5805,-0.3537,0,0.5,0.0,,
ENSG00000105997,2,2,1,0,0,0,383158.3001114715,500292.45069431677,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,HOXA3,0.45599997,-0.72322,-1.5539,1,-1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000106328,2,2,0,0,0,1,38886.589732507324,294387.2978738704,2016-01-28,0,0,0,0,0,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,FSCN3,-0.11800003,1.0575,0.67496,0,1.0,1.0,,
ENSG00000106772,2,2,0,0,1,1,256331.89034791503,341207.7500533011,2019-06-24,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,5,PRUNE2,0.311,2.1902,1.5632,0,0.5,-1.0,,
ENSG00000106948,2,2,1,0,0,1,109409.27518493953,170747.68362649818,2024-07-19,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,AKNA,0.36900002,0.39093,-0.042052,0,0.5,-1.0,,
ENSG00000107165,8,2,0,1,0,1,13564.515570375948,133918.94977035935,2018-05-08,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,11,TYRP1,-0.398,-2.0852,-1.0558,2,0.75,0.0,Developmental Biology,R-HSA-1266738
ENSG00000107341,2,2,1,0,0,1,54831.766913996034,406587.2658730814,2023-11-09,2,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,UBE2R2,0.81,4.1657,0.68435,2,-1.0,-1.0,Immune System;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Protein ubiquitination;Post-translational protein modification,R-HSA-168256;R-HSA-8866652;R-HSA-8852135;R-HSA-597592
ENSG00000107518,2,2,0,0,0,1,3933.1966790664083,433862.5685735124,2024-06-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,ATRNL1,0.462,1.6631,-0.37298,0,0.5,0.0,,
ENSG00000107593,2,2,0,0,0,1,173193.7688415446,394357.452283155,2020-10-05,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PKD2L1,-0.003000021,0.74033,0.17159,0,0.5,0.5,,
ENSG00000107614,5,2,1,1,1,1,46977.28346057821,282360.54876783554,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,5,0,0,0,0,8,TRDMT1,-0.43700004,-1.1039,-0.62912,1,-1.0,0.0,,
ENSG00000107798,12,2,1,0,1,1,25464.040702316375,502231.5406594711,2015-09-07,0,0,0,0,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,36,LIPA,-0.37699997,0.64031,-0.12382,1,0.5,-1.0,,
ENSG00000107929,2,2,1,0,0,1,230316.30849350386,521818.7070055739,2019-05-31,5,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,LARP4B,0.71099997,1.9892,0.30502,0,-1.0,-1.0,,
ENSG00000108239,3,2,0,0,0,0,59922.028203228016,81243.5903011504,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,TBC1D12,0.125,-1.6832,-2.2655,0,0.5,-1.0,,
ENSG00000108344,4,2,1,0,0,1,16630.62199161505,360837.067725683,2017-10-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,3,9,PSMD3,0.829,2.5855,0.66268,62,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000108395,2,2,1,0,0,1,383158.3001114715,1424218.0900670097,2023-01-18,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TRIM37,0.21100003,1.7581,0.39629,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000108433,8,2,1,0,1,1,5414.650230111769,756470.9740366563,2017-02-24,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,13,GOSR2,-0.26999998,0.22975,0.55519,5,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000108468,2,2,1,0,0,1,195005.6685718255,1424218.0900670097,2020-06-15,0,0,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,CBX1,0.27899998,2.8893,1.0346,1,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000108510,3,2,1,0,0,1,50641.99826116222,76832.90012167432,2020-02-08,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,2,MED13,0.87,3.3253,-0.073572,5,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685
ENSG00000108556,2,2,1,0,0,1,259947.56530348706,1424218.0900670097,2021-06-07,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,CHRNE,-0.29799998,-1.4499,-2.8095,1,0.75,0.5,,
ENSG00000108854,3,2,1,0,0,1,72982.48880358285,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,3,SMURF2,0.453,3.6678,0.9648,9,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Asymmetric localization of PCP proteins;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-4608870;R-HSA-2173793;R-HSA-597592;R-HSA-8878159
ENSG00000108950,2,2,0,0,1,1,11608.613380386345,19030.690300153117,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,0,0,0,4,FAM20A,-0.10800004,-0.67761,-0.66338,2,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000109047,3,2,1,0,0,1,75245.66341852833,1424218.0900670097,2018-10-08,0,0,0,4,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,RCVRN,-0.61600006,0.4617,0.3878,1,1.0,0.5,,
ENSG00000109101,2,2,0,0,1,0,113702.83228541304,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,FOXN1,0.55799997,0.81588,0.85941,0,0.5,0.5,,
ENSG00000109321,3,2,0,0,0,1,22235.35344772114,86355.0747064496,2023-01-18,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,AREG,0.17699999,0.76552,0.22052,18,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202;R-HSA-597592
ENSG00000109332,4,2,1,0,0,1,358386.30063935445,1424218.0900670097,2021-11-04,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,UBE2D3,0.78,3.6975,0.43653,13,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);IKK complex recruitment mediated by RIP1;Peroxisomal protein import;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-937041;R-HSA-9033241;R-HSA-8866654;R-HSA-8852135;R-HSA-1234176;R-HSA-2173793;R-HSA-597592
ENSG00000109472,2,2,0,0,0,1,4887.636075264942,141293.18354755783,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,CPE,0.435,1.0303,-0.21385,1,0.5,-1.0,,
ENSG00000109756,3,2,0,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,RAPGEF2,0.629,4.1603,0.3119,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000109906,3,2,0,0,0,1,3170.025142372042,55985.57959589327,2015-10-01,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,7,ZBTB16,0.755,3.8507,0.68374,2,-1.0,0.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000110031,2,2,0,0,0,1,21724.94108458234,107949.90929360976,2023-06-29,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,LPXN,0.213,0.57402,0.54734,0,0.5,-1.0,,
ENSG00000110076,3,2,1,0,1,1,1639.4039301310045,572390.9560934792,2016-11-29,0,0,0,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,1,0,0,0,0,17,NRXN2,0.68299997,3.0987,-1.5238,1,1.0,0.0,,
ENSG00000110172,2,2,0,0,0,1,28863.30790298137,409691.21276290494,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,CHORDC1,0.11799997,0.85959,-0.52564,0,-1.0,-1.0,,
ENSG00000110680,2,2,0,0,1,1,54272.859706395815,243159.30781957568,2018-09-03,0,0,0,0,3,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,CALCA,-0.18599999,0.3278,-0.22844,3,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000110888,2,2,1,0,1,1,196178.71491042234,239970.53614968536,2021-06-14,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,CAPRIN2,0.42000002,1.0934,-0.39649,0,-1.0,-1.0,,
ENSG00000111057,3,2,0,0,0,1,5414.650230111769,278190.43024910334,2017-02-24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,KRT18,0.589,2.2718,0.92405,2,-1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000111339,4,2,1,0,1,1,34084.683440731395,183427.12489668437,2021-08-24,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,4,ART4,0.10500002,0.44443,0.18971,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000111642,3,2,1,0,0,1,175540.09121723313,1424218.0900670097,2020-06-15,0,0,0,1,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,CHD4,0.80799997,8.6275,-0.29807,10,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Regulation of endogenous retroelements by KRAB-ZFP proteins;Disease;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-427389;R-HSA-9843940;R-HSA-1643685;R-HSA-73762;R-HSA-73864;R-HSA-73854;R-HSA-9006934
ENSG00000111664,4,2,0,0,1,1,10353.132295719844,326545.22790564946,2019-12-09,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,11,GNB3,-0.07200003,1.0111,0.28811,31,1.0,0.0,"Signal Transduction;Presynaptic function of Kainate receptors;ADP signalling through P2Y purinoceptor 12;Thromboxane signalling through TP receptor;G beta:gamma signalling through PLC beta;Prostacyclin signalling through prostacyclin receptor;G beta:gamma signalling through BTK;ADP signalling through P2Y purinoceptor 1;G beta:gamma signalling through PI3Kgamma;Signal amplification;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Disease;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Activation of kainate receptors upon glutamate binding;Adrenaline,noradrenaline inhibits insulin secretion;G-protein beta:gamma signalling;Inwardly rectifying K+ channels",R-HSA-162582;R-HSA-500657;R-HSA-392170;R-HSA-428930;R-HSA-418217;R-HSA-392851;R-HSA-8964315;R-HSA-418592;R-HSA-392451;R-HSA-392518;R-HSA-202040;R-HSA-6814122;R-HSA-1643685;R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-451326;R-HSA-400042;R-HSA-397795;R-HSA-1296065
ENSG00000111816,5,2,1,0,1,1,6375.502972651605,384314.83364002535,2011-06-10,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,0,0,0,6,FRK,-0.016000032,1.0566,-0.44169,2,-1.0,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000111837,3,2,0,0,0,1,32601.942308977235,35247.084450686016,2024-07-19,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,3,MAK,0.106000006,1.1039,1.0734,0,1.0,0.5,,
ENSG00000111860,6,2,1,0,0,1,21724.94108458234,645988.1975077938,2018-07-30,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,14,CEP85L,0.30400002,0.048639,0.68654,0,0.5,0.0,,
ENSG00000112053,2,2,0,0,0,1,2605.1509433962265,20751.495140412953,2021-09-30,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,SLC26A8,0.213,2.4667,1.0245,0,1.0,0.5,,
ENSG00000112297,2,2,0,0,0,1,27242.67952009354,49724.14538298504,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,CRYBG1,0.144,0.94747,0.38575,0,0.5,0.0,,
ENSG00000112414,3,2,1,0,1,1,2428.7454110135673,438004.58573217486,2013-05-12,0,0,0,0,0,0,0,0,0,0,11,0,5,0,0,0,0,0,0,0,0,0,0,16,ADGRG6,0.37,0.89445,0.55294,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000112559,5,2,0,0,0,1,189845.9324918578,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,2,10,MDFI,-0.35500002,-0.37429,-0.63919,0,0.5,0.0,,
ENSG00000113013,2,2,1,0,0,1,171880.2916512608,645988.1975077938,2022-04-08,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,HSPA9,0.47500002,2.2248,0.17595,8,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Complex I biogenesis;Signaling by Interleukins;Cristae formation,R-HSA-1280215;R-HSA-168256;R-HSA-6799198;R-HSA-449147;R-HSA-8949613
ENSG00000113269,2,2,1,0,0,1,78355.43324299547,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,2,RNF130,0.24299997,0.62709,-0.80069,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000113391,3,2,1,0,0,1,672632.4785173276,1778690.168860174,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,ARB2A,0.013999999,0.10251,0.23264,0,-1.0,-1.0,,
ENSG00000113532,2,2,1,0,0,1,22938.587937312015,294387.2978738704,2017-07-17,0,0,0,0,0,1,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,ST8SIA4,0.31699997,2.2534,-0.4295,2,0.5,0.0,Developmental Biology;Post-translational protein modification,R-HSA-1266738;R-HSA-597592
ENSG00000113594,2,2,1,0,0,1,100620.50186431198,598869.4096893278,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,3,LIFR,0.20200002,0.75576,1.242,2,-1.0,0.0,Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins,R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147
ENSG00000113716,2,2,1,0,1,1,86992.9057658324,360605.992793193,2022-02-03,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HMGXB3,0.533,2.5475,1.1094,0,1.0,-1.0,,
ENSG00000114013,4,2,1,1,0,1,11635.351260982607,31828.071233716477,2011-08-11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,5,CD86,0.445,1.1111,0.39967,8,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-5663202
ENSG00000114268,2,2,0,0,0,1,405722.3511294316,521818.7070055739,2021-06-29,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,PFKFB4,0.08499998,2.3941,1.4178,1,0.5,-1.0,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",R-HSA-9634600
ENSG00000114315,6,2,0,0,0,1,12511.068286850166,260631.24114204012,2021-09-30,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,0,0,0,3,0,0,0,16,HES1,0.393,0.4433,-0.7074,9,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-8878159
ENSG00000114450,2,2,1,0,0,1,86355.0747064496,645988.1975077938,2018-06-11,0,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,GNB4,0.13700002,1.8036,0.72656,29,-1.0,-1.0,"Signal Transduction;Presynaptic function of Kainate receptors;ADP signalling through P2Y purinoceptor 12;Thromboxane signalling through TP receptor;G beta:gamma signalling through PLC beta;Prostacyclin signalling through prostacyclin receptor;G beta:gamma signalling through BTK;ADP signalling through P2Y purinoceptor 1;G beta:gamma signalling through PI3Kgamma;Signal amplification;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Disease;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Activation of kainate receptors upon glutamate binding;Adrenaline,noradrenaline inhibits insulin secretion;G-protein beta:gamma signalling;Inwardly rectifying K+ channels",R-HSA-162582;R-HSA-500657;R-HSA-392170;R-HSA-428930;R-HSA-418217;R-HSA-392851;R-HSA-8964315;R-HSA-418592;R-HSA-392451;R-HSA-392518;R-HSA-202040;R-HSA-6814122;R-HSA-1643685;R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-451326;R-HSA-400042;R-HSA-397795;R-HSA-1296065
ENSG00000114541,3,2,1,0,0,1,9387.521501785945,645988.1975077938,2018-07-30,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,9,FRMD4B,0.36299998,-0.71312,-0.794,0,-1.0,-1.0,,
ENSG00000114784,2,2,1,0,0,1,201549.9575922349,376569.5597064443,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,2,EIF1B,0.19999999,2.4483,0.16039,0,0.5,-1.0,,
ENSG00000114988,9,2,1,1,0,1,14577.354388342934,633132.2332759313,2011-12-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,0,7,LMAN2L,0.10399997,0.5004,-0.058346,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000115112,2,2,0,0,0,1,208836.15741332836,384314.83364002535,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,3,TFCP2L1,0.723,2.0247,-0.11531,0,0.5,0.0,,
ENSG00000115271,3,2,0,0,0,1,20538.94126578784,108425.35980999071,2018-12-20,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,GCA,-0.847,-0.33357,-0.082258,1,1.0,-1.0,Immune System,R-HSA-168256
ENSG00000115414,4,2,0,1,1,1,18547.897677202665,394357.452283155,2017-07-17,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,12,FN1,0.59599996,3.6666,0.91065,29,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202;R-HSA-597592;R-HSA-6785807
ENSG00000115474,4,2,1,0,1,1,52344.76197757555,1076472.0138856068,2017-12-06,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,KCNJ13,0.36,2.1909,0.58675,0,0.75,0.5,,
ENSG00000115514,2,2,0,1,0,0,137776.79053446153,355284.1215006515,2023-02-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,TXNDC9,0.485,1.2722,1.2198,0,-1.0,-1.0,,
ENSG00000115520,2,2,0,0,0,1,22232.923404782556,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,2,COQ10B,-0.14699996,-0.027309,-0.48316,2,-1.0,-1.0,Complex IV assembly,R-HSA-9864848
ENSG00000115718,9,2,1,1,0,1,9908.45619341723,168116.01355658393,2022-10-12,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,18,PROC,0.106000006,1.6178,0.89982,8,1.0,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000115839,3,2,0,0,0,1,832.4060913705583,45736.28457081111,2011-10-06,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,RAB3GAP1,0.20200002,2.0402,1.5282,2,-1.0,-1.0,Golgi-to-ER retrograde transport;Rab regulation of trafficking,R-HSA-8856688;R-HSA-9007101
ENSG00000115844,6,2,0,0,0,1,22345.675520395987,322107.4898639223,2013-04-01,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,DLX2,0.47100002,0.31064,-0.70117,0,0.5,1.0,,
ENSG00000115935,4,2,1,0,0,1,32996.93546153374,645988.1975077938,2018-07-30,0,0,0,0,10,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,WIPF1,0.435,1.3937,0.45318,5,0.5,-1.0,Signal Transduction;Immune System;Disease;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000115947,2,2,1,0,0,1,40455.65678857565,75715.46734074537,2022-10-12,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,ORC4,-0.53199995,0.2977,0.59357,7,-1.0,-1.0,E2F-enabled inhibition of pre-replication complex formation;Assembly of the ORC complex at the origin of replication;E2F mediated regulation of DNA replication,R-HSA-113507;R-HSA-68616;R-HSA-113510
ENSG00000115977,3,2,1,0,0,1,89519.16315227402,427337.4491868293,2022-10-12,0,0,0,0,2,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,9,AAK1,0.594,2.6964,-0.19531,2,0.5,-1.0,,
ENSG00000116095,2,2,0,0,0,1,57425.85429872698,298878.49542603496,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,PLEKHA3,0.305,1.8111,0.9878,1,-1.0,-1.0,,
ENSG00000116151,3,2,1,0,0,1,138890.6106237268,1470466.6505612188,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,MORN1,-0.39100003,-1.542,-1.1755,0,0.5,0.0,,
ENSG00000116521,2,2,1,1,0,1,17831.529851792977,30182.28889075047,2010-11-21,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,SCAMP3,0.116999984,0.89743,0.29061,0,-1.0,0.0,,
ENSG00000116698,2,2,0,0,0,1,71370.26196812681,71370.26196812681,2022-11-03,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,SMG7,0.629,2.9934,1.0416,1,-1.0,-1.0,,
ENSG00000117505,2,2,1,0,0,1,160010.51072069994,384314.83364002535,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,2,0,0,0,6,DR1,0.351,2.8284,0.01396,2,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000117533,2,2,1,0,0,1,188264.63129042363,355284.1215006515,2023-12-28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,VAMP4,-0.584,0.44505,0.97979,3,-1.0,-1.0,,
ENSG00000117597,4,2,1,0,0,1,2397.122003085852,180089.50342935527,2017-02-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,4,UTP25,0.24000001,1.3389,0.7961,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000117598,2,2,0,0,0,1,636.1886490807354,4305.001232640316,2012-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,PLPPR5,0.29799998,2.1289,-0.25307,1,0.5,0.5,Signal Transduction;Lysosphingolipid and LPA receptors,R-HSA-162582;R-HSA-419408
ENSG00000117602,2,2,0,0,0,1,2397.122003085852,2397.122003085852,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,RCAN3,-0.306,1.0357,-0.30228,1,0.5,0.0,Disease,R-HSA-1643685
ENSG00000118369,3,2,1,0,0,1,3288.4396493594068,464892.4593283075,2015-10-27,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,USP35,-0.08200002,-2.1889,-3.8551,0,-1.0,-1.0,,
ENSG00000118596,4,2,0,0,0,1,132781.32332824613,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,4,SLC16A7,-0.23300004,0.54902,0.41223,1,0.5,-1.0,,
ENSG00000118640,5,2,1,0,0,1,13552.542477876106,406587.2658730814,2011-07-10,6,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,VAMP8,-0.51900005,0.7189,0.17138,7,-1.0,-1.0,Immune System;Lysosome Vesicle Biogenesis,R-HSA-168256;R-HSA-432720
ENSG00000118762,2,2,1,1,0,1,1532.498589960519,230312.26972227366,2015-02-02,0,0,0,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,1,0,0,0,16,PKD2,0.31699997,1.0272,-0.19603,1,-1.0,-1.0,VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620916;R-HSA-5620920
ENSG00000118898,2,2,1,0,1,0,275248.1975391687,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,PPL,-0.15999997,-4.1481,-3.9228,2,0.5,0.0,Immune System;Developmental Biology,R-HSA-168256;R-HSA-1266738
ENSG00000118961,3,2,1,0,0,1,3750.4,521818.7070055739,2023-01-18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,LDAH,-0.16999996,1.1827,1.0809,0,-1.0,-1.0,,
ENSG00000118972,3,2,0,0,0,1,7086.73896159931,198739.68381728645,2018-01-31,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,FGF23,-0.60800004,0.82946,1.3812,40,0.5,0.5,Signal Transduction;Disease;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-1643685;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202;R-HSA-597592
ENSG00000119383,2,2,1,0,0,1,442.69958847736626,205433.03502595585,2018-09-28,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,PTPA,0.47000003,1.2584,-0.50581,0,-1.0,-1.0,,
ENSG00000119638,2,2,0,0,1,1,166713.81901525118,228688.0296088316,2017-12-06,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NEK9,0.16299999,2.2041,0.59266,3,-1.0,-1.0,,
ENSG00000119684,3,2,1,0,1,1,45211.17776837424,45211.17776837424,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,MLH3,0.265,2.2858,2.1885,1,-1.0,-1.0,,
ENSG00000119685,2,2,0,0,0,1,8026.326570749936,187674.40497870417,2019-03-04,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,TTLL5,0.11199999,0.90487,1.1162,1,0.5,-1.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000119737,5,2,0,0,0,1,183427.12489668437,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,2,5,GPR75,-0.39499998,0.01619,-0.47163,0,0.5,0.0,,
ENSG00000119820,2,2,0,0,0,1,10672.856469185797,384314.83364002535,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,3,YIPF4,-0.37399995,-1.0472,-1.0654,0,-1.0,-1.0,,
ENSG00000119913,2,2,0,0,0,1,72318.77242389097,172076.47010352428,2024-04-17,1,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,TECTB,-0.25600004,0.46847,-0.15747,1,,,Post-translational protein modification,R-HSA-597592
ENSG00000120029,3,2,1,0,0,1,87748.84971094332,545988.1005477115,2023-01-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,ARMH3,0.23500001,2.2623,0.88716,0,-1.0,-1.0,,
ENSG00000120160,2,2,0,0,0,1,15454.955799405188,95413.07358079177,2016-09-09,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,0,0,3,EQTN,-0.732,-0.32171,0.012332,0,1.0,1.0,,
ENSG00000120280,2,2,0,0,0,1,13219.952617929488,62043.890063935265,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,2,TASL,,,,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000120498,5,2,1,0,0,1,72098.8014618248,223386.61486493575,2021-09-30,8,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,TEX11,,,,0,1.0,0.5,,
ENSG00000120669,2,2,0,0,0,1,17285.31431524312,42362.45324254164,2021-04-19,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,SOHLH2,0.40499997,1.8061,0.41262,0,1.0,0.0,,
ENSG00000120693,6,2,1,0,0,1,48439.20423385324,124801.11117486731,2018-12-03,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,SMAD9,-0.018000007,0.83595,0.25063,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000120860,2,2,1,0,0,1,39053.6332038119,521818.7070055739,2021-01-04,3,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,WASHC3,-0.62100005,-0.20623,-0.70752,0,-1.0,-1.0,,
ENSG00000120903,2,2,0,0,0,1,136665.8227530756,307158.2364521972,2022-10-12,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,3,CHRNA2,-0.19500005,0.89981,0.26989,2,1.0,0.5,,
ENSG00000120915,2,2,0,0,0,0,79107.30622448129,119033.45662439712,2020-10-20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,EPHX2,-0.093000054,0.023314,0.31173,3,0.5,-1.0,Peroxisomal protein import;Arachidonate metabolism,R-HSA-9033241;R-HSA-2142753
ENSG00000121075,2,2,0,0,1,1,189845.9324918578,356440.71671986027,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,1,4,TBX4,0.621,1.3665,-0.12795,0,0.5,0.5,,
ENSG00000121101,3,2,1,0,1,1,1500.8351648351647,427337.4491868293,2013-05-12,4,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,TEX14,-0.042999983,0.56737,0.69194,0,1.0,0.5,,
ENSG00000121671,2,2,1,0,0,1,195005.6685718255,1424218.0900670097,2020-06-15,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,6,CRY2,0.40399998,2.5509,0.47564,5,-1.0,-1.0,Phosphorylation and nuclear translocation of the CRY:PER:kinase complex,R-HSA-9931530
ENSG00000122145,2,2,0,0,0,1,2121.7407966796336,2373.1792752244437,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,TBX22,,,,0,0.75,0.5,,
ENSG00000122481,3,2,0,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,RWDD3,-0.605,0.2346,0.19708,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000122507,3,2,1,0,0,1,6206.927802406586,143413.24457139417,2016-12-15,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,BBS9,0.04100001,1.1685,0.35428,1,-1.0,-1.0,BBSome-mediated cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620922;R-HSA-5620920
ENSG00000122644,2,2,0,0,0,1,75715.46734074537,155552.2805078301,2023-01-18,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ARL4A,0.23000002,1.9688,0.40057,0,0.5,-1.0,,
ENSG00000122729,2,2,0,0,0,1,286746.1002745869,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,ACO1,0.16100001,2.1148,1.2683,2,0.5,-1.0,Iron uptake and transport,R-HSA-917937
ENSG00000122859,3,2,0,0,1,1,75632.36795352261,1424218.0900670097,2018-07-27,0,0,0,2,0,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,NEUROG3,-0.89199996,0.076161,-0.74772,2,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000122861,5,2,1,1,1,1,8844.888938597473,160010.51072069994,2012-11-01,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,9,PLAU,0.148,1.7867,0.70124,2,0.5,0.0,Immune System,R-HSA-168256
ENSG00000122966,3,2,0,0,0,1,634722.4486407059,645988.1975077938,2022-10-12,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CIT,0.647,5.1795,1.1516,5,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000122971,4,2,0,0,0,1,6149.559264013693,521433.73994041845,2018-10-03,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,ACADS,0.148,0.79366,-0.048199,2,0.5,0.0,,
ENSG00000123143,3,2,1,0,1,1,3038.749948464234,43732.839609234245,2018-09-11,1,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,PKN1,0.254,0.61935,-1.6962,6,-1.0,-1.0,Signal Transduction;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,R-HSA-162582;R-HSA-5625886
ENSG00000123240,2,2,1,0,0,1,1636.6024808033078,30049.94565242696,2010-05-02,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,0,0,0,4,OPTN,0.123000026,1.2212,0.34547,10,0.75,-1.0,Signal Transduction;Immune System;TBC/RABGAPs;Rab regulation of trafficking,R-HSA-162582;R-HSA-168256;R-HSA-8854214;R-HSA-9007101
ENSG00000123364,2,2,0,0,0,1,98404.80972454042,366584.236923103,2024-07-19,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,HOXC13,0.17199999,-0.70986,-1.9506,0,1.0,1.0,,
ENSG00000123444,2,2,0,0,0,1,56614.28807963426,62629.11170662631,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,2,KBTBD4,0.07700002,1.756,0.45971,0,-1.0,-1.0,,
ENSG00000123453,2,2,0,0,0,1,42359.490817992155,427337.4491868293,2023-01-18,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,SARDH,-0.08800006,0.0029133,-1.1745,1,0.75,0.0,,
ENSG00000123607,3,2,1,0,0,1,59922.028203228016,60071.18744394619,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,TTC21B,0.16900003,0.6014,0.78902,2,-1.0,-1.0,Signal Transduction;Intraflagellar transport,R-HSA-162582;R-HSA-5620924
ENSG00000123612,2,2,1,0,1,1,427337.4491868293,1424218.0900670097,2020-06-15,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ACVR1C,0.39999998,1.9661,0.23128,3,1.0,0.5,Signal Transduction;Developmental Biology;Regulation of signaling by NODAL,R-HSA-162582;R-HSA-1266738;R-HSA-1433617
ENSG00000124198,3,2,1,0,0,1,4917.108320036471,95776.89591443514,2018-03-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,3,ARFGEF2,0.60899997,4.368,1.9999,1,0.5,-1.0,,
ENSG00000124212,2,2,1,0,0,1,52982.28647069224,116547.04276487474,2018-10-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,PTGIS,-0.14600003,0.16818,0.40455,2,0.5,0.0,Eicosanoids;Arachidonate metabolism,R-HSA-211979;R-HSA-2142753
ENSG00000124214,3,2,1,0,0,1,358386.30063935445,1778690.168860174,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,STAU1,0.673,2.313,0.31687,0,-1.0,-1.0,,
ENSG00000124216,2,2,0,0,1,1,10942.8382813241,309256.4614031486,2015-01-08,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,8,SNAI1,0.10399997,1.3068,-0.64182,3,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000124772,2,2,1,0,0,1,49724.14538298504,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,2,CPNE5,0.305,2.4213,-0.038631,0,0.75,0.0,,
ENSG00000124786,2,2,0,0,0,1,5920.046363037069,87545.45580019058,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,SLC35B3,-0.13800001,1.0811,0.63691,2,-1.0,-1.0,"Transport of vitamins, nucleosides, and related molecules",R-HSA-425397
ENSG00000124831,3,2,1,0,0,1,49127.555514088446,645988.1975077938,2023-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,LRRFIP1,0.18699998,-0.13801,-0.54677,3,-1.0,-1.0,Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-168256;R-HSA-1643685;R-HSA-5663202
ENSG00000125246,2,2,1,0,1,0,42879.69557188197,108816.31098183901,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,3,CLYBL,-0.18599999,-0.33093,-0.61319,0,0.5,-1.0,,
ENSG00000125354,2,2,1,0,0,1,125894.9248389576,141293.18354755783,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,SEPTIN6,,,,0,0.5,-1.0,,
ENSG00000125485,2,2,1,0,0,0,233499.4066209918,233499.4066209918,2023-01-18,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,DDX31,0.09799999,0.65916,0.05079,0,-1.0,0.0,,
ENSG00000125538,3,2,1,0,0,1,248902.39286982678,295500.356444329,2019-07-30,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,4,IL1B,0.35799998,1.7508,0.27967,7,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-6785807
ENSG00000125686,2,2,0,0,0,0,183761.6081180644,185805.42963097955,2021-11-04,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,2,MED1,0.828,3.8093,1.4299,15,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-8957322;R-HSA-1655829
ENSG00000125735,2,2,1,1,0,1,11635.351260982607,258213.8601133611,2011-08-11,0,0,0,0,0,0,0,0,0,1,0,0,0,0,4,0,0,0,0,0,0,0,0,5,TNFSF14,0.08200002,0.85016,0.52947,3,0.75,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000125820,2,2,0,0,0,1,1898.2549302549303,272025.74568937684,2018-08-09,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NKX2-2,0.36,-0.10674,-1.5756,2,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000125821,3,2,1,0,0,1,155552.2805078301,1424218.0900670097,2023-01-18,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DTD1,0.19099998,1.5902,-0.24686,0,-1.0,-1.0,,
ENSG00000125885,5,2,0,0,1,1,64339.76089271658,355284.1215006515,2018-09-07,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,10,MCM8,0.029999971,1.0558,-0.033607,6,-1.0,-1.0,E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Unwinding of DNA,R-HSA-113507;R-HSA-113510;R-HSA-176974
ENSG00000125952,2,2,1,1,0,1,87248.80974040499,598869.4096893278,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,MAX,0.712,1.8678,0.79784,4,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8953750
ENSG00000125998,2,2,1,0,0,1,179853.90625477568,221804.66439828966,2021-07-21,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,FAM83C,-0.32099998,0.32239,-0.021525,0,0.75,0.5,,
ENSG00000126246,2,2,1,1,1,0,233499.4066209918,233499.4066209918,2023-01-18,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,IGFLR1,-0.07000005,-1.293,-1.8215,0,0.5,-1.0,,
ENSG00000126353,2,2,1,0,0,1,53369.71648873449,145011.35140303092,2019-03-28,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,CCR7,0.33999997,2.6932,0.92674,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000126778,4,2,1,0,0,1,46735.522883704674,521818.7070055739,2014-09-14,6,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,SIX1,0.30800003,1.0287,-0.076723,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000126804,2,2,1,0,0,1,76062.08958444146,215157.94798738702,2021-11-16,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,2,ZBTB1,0.61899996,4.0735,1.8901,0,-1.0,-1.0,,
ENSG00000126838,2,2,1,0,1,1,75715.46734074537,320319.7525060048,2023-01-18,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,PZP,0.069000006,1.2626,1.1308,0,1.0,0.5,,
ENSG00000127129,2,2,1,0,0,1,77544.39441764928,189557.6027707886,2022-12-10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,EDN2,0.031000018,0.26787,0.20324,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000127318,3,2,0,1,0,1,41398.32424291887,233499.4066209918,2021-08-26,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,2,10,IL22,-0.52900004,0.12619,-0.33715,2,0.5,1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-5663202
ENSG00000128045,2,2,0,0,0,1,100711.28404230655,127123.38472704956,2021-09-30,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RASL11B,0.022000015,1.2276,-0.5326,0,0.5,0.0,,
ENSG00000128245,3,2,0,0,0,1,260210.21963428933,515513.2178404211,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,5,YWHAH,0.40100002,2.5625,-0.8725,8,1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-75035
ENSG00000128274,4,2,1,0,0,1,17243.0319680403,407080.5516610372,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,6,11,A4GALT,-0.393,-0.27835,-1.1415,1,-1.0,0.0,,
ENSG00000128591,11,2,1,0,1,1,8389.22186817101,756470.9740366563,2021-01-25,0,0,0,0,17,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,19,FLNC,0.576,5.9661,2.4274,1,0.5,0.0,,
ENSG00000128594,2,2,1,0,0,1,254373.32653042395,1129585.974638378,2020-05-06,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,LRRC4,0.541,2.1144,-1.0608,0,0.5,0.0,,
ENSG00000128602,3,2,0,0,1,1,60311.48086819863,85439.42346498996,2018-10-29,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,1,5,SMO,0.29400003,1.4693,-0.23049,5,-1.0,0.0,Signal Transduction;BBSome-mediated cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-162582;R-HSA-5620922;R-HSA-5620920
ENSG00000128610,2,2,0,0,0,1,399832.86333511875,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,2,FEZF1,0.58000004,1.3867,0.66509,0,0.5,0.5,,
ENSG00000128655,2,2,0,0,1,1,21381.561783724817,134717.76666505725,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,4,PDE11A,-0.11800003,0.27814,1.2828,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000128709,2,2,0,0,0,1,180089.50342935527,384314.83364002535,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,3,HOXD9,-0.655,-1.7586,-2.585,0,0.5,0.0,,
ENSG00000128928,2,2,1,0,0,0,3721.3983572895277,31819.668816367906,2013-04-14,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,IVD,0.22399998,1.648,0.9894,2,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000129170,3,2,1,0,0,1,25495.37001303781,306980.8575290048,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,5,CSRP3,-0.30700004,0.46588,-0.28843,0,0.5,0.5,,
ENSG00000129595,5,2,1,0,0,1,9539.551199137346,196178.71491042234,2017-02-14,8,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,EPB41L4A,-0.26100004,-1.4707,-0.69722,0,-1.0,0.0,,
ENSG00000129757,4,2,0,0,0,1,93616.86016863462,575147.0632428399,2021-04-08,1,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,CDKN1C,-0.94299996,-1.85,-4.566,2,0.5,0.0,Disease,R-HSA-1643685
ENSG00000129951,4,2,1,0,0,1,11679.569250778799,324308.4770735607,2020-01-20,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,PLPPR3,-0.03400004,-5.509,-6.7376,1,0.5,0.5,Signal Transduction;Lysosphingolipid and LPA receptors,R-HSA-162582;R-HSA-419408
ENSG00000130147,2,2,0,0,0,1,104792.02869450308,104792.02869450308,2018-05-21,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,SH3BP4,0.342,1.7255,0.26063,1,0.5,-1.0,Amino acids regulate mTORC1;Cellular response to starvation,R-HSA-9639288;R-HSA-9711097
ENSG00000130402,2,2,1,0,0,1,53702.37852035605,53702.37852035605,2023-06-07,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,ACTN4,0.76199996,5.6941,0.020859,2,-1.0,-1.0,,
ENSG00000130429,2,2,1,0,0,0,21201.639474894007,21201.639474894007,2023-03-22,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ARPC1B,0.12400001,0.86139,0.34225,4,0.5,0.0,Signal Transduction;Immune System;Developmental Biology;Disease,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685
ENSG00000130477,4,2,0,0,0,1,1055.5815170008718,95413.07358079177,2009-09-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,2,0,0,0,8,UNC13A,0.611,5.2074,-1.4206,0,0.75,0.5,,
ENSG00000130720,2,2,0,0,0,0,765591.3646788632,1778690.168860174,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,FIBCD1,-0.53,-0.21282,-1.1199,0,0.75,0.5,,
ENSG00000130783,2,2,0,0,0,0,14775.77846934071,275021.63051358337,2011-02-01,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,6,CCDC62,-0.011999965,1.3803,0.36497,0,1.0,0.5,,
ENSG00000131023,2,2,0,0,0,0,17115.61307125707,360605.992793193,2017-06-12,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,LATS1,0.681,3.8572,0.1986,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000131067,6,2,1,0,0,1,60117.99815104478,279825.00883385167,2021-04-08,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,7,GGT7,0.32,1.3697,-0.37561,3,-1.0,-1.0,Glutathione conjugation;Aflatoxin activation and detoxification;Glutathione synthesis and recycling;Phase II - Conjugation of compounds,R-HSA-156590;R-HSA-5423646;R-HSA-174403;R-HSA-156580
ENSG00000131187,2,2,1,1,0,1,43732.839609234245,196816.54442141854,2021-09-30,0,0,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,F12,-0.286,-0.22747,-1.4778,3,1.0,0.5,Disease,R-HSA-1643685
ENSG00000131697,2,2,1,0,0,1,3914.644422310757,13785.673050095118,2019-09-27,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NPHP4,-0.18299997,-0.325,-0.53866,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000131828,2,2,0,0,0,1,275021.63051358337,383158.3001114715,2023-01-18,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PDHA1,,,,4,0.5,-1.0,Signal Transduction;Regulation of pyruvate metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism,R-HSA-162582;R-HSA-9861718;R-HSA-204174;R-HSA-70268
ENSG00000131981,3,2,1,0,1,0,156470.480665571,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,2,4,LGALS3,-0.15199995,0.22418,0.25425,4,0.5,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000132205,2,2,1,0,0,1,645988.1975077938,1424218.0900670097,2024-02-19,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,EMILIN2,-0.04700005,-0.88715,-1.1799,1,0.5,0.0,,
ENSG00000132256,2,2,0,0,1,1,122069.83349127392,464892.4593283075,2017-12-06,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,TRIM5,-0.032999992,0.073201,-0.75971,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000132294,2,2,0,0,0,1,51573.04760983911,1424218.0900670097,2024-02-19,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,EFR3A,0.032999992,0.15178,-0.27386,0,0.5,-1.0,,
ENSG00000132334,2,2,0,0,0,1,606.6666666666666,427337.4491868293,2020-12-11,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PTPRE,0.365,2.3507,0.28841,0,0.5,0.0,,
ENSG00000132356,4,2,1,0,0,1,2789.433363830436,196816.54442141854,2011-10-30,8,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,PRKAA1,0.42400002,3.8943,0.48865,5,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;MTOR signalling,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-165159
ENSG00000132446,2,2,0,0,0,1,4686.237429198936,38970.013185525226,2021-03-23,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,FTHL17,,,,0,1.0,1.0,,
ENSG00000132640,4,2,0,0,0,1,54580.46858134564,294763.3750742061,2021-02-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,BTBD3,0.473,3.6698,-0.10489,0,0.5,-1.0,,
ENSG00000132676,2,2,0,0,0,1,18163.274234023927,521818.7070055739,2023-01-18,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DAP3,0.29400003,0.75609,0.43464,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000132692,3,2,0,1,0,1,26020.4828907398,95905.57783546533,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,2,4,BCAN,0.305,0.79975,0.19022,12,1.0,0.0,Disease;Glycosaminoglycan-protein linkage region biosynthesis,R-HSA-1643685;R-HSA-1971475
ENSG00000132703,3,2,0,1,0,1,26020.4828907398,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,3,APCS,-0.826,-0.68722,-0.014758,1,1.0,0.5,,
ENSG00000132793,2,2,1,0,0,1,38092.548464040476,120127.55185031837,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,2,LPIN3,0.004000008,1.5265,1.1216,4,-1.0,0.0,Depolymerization of the Nuclear Lamina,R-HSA-4419969
ENSG00000132849,2,2,0,0,1,0,240639.50239824195,1424218.0900670097,2018-10-08,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,4,PATJ,0.15899998,1.685,1.6551,2,-1.0,-1.0,Tight junction interactions;Disease,R-HSA-420029;R-HSA-1643685
ENSG00000132965,3,2,1,0,0,1,191477.8325312717,229954.37886203246,2023-12-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,4,ALOX5AP,0.20499998,1.0133,0.1326,3,0.75,-1.0,Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonate metabolism,R-HSA-2142691;R-HSA-2142753
ENSG00000133019,2,2,0,0,0,1,75846.20940126595,323648.5577791949,2019-02-25,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,5,CHRM3,0.58000004,2.6775,0.51305,3,0.5,0.0,Signal Transduction;Amine ligand-binding receptors,R-HSA-162582;R-HSA-375280
ENSG00000133056,5,2,1,0,0,1,6489.4621952607295,355284.1215006515,2020-09-04,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6,PIK3C2B,0.44300002,3.0947,1.4685,1,-1.0,-1.0,,
ENSG00000133067,5,2,1,0,0,1,11576.255781975746,23926.062302686023,2013-04-01,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,LGR6,0.11400002,1.3471,0.23676,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000133195,3,2,0,0,1,1,32254.717802479194,1424218.0900670097,2012-11-01,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,10,SLC39A11,-0.24699998,0.18987,0.66266,0,-1.0,-1.0,,
ENSG00000133937,4,2,1,0,0,1,5414.650230111769,156470.480665571,2017-02-24,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,GSC,-0.398,-1.8904,-2.8545,3,0.5,0.5,Developmental Biology;Formation of definitive endoderm,R-HSA-1266738;R-HSA-9823730
ENSG00000134020,2,2,0,0,0,1,20680.094509485723,125392.97184483419,2023-01-18,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PEBP4,-0.26600003,-0.54136,-0.41422,0,0.5,0.0,,
ENSG00000134121,2,2,0,1,0,1,5635.811167292289,6736.511707755347,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,CHL1,0.32200003,-2.629,-1.7361,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000134138,9,2,0,0,0,1,251087.15447712908,1778690.168860174,2016-08-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,1,0,0,0,10,MEIS2,0.745,3.428,0.75485,0,0.5,0.0,,
ENSG00000134183,2,2,0,0,0,1,85474.33432267047,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,3,GNAT2,-0.176,1.4883,0.74807,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000134326,2,2,0,0,0,1,1492.3520749665329,180089.50342935527,2021-11-04,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,CMPK2,-0.70799994,-2.6199,-3.1446,0,0.5,0.0,,
ENSG00000134343,5,2,0,0,0,1,3031.996829799881,306980.8575290048,2014-10-26,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,4,6,ANO3,0.08899999,2.8578,0.20387,2,0.75,0.5,Disease;Stimuli-sensing channels,R-HSA-1643685;R-HSA-2672351
ENSG00000134463,3,2,0,0,0,1,1321.7688442211056,340825.7076940272,2019-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,1,10,ECHDC3,-0.61399996,-0.62354,-1.0311,0,0.5,-1.0,,
ENSG00000134571,3,2,1,0,0,1,97822.37358221927,1778690.168860174,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,MYBPC3,0.08499998,0.10236,-1.6331,1,1.0,0.5,,
ENSG00000134697,3,2,1,0,0,1,61563.70725571889,444537.33605315426,2021-02-24,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,GNL2,0.18800002,1.1348,0.78654,0,-1.0,-1.0,,
ENSG00000134812,4,2,0,0,1,1,46977.28346057821,90664.10805347394,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,2,0,0,0,0,5,CBLIF,0.13499999,0.66559,0.65662,4,1.0,1.0,Disease,R-HSA-1643685
ENSG00000134873,3,2,1,0,0,1,66821.18426408028,384314.83364002535,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,3,CLDN10,-0.20799994,1.1408,0.054195,2,0.75,0.0,Tight junction interactions,R-HSA-420029
ENSG00000135074,5,2,1,0,1,1,32217.23287013741,502231.5406594711,2017-02-06,0,0,0,0,1,0,0,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,16,ADAM19,0.26099998,1.5181,-0.27955,2,-1.0,0.0,,
ENSG00000135077,2,2,0,1,0,1,79958.75176875875,332375.5317723021,2021-09-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,HAVCR2,0.20899999,0.82085,0.010616,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000135097,3,2,0,0,0,1,26561.371714038676,42193.37905314073,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,MSI1,0.476,2.5071,-0.87675,1,1.0,0.0,Developmental Biology;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-9010553
ENSG00000135175,2,2,0,0,0,1,42061.79578384488,298504.9722193353,2020-09-04,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,OCM2,0.060000002,0.56578,0.7844,0,,,,
ENSG00000135218,2,2,1,0,0,1,25495.37001303781,112218.78632625614,2023-12-08,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,CD36,-0.95299995,-1.819,1.0594,15,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Free fatty acids regulate insulin secretion;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-400451;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-6785807
ENSG00000135312,2,2,0,0,0,1,4428.676231326727,40127.05632528215,2021-02-17,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,2,HTR1B,0.28100002,1.3271,0.41388,2,0.5,0.5,Signal Transduction;Serotonin receptors;Amine ligand-binding receptors,R-HSA-162582;R-HSA-390666;R-HSA-375280
ENSG00000135333,3,2,0,0,0,1,208254.04981354356,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,5,EPHA7,0.718,3.0052,-0.32905,3,0.75,0.0,Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-1266738;R-HSA-3928665
ENSG00000135390,2,2,1,0,0,1,191895.42310022408,384314.83364002535,2023-11-02,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,2,ATP5MC2,-0.47099996,1.307,0.41889,2,-1.0,-1.0,Formation of ATP by chemiosmotic coupling;Cristae formation,R-HSA-163210;R-HSA-8949613
ENSG00000135441,2,2,1,0,0,0,10353.132295719844,50257.8675688925,2019-12-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,3,5,BLOC1S1,0.027999997,-0.48422,-0.93184,2,-1.0,-1.0,Lysosome Vesicle Biogenesis,R-HSA-432720
ENSG00000135636,4,2,0,0,0,1,27252.506771148335,356440.71671986027,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,2,6,DYSF,0.16399997,1.3979,0.45204,1,0.5,-1.0,,
ENSG00000135776,3,2,0,0,0,1,93616.86016863462,1424218.0900670097,2018-07-27,0,0,0,2,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,ABCB10,-0.14199996,0.35076,-1.6738,1,0.5,-1.0,,
ENSG00000135823,2,2,1,0,0,1,3328.0781640536243,12618.041744442558,2011-06-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,4,STX6,0.16500002,1.074,-0.13115,2,-1.0,-1.0,,
ENSG00000135960,3,2,0,0,1,1,17802.759575335567,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,3,EDAR,0.073000014,1.2955,0.76158,1,0.5,0.5,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000135972,2,2,0,0,0,1,3182.5825880914163,94665.79117035728,2022-01-31,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,MRPS9,-0.26,0.40878,0.22179,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000136111,4,2,1,0,1,1,1131.651289009498,141293.18354755783,2018-06-20,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,TBC1D4,0.02700001,1.8015,0.74532,1,0.5,-1.0,,
ENSG00000136122,2,2,0,0,0,0,7113.6472583678205,80033.9345349278,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,2,BORA,0.241,1.6574,1.0348,2,-1.0,0.0,,
ENSG00000136235,2,2,1,1,1,1,47935.61449674282,263416.51565448404,2014-07-27,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,0,0,0,5,GPNMB,-0.49600005,0.59195,0.35324,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000136237,2,2,0,0,0,1,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,RAPGEF5,0.259,0.16206,-1.1104,0,0.75,0.0,,
ENSG00000136250,3,2,1,0,0,1,225895.43837715342,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,AOAH,0.12400001,0.94951,0.057685,0,0.5,0.0,,
ENSG00000136271,2,2,1,0,0,1,219793.50457789513,464892.4593283075,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,DDX56,0.09500003,-0.016121,0.12701,0,-1.0,-1.0,,
ENSG00000136448,2,2,1,0,0,1,358386.30063935445,1778690.168860174,2021-11-04,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,7,NMT1,0.68200004,3.2164,0.52545,4,-1.0,-1.0,Disease;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-1643685;R-HSA-162587;R-HSA-162599
ENSG00000136485,2,2,1,0,0,1,358386.30063935445,1424218.0900670097,2021-11-04,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DCAF7,0.765,5.6137,1.208,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000136504,2,2,0,0,0,1,83710.65550453523,83710.65550453523,2022-12-23,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,KAT7,0.725,4.3936,0.4364,1,-1.0,-1.0,,
ENSG00000136603,3,2,1,0,0,1,7151.337105494782,1778690.168860174,2020-09-04,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,21,SKIL,0.47500002,0.89894,-0.51261,1,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-2173793
ENSG00000136929,2,2,1,0,0,1,100358.73833384078,183579.49764748462,2022-08-20,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,2,HEMGN,0.058000028,0.94695,0.29948,0,1.0,0.5,,
ENSG00000136936,5,2,0,0,1,1,15258.981958714061,189557.6027707886,2021-09-30,9,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,11,XPA,-0.06799996,-0.55916,-1.0158,4,-1.0,-1.0,Formation of TC-NER Pre-Incision Complex;Formation of Incision Complex in GG-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-6781823;R-HSA-5696395;R-HSA-6782135;R-HSA-6781827
ENSG00000136999,2,2,1,1,1,1,100857.20347685824,242123.900206037,2018-08-13,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6,CCN3,0.03399998,0.12975,-1.1517,0,1.0,0.0,,
ENSG00000137077,2,2,0,1,0,1,2209.8301559792026,183438.04190920538,2012-12-01,0,1,0,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,11,CCL21,-0.123000026,0.49282,0.10836,2,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000137203,2,2,1,0,0,1,21014.7618737575,96018.8961005241,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,5,TFAP2A,0.666,2.4812,0.23073,10,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Post-translational protein modification;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-597592;R-HSA-8864260
ENSG00000137251,2,2,0,0,0,1,21201.639474894007,21201.639474894007,2023-03-22,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TINAG,-0.362,-1.5975,-1.3993,0,1.0,0.5,,
ENSG00000137673,3,2,1,0,0,1,4447.295196209435,521818.7070055739,2013-04-01,9,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,MMP7,-0.09500003,-0.48441,-0.6118,5,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000137710,3,2,1,0,0,1,54391.03477538057,151416.12986435954,2021-09-30,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,RDX,0.458,1.5649,-0.04844,3,0.5,-1.0,Developmental Biology;Recycling pathway of L1,R-HSA-1266738;R-HSA-437239
ENSG00000137713,3,2,1,0,0,1,180344.38517486732,384314.83364002535,2022-10-20,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,1,0,0,0,0,0,0,4,PPP2R1B,0.045000017,0.93519,0.7579,36,0.5,-1.0,"Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;E2F mediated regulation of DNA replication;RNA Polymerase II Transcription;Cyclin A/B1/B2 associated events during G2/M transition;Gene expression (Transcription);MASTL Facilitates Mitotic Progression;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;APC truncation mutants have impaired AXIN binding;Truncations of AMER1 destabilize the destruction complex;AXIN missense mutants destabilize the destruction complex;Signaling by AMER1 mutants;Signaling by APC mutants;Signaling by AXIN mutants;Inhibition of replication initiation of damaged DNA by RB1/E2F1;ERKs are inactivated;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers",R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-113510;R-HSA-73857;R-HSA-69273;R-HSA-74160;R-HSA-2465910;R-HSA-9634600;R-HSA-5467337;R-HSA-5467348;R-HSA-5467340;R-HSA-4839748;R-HSA-4839744;R-HSA-4839735;R-HSA-113501;R-HSA-202670;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202
ENSG00000137812,3,2,0,0,1,1,24863.82699583697,521818.7070055739,2020-12-08,5,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,KNL1,0.634,-0.4989,0.7373,7,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000137824,2,2,1,0,0,1,50087.52781663962,220837.49604317299,2023-01-18,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RMDN3,0.19800001,0.81805,-0.085385,0,-1.0,-1.0,,
ENSG00000137877,2,2,1,0,1,1,62043.890063935265,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,SPTBN5,-0.35899997,-4.3435,-4.5603,4,0.75,0.0,Signal Transduction;Developmental Biology;Interaction between L1 and Ankyrins;Post-translational protein modification,R-HSA-162582;R-HSA-1266738;R-HSA-445095;R-HSA-597592
ENSG00000137947,2,2,1,0,1,1,252346.18526092035,1778690.168860174,2018-08-13,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,GTF2B,0.125,2.4583,-0.018396,9,-1.0,-1.0,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;RNA Polymerase II Pre-transcription Events;Transcription of the HIV genome;RNA polymerase II transcribes snRNA genes;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-674695;R-HSA-167172;R-HSA-6807505;R-HSA-162587;R-HSA-162599
ENSG00000138303,3,2,1,0,0,0,205425.60717824215,466632.7979326389,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,3,ASCC1,-0.0019999743,1.2584,0.39595,1,-1.0,-1.0,DNA Damage Reversal,R-HSA-73942
ENSG00000138433,2,2,1,0,0,1,960369.5592648841,1424218.0900670097,2021-05-27,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,CIRSR,0.028999984,1.2537,-0.52526,0,-1.0,-1.0,,
ENSG00000138435,2,2,0,0,0,1,116388.33957200912,545988.1005477115,2018-06-11,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,CHRNA1,0.05699998,1.6855,0.26503,2,1.0,0.5,,
ENSG00000138594,2,2,1,0,0,1,183427.12489668437,598869.4096893278,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,3,TMOD3,0.232,0.81686,0.12315,3,-1.0,-1.0,Signal Transduction;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9706574
ENSG00000138613,3,2,1,0,1,1,1321.7688442211056,340825.7076940272,2021-09-07,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,0,0,0,0,0,0,6,APH1B,-0.32700002,0.34319,-0.63176,13,1.0,-1.0,Signal Transduction;Developmental Biology;Disease;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-3928665;R-HSA-9006934;R-HSA-5663202
ENSG00000138772,2,2,1,0,0,1,13129.29816360601,1778690.168860174,2012-03-25,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,3,ANXA3,-0.24399996,0.2345,0.44067,1,0.5,-1.0,,
ENSG00000138785,4,2,1,0,1,1,39507.00295325707,562534.7696387965,2017-02-06,0,1,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,5,INTS12,0.468,1.7414,-0.15931,1,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000138814,2,2,1,0,0,1,1129585.974638378,1424218.0900670097,2022-07-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,PPP3CA,0.75699997,4.5031,0.096954,5,0.5,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000138892,2,2,0,0,0,0,67142.73298165268,254373.32653042395,2020-05-06,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TTLL8,-0.19200003,0.50522,-0.17983,1,1.0,1.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000139263,3,2,0,0,0,1,60311.48086819863,356440.71671986027,2019-01-21,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,2,6,LRIG3,0.195,1.4792,0.24157,0,-1.0,0.0,,
ENSG00000139289,4,2,0,0,0,1,7174.748443718747,645988.1975077938,2015-10-01,2,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,PHLDA1,-0.40900004,-1.3235,-1.8376,2,0.5,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000139292,2,2,0,0,1,1,18290.737976096676,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,LGR5,0.26099998,0.63088,0.53496,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000139323,3,2,1,0,0,1,171880.2916512608,502231.5406594711,2022-04-08,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,POC1B,0.032999992,0.31956,0.54236,0,-1.0,-1.0,,
ENSG00000139445,2,2,0,0,1,1,54391.03477538057,415452.66715166246,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,FOXN4,0.565,1.8212,-0.10786,0,1.0,0.5,,
ENSG00000139624,2,2,1,0,1,1,5105.1756007393715,358386.30063935445,2021-10-15,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,CERS5,0.018999994,1.4045,0.86997,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000140015,2,2,0,0,0,1,40569.14132202889,40569.14132202889,2023-11-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,2,KCNH5,0.445,3.7422,0.84818,1,0.5,0.5,,
ENSG00000140511,5,2,0,0,0,1,14893.547912975559,270267.2992956902,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,6,HAPLN3,-0.28400004,0.13051,0.36902,0,-1.0,0.0,,
ENSG00000140519,2,2,1,0,1,1,383158.3001114715,500292.45069431677,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,RHCG,0.083000004,0.23274,0.11648,1,0.5,0.0,,
ENSG00000140526,6,2,1,0,0,1,51097.36703420978,394357.452283155,2017-12-06,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,16,ABHD2,0.43,2.6532,0.5942,0,0.5,-1.0,,
ENSG00000140543,4,2,1,0,0,1,6436.334040236144,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,0,0,0,1,0,0,0,12,DET1,0.30800003,0.40873,-1.1082,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000140545,6,2,1,0,1,1,52982.28647069224,279825.00883385167,2021-09-30,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,7,MFGE8,-0.044999957,0.29559,-0.30926,3,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000140612,2,2,0,0,0,1,21724.94108458234,31185.468149065946,2023-01-18,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SEC11A,0.065,1.2355,-0.22168,5,-1.0,-1.0,Disease;Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-1643685;R-HSA-72766;R-HSA-1799339
ENSG00000140961,2,2,1,0,0,1,170747.68362649818,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,OSGIN1,-0.43400002,-2.3438,-2.0499,0,1.0,0.0,,
ENSG00000140986,4,2,1,0,1,1,57060.02774555957,645988.1975077938,2018-06-11,0,0,0,0,22,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,25,RPL3L,-0.32099998,-0.87076,-2.1513,13,0.5,0.5,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000141232,3,2,1,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,TOB1,0.73399997,2.4945,0.19423,0,-1.0,-1.0,,
ENSG00000141469,3,2,1,0,1,1,8480.607888313525,271154.8062006991,2011-07-12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,7,SLC14A1,-0.110000014,0.59808,0.76498,1,0.5,0.0,,
ENSG00000141627,2,2,1,0,0,1,183427.12489668437,183427.12489668437,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,DYM,-0.08099997,0.92126,0.25829,0,-1.0,-1.0,,
ENSG00000141668,2,2,0,0,0,1,1031.590909090909,323648.5577791949,2013-03-17,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,CBLN2,-0.11800003,0.6369,-1.8867,0,1.0,0.5,,
ENSG00000141736,3,2,1,0,1,1,15223.454539395489,28923.750134754748,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,3,ERBB2,0.482,4.2475,1.0641,30,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Constitutive Signaling by Overexpressed ERBB2;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-9634285;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202;R-HSA-8864260
ENSG00000141956,2,2,1,0,0,1,1173.5007132667617,1129585.974638378,2022-07-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,PRDM15,0.39200002,3.1503,0.17563,0,-1.0,-1.0,,
ENSG00000142089,2,2,1,0,0,1,38092.548464040476,183579.49764748462,2019-09-01,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,2,IFITM3,-0.66700006,0.60326,-0.32248,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000142168,2,2,0,0,1,1,5811.029019802218,95413.07358079177,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,SOD1,-0.51400006,1.2237,-0.30519,3,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000142233,2,2,0,0,0,1,5733.966655088572,196816.54442141854,2016-08-23,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,NTN5,-0.607,-1.0104,-2.8853,0,0.5,0.0,,
ENSG00000142632,2,2,1,0,1,1,90049.68162979394,180089.50342935527,2021-08-24,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,ARHGEF19,-0.32700002,-0.51321,-0.34373,5,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000143028,3,2,1,0,0,0,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,SYPL2,-0.13800001,0.38207,-0.23313,0,0.75,0.0,,
ENSG00000143164,2,2,1,0,0,1,9495.008807985907,168116.01355658393,2011-10-30,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,DCAF6,0.43300003,1.9044,0.57186,1,0.75,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000143183,5,2,1,0,0,1,2053.7087549494063,414433.58532016096,2011-05-01,0,0,0,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,46,TMCO1,-0.40400004,1.376,0.0294,0,-1.0,-1.0,,
ENSG00000143376,3,2,0,0,0,1,112025.85662838118,322220.1169395476,2021-11-04,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,SNX27,0.48000002,1.7731,-0.48442,0,-1.0,-1.0,,
ENSG00000143401,2,2,1,0,0,1,44660.84794838759,62282.85017627731,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,3,ANP32E,0.23799998,2.2372,1.6317,0,-1.0,-1.0,,
ENSG00000143436,2,2,1,0,1,1,112025.85662838118,163819.92615728398,2021-09-30,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,MRPL9,-0.35899997,-0.5417,-0.64476,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000143457,4,2,0,0,0,1,40890.880548672525,125392.97184483419,2014-09-14,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,GOLPH3L,-0.51400006,1.0684,0.53261,0,-1.0,-1.0,,
ENSG00000143515,3,2,1,0,0,1,9724.911607071434,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,4,ATP8B2,0.376,4.5518,2.2723,1,-1.0,-1.0,,
ENSG00000143622,2,2,1,0,0,1,32254.717802479194,230312.26972227366,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,3,RIT1,0.477,1.5009,1.0153,1,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000143674,2,2,1,0,1,1,260210.21963428933,521818.7070055739,2023-01-18,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,MAP3K21,-0.06099999,0.051879,-1.6219,0,0.5,0.0,,
ENSG00000143740,2,2,1,0,0,1,40349.61643935261,187674.40497870417,2021-08-24,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,4,SNAP47,0.17400002,0.99488,1.1192,0,-1.0,-1.0,,
ENSG00000143761,3,2,0,0,0,1,17426.74725331541,252346.18526092035,2018-08-13,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,4,ARF1,0.753,4.1558,-0.62933,12,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Lysosome Vesicle Biogenesis;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-8856688;R-HSA-6811434;R-HSA-432720;R-HSA-597592
ENSG00000143847,5,2,1,0,0,0,2274.83989021043,645988.1975077938,2017-04-17,0,0,0,0,26,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,27,PPFIA4,0.08399999,0.59933,-0.75505,6,1.0,0.0,Acetylcholine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Receptor-type tyrosine-protein phosphatases;Neurotransmitter release cycle,R-HSA-264642;R-HSA-210500;R-HSA-212676;R-HSA-181429;R-HSA-388844;R-HSA-112310
ENSG00000143858,2,2,0,0,0,1,107949.90929360976,207220.14223281175,2023-01-18,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,SYT2,0.41500002,2.565,1.4423,4,1.0,0.5,Neurotoxicity of clostridium toxins;Disease,R-HSA-168799;R-HSA-1643685
ENSG00000144035,2,2,1,0,0,1,90566.66054026398,90566.66054026398,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,NAT8,-0.888,-1.224,-0.58989,1,1.0,0.5,,
ENSG00000144118,3,2,1,1,0,0,28292.123952140868,220837.49604317299,2020-05-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,RALB,-0.17700005,2.2621,0.31109,1,1.0,-1.0,Signal Transduction;p38MAPK events;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-171007;R-HSA-9006934
ENSG00000144320,3,2,1,0,0,1,47738.39631923835,1778690.168860174,2019-03-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,4,LNPK,0.036000013,0.16071,0.44472,0,-1.0,-1.0,,
ENSG00000144426,6,2,1,0,1,1,52982.28647069224,327782.2658449885,2011-03-06,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,12,NBEAL1,0.092999995,1.1655,0.28953,0,-1.0,0.0,,
ENSG00000144468,2,2,1,0,0,1,61130.50361100096,414433.58532016096,2021-09-30,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,RHBDD1,-0.42900002,0.21734,-0.32523,0,-1.0,-1.0,,
ENSG00000144649,3,2,1,1,1,1,78906.83616868555,356440.71671986027,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,2,7,GASK1A,-0.33500004,1.1043,-0.0039771,0,-1.0,0.0,,
ENSG00000144771,2,2,0,0,0,1,123127.18790121445,1424218.0900670097,2018-10-08,0,0,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,LRTM1,-0.41499996,-0.47969,-0.30223,0,0.5,0.5,,
ENSG00000145358,2,2,1,0,1,1,100075.58738100652,384314.83364002535,2024-04-26,6,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,8,DDIT4L,-0.26600003,0.029146,0.45038,0,0.75,0.0,,
ENSG00000145687,2,2,0,0,0,1,150669.89240227733,360605.992793193,2021-05-17,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,SSBP2,0.435,1.2577,-0.43544,0,-1.0,-1.0,,
ENSG00000145908,4,2,1,0,0,1,7741.739669934235,87248.80974040499,2008-06-29,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,11,ZNF300,0.06300002,1.1808,0.56779,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000145949,2,2,1,0,0,1,50607.05064309989,56432.02918263991,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,MYLK4,-0.15799999,0.76475,0.67209,0,0.75,0.5,,
ENSG00000145990,2,2,0,0,0,1,270267.2992956902,384314.83364002535,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,GFOD1,0.37,2.5437,0.11558,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000146013,2,2,0,0,0,0,248902.39286982678,248902.39286982678,2019-07-30,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,2,GFRA3,0.171,1.785,0.012136,2,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000146021,2,2,1,0,0,1,30756.747122207347,756470.9740366563,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,KLHL3,0.623,3.575,1.4265,2,0.5,0.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000146038,3,2,0,0,0,1,7860.029549549549,409691.21276290494,2020-03-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,DCDC2,-0.062000036,0.58407,-0.29261,0,0.5,0.0,,
ENSG00000146205,3,2,1,0,1,1,51573.04760983911,521818.7070055739,2021-01-04,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,23,ANO7,-0.15900004,-1.2481,-1.7046,2,0.5,0.5,Disease;Stimuli-sensing channels,R-HSA-1643685;R-HSA-2672351
ENSG00000146350,2,2,1,0,1,1,2755.335499659004,196178.71491042234,2018-12-10,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,TBC1D32,0.015999973,0.61374,-0.16767,0,0.5,0.0,,
ENSG00000146409,2,2,1,0,1,1,17541.24297681336,263416.51565448404,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,2,SLC18B1,-0.53699994,-0.68466,-0.64173,0,-1.0,-1.0,,
ENSG00000146839,2,2,1,0,1,1,576.1087314662274,189557.6027707886,2022-03-28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,ZAN,-0.052999973,0.99524,0.085541,0,,,,
ENSG00000147183,2,2,0,0,0,1,3114.677466385874,58392.07057732553,2012-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,2,CPXCR1,,,,0,1.0,1.0,,
ENSG00000147419,2,2,1,0,0,1,11422.490550188997,1778690.168860174,2022-07-14,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,CCDC25,0.07700002,1.3791,-0.024321,0,-1.0,-1.0,,
ENSG00000147481,2,2,0,0,0,1,358386.30063935445,512656.0695323204,2021-11-04,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,SNTG1,0.362,-0.66504,-0.83542,0,0.5,0.5,,
ENSG00000147576,2,2,1,0,0,0,195005.6685718255,383158.3001114715,2023-01-18,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ADHFE1,0.03399998,-0.026422,0.95682,1,0.5,0.0,,
ENSG00000147596,2,2,0,0,0,1,1173.5007132667617,1122672.658801146,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,PRDM14,0.464,2.1196,0.38418,1,,,Developmental Biology,R-HSA-1266738
ENSG00000147642,2,2,0,0,0,1,165565.7343481966,165565.7343481966,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,2,SYBU,0.10699999,1.2637,0.50898,0,0.5,0.0,,
ENSG00000148110,2,2,0,0,0,1,9371.068095280261,645988.1975077938,2023-01-11,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,MFSD14B,0.15799999,1.4513,-0.43706,0,-1.0,-1.0,,
ENSG00000148123,3,2,1,0,0,1,190279.23963861223,275021.63051358337,2023-01-18,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,PLPPR1,0.462,2.2188,0.52948,1,0.75,0.5,Signal Transduction;Lysosphingolipid and LPA receptors,R-HSA-162582;R-HSA-419408
ENSG00000148156,3,2,0,0,0,1,5440.423435642404,46437.13674418605,2023-01-18,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,ACTL7B,-0.41400003,-0.60995,-0.71434,0,1.0,1.0,,
ENSG00000148175,2,2,0,0,0,1,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,STOM,-0.12600005,1.4046,0.69537,9,-1.0,-1.0,Signal Transduction;Immune System;Stimuli-sensing channels,R-HSA-162582;R-HSA-168256;R-HSA-2672351
ENSG00000148357,2,2,1,1,1,1,49716.917726985695,197485.87952538437,2021-08-11,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,HMCN2,0.06099999,2.6967,1.7485,0,0.5,0.0,,
ENSG00000148672,2,2,1,0,0,1,2287.4930875576038,104168.97660865163,2020-04-01,0,0,0,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,0,0,0,0,5,GLUD1,0.25199997,2.9685,1.0488,3,0.75,-1.0,,
ENSG00000148704,4,2,0,0,0,1,1225.1182294700059,5414.650230111769,2012-08-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,6,VAX1,0.32200003,0.20949,-1.9689,0,1.0,1.0,,
ENSG00000148798,2,2,1,0,0,1,355284.1215006515,1424218.0900670097,2024-02-19,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,INA,-0.48099995,0.36437,-0.37853,0,0.75,0.5,,
ENSG00000148935,3,2,1,0,0,1,162367.55694122918,551389.5206213495,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,4,GAS2,0.245,1.0416,-0.071053,1,0.5,0.0,,
ENSG00000148948,5,2,0,0,0,0,4435.36939554283,326545.22790564946,2019-12-09,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,12,LRRC4C,0.703,3.5149,-0.29998,0,0.75,0.0,,
ENSG00000149021,2,2,0,0,0,1,133918.94977035935,133918.94977035935,2020-04-27,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,SCGB1A1,-0.752,-0.26595,-0.202,0,1.0,0.0,,
ENSG00000149100,3,2,1,0,0,1,64537.09582160982,1076472.0138856068,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,3,EIF3M,0.36900002,1.6399,-0.14475,6,-1.0,-1.0,Translation,R-HSA-72766
ENSG00000149256,2,2,0,0,0,1,23170.475088449533,1424218.0900670097,2014-03-11,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,TENM4,0.584,3.5466,0.95722,0,0.5,0.0,,
ENSG00000149305,2,2,0,0,0,1,406587.2658730814,467606.0891342802,2020-12-08,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,HTR3B,-0.21200001,0.5251,0.29369,1,0.5,1.0,,
ENSG00000149527,2,2,0,0,0,1,2464.7717968157694,323648.5577791949,2011-12-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,1,0,0,0,7,PLCH2,-0.011999965,-1.0552,-3.7154,1,0.5,0.0,,
ENSG00000149571,2,2,0,0,0,1,135593.17169557852,1122672.658801146,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,5,KIRREL3,0.324,1.5989,-0.68806,1,1.0,0.5,,
ENSG00000149577,3,2,1,0,0,1,141553.2677895436,258213.8601133611,2021-12-06,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,3,SIDT2,0.29000002,2.3074,-0.37102,0,-1.0,-1.0,,
ENSG00000149922,2,2,1,0,0,1,38092.548464040476,113567.57166187582,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,2,TBX6,0.06400001,0.49071,-0.2204,3,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000149930,2,2,1,0,0,0,99863.42410604075,438004.58573217486,2018-02-26,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,2,TAOK2,0.541,3.3735,-0.48808,0,-1.0,-1.0,,
ENSG00000149968,5,2,1,1,1,1,8671.61743288773,315753.8718331748,2014-02-07,0,0,0,0,5,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,MMP3,-0.26199996,0.48588,-0.053031,7,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;EGFR Transactivation by Gastrin;Signaling by Interleukins;Gastrin-CREB signalling pathway via PKC and MAPK;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-2179392;R-HSA-449147;R-HSA-881907;R-HSA-6785807
ENSG00000149970,7,2,0,0,0,1,80746.41870861933,1778690.168860174,2014-07-22,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,8,CNKSR2,,,,7,0.75,0.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000150275,2,2,0,0,0,1,2415.901095813431,1424218.0900670097,2015-06-01,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PCDH15,0.181,-0.14461,-0.73173,2,0.75,0.5,,
ENSG00000150394,5,2,0,0,0,1,95776.89591443514,1778690.168860174,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,2,6,CDH8,0.63100004,3.2124,0.29495,2,0.75,0.5,,
ENSG00000150991,3,2,0,0,0,1,161092.74087321138,279825.00883385167,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,UBC,0.51,4.8134,-4.8364,188,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;ER Quality Control Compartment (ERQC);Endosomal Sorting Complex Required For Transport (ESCRT);Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Glycogen metabolism;Immune System;Budding and maturation of HIV virion;RNA Polymerase II Transcription;IRAK1 recruits IKK complex;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;Formation of TC-NER Pre-Incision Complex;Developmental Biology;Gene expression (Transcription);Glycogen storage diseases;Glycogen synthesis;Alpha-protein kinase 1 signaling pathway;IRAK2 mediated activation of TAK1 complex;Translation of Structural Proteins_9683701;Disease;Late endosomal microautophagy;Downregulation of ERBB4 signaling;Response of Mtb to phagocytosis;Aggrephagy;Signaling by Interleukins;IKK complex recruitment mediated by RIP1;Regulation of pyruvate metabolism;Suppression of phagosomal maturation;Infection with Mycobacterium tuberculosis;Regulation of signaling by CBL;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Chaperone Mediated Autophagy;Iron uptake and transport;Gap-filling DNA repair synthesis and ligation in TC-NER;Formation of Incision Complex in GG-NER;Pyruvate metabolism;Regulation of expression of SLITs and ROBOs;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Stimuli-sensing channels;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Peroxisomal protein import;Dectin-1 mediated noncanonical NF-kB signaling;ISG15 antiviral mechanism;E3 ubiquitin ligases ubiquitinate target proteins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Protein ubiquitination;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-901032;R-HSA-917729;R-HSA-901042;R-HSA-532668;R-HSA-8982491;R-HSA-168256;R-HSA-162588;R-HSA-73857;R-HSA-937039;R-HSA-975144;R-HSA-6781823;R-HSA-1266738;R-HSA-74160;R-HSA-3229121;R-HSA-3322077;R-HSA-9645460;R-HSA-937042;R-HSA-9683701;R-HSA-1643685;R-HSA-9615710;R-HSA-1253288;R-HSA-9637690;R-HSA-9646399;R-HSA-449147;R-HSA-937041;R-HSA-9861718;R-HSA-9637687;R-HSA-9635486;R-HSA-912631;R-HSA-8866652;R-HSA-9613829;R-HSA-917937;R-HSA-6782210;R-HSA-5696395;R-HSA-70268;R-HSA-9010553;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-2672351;R-HSA-6781827;R-HSA-9033241;R-HSA-5607761;R-HSA-1169408;R-HSA-8866654;R-HSA-450408;R-HSA-5358346;R-HSA-8852135;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-9006934;R-HSA-5663202;R-HSA-2173796;R-HSA-2173793;R-HSA-597592;R-HSA-8878159
ENSG00000151136,2,2,0,0,0,0,2040.6390654526713,2040.6390654526713,2021-10-12,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ABTB3,0.549,0.8161,-0.20528,0,0.5,0.0,,
ENSG00000151150,3,2,1,0,0,1,10282.704039260097,191477.8325312717,2008-08-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,1,0,0,0,11,ANK3,0.84000003,5.3717,1.5063,2,-1.0,-1.0,Developmental Biology;Interaction between L1 and Ankyrins;Post-translational protein modification,R-HSA-1266738;R-HSA-445095;R-HSA-597592
ENSG00000151611,4,2,1,0,1,1,46977.28346057821,90664.10805347394,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,6,MMAA,-0.15600002,1.0218,1.3999,4,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000151883,4,2,1,0,0,1,913.5802469135803,1424218.0900670097,2019-02-04,2,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,PARP8,0.394,1.7591,-0.46084,3,0.5,-1.0,Translation of Structural Proteins_9683701;Disease,R-HSA-9683701;R-HSA-1643685
ENSG00000152092,8,2,0,0,0,1,15866.724081734988,1076472.0138856068,2017-05-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,0,0,1,0,0,0,15,ASTN1,0.60800004,2.2494,0.80616,0,0.5,0.5,,
ENSG00000152104,7,2,1,0,0,1,13731.993981048436,189557.6027707886,2020-04-27,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,10,PTPN14,0.477,2.97,-0.42213,1,-1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000152192,2,2,0,0,0,1,13803.505764554428,117090.1108836121,2021-01-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,2,POU4F1,0.287,1.115,-1.7523,1,0.5,1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000152208,3,2,0,0,0,0,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,GRID2,0.668,1.1151,0.14168,0,0.75,0.5,,
ENSG00000152409,3,2,1,0,1,1,26223.342196176316,1424218.0900670097,2020-06-15,0,0,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,JMY,0.352,-0.092037,-1.1125,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000152556,2,2,1,0,0,0,156100.20896497899,575147.0632428399,2024-07-19,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,PFKM,0.22600001,4.0772,0.96093,1,0.75,-1.0,,
ENSG00000152578,3,2,0,0,0,1,4660.923966257744,433862.5685735124,2022-07-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,4,GRIA4,0.588,3.1441,0.43688,5,0.75,0.5,,
ENSG00000152582,4,2,0,0,0,1,15470.157370570181,81805.8846123197,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,4,SPEF2,0.07700002,0.49092,0.38813,0,-1.0,0.0,,
ENSG00000152591,2,2,0,0,0,0,10448.314561010842,10448.314561010842,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,2,DSPP,-0.27100003,3.2166,-0.13071,1,,,,
ENSG00000152595,2,2,1,0,0,1,5920.046363037069,13959.203480505423,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,3,MEPE,-0.834,0.54415,0.38019,2,1.0,1.0,Post-translational protein modification,R-HSA-597592
ENSG00000152611,3,2,0,0,0,1,5426.200199914322,220001.25209802805,2011-03-13,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CAPSL,-0.16999996,-0.31643,-0.48678,0,0.75,0.0,,
ENSG00000152779,3,2,1,0,0,1,281079.0730593847,645988.1975077938,2023-01-18,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,SLC16A12,0.37699997,1.6398,0.7075,0,0.5,0.0,,
ENSG00000152932,2,2,0,0,0,1,227752.06557835746,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,RAB3C,-0.069000006,0.79112,0.55529,1,0.5,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000152952,4,2,0,0,1,1,104865.12229088554,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,1,13,PLOD2,-0.20899999,0.24827,0.024934,1,-1.0,0.0,,
ENSG00000153140,3,2,0,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,CETN3,-0.75,0.66696,0.61241,0,0.5,-1.0,,
ENSG00000153234,7,2,0,0,0,1,132781.32332824613,1122672.658801146,2019-02-04,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,10,0,0,0,0,0,0,12,NR4A2,0.907,2.3057,-0.23846,2,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000153310,2,2,1,0,0,1,2010.4597478176527,220837.49604317299,2019-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,CYRIB,0.597,2.7554,-0.26045,1,0.5,-1.0,,
ENSG00000153823,5,2,0,0,0,1,39507.00295325707,394357.452283155,2017-02-06,0,0,0,0,4,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,11,PID1,0.09500003,0.99893,-0.43703,0,-1.0,-1.0,,
ENSG00000153933,4,2,1,0,0,1,189845.9324918578,1470466.6505612188,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,3,6,DGKE,0.004999995,0.88371,-1.1977,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000154027,5,2,0,0,0,0,17601.10520641419,136665.8227530756,2017-06-12,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,AK5,0.5,2.5537,-0.30833,1,1.0,0.0,Interconversion of nucleotide di- and triphosphates;Metabolism of nucleotides,R-HSA-499943;R-HSA-15869
ENSG00000154124,4,2,0,0,0,1,203321.91836345146,322220.1169395476,2019-07-30,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,6,OTULIN,0.333,2.1003,0.58767,2,0.5,-1.0,Signal Transduction;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Protein ubiquitination;Post-translational protein modification,R-HSA-162582;R-HSA-8866652;R-HSA-8852135;R-HSA-597592
ENSG00000154319,2,2,1,0,0,1,11252.882952659449,353105.3286394775,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,5,FAM167A,-0.934,-2.4435,-2.6002,0,0.5,0.0,,
ENSG00000154447,2,2,1,0,0,1,131525.74533408263,521818.7070055739,2019-11-18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,5,SH3RF1,0.40600002,2.2881,1.5555,2,-1.0,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000154678,2,2,0,0,0,1,4917.108320036471,26547.65100671141,2018-03-08,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,PDE1C,0.157,2.1004,0.20479,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000154719,2,2,0,0,0,1,14639.784588829983,190279.23963861223,2020-07-28,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,MRPL39,-0.17799997,-0.35981,-0.11015,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000155087,2,2,1,0,0,1,5055.931872674659,384314.83364002535,2015-06-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,ODF1,0.27999997,0.9118,0.53495,0,1.0,1.0,,
ENSG00000155269,2,2,1,0,0,1,2240.9147424511543,13668.611881626193,2018-03-01,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,2,GPR78,-0.975,-2.8922,-4.1603,0,0.75,0.5,,
ENSG00000155307,2,2,1,0,0,1,42362.45324254164,145011.35140303092,2024-04-23,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SAMSN1,-0.113000035,-0.057998,-0.58574,0,0.5,0.0,,
ENSG00000155363,2,2,1,0,0,0,39406.19595155135,143413.24457139417,2021-02-24,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,5,MOV10,0.565,3.9656,1.2862,20,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000155530,5,2,1,0,0,1,4917.108320036471,225895.43837715342,2018-03-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,4,LRGUK,-0.125,-0.10489,-0.052592,0,0.5,0.5,,
ENSG00000155754,2,2,0,0,0,1,165565.7343481966,165565.7343481966,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,2,C2CD6,0.09200001,3.3273,2.4099,0,1.0,0.5,,
ENSG00000155868,2,2,1,0,0,1,190279.23963861223,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,2,MED7,0.23900002,1.2989,0.56344,5,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685
ENSG00000155875,3,2,1,0,0,1,1173.5007132667617,220837.49604317299,2022-07-22,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SAXO1,-0.523,-3.1546,-1.6061,0,1.0,1.0,,
ENSG00000155918,2,2,1,0,1,1,3190.2234533702676,189557.6027707886,2010-07-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,RAET1L,-0.20899999,0.24276,0.85089,1,0.75,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000155959,2,2,0,0,0,1,201549.9575922349,226101.35678720698,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,3,VBP1,,,,1,-1.0,-1.0,Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,R-HSA-389957;R-HSA-389958
ENSG00000156011,2,2,0,0,0,0,7987.2,323648.5577791949,2018-10-03,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,4,PSD3,0.42900002,-2.4081,-1.807,0,0.5,-1.0,,
ENSG00000156232,2,2,1,0,0,1,15300.00006269848,236328.22905445524,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,2,WHAMM,-0.22000003,-0.76399,-0.43617,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000156269,9,2,0,0,0,1,139549.80122422232,1122672.658801146,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,1,0,0,0,11,NAA11,-0.39699996,0.23872,-0.052128,0,0.75,0.5,,
ENSG00000157087,3,2,1,0,0,1,94951.97167384504,1778690.168860174,2021-05-17,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,5,ATP2B2,0.81,6.3085,0.61953,5,0.5,0.0,,
ENSG00000157216,2,2,0,0,0,1,15603.785966148887,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,SSBP3,0.825,2.9064,-0.72323,0,-1.0,-1.0,,
ENSG00000157426,2,2,1,0,1,1,195005.6685718255,286678.73247515375,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,AASDH,0.05400002,0.90632,1.8858,0,-1.0,-1.0,,
ENSG00000157445,2,2,0,0,0,0,1173.5007132667617,1424218.0900670097,2018-10-08,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,CACNA2D3,0.546,1.5521,-1.2837,1,0.5,0.0,Presynaptic depolarization and calcium channel opening,R-HSA-112308
ENSG00000157540,2,2,1,0,0,1,263416.51565448404,265350.9613355119,2018-11-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,DYRK1A,0.828,4.1205,-0.21603,1,-1.0,-1.0,,
ENSG00000157542,3,2,0,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,KCNJ6,0.518,4.9961,0.77381,2,0.5,0.5,Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Inwardly rectifying K+ channels,R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-1296065
ENSG00000157613,4,2,0,0,0,1,21724.94108458234,1778690.168860174,2019-07-08,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,CREB3L1,0.046000004,-0.59648,-0.69636,1,0.5,0.0,,
ENSG00000157764,2,2,1,0,0,1,130268.25219927442,1424218.0900670097,2017-09-04,0,0,0,0,0,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,BRAF,0.763,4.9103,1.2188,16,-1.0,-1.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000157895,3,2,1,0,0,1,22008.059288087163,136025.05987988086,2017-09-04,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,C12orf43,-0.18299997,0.14109,-0.67812,0,-1.0,-1.0,,
ENSG00000158258,3,2,0,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,CLSTN2,0.422,1.3097,-0.12872,0,0.5,0.0,,
ENSG00000158458,3,2,0,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,NRG2,0.42000002,-0.76314,-2.1604,19,0.5,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000158786,2,2,0,0,0,1,21201.639474894007,21201.639474894007,2023-03-22,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PLA2G2F,-0.48399997,-0.50716,-0.71222,6,0.75,0.5,Acyl chain remodelling of PS;Acyl chain remodelling of PG;Acyl chain remodelling of PI;Synthesis of PA;Acyl chain remodelling of PC;Acyl chain remodelling of PE,R-HSA-1482801;R-HSA-1482925;R-HSA-1482922;R-HSA-1483166;R-HSA-1482788;R-HSA-1482839
ENSG00000158813,2,2,1,0,0,1,2395.7541411865996,397765.9672627851,2018-01-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,3,EDA,,,,1,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000159461,2,2,1,0,0,1,468121.8445229682,468121.8445229682,2022-07-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,AMFR,0.36699998,1.6276,0.23792,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000159753,2,2,0,0,1,0,205739.47405036874,334911.3573752668,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,2,CARMIL2,0.29900002,0.63741,-0.51365,0,0.5,0.0,,
ENSG00000160013,2,2,1,0,0,1,32254.717802479194,79958.75176875875,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,PTGIR,-0.878,-0.87887,-2.0557,3,0.5,0.0,Signal Transduction;Prostacyclin signalling through prostacyclin receptor,R-HSA-162582;R-HSA-392851
ENSG00000160113,2,2,0,0,1,1,235397.69820205137,235397.69820205137,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,NR2F6,-0.25600004,-0.97621,-2.9247,1,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000160117,6,2,1,0,0,1,8116.851928965095,59389.77313114188,2013-04-01,8,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,ANKLE1,-0.36800003,0.07189,-0.57188,0,1.0,0.5,,
ENSG00000160202,2,2,0,0,0,1,180089.50342935527,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,CRYAA,,,,0,0.75,0.5,,
ENSG00000160282,3,2,0,1,1,1,898.4958904109589,1470466.6505612188,2020-07-31,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,FTCD,-0.61,-2.0472,-2.5074,1,1.0,0.0,,
ENSG00000160752,2,2,1,0,1,0,187674.40497870417,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,FDPS,0.25599998,1.8797,1.3128,2,0.5,-1.0,Cholesterol biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-191273;R-HSA-8957322;R-HSA-1655829
ENSG00000161395,3,2,1,0,0,1,29050.862407491317,645988.1975077938,2023-06-01,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,PGAP3,-0.14699996,-0.46076,-1.0626,0,-1.0,-1.0,,
ENSG00000162374,2,2,0,0,0,1,118061.55082048493,1122672.658801146,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,1,0,0,0,0,7,ELAVL4,0.86300004,3.6603,0.95894,0,0.5,0.5,,
ENSG00000162409,3,2,0,0,0,1,52982.28647069224,161092.74087321138,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,PRKAA2,0.047999978,1.5222,0.54736,11,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;MTOR signalling;Carnitine shuttle,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-165159;R-HSA-200425
ENSG00000162517,3,2,1,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,PEF1,0.213,0.2852,0.76408,0,-1.0,-1.0,,
ENSG00000162542,4,2,0,0,0,1,10218.151507183115,36159.555758564435,2017-01-09,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,8,TMCO4,-0.052999973,1.0365,1.136,0,-1.0,0.0,,
ENSG00000162620,2,2,1,0,0,0,294763.3750742061,1129585.974638378,2021-02-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,LRRIQ3,-0.602,-1.2027,-0.57077,0,1.0,0.5,,
ENSG00000162631,2,2,0,0,0,1,572390.9560934792,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,3,NTNG1,0.556,2.4278,0.57824,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000162692,3,2,1,0,0,1,61563.70725571889,334911.3573752668,2021-02-24,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,9,VCAM1,0.16299999,1.4491,-0.14621,4,1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000162711,2,2,0,0,1,1,169088.90478978804,205739.47405036874,2019-03-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,NLRP3,0.361,3.5159,-0.61231,7,1.0,0.0,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000162745,2,2,0,0,0,1,26020.4828907398,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,3,6,OLFML2B,0.06400001,0.1848,0.7878,0,0.5,0.0,,
ENSG00000162746,3,2,1,0,0,1,26020.4828907398,95905.57783546533,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,3,FCRLB,-0.62100005,0.14703,-1.2555,0,0.5,1.0,,
ENSG00000162753,2,2,0,0,0,0,21201.639474894007,21201.639474894007,2023-03-22,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC9C2,0.29400003,2.5592,1.4528,1,1.0,1.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000162761,3,2,0,0,0,1,11786.661185394927,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,5,LMX1A,0.524,2.103,1.1623,0,1.0,0.5,,
ENSG00000162849,2,2,0,0,0,1,155552.2805078301,360605.992793193,2022-02-03,0,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,KIF26B,0.42900002,-0.02269,-2.2691,2,0.5,0.5,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000162885,2,2,1,0,0,1,31137.07865241903,272025.74568937684,2018-10-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,B3GALNT2,-0.04100001,1.2709,0.3046,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000162959,2,2,0,0,0,1,143284.77790855977,180089.50342935527,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,MEMO1,0.649,2.6149,1.6527,1,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000163121,2,2,0,0,0,1,43039.044982671156,52830.887409864736,2023-01-18,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NEURL3,-0.91499996,-0.30601,-2.0615,0,0.75,0.5,,
ENSG00000163141,2,2,1,0,1,1,6356.593451690605,43372.03071242184,2018-08-13,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,BNIPL,0.08899999,0.88997,0.96016,0,0.75,0.0,,
ENSG00000163297,2,2,1,0,0,1,320319.7525060048,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,ANTXR2,0.018999994,-0.66076,-1.3448,1,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000163349,2,2,0,0,0,1,68837.80679818468,183579.49764748462,2021-09-30,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,3,HIPK1,0.644,3.5872,-0.41345,3,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000163354,3,2,1,0,0,1,41776.691335261115,545988.1005477115,2018-07-30,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,DCST2,0.059000015,1.0553,1.7328,0,0.5,0.5,,
ENSG00000163376,3,2,0,0,0,1,29803.01405728205,1424218.0900670097,2020-01-20,0,0,0,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,KBTBD8,0.30299997,1.7395,0.47986,2,0.5,0.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000163382,2,2,1,0,0,0,26020.4828907398,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,NAXE,-0.078999996,0.54628,0.6901,1,-1.0,-1.0,,
ENSG00000163517,3,2,0,0,0,1,281258.82202219026,281258.82202219026,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,HDAC11,0.194,1.3533,0.15909,4,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000163519,4,2,1,0,0,1,116089.30071075787,269829.0934099178,2020-06-24,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,1,0,0,0,7,TRAT1,-0.73399997,-0.056839,0.1591,4,1.0,0.5,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202
ENSG00000163535,2,2,1,0,1,1,32705.240805002948,50087.52781663962,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,2,SGO2,0.18300003,1.2044,1.2986,6,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000163577,3,2,1,0,0,1,93616.86016863462,575147.0632428399,2021-04-08,0,0,0,0,0,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,EIF5A2,-0.301,0.98438,0.7724,1,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000163624,2,2,0,0,0,1,383158.3001114715,464892.4593283075,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,CDS1,0.035000026,0.50743,-0.55022,1,-1.0,0.0,,
ENSG00000163626,2,2,0,0,0,1,87037.83598345588,521818.7070055739,2014-09-14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,COX18,-0.68200004,-1.117,-0.81444,1,-1.0,0.0,Complex IV assembly,R-HSA-9864848
ENSG00000163630,2,2,0,0,0,1,5617.422898742555,8761.537659856074,2021-11-04,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SYNPR,0.0009999871,0.77468,-0.27502,0,1.0,0.5,,
ENSG00000163632,2,2,0,0,0,1,239970.53614968536,294387.2978738704,2021-06-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,C3orf49,,,,0,-1.0,0.5,,
ENSG00000163633,2,2,1,0,0,1,14959.796450585092,141293.18354755783,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,C4orf36,-0.44500005,0.13598,0.049411,0,1.0,0.5,,
ENSG00000163877,3,2,1,0,0,1,42359.490817992155,298504.9722193353,2023-01-18,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,4,SNIP1,0.13499999,1.5161,1.2087,1,-1.0,-1.0,,
ENSG00000163931,2,2,1,0,0,1,21117.402887671095,155552.2805078301,2023-01-18,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TKT,0.07700002,1.6623,0.051106,3,1.0,-1.0,,
ENSG00000163938,3,2,1,0,1,0,103877.27822338727,191477.8325312717,2017-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,0,0,0,5,GNL3,-0.37800002,0.10216,-0.68661,1,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000163945,2,2,1,0,0,1,54580.46858134564,415452.66715166246,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,UVSSA,-0.21399999,-1.8844,-1.3663,4,-1.0,-1.0,Formation of TC-NER Pre-Incision Complex;Gap-filling DNA repair synthesis and ligation in TC-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-6781823;R-HSA-6782210;R-HSA-6782135;R-HSA-6781827
ENSG00000164024,3,2,1,0,0,1,5504.0130519525,1778690.168860174,2021-09-30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6,METAP1,0.123000026,1.4202,-0.56449,1,-1.0,-1.0,,
ENSG00000164035,2,2,0,0,0,1,42359.490817992155,1778690.168860174,2022-07-14,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,5,EMCN,-0.35500002,0.28662,1.1277,0,-1.0,0.0,,
ENSG00000164068,2,2,1,0,0,1,36814.73155129084,252346.18526092035,2018-08-13,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RNF123,0.39600003,3.0757,0.85347,2,0.5,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000164109,5,2,0,0,0,1,52463.65429696694,394357.452283155,2017-07-17,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,10,MAD2L1,0.31599998,1.488,0.17856,11,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000164167,2,2,1,0,0,1,132101.59514050526,132101.59514050526,2024-03-31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,LSM6,,,,2,-1.0,-1.0,,
ENSG00000164168,4,2,0,0,0,1,67074.2020152457,161092.74087321138,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,TMEM184C,0.40600002,3.1143,1.6456,0,1.0,-1.0,,
ENSG00000164181,3,2,1,0,0,1,6306.411000302206,263416.51565448404,2020-02-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,0,0,0,4,ELOVL7,-0.034999967,0.56208,0.66987,1,-1.0,0.0,Synthesis of very long-chain fatty acyl-CoAs;Fatty acyl-CoA biosynthesis,R-HSA-75876;R-HSA-75105
ENSG00000164253,2,2,1,0,1,1,190279.23963861223,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,2,WDR41,-0.044999957,0.079544,0.74967,0,-1.0,-1.0,,
ENSG00000164258,2,2,1,0,0,1,521818.7070055739,575147.0632428399,2023-11-09,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NDUFS4,-0.51900005,-0.032322,-1.2093,2,-1.0,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000164265,3,2,0,1,0,1,19069.86518571448,48835.29892898929,2023-01-18,0,0,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SCGB3A2,-0.23000002,-0.25569,0.076876,1,1.0,0.0,,
ENSG00000164296,2,2,1,0,0,1,28061.17463598858,360605.992793193,2022-02-03,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TIGD6,-0.36600006,0.90486,1.5192,0,-1.0,-1.0,,
ENSG00000164325,2,2,0,0,0,1,17831.529851792977,94870.11495236546,2010-11-21,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,0,0,0,5,TMEM174,-0.23000002,-0.10344,-0.073741,0,1.0,1.0,,
ENSG00000164506,3,2,1,0,1,1,56614.28807963426,135593.17169557852,2019-08-16,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,4,STXBP5,0.656,2.607,0.28956,0,0.5,0.0,,
ENSG00000164530,2,2,1,1,0,1,155552.2805078301,1424218.0900670097,2023-01-18,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PI16,-0.22000003,0.5515,-0.60229,0,0.5,0.0,,
ENSG00000164532,6,2,1,0,0,1,8798.945480071758,394357.452283155,2020-10-05,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,9,TBX20,0.622,2.4629,1.0728,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000164715,4,2,1,0,1,1,3747.57310565635,1424218.0900670097,2008-02-10,17,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,LMTK2,0.592,2.0319,0.0055803,0,-1.0,-1.0,,
ENSG00000164736,6,2,0,0,0,1,5048.920570264766,464892.4593283075,2008-11-09,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,8,SOX17,0.38599998,-1.5376,-3.2133,4,0.5,0.0,Signal Transduction;Developmental Biology;Formation of definitive endoderm,R-HSA-162582;R-HSA-1266738;R-HSA-9823730
ENSG00000164742,2,2,0,0,0,1,110500.54208463429,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,ADCY1,0.65400004,4.711,-0.30409,15,0.75,0.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000164796,2,2,0,0,0,1,33410.38706087121,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,1,0,0,0,4,CSMD3,0.536,2.2394,-0.87968,0,0.5,1.0,,
ENSG00000164935,2,2,0,0,1,1,1173.5007132667617,2325.5337209302324,2011-05-29,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,DCSTAMP,-0.003000021,0.82257,-0.6304,1,0.5,0.5,,
ENSG00000164946,2,2,0,0,0,1,48013.53134222642,433862.5685735124,2024-06-05,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,FREM1,-0.15699995,-4.442,-2.901,0,0.5,0.0,,
ENSG00000165105,2,2,0,0,0,1,515513.2178404211,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,RASEF,-0.20200002,-0.50349,-0.15563,0,0.5,0.0,,
ENSG00000165125,2,2,0,0,0,1,33144.02982075252,48835.29892898929,2023-01-18,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TRPV6,0.362,2.6896,0.99328,1,0.5,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000165209,3,2,0,0,0,1,44692.894702471654,205425.60717824215,2022-04-07,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,STRBP,0.719,4.4474,0.75586,0,-1.0,-1.0,,
ENSG00000165410,2,2,1,0,0,1,3669.3510358914505,645988.1975077938,2018-06-11,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,12,CFL2,0.089999974,1.3419,0.54193,0,0.75,-1.0,,
ENSG00000165526,2,2,0,0,0,1,39406.19595155135,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,RPUSD4,-0.29900002,0.032106,-0.19711,0,0.5,-1.0,rRNA modification in the mitochondrion;rRNA processing in the mitochondrion;rRNA processing,R-HSA-6793080;R-HSA-8868766;R-HSA-72312
ENSG00000165591,2,2,0,0,0,1,130268.25219927442,427337.4491868293,2020-06-08,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FAAH2,,,,1,-1.0,0.0,Arachidonate metabolism,R-HSA-2142753
ENSG00000165626,3,2,1,0,0,1,195005.6685718255,1778690.168860174,2020-06-15,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8,BEND7,0.15799999,0.61951,0.62425,0,-1.0,-1.0,,
ENSG00000165660,4,2,0,0,0,1,183427.12489668437,281258.82202219026,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,2,4,ABRAXAS2,0.35900003,1.0646,1.2586,1,-1.0,-1.0,,
ENSG00000165694,3,2,1,0,0,1,29713.571045654095,223386.61486493575,2021-09-30,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,FRMD7,,,,0,0.75,0.5,,
ENSG00000165752,2,2,0,0,0,1,132101.59514050526,132101.59514050526,2024-03-31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,STK32C,0.13700002,0.74369,-1.7137,0,0.5,-1.0,,
ENSG00000165917,2,2,1,0,0,1,86992.9057658324,1470466.6505612188,2021-02-24,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,RAPSN,-0.09200001,0.095373,-1.0845,0,0.75,0.5,,
ENSG00000166152,5,2,0,0,0,1,195666.44200393453,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,4,C16orf78,-0.021999955,0.066645,-0.66909,0,1.0,1.0,,
ENSG00000166317,8,2,0,0,1,1,5495.191484272216,756470.9740366563,2012-04-29,0,0,0,0,22,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,23,SYNPO2L,0.032999992,-0.03933,-0.68352,0,0.75,0.5,,
ENSG00000166326,2,2,1,0,0,1,25903.3352616996,87545.45580019058,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,TRIM44,0.439,0.44227,-0.50067,0,-1.0,-1.0,,
ENSG00000166363,2,2,0,0,0,1,23904.70005980788,23904.70005980788,2024-07-19,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,OR10A5,-0.42799997,0.35762,0.18351,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000166405,2,2,1,0,0,1,162367.55694122918,220320.9576294899,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,RIC3,-0.21700001,-0.58789,-0.69495,0,-1.0,0.0,,
ENSG00000166471,2,2,1,0,0,1,200944.0765227402,270267.2992956902,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,TMEM41B,0.16600001,0.29212,-1.3823,0,-1.0,-1.0,,
ENSG00000166477,2,2,0,0,0,1,396735.32121509424,598869.4096893278,2022-06-03,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,2,LEO1,0.51199996,1.8732,0.79291,5,-1.0,-1.0,Signal Transduction;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Formation of the beta-catenin:TCF transactivating complex;Post-translational protein modification,R-HSA-162582;R-HSA-73857;R-HSA-74160;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-8866654;R-HSA-8852135;R-HSA-201722;R-HSA-597592
ENSG00000166562,2,2,1,0,0,1,232586.34864014547,1778690.168860174,2021-01-04,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,SEC11C,0.116,1.6258,0.1548,5,-1.0,-1.0,Disease;Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-1643685;R-HSA-72766;R-HSA-1799339
ENSG00000166689,4,2,1,0,0,1,6216.448089338684,427337.4491868293,2012-08-26,0,0,0,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,PLEKHA7,0.274,0.64486,0.25056,0,-1.0,0.0,,
ENSG00000166831,2,2,1,1,0,1,111599.28184123649,228688.0296088316,2017-12-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,RBPMS2,0.045000017,0.16399,-1.1715,0,0.5,-1.0,,
ENSG00000166845,2,2,0,0,0,1,23467.651805886748,49724.14538298504,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,C18orf54,-0.33000004,-0.48658,0.57547,0,1.0,0.0,,
ENSG00000166974,2,2,1,0,0,1,8798.945480071758,333304.3295866077,2022-02-24,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,MAPRE2,0.50600004,4.3344,0.93098,0,0.5,-1.0,,
ENSG00000167114,2,2,1,1,1,0,118061.55082048493,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,SLC27A4,0.339,1.1324,0.28413,2,-1.0,-1.0,"Disease;Transport of vitamins, nucleosides, and related molecules",R-HSA-1643685;R-HSA-425397
ENSG00000167118,2,2,1,0,0,1,85474.33432267047,1424218.0900670097,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,URM1,0.013999999,0.16382,0.49661,1,-1.0,-1.0,,
ENSG00000167139,6,2,0,0,0,1,73288.05634049492,1076472.0138856068,2021-09-30,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,6,TBC1D21,-0.052000046,0.40074,0.55332,0,1.0,1.0,,
ENSG00000167183,2,2,1,0,0,1,55635.00408218119,574782.4268116049,2021-06-14,0,0,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,PRR15L,0.22899997,0.23089,-0.21496,0,0.5,0.0,,
ENSG00000167460,2,2,1,0,0,1,74722.59037384245,107200.17738606388,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,3,TPM4,0.199,0.89838,-0.2921,4,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000167526,2,2,1,0,0,1,150669.89240227733,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,RPL13,0.75,-0.61989,-1.8022,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000167641,4,2,1,1,0,1,7457.218313253012,521818.7070055739,2009-09-20,19,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,PPP1R14A,-0.59800005,-1.5491,-2.1525,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000167720,3,2,1,0,0,0,323648.5577791949,714039.8414241908,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,2,SRR,0.13599998,0.97016,0.35165,1,-1.0,-1.0,Serine metabolism,R-HSA-977347
ENSG00000167775,4,2,1,0,1,1,13035.0221976327,108816.31098183901,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,5,0,0,0,0,8,CD320,-0.48800004,-1.0094,-1.6273,2,-1.0,-1.0,Transport of RCbl within the body;Disease,R-HSA-9758890;R-HSA-1643685
ENSG00000167840,2,2,1,0,0,1,319780.6514762748,319780.6514762748,2022-07-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,ZNF232,-0.342,0.49458,0.040861,0,-1.0,0.0,,
ENSG00000167904,2,2,1,0,0,1,636.1886490807354,1778690.168860174,2012-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,TMEM68,0.058000028,1.4333,0.067317,0,-1.0,-1.0,,
ENSG00000167969,2,2,0,0,0,0,4557.552521218773,8634.42436064499,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,2,ECI1,-0.485,-1.3647,-1.8679,2,-1.0,-1.0,,
ENSG00000168016,4,2,1,0,0,0,15866.724081734988,191477.8325312717,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,0,0,1,0,0,0,12,TRANK1,0.20700002,2.7444,0.80665,0,0.5,0.0,,
ENSG00000168140,2,2,1,0,1,1,155552.2805078301,521818.7070055739,2023-01-18,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,VASN,-0.90400004,-0.93642,-2.405,0,-1.0,0.0,,
ENSG00000168398,2,2,1,0,0,1,1832.1461757005181,4428.202703899027,2021-08-01,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,6,BDKRB2,-0.929,0.20862,-0.92407,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000168487,8,2,1,0,0,1,52982.28647069224,279825.00883385167,2017-12-06,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,13,BMP1,0.352,2.193,0.33994,5,-1.0,0.0,,
ENSG00000168589,2,2,0,0,0,1,180089.50342935527,278498.5074409075,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,DYNLRB2,-0.62399995,-0.6806,-1.2216,1,0.75,0.0,Intraflagellar transport,R-HSA-5620924
ENSG00000168763,2,2,0,0,0,0,190631.40295152203,190631.40295152203,2023-12-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,CNNM3,-0.23000002,-1.7171,-3.0191,0,-1.0,-1.0,,
ENSG00000168779,10,2,0,0,0,0,208836.15741332836,960369.5592648841,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,1,0,0,0,5,SHOX2,0.231,-0.86656,-1.867,0,0.5,0.5,,
ENSG00000168818,3,2,0,0,0,1,5379.318429349384,9633.181385755513,2013-05-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,3,STX18,0.086000025,0.31267,-0.086251,1,0.5,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic,R-HSA-8856688;R-HSA-6811434
ENSG00000168916,9,2,0,0,0,1,76832.90012167432,1122672.658801146,2018-04-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,2,0,0,0,8,ZNF608,0.839,2.2465,0.50778,0,-1.0,-1.0,,
ENSG00000169016,3,2,1,0,0,1,21724.94108458234,756470.9740366563,2023-02-01,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,E2F6,-0.072999954,1.245,0.1533,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);G1/S-Specific Transcription;Transcriptional Regulation by E2F6,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-69205;R-HSA-8953750
ENSG00000169032,5,2,1,0,0,1,11343.053400273848,1778690.168860174,2017-06-12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,MAP2K1,0.485,3.7569,0.267,15,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202
ENSG00000169064,2,2,0,0,0,1,271154.8062006991,338763.57771536184,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,2,ZBBX,-0.14699996,-0.64815,-0.65403,0,0.75,0.5,,
ENSG00000169067,2,2,0,0,0,1,5495.191484272216,180089.50342935527,2021-01-25,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,6,ACTBL2,-0.62399995,-0.11385,0.82359,0,,,,
ENSG00000169155,3,2,0,0,0,1,31451.02499590231,433862.5685735124,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,8,ZBTB43,0.20099998,2.6562,-0.069975,0,0.5,-1.0,,
ENSG00000169247,3,2,1,0,0,1,29595.74025786674,448058.917711015,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,6,SH3TC2,0.19999999,1.0273,0.62376,0,0.5,0.5,,
ENSG00000169302,2,2,0,0,0,1,18370.005317532665,131525.74533408263,2019-11-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,STK32A,-0.15699995,0.5646,-0.28647,0,0.5,0.0,,
ENSG00000169306,2,2,0,0,0,1,606.6666666666666,171880.2916512608,2019-11-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,IL1RAPL1,,,,2,1.0,1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Receptor-type tyrosine-protein phosphatases,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-388844
ENSG00000169359,2,2,1,0,0,1,2755.335499659004,101603.42051482818,2018-12-10,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,2,SLC33A1,0.445,2.228,-0.18459,2,-1.0,-1.0,"Disease;Transport of vitamins, nucleosides, and related molecules",R-HSA-1643685;R-HSA-425397
ENSG00000169504,2,2,1,0,0,1,358386.30063935445,500292.45069431677,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,CLIC4,0.09899998,1.1794,0.19658,0,-1.0,-1.0,,
ENSG00000169744,2,2,1,0,0,1,151416.12986435954,1778690.168860174,2022-07-14,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,LDB2,0.565,2.2932,0.67182,0,-1.0,0.0,,
ENSG00000169758,2,2,0,0,0,1,197485.87952538437,275021.63051358337,2023-01-18,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TMEM266,0.07800001,0.52447,-0.73788,0,0.75,0.5,,
ENSG00000169851,3,2,0,0,0,1,13217.328579372608,286746.1002745869,2014-07-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,4,PCDH7,0.54499996,1.915,-1.1156,3,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000169860,2,2,0,0,0,1,254373.32653042395,1424218.0900670097,2020-05-06,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,P2RY1,0.06699997,1.6906,0.3474,3,0.5,0.0,Signal Transduction;P2Y receptors;Nucleotide-like (purinergic) receptors;ADP signalling through P2Y purinoceptor 1;Signal amplification,R-HSA-162582;R-HSA-417957;R-HSA-418038;R-HSA-418592;R-HSA-392518
ENSG00000169862,2,2,0,0,0,1,1173.5007132667617,73410.36533319784,2022-07-22,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CTNND2,0.772,2.5135,-1.1318,0,1.0,0.0,,
ENSG00000169951,2,2,0,0,1,1,83433.17248405184,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,ZNF764,-0.33800006,-1.7337,-2.868,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000170011,2,2,0,0,0,1,201549.9575922349,376569.5597064443,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,2,MYRIP,0.36400002,1.1092,0.64954,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000170092,4,2,1,0,1,1,303059.79257468163,756470.9740366563,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,3,SPDYE5,0.343,1.5494,1.47,0,,,,
ENSG00000170128,3,2,0,0,0,1,116089.30071075787,381165.6245253304,2020-06-24,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,3,GPR25,-0.93499994,-1.5922,-2.5682,1,1.0,1.0,Signal Transduction,R-HSA-162582
ENSG00000170209,2,2,1,0,1,1,161053.42428938235,376569.5597064443,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,ANKK1,-0.38199997,-1.1404,-0.78213,0,0.5,0.5,,
ENSG00000170291,2,2,1,0,0,0,260631.24114204012,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ELP5,-0.329,0.32561,-0.28541,1,0.5,-1.0,,
ENSG00000170348,2,2,1,0,0,1,15015.241596403896,122549.0830919942,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,TMED10,0.42299998,2.7563,0.075646,4,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000170382,2,2,0,0,1,1,50941.74188198324,278190.43024910334,2023-01-18,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,3,LRRN2,0.48400003,2.9368,1.0349,0,0.5,0.0,,
ENSG00000170426,3,2,0,0,0,1,180344.38517486732,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,3,SDR9C7,0.15600002,0.74895,-0.13356,1,0.5,0.5,The canonical retinoid cycle in rods (twilight vision),R-HSA-2453902
ENSG00000170558,2,2,1,1,0,1,65794.6850968381,76632.8325989884,2017-10-23,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CDH2,0.66400003,2.8683,0.019887,5,0.5,0.0,Developmental Biology;Post-translational protein modification,R-HSA-1266738;R-HSA-597592
ENSG00000170613,2,2,1,0,0,0,190279.23963861223,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,2,GARIN3,-0.24800003,0.35206,1.0499,0,1.0,1.0,,
ENSG00000170703,2,2,0,0,1,1,86537.94134095173,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TTLL6,0.123000026,1.1794,0.72837,1,0.5,0.5,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000170775,3,2,0,1,0,1,33954.407278742765,156470.480665571,2020-04-27,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,GPR37,0.33499998,1.2065,0.47505,2,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000170837,3,2,1,0,0,1,180344.38517486732,1076472.0138856068,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,3,GPR27,-0.36300004,-3.2241,-5.8802,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000170965,4,2,0,0,0,1,69915.00897904889,223386.61486493575,2023-01-18,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,PLAC1,,,,0,1.0,1.0,,
ENSG00000171033,3,2,0,0,0,1,29803.01405728205,414433.58532016096,2019-09-01,0,0,0,5,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,PKIA,-0.47500002,-0.18054,0.79954,0,0.75,0.0,,
ENSG00000171109,2,2,1,0,0,1,468121.8445229682,468121.8445229682,2022-07-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,MFN1,0.045000017,1.0383,0.1591,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000171163,2,2,1,0,0,1,636.1886490807354,355284.1215006515,2012-10-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,ZNF692,-0.10899997,0.17748,-1.2467,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000171206,2,2,1,0,0,1,22541.66311868015,1076472.0138856068,2013-04-01,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8,TRIM8,0.709,2.5107,0.098638,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000171435,3,2,0,0,0,1,130268.25219927442,1778690.168860174,2018-10-08,0,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,KSR2,0.68200004,4.1817,0.96859,7,0.5,0.5,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000171450,3,2,0,0,0,1,48088.08731084698,295912.38030484633,2021-11-04,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,0,0,0,4,CDK5R2,0.255,1.0557,-0.77209,1,0.75,0.5,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000171497,2,2,1,0,0,1,115123.9652207147,294763.3750742061,2021-02-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,PPID,-0.30299997,0.40955,-0.59568,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000171695,2,2,1,0,0,1,116002.32385328812,233499.4066209918,2023-01-18,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,LKAAEAR1,-0.96300006,-3.414,-2.5863,0,1.0,0.5,,
ENSG00000171703,2,2,1,0,0,1,36159.555758564435,598869.4096893278,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,TCEA2,0.27600002,1.8575,-0.04144,0,-1.0,-1.0,,
ENSG00000171714,2,2,0,0,1,1,42341.12463940832,645988.1975077938,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,ANO5,-0.03400004,0.71114,-0.70694,2,0.75,0.0,Disease;Stimuli-sensing channels,R-HSA-1643685;R-HSA-2672351
ENSG00000171720,2,2,1,0,0,0,360837.067725683,562534.7696387965,2017-10-30,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,HDAC3,0.537,4.7845,0.7929,24,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000171759,3,2,0,0,0,1,29713.571045654095,355284.1215006515,2021-09-30,10,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,PAH,-0.265,-0.00030735,0.43933,2,0.75,0.5,Disease,R-HSA-1643685
ENSG00000171786,3,2,0,0,0,1,26020.4828907398,95905.57783546533,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,1,4,NHLH1,-0.19000006,0.52708,-0.30675,0,0.5,1.0,,
ENSG00000171840,2,2,1,0,0,1,5689.532088562391,190279.23963861223,2009-04-15,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,NINJ2,-0.554,0.12232,-0.73751,0,0.5,0.0,,
ENSG00000171862,2,2,0,0,0,1,135108.48254553688,1424218.0900670097,2020-05-06,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,PTEN,0.315,4.1195,1.3179,13,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000171885,6,2,1,0,0,1,22345.675520395987,230316.30849350386,2013-04-01,7,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,AQP4,0.097,0.3668,0.48289,2,0.75,0.0,Passive transport by Aquaporins,R-HSA-432047
ENSG00000172037,4,2,1,0,1,0,122069.83349127392,383158.3001114715,2017-12-06,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,LAMB2,0.348,2.8708,2.3148,8,-1.0,-1.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-597592
ENSG00000172071,2,2,1,0,1,1,3328.0781640536243,355284.1215006515,2011-06-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,EIF2AK3,0.394,1.8175,0.91679,5,0.5,0.0,Cytokine Signaling in Immune system;Immune System;PERK regulates gene expression;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1280215;R-HSA-168256;R-HSA-381042;R-HSA-1643685;R-HSA-5663202
ENSG00000172197,2,2,0,0,0,1,1173.5007132667617,100472.44526492403,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,MBOAT1,-0.23000002,0.92374,-0.26667,2,-1.0,-1.0,Acyl chain remodelling of PS;Acyl chain remodelling of PE,R-HSA-1482801;R-HSA-1482839
ENSG00000172590,2,2,1,0,0,0,232586.34864014547,1424218.0900670097,2021-01-04,4,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,MRPL52,-0.181,0.22468,0.81073,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000172638,2,2,1,0,0,1,77544.39441764928,251932.6025865064,2019-06-07,4,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,6,EFEMP2,0.44,1.7076,-0.84863,1,-1.0,-1.0,,
ENSG00000172845,3,2,1,0,0,1,31711.504552099814,521818.7070055739,2018-09-13,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,SP3,0.775,1.7654,-1.2692,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000173156,2,2,1,0,0,1,406587.2658730814,1778690.168860174,2022-07-14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,RHOD,-0.19099998,-0.23972,-0.66389,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000173207,2,2,0,0,0,1,242123.900206037,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,CKS1B,0.009000003,1.6699,0.72303,2,-1.0,-1.0,,
ENSG00000173210,3,2,1,0,0,0,96018.8961005241,404399.6052088398,2021-06-09,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,ABLIM3,0.30900002,1.5617,1.1344,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000173542,3,2,1,0,0,1,114439.41769154315,1424218.0900670097,2019-02-04,0,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,12,MOB1B,-0.24100006,0.35131,0.92285,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000173610,2,2,0,0,0,1,137776.79053446153,147316.01557138463,2023-02-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,UGT2A1,-0.612,-0.71639,-0.87332,2,0.75,0.5,Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000173714,4,2,0,1,0,0,189845.9324918578,356440.71671986027,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,2,5,WFIKKN2,0.16000003,0.95599,-0.085192,0,1.0,0.5,,
ENSG00000173890,2,2,1,0,0,1,5811.029019802218,11343.053400273848,2017-06-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,GPR160,-0.648,0.93781,-0.23949,0,0.5,0.0,,
ENSG00000173898,2,2,0,0,0,1,306980.8575290048,466632.7979326389,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,3,SPTBN2,0.548,4.5181,0.675,5,0.5,0.0,Signal Transduction;Immune System;Developmental Biology;Interaction between L1 and Ankyrins;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-445095;R-HSA-597592
ENSG00000174059,2,2,1,0,0,1,4693.522174849374,125392.97184483419,2023-01-18,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CD34,-0.18400002,0.65335,-0.77317,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000174099,4,2,0,0,0,1,49127.555514088446,512656.0695323204,2023-01-18,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,4,MSRB3,0.038999975,0.74456,0.93826,1,-1.0,-1.0,,
ENSG00000174307,3,2,0,0,1,1,3235.5860731550038,141076.9910731678,2020-05-18,1,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,PHLDA3,-0.94000006,0.11301,-1.0025,0,-1.0,0.0,,
ENSG00000174371,13,2,1,0,1,1,22667.68960369517,468121.8445229682,2019-06-07,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,21,EXO1,-0.013000011,0.1399,0.067009,16,0.5,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000174429,3,2,0,0,0,1,29803.01405728205,1129585.974638378,2018-06-11,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,7,ABRA,0.007000029,0.27635,-0.25798,0,0.5,0.5,,
ENSG00000174599,3,2,0,0,0,1,86334.97261459603,203090.6413944402,2020-11-10,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,TRAM1L1,-0.635,0.25074,-0.54167,0,-1.0,0.0,,
ENSG00000174640,3,2,1,0,1,1,31574.759050873334,124801.11117486731,2018-12-03,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,SLCO2A1,-0.036000013,1.1063,0.84117,2,0.5,0.0,"Disease;Transport of vitamins, nucleosides, and related molecules",R-HSA-1643685;R-HSA-425397
ENSG00000174695,2,2,1,0,0,1,3979.099342105263,180089.50342935527,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,TMEM167A,-0.592,0.82438,0.64028,0,-1.0,-1.0,,
ENSG00000174705,2,2,1,0,0,1,180089.50342935527,521818.7070055739,2021-11-04,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,SH3PXD2B,0.34500003,1.9554,0.93011,0,-1.0,0.0,,
ENSG00000174738,4,2,0,0,0,1,95776.89591443514,137776.79053446153,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,3,NR1D2,0.29799998,0.81559,-0.82369,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000174807,6,2,1,1,1,1,156470.480665571,313882.50400013494,2016-07-17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,4,CD248,-0.594,0.79911,-0.014373,0,0.5,0.0,,
ENSG00000174808,3,2,1,0,1,1,9140.849127733147,562534.7696387965,2019-02-25,0,0,0,0,0,0,0,0,0,0,6,1,0,0,0,0,0,0,0,0,0,0,0,7,BTC,-0.20899999,-0.2717,-0.47763,28,0.5,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000174989,2,2,0,0,0,1,12746.766223187618,12746.766223187618,2019-08-13,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,FBXW8,-0.20299995,-0.050453,-0.23515,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000175175,3,2,0,0,1,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,PPM1E,0.522,2.8494,0.53489,1,0.5,0.5,,
ENSG00000175213,2,2,1,0,1,1,70918.12845178662,143413.24457139417,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,ZNF408,-0.14600003,0.87539,-0.076688,0,-1.0,-1.0,,
ENSG00000175262,2,2,1,0,0,1,1555.3915044988491,180089.50342935527,2012-02-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,3,CIROZ,0.055000007,0.75201,0.43926,0,0.5,0.5,,
ENSG00000175315,2,2,1,1,0,1,72982.48880358285,100711.28404230655,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,CST6,-0.48800004,-0.53571,-1.2634,0,1.0,0.0,,
ENSG00000175318,2,2,0,0,0,1,147105.90765133628,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,GRAMD2A,0.06699997,0.34738,1.0729,0,0.5,0.0,,
ENSG00000175387,2,2,1,0,0,1,406587.2658730814,562534.7696387965,2022-10-12,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,SMAD2,0.751,4.4773,0.11195,17,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Loss of Function of TGFBR1 in Cancer;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Post-translational protein modification;FOXO-mediated transcription of cell cycle genes;Formation of definitive endoderm,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-2173796;R-HSA-3656534;R-HSA-2173793;R-HSA-597592;R-HSA-9617828;R-HSA-9823730
ENSG00000175390,5,2,1,0,0,1,13401.327408754974,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,1,7,EIF3F,0.53999996,0.27315,-0.43429,6,-1.0,-1.0,Translation,R-HSA-72766
ENSG00000175591,2,2,1,0,1,1,32705.240805002948,50087.52781663962,2023-01-18,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,0,3,P2RY2,-0.91700006,-0.97568,-0.7028,4,0.5,0.0,Signal Transduction;P2Y receptors;Nucleotide-like (purinergic) receptors;Surfactant metabolism,R-HSA-162582;R-HSA-417957;R-HSA-418038;R-HSA-5683826
ENSG00000175764,2,2,0,0,0,1,2288.8778073359817,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,3,TTLL11,-0.04400003,1.0347,-0.73654,1,0.5,-1.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000175877,2,2,0,0,1,1,16421.798554291887,672632.4785173276,2018-08-13,0,0,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,TMEM270,-0.39199996,-0.03808,0.34228,0,1.0,1.0,,
ENSG00000175893,3,2,1,0,0,1,149644.92262336772,1122672.658801146,2020-11-10,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,4,ZDHHC21,0.143,0.097733,-1.8966,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000175906,2,2,1,0,0,1,278498.5074409075,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,ARL4D,-0.79999995,0.95685,0.78336,0,-1.0,0.0,,
ENSG00000176160,2,2,0,0,0,1,20393.928394796258,327782.2658449885,2022-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,4,HSF5,0.745,2.1972,-0.42943,0,1.0,0.5,,
ENSG00000176171,3,2,0,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,BNIP3,-0.09500003,0.86854,0.28354,0,0.5,-1.0,,
ENSG00000176358,2,2,0,0,0,1,17601.10520641419,191895.42310022408,2020-05-13,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,11,TAC4,-0.40400004,0.35048,-0.59509,0,0.5,0.5,,
ENSG00000176390,2,2,1,0,0,1,114439.41769154315,1990918.947961699,2022-11-21,0,0,0,0,0,1,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,CRLF3,0.12900001,0.70979,-1.2879,0,0.5,-1.0,,
ENSG00000176406,2,2,1,0,0,0,195005.6685718255,286746.1002745869,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,RIMS2,0.605,0.98127,0.16989,0,0.5,0.0,,
ENSG00000176438,2,2,1,0,0,1,86992.9057658324,645988.1975077938,2023-06-29,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SYNE3,-0.13100004,0.81685,-0.18528,0,0.5,0.0,,
ENSG00000176495,2,2,0,0,0,1,21724.94108458234,108816.31098183901,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,2,OR5AN1,-0.872,-1.6462,-1.3061,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000176540,2,2,0,0,0,1,107949.90929360976,156470.480665571,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,OR4C5,,,,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000176566,5,2,0,0,0,1,2201.7501988862373,414433.58532016096,2017-01-04,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,7,DCAF4L2,-0.095999956,0.34103,-1.1488,0,1.0,1.0,,
ENSG00000176567,2,2,0,0,0,1,11798.46653227782,49338.897692059916,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,3,OR4X1,,-2.2739,-1.4852,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000176601,2,2,0,0,0,1,832.4060913705583,5173.800802905755,2011-10-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,MAP3K19,0.038999975,1.4711,0.8605,0,0.5,0.5,,
ENSG00000177082,2,2,1,0,0,1,21724.94108458234,1470466.6505612188,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,WDR73,0.026000023,-0.46347,-0.90504,0,-1.0,-1.0,,
ENSG00000177125,2,2,0,0,0,1,11679.569250778799,323648.5577791949,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,ZBTB34,0.86300004,3.9744,-0.51145,0,-1.0,-1.0,,
ENSG00000177189,2,2,1,0,0,1,48439.20423385324,219437.49527928562,2023-01-18,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,RPS6KA3,,,,7,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;CREB phosphorylation;Signaling by Interleukins;Gastrin-CREB signalling pathway via PKC and MAPK;Recycling pathway of L1;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-199920;R-HSA-449147;R-HSA-881907;R-HSA-437239;R-HSA-9006934
ENSG00000177688,2,2,0,0,1,1,13883.57970142381,219793.50457789513,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,SUMO4,-0.64,-0.24874,0.30933,0,-1.0,0.5,,
ENSG00000177994,2,2,1,0,1,1,57035.41574163062,157104.75632914572,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,2,CIMIP6,-0.888,-0.95478,-1.1421,0,1.0,0.5,,
ENSG00000178188,2,2,1,0,1,1,61498.92173410762,572390.9560934792,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,0,0,3,SH2B1,0.626,0.80182,-0.1744,4,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System,R-HSA-162582;R-HSA-1280215;R-HSA-168256
ENSG00000178217,4,2,0,0,1,1,31828.071233716477,404399.6052088398,2021-06-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,SH2D4B,-0.021999955,-0.28468,-0.59724,0,,,,
ENSG00000178222,3,2,1,0,0,1,191895.42310022408,714039.8414241908,2023-11-02,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,2,RNF212,-0.34800005,-0.12079,0.40157,0,0.5,0.0,,
ENSG00000178394,4,2,0,0,0,1,95776.89591443514,1778690.168860174,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,HTR1A,0.038999975,1.3278,0.1275,1,0.75,0.5,Signal Transduction;Amine ligand-binding receptors,R-HSA-162582;R-HSA-375280
ENSG00000178425,6,2,1,0,0,1,87545.45580019058,1470466.6505612188,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,3,8,NT5DC1,-0.40600002,0.35403,-0.77961,0,0.5,-1.0,,
ENSG00000178719,2,2,1,0,0,1,191477.8325312717,191477.8325312717,2023-12-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,GRINA,0.13999999,1.1594,-1.3626,0,-1.0,-1.0,,
ENSG00000178796,2,2,1,0,0,1,116388.33957200912,226155.40757232966,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,RIIAD1,-0.96000004,-2.011,-2.2036,0,0.75,0.5,,
ENSG00000178852,2,2,0,0,1,1,207220.14223281175,269829.0934099178,2023-01-18,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,3,EFCAB13,0.04699999,1.6529,1.4217,0,0.5,0.0,,
ENSG00000178860,2,2,1,0,0,1,133918.94977035935,414433.58532016096,2020-04-27,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MSC,-0.78400004,-0.91691,-1.9633,0,-1.0,0.0,,
ENSG00000178966,2,2,0,0,1,1,634722.4486407059,634722.4486407059,2022-10-12,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RMI1,0.003000021,1.0149,0.48623,14,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000179008,9,2,1,0,1,1,2885.810854728632,414433.58532016096,2012-04-26,0,0,0,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,34,C14orf39,-0.306,-0.5849,-1.167,0,0.5,0.5,,
ENSG00000179142,2,2,0,0,1,1,50161.278626555366,1910759.9043975426,2018-08-13,0,0,0,0,5,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,8,CYP11B2,-0.008000016,0.01061,-0.42478,4,1.0,1.0,Disease;Metabolism of steroids,R-HSA-1643685;R-HSA-8957322
ENSG00000179242,3,2,0,0,0,1,162367.55694122918,433862.5685735124,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,3,CDH4,0.467,2.2343,-1.4431e-05,2,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000179912,2,2,0,0,0,1,16386.12478006288,323648.5577791949,2018-02-26,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,4,0,0,0,0,0,0,6,R3HDM2,0.611,3.7684,1.2519,0,-1.0,-1.0,,
ENSG00000180155,4,2,1,0,0,1,30182.28889075047,442877.006007271,2021-09-30,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,LYNX1,-0.57500005,0.031383,-0.45752,0,0.5,0.0,,
ENSG00000180269,2,2,0,0,0,1,383158.3001114715,433862.5685735124,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,GPR139,0.272,1.5414,0.19568,0,,,,
ENSG00000180488,2,2,0,0,0,0,183438.04190920538,183438.04190920538,2023-02-10,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,MIGA1,-0.029000044,0.081693,-0.39546,1,-1.0,-1.0,Synthesis of PA,R-HSA-1483166
ENSG00000180644,2,2,0,0,1,1,12748.270862028934,22669.576834673207,2023-05-15,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,PRF1,-0.43799996,0.6948,0.81408,1,0.75,0.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000180776,2,2,1,0,0,1,281079.0730593847,281079.0730593847,2023-01-18,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,ZDHHC20,-0.013000011,0.49331,-0.13822,1,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000180806,2,2,0,0,0,1,75639.5973879004,223386.61486493575,2023-03-13,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,HOXC9,0.065999985,-0.55256,-1.6641,0,0.5,0.0,,
ENSG00000180988,2,2,0,0,0,1,1560.6893280632412,48578.54898906086,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,OR52N2,,,,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000181523,5,2,1,0,0,1,74849.51324866469,152547.21264052036,2024-07-19,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,0,0,0,6,SGSH,-0.26,0.58086,-0.44263,2,-1.0,-1.0,Disease;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1643685;R-HSA-1638091
ENSG00000181856,2,2,1,0,0,1,50087.52781663962,383158.3001114715,2018-08-13,0,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SLC2A4,0.227,1.9782,0.45265,3,0.5,0.0,Developmental Biology;Cellular hexose transport,R-HSA-1266738;R-HSA-189200
ENSG00000181991,2,2,0,0,0,1,16853.230163428838,106176.1187815965,2023-01-18,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MRPS11,-0.53400004,-0.17932,-0.15127,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000182054,2,2,1,0,0,1,25415.17921452856,384314.83364002535,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,1,0,0,0,5,IDH2,0.49800003,1.5569,-1.36,4,0.75,-1.0,Maturation of TCA enzymes and regulation of TCA cycle;Citric acid cycle (TCA cycle),R-HSA-9854311;R-HSA-71403
ENSG00000182093,2,2,1,0,0,1,2589.013361278491,3279.331941544885,2018-08-01,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,GET1,-0.23699999,0.5683,-0.26415,1,0.5,-1.0,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,R-HSA-9609523
ENSG00000182208,2,2,1,0,1,1,197485.87952538437,521818.7070055739,2021-01-04,4,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,MOB2,0.059000015,0.81827,-0.45792,0,-1.0,0.0,,
ENSG00000182447,2,2,0,0,0,1,1173.5007132667617,169088.90478978804,2019-03-05,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,3,OTOL1,-0.525,-1.4558,-0.89107,0,,,,
ENSG00000182504,2,2,1,0,0,1,143220.026689682,213435.01458839694,2020-05-13,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,CEP97,0.153,1.397,1.3633,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000182957,4,2,1,0,0,1,54703.55383629191,269829.0934099178,2018-08-13,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,0,0,0,2,0,0,0,15,SPATA13,0.399,2.0983,1.7057,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000183087,3,2,1,1,0,1,141293.18354755783,464892.4593283075,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,3,GAS6,0.213,0.41038,-1.3239,7,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000183098,3,2,1,0,0,1,1076472.0138856068,1778690.168860174,2022-07-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,4,GPC6,0.616,1.3324,-0.18122,12,-1.0,0.0,Disease;Glycosaminoglycan-protein linkage region biosynthesis;HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1643685;R-HSA-1971475;R-HSA-2022928;R-HSA-1638091
ENSG00000183324,2,2,0,0,0,1,100711.28404230655,131870.09182409043,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,REC114,-0.268,-0.61446,-0.5373,0,1.0,0.5,,
ENSG00000183741,2,2,1,0,0,1,141076.9910731678,645988.1975077938,2020-05-18,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CBX6,0.417,0.37022,-1.6657,3,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000183775,8,2,0,0,0,1,87545.45580019058,1778690.168860174,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,1,8,KCTD16,0.463,1.6781,0.35513,0,0.5,0.5,,
ENSG00000183779,2,2,0,0,0,1,54580.46858134564,1424218.0900670097,2020-05-06,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ZNF703,-0.576,-2.694,-4.0025,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000183785,5,2,0,0,1,1,21117.402887671095,645988.1975077938,2018-06-11,0,0,0,0,12,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,TUBA8,-0.116999984,1.2844,0.57456,28,0.5,0.0,Signal Transduction;Post-chaperonin tubulin folding pathway;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Gap junction assembly;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Disease;Aggrephagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Recycling pathway of L1;Carboxyterminal post-translational modifications of tubulin;Gap junction trafficking and regulation;Kinesins;Gap junction trafficking;Post-translational protein modification,R-HSA-162582;R-HSA-389977;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-190861;R-HSA-389958;R-HSA-1643685;R-HSA-9646399;R-HSA-9668328;R-HSA-8856688;R-HSA-6811434;R-HSA-437239;R-HSA-8955332;R-HSA-157858;R-HSA-983189;R-HSA-190828;R-HSA-597592
ENSG00000183826,6,2,0,0,0,1,1200.5470256731371,1778690.168860174,2007-07-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,0,0,0,0,0,0,27,BTBD9,0.04100001,2.491,0.85073,0,-1.0,-1.0,,
ENSG00000183864,3,2,0,0,0,1,142744.17442731425,295500.356444329,2019-07-30,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,4,TOB2,0.579,1.0339,1.2417,0,-1.0,-1.0,,
ENSG00000184056,2,2,1,0,1,1,135095.86576106868,433862.5685735124,2020-05-06,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6,VPS33B,0.028999984,1.0991,0.33245,2,-1.0,-1.0,Disease;Response of Mtb to phagocytosis;Suppression of phagosomal maturation;Infection with Mycobacterium tuberculosis,R-HSA-1643685;R-HSA-9637690;R-HSA-9637687;R-HSA-9635486
ENSG00000184108,2,2,0,0,0,1,636.1886490807354,5532.1550014722625,2012-10-09,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,TRIML1,-0.43200004,-0.068157,-0.3839,0,1.0,1.0,,
ENSG00000184178,2,2,1,0,0,1,56101.88409046092,143413.24457139417,2021-02-24,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,9,SCFD2,-0.18200004,1.0464,0.94878,0,-1.0,-1.0,,
ENSG00000184206,3,2,1,0,0,1,54892.674160393246,356440.71671986027,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,8,0,0,0,0,0,0,9,GOLGA6L4,,,,0,-1.0,-1.0,,
ENSG00000184302,6,2,1,0,1,1,7053.66653679005,414433.58532016096,2016-01-11,2,0,0,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,SIX6,0.078999996,0.62234,1.2473,0,1.0,0.5,,
ENSG00000184445,5,2,1,0,1,1,183427.12489668437,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,2,6,KNTC1,0.16500002,1.4758,0.36918,6,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000184465,2,2,0,0,0,1,47408.95172709719,52982.28647069224,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,2,WDR27,-0.13199997,-0.75444,-0.95845,0,-1.0,0.0,,
ENSG00000184486,3,2,1,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,POU3F2,0.17799997,1.5178,-2.2647,3,1.0,1.0,Developmental Biology,R-HSA-1266738
ENSG00000184601,2,2,0,0,0,1,10966.621263335262,427337.4491868293,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,C14orf180,-0.63100004,-1.1949,-1.8333,0,0.5,0.0,,
ENSG00000184611,3,2,0,0,0,1,6131.4565483476135,1424218.0900670097,2010-10-17,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,7,KCNH7,0.502,3.8438,-0.1949,1,0.5,0.5,,
ENSG00000184752,3,2,0,0,0,1,54391.03477538057,782476.8109259979,2017-12-06,0,0,0,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,NDUFA12,-0.18799996,0.083702,-0.24676,2,0.5,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000184792,2,2,0,0,0,1,328052.24452619,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,0,0,0,0,0,0,3,OSBP2,0.10699999,1.7813,0.27696,0,0.5,-1.0,,
ENSG00000184860,2,2,0,0,0,1,78728.4671948324,94458.73018015742,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,SDR42E1,-0.80499995,-1.5093,-1.2209,0,0.5,0.0,,
ENSG00000184949,2,2,1,0,0,1,31535.173607928213,190279.23963861223,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,FAM227A,-0.20200002,0.67233,0.99583,0,0.5,0.5,,
ENSG00000185000,3,2,1,0,0,1,13883.57970142381,1424218.0900670097,2018-08-13,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,DGAT1,-0.054999948,0.41962,-1.4527,3,0.5,0.0,Immune System;Acyl chain remodeling of DAG and TAG,R-HSA-168256;R-HSA-1482883
ENSG00000185201,2,2,1,0,1,1,27408.031319588463,116089.30071075787,2020-06-24,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,3,IFITM2,-0.546,0.57329,-0.43671,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000185220,2,2,0,0,0,1,64339.76089271658,137776.79053446153,2018-09-07,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,PGBD2,-0.52199996,-0.30959,-0.94455,0,-1.0,-1.0,,
ENSG00000185436,3,2,1,0,1,1,8844.888938597473,309256.4614031486,2015-11-28,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,9,IFNLR1,0.231,0.56021,-0.14636,2,-1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000185532,2,2,0,0,0,1,88771.02207231094,197485.87952538437,2023-01-18,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,PRKG1,0.46600002,3.881,0.040818,3,0.5,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000185736,2,2,0,0,0,1,1173.5007132667617,1076472.0138856068,2019-02-04,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,ADARB2,0.319,-1.5461,-3.2812,0,1.0,0.5,,
ENSG00000185774,4,2,0,0,0,1,4942.697740112994,1778690.168860174,2015-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,4,KCNIP4,0.14600003,0.94943,-0.54026,1,0.5,0.0,,
ENSG00000185823,2,2,0,0,0,1,4847.839591114606,170842.91114447502,2019-06-23,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,5,NPAP1,-0.93499994,-0.055252,-0.68279,0,0.5,1.0,,
ENSG00000185869,3,2,0,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,ZNF829,0.08899999,1.9321,1.3519,0,1.0,0.0,,
ENSG00000185924,3,2,0,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,RTN4RL1,0.374,1.2492,-0.69679,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000185958,2,2,0,0,1,1,22585.092924102493,358386.30063935445,2021-11-04,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FAM186A,0.148,3.992,3.4883,0,1.0,0.5,,
ENSG00000185966,2,2,0,0,0,1,8565.645362637362,69922.35818009122,2012-10-01,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,LCE3E,-0.855,-0.34944,0.6994,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000186063,3,2,1,0,0,1,135357.37232135262,280228.4034560385,2020-05-29,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,3,AIDA,0.45499998,1.5646,0.70049,0,-1.0,-1.0,,
ENSG00000186106,3,2,0,0,0,1,248902.39286982678,322220.1169395476,2019-07-30,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,3,ANKRD46,0.035000026,2.147,1.0917,0,-1.0,-1.0,,
ENSG00000186115,3,2,0,0,1,1,51940.508691272094,574261.7466389402,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,6,CYP4F2,-0.19700003,1.0949,-0.85184,5,0.5,0.5,Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonate metabolism,R-HSA-211979;R-HSA-2142691;R-HSA-2142753
ENSG00000186146,2,2,0,0,0,1,3789.532716625647,94870.11495236546,2020-09-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,3,DEFB131A,-0.90900004,-1.5381,-0.75948,2,1.0,0.5,,
ENSG00000186367,3,2,0,0,0,1,47336.27089212796,414433.58532016096,2023-01-18,0,0,0,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,5,MINAR2,-0.822,-1.2798,-0.83664,0,1.0,1.0,,
ENSG00000186635,3,2,1,0,0,1,26908.700469045143,1424218.0900670097,2010-06-27,0,0,0,0,0,22,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,27,ARAP1,0.42799997,1.8747,-0.43224,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000186638,3,2,0,0,0,1,281258.82202219026,281258.82202219026,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,KIF24,0.268,1.5384,0.67246,1,0.5,0.5,,
ENSG00000186642,2,2,1,0,0,1,13129.29816360601,1778690.168860174,2012-03-25,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0,0,0,0,0,0,4,PDE2A,0.436,3.8751,-0.45213,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000186714,2,2,0,0,0,1,71387.66703162997,1122672.658801146,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,3,CCDC73,-0.103000045,1.6539,0.37989,0,1.0,1.0,,
ENSG00000186994,4,2,1,0,1,1,46977.28346057821,108816.31098183901,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,2,0,0,0,0,7,KANK3,-0.673,-3.5271,-4.8244,0,-1.0,0.0,,
ENSG00000187033,2,2,0,0,0,0,201549.9575922349,226101.35678720698,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,2,SAMD7,-0.18299997,0.093358,-0.22127,0,1.0,1.0,,
ENSG00000187134,2,2,1,1,0,1,12724.75719835148,116388.33957200912,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,AKR1C1,-0.255,0.51475,0.87652,5,0.5,0.0,Prednisone ADME;Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-9757110;R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000187166,4,2,1,0,1,1,156100.20896497899,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,4,H1-7,-0.934,-0.6545,-0.84106,0,1.0,1.0,,
ENSG00000187240,2,2,0,0,1,1,384314.83364002535,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,DYNC2H1,0.14099997,0.47463,-0.79369,2,0.5,0.0,Signal Transduction;Intraflagellar transport,R-HSA-162582;R-HSA-5620924
ENSG00000187257,2,2,0,0,0,1,1163.529842548517,645988.1975077938,2023-09-14,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RSBN1L,0.44,0.72651,-0.80663,0,-1.0,-1.0,,
ENSG00000187416,2,2,0,0,0,1,5268.7042958444,18531.1622981202,2021-11-04,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,LHFPL3,0.453,1.5263,0.10488,0,0.75,0.5,,
ENSG00000187733,2,2,0,1,0,1,256331.89034791503,258456.3496858129,2019-06-24,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,4,AMY1C,0.436,1.9703,1.5748,1,1.0,0.5,,
ENSG00000187791,2,2,0,0,1,1,104792.02869450308,104792.02869450308,2018-05-21,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,SPATA31F3,,,,0,1.0,1.0,,
ENSG00000187796,6,2,1,0,1,1,6482.24749962681,71117.27631467933,2010-11-21,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,12,CARD9,-0.143,-0.92366,-2.6337,2,0.5,0.0,Immune System,R-HSA-168256
ENSG00000187954,3,2,1,0,0,0,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,ZFTRAF1,-0.16299999,2.1883,-1.2415,0,0.5,0.0,,
ENSG00000188107,5,2,0,0,1,1,171880.2916512608,1778690.168860174,2019-02-04,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,12,EYS,0.04000002,-0.45186,-0.19373,0,1.0,1.0,,
ENSG00000188293,3,2,0,0,0,1,78728.4671948324,101032.95487940393,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,2,4,IGFL1,-0.561,-0.039872,-0.25833,0,0.75,0.5,,
ENSG00000188316,3,2,0,0,0,1,324308.4770735607,765591.3646788632,2020-06-15,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ENO4,0.11199999,0.73538,0.33923,2,0.5,0.5,Gluconeogenesis,R-HSA-70263
ENSG00000188394,2,2,0,0,0,0,306980.8575290048,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,GPR21,0.36,0.57754,-0.030975,0,0.5,1.0,,
ENSG00000188636,2,2,0,0,0,1,576.1087314662274,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,RTL6,-0.20000005,1.0877,-0.42018,0,-1.0,-1.0,,
ENSG00000188763,2,2,0,0,0,1,167129.38535790148,299999.7750406064,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,FZD9,-0.36800003,-0.77585,-1.1683,1,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000188959,2,2,0,0,1,1,358386.30063935445,521818.7070055739,2021-11-04,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,C9orf152,-0.74300003,-0.37721,-0.10353,0,0.5,0.0,,
ENSG00000189143,2,2,1,0,0,1,328052.24452619,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,CLDN4,-0.43799996,1.1371,-0.31931,1,0.5,0.0,Tight junction interactions,R-HSA-420029
ENSG00000189195,2,2,0,0,1,0,116174.4371191816,116174.4371191816,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,2,BTBD8,0.24699998,1.9683,1.4966,0,0.75,0.0,,
ENSG00000196092,6,2,0,0,0,1,86334.97261459603,1778690.168860174,2016-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,12,PAX5,0.639,2.3767,-0.31591,1,1.0,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000196151,2,2,0,0,0,1,4822.628388854954,433862.5685735124,2011-06-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,WDSUB1,-0.13499999,1.0209,0.36614,0,-1.0,-1.0,,
ENSG00000196199,2,2,1,1,0,1,201549.9575922349,226101.35678720698,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,2,MPHOSPH8,0.365,1.6757,0.29864,1,-1.0,-1.0,Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex;Gene expression (Transcription),R-HSA-9843970;R-HSA-74160
ENSG00000196266,2,2,0,0,0,1,33910.05821821659,157563.09954473734,2023-01-18,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,1,4,OR10J3,,-0.98385,-0.19596,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000196547,2,2,0,0,0,1,161092.74087321138,279825.00883385167,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,MAN2A2,0.278,1.821,-0.44067,2,-1.0,-1.0,Reactions specific to the complex N-glycan synthesis pathway;Post-translational protein modification,R-HSA-975578;R-HSA-597592
ENSG00000196562,4,2,1,0,0,1,89519.16315227402,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,1,8,SULF2,0.38599998,1.8008,-0.28703,0,-1.0,-1.0,,
ENSG00000196683,2,2,1,0,0,1,17601.10520641419,1424218.0900670097,2024-02-19,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TOMM7,-0.584,-0.32952,-0.45809,2,-1.0,-1.0,,
ENSG00000197006,3,2,1,0,0,1,94665.79117035728,1122672.658801146,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,1,0,0,0,8,METTL9,0.499,2.2577,-1.5975,0,-1.0,-1.0,,
ENSG00000197020,2,2,1,0,1,1,130268.25219927442,718784.6890415357,2020-05-06,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ZNF100,-0.32099998,-0.38158,-0.47643,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000197136,3,2,0,0,0,1,78016.97193351923,358386.30063935445,2017-12-06,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,PCNX3,0.605,1.7468,-3.1746,0,-1.0,-1.0,,
ENSG00000197177,2,2,1,0,0,0,405722.3511294316,1778690.168860174,2021-06-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,ADGRA1,-0.024999976,-0.99682,-1.77,0,1.0,0.5,,
ENSG00000197223,4,2,0,0,0,1,2298.97385620915,1778690.168860174,2011-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,0,0,2,0,0,0,18,C1D,0.17400002,0.2371,-0.20847,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000197256,3,2,1,0,0,1,29803.01405728205,427337.4491868293,2020-01-20,0,0,0,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,KANK2,0.296,0.62293,-0.31898,0,-1.0,-1.0,,
ENSG00000197520,6,2,1,0,1,1,46437.13674418605,353692.15712867765,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,6,FAM177B,-0.76699996,0.23783,0.21272,0,0.5,0.5,,
ENSG00000197555,4,2,1,0,0,1,20841.620346446787,358386.30063935445,2018-08-13,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SIPA1L1,0.774,3.4383,1.0179,1,-1.0,-1.0,,
ENSG00000197584,2,2,1,0,0,1,572390.9560934792,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,3,KCNMB2,0.41399997,1.4986,0.14564,2,0.5,0.0,,
ENSG00000197594,3,2,1,0,0,1,13059.485283664542,156100.20896497899,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,3,8,ENPP1,0.27100003,1.2082,0.045816,2,0.5,0.0,Vitamin B5 (pantothenate) metabolism,R-HSA-199220
ENSG00000197616,4,2,0,0,1,1,32996.93546153374,645988.1975077938,2018-06-11,0,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,14,MYH6,0.366,4.1453,1.1143,1,1.0,0.5,,
ENSG00000197756,2,2,1,0,0,1,21201.639474894007,21201.639474894007,2023-03-22,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RPL37A,0.13200003,1.2748,-0.36229,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000197982,2,2,1,0,0,1,22938.587937312015,124837.11004999638,2021-02-03,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,2,C1orf122,-0.913,-0.77245,-1.0498,0,0.5,-1.0,,
ENSG00000198010,2,2,1,0,0,1,7987.2,323648.5577791949,2023-10-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,DLGAP2,0.575,-4.7074,-6.1444,1,0.5,0.5,,
ENSG00000198026,7,2,0,0,0,1,33892.13656698846,394357.452283155,2015-12-21,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,7,ZNF335,0.282,-0.54217,-0.88006,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000198064,2,2,1,0,0,1,87248.80974040499,598869.4096893278,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,NPIPB13,,,,0,-1.0,-1.0,,
ENSG00000198077,2,2,1,0,1,1,13045.478778177418,307158.2364521972,2020-06-08,0,0,0,0,1,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,6,CYP2A7,-0.15799999,-0.67091,-0.73489,3,1.0,0.5,,
ENSG00000198168,4,2,0,0,0,1,162367.55694122918,551389.5206213495,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,3,5,SVIP,-0.88900006,-0.46276,-0.58598,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000198205,3,2,0,0,0,1,260210.21963428933,298878.49542603496,2023-01-18,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ZXDA,,,,0,-1.0,0.0,,
ENSG00000198399,2,2,1,0,1,1,141293.18354755783,314481.0395324854,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,ITSN2,0.23699999,1.7434,0.55959,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000198400,2,2,0,0,0,1,26020.4828907398,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,2,NTRK1,0.046000004,0.91609,-0.83758,10,0.5,0.5,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000198498,3,2,0,0,0,1,12603.236825665355,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,4,TMA16,-0.59800005,-0.017774,0.41497,0,-1.0,-1.0,,
ENSG00000198522,2,2,1,0,0,1,5475.33700166113,160062.83409140486,2020-04-13,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,GPN1,-0.431,-0.34894,-1.6519,0,-1.0,-1.0,,
ENSG00000198523,7,2,0,0,0,1,5495.191484272216,545988.1005477115,2017-04-17,0,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,16,PLN,-0.704,-0.41779,-0.52143,2,0.75,0.0,,
ENSG00000198624,2,2,1,0,0,1,1173.5007132667617,123127.18790121445,2019-02-25,0,0,0,0,0,1,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,4,CCDC69,-0.181,-0.16267,0.09259,0,0.5,-1.0,,
ENSG00000198680,2,2,0,0,0,1,205425.60717824215,1122672.658801146,2020-03-30,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,4,0,0,0,0,0,0,5,TUSC1,-0.97300005,-5.1947,-5.2478,0,-1.0,-1.0,,
ENSG00000198746,2,2,0,0,0,0,26497.336478101235,219793.50457789513,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,GPATCH3,-0.008999944,0.66974,0.31721,0,-1.0,-1.0,,
ENSG00000198793,2,2,1,0,0,1,36494.548446257475,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,3,MTOR,0.732,9.505,1.4185,14,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;mTORC1-mediated signalling;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Energy dependent regulation of mTOR by LKB1-AMPK;Amino acids regulate mTORC1;MTOR signalling;Cellular response to starvation;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-166208;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-380972;R-HSA-9639288;R-HSA-165159;R-HSA-9711097;R-HSA-9006934;R-HSA-5663202
ENSG00000198898,2,2,0,0,0,1,67462.33624005377,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,CAPZA2,0.556,1.2482,0.09538,7,-1.0,-1.0,Immune System;Golgi-to-ER retrograde transport;Post-translational protein modification,R-HSA-168256;R-HSA-8856688;R-HSA-597592
ENSG00000203710,5,2,1,1,1,1,1321.7688442211056,340825.7076940272,2011-04-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,0,0,0,0,0,2,24,CR1,0.22600001,1.8867,2.2281,3,0.5,0.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-8877330
ENSG00000203737,2,2,0,0,0,1,100711.28404230655,1990918.947961699,2022-11-21,0,0,0,1,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,5,GPR52,0.42299998,0.9897,0.96214,0,1.0,1.0,,
ENSG00000204140,2,2,0,0,1,1,31137.07865241903,83932.6290685273,2020-12-11,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,CLPSL1,-0.867,-0.70148,-0.18599,0,0.75,0.5,,
ENSG00000204178,3,2,1,0,0,1,178948.78717378277,551389.5206213495,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,3,MACO1,0.71099997,3.8599,0.41727,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000204262,3,2,1,0,0,1,46282.676044693806,356440.71671986027,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,2,7,COL5A2,0.894,3.3665,0.44883,13,-1.0,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000204335,2,2,0,0,0,1,7829.805429864254,12685.217791998773,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,SP5,-0.11500001,-2.4407,-3.0192,0,0.5,0.0,,
ENSG00000204548,2,2,0,0,0,1,20116.397853009086,427337.4491868293,2018-10-03,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DEFB121,-0.956,0.073323,-0.49811,2,1.0,1.0,Immune System;Defensins;Antimicrobial peptides,R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000204950,3,2,0,0,0,1,50161.278626555366,500292.45069431677,2018-11-28,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,6,LRRC10B,-0.89400005,-0.96431,-1.8054,0,0.75,0.0,,
ENSG00000205078,2,2,0,0,0,1,21201.639474894007,1424218.0900670097,2023-03-22,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SYCE1L,-0.673,-3.0972,-2.1672,0,0.5,0.0,,
ENSG00000205420,2,2,1,0,0,1,53157.639291331456,173193.7688415446,2018-08-13,1,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,KRT6A,0.245,0.57996,-0.10262,2,0.75,0.0,Developmental Biology,R-HSA-1266738
ENSG00000205436,3,2,1,0,1,1,5426.200199914322,90049.68162979394,2011-03-13,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,EXOC3L4,-0.53199995,-3.0248,-3.5776,0,0.75,0.5,,
ENSG00000205442,2,2,1,0,0,1,101825.50588235294,205425.60717824215,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,IZUMO3,-0.655,-1.96,-1.203,1,1.0,1.0,Fertilization,R-HSA-1187000
ENSG00000205863,2,2,0,0,0,0,5305.093934911242,7972.209256466767,2011-07-03,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,C1QTNF9B,-0.411,2.9406,2.3543,0,0.5,0.0,,
ENSG00000205882,2,2,0,0,0,1,105845.44891077634,256331.89034791503,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,DEFB134,-0.67200005,-1.0764,-0.66563,2,1.0,0.5,Immune System;Defensins;Antimicrobial peptides,R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000206432,2,2,0,0,0,1,132101.59514050526,132101.59514050526,2024-03-31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,TMEM200C,-0.778,-1.6957,-2.6947,0,0.5,0.5,,
ENSG00000206530,2,2,1,0,1,1,195005.6685718255,521818.7070055739,2021-09-30,1,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CFAP44,0.30299997,1.8195,0.99029,0,-1.0,0.0,,
ENSG00000206531,3,2,1,0,0,1,248902.39286982678,322220.1169395476,2019-07-30,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,3,CD200R1L,0.18300003,0.15007,0.21538,0,1.0,1.0,,
ENSG00000206560,2,2,0,0,0,1,286678.73247515375,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,5,ANKRD28,0.54499996,1.8194,0.63439,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000213672,2,2,1,0,0,1,52041.91017278707,324308.4770735607,2019-07-15,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,NCKIPSD,0.11400002,0.60867,-0.86391,3,0.5,-1.0,Signal Transduction;Immune System;Disease,R-HSA-162582;R-HSA-168256;R-HSA-1643685
ENSG00000213809,2,2,1,1,0,0,2491.407942238267,45951.29495376284,2013-01-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,KLRK1,-0.663,0.42733,0.31612,3,0.5,0.0,Immune System,R-HSA-168256
ENSG00000213892,4,2,0,0,1,1,46668.53011336361,551389.5206213495,2013-10-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,6,9,CEACAM16,-0.13900006,0.60416,-0.2328,0,0.5,1.0,,
ENSG00000214226,5,2,1,0,0,1,46282.676044693806,1470466.6505612188,2021-08-24,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,0,0,0,3,13,C17orf67,-0.678,0.13793,-0.78129,0,-1.0,0.0,,
ENSG00000214290,15,2,1,0,0,1,1982.7776096822995,473900.221403792,2008-03-30,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,27,POU2AF3,0.301,0.42318,0.39307,0,-1.0,0.0,,
ENSG00000214530,3,2,1,0,0,0,75632.36795352261,575147.0632428399,2024-01-05,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,STARD10,0.092999995,1.3985,0.45731,1,0.5,-1.0,,
ENSG00000214787,5,2,1,0,0,1,1321.7688442211056,332375.5317723021,2015-03-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,1,8,MS4A4E,-0.85899997,-0.20519,0.20145,0,-1.0,0.0,,
ENSG00000214929,3,2,0,0,0,1,80746.41870861933,323648.5577791949,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,9,SPATA31D1,0.123000026,-4.2084,-3.234,0,1.0,1.0,,
ENSG00000217236,2,2,0,0,0,1,358386.30063935445,765591.3646788632,2020-06-15,0,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SP9,0.269,0.45417,-2.5432,0,1.0,1.0,,
ENSG00000218305,2,2,0,0,0,1,515513.2178404211,1778690.168860174,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,CDC14C,-0.43400002,0.39305,-1.1211,0,0.75,0.5,,
ENSG00000219073,5,2,1,0,0,1,19965.24128263536,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,5,CELA3B,-0.27999997,0.1851,0.61141,1,1.0,0.0,,
ENSG00000220205,2,2,1,0,0,0,25967.06754524981,1076472.0138856068,2021-05-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,3,VAMP2,0.824,1.7472,-0.39665,22,0.5,-1.0,"Cytokine Signaling in Immune system;Immune System;GABA synthesis, release, reuptake and degradation;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Acetylcholine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Neurotoxicity of clostridium toxins;Disease;Signaling by Interleukins;Dopamine Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Lysosome Vesicle Biogenesis;Neurotransmitter release cycle",R-HSA-1280215;R-HSA-168256;R-HSA-888590;R-HSA-9609523;R-HSA-264642;R-HSA-210500;R-HSA-168799;R-HSA-1643685;R-HSA-449147;R-HSA-212676;R-HSA-181429;R-HSA-432720;R-HSA-112310
ENSG00000221914,2,2,0,0,0,1,232586.34864014547,574261.7466389402,2021-01-04,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,PPP2R2A,0.63600004,4.4593,0.38458,5,-1.0,-1.0,Cyclin A/B1/B2 associated events during G2/M transition,R-HSA-69273
ENSG00000221954,2,2,0,0,0,1,294387.2978738704,448058.917711015,2021-09-30,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,OR4C12,-0.487,-0.56506,-0.13938,2,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000226490,3,2,0,0,0,1,95776.89591443514,95776.89591443514,2022-06-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,2,C8orf90,,,,0,1.0,0.5,,
ENSG00000227234,3,2,0,0,0,1,498258.534626183,498258.534626183,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,2,SPANXB1,,,,0,1.0,0.5,,
ENSG00000234545,2,2,0,0,0,1,356440.71671986027,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,FAM133B,0.06699997,0.97554,0.046082,0,-1.0,-1.0,,
ENSG00000235173,2,2,1,0,0,1,78751.06843456876,279825.00883385167,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,HGH1,-0.44099998,-2.7864,-2.4797,0,-1.0,0.0,,
ENSG00000235272,3,2,0,0,0,1,94951.97167384504,521818.7070055739,2021-05-17,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,4,RAMACL,-0.43299997,0.28959,0.82296,0,,,,
ENSG00000235608,2,2,0,0,0,1,135095.86576106868,1778690.168860174,2020-05-06,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,NKX1-1,,,,0,,,,
ENSG00000235718,2,2,0,0,1,1,25105.63490580795,286678.73247515375,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,MFRP,-0.30700004,-0.95615,-1.1028,0,1.0,1.0,,
ENSG00000236699,2,2,1,0,1,1,24992.840440553515,91172.20051337926,2023-01-18,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,ARHGEF38,-0.21000004,-0.14958,-0.52761,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000237412,3,2,1,0,1,1,10353.132295719844,326545.22790564946,2019-12-09,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,10,PRSS56,-0.110000014,-1.1646,-1.4833,0,0.75,0.5,,
ENSG00000237693,4,2,1,0,0,1,4383.801963294921,160010.51072069994,2007-06-06,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,10,IRGM,-0.788,-1.4044,-0.76397,0,,,,
ENSG00000240344,2,2,1,0,0,1,190279.23963861223,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,2,PPIL3,-0.63699996,0.74774,-0.64521,1,-1.0,-1.0,,
ENSG00000240857,2,2,0,0,0,1,286678.73247515375,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,5,RDH14,-0.623,-2.3701,-1.8948,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000241127,2,2,0,0,0,1,97181.90375256384,433862.5685735124,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,2,YAE1,-0.26600003,0.37453,0.12719,0,-1.0,-1.0,,
ENSG00000242689,3,2,1,0,0,1,100711.28404230655,1424218.0900670097,2023-01-18,0,0,0,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CNTF,-0.55499995,-0.4028,-0.019002,1,0.5,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000243147,2,2,0,0,0,1,42027.118313217856,104168.97660865163,2019-04-11,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,2,MRPL33,-0.13499999,0.22712,0.44613,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000243646,2,2,1,1,0,1,17224.294436185013,278739.419613982,2020-05-13,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,IL10RB,-0.052999973,1.4655,0.37114,3,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000243927,2,2,1,0,0,0,93675.90571045545,343998.09227709647,2022-08-03,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,MRPS6,-0.03699994,-0.28114,-0.27933,3,0.5,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000247596,2,2,0,0,0,0,100620.50186431198,100620.50186431198,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,2,TWF2,0.47500002,0.85241,0.83772,2,0.5,0.0,,
ENSG00000250361,2,2,0,0,0,1,32217.23287013741,384314.83364002535,2020-10-27,0,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,3,GYPB,-0.69000006,0.45443,0.61449,1,1.0,0.5,,
ENSG00000250803,5,2,1,0,1,1,27094.55086624802,410642.56898295006,2018-03-12,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,8,ZNF475,-0.84599996,-0.66239,-1.0631,0,1.0,0.5,,
ENSG00000253293,2,2,0,0,0,1,197485.87952538437,223386.61486493575,2023-03-13,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HOXA10,0.16600001,-1.8774,-2.6766,0,0.5,0.0,,
ENSG00000253506,5,2,0,0,1,1,60311.48086819863,356440.71671986027,2018-10-29,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,3,15,NACA2,-0.021999955,0.17796,-0.36101,0,1.0,0.5,,
ENSG00000258947,4,2,0,0,0,1,10691.1777495085,100272.30573726878,2018-08-13,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,8,TUBB3,0.31,5.6731,-1.5886,31,1.0,0.0,Signal Transduction;Post-chaperonin tubulin folding pathway;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Prefoldin mediated transfer of substrate  to CCT/TriC;Gap junction assembly;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Disease;Aggrephagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Intraflagellar transport;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Recycling pathway of L1;Carboxyterminal post-translational modifications of tubulin;Gap junction trafficking and regulation;Kinesins;Gap junction trafficking;Post-translational protein modification,R-HSA-162582;R-HSA-389977;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-389957;R-HSA-190861;R-HSA-389958;R-HSA-1643685;R-HSA-9646399;R-HSA-9668328;R-HSA-5620924;R-HSA-8856688;R-HSA-6811434;R-HSA-437239;R-HSA-8955332;R-HSA-157858;R-HSA-983189;R-HSA-190828;R-HSA-597592
ENSG00000259207,2,2,1,0,0,1,143413.24457139417,167055.73472660675,2021-11-04,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,ITGB3,0.315,2.1743,1.1136,22,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000259803,2,2,1,0,1,1,17601.10520641419,165324.69367515197,2022-03-07,0,4,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,SLC22A31,-0.89199996,-1.6006,-2.1221,0,0.5,0.5,,
ENSG00000261150,2,2,0,1,0,0,116388.33957200912,286678.73247515375,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,2,EPPK1,-0.929,-4.3254,-5.7998,0,1.0,0.0,,
ENSG00000261308,2,2,1,0,0,1,221280.45048451523,410642.56898295006,2022-09-30,0,0,0,0,1,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,5,FIGNL2,-0.906,-4.2733,-4.7553,0,0.5,0.5,,
ENSG00000267508,2,2,0,0,0,1,66438.21345734232,283145.34784240765,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,2,ZNF285,-0.38900006,0.46979,0.42614,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000267855,2,2,0,0,0,1,63367.23432105128,90664.10805347394,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,0,0,0,0,3,NDUFA7,-0.88699996,-0.65256,-1.1259,2,-1.0,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000274070,2,2,0,0,0,1,5205.737346049966,79847.99047557941,2021-07-07,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,CASTOR2,0.54499996,3.2422,0.13069,1,0.75,0.0,,
ENSG00000278053,2,2,0,0,0,1,2699.1085295016815,260210.21963428933,2022-01-25,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DDX52,0.111,0.34871,0.84924,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000279514,2,2,0,0,1,1,56614.28807963426,448058.917711015,2023-11-10,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,OR4C16,-0.92999995,-5.4286,-4.3445,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000283199,2,2,0,0,0,1,133918.94977035935,133918.94977035935,2020-04-27,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,2,C13orf46,,,,0,0.5,0.5,,
ENSG00000283227,2,2,0,0,0,0,145011.35140303092,205433.03502595585,2022-11-07,0,0,0,0,0,0,0,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,SPRR5,,,,0,1.0,0.5,,
ENSG00000283434,3,2,1,0,0,1,101825.50588235294,414433.58532016096,2023-01-18,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,8,CSNK2A2IP,,0.44871,0.14057,0,1.0,1.0,,
ENSG00000283632,3,2,1,0,1,1,141553.2677895436,502231.5406594711,2021-12-06,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,5,EXOC3L2,0.31300002,0.061545,-0.87844,0,0.5,0.0,,
ENSG00000285043,2,2,1,0,0,1,239970.53614968536,272025.74568937684,2018-10-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,2,ENSG00000285043,,,,0,1.0,0.0,,
ENSG00000288715,3,2,0,0,0,1,28498.101402717097,70321.24039683424,2019-06-07,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,4,ENSG00000288715,,-0.27844,-0.72016,0,,,,
ENSG00000289325,3,2,0,0,0,0,260210.21963428933,409691.21276290494,2021-11-04,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,ENSG00000289325,,,,0,,,,
ENSG00000289490,2,2,0,0,0,0,286678.73247515375,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,ENSG00000289490,,,,0,1.0,1.0,,
ENSG00000004948,1,1,0,0,0,1,254373.32653042395,1424218.0900670097,2020-05-06,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CALCR,-0.039000034,0.83346,-0.13128,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000005073,1,1,1,0,0,1,252346.18526092035,252346.18526092035,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HOXA11,0.39499998,0.78809,-0.60903,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000005175,1,1,0,0,0,1,136665.8227530756,136665.8227530756,2024-10-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RPAP3,-0.14400005,0.52157,0.11517,0,-1.0,-1.0,,
ENSG00000005513,1,1,1,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,SOX8,0.096000016,-2.6214,-4.1059,0,1.0,0.0,,
ENSG00000005882,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PDK2,0.07999998,2.5804,-0.20943,2,0.5,-1.0,Signal Transduction;Regulation of pyruvate metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism,R-HSA-162582;R-HSA-9861718;R-HSA-204174;R-HSA-70268
ENSG00000006015,1,1,0,0,0,1,169088.90478978804,169088.90478978804,2019-03-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,REX1BD,-0.86399996,-1.7876,-3.0215,0,-1.0,0.0,,
ENSG00000006555,2,1,1,0,1,0,82912.80518893801,124801.11117486731,2018-12-03,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TTC22,-0.37800002,-1.46,-1.6749,0,0.5,0.0,,
ENSG00000007001,1,1,0,0,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,UPP2,-0.09800005,0.41468,1.0463,2,0.75,0.5,Nucleotide salvage;Metabolism of nucleotides,R-HSA-8956321;R-HSA-15869
ENSG00000007923,1,1,0,0,0,1,149644.92262336772,149644.92262336772,2020-11-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,DNAJC11,0.718,2.4974,-0.37431,1,-1.0,-1.0,Cristae formation,R-HSA-8949613
ENSG00000008282,1,1,1,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,SYPL1,0.45599997,0.77993,0.16295,0,-1.0,-1.0,,
ENSG00000008283,2,1,1,0,0,1,197775.78125685986,399832.86333511875,2022-10-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,CYB561,0.29299998,0.93206,-0.04921,0,-1.0,-1.0,,
ENSG00000008853,3,1,1,0,0,1,28221.648477075985,189557.6027707886,2017-06-09,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,RHOBTB2,0.23900002,3.1376,0.50143,1,0.5,-1.0,Signal Transduction;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9706574
ENSG00000009694,1,1,0,0,0,1,23259.474374071426,23259.474374071426,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TENM1,,,,0,0.5,0.0,,
ENSG00000009790,1,1,0,0,0,0,8039.7712009106435,8039.7712009106435,2020-10-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TRAF3IP3,0.14200002,0.92088,1.1006,0,1.0,0.0,,
ENSG00000010319,1,1,1,1,0,0,155552.2805078301,197485.87952538437,2023-01-18,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SEMA3G,-0.0069999695,0.80015,0.62046,0,0.5,0.0,,
ENSG00000011105,1,1,1,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TSPAN9,0.16399997,0.79949,-0.99787,0,0.5,0.0,,
ENSG00000011304,2,1,1,0,0,1,107949.90929360976,414433.58532016096,2023-06-29,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PTBP1,0.751,1.0738,-4.9112,3,-1.0,-1.0,Signal Transduction;FGFR2 alternative splicing;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-6803529;R-HSA-9006934
ENSG00000011347,1,1,0,0,1,0,151809.24791469253,151809.24791469253,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,SYT7,0.44700003,3.0267,0.56281,1,0.5,0.0,,
ENSG00000011566,1,1,1,0,0,1,54086.717117394765,54086.717117394765,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MAP4K3,0.208,0.2601,-1.1973,0,-1.0,-1.0,,
ENSG00000012779,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ALOX5,0.06699997,0.866,-0.93892,15,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Synthesis of Leukotrienes (LT) and Eoxins (EX);Signaling by Interleukins;Arachidonate metabolism;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-2142691;R-HSA-449147;R-HSA-2142753;R-HSA-6785807
ENSG00000013503,1,1,0,0,0,1,5752.486439574745,5752.486439574745,2015-10-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,POLR3B,0.16000003,3.4949,1.0668,7,-1.0,-1.0,RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;Immune System;RNA Polymerase III Chain Elongation;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-76046;R-HSA-76071;R-HSA-76061;R-HSA-76066;R-HSA-168256;R-HSA-73780;R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000013563,1,1,1,0,0,1,64148.70787518679,64148.70787518679,2021-03-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DNASE1L1,,,,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000018236,3,1,0,0,0,1,78751.06843456876,263416.51565448404,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,CNTN1,0.569,2.7437,0.68834,4,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000020577,1,1,0,0,0,1,23951.9807071219,26685.217785743116,2022-10-12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SAMD4A,0.287,0.51274,-0.41964,0,0.5,0.0,,
ENSG00000020922,1,1,0,0,0,0,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MRE11,0.199,1.0907,0.39868,22,-1.0,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);IRF3-mediated induction of type I IFN;Disease,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-3270619;R-HSA-1643685
ENSG00000021488,1,1,1,0,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,SLC7A9,0.092999995,1.8293,0.26716,4,0.75,0.5,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000021762,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,OSBPL5,0.11799997,-0.91784,-1.4901,1,-1.0,-1.0,Acyl chain remodelling of PS,R-HSA-1482801
ENSG00000022355,1,1,1,0,0,1,1076472.0138856068,1076472.0138856068,2023-07-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,GABRA1,0.718,4.2735,-0.12892,2,0.75,0.5,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000027001,1,1,1,0,0,1,1030.5551470588234,1030.5551470588234,2011-06-02,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MIPEP,-0.181,-0.95513,-1.5245,0,-1.0,-1.0,,
ENSG00000029364,1,1,1,0,0,1,16534.94713490521,16534.94713490521,2024-11-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,SLC39A9,0.25800002,2.1821,1.6107,0,-1.0,-1.0,,
ENSG00000029725,1,1,1,0,0,0,340825.7076940272,340825.7076940272,2023-05-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,RABEP1,0.508,1.5513,0.4708,1,-1.0,-1.0,TBC/RABGAPs;Rab regulation of trafficking,R-HSA-8854214;R-HSA-9007101
ENSG00000033627,1,1,0,0,0,1,59389.77313114188,59389.77313114188,2022-01-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATP6V0A1,0.522,4.4412,0.6912,6,0.5,-1.0,Signal Transduction;Transferrin endocytosis and recycling;Immune System;Developmental Biology;Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy;Iron uptake and transport;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-917977;R-HSA-168256;R-HSA-1266738;R-HSA-9857377;R-HSA-917937;R-HSA-9006934
ENSG00000034533,1,1,0,0,0,0,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ASTE1,-0.291,1.6752,0.89071,0,-1.0,-1.0,,
ENSG00000035681,1,1,0,0,0,1,306980.8575290048,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,NSMAF,0.21399999,1.2697,1.0648,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000036549,1,1,0,0,0,1,165324.69367515197,165324.69367515197,2023-05-17,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZZZ3,0.71099997,2.4554,1.0187,2,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000036565,1,1,0,0,0,1,228688.0296088316,228688.0296088316,2017-12-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC18A1,-0.48899996,-3.287,-2.3824,1,1.0,0.5,,
ENSG00000039523,1,1,0,0,1,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RIPOR1,0.39099997,2.2718,1.3486,0,-1.0,-1.0,,
ENSG00000039987,1,1,0,0,1,1,473900.221403792,473900.221403792,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BEST2,0.03399998,0.0013408,-1.4744,1,0.75,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000048462,1,1,0,1,0,0,3664.4295302013425,3664.4295302013425,2020-05-20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TNFRSF17,-0.65900004,-1.5691,-0.58429,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000048540,1,1,0,0,0,0,133918.94977035935,133918.94977035935,2020-04-27,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LMO3,0.49400002,2.6675,0.44474,0,0.5,0.0,,
ENSG00000049449,1,1,1,0,0,1,61813.08013553196,61813.08013553196,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RCN1,0.231,0.86594,0.66729,2,1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000051523,1,1,1,0,0,1,226155.40757232966,226155.40757232966,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CYBA,-0.72599995,-2.4309,-3.0687,10,0.5,-1.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000053524,1,1,0,0,0,1,31104.940443685748,36494.548446257475,2023-06-01,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,MCF2L2,0.19099998,1.3676,1.0659,0,0.75,0.5,,
ENSG00000055813,1,1,0,0,0,1,1495.090521831736,1495.090521831736,2023-11-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CCDC85A,-0.05799997,-1.2562,-2.1835,0,0.5,0.0,,
ENSG00000056277,1,1,1,0,0,1,24006.171773641356,24006.171773641356,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZNF280C,,,,0,0.5,0.0,,
ENSG00000057704,1,1,1,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,TMCC3,-0.037999988,0.65764,-0.12014,0,-1.0,0.0,,
ENSG00000058085,1,1,1,0,0,1,17710.3869470848,125821.84557838629,2018-12-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,LAMC2,0.20300001,1.3268,1.3605,9,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000058262,1,1,0,0,0,1,278190.43024910334,278190.43024910334,2023-08-23,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SEC61A1,0.59599996,4.9525,-0.18973,2,-1.0,-1.0,Immune System;Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-168256;R-HSA-72766;R-HSA-1799339
ENSG00000059588,1,1,0,0,0,1,6595.0472017181655,6595.0472017181655,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TARBP1,0.050000012,-1.8289,-1.7341,0,-1.0,-1.0,,
ENSG00000061656,1,1,0,0,0,1,26667.58037719927,26667.58037719927,2020-09-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPAG4,-0.27999997,0.017026,-0.54078,0,0.75,0.0,,
ENSG00000061794,1,1,0,0,0,1,84563.14597380339,84563.14597380339,2023-06-12,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MRPS35,-0.16900003,0.46941,-0.12919,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000061936,1,1,0,0,0,1,62813.83754956452,63469.06848576706,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,SFSWAP,0.76,2.8134,0.4073,0,-1.0,-1.0,,
ENSG00000061987,1,1,0,0,1,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MON2,0.574,3.7594,1.3397,0,-1.0,-1.0,,
ENSG00000063127,1,1,1,0,0,1,22938.587937312015,22938.587937312015,2021-02-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,SLC6A16,0.061999977,1.735,1.0489,0,1.0,0.0,,
ENSG00000063660,1,1,1,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,GPC1,0.15799999,-0.38913,-1.5888,14,0.5,0.0,Developmental Biology;Disease;Glycosaminoglycan-protein linkage region biosynthesis;HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1266738;R-HSA-1643685;R-HSA-1971475;R-HSA-2022928;R-HSA-1638091
ENSG00000063761,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ADCK1,0.08399999,0.56128,1.2215,0,-1.0,-1.0,,
ENSG00000065325,1,1,1,0,1,0,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GLP2R,-0.33099997,1.4315,0.54459,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000065970,1,1,0,0,0,1,122549.0830919942,166713.81901525118,2024-07-19,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FOXJ2,0.602,0.89953,-0.10759,0,-1.0,-1.0,,
ENSG00000066926,1,1,0,0,0,1,360605.992793193,360605.992793193,2022-02-03,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FECH,0.14099997,1.6367,1.0213,2,-1.0,-1.0,Heme biosynthesis,R-HSA-189451
ENSG00000067057,1,1,0,0,0,1,14384.271192298276,14384.271192298276,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PFKP,-0.286,-0.30078,-3.2068,1,0.5,-1.0,,
ENSG00000067167,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TRAM1,0.47000003,1.5921,-1.35,1,-1.0,-1.0,Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-72766;R-HSA-1799339
ENSG00000068024,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HDAC4,0.80799997,3.7634,-0.53352,8,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000068697,1,1,0,0,0,1,183761.6081180644,183761.6081180644,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,LAPTM4A,-0.176,-0.13849,-0.013907,0,-1.0,-1.0,,
ENSG00000069018,1,1,0,0,0,1,727796.3668420183,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,TRPC7,0.40399998,2.0989,0.16563,4,,,Signal Transduction;Developmental Biology;Role of second messengers in netrin-1 signaling;Stimuli-sensing channels,R-HSA-162582;R-HSA-1266738;R-HSA-418890;R-HSA-2672351
ENSG00000069431,1,1,0,0,0,0,860.2376060741402,860.2376060741402,2014-04-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ABCC9,0.44300002,7.0369,0.57664,4,0.5,0.0,Disease;Inwardly rectifying K+ channels,R-HSA-1643685;R-HSA-1296065
ENSG00000069849,1,1,1,0,0,1,718784.6890415357,718784.6890415357,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATP1B3,0.38099998,1.3411,0.12749,4,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000070501,1,1,1,0,0,1,91656.48445754324,453046.0257943742,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,POLB,-0.77199996,0.6762,0.36032,7,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000070915,1,1,0,0,1,0,3750.4,3750.4,2023-10-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC12A3,-0.0039999485,0.72585,0.18151,2,1.0,1.0,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000070950,1,1,1,0,0,1,355284.1215006515,355284.1215006515,2025-03-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RAD18,-0.049999952,-0.21425,-0.67115,2,-1.0,0.0,E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000071537,1,1,1,0,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SEL1L,0.459,2.7811,-0.62309,6,1.0,-1.0,Signal Transduction;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Disease;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Hh mutants abrogate ligand secretion;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-901032;R-HSA-901042;R-HSA-532668;R-HSA-1643685;R-HSA-5358346;R-HSA-5362768;R-HSA-5387390;R-HSA-5663202;R-HSA-597592
ENSG00000072071,1,1,1,0,0,1,25510.438977065303,25510.438977065303,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ADGRL1,0.698,4.0328,-1.1111,0,0.5,0.0,,
ENSG00000072121,5,1,0,0,0,0,54580.46858134564,141076.9910731678,2020-05-18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ZFYVE26,0.296,2.8433,2.2155,0,-1.0,-1.0,,
ENSG00000073067,2,1,0,0,0,1,19965.24128263536,29811.1438239137,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,CYP2W1,-0.83500004,-2.2878,-3.1919,2,0.75,0.5,,
ENSG00000073756,3,1,1,0,0,1,50641.99826116222,191310.84064467996,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,PTGS2,0.66999996,3.09,-0.079405,8,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Arachidonate metabolism;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-2142753;R-HSA-6785807
ENSG00000074855,1,1,1,0,0,0,26264.552756469657,26264.552756469657,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ANO8,0.20499998,0.65474,-0.9343,4,0.5,-1.0,Disease;Stimuli-sensing channels;Post-translational protein modification,R-HSA-1643685;R-HSA-2672351;R-HSA-597592
ENSG00000075303,1,1,0,0,1,0,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SLC25A40,-0.22899997,0.61869,0.67038,0,-1.0,-1.0,,
ENSG00000075391,1,1,0,0,0,1,19257.690392998462,19257.690392998462,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RASAL2,0.448,2.6317,0.87605,3,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000075673,1,1,0,0,0,1,3725.450516986706,3725.450516986706,2019-02-26,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATP12A,0.15200001,1.7842,0.67762,1,0.75,0.5,,
ENSG00000075702,1,1,1,0,0,1,6282.667000877303,6282.667000877303,2020-03-30,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,WDR62,0.194,1.767,0.7965,0,0.5,0.0,,
ENSG00000076043,1,1,0,0,0,1,36159.555758564435,36159.555758564435,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,REXO2,-0.314,0.14513,-0.66813,1,-1.0,-1.0,,
ENSG00000076351,1,1,0,0,0,1,36234.261012557305,36234.261012557305,2017-09-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC46A1,0.13499999,0.87996,0.58059,3,0.5,-1.0,Iron uptake and transport;Metabolism of folate and pterines,R-HSA-917937;R-HSA-196757
ENSG00000076662,1,1,1,1,1,1,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ICAM3,-0.538,0.3197,0.51669,3,0.5,0.0,Immune System,R-HSA-168256
ENSG00000077157,1,1,1,0,0,1,78016.97193351923,125821.84557838629,2022-02-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,PPP1R12B,0.272,1.7861,2.2624,5,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000078668,1,1,0,0,0,1,205425.60717824215,205425.60717824215,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,VDAC3,0.578,1.7561,1.3128,3,0.75,-1.0,Mitochondrial calcium ion transport;Post-translational protein modification,R-HSA-8949215;R-HSA-597592
ENSG00000079257,1,1,1,0,1,0,756470.9740366563,756470.9740366563,2025-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LXN,-0.26699996,0.85615,0.82029,0,-1.0,-1.0,,
ENSG00000079387,1,1,1,0,0,0,574261.7466389402,574261.7466389402,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SENP1,0.574,2.0356,0.224,2,0.5,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000081154,1,1,1,0,0,1,756470.9740366563,756470.9740366563,2025-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PCNP,0.148,0.42218,0.33166,0,-1.0,-1.0,,
ENSG00000081760,1,1,1,0,0,0,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,AACS,0.032999992,0.48387,0.48462,1,-1.0,-1.0,,
ENSG00000082213,1,1,0,0,0,1,932.622440120525,932.622440120525,2022-06-27,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,C5orf22,0.075999975,0.86528,1.6798,0,-1.0,-1.0,,
ENSG00000082497,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SERTAD4,0.12599999,0.87974,0.34639,0,-1.0,0.0,,
ENSG00000082701,1,1,1,0,0,1,135302.01076433487,135302.01076433487,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GSK3B,0.48799998,1.2893,0.29139,24,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);APC truncation mutants have impaired AXIN binding;Truncations of AMER1 destabilize the destruction complex;AXIN missense mutants destabilize the destruction complex;Signaling by AMER1 mutants;Signaling by APC mutants;Signaling by AXIN mutants;Translation of Structural Proteins_9683701;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-5467337;R-HSA-5467348;R-HSA-5467340;R-HSA-4839748;R-HSA-4839744;R-HSA-4839735;R-HSA-9683701;R-HSA-1643685;R-HSA-5663202
ENSG00000083444,1,1,1,0,0,0,1470466.6505612188,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PLOD1,0.061999977,1.0078,-0.41525,1,-1.0,-1.0,,
ENSG00000083454,1,1,0,0,0,1,10529.240292414317,10529.240292414317,2021-05-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,P2RX5,-0.07099998,0.019296,0.22499,2,0.5,0.0,,
ENSG00000083544,1,1,0,0,0,0,15029.741120135644,15029.741120135644,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TDRD3,0.31800002,1.3246,0.54155,0,-1.0,-1.0,,
ENSG00000085760,1,1,1,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MTIF2,-0.019000053,-0.91945,-0.54905,1,-1.0,-1.0,Translation;Mitochondrial translation initiation;Mitochondrial translation,R-HSA-72766;R-HSA-5368286;R-HSA-5368287
ENSG00000086730,1,1,1,0,0,1,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,LAT2,0.28399998,0.66721,-0.1244,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000087074,1,1,1,0,1,0,192848.64833759028,474830.9126255118,2021-07-08,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PPP1R15A,-0.09200001,0.17636,0.45713,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000087076,1,1,0,0,0,1,35269.470595523715,35269.470595523715,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,HSD17B14,-0.337,0.013931,0.71601,1,0.5,-1.0,Metabolism of steroids,R-HSA-8957322
ENSG00000087077,1,1,1,0,0,0,89779.31151140569,89779.31151140569,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRIP6,0.09899998,-0.35412,0.33413,0,-1.0,-1.0,,
ENSG00000087274,1,1,1,0,0,1,91172.20051337926,91172.20051337926,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,ADD1,0.61300004,1.3492,1.0598,3,-1.0,-1.0,,
ENSG00000087842,1,1,1,0,0,0,17601.10520641419,17601.10520641419,2024-10-03,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PIR,,,,1,-1.0,-1.0,Digestion and absorption;Digestion,R-HSA-8963743;R-HSA-8935690
ENSG00000088386,1,1,0,0,0,1,3141.278019404483,3141.278019404483,2019-10-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SLC15A1,-0.116999984,0.74349,0.58861,1,1.0,0.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000088881,1,1,0,0,0,1,50087.52781663962,50087.52781663962,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EBF4,0.13200003,-1.8613,-2.793,0,-1.0,0.0,,
ENSG00000089041,1,1,1,0,0,1,399832.86333511875,399832.86333511875,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,P2RX7,0.041999996,0.96277,-0.24256,5,0.5,0.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000089060,1,1,0,0,0,1,54391.03477538057,54391.03477538057,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC8B1,0.0,1.459,-0.097735,2,0.5,-1.0,Mitochondrial calcium ion transport;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-8949215;R-HSA-425393
ENSG00000089693,1,1,1,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MLF2,0.352,1.7006,0.55245,0,-1.0,-1.0,,
ENSG00000089820,1,1,1,0,1,1,226101.35678720698,226101.35678720698,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ARHGAP4,,,,3,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000090539,1,1,1,0,0,0,100358.73833384078,100358.73833384078,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CHRD,0.23699999,0.72449,-0.81228,0,0.5,0.0,,
ENSG00000090989,1,1,0,0,0,1,3761.559198542805,3761.559198542805,2013-06-30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EXOC1,0.314,2.6685,0.36156,3,-1.0,-1.0,VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620916;R-HSA-5620920
ENSG00000091317,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CMTM6,-0.32099998,-0.17921,-1.4141,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000092345,2,1,0,0,0,1,3288.4396493594068,17115.61307125707,2013-05-12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,DAZL,0.8,0.6824,-1.0144,0,1.0,1.0,,
ENSG00000094916,1,1,0,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CBX5,0.274,2.7283,0.31606,4,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of endogenous retroelements by KRAB-ZFP proteins;Transcriptional Regulation by E2F6;Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9843940;R-HSA-8953750;R-HSA-597592
ENSG00000095110,3,1,1,0,1,1,19974.136110585117,160010.51072069994,2011-02-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,6,NXPE1,-0.26600003,0.40798,0.49268,0,1.0,0.5,,
ENSG00000095794,2,1,1,0,0,1,10351.48329956029,160010.51072069994,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,CREM,0.467,1.7544,0.19371,1,0.5,-1.0,,
ENSG00000096093,2,1,1,0,0,1,91172.20051337926,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,EFHC1,0.09399998,1.3019,1.2561,0,0.5,-1.0,,
ENSG00000096264,1,1,0,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NCR2,-0.472,0.51199,-0.22453,2,,,Immune System,R-HSA-168256
ENSG00000099783,1,1,0,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HNRNPM,0.6,1.8837,-1.6703,3,-1.0,-1.0,Signal Transduction;FGFR2 alternative splicing;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-6803529;R-HSA-9006934
ENSG00000099834,1,1,0,0,1,0,215157.94798738702,215157.94798738702,2024-07-27,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CDHR5,-0.47899997,-1.6126,-2.5471,0,0.75,0.5,,
ENSG00000099864,1,1,1,0,0,1,33954.407278742765,33954.407278742765,2023-05-26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PALM,0.045000017,-0.20706,-2.0345,0,0.5,0.0,,
ENSG00000099866,1,1,0,0,0,1,17257.066666666666,17257.066666666666,2021-04-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MADCAM1,-0.901,-2.1271,-3.3002,2,0.5,0.0,Immune System,R-HSA-168256
ENSG00000099889,1,1,1,0,1,1,765591.3646788632,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ARVCF,-0.031999946,-1.8821,-2.151,0,0.5,0.0,,
ENSG00000099956,4,1,1,0,0,1,3953.154495309038,756470.9740366563,2021-01-25,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,SMARCB1,0.779,4.8624,0.38152,8,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000099994,1,1,1,0,1,1,1590.9581395348837,2282.7743876235495,2013-04-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,SUSD2,-0.13800001,0.59857,-0.033441,0,0.5,0.0,,
ENSG00000100055,1,1,0,0,0,1,8696.216364258815,8696.216364258815,2017-08-23,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CYTH4,0.48400003,2.1796,1.1603,1,0.5,0.0,,
ENSG00000100151,1,1,1,0,0,1,337860.4854363166,337860.4854363166,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PICK1,0.23000002,2.1328,0.58504,2,-1.0,-1.0,,
ENSG00000100226,1,1,0,0,0,1,38851.92581543917,38851.92581543917,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GTPBP1,0.36900002,2.9502,-0.1707,0,0.5,-1.0,,
ENSG00000100324,1,1,0,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TAB1,0.24800003,1.4901,0.15222,15,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Alpha-protein kinase 1 signaling pathway;IRAK2 mediated activation of TAK1 complex;Disease;Signaling by Interleukins;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9645460;R-HSA-937042;R-HSA-1643685;R-HSA-449147;R-HSA-597592
ENSG00000100351,1,1,0,0,0,0,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,GRAP2,-0.11800003,1.2159,0.21511,8,1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9006934
ENSG00000100418,1,1,1,0,0,1,183761.6081180644,183761.6081180644,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,DESI1,-0.11800003,0.9977,-0.25729,0,-1.0,-1.0,,
ENSG00000100526,2,1,0,0,0,1,134717.76666505725,156470.480665571,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,CDKN3,-0.123000026,1.1129,0.63861,0,1.0,0.0,,
ENSG00000100554,1,1,1,0,0,0,29395.66760774176,29395.66760774176,2019-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ATP6V1D,0.17199999,1.5925,0.48972,7,-1.0,-1.0,Signal Transduction;Transferrin endocytosis and recycling;Immune System;Developmental Biology;Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy;Iron uptake and transport;Amino acids regulate mTORC1;Cellular response to starvation;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-917977;R-HSA-168256;R-HSA-1266738;R-HSA-9857377;R-HSA-917937;R-HSA-9639288;R-HSA-9711097;R-HSA-9006934
ENSG00000100567,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PSMA3,0.594,1.6243,-0.41301,62,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000100652,1,1,0,0,0,1,16534.94713490521,16534.94713490521,2024-11-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SLC10A1,-0.956,-1.4172,-0.56205,1,1.0,1.0,Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-8957322;R-HSA-194068
ENSG00000100968,1,1,1,0,0,1,251325.91086204,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NFATC4,0.5,0.86953,-0.20453,0,-1.0,0.0,,
ENSG00000101115,1,1,0,0,0,1,112671.63835589515,143541.33221810492,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,SALL4,0.816,2.7099,0.54028,3,0.5,0.5,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000101152,1,1,0,0,0,1,279825.00883385167,279825.00883385167,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DNAJC5,0.795,1.7888,-0.86094,3,0.5,-1.0,"Immune System;GABA synthesis, release, reuptake and degradation;Neurotransmitter release cycle",R-HSA-168256;R-HSA-888590;R-HSA-112310
ENSG00000101188,2,1,1,0,0,1,76696.83687179488,337665.15408826765,2022-06-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,3,NTSR1,-0.26100004,-1.3898,-0.17184,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000101251,1,1,1,0,1,0,117090.1108836121,117090.1108836121,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SEL1L2,0.021000028,0.38956,0.4483,0,1.0,1.0,,
ENSG00000101331,1,1,0,0,0,0,200788.16423598543,200788.16423598543,2016-06-20,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCM2L,0.092999995,0.32407,-1.0276,0,1.0,0.0,,
ENSG00000101337,1,1,1,0,0,1,32254.717802479194,32254.717802479194,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TM9SF4,0.623,4.0394,1.1991,0,-1.0,-1.0,,
ENSG00000101349,1,1,1,0,0,1,3849.347881248414,3849.347881248414,2024-09-11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PAK5,0.671,1.8177,-0.083606,5,0.75,0.5,Signal Transduction;Developmental Biology;Activation of RAC1,R-HSA-162582;R-HSA-1266738;R-HSA-428540
ENSG00000101542,1,1,0,0,0,1,7113.6472583678205,7113.6472583678205,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,CDH20,0.468,1.1364,-1.1879,0,0.5,0.5,,
ENSG00000102445,1,1,0,0,0,1,30291.903854076274,30291.903854076274,2021-11-04,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RUBCNL,-0.21599996,0.26122,0.50931,0,0.5,0.0,,
ENSG00000102804,1,1,0,0,0,1,12852.775911986104,135108.48254553688,2015-04-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,TSC22D1,0.801,-0.59418,-1.6946,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000102996,1,1,0,0,0,1,111599.28184123649,111599.28184123649,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MMP15,0.23699999,0.93604,-1.1424,3,-1.0,0.0,,
ENSG00000103037,1,1,1,0,0,1,99863.42410604075,99863.42410604075,2018-02-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SETD6,-0.64100003,-2.0787,-2.6973,1,-1.0,-1.0,,
ENSG00000103047,1,1,0,0,0,1,397765.9672627851,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TANGO6,0.038999975,0.55198,0.88554,0,-1.0,-1.0,,
ENSG00000103056,1,1,0,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SMPD3,0.39999998,0.49134,-1.644,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000103245,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CIAO3,-0.13999999,-0.71506,-1.7754,1,-1.0,-1.0,,
ENSG00000103423,1,1,1,0,1,0,103877.27822338727,131525.74533408263,2017-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,DNAJA3,0.263,-0.79035,-1.7915,0,-1.0,-1.0,,
ENSG00000103855,1,1,1,1,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CD276,0.11199999,1.3232,1.2778,0,-1.0,0.0,,
ENSG00000103876,1,1,1,0,0,1,26908.700469045143,1424218.0900670097,2010-06-27,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FAH,-0.06700003,1.1148,0.5553,1,0.5,-1.0,,
ENSG00000103888,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CEMIP,0.236,3.3221,0.26711,1,0.5,0.0,Hyaluronan degradation,R-HSA-2160916
ENSG00000104332,1,1,0,0,0,1,24271.10331687743,24271.10331687743,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,SFRP1,0.328,1.1482,-0.21535,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000104369,1,1,0,0,0,1,254373.32653042395,1424218.0900670097,2020-05-06,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,JPH1,0.635,1.4744,0.062885,0,0.75,0.0,,
ENSG00000104371,1,1,0,1,0,1,71415.15997511255,71415.15997511255,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,DKK4,-0.63600004,0.46831,1.1626,3,0.5,0.5,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000104524,1,1,1,0,1,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PYCR3,-0.46899998,-0.17338,-1.5573,1,-1.0,0.0,,
ENSG00000104549,1,1,1,0,0,0,21781.337520231158,21781.337520231158,2021-01-25,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SQLE,0.371,0.96058,0.328,2,-1.0,-1.0,Cholesterol biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-191273;R-HSA-8957322;R-HSA-1655829
ENSG00000104826,1,1,1,0,0,0,42150.86382443902,42150.86382443902,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LHB,-0.60300004,0.43156,-0.15091,6,1.0,0.0,Signal Transduction;Reactions specific to the complex N-glycan synthesis pathway;Metabolism of steroids;Post-translational protein modification,R-HSA-162582;R-HSA-975578;R-HSA-8957322;R-HSA-597592
ENSG00000104872,2,1,0,0,0,0,227752.06557835746,399832.86333511875,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PIH1D1,-0.01699996,0.82035,0.24996,0,-1.0,-1.0,,
ENSG00000104880,1,1,1,0,0,1,357481.5311387202,427337.4491868293,2021-11-04,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,ARHGEF18,0.18900001,0.82813,-1.1213,5,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000104886,1,1,1,0,0,1,718784.6890415357,718784.6890415357,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PLEKHJ1,-0.59300005,-1.5888,-2.3861,0,-1.0,-1.0,,
ENSG00000104915,1,1,1,0,0,1,99227.16426999423,102866.95819249244,2019-08-16,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,STX10,-0.29900002,-0.29744,-0.80239,1,-1.0,-1.0,,
ENSG00000104951,1,1,1,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IL4I1,-0.12600005,0.73472,-1.4046,1,0.75,0.0,,
ENSG00000105664,1,1,0,0,1,1,24006.171773641356,24006.171773641356,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,COMP,-0.072999954,1.5119,-0.32209,2,0.5,0.0,,
ENSG00000105672,1,1,1,0,1,1,78728.4671948324,78728.4671948324,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ETV2,-0.44799995,-1.3407,-0.90334,0,1.0,0.5,,
ENSG00000105982,1,1,0,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,RNF32,-0.19500005,0.77501,0.68152,0,1.0,0.0,,
ENSG00000105996,2,1,1,0,0,1,203090.6413944402,203090.6413944402,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HOXA2,0.666,0.78704,0.18828,2,-1.0,0.0,Developmental Biology;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-9010553
ENSG00000106004,2,1,1,0,0,1,29713.571045654095,69915.00897904889,2023-01-18,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,HOXA5,0.004000008,0.57199,-0.10115,0,0.5,0.0,,
ENSG00000106018,2,1,1,0,0,1,1571.446153846154,63200.72664467542,2013-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,4,VIPR2,-0.044999957,0.44403,-0.47687,2,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000106025,1,1,1,0,0,1,143284.77790855977,355284.1215006515,2023-01-18,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,TSPAN12,0.34500003,1.2581,0.66228,0,0.5,0.0,,
ENSG00000106333,1,1,0,0,0,0,72959.43243297456,72959.43243297456,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,PCOLCE,-0.074,-0.11623,-0.14017,2,-1.0,0.0,,
ENSG00000106565,1,1,1,0,0,0,89589.23835564002,89589.23835564002,2024-01-05,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM176B,-0.25600004,-0.1063,0.62277,0,1.0,-1.0,,
ENSG00000106624,1,1,1,0,1,1,47738.39631923835,116388.33957200912,2019-03-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,AEBP1,0.265,1.3129,0.12213,0,-1.0,-1.0,,
ENSG00000106868,1,1,0,0,0,1,219793.50457789513,219793.50457789513,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SUSD1,0.065999985,1.1384,0.036394,0,-1.0,-1.0,,
ENSG00000107014,1,1,0,0,0,1,7395.812695606637,7395.812695606637,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RLN2,-0.78400004,-1.7136,-0.93074,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000107731,1,1,0,0,0,1,286746.1002745869,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,UNC5B,0.30800003,0.92217,-0.88527,3,-1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000107779,1,1,1,0,0,0,57425.85429872698,57425.85429872698,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,BMPR1A,0.805,3.9074,1.2039,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000107984,1,1,0,0,0,0,15015.241596403896,15015.241596403896,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DKK1,-0.10099995,0.33864,0.24496,4,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-5663202
ENSG00000108187,1,1,0,0,0,0,414433.58532016096,414433.58532016096,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PBLD,0.0019999743,1.2225,0.96497,0,0.75,-1.0,,
ENSG00000108511,2,1,0,0,0,0,572390.9560934792,574170.6270919729,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,2,HOXB6,-0.15799999,-0.6416,-0.93211,0,0.5,0.0,,
ENSG00000108551,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,RASD1,-0.286,0.35624,0.24639,0,0.5,-1.0,,
ENSG00000108591,1,1,1,0,0,1,40939.08484366117,40939.08484366117,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DRG2,0.06800002,2.3504,1.2566,1,-1.0,-1.0,Protein hydroxylation;Post-translational protein modification,R-HSA-9629569;R-HSA-597592
ENSG00000108669,2,1,1,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CYTH1,0.58599997,2.9958,0.70663,1,-1.0,-1.0,,
ENSG00000108688,3,1,0,1,0,1,17831.529851792977,78751.06843456876,2010-11-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,8,CCL7,-0.727,-0.63313,-0.22409,1,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000108798,1,1,0,0,1,1,34059.281207935855,34059.281207935855,2017-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ABI3,-0.113000035,-0.38629,-0.85011,0,0.5,0.0,,
ENSG00000109099,1,1,0,0,0,1,11471.248019087781,11471.248019087781,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PMP22,0.626,0.70125,-0.5868,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000109182,1,1,0,0,1,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CWH43,-0.31299996,0.10679,-0.038052,0,0.5,0.0,,
ENSG00000109339,1,1,0,0,0,1,84270.16077055593,84270.16077055593,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MAPK10,0.45999998,3.643,0.67326,4,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Activation of the AP-1 family of transcription factors,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-450341
ENSG00000109381,1,1,1,0,0,0,727796.3668420183,727796.3668420183,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ELF2,0.729,2.8502,1.6512,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000109458,1,1,0,0,0,1,94870.11495236546,94870.11495236546,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,GAB1,0.49699998,1.8962,0.58545,25,-1.0,-1.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000109851,2,1,0,0,0,1,32996.93546153374,645988.1975077938,2018-06-11,0,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,DBX1,0.01999998,-0.69941,-1.2478,0,,,,
ENSG00000110042,1,1,1,0,0,0,278190.43024910334,278190.43024910334,2023-08-23,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DTX4,0.268,1.29,0.26332,4,0.5,-1.0,Signal Transduction;Immune System;IRF3-mediated induction of type I IFN,R-HSA-162582;R-HSA-168256;R-HSA-3270619
ENSG00000110079,1,1,0,0,0,1,21724.94108458234,21724.94108458234,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MS4A4A,-0.35599995,0.3553,1.01,0,0.5,-1.0,,
ENSG00000110435,1,1,0,0,0,0,113379.18614909897,113379.18614909897,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PDHX,0.20300001,0.30442,-0.46209,3,0.5,-1.0,Signal Transduction;Regulation of pyruvate metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism,R-HSA-162582;R-HSA-9861718;R-HSA-204174;R-HSA-70268
ENSG00000110455,1,1,1,0,1,1,5055.931872674659,5055.931872674659,2015-06-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ACCS,0.10100001,0.79116,0.72026,0,-1.0,-1.0,,
ENSG00000110651,1,1,1,0,0,1,195005.6685718255,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CD81,0.29799998,1.0663,-0.44866,2,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000110768,1,1,0,0,0,1,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,GTF2H1,0.584,1.9592,-0.12542,29,-1.0,-1.0,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;RNA Pol II CTD phosphorylation and interaction with CE;mRNA Capping;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;Generic Transcription Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;Formation of TC-NER Pre-Incision Complex;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;RNA Polymerase I Transcription Initiation;Gap-filling DNA repair synthesis and ligation in TC-NER;Formation of Incision Complex in GG-NER;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-167160;R-HSA-77075;R-HSA-72086;R-HSA-113418;R-HSA-167158;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-212436;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-73863;R-HSA-6781823;R-HSA-74160;R-HSA-73772;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-73762;R-HSA-6782210;R-HSA-5696395;R-HSA-73864;R-HSA-73854;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-6781827
ENSG00000111011,1,1,1,0,0,0,1470466.6505612188,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RSRC2,0.865,2.173,-0.97749,0,0.5,-1.0,,
ENSG00000111218,1,1,0,0,0,1,286746.1002745869,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PRMT8,0.707,4.7513,0.45883,0,1.0,0.5,,
ENSG00000111432,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,FZD10,0.144,1.0978,-0.35005,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000111530,1,1,0,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CAND1,0.924,4.8229,0.20823,3,-1.0,-1.0,Immune System;Iron uptake and transport;Post-translational protein modification,R-HSA-168256;R-HSA-917937;R-HSA-597592
ENSG00000111647,1,1,0,0,0,0,376569.5597064443,376569.5597064443,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,BLTP3B,0.422,1.7257,0.42121,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000111700,1,1,0,0,0,1,270267.2992956902,270267.2992956902,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SLCO1B3,-0.15100002,-1.0697,-0.40018,5,1.0,0.5,"Atorvastatin ADME;Disease;Transport of vitamins, nucleosides, and related molecules;Metabolism of steroids;Bile acid and bile salt metabolism",R-HSA-9754706;R-HSA-1643685;R-HSA-425397;R-HSA-8957322;R-HSA-194068
ENSG00000111727,1,1,0,0,0,1,545988.1005477115,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HCFC2,0.742,4.145,0.88363,1,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000111897,1,1,0,0,0,1,54580.46858134564,54580.46858134564,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SERINC1,0.324,1.2424,-0.40341,1,-1.0,-1.0,Serine metabolism,R-HSA-977347
ENSG00000111906,1,1,1,0,0,1,2386.884226884227,11366.70347515427,2022-02-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,HDDC2,-0.42200005,-0.43142,-1.2699,0,-1.0,-1.0,,
ENSG00000112116,2,1,0,1,1,1,115338.82014347943,144127.33793912127,2024-07-19,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,IL17F,-0.110000014,0.40232,-0.53577,3,0.5,1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-6785807
ENSG00000112186,1,1,0,0,0,1,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CAP2,0.23699999,1.3087,0.39565,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000112511,1,1,0,0,1,1,36204.236233123425,36204.236233123425,2013-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,PHF1,0.662,3.2379,0.46652,1,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000112902,1,1,1,0,0,1,122069.83349127392,380831.7787965888,2017-12-06,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SEMA5A,0.505,1.8063,-0.30859,3,-1.0,0.0,Developmental Biology;Disease;Post-translational protein modification,R-HSA-1266738;R-HSA-1643685;R-HSA-597592
ENSG00000112941,1,1,1,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,TENT4A,0.792,1.4626,-1.2495,2,-1.0,-1.0,Disease;Nuclear RNA decay;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-9930044;R-HSA-5663202
ENSG00000113327,1,1,0,0,0,1,16548.58403989127,16548.58403989127,2022-01-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GABRG2,0.572,3.9288,0.28574,2,0.75,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000113368,1,1,0,0,0,1,73410.36533319784,73410.36533319784,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LMNB1,0.45,0.33003,-0.98017,10,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Depolymerization of the Nuclear Lamina,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-4419969
ENSG00000113387,1,1,0,0,0,1,33670.70607708678,33670.70607708678,2015-04-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SUB1,0.606,2.0047,-0.019275,0,-1.0,-1.0,,
ENSG00000113597,1,1,0,0,0,1,37230.46396212222,48998.92396570104,2024-07-19,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TRAPPC13,-0.10800004,1.2265,0.4959,1,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000113851,1,1,0,0,0,1,21223.64451016636,433862.5685735124,2017-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,6,CRBN,-0.14699996,-0.91879,-1.0882,1,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000114353,1,1,1,0,0,0,138626.81357188412,138626.81357188412,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GNAI2,0.772,4.0697,-0.016743,10,-1.0,-1.0,"Signal Transduction;ADP signalling through P2Y purinoceptor 12;Signal amplification;Disease;Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-162582;R-HSA-392170;R-HSA-392518;R-HSA-1643685;R-HSA-400042
ENSG00000114446,1,1,0,0,0,1,9613.374651242735,9613.374651242735,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,IFT57,-0.42499995,0.91091,-0.33987,2,-1.0,-1.0,Signal Transduction;Intraflagellar transport,R-HSA-162582;R-HSA-5620924
ENSG00000114742,1,1,1,0,0,0,135593.17169557852,135593.17169557852,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,WDR48,0.66499996,3.74,0.26979,4,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000114757,1,1,0,0,0,1,263689.107847073,263689.107847073,2024-07-19,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PEX5L,0.472,2.8517,0.88327,0,0.5,0.5,,
ENSG00000114999,1,1,1,0,0,1,539013.8231881644,539013.8231881644,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TTL,0.577,1.7814,0.22848,1,-1.0,0.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000115207,1,1,1,0,0,1,144712.0807038357,144712.0807038357,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,GTF3C2,0.78,2.5391,-0.14395,3,-1.0,-1.0,RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-76046;R-HSA-76061;R-HSA-76066;R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000115263,1,1,0,0,0,1,40775.6706596318,45809.99756555466,2021-11-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,GCG,0.05699998,0.32807,0.18159,7,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000115355,1,1,1,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCDC88A,0.75,1.5949,0.41265,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000115648,2,1,1,0,1,1,13552.542477876106,521818.7070055739,2011-07-10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,MLPH,0.144,0.59986,0.68729,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000115758,1,1,0,0,0,1,42879.69557188197,42879.69557188197,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ODC1,0.38300002,1.7383,0.21801,2,-1.0,-1.0,Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines,R-HSA-350562;R-HSA-351202
ENSG00000115944,1,1,1,0,0,1,207220.14223281175,207220.14223281175,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,COX7A2L,-0.765,-0.97041,-0.25502,4,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Complex IV assembly,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9864848
ENSG00000115993,1,1,1,0,0,1,23288.403519798867,88186.71873814042,2021-09-30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TRAK2,0.10699999,1.3212,0.4685,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000116035,1,1,0,0,0,1,69922.35818009122,225599.91693237546,2015-10-19,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,VAX2,-0.508,-2.0296,-0.60445,0,0.75,0.5,,
ENSG00000116194,1,1,1,1,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ANGPTL1,0.018999994,0.70826,-0.23856,0,0.5,0.0,,
ENSG00000116574,6,1,1,0,0,1,3618.387523129791,298389.02809443185,2008-10-12,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,RHOU,0.24699998,1.0136,-1.2638,2,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000116745,2,1,0,0,0,1,86992.9057658324,414433.58532016096,2023-06-29,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,RPE65,0.0019999743,0.29164,0.537,1,0.5,0.5,The canonical retinoid cycle in rods (twilight vision),R-HSA-2453902
ENSG00000117016,1,1,1,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,RIMS3,0.254,1.6308,0.63088,0,1.0,0.0,,
ENSG00000117090,1,1,0,0,0,1,145011.35140303092,145011.35140303092,2024-04-23,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLAMF1,0.39200002,0.75784,-0.37167,0,1.0,0.0,,
ENSG00000117115,1,1,1,0,0,1,58392.07057732553,83932.6290685273,2013-12-25,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,PADI2,-0.32500005,0.17522,0.60578,2,0.5,0.0,Immune System,R-HSA-168256
ENSG00000117122,1,1,1,0,0,1,123127.18790121445,123127.18790121445,2019-02-25,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,MFAP2,-0.06500006,0.52283,0.96014,2,-1.0,0.0,,
ENSG00000117139,1,1,1,0,0,1,49724.14538298504,49724.14538298504,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KDM5B,0.14200002,1.0125,1.0889,3,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Chromatin modifications during the maternal to zygotic transition (MZT);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9821002;R-HSA-8864260
ENSG00000117155,2,1,0,0,0,1,17366.699086943623,17366.699086943623,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SSX2IP,0.14899999,0.88275,0.33739,0,0.5,-1.0,,
ENSG00000117400,1,1,0,0,1,1,100358.73833384078,100358.73833384078,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MPL,-0.021999955,1.7057,1.9617,1,-1.0,0.5,,
ENSG00000118197,1,1,1,0,0,1,228688.0296088316,228688.0296088316,2017-12-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DDX59,0.13599998,1.2315,0.22315,0,-1.0,-1.0,,
ENSG00000118363,1,1,1,0,0,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPCS2,0.611,1.8523,1.215,5,-1.0,-1.0,Disease;Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-1643685;R-HSA-72766;R-HSA-1799339
ENSG00000118508,1,1,0,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,RAB32,-0.339,0.15918,0.090754,2,0.5,-1.0,Rab regulation of trafficking;Post-translational protein modification,R-HSA-9007101;R-HSA-597592
ENSG00000118894,1,1,0,0,0,1,2209.8301559792026,2209.8301559792026,2018-11-13,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,EEF2KMT,-0.37699997,-1.4101,-0.70942,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000119185,1,1,0,0,0,1,574261.7466389402,574261.7466389402,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ITGB1BP1,0.04400003,0.61367,-0.43437,0,-1.0,-1.0,,
ENSG00000119514,1,1,1,0,0,1,201549.9575922349,201549.9575922349,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,GALNT12,-0.05400002,-0.13022,-0.75752,2,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000119541,1,1,0,0,0,1,46437.13674418605,46437.13674418605,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,VPS4B,0.45200002,2.697,0.36813,2,-1.0,-1.0,Endosomal Sorting Complex Required For Transport (ESCRT);Budding and maturation of HIV virion;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-917729;R-HSA-162588;R-HSA-1643685;R-HSA-162587;R-HSA-162599
ENSG00000119718,1,1,1,0,0,1,394357.452283155,394357.452283155,2020-10-05,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EIF2B2,-0.25,1.8987,1.1877,1,-1.0,-1.0,Translation,R-HSA-72766
ENSG00000119912,1,1,1,0,0,1,17049.376765399466,294387.2978738704,2020-05-06,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,IDE,0.362,2.1505,0.55622,3,-1.0,-1.0,Signal Transduction;Peroxisomal protein import;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-9033241;R-HSA-9006934;R-HSA-597592
ENSG00000120211,1,1,0,0,0,1,1764.1848114710567,1764.1848114710567,2016-01-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,INSL4,-0.821,-1.4727,-0.64109,0,1.0,0.5,,
ENSG00000120215,1,1,0,0,0,1,195666.44200393453,195666.44200393453,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MLANA,-0.93299997,-0.20531,-0.126,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000120332,1,1,1,0,1,1,1990918.947961699,1990918.947961699,2022-11-21,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TNN,-0.08899999,-0.14698,-0.58411,1,0.5,0.5,,
ENSG00000120333,1,1,0,0,0,1,7794.273577144567,7794.273577144567,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MRPS14,-0.26400006,0.61562,0.79307,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000120437,1,1,1,0,0,1,220837.49604317299,220837.49604317299,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ACAT2,0.00999999,0.84893,0.57236,1,1.0,-1.0,Metabolism of steroids,R-HSA-8957322
ENSG00000120563,1,1,0,0,0,1,21781.337520231158,21781.337520231158,2021-01-25,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LYZL1,-0.73899996,0.91205,1.045,0,1.0,1.0,,
ENSG00000120685,1,1,0,0,0,0,338763.57771536184,415452.66715166246,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,PROSER1,0.402,0.92681,-0.38632,0,-1.0,-1.0,,
ENSG00000120820,1,1,0,0,0,1,97822.37358221927,109001.36551434857,2022-10-12,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GLT8D2,-0.33099997,1.1535,0.61112,0,0.5,0.0,,
ENSG00000120942,1,1,0,0,0,1,9967.297705884575,9967.297705884575,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UBIAD1,0.07999998,1.9475,-0.14842,1,-1.0,-1.0,,
ENSG00000121104,1,1,0,0,0,0,5691.114246503779,5691.114246503779,2023-09-08,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM117A,0.23299998,1.4721,0.65855,0,0.5,-1.0,,
ENSG00000121210,1,1,1,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TMEM131L,0.59599996,1.0937,0.57044,0,0.5,0.0,,
ENSG00000121316,2,1,1,0,0,1,3269.0604117448534,17115.61307125707,2010-06-13,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PLBD1,-0.227,1.0351,-0.45518,4,0.5,0.0,Acyl chain remodelling of PI;Acyl chain remodelling of PC;Acyl chain remodelling of PE,R-HSA-1482922;R-HSA-1482788;R-HSA-1482839
ENSG00000121390,1,1,1,0,0,0,219437.49527928562,219437.49527928562,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,PSPC1,0.523,3.1224,1.3304,0,-1.0,-1.0,,
ENSG00000121749,1,1,1,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,TBC1D15,0.36699998,0.88766,0.33298,1,-1.0,-1.0,TBC/RABGAPs;Rab regulation of trafficking,R-HSA-8854214;R-HSA-9007101
ENSG00000121853,1,1,0,0,0,1,138626.81357188412,138626.81357188412,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GHSR,-0.032999992,0.074722,-0.51978,2,1.0,1.0,Signal Transduction,R-HSA-162582
ENSG00000122367,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LDB3,0.13599998,0.90565,0.6153,0,0.75,0.0,,
ENSG00000122490,1,1,1,0,0,1,55416.28042655659,70918.12845178662,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,SLC66A2,-0.26199996,-0.20988,-0.88874,0,0.5,-1.0,,
ENSG00000122679,2,1,0,0,0,1,195005.6685718255,275021.63051358337,2023-01-18,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,RAMP3,-0.712,-0.048385,-1.3113,2,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000122873,1,1,0,0,0,0,17831.529851792977,17831.529851792977,2010-11-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CISD1,-0.34399998,0.75331,0.42293,0,0.5,0.0,,
ENSG00000122958,1,1,0,0,0,1,75632.36795352261,75632.36795352261,2024-01-05,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VPS26A,0.125,1.8261,1.1252,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000123405,1,1,0,1,0,0,56614.28807963426,56614.28807963426,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NFE2,0.20200002,1.7192,0.079076,2,0.75,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000123892,1,1,0,0,0,1,72148.96319633072,85928.28663449686,2024-07-19,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,RAB38,-0.18900001,-0.22979,0.52449,2,0.5,0.0,Rab regulation of trafficking;Post-translational protein modification,R-HSA-9007101;R-HSA-597592
ENSG00000124151,1,1,0,0,1,1,17199.976915777446,17199.976915777446,2013-08-29,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,NCOA3,0.624,2.6824,1.8477,6,-1.0,-1.0,Signal Transduction;Developmental Biology;Gene expression (Transcription),R-HSA-162582;R-HSA-1266738;R-HSA-74160
ENSG00000124194,1,1,0,0,0,1,40100.67080961279,89589.23835564002,2012-09-01,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,GDAP1L1,0.116999984,2.0135,0.47689,0,0.75,0.5,,
ENSG00000124222,1,1,1,1,0,1,82152.41442677261,82152.41442677261,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STX16,0.023000002,1.2834,0.31367,2,-1.0,-1.0,,
ENSG00000124939,1,1,0,0,0,1,97257.17815683526,97257.17815683526,2024-03-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SCGB2A1,-0.556,-0.85957,0.048525,0,0.75,0.0,,
ENSG00000125149,1,1,1,0,0,0,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PHAF1,0.40399998,1.3562,0.88497,0,0.5,-1.0,,
ENSG00000125207,1,1,0,0,0,1,10261.413828663603,10261.413828663603,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,PIWIL1,0.21200001,4.1657,0.39103,1,1.0,0.5,Gene expression (Transcription);PIWI-interacting RNA (piRNA) biogenesis;Gene Silencing by RNA,R-HSA-74160;R-HSA-5601884;R-HSA-211000
ENSG00000125450,1,1,1,0,0,1,38944.05949995025,38944.05949995025,2024-01-31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,NUP85,0.648,1.1163,0.056768,35,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Postmitotic nuclear pore complex (NPC) reformation;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9615933;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000125851,1,1,0,0,0,1,433862.5685735124,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PCSK2,0.751,3.5998,0.71307,1,0.5,0.0,,
ENSG00000125864,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,BFSP1,-0.37100005,-0.76131,-1.0372,0,-1.0,0.0,,
ENSG00000125868,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DSTN,-0.004999995,1.5791,0.30525,0,-1.0,-1.0,,
ENSG00000125977,1,1,0,0,0,1,28863.30790298137,28863.30790298137,2022-12-10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EIF2S2,0.73899996,3.9025,0.77923,12,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;PERK regulates gene expression;Translation;Cellular response to starvation,R-HSA-1280215;R-HSA-168256;R-HSA-381042;R-HSA-72766;R-HSA-9711097
ENSG00000125999,1,1,0,0,0,1,28863.30790298137,28863.30790298137,2022-12-10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BPIFB1,0.20499998,1.221,0.72528,1,0.75,0.0,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000126005,1,1,0,0,0,1,130268.53228984597,130268.53228984597,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MMP24OS,,,,0,-1.0,-1.0,,
ENSG00000126215,1,1,1,0,1,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,XRCC3,-0.79700005,-0.82052,-1.5462,4,-1.0,-1.0,,
ENSG00000126458,1,1,0,0,1,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RRAS,-0.17499995,-0.17086,-0.80909,2,-1.0,-1.0,Developmental Biology;Sema4D mediated inhibition of cell attachment and migration,R-HSA-1266738;R-HSA-416550
ENSG00000126467,1,1,0,0,0,1,71913.46219676935,384314.83364002535,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,6,TSKS,0.413,-0.14073,0.29041,0,1.0,0.5,,
ENSG00000126500,1,1,1,0,0,1,49367.473680139236,49367.473680139236,2021-01-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FLRT1,0.31800002,2.8445,1.9954,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000126581,1,1,0,0,0,1,158370.2523752734,158370.2523752734,2025-04-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BECN1,0.66999996,2.3443,1.2587,8,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Translation of Replicase and Assembly of the Replication Transcription Complex_9679504;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-9679504;R-HSA-1169408;R-HSA-597592
ENSG00000126822,1,1,1,0,0,1,551389.5206213495,551389.5206213495,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PLEKHG3,0.19099998,1.6196,0.96551,5,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000127914,1,1,1,0,1,0,303059.79257468163,303059.79257468163,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,AKAP9,0.338,2.0527,1.2107,10,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000127954,1,1,0,0,0,1,11231.262381898725,11231.262381898725,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,STEAP4,-0.10699999,1.2978,0.55049,1,0.5,0.0,Transferrin endocytosis and recycling;Iron uptake and transport,R-HSA-917977;R-HSA-917937
ENSG00000127995,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CASD1,0.38300002,1.1221,-0.44813,0,-1.0,-1.0,,
ENSG00000128228,1,1,0,0,0,1,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SDF2L1,-0.849,-0.056208,-1.7156,0,0.5,-1.0,,
ENSG00000128596,4,1,1,0,1,1,5495.191484272216,506796.91138105374,2021-01-25,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,CCDC136,0.075999975,1.1734,0.60983,0,0.75,0.0,,
ENSG00000128944,2,1,1,0,1,0,225895.43837715342,225895.43837715342,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,KNSTRN,-0.10899997,-0.24472,-0.051458,0,0.5,-1.0,,
ENSG00000129235,2,1,1,0,0,0,260210.21963428933,275021.63051358337,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TXNDC17,-0.38,-0.042434,-0.29441,0,0.5,-1.0,,
ENSG00000129675,1,1,1,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ARHGEF6,,,,7,-1.0,-1.0,Signal Transduction;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components;G-protein beta:gamma signalling,R-HSA-162582;R-HSA-446388;R-HSA-397795
ENSG00000129946,1,1,0,0,1,0,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SHC2,-0.48399997,-2.2722,-1.6876,3,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000130226,2,1,0,0,0,1,323648.5577791949,399832.86333511875,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,DPP6,0.24900001,1.372,-0.31178,0,0.5,0.0,,
ENSG00000130294,1,1,1,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,KIF1A,0.696,5.035,-0.55926,2,0.5,0.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000130348,1,1,0,0,0,1,286678.73247515375,286678.73247515375,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,QRSL1,-0.10500002,1.9873,0.24875,0,-1.0,-1.0,,
ENSG00000130479,3,1,1,0,1,1,64006.74892515976,461914.58891516324,2017-12-06,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,MAP1S,0.22299999,-2.4142,-4.1559,0,0.5,-1.0,,
ENSG00000130545,2,1,0,0,1,1,260210.21963428933,275021.63051358337,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CRB3,-0.36800003,-0.18461,-0.68848,2,0.5,0.0,Tight junction interactions;Disease,R-HSA-420029;R-HSA-1643685
ENSG00000130699,1,1,1,0,0,1,107949.90929360976,143413.24457139417,2023-06-29,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TAF4,0.795,0.80468,-3.548,9,-1.0,0.0,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;RNA Polymerase II Pre-transcription Events;Transcription of the HIV genome;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-674695;R-HSA-167172;R-HSA-162587;R-HSA-162599
ENSG00000130751,1,1,0,0,0,0,101032.95487940393,101032.95487940393,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NPAS1,0.08200002,-1.4003,-2.4275,0,0.5,0.5,,
ENSG00000131094,1,1,0,0,0,1,195666.44200393453,195666.44200393453,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,C1QL1,-0.72300005,-0.041812,-0.80625,0,0.5,0.0,,
ENSG00000131183,3,1,1,0,0,1,43732.839609234245,230316.30849350386,2016-01-21,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,SLC34A1,-0.288,0.96869,0.23249,3,1.0,0.5,Disease;Surfactant metabolism;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-5683826;R-HSA-425393
ENSG00000131626,2,1,1,0,0,1,101603.42051482818,182720.23308494932,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,PPFIA1,0.776,1.8893,0.58705,6,-1.0,-1.0,Acetylcholine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Receptor-type tyrosine-protein phosphatases;Neurotransmitter release cycle,R-HSA-264642;R-HSA-210500;R-HSA-212676;R-HSA-181429;R-HSA-388844;R-HSA-112310
ENSG00000131778,2,1,1,0,1,1,195005.6685718255,1424218.0900670097,2021-09-30,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,CHD1L,-0.15199995,-0.75107,-0.48488,2,-1.0,-1.0,Formation of Incision Complex in GG-NER,R-HSA-5696395
ENSG00000131831,1,1,0,0,0,1,129783.42151918238,129783.42151918238,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RAI2,,,,0,-1.0,0.0,,
ENSG00000131951,1,1,0,0,0,0,11679.569250778799,11679.569250778799,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LRRC9,,,,0,0.75,0.5,,
ENSG00000132026,1,1,1,1,0,0,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RTBDN,-0.60800004,-0.23395,-0.62775,0,1.0,0.5,,
ENSG00000132153,1,1,0,0,0,0,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DHX30,0.92,6.9127,-0.40554,0,-1.0,-1.0,,
ENSG00000132185,1,1,0,0,0,1,22938.587937312015,22938.587937312015,2021-02-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,FCRLA,-0.18400002,0.57396,0.16114,0,1.0,0.5,,
ENSG00000132376,2,1,1,0,0,0,138890.6106237268,203090.6413944402,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,INPP5K,-0.113000035,0.4278,-0.5239,1,0.5,-1.0,,
ENSG00000132623,1,1,0,0,0,1,86219.88882073302,86219.88882073302,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ANKEF1,0.23000002,0.80586,1.0327,0,0.5,0.0,,
ENSG00000132740,1,1,1,0,0,0,278498.5074409075,278498.5074409075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,IGHMBP2,-0.019000053,1.2105,0.28861,0,-1.0,0.0,,
ENSG00000132881,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CPLANE2,-0.64900005,0.45979,0.48907,0,-1.0,-1.0,,
ENSG00000133302,1,1,0,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLF1,-0.019000053,0.439,-0.45615,0,0.5,0.0,,
ENSG00000133477,1,1,0,0,1,1,232586.34864014547,521818.7070055739,2021-01-04,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,FAM83F,-0.54999995,0.05118,-1.1472,0,0.5,0.0,,
ENSG00000133703,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KRAS,0.736,3.0903,0.5771,71,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Constitutive Signaling by Overexpressed ERBB2;Developmental Biology;Gene expression (Transcription);p38MAPK events;Disease;EGFR Transactivation by Gastrin;SHC-mediated cascade:FGFR4;Gastrin-CREB signalling pathway via PKC and MAPK;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-9634285;R-HSA-1266738;R-HSA-74160;R-HSA-171007;R-HSA-1643685;R-HSA-2179392;R-HSA-5654719;R-HSA-881907;R-HSA-9006934;R-HSA-5663202;R-HSA-8878159
ENSG00000133985,1,1,0,0,0,1,87037.83598345588,278190.43024910334,2014-09-14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TTC9,0.07499999,-0.39369,-1.4636,0,0.5,0.0,,
ENSG00000134255,1,1,1,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CEPT1,0.64100003,3.3681,0.35071,2,-1.0,-1.0,,
ENSG00000134278,1,1,0,0,0,0,9724.911607071434,9724.911607071434,2020-10-26,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SPIRE1,0.38599998,0.82881,-1.0227,0,-1.0,-1.0,,
ENSG00000134318,2,1,1,0,0,1,143284.77790855977,189557.6027707886,2023-01-18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ROCK2,0.65400004,4.2964,0.82743,12,-1.0,-1.0,Signal Transduction;Developmental Biology;Disease;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9013422;R-HSA-9706574;R-HSA-9006934
ENSG00000134480,1,1,1,0,1,1,515513.2178404211,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CCNH,-0.049999952,0.5227,0.43785,33,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;Cyclin A/B1/B2 associated events during G2/M transition;Formation of TC-NER Pre-Incision Complex;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;RNA Polymerase I Transcription Initiation;Gap-filling DNA repair synthesis and ligation in TC-NER;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-212436;R-HSA-73857;R-HSA-73863;R-HSA-69273;R-HSA-6781823;R-HSA-74160;R-HSA-73772;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-73762;R-HSA-6782210;R-HSA-73864;R-HSA-73854;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-6781827
ENSG00000134757,1,1,0,0,0,1,11635.351260982607,11635.351260982607,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,DSG3,0.13800001,0.42856,0.34031,3,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000135346,1,1,0,0,0,1,4529.317023064712,5831.6298337927,2019-07-24,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,CGA,0.204,1.123,-0.4731,8,1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of amine-derived hormones;Metabolism of steroids;Post-translational protein modification;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-209776;R-HSA-8957322;R-HSA-597592;R-HSA-8864260
ENSG00000135404,1,1,0,0,1,0,21408.6965896625,21408.6965896625,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CD63,0.19999999,1.2923,-0.0032855,2,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000135486,1,1,0,0,0,1,56614.28807963426,56614.28807963426,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,HNRNPA1,0.643,4.1174,0.25937,5,-1.0,-1.0,Signal Transduction;FGFR2 alternative splicing;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-6803529;R-HSA-1643685;R-HSA-9006934
ENSG00000135506,1,1,1,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,OS9,0.10900003,1.3387,1.6959,5,-1.0,-1.0,Signal Transduction;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Disease;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Hh mutants abrogate ligand secretion;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-901032;R-HSA-901042;R-HSA-532668;R-HSA-1643685;R-HSA-5358346;R-HSA-5362768;R-HSA-5387390;R-HSA-5663202;R-HSA-597592
ENSG00000135801,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TAF5L,0.78,2.8138,0.97681,1,-1.0,-1.0,,
ENSG00000135899,1,1,1,0,0,0,78751.06843456876,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SP110,0.17400002,1.5861,1.1541,0,0.5,-1.0,,
ENSG00000135912,2,1,0,0,0,1,29713.571045654095,39053.6332038119,2023-01-18,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TTLL4,0.24599999,1.8831,1.0432,1,-1.0,-1.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000135976,1,1,1,0,1,0,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ANKRD36,-0.13199997,0.77497,2.2705,0,0.5,0.0,,
ENSG00000136231,1,1,0,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,IGF2BP3,0.804,2.3455,0.44635,1,0.5,0.5,,
ENSG00000136436,1,1,1,1,1,1,125558.52890364222,125558.52890364222,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,CALCOCO2,0.06699997,1.0594,0.21309,0,-1.0,-1.0,,
ENSG00000136492,1,1,0,0,0,1,263416.51565448404,263416.51565448404,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,BRIP1,0.15200001,2.4664,1.8699,15,0.75,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000136750,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GAD2,0.61,1.5767,-0.020229,3,1.0,0.5,"Generic Transcription Pathway;RNA Polymerase II Transcription;GABA synthesis, release, reuptake and degradation;Gene expression (Transcription);Neurotransmitter release cycle",R-HSA-212436;R-HSA-73857;R-HSA-888590;R-HSA-74160;R-HSA-112310
ENSG00000136874,1,1,0,0,0,1,11608.613380386345,11608.613380386345,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,STX17,-0.08200002,0.97077,1.536,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000136928,1,1,1,0,0,0,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,GABBR2,0.606,4.1068,-0.24952,5,1.0,0.5,Signal Transduction;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Inwardly rectifying K+ channels,R-HSA-162582;R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-1296065
ENSG00000136932,1,1,1,0,0,1,18319.91238877481,269829.0934099178,2024-07-19,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,4,TRMO,0.04400003,0.23392,-1.0908,0,-1.0,-1.0,,
ENSG00000137076,1,1,0,0,0,0,107273.75397646755,112218.78632625614,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TLN1,0.764,5.76,2.7697,15,-1.0,-1.0,Signal Transduction;Developmental Biology;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-5663202
ENSG00000137078,1,1,0,0,1,0,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,SIT1,-0.24000001,0.67613,-0.66706,0,1.0,0.5,,
ENSG00000137252,1,1,0,0,0,1,144712.0807038357,144712.0807038357,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,HCRTR2,0.39999998,1.1883,-0.73875,2,,,Signal Transduction,R-HSA-162582
ENSG00000137413,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TAF8,-0.65999997,-0.1324,-0.3129,1,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000137558,1,1,0,0,0,1,133119.54945431868,133119.54945431868,2022-01-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PI15,-0.599,0.97265,-0.1792,0,0.5,0.0,,
ENSG00000137601,1,1,0,0,0,0,116547.04276487474,171880.2916512608,2018-10-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,NEK1,0.04100001,0.90172,-0.37874,1,-1.0,-1.0,Regulation of pyruvate metabolism;Pyruvate metabolism,R-HSA-9861718;R-HSA-70268
ENSG00000137692,1,1,1,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DCUN1D5,0.55700004,2.1883,-0.35057,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000137766,1,1,0,0,0,1,433862.5685735124,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,UNC13C,0.143,-1.3608,-1.2568,0,0.75,0.5,,
ENSG00000137875,1,1,0,0,0,1,598869.4096893278,598869.4096893278,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,BCL2L10,-0.888,-1.8873,-2.1961,0,0.5,0.5,,
ENSG00000137975,1,1,0,0,0,0,5641.082869198312,5641.082869198312,2020-03-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CLCA2,-0.14400005,0.93036,-0.25521,1,0.5,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000138172,1,1,0,0,0,1,78894.16685939343,327782.2658449885,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,CALHM2,-0.21200001,0.76397,0.31685,0,-1.0,0.0,,
ENSG00000138271,1,1,0,0,0,0,100857.20347685824,101004.25318287517,2018-08-13,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GPR87,-0.63399994,0.28314,-0.032859,0,0.5,0.0,,
ENSG00000138336,2,1,0,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,TET1,0.849,3.4456,1.3554,1,-1.0,0.5,Gene expression (Transcription),R-HSA-74160
ENSG00000138347,1,1,0,0,0,1,298878.49542603496,298878.49542603496,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MYPN,0.40399998,1.1815,0.12252,0,0.5,0.5,,
ENSG00000138376,1,1,1,0,0,1,936.4488286066585,5602.666666666667,2009-05-03,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,BARD1,-0.08700001,-0.16636,-1.0676,20,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-597592
ENSG00000138411,2,1,0,0,0,0,227752.06557835746,399832.86333511875,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,HECW2,0.502,3.6566,1.4349,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000138443,1,1,0,0,0,1,208763.74686288778,208763.74686288778,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ABI2,0.41500002,1.8219,0.80216,7,-1.0,-1.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000138642,1,1,0,0,0,1,147105.90765133628,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,HERC6,-0.31799996,0.74675,0.18703,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000138668,1,1,0,0,0,1,205425.60717824215,205425.60717824215,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,HNRNPD,0.778,2.3768,-0.83375,3,-1.0,-1.0,AUF1 (hnRNP D0) binds and destabilizes mRNA,R-HSA-450408
ENSG00000138722,2,1,1,0,0,1,6306.411000302206,159189.58506586426,2021-02-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,MMRN1,-0.016000032,-0.91179,-0.92834,2,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000138741,1,1,0,0,0,1,17257.066666666666,56716.257154516876,2021-04-08,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TRPC3,0.24900001,3.1086,0.7666,5,0.5,0.5,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Role of second messengers in netrin-1 signaling;Stimuli-sensing channels,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-418890;R-HSA-2672351
ENSG00000138798,1,1,0,0,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,EGF,0.259,2.2238,0.80806,34,0.75,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000138813,1,1,0,0,1,1,5504.0130519525,5504.0130519525,2021-09-30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,C4orf17,-0.13100004,0.35398,0.34317,0,1.0,1.0,,
ENSG00000138823,1,1,1,0,1,1,114223.3773112726,172076.47010352428,2024-07-19,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,MTTP,0.328,1.9465,1.5328,3,0.75,0.5,Chylomicron assembly;Plasma lipoprotein remodeling,R-HSA-8963888;R-HSA-8963899
ENSG00000139168,1,1,1,0,0,0,230312.26972227366,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ZCRB1,-0.05700004,1.4269,0.37823,3,-1.0,-1.0,mRNA Splicing - Minor Pathway;Disease,R-HSA-72165;R-HSA-1643685
ENSG00000139567,1,1,1,1,0,1,322220.1169395476,322220.1169395476,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ACVRL1,0.43,3.1905,-0.18684,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000140263,1,1,0,0,0,1,183482.5964890485,198317.64799485338,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,SORD,0.07099998,0.69235,0.23941,2,0.5,-1.0,,
ENSG00000140320,1,1,0,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BAHD1,0.553,1.834,0.84374,0,-1.0,-1.0,,
ENSG00000140323,1,1,1,0,0,1,100857.20347685824,197485.87952538437,2018-08-13,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,DISP2,0.18699998,0.28516,-0.89703,1,1.0,0.5,Signal Transduction;Release of Hh-Np from the secreting cell;Hedgehog ligand biogenesis,R-HSA-162582;R-HSA-5362798;R-HSA-5358346
ENSG00000140326,2,1,1,0,1,1,48439.20423385324,76632.8325989884,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CDAN1,0.09200001,-1.1406,-2.9316,0,-1.0,-1.0,,
ENSG00000140400,1,1,1,0,0,1,28892.29425546899,28892.29425546899,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MAN2C1,-0.013000011,0.14545,-0.020855,1,-1.0,-1.0,,
ENSG00000140563,1,1,0,0,0,0,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MCTP2,-0.32799995,-0.6634,0.44703,0,0.5,0.0,,
ENSG00000140853,1,1,1,0,0,0,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,NLRC5,0.34899998,2.59,0.51987,3,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000141076,1,1,1,0,1,0,125392.97184483419,125392.97184483419,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UTP4,0.23400003,0.99697,-0.75518,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000141298,1,1,0,0,1,0,123127.18790121445,123127.18790121445,2019-02-25,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,SSH2,0.626,3.5239,1.0842,0,0.5,-1.0,,
ENSG00000141367,1,1,0,0,0,0,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CLTC,0.896,10.229,1.1889,19,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Disease;WNT5A-dependent internalization of FZD4;Recycling pathway of L1;EPH-ephrin mediated repulsion of cells;Lysosome Vesicle Biogenesis;Gap junction trafficking and regulation;Gap junction trafficking;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-5099900;R-HSA-437239;R-HSA-3928665;R-HSA-432720;R-HSA-157858;R-HSA-190828;R-HSA-9006934;R-HSA-5663202
ENSG00000141503,1,1,1,1,0,0,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,MINK1,0.597,2.8194,-3.2599,1,-1.0,-1.0,,
ENSG00000141569,1,1,1,0,0,0,718784.6890415357,718784.6890415357,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRIM65,-0.949,-1.9746,-2.6949,0,-1.0,-1.0,,
ENSG00000141682,1,1,0,0,0,1,3730.789802911422,3730.789802911422,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PMAIP1,-0.855,-0.74821,-0.6792,3,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000141744,1,1,0,0,0,0,33224.221295945434,33224.221295945434,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PNMT,-0.45799994,-0.39318,-0.39123,1,0.5,0.0,Metabolism of amine-derived hormones,R-HSA-209776
ENSG00000142409,1,1,0,0,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZNF787,-0.21399999,-1.8941,-4.2881,0,-1.0,-1.0,,
ENSG00000142449,1,1,0,0,0,1,13035.0221976327,13035.0221976327,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,FBN3,0.15600002,1.3517,0.45489,3,0.5,0.5,,
ENSG00000142784,1,1,0,0,0,1,111071.83376541243,111071.83376541243,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,WDTC1,0.754,5.1658,1.217,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000142794,1,1,1,0,0,1,43732.839609234245,43732.839609234245,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,NBPF3,-0.13600004,1.2388,1.5032,0,0.5,0.0,,
ENSG00000143006,1,1,0,0,0,1,124531.34246675359,124531.34246675359,2021-02-24,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DMRTB1,0.28399998,-1.8764,-2.2415,0,1.0,1.0,,
ENSG00000143067,3,1,1,0,0,1,714039.8414241908,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,ZNF697,-0.712,-3.7674,-4.7562,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000143294,1,1,1,0,0,0,107354.09904306603,107354.09904306603,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PRCC,0.597,0.45215,-0.84833,1,-1.0,-1.0,,
ENSG00000143340,1,1,1,0,0,0,38851.92581543917,38851.92581543917,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM163A,-0.204,0.4689,-0.3555,0,0.5,0.5,,
ENSG00000143387,1,1,1,0,0,1,232586.34864014547,232586.34864014547,2021-01-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CTSK,0.25199997,2.1653,0.83,6,0.5,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000143493,2,1,1,0,0,1,286678.73247515375,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,INTS7,0.53400004,1.8872,0.11761,1,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000143570,1,1,1,0,0,0,144102.0022515395,144102.0022515395,2023-05-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC39A1,-0.21399999,1.3388,0.52191,1,-1.0,-1.0,Zinc transporters,R-HSA-435354
ENSG00000143578,2,1,1,0,1,1,130179.01328473506,278190.43024910334,2023-08-23,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CREB3L4,0.015999973,0.77553,1.0881,1,0.5,-1.0,,
ENSG00000143595,1,1,0,0,1,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,AQP10,0.009000003,2.1673,0.70064,1,1.0,0.5,Passive transport by Aquaporins,R-HSA-432047
ENSG00000143669,1,1,1,0,0,1,13219.952617929488,83896.55822718568,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,LYST,0.495,4.1055,1.8897,0,0.5,-1.0,,
ENSG00000143799,5,1,1,1,1,1,5691.114246503779,355284.1215006515,2020-04-27,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,PARP1,0.546,2.0272,0.48027,8,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Formation of Incision Complex in GG-NER;Influenza Viral RNA Transcription and Replication;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5696395;R-HSA-168273;R-HSA-2173793;R-HSA-597592
ENSG00000143924,1,1,0,0,1,0,4245.506600377164,4245.506600377164,2018-10-02,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EML4,0.32,-1.334,-2.0667,3,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000143942,3,1,1,0,0,1,226101.35678720698,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,5,CHAC2,-0.673,-0.86938,-0.55943,1,-1.0,0.0,Glutathione conjugation;Glutathione synthesis and recycling;Phase II - Conjugation of compounds,R-HSA-156590;R-HSA-174403;R-HSA-156580
ENSG00000143954,1,1,0,0,0,1,1470466.6505612188,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,REG3G,-0.41199994,-0.64313,-0.52018,1,1.0,0.5,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000144224,1,1,1,0,0,0,53182.30026560605,53182.30026560605,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,UBXN4,0.22399998,1.1843,0.17379,0,-1.0,-1.0,,
ENSG00000144355,1,1,0,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,DLX1,0.454,2.1748,-0.38908,0,1.0,0.5,,
ENSG00000144366,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GULP1,,,,0,0.5,0.0,,
ENSG00000144559,1,1,0,0,0,1,8142.9975274725275,14573.217105917454,2019-09-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,TAMM41,-0.08000004,0.10906,-0.078147,0,-1.0,-1.0,,
ENSG00000144868,1,1,0,0,0,1,1076472.0138856068,1076472.0138856068,2023-07-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TMEM108,0.41399997,1.344,1.0048,0,0.5,0.0,,
ENSG00000145014,2,1,1,0,0,1,48439.20423385324,58357.815018992726,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TMEM44,-0.311,-0.8337,-2.0939,0,-1.0,0.0,,
ENSG00000145107,1,1,0,0,1,1,466632.7979326389,466632.7979326389,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TM4SF19,-0.102,1.1033,0.28459,0,0.5,0.5,,
ENSG00000145217,1,1,1,0,1,1,1321.7688442211056,283145.34784240765,2022-04-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,SLC26A1,-0.849,-1.5378,-1.777,2,0.5,0.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000145247,1,1,1,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,OCIAD2,-0.96500003,0.15239,0.22923,0,0.5,-1.0,,
ENSG00000145414,1,1,1,0,0,1,50175.980946411786,72659.90666629994,2023-05-26,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NAF1,0.074,-0.11779,-0.82104,0,-1.0,-1.0,,
ENSG00000145692,2,1,1,0,0,1,260210.21963428933,515513.2178404211,2018-10-08,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,BHMT,0.116,1.5116,0.66529,2,0.75,0.5,,
ENSG00000145700,1,1,0,0,1,1,93133.65990326442,93133.65990326442,2022-12-16,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,ANKRD31,0.15600002,1.7367,1.7466,0,1.0,1.0,,
ENSG00000145757,1,1,0,0,0,1,123127.18790121445,123127.18790121445,2019-02-25,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,SPATA9,-0.40199995,0.37037,0.45238,0,1.0,0.5,,
ENSG00000145864,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,GABRB2,0.574,4.0985,-0.026682,2,1.0,0.5,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000145868,5,1,1,0,1,1,32217.23287013741,562534.7696387965,2017-02-06,0,0,0,0,0,0,0,0,0,0,24,0,0,0,0,0,0,0,0,0,0,0,0,24,FBXO38,0.46100003,3.8422,1.6281,0,-1.0,-1.0,,
ENSG00000146047,1,1,0,0,0,0,341207.7500533011,341207.7500533011,2024-08-27,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,H2BC1,-0.712,-1.1677,-4.8702,49,1.0,1.0,"Signal Transduction;Generic Transcription Pathway;Replacement of protamines by nucleosomes in the male pronucleus;Assembly of the ORC complex at the origin of replication;Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex;SIRT1 negatively regulates rRNA expression;RNA Polymerase II Transcription;Developmental Biology;Depyrimidination;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine;Base-Excision Repair, AP Site Formation;Inhibition of DNA recombination at telomere;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin modifications during the maternal to zygotic transition (MZT);RNA Polymerase I Promoter Escape;Condensation of Prophase Chromosomes;Regulation of endogenous retroelements by KRAB-ZFP proteins;Disease;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase I Promoter Opening;Transcriptional regulation by small RNAs;Gene Silencing by RNA;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;HCMV Late Events;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Formation of the beta-catenin:TCF transactivating complex;Post-translational protein modification",R-HSA-162582;R-HSA-212436;R-HSA-9821993;R-HSA-68616;R-HSA-9843970;R-HSA-427359;R-HSA-73857;R-HSA-1266738;R-HSA-73928;R-HSA-110328;R-HSA-110329;R-HSA-73929;R-HSA-9670095;R-HSA-74160;R-HSA-427389;R-HSA-9821002;R-HSA-73772;R-HSA-2299718;R-HSA-9843940;R-HSA-1643685;R-HSA-5625886;R-HSA-5250941;R-HSA-427413;R-HSA-73728;R-HSA-5578749;R-HSA-211000;R-HSA-73864;R-HSA-73854;R-HSA-9610379;R-HSA-8866654;R-HSA-8852135;R-HSA-201722;R-HSA-597592
ENSG00000146143,1,1,0,0,0,1,122069.83349127392,394357.452283155,2017-12-06,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,PRIM2,0.07499999,1.2846,0.91398,9,0.5,-1.0,E2F mediated regulation of DNA replication;Inhibition of replication initiation of damaged DNA by RB1/E2F1;Disease,R-HSA-113510;R-HSA-113501;R-HSA-1643685
ENSG00000146242,1,1,0,0,0,1,14656.210545721095,14656.210545721095,2021-11-04,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TPBG,-0.06400001,-1.5438,-2.7821,0,-1.0,0.0,,
ENSG00000146247,1,1,0,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PHIP,0.754,4.4459,0.29276,1,-1.0,-1.0,Signal Transduction;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9706574
ENSG00000146426,1,1,0,0,1,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TIAM2,0.42799997,2.1074,1.3998,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000146530,1,1,1,0,0,1,380831.7787965888,380831.7787965888,2017-12-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VWDE,-0.28400004,-2.526,-1.424,0,0.5,0.5,,
ENSG00000146618,1,1,0,0,0,1,48439.20423385324,48439.20423385324,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FERD3L,-0.34099996,-0.84183,-1.2188,0,,,,
ENSG00000146938,2,1,1,0,0,1,99863.42410604075,1778690.168860174,2018-02-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,NLGN4X,,,,1,0.5,0.0,,
ENSG00000146966,1,1,1,0,0,0,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DENND2A,0.36799997,1.8551,0.055781,1,-1.0,0.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000147488,1,1,1,0,0,1,320319.7525060048,320319.7525060048,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ST18,0.445,0.30922,0.27446,0,1.0,0.5,,
ENSG00000147606,1,1,0,0,0,1,4590.720340172332,4590.720340172332,2024-07-19,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC26A7,-0.02699995,-0.02327,0.73424,1,1.0,0.5,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000147869,1,1,0,0,0,0,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CER1,-0.45099998,-1.7394,-0.58348,4,0.5,1.0,Signal Transduction;Developmental Biology;Regulation of signaling by NODAL,R-HSA-162582;R-HSA-1266738;R-HSA-1433617
ENSG00000147896,1,1,0,0,0,0,7387.861326746648,7387.861326746648,2009-09-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,IFNK,-0.64199996,0.032731,-0.36492,0,,,,
ENSG00000148484,1,1,0,0,0,1,18767.541536687917,18767.541536687917,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RSU1,-0.03699994,0.52609,-0.9399,1,-1.0,-1.0,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,R-HSA-446388
ENSG00000148516,1,1,0,0,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZEB1,0.661,2.8421,1.8669,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Developmental Biology;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-449147;R-HSA-6785807
ENSG00000148604,1,1,0,0,0,1,10353.132295719844,10353.132295719844,2019-12-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RGR,-0.413,-0.15601,-0.56704,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000148606,1,1,0,0,0,0,23673.544430600137,23673.544430600137,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,POLR3A,0.16399997,3.679,1.4867,7,-1.0,0.0,RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;Immune System;RNA Polymerase III Chain Elongation;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-76046;R-HSA-76071;R-HSA-76061;R-HSA-76066;R-HSA-168256;R-HSA-73780;R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000148634,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HERC4,0.671,4.6381,0.64568,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000148677,1,1,0,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ANKRD1,-0.037999988,0.80164,-0.006805,1,1.0,0.0,,
ENSG00000148814,1,1,0,0,0,1,88247.21228328612,88247.21228328612,2022-07-13,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LRRC27,-0.329,-0.62187,-0.54244,0,1.0,-1.0,,
ENSG00000148840,1,1,0,0,0,0,433862.5685735124,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PPRC1,0.752,1.246,-0.09154,1,-1.0,-1.0,,
ENSG00000149089,1,1,1,0,0,1,765591.3646788632,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,APIP,-0.42299998,0.73321,-0.48497,3,-1.0,-1.0,Cytochrome c-mediated apoptotic response,R-HSA-111461
ENSG00000149124,1,1,0,0,0,0,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GLYAT,-0.91499996,-0.5518,-0.37605,3,0.75,0.5,Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156580;R-HSA-9749641
ENSG00000149646,4,1,0,0,0,1,26667.58037719927,224333.96758339784,2020-09-04,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CNBD2,-0.17299998,0.75914,1.1915,0,0.5,-1.0,,
ENSG00000149743,1,1,1,0,1,0,150669.89240227733,150669.89240227733,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TRPT1,-0.22800004,0.028173,-0.41044,0,0.5,-1.0,,
ENSG00000150687,2,1,1,0,0,1,29803.01405728205,414433.58532016096,2020-01-20,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,PRSS23,0.045000017,0.94584,0.83305,2,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000150967,1,1,0,0,0,1,272025.74568937684,272025.74568937684,2018-10-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ABCB9,0.204,1.0889,0.40573,1,0.5,-1.0,,
ENSG00000151151,3,1,1,0,0,1,28923.750134754748,160010.51072069994,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,4,IPMK,0.39999998,1.1483,-0.098146,1,0.5,0.0,,
ENSG00000151224,2,1,1,0,0,1,42359.490817992155,414433.58532016096,2023-01-18,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,MAT1A,0.347,2.3888,0.29421,4,1.0,0.5,Disease;Phase II - Conjugation of compounds,R-HSA-1643685;R-HSA-156580
ENSG00000151379,1,1,0,0,0,1,242964.12552687144,242964.12552687144,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MSGN1,0.292,0.29728,-0.040211,2,1.0,1.0,Developmental Biology,R-HSA-1266738
ENSG00000151466,1,1,0,0,0,0,270359.2512882127,270359.2512882127,2023-05-27,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SCLT1,-0.09899998,0.41463,-0.11513,1,-1.0,-1.0,,
ENSG00000151632,1,1,1,0,0,1,12724.75719835148,12724.75719835148,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,AKR1C2,-0.034999967,0.93379,0.58106,3,0.5,0.0,Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-193775;R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000151773,2,1,1,0,0,1,19965.24128263536,78751.06843456876,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,5,CCDC122,-0.53499997,0.41196,0.47465,0,-1.0,0.0,,
ENSG00000151838,3,1,1,0,0,1,134280.23494429077,1778690.168860174,2019-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,6,CCDC175,-0.23500001,-0.15011,-0.23467,0,0.5,0.5,,
ENSG00000151893,1,1,1,0,0,0,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CACUL1,0.357,-0.20735,-1.0704,0,-1.0,-1.0,,
ENSG00000151952,1,1,0,0,0,1,2324.6716622691292,2324.6716622691292,2023-04-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM132D,0.5,1.1688,-0.47901,0,1.0,1.0,,
ENSG00000152049,1,1,0,0,0,1,13219.952617929488,13219.952617929488,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,KCNE4,-0.22599995,0.46145,-0.30538,2,0.5,0.0,,
ENSG00000152223,1,1,1,0,0,0,3466.7409637187616,3466.7409637187616,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,EPG5,0.42000002,1.7487,0.21291,0,-1.0,-1.0,,
ENSG00000152284,2,1,1,0,0,0,190607.69339444506,461914.58891516324,2024-07-19,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TCF7L1,0.528,1.1757,-0.76118,8,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Regulation of MITF-M-dependent genes involved in cell cycle and proliferation;Formation of the beta-catenin:TCF transactivating complex;Transcriptional regulation by RUNX3;Binding of TCF/LEF:CTNNB1 to target gene promoters;RUNX3 regulates WNT signaling,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9825892;R-HSA-201722;R-HSA-8878159;R-HSA-4411364;R-HSA-8951430
ENSG00000152291,1,1,0,0,0,1,219793.50457789513,219793.50457789513,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TGOLN2,0.08700001,0.55462,0.49829,6,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000152348,2,1,1,0,1,1,87515.7591699547,87515.7591699547,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATG10,-0.74399996,0.68629,0.32813,1,-1.0,-1.0,,
ENSG00000152413,1,1,1,0,0,1,94951.97167384504,94951.97167384504,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,HOMER1,0.815,3.1878,0.25913,1,0.5,0.0,,
ENSG00000152583,1,1,0,1,0,1,221280.45048451523,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,4,SPARCL1,0.06800002,1.1616,1.9509,2,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000153086,1,1,0,0,0,1,14775.77846934071,125299.9543761523,2011-02-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,5,ACMSD,-0.062999964,0.12934,0.66415,1,0.75,0.5,,
ENSG00000153317,1,1,0,0,0,1,11136.467630421119,11136.467630421119,2015-03-16,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ASAP1,0.561,3.4319,-0.42012,1,-1.0,-1.0,VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620916;R-HSA-5620920
ENSG00000153560,1,1,1,0,0,1,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,UBP1,0.508,3.1195,0.45268,0,-1.0,-1.0,,
ENSG00000153885,1,1,1,0,0,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KCTD15,0.319,0.90636,0.45409,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8864260
ENSG00000154358,4,1,1,0,1,1,203090.6413944402,302356.0064883874,2021-10-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,OBSCN,-0.0069999695,-0.78392,-1.6019,4,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000154727,1,1,0,0,0,1,107949.90929360976,107949.90929360976,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GABPA,0.917,4.113,0.026672,1,-1.0,-1.0,,
ENSG00000154734,1,1,0,0,0,1,1321.7688442211056,283145.34784240765,2022-04-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ADAMTS1,0.671,0.124,-1.2631,3,0.5,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000154864,1,1,1,0,0,1,155552.2805078301,197485.87952538437,2023-01-18,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PIEZO2,0.43699998,3.0264,0.30423,0,0.5,0.0,,
ENSG00000154978,1,1,0,0,0,1,69915.00897904889,69915.00897904889,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VOPP1,-0.011000037,0.48713,-0.23397,0,0.5,-1.0,,
ENSG00000155115,1,1,0,0,1,1,2521.196518187979,2521.196518187979,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GTF3C6,-0.37199998,0.52081,-0.13861,3,-1.0,-1.0,RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-76046;R-HSA-76061;R-HSA-76066;R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000155367,1,1,0,0,1,1,53182.30026560605,53182.30026560605,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PPM1J,-0.06700003,-0.12628,-0.39197,0,0.5,0.0,,
ENSG00000156017,1,1,0,0,0,1,37912.391866997306,37912.391866997306,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,CARNMT1,-0.15699995,0.30678,-0.45895,1,-1.0,-1.0,,
ENSG00000156150,2,1,1,0,0,1,107949.90929360976,414433.58532016096,2023-06-29,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ALX3,-0.051,-0.60958,-1.1231,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000156219,1,1,1,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ART3,-0.37699997,0.54591,0.99842,1,0.75,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000156284,1,1,1,0,1,1,221280.45048451523,384314.83364002535,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,CLDN8,-0.865,-0.43356,0.23744,1,0.5,0.0,Tight junction interactions,R-HSA-420029
ENSG00000156384,1,1,1,0,0,1,127123.38472704956,127123.38472704956,2021-09-30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SFR1,-0.35599995,0.061771,1.0508,0,-1.0,-1.0,,
ENSG00000156475,1,1,1,0,0,1,139549.80122422232,139549.80122422232,2021-08-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PPP2R2B,0.827,3.524,0.15137,0,0.5,0.0,,
ENSG00000156603,8,1,1,0,0,0,94665.79117035728,1778690.168860174,2018-02-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,10,MED19,0.502,-0.13578,-1.5185,3,-1.0,-1.0,Developmental Biology;Disease,R-HSA-1266738;R-HSA-1643685
ENSG00000157077,1,1,0,0,0,0,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZFYVE9,0.592,2.5394,2.2336,4,-1.0,-1.0,Signal Transduction;Disease;TGFBR1 KD Mutants in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;Loss of Function of SMAD2/3 in Cancer;Loss of Function of TGFBR1 in Cancer,R-HSA-162582;R-HSA-1643685;R-HSA-3656532;R-HSA-3304356;R-HSA-5663202;R-HSA-3304349;R-HSA-3656534
ENSG00000157551,1,1,0,0,1,1,40486.1226680631,40486.1226680631,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KCNJ15,0.09799999,1.6359,0.35107,2,0.5,0.0,Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Inwardly rectifying K+ channels,R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-1296065
ENSG00000157600,1,1,1,0,0,1,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,TMEM164,,,,0,-1.0,-1.0,,
ENSG00000157657,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZNF618,0.541,2.5697,-0.068609,0,-1.0,-1.0,,
ENSG00000157703,1,1,0,0,0,1,59049.74494220139,86537.94134095173,2024-07-19,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SVOPL,-0.17499995,-0.020049,-0.58882,0,0.5,0.5,,
ENSG00000157884,1,1,0,0,0,1,17601.10520641419,17601.10520641419,2024-10-03,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CIB4,-0.45599997,-0.17873,0.53387,0,1.0,0.5,,
ENSG00000158042,1,1,0,0,0,1,16516.60902750872,16516.60902750872,2024-07-19,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MRPL17,-0.20799994,-0.27475,-0.45058,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000158125,1,1,0,0,0,1,221280.45048451523,286678.73247515375,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,XDH,0.00999999,-0.79461,-0.30006,3,0.75,0.0,Immune System;Azathioprine ADME;Purine catabolism;Metabolism of nucleotides,R-HSA-168256;R-HSA-9748787;R-HSA-74259;R-HSA-15869
ENSG00000158526,1,1,0,0,0,1,13785.673050095118,13785.673050095118,2019-09-27,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TSR2,,,,0,0.5,-1.0,,
ENSG00000158669,1,1,0,0,0,1,135095.86576106868,135095.86576106868,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPAT4,0.56700003,3.2446,0.45646,1,-1.0,-1.0,Synthesis of PA,R-HSA-1483166
ENSG00000158683,1,1,0,0,0,0,39053.6332038119,39053.6332038119,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PKD1L1,0.20700002,1.7754,0.61218,0,-1.0,0.5,,
ENSG00000158715,1,1,1,0,0,1,125299.9543761523,263416.51565448404,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,SLC45A3,0.272,2.0771,1.6301,1,1.0,0.0,Cellular hexose transport,R-HSA-189200
ENSG00000158748,1,1,1,0,0,1,94951.97167384504,94951.97167384504,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,HTR6,-0.41199994,0.5741,-0.84624,2,1.0,1.0,Signal Transduction;Serotonin receptors;Amine ligand-binding receptors,R-HSA-162582;R-HSA-390666;R-HSA-375280
ENSG00000159228,1,1,1,0,0,1,3624.878124194795,3624.878124194795,2015-08-24,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CBR1,-0.41900003,0.23959,-0.15502,1,0.5,-1.0,Arachidonate metabolism,R-HSA-2142753
ENSG00000159251,1,1,0,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ACTC1,0.48900002,6.3225,-0.0055469,4,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000159579,1,1,0,0,0,0,221899.14754742323,221899.14754742323,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RSPRY1,0.555,3.0301,1.3958,0,-1.0,-1.0,,
ENSG00000160216,1,1,0,0,0,0,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,AGPAT3,0.79,3.157,0.10708,2,-1.0,-1.0,Synthesis of PA;Golgi-to-ER retrograde transport,R-HSA-1483166;R-HSA-8856688
ENSG00000160256,1,1,0,0,0,1,6356.593451690605,6356.593451690605,2023-05-29,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLX9,-0.45799994,-0.5785,-0.24802,0,-1.0,-1.0,,
ENSG00000160551,1,1,1,0,0,1,11679.569250778799,11679.569250778799,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TAOK1,0.784,5.9261,1.4762,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000160593,1,1,1,0,1,1,39707.309018073414,50175.980946411786,2019-07-17,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,JAML,0.16399997,1.1666,1.0417,2,0.5,0.0,Immune System,R-HSA-168256
ENSG00000160613,1,1,0,0,0,0,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,PCSK7,0.11900002,2.1121,0.92709,0,-1.0,-1.0,,
ENSG00000160991,2,1,0,0,0,1,62627.34914844415,260210.21963428933,2021-09-30,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ORAI2,-0.027999997,2.3739,0.51794,3,0.5,0.0,Immune System,R-HSA-168256
ENSG00000161835,1,1,0,0,0,1,180344.38517486732,180344.38517486732,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TAMALIN,0.413,-1.6638,-3.554,0,-1.0,0.0,,
ENSG00000161929,1,1,1,0,0,1,1321.7688442211056,283145.34784240765,2019-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,SCIMP,-0.26600003,0.83966,0.57996,0,0.5,0.0,,
ENSG00000161956,1,1,1,0,0,0,92895.08340078588,92895.08340078588,2024-07-19,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SENP3,0.718,2.4652,-0.43216,1,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000162105,3,1,0,0,0,0,49367.473680139236,684816.7338614308,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,SHANK2,0.583,3.1048,0.59377,1,0.5,0.0,,
ENSG00000162385,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MAGOH,0.691,2.5657,1.1439,6,-1.0,-1.0,RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Regulation of expression of SLITs and ROBOs;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm,R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9010553;R-HSA-159236;R-HSA-72202
ENSG00000162398,1,1,0,0,0,1,41464.78416310977,41464.78416310977,2021-08-24,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CIMAP2,-0.19599998,0.093234,0.27814,0,0.75,0.5,,
ENSG00000162419,1,1,1,0,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GMEB1,0.849,2.7676,0.49582,0,-1.0,-1.0,,
ENSG00000162585,1,1,1,0,0,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,FAAP20,-0.339,-0.81118,-1.3541,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000162722,1,1,0,1,1,1,100358.73833384078,100358.73833384078,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TRIM58,-0.888,-1.7804,-1.4771,0,0.75,0.5,,
ENSG00000162777,1,1,0,0,0,1,123127.18790121445,123127.18790121445,2019-02-25,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,DENND2D,0.21499997,1.2268,0.021531,1,0.5,0.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000162877,1,1,1,1,0,0,21168.40842438638,21168.40842438638,2020-04-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PM20D1,-0.17700005,0.82274,0.17631,1,0.75,0.5,,
ENSG00000162923,1,1,1,0,0,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,WDR26,0.856,3.3494,-1.251,1,-1.0,-1.0,Regulation of pyruvate metabolism;Pyruvate metabolism,R-HSA-9861718;R-HSA-70268
ENSG00000162929,1,1,1,0,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,SANBR,0.013000011,-0.26766,0.84631,0,0.5,-1.0,,
ENSG00000163071,1,1,0,0,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPATA18,0.03399998,-0.29601,0.53245,0,0.5,0.0,,
ENSG00000163239,1,1,1,0,1,1,55635.00408218119,55635.00408218119,2021-06-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TDRD10,-0.06099999,1.286,0.58662,0,1.0,0.0,,
ENSG00000163257,1,1,1,0,0,0,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,DCAF16,0.014999986,0.27219,-0.6677,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000163346,1,1,1,0,1,0,197775.78125685986,197775.78125685986,2022-10-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PBXIP1,-0.18400002,1.4649,1.4038,0,1.0,-1.0,,
ENSG00000163357,3,1,1,0,0,1,52001.717100897775,189557.6027707886,2021-09-30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,DCST1,-0.031999946,0.5559,0.36767,0,0.75,0.5,,
ENSG00000163440,1,1,0,0,0,1,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PDCL2,-0.26699996,0.10236,0.57342,0,1.0,1.0,,
ENSG00000163466,1,1,1,0,0,1,78751.06843456876,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ARPC2,0.681,2.8405,0.75438,5,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Disease,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685
ENSG00000163520,2,1,1,1,0,1,156470.480665571,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,4,FBLN2,0.065,0.056492,-0.57805,1,0.5,0.0,,
ENSG00000163531,1,1,0,0,0,1,10389.295774647888,10389.295774647888,2018-08-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NFASC,0.638,3.5241,1.1274,3,0.5,0.0,Immune System;Developmental Biology;Interaction between L1 and Ankyrins,R-HSA-168256;R-HSA-1266738;R-HSA-445095
ENSG00000163558,1,1,0,0,0,1,31535.173607928213,52626.33085717853,2020-12-08,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PRKCI,0.338,3.0677,0.85968,4,-1.0,-1.0,Signal Transduction;Tight junction interactions,R-HSA-162582;R-HSA-420029
ENSG00000163563,1,1,0,0,0,1,3552.1418674698793,3552.1418674698793,2021-07-23,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MNDA,-0.556,-0.5355,-0.18168,1,0.75,-1.0,Immune System,R-HSA-168256
ENSG00000163611,1,1,1,0,0,0,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPICE1,0.10500002,0.95005,1.5843,0,-1.0,-1.0,,
ENSG00000163637,2,1,0,0,0,1,324308.4770735607,414433.58532016096,2024-07-19,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PRICKLE2,0.65999997,2.3305,-0.29335,0,-1.0,0.0,,
ENSG00000163646,1,1,0,0,0,1,286746.1002745869,286746.1002745869,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CLRN1,-0.16799998,-0.36895,0.22084,0,0.75,0.5,,
ENSG00000163659,4,1,0,0,0,1,8116.851928965095,60436.282913699004,2013-04-01,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,TIPARP,0.65400004,2.7307,-0.4824,0,-1.0,-1.0,,
ENSG00000163749,3,1,1,0,0,1,203090.6413944402,298878.49542603496,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CCDC158,0.042999983,1.0212,0.78561,0,1.0,0.5,,
ENSG00000163792,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TCF23,-0.171,0.4263,-0.19328,0,0.75,0.5,,
ENSG00000163806,1,1,0,0,0,1,51251.954839862,51251.954839862,2020-05-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPDYA,0.41399997,1.4879,0.58896,0,1.0,0.0,,
ENSG00000163956,1,1,1,0,0,1,3141.278019404483,3141.278019404483,2019-10-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LRPAP1,-0.375,-1.5021,-2.0532,0,-1.0,-1.0,,
ENSG00000164023,1,1,0,0,0,1,48662.99214856774,48662.99214856774,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SGMS2,0.376,1.3713,0.088457,1,-1.0,0.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000164031,1,1,0,0,0,0,100075.58738100652,112184.2204720767,2024-04-26,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DNAJB14,0.36,2.5698,0.98426,0,-1.0,-1.0,,
ENSG00000164038,1,1,0,0,0,1,136025.05987988086,227570.98695011192,2017-09-04,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC9B2,0.008000016,0.48348,0.86484,1,0.5,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000164061,2,1,0,0,0,1,87248.80974040499,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,BSN,0.729,3.3318,1.3144,1,1.0,0.5,,
ENSG00000164066,2,1,0,0,1,1,86992.9057658324,143413.24457139417,2022-10-12,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,INTU,-0.011999965,0.9461,1.6221,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000164076,1,1,1,0,0,1,239818.6565166969,239818.6565166969,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,CAMKV,0.798,4.3398,1.0492,0,1.0,0.5,,
ENSG00000164089,1,1,0,0,0,1,100075.58738100652,112184.2204720767,2024-04-26,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ETNPPL,0.34899998,1.4378,0.68308,1,0.75,0.0,,
ENSG00000164182,1,1,0,0,0,1,37368.38182683358,76832.90012167432,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,NDUFAF2,-0.10699999,0.70328,0.52955,1,-1.0,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000164294,1,1,1,0,0,1,7618.01117783872,7618.01117783872,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GPX8,-0.072999954,0.54974,0.094662,1,-1.0,0.0,,
ENSG00000164366,2,1,1,0,0,1,203090.6413944402,203090.6413944402,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCDC127,-0.42999995,0.67569,0.72448,0,-1.0,-1.0,,
ENSG00000164576,1,1,0,0,0,1,25129.86299666951,25129.86299666951,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SAP30L,0.181,0.4786,0.024101,3,-1.0,-1.0,Gene expression (Transcription);Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression,R-HSA-74160;R-HSA-1643685;R-HSA-5250941;R-HSA-427413
ENSG00000164692,1,1,0,0,0,1,312829.3312654393,312829.3312654393,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,COL1A2,0.661,3.5486,-0.65571,27,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Platelet Adhesion to exposed collagen;Signaling by Receptor Tyrosine Kinases;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-75892;R-HSA-9006934;R-HSA-2173796;R-HSA-2173793;R-HSA-6785807
ENSG00000164818,1,1,0,0,0,0,37221.07677995828,37221.07677995828,2018-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DNAAF5,-0.120000005,-2.1906,-3.8293,0,-1.0,-1.0,,
ENSG00000164919,1,1,1,0,0,1,129783.42151918238,129783.42151918238,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,COX6C,-0.23099995,0.20052,-0.014685,4,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Complex IV assembly,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9864848
ENSG00000164949,1,1,0,0,1,1,394357.452283155,394357.452283155,2020-10-05,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GEM,-0.25,0.9267,0.4065,1,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000165118,1,1,1,0,0,1,25967.06754524981,25967.06754524981,2023-08-31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,QNG1,-0.120000005,0.60715,1.0784,0,-1.0,-1.0,,
ENSG00000165138,1,1,1,0,0,1,195005.6685718255,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ANKS6,0.13099998,-0.7649,-0.57238,0,0.5,-1.0,,
ENSG00000165233,1,1,0,0,0,1,117090.1108836121,117090.1108836121,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CARD19,-0.56500006,-0.11294,-0.27582,0,-1.0,0.0,,
ENSG00000165376,1,1,1,0,0,0,7502.407941951862,18370.005317532665,2021-09-30,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CLDN2,,,,1,0.5,0.0,Tight junction interactions,R-HSA-420029
ENSG00000165556,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CDX2,0.39099997,-0.014577,-1.5421,2,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000165566,1,1,0,0,0,1,414433.58532016096,414433.58532016096,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,AMER2,0.34500003,-1.1384,-2.2203,0,0.75,0.5,,
ENSG00000165572,1,1,0,0,0,1,515513.2178404211,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,KBTBD6,0.65900004,4.038,1.6359,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000165630,1,1,0,0,0,1,23177.813642848687,23177.813642848687,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PRPF18,-0.171,2.8142,-0.060775,1,-1.0,-1.0,,
ENSG00000165644,1,1,0,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,COMTD1,-0.86899996,-1.9646,-1.5514,0,0.5,0.0,,
ENSG00000165730,2,1,0,0,0,1,195005.6685718255,260210.21963428933,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,STOX1,0.06699997,1.7051,1.1942,0,0.5,0.0,,
ENSG00000165841,1,1,1,0,0,0,143284.77790855977,143284.77790855977,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CYP2C19,-0.668,-2.2833,-1.6514,5,1.0,0.5,Aspirin ADME;Arachidonate metabolism,R-HSA-9749641;R-HSA-2142753
ENSG00000165868,1,1,0,0,0,1,107949.90929360976,143413.24457139417,2023-06-29,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HSPA12A,0.40399998,2.7623,0.94262,1,0.5,0.0,,
ENSG00000166181,1,1,0,0,0,1,48578.54898906086,48578.54898906086,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,API5,0.78900003,3.6846,1.103,0,-1.0,-1.0,,
ENSG00000166226,1,1,1,0,0,1,232656.1405260205,303059.79257468163,2018-06-11,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CCT2,0.555,1.2725,-0.86135,9,-1.0,-1.0,Signal Transduction;Immune System;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;BBSome-mediated cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-168256;R-HSA-389957;R-HSA-389958;R-HSA-5620922;R-HSA-5620920;R-HSA-9706574
ENSG00000166263,2,1,1,0,1,1,22345.675520395987,141076.9910731678,2013-04-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,STXBP4,-0.039000034,0.23177,1.0084,0,-1.0,0.0,,
ENSG00000166452,1,1,0,0,0,1,11608.613380386345,11608.613380386345,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,AKIP1,-0.324,-0.61902,-1.0199,0,-1.0,-1.0,,
ENSG00000166483,4,1,1,0,0,1,60436.282913699004,332092.8064672836,2020-02-10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,WEE1,0.595,1.8732,-1.5819,7,-1.0,-1.0,Cyclin A/B1/B2 associated events during G2/M transition;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,R-HSA-69273;R-HSA-75035
ENSG00000166801,2,1,1,0,1,1,23627.17709700948,521818.7070055739,2021-01-04,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,FAM111A,-0.89,1.0515,0.91589,0,-1.0,-1.0,,
ENSG00000166938,1,1,0,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DIS3L,0.036000013,1.3836,1.1893,0,-1.0,-1.0,,
ENSG00000167034,2,1,1,0,0,1,3747.57310565635,521818.7070055739,2009-09-20,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,NKX3-1,-0.17900002,-1.7491,-2.3278,0,1.0,0.0,,
ENSG00000167105,1,1,0,0,0,1,5489.431759075451,5489.431759075451,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM92,-0.51699996,0.92512,0.15412,0,0.5,0.0,,
ENSG00000167202,1,1,0,0,0,1,16954.933657438592,16954.933657438592,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TBC1D2B,0.26099998,1.5138,-0.45548,0,-1.0,-1.0,,
ENSG00000167210,1,1,0,0,1,1,404399.6052088398,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LOXHD1,0.10399997,0.87106,1.4524,0,0.75,0.5,,
ENSG00000167447,1,1,0,0,0,1,20393.928394796258,20393.928394796258,2023-11-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,SMG8,0.274,2.8653,1.4641,1,-1.0,-1.0,,
ENSG00000167525,1,1,1,0,0,0,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PROCA1,-0.171,-0.0010296,0.10059,0,1.0,0.0,,
ENSG00000167549,1,1,1,0,0,1,122069.83349127392,394357.452283155,2017-12-06,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CORO6,-0.17700005,0.089361,0.96292,0,0.5,0.0,,
ENSG00000167565,1,1,0,0,0,1,258213.8601133611,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SERTAD3,-0.14999998,-0.73448,-0.4121,0,-1.0,-1.0,,
ENSG00000167916,1,1,0,0,0,1,97691.2238787727,97691.2238787727,2019-03-28,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,KRT24,-0.09399998,0.93767,0.97533,3,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000168065,1,1,0,0,0,1,7310.825292493756,230312.26972227366,2020-04-01,0,0,0,0,0,0,0,0,0,0,0,0,22,0,0,0,0,0,0,0,0,0,0,22,SLC22A11,-0.10500002,0.74393,0.51694,1,0.75,0.5,,
ENSG00000168280,1,1,0,0,0,1,1173.5007132667617,1424218.0900670097,2020-05-06,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,KIF5C,0.751,3.6286,0.090061,1,1.0,0.0,Immune System;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-168256;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000168539,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CHRM1,0.675,4.2948,1.1218,2,0.75,0.5,Signal Transduction;Amine ligand-binding receptors,R-HSA-162582;R-HSA-375280
ENSG00000168703,1,1,0,1,0,1,54892.674160393246,54892.674160393246,2020-12-02,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,WFDC12,-0.10800004,-0.44817,0.34308,0,1.0,0.0,,
ENSG00000168734,2,1,1,0,0,1,62627.34914844415,275021.63051358337,2021-04-08,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,PKIG,-0.078999996,1.0495,0.34297,0,-1.0,-1.0,,
ENSG00000168792,1,1,0,0,0,1,28292.123952140868,28292.123952140868,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ABHD15,-0.47899997,-0.4131,-1.0194,0,0.5,-1.0,,
ENSG00000168913,3,1,0,0,0,1,598869.4096893278,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,ENHO,-0.87100005,0.59254,0.027986,0,1.0,0.0,,
ENSG00000168993,1,1,0,0,0,1,25192.33154703145,25192.33154703145,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,CPLX1,0.24400002,-1.2146,-0.91421,6,1.0,0.0,"GABA synthesis, release, reuptake and degradation;Acetylcholine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Neurotransmitter release cycle",R-HSA-888590;R-HSA-264642;R-HSA-210500;R-HSA-212676;R-HSA-112310
ENSG00000169035,2,1,1,1,0,1,115338.82014347943,144127.33793912127,2024-07-19,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,KLK7,-0.265,-0.25045,-0.68813,2,0.75,0.0,,
ENSG00000169057,1,1,0,0,0,1,39253.61883144178,39253.61883144178,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MECP2,,,,11,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000169180,1,1,1,0,0,1,117707.74532698281,117707.74532698281,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,XPO6,0.96,4.4058,1.0707,0,-1.0,-1.0,,
ENSG00000169371,1,1,0,0,0,0,135095.86576106868,135095.86576106868,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SNUPN,0.20200002,1.2285,1.4591,1,-1.0,-1.0,snRNP Assembly;Metabolism of non-coding RNA,R-HSA-191859;R-HSA-194441
ENSG00000169410,2,1,0,0,0,1,135095.86576106868,1424218.0900670097,2020-06-15,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,PTPN9,0.47100002,2.6314,0.29689,1,-1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000169418,1,1,0,0,1,1,358386.30063935445,448058.917711015,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NPR1,0.329,2.0927,-0.44956,1,0.5,0.0,,
ENSG00000169826,1,1,1,1,1,1,133119.54945431868,156470.480665571,2022-01-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,CSGALNACT2,0.11400002,1.9283,1.3226,1,1.0,-1.0,,
ENSG00000169891,1,1,1,0,0,1,72098.8014618248,72098.8014618248,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,REPS2,,,,2,-1.0,0.0,,
ENSG00000169894,1,1,1,0,0,1,62421.61027110889,672632.4785173276,2018-08-13,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,MUC3A,-0.301,-8.717,-7.4633,6,0.5,0.5,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000170044,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZPLD1,-0.03699994,0.25918,0.65973,0,0.5,0.5,,
ENSG00000170100,1,1,1,0,1,1,27202.138632157865,27202.138632157865,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF778,-0.89,-3.7592,-3.5631,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of endogenous retroelements by KRAB-ZFP proteins,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9843940
ENSG00000170236,1,1,1,0,0,1,598869.4096893278,598869.4096893278,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,USP50,-0.268,0.67304,0.43347,0,0.5,1.0,,
ENSG00000170255,1,1,0,0,0,1,6375.838537521578,6375.838537521578,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MRGPRX1,-0.81799996,-0.40112,-1.5222,0,,,,
ENSG00000170279,1,1,0,0,0,1,78751.06843456876,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,C7orf33,-0.68499994,1.1751,0.82626,0,1.0,1.0,,
ENSG00000170293,1,1,0,0,0,0,2354.946760250557,2354.946760250557,2021-08-11,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CMTM8,-0.13699996,0.28919,-0.33298,0,0.5,-1.0,,
ENSG00000170381,1,1,1,0,0,1,56101.88409046092,124531.34246675359,2021-02-24,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SEMA3E,0.33200002,1.1196,-0.47113,1,-1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000170458,1,1,1,0,0,1,286678.73247515375,286678.73247515375,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CD14,-0.944,0.88632,0.6765,20,0.5,-1.0,Immune System;Disease;IKK complex recruitment mediated by RIP1,R-HSA-168256;R-HSA-1643685;R-HSA-937041
ENSG00000170542,1,1,1,0,0,1,15231.734702250344,15231.734702250344,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SERPINB9,-0.14900005,0.052371,-0.012873,0,0.5,-1.0,,
ENSG00000170689,1,1,1,0,1,1,80033.9345349278,80033.9345349278,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,HOXB9,0.037999988,-1.2133,-0.91946,0,0.5,0.5,,
ENSG00000170852,2,1,0,0,0,1,727796.3668420183,1076472.0138856068,2021-05-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,KBTBD2,0.59099996,3.5226,0.41903,0,-1.0,-1.0,,
ENSG00000171189,1,1,0,0,0,1,279825.00883385167,279825.00883385167,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GRIK1,0.194,0.96862,-0.084921,2,0.75,0.5,Activation of Ca-permeable Kainate Receptor;Ionotropic activity of kainate receptors;Activation of kainate receptors upon glutamate binding,R-HSA-451308;R-HSA-451306;R-HSA-451326
ENSG00000171219,1,1,1,0,0,1,125821.84557838629,125821.84557838629,2023-03-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,CDC42BPG,-0.039000034,0.04915,-2.2933,0,0.5,0.0,,
ENSG00000171262,1,1,1,0,0,1,2235.282959215934,2235.282959215934,2014-05-29,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,FAM98B,-0.28199995,-0.034487,-0.41164,1,-1.0,-1.0,tRNA processing in the nucleus,R-HSA-6784531
ENSG00000171444,1,1,1,0,0,0,156470.480665571,156470.480665571,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MCC,0.08200002,-1.7514,-1.4125,0,0.5,0.0,,
ENSG00000171517,1,1,0,0,0,1,11823.945078454788,11823.945078454788,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LPAR3,0.37699997,1.4344,0.39396,3,0.5,0.0,Signal Transduction;Lysosphingolipid and LPA receptors,R-HSA-162582;R-HSA-419408
ENSG00000171552,2,1,1,0,0,1,5691.114246503779,521818.7070055739,2023-09-08,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,BCL2L1,0.73899996,2.1944,1.1779,7,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-6785807
ENSG00000171604,1,1,1,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,CXXC5,0.633,2.1111,1.0721,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000171680,1,1,1,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PLEKHG5,0.29400003,0.82345,-1.1068,5,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000171823,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,FBXL14,0.259,2.7005,-1.6808,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000172137,1,1,0,0,0,1,28502.825402836763,37901.36603279362,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CALB2,0.041999996,-0.13079,-0.25372,0,0.5,0.0,,
ENSG00000172296,2,1,1,0,0,1,2201.586503948313,178948.78717378277,2017-12-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,SPTLC3,0.139,1.0492,0.063146,1,-1.0,0.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000172687,1,1,0,0,0,1,254373.32653042395,294387.2978738704,2020-05-06,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ZNF738,,,,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000172738,1,1,0,0,0,0,15186.98390755667,15186.98390755667,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TMEM217,-0.755,1.2805,0.90764,0,0.5,0.5,,
ENSG00000172785,1,1,1,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZNG1A,0.342,1.824,1.5862,0,-1.0,-1.0,,
ENSG00000172840,1,1,1,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PDP2,0.038999975,1.7025,0.33473,1,-1.0,-1.0,Regulation of pyruvate metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism,R-HSA-9861718;R-HSA-204174;R-HSA-70268
ENSG00000172943,1,1,0,0,0,1,195005.6685718255,275021.63051358337,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PHF8,,,,2,-1.0,-1.0,Condensation of Prophase Chromosomes,R-HSA-2299718
ENSG00000172954,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,LCLAT1,0.32,1.2731,0.039639,2,-1.0,-1.0,Synthesis of PA,R-HSA-1483166
ENSG00000173421,2,1,1,0,0,1,192229.28080894228,353105.3286394775,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,IHO1,0.413,1.6122,1.4323,0,1.0,0.0,,
ENSG00000173473,1,1,0,0,0,0,294387.2978738704,515513.2178404211,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SMARCC1,0.63100004,2.0038,-0.92895,9,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Formation of the non-canonical BAF (ncBAF) complex,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9933947
ENSG00000173482,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PTPRM,0.666,3.3309,0.54695,0,-1.0,-1.0,,
ENSG00000173535,2,1,0,0,0,1,30765.13172878222,111599.28184123649,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,TNFRSF10C,-0.472,2.2257,2.7081,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000173715,2,1,1,0,0,1,40455.65678857565,205512.54339369212,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,TOP6BL,-0.15699995,-0.36805,-0.96146,0,-1.0,-1.0,,
ENSG00000173917,1,1,1,0,0,1,360605.992793193,360605.992793193,2022-02-03,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HOXB2,-0.64900005,-1.4621,-0.84246,1,-1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000173960,1,1,1,0,0,0,71391.66598794363,71391.66598794363,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,UBXN2A,-0.12100005,0.8074,0.07623,0,-1.0,-1.0,,
ENSG00000174010,1,1,0,0,0,1,205425.60717824215,205425.60717824215,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,KLHL15,,,,0,0.5,-1.0,,
ENSG00000174165,1,1,1,0,1,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ZDHHC24,-0.50399995,-0.63859,-1.0556,0,-1.0,-1.0,,
ENSG00000174197,3,1,1,0,1,1,236328.22905445524,574170.6270919729,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,4,MGA,0.803,2.1966,0.53351,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8953750
ENSG00000174327,2,1,0,0,0,1,98524.26480884294,294387.2978738704,2020-05-06,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SLC16A13,-0.29900002,1.2195,0.86664,0,0.5,0.0,,
ENSG00000174405,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LIG4,-0.042999983,1.2953,0.46022,2,-1.0,-1.0,Disease;HIV Life Cycle,R-HSA-1643685;R-HSA-162587
ENSG00000174611,1,1,1,0,0,1,208790.0,208790.0,2022-12-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KY,0.23299998,1.6862,1.7064,0,0.75,0.0,,
ENSG00000174721,1,1,0,0,0,0,117707.74532698281,117707.74532698281,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FGFBP3,-0.68499994,-2.5261,-3.1819,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000174744,1,1,1,0,0,1,197485.87952538437,270756.050710225,2023-06-05,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,BRMS1,0.12599999,0.60095,0.94685,2,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000174792,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ODAPH,-0.704,0.3853,-0.76249,0,1.0,0.5,,
ENSG00000174871,1,1,0,0,0,1,2124.717330861909,2124.717330861909,2015-02-02,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CNIH2,0.35000002,2.3708,0.070235,2,1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000175305,2,1,1,0,0,1,195005.6685718255,294387.2978738704,2021-09-30,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CCNE2,0.463,1.1115,0.03891,11,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000175322,1,1,0,0,0,1,890.6902263942574,890.6902263942574,2020-03-06,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF519,-0.724,0.71145,0.80854,2,0.5,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of endogenous retroelements by KRAB-ZFP proteins,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9843940
ENSG00000175470,2,1,1,0,1,1,219793.50457789513,279825.00883385167,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PPP2R2D,0.39499998,1.3828,0.53538,1,0.5,0.0,MASTL Facilitates Mitotic Progression,R-HSA-2465910
ENSG00000175471,2,1,0,0,0,0,260210.21963428933,275021.63051358337,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MCTP1,0.123000026,-0.69539,-1.7451,0,0.5,-1.0,,
ENSG00000175497,1,1,0,0,0,0,170927.93242310252,170927.93242310252,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DPP10,0.622,1.7288,-0.24144,0,0.75,0.5,,
ENSG00000175711,1,1,1,0,0,0,88632.90640619362,88632.90640619362,2024-06-13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,B3GNTL1,-0.37399995,-0.29628,-0.80049,1,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000175868,2,1,1,0,0,1,42518.059957017445,270756.050710225,2018-08-13,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,CALCB,-0.39199996,-0.1422,-0.30353,2,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000176435,2,1,0,0,0,1,84563.14597380339,1424218.0900670097,2020-05-06,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,CLEC14A,-0.883,-0.58302,-2.1367,0,-1.0,0.0,,
ENSG00000176571,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CNBD1,-0.78,-1.36,-0.51155,0,1.0,1.0,,
ENSG00000176624,1,1,0,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,MEX3C,0.28500003,1.5989,-1.1478,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000176974,1,1,1,1,0,0,13298.635084734673,13298.635084734673,2016-06-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,SHMT1,-0.07700002,1.4092,0.87006,2,0.5,-1.0,Metabolism of folate and pterines,R-HSA-196757
ENSG00000177051,1,1,0,0,0,0,254373.32653042395,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FBXO46,0.32999998,1.2172,-2.3084,0,-1.0,-1.0,,
ENSG00000177150,3,1,0,0,0,1,13312.747480325832,191895.42310022408,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,7,FAM210A,0.24000001,0.44527,-0.041596,0,0.5,-1.0,,
ENSG00000177354,1,1,1,0,0,1,545988.1005477115,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,C10orf71,-0.73899996,0.079643,-0.011914,0,0.75,0.5,,
ENSG00000177453,1,1,0,0,0,0,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NIM1K,-0.18900001,0.23898,-0.44204,0,0.75,0.5,,
ENSG00000177455,1,1,0,0,0,1,21408.6965896625,21408.6965896625,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CD19,0.37300003,1.3202,0.19332,6,0.75,0.5,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202
ENSG00000177683,1,1,0,0,0,0,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,THAP5,-0.08899999,1.0914,1.3588,0,-1.0,-1.0,,
ENSG00000177694,1,1,0,0,0,0,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NAALADL2,-0.13699996,-1.1311,-0.082373,0,-1.0,0.0,,
ENSG00000177707,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,NECTIN3,0.684,1.321,-1.0695,2,0.5,0.0,Nectin/Necl  trans heterodimerization,R-HSA-420597
ENSG00000177732,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SOX12,0.110000014,-0.43121,-2.2703,0,-1.0,-1.0,,
ENSG00000177733,1,1,0,0,0,1,545988.1005477115,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HNRNPA0,-0.34899998,3.506,-1.3625,0,-1.0,-1.0,,
ENSG00000177990,1,1,0,0,0,1,98744.41493028583,98744.41493028583,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,DPY19L2,0.268,2.0125,0.96406,0,0.5,0.0,,
ENSG00000178297,2,1,0,0,1,1,269000.70907194994,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,TMPRSS9,-0.32599998,-3.5665,-4.0465,0,0.75,0.5,,
ENSG00000178502,1,1,0,0,0,1,382631.1172224132,382631.1172224132,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,KLHL11,0.353,3.5609,0.55706,2,-1.0,0.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000178607,1,1,0,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ERN1,0.502,2.9016,-0.05016,1,0.5,-1.0,,
ENSG00000178685,1,1,1,0,1,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PARP10,0.089999974,0.88293,-0.066465,3,-1.0,-1.0,Translation of Structural Proteins_9683701;Disease,R-HSA-9683701;R-HSA-1643685
ENSG00000178718,1,1,1,0,0,1,270359.2512882127,270359.2512882127,2023-05-27,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RPP25,-0.722,-1.4028,-1.3986,2,-1.0,0.0,rRNA processing;tRNA processing in the nucleus,R-HSA-72312;R-HSA-6784531
ENSG00000178814,1,1,0,0,0,1,332375.5317723021,332375.5317723021,2021-09-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,OPLAH,-0.16299999,-1.8665,-3.044,2,0.5,0.0,Glutathione conjugation;Disease;Glutathione synthesis and recycling;Phase II - Conjugation of compounds,R-HSA-156590;R-HSA-1643685;R-HSA-174403;R-HSA-156580
ENSG00000178922,1,1,1,0,0,1,383158.3001114715,448058.917711015,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,HYI,-0.597,-2.6228,-2.1459,0,-1.0,-1.0,,
ENSG00000179021,1,1,0,0,0,1,360605.992793193,360605.992793193,2022-02-03,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,C3orf38,0.07999998,0.93517,0.0636,0,-1.0,-1.0,,
ENSG00000179023,1,1,1,0,1,1,141076.9910731678,141076.9910731678,2020-05-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KLHDC7A,-0.842,-0.65364,0.070795,0,0.5,0.0,,
ENSG00000179889,1,1,1,0,0,0,226155.40757232966,226155.40757232966,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PDXDC1,0.366,2.463,1.4665,0,-1.0,-1.0,,
ENSG00000179930,1,1,0,0,0,1,220320.9576294899,220320.9576294899,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZNF648,-0.849,-1.2349,-1.2199,0,,,,
ENSG00000180011,1,1,0,0,0,0,232586.34864014547,232586.34864014547,2021-01-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PTGR3,-0.16600001,-0.45794,-0.68554,0,-1.0,-1.0,,
ENSG00000180053,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NKX2-6,-0.68700004,-1.5394,-1.351,0,0.5,1.0,,
ENSG00000180089,1,1,1,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TMEM86B,-0.816,-1.0639,-1.9688,1,0.5,0.0,Acyl chain remodelling of PC,R-HSA-1482788
ENSG00000180304,1,1,0,0,0,1,258213.8601133611,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OAZ2,-0.15999997,0.2042,-0.74352,1,-1.0,-1.0,Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines,R-HSA-350562;R-HSA-351202
ENSG00000180447,1,1,0,0,0,1,414433.58532016096,414433.58532016096,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GAS1,-0.79499996,-3.137,-4.8601,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000180938,1,1,0,0,0,1,13686.45239978903,220837.49604317299,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ZNF572,-0.51600003,1.1824,1.0854,0,-1.0,0.0,,
ENSG00000180974,2,1,0,0,1,1,3841.552411204158,4717.2370452039695,2018-09-04,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,OR52E4,-0.95500004,-0.72111,-1.1176,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000181061,1,1,1,0,0,0,195005.6685718255,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HIGD1A,-0.44099998,0.48464,0.32838,2,-1.0,-1.0,Complex IV assembly,R-HSA-9864848
ENSG00000181104,1,1,0,0,0,1,315325.55297640257,315325.55297640257,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,F2R,0.120000005,1.5448,0.4372,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000181234,1,1,0,0,0,0,355284.1215006515,355284.1215006515,2025-03-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM132C,0.28100002,0.39858,-0.94803,0,0.5,0.0,,
ENSG00000181282,2,1,0,0,0,1,39979.04830391424,135593.17169557852,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,5,OR5AK3P,,,,0,,,,
ENSG00000181619,1,1,0,0,1,1,151416.12986435954,151416.12986435954,2023-10-16,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPR135,-0.944,-2.0994,-2.1888,0,-1.0,0.0,,
ENSG00000181631,1,1,0,0,0,1,197485.87952538437,197485.87952538437,2023-06-05,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,P2RY13,-0.13300002,0.58515,0.43339,2,0.5,0.0,Signal Transduction;P2Y receptors;Nucleotide-like (purinergic) receptors,R-HSA-162582;R-HSA-417957;R-HSA-418038
ENSG00000181788,2,1,1,0,0,1,20455.424315535507,521818.7070055739,2019-11-22,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,SIAH2,0.53999996,2.7892,0.21623,4,-1.0,-1.0,Immune System;Developmental Biology;Post-translational protein modification,R-HSA-168256;R-HSA-1266738;R-HSA-597592
ENSG00000181885,1,1,1,0,0,0,100075.58738100652,100075.58738100652,2024-04-26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CLDN7,-0.19799995,0.5802,-0.27629,2,0.5,0.0,Developmental Biology;Tight junction interactions,R-HSA-1266738;R-HSA-420029
ENSG00000181963,1,1,0,0,1,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR52K2,-0.41700006,-1.1187,-1.9476,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000182107,1,1,0,0,0,1,278190.43024910334,406587.2658730814,2023-08-23,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TMEM30B,-0.643,-0.54114,-0.96403,0,-1.0,0.0,,
ENSG00000182156,2,1,1,1,1,1,4518.532006719214,13756.062794259458,2022-08-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,4,ENPP7,-0.47099996,0.94102,1.1557,1,1.0,0.5,,
ENSG00000182183,2,1,0,0,0,1,117707.74532698281,645988.1975077938,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SHISAL2A,-0.88,-0.047637,0.53705,0,0.5,0.5,,
ENSG00000182326,1,1,0,1,1,1,122069.83349127392,394357.452283155,2017-12-06,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,C1S,0.21700001,2.0076,0.72888,3,1.0,-1.0,Immune System,R-HSA-168256
ENSG00000182379,1,1,1,0,0,1,87545.45580019058,87545.45580019058,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NXPH4,-0.042000055,-0.86888,-1.9658,0,0.5,0.0,,
ENSG00000182389,1,1,0,0,0,1,901.5722738799661,901.5722738799661,2013-09-11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CACNB4,0.222,1.9354,0.3022,2,0.75,0.0,Presynaptic depolarization and calcium channel opening;Developmental Biology,R-HSA-112308;R-HSA-1266738
ENSG00000182472,1,1,1,0,0,1,18990.626824574996,18990.626824574996,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CAPN12,-0.398,-1.9667,-2.6137,1,0.75,0.0,,
ENSG00000182575,1,1,0,0,0,1,51573.04760983911,51573.04760983911,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NXPH3,0.288,1.2207,1.8131,0,0.5,0.0,,
ENSG00000182600,1,1,1,0,0,1,103877.27822338727,323648.5577791949,2015-07-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,6,SNORC,-0.972,-2.6529,-3.2505,0,0.75,0.0,,
ENSG00000182631,2,1,0,0,0,1,28863.30790298137,77544.39441764928,2022-12-10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RXFP3,-0.53699994,-0.32161,-1.6305,2,,,Signal Transduction,R-HSA-162582
ENSG00000182768,1,1,1,0,0,1,101791.22293364709,101791.22293364709,2021-09-30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NGRN,-0.61600006,-0.39323,0.2346,0,0.5,-1.0,rRNA modification in the mitochondrion;rRNA processing in the mitochondrion;rRNA processing,R-HSA-6793080;R-HSA-8868766;R-HSA-72312
ENSG00000183035,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CYLC1,,,,0,1.0,1.0,,
ENSG00000183067,1,1,0,0,0,1,7987.2,7987.2,2023-10-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IGSF5,-0.46599996,0.6898,0.49655,0,-1.0,0.5,,
ENSG00000183379,1,1,0,0,0,1,112237.0074902361,112237.0074902361,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SYNDIG1L,-0.17700005,0.025905,-0.23166,0,1.0,0.5,,
ENSG00000183421,5,1,0,0,0,1,43372.03071242184,298389.02809443185,2018-08-13,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,RIPK4,0.42299998,2.2992,-0.017557,0,0.5,0.0,,
ENSG00000183542,1,1,1,0,1,1,2491.407942238267,2491.407942238267,2013-01-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KLRC4,0.089999974,0.81136,0.72926,0,0.5,0.5,,
ENSG00000183722,1,1,1,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,LHFPL6,0.18900001,0.94534,-0.13937,0,-1.0,-1.0,,
ENSG00000183783,2,1,0,0,0,1,574170.6270919729,574170.6270919729,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,KCTD8,-0.20000005,-0.50126,-0.86991,0,0.75,0.0,,
ENSG00000184005,1,1,1,0,0,0,1470466.6505612188,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ST6GALNAC3,0.0059999824,0.77392,0.50312,5,-1.0,0.0,Translation of Structural Proteins_9683701;Disease;Post-translational protein modification,R-HSA-9683701;R-HSA-1643685;R-HSA-597592
ENSG00000184232,1,1,1,1,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,OAF,0.049000025,0.37203,-0.35432,0,1.0,-1.0,,
ENSG00000184350,1,1,1,0,1,1,54272.859706395815,360605.992793193,2021-04-08,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,MRGPRE,,-1.2739,-1.7685,0,,,,
ENSG00000184389,1,1,1,0,0,1,336609.70876314654,336609.70876314654,2018-05-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,A3GALT2,-0.52900004,-4.0799,-3.997,0,,,,
ENSG00000184584,2,1,0,0,0,1,11105.796116504855,77165.96432486812,2014-08-17,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,STING1,0.15399998,2.1644,0.69471,7,-1.0,0.0,Immune System;IRF3-mediated induction of type I IFN;Disease,R-HSA-168256;R-HSA-3270619;R-HSA-1643685
ENSG00000184613,1,1,0,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NELL2,0.505,1.8525,0.47488,1,0.5,0.0,Developmental Biology;Regulation of commissural axon pathfinding by SLIT and ROBO,R-HSA-1266738;R-HSA-428542
ENSG00000184672,1,1,0,0,0,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RALYL,-0.06500006,0.42874,0.48017,0,0.5,0.0,,
ENSG00000184897,1,1,0,0,0,1,756470.9740366563,756470.9740366563,2025-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,H1-10,-0.83000004,-1.849,-3.5039,0,0.5,-1.0,,
ENSG00000184908,1,1,0,0,1,1,232586.34864014547,521818.7070055739,2021-01-04,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CLCNKB,-0.07200003,1.2899,0.087947,1,1.0,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000184979,1,1,1,0,1,1,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,USP18,0.541,1.9593,1.3688,5,-1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-1169408;R-HSA-597592
ENSG00000185008,1,1,0,1,0,0,272025.74568937684,1424218.0900670097,2018-10-08,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ROBO2,0.588,1.8944,-0.54742,6,0.5,0.0,Developmental Biology;Regulation of commissural axon pathfinding by SLIT and ROBO;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-428542;R-HSA-9010553
ENSG00000185112,1,1,0,0,0,1,51940.508691272094,51940.508691272094,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FAM43A,-0.45799994,-1.204,-3.1828,0,0.5,0.0,,
ENSG00000185324,1,1,0,0,0,1,1816.5514537732768,8198.377278833237,2009-07-05,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CDK10,-0.34399998,-1.8828,-2.1741,0,-1.0,-1.0,,
ENSG00000185519,1,1,0,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM131C,-0.059000015,0.57874,1.0009,0,1.0,0.0,,
ENSG00000185585,1,1,1,0,0,1,47408.95172709719,47408.95172709719,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,OLFML2A,-0.00999999,-0.16444,0.34658,0,-1.0,0.0,,
ENSG00000185664,1,1,1,0,0,0,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,PMEL,0.035000026,1.7604,0.9851,1,0.75,0.0,Developmental Biology,R-HSA-1266738
ENSG00000185681,1,1,0,0,0,1,25589.049152779724,25589.049152779724,2019-07-17,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MORN5,-0.245,0.39945,0.25082,0,0.5,0.0,,
ENSG00000185728,1,1,0,0,0,0,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,YTHDF3,0.728,2.8108,-0.78234,0,-1.0,-1.0,,
ENSG00000185860,1,1,0,0,0,1,44660.84794838759,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CCDC190,-0.22399998,-0.061263,-0.029753,0,0.5,0.5,,
ENSG00000185960,1,1,0,0,0,1,47692.964985095256,47692.964985095256,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,SHOX,,,,0,-1.0,1.0,,
ENSG00000185973,1,1,0,0,0,0,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TMLHE,,,,1,-1.0,-1.0,,
ENSG00000185985,1,1,0,0,0,1,197775.78125685986,197775.78125685986,2022-10-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLITRK2,,,,1,0.5,0.5,Receptor-type tyrosine-protein phosphatases,R-HSA-388844
ENSG00000186190,1,1,0,0,0,1,187203.10687937262,187203.10687937262,2024-01-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BPIFB3,-0.15799999,-0.24215,0.29016,0,,,,
ENSG00000186226,1,1,0,0,0,1,112025.85662838118,112025.85662838118,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LCE1E,-0.635,-0.15181,-0.60023,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000186452,1,1,0,0,0,1,756470.9740366563,756470.9740366563,2025-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMPRSS12,-0.49399996,-0.21271,0.37137,0,1.0,1.0,,
ENSG00000186526,1,1,0,0,1,1,83896.55822718568,83896.55822718568,2023-02-07,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,CYP4F8,-0.232,0.3925,-0.22976,3,1.0,0.5,Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonate metabolism,R-HSA-211979;R-HSA-2142691;R-HSA-2142753
ENSG00000186628,1,1,0,0,0,1,515513.2178404211,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FSD2,-0.09800005,0.19533,-0.68787,0,0.75,0.5,,
ENSG00000186660,1,1,0,0,1,0,32254.717802479194,32254.717802479194,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZFP91,0.763,1.0971,-2.1006,0,-1.0,-1.0,,
ENSG00000186765,2,1,0,0,1,1,157962.97296027775,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,6,FSCN2,-0.781,-2.78,-2.7492,2,0.5,0.5,,
ENSG00000187010,1,1,1,0,0,0,62043.890063935265,62043.890063935265,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RHD,0.25800002,2.2633,2.0562,1,1.0,0.5,,
ENSG00000187116,1,1,1,0,0,1,332375.5317723021,332375.5317723021,2021-09-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LILRA5,-0.09399998,0.85446,0.32249,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000187244,2,1,0,0,0,1,170842.91114447502,283145.34784240765,2022-04-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,BCAM,-0.102,-0.54318,-0.94152,0,0.5,-1.0,,
ENSG00000187513,1,1,1,0,1,1,26890.87319873561,40045.802595434,2024-07-19,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GJA4,0.21700001,1.6935,1.2493,1,-1.0,0.0,Gap junction assembly;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-190861;R-HSA-157858;R-HSA-190828
ENSG00000187642,1,1,1,0,1,1,545988.1005477115,645988.1975077938,2023-01-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PERM1,-0.48300004,-1.5295,-2.9376,1,0.75,0.5,,
ENSG00000187754,1,1,0,0,0,1,232586.34864014547,232586.34864014547,2021-01-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SSX7,,,,0,,,,
ENSG00000187800,1,1,1,1,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,PEAR1,-0.051,-0.2009,-0.84372,0,-1.0,0.0,,
ENSG00000188026,1,1,0,0,0,1,153400.07480928372,153400.07480928372,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RILPL1,0.051999986,1.1979,-0.091259,0,0.5,-1.0,,
ENSG00000188037,1,1,0,0,1,0,18548.827831829047,18548.827831829047,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CLCN1,-0.026000023,0.96457,0.14874,1,1.0,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000188343,2,1,0,0,0,1,960369.5592648841,1778690.168860174,2021-05-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,CIBAR1,-0.059000015,0.72079,0.29881,0,0.5,-1.0,,
ENSG00000188487,1,1,0,0,0,1,360605.992793193,360605.992793193,2022-02-03,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,INSC,-0.38300002,0.11487,0.71664,0,1.0,0.5,,
ENSG00000188523,1,1,0,0,0,1,353105.3286394775,353105.3286394775,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CFAP77,-0.09200001,0.21054,-0.010263,0,0.75,0.5,,
ENSG00000188770,2,1,0,0,0,1,260210.21963428933,1424218.0900670097,2023-01-18,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,OPTC,-0.232,0.50844,0.81861,1,,,,
ENSG00000188786,1,1,1,0,0,1,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,MTF1,0.583,3.4757,1.1351,3,0.5,-1.0,Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-8957322;R-HSA-1655829
ENSG00000188816,1,1,0,0,0,0,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,HMX2,-0.21399999,-1.2266,-0.7169,0,0.75,0.5,,
ENSG00000188859,1,1,0,0,0,1,100711.28404230655,100711.28404230655,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM78B,0.102,1.2467,-0.08736,0,-1.0,1.0,,
ENSG00000188906,2,1,1,0,1,1,1827.9898862199748,159189.58506586426,2008-06-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,9,LRRK2,0.222,1.6639,0.2502,1,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000188931,1,1,0,0,0,1,28923.750134754748,28923.750134754748,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CFAP126,-0.59099996,1.2502,0.79998,0,0.5,0.0,,
ENSG00000188997,1,1,0,0,0,0,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,KCTD21,-0.12399995,0.98956,0.14365,0,-1.0,-1.0,,
ENSG00000189099,1,1,1,0,1,1,197485.87952538437,197485.87952538437,2023-06-05,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PRSS48,-0.15600002,0.5947,0.1308,0,,,,
ENSG00000189120,1,1,0,0,0,1,2324.6716622691292,2324.6716622691292,2023-04-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SP6,0.12699997,0.3429,-0.14576,0,0.5,0.0,,
ENSG00000189167,1,1,0,0,0,1,55416.28042655659,131525.74533408263,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,ZAR1L,0.09399998,0.41152,-1.2594,0,,,,
ENSG00000189253,1,1,0,0,0,1,218859.40268188025,218859.40268188025,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TRIM64B,0.88199997,5.4084,4.6439,0,1.0,1.0,,
ENSG00000189362,1,1,1,0,0,1,11664.35640110979,22938.587937312015,2021-02-03,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,NEMP2,-0.35000002,0.88329,-0.58055,0,-1.0,0.0,,
ENSG00000196072,1,1,1,0,0,1,45951.29495376284,45951.29495376284,2017-05-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,BLOC1S2,-0.08500004,0.98512,0.1246,0,-1.0,-1.0,,
ENSG00000196345,1,1,0,0,1,0,684816.7338614308,1076472.0138856068,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,ZKSCAN7,0.19599998,1.3155,0.1513,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000196591,1,1,0,0,0,1,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,HDAC2,0.633,1.843,-0.37969,22,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Regulation of endogenous retroelements by KRAB-ZFP proteins;Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-427389;R-HSA-9843940;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-73762;R-HSA-73864;R-HSA-73854;R-HSA-9006934;R-HSA-5663202;R-HSA-597592
ENSG00000196678,1,1,1,0,0,0,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ERI2,0.018999994,1.7558,1.8806,0,-1.0,-1.0,,
ENSG00000196700,2,1,1,0,0,0,110500.54208463429,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,4,ZNF512B,0.587,1.4329,-1.1492,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000196793,1,1,1,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF239,0.194,0.74763,0.25388,0,-1.0,0.0,,
ENSG00000196865,1,1,0,0,0,1,14835.589811498108,14835.589811498108,2024-07-19,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NHLRC2,0.27600002,0.745,-0.19569,1,-1.0,-1.0,,
ENSG00000196981,1,1,1,0,0,1,303059.79257468163,303059.79257468163,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,WDR5B,-0.00999999,0.67003,0.23468,0,-1.0,-1.0,,
ENSG00000197016,1,1,1,0,0,1,7208.2506652111615,7208.2506652111615,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZNF470,-0.36899996,-0.51213,-0.091513,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000197077,1,1,0,0,0,1,2521.196518187979,2521.196518187979,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KIAA1671,0.47500002,0.22796,-0.29481,0,-1.0,0.0,,
ENSG00000197106,2,1,0,0,0,1,28863.30790298137,77544.39441764928,2022-12-10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC6A17,0.549,3.6137,1.1572,0,0.75,0.5,,
ENSG00000197111,1,1,1,0,0,0,286678.73247515375,286678.73247515375,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PCBP2,0.861,4.6626,-0.31555,4,-1.0,-1.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000197114,1,1,0,0,0,1,220837.49604317299,220837.49604317299,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZGPAT,-0.10099995,-0.61565,-1.85,0,1.0,-1.0,,
ENSG00000197122,1,1,0,0,0,1,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SRC,0.617,2.8596,-0.40727,68,-1.0,0.0,Signal Transduction;Ephrin signaling;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;ADP signalling through P2Y purinoceptor 1;Gene expression (Transcription);Signal amplification;p38MAPK events;Regulation of commissural axon pathfinding by SLIT and ROBO;Activated NTRK2 signals through FYN;Disease;Downregulation of ERBB4 signaling;Receptor Mediated Mitophagy;Recycling pathway of L1;EPH-ephrin mediated repulsion of cells;Gap junction trafficking and regulation;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-3928664;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-418592;R-HSA-74160;R-HSA-392518;R-HSA-171007;R-HSA-428542;R-HSA-9032500;R-HSA-1643685;R-HSA-1253288;R-HSA-8934903;R-HSA-437239;R-HSA-3928665;R-HSA-157858;R-HSA-9006934;R-HSA-5663202;R-HSA-8878159
ENSG00000197165,1,1,1,0,1,1,322220.1169395476,322220.1169395476,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SULT1A2,-0.23699999,0.40941,0.27506,1,0.75,0.0,Cytosolic sulfonation of small molecules;Phase II - Conjugation of compounds,R-HSA-156584;R-HSA-156580
ENSG00000197168,1,1,0,0,0,0,58331.23271678036,160010.51072069994,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,NEK5,0.06300002,1.2369,0.5282,0,0.5,0.5,,
ENSG00000197273,1,1,0,0,0,0,83896.55822718568,83896.55822718568,2023-02-07,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,GUCA2A,-0.96000004,-0.78058,-0.36052,1,1.0,0.5,Digestion and absorption;Digestion,R-HSA-8963743;R-HSA-8935690
ENSG00000197283,1,1,0,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SYNGAP1,0.873,7.6898,2.77,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000197323,1,1,0,0,0,1,215157.94798738702,215157.94798738702,2024-07-27,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRIM33,0.77,2.7485,-2.6025,2,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-2173793
ENSG00000197586,1,1,0,0,0,1,82295.36127718941,82295.36127718941,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ENTPD6,0.051,0.40707,0.059765,1,-1.0,-1.0,Metabolism of nucleotides,R-HSA-15869
ENSG00000197653,1,1,0,0,0,0,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DNAH10,0.23699999,3.5163,2.1261,0,0.5,0.5,,
ENSG00000197818,1,1,1,0,0,1,87380.83817331228,95413.07358079177,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,SLC9A8,-0.00999999,1.9447,0.51442,1,-1.0,-1.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000197948,2,1,0,0,0,1,160062.83409140486,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,3,FCHSD1,-0.319,0.51675,1.44,0,0.5,-1.0,,
ENSG00000198113,1,1,0,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TOR4A,-0.964,-2.5853,-4.5148,1,-1.0,0.0,,
ENSG00000198173,1,1,0,0,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,FAM47C,,,,0,1.0,1.0,,
ENSG00000198453,1,1,1,0,0,1,78751.06843456876,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZNF568,-0.03400004,2.1464,1.439,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000198455,1,1,0,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZXDB,,,,0,-1.0,-1.0,,
ENSG00000198483,1,1,0,0,0,1,141076.9910731678,141076.9910731678,2020-05-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ANKRD35,-0.07099998,0.28094,0.31164,0,0.5,0.0,,
ENSG00000198720,1,1,1,0,0,0,122069.83349127392,122069.83349127392,2017-12-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ANKRD13B,0.328,1.4625,-0.69267,0,0.5,0.0,,
ENSG00000198755,1,1,1,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,RPL10A,0.27999997,2.9581,0.51679,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000198829,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,SUCNR1,-0.97,0.8835,-0.38454,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000198909,1,1,1,0,0,1,12724.75719835148,12724.75719835148,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MAP3K3,0.791,3.3165,1.2049,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000198937,1,1,0,0,0,1,40153.0728800662,433862.5685735124,2017-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,CCDC167,-0.702,0.13261,-0.046811,0,-1.0,-1.0,,
ENSG00000203805,1,1,0,0,0,1,1863.980686695279,1863.980686695279,2021-11-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PLPP4,-0.018000007,1.8546,0.29482,1,1.0,1.0,Immune System,R-HSA-168256
ENSG00000203867,3,1,0,0,0,0,19318.919999180947,645988.1975077938,2022-03-04,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,RBM20,0.43199998,0.73614,0.73239,0,0.5,0.0,,
ENSG00000204219,1,1,1,0,0,0,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TCEA3,-0.062999964,0.98212,-0.060187,0,0.5,0.0,,
ENSG00000204278,1,1,0,0,0,1,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TMEM235,-0.73599994,-1.3833,-1.0771,0,0.75,0.5,,
ENSG00000204897,1,1,0,0,0,1,15223.454539395489,15223.454539395489,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KRT25,-0.003000021,0.63462,0.56097,2,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000204954,1,1,1,0,0,0,109001.36551434857,109001.36551434857,2022-10-12,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UQCC6,-0.87899995,-0.83152,0.37757,1,0.5,-1.0,,
ENSG00000204962,1,1,0,0,1,0,715125.8126650311,1122672.658801146,2021-05-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,PCDHA8,-0.036000013,-0.13706,-0.9665,0,0.5,1.0,,
ENSG00000205085,1,1,0,0,1,0,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GARIN1A,-0.35500002,-1.0173,-0.76723,0,1.0,0.0,,
ENSG00000205108,1,1,0,0,0,1,83932.6290685273,83932.6290685273,2020-12-11,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SPATA31F1,0.59000003,3.461,3.3729,0,1.0,1.0,,
ENSG00000205502,1,1,1,0,0,1,38886.589732507324,38886.589732507324,2016-01-28,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,C2CD4B,,-4.76,-5.8247,0,1.0,0.0,,
ENSG00000205929,1,1,0,0,0,1,405722.3511294316,405722.3511294316,2021-06-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,EPCIP,-0.653,1.3745,1.6322,0,0.5,0.5,,
ENSG00000206190,1,1,0,0,0,1,11095.106184492126,11095.106184492126,2020-10-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ATP10A,0.123000026,0.49657,-0.29845,1,-1.0,0.0,,
ENSG00000206527,1,1,1,0,0,0,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HACD2,0.059000015,-0.45288,-0.53043,1,-1.0,-1.0,Synthesis of very long-chain fatty acyl-CoAs;Fatty acyl-CoA biosynthesis,R-HSA-75876;R-HSA-75105
ENSG00000211460,1,1,0,0,0,1,353105.3286394775,353105.3286394775,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TSN,0.691,2.7809,-0.041218,1,-1.0,-1.0,Gene expression (Transcription);Gene Silencing by RNA,R-HSA-74160;R-HSA-211000
ENSG00000213024,4,1,1,0,1,1,203090.6413944402,383158.3001114715,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NUP62,0.842,0.89112,0.24779,29,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Postmitotic nuclear pore complex (NPC) reformation;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-9615933;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000213079,1,1,1,0,0,1,142744.17442731425,295550.4496098593,2019-07-30,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,3,SCAF8,0.72,1.1936,-0.13313,0,-1.0,-1.0,,
ENSG00000213619,1,1,0,0,0,0,56614.28807963426,56614.28807963426,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NDUFS3,0.144,0.46001,-0.47593,4,0.5,-1.0,Signal Transduction;Complex I biogenesis,R-HSA-162582;R-HSA-6799198
ENSG00000213625,1,1,1,0,0,1,3193.837030670892,3193.837030670892,2020-04-13,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LEPROT,0.38200003,0.32969,-0.40892,0,-1.0,-1.0,,
ENSG00000213639,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PPP1CB,0.753,4.74,0.086297,12,-1.0,-1.0,Signal Transduction;Phosphorylation and nuclear translocation of the CRY:PER:kinase complex;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-9931530;R-HSA-1643685;R-HSA-5663202
ENSG00000213967,1,1,0,0,0,1,17115.61307125707,17115.61307125707,2017-06-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF726,-0.84099996,-2.4687,-2.0804,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000214194,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SMIM30,,,,0,-1.0,-1.0,,
ENSG00000214414,1,1,0,0,1,0,225499.30235578204,225499.30235578204,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRIM77,-0.13800001,1.1724,0.6622,0,,,,
ENSG00000214688,1,1,1,0,0,1,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,C10orf105,-0.96800005,-1.0127,-1.4279,0,1.0,0.5,,
ENSG00000214711,1,1,0,0,0,1,2068.9726415094337,6762.688254947314,2014-07-13,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CAPN14,-0.10899997,0.32892,-0.16698,1,1.0,0.5,,
ENSG00000214866,2,1,0,0,0,1,40153.0728800662,433862.5685735124,2017-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,8,DCDC2C,-0.49800003,-0.57573,-1.4932,0,0.75,0.5,,
ENSG00000214960,1,1,1,0,0,1,73985.70318108075,187674.40497870417,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,CRPPA,-0.462,-1.6315,-2.0598,0,0.5,0.0,Matriglycan biosynthesis on DAG1;DAG1 glycosylations;Post-translational protein modification,R-HSA-9939291;R-HSA-8931838;R-HSA-597592
ENSG00000215012,2,1,1,0,0,1,28101.363988919667,100711.28404230655,2018-06-11,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,RTL10,,0.23004,-0.10187,0,-1.0,-1.0,,
ENSG00000219200,1,1,1,0,0,0,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RNASEK,-0.194,0.89182,0.36361,0,-1.0,-1.0,,
ENSG00000219545,1,1,0,0,0,0,25352.520712885682,25352.520712885682,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UMAD1,,,,0,-1.0,-1.0,,
ENSG00000221840,1,1,0,0,0,0,107949.90929360976,107949.90929360976,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR4A5,,-5.0471,-4.8072,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000221866,1,1,0,0,0,1,16032.459098045585,16032.459098045585,2020-10-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,PLXNA4,0.71099997,5.5996,-0.58777,5,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000221989,1,1,0,0,0,1,756470.9740366563,756470.9740366563,2025-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR2A2,,0.24267,-0.34725,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000229894,1,1,0,0,1,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,GK3,-0.25800002,0.66977,0.63066,1,1.0,1.0,,
ENSG00000230601,2,1,0,0,0,1,9906.450032092875,10897.347517404974,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,TEX48,-0.56299996,0.47285,0.44252,0,1.0,1.0,,
ENSG00000234224,1,1,0,0,0,1,87748.84971094332,106745.15703198666,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TMEM229A,-0.13800001,-0.20823,-0.97513,0,0.5,0.5,,
ENSG00000235106,1,1,1,0,0,1,515513.2178404211,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,BRD3OS,,,,0,-1.0,-1.0,,
ENSG00000237136,1,1,0,0,0,1,108816.31098183901,108816.31098183901,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,C4orf51,-0.485,-0.09251,-1.0486,0,1.0,1.0,,
ENSG00000239282,1,1,1,0,0,1,21408.6965896625,21408.6965896625,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CASTOR1,0.09399998,1.2622,0.28946,1,0.5,-1.0,,
ENSG00000240747,2,1,0,0,0,1,49127.555514088446,49127.555514088446,2023-04-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KRBOX1,-0.801,-0.88754,-0.10207,0,1.0,0.0,,
ENSG00000240891,1,1,1,0,0,1,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PLCXD2,0.004000008,0.4663,0.88213,0,0.5,0.5,,
ENSG00000241484,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ARHGAP8,-0.648,-5.199,-4.4049,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000241837,1,1,0,0,0,1,17601.10520641419,165324.69367515197,2022-03-07,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ATP5PO,0.13,0.51708,-0.36682,3,0.5,-1.0,Formation of ATP by chemiosmotic coupling;Cristae formation,R-HSA-163210;R-HSA-8949613
ENSG00000242802,1,1,0,0,0,1,286746.1002745869,286746.1002745869,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,AP5Z1,-0.64100003,-6.1066,-6.3235,0,-1.0,0.0,,
ENSG00000243667,1,1,0,0,0,1,356440.71671986027,356440.71671986027,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,DNAAF10,0.009000003,0.95957,0.57814,0,-1.0,-1.0,,
ENSG00000244005,1,1,0,0,0,0,46601.3671671619,46601.3671671619,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NFS1,0.33099997,1.2628,-0.13667,4,-1.0,-1.0,Maturation of TCA enzymes and regulation of TCA cycle;Citric acid cycle (TCA cycle);Mitochondrial iron-sulfur cluster biogenesis,R-HSA-9854311;R-HSA-71403;R-HSA-1362409
ENSG00000244486,1,1,0,1,0,1,143413.24457139417,143413.24457139417,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SCARF2,0.008000016,-1.4181,-3.7718,0,-1.0,0.0,,
ENSG00000247626,1,1,0,0,0,0,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MARS2,0.047999978,1.1414,-0.06001,1,-1.0,0.0,tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-379726;R-HSA-72766
ENSG00000250254,1,1,0,0,0,1,37609.999325948724,47017.25726842515,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,PTTG2,-0.94500005,0.30279,-0.14706,0,-1.0,0.5,,
ENSG00000250719,1,1,0,0,0,1,167710.975815407,167710.975815407,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,P3R3URF,-0.398,0.033957,-0.061279,0,1.0,1.0,,
ENSG00000251258,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RFPL4B,,0.58406,0.73812,0,1.0,1.0,,
ENSG00000253457,1,1,1,0,0,1,86992.9057658324,86992.9057658324,2024-02-01,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SMIM18,-0.44299996,0.90063,0.21632,0,0.75,0.5,,
ENSG00000254087,1,1,0,0,0,1,29997.958300125974,29997.958300125974,2023-06-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,LYN,0.718,3.9975,0.55204,36,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Platelet Adhesion to exposed collagen;Regulation of signaling by CBL;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-75892;R-HSA-912631;R-HSA-3928665;R-HSA-9006934;R-HSA-5663202
ENSG00000254685,1,1,0,0,0,1,294763.3750742061,294763.3750742061,2021-02-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,FPGT,-0.11800003,-0.41973,-0.63546,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000255009,2,1,0,0,0,1,28863.30790298137,77544.39441764928,2022-12-10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,UBTFL1,0.01700002,2.068,1.6886,0,,,,
ENSG00000255501,1,1,0,0,0,1,286746.1002745869,286746.1002745869,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CARD18,-0.54499996,-0.7853,0.28446,0,1.0,0.5,,
ENSG00000256043,1,1,0,0,0,1,3400.4411583487367,3400.4411583487367,2014-08-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CTSO,-0.50600004,-1.4696,-1.1994,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000256162,1,1,1,0,0,1,43732.839609234245,43732.839609234245,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,SMLR1,-0.11500001,0.099856,0.082106,0,1.0,0.5,,
ENSG00000256525,1,1,1,0,0,1,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,POLG2,-0.15600002,0.3348,0.043068,2,-1.0,-1.0,,
ENSG00000258818,1,1,1,1,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,RNASE4,-0.88900006,0.08025,-1.3563,0,1.0,-1.0,,
ENSG00000259417,3,1,1,0,0,1,138890.6106237268,545988.1005477115,2023-01-18,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CTXND1,,,,0,0.5,0.5,,
ENSG00000259916,1,1,0,0,0,0,14273.936507230454,14273.936507230454,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,AQP7B,-0.796,-1.7283,-0.86677,0,1.0,0.5,,
ENSG00000260027,1,1,1,0,0,0,183098.6090161679,183098.6090161679,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HOXB7,-0.20700002,-0.82236,-0.93339,0,1.0,0.0,,
ENSG00000263429,3,1,0,0,1,1,35755.26193984629,124801.11117486731,2018-12-03,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,TMEM238L,,,,0,0.75,0.0,,
ENSG00000264364,1,1,0,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DYNLL2,0.538,2.8055,0.59518,15,-1.0,-1.0,Signal Transduction;Immune System;Disease;Aggrephagy;Intraflagellar transport;Golgi-to-ER retrograde transport;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9646399;R-HSA-5620924;R-HSA-8856688;R-HSA-597592
ENSG00000265491,1,1,1,0,0,1,33670.70607708678,33670.70607708678,2015-04-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RNF115,-0.20899999,-0.10821,0.090982,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000265972,1,1,0,0,0,1,141076.9910731678,141076.9910731678,2020-05-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TXNIP,0.291,-0.64546,-2.0519,4,-1.0,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000266173,1,1,1,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,STRADA,0.351,1.9204,0.87092,1,-1.0,-1.0,Signal Transduction;Energy dependent regulation of mTOR by LKB1-AMPK;MTOR signalling,R-HSA-162582;R-HSA-380972;R-HSA-165159
ENSG00000266524,1,1,0,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GDF10,-0.113000035,-1.5894,-1.1405,0,0.5,0.0,,
ENSG00000268041,1,1,0,0,0,1,251325.91086204,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ERFL,0.397,1.7464,0.17963,0,0.5,0.5,,
ENSG00000268104,1,1,0,0,0,1,3725.450516986706,3725.450516986706,2019-02-26,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC6A14,,,,3,0.5,0.0,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000269067,1,1,0,0,1,1,11343.053400273848,11343.053400273848,2017-06-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF728,-0.546,0.16608,1.1338,0,1.0,0.5,,
ENSG00000269113,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TRABD2B,0.29000002,1.0128,-0.14169,0,0.5,0.0,,
ENSG00000269404,2,1,1,0,1,1,1224.8497854077252,21584.376825785395,2010-07-18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SPIB,0.43,-0.35501,-1.3373,0,0.75,0.0,,
ENSG00000272886,1,1,1,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,DCP1A,0.58599997,1.2333,0.16544,4,-1.0,-1.0,,
ENSG00000273079,1,1,0,0,0,1,7794.273577144567,7794.273577144567,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,GRIN2B,0.898,7.3414,0.021062,11,1.0,1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Activated NTRK2 signals through FYN;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9032500;R-HSA-9006934
ENSG00000273777,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CEACAM20,-0.05400002,0.9907,0.39092,0,1.0,0.5,,
ENSG00000275832,1,1,1,0,0,1,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ARHGAP23,0.58599997,0.67825,-0.51741,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000275896,3,1,1,1,1,1,5130.778833931584,33144.02982075252,2017-07-28,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,PRSS2,-0.59099996,-1.2857,-0.90257,5,1.0,0.0,Alpha-defensins;Immune System;Defensins;Antimicrobial peptides,R-HSA-1462054;R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000283873,1,1,0,0,0,1,1560.6893280632412,1560.6893280632412,2024-10-22,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SSU72L4,,,,0,,,,
ENSG00000284194,1,1,1,0,0,1,112184.2204720767,112184.2204720767,2024-04-26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SCO2,-0.76100004,-1.4378,-1.9464,2,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Complex IV assembly,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9864848
ENSG00000286264,1,1,1,0,0,1,150669.89240227733,150669.89240227733,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ENSG00000286264,,,,0,-1.0,0.0,,
ENSG00000288705,1,1,0,0,1,1,112345.61202884468,376845.12303102604,2021-01-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,UGT1A5,0.06400001,0.35516,0.50999,2,0.5,0.5,Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000288920,1,1,0,0,0,0,11343.053400273848,11343.053400273848,2017-06-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RPSA2,-0.64400005,0.4784,0.037524,0,-1.0,-1.0,,
ENSG00000289715,1,1,0,0,0,1,156100.20896497899,156100.20896497899,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ENSG00000289715,,,,0,1.0,1.0,,
ENSG00000292259,1,1,0,0,0,0,15680.736809263815,15680.736809263815,2021-09-30,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,ENSG00000292259,,,,0,,,,
ENSG00000293606,1,1,0,0,0,0,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ENSG00000293606,,,,0,,,,
ENSG00000001167,1,1,0,0,0,0,57692.51997622251,57692.51997622251,2019-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NFYA,0.32,3.7991,0.46832,5,-1.0,-1.0,ATF6 (ATF6-alpha) activates chaperone genes;ATF6 (ATF6-alpha) activates chaperones;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);PERK regulates gene expression;ATF4 activates genes in response to endoplasmic reticulum  stress;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-381183;R-HSA-381033;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-381042;R-HSA-380994;R-HSA-8957322;R-HSA-1655829
ENSG00000001460,1,1,1,0,0,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STPG1,-0.08899999,0.561,0.54616,0,0.5,-1.0,,
ENSG00000001497,1,1,0,0,0,1,500292.45069431677,500292.45069431677,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LAS1L,,,,1,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000003402,1,1,0,0,0,0,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,CFLAR,0.603,2.8938,0.47929,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000004468,1,1,1,1,0,1,2839.268167569108,76832.90012167432,2009-11-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,CD38,-0.29200006,0.34252,0.44215,1,0.5,0.0,,
ENSG00000005001,2,1,1,1,0,1,115338.82014347943,144127.33793912127,2024-07-19,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PRSS22,-0.296,-0.90841,-2.2346,0,0.5,0.0,,
ENSG00000005022,1,1,1,0,1,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,SLC25A5,,,,3,-1.0,-1.0,"Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane;Disease;Interactions of Vpr with host cellular proteins;Transport of vitamins, nucleosides, and related molecules",R-HSA-83936;R-HSA-1643685;R-HSA-176033;R-HSA-425397
ENSG00000005206,1,1,0,0,0,1,263416.51565448404,263416.51565448404,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SPPL2B,-0.10800004,-1.3362,-2.6181,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000007312,1,1,1,0,0,0,221304.1606010112,221304.1606010112,2022-02-02,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,CD79B,0.579,1.9247,0.32063,3,1.0,0.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000007545,1,1,0,0,0,1,228220.5662976458,228220.5662976458,2018-07-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CRAMP1,0.32,-0.74244,-3.4101,0,-1.0,-1.0,,
ENSG00000008988,1,1,0,0,0,1,89519.16315227402,89519.16315227402,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RPS20,0.519,2.3201,-1.1766,18,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000010017,5,1,1,0,0,1,22345.675520395987,141076.9910731678,2013-04-01,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,RANBP9,0.681,0.59042,-1.8878,4,-1.0,-1.0,Signal Transduction;Developmental Biology;Regulation of pyruvate metabolism;Pyruvate metabolism;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9861718;R-HSA-70268;R-HSA-9006934
ENSG00000011275,2,1,0,0,0,0,78751.06843456876,87248.80974040499,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,RNF216,0.181,-1.4879,-1.694,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000015676,1,1,1,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,NUDCD3,0.508,0.35014,0.13536,0,-1.0,-1.0,,
ENSG00000016402,2,1,1,0,0,0,88825.27591578313,575147.0632428399,2017-05-31,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,IL20RA,-0.095999956,0.34761,-0.24365,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000019995,1,1,0,0,0,1,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZRANB1,0.71099997,4.0454,0.54672,2,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000025770,1,1,0,0,0,0,112184.2204720767,112184.2204720767,2024-04-26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NCAPH2,0.208,-0.1988,-2.1307,1,-1.0,-1.0,Condensation of Prophase Chromosomes,R-HSA-2299718
ENSG00000032389,1,1,0,0,0,0,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,EIPR1,0.24000001,1.4553,-0.079905,0,-1.0,-1.0,,
ENSG00000032742,1,1,1,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,IFT88,-0.023000002,0.27734,0.50149,5,0.5,-1.0,Signal Transduction;Late endosomal microautophagy;Aggrephagy;Chaperone Mediated Autophagy;Intraflagellar transport,R-HSA-162582;R-HSA-9615710;R-HSA-9646399;R-HSA-9613829;R-HSA-5620924
ENSG00000033100,1,1,1,0,0,1,42362.45324254164,42362.45324254164,2024-08-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CHPF2,-0.13600004,0.065435,0.081252,1,-1.0,-1.0,,
ENSG00000036257,1,1,1,0,0,1,80746.41870861933,323648.5577791949,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,8,CUL3,0.635,5.156,-1.2875,10,0.5,-1.0,Signal Transduction;Immune System;Disease;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle;Degradation of DVL;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9013422;R-HSA-9706574;R-HSA-4641258;R-HSA-597592
ENSG00000038274,3,1,0,0,0,1,4435.36939554283,48114.22515098965,2023-04-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,MAT2B,0.329,1.2848,-0.41594,2,-1.0,-1.0,Phase II - Conjugation of compounds;Post-translational protein modification,R-HSA-156580;R-HSA-597592
ENSG00000038382,1,1,0,0,0,1,9273.589894798382,9273.589894798382,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TRIO,0.783,4.6931,-2.0975,11,-1.0,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000042062,2,1,0,0,1,0,42359.490817992155,100711.28404230655,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RIPOR3,-0.014999986,-0.0064949,-0.87276,0,-1.0,0.0,,
ENSG00000042088,2,1,1,0,0,0,1080.7549234135668,1544.1474358974358,2019-10-11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TDP1,0.01700002,0.69285,0.39112,1,-1.0,-1.0,,
ENSG00000042493,1,1,1,0,0,1,186139.38238354117,186139.38238354117,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CAPG,0.052999973,0.63187,0.4188,0,-1.0,-1.0,,
ENSG00000043514,1,1,1,0,0,0,155552.2805078301,155552.2805078301,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRIT1,-0.006000042,1.176,1.1118,2,-1.0,-1.0,,
ENSG00000044459,4,1,0,0,0,1,21878.141822721598,1778690.168860174,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,10,CNTLN,-0.431,-3.7713,-3.1213,0,-1.0,-1.0,,
ENSG00000046604,1,1,0,0,1,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DSG2,0.236,1.3758,1.8546,6,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000046647,2,1,0,0,0,1,27866.667115075303,100711.28404230655,2022-07-13,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,GEMIN8,,,,2,-1.0,-1.0,Disease;snRNP Assembly;Metabolism of non-coding RNA,R-HSA-1643685;R-HSA-191859;R-HSA-194441
ENSG00000046774,1,1,0,0,0,1,3114.677466385874,3114.677466385874,2012-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,MAGEC2,,,,0,1.0,1.0,,
ENSG00000047056,1,1,0,0,0,1,69453.1498757531,69453.1498757531,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,WDR37,0.577,3.0231,0.83893,0,-1.0,-1.0,,
ENSG00000047188,1,1,0,0,0,1,10936.908626198083,10936.908626198083,2020-11-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,YTHDC2,0.673,0.94123,-1.6075,1,-1.0,-1.0,Nuclear RNA decay,R-HSA-9930044
ENSG00000050555,1,1,1,0,1,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,LAMC3,0.09100002,0.79044,0.093427,5,0.5,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000052795,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FNIP2,0.58000004,2.0221,0.79812,1,-1.0,-1.0,Amino acids regulate mTORC1;Cellular response to starvation,R-HSA-9639288;R-HSA-9711097
ENSG00000053108,1,1,0,0,0,1,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,FSTL4,0.559,2.199,0.81637,0,-1.0,0.0,,
ENSG00000054219,1,1,1,0,0,0,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LY75,0.10799998,1.3629,1.0325,0,1.0,0.0,,
ENSG00000055147,2,1,0,0,0,1,208836.15741332836,1122672.658801146,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,FAM114A2,-0.15499997,0.17971,-0.087896,1,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000057019,1,1,0,0,0,1,107949.90929360976,143413.24457139417,2023-06-29,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DCBLD2,0.19199997,0.49955,-0.59166,0,-1.0,-1.0,,
ENSG00000059728,1,1,1,0,0,1,125894.9248389576,125894.9248389576,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MXD1,0.3,0.6175,0.2579,0,0.5,-1.0,,
ENSG00000063046,1,1,0,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,EIF4B,0.824,3.5295,1.2837,9,-1.0,-1.0,Signal Transduction;mTORC1-mediated signalling;Deadenylation of mRNA;Developmental Biology;Translation;MTOR signalling,R-HSA-162582;R-HSA-166208;R-HSA-429947;R-HSA-1266738;R-HSA-72766;R-HSA-165159
ENSG00000063587,3,1,1,0,0,1,10227.197550504849,27388.747575018435,2023-01-18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ZNF275,,,,0,0.5,-1.0,,
ENSG00000064545,1,1,0,0,0,1,135543.2647170254,135543.2647170254,2023-05-23,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM161A,-0.08200002,-0.15775,-0.77707,0,-1.0,-1.0,,
ENSG00000064692,1,1,0,0,0,1,7780.207801253773,7780.207801253773,2019-09-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,SNCAIP,0.36400002,1.6322,0.85994,1,0.5,0.0,,
ENSG00000065183,1,1,0,0,0,1,404399.6052088398,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,WDR3,0.22100002,1.5713,0.56311,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000065526,1,1,0,0,0,1,545988.1005477115,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPEN,0.906,5.1216,1.4466,1,-1.0,-1.0,Signal Transduction;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9013422;R-HSA-9706574
ENSG00000065548,1,1,0,0,0,1,61498.92173410762,61498.92173410762,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,ZC3H15,0.621,1.7683,0.57737,1,-1.0,-1.0,Protein hydroxylation;Post-translational protein modification,R-HSA-9629569;R-HSA-597592
ENSG00000065833,2,1,0,0,0,0,86334.97261459603,228168.37020113936,2020-11-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,ME1,-0.23899996,-0.44102,-0.54722,4,-1.0,0.0,Regulation of pyruvate metabolism;Pyruvate metabolism,R-HSA-9861718;R-HSA-70268
ENSG00000066117,1,1,1,0,0,0,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,SMARCD1,0.661,3.2726,-0.23409,9,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Formation of the non-canonical BAF (ncBAF) complex,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9933947
ENSG00000066427,1,1,1,0,0,0,725.727950310559,725.727950310559,2017-09-08,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATXN3,0.41900003,1.6462,0.77202,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000066651,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TRMT11,-0.07799995,0.28996,0.68704,1,-1.0,-1.0,,
ENSG00000067445,1,1,0,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRO,,,,0,0.5,0.0,,
ENSG00000067992,1,1,1,0,0,0,376569.5597064443,376569.5597064443,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PDK3,,,,2,-1.0,-1.0,Signal Transduction;Regulation of pyruvate metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism,R-HSA-162582;R-HSA-9861718;R-HSA-204174;R-HSA-70268
ENSG00000068097,1,1,0,0,0,1,4392.463820224719,4392.463820224719,2023-02-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,HEATR6,0.11799997,1.3624,0.7318,0,-1.0,-1.0,,
ENSG00000069188,1,1,0,0,0,1,8208.0,8208.0,2022-12-29,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SDK2,0.44599998,1.7962,-1.349,1,0.5,0.5,,
ENSG00000070061,1,1,1,0,0,0,143413.24457139417,143413.24457139417,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ELP1,0.19700003,0.98074,1.1374,1,-1.0,-1.0,,
ENSG00000070770,1,1,1,0,0,1,83896.55822718568,83896.55822718568,2023-02-07,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,CSNK2A2,0.576,3.0647,0.351,12,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Phosphorylation and nuclear translocation of the CRY:PER:kinase complex;Gene expression (Transcription);Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Disease;Receptor Mediated Mitophagy,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-9931530;R-HSA-74160;R-HSA-6814122;R-HSA-1643685;R-HSA-8934903
ENSG00000071242,1,1,0,0,0,0,13661.736030569899,13661.736030569899,2018-08-13,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RPS6KA2,0.376,1.9009,-0.99974,7,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;CREB phosphorylation;Signaling by Interleukins;Gastrin-CREB signalling pathway via PKC and MAPK;Recycling pathway of L1;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-199920;R-HSA-449147;R-HSA-881907;R-HSA-437239;R-HSA-9006934
ENSG00000071889,1,1,0,0,0,1,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,FAM3A,,,,0,-1.0,-1.0,,
ENSG00000072080,2,1,0,0,0,1,50641.99826116222,50641.99826116222,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,SPP2,-0.655,0.19024,-0.33764,3,1.0,1.0,Post-translational protein modification,R-HSA-597592
ENSG00000072133,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,RPS6KA6,,,,3,-1.0,0.0,Developmental Biology;Recycling pathway of L1,R-HSA-1266738;R-HSA-437239
ENSG00000072422,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,RHOBTB1,0.32,1.705,0.9716,1,0.5,0.0,Signal Transduction;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9013422;R-HSA-9706574
ENSG00000072778,2,1,1,0,0,1,269000.70907194994,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,ACADVL,-0.07700002,0.10097,-1.6866,2,0.5,-1.0,,
ENSG00000073331,1,1,1,0,0,0,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ALPK1,-0.078999996,0.51701,0.18048,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000074771,1,1,0,0,0,1,11608.613380386345,11608.613380386345,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,NOX3,-0.20000005,0.21162,0.40386,3,,,Signal Transduction,R-HSA-162582
ENSG00000075239,1,1,1,0,0,1,56612.81533803308,56612.81533803308,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ACAT1,0.20200002,1.0654,-0.28536,6,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000075975,1,1,1,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MKRN2,0.050000012,0.46182,-0.091584,0,-1.0,-1.0,,
ENSG00000076641,1,1,1,0,0,1,41642.5373617829,67051.76345250831,2024-07-19,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,PAG1,-0.047999978,1.4722,0.31363,2,-1.0,0.0,Signal Transduction;Immune System;Phosphorylation of CD3 and TCR zeta chains;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-202427;R-HSA-9006934
ENSG00000077943,1,1,0,0,0,1,448058.917711015,448058.917711015,2023-11-10,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ITGA8,0.199,-0.77047,-0.84394,5,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000078369,2,1,1,0,0,1,205425.60717824215,306980.8575290048,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,GNB1,0.778,3.4867,0.3547,34,1.0,-1.0,"Signal Transduction;ADP signalling through P2Y purinoceptor 12;Thromboxane signalling through TP receptor;Prostacyclin signalling through prostacyclin receptor;G beta:gamma signalling through BTK;ADP signalling through P2Y purinoceptor 1;G beta:gamma signalling through PI3Kgamma;Signal amplification;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Disease;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Activation of kainate receptors upon glutamate binding;Adrenaline,noradrenaline inhibits insulin secretion;Olfactory Signaling Pathway;G-protein beta:gamma signalling;Inwardly rectifying K+ channels",R-HSA-162582;R-HSA-392170;R-HSA-428930;R-HSA-392851;R-HSA-8964315;R-HSA-418592;R-HSA-392451;R-HSA-392518;R-HSA-202040;R-HSA-6814122;R-HSA-1643685;R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-451326;R-HSA-400042;R-HSA-381753;R-HSA-397795;R-HSA-1296065
ENSG00000078579,2,1,0,0,0,1,6306.411000302206,263416.51565448404,2017-09-11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,8,FGF20,-0.14499998,-3.5757,-3.031,37,0.5,0.5,Signal Transduction;Disease;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202
ENSG00000078618,1,1,1,0,1,1,449855.9086123723,1122672.658801146,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,7,NRDC,0.49699998,2.7213,1.2728,0,0.5,-1.0,,
ENSG00000078902,1,1,0,0,0,1,82295.36127718941,82295.36127718941,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TOLLIP,0.25300002,1.3236,-0.36299,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000079215,1,1,0,0,0,1,75639.5973879004,93132.96870045633,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,SLC1A3,0.393,2.4349,0.86918,4,0.75,-1.0,Glutamate Neurotransmitter Release Cycle;Disease;Transport of inorganic cations/anions and amino acids/oligopeptides;Neurotransmitter release cycle,R-HSA-210500;R-HSA-1643685;R-HSA-425393;R-HSA-112310
ENSG00000079739,2,1,1,1,1,1,23238.11336553945,1424218.0900670097,2020-01-31,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,PGM1,-0.18900001,0.48596,-0.10072,5,0.75,-1.0,Glycogen metabolism;Immune System;Glycogen synthesis;Disease,R-HSA-8982491;R-HSA-168256;R-HSA-3322077;R-HSA-1643685
ENSG00000079785,1,1,1,0,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,DDX1,0.66999996,1.278,-0.21452,1,-1.0,-1.0,tRNA processing in the nucleus,R-HSA-6784531
ENSG00000080293,1,1,1,0,1,1,135095.86576106868,1424218.0900670097,2020-05-06,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SCTR,-0.37300003,-0.35899,-0.012836,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000080371,1,1,0,0,0,1,2373.1792752244437,2373.1792752244437,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,RAB21,-0.35399997,-0.61365,-0.4209,2,-1.0,-1.0,Rab regulation of trafficking;Post-translational protein modification,R-HSA-9007101;R-HSA-597592
ENSG00000080511,1,1,0,0,0,1,251325.91086204,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RDH8,-0.069000006,0.56121,0.12124,1,1.0,0.5,The canonical retinoid cycle in rods (twilight vision),R-HSA-2453902
ENSG00000080573,1,1,0,0,0,0,205425.60717824215,205425.60717824215,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,COL5A3,0.18800002,-0.57062,-1.6078,13,-1.0,0.0,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000081320,2,1,0,0,0,1,195666.44200393453,208836.15741332836,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,STK17B,0.110000014,1.3085,-0.35228,0,0.75,0.0,,
ENSG00000082074,1,1,1,0,0,1,87248.80974040499,87248.80974040499,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,FYB1,0.564,-0.066729,-0.025947,2,0.75,0.0,,
ENSG00000082153,1,1,0,0,0,1,77544.39441764928,77544.39441764928,2022-12-10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BZW1,0.814,3.8747,-0.1512,0,-1.0,-1.0,,
ENSG00000083720,1,1,1,0,0,1,71011.37773385248,115018.85440898917,2019-04-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,OXCT1,0.47899997,2.3964,0.94703,2,0.5,-1.0,,
ENSG00000083937,3,1,1,0,0,1,7211.241069373615,521818.7070055739,2020-09-04,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,CHMP2B,-0.503,-0.0395,0.041347,9,-1.0,-1.0,Endosomal Sorting Complex Required For Transport (ESCRT);Budding and maturation of HIV virion;Disease;Late endosomal microautophagy;Translation of Replicase and Assembly of the Replication Transcription Complex_9679504;Sealing of the nuclear envelope (NE) by ESCRT-III;Translation of Replicase and Assembly of the Replication Transcription Complex_9694676;HIV Life Cycle;Late Phase of HIV Life Cycle;HCMV Late Events,R-HSA-917729;R-HSA-162588;R-HSA-1643685;R-HSA-9615710;R-HSA-9679504;R-HSA-9668328;R-HSA-9694676;R-HSA-162587;R-HSA-162599;R-HSA-9610379
ENSG00000085491,1,1,0,0,0,1,160010.51072069994,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SLC25A24,-0.10599995,0.68596,0.43552,0,-1.0,-1.0,,
ENSG00000085998,1,1,1,0,0,1,161771.60650486936,161771.60650486936,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,POMGNT1,0.185,2.1397,1.0642,2,-1.0,-1.0,Matriglycan biosynthesis on DAG1;DAG1 glycosylations;Disease;Post-translational protein modification,R-HSA-9939291;R-HSA-8931838;R-HSA-1643685;R-HSA-597592
ENSG00000086712,1,1,0,0,0,1,129783.42151918238,129783.42151918238,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TXLNG,,,,0,-1.0,-1.0,,
ENSG00000086758,2,1,0,0,0,1,195005.6685718255,294387.2978738704,2021-09-30,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,HUWE1,,,,2,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000087085,1,1,0,0,0,1,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ACHE,0.454,2.7525,-0.72881,3,0.75,0.0,,
ENSG00000087250,1,1,0,0,0,1,28892.29425546899,28892.29425546899,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MT3,-0.30799997,0.39005,-0.097538,1,1.0,0.0,,
ENSG00000088543,1,1,1,0,1,0,208836.15741332836,208836.15741332836,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,C3orf18,-0.41999996,0.35038,0.33991,0,0.5,0.0,,
ENSG00000088826,1,1,0,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SMOX,0.348,2.6626,0.65327,2,0.5,-1.0,Metabolism of polyamines,R-HSA-351202
ENSG00000089472,1,1,0,0,1,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HEPH,,,,3,0.5,0.0,Disease;Iron uptake and transport,R-HSA-1643685;R-HSA-917937
ENSG00000089692,1,1,0,0,1,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,LAG3,0.10699999,-0.79933,-1.4722,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000089737,1,1,0,0,0,1,31818.916809874692,47832.98019165416,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,2,DDX24,0.47899997,1.1125,0.29519,0,-1.0,0.0,,
ENSG00000091010,1,1,0,0,0,1,309838.540915932,360605.992793193,2021-07-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,POU4F3,0.435,0.61049,-0.40231,0,,,,
ENSG00000092067,2,1,1,0,0,1,4007.0755416747998,16133.130668122072,2013-03-19,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,CEBPE,0.15200001,0.032337,-0.45532,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000092068,1,1,0,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC7A8,0.20700002,1.3086,1.0633,2,0.5,-1.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000092208,1,1,0,0,0,0,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GEMIN2,-0.80499995,-0.40151,0.043654,2,-1.0,-1.0,Disease;snRNP Assembly;Metabolism of non-coding RNA,R-HSA-1643685;R-HSA-191859;R-HSA-194441
ENSG00000092445,1,1,0,1,0,1,91172.20051337926,91172.20051337926,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,TYRO3,0.435,2.948,1.5307,0,0.5,0.0,,
ENSG00000092847,1,1,0,0,0,0,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,AGO1,0.83599997,6.4391,0.28929,24,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Transcriptional regulation by small RNAs;Gene Silencing by RNA;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5578749;R-HSA-211000;R-HSA-5663202
ENSG00000094661,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR1I1,,0.14888,0.89302,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000094796,1,1,1,0,1,1,98404.80972454042,98404.80972454042,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KRT31,0.12099999,0.75909,0.26942,2,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000095203,1,1,0,0,0,0,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,EPB41L4B,0.714,1.0978,0.79787,0,0.5,0.0,,
ENSG00000095397,2,1,1,0,1,0,260210.21963428933,1424218.0900670097,2023-01-18,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,WHRN,0.19199997,-0.01313,-0.098399,2,0.5,0.0,,
ENSG00000095981,1,1,0,0,1,0,135095.86576106868,1424218.0900670097,2020-05-06,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,KCNK16,-0.46300006,0.63493,0.36495,2,0.75,0.5,,
ENSG00000099203,1,1,0,0,0,1,54391.03477538057,54391.03477538057,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMED1,-0.43499994,-0.23746,-0.62172,0,-1.0,-1.0,,
ENSG00000099381,1,1,0,0,0,1,17820.993879369486,17820.993879369486,2021-09-30,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SETD1A,0.72099996,1.8252,-2.9989,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000099385,1,1,1,0,0,1,159189.58506586426,159189.58506586426,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,BCL7C,0.454,0.76861,1.2772,7,-1.0,-1.0,Developmental Biology;Gene expression (Transcription);Formation of the non-canonical BAF (ncBAF) complex,R-HSA-1266738;R-HSA-74160;R-HSA-9933947
ENSG00000099849,1,1,0,0,0,1,13219.952617929488,13219.952617929488,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,RASSF7,-0.85800004,-2.6199,-3.7426,0,0.5,0.0,,
ENSG00000099958,2,1,1,0,0,1,7015.217468683688,645988.1975077938,2021-01-25,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DERL3,-0.41400003,-0.87251,-1.1058,2,0.5,0.0,Disease,R-HSA-1643685
ENSG00000099991,1,1,1,0,0,0,122069.83349127392,122069.83349127392,2017-12-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CABIN1,0.339,3.5716,1.631,1,-1.0,-1.0,,
ENSG00000099998,1,1,1,0,0,1,70963.50951054243,70963.50951054243,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,GGT5,-0.19299996,-0.73053,-1.5365,5,-1.0,-1.0,Glutathione conjugation;Disease;Aflatoxin activation and detoxification;Synthesis of Leukotrienes (LT) and Eoxins (EX);Glutathione synthesis and recycling;Phase II - Conjugation of compounds;Arachidonate metabolism,R-HSA-156590;R-HSA-1643685;R-HSA-5423646;R-HSA-2142691;R-HSA-174403;R-HSA-156580;R-HSA-2142753
ENSG00000100027,2,1,0,0,0,1,301203.06999851385,301203.06999851385,2023-10-16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,YPEL1,0.227,1.9407,0.14026,0,0.5,-1.0,,
ENSG00000100065,1,1,1,0,0,1,122549.0830919942,122549.0830919942,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CARD10,0.32200003,0.41014,-2.0274,0,0.5,0.0,,
ENSG00000100078,1,1,1,0,1,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PLA2G3,0.032999992,-0.046566,-0.78193,3,0.5,0.5,Acyl chain remodelling of PG;Acyl chain remodelling of PC;Acyl chain remodelling of PE,R-HSA-1482925;R-HSA-1482788;R-HSA-1482839
ENSG00000100095,1,1,0,0,0,1,10427.636258466284,10427.636258466284,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SEZ6L,0.55,2.0277,1.2115,0,1.0,0.5,,
ENSG00000100121,3,1,0,0,0,1,15722.507790577758,43039.044982671156,2023-01-18,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,3,GGTLC2,-0.23899996,0.86834,0.68166,0,1.0,0.5,,
ENSG00000100170,1,1,0,0,0,1,158370.2523752734,158370.2523752734,2025-04-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC5A1,0.29500002,3.1446,1.0144,3,1.0,0.0,Digestion and absorption;Disease;Cellular hexose transport,R-HSA-8963743;R-HSA-1643685;R-HSA-189200
ENSG00000100228,2,1,1,0,0,0,157277.57551067916,183761.6081180644,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,RAB36,-0.17299998,0.98713,0.40521,2,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000100281,2,1,1,0,0,1,87248.80974040499,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,HMGXB4,0.3,1.2848,0.41881,0,-1.0,-1.0,,
ENSG00000100290,3,1,1,0,0,1,3747.57310565635,521818.7070055739,2009-09-20,29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,BIK,-0.83800006,-0.54037,-0.51845,0,0.5,0.0,,
ENSG00000100410,2,1,0,0,0,1,53369.71648873449,142905.851430916,2019-03-28,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,PHF5A,0.795,3.687,-0.38562,1,-1.0,-1.0,,
ENSG00000100412,1,1,1,0,0,0,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ACO2,0.51100004,4.3358,0.43968,4,0.5,-1.0,Maturation of TCA enzymes and regulation of TCA cycle;Citric acid cycle (TCA cycle),R-HSA-9854311;R-HSA-71403
ENSG00000100490,1,1,0,0,0,1,28863.30790298137,28863.30790298137,2022-12-10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CDKL1,-0.20700002,0.75013,0.4848,0,-1.0,0.0,,
ENSG00000100592,1,1,0,0,0,1,28923.750134754748,28923.750134754748,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DAAM1,0.491,1.9445,0.14076,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000100678,1,1,0,0,0,1,16534.94713490521,16534.94713490521,2024-11-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SLC8A3,0.20599997,1.2804,0.11971,4,0.75,0.5,Mitochondrial calcium ion transport;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-8949215;R-HSA-425393
ENSG00000100796,1,1,0,0,0,1,272025.74568937684,1424218.0900670097,2018-10-08,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,PPP4R3A,0.737,4.1982,-0.63066,0,-1.0,-1.0,,
ENSG00000101003,1,1,1,0,0,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GINS1,-0.888,0.20354,-0.55796,1,0.5,0.0,Unwinding of DNA,R-HSA-176974
ENSG00000101074,1,1,0,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,R3HDML,-0.19799995,1.0767,0.21066,0,1.0,1.0,,
ENSG00000101084,2,1,0,0,0,1,40890.880548672525,194667.2540182328,2024-07-19,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RAB5IF,-0.14400005,0.29898,-0.24038,1,0.5,-1.0,Complex IV assembly,R-HSA-9864848
ENSG00000101109,2,1,0,0,1,0,94951.97167384504,150669.89240227733,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,STK4,0.39999998,2.3144,1.2767,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000101126,1,1,0,0,0,1,87037.83598345588,521818.7070055739,2014-09-14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,ADNP,0.894,2.5832,-1.4344,0,-1.0,-1.0,,
ENSG00000101158,1,1,0,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NELFCD,0.13800001,2.8496,0.05699,14,-1.0,-1.0,Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;Generic Transcription Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;Gene expression (Transcription);Abortive elongation of HIV-1 transcript in the absence of Tat;Disease;Pausing and recovery of HIV elongation;Tat-mediated HIV elongation arrest and recovery;HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-113418;R-HSA-167158;R-HSA-212436;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-74160;R-HSA-167242;R-HSA-1643685;R-HSA-167290;R-HSA-167243;R-HSA-167287;R-HSA-167238;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-162587;R-HSA-162599
ENSG00000101346,1,1,1,0,0,0,444537.33605315426,444537.33605315426,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,POFUT1,0.35900003,0.54158,0.0052927,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000101435,1,1,0,0,0,1,14145.711748532529,14145.711748532529,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,CST9L,-0.826,0.17931,-0.59495,0,0.75,0.5,,
ENSG00000101558,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,VAPA,0.597,0.54194,-0.35531,3,-1.0,-1.0,Signal Transduction;Immune System;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Sphingolipid de novo biosynthesis,R-HSA-162582;R-HSA-168256;R-HSA-9609523;R-HSA-1660661
ENSG00000101849,1,1,0,0,0,1,574261.7466389402,574261.7466389402,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TBL1X,,,,20,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-8957322;R-HSA-1655829;R-HSA-5663202
ENSG00000101871,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MID1,,,,1,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000101911,1,1,0,0,0,1,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,PRPS2,,,,1,0.5,-1.0,,
ENSG00000101986,1,1,1,0,0,0,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ABCD1,,,,6,-1.0,0.0,Disease,R-HSA-1643685
ENSG00000102081,1,1,0,0,0,1,135095.86576106868,294387.2978738704,2021-09-30,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FMR1,,,,0,-1.0,-1.0,,
ENSG00000102103,1,1,1,0,0,0,135095.86576106868,135095.86576106868,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PQBP1,,,,1,-1.0,-1.0,,
ENSG00000102359,1,1,0,0,1,0,397765.9672627851,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SRPX2,,,,0,0.5,0.0,,
ENSG00000102781,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KATNAL1,0.11500001,1.8605,-0.35192,0,-1.0,-1.0,,
ENSG00000102879,1,1,0,0,0,1,1470466.6505612188,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CORO1A,0.42799997,3.0728,-0.61169,1,0.75,0.0,Disease;Response of Mtb to phagocytosis;Suppression of phagosomal maturation;Infection with Mycobacterium tuberculosis,R-HSA-1643685;R-HSA-9637690;R-HSA-9637687;R-HSA-9635486
ENSG00000102934,1,1,0,0,0,1,74207.71608321255,111599.28184123649,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,PLLP,-0.39900005,-0.44288,-0.34308,0,0.5,-1.0,,
ENSG00000102962,1,1,0,1,0,1,22938.587937312015,50072.877304794354,2017-07-17,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,CCL22,-0.63399994,0.15966,-0.501,4,0.5,0.5,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Dectin-1 mediated noncanonical NF-kB signaling;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-5607761;R-HSA-6785807
ENSG00000103044,2,1,0,0,0,1,98271.38571086437,105759.0908630975,2023-01-18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,HAS3,0.21899998,3.223,-0.61264,1,0.5,0.0,,
ENSG00000103091,1,1,0,0,0,1,15300.00006269848,15300.00006269848,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,WDR59,0.09500003,0.88048,-2.8741,1,-1.0,-1.0,Amino acids regulate mTORC1;Cellular response to starvation,R-HSA-9639288;R-HSA-9711097
ENSG00000103197,1,1,1,0,0,1,258673.33020768655,258673.33020768655,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TSC2,0.797,0.17171,-4.9417,7,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Energy dependent regulation of mTOR by LKB1-AMPK;TBC/RABGAPs;MTOR signalling;Rab regulation of trafficking;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-380972;R-HSA-8854214;R-HSA-165159;R-HSA-9007101;R-HSA-5663202
ENSG00000103550,1,1,1,0,0,1,240639.50239824195,240639.50239824195,2021-10-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,KNOP1,0.037999988,0.73107,0.59864,0,-1.0,-1.0,,
ENSG00000103769,1,1,0,0,0,1,66500.25601124117,82295.36127718941,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RAB11A,0.42299998,3.5737,0.45319,6,-1.0,-1.0,VxPx cargo-targeting to cilium;TBC/RABGAPs;Rab regulation of trafficking;Cargo trafficking to the periciliary membrane;Post-translational protein modification,R-HSA-5620916;R-HSA-8854214;R-HSA-9007101;R-HSA-5620920;R-HSA-597592
ENSG00000104231,1,1,1,0,0,0,59389.77313114188,59389.77313114188,2022-01-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZFAND1,-0.40699995,-0.73853,-0.8768,0,-1.0,-1.0,,
ENSG00000104375,1,1,0,0,0,1,129783.42151918238,129783.42151918238,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,STK3,-0.06500006,1.5527,0.85332,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000104413,1,1,0,0,0,0,93616.86016863462,93616.86016863462,2021-04-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ESRP1,0.555,2.2465,0.0081792,2,-1.0,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000104517,1,1,0,0,0,1,727796.3668420183,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,UBR5,0.927,8.3809,0.98893,0,-1.0,-1.0,,
ENSG00000104643,1,1,0,0,0,1,18988.45997716481,18988.45997716481,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MTMR9,0.22899997,-2.6989,-3.2738,3,-1.0,-1.0,,
ENSG00000104856,1,1,0,0,0,0,83433.17248405184,83433.17248405184,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,RELB,0.48799998,0.92268,-2.3381,3,-1.0,0.0,Cytokine Signaling in Immune system;Immune System;Dectin-1 mediated noncanonical NF-kB signaling;NIK-->noncanonical NF-kB signaling,R-HSA-1280215;R-HSA-168256;R-HSA-5607761;R-HSA-5676590
ENSG00000105048,1,1,1,0,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,TNNT1,-0.41499996,0.49022,-0.25675,1,0.75,0.0,,
ENSG00000105088,1,1,0,0,0,1,415452.66715166246,415452.66715166246,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,OLFM2,0.264,3.3098,0.31086,0,0.5,0.0,,
ENSG00000105186,1,1,1,0,0,0,2068.9726415094337,2068.9726415094337,2014-11-19,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ANKRD27,0.035000026,0.97786,0.44191,1,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000105339,1,1,1,0,0,1,119960.45133411254,119960.45133411254,2023-05-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,DENND3,0.195,2.7116,0.61367,1,0.5,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000105383,1,1,1,1,1,1,332375.5317723021,332375.5317723021,2021-09-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CD33,-0.07200003,0.97413,0.46451,2,0.5,0.0,Immune System,R-HSA-168256
ENSG00000105392,1,1,0,0,0,1,134159.95265752633,134159.95265752633,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CRX,0.32700002,1.0896,0.075424,0,1.0,0.5,,
ENSG00000105419,1,1,0,0,0,1,114439.41769154315,114439.41769154315,2024-07-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MEIS3,-0.08399999,0.50863,-0.24137,0,0.5,0.0,,
ENSG00000105523,1,1,0,0,0,1,82999.78609625668,108816.31098183901,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,2,FAM83E,-0.42299998,-1.4142,-1.8995,0,0.5,0.0,,
ENSG00000105559,1,1,1,0,0,1,426681.33856181684,426681.33856181684,2022-08-03,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PLEKHA4,0.10100001,0.38056,0.23582,1,-1.0,0.0,,
ENSG00000105612,1,1,0,0,0,1,466632.7979326389,466632.7979326389,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DNASE2,-0.19500005,0.88396,0.29319,1,-1.0,-1.0,Lysosome Vesicle Biogenesis,R-HSA-432720
ENSG00000105732,1,1,0,0,1,0,42341.12463940832,42341.12463940832,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ZNF574,0.40100002,2.1615,-0.58664,0,-1.0,-1.0,,
ENSG00000105929,1,1,1,0,0,1,337860.4854363166,337860.4854363166,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ATP6V0A4,0.08399999,2.1353,1.2749,4,0.75,0.0,Signal Transduction;Transferrin endocytosis and recycling;Immune System;Iron uptake and transport;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-917977;R-HSA-168256;R-HSA-917937;R-HSA-9006934
ENSG00000105953,1,1,0,0,0,0,75632.36795352261,75632.36795352261,2024-01-05,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OGDH,0.58500004,5.6656,1.62,3,0.5,-1.0,Citric acid cycle (TCA cycle),R-HSA-71403
ENSG00000106034,1,1,1,0,0,1,188264.63129042363,188264.63129042363,2025-03-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CPED1,-0.14199996,0.33451,-0.58872,0,-1.0,0.0,,
ENSG00000106069,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CHN2,0.11500001,1.4685,0.56562,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000106113,2,1,0,0,0,1,272025.74568937684,1424218.0900670097,2018-10-08,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,CRHR2,-0.22099996,-0.06396,-0.25541,3,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000106125,1,1,0,0,0,1,25722.394506078992,69761.9825146311,2019-04-11,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,MINDY4,0.092999995,0.50358,-0.13034,0,-1.0,-1.0,,
ENSG00000106399,1,1,0,0,0,1,25352.520712885682,25352.520712885682,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RPA3,-0.96800005,-1.0015,-1.3215,29,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Gap-filling DNA repair synthesis and ligation in TC-NER;Formation of Incision Complex in GG-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-6782210;R-HSA-5696395;R-HSA-6782135;R-HSA-6781827
ENSG00000106554,1,1,0,0,0,1,727796.3668420183,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,CHCHD3,0.13099998,0.48765,0.626,2,0.75,-1.0,Cristae formation,R-HSA-8949613
ENSG00000106603,1,1,0,0,0,0,6642.252991175356,6642.252991175356,2021-11-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,COA1,-0.84099996,-0.0028571,0.54933,3,-1.0,-1.0,Complex I biogenesis;Complex IV assembly,R-HSA-6799198;R-HSA-9864848
ENSG00000106701,2,1,0,0,0,1,4352.428173176713,4352.428173176713,2020-09-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FSD1L,0.162,1.2852,0.13431,0,0.5,0.0,,
ENSG00000106785,1,1,1,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,TRIM14,-0.062000036,-1.1956,-2.4016,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000106803,1,1,0,0,0,1,151706.1907321582,166624.24147696298,2022-11-07,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,SEC61B,-0.39,-0.027791,-1.2571,3,-1.0,-1.0,Immune System;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-168256;R-HSA-9609523;R-HSA-72766;R-HSA-1799339
ENSG00000106809,1,1,1,1,0,0,512656.0695323204,512656.0695323204,2023-03-27,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,OGN,0.112999976,1.4121,0.44222,5,0.5,0.0,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Defective ST3GAL3 causes MCT12 and EIEE15;Disease,R-HSA-3656244;R-HSA-3656243;R-HSA-1643685
ENSG00000106819,1,1,0,1,0,0,173193.7688415446,173193.7688415446,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ASPN,-0.526,1.2723,0.90308,1,0.5,0.0,,
ENSG00000107317,1,1,1,1,0,0,7794.273577144567,7794.273577144567,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PTGDS,-0.049999952,0.28116,0.43193,2,0.5,-1.0,Developmental Biology;Arachidonate metabolism,R-HSA-1266738;R-HSA-2142753
ENSG00000107338,2,1,1,0,0,1,78016.97193351923,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,SHB,0.26,-3.0463,-4.202,1,-1.0,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000107372,2,1,1,0,0,1,163479.85522876077,163479.85522876077,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZFAND5,0.58599997,2.2419,0.78502,0,0.5,-1.0,,
ENSG00000107864,1,1,0,0,0,1,84563.14597380339,515513.2178404211,2020-05-06,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CPEB3,0.41500002,1.2937,-0.69673,0,0.5,-1.0,,
ENSG00000108039,2,1,0,0,0,1,94951.97167384504,150669.89240227733,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,XPNPEP1,0.45499998,2.8174,0.52712,0,-1.0,-1.0,,
ENSG00000108061,1,1,0,0,0,0,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SHOC2,0.799,3.7919,1.2343,3,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000108381,1,1,0,0,0,1,636.1886490807354,636.1886490807354,2012-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ASPA,-0.09800005,1.2489,0.37343,1,0.5,0.0,,
ENSG00000108515,1,1,1,1,0,0,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ENO3,-0.181,0.26335,0.56312,2,0.75,-1.0,Gluconeogenesis,R-HSA-70263
ENSG00000108576,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC6A4,0.579,3.0565,1.5948,1,0.75,0.5,,
ENSG00000108578,1,1,0,0,0,0,180344.38517486732,180344.38517486732,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,BLMH,0.27600002,1.7094,0.83007,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000108587,2,1,1,0,0,1,87515.7591699547,87515.7591699547,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GOSR1,-0.753,-0.52354,-0.5525,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000108671,1,1,0,0,0,1,149644.92262336772,149644.92262336772,2020-11-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PSMD11,0.918,3.5703,0.55924,62,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000108771,1,1,1,0,1,0,122069.83349127392,394357.452283155,2017-12-06,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DHX58,0.041999996,1.8318,0.8703,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000108773,1,1,0,0,0,1,135108.48254553688,135108.48254553688,2025-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KAT2A,0.413,3.8125,0.0098037,16,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-73762;R-HSA-73864;R-HSA-73854;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000108784,1,1,1,0,0,1,295550.4496098593,295550.4496098593,2020-04-15,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,NAGLU,-0.029000044,0.096459,-0.77668,2,-1.0,-1.0,Disease;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1643685;R-HSA-1638091
ENSG00000108821,1,1,0,0,0,1,7794.273577144567,7794.273577144567,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,COL1A1,0.841,5.7881,0.36959,26,0.5,0.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Platelet Adhesion to exposed collagen;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-75892;R-HSA-9006934
ENSG00000108852,1,1,1,0,0,0,93132.96870045633,93132.96870045633,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MPP2,0.11900002,1.8752,0.5023,0,0.5,0.0,,
ENSG00000109132,1,1,0,0,0,1,23238.11336553945,23238.11336553945,2020-01-31,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PHOX2B,0.651,1.2908,-1.4792,0,0.75,0.5,,
ENSG00000109255,2,1,0,0,0,1,117707.74532698281,427337.4491868293,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NMU,-0.283,-0.84147,-0.52459,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000109511,1,1,0,0,0,1,95491.56815792594,95491.56815792594,2023-05-17,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ANXA10,-0.14600003,0.06281,-0.063733,0,1.0,0.5,,
ENSG00000109846,1,1,1,0,0,0,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CRYAB,-0.17999995,1.1939,-0.16742,1,0.5,0.0,,
ENSG00000109991,1,1,0,0,1,0,727796.3668420183,727796.3668420183,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,P2RX3,-0.04100001,1.067,0.24524,2,0.5,0.5,,
ENSG00000110628,2,1,1,0,0,0,195005.6685718255,260210.21963428933,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC67A1,-0.362,-0.71741,-0.95009,2,0.5,0.0,,
ENSG00000110719,1,1,1,0,1,0,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TCIRG1,-0.222,0.15667,-0.84343,6,0.5,0.0,Signal Transduction;Transferrin endocytosis and recycling;Immune System;Iron uptake and transport;Amino acids regulate mTORC1;Cellular response to starvation;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-917977;R-HSA-168256;R-HSA-917937;R-HSA-9639288;R-HSA-9711097;R-HSA-9006934
ENSG00000110900,2,1,1,0,0,1,42359.490817992155,107949.90929360976,2023-01-18,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TSPAN11,-0.116999984,1.0627,0.1992,0,0.5,0.0,,
ENSG00000110944,1,1,1,0,0,1,2758.3907212758245,16461.04650907092,2009-01-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,4,IL23A,-0.40100002,0.89375,-0.1884,2,1.0,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000111052,1,1,0,0,0,1,765591.3646788632,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,LIN7A,-0.38100004,0.79278,-0.8153,3,0.5,0.0,Dopamine Neurotransmitter Release Cycle;Neurotransmitter release cycle,R-HSA-212676;R-HSA-112310
ENSG00000111237,1,1,1,0,0,0,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VPS29,0.645,2.4897,0.070058,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000111615,1,1,0,0,0,1,36711.14417421714,55985.57959589327,2018-12-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,KRR1,0.264,0.41426,0.81401,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000111850,1,1,1,0,0,1,228220.5662976458,545988.1005477115,2023-01-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SMIM8,-0.714,-0.11235,-0.37332,0,-1.0,-1.0,,
ENSG00000111859,1,1,1,0,0,1,87037.83598345588,521818.7070055739,2014-09-14,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,NEDD9,0.56799996,1.8292,1.0835,0,-1.0,-1.0,,
ENSG00000111863,1,1,1,0,0,1,196178.71491042234,196178.71491042234,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ADTRP,-0.074,0.84923,0.45463,0,0.5,0.0,,
ENSG00000111877,1,1,0,0,0,0,10970.164490603047,10970.164490603047,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MCM9,0.08399999,1.4694,1.1593,0,-1.0,-1.0,,
ENSG00000111962,1,1,0,0,0,1,36494.548446257475,36494.548446257475,2024-01-03,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,UST,0.28100002,0.57432,-0.89416,1,-1.0,0.0,DS-GAG biosynthesis,R-HSA-2022923
ENSG00000112212,1,1,0,0,0,0,4074.958527607362,4074.958527607362,2011-06-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TSPO2,-0.64,0.11141,0.81188,0,1.0,0.5,,
ENSG00000112234,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FBXL4,0.15899998,1.294,0.58711,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000112238,1,1,0,0,0,1,13803.505764554428,13803.505764554428,2021-01-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,PRDM13,0.306,-1.2638,-2.4112,0,,,,
ENSG00000112276,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,POPDC1,0.08499998,0.61619,-0.16246,0,0.5,0.0,,
ENSG00000112312,1,1,0,0,0,1,70029.51727197871,70029.51727197871,2023-01-18,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GMNN,,,,3,0.5,-1.0,,
ENSG00000112659,1,1,1,0,1,0,131525.74533408263,323648.5577791949,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,CUL9,0.666,5.2734,2.2888,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000112742,2,1,0,0,0,1,105281.95721639719,105281.95721639719,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,TTK,0.334,0.74887,0.65592,0,0.75,0.0,,
ENSG00000113068,1,1,1,0,0,1,545988.1005477115,645988.1975077938,2023-01-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PFDN1,-0.86099994,0.33234,-1.3243,1,-1.0,-1.0,Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,R-HSA-389957;R-HSA-389958
ENSG00000113249,1,1,0,1,0,0,20307.85640079949,20307.85640079949,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,HAVCR1,-0.94000006,-0.15547,-0.38162,1,0.75,0.5,Disease,R-HSA-1643685
ENSG00000114248,3,1,0,0,0,1,3512.4789695057834,367949.31877243903,2014-06-08,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,LRRC31,0.004999995,0.59168,0.27855,0,0.5,0.5,,
ENSG00000114698,2,1,0,0,0,1,714039.8414241908,714039.8414241908,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PLSCR4,0.292,0.47716,0.74075,0,-1.0,-1.0,,
ENSG00000115233,1,1,0,0,0,0,135108.48254553688,135108.48254553688,2025-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PSMD14,0.627,3.5088,0.11708,63,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000115241,1,1,1,0,0,1,32254.717802479194,78751.06843456876,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,PPM1G,0.674,4.0766,0.4787,0,0.5,-1.0,,
ENSG00000115310,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RTN4,0.454,-3.1093,-2.4443,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000115423,1,1,1,0,1,1,3400.4411583487367,3400.4411583487367,2014-08-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DNAH6,0.25,3.4249,1.7761,0,0.5,0.5,,
ENSG00000115457,1,1,0,0,0,1,4074.958527607362,4074.958527607362,2012-09-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IGFBP2,0.01999998,0.67465,-1.1979,1,0.5,-1.0,,
ENSG00000115468,2,1,1,0,0,1,220837.49604317299,882833.0320407465,2023-03-17,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,EFHD1,-0.12100005,-0.58425,-1.5686,0,0.5,0.0,,
ENSG00000115556,1,1,1,0,0,0,136856.22408102124,136856.22408102124,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PLCD4,0.19700003,1.9351,2.2222,1,0.75,0.0,,
ENSG00000115694,1,1,0,0,0,1,448058.917711015,448058.917711015,2023-11-10,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STK25,0.296,2.5215,0.074369,0,0.5,-1.0,,
ENSG00000115866,2,1,0,0,0,1,98519.86755375637,99555.73125976526,2024-07-19,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DARS1,-0.023000002,0.94301,0.25015,3,-1.0,-1.0,tRNA Aminoacylation;Developmental Biology;Cytosolic tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-1266738;R-HSA-379716;R-HSA-72766
ENSG00000115902,1,1,1,0,0,1,2982.5449101796407,3332.1274147143445,2021-03-02,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC1A4,0.20499998,1.4682,-0.1253,1,0.5,-1.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000116218,1,1,0,0,1,1,286678.73247515375,286678.73247515375,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,NPHS2,-0.319,0.04525,-1.0765,1,1.0,0.5,,
ENSG00000116497,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,S100PBP,0.47399998,-0.049745,0.41968,0,-1.0,-1.0,,
ENSG00000116560,1,1,0,0,0,1,322220.1169395476,322220.1169395476,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SFPQ,0.71599996,0.11922,-5.8356,2,-1.0,-1.0,Signal Transduction;Disease;Response of Mtb to phagocytosis;Infection with Mycobacterium tuberculosis,R-HSA-162582;R-HSA-1643685;R-HSA-9637690;R-HSA-9635486
ENSG00000116954,2,1,0,0,0,1,121238.60518192011,167129.38535790148,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,RRAGC,0.45499998,1.8505,-0.5692,7,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;mTORC1-mediated signalling;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;Amino acids regulate mTORC1;MTOR signalling;Cellular response to starvation,R-HSA-162582;R-HSA-212436;R-HSA-166208;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-9639288;R-HSA-165159;R-HSA-9711097
ENSG00000116996,1,1,0,0,0,1,25967.06754524981,25967.06754524981,2023-08-31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZP4,-0.17400002,-1.1944,-1.0008,1,1.0,1.0,Interaction With Cumulus Cells And The Zona Pellucida;Fertilization,R-HSA-2534343;R-HSA-1187000
ENSG00000117143,1,1,1,0,0,0,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,UAP1,0.375,1.1087,0.6054,1,0.5,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000117148,2,1,0,0,0,1,449855.9086123723,1129585.974638378,2021-01-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ACTL8,0.24400002,1.9958,-0.40194,0,1.0,1.0,,
ENSG00000117281,1,1,0,0,0,1,84270.16077055593,84270.16077055593,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CD160,0.12400001,1.0647,0.55381,1,0.75,0.5,Immune System,R-HSA-168256
ENSG00000117594,1,1,0,0,0,1,254380.61820530874,254380.61820530874,2023-05-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,HSD11B1,0.024999976,1.7275,0.47704,2,1.0,0.0,Prednisone ADME;Metabolism of steroids,R-HSA-9757110;R-HSA-8957322
ENSG00000117616,1,1,1,0,0,1,62043.890063935265,62043.890063935265,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RSRP1,-0.42299998,0.24053,0.11746,0,-1.0,0.0,,
ENSG00000117758,1,1,0,0,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STX12,0.431,0.48256,0.64775,0,-1.0,-1.0,,
ENSG00000117859,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,OSBPL9,0.58500004,3.5802,1.4834,1,-1.0,-1.0,Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000118242,1,1,0,0,0,1,1409.8320610687024,1409.8320610687024,2009-07-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MREG,-0.599,-0.2548,-0.2214,0,0.5,0.0,,
ENSG00000118402,1,1,0,0,0,1,57274.55741575397,63475.2016898578,2024-07-19,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ELOVL4,0.351,1.718,0.7486,1,0.5,0.0,Synthesis of very long-chain fatty acyl-CoAs;Fatty acyl-CoA biosynthesis,R-HSA-75876;R-HSA-75105
ENSG00000118520,1,1,1,1,0,1,275021.63051358337,765591.3646788632,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ARG1,0.167,0.58597,0.12382,2,1.0,0.5,Immune System,R-HSA-168256
ENSG00000119004,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CYP20A1,-0.61099994,0.17444,0.035011,0,-1.0,0.0,,
ENSG00000119688,1,1,1,0,1,1,82999.78609625668,108816.31098183901,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,3,ABCD4,0.22799999,0.53147,-0.12126,3,-1.0,-1.0,Transport of RCbl within the body;Disease,R-HSA-9758890;R-HSA-1643685
ENSG00000119915,1,1,0,0,0,1,160010.51072069994,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ELOVL3,-0.13399994,1.5541,0.69748,5,1.0,0.5,Synthesis of very long-chain fatty acyl-CoAs;Developmental Biology;Fatty acyl-CoA biosynthesis,R-HSA-75876;R-HSA-1266738;R-HSA-75105
ENSG00000119977,1,1,1,0,0,1,37323.99073154585,270756.050710225,2023-01-18,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,TCTN3,0.061999977,0.8676,0.82321,1,-1.0,-1.0,,
ENSG00000120054,1,1,0,0,0,0,90049.68162979394,90049.68162979394,2021-08-24,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CPN1,-0.00999999,1.0034,0.83532,1,1.0,0.5,Immune System,R-HSA-168256
ENSG00000120075,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HOXB5,0.078999996,0.73171,0.19333,0,0.5,0.0,,
ENSG00000120093,1,1,0,0,0,0,38913.031770896094,38913.031770896094,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HOXB3,0.035000026,-0.63362,-1.4567,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000120149,1,1,0,0,0,1,41642.5373617829,67051.76345250831,2024-07-19,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,MSX2,-0.013000011,0.18263,-0.44772,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000120686,1,1,0,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,UFM1,0.14999998,0.40604,0.41069,0,-1.0,-1.0,,
ENSG00000120725,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SIL1,-0.023000002,1.3969,0.1247,0,-1.0,-1.0,,
ENSG00000120837,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NFYB,0.123000026,2.6178,-0.15608,5,-1.0,-1.0,ATF6 (ATF6-alpha) activates chaperone genes;ATF6 (ATF6-alpha) activates chaperones;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);PERK regulates gene expression;ATF4 activates genes in response to endoplasmic reticulum  stress;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-381183;R-HSA-381033;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-381042;R-HSA-380994;R-HSA-8957322;R-HSA-1655829
ENSG00000121653,1,1,1,0,0,1,272025.74568937684,272025.74568937684,2018-10-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MAPK8IP1,0.616,1.5995,-0.21825,0,0.75,-1.0,,
ENSG00000121871,2,1,0,0,0,1,4804.684371102268,11101.688409289527,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLITRK3,0.63600004,1.3396,-1.699,2,0.5,0.0,Signal Transduction;Receptor-type tyrosine-protein phosphatases,R-HSA-162582;R-HSA-388844
ENSG00000122035,1,1,1,0,0,1,38913.031770896094,38913.031770896094,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RASL11A,-0.27600002,0.61892,-0.62319,0,-1.0,0.0,,
ENSG00000122042,1,1,0,0,0,1,52266.74459856323,75902.72761298594,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,UBL3,0.30800003,1.1057,0.044726,0,-1.0,-1.0,,
ENSG00000122223,1,1,0,0,0,1,34004.8644513982,34004.8644513982,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CD244,0.499,0.69468,-0.38025,1,0.5,0.0,,
ENSG00000122483,1,1,1,0,0,1,78751.06843456876,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CCDC18,0.09899998,1.0462,0.74417,0,0.5,0.0,,
ENSG00000122965,1,1,0,0,0,1,2651.987951807229,2651.987951807229,2014-09-07,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RBM19,0.047999978,0.9541,0.69424,0,-1.0,-1.0,,
ENSG00000123091,1,1,0,0,0,1,545988.1005477115,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RNF11,0.463,1.66,0.55206,0,-1.0,-1.0,,
ENSG00000123124,1,1,1,0,0,1,221280.45048451523,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,WWP1,0.532,3.3077,1.0756,4,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Downregulation of ERBB4 signaling;Stimuli-sensing channels;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1253288;R-HSA-2672351;R-HSA-9006934
ENSG00000123179,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EBPL,-0.41199994,0.054108,-0.5341,0,0.5,-1.0,,
ENSG00000123200,1,1,1,0,0,0,765591.3646788632,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ZC3H13,0.624,2.6074,1.1024,0,-1.0,-1.0,,
ENSG00000123360,1,1,0,0,0,1,26841.183331692897,26841.183331692897,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,PDE1B,0.623,2.9474,1.05,3,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000123609,1,1,1,0,1,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NMI,-0.46000004,0.67659,0.54319,1,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000124205,1,1,1,0,0,1,42879.69557188197,160010.51072069994,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,4,EDN3,0.30400002,-0.0517,0.0054371,3,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000124237,3,1,0,0,0,1,33892.13656698846,33892.13656698846,2015-12-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CIMIP1,-0.32700002,-0.22837,-0.34316,0,1.0,0.5,,
ENSG00000124564,1,1,0,0,0,0,292977.1806919819,292977.1806919819,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SLC17A3,-0.181,-0.057024,1.0453,1,1.0,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000124574,1,1,0,0,0,1,35617.65636301977,35617.65636301977,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ABCC10,0.106000006,2.2209,1.4442,1,-1.0,-1.0,,
ENSG00000124767,1,1,0,1,1,0,196178.71491042234,196178.71491042234,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GLO1,,,,1,-1.0,-1.0,Pyruvate metabolism,R-HSA-70268
ENSG00000124920,1,1,0,0,0,1,2201.586503948313,2201.586503948313,2017-12-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MYRF,0.78499997,3.5595,0.10973,0,0.75,0.0,,
ENSG00000124935,2,1,0,0,1,1,41179.92526801346,97257.17815683526,2023-01-18,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SCGB1D2,-0.70500004,-0.23694,0.42536,0,0.75,0.0,,
ENSG00000125107,2,1,1,0,0,1,15866.724081734988,323648.5577791949,2015-07-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,CNOT1,0.936,9.1629,0.68676,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000125266,1,1,0,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,EFNB2,0.73899996,3.1166,0.30199,4,-1.0,0.0,Ephrin signaling;Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-3928664;R-HSA-1266738;R-HSA-3928665
ENSG00000125458,1,1,1,0,0,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NT5C,-0.18700004,-1.7993,-2.7439,2,-1.0,-1.0,Purine catabolism;Metabolism of nucleotides,R-HSA-74259;R-HSA-15869
ENSG00000125533,1,1,0,0,0,1,72098.8014618248,72098.8014618248,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BHLHE23,-0.89199996,-2.8041,-3.3999,0,,,,
ENSG00000125630,2,1,0,0,0,1,207220.14223281175,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,POLR1B,0.63699996,4.7517,0.9814,5,-1.0,-1.0,RNA Polymerase I Transcription Termination;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance,R-HSA-73863;R-HSA-74160;R-HSA-73772;R-HSA-5250941;R-HSA-427413;R-HSA-73762;R-HSA-73864;R-HSA-73854
ENSG00000125743,1,1,0,0,0,1,157277.57551067916,157277.57551067916,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,SNRPD2,0.604,2.4566,0.07252,4,-1.0,-1.0,mRNA Splicing - Minor Pathway;Disease;snRNP Assembly;Metabolism of non-coding RNA,R-HSA-72165;R-HSA-1643685;R-HSA-191859;R-HSA-194441
ENSG00000125780,8,1,1,0,1,1,10352.610157160763,367949.31877243903,2014-01-08,51,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51,TGM3,0.10500002,0.1736,-0.025904,0,1.0,0.0,,
ENSG00000125818,1,1,1,0,0,1,22541.01007366447,22541.01007366447,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PSMF1,-0.38199997,0.46466,0.61057,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000125826,2,1,0,0,0,1,54297.13859953472,78728.4671948324,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,RBCK1,0.110000014,1.3172,-1.1535,4,-1.0,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000125931,1,1,0,0,1,1,145320.08042080907,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,CITED1,,,,2,1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8864260
ENSG00000125944,1,1,1,0,0,0,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,HNRNPR,0.871,4.0518,1.1431,2,-1.0,-1.0,,
ENSG00000126464,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PRR12,0.82,-1.0343,-6.1211,0,-1.0,-1.0,,
ENSG00000126561,2,1,0,0,0,1,53369.71648873449,382631.1172224132,2019-03-28,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,STAT5A,0.63600004,4.4037,2.3499,22,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202
ENSG00000126602,1,1,1,0,1,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TRAP1,-0.34300005,-3.3842,-3.355,2,-1.0,-1.0,Citric acid cycle (TCA cycle),R-HSA-71403
ENSG00000126733,1,1,0,0,0,0,72098.8014618248,72098.8014618248,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DACH2,,,,0,0.75,0.5,,
ENSG00000127054,1,1,0,0,0,0,87248.80974040499,87248.80974040499,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,INTS11,-0.22300005,-0.90214,-3.8573,1,-1.0,-1.0,,
ENSG00000127220,4,1,1,0,0,1,4516.91487502968,51251.954839862,2020-05-18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ABHD8,0.33600003,0.98917,-0.22497,0,0.5,-1.0,,
ENSG00000127325,1,1,1,0,0,1,125894.9248389576,545988.1005477115,2018-06-11,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,BEST3,-0.27499998,1.0688,0.99704,1,0.75,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000127445,1,1,0,0,0,1,466632.7979326389,466632.7979326389,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PIN1,-0.176,0.63017,-0.3239,5,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);ISG15 antiviral mechanism,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1169408
ENSG00000127527,1,1,0,0,0,1,11635.351260982607,38092.548464040476,2013-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,3,EPS15L1,0.547,2.5635,0.98439,3,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000128266,1,1,0,0,0,1,21836.040905626443,66821.18426408028,2019-11-15,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,GNAZ,0.698,4.4401,0.1197,5,0.5,0.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000128487,1,1,1,0,0,1,116547.04276487474,131525.74533408263,2018-10-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,SPECC1,0.24800003,0.78852,0.33927,0,-1.0,-1.0,,
ENSG00000128513,5,1,1,0,1,1,15891.17875483048,100075.58738100652,2020-06-08,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,POT1,0.12900001,1.6079,0.25584,14,-1.0,-1.0,"Depyrimidination;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine;Base-Excision Repair, AP Site Formation;Inhibition of DNA recombination at telomere",R-HSA-73928;R-HSA-110328;R-HSA-110329;R-HSA-73929;R-HSA-9670095
ENSG00000128564,1,1,1,0,0,1,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,VGF,0.13599998,-2.4917,-3.7343,3,0.75,0.5,Signal Transduction;Signaling by Receptor Tyrosine Kinases;Post-translational protein modification,R-HSA-162582;R-HSA-9006934;R-HSA-597592
ENSG00000128626,1,1,1,0,0,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MRPS12,-0.56799996,-0.037594,0.095576,3,-1.0,-1.0,,
ENSG00000128710,1,1,0,0,0,0,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,HOXD10,0.194,0.24151,-0.43371,0,0.5,0.0,,
ENSG00000128789,2,1,0,0,0,1,78751.06843456876,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,PSMG2,0.21200001,0.077288,-0.33398,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000128891,1,1,1,0,0,0,232586.34864014547,406587.2658730814,2021-01-04,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CCDC32,0.24000001,0.49157,1.1427,0,-1.0,-1.0,,
ENSG00000128923,3,1,0,0,0,1,1321.7688442211056,340825.7076940272,2021-03-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,5,MINDY2,-0.01699996,-1.2077,-1.648,0,-1.0,-1.0,,
ENSG00000129167,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TPH1,0.078999996,1.0777,1.2789,2,0.75,0.5,Signal Transduction;Metabolism of amine-derived hormones;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-209776;R-HSA-9006934
ENSG00000129173,1,1,0,0,0,1,107273.75397646755,112218.78632625614,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,E2F8,0.46100003,1.547,0.79692,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000129474,2,1,1,0,0,1,324308.4770735607,414433.58532016096,2024-07-19,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,AJUBA,0.41900003,1.5197,-0.40769,4,0.5,0.0,Developmental Biology;Gene expression (Transcription);Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,R-HSA-1266738;R-HSA-74160;R-HSA-1234176
ENSG00000129562,1,1,0,0,0,1,1296.515474378488,22669.576834673207,2009-05-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,5,DAD1,0.041999996,0.85016,0.51595,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000130177,1,1,1,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CDC16,0.343,1.2685,-0.079976,18,-1.0,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000130338,1,1,0,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TULP4,0.805,1.9436,-2.1835,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000130413,1,1,1,0,0,0,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STK33,-0.011000037,-0.41847,-0.45644,0,0.5,0.0,,
ENSG00000130598,1,1,0,0,0,1,500292.45069431677,500292.45069431677,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TNNI2,0.17799997,1.1774,-1.2611,1,0.75,0.0,,
ENSG00000130638,1,1,0,0,0,1,36494.548446257475,36494.548446257475,2024-01-03,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ATXN10,0.28100002,0.39062,0.078923,0,-1.0,-1.0,,
ENSG00000130741,2,1,1,0,0,1,129783.42151918238,182108.85640724926,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,EIF2S3,,,,12,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;PERK regulates gene expression;Translation;Cellular response to starvation,R-HSA-1280215;R-HSA-168256;R-HSA-381042;R-HSA-72766;R-HSA-9711097
ENSG00000130768,1,1,0,0,1,0,2201.586503948313,2201.586503948313,2017-12-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SMPDL3B,-0.029000044,1.4874,0.63131,0,0.5,0.0,,
ENSG00000130939,2,1,0,0,0,1,138890.6106237268,303059.79257468163,2018-06-11,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,UBE4B,0.763,4.8756,1.1052,0,-1.0,-1.0,,
ENSG00000131050,1,1,0,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,BPIFA2,-0.12199998,0.30581,0.30248,1,1.0,0.5,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000131069,1,1,1,0,0,0,117707.74532698281,117707.74532698281,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ACSS2,0.21499997,1.6667,0.81016,2,0.5,-1.0,,
ENSG00000131508,1,1,1,0,0,0,48013.53134222642,138626.81357188412,2024-07-19,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,UBE2D2,0.765,3.6613,-0.16021,15,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;IKK complex recruitment mediated by RIP1;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Peroxisomal protein import;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-937041;R-HSA-8866652;R-HSA-9033241;R-HSA-8866654;R-HSA-8852135;R-HSA-1234176;R-HSA-597592
ENSG00000131669,1,1,1,0,0,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,NINJ1,-0.103000045,0.96412,-0.34387,0,0.5,-1.0,,
ENSG00000131899,1,1,1,0,0,1,88551.50890979878,88551.50890979878,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LLGL1,0.33200002,2.458,-1.0507,0,1.0,-1.0,,
ENSG00000131969,2,1,1,0,1,1,51767.214940712445,88632.90640619362,2021-02-25,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ABHD12B,-0.148,-0.86724,-0.67676,0,0.75,0.5,,
ENSG00000132199,1,1,1,0,0,0,143284.77790855977,355284.1215006515,2023-01-18,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,ENOSF1,-0.23599994,-0.12381,-0.086905,0,-1.0,-1.0,,
ENSG00000132432,3,1,0,0,0,1,12699.772939551405,29591.455690009458,2017-03-27,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SEC61G,-0.615,0.65692,0.38448,3,-1.0,-1.0,Immune System;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-168256;R-HSA-9609523;R-HSA-72766;R-HSA-1799339
ENSG00000132471,1,1,1,0,0,1,45809.99756555466,45809.99756555466,2021-11-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,WBP2,-0.07799995,-0.080367,-1.1551,0,-1.0,-1.0,,
ENSG00000132704,1,1,0,0,0,1,258213.8601133611,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FCRL2,-0.024000049,-0.33524,-0.25276,0,0.75,0.5,,
ENSG00000133048,1,1,1,1,0,0,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,CHI3L1,0.0,0.2253,-0.38916,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000133063,1,1,0,0,0,1,444537.33605315426,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,CHIT1,-0.14699996,0.59405,-0.0056865,2,0.5,0.0,Immune System;Digestion and absorption;Digestion,R-HSA-168256;R-HSA-8963743;R-HSA-8935690
ENSG00000133107,1,1,0,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TRPC4,0.39,3.1525,-0.24353,2,0.5,0.0,Developmental Biology;Role of second messengers in netrin-1 signaling;Stimuli-sensing channels,R-HSA-1266738;R-HSA-418890;R-HSA-2672351
ENSG00000133226,1,1,0,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SRRM1,0.775,2.3387,-0.39261,6,-1.0,-1.0,Signal Transduction;RNA Polymerase II Transcription;Gene expression (Transcription);RHOBTB1 GTPase cycle;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-73857;R-HSA-74160;R-HSA-9013422;R-HSA-159236;R-HSA-72202;R-HSA-9706574
ENSG00000133619,1,1,1,0,0,0,195005.6685718255,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KRBA1,-0.21300006,-1.0638,-0.83132,1,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000133639,1,1,0,0,0,1,116547.04276487474,323648.5577791949,2018-10-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,BTG1,0.542,1.522,-1.7359,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000133665,1,1,1,0,0,1,16954.933657438592,16954.933657438592,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DYDC2,-0.40400004,0.93766,0.54206,0,0.75,0.5,,
ENSG00000134115,1,1,0,0,0,1,9214.060823091124,9214.060823091124,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CNTN6,-0.31599998,-3.4526,-3.1705,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000134201,1,1,1,0,0,1,53449.348719171874,53449.348719171874,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GSTM5,-0.06700003,-0.39681,0.50237,1,1.0,0.0,Glutathione conjugation;Phase II - Conjugation of compounds,R-HSA-156590;R-HSA-156580
ENSG00000134256,2,1,1,0,0,1,84563.14597380339,260210.21963428933,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CD101,0.111,1.3609,0.69623,1,0.5,0.5,Immune System,R-HSA-168256
ENSG00000134317,3,1,1,0,1,1,72098.8014618248,521818.7070055739,2021-01-04,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,GRHL1,0.16600001,2.1723,0.65511,1,0.5,0.0,,
ENSG00000134438,1,1,0,0,0,1,96018.8961005241,96018.8961005241,2024-07-19,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RAX,-0.19700003,-1.0259,-1.6435,0,0.75,0.5,,
ENSG00000134461,1,1,0,0,0,1,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,ANKRD16,-0.35599995,-0.7237,-1.1219,0,-1.0,-1.0,,
ENSG00000134533,1,1,0,0,0,1,223386.61486493575,223386.61486493575,2023-03-13,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RERG,-0.528,-0.088827,0.59097,0,0.5,0.0,,
ENSG00000134698,1,1,0,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,AGO4,0.607,4.4551,1.4549,23,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);MicroRNA (miRNA) biogenesis;Disease;Gene Silencing by RNA;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-203927;R-HSA-1643685;R-HSA-211000;R-HSA-5663202
ENSG00000134851,1,1,1,0,0,1,598869.4096893278,598869.4096893278,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TMEM165,-0.07099998,0.69446,-1.158,0,-1.0,-1.0,,
ENSG00000134905,1,1,1,0,0,1,122069.83349127392,122069.83349127392,2017-12-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CARS2,-0.22500002,-1.0737,-1.4058,1,-1.0,-1.0,tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-379726;R-HSA-72766
ENSG00000135090,1,1,0,0,0,0,23238.11336553945,23238.11336553945,2020-01-31,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TAOK3,0.661,3.6534,1.2753,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000135127,1,1,0,0,0,1,56739.697999163676,56739.697999163676,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BICDL1,0.556,0.53501,-2.1986,0,0.5,0.0,,
ENSG00000135144,1,1,0,0,0,1,54391.03477538057,54391.03477538057,2021-09-30,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DTX1,0.26,1.3033,-1.3786,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000135226,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,UGT2B28,-0.45799994,-0.81972,-0.28687,2,1.0,0.5,Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000135269,2,1,1,0,0,1,29803.01405728205,414433.58532016096,2018-06-11,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,TES,-0.120000005,1.0923,0.69359,0,0.5,-1.0,,
ENSG00000135298,2,1,0,0,0,0,433862.5685735124,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ADGRB3,0.754,2.427,-0.397,0,0.75,0.0,,
ENSG00000135318,1,1,0,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NT5E,-0.25399995,0.64818,0.52084,4,0.5,0.0,Disease;Purine catabolism;Metabolism of nucleotides,R-HSA-1643685;R-HSA-74259;R-HSA-15869
ENSG00000135457,1,1,0,0,0,0,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TFCP2,0.436,3.4575,0.7021,0,-1.0,-1.0,,
ENSG00000135540,1,1,1,0,0,1,44692.894702471654,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NHSL1,0.362,0.97543,1.0106,0,0.5,0.0,,
ENSG00000135698,3,1,1,0,1,1,72659.90666629994,521818.7070055739,2020-04-27,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,MPHOSPH6,-0.6,-2.2195,-1.9416,2,-1.0,-1.0,Nuclear RNA decay;rRNA processing,R-HSA-9930044;R-HSA-72312
ENSG00000135736,1,1,1,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CCDC102A,-0.13,-0.80329,-0.97357,0,-1.0,0.0,,
ENSG00000135749,2,1,0,0,0,1,10345.632006286014,26685.217785743116,2017-02-14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,PCNX2,0.134,1.2273,0.6435,0,0.5,0.0,,
ENSG00000135913,2,1,1,0,0,1,97181.90375256384,205425.60717824215,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,USP37,0.719,3.0618,0.92936,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000135919,1,1,1,1,0,1,109001.36551434857,109001.36551434857,2022-10-12,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SERPINE2,0.352,1.5224,0.29862,3,0.75,-1.0,,
ENSG00000136099,1,1,0,0,0,1,112068.90873552008,112068.90873552008,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PCDH8,-0.14600003,-2.2748,-3.9375,0,1.0,0.5,,
ENSG00000136167,1,1,1,0,0,1,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,LCP1,0.61,2.6522,1.2867,1,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000136810,1,1,1,0,0,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TXN,-0.47099996,1.3092,-0.065532,9,0.5,-1.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Interconversion of nucleotide di- and triphosphates;Metabolism of nucleotides,R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-499943;R-HSA-15869
ENSG00000136854,1,1,1,0,0,1,278190.43024910334,521818.7070055739,2023-08-23,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,STXBP1,0.901,5.8468,1.428,8,0.5,-1.0,"GABA synthesis, release, reuptake and degradation;Acetylcholine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Neurotransmitter release cycle",R-HSA-888590;R-HSA-264642;R-HSA-210500;R-HSA-212676;R-HSA-181429;R-HSA-112310
ENSG00000136925,1,1,1,0,1,1,105759.0908630975,105759.0908630975,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TSTD2,-0.023000002,0.6872,0.88394,0,-1.0,-1.0,,
ENSG00000136933,1,1,1,0,0,1,80065.63748488021,80065.63748488021,2022-07-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,RABEPK,-0.07099998,0.63918,0.35236,1,-1.0,-1.0,,
ENSG00000137075,1,1,0,0,0,1,4435.36939554283,4435.36939554283,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RNF38,0.61899996,1.5957,0.28362,0,-1.0,-1.0,,
ENSG00000137161,1,1,1,0,0,1,75715.46734074537,75715.46734074537,2023-01-18,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CNPY3,0.11799997,0.77674,0.19842,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000137414,3,1,1,0,0,1,11231.262381898725,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,4,FAM8A1,-0.24100006,-1.7483,-2.0956,0,-1.0,-1.0,,
ENSG00000137449,1,1,0,0,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,CPEB2,-0.32799995,-3.9218,-5.8081,0,-1.0,-1.0,,
ENSG00000137500,1,1,1,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CCDC90B,-0.11199999,-0.4792,-0.83532,0,-1.0,-1.0,,
ENSG00000137575,1,1,0,0,0,0,104829.95456615865,104829.95456615865,2018-11-30,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SDCBP,-0.09000003,0.84671,1.1596,5,-1.0,-1.0,Ephrin signaling;Immune System;Developmental Biology,R-HSA-3928664;R-HSA-168256;R-HSA-1266738
ENSG00000137727,1,1,0,0,0,1,138626.81357188412,143413.24457139417,2023-06-29,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ARHGAP20,0.38700002,1.266,0.27831,3,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000137745,1,1,0,0,0,1,25464.040702316375,25464.040702316375,2022-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MMP13,-0.06700003,0.58112,0.69379,5,1.0,1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX2 regulates genes involved in cell migration,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8941332
ENSG00000137760,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ALKBH8,0.20300001,0.54694,0.21861,1,-1.0,-1.0,,
ENSG00000137806,1,1,1,0,0,1,116566.20935579021,116566.20935579021,2023-01-18,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NDUFAF1,0.15899998,0.24644,1.4787,1,-1.0,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000137841,1,1,1,1,0,0,80746.41870861933,323648.5577791949,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,PLCB2,0.037999988,1.2513,-0.48191,9,0.5,0.0,Signal Transduction;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Presynaptic function of Kainate receptors;G beta:gamma signalling through PLC beta;Free fatty acids regulate insulin secretion;Acetylcholine regulates insulin secretion;Activation of kainate receptors upon glutamate binding;G-protein beta:gamma signalling,R-HSA-162582;R-HSA-434316;R-HSA-500657;R-HSA-418217;R-HSA-400451;R-HSA-399997;R-HSA-451326;R-HSA-397795
ENSG00000137860,1,1,1,0,0,0,407080.5516610372,407080.5516610372,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,SLC28A2,-0.17700005,0.86948,0.07815,3,1.0,0.5,"Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane;Azathioprine ADME;Transport of vitamins, nucleosides, and related molecules",R-HSA-83936;R-HSA-9748787;R-HSA-425397
ENSG00000137959,2,1,1,0,1,1,3031.996829799881,5382.953735491254,2014-10-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,IFI44L,-0.26600003,-0.82804,-0.16516,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000138286,1,1,0,0,1,0,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM149B1,0.01999998,0.80716,-0.29971,0,-1.0,-1.0,,
ENSG00000138308,1,1,0,0,0,1,90981.08128104238,90981.08128104238,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PLA2G12B,-0.29200006,1.4574,1.0159,0,0.5,0.5,,
ENSG00000138802,1,1,0,0,0,1,105759.0908630975,105759.0908630975,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SEC24B,0.55799997,0.66518,-0.33936,6,-1.0,-1.0,Immune System;Disease;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-8957322;R-HSA-1655829;R-HSA-597592
ENSG00000139055,1,1,1,0,0,1,158681.3360509801,158681.3360509801,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,ERP27,-0.07200003,-0.3622,-1.6297,0,1.0,0.0,,
ENSG00000139132,2,1,0,0,0,1,72170.02447217306,72170.02447217306,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FGD4,0.482,2.5067,0.37229,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000139291,2,1,1,0,0,1,5414.650230111769,5414.650230111769,2017-02-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TMEM19,0.07099998,0.28767,0.085422,0,-1.0,-1.0,,
ENSG00000139405,1,1,1,0,1,0,79958.75176875875,79958.75176875875,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RITA1,-0.92999995,0.7955,0.65495,0,-1.0,-1.0,,
ENSG00000139629,1,1,1,0,0,0,7794.273577144567,7794.273577144567,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,GALNT6,-0.024000049,1.4786,0.64784,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000139648,1,1,1,0,1,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KRT71,-0.116000056,-0.046822,-0.0052982,2,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000139746,1,1,1,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,RBM26,0.582,2.0943,0.34848,1,-1.0,-1.0,Nuclear RNA decay,R-HSA-9930044
ENSG00000139842,1,1,1,0,1,1,150669.89240227733,150669.89240227733,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CUL4A,0.676,2.9265,-1.1821,9,0.5,-1.0,Formation of TC-NER Pre-Incision Complex;Gap-filling DNA repair synthesis and ligation in TC-NER;Formation of Incision Complex in GG-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Post-translational protein modification,R-HSA-6781823;R-HSA-6782210;R-HSA-5696395;R-HSA-6782135;R-HSA-6781827;R-HSA-597592
ENSG00000139985,1,1,0,0,0,1,16534.94713490521,16534.94713490521,2024-11-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ADAM21,-0.913,2.3347,1.1668,1,1.0,0.5,Interaction With Cumulus Cells And The Zona Pellucida;Fertilization,R-HSA-2534343;R-HSA-1187000
ENSG00000140299,1,1,1,0,0,1,48662.99214856774,48662.99214856774,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,BNIP2,-0.047999978,-1.0956,-1.4857,1,0.5,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000140307,1,1,1,0,0,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GTF2A2,,,,10,-1.0,-1.0,Signal Transduction;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;RNA Polymerase II Pre-transcription Events;Transcription of the HIV genome;RNA polymerase II transcribes snRNA genes;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-162582;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-674695;R-HSA-167172;R-HSA-6807505;R-HSA-162587;R-HSA-162599
ENSG00000140350,1,1,0,0,0,1,4074.958527607362,4074.958527607362,2011-06-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ANP32A,0.857,3.2971,0.58073,1,-1.0,-1.0,,
ENSG00000140365,1,1,0,0,0,1,130268.25219927442,294387.2978738704,2020-06-08,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,COMMD4,0.018000007,0.11956,-0.20488,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000140463,1,1,1,0,1,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,BBS4,0.04699999,-0.37523,0.16178,1,-1.0,-1.0,BBSome-mediated cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620922;R-HSA-5620920
ENSG00000140521,3,1,0,0,0,1,131525.74533408263,225895.43837715342,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,POLG,0.153,-0.43598,-1.6669,1,-1.0,0.0,TBC/RABGAPs;Rab regulation of trafficking,R-HSA-8854214;R-HSA-9007101
ENSG00000140749,2,1,0,0,0,1,225895.43837715342,1122672.658801146,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,IGSF6,-0.765,0.3617,0.57452,0,1.0,0.0,,
ENSG00000141034,1,1,0,0,0,1,103877.27822338727,116547.04276487474,2017-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,GID4,0.29799998,-1.0091,-2.1651,1,0.5,-1.0,Regulation of pyruvate metabolism;Pyruvate metabolism,R-HSA-9861718;R-HSA-70268
ENSG00000141127,1,1,0,0,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,PRPSAP2,0.21399999,3.0871,0.73566,0,-1.0,-1.0,,
ENSG00000141556,1,1,1,0,0,1,275248.1975391687,322107.4898639223,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,TBCD,0.23699999,0.89228,-1.5853,1,-1.0,-1.0,Post-chaperonin tubulin folding pathway,R-HSA-389977
ENSG00000141570,1,1,1,0,1,1,33670.70607708678,33670.70607708678,2015-04-01,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CBX8,0.572,0.22172,-1.9379,8,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);SUMOylation of RNA binding proteins;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-4570464;R-HSA-597592
ENSG00000141741,1,1,0,0,0,1,26873.80285776456,26873.80285776456,2017-07-17,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,MIEN1,-0.45200002,-0.75689,-0.39884,0,-1.0,-1.0,,
ENSG00000142182,1,1,0,0,0,1,124837.11004999638,124837.11004999638,2022-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,DNMT3L,-0.17900002,0.15019,0.46649,2,0.5,1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000142188,2,1,1,0,0,1,78751.06843456876,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,TMEM50B,0.045000017,1.1536,-0.21275,0,-1.0,-1.0,,
ENSG00000142230,1,1,1,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,SAE1,0.51,1.4241,0.017679,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000142405,1,1,0,0,0,1,17115.61307125707,17115.61307125707,2017-06-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NLRP12,-0.33599997,-0.98489,-0.25443,1,0.75,0.5,Disease,R-HSA-1643685
ENSG00000142494,1,1,1,0,0,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SLC47A1,-0.10500002,0.27647,0.41322,1,0.5,0.0,,
ENSG00000142534,1,1,1,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RPS11,0.855,2.3459,-1.7489,18,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000142669,1,1,1,0,0,1,195005.6685718255,275021.63051358337,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SH3BGRL3,-0.21399999,-0.048512,-0.20319,0,-1.0,-1.0,,
ENSG00000142867,1,1,1,0,0,1,36204.236233123425,38092.548464040476,2013-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2,BCL10,0.36299998,1.844,-0.34934,5,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000142973,1,1,1,0,0,1,17601.10520641419,17601.10520641419,2024-10-03,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CYP4B1,-0.016000032,0.35604,0.4175,4,0.5,0.0,Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonate metabolism,R-HSA-211979;R-HSA-2142691;R-HSA-2142753
ENSG00000143036,2,1,0,0,0,1,69453.1498757531,672632.4785173276,2021-04-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC44A3,-0.176,1.3502,-0.0057892,2,-1.0,0.0,,
ENSG00000143106,1,1,0,0,1,0,91172.20051337926,91172.20051337926,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,PSMA5,0.681,3.3912,0.39047,63,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000143157,1,1,1,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,POGK,0.581,4.035,1.4741,0,-1.0,-1.0,,
ENSG00000143278,2,1,0,1,0,1,31971.308488731265,378712.0243337037,2024-07-19,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,F13B,0.10699999,0.62963,-0.29666,1,1.0,1.0,,
ENSG00000143333,1,1,0,0,1,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,RGS16,0.009000003,0.34153,0.89229,3,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000143337,1,1,1,0,0,0,38851.92581543917,521818.7070055739,2023-08-23,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TOR1AIP1,0.13099998,-0.085041,-0.21993,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000143374,1,1,0,0,0,0,116547.04276487474,116547.04276487474,2018-10-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TARS2,0.24000001,2.9103,0.40097,1,-1.0,-1.0,tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-379726;R-HSA-72766
ENSG00000143458,1,1,0,0,0,1,225599.91693237546,225599.91693237546,2023-10-04,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GABPB2,0.148,1.6122,1.0891,0,-1.0,-1.0,,
ENSG00000143498,2,1,1,0,0,1,95470.48963056858,159902.65410399486,2023-11-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,TAF1A,0.199,1.6161,0.14,6,-1.0,-1.0,SIRT1 negatively regulates rRNA expression;RNA Polymerase I Transcription Termination;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance,R-HSA-427359;R-HSA-73863;R-HSA-74160;R-HSA-73772;R-HSA-5250941;R-HSA-427413;R-HSA-73762;R-HSA-73864;R-HSA-73854
ENSG00000143536,1,1,0,0,0,1,44660.84794838759,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CRNN,-0.11099994,0.4014,0.079625,0,0.5,0.0,,
ENSG00000143614,1,1,0,0,0,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GATAD2B,0.764,3.9897,-0.15484,9,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Regulation of endogenous retroelements by KRAB-ZFP proteins;Disease;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-427389;R-HSA-9843940;R-HSA-1643685;R-HSA-73762;R-HSA-73864;R-HSA-73854
ENSG00000143630,1,1,1,0,0,0,575147.0632428399,575147.0632428399,2024-07-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HCN3,0.18400002,1.8806,0.54672,1,0.5,0.0,,
ENSG00000143816,1,1,0,0,0,1,2201.586503948313,2201.586503948313,2017-12-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,WNT9A,0.45599997,0.7242,-1.1272,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000143842,1,1,1,0,0,1,278190.43024910334,521818.7070055739,2023-08-23,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SOX13,0.36900002,2.0361,-0.083369,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000143850,1,1,1,0,0,1,155552.2805078301,155552.2805078301,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PLEKHA6,0.30800003,0.63162,1.4398,1,-1.0,0.0,,
ENSG00000144015,1,1,0,0,0,1,46629.15803069246,62282.85017627731,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,TRIM43,0.28100002,2.0171,1.5349,0,,,,
ENSG00000144214,1,1,0,0,0,1,42879.69557188197,42879.69557188197,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,LYG1,-0.075999975,0.99997,0.63887,0,1.0,0.0,,
ENSG00000144228,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SPOPL,0.41500002,0.75697,-0.30369,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000144339,2,1,0,0,0,1,415452.66715166246,598869.4096893278,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,TMEFF2,0.31699997,1.9614,0.33646,0,0.5,0.5,,
ENSG00000144488,1,1,0,0,0,1,135108.48254553688,135108.48254553688,2025-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ESPNL,-0.651,-3.0173,-2.3421,2,0.5,0.5,,
ENSG00000144655,2,1,0,0,0,1,225895.43837715342,225895.43837715342,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CSRNP1,0.38599998,1.2106,0.12414,0,0.5,-1.0,,
ENSG00000144730,2,1,1,0,0,1,26895.554637812835,26895.554637812835,2022-01-29,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,IL17RD,0.047999978,-0.66188,-0.60091,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000144736,2,1,1,0,1,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,SHQ1,-0.23899996,-0.19763,0.76055,1,-1.0,-1.0,,
ENSG00000144893,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MED12L,0.774,4.0075,0.94488,0,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000145088,1,1,1,0,0,0,142905.851430916,142905.851430916,2019-03-28,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,EAF2,-0.13600004,0.57549,0.18387,3,0.5,0.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation,R-HSA-73857;R-HSA-74160;R-HSA-674695;R-HSA-112382;R-HSA-75955
ENSG00000145192,1,1,0,1,1,1,11608.613380386345,13959.203480505423,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,AHSG,-0.042000055,0.14138,1.4171,4,1.0,0.5,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000145246,1,1,0,0,0,1,67142.73298165268,67142.73298165268,2023-11-30,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATP10D,0.29299998,1.7075,1.6958,1,-1.0,-1.0,,
ENSG00000145348,1,1,0,0,0,1,444537.33605315426,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,TBCK,-0.062000036,0.49858,-0.5399,0,-1.0,-1.0,,
ENSG00000145495,1,1,0,0,0,1,6990.419804844821,6990.419804844821,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MARCHF6,0.686,3.9835,0.87646,1,-1.0,-1.0,ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification,R-HSA-901032;R-HSA-901042;R-HSA-532668;R-HSA-597592
ENSG00000145907,1,1,1,0,0,1,187203.10687937262,189557.6027707886,2024-01-05,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,G3BP1,-0.16100001,0.62588,0.56183,1,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000146006,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LRRTM2,0.449,2.6266,0.93235,1,1.0,0.5,,
ENSG00000146192,2,1,1,0,0,1,43039.044982671156,183579.49764748462,2022-08-20,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FGD2,0.10699999,1.0957,0.09959,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000146221,1,1,1,0,1,1,16464.037617731923,41299.82664585649,2020-06-08,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,DRC5,-0.21700001,0.74016,1.479,0,0.75,0.5,,
ENSG00000146232,1,1,0,1,1,1,2209.8301559792026,124837.11004999638,2012-03-25,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,9,NFKBIE,0.34500003,1.6308,0.14306,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000146250,1,1,0,0,0,1,466632.7979326389,466632.7979326389,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PRSS35,-0.459,-0.24761,0.078094,0,0.5,0.0,,
ENSG00000146360,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPR6,-0.13699996,0.20034,-1.925,0,1.0,0.5,,
ENSG00000146416,2,1,1,0,0,1,156470.480665571,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,AIG1,-0.27900004,0.076739,0.10914,0,0.5,-1.0,,
ENSG00000146457,1,1,1,0,0,1,220837.49604317299,278190.43024910334,2023-08-23,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,WTAP,0.657,2.9385,-0.38767,1,-1.0,-1.0,,
ENSG00000146955,1,1,0,0,0,0,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RAB19,-0.63199997,0.51236,-0.48806,1,0.5,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000147223,2,1,0,0,0,1,7502.407941951862,294387.2978738704,2021-09-30,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,RIPPLY1,,,,0,0.5,0.5,,
ENSG00000147231,1,1,0,0,0,1,5916.919614951869,5916.919614951869,2017-07-28,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RADX,,,,0,0.5,0.0,,
ENSG00000147316,1,1,0,0,0,0,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MCPH1,-0.342,-4.7142,-3.3146,1,-1.0,-1.0,Condensation of Prophase Chromosomes,R-HSA-2299718
ENSG00000147394,1,1,0,0,0,1,396735.32121509424,396735.32121509424,2022-06-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ZNF185,,,,0,0.5,-1.0,,
ENSG00000147408,1,1,0,0,0,1,299999.7750406064,299999.7750406064,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CSGALNACT1,-0.25699997,-3.0062,-2.4549,1,0.5,-1.0,,
ENSG00000147465,1,1,0,0,1,1,10227.197550504849,10227.197550504849,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STAR,-0.29700005,0.21632,0.39353,2,1.0,0.0,Pregnenolone biosynthesis;Metabolism of steroids,R-HSA-196108;R-HSA-8957322
ENSG00000148154,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UGCG,0.64,2.8695,-0.99695,1,0.5,-1.0,,
ENSG00000148290,1,1,1,0,0,0,160062.83409140486,192594.63282947522,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,SURF1,-0.559,-1.3117,-1.8555,1,-1.0,-1.0,Complex IV assembly,R-HSA-9864848
ENSG00000148468,1,1,0,0,0,1,76832.90012167432,263416.51565448404,2017-09-11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,FAM171A1,0.554,0.53226,-0.090634,0,0.5,0.0,,
ENSG00000148680,1,1,0,0,0,1,97181.90375256384,97181.90375256384,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,HTR7,0.255,2.0505,0.067874,3,0.75,0.5,Signal Transduction;Serotonin receptors;Amine ligand-binding receptors,R-HSA-162582;R-HSA-390666;R-HSA-375280
ENSG00000148824,1,1,0,0,0,1,83086.61719470083,83086.61719470083,2023-03-13,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MTG1,-0.08500004,-1.3051,-1.7014,0,-1.0,-1.0,,
ENSG00000148908,1,1,0,0,0,1,195005.6685718255,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RGS10,0.28100002,1.1363,0.34775,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000149115,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TNKS1BP1,0.56200004,0.82671,0.58758,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Deadenylation of mRNA;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-429947;R-HSA-1266738;R-HSA-74160
ENSG00000149212,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SESN3,0.575,2.8277,1.025,1,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000149257,4,1,1,1,0,1,122069.83349127392,502231.5406594711,2017-12-06,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,SERPINH1,0.028999984,0.71087,0.054501,5,-1.0,-1.0,,
ENSG00000149782,1,1,0,0,1,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PLCB3,0.532,3.7091,-0.57388,8,0.5,-1.0,Signal Transduction;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Presynaptic function of Kainate receptors;G beta:gamma signalling through PLC beta;Free fatty acids regulate insulin secretion;Acetylcholine regulates insulin secretion;Activation of kainate receptors upon glutamate binding;G-protein beta:gamma signalling,R-HSA-162582;R-HSA-434316;R-HSA-500657;R-HSA-418217;R-HSA-400451;R-HSA-399997;R-HSA-451326;R-HSA-397795
ENSG00000149927,1,1,1,0,1,1,1321.7688442211056,340825.7076940272,2022-04-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,DOC2A,0.026000023,1.3197,-0.25992,0,0.75,0.0,,
ENSG00000150093,1,1,0,0,0,1,55635.00408218119,56716.257154516876,2021-06-14,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ITGB1,0.604,3.987,0.20126,31,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Platelet Adhesion to exposed collagen;Signaling by Receptor Tyrosine Kinases;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-75892;R-HSA-9006934;R-HSA-6785807
ENSG00000150630,2,1,1,0,0,1,143585.2019681512,269829.0934099178,2024-07-19,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,4,VEGFC,0.621,0.72619,-1.2608,3,-1.0,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000151025,2,1,0,0,0,1,42518.059957017445,270756.050710225,2018-08-13,0,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,GPR158,0.32099998,0.82913,0.79257,0,0.75,0.5,,
ENSG00000151575,4,1,1,0,0,0,6455.028095238095,31828.071233716477,2013-06-16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TEX9,-0.39199996,-0.86094,-1.0709,0,-1.0,0.0,,
ENSG00000151702,1,1,0,0,0,1,55635.00408218119,55635.00408218119,2021-06-14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FLI1,0.633,2.9612,-0.0076298,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000151726,2,1,1,0,0,1,88825.27591578313,1424218.0900670097,2017-05-31,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,ACSL1,0.445,2.1766,0.73059,5,0.5,-1.0,Synthesis of very long-chain fatty acyl-CoAs;Gene expression (Transcription);Fatty acyl-CoA biosynthesis,R-HSA-75876;R-HSA-74160;R-HSA-75105
ENSG00000151923,1,1,0,0,0,1,37368.38182683358,37368.38182683358,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TIAL1,0.787,4.1814,0.37902,1,-1.0,-1.0,Signal Transduction;FGFR2 alternative splicing;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-6803529;R-HSA-9006934
ENSG00000152402,2,1,0,0,0,1,358386.30063935445,574261.7466389402,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,GUCY1A2,0.296,1.5846,-0.85804,2,0.5,0.0,,
ENSG00000152495,2,1,1,0,0,1,116089.30071075787,183579.49764748462,2020-06-24,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CAMK4,-0.09800005,0.67238,0.28925,6,0.75,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000152520,1,1,0,0,0,1,183579.49764748462,183579.49764748462,2022-08-20,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PAN3,0.73800004,2.0705,-0.88318,1,-1.0,-1.0,Deadenylation of mRNA,R-HSA-429947
ENSG00000152683,1,1,0,0,0,0,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SLC30A6,0.0,0.27957,-0.68673,0,-1.0,-1.0,,
ENSG00000153406,1,1,0,0,0,1,210511.72353576875,210511.72353576875,2021-08-24,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,NMRAL1,-0.47099996,-0.16356,0.41007,1,-1.0,-1.0,,
ENSG00000153531,1,1,1,0,1,1,7015.217468683688,21724.94108458234,2021-01-25,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ADPRHL1,-0.26400006,1.2063,0.33908,0,0.75,0.0,,
ENSG00000153721,1,1,1,0,0,1,75715.46734074537,75715.46734074537,2023-01-18,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CNKSR3,0.329,0.80061,0.30484,0,-1.0,0.0,,
ENSG00000153789,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,CIBAR2,-0.39,-1.4226,-1.1489,0,0.5,0.5,,
ENSG00000153989,2,1,1,0,0,1,118492.7744519305,1424218.0900670097,2019-02-04,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,NUS1,0.818,1.0355,-0.34755,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000154080,2,1,0,0,0,0,88186.71873814042,141076.9910731678,2020-05-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CHST9,-0.42200005,0.27971,0.94541,1,0.5,0.0,,
ENSG00000155096,1,1,1,0,0,1,195005.6685718255,1424218.0900670097,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,AZIN1,0.64,2.3181,1.1429,1,-1.0,-1.0,Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines,R-HSA-350562;R-HSA-351202
ENSG00000155592,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ZKSCAN2,0.48400003,1.0121,0.41351,0,-1.0,0.0,,
ENSG00000155744,1,1,0,0,0,1,249965.96240703977,249965.96240703977,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HYCC2,0.426,2.1671,1.834,0,-1.0,-1.0,,
ENSG00000155755,1,1,1,0,0,1,45377.72423794958,45377.72423794958,2021-03-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM237,-0.31799996,-0.12129,0.97752,0,1.0,0.0,,
ENSG00000155792,1,1,0,0,0,1,8143.099031885603,13731.993981048436,2019-11-11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DEPTOR,-0.24300003,0.5964,0.2497,0,0.5,-1.0,,
ENSG00000156162,1,1,0,0,0,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,DPY19L4,-0.19799995,0.33896,0.49426,0,-1.0,-1.0,,
ENSG00000156398,1,1,0,0,0,1,137776.79053446153,137776.79053446153,2023-02-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,SFXN2,-0.10099995,1.0648,0.46402,0,0.5,0.0,,
ENSG00000156509,1,1,1,0,0,1,15702.824330266134,15702.824330266134,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,FBXO43,0.546,1.3901,0.063199,0,1.0,1.0,,
ENSG00000156671,2,1,0,0,0,0,203090.6413944402,203090.6413944402,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SAMD8,0.286,3.0927,0.7188,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000156735,1,1,0,0,0,1,286678.73247515375,286678.73247515375,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,BAG4,0.296,0.77712,0.50995,4,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000156795,1,1,1,0,1,1,100711.28404230655,100711.28404230655,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NTAQ1,-0.05700004,-0.26594,-1.0502,0,-1.0,-1.0,,
ENSG00000156858,1,1,1,0,1,0,31711.504552099814,31711.504552099814,2018-09-13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PRR14,0.232,1.0711,0.60189,0,-1.0,-1.0,,
ENSG00000157827,2,1,1,0,0,1,29803.01405728205,414433.58532016096,2018-06-11,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,FMNL2,0.458,3.164,0.36329,3,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000157911,1,1,0,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PEX10,-0.23399997,-0.87849,-0.46683,2,-1.0,-1.0,Peroxisomal protein import;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-9033241;R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000158079,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PTPDC1,0.162,1.2436,1.078,0,-1.0,0.0,,
ENSG00000158716,1,1,0,0,0,1,123718.25364614776,123718.25364614776,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,DUSP23,-0.352,-1.2326,-1.4456,0,-1.0,-1.0,,
ENSG00000158856,2,1,1,0,0,0,464892.4593283075,551389.5206213495,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,DMTN,0.305,1.315,-0.58995,1,0.5,-1.0,Miscellaneous transport and binding events,R-HSA-5223345
ENSG00000159023,1,1,0,0,1,1,286678.73247515375,286678.73247515375,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,EPB41,0.26200002,2.3584,0.99394,1,0.5,-1.0,,
ENSG00000159131,2,1,1,0,1,1,78751.06843456876,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,GART,0.504,1.4441,0.1965,1,-1.0,-1.0,Nucleotide biosynthesis;Metabolism of nucleotides,R-HSA-8956320;R-HSA-15869
ENSG00000159202,1,1,1,0,0,1,252346.18526092035,252346.18526092035,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UBE2Z,0.44199997,1.3357,-0.81447,2,-1.0,-1.0,Immune System;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Protein ubiquitination;Post-translational protein modification,R-HSA-168256;R-HSA-8866652;R-HSA-8852135;R-HSA-597592
ENSG00000159231,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CBR3,-0.84599996,0.99634,0.85283,1,0.5,0.0,,
ENSG00000159263,1,1,1,0,1,1,220837.49604317299,521818.7070055739,2023-11-09,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,SIM2,0.333,-0.44908,-1.6264,0,0.75,0.5,,
ENSG00000160072,2,1,1,0,0,1,87248.80974040499,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,ATAD3B,-0.15199995,-1.7987,-2.0932,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000160182,1,1,0,0,0,1,2628.763122476447,2628.763122476447,2011-12-11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TFF1,-0.689,-0.20875,-0.055807,1,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000160229,1,1,0,0,0,1,6743.786010935915,6743.786010935915,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ZNF66,-0.11500001,0.041032,-1.1803,0,-1.0,0.0,,
ENSG00000160271,1,1,0,0,0,1,200944.0765227402,200944.0765227402,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RALGDS,0.411,1.5975,-0.97477,2,-1.0,-1.0,Signal Transduction;p38MAPK events;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-171007;R-HSA-9006934
ENSG00000160325,1,1,1,0,0,1,59389.77313114188,59389.77313114188,2022-01-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CACFD1,-0.857,-1.1464,-1.2419,0,0.5,-1.0,,
ENSG00000160469,2,1,0,0,0,0,356440.71671986027,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,BRSK1,0.701,3.7696,-0.95943,0,0.75,0.0,,
ENSG00000160539,1,1,0,0,0,0,155978.81883421048,155978.81883421048,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PLPP7,-0.30900002,-0.062108,-1.113,0,0.75,0.0,,
ENSG00000160741,1,1,1,0,0,0,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CRTC2,0.49800003,2.1356,1.4678,3,-1.0,-1.0,,
ENSG00000160791,1,1,0,0,0,1,28462.455044254875,28462.455044254875,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CCR5,-0.592,-0.38831,-0.68323,4,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;HIV Life Cycle,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-162587
ENSG00000160818,1,1,0,0,0,0,155552.2805078301,155552.2805078301,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPATCH4,-0.669,1.1672,1.373,0,0.5,-1.0,,
ENSG00000160888,1,1,1,0,0,1,99227.16426999423,102866.95819249244,2019-08-16,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,IER2,0.045000017,-1.7215,-2.7722,0,-1.0,-1.0,,
ENSG00000161048,1,1,1,0,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NAPEPLD,0.199,1.4259,1.0041,1,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000161204,1,1,1,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ABCF3,0.22399998,1.3928,0.56259,0,-1.0,-1.0,,
ENSG00000161277,1,1,0,0,1,0,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,THAP8,-0.615,-1.2168,-1.1419,0,-1.0,0.0,,
ENSG00000161526,1,1,1,0,0,1,1112.9417344173442,1112.9417344173442,2015-09-05,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SAP30BP,-0.110000014,1.5899,-0.96775,1,-1.0,-1.0,Gene expression (Transcription);Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression,R-HSA-74160;R-HSA-5250941;R-HSA-427413
ENSG00000161647,2,1,0,0,0,1,102471.73707899301,175016.11286382115,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,MPP3,0.26099998,1.8158,-0.42866,0,0.75,0.0,,
ENSG00000161714,1,1,0,0,0,1,292977.1806919819,292977.1806919819,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PLCD3,-0.17299998,-0.55098,-2.0524,1,0.5,-1.0,,
ENSG00000161973,1,1,0,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCDC42,-0.222,0.96794,1.2947,0,1.0,1.0,,
ENSG00000162086,1,1,1,0,1,1,251325.91086204,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZNF75A,0.046000004,-0.066217,-1.1443,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000162148,1,1,1,0,0,1,448058.917711015,448058.917711015,2023-11-10,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SAXO4,0.018000007,0.48545,0.78171,0,0.5,-1.0,,
ENSG00000162174,1,1,0,0,0,1,21724.94108458234,21724.94108458234,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ASRGL1,-0.12100005,0.12731,-0.2304,1,0.5,-1.0,,
ENSG00000162373,1,1,0,0,0,1,960369.5592648841,960369.5592648841,2021-05-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,BEND5,0.245,1.7351,-0.48545,0,-1.0,0.0,,
ENSG00000162496,2,1,0,0,0,1,143413.24457139417,414433.58532016096,2023-06-29,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DHRS3,0.20999998,1.8287,0.83415,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000162621,1,1,1,0,0,1,28368.758914837086,28368.758914837086,2019-07-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,LRRC53,,,,0,,,,
ENSG00000162623,1,1,1,0,0,1,2282.7743876235495,2282.7743876235495,2019-11-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TYW3,-0.64699996,-0.030187,0.38561,1,-1.0,-1.0,,
ENSG00000162704,1,1,1,0,0,1,22938.587937312015,22938.587937312015,2021-02-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,ARPC5,0.27499998,1.5472,-0.55624,6,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Disease,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685
ENSG00000162734,1,1,0,0,0,1,4610.656076150852,4610.656076150852,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PEA15,0.76,2.5832,0.38339,2,1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000162869,1,1,1,0,0,1,61672.68175758092,61672.68175758092,2018-12-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PPP1R21,-0.029000044,-2.6565,-1.1196,0,-1.0,-1.0,,
ENSG00000163006,1,1,0,0,0,1,17802.759575335567,17802.759575335567,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CCDC138,0.08499998,-0.35196,-0.98667,0,0.5,0.0,,
ENSG00000163041,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,H3-3A,,,,32,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Replacement of protamines by nucleosomes in the male pronucleus;Assembly of the ORC complex at the origin of replication;Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex;SIRT1 negatively regulates rRNA expression;RNA Polymerase II Transcription;Developmental Biology;Inhibition of DNA recombination at telomere;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin modifications during the maternal to zygotic transition (MZT);RNA Polymerase I Promoter Escape;Condensation of Prophase Chromosomes;Regulation of endogenous retroelements by KRAB-ZFP proteins;Disease;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase I Promoter Opening;Transcriptional regulation by small RNAs;Gene Silencing by RNA;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Formation of the beta-catenin:TCF transactivating complex,R-HSA-162582;R-HSA-212436;R-HSA-9821993;R-HSA-68616;R-HSA-9843970;R-HSA-427359;R-HSA-73857;R-HSA-1266738;R-HSA-9670095;R-HSA-74160;R-HSA-427389;R-HSA-9821002;R-HSA-73772;R-HSA-2299718;R-HSA-9843940;R-HSA-1643685;R-HSA-5625886;R-HSA-5250941;R-HSA-427413;R-HSA-73728;R-HSA-5578749;R-HSA-211000;R-HSA-73864;R-HSA-73854;R-HSA-201722
ENSG00000163060,1,1,0,0,0,1,38772.287745457244,38772.287745457244,2025-03-12,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TEKT4,-0.42200005,-2.7406,-2.2988,0,1.0,0.5,,
ENSG00000163293,1,1,1,0,0,1,1639.4039301310045,1639.4039301310045,2016-11-29,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,NIPAL1,-0.29700005,1.1719,1.064,1,0.5,0.0,Miscellaneous transport and binding events,R-HSA-5223345
ENSG00000163295,1,1,0,0,0,1,69761.9825146311,69761.9825146311,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,ALPI,-0.16299999,0.52949,-0.49725,3,1.0,1.0,Synthesis of PA;Post-translational protein modification,R-HSA-1483166;R-HSA-597592
ENSG00000163412,1,1,1,0,0,1,421288.2605201189,421288.2605201189,2022-02-02,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,EIF4E3,-0.25600004,-0.70309,-1.1383,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;ISG15 antiviral mechanism,R-HSA-1280215;R-HSA-168256;R-HSA-1169408
ENSG00000163527,1,1,0,0,0,1,11096.901865369018,11096.901865369018,2021-02-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STT3B,0.52,3.2484,-0.54475,3,-1.0,-1.0,Developmental Biology;Disease;Post-translational protein modification,R-HSA-1266738;R-HSA-1643685;R-HSA-597592
ENSG00000163565,2,1,1,0,0,1,26020.4828907398,95905.57783546533,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,3,IFI16,0.06400001,0.43123,0.32717,2,-1.0,-1.0,Immune System;IRF3-mediated induction of type I IFN,R-HSA-168256;R-HSA-3270619
ENSG00000163576,1,1,0,0,0,1,5785.292188770647,5785.292188770647,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,EFHB,-0.24399996,-0.53957,0.57392,0,0.5,0.5,,
ENSG00000163629,1,1,0,0,0,1,147105.90765133628,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,5,PTPN13,0.263,1.1963,1.2577,5,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000163645,1,1,1,0,0,1,23288.403519798867,23288.403519798867,2021-09-30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ERICH6,-0.14699996,0.28976,0.88118,0,1.0,0.5,,
ENSG00000163681,2,1,1,0,0,1,192594.63282947522,207220.14223281175,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,SLMAP,0.46899998,2.0271,0.54869,0,-1.0,-1.0,,
ENSG00000163754,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GYG1,-0.38399994,-0.055641,0.82015,7,0.5,-1.0,Glycogen metabolism;Immune System;Glycogen storage diseases;Glycogen synthesis;Disease,R-HSA-8982491;R-HSA-168256;R-HSA-3229121;R-HSA-3322077;R-HSA-1643685
ENSG00000163825,1,1,0,0,0,1,17601.10520641419,17601.10520641419,2024-10-03,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RTP3,0.003000021,0.93892,-0.082733,0,1.0,1.0,,
ENSG00000163832,2,1,1,0,0,1,28462.455044254875,160010.51072069994,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,ELP6,-0.204,0.70302,0.37403,1,-1.0,-1.0,,
ENSG00000163898,1,1,0,0,0,1,135095.86576106868,135095.86576106868,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LIPH,0.18900001,0.90155,0.32482,1,0.5,0.0,Synthesis of PA,R-HSA-1483166
ENSG00000163932,1,1,1,0,0,1,11608.613380386345,11608.613380386345,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PRKCD,0.656,3.8706,1.141,14,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;HuR (ELAVL1) binds and stabilizes mRNA;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-450520;R-HSA-9006934
ENSG00000163958,1,1,0,0,0,1,306980.8575290048,306980.8575290048,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ZDHHC19,-0.20500004,0.44461,-0.97116,0,1.0,0.5,,
ENSG00000164088,1,1,1,0,0,1,14577.354388342934,14577.354388342934,2011-12-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PPM1M,-0.110000014,0.22399,0.13947,0,-1.0,-1.0,,
ENSG00000164100,1,1,0,0,0,1,131525.74533408263,323648.5577791949,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,NDST3,0.301,3.0569,1.1572,1,0.5,0.5,HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-2022928;R-HSA-1638091
ENSG00000164241,2,1,1,0,0,0,42359.490817992155,100711.28404230655,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,C5orf63,-0.956,0.41698,0.52894,0,-1.0,-1.0,,
ENSG00000164251,1,1,1,0,0,1,99788.44320353035,99788.44320353035,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,F2RL1,0.010999978,1.0323,0.4671,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000164252,1,1,0,0,0,1,37221.07677995828,37221.07677995828,2018-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,AGGF1,0.19199997,0.74272,0.069336,1,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000164287,1,1,1,0,0,1,59389.77313114188,76621.60987623724,2022-01-14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CDC20B,-0.25,0.79597,-0.22155,0,0.5,0.5,,
ENSG00000164300,1,1,0,0,0,1,5239.92068427331,5239.92068427331,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SERINC5,0.08899999,0.66566,-0.24998,1,-1.0,-1.0,Serine metabolism,R-HSA-977347
ENSG00000164306,1,1,1,0,0,0,1501.5536071373635,1501.5536071373635,2021-03-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PRIMPOL,-0.148,0.60022,0.38393,0,-1.0,-1.0,,
ENSG00000164619,1,1,0,0,0,1,29803.01405728205,29803.01405728205,2020-01-20,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BMPER,0.348,1.5503,0.27363,0,-1.0,0.0,,
ENSG00000164694,1,1,0,0,0,1,52982.28647069224,52982.28647069224,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,FNDC1,0.324,-0.55286,-1.2695,0,0.5,0.0,,
ENSG00000164708,1,1,0,0,0,1,226155.40757232966,226155.40757232966,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PGAM2,-0.421,0.2436,0.32527,2,0.75,0.0,Gluconeogenesis,R-HSA-70263
ENSG00000164758,1,1,0,0,0,1,6206.927802406586,6206.927802406586,2016-12-15,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MED30,0.153,0.56493,0.68564,5,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685
ENSG00000164794,2,1,0,0,0,1,15866.724081734988,323648.5577791949,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,11,KCNV1,0.823,4.558,-0.65597,1,1.0,1.0,,
ENSG00000164808,1,1,0,0,0,1,60436.282913699004,60436.282913699004,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPIDR,0.022000015,0.30627,0.46978,1,-1.0,-1.0,,
ENSG00000164816,1,1,0,0,0,1,6482.24749962681,8565.305898104432,2014-10-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,DEFA5,-0.87899995,-1.7944,-0.51953,3,1.0,0.5,Alpha-defensins;Immune System;Defensins;Antimicrobial peptides,R-HSA-1462054;R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000164821,1,1,0,0,0,1,11431.413302639152,22306.375831657126,2023-06-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,DEFA4,-0.954,-2.663,-2.2352,3,1.0,0.5,Alpha-defensins;Immune System;Defensins;Antimicrobial peptides,R-HSA-1462054;R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000165006,1,1,1,0,0,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UBAP1,0.71500003,1.9839,0.84013,5,-1.0,-1.0,Endosomal Sorting Complex Required For Transport (ESCRT);Budding and maturation of HIV virion;Disease;Late endosomal microautophagy;HIV Life Cycle;Late Phase of HIV Life Cycle;HCMV Late Events,R-HSA-917729;R-HSA-162588;R-HSA-1643685;R-HSA-9615710;R-HSA-162587;R-HSA-162599;R-HSA-9610379
ENSG00000165071,1,1,1,0,0,1,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,TMEM71,-0.51600003,-0.0055947,-0.027799,0,0.5,0.0,,
ENSG00000165078,1,1,0,0,0,0,117900.18012455685,117900.18012455685,2021-04-08,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CPA6,-0.33800006,-0.080037,0.28679,0,0.5,0.5,,
ENSG00000165091,1,1,0,0,0,1,2967.1433315811582,2967.1433315811582,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TMC1,0.086000025,1.5789,0.22101,2,0.5,1.0,,
ENSG00000165288,2,1,0,0,0,1,87545.45580019058,163819.92615728398,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,3,BRWD3,,,,0,-1.0,0.0,,
ENSG00000165325,1,1,1,0,0,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DEUP1,-0.08000004,0.06221,0.30147,0,0.75,0.5,,
ENSG00000165355,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,FBXO33,0.31699997,0.10598,-1.9736,0,0.5,-1.0,,
ENSG00000165389,2,1,0,0,0,1,29803.01405728205,414433.58532016096,2020-01-20,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,SPTSSA,-0.952,-1.2167,-0.86654,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000165392,1,1,0,0,0,1,14981.79953368106,14981.79953368106,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,WRN,0.100000024,0.99458,1.0721,17,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-597592
ENSG00000165487,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MICU2,-0.35399997,-0.47828,-0.8769,3,-1.0,-1.0,Mitochondrial calcium ion transport,R-HSA-8949215
ENSG00000165813,1,1,0,0,0,0,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCDC186,0.44,1.6756,0.20742,0,-1.0,-1.0,,
ENSG00000165879,1,1,1,0,0,1,89589.23835564002,765591.3646788632,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,FRAT1,-0.798,-1.5161,-2.3309,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000165973,1,1,0,1,1,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NELL1,0.17400002,0.44388,0.23205,0,0.5,0.5,,
ENSG00000165997,2,1,0,0,0,0,15866.724081734988,171880.2916512608,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,7,ARL5B,0.42799997,1.1208,-0.88083,0,-1.0,-1.0,,
ENSG00000166006,1,1,0,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,KCNC2,0.334,3.2013,-1.3261,2,1.0,0.5,,
ENSG00000166073,1,1,0,0,0,1,254373.32653042395,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPR176,-0.055999994,0.92467,-0.2305,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000166123,1,1,0,0,0,1,5205.737346049966,5205.737346049966,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,GPT2,0.323,2.2046,0.34294,1,0.5,-1.0,,
ENSG00000166171,1,1,0,0,0,1,16168.601665727347,16168.601665727347,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DPCD,-0.07000005,1.3313,0.075599,0,0.5,-1.0,,
ENSG00000166183,1,1,0,0,0,1,58331.23271678036,160010.51072069994,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,ASPG,-0.22599995,-0.61289,-1.7317,1,0.5,0.0,,
ENSG00000166197,1,1,0,0,0,1,158370.2523752734,355284.1215006515,2025-03-06,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NOLC1,0.36,-0.50137,-0.27202,0,-1.0,-1.0,,
ENSG00000166436,2,1,1,0,1,1,294387.2978738704,1424218.0900670097,2020-06-15,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,TRIM66,0.26200002,0.86425,0.90516,0,0.5,0.0,,
ENSG00000166509,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CLEC3A,-0.72800004,-2.4086,-0.94396,0,0.5,0.5,,
ENSG00000166573,1,1,0,0,0,1,6356.593451690605,6356.593451690605,2023-05-29,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GALR1,0.01700002,0.28713,0.012365,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000166716,1,1,1,0,0,1,260631.24114204012,269829.0934099178,2024-07-19,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ZNF592,0.788,2.5546,0.49233,0,-1.0,-1.0,,
ENSG00000166866,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MYO1A,0.0,1.4574,1.1632,0,1.0,0.5,,
ENSG00000166897,1,1,0,0,0,1,93616.86016863462,93616.86016863462,2021-04-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ELFN2,0.43400002,3.0022,0.15182,0,0.75,0.5,,
ENSG00000166920,1,1,1,0,0,1,338763.57771536184,415452.66715166246,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,C15orf48,-0.35300004,0.82266,0.47746,0,1.0,0.0,,
ENSG00000167077,1,1,1,0,0,1,545988.1005477115,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MEI1,0.14700001,0.3362,-0.25455,0,0.5,0.0,,
ENSG00000167196,1,1,1,0,0,1,71913.46219676935,286678.73247515375,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,7,FBXO22,0.31699997,1.0336,0.092281,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000167244,1,1,0,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,IGF2,0.504,1.269,0.27898,5,1.0,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000167394,1,1,1,0,0,1,159189.58506586426,159189.58506586426,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZNF668,0.542,1.6316,-1.182,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000167566,3,1,1,0,0,1,98271.38571086437,125392.97184483419,2023-01-18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NCKAP5L,0.22399998,-1.2471,-1.8819,0,-1.0,-1.0,,
ENSG00000167580,1,1,1,0,0,1,171699.39272110126,171699.39272110126,2018-07-16,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,AQP2,-0.375,0.67634,-0.081682,2,0.75,0.5,Passive transport by Aquaporins,R-HSA-432047
ENSG00000167601,1,1,1,0,0,1,14145.711748532529,14145.711748532529,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,AXL,0.375,2.1744,0.87734,1,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000167632,1,1,1,0,0,0,20209.09625085965,20209.09625085965,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRAPPC9,0.21399999,2.2235,-0.21165,2,-1.0,-1.0,Rab regulation of trafficking;Post-translational protein modification,R-HSA-9007101;R-HSA-597592
ENSG00000167646,1,1,1,0,1,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,DNAAF3,-0.13900006,-0.80759,-0.82124,0,0.75,0.0,,
ENSG00000167693,4,1,0,0,0,1,63535.33318574275,473900.221403792,2018-12-03,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,NXN,0.36,0.25863,-1.9898,0,-1.0,-1.0,,
ENSG00000167778,2,1,1,0,0,1,55635.00408218119,114439.41769154315,2021-06-14,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SPRYD3,0.485,2.9557,0.81864,0,-1.0,-1.0,,
ENSG00000167881,1,1,1,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SRP68,0.66499996,2.582,1.1997,1,-1.0,-1.0,Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-72766;R-HSA-1799339
ENSG00000168032,1,1,1,0,0,1,100075.58738100652,112184.2204720767,2024-04-26,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ENTPD3,-0.454,1.151,1.1055,1,0.5,0.0,Metabolism of nucleotides,R-HSA-15869
ENSG00000168303,1,1,0,0,0,0,309838.540915932,360605.992793193,2021-07-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MPLKIP,-0.81500006,-1.9606,-2.6412,0,-1.0,-1.0,,
ENSG00000168476,1,1,1,1,0,0,134703.04231665854,134703.04231665854,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,REEP4,0.21399999,0.24406,-0.68114,0,0.5,-1.0,,
ENSG00000168502,1,1,1,0,0,1,39507.00295325707,123127.18790121445,2017-02-06,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,4,MTCL1,0.337,-0.20234,-0.38715,0,0.75,0.0,,
ENSG00000168582,1,1,0,0,0,1,278498.5074409075,278498.5074409075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CRYGA,-0.245,-0.3959,-0.30411,0,,,,
ENSG00000168594,5,1,1,0,0,1,22345.675520395987,141076.9910731678,2013-04-01,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,ADAM29,-0.939,0.82639,-0.33771,0,1.0,1.0,,
ENSG00000168827,1,1,0,0,0,1,167055.73472660675,167055.73472660675,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GFM1,0.171,1.1282,1.0581,1,-1.0,-1.0,Translation;Mitochondrial translation elongation;Mitochondrial translation,R-HSA-72766;R-HSA-5389840;R-HSA-5368287
ENSG00000168874,1,1,1,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ATOH8,0.20599997,-1.3834,-1.608,0,0.5,0.0,,
ENSG00000169062,1,1,1,0,1,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,UPF3A,-0.19799995,-0.38457,-1.6273,2,-1.0,-1.0,Developmental Biology;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-9010553
ENSG00000169129,1,1,0,0,0,1,195005.6685718255,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,AFAP1L2,0.39499998,0.94741,0.81861,0,0.5,0.0,,
ENSG00000169139,1,1,0,0,0,1,87248.80974040499,87248.80974040499,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,UBE2V2,-0.19500005,0.5051,-1.0264,7,-1.0,-1.0,Immune System;Formation of Incision Complex in GG-NER;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-168256;R-HSA-5696395;R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000169255,1,1,0,0,0,0,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,B3GALNT1,0.100000024,1.0723,0.40874,1,0.5,-1.0,,
ENSG00000169313,1,1,1,0,0,1,263416.51565448404,263416.51565448404,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,P2RY12,-0.15999997,1.262,0.61445,3,1.0,0.0,Signal Transduction;P2Y receptors;Nucleotide-like (purinergic) receptors;ADP signalling through P2Y purinoceptor 12;Signal amplification,R-HSA-162582;R-HSA-417957;R-HSA-418038;R-HSA-392170;R-HSA-392518
ENSG00000169507,1,1,0,0,0,1,143413.24457139417,143413.24457139417,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC38A11,-0.57299995,0.041992,0.29124,0,0.5,0.0,,
ENSG00000169548,1,1,0,0,0,1,428754.4911049721,428754.4911049721,2022-11-14,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF280A,0.01999998,0.40815,0.50373,0,1.0,1.0,,
ENSG00000169594,1,1,0,0,0,1,64063.25715989478,64063.25715989478,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BNC1,0.788,2.2593,0.57339,0,0.5,0.5,,
ENSG00000169752,1,1,1,0,0,1,30311.18982428984,384314.83364002535,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,8,NRG4,,,,17,1.0,0.5,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000169813,1,1,1,0,0,0,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HNRNPF,0.767,4.1106,-0.41241,4,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;FGFR2 alternative splicing;Immune System;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-6803529;R-HSA-168256;R-HSA-449147;R-HSA-9006934
ENSG00000169964,1,1,0,0,0,1,8143.099031885603,13731.993981048436,2019-11-11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TMEM42,-0.021999955,-0.68358,-1.8563,0,-1.0,-1.0,,
ENSG00000170144,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,HNRNPA3,0.838,4.2282,-0.65419,2,-1.0,-1.0,,
ENSG00000170214,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ADRA1B,-0.449,-0.96775,-2.9023,3,0.5,0.0,Signal Transduction;Adrenoceptors;Amine ligand-binding receptors,R-HSA-162582;R-HSA-390696;R-HSA-375280
ENSG00000170234,1,1,1,0,0,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PWWP2A,0.40100002,0.78721,-1.0741,0,-1.0,-1.0,,
ENSG00000170264,1,1,0,0,0,1,182720.23308494932,182720.23308494932,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,FAM161A,-0.024999976,0.029301,0.47082,0,1.0,0.0,,
ENSG00000170374,1,1,1,0,0,1,71245.27443883417,75639.5973879004,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,SP7,0.19199997,0.97476,0.59791,1,,,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000170502,1,1,0,0,0,1,221280.45048451523,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,NUDT9,-0.059999943,0.94893,0.23399,1,-1.0,-1.0,Purine catabolism;Metabolism of nucleotides,R-HSA-74259;R-HSA-15869
ENSG00000170577,1,1,0,0,0,1,134159.95265752633,134159.95265752633,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SIX2,-0.24000001,1.0655,-0.13172,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000170608,1,1,0,0,0,0,91756.48561848814,91756.48561848814,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FOXA3,-0.047999978,0.74764,-0.50362,1,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000170802,1,1,1,0,0,1,149644.92262336772,149644.92262336772,2020-11-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FOXN2,0.265,-0.78366,-0.30935,0,0.5,-1.0,,
ENSG00000170891,2,1,0,0,0,1,260210.21963428933,1424218.0900670097,2023-01-18,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CYTL1,-0.776,-1.4005,-1.3771,0,0.5,0.0,,
ENSG00000171094,1,1,0,0,0,0,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ALK,0.43800002,0.95723,-1.4735,11,0.5,0.5,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000171150,1,1,1,0,0,1,95923.70398286148,95923.70398286148,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SOCS5,0.01999998,0.71332,-1.527,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-597592;R-HSA-6785807
ENSG00000171224,1,1,0,0,0,1,42186.403296875666,42186.403296875666,2018-01-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM241B,-0.33200002,0.84411,0.45565,0,0.5,-1.0,,
ENSG00000171310,1,1,0,0,0,1,97822.37358221927,168116.01355658393,2022-10-12,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CHST11,0.48900002,2.2076,1.851,1,0.5,-1.0,,
ENSG00000171402,1,1,1,0,0,1,87037.83598345588,87037.83598345588,2014-09-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,XAGE3,,,,0,1.0,0.5,,
ENSG00000171530,1,1,0,0,0,1,156470.480665571,156470.480665571,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TBCA,-0.07000005,0.54273,0.38009,1,-1.0,-1.0,Post-chaperonin tubulin folding pathway,R-HSA-389977
ENSG00000171617,1,1,0,0,0,1,187203.10687937262,189557.6027707886,2024-01-05,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ENC1,0.347,3.872,0.68913,0,1.0,-1.0,,
ENSG00000171766,2,1,1,0,1,1,44303.34314855119,407080.5516610372,2016-01-21,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,8,GATM,0.403,2.2175,0.65928,1,0.75,-1.0,,
ENSG00000171806,1,1,0,0,0,0,97822.37358221927,109001.36551434857,2022-10-12,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,METTL18,-0.116000056,0.84754,1.0021,0,-1.0,-1.0,,
ENSG00000171873,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ADRA1D,-0.77199996,-1.073,-0.94272,3,0.5,0.0,Signal Transduction;Adrenoceptors;Amine ligand-binding receptors,R-HSA-162582;R-HSA-390696;R-HSA-375280
ENSG00000171877,1,1,0,0,0,0,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,FRMD5,0.51199996,1.2988,-0.40509,0,0.5,0.5,,
ENSG00000172215,1,1,0,0,0,1,47510.88174825013,47510.88174825013,2022-08-03,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CXCR6,-0.47599995,1.9772,-0.047475,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000172262,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF131,0.81,3.6456,0.37126,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000172340,1,1,1,0,1,1,108816.31098183901,108816.31098183901,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,SUCLG2,-0.12399995,-0.66015,0.031068,2,0.5,-1.0,Citric acid cycle (TCA cycle),R-HSA-71403
ENSG00000172425,1,1,0,0,0,1,727796.3668420183,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,TTC36,-0.796,-1.917,-1.3969,0,1.0,0.0,,
ENSG00000172476,1,1,0,0,0,1,85474.33432267047,85474.33432267047,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,RAB40A,,,,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000172500,2,1,1,0,0,1,32254.717802479194,108425.35980999071,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,FIBP,-0.008999944,0.9998,-0.81682,0,-1.0,-1.0,,
ENSG00000172671,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ZFAND4,0.157,-0.36829,0.80767,0,1.0,0.0,,
ENSG00000172732,1,1,1,0,0,0,75978.4105377159,75978.4105377159,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MUS81,-0.116000056,0.27152,-0.085751,2,-1.0,-1.0,,
ENSG00000172878,2,1,0,0,0,1,320319.7525060048,326545.22790564946,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,METAP1D,-0.23500001,0.21816,0.059649,0,-1.0,-1.0,,
ENSG00000172955,1,1,0,0,0,1,38913.031770896094,38913.031770896094,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ADH6,-0.263,0.33671,-0.03487,1,1.0,0.5,,
ENSG00000172985,1,1,1,0,0,1,151416.12986435954,151416.12986435954,2023-10-16,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SH3RF3,0.306,-0.96603,-1.7891,0,-1.0,0.0,,
ENSG00000173124,1,1,1,0,1,1,57274.55741575397,57274.55741575397,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ACSM6,0.088,1.4407,1.5073,1,0.5,0.5,,
ENSG00000173157,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ADAMTS20,0.052999973,-0.18347,-0.20641,2,,,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000173320,1,1,0,0,0,1,86992.9057658324,143413.24457139417,2021-02-24,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,STOX2,0.426,2.0892,0.15141,0,-1.0,0.0,,
ENSG00000173486,1,1,0,0,1,1,150669.89240227733,150669.89240227733,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FKBP2,-0.21899998,0.018599,-0.32276,0,-1.0,-1.0,,
ENSG00000173567,1,1,0,0,0,0,228220.5662976458,228220.5662976458,2018-07-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ADGRF3,-0.069000006,1.5875,0.45265,0,0.5,1.0,,
ENSG00000173612,1,1,0,0,1,0,18077.579543489537,18958.889426147794,2024-04-17,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GPRC6A,-0.42299998,0.44139,1.5315,2,,,Signal Transduction,R-HSA-162582
ENSG00000173621,1,1,1,0,1,1,94951.97167384504,94951.97167384504,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LRFN4,0.195,-0.66756,-2.9471,1,0.5,0.0,,
ENSG00000173702,1,1,0,0,1,1,42359.490817992155,64507.782812759775,2022-10-12,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MUC13,0.167,1.1173,1.32,9,1.0,0.5,Signal Transduction;Immune System;Disease;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000173950,1,1,0,0,0,1,545988.1005477115,645988.1975077938,2023-01-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,XXYLT1,-0.13199997,-1.1913,-1.9349,0,-1.0,-1.0,,
ENSG00000174145,4,1,0,0,0,1,208836.15741332836,323648.5577791949,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,NWD2,0.677,4.5615,2.4999,0,0.5,0.5,,
ENSG00000174417,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TRHR,0.24900001,0.96315,0.23426,2,,,Signal Transduction,R-HSA-162582
ENSG00000174564,1,1,0,0,0,1,83896.55822718568,83896.55822718568,2023-02-07,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,IL20RB,0.003000021,0.9027,-0.11297,1,0.75,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000174628,1,1,1,0,1,0,240639.50239824195,240639.50239824195,2021-10-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,IQCK,-0.582,-0.87678,0.041529,0,-1.0,0.0,,
ENSG00000174669,1,1,0,0,0,1,40455.65678857565,40455.65678857565,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SLC29A2,-0.014999986,0.79875,1.0034,2,0.75,0.0,"Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane;Azathioprine ADME;Transport of vitamins, nucleosides, and related molecules",R-HSA-83936;R-HSA-9748787;R-HSA-425397
ENSG00000174748,1,1,0,0,0,0,4917.108320036471,4917.108320036471,2018-03-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RPL15,0.86800003,2.1186,-0.4822,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000174885,1,1,0,0,0,1,47450.88644524237,47450.88644524237,2021-09-30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NLRP6,-0.23599994,-1.5483,-3.1006,0,1.0,0.5,,
ENSG00000174914,1,1,0,0,0,1,1446.3843469898532,2491.2032226869273,2021-06-01,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,OR9G1,-0.92700005,-3.2404,-2.6902,2,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000174938,1,1,0,0,0,1,306980.8575290048,306980.8575290048,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SEZ6L2,0.41399997,1.6056,0.25377,0,0.5,0.0,,
ENSG00000174944,1,1,1,0,0,0,64514.85721423125,155552.2805078301,2018-08-13,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,P2RY14,-0.84800005,0.75581,-0.084763,2,0.5,0.0,Signal Transduction;P2Y receptors;Nucleotide-like (purinergic) receptors,R-HSA-162582;R-HSA-417957;R-HSA-418038
ENSG00000175105,1,1,0,0,1,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF654,0.695,2.4206,1.1114,0,-1.0,-1.0,,
ENSG00000175166,1,1,1,0,1,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PSMD2,0.85899997,4.1077,0.61977,62,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000175216,1,1,1,0,0,0,309838.540915932,309838.540915932,2021-07-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CKAP5,0.857,4.8899,2.0812,13,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000175274,1,1,0,0,0,1,21724.94108458234,21724.94108458234,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TP53I11,0.34500003,1.8373,0.362,0,-1.0,-1.0,,
ENSG00000175324,1,1,1,0,0,0,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LSM1,-0.398,0.16151,0.8935,1,-1.0,-1.0,,
ENSG00000175866,1,1,1,0,1,0,1122672.658801146,1122672.658801146,2024-01-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,BAIAP2,0.554,1.3039,-2.628,7,-1.0,-1.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000176105,1,1,1,0,0,1,50161.278626555366,50161.278626555366,2018-11-28,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,YES1,0.24900001,1.9699,0.89372,17,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of signaling by CBL;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-912631;R-HSA-3928665;R-HSA-9006934;R-HSA-5663202
ENSG00000176108,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CHMP6,0.40100002,-0.51574,-1.3069,9,-1.0,-1.0,Endosomal Sorting Complex Required For Transport (ESCRT);Budding and maturation of HIV virion;Disease;Late endosomal microautophagy;Translation of Replicase and Assembly of the Replication Transcription Complex_9679504;Sealing of the nuclear envelope (NE) by ESCRT-III;Translation of Replicase and Assembly of the Replication Transcription Complex_9694676;HIV Life Cycle;Late Phase of HIV Life Cycle;HCMV Late Events,R-HSA-917729;R-HSA-162588;R-HSA-1643685;R-HSA-9615710;R-HSA-9679504;R-HSA-9668328;R-HSA-9694676;R-HSA-162587;R-HSA-162599;R-HSA-9610379
ENSG00000176225,1,1,0,0,0,0,3638.1832995745694,3638.1832995745694,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RTTN,0.21399999,1.048,0.15521,0,-1.0,0.0,,
ENSG00000176476,1,1,1,0,0,1,28923.750134754748,28923.750134754748,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SGF29,0.41799998,4.0353,0.65598,2,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000177054,1,1,0,0,0,0,10174.701476142087,10174.701476142087,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,ZDHHC13,-0.314,0.10958,-0.70603,0,-1.0,-1.0,,
ENSG00000177663,1,1,1,0,0,1,135108.48254553688,135108.48254553688,2025-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,IL17RA,0.102999985,-1.468,-2.3183,2,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147
ENSG00000177692,1,1,1,0,0,1,78751.06843456876,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DNAJC28,0.027999997,0.47727,1.3381,0,0.5,0.0,,
ENSG00000177885,1,1,1,0,0,0,12492.61701176821,12492.61701176821,2018-05-30,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,GRB2,0.784,3.8851,0.711,97,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Constitutive Signaling by Overexpressed ERBB2;Developmental Biology;Disease;EGFR Transactivation by Gastrin;Signaling by Interleukins;SHC-mediated cascade:FGFR4;Regulation of signaling by CBL;Gastrin-CREB signalling pathway via PKC and MAPK;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9634285;R-HSA-1266738;R-HSA-1643685;R-HSA-2179392;R-HSA-449147;R-HSA-5654719;R-HSA-912631;R-HSA-881907;R-HSA-9006934;R-HSA-5663202
ENSG00000177910,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPATA31C2,-0.76699996,-0.86443,-0.57079,0,0.75,0.5,,
ENSG00000177943,1,1,1,1,0,1,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,MAMDC4,-0.329,-1.9013,-2.3696,0,0.5,0.0,,
ENSG00000178449,1,1,0,0,0,1,252346.18526092035,427337.4491868293,2018-08-13,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,COX14,-0.20299995,0.16147,0.28895,1,-1.0,-1.0,Complex IV assembly,R-HSA-9864848
ENSG00000178567,1,1,1,0,0,0,50469.22952482314,50469.22952482314,2021-02-25,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EPM2AIP1,0.30900002,1.7551,-0.21714,0,-1.0,-1.0,,
ENSG00000178691,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SUZ12,0.656,4.0209,1.1025,9,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Transcriptional Regulation by E2F6;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-8953750;R-HSA-597592
ENSG00000178971,2,1,1,0,0,1,86653.63443341189,143284.77790855977,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CTC1,0.22399998,1.0969,0.63151,2,-1.0,-1.0,,
ENSG00000179051,7,1,1,0,0,1,22902.966768273185,298389.02809443185,2018-05-08,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,RCC2,0.49199998,2.0636,-2.315,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000179213,1,1,1,0,0,1,421288.2605201189,421288.2605201189,2022-02-02,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,SIGLECL1,-0.16100001,0.94166,0.32106,0,1.0,1.0,,
ENSG00000179218,2,1,1,0,0,0,260210.21963428933,1424218.0900670097,2018-10-08,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,CALR,0.577,1.1558,-0.77658,7,-1.0,-1.0,ATF6 (ATF6-alpha) activates chaperone genes;ATF6 (ATF6-alpha) activates chaperones;Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Immune System;Disease;Post-translational protein modification,R-HSA-381183;R-HSA-381033;R-HSA-901042;R-HSA-532668;R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000179222,1,1,0,0,0,1,367949.31877243903,367949.31877243903,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MAGED1,,,,3,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000179520,1,1,0,0,0,0,2625.212121212121,2625.212121212121,2013-01-17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC17A8,0.30900002,1.3957,1.1583,3,0.5,0.5,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000179600,1,1,0,0,1,1,15911.334729431392,15911.334729431392,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPHB5,-0.34000003,0.22354,0.0503,2,,,Signal Transduction,R-HSA-162582
ENSG00000179832,1,1,1,0,0,0,31104.940443685748,31104.940443685748,2023-06-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MROH1,-0.003000021,0.26196,-0.79782,0,0.5,0.0,,
ENSG00000179862,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CITED4,-0.95799994,-4.5213,-4.9145,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8864260
ENSG00000179922,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ZNF784,-0.92999995,-1.8892,-2.107,0,0.5,-1.0,,
ENSG00000180061,1,1,1,0,0,1,143284.77790855977,143284.77790855977,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM150B,-0.755,-0.30485,-0.049635,0,1.0,0.0,,
ENSG00000180245,1,1,0,0,0,0,51573.04760983911,51573.04760983911,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RRH,-0.36399996,0.96791,1.2012,2,1.0,1.0,Signal Transduction,R-HSA-162582
ENSG00000180340,1,1,0,0,0,1,162367.55694122918,162367.55694122918,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FZD2,0.31,3.5551,0.54802,6,0.5,0.0,Signal Transduction;Asymmetric localization of PCP proteins,R-HSA-162582;R-HSA-4608870
ENSG00000180432,2,1,1,0,0,1,11231.262381898725,13756.062794259458,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,CYP8B1,-0.865,0.57996,0.85505,6,1.0,0.5,Eicosanoids;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts;Metabolism of steroids;Arachidonate metabolism;Bile acid and bile salt metabolism,R-HSA-211979;R-HSA-193775;R-HSA-192105;R-HSA-8957322;R-HSA-2142753;R-HSA-194068
ENSG00000180535,2,1,1,0,0,1,29919.773016359526,72098.8014618248,2020-09-04,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,BHLHA15,-0.64199996,-1.3403,-1.7341,1,0.75,0.0,,
ENSG00000180730,1,1,0,0,0,1,42879.69557188197,42879.69557188197,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SHISA2,-0.329,-1.6621,-1.8204,0,0.5,0.0,,
ENSG00000180739,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,S1PR5,,-0.14482,-0.98704,2,0.5,0.0,Signal Transduction;Lysosphingolipid and LPA receptors,R-HSA-162582;R-HSA-419408
ENSG00000181026,1,1,0,0,0,1,16853.230163428838,16853.230163428838,2024-09-13,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,AEN,-0.666,-0.25496,-0.45316,0,-1.0,0.0,,
ENSG00000181192,1,1,1,0,0,1,62627.34914844415,62627.34914844415,2024-01-05,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DHTKD1,0.13599998,0.030914,0.15253,1,0.5,-1.0,,
ENSG00000181291,1,1,0,0,0,1,108784.9761126256,108784.9761126256,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,TMEM132E,0.13300002,0.49349,-1.1516,0,1.0,0.5,,
ENSG00000181481,1,1,0,0,0,1,636.1886490807354,636.1886490807354,2012-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RNF135,-0.49100006,-0.19761,-0.76016,8,-1.0,-1.0,Immune System;Disease;Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-597592
ENSG00000181652,2,1,1,0,0,1,203090.6413944402,203090.6413944402,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATG9B,-0.39900005,-2.9257,-3.1865,1,0.5,0.5,,
ENSG00000181827,2,1,0,0,1,1,33954.407278742765,521818.7070055739,2021-01-04,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,RFX7,0.7,2.0228,0.4774,0,-1.0,0.0,,
ENSG00000181961,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR4A16,,-3.6344,-3.2017,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000182329,1,1,0,0,0,0,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KIAA2012,0.073000014,1.7792,1.3657,0,1.0,0.5,,
ENSG00000182541,1,1,0,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,LIMK2,0.41799998,2.5702,0.94394,3,-1.0,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000182583,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VCX,,,,0,1.0,1.0,,
ENSG00000182674,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KCNB2,0.646,3.8314,0.42455,1,0.5,0.5,,
ENSG00000182742,2,1,0,0,0,1,20209.09625085965,196178.71491042234,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HOXB4,-0.17700005,-0.021152,-1.2815,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000183337,1,1,0,0,0,1,99788.44320353035,100083.61852522385,2019-11-01,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,BCOR,,,,0,-1.0,-1.0,,
ENSG00000183346,1,1,0,0,0,1,239405.90751969456,448058.917711015,2018-08-13,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,CABCOCO1,-0.14999998,0.33458,0.29537,0,0.5,0.0,,
ENSG00000183496,1,1,0,0,0,1,117130.50022212768,117130.50022212768,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MEX3B,-0.826,-0.85437,-4.5259,0,0.75,0.0,,
ENSG00000183530,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PRR14L,0.362,1.4663,1.3665,0,-1.0,-1.0,,
ENSG00000183571,1,1,0,0,0,1,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PGPEP1L,-0.827,-0.30681,-0.94045,0,1.0,0.5,,
ENSG00000183625,1,1,0,0,0,1,167055.73472660675,169088.90478978804,2019-03-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,CCR3,-0.92499995,0.72932,-0.56128,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000183640,1,1,0,0,0,1,25967.06754524981,25967.06754524981,2023-08-31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KRTAP8-1,-0.61899996,0.21057,0.18343,1,1.0,1.0,Developmental Biology,R-HSA-1266738
ENSG00000183773,1,1,1,0,0,1,7794.273577144567,7794.273577144567,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,AIFM3,-0.10899997,0.73396,-0.39579,0,0.5,0.5,,
ENSG00000183914,1,1,0,0,0,0,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DNAH2,0.34500003,4.8263,2.0919,0,0.5,0.5,,
ENSG00000183963,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SMTN,0.26200002,0.54955,0.39527,0,0.5,-1.0,,
ENSG00000184009,1,1,1,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ACTG1,0.38300002,4.8895,-7.2075,27,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Disease;Interaction between L1 and Ankyrins;Recycling pathway of L1;EPH-ephrin mediated repulsion of cells;Gap junction trafficking and regulation;Gap junction trafficking;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-445095;R-HSA-437239;R-HSA-3928665;R-HSA-157858;R-HSA-190828;R-HSA-9006934;R-HSA-5663202
ENSG00000184292,1,1,1,0,0,1,286746.1002745869,286746.1002745869,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TACSTD2,-0.86800003,-1.56,-1.0143,0,0.5,0.0,,
ENSG00000184408,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,KCND2,0.572,4.657,0.18854,2,1.0,0.0,,
ENSG00000184470,2,1,1,0,0,0,13821.38483379316,414433.58532016096,2016-01-11,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,TXNRD2,-0.17999995,0.74275,-0.67551,1,-1.0,-1.0,,
ENSG00000184489,1,1,0,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PTP4A3,0.08399999,0.20563,0.14036,0,0.75,0.0,,
ENSG00000184545,1,1,0,0,0,1,86869.04450932604,86869.04450932604,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DUSP8,0.18699998,-0.35229,-3.788,3,0.5,0.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000184616,1,1,1,0,0,0,358386.30063935445,383158.3001114715,2021-11-04,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SPDYE12,0.110000014,1.6912,1.7417,0,0.5,0.5,,
ENSG00000184702,1,1,0,0,0,1,574261.7466389402,574261.7466389402,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SEPTIN5,0.51100004,2.1183,-0.42938,0,0.5,-1.0,,
ENSG00000185262,1,1,1,0,0,1,221280.45048451523,384314.83364002535,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,UBALD2,-0.852,0.23089,-1.6928,0,0.5,-1.0,,
ENSG00000185513,1,1,0,0,0,1,62627.34914844415,89589.23835564002,2024-01-05,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,L3MBTL1,0.16000003,0.89692,-0.18287,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000185615,1,1,0,0,1,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PDIA2,-0.76199996,-3.2032,-3.4803,1,1.0,0.0,,
ENSG00000185758,1,1,1,0,0,0,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CLDN24,-0.9,0.73382,-0.036082,0,,,,
ENSG00000185821,1,1,0,0,1,0,298504.9722193353,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,OR6C76,,0.36502,0.28637,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000185838,1,1,1,0,0,1,75245.66341852833,75245.66341852833,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GNB1L,-0.01999998,0.93229,0.71585,0,-1.0,0.0,,
ENSG00000185880,1,1,1,0,1,1,219793.50457789513,219793.50457789513,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRIM69,0.021000028,0.1282,0.5456,1,1.0,0.0,Immune System,R-HSA-168256
ENSG00000186230,1,1,1,0,0,1,72148.96319633072,85928.28663449686,2024-07-19,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ZNF749,-0.814,0.97058,0.86532,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000186318,1,1,0,0,0,1,35408.731264242386,35408.731264242386,2024-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,BACE1,0.444,2.2123,0.84792,1,0.75,-1.0,,
ENSG00000186364,1,1,1,0,0,0,71913.46219676935,144712.0807038357,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,NUDT17,-0.37399995,-1.3791,-1.3006,0,-1.0,0.0,,
ENSG00000186409,1,1,1,0,0,1,292977.1806919819,292977.1806919819,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CCDC30,0.089999974,1.5212,0.59508,0,0.5,0.0,,
ENSG00000186462,3,1,0,0,0,1,203090.6413944402,427337.4491868293,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NAP1L2,,,,0,1.0,0.0,,
ENSG00000186480,1,1,1,0,0,1,299999.7750406064,299999.7750406064,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,INSIG1,-0.018000007,1.2025,0.024682,1,1.0,-1.0,Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-8957322;R-HSA-1655829
ENSG00000186513,1,1,0,0,0,1,99788.44320353035,99788.44320353035,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR9Q2,-0.65199995,0.33292,-0.34246,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000186827,1,1,1,1,0,0,33224.221295945434,33224.221295945434,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TNFRSF4,-0.48899996,-1.629,-2.3325,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000187260,1,1,0,0,0,1,3534.485612498504,3534.485612498504,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,WDR86,-0.43499994,-1.1093,-1.415,0,0.5,0.0,,
ENSG00000187266,1,1,0,0,0,1,380831.7787965888,380831.7787965888,2017-12-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EPOR,0.213,1.0613,-0.39387,5,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000187474,1,1,0,0,0,1,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,FPR3,-0.906,2.0529,1.5705,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000187758,1,1,1,0,0,1,5504.0130519525,5504.0130519525,2021-09-30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ADH1A,-0.10399997,0.16864,0.91012,3,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000187775,1,1,0,0,0,1,2324.6716622691292,2324.6716622691292,2023-04-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DNAH17,0.14099997,-1.9781,-6.2879,0,0.75,0.5,,
ENSG00000188162,1,1,0,0,1,1,182481.56964523086,182481.56964523086,2021-10-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,OTOG,-0.09099996,-0.92884,-0.084857,1,0.5,1.0,,
ENSG00000188227,1,1,1,0,0,0,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF793,0.19099998,1.0423,0.84839,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000188282,1,1,0,0,0,1,21897.542503344637,21897.542503344637,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,RUFY4,-0.416,-1.6561,-1.4128,0,0.5,0.5,,
ENSG00000188313,1,1,1,0,1,1,21020.801882160395,165324.69367515197,2022-03-07,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PLSCR1,0.32700002,0.7579,0.70788,0,-1.0,-1.0,,
ENSG00000188428,2,1,1,0,0,1,598869.4096893278,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,BLOC1S5,-0.625,-0.085043,-0.67424,0,-1.0,-1.0,,
ENSG00000188674,2,1,1,0,0,1,1871.6973317403424,17634.65533758174,2017-03-27,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,C2orf80,-0.30299997,0.53212,0.17497,0,1.0,0.5,,
ENSG00000188730,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VWC2,-0.10099995,-1.6592,-2.5621,0,0.75,0.5,,
ENSG00000188783,1,1,0,1,0,1,356440.71671986027,356440.71671986027,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PRELP,-0.05700004,1.1974,-0.4049,5,-1.0,0.0,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Defective ST3GAL3 causes MCT12 and EIEE15;Disease,R-HSA-3656244;R-HSA-3656243;R-HSA-1643685
ENSG00000188811,1,1,0,0,0,1,415452.66715166246,415452.66715166246,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,NHLRC3,-0.15400004,0.031817,-0.54846,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000188994,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF292,0.839,2.0272,-1.7057,0,-1.0,-1.0,,
ENSG00000189320,2,1,0,0,0,1,155552.2805078301,333304.3295866077,2023-01-18,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FAM180A,-0.40699995,0.72466,0.54758,0,0.5,0.0,,
ENSG00000189325,1,1,0,0,0,1,108079.44677357117,108079.44677357117,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,BNIP5,-0.11199999,0.25066,0.56583,0,1.0,0.5,,
ENSG00000196109,3,1,1,0,1,1,9539.551199137346,26685.217785743116,2022-10-12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,ZNF676,-0.77,-0.074399,0.17622,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000196196,1,1,1,0,1,1,252346.18526092035,427337.4491868293,2018-08-13,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,HRCT1,,-1.0957,-0.82195,0,0.5,0.0,,
ENSG00000196233,1,1,0,0,0,1,19008.705439555517,87248.80974040499,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,LCOR,0.662,2.0578,1.2013,0,0.5,-1.0,,
ENSG00000196247,2,1,1,0,0,1,11231.262381898725,13756.062794259458,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,ZNF107,-0.93200004,0.36894,0.39385,0,0.5,0.0,,
ENSG00000196344,1,1,0,0,0,1,5504.0130519525,5504.0130519525,2021-09-30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ADH7,-0.42900002,-0.93414,-0.41811,1,1.0,0.5,,
ENSG00000196405,1,1,1,0,0,0,162367.55694122918,162367.55694122918,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,EVL,0.499,1.7068,0.70141,3,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology,R-HSA-162582;R-HSA-168256;R-HSA-1266738
ENSG00000196415,1,1,0,0,0,1,3552.594775619558,3552.594775619558,2016-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,PRTN3,-0.885,-1.7296,-2.388,4,1.0,0.5,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Antimicrobial peptides,R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6803157
ENSG00000196419,1,1,0,0,0,1,49934.412283564205,49934.412283564205,2018-08-13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,XRCC6,0.828,4.1859,0.29699,5,-1.0,-1.0,Immune System;IRF3-mediated induction of type I IFN;Disease;HIV Life Cycle,R-HSA-168256;R-HSA-3270619;R-HSA-1643685;R-HSA-162587
ENSG00000196504,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PRPF40A,0.56,1.5779,-2.1049,1,-1.0,-1.0,,
ENSG00000196531,3,1,1,0,1,1,87748.84971094332,645988.1975077938,2018-06-11,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,NACA,0.37300003,0.88842,-0.23074,0,-1.0,-1.0,,
ENSG00000196655,1,1,1,0,0,0,29404.874895307225,29404.874895307225,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRAPPC4,-0.689,0.82914,-0.94127,3,-1.0,-1.0,Rab regulation of trafficking;Post-translational protein modification,R-HSA-9007101;R-HSA-597592
ENSG00000196843,1,1,0,0,0,1,30049.94565242696,38772.287745457244,2025-03-12,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,ARID5A,0.19800001,1.0596,-0.50989,0,-1.0,-1.0,,
ENSG00000196862,2,1,0,0,0,1,1305.1661385242191,1305.1661385242191,2018-02-02,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,RGPD4,-0.22300005,1.9574,2.1604,0,0.5,0.5,,
ENSG00000197024,1,1,0,0,0,1,21669.239405495955,21669.239405495955,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZNF398,0.22399998,2.3414,1.8382,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000197043,1,1,1,0,0,0,11252.882952659449,11252.882952659449,2021-02-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,ANXA6,0.12800002,0.65771,0.93297,1,-1.0,-1.0,,
ENSG00000197081,3,1,1,1,0,1,122069.83349127392,228688.0296088316,2017-12-06,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,IGF2R,0.579,2.7604,-0.65554,5,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000197265,2,1,1,0,0,1,105453.60460439936,414433.58532016096,2021-02-24,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,GTF2E2,-0.10699999,0.23657,0.23209,9,-1.0,-1.0,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;RNA Polymerase II Pre-transcription Events;Transcription of the HIV genome;RNA polymerase II transcribes snRNA genes;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-674695;R-HSA-167172;R-HSA-6807505;R-HSA-162587;R-HSA-162599
ENSG00000197465,1,1,1,0,0,1,60111.20110003438,75457.10036559975,2020-10-27,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,GYPE,-0.12100005,0.061714,-0.11695,0,1.0,0.5,,
ENSG00000197714,1,1,0,0,0,0,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF460,0.45200002,3.6921,0.46141,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000197747,1,1,1,0,0,1,100857.20347685824,197485.87952538437,2018-08-13,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,S100A10,-0.08099997,0.49441,-0.068973,1,0.5,-1.0,,
ENSG00000197921,1,1,0,0,0,1,58331.23271678036,58331.23271678036,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,HES5,-0.92700005,-2.6986,-3.0008,6,0.5,0.5,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000197933,1,1,1,0,0,1,131525.74533408263,323648.5577791949,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,ZNF823,0.12699997,2.4797,0.95939,0,-1.0,-1.0,,
ENSG00000198060,1,1,1,0,0,1,84563.14597380339,294387.2978738704,2021-09-30,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MARCHF5,0.606,3.2094,0.59995,0,-1.0,-1.0,,
ENSG00000198088,1,1,0,0,0,0,5916.919614951869,5916.919614951869,2017-07-28,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NUP62CL,,,,0,0.5,0.0,,
ENSG00000198162,1,1,1,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,MAN1A2,0.47500002,2.1342,0.77211,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000198216,1,1,0,0,0,1,684816.7338614308,1122672.658801146,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,CACNA1E,0.779,6.7175,0.76299,2,1.0,0.5,Presynaptic depolarization and calcium channel opening,R-HSA-112308
ENSG00000198246,1,1,1,0,1,1,15379.838790371894,15379.838790371894,2021-11-15,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,SLC29A3,0.06699997,0.8043,0.73408,3,-1.0,0.0,"Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane;Disease;Transport of vitamins, nucleosides, and related molecules",R-HSA-83936;R-HSA-1643685;R-HSA-425397
ENSG00000198270,1,1,0,0,0,1,15379.838790371894,15379.838790371894,2021-11-15,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,TMEM116,-0.10099995,0.95075,0.91791,0,0.5,-1.0,,
ENSG00000198431,1,1,1,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,TXNRD1,-0.006000042,0.83248,-0.2083,8,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Interconversion of nucleotide di- and triphosphates;Metabolism of nucleotides,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-499943;R-HSA-15869
ENSG00000198471,1,1,0,0,0,0,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,RTP2,-0.181,-0.57281,-0.46316,1,0.75,0.5,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000198492,1,1,1,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,YTHDF2,0.86800003,3.3959,1.4715,0,-1.0,-1.0,,
ENSG00000198513,1,1,0,0,0,1,8479.376416968564,31120.920520971555,2017-09-07,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,ATL1,0.43,3.8464,0.57501,0,0.5,0.0,,
ENSG00000198515,1,1,1,0,0,0,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CNGA1,0.22100002,1.0037,1.6259,2,1.0,0.0,,
ENSG00000198791,1,1,1,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CNOT7,0.745,3.1484,-0.8516,3,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Deadenylation of mRNA;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-429947;R-HSA-1266738;R-HSA-74160
ENSG00000198797,3,1,0,0,1,1,15866.724081734988,684816.7338614308,2017-05-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,10,BRINP2,0.589,1.7741,0.96157,0,0.75,0.5,,
ENSG00000198812,1,1,0,0,0,1,228220.5662976458,645988.1975077938,2023-01-19,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,LRRC10,0.065,1.0124,0.72556,0,1.0,1.0,,
ENSG00000198892,1,1,0,0,1,1,252346.18526092035,252346.18526092035,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SHISA4,0.009000003,0.34894,-0.2381,0,0.5,0.0,,
ENSG00000203499,1,1,1,0,1,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,IQANK1,-0.911,-0.3176,-0.22975,0,0.5,0.0,,
ENSG00000203778,2,1,1,0,0,1,156470.480665571,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,FAM229B,0.426,0.35605,0.6026,0,1.0,-1.0,,
ENSG00000203952,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CCDC160,,,,0,0.5,0.0,,
ENSG00000204138,1,1,1,0,0,1,188264.63129042363,355284.1215006515,2025-03-06,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PHACTR4,0.106000006,1.9516,2.008,0,-1.0,-1.0,,
ENSG00000204161,2,1,0,0,0,1,138890.6106237268,645988.1975077938,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TMEM273,-0.43299997,-0.83025,-0.023238,0,-1.0,-1.0,,
ENSG00000204186,1,1,0,0,0,1,98744.41493028583,98744.41493028583,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ZDBF2,-0.39600003,1.3679,1.6659,0,-1.0,0.0,,
ENSG00000204272,1,1,0,0,0,1,72098.8014618248,72098.8014618248,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NBDY,,,,0,-1.0,-1.0,,
ENSG00000204403,1,1,0,0,0,1,184666.1521051339,323648.5577791949,2020-11-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,CASP12,,0.11099,0.24092,0,0.5,0.0,,
ENSG00000204839,1,1,1,0,1,1,114817.16866287061,114817.16866287061,2019-07-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MROH6,-0.398,-3.5323,-4.745,0,0.5,0.0,,
ENSG00000205060,1,1,1,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC35B4,0.12699997,1.4443,0.46762,1,-1.0,-1.0,"Transport of vitamins, nucleosides, and related molecules",R-HSA-425397
ENSG00000205352,1,1,1,0,0,1,4634.000517221562,33762.84339699367,2021-11-04,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PRR13,-0.35099995,0.33392,0.64031,0,-1.0,-1.0,,
ENSG00000205476,1,1,0,0,0,1,208059.85546229704,208059.85546229704,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CCDC85C,0.052999973,-2.191,-2.1529,0,0.5,-1.0,,
ENSG00000205643,1,1,1,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CDPF1,-0.566,0.31084,0.31337,0,-1.0,-1.0,,
ENSG00000205678,1,1,0,0,0,1,118061.55082048493,118061.55082048493,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,TECRL,-0.56299996,-0.78184,0.16358,1,1.0,0.5,Synthesis of very long-chain fatty acyl-CoAs;Fatty acyl-CoA biosynthesis,R-HSA-75876;R-HSA-75105
ENSG00000205730,1,1,0,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ITPRIPL2,-0.342,0.048347,-0.71932,0,-1.0,0.0,,
ENSG00000205810,1,1,1,0,0,1,135108.48254553688,135108.48254553688,2025-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KLRC3,-0.25199997,0.8722,-0.13935,0,0.75,0.5,,
ENSG00000205903,1,1,1,0,1,1,382631.1172224132,382631.1172224132,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF316,-0.17499995,-2.2652,-5.8027,0,-1.0,-1.0,,
ENSG00000211584,1,1,0,0,0,1,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC48A1,-0.021999955,0.33821,-0.66019,0,0.5,-1.0,,
ENSG00000213347,2,1,1,0,0,1,7483.094846362048,7483.094846362048,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,MXD3,-0.17400002,-0.85396,-1.5684,0,0.5,0.0,,
ENSG00000213390,2,1,1,0,0,1,44692.894702471654,1424218.0900670097,2020-05-06,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,ARHGAP19,-0.023000002,0.98781,0.64202,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000213424,1,1,0,0,0,1,185805.42963097955,185805.42963097955,2021-11-04,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,KRT222,0.20700002,0.33985,0.74001,0,0.5,0.5,,
ENSG00000213585,1,1,0,0,0,1,107949.90929360976,143413.24457139417,2023-06-29,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,VDAC1,0.463,2.2601,0.40634,5,0.5,-1.0,Mitochondrial calcium ion transport;Pyruvate metabolism;Post-translational protein modification,R-HSA-8949215;R-HSA-70268;R-HSA-597592
ENSG00000213694,1,1,0,0,0,1,74722.59037384245,74722.59037384245,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,S1PR3,-0.26699996,1.2878,-0.085957,3,-1.0,-1.0,Signal Transduction;Lysosphingolipid and LPA receptors,R-HSA-162582;R-HSA-419408
ENSG00000213699,1,1,1,0,0,1,265186.2821240392,265186.2821240392,2024-07-19,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC35F6,-0.26199996,1.0432,1.1848,0,-1.0,-1.0,,
ENSG00000213762,1,1,0,0,1,1,898.4958904109589,898.4958904109589,2020-07-31,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF134,-0.959,0.038663,0.35805,0,-1.0,-1.0,,
ENSG00000215193,1,1,0,0,0,1,545988.1005477115,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PEX26,0.10699999,-0.068794,-0.54517,2,-1.0,-1.0,Class I peroxisomal membrane protein import;Peroxisomal protein import,R-HSA-9603798;R-HSA-9033241
ENSG00000216937,1,1,1,0,0,1,545988.1005477115,645988.1975077938,2023-01-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CCDC7,-0.10699999,0.0017368,-0.72921,0,1.0,0.0,,
ENSG00000220201,3,1,1,0,0,1,31137.07865241903,49724.14538298504,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,ZGLP1,0.102,0.44944,-0.6,0,-1.0,0.0,,
ENSG00000223614,1,1,0,0,0,0,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF735,-0.556,-0.3975,-0.52112,1,,,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000224109,1,1,0,0,0,1,65127.395275883,65127.395275883,2021-09-30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CENPVL3,,,,0,0.75,0.5,,
ENSG00000225830,1,1,0,0,0,0,313882.50400013494,313882.50400013494,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ERCC6,0.19700003,1.7245,0.22508,7,-1.0,-1.0,Formation of TC-NER Pre-Incision Complex;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;RNA Polymerase I Transcription Initiation;Gap-filling DNA repair synthesis and ligation in TC-NER;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-6781823;R-HSA-74160;R-HSA-427389;R-HSA-73762;R-HSA-6782210;R-HSA-73864;R-HSA-73854;R-HSA-6782135;R-HSA-6781827
ENSG00000226650,1,1,0,0,0,0,50366.5001531924,50366.5001531924,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,KIF4B,-0.029000044,1.4848,1.5203,4,1.0,1.0,Immune System;Developmental Biology;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Recycling pathway of L1;Kinesins,R-HSA-168256;R-HSA-1266738;R-HSA-8856688;R-HSA-6811434;R-HSA-437239;R-HSA-983189
ENSG00000231256,1,1,0,0,0,1,75639.5973879004,93132.96870045633,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,CFAP97D1,0.008000016,1.0928,1.0326,0,1.0,1.0,,
ENSG00000231989,1,1,0,0,0,1,718784.6890415357,718784.6890415357,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PPP1R2B,-0.56700003,0.36323,-0.89645,0,1.0,1.0,,
ENSG00000232237,1,1,1,0,0,1,6021.72810122829,6021.72810122829,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ASCL5,-0.704,-0.40999,-0.41441,0,0.5,1.0,,
ENSG00000233041,1,1,0,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PHGR1,-0.44599998,1.2165,0.99471,0,1.0,0.0,,
ENSG00000233232,2,1,0,0,0,1,71117.27631467933,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,NPIPB7,-0.44599998,1.8135,1.2563,0,0.5,0.0,,
ENSG00000233436,1,1,0,0,0,1,21724.94108458234,21724.94108458234,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BTBD18,0.561,1.2032,0.92724,0,1.0,1.0,,
ENSG00000239605,1,1,0,0,0,1,192594.63282947522,192594.63282947522,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,STPG4,-0.605,-1.3208,-1.2951,1,1.0,1.0,,
ENSG00000239839,1,1,0,0,0,1,10736.940639920189,10736.940639920189,2024-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DEFA3,0.26,1.552,1.1607,2,1.0,0.0,Alpha-defensins;Immune System;Defensins;Antimicrobial peptides,R-HSA-1462054;R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000241973,1,1,1,0,0,0,86869.04450932604,86869.04450932604,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PI4KA,0.45200002,4.6448,-0.056819,2,0.5,-1.0,Synthesis of PIPs at the Golgi membrane,R-HSA-1660514
ENSG00000242221,2,1,0,0,0,1,37099.31252818776,42341.12463940832,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PSG2,-0.707,-3.4754,-4.6057,1,1.0,1.0,,
ENSG00000242265,1,1,0,0,0,0,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PEG10,0.468,1.2721,0.93308,0,0.5,0.0,,
ENSG00000243232,1,1,1,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PCDHAC2,0.504,1.6451,-0.23907,0,1.0,0.0,,
ENSG00000244165,1,1,0,0,0,1,155552.2805078301,155552.2805078301,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,P2RY11,-0.905,-2.6993,-2.9087,3,-1.0,0.0,Signal Transduction;P2Y receptors;Nucleotide-like (purinergic) receptors,R-HSA-162582;R-HSA-417957;R-HSA-418038
ENSG00000245848,3,1,0,0,0,1,17831.529851792977,87248.80974040499,2010-11-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,7,CEBPA,-0.37199998,-1.2385,-3.0249,3,0.75,0.0,Developmental Biology;Gene expression (Transcription),R-HSA-1266738;R-HSA-74160
ENSG00000248483,2,1,0,0,0,1,684816.7338614308,1129585.974638378,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,5,POU5F2,-0.89100003,0.79109,-0.14285,0,0.5,0.5,,
ENSG00000248713,1,1,0,0,0,1,141553.2677895436,141553.2677895436,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,C4orf54,-0.024999976,-0.65912,-0.54746,0,1.0,0.5,,
ENSG00000250878,1,1,0,0,0,1,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,METTL21EP,,,,0,,,,
ENSG00000253649,1,1,0,0,0,1,22650.1728716785,960369.5592648841,2021-04-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PRSS51,,,,0,1.0,0.5,,
ENSG00000254858,1,1,1,0,1,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,MPV17L2,-0.53499997,-0.59271,-0.84394,0,-1.0,-1.0,,
ENSG00000255307,1,1,0,0,0,1,67142.73298165268,67142.73298165268,2023-11-30,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR52B2,-0.70799994,-0.66594,-0.36267,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000255398,1,1,1,0,0,1,167055.73472660675,169088.90478978804,2019-03-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,HCAR3,-0.824,1.2917,0.76662,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000255423,1,1,0,0,0,1,155987.83221129785,155987.83221129785,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EBLN2,-0.962,-1.1814,-0.73156,0,1.0,0.0,,
ENSG00000256053,3,1,1,0,0,1,15866.724081734988,116547.04276487474,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,7,COA8,-0.30499995,-1.074,-1.8538,0,0.5,-1.0,,
ENSG00000256463,1,1,0,0,0,1,22541.66311868015,521818.7070055739,2013-04-01,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,SALL3,0.24599999,-3.2698,-5.8376,0,0.75,0.5,,
ENSG00000258223,1,1,0,0,0,1,22669.576834673207,22669.576834673207,2023-05-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PRSS58,-0.594,-0.42615,-0.5686,0,1.0,1.0,,
ENSG00000258315,1,1,1,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BACC1,-0.35599995,0.44662,-0.55862,0,-1.0,-1.0,,
ENSG00000258429,1,1,1,0,0,1,298504.9722193353,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,PDF,-0.98399997,-3.8637,-5.5007,0,0.5,0.0,,
ENSG00000260097,1,1,0,0,0,1,75632.36795352261,275021.63051358337,2023-01-18,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SPDYE6,0.697,3.8574,3.3268,0,0.5,0.0,,
ENSG00000260220,1,1,0,0,1,0,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CCDC187,-0.16199994,2.2718,1.3913,1,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000261794,1,1,0,0,0,1,191072.61653508648,191072.61653508648,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GOLGA8H,-0.73099995,-1.4662,-0.87789,0,0.5,0.0,,
ENSG00000261857,1,1,0,1,0,1,1519.5292881534017,1519.5292881534017,2012-03-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MIA,-0.288,0.6096,0.90675,0,0.5,0.0,,
ENSG00000263353,1,1,0,0,0,1,160010.51072069994,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PPIAL4A,-0.74399996,-0.92726,0.28632,0,,,,
ENSG00000263761,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GDF2,-0.20799994,0.76019,-1.1527,1,1.0,1.0,Signal Transduction,R-HSA-162582
ENSG00000267673,1,1,1,0,0,1,62043.890063935265,124837.11004999638,2022-11-04,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,FDX2,-0.16400003,0.34471,-1.2042,5,-1.0,-1.0,Disease;Mitochondrial iron-sulfur cluster biogenesis;Pregnenolone biosynthesis;Metabolism of steroids,R-HSA-1643685;R-HSA-1362409;R-HSA-196108;R-HSA-8957322
ENSG00000270231,1,1,0,0,1,1,195005.6685718255,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NBPF8,,,,0,-1.0,0.0,,
ENSG00000272047,1,1,0,0,0,1,269000.70907194994,337860.4854363166,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,GTF2H5,-0.727,0.12883,0.56068,29,-1.0,-1.0,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;RNA Pol II CTD phosphorylation and interaction with CE;mRNA Capping;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;Generic Transcription Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;Formation of TC-NER Pre-Incision Complex;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;RNA Polymerase I Transcription Initiation;Gap-filling DNA repair synthesis and ligation in TC-NER;Formation of Incision Complex in GG-NER;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-167160;R-HSA-77075;R-HSA-72086;R-HSA-113418;R-HSA-167158;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-212436;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-73863;R-HSA-6781823;R-HSA-74160;R-HSA-73772;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-73762;R-HSA-6782210;R-HSA-5696395;R-HSA-73864;R-HSA-73854;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-6781827
ENSG00000272573,1,1,1,0,0,1,133979.87941345197,133979.87941345197,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MUSTN1,-0.783,-0.24359,-0.10981,0,1.0,0.0,,
ENSG00000273213,1,1,0,0,0,1,42879.69557188197,42879.69557188197,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,H3-7,-0.72099996,-0.48078,-0.8808,0,-1.0,0.0,,
ENSG00000274588,1,1,0,0,0,1,3400.4411583487367,3400.4411583487367,2014-08-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DGKK,,,,1,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000277363,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SRCIN1,0.296,-0.33003,-2.7212,0,1.0,0.0,,
ENSG00000278505,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,C17orf78,-0.49,1.2352,0.31435,0,1.0,0.5,,
ENSG00000280021,1,1,0,0,0,1,12141.498863267294,12141.498863267294,2013-05-23,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR51F1,-0.49699998,-0.66303,0.28754,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000283267,1,1,0,0,0,1,254373.32653042395,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM237B,,,,0,,,,
ENSG00000283324,1,1,0,0,0,1,194667.2540182328,298389.02809443185,2024-07-19,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CTXND2,,,,0,,,,
ENSG00000284635,2,1,0,0,0,1,19965.24128263536,29811.1438239137,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,SCYGR8,,,,0,,,,
ENSG00000284770,1,1,0,0,0,1,515513.2178404211,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TBCE,0.13200003,0.41471,0.62049,1,-1.0,0.0,Post-chaperonin tubulin folding pathway,R-HSA-389977
ENSG00000285946,1,1,0,0,0,1,112025.85662838118,112025.85662838118,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LCE7A,,,,0,1.0,1.0,,
ENSG00000288529,1,1,0,0,0,1,220837.49604317299,521818.7070055739,2023-11-09,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ENSG00000288529,,0.206,,0,0.5,0.5,,
ENSG00000288702,1,1,0,0,1,1,14094.133420328406,178948.78717378277,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,UGT1A3,0.028999984,-0.54103,0.21755,5,1.0,0.5,Signal Transduction;Prednisone ADME;Atorvastatin ADME;Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-162582;R-HSA-9757110;R-HSA-9754706;R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000288708,1,1,0,0,0,1,228220.5662976458,228220.5662976458,2018-07-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ENSG00000288708,-0.84099996,-0.015821,-0.80307,0,0.75,0.5,,
ENSG00000289653,1,1,0,0,0,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ENSG00000289653,,,,0,1.0,1.0,,
ENSG00000293164,1,1,0,0,1,1,252346.18526092035,427337.4491868293,2018-08-13,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ENSG00000293164,,,,0,,,,
ENSG00000310562,2,1,0,0,0,1,133119.54945431868,251325.91086204,2022-01-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,3,ENSG00000310562,,,,0,,,,
ENSG00000001084,2,1,1,0,0,1,33954.407278742765,521818.7070055739,2023-05-26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,GCLC,0.59599996,2.1807,-0.18886,3,0.5,-1.0,Glutathione conjugation;Disease;Glutathione synthesis and recycling;Phase II - Conjugation of compounds,R-HSA-156590;R-HSA-1643685;R-HSA-174403;R-HSA-156580
ENSG00000002016,2,1,1,0,1,1,32536.054824140134,143284.77790855977,2021-09-30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RAD52,-0.18499994,1.0717,0.80436,3,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000002746,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HECW1,0.577,3.0511,0.00054384,1,0.5,0.5,Signal Transduction;Degradation of DVL,R-HSA-162582;R-HSA-4641258
ENSG00000003249,8,1,1,0,0,1,1518.476507995959,125392.97184483419,2020-09-04,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,DBNDD1,-0.46000004,-0.64035,-0.67381,0,0.5,0.0,,
ENSG00000004866,1,1,0,0,0,1,12724.75719835148,12724.75719835148,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ST7,0.48000002,3.6992,-0.0071719,0,-1.0,-1.0,,
ENSG00000005421,1,1,0,0,0,1,118061.55082048493,118061.55082048493,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,PON1,-0.15900004,0.67701,0.51275,2,1.0,0.5,Atorvastatin ADME;Arachidonate metabolism,R-HSA-9754706;R-HSA-2142753
ENSG00000005436,2,1,1,0,0,1,171880.2916512608,433862.5685735124,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,GCFC2,-0.94500005,-2.8594,-2.1564,1,-1.0,-1.0,,
ENSG00000005469,1,1,0,0,0,1,32054.215858379364,32054.215858379364,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CROT,-0.003000021,0.61739,1.406,2,-1.0,-1.0,Peroxisomal protein import,R-HSA-9033241
ENSG00000005889,1,1,0,0,0,1,306980.8575290048,306980.8575290048,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ZFX,,,,0,-1.0,-1.0,,
ENSG00000006695,1,1,0,0,0,1,151706.1907321582,151706.1907321582,2022-11-07,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,COX10,0.065999985,1.3958,0.14622,1,0.5,-1.0,Heme biosynthesis,R-HSA-189451
ENSG00000006747,1,1,0,0,0,1,22516.834055473177,22516.834055473177,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SCIN,-0.16199994,-2.3641,-1.3924,0,0.5,0.0,,
ENSG00000006788,1,1,0,0,1,1,124531.34246675359,124531.34246675359,2021-02-24,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MYH13,0.14099997,1.6769,1.0483,0,0.5,0.5,,
ENSG00000007129,1,1,1,0,1,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CEACAM21,-0.42900002,-0.11829,-0.36172,0,0.5,0.0,,
ENSG00000007168,2,1,0,0,0,0,228168.37020113936,396735.32121509424,2022-06-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PAFAH1B1,0.9,3.7117,0.64085,14,-1.0,-1.0,Signal Transduction;Golgi-to-ER retrograde transport,R-HSA-162582;R-HSA-8856688
ENSG00000007402,1,1,0,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CACNA2D2,0.604,3.1353,0.36795,6,0.5,0.0,"Presynaptic depolarization and calcium channel opening;Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-112308;R-HSA-400042
ENSG00000007866,1,1,0,0,0,1,62043.890063935265,62043.890063935265,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TEAD3,0.565,2.3837,0.54937,2,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8878159
ENSG00000007908,1,1,0,0,0,1,56614.28807963426,56614.28807963426,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SELE,0.13999999,0.1583,-0.38326,1,0.5,0.0,,
ENSG00000008277,1,1,0,0,0,1,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ADAM22,0.482,2.2901,0.47679,1,1.0,0.0,LGI-ADAM interactions;Developmental Biology,R-HSA-5682910;R-HSA-1266738
ENSG00000008294,1,1,0,0,0,1,43931.768802862716,43931.768802862716,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SPAG9,0.73800004,3.8465,1.3923,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000008323,3,1,1,0,1,1,6263.050060459492,124801.11117486731,2014-05-18,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,PLEKHG6,-0.17799997,-0.81588,-1.8785,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000008513,1,1,0,0,0,1,58995.33218928629,58995.33218928629,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ST3GAL1,0.272,1.8261,0.097999,6,-1.0,-1.0,Translation of Structural Proteins_9683701;Disease;Post-translational protein modification,R-HSA-9683701;R-HSA-1643685;R-HSA-597592
ENSG00000008710,1,1,0,0,0,1,58331.23271678036,160010.51072069994,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,PKD1,0.63600004,-5.6666,-12.454,1,0.5,-1.0,VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane,R-HSA-5620916;R-HSA-5620920
ENSG00000010327,1,1,1,0,0,1,46282.676044693806,46282.676044693806,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,STAB1,0.157,1.5751,-1.0378,1,0.5,0.0,,
ENSG00000011007,1,1,0,0,0,1,16461.04650907092,16461.04650907092,2015-01-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ELOA,0.71500003,2.1575,0.45082,11,-1.0,0.0,Generic Transcription Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Pausing and recovery of HIV elongation;Tat-mediated HIV elongation arrest and recovery;HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-212436;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-167290;R-HSA-167243;R-HSA-167287;R-HSA-167238;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-162587;R-HSA-162599
ENSG00000011295,1,1,1,0,0,0,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,TTC19,-0.049000025,-0.48028,-1.6167,1,-1.0,-1.0,,
ENSG00000011426,1,1,0,0,1,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ANLN,0.463,1.8024,1.629,3,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000012171,1,1,0,0,0,1,107949.90929360976,143413.24457139417,2023-06-29,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SEMA3B,-0.21899998,-0.39108,-1.7077,0,0.5,0.0,,
ENSG00000013297,1,1,0,0,0,1,13552.542477876106,521818.7070055739,2011-07-10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,CLDN11,0.652,1.8943,-0.082441,1,0.75,0.0,Tight junction interactions,R-HSA-420029
ENSG00000013588,1,1,0,0,0,1,133918.94977035935,133918.94977035935,2020-04-27,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPRC5A,-0.23300004,0.12115,-0.10658,0,0.5,0.0,HuR (ELAVL1) binds and stabilizes mRNA,R-HSA-450520
ENSG00000014138,1,1,1,0,1,1,220837.49604317299,220837.49604317299,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,POLA2,0.301,1.5884,0.56518,9,-1.0,0.0,E2F mediated regulation of DNA replication;Inhibition of replication initiation of damaged DNA by RB1/E2F1;Disease,R-HSA-113510;R-HSA-113501;R-HSA-1643685
ENSG00000014919,1,1,0,0,0,0,278498.5074409075,278498.5074409075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,COX15,-0.19799995,1.6685,0.4112,2,-1.0,-1.0,Heme biosynthesis;Complex IV assembly,R-HSA-189451;R-HSA-9864848
ENSG00000015133,4,1,1,0,0,1,22345.675520395987,521818.7070055739,2013-04-01,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,CCDC88C,0.241,-0.39584,-1.742,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000016391,1,1,1,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CHDH,-0.09200001,-0.45895,-1.1323,1,0.5,0.0,,
ENSG00000017260,2,1,0,0,0,1,59742.17313930438,286746.1002745869,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,ATP2C1,0.598,3.7791,0.99368,1,-1.0,-1.0,,
ENSG00000018510,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,AGPS,0.592,2.8043,-0.41337,3,-1.0,-1.0,Peroxisomal protein import,R-HSA-9033241
ENSG00000020426,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MNAT1,-0.28499997,1.2138,0.22549,33,-1.0,-1.0,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;RNA Pol II CTD phosphorylation and interaction with CE;mRNA Capping;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;Generic Transcription Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;Cyclin A/B1/B2 associated events during G2/M transition;Formation of TC-NER Pre-Incision Complex;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;RNA Polymerase I Transcription Initiation;Gap-filling DNA repair synthesis and ligation in TC-NER;Formation of Incision Complex in GG-NER;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-167160;R-HSA-77075;R-HSA-72086;R-HSA-113418;R-HSA-167158;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-212436;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-73863;R-HSA-69273;R-HSA-6781823;R-HSA-74160;R-HSA-73772;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-73762;R-HSA-6782210;R-HSA-5696395;R-HSA-73864;R-HSA-73854;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-6781827
ENSG00000023191,1,1,1,0,0,1,28923.750134754748,28923.750134754748,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,RNH1,-0.16900003,0.12944,-1.3358,0,-1.0,-1.0,,
ENSG00000023228,1,1,0,0,0,1,97181.90375256384,97181.90375256384,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,NDUFS1,0.16399997,0.5895,1.0088,3,0.5,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000025039,1,1,0,0,0,0,756470.9740366563,756470.9740366563,2025-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RRAGD,0.37,2.3958,0.81967,7,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;mTORC1-mediated signalling;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;Amino acids regulate mTORC1;MTOR signalling;Cellular response to starvation,R-HSA-162582;R-HSA-212436;R-HSA-166208;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-9639288;R-HSA-165159;R-HSA-9711097
ENSG00000025293,2,1,0,0,0,1,77544.39441764928,179853.90625477568,2021-07-21,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PHF20,0.751,3.177,0.9789,5,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000025423,1,1,0,0,0,1,545988.1005477115,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HSD17B6,0.171,0.87014,0.9752,1,1.0,0.0,The canonical retinoid cycle in rods (twilight vision),R-HSA-2453902
ENSG00000025708,1,1,1,1,0,0,112184.2204720767,112184.2204720767,2024-04-26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TYMP,-0.518,-3.4365,-2.6138,2,-1.0,0.0,Nucleotide salvage;Metabolism of nucleotides,R-HSA-8956321;R-HSA-15869
ENSG00000026025,1,1,1,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,VIM,0.458,0.8557,-0.17392,7,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Late endosomal microautophagy;RHOBTB1 GTPase cycle;Aggrephagy;Signaling by Interleukins;Chaperone Mediated Autophagy;RHOBTB GTPase Cycle;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9615710;R-HSA-9013422;R-HSA-9646399;R-HSA-449147;R-HSA-9613829;R-HSA-9706574;R-HSA-6785807
ENSG00000026751,1,1,1,1,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,SLAMF7,0.012000024,0.53712,-0.36488,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000028277,1,1,0,0,1,0,101032.95487940393,101032.95487940393,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,POU2F2,0.72099996,2.3051,0.75473,1,0.5,0.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000028839,1,1,1,0,1,1,220837.49604317299,521818.7070055739,2021-01-04,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,TBPL1,0.579,2.5405,0.59233,0,0.5,-1.0,,
ENSG00000029153,1,1,0,0,0,1,100711.28404230655,100711.28404230655,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BMAL2,0.16900003,1.2754,0.23774,1,0.5,0.0,,
ENSG00000029363,1,1,0,0,0,0,414433.58532016096,414433.58532016096,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BCLAF1,0.787,3.8418,2.0086,0,0.5,-1.0,,
ENSG00000033030,2,1,0,0,0,1,97181.90375256384,182720.23308494932,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,ZCCHC8,0.291,1.0614,0.15262,2,0.5,-1.0,Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex;Gene expression (Transcription);Nuclear RNA decay,R-HSA-9843970;R-HSA-74160;R-HSA-9930044
ENSG00000034053,1,1,0,0,0,1,13256.978819302958,34185.659640669364,2024-07-19,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,APBA2,0.476,2.9096,-0.43399,1,1.0,0.0,,
ENSG00000034677,1,1,0,0,0,1,121431.94148574545,121431.94148574545,2022-04-25,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RNF19A,0.459,3.2898,0.70033,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000035499,1,1,0,0,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DEPDC1B,0.04100001,1.2925,0.25092,17,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000036672,1,1,1,0,0,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,USP2,0.37699997,1.4887,0.57323,5,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000037042,1,1,1,0,1,1,108425.35980999071,108425.35980999071,2025-01-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TUBG2,0.097,3.6946,0.62857,2,0.5,-1.0,,
ENSG00000038002,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,AGA,0.061999977,0.11808,0.080157,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000038945,1,1,0,0,0,1,718784.6890415357,718784.6890415357,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MSR1,-0.36600006,-3.1333,-1.7835,1,1.0,-1.0,,
ENSG00000039068,3,1,1,0,0,1,3830.8097102584184,473900.221403792,2008-11-16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CDH1,0.486,1.9041,0.90497,11,0.5,0.0,Signal Transduction;Immune System;Developmental Biology;Disease,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685
ENSG00000040731,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CDH10,0.34500003,1.6532,0.70012,1,1.0,0.5,,
ENSG00000041988,1,1,1,0,1,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,THAP3,-0.24100006,0.46316,-0.41346,0,-1.0,-1.0,,
ENSG00000043039,2,1,0,0,0,1,141076.9910731678,521818.7070055739,2020-05-18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,BARX2,0.27100003,0.21883,0.71137,0,0.5,0.0,,
ENSG00000047315,1,1,0,0,0,1,117707.74532698281,117707.74532698281,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,POLR2B,0.43199998,6.4712,0.77268,41,-1.0,-1.0,Signal Transduction;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;RNA Pol II CTD phosphorylation and interaction with CE;mRNA Capping;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;Generic Transcription Pathway;FGFR2 alternative splicing;mRNA Splicing - Minor Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;Formation of TC-NER Pre-Incision Complex;Developmental Biology;Inhibition of DNA recombination at telomere;Gene expression (Transcription);PIWI-interacting RNA (piRNA) biogenesis;Viral Messenger RNA Synthesis;MicroRNA (miRNA) biogenesis;Abortive elongation of HIV-1 transcript in the absence of Tat;Disease;Pausing and recovery of HIV elongation;Tat-mediated HIV elongation arrest and recovery;HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;Gap-filling DNA repair synthesis and ligation in TC-NER;Transcriptional regulation by small RNAs;Gene Silencing by RNA;RNA polymerase II transcribes snRNA genes;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-167160;R-HSA-77075;R-HSA-72086;R-HSA-113418;R-HSA-167158;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-212436;R-HSA-6803529;R-HSA-72165;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-6781823;R-HSA-1266738;R-HSA-9670095;R-HSA-74160;R-HSA-5601884;R-HSA-168325;R-HSA-203927;R-HSA-167242;R-HSA-1643685;R-HSA-167290;R-HSA-167243;R-HSA-167287;R-HSA-167238;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-6782210;R-HSA-5578749;R-HSA-211000;R-HSA-6807505;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-6781827;R-HSA-9006934;R-HSA-5663202
ENSG00000047617,3,1,0,0,0,1,42398.05428047667,168116.01355658393,2024-05-27,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ANO2,-0.021999955,-0.095607,-0.20955,3,1.0,0.0,Disease;Olfactory Signaling Pathway;Stimuli-sensing channels,R-HSA-1643685;R-HSA-381753;R-HSA-2672351
ENSG00000047932,1,1,1,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GOPC,0.18699998,2.0372,0.75338,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000048392,1,1,0,0,0,1,253768.6150468714,253768.6150468714,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,RRM2B,0.31199998,1.1926,0.47898,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Interconversion of nucleotide di- and triphosphates;Metabolism of nucleotides,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-499943;R-HSA-15869
ENSG00000049246,1,1,1,0,0,0,17831.529851792977,17831.529851792977,2010-11-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PER3,-0.008999944,0.23939,-0.41999,5,-1.0,0.0,Phosphorylation and nuclear translocation of the CRY:PER:kinase complex,R-HSA-9931530
ENSG00000049247,1,1,1,0,1,1,12410.70681955995,12410.70681955995,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,UTS2,-0.29900002,0.17841,-0.054165,2,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000049769,2,1,0,0,0,1,53369.71648873449,142905.851430916,2019-03-28,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,PPP1R3F,,,,0,0.5,-1.0,,
ENSG00000050327,3,1,1,1,0,1,22345.675520395987,236661.2413729175,2013-04-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ARHGEF5,0.58599997,5.9918,5.1273,8,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000050767,1,1,1,0,1,1,220837.49604317299,521818.7070055739,2021-01-04,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,COL23A1,-0.324,-1.4784,-2.3953,4,0.75,0.0,,
ENSG00000052344,1,1,0,1,0,0,1321.7688442211056,340825.7076940272,2022-04-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,PRSS8,0.21100003,1.5053,0.24431,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000054116,1,1,1,0,0,1,107949.90929360976,143413.24457139417,2021-02-24,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TRAPPC3,0.375,0.89286,1.1971,2,-1.0,-1.0,Rab regulation of trafficking;Post-translational protein modification,R-HSA-9007101;R-HSA-597592
ENSG00000054690,1,1,0,0,0,1,47935.61449674282,76832.90012167432,2014-07-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,PLEKHH1,0.14600003,2.5053,1.1069,0,0.5,0.0,,
ENSG00000055609,2,1,0,0,0,1,156470.480665571,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,KMT2C,0.798,4.3119,0.30638,6,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000057608,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GDI2,0.22600001,0.78776,0.58062,2,-1.0,-1.0,Immune System;Rab regulation of trafficking,R-HSA-168256;R-HSA-9007101
ENSG00000059377,1,1,0,0,0,0,161092.74087321138,161092.74087321138,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TBXAS1,0.051999986,0.49075,-0.12073,3,0.5,0.0,Eicosanoids;Disease;Arachidonate metabolism,R-HSA-211979;R-HSA-1643685;R-HSA-2142753
ENSG00000060138,1,1,1,0,0,1,87627.83156192786,394357.452283155,2020-10-05,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,YBX3,-0.011999965,-0.59526,-1.1403,0,0.75,-1.0,,
ENSG00000060558,1,1,1,0,0,1,166624.24147696298,251932.6025865064,2020-01-20,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,5,GNA15,0.09399998,-0.2296,-0.88932,9,0.5,0.0,Signal Transduction;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Thromboxane signalling through TP receptor;Free fatty acids regulate insulin secretion;Acetylcholine regulates insulin secretion;ADP signalling through P2Y purinoceptor 1;Signal amplification;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,R-HSA-162582;R-HSA-434316;R-HSA-428930;R-HSA-400451;R-HSA-399997;R-HSA-418592;R-HSA-392518;R-HSA-202040;R-HSA-6814122
ENSG00000060982,3,1,0,0,0,1,25001.14127082048,645988.1975077938,2018-06-11,0,0,0,0,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,BCAT1,-0.21899998,0.46675,-0.058636,1,0.5,0.0,,
ENSG00000061337,1,1,0,0,0,0,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LZTS1,-0.006000042,-0.56881,-0.31589,0,0.75,0.0,,
ENSG00000062194,1,1,1,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GPBP1,0.725,1.1455,-0.085428,0,-1.0,-1.0,,
ENSG00000062370,1,1,0,0,0,1,141553.2677895436,141553.2677895436,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZNF112,0.412,1.9532,1.4274,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000062524,1,1,0,0,0,1,272025.74568937684,765591.3646788632,2018-10-08,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,LTK,-0.41999996,-1.6649,-2.6193,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000063015,1,1,0,0,1,1,286678.73247515375,286678.73247515375,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SEZ6,0.292,1.6654,0.42075,0,1.0,0.5,,
ENSG00000063169,2,1,0,0,0,1,138890.6106237268,645988.1975077938,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,BICRA,0.34100002,-3.9229,-7.8737,1,-1.0,0.0,,
ENSG00000063180,1,1,1,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CA11,0.32099998,1.8359,0.51969,0,1.0,-1.0,,
ENSG00000064205,1,1,0,0,0,1,75632.36795352261,75632.36795352261,2024-01-05,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCN5,-0.47000003,-0.83267,0.038752,0,0.5,0.0,,
ENSG00000064270,1,1,0,0,1,1,19068.334286166748,19068.334286166748,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATP2C2,-0.712,-6.8581,-6.5372,1,0.5,0.0,,
ENSG00000064652,1,1,0,0,0,1,309838.540915932,360605.992793193,2021-07-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SNX24,-0.80700004,-0.19836,0.87146,0,-1.0,-1.0,,
ENSG00000064995,1,1,1,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TAF11,0.34399998,1.7988,1.19,10,-1.0,-1.0,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;RNA Polymerase II Pre-transcription Events;Transcription of the HIV genome;RNA polymerase II transcribes snRNA genes;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-674695;R-HSA-167172;R-HSA-6807505;R-HSA-162587;R-HSA-162599
ENSG00000065150,1,1,0,0,0,1,2548.6132437619963,2548.6132437619963,2015-10-21,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IPO5,0.844,3.6033,-0.16732,1,0.5,-1.0,Disease;Influenza Viral RNA Transcription and Replication,R-HSA-1643685;R-HSA-168273
ENSG00000065320,3,1,0,0,0,1,1677.2067549064354,6795.36191383508,2015-03-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,7,NTN1,0.556,0.57483,-1.2732,6,0.5,0.0,Developmental Biology;Regulation of commissural axon pathfinding by SLIT and ROBO;Role of second messengers in netrin-1 signaling,R-HSA-1266738;R-HSA-428542;R-HSA-418890
ENSG00000066027,1,1,1,0,0,1,195005.6685718255,275021.63051358337,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PPP2R5A,0.22299999,1.1882,-0.88112,24,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;APC truncation mutants have impaired AXIN binding;Truncations of AMER1 destabilize the destruction complex;AXIN missense mutants destabilize the destruction complex;Signaling by AMER1 mutants;Signaling by APC mutants;Signaling by AXIN mutants;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-5467337;R-HSA-5467348;R-HSA-5467340;R-HSA-4839748;R-HSA-4839744;R-HSA-4839735;R-HSA-1643685;R-HSA-5663202
ENSG00000066230,1,1,0,0,0,1,28923.750134754748,28923.750134754748,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SLC9A3,0.39999998,0.99172,-2.086,1,0.5,0.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000066933,1,1,0,0,0,0,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,MYO9A,0.58599997,2.7624,1.2858,3,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000067955,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CBFB,-0.06500006,0.50011,-1.3677,25,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);RUNX2 regulates genes involved in cell migration;RUNX1 regulates estrogen receptor mediated transcription;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-8941332;R-HSA-8931987;R-HSA-8878159
ENSG00000068137,1,1,1,0,0,0,116002.32385328812,116002.32385328812,2023-01-18,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PLEKHH3,-0.08200002,-1.4995,-0.7465,0,-1.0,0.0,,
ENSG00000068400,1,1,1,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GRIPAP1,,,,0,-1.0,-1.0,,
ENSG00000068489,1,1,0,0,0,0,17257.066666666666,17257.066666666666,2021-04-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PRR11,0.045000017,1.1471,1.2938,0,0.5,0.0,,
ENSG00000068615,1,1,1,0,0,1,228220.5662976458,545988.1005477115,2018-07-30,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,REEP1,0.08499998,1.4416,1.0405,1,0.5,0.0,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000068724,1,1,0,0,0,1,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TTC7A,-0.19799995,-2.2052,-1.2192,0,0.5,0.0,,
ENSG00000068976,1,1,1,0,0,1,221280.45048451523,221280.45048451523,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PYGM,0.037999988,1.6921,0.51388,1,0.75,0.0,Glycogen metabolism,R-HSA-8982491
ENSG00000069248,2,1,0,0,0,1,254373.32653042395,314267.0072815654,2020-05-06,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NUP133,0.43,1.07,-0.55988,35,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Postmitotic nuclear pore complex (NPC) reformation;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9615933;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000069482,1,1,0,0,0,1,186226.43118124627,186226.43118124627,2018-12-31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,GAL,-0.72,-0.19023,-0.78315,2,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000070018,1,1,1,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,LRP6,0.73,4.272,0.21354,5,-1.0,0.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000070019,1,1,0,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GUCY2C,-0.11800003,1.6022,0.44099,2,1.0,0.5,Digestion and absorption;Digestion;Disease,R-HSA-8963743;R-HSA-8935690;R-HSA-1643685
ENSG00000070081,1,1,0,1,1,1,151416.12986435954,151416.12986435954,2023-10-16,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NUCB2,-0.25399995,0.64679,0.13758,0,0.5,-1.0,,
ENSG00000070087,1,1,0,0,0,1,124531.34246675359,124531.34246675359,2021-02-24,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PFN2,-0.398,1.483,-0.94341,2,0.5,-1.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000070269,1,1,0,0,0,1,112237.0074902361,112237.0074902361,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TMEM260,-0.049000025,-0.54649,-0.46622,0,0.5,-1.0,,
ENSG00000070614,3,1,0,1,0,1,714039.8414241908,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,NDST1,0.51600003,4.325,0.80797,1,-1.0,-1.0,HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-2022928;R-HSA-1638091
ENSG00000070808,2,1,1,0,0,0,58331.23271678036,160010.51072069994,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,CAMK2A,0.81299996,6.1108,0.47818,21,0.75,0.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-5663202
ENSG00000070882,1,1,0,0,0,0,49923.59387648704,49923.59387648704,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,OSBPL3,0.265,1.1547,-0.19339,1,-1.0,0.0,Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000071051,1,1,0,0,0,1,283145.34784240765,283145.34784240765,2022-04-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NCK2,0.269,1.8248,-0.98685,8,-1.0,-1.0,Signal Transduction;Ephrin signaling;Developmental Biology;Activation of RAC1;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-3928664;R-HSA-1266738;R-HSA-428540;R-HSA-9006934
ENSG00000071189,1,1,0,0,0,1,15478.15960567608,15478.15960567608,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SNX13,0.495,1.2065,-0.78216,0,-1.0,-1.0,,
ENSG00000071205,2,1,1,0,0,1,36733.9862649063,645988.1975077938,2018-06-11,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,ARHGAP10,0.106000006,0.46451,0.13227,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000071564,1,1,0,0,0,1,5903.077272258331,5903.077272258331,2014-06-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TCF3,-0.23899996,-3.412,-4.6748,3,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000071794,2,1,1,0,0,1,138890.6106237268,138890.6106237268,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HLTF,-0.482,0.39512,1.3593,1,-1.0,-1.0,E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000071967,1,1,1,0,0,1,258213.8601133611,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CYBRD1,0.059000015,0.83951,-0.051669,1,-1.0,-1.0,Iron uptake and transport,R-HSA-917937
ENSG00000072134,1,1,1,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,EPN2,0.19599998,1.5505,0.11057,2,-1.0,-1.0,,
ENSG00000073008,1,1,1,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,PVR,-0.14199996,1.1156,0.31706,2,-1.0,-1.0,Immune System;Nectin/Necl  trans heterodimerization,R-HSA-168256;R-HSA-420597
ENSG00000073734,2,1,0,0,1,1,4518.532006719214,16534.94713490521,2022-08-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,10,ABCB11,0.26099998,1.2052,-0.064409,3,1.0,0.5,Disease,R-HSA-1643685
ENSG00000073803,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MAP3K13,0.348,3.5871,1.7488,0,-1.0,-1.0,,
ENSG00000073910,1,1,0,0,0,0,31285.114175911036,31285.114175911036,2024-10-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FRY,0.572,5.334,1.0371,0,0.5,0.0,,
ENSG00000074201,1,1,0,0,0,1,6254.925173678736,6254.925173678736,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CLNS1A,0.22399998,1.0552,0.46115,1,-1.0,-1.0,snRNP Assembly;Metabolism of non-coding RNA,R-HSA-191859;R-HSA-194441
ENSG00000074416,1,1,0,0,0,1,31535.173607928213,38851.92581543917,2023-08-23,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MGLL,0.5,1.1615,0.94689,4,-1.0,-1.0,Signal Transduction;Gene expression (Transcription);Acyl chain remodeling of DAG and TAG,R-HSA-162582;R-HSA-74160;R-HSA-1482883
ENSG00000074803,1,1,0,0,0,0,414433.58532016096,414433.58532016096,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC12A1,0.028999984,0.38536,-0.46902,2,1.0,1.0,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000074966,1,1,1,0,1,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,TXK,0.15899998,1.0284,0.47805,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000075131,2,1,0,0,0,1,100075.58738100652,278190.43024910334,2023-08-23,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TIPIN,-0.075999975,1.0627,1.3515,1,-1.0,-1.0,,
ENSG00000075388,1,1,0,0,0,0,72098.8014618248,72098.8014618248,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FGF4,-0.39699996,-1.5272,-2.6996,39,,,Signal Transduction;Developmental Biology;Disease;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202
ENSG00000075568,1,1,1,0,0,0,183579.49764748462,183579.49764748462,2022-08-20,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM131,0.626,1.8291,0.027147,0,-1.0,-1.0,,
ENSG00000075856,2,1,1,0,0,1,324308.4770735607,414433.58532016096,2024-07-19,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SART3,0.581,1.9025,0.82685,0,-1.0,-1.0,,
ENSG00000075945,3,1,1,0,0,1,97822.37358221927,303059.79257468163,2022-10-12,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,KIFAP3,-0.006000042,1.2864,0.029291,5,-1.0,-1.0,Immune System;Intraflagellar transport;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-168256;R-HSA-5620924;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000076067,1,1,1,0,0,0,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RBMS2,0.12800002,2.098,1.0265,0,-1.0,-1.0,,
ENSG00000076382,1,1,0,0,0,0,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SPAG5,0.236,2.8429,1.8122,0,0.5,0.0,,
ENSG00000076650,1,1,0,0,0,1,19647.791792877917,54386.031224322105,2024-07-19,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GPATCH1,0.27899998,1.2849,1.2666,1,-1.0,-1.0,,
ENSG00000076984,2,1,0,0,0,1,72258.6642662147,1424218.0900670097,2018-08-13,0,0,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,MAP2K7,0.546,2.388,-2.2757,4,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147
ENSG00000077097,1,1,0,0,0,1,75457.10036559975,75457.10036559975,2020-10-27,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,TOP2B,0.672,3.7013,-0.056872,1,-1.0,-1.0,SUMOylation of DNA replication proteins;Post-translational protein modification,R-HSA-4615885;R-HSA-597592
ENSG00000077312,1,1,0,0,0,1,15680.736809263815,15680.736809263815,2021-09-30,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,SNRPA,0.28899997,2.1055,-0.52439,1,-1.0,-1.0,,
ENSG00000077327,1,1,0,0,0,1,25209.39839469752,25209.39839469752,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPAG6,-0.014000058,1.2235,-0.097016,0,0.75,0.5,,
ENSG00000077522,2,1,1,0,0,1,21117.402887671095,756470.9740366563,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ACTN2,0.56799996,2.2746,0.81168,9,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000077942,1,1,0,0,0,1,45773.55092334024,45773.55092334024,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,FBLN1,0.503,2.6052,0.050425,1,0.5,-1.0,,
ENSG00000078018,1,1,1,0,0,1,156726.33904066778,156726.33904066778,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MAP2,0.866,1.4736,0.74033,0,0.75,0.0,,
ENSG00000078070,2,1,0,0,0,1,4392.463820224719,263416.51565448404,2011-02-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,0,12,MCCC1,0.181,1.5436,0.24885,4,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000078140,1,1,0,0,0,1,42786.63570512048,42817.64953318068,2025-04-14,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,UBE2K,0.272,2.631,-0.34885,3,-1.0,-1.0,Immune System;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Protein ubiquitination;Post-translational protein modification,R-HSA-168256;R-HSA-8866652;R-HSA-8852135;R-HSA-597592
ENSG00000078237,2,1,1,1,0,0,129069.13663722646,575147.0632428399,2023-01-18,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TIGAR,-0.194,1.5936,0.84546,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000078304,1,1,0,0,0,0,286746.1002745869,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PPP2R5C,0.802,4.0695,0.7733,24,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);APC truncation mutants have impaired AXIN binding;Truncations of AMER1 destabilize the destruction complex;AXIN missense mutants destabilize the destruction complex;Signaling by AMER1 mutants;Signaling by APC mutants;Signaling by AXIN mutants;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-5467337;R-HSA-5467348;R-HSA-5467340;R-HSA-4839748;R-HSA-4839744;R-HSA-4839735;R-HSA-1643685;R-HSA-5663202
ENSG00000078687,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TNRC6C,0.799,1.2244,0.22503,21,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Gene Silencing by RNA;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-211000;R-HSA-5663202
ENSG00000078699,4,1,1,0,0,1,189557.6027707886,482893.2730520582,2020-09-04,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CBFA2T2,0.686,2.5578,0.32177,1,-1.0,-1.0,,
ENSG00000078900,1,1,0,0,0,0,322107.4898639223,322107.4898639223,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TP73,0.42400002,1.6543,-1.2981,7,0.5,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000079150,1,1,1,0,0,0,30756.747122207347,30756.747122207347,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,FKBP7,-0.339,0.4966,-0.035562,0,0.5,0.0,,
ENSG00000079335,1,1,1,0,0,1,52982.28647069224,52982.28647069224,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CDC14A,-0.14100003,1.3835,0.64169,2,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000080345,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RIF1,0.746,-0.68007,-0.96118,1,-1.0,-1.0,,
ENSG00000080493,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC4A4,0.671,4.3853,1.3037,3,0.5,0.0,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000080815,1,1,1,0,0,1,228220.5662976458,228220.5662976458,2018-07-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PSEN1,0.575,3.1063,0.55796,14,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Disease;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-3928665;R-HSA-9006934;R-HSA-5663202
ENSG00000080910,1,1,0,0,0,1,378712.0243337037,378712.0243337037,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CFHR2,-0.49800003,-0.0028177,0.36637,1,1.0,1.0,Immune System,R-HSA-168256
ENSG00000081277,1,1,0,0,0,0,322107.4898639223,322107.4898639223,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PKP1,0.501,0.26269,-0.19316,4,0.75,0.0,Immune System;Developmental Biology,R-HSA-168256;R-HSA-1266738
ENSG00000081870,1,1,0,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,IFT25,-0.06500006,0.44579,-0.97797,1,-1.0,-1.0,,
ENSG00000082068,1,1,1,0,0,0,100857.20347685824,197485.87952538437,2018-08-13,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,WDR70,0.26999998,2.951,0.046521,1,-1.0,-1.0,,
ENSG00000082126,1,1,0,0,0,1,6803.409028601952,6803.409028601952,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MPP4,-0.100000024,0.68965,-0.2086,0,1.0,0.5,,
ENSG00000082805,1,1,1,0,0,1,197485.87952538437,197485.87952538437,2023-06-05,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ERC1,0.49699998,2.0596,0.68725,0,-1.0,-1.0,,
ENSG00000083750,1,1,0,0,0,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RRAGB,,,,7,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;mTORC1-mediated signalling;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;Amino acids regulate mTORC1;MTOR signalling;Cellular response to starvation,R-HSA-162582;R-HSA-212436;R-HSA-166208;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-9639288;R-HSA-165159;R-HSA-9711097
ENSG00000085382,1,1,0,0,0,1,5602.666666666667,5602.666666666667,2012-09-02,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HACE1,0.01999998,2.4336,0.1742,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000085415,1,1,0,0,0,1,29811.1438239137,29811.1438239137,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SEH1L,0.371,2.1672,0.80402,36,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Postmitotic nuclear pore complex (NPC) reformation;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Amino acids regulate mTORC1;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9615933;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-9639288;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-9711097;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000085433,1,1,0,0,0,0,183579.49764748462,183579.49764748462,2022-08-20,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,WDR47,0.56,3.965,0.50161,0,0.5,-1.0,,
ENSG00000085871,1,1,1,0,0,1,2149.6485623003196,2149.6485623003196,2013-05-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MGST2,0.065,0.56223,-0.54,2,0.5,-1.0,Glutathione conjugation;Aflatoxin activation and detoxification;Phase II - Conjugation of compounds,R-HSA-156590;R-HSA-5423646;R-HSA-156580
ENSG00000086619,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ERO1B,0.16500002,0.43392,-0.71683,1,1.0,-1.0,,
ENSG00000087258,1,1,1,0,0,1,727796.3668420183,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,GNAO1,0.895,4.5551,0.90992,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000087338,2,1,1,0,0,1,31934.419412736017,645988.1975077938,2017-04-17,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,GMCL1,-0.48099995,-0.35868,-1.1552,0,-1.0,-1.0,,
ENSG00000087495,1,1,0,0,0,0,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PHACTR3,0.698,0.71416,-1.0969,0,1.0,0.0,,
ENSG00000087589,2,1,1,0,0,1,1321.7688442211056,340825.7076940272,2021-09-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,5,CASS4,0.47000003,2.0672,0.057916,0,0.5,0.0,,
ENSG00000088002,1,1,0,0,0,1,14312.812043346483,14312.812043346483,2024-07-19,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,SULT2B1,0.148,-0.17497,0.17213,1,0.5,0.0,Cytosolic sulfonation of small molecules;Phase II - Conjugation of compounds,R-HSA-156584;R-HSA-156580
ENSG00000088726,1,1,0,0,0,1,19318.919999180947,19318.919999180947,2022-03-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM40,-0.06099999,-0.12452,0.3051,0,0.5,0.0,,
ENSG00000088727,1,1,0,0,0,1,160010.51072069994,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KIF9,0.12699997,1.5771,1.1337,2,0.5,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000089006,2,1,0,0,0,1,116089.30071075787,215157.94798738702,2020-06-24,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SNX5,0.004000008,-0.12783,-0.23914,1,-1.0,-1.0,,
ENSG00000089101,1,1,1,0,0,1,44692.894702471654,44692.894702471654,2022-04-07,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CFAP61,0.10799998,0.97607,0.81066,0,0.5,0.5,,
ENSG00000089177,1,1,0,0,0,1,1765.939149399643,1765.939149399643,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KIF16B,0.21399999,1.4736,1.2679,2,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000089902,1,1,1,0,0,0,295550.4496098593,295550.4496098593,2020-04-15,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,RCOR1,0.32599998,0.22747,-2.5057,4,-1.0,-1.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000090372,1,1,1,0,0,0,151416.12986435954,151416.12986435954,2023-10-16,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STRN4,0.477,2.1477,-1.1076,0,-1.0,-1.0,,
ENSG00000090581,1,1,1,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GNPTG,-0.36899996,-2.4992,-3.187,0,-1.0,-1.0,,
ENSG00000090686,1,1,1,0,0,1,118492.7744519305,294387.2978738704,2019-02-04,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,USP48,0.627,4.46,0.92104,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000091106,1,1,1,0,0,1,338763.57771536184,338763.57771536184,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,NLRC4,0.051999986,1.9922,0.62752,2,0.5,0.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000091262,2,1,0,0,1,1,122749.39281265943,183761.6081180644,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,ABCC6,0.083000004,1.031,0.75439,2,0.5,0.0,Disease,R-HSA-1643685
ENSG00000091428,1,1,0,0,0,0,2021.7557828674608,2021.7557828674608,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RAPGEF4,0.458,2.3345,1.0911,4,1.0,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000091536,2,1,1,0,1,1,102471.73707899301,102471.73707899301,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MYO15A,0.111,0.29742,-0.29157,2,1.0,0.5,,
ENSG00000091592,1,1,0,0,0,1,200788.16423598543,200788.16423598543,2016-06-20,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NLRP1,0.16500002,2.4153,1.2678,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000091704,1,1,0,0,1,1,118492.7744519305,146036.54470217813,2019-02-04,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CPA1,-0.13999999,1.3589,0.87362,1,1.0,0.0,,
ENSG00000091986,1,1,1,0,0,1,4970.162871968654,244820.6919736302,2012-10-07,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,CCDC80,0.251,0.62287,-0.48423,0,-1.0,-1.0,,
ENSG00000092140,1,1,1,0,0,1,95413.07358079177,95413.07358079177,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,G2E3,0.39999998,1.2476,-0.13453,0,0.5,-1.0,,
ENSG00000092203,1,1,0,0,0,1,112237.0074902361,112237.0074902361,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TOX4,0.689,3.6853,0.42178,0,-1.0,-1.0,,
ENSG00000092295,2,1,0,0,0,1,38851.92581543917,127123.38472704956,2021-09-30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TGM1,0.153,1.763,0.87127,1,1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000092758,1,1,0,0,1,1,396735.32121509424,396735.32121509424,2022-06-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,COL9A3,-0.026000023,-1.6352,-3.0514,8,0.5,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000092964,1,1,1,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DPYSL2,0.71000004,3.9345,0.79351,2,0.5,-1.0,Developmental Biology;Recycling pathway of L1,R-HSA-1266738;R-HSA-437239
ENSG00000094755,1,1,0,0,0,1,196178.71491042234,196178.71491042234,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GABRP,-0.35099995,0.60757,-0.085968,0,0.5,-1.0,,
ENSG00000095587,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TLL2,0.00999999,0.50775,1.0514,4,0.5,0.5,,
ENSG00000095970,2,1,0,1,1,1,10147.097604116418,283145.34784240765,2012-11-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,TREM2,-0.21099997,0.76015,0.80451,4,0.5,0.0,Immune System;Developmental Biology,R-HSA-168256;R-HSA-1266738
ENSG00000096717,1,1,1,0,0,0,545988.1005477115,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SIRT1,0.473,0.43798,-1.0946,8,-1.0,-1.0,Generic Transcription Pathway;SIRT1 negatively regulates rRNA expression;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Negative epigenetic regulation of rRNA expression,R-HSA-212436;R-HSA-427359;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-5250941
ENSG00000097046,3,1,0,0,0,1,11679.569250778799,414433.58532016096,2020-01-20,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,CDC7,0.111,1.491,0.54414,3,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8953750
ENSG00000099204,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ABLIM1,0.485,2.0405,0.53511,1,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000099365,1,1,1,0,0,0,444537.33605315426,444537.33605315426,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,STX1B,0.69200003,3.6087,0.52664,2,1.0,0.0,LGI-ADAM interactions;Developmental Biology;Neurotoxicity of clostridium toxins;Disease,R-HSA-5682910;R-HSA-1266738;R-HSA-168799;R-HSA-1643685
ENSG00000099624,1,1,1,0,0,0,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATP5F1D,-0.96000004,-2.6522,-2.4858,2,0.5,-1.0,Formation of ATP by chemiosmotic coupling;Cristae formation,R-HSA-163210;R-HSA-8949613
ENSG00000099625,1,1,0,0,1,0,3953.154495309038,3953.154495309038,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CBARP,-0.10699999,-2.035,-2.9125,0,0.5,0.5,,
ENSG00000099875,1,1,1,0,0,1,187674.40497870417,187674.40497870417,2022-03-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MKNK2,-0.46300006,-1.8882,-3.4237,0,0.5,-1.0,,
ENSG00000100003,1,1,1,0,1,1,31631.612453732203,31631.612453732203,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SEC14L2,-0.06700003,1.7083,0.62461,0,0.5,0.0,,
ENSG00000100024,1,1,0,0,0,1,17710.3869470848,78016.97193351923,2018-12-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,UPB1,0.018000007,0.54908,0.086506,1,1.0,0.5,Metabolism of nucleotides,R-HSA-15869
ENSG00000100029,1,1,0,0,0,1,8021.72006827603,8021.72006827603,2021-08-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PES1,0.45599997,1.7265,0.841,1,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000100030,1,1,1,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,MAPK1,0.623,3.6281,-0.73317,62,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);ERKs are inactivated;Disease;Response of Mtb to phagocytosis;Signaling by Interleukins;Infection with Mycobacterium tuberculosis;Cytochrome c-mediated apoptotic response;Activation of the AP-1 family of transcription factors;Gastrin-CREB signalling pathway via PKC and MAPK;Recycling pathway of L1;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;MAPK1 (ERK2) activation,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-202670;R-HSA-1643685;R-HSA-9637690;R-HSA-449147;R-HSA-9635486;R-HSA-111461;R-HSA-450341;R-HSA-881907;R-HSA-437239;R-HSA-9006934;R-HSA-5663202;R-HSA-2173796;R-HSA-2173793;R-HSA-112411
ENSG00000100031,5,1,1,1,0,1,2998.164755838641,196816.54442141854,2021-08-13,0,0,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,GGT1,0.426,3.5504,2.2699,7,0.5,0.0,Glutathione conjugation;Disease;Aflatoxin activation and detoxification;Synthesis of Leukotrienes (LT) and Eoxins (EX);Glutathione synthesis and recycling;Phase II - Conjugation of compounds;Arachidonate metabolism,R-HSA-156590;R-HSA-1643685;R-HSA-5423646;R-HSA-2142691;R-HSA-174403;R-HSA-156580;R-HSA-2142753
ENSG00000100038,1,1,0,0,0,1,5538.547795606575,5538.547795606575,2024-07-19,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TOP3B,0.36799997,2.9945,1.4399,0,-1.0,-1.0,,
ENSG00000100129,1,1,0,0,0,1,86992.9057658324,86992.9057658324,2024-02-01,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EIF3L,0.41500002,3.403,0.30987,6,-1.0,-1.0,Translation,R-HSA-72766
ENSG00000100142,1,1,0,0,0,1,12861.264927560305,12861.264927560305,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,POLR2F,0.012000024,1.2542,0.57701,53,-1.0,-1.0,Signal Transduction;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;RNA Pol II CTD phosphorylation and interaction with CE;mRNA Capping;RNA Polymerase III Transcription Initiation;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Initiation From Type 1 Promoter;Generic Transcription Pathway;RNA Polymerase III Transcription Initiation From Type 2 Promoter;FGFR2 alternative splicing;Immune System;mRNA Splicing - Minor Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;Formation of TC-NER Pre-Incision Complex;Developmental Biology;RNA Polymerase III Chain Elongation;Inhibition of DNA recombination at telomere;Gene expression (Transcription);PIWI-interacting RNA (piRNA) biogenesis;RNA Polymerase I Promoter Escape;Viral Messenger RNA Synthesis;MicroRNA (miRNA) biogenesis;Abortive elongation of HIV-1 transcript in the absence of Tat;Disease;Pausing and recovery of HIV elongation;Tat-mediated HIV elongation arrest and recovery;HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase II Pre-transcription Events;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;RNA Polymerase I Transcription Initiation;Gap-filling DNA repair synthesis and ligation in TC-NER;Transcriptional regulation by small RNAs;Gene Silencing by RNA;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;RNA polymerase II transcribes snRNA genes;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-167160;R-HSA-77075;R-HSA-72086;R-HSA-76046;R-HSA-113418;R-HSA-167158;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-76071;R-HSA-76061;R-HSA-212436;R-HSA-76066;R-HSA-6803529;R-HSA-168256;R-HSA-72165;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-73863;R-HSA-6781823;R-HSA-1266738;R-HSA-73780;R-HSA-9670095;R-HSA-74160;R-HSA-5601884;R-HSA-73772;R-HSA-168325;R-HSA-203927;R-HSA-167242;R-HSA-1643685;R-HSA-167290;R-HSA-167243;R-HSA-167287;R-HSA-167238;R-HSA-5250941;R-HSA-427413;R-HSA-674695;R-HSA-749476;R-HSA-74158;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-73762;R-HSA-6782210;R-HSA-5578749;R-HSA-211000;R-HSA-73864;R-HSA-73854;R-HSA-6807505;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-6781827;R-HSA-9006934;R-HSA-5663202
ENSG00000100167,1,1,0,0,1,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SEPTIN3,0.412,2.9494,1.1626,0,1.0,0.0,,
ENSG00000100196,1,1,0,0,0,1,20562.141146990773,65127.395275883,2020-06-08,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,KDELR3,-0.39400005,-0.56909,-0.62996,3,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000100207,1,1,0,0,0,1,75846.20940126595,116547.04276487474,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,6,TCF20,0.95,1.5158,-1.5561,0,-1.0,0.0,,
ENSG00000100209,1,1,0,0,0,1,414433.58532016096,414433.58532016096,2024-07-19,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HSCB,0.09200001,0.19428,0.16213,4,-1.0,-1.0,Complex I biogenesis;Mitochondrial iron-sulfur cluster biogenesis,R-HSA-6799198;R-HSA-1362409
ENSG00000100216,1,1,0,0,0,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TOMM22,0.542,0.7562,-0.79911,2,-1.0,-1.0,,
ENSG00000100221,1,1,1,0,0,0,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,JOSD1,0.33999997,1.6996,-0.7728,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000100225,1,1,1,0,0,1,28061.17463598858,28061.17463598858,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FBXO7,0.045000017,-0.0088092,-0.00015137,2,0.5,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000100243,1,1,1,0,0,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CYB5R3,-0.074,-1.0086,-0.85444,3,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000100271,1,1,0,0,0,1,72098.8014618248,72098.8014618248,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TTLL1,0.111,1.0382,-0.20768,1,-1.0,-1.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000100280,1,1,0,0,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,AP1B1,0.524,3.2212,0.3414,4,-1.0,-1.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000100284,1,1,0,0,0,1,765591.3646788632,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TOM1,0.134,1.0362,0.067801,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000100307,1,1,1,0,0,1,5410.6446575953605,42362.45324254164,2013-03-17,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,CBX7,0.23299998,0.78564,-0.77128,0,-1.0,-1.0,,
ENSG00000100314,1,1,0,0,0,1,56455.913944919754,56455.913944919754,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CABP7,0.18300003,0.79742,-0.74777,0,1.0,0.5,,
ENSG00000100372,1,1,0,0,0,1,49367.473680139236,49367.473680139236,2021-01-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC25A17,0.10100001,1.0113,0.56821,2,-1.0,-1.0,Class I peroxisomal membrane protein import,R-HSA-9603798
ENSG00000100401,1,1,1,0,0,0,158370.2523752734,158370.2523752734,2025-04-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RANGAP1,0.19199997,1.4669,-0.54817,10,-1.0,-1.0,Signal Transduction;Postmitotic nuclear pore complex (NPC) reformation;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;Post-translational protein modification,R-HSA-162582;R-HSA-9615933;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-597592
ENSG00000100403,1,1,0,0,0,1,355284.1215006515,355284.1215006515,2025-03-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZC3H7B,0.599,3.4149,1.4613,0,-1.0,-1.0,,
ENSG00000100564,1,1,0,0,0,1,24407.480025615696,24407.480025615696,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PIGH,-0.778,0.28956,0.32197,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000100565,2,1,0,0,0,1,130268.25219927442,1424218.0900670097,2020-05-06,0,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,LRRC74A,0.037,0.14884,1.0773,0,1.0,1.0,,
ENSG00000100600,1,1,0,1,0,1,12861.264927560305,12861.264927560305,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,LGMN,0.148,1.2732,0.2341,3,-1.0,-1.0,Immune System;Vitamin D (calciferol) metabolism;Metabolism of steroids,R-HSA-168256;R-HSA-196791;R-HSA-8957322
ENSG00000100614,2,1,0,0,0,1,13140.372888791402,414433.58532016096,2018-02-14,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,PPM1A,0.62,4.1142,0.9299,2,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;MTOR signalling;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-165159;R-HSA-2173793
ENSG00000100647,1,1,1,0,0,0,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SUSD6,0.18599999,1.1415,0.92283,0,-1.0,-1.0,,
ENSG00000100721,2,1,1,1,0,1,5691.114246503779,20139.580688207345,2022-07-14,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TCL1A,0.078999996,0.53645,-0.11256,0,1.0,0.5,,
ENSG00000100726,1,1,1,0,0,0,13959.203480505423,13959.203480505423,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TELO2,-0.029999971,-0.88114,-2.1811,0,-1.0,-1.0,,
ENSG00000100784,1,1,0,0,0,1,129793.30591418748,129793.30591418748,2018-08-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,RPS6KA5,0.514,1.8142,0.53557,5,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;CREB phosphorylation;Signaling by Interleukins;Recycling pathway of L1;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-199920;R-HSA-449147;R-HSA-437239;R-HSA-9006934
ENSG00000100867,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DHRS2,-0.39999998,-1.0657,-0.24324,0,0.5,0.0,,
ENSG00000100902,2,1,0,0,0,1,11052.199934661876,19965.24128263536,2015-01-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,PSMA6,0.878,2.6053,0.64399,62,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000100982,1,1,0,0,0,1,18944.728646379852,22082.33640110913,2016-11-29,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PCIF1,0.771,3.1915,-0.42771,0,-1.0,-1.0,,
ENSG00000100997,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ABHD12,0.032999992,-0.50211,-1.0699,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000101052,1,1,1,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IFT52,-0.116000056,1.122,0.03156,2,-1.0,-1.0,Signal Transduction;Intraflagellar transport,R-HSA-162582;R-HSA-5620924
ENSG00000101057,2,1,1,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,MYBL2,0.504,2.1825,-0.20917,3,0.75,0.0,Generic Transcription Pathway;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-1362300;R-HSA-73857;R-HSA-74160;R-HSA-8864260
ENSG00000101082,1,1,0,0,0,1,189557.6027707886,189557.6027707886,2024-01-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLA2,-0.036000013,0.67367,0.65313,1,0.5,0.5,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000101132,1,1,0,0,0,1,1259.1301636788776,1259.1301636788776,2016-01-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PFDN4,-0.831,-1.2676,-0.59479,1,-1.0,-1.0,Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,R-HSA-389957;R-HSA-389958
ENSG00000101134,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DOK5,0.06800002,0.37233,-0.29994,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000101146,1,1,1,0,0,1,1594.2494117647059,1594.2494117647059,2023-09-30,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RAE1,0.589,3.4728,-0.19601,28,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000101191,1,1,1,0,0,0,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DIDO1,0.765,0.54322,-1.4963,1,-1.0,-1.0,,
ENSG00000101276,1,1,1,0,1,1,16007.105585235551,16007.105585235551,2022-07-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC52A3,-0.011999965,1.0335,-0.82958,1,0.5,0.0,,
ENSG00000101306,1,1,1,0,0,0,263416.51565448404,263416.51565448404,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MYLK2,0.365,1.5451,-0.055299,0,1.0,0.5,,
ENSG00000101353,1,1,0,0,0,0,187203.10687937262,187203.10687937262,2024-01-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MROH8,0.14899999,1.7153,1.0209,0,0.5,0.0,,
ENSG00000101400,1,1,0,0,0,0,5691.114246503779,5691.114246503779,2023-09-08,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SNTA1,0.018999994,0.812,-0.58725,1,0.5,-1.0,,
ENSG00000101412,1,1,0,0,1,0,129783.42151918238,242964.12552687144,2023-01-18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,E2F1,0.601,1.8728,-0.69352,17,0.5,0.0,Signal Transduction;Generic Transcription Pathway;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;E2F mediated regulation of DNA replication;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);G1/S-Specific Transcription;Disease;Transcriptional Regulation by E2F6,R-HSA-162582;R-HSA-212436;R-HSA-1362300;R-HSA-113510;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-69205;R-HSA-1643685;R-HSA-8953750
ENSG00000101417,2,1,1,0,0,0,40890.880548672525,182108.85640724926,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PXMP4,-0.10500002,1.1042,0.19139,1,-1.0,-1.0,Class I peroxisomal membrane protein import,R-HSA-9603798
ENSG00000101438,1,1,0,0,0,1,433862.5685735124,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC32A1,0.604,3.4592,0.89404,2,1.0,0.5,"GABA synthesis, release, reuptake and degradation;Transport of inorganic cations/anions and amino acids/oligopeptides;Neurotransmitter release cycle",R-HSA-888590;R-HSA-425393;R-HSA-112310
ENSG00000101624,1,1,0,0,0,0,12129.582986241576,12129.582986241576,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CEP76,0.28399998,1.6558,0.54076,7,-1.0,-1.0,,
ENSG00000101670,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LIPG,0.116999984,1.4375,0.44731,1,0.75,0.0,HDL remodeling;Plasma lipoprotein remodeling,R-HSA-8964058;R-HSA-8963899
ENSG00000101680,1,1,0,0,0,1,22375.967154187347,1424218.0900670097,2012-05-31,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,LAMA1,0.32700002,1.7732,0.80809,7,0.5,0.5,Signal Transduction;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000101695,1,1,0,0,0,1,207220.14223281175,207220.14223281175,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,RNF125,-0.07099998,0.25629,0.28583,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000101850,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPR143,,,,3,0.5,0.0,Signal Transduction;Developmental Biology;Amine ligand-binding receptors,R-HSA-162582;R-HSA-1266738;R-HSA-375280
ENSG00000101981,2,1,0,1,1,1,49742.651617673284,100083.61852522385,2019-11-01,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,F9,,,,12,1.0,1.0,Protein hydroxylation;Disease;Post-translational protein modification,R-HSA-9629569;R-HSA-1643685;R-HSA-597592
ENSG00000102010,1,1,0,0,0,1,17601.10520641419,95491.56815792594,2023-05-17,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,BMX,,,,2,1.0,0.0,,
ENSG00000102054,1,1,1,0,0,1,182108.85640724926,182108.85640724926,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RBBP7,,,,20,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Regulation of endogenous retroelements by KRAB-ZFP proteins;Disease;Transcriptional Regulation by E2F6;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-427389;R-HSA-9843940;R-HSA-1643685;R-HSA-8953750;R-HSA-73762;R-HSA-73864;R-HSA-73854;R-HSA-597592
ENSG00000102109,1,1,1,0,0,1,130268.25219927442,130268.25219927442,2020-06-08,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PCSK1N,,,,0,0.75,0.0,,
ENSG00000102189,1,1,0,0,0,1,143413.24457139417,143413.24457139417,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EEA1,0.337,2.0998,0.38646,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000102221,1,1,0,0,0,0,143284.77790855977,143284.77790855977,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,JADE3,,,,1,-1.0,-1.0,,
ENSG00000102385,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DRP2,,,,2,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000102452,1,1,0,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NALCN,0.421,6.7689,0.82182,1,0.5,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000102543,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CDADC1,0.083000004,1.1985,0.47556,0,-1.0,-1.0,,
ENSG00000102580,1,1,0,0,0,1,25903.3352616996,25903.3352616996,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,DNAJC3,0.26200002,1.0366,0.13593,6,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Influenza Viral RNA Transcription and Replication;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-168273;R-HSA-597592
ENSG00000102760,1,1,0,0,0,1,147105.90765133628,147105.90765133628,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RGCC,-0.972,-0.86679,-1.2399,1,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000102910,1,1,1,0,0,0,3613.737329219921,3613.737329219921,2018-06-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LONP2,0.09399998,2.4423,-0.21455,2,-1.0,-1.0,Peroxisomal protein import,R-HSA-9033241
ENSG00000102970,1,1,0,1,0,1,83896.55822718568,83896.55822718568,2023-02-07,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,CCL17,-0.79700005,0.17578,0.67637,2,1.0,0.0,Signal Transduction;Immune System;Dectin-1 mediated noncanonical NF-kB signaling,R-HSA-162582;R-HSA-168256;R-HSA-5607761
ENSG00000103018,1,1,0,0,0,1,207220.14223281175,207220.14223281175,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,CYB5B,-0.09200001,0.81732,-0.23084,3,1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000103042,1,1,1,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC38A7,0.18699998,1.758,-0.1514,0,0.5,-1.0,,
ENSG00000103154,1,1,0,0,0,1,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,NECAB2,-0.71300006,-6.0733,-5.0763,0,1.0,0.0,,
ENSG00000103248,1,1,1,0,0,1,129783.42151918238,129783.42151918238,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MTHFSD,-0.587,-2.8014,-0.65278,0,-1.0,-1.0,,
ENSG00000103342,1,1,0,0,0,1,107273.75397646755,112218.78632625614,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GSPT1,0.73,0.7363,-2.2981,4,-1.0,-1.0,Developmental Biology;Translation;Regulation of expression of SLITs and ROBOs;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-72766;R-HSA-9010553;R-HSA-975956
ENSG00000103528,1,1,0,0,0,0,37368.38182683358,76832.90012167432,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,SYT17,0.33499998,1.7525,0.37539,0,0.5,0.0,,
ENSG00000103942,1,1,1,0,0,0,38772.287745457244,38772.287745457244,2025-03-12,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,HOMER2,0.078999996,-0.27837,0.097475,1,0.5,0.0,,
ENSG00000104147,1,1,1,0,0,0,171699.39272110126,171699.39272110126,2018-07-16,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,OIP5,-0.74300003,-0.76659,-0.73196,1,0.5,0.0,,
ENSG00000104219,1,1,1,0,0,1,103877.27822338727,131525.74533408263,2017-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,ZDHHC2,-0.39499998,-1.2793,-2.6659,2,0.5,-1.0,Disease;Surfactant metabolism,R-HSA-1643685;R-HSA-5683826
ENSG00000104228,1,1,1,0,0,1,433862.5685735124,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TRIM35,0.026000023,0.82474,-0.29081,1,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000104320,1,1,1,0,1,0,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NBN,-0.05700004,0.10899,-0.36364,20,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000104327,1,1,0,0,0,1,376569.5597064443,376569.5597064443,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CALB1,0.388,1.0394,0.50925,1,0.5,0.0,,
ENSG00000104381,2,1,1,0,0,1,28783.576939547238,223386.61486493575,2023-01-18,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,GDAP1,0.037,1.171,-0.2353,1,0.5,-1.0,Class I peroxisomal membrane protein import,R-HSA-9603798
ENSG00000104419,1,1,0,0,0,1,82225.87074718371,82225.87074718371,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NDRG1,0.27600002,0.77465,-0.14123,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000104432,1,1,0,0,0,1,98271.38571086437,100808.28156961637,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,IL7,-0.51699996,0.59287,0.37428,1,-1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000104442,2,1,0,0,0,1,72170.02447217306,72170.02447217306,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ARMC1,0.11500001,1.7875,0.35035,0,-1.0,-1.0,,
ENSG00000104497,1,1,1,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SNX16,-0.40699995,0.83527,-0.21637,0,-1.0,-1.0,,
ENSG00000104518,1,1,1,0,0,1,167055.73472660675,169088.90478978804,2019-03-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,GSDMD,-0.49300003,-0.63452,-1.5253,6,-1.0,0.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147
ENSG00000104626,2,1,1,0,0,1,11350.321701851115,26685.217785743116,2022-10-12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ERI1,-0.526,-2.4737,-1.8345,1,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000104765,1,1,0,0,0,1,103877.27822338727,323648.5577791949,2017-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,5,BNIP3L,0.34100002,1.4414,-0.42815,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000104783,2,1,1,0,0,1,22345.675520395987,141076.9910731678,2013-04-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,KCNN4,0.027999997,1.6028,0.69062,1,0.5,0.0,,
ENSG00000104881,1,1,0,0,0,1,141553.2677895436,141553.2677895436,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PPP1R13L,0.026000023,-1.8626,-3.6916,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000104946,1,1,1,1,1,0,756470.9740366563,756470.9740366563,2025-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TBC1D17,-0.11199999,-1.5725,-3.0934,1,0.5,-1.0,TBC/RABGAPs;Rab regulation of trafficking,R-HSA-8854214;R-HSA-9007101
ENSG00000104960,1,1,0,0,0,1,94870.11495236546,144712.0807038357,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,PTOV1,0.478,-0.77927,-3.8737,0,-1.0,-1.0,,
ENSG00000104976,1,1,0,0,1,1,254373.32653042395,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SNAPC2,-0.77400005,-2.1157,-2.959,3,-1.0,-1.0,RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription;RNA polymerase II transcribes snRNA genes,R-HSA-76046;R-HSA-76071;R-HSA-73857;R-HSA-74160;R-HSA-749476;R-HSA-74158;R-HSA-6807505
ENSG00000105053,1,1,0,0,0,0,94870.11495236546,144712.0807038357,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,VRK3,-0.003000021,0.93051,-0.22163,1,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;ERKs are inactivated;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-202670;R-HSA-449147;R-HSA-9006934
ENSG00000105063,1,1,0,0,0,1,116566.20935579021,116566.20935579021,2023-01-18,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PPP6R1,0.467,-0.90964,-2.3129,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000105171,2,1,0,0,0,1,29713.571045654095,39053.6332038119,2023-01-18,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,POP4,-0.44000006,0.13178,0.069077,1,-1.0,-1.0,tRNA processing in the nucleus,R-HSA-6784531
ENSG00000105173,5,1,1,0,0,1,5795.555913631969,129783.42151918238,2010-10-24,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,CCNE1,0.634,1.2212,0.54707,14,0.5,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);G1/S-Specific Transcription;Disease,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-69205;R-HSA-1643685
ENSG00000105185,1,1,0,0,0,1,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,PDCD5,-0.837,-1.1667,-0.46891,0,-1.0,-1.0,,
ENSG00000105221,1,1,0,0,1,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,AKT2,0.602,3.4263,0.36835,32,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);G beta:gamma signalling through PI3Kgamma;RUNX2 regulates genes involved in cell migration;Disease;G-protein beta:gamma signalling;MTOR signalling;Rab regulation of trafficking;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-392451;R-HSA-8941332;R-HSA-1643685;R-HSA-397795;R-HSA-165159;R-HSA-9007101;R-HSA-9006934;R-HSA-5663202
ENSG00000105254,1,1,1,0,0,0,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TBCB,-0.072999954,-0.59401,-2.4524,1,0.5,-1.0,Post-chaperonin tubulin folding pathway,R-HSA-389977
ENSG00000105364,1,1,1,0,0,1,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,MRPL4,-0.23599994,0.63882,-0.10721,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000105438,1,1,0,0,0,1,237176.1991038335,237176.1991038335,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,KDELR1,0.01999998,2.2428,-0.4889,2,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000105509,2,1,1,0,1,1,11727.668770324402,188369.12073246657,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,5,HAS1,-0.24899995,-2.5772,-2.0493,1,0.5,0.0,,
ENSG00000105519,1,1,1,0,0,0,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CAPS,-0.45799994,-0.25936,-0.019698,0,0.5,-1.0,,
ENSG00000105609,1,1,1,0,0,1,283145.34784240765,283145.34784240765,2022-04-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LILRB5,-0.14100003,-0.12918,-1.1108,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000105767,1,1,1,0,0,1,200944.0765227402,200944.0765227402,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CADM4,0.504,1.7497,0.50475,0,0.5,0.0,,
ENSG00000105784,1,1,1,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,RUNDC3B,0.30299997,0.41592,0.092121,0,0.5,0.0,,
ENSG00000105792,1,1,1,0,0,1,254373.32653042395,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CFAP69,0.0,0.073999,-0.27189,0,0.5,0.0,,
ENSG00000105821,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DNAJC2,0.53400004,2.1712,0.76484,1,-1.0,-1.0,,
ENSG00000105894,3,1,1,0,0,1,15866.724081734988,1778690.168860174,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,10,PTN,0.004000008,0.83803,-1.0688,2,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000105967,1,1,0,0,0,1,228220.5662976458,645988.1975077938,2024-11-13,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TFEC,0.09500003,0.28519,0.37841,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000106128,2,1,0,0,0,1,105281.95721639719,105281.95721639719,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,GHRHR,0.015999973,-0.038654,-1.2569,2,1.0,1.0,Signal Transduction,R-HSA-162582
ENSG00000106153,1,1,1,0,0,1,53789.89362927337,53789.89362927337,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CHCHD2,-0.58599997,0.56,0.53612,2,-1.0,-1.0,,
ENSG00000106258,1,1,1,0,0,0,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CYP3A5,-0.027999997,1.3209,1.0493,2,0.5,0.0,Aflatoxin activation and detoxification,R-HSA-5423646
ENSG00000106348,1,1,0,0,0,1,57506.71651524692,106850.5808972156,2020-03-17,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,IMPDH1,0.23699999,1.944,-0.021787,4,0.5,-1.0,Immune System;Azathioprine ADME;Disease;Nucleotide biosynthesis;Metabolism of nucleotides,R-HSA-168256;R-HSA-9748787;R-HSA-1643685;R-HSA-8956320;R-HSA-15869
ENSG00000106367,1,1,1,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,AP1S1,-0.07799995,1.731,-0.70005,4,0.5,-1.0,Immune System;Disease;Lysosome Vesicle Biogenesis,R-HSA-168256;R-HSA-1643685;R-HSA-432720
ENSG00000106436,1,1,0,0,0,1,397765.9672627851,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MYL10,-0.10899997,0.55456,0.0067987,1,,,,
ENSG00000106459,1,1,0,0,0,1,135095.86576106868,1424218.0900670097,2021-09-30,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NRF1,0.81200004,5.0758,0.93936,3,-1.0,-1.0,,
ENSG00000106483,1,1,0,1,0,0,36494.548446257475,36494.548446257475,2024-01-03,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SFRP4,0.143,0.096304,0.22569,0,0.5,0.0,,
ENSG00000106511,1,1,0,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,MEOX2,0.24400002,-0.8508,-1.4766,0,0.5,0.0,,
ENSG00000106635,1,1,1,0,0,0,195005.6685718255,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BCL7B,0.13300002,0.6215,-0.47166,7,-1.0,-1.0,Developmental Biology;Gene expression (Transcription);Formation of the non-canonical BAF (ncBAF) complex,R-HSA-1266738;R-HSA-74160;R-HSA-9933947
ENSG00000106689,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LHX2,0.63199997,2.0356,-1.5071,2,0.75,0.5,Developmental Biology;Expression and translocation of olfactory receptors;Olfactory Signaling Pathway;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-9752946;R-HSA-381753;R-HSA-9010553
ENSG00000106692,1,1,1,0,1,0,213085.6895276826,239970.53614968536,2021-06-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,FKTN,-0.021999955,0.12731,0.80421,0,-1.0,-1.0,Matriglycan biosynthesis on DAG1;DAG1 glycosylations;Post-translational protein modification,R-HSA-9939291;R-HSA-8931838;R-HSA-597592
ENSG00000106771,1,1,1,0,0,0,756470.9740366563,756470.9740366563,2025-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM245,0.08700001,-0.64915,-3.4802,0,-1.0,-1.0,,
ENSG00000106789,1,1,0,0,0,0,54721.83044722055,54721.83044722055,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,CORO2A,0.09799999,1.4431,0.24587,0,0.5,0.0,,
ENSG00000106927,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,AMBP,-0.01699996,0.14387,0.43421,1,1.0,0.5,,
ENSG00000107020,2,1,1,0,0,1,54703.55383629191,215157.94798738702,2018-08-13,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,6,PLGRKT,-0.954,-0.92963,-0.28893,0,-1.0,-1.0,,
ENSG00000107130,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NCS1,0.616,2.4979,0.53016,0,0.5,-1.0,,
ENSG00000107164,3,1,0,0,0,1,105281.95721639719,129793.30591418748,2018-08-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,FUBP3,0.47500002,1.4537,0.19319,0,-1.0,-1.0,,
ENSG00000107187,1,1,0,0,0,1,228220.5662976458,645988.1975077938,2018-07-30,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,LHX3,-0.024000049,-1.7121,-1.2429,1,1.0,0.5,Developmental Biology;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-9010553
ENSG00000107242,1,1,1,0,0,0,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,PIP5K1B,0.112999976,2.2269,0.24492,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000107331,1,1,0,0,0,1,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ABCA2,0.564,3.7441,-3.8076,1,1.0,-1.0,,
ENSG00000107521,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HPS1,0.12099999,0.48509,0.050093,1,-1.0,0.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000107537,1,1,0,0,0,1,6261.858301765341,6261.858301765341,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PHYH,-0.14699996,0.45192,-0.54797,3,0.5,-1.0,Peroxisomal protein import,R-HSA-9033241
ENSG00000107581,1,1,0,0,0,0,7794.273577144567,7794.273577144567,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,EIF3A,0.82,4.0897,1.0918,6,-1.0,-1.0,Translation,R-HSA-72766
ENSG00000107736,2,1,0,0,1,0,337860.4854363166,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,CDH23,0.315,1.6119,0.89337,2,0.5,0.0,,
ENSG00000107796,2,1,1,1,0,0,12618.420467807711,25635.81848749961,2024-07-19,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ACTA2,0.528,4.6189,1.3281,3,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000107854,1,1,1,0,0,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TNKS2,0.287,2.9841,-0.60855,5,-1.0,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-1643685;R-HSA-5663202;R-HSA-597592
ENSG00000108001,3,1,0,0,0,1,59742.17313930438,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,8,EBF3,0.647,3.1501,-0.70756,0,0.5,0.0,,
ENSG00000108021,1,1,1,0,0,1,278190.43024910334,521818.7070055739,2023-08-23,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TASOR2,0.537,1.2052,0.091592,0,-1.0,-1.0,,
ENSG00000108091,1,1,0,0,0,1,1321.7688442211056,340825.7076940272,2022-04-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,CCDC6,0.43800002,2.6685,0.12764,0,-1.0,-1.0,,
ENSG00000108094,3,1,1,0,0,1,7741.739669934235,87248.80974040499,2008-06-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,9,CUL2,0.695,2.5557,1.1265,4,-1.0,-1.0,Immune System;Developmental Biology;Regulation of expression of SLITs and ROBOs;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Post-translational protein modification,R-HSA-168256;R-HSA-1266738;R-HSA-9010553;R-HSA-1234176;R-HSA-597592
ENSG00000108100,2,1,0,0,0,1,28923.750134754748,160010.51072069994,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,CCNY,0.23900002,0.99461,-0.21235,0,-1.0,-1.0,,
ENSG00000108176,1,1,0,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DNAJC12,-0.19299996,0.30641,0.34943,0,0.5,0.0,,
ENSG00000108387,1,1,1,0,1,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SEPTIN4,0.398,2.6045,1.8809,2,0.75,0.0,,
ENSG00000108509,1,1,1,0,1,0,7794.273577144567,7794.273577144567,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CAMTA2,0.48799998,2.2687,0.79058,0,0.5,-1.0,,
ENSG00000108588,1,1,1,0,0,0,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCDC47,0.08200002,1.2024,0.19672,0,-1.0,-1.0,,
ENSG00000108602,1,1,1,0,0,1,7794.273577144567,7794.273577144567,2021-03-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ALDH3A1,-0.24600005,0.26411,-0.43091,1,0.5,0.0,,
ENSG00000108654,1,1,1,0,0,1,203321.91836345146,203321.91836345146,2020-04-15,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,DDX5,0.823,3.7661,-3.0076,5,-1.0,-1.0,Signal Transduction;Disease;Post-translational protein modification,R-HSA-162582;R-HSA-1643685;R-HSA-597592
ENSG00000108684,1,1,0,0,0,1,960369.5592648841,1076472.0138856068,2021-05-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ASIC2,0.40899998,1.1337,-0.37806,1,0.75,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000108797,1,1,0,0,0,1,62507.19385670474,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,CNTNAP1,0.422,3.8452,1.3632,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000108799,1,1,1,0,0,0,146036.54470217813,146036.54470217813,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EZH1,0.561,5.5939,1.6559,0,0.5,-1.0,,
ENSG00000108960,1,1,0,0,0,1,101603.42051482818,101603.42051482818,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MMD,-0.291,0.77309,-0.25275,0,0.75,-1.0,,
ENSG00000108963,1,1,1,0,0,0,13490.640854493924,13490.640854493924,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DPH1,-0.32099998,-0.4356,0.07343,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000109046,1,1,0,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,WSB1,0.35399997,0.86754,0.014079,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000109072,1,1,0,1,1,1,11422.490550188997,11422.490550188997,2024-05-08,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VTN,-0.037999988,0.88423,0.31724,6,1.0,0.0,Immune System;Developmental Biology,R-HSA-168256;R-HSA-1266738
ENSG00000109084,1,1,0,0,0,1,13145.557655954632,13145.557655954632,2013-11-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TMEM97,-0.082999945,0.312,0.70305,0,0.5,-1.0,,
ENSG00000109184,1,1,0,0,0,0,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DCUN1D4,0.213,0.8936,-0.51072,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000109189,1,1,0,0,0,1,25462.711467435365,25462.711467435365,2024-07-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,USP46,0.518,3.2505,0.34155,6,-1.0,-1.0,,
ENSG00000109193,1,1,0,0,0,1,143284.77790855977,158370.2523752734,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SULT1E1,-0.38399994,0.031338,-0.54933,2,0.5,0.5,Cytosolic sulfonation of small molecules;Phase II - Conjugation of compounds,R-HSA-156584;R-HSA-156580
ENSG00000109475,1,1,0,0,0,1,258213.8601133611,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RPL34,0.28399998,1.2357,-0.45638,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000109576,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,AADAT,0.375,2.025,0.26635,2,0.5,0.0,,
ENSG00000109618,1,1,0,0,0,1,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,SEPSECS,-0.095999956,0.45776,0.063142,1,0.5,0.0,,
ENSG00000109743,2,1,1,1,0,1,2839.268167569108,263416.51565448404,2009-11-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,10,BST1,-0.638,-0.76804,-0.51237,3,0.75,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000109814,1,1,1,0,0,0,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UGDH,0.09799999,2.2005,1.4538,1,0.5,-1.0,Glucuronidation;Phase II - Conjugation of compounds,R-HSA-156588;R-HSA-156580
ENSG00000109927,1,1,0,0,1,1,182481.56964523086,205342.54344682425,2021-10-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,TECTA,0.339,2.4637,1.3118,1,-1.0,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000110025,1,1,0,1,0,0,360605.992793193,360605.992793193,2023-02-20,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SNX15,-0.116999984,0.80786,0.14331,0,-1.0,-1.0,,
ENSG00000110063,2,1,1,0,0,1,312829.3312654393,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,DCPS,0.0,-0.11585,0.44388,1,0.5,-1.0,,
ENSG00000110074,1,1,1,0,0,1,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,FOXRED1,-0.11800003,0.86475,-0.3038,1,-1.0,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000110090,1,1,1,0,0,1,57530.63913504606,274828.8365545636,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,4,CPT1A,0.291,3.0969,1.3481,3,-1.0,-1.0,Carnitine shuttle,R-HSA-200425
ENSG00000110148,5,1,1,0,0,1,18163.274234023927,259389.4725670933,2021-02-19,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,CCKBR,-0.17999995,-0.25815,0.091122,3,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000110318,2,1,0,0,0,1,124801.11117486731,124801.11117486731,2018-12-03,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CEP126,0.268,1.002,0.39751,0,0.5,0.0,,
ENSG00000110446,1,1,0,0,0,0,21724.94108458234,21724.94108458234,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC15A3,-0.19000006,-0.83074,-0.78612,1,-1.0,-1.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000110700,1,1,0,0,0,1,727796.3668420183,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,RPS13,0.763,1.3507,-0.80429,18,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000110723,1,1,0,0,0,1,220837.49604317299,521818.7070055739,2023-11-09,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,EXPH5,-0.14199996,0.90174,1.6206,0,0.5,0.0,,
ENSG00000110955,1,1,0,0,0,1,56455.913944919754,56455.913944919754,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATP5F1B,0.46899998,4.3493,1.6283,5,0.5,-1.0,Formation of ATP by chemiosmotic coupling;Cristae formation,R-HSA-163210;R-HSA-8949613
ENSG00000111046,1,1,0,0,0,1,55267.6400199672,55267.6400199672,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MYF6,-0.24000001,0.10878,0.50577,2,0.75,0.5,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000111110,1,1,0,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PPM1H,0.18699998,0.77812,-1.2211,0,0.5,0.0,,
ENSG00000111144,2,1,0,0,0,1,1104.3490937746258,1765.939149399643,2016-08-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,LTA4H,0.17400002,1.044,0.64893,7,-1.0,-1.0,Immune System;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonate metabolism,R-HSA-168256;R-HSA-2142691;R-HSA-2142753
ENSG00000111224,1,1,0,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PARP11,-0.06099999,1.1285,0.055861,0,-1.0,0.0,,
ENSG00000111262,1,1,0,0,0,1,13219.952617929488,13219.952617929488,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,KCNA1,0.065,3.8753,-0.65135,1,1.0,0.5,,
ENSG00000111319,1,1,0,0,0,1,135108.48254553688,135108.48254553688,2025-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SCNN1A,-0.10500002,0.28764,0.59016,2,0.5,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000111445,1,1,1,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RFC5,0.23900002,1.4565,0.59874,21,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Gap-filling DNA repair synthesis and ligation in TC-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-6782210;R-HSA-6782135;R-HSA-6781827
ENSG00000111481,1,1,1,0,0,0,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,COPZ1,0.55700004,1.0262,0.76211,2,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000111671,1,1,1,0,1,1,14178.745544178992,14178.745544178992,2016-03-08,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPSB2,-0.63199997,-1.1413,0.2162,2,-1.0,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000111707,1,1,0,0,0,1,129783.42151918238,129783.42151918238,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SUDS3,0.268,1.3329,-0.79339,4,-1.0,-1.0,Gene expression (Transcription);Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;Post-translational protein modification,R-HSA-74160;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-597592
ENSG00000111716,1,1,1,0,0,1,275021.63051358337,1424218.0900670097,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,LDHB,0.073000014,0.98719,0.8745,1,0.5,-1.0,Pyruvate metabolism,R-HSA-70268
ENSG00000111725,1,1,1,0,0,1,160010.51072069994,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,PRKAB1,0.24299997,2.0242,0.35073,8,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;MTOR signalling,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-165159
ENSG00000111783,2,1,1,0,0,1,107949.90929360976,414433.58532016096,2021-02-24,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,RFX4,0.822,3.7971,1.017,0,0.75,0.5,,
ENSG00000112029,1,1,0,0,1,1,15702.824330266134,15702.824330266134,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,FBXO5,0.638,0.62963,-0.36635,5,0.75,0.0,G1/S-Specific Transcription,R-HSA-69205
ENSG00000112031,1,1,1,0,1,1,27388.747575018435,27388.747575018435,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MTRF1L,-0.232,0.23253,0.51006,1,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation,R-HSA-72766;R-HSA-5419276;R-HSA-5368287
ENSG00000112078,1,1,0,0,0,1,19008.705439555517,19008.705439555517,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KCTD20,-0.093000054,1.8699,1.3921,0,-1.0,-1.0,,
ENSG00000112081,3,1,1,0,0,1,11679.569250778799,414433.58532016096,2021-02-24,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,SRSF3,0.855,4.0316,-0.72428,5,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm,R-HSA-73857;R-HSA-74160;R-HSA-159236;R-HSA-72202
ENSG00000112130,1,1,0,0,0,1,6796.671949604783,6796.671949604783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RNF8,0.778,2.6482,1.6224,4,-1.0,-1.0,,
ENSG00000112245,1,1,1,0,0,1,444537.33605315426,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,PTP4A1,0.19700003,1.9918,-0.68126,0,0.5,-1.0,,
ENSG00000112246,2,1,1,0,0,1,22650.1728716785,1778690.168860174,2021-04-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,SIM1,0.668,1.0526,-0.17265,0,0.5,0.5,,
ENSG00000112282,1,1,1,0,0,1,254373.32653042395,1424218.0900670097,2020-05-06,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,MED23,0.232,6.0073,0.78462,5,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685
ENSG00000112309,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,B3GAT2,-0.36,-0.65957,-1.8306,1,0.75,0.0,Glycosaminoglycan-protein linkage region biosynthesis,R-HSA-1971475
ENSG00000112378,1,1,0,0,1,1,119459.84213494582,119459.84213494582,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PERP,-0.021999955,0.31564,0.31321,2,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000112425,1,1,0,0,0,1,44450.32231167108,44450.32231167108,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EPM2A,-0.19099998,-0.9603,-2.4816,2,0.5,-1.0,Glycogen metabolism;Disease,R-HSA-8982491;R-HSA-1643685
ENSG00000112539,1,1,0,0,0,1,113567.57166187582,113567.57166187582,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,C6orf118,-0.288,-0.73473,-0.092257,0,0.75,0.5,,
ENSG00000112562,1,1,1,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SMOC2,0.176,0.37496,-0.40318,0,0.5,0.0,,
ENSG00000112576,1,1,1,0,1,0,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,CCND3,0.45200002,1.4122,-0.034796,6,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685
ENSG00000112655,1,1,1,0,0,0,444537.33605315426,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,PTK7,0.578,2.8665,0.75346,0,-1.0,0.0,,
ENSG00000112761,1,1,1,0,1,1,99445.63572998076,99445.63572998076,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCN6,-0.054999948,1.1806,0.62662,0,0.5,0.5,,
ENSG00000112851,1,1,0,0,0,1,9098.85091274504,9098.85091274504,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ERBIN,0.47399998,0.16586,0.36285,23,-1.0,-1.0,Signal Transduction;Constitutive Signaling by Overexpressed ERBB2;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-9634285;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000112893,1,1,1,0,1,1,103877.27822338727,323648.5577791949,2017-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,MAN2A1,0.24800003,0.91506,-1.3349,3,-1.0,0.0,Disease;Reactions specific to the complex N-glycan synthesis pathway;Post-translational protein modification,R-HSA-1643685;R-HSA-975578;R-HSA-597592
ENSG00000112964,1,1,0,0,0,0,356440.71671986027,356440.71671986027,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,GHR,0.35000002,0.17358,-0.069342,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000112972,1,1,1,0,0,1,220837.49604317299,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HMGCS1,0.824,4.1317,1.6411,3,0.5,-1.0,Cholesterol biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-191273;R-HSA-8957322;R-HSA-1655829
ENSG00000113048,1,1,1,0,1,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MRPS27,-0.14999998,0.095644,-0.1579,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000113163,1,1,0,0,0,1,67624.25227505878,67624.25227505878,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,CERT1,0.34399998,2.6715,-1.2717,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000113196,1,1,0,0,0,1,10983.062958035911,10983.062958035911,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,HAND1,-0.18799996,0.08671,0.075457,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000113296,1,1,1,0,0,1,101825.50588235294,101825.50588235294,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,THBS4,0.05400002,1.5817,0.50344,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000113360,1,1,1,0,0,1,16716.61368728359,16716.61368728359,2022-11-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DROSHA,0.61,4.5499,1.6689,1,-1.0,-1.0,Gene expression (Transcription);MicroRNA (miRNA) biogenesis;Gene Silencing by RNA,R-HSA-74160;R-HSA-203927;R-HSA-211000
ENSG00000113396,2,1,1,0,0,1,228220.5662976458,645988.1975077938,2018-07-30,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,SLC27A6,-0.38900006,-0.54525,-0.6815,1,0.5,0.0,"Transport of vitamins, nucleosides, and related molecules",R-HSA-425397
ENSG00000113504,1,1,0,0,0,1,143284.77790855977,143284.77790855977,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC12A7,-0.026000023,1.2057,-1.9365,1,0.5,0.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000113525,2,1,0,0,0,1,207220.14223281175,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,IL5,-0.065999985,0.18625,0.29683,3,1.0,1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000113575,1,1,0,0,0,1,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,PPP2CA,0.685,5.568,-0.72979,39,-1.0,-1.0,"Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;E2F mediated regulation of DNA replication;RNA Polymerase II Transcription;Cyclin A/B1/B2 associated events during G2/M transition;Gene expression (Transcription);MASTL Facilitates Mitotic Progression;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;APC truncation mutants have impaired AXIN binding;Truncations of AMER1 destabilize the destruction complex;AXIN missense mutants destabilize the destruction complex;Signaling by AMER1 mutants;Signaling by APC mutants;Signaling by AXIN mutants;Inhibition of replication initiation of damaged DNA by RB1/E2F1;ERKs are inactivated;Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers",R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-113510;R-HSA-73857;R-HSA-69273;R-HSA-74160;R-HSA-2465910;R-HSA-9634600;R-HSA-5467337;R-HSA-5467348;R-HSA-5467340;R-HSA-4839748;R-HSA-4839744;R-HSA-4839735;R-HSA-113501;R-HSA-202670;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202
ENSG00000113583,1,1,0,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,C5orf15,0.024999976,0.39832,0.51087,0,-1.0,-1.0,,
ENSG00000113722,1,1,0,0,1,1,82852.03719378977,82852.03719378977,2021-02-25,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CDX1,-0.625,-2.3646,-2.2291,0,1.0,0.5,,
ENSG00000113790,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,EHHADH,0.12699997,0.62203,0.76571,2,0.75,-1.0,Peroxisomal protein import,R-HSA-9033241
ENSG00000113971,1,1,1,0,0,0,397765.9672627851,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,NPHP3,0.12699997,0.91316,0.62164,1,-1.0,-1.0,Cargo trafficking to the periciliary membrane,R-HSA-5620920
ENSG00000114023,1,1,0,0,0,1,207233.9114391144,207233.9114391144,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM162A,-0.643,0.33842,0.31161,0,-1.0,-1.0,,
ENSG00000114062,1,1,0,0,0,1,220837.49604317299,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,UBE3A,0.861,6.9548,0.84917,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000114126,1,1,0,0,0,1,3288.4396493594068,3288.4396493594068,2015-10-27,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TFDP2,0.55700004,2.3397,0.90357,18,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;E2F mediated regulation of DNA replication;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);G1/S-Specific Transcription;Inhibition of replication initiation of damaged DNA by RB1/E2F1;Disease;Transcriptional Regulation by E2F6;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-162582;R-HSA-212436;R-HSA-1362300;R-HSA-113510;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-69205;R-HSA-113501;R-HSA-1643685;R-HSA-8953750;R-HSA-2173796;R-HSA-2173793
ENSG00000114270,2,1,1,0,0,1,50641.99826116222,50641.99826116222,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,COL7A1,0.31,4.0644,1.6087,10,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000114331,1,1,1,0,0,1,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ACAP2,0.53,3.0871,1.1653,0,-1.0,-1.0,,
ENSG00000114349,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,GNAT1,-0.13800001,1.5959,0.39162,3,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000114378,1,1,0,0,0,1,131525.74533408263,131525.74533408263,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,HYAL1,0.125,1.6932,1.4652,3,0.5,0.0,Hyaluronan degradation;Disease,R-HSA-2160916;R-HSA-1643685
ENSG00000114391,1,1,0,0,0,0,192848.64833759028,192848.64833759028,2021-07-08,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RPL24,0.41500002,2.2565,-0.25828,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000114395,1,1,1,0,0,0,70918.12845178662,70918.12845178662,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CYB561D2,-0.13499999,0.76273,-0.095279,0,-1.0,-1.0,,
ENSG00000114416,1,1,1,0,0,1,99863.42410604075,114817.16866287061,2015-07-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,FXR1,0.634,1.5462,-0.95688,1,0.75,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000114455,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,HHLA2,-0.32299995,0.83715,0.62114,0,1.0,0.0,,
ENSG00000114554,1,1,1,0,0,1,96018.8961005241,96018.8961005241,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PLXNA1,0.514,4.1696,0.53644,6,-1.0,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000114626,1,1,1,0,0,1,185805.42963097955,185805.42963097955,2021-11-04,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,ABTB1,-0.003000021,0.52501,-0.69479,0,-1.0,-1.0,,
ENSG00000114670,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,NEK11,-0.16700006,0.40985,0.19451,0,0.5,0.0,,
ENSG00000114686,1,1,0,0,0,1,218230.87456148196,218230.87456148196,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MRPL3,-0.403,0.6074,-0.92411,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000114735,1,1,1,0,0,0,93393.2908111381,93393.2908111381,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,HEMK1,0.041999996,1.2435,0.81425,0,-1.0,-1.0,,
ENSG00000114739,2,1,1,0,0,1,203090.6413944402,203090.6413944402,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ACVR2B,0.592,3.0549,-0.2546,4,-1.0,0.0,Signal Transduction;Developmental Biology;Regulation of signaling by NODAL,R-HSA-162582;R-HSA-1266738;R-HSA-1433617
ENSG00000114770,1,1,1,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ABCC5,0.54499996,4.8355,1.4276,4,-1.0,-1.0,Azathioprine ADME,R-HSA-9748787
ENSG00000114805,1,1,0,0,0,1,727796.3668420183,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,PLCH1,0.34600002,2.7887,0.90738,1,0.5,0.0,,
ENSG00000114812,1,1,1,0,0,1,197485.87952538437,197485.87952538437,2023-06-05,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VIPR1,-0.33599997,-0.63565,-0.64499,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000114841,1,1,0,0,1,0,85407.4445149281,85407.4445149281,2021-02-25,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DNAH1,0.241,2.589,0.13528,0,-1.0,0.0,,
ENSG00000114867,1,1,0,0,1,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EIF4G1,0.952,4.0767,-0.52175,14,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;mTORC1-mediated signalling;Immune System;Deadenylation of mRNA;Developmental Biology;Translation;MTOR signalling;Regulation of expression of SLITs and ROBOs;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);ISG15 antiviral mechanism;AUF1 (hnRNP D0) binds and destabilizes mRNA,R-HSA-162582;R-HSA-1280215;R-HSA-166208;R-HSA-168256;R-HSA-429947;R-HSA-1266738;R-HSA-72766;R-HSA-165159;R-HSA-9010553;R-HSA-975956;R-HSA-1169408;R-HSA-450408
ENSG00000115137,1,1,0,0,0,1,313882.50400013494,313882.50400013494,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DNAJC27,0.20099998,0.35094,0.73285,0,0.5,-1.0,,
ENSG00000115165,1,1,0,0,0,1,195005.6685718255,515513.2178404211,2018-10-08,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CYTIP,0.102999985,0.42787,0.25147,0,0.5,0.0,,
ENSG00000115211,1,1,1,0,0,1,94870.11495236546,94870.11495236546,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,EIF2B4,0.31300002,0.67524,-0.66304,1,-1.0,-1.0,Translation,R-HSA-72766
ENSG00000115216,1,1,1,0,0,0,183761.6081180644,183761.6081180644,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,NRBP1,0.78499997,4.7025,0.66403,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000115365,1,1,1,0,0,1,397765.9672627851,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,LANCL1,-0.30400002,-0.48863,-0.12116,0,0.5,-1.0,,
ENSG00000115526,1,1,0,0,0,1,85474.33432267047,85474.33432267047,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,CHST10,0.06400001,1.2164,0.73943,1,-1.0,-1.0,Matriglycan biosynthesis on DAG1;DAG1 glycosylations;Reactions specific to the complex N-glycan synthesis pathway;Post-translational protein modification,R-HSA-9939291;R-HSA-8931838;R-HSA-975578;R-HSA-597592
ENSG00000115548,1,1,0,0,0,1,232656.1405260205,293292.679301805,2018-06-11,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,KDM3A,0.531,2.8242,-0.76074,2,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000115561,1,1,0,0,0,1,684816.7338614308,1122672.658801146,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,CHMP3,0.45700002,1.4152,-0.021897,9,-1.0,-1.0,Endosomal Sorting Complex Required For Transport (ESCRT);Budding and maturation of HIV virion;Disease;Late endosomal microautophagy;Translation of Replicase and Assembly of the Replication Transcription Complex_9679504;Sealing of the nuclear envelope (NE) by ESCRT-III;Translation of Replicase and Assembly of the Replication Transcription Complex_9694676;HIV Life Cycle;Late Phase of HIV Life Cycle;HCMV Late Events,R-HSA-917729;R-HSA-162588;R-HSA-1643685;R-HSA-9615710;R-HSA-9679504;R-HSA-9668328;R-HSA-9694676;R-HSA-162587;R-HSA-162599;R-HSA-9610379
ENSG00000115616,1,1,0,0,0,1,219437.49527928562,219437.49527928562,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC9A2,0.23000002,2.2545,0.098998,1,0.5,0.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000115685,1,1,1,0,0,0,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PPP1R7,0.458,2.5471,0.40819,0,-1.0,-1.0,,
ENSG00000115750,2,1,1,0,0,1,5414.650230111769,5414.650230111769,2017-02-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TAF1B,0.26999998,0.92082,0.45504,6,-1.0,-1.0,SIRT1 negatively regulates rRNA expression;RNA Polymerase I Transcription Termination;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance,R-HSA-427359;R-HSA-73863;R-HSA-74160;R-HSA-73772;R-HSA-5250941;R-HSA-427413;R-HSA-73762;R-HSA-73864;R-HSA-73854
ENSG00000115761,2,1,1,0,0,1,72098.8014618248,521818.7070055739,2021-01-04,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,NOL10,-0.0069999695,0.31565,-0.087644,0,-1.0,0.0,,
ENSG00000115827,1,1,0,0,0,0,87030.31235300079,87030.31235300079,2022-11-14,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,DCAF17,0.14499998,0.92354,0.14346,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000115828,1,1,1,0,0,1,31519.426313660828,323648.5577791949,2013-08-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,QPCT,-0.29999995,-1.2459,0.35897,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000115840,1,1,0,0,0,0,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,SLC25A12,0.47500002,3.0138,0.53821,3,0.5,-1.0,,
ENSG00000115841,3,1,0,0,0,1,138890.6106237268,645988.1975077938,2023-01-18,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,RMDN2,-0.58500004,-1.0572,-0.43051,0,0.5,-1.0,,
ENSG00000115942,1,1,0,0,0,1,66575.78981395929,66575.78981395929,2021-02-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ORC2,0.351,1.0126,0.56649,7,-1.0,-1.0,E2F-enabled inhibition of pre-replication complex formation;Assembly of the ORC complex at the origin of replication;E2F mediated regulation of DNA replication,R-HSA-113507;R-HSA-68616;R-HSA-113510
ENSG00000115946,1,1,1,0,1,1,93087.1378694554,93087.1378694554,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PNO1,0.0009999871,0.39898,0.8434,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000116062,1,1,0,0,0,1,55985.57959589327,55985.57959589327,2025-04-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MSH6,0.15899998,-3.8555,-4.7675,3,-1.0,-1.0,Disease,R-HSA-1643685
ENSG00000116120,1,1,1,0,1,0,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,FARSB,-0.13100004,0.31792,-0.25833,1,-1.0,-1.0,tRNA Aminoacylation;Cytosolic tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-379716;R-HSA-72766
ENSG00000116237,1,1,1,0,0,1,57425.85429872698,57425.85429872698,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ICMT,0.39600003,1.2856,-1.728,2,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000116251,1,1,0,0,0,1,143284.77790855977,355284.1215006515,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RPL22,0.35500002,1.7109,0.71447,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000116406,1,1,1,0,0,1,2235.282959215934,2235.282959215934,2014-05-29,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,EDEM3,0.329,1.4624,1.1832,1,-1.0,-1.0,ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification,R-HSA-901032;R-HSA-901042;R-HSA-532668;R-HSA-597592
ENSG00000116641,2,1,1,0,0,1,66919.01590020242,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,DOCK7,0.449,3.8839,1.3355,4,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000116667,1,1,0,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,C1orf21,0.651,1.3273,0.59906,0,0.5,0.0,,
ENSG00000116691,1,1,1,0,0,1,225599.91693237546,225599.91693237546,2023-10-04,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MIIP,-0.24399996,0.44671,-0.072285,0,-1.0,-1.0,,
ENSG00000116711,1,1,0,0,0,1,191310.84064467996,191310.84064467996,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,PLA2G4A,0.110000014,1.6164,-0.098968,13,0.5,0.0,Signal Transduction;Acyl chain remodelling of PS;ADP signalling through P2Y purinoceptor 1;Acyl chain remodelling of PG;Acyl chain remodelling of PI;Signal amplification;Synthesis of PA;Acyl chain remodelling of PC;Acyl chain remodelling of PE;Golgi-to-ER retrograde transport;Arachidonate metabolism,R-HSA-162582;R-HSA-1482801;R-HSA-418592;R-HSA-1482925;R-HSA-1482922;R-HSA-392518;R-HSA-1483166;R-HSA-1482788;R-HSA-1482839;R-HSA-8856688;R-HSA-2142753
ENSG00000116783,1,1,0,0,0,0,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TNNI3K,-0.40400004,-0.85077,0.47598,0,1.0,0.0,,
ENSG00000116809,3,1,1,0,0,1,21781.337520231158,645988.1975077938,2021-01-25,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ZBTB17,0.559,3.6195,-0.18468,1,-1.0,-1.0,,
ENSG00000116871,1,1,1,0,0,1,219437.49527928562,219437.49527928562,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,MAP7D1,0.41399997,-1.4333,-3.0342,0,0.5,-1.0,,
ENSG00000117154,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IGSF21,0.14200002,0.69287,-0.25915,0,1.0,0.0,,
ENSG00000117394,1,1,0,0,0,1,27388.747575018435,27388.747575018435,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC2A1,0.861,4.6812,0.95491,5,0.5,0.0,Disease;Cellular hexose transport,R-HSA-1643685;R-HSA-189200
ENSG00000117410,1,1,1,0,0,1,55416.28042655659,55416.28042655659,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ATP6V0B,0.628,2.0567,-0.34786,6,-1.0,-1.0,Signal Transduction;Transferrin endocytosis and recycling;Immune System;Developmental Biology;Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy;Iron uptake and transport;Cellular response to starvation;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-917977;R-HSA-168256;R-HSA-1266738;R-HSA-9857377;R-HSA-917937;R-HSA-9711097;R-HSA-9006934
ENSG00000117448,1,1,0,0,0,1,108816.31098183901,108816.31098183901,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,AKR1A1,0.12900001,0.91168,0.95344,2,-1.0,-1.0,Phase II - Conjugation of compounds,R-HSA-156580
ENSG00000117481,1,1,1,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NSUN4,0.07099998,0.98598,1.0476,1,1.0,-1.0,rRNA modification in the mitochondrion;rRNA processing in the mitochondrion;rRNA processing,R-HSA-6793080;R-HSA-8868766;R-HSA-72312
ENSG00000117500,1,1,1,0,1,0,263416.51565448404,263416.51565448404,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TMED5,-0.66199994,0.70189,0.35602,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000117525,1,1,0,0,0,1,6356.593451690605,6356.593451690605,2023-05-29,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,F3,0.16100001,0.11136,-0.40623,2,-1.0,-1.0,,
ENSG00000117601,1,1,0,0,0,0,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SERPINC1,0.56,2.7691,0.77957,4,1.0,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000118058,1,1,0,0,0,1,62043.890063935265,62043.890063935265,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,KMT2A,0.935,8.7941,3.2926,8,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160
ENSG00000118096,1,1,1,0,0,1,28923.750134754748,28923.750134754748,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,IFT46,0.296,0.88089,1.0423,1,-1.0,-1.0,Intraflagellar transport,R-HSA-5620924
ENSG00000118260,1,1,0,0,0,1,756470.9740366563,756470.9740366563,2025-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CREB1,0.811,3.5959,0.95312,27,-1.0,-1.0,Signal Transduction;CREB1 phosphorylation through the activation of Adenylate Cyclase;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);CREB phosphorylation;Disease;Signaling by Interleukins;Gastrin-CREB signalling pathway via PKC and MAPK;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-442720;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-199920;R-HSA-1643685;R-HSA-449147;R-HSA-881907;R-HSA-9006934;R-HSA-5663202
ENSG00000118420,1,1,0,0,0,1,985.590015128593,985.590015128593,2016-02-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,UBE3D,-0.15400004,0.86682,-0.057604,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000118434,1,1,0,0,0,1,161053.42428938235,161053.42428938235,2023-11-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SPACA1,-0.004999995,-0.064636,-0.53379,0,1.0,1.0,,
ENSG00000118492,1,1,0,0,0,1,2506.878320343566,5002.767245657568,2011-10-23,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ADGB,0.059000015,0.023131,0.22786,0,0.5,0.5,,
ENSG00000118523,1,1,0,0,0,1,49742.651617673284,49742.651617673284,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCN2,-0.049999952,-0.22824,0.083145,2,-1.0,-1.0,,
ENSG00000118729,2,1,1,0,1,1,87748.84971094332,645988.1975077938,2018-06-11,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,CASQ2,-0.32200003,0.30635,0.46569,2,1.0,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000118849,1,1,0,0,0,1,169088.90478978804,169088.90478978804,2019-03-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RARRES1,-0.472,-0.18339,-0.89005,0,0.5,0.0,,
ENSG00000118873,1,1,0,0,0,1,251325.91086204,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RAB3GAP2,0.46499997,1.9223,0.96795,2,-1.0,-1.0,Golgi-to-ER retrograde transport;Rab regulation of trafficking,R-HSA-8856688;R-HSA-9007101
ENSG00000118997,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DNAH7,0.038999975,0.35611,0.51918,0,0.5,0.0,,
ENSG00000119121,2,1,0,0,0,1,66821.18426408028,183761.6081180644,2023-10-03,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,TRPM6,0.50600004,3.0997,0.25117,1,1.0,0.5,Stimuli-sensing channels,R-HSA-2672351
ENSG00000119414,1,1,1,0,0,0,161053.42428938235,161053.42428938235,2023-11-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PPP6C,0.578,3.0704,0.36118,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000119537,1,1,1,0,0,1,220837.49604317299,220837.49604317299,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KDSR,0.035000026,0.59385,0.11255,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000119599,1,1,0,0,0,0,228220.5662976458,545988.1005477115,2023-01-19,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DCAF4,0.213,1.396,0.79176,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000119650,1,1,0,0,0,1,360605.992793193,360605.992793193,2022-02-03,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IFT43,-0.28199995,0.15745,0.53918,1,-1.0,-1.0,Intraflagellar transport,R-HSA-5620924
ENSG00000119673,1,1,0,0,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ACOT2,-0.19099998,0.27326,-1.1529,3,-1.0,-1.0,Peroxisomal protein import,R-HSA-9033241
ENSG00000119698,1,1,0,0,0,1,99788.44320353035,99788.44320353035,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PPP4R4,0.28500003,1.873,0.50771,0,0.5,0.5,,
ENSG00000119787,1,1,0,0,0,1,60436.282913699004,60436.282913699004,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATL2,0.353,-0.40361,-1.6292,0,-1.0,-1.0,,
ENSG00000119865,1,1,0,0,0,1,168116.01355658393,168116.01355658393,2024-05-27,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CNRIP1,-0.17799997,-0.27913,-0.98569,0,0.5,-1.0,,
ENSG00000119938,2,1,1,0,0,1,219793.50457789513,360605.992793193,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PPP1R3C,0.055000007,1.5411,1.2256,2,0.5,0.0,Glycogen metabolism;Glycogen storage diseases;Glycogen synthesis;Disease,R-HSA-8982491;R-HSA-3229121;R-HSA-3322077;R-HSA-1643685
ENSG00000119973,2,1,0,0,0,1,2628.763122476447,355284.1215006515,2011-12-11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PRLHR,-0.71000004,-1.4957,-1.0554,1,0.5,0.5,Signal Transduction,R-HSA-162582
ENSG00000120217,1,1,1,1,0,1,36159.555758564435,36159.555758564435,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CD274,0.524,0.44887,-0.97165,2,0.5,0.0,Signal Transduction;Immune System;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-9006934
ENSG00000120314,1,1,1,0,1,0,94951.97167384504,94951.97167384504,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,WDR55,-0.273,1.2658,1.2938,0,-1.0,-1.0,,
ENSG00000120440,2,1,0,0,0,1,6902.838548609505,6902.838548609505,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TTLL2,-0.83500004,0.46372,0.21214,1,1.0,0.5,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000120519,1,1,0,0,0,0,500292.45069431677,500292.45069431677,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SLC10A7,0.03399998,2.0895,0.088389,0,-1.0,-1.0,,
ENSG00000120645,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,IQSEC3,0.268,-0.044108,-1.774,1,1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000120647,1,1,0,0,0,1,512656.0695323204,512656.0695323204,2023-03-27,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,CCDC77,-0.07700002,0.56478,0.12169,0,-1.0,-1.0,,
ENSG00000120662,1,1,0,0,0,1,8785.223357377507,8785.223357377507,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,MTRF1,-0.01699996,1.6513,1.234,0,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation,R-HSA-72766;R-HSA-5419276;R-HSA-5368287
ENSG00000120688,1,1,0,0,0,1,19965.24128263536,19965.24128263536,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,WBP4,0.028999984,0.51855,0.11581,1,-1.0,-1.0,,
ENSG00000120705,2,1,0,0,0,1,15866.724081734988,323648.5577791949,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,9,ETF1,0.81,5.828,1.2511,5,-1.0,-1.0,Developmental Biology;Protein hydroxylation;Translation;Regulation of expression of SLITs and ROBOs;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Post-translational protein modification,R-HSA-1266738;R-HSA-9629569;R-HSA-72766;R-HSA-9010553;R-HSA-975956;R-HSA-597592
ENSG00000120738,1,1,0,0,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EGR1,0.538,2.5696,-0.21026,3,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9006934
ENSG00000120798,1,1,0,0,0,1,43000.99374052331,43000.99374052331,2020-05-29,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NR2C1,0.29900002,1.6877,0.3324,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000120802,1,1,0,0,0,1,309838.540915932,360605.992793193,2021-07-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TMPO,0.264,0.85831,-1.2004,13,0.5,-1.0,Signal Transduction;Depolymerization of the Nuclear Lamina,R-HSA-162582;R-HSA-4419969
ENSG00000120875,2,1,1,0,0,1,22345.675520395987,141076.9910731678,2013-04-01,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DUSP4,0.19199997,1.2889,-0.89225,3,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;ERKs are inactivated;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-202670;R-HSA-449147;R-HSA-9006934
ENSG00000121005,1,1,1,0,0,1,453046.0257943742,453046.0257943742,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CRISPLD1,-0.047999978,0.29371,0.60248,0,0.5,0.0,,
ENSG00000121057,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,AKAP1,0.47399998,2.489,1.872,2,0.5,-1.0,Mitochondrial calcium ion transport,R-HSA-8949215
ENSG00000121289,1,1,1,0,0,0,11843.109477001575,11843.109477001575,2024-01-27,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CEP89,-0.17299998,0.86542,0.001583,1,-1.0,-1.0,,
ENSG00000121481,1,1,1,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,RNF2,0.679,2.9682,0.31069,9,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);SUMOylation of RNA binding proteins;Transcriptional Regulation by E2F6;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-4570464;R-HSA-8953750;R-HSA-597592
ENSG00000121634,2,1,0,0,0,1,298878.49542603496,645988.1975077938,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GJA8,-0.30400002,-0.35005,-1.6671,1,1.0,1.0,Gap junction assembly;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-190861;R-HSA-157858;R-HSA-190828
ENSG00000121716,1,1,0,0,0,1,160863.76979916374,160863.76979916374,2024-07-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PILRB,-0.30700004,0.73549,-0.68192,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000121743,1,1,0,0,1,1,14325.237922401007,14325.237922401007,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,GJA3,-0.92200005,-0.018681,-1.1284,1,0.5,0.5,Gap junction assembly;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-190861;R-HSA-157858;R-HSA-190828
ENSG00000121879,1,1,1,0,0,1,263416.51565448404,263416.51565448404,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PIK3CA,0.779,6.1494,1.6605,60,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Regulation of signaling by CBL;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-912631;R-HSA-9006934;R-HSA-5663202
ENSG00000121903,1,1,1,0,0,1,11366.70347515427,11366.70347515427,2024-05-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZSCAN20,0.49299997,2.3448,0.79737,0,-1.0,0.0,,
ENSG00000122008,1,1,1,0,0,1,130268.25219927442,294387.2978738704,2020-06-08,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,POLK,0.075999975,0.95401,0.48022,7,-1.0,-1.0,Gap-filling DNA repair synthesis and ligation in TC-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-6782210;R-HSA-6782135;R-HSA-6781827
ENSG00000122034,1,1,1,0,1,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GTF3A,-0.893,-1.5876,-1.2002,2,-1.0,-1.0,RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-76046;R-HSA-76061;R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000122085,1,1,1,0,1,1,187674.40497870417,187674.40497870417,2022-03-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MTERF4,-0.03699994,1.13,0.78143,1,-1.0,-1.0,rRNA modification in the mitochondrion;rRNA processing in the mitochondrion;rRNA processing,R-HSA-6793080;R-HSA-8868766;R-HSA-72312
ENSG00000122176,1,1,0,0,0,1,356440.71671986027,356440.71671986027,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,FMOD,0.195,0.74625,0.54955,6,-1.0,0.0,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Defective ST3GAL3 causes MCT12 and EIEE15;Disease,R-HSA-3656244;R-HSA-3656243;R-HSA-1643685
ENSG00000122304,1,1,0,0,0,0,32254.717802479194,32254.717802479194,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PRM2,0.023000002,-1.1548,-0.51111,1,1.0,0.0,Replacement of protamines by nucleosomes in the male pronucleus;Developmental Biology,R-HSA-9821993;R-HSA-1266738
ENSG00000122378,2,1,1,0,0,0,448058.917711015,756470.9740366563,2023-11-10,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PRXL2A,-0.42299998,0.76654,0.44224,0,0.5,-1.0,,
ENSG00000122482,1,1,0,0,0,1,221280.45048451523,384314.83364002535,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,ZNF644,0.776,2.7213,0.56504,0,-1.0,-1.0,,
ENSG00000122545,2,1,1,0,0,1,86992.9057658324,414433.58532016096,2023-06-29,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SEPTIN7,0.68700004,1.5222,0.587,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000122550,1,1,0,0,0,1,37368.38182683358,76832.90012167432,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,KLHL7,0.21100003,5.0385,0.011067,0,0.5,-1.0,,
ENSG00000122584,1,1,0,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,NXPH1,0.574,0.29565,-0.66132,0,0.75,0.5,,
ENSG00000122585,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NPY,-0.41900003,0.63028,0.6977,3,0.75,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000122642,1,1,1,0,1,1,29803.01405728205,100711.28404230655,2020-01-20,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FKBP9,0.27100003,2.1731,0.37301,1,-1.0,-1.0,,
ENSG00000122733,1,1,0,0,0,1,118061.55082048493,118061.55082048493,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,PHF24,0.19700003,1.3437,1.0783,0,0.75,0.5,,
ENSG00000122756,1,1,0,0,0,1,17426.74725331541,17426.74725331541,2019-08-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CNTFR,0.453,1.0229,-0.016861,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000122912,1,1,0,0,0,0,2086.9802413009265,2086.9802413009265,2021-06-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC25A16,-0.30299997,-0.19079,-0.48149,1,-1.0,-1.0,Vitamin B5 (pantothenate) metabolism,R-HSA-199220
ENSG00000123094,1,1,0,0,0,1,11651.301498096203,11651.301498096203,2017-12-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RASSF8,0.342,1.5933,2.1662,0,0.5,-1.0,,
ENSG00000123213,1,1,0,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NLN,0.065999985,0.35967,0.6364,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000123243,1,1,0,1,1,1,7366.095640042161,7366.095640042161,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ITIH5,0.03399998,0.60582,-0.4014,0,0.5,0.0,,
ENSG00000123329,1,1,1,0,1,0,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ARHGAP9,-0.023000002,0.46219,0.51771,4,0.5,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000123353,1,1,0,0,0,1,63200.72664467542,63200.72664467542,2022-07-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ORMDL2,-0.28100002,1.0808,0.50485,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000123388,1,1,0,0,0,1,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HOXC11,-0.116000056,0.11509,-0.11058,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000123415,1,1,1,0,0,1,114439.41769154315,114439.41769154315,2024-07-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SMUG1,0.181,0.70068,0.38626,3,-1.0,-1.0,"Depyrimidination;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine;Base-Excision Repair, AP Site Formation",R-HSA-73928;R-HSA-110328;R-HSA-110329;R-HSA-73929
ENSG00000123636,1,1,1,0,0,1,258213.8601133611,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BAZ2B,0.61399996,2.1127,0.83224,0,-1.0,-1.0,,
ENSG00000123737,1,1,1,0,0,1,129783.42151918238,129783.42151918238,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EXOSC9,-0.12100005,-0.059334,0.10891,7,-1.0,-1.0,PERK regulates gene expression;ATF4 activates genes in response to endoplasmic reticulum  stress;Nuclear RNA decay;rRNA processing,R-HSA-381042;R-HSA-380994;R-HSA-9930044;R-HSA-72312
ENSG00000123836,1,1,1,1,0,0,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PFKFB2,0.009000003,2.9472,0.49904,1,0.5,-1.0,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",R-HSA-9634600
ENSG00000123838,1,1,0,0,0,1,99227.16426999423,102866.95819249244,2019-08-16,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,C4BPA,0.283,2.0774,0.49079,1,1.0,0.0,Immune System,R-HSA-168256
ENSG00000123843,1,1,0,1,0,0,99227.16426999423,102866.95819249244,2019-08-16,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,C4BPB,-0.14699996,0.70528,-0.7045,1,1.0,0.0,Immune System,R-HSA-168256
ENSG00000123999,1,1,0,0,1,1,93139.63789601182,93139.63789601182,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,INHA,0.314,0.75338,-0.61312,4,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000124140,6,1,1,0,0,1,409691.21276290494,715125.8126650311,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,SLC12A5,0.775,6.274,0.090753,1,0.5,0.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000124164,1,1,1,0,0,0,107354.09904306603,107354.09904306603,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,VAPB,0.301,0.69832,0.06796,6,-1.0,-1.0,Signal Transduction;Sphingolipid de novo biosynthesis,R-HSA-162582;R-HSA-1660661
ENSG00000124193,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SRSF6,0.361,1.2432,-1.7362,6,-1.0,-1.0,mRNA Splicing - Minor Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm,R-HSA-72165;R-HSA-73857;R-HSA-74160;R-HSA-159236;R-HSA-72202
ENSG00000124201,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNFX1,0.51100004,4.0932,1.3231,0,-1.0,-1.0,,
ENSG00000124207,2,1,1,0,0,1,197775.78125685986,960369.5592648841,2021-05-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,CSE1L,0.723,3.387,0.44686,0,-1.0,-1.0,,
ENSG00000124243,5,1,0,0,0,1,43372.03071242184,189557.6027707886,2018-08-13,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,BCAS4,-0.08099997,0.15306,-0.21021,0,0.5,0.0,,
ENSG00000124256,1,1,0,0,0,1,18726.942523270427,18726.942523270427,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,ZBP1,-0.29400003,-0.0030975,-0.2165,5,0.5,0.0,Immune System;Disease,R-HSA-168256;R-HSA-1643685
ENSG00000124380,1,1,1,0,0,1,232656.1405260205,232656.1405260205,2018-06-11,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SNRNP27,-0.732,1.4587,0.05898,1,-1.0,-1.0,,
ENSG00000124440,1,1,1,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HIF3A,0.167,0.58436,0.29825,4,-1.0,0.0,Developmental Biology;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Post-translational protein modification,R-HSA-1266738;R-HSA-1234176;R-HSA-597592
ENSG00000124596,1,1,0,0,0,1,57692.51997622251,57692.51997622251,2019-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,OARD1,-0.76400006,-0.014183,-0.42374,0,-1.0,-1.0,,
ENSG00000124608,1,1,1,0,0,1,20751.495140412953,83932.6290685273,2013-12-25,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,5,AARS2,0.24800003,1.8985,1.1422,1,-1.0,-1.0,tRNA Aminoacylation;Translation,R-HSA-379724;R-HSA-72766
ENSG00000124688,1,1,0,0,1,0,22794.303125024984,22794.303125024984,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,MAD2L1BP,-0.07099998,0.65178,-0.3798,0,-1.0,-1.0,,
ENSG00000124787,3,1,0,0,0,1,38106.7872841086,120940.93870730935,2019-06-07,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,RPP40,-0.08899999,0.48014,-0.32573,2,-1.0,0.0,rRNA processing;tRNA processing in the nucleus,R-HSA-72312;R-HSA-6784531
ENSG00000125285,1,1,0,0,0,1,195666.44200393453,195666.44200393453,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SOX21,-0.71599996,-0.99906,-2.7658,0,0.75,0.5,,
ENSG00000125386,1,1,0,0,0,0,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM193A,0.729,1.143,-0.95728,0,-1.0,-1.0,,
ENSG00000125388,1,1,1,0,1,0,298504.9722193353,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,GRK4,-0.26199996,0.14616,0.13895,1,0.5,-1.0,,
ENSG00000125430,1,1,0,0,0,1,15603.785966148887,15603.785966148887,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,HS3ST3B1,-0.546,-0.35601,-0.998,1,0.5,0.0,HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-2022928;R-HSA-1638091
ENSG00000125459,1,1,0,0,0,1,6306.411000302206,6306.411000302206,2021-02-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MSTO1,0.16900003,2.1196,1.5603,0,-1.0,-1.0,,
ENSG00000125510,1,1,1,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,OPRL1,0.282,2.0497,0.65722,2,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000125522,1,1,0,0,0,1,15223.454539395489,15223.454539395489,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NPBWR2,-0.878,1.4588,0.88614,2,,,Signal Transduction,R-HSA-162582
ENSG00000125633,1,1,0,0,0,1,208059.85546229704,208059.85546229704,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CCDC93,0.013999999,0.36196,0.1298,0,-1.0,-1.0,,
ENSG00000125703,1,1,1,0,0,1,78751.06843456876,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ATG4C,-0.23399997,-0.81861,0.64377,1,-1.0,-1.0,,
ENSG00000125726,3,1,0,1,0,1,13871.81130624279,38819.168478218926,2023-01-18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CD70,-0.25100005,0.79554,0.5357,1,0.5,0.5,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000125814,1,1,1,0,0,1,233951.33040728344,233951.33040728344,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NAPB,-0.044999957,0.60635,-0.14444,5,0.75,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000126001,1,1,1,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CEP250,0.13999999,2.781,1.6976,7,-1.0,-1.0,,
ENSG00000126351,1,1,1,0,0,1,123127.18790121445,220463.13948652346,2019-02-25,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,THRA,0.561,4.6106,1.086,2,1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-597592
ENSG00000126391,1,1,0,0,0,1,21939.796916619583,25903.3352616996,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,FRMD8,-0.148,-0.073159,0.064058,0,-1.0,-1.0,,
ENSG00000126432,1,1,1,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,PRDX5,-0.23699999,0.81878,0.43499,2,0.5,-1.0,,
ENSG00000126768,1,1,1,0,0,1,118492.7744519305,135095.86576106868,2019-02-04,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TIMM17B,,,,1,-1.0,-1.0,,
ENSG00000126785,1,1,0,0,0,1,646.3304347826087,646.3304347826087,2017-09-01,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RHOJ,0.15100002,0.75912,0.50392,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000126803,1,1,1,1,0,0,414433.58532016096,414433.58532016096,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HSPA2,0.482,4.5012,1.2036,5,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000126861,1,1,0,0,1,0,306980.8575290048,306980.8575290048,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,OMG,0.435,2.2004,0.8992,1,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000127125,1,1,1,0,0,0,144102.0022515395,144102.0022515395,2023-05-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PPCS,-0.06400001,0.81988,-0.71998,1,-1.0,-1.0,Vitamin B5 (pantothenate) metabolism,R-HSA-199220
ENSG00000127184,2,1,0,0,0,1,1321.7688442211056,340825.7076940272,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,COX7C,-0.016000032,0.52081,0.32568,4,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Complex IV assembly,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9864848
ENSG00000127249,1,1,1,0,0,1,256331.89034791503,256331.89034791503,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ATP13A4,0.10399997,1.0661,1.1694,1,0.5,0.0,,
ENSG00000127328,1,1,1,0,0,0,228220.5662976458,228220.5662976458,2018-07-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RAB3IP,-0.024000049,0.52332,0.088877,4,0.5,-1.0,BBSome-mediated cargo-targeting to cilium;VxPx cargo-targeting to cilium;Rab regulation of trafficking;Cargo trafficking to the periciliary membrane,R-HSA-5620922;R-HSA-5620916;R-HSA-9007101;R-HSA-5620920
ENSG00000127472,1,1,0,0,0,1,3865.396263381562,3865.396263381562,2024-07-19,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,PLA2G5,-0.05700004,0.33451,0.33039,6,0.5,0.0,Acyl chain remodelling of PS;Acyl chain remodelling of PG;Acyl chain remodelling of PI;Synthesis of PA;Acyl chain remodelling of PC;Acyl chain remodelling of PE,R-HSA-1482801;R-HSA-1482925;R-HSA-1482922;R-HSA-1483166;R-HSA-1482788;R-HSA-1482839
ENSG00000127603,3,1,1,0,1,1,98524.26480884294,575147.0632428399,2018-07-27,0,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,MACF1,0.76199996,6.219,2.1382,0,-1.0,-1.0,,
ENSG00000127720,1,1,0,0,0,0,9546.95422575261,9546.95422575261,2022-01-12,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,METTL25,-0.10899997,-1.0237,-1.0286,0,-1.0,-1.0,,
ENSG00000127838,1,1,1,0,0,0,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PNKD,-0.13100004,0.079285,0.69314,1,-1.0,-1.0,Complex IV assembly,R-HSA-9864848
ENSG00000127863,1,1,1,0,0,1,3449.182628702905,5464.005431093007,2010-05-30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TNFRSF19,0.14099997,0.61677,0.32486,0,0.5,0.0,,
ENSG00000127870,2,1,0,0,0,1,118492.7744519305,1424218.0900670097,2017-09-04,0,0,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,RNF6,0.397,2.2006,1.7234,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000127903,1,1,1,0,1,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ZNF835,-0.854,-0.075579,0.30223,0,-1.0,0.0,,
ENSG00000127948,1,1,0,0,0,1,34005.64413479755,34005.64413479755,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,POR,0.112999976,-0.35506,-1.0222,1,0.5,-1.0,,
ENSG00000127952,1,1,1,0,0,0,80065.63748488021,80065.63748488021,2022-07-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,STYXL1,-0.21599996,0.93213,0.94952,0,-1.0,-1.0,,
ENSG00000128159,2,1,0,0,0,1,521433.73994041845,521433.73994041845,2019-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TUBGCP6,-0.07099998,-1.0132,-2.7104,2,-1.0,-1.0,,
ENSG00000128242,1,1,0,0,1,0,12618.041744442558,12618.041744442558,2020-09-16,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GAL3ST1,0.227,2.0652,0.049189,1,0.75,0.0,,
ENSG00000128383,7,1,1,0,0,1,5795.555913631969,88186.71873814042,2010-10-24,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,APOBEC3A,0.100000024,0.78736,0.42815,2,0.75,0.0,,
ENSG00000128519,1,1,0,0,0,1,415452.66715166246,415452.66715166246,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TAS2R16,-0.88699996,0.027811,-0.55289,3,,,Signal Transduction,R-HSA-162582
ENSG00000128563,1,1,1,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PRKRIP1,-0.31500006,-0.02794,-0.40713,1,-1.0,-1.0,,
ENSG00000128581,1,1,1,0,0,1,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,IFT22,0.116,0.30574,1.0573,1,-1.0,-1.0,Intraflagellar transport,R-HSA-5620924
ENSG00000128617,1,1,0,0,0,1,228220.5662976458,645988.1975077938,2018-07-30,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,OPN1SW,-0.029999971,0.80869,-0.34348,4,1.0,1.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000128645,1,1,0,0,0,1,25415.17921452856,25415.17921452856,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,HOXD1,-0.37800002,-1.6844,-1.6854,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000128683,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GAD1,0.431,3.7496,0.77398,3,0.75,0.5,"Generic Transcription Pathway;RNA Polymerase II Transcription;GABA synthesis, release, reuptake and degradation;Gene expression (Transcription);Neurotransmitter release cycle",R-HSA-212436;R-HSA-73857;R-HSA-888590;R-HSA-74160;R-HSA-112310
ENSG00000128708,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HAT1,-0.439,-0.24801,0.82807,1,-1.0,-1.0,,
ENSG00000128833,2,1,1,0,0,1,135095.86576106868,1424218.0900670097,2020-05-06,0,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,MYO5C,0.10699999,1.2128,1.3411,0,-1.0,0.0,,
ENSG00000128872,2,1,1,0,0,1,89519.16315227402,1470466.6505612188,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,TMOD2,0.20599997,0.84837,1.2996,1,1.0,0.0,,
ENSG00000129007,1,1,1,0,0,1,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CALML4,-0.37399995,0.13753,-0.66015,0,0.5,0.0,,
ENSG00000129084,1,1,0,0,0,0,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PSMA1,0.657,1.7376,0.12235,62,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000129116,1,1,0,0,0,0,279825.00883385167,279825.00883385167,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PALLD,0.356,1.6038,1.1421,0,-1.0,-1.0,,
ENSG00000129158,1,1,0,0,0,1,727796.3668420183,727796.3668420183,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SERGEF,-0.10099995,0.65754,0.54347,0,-1.0,-1.0,,
ENSG00000129219,1,1,0,0,1,1,13219.952617929488,13219.952617929488,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,PLD2,0.06699997,1.0679,0.12388,5,-1.0,-1.0,Signal Transduction;Immune System;Synthesis of PA,R-HSA-162582;R-HSA-168256;R-HSA-1483166
ENSG00000129451,1,1,0,1,0,0,118061.55082048493,118061.55082048493,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,KLK10,-0.668,-0.99079,-1.5712,0,0.5,0.0,,
ENSG00000129467,1,1,1,0,0,1,31104.940443685748,31104.940443685748,2023-06-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ADCY4,-0.08899999,0.7502,-0.30254,14,-1.0,0.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000129521,2,1,0,0,0,1,161901.8662742023,213982.31715359434,2024-07-19,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,EGLN3,0.19999999,1.8425,-0.47673,1,0.5,0.0,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,R-HSA-1234176
ENSG00000129559,2,1,0,0,0,0,355284.1215006515,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NEDD8,0.648,3.2247,0.26262,5,-1.0,-1.0,Signal Transduction;Iron uptake and transport;Post-translational protein modification,R-HSA-162582;R-HSA-917937;R-HSA-597592
ENSG00000129646,1,1,1,0,0,0,230312.26972227366,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,QRICH2,0.16799998,2.0207,1.1927,0,0.5,0.0,,
ENSG00000129680,1,1,1,0,1,1,574261.7466389402,574261.7466389402,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MAP7D3,,,,0,-1.0,-1.0,,
ENSG00000129682,1,1,0,0,0,1,125894.9248389576,125894.9248389576,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FGF13,,,,1,0.5,-1.0,,
ENSG00000130234,1,1,0,1,0,1,195626.00760327786,474830.9126255118,2022-03-03,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ACE2,,,,5,0.5,0.0,Metabolism of Angiotensinogen to Angiotensins;Disease,R-HSA-2022377;R-HSA-1643685
ENSG00000130303,1,1,1,1,0,0,258213.8601133611,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BST2,0.031000018,1.193,1.4295,3,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Disease,R-HSA-1280215;R-HSA-168256;R-HSA-1643685
ENSG00000130312,1,1,1,0,0,0,9728.965589373496,9728.965589373496,2024-05-13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MRPL34,-0.901,-0.81426,-0.52667,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000130508,1,1,1,0,0,1,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PXDN,0.323,1.5421,-1.2913,2,-1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000130511,1,1,1,0,0,0,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,SSBP4,0.277,-1.4006,-1.9317,0,-1.0,-1.0,,
ENSG00000130520,1,1,1,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LSM4,-0.026000023,1.5754,-0.87405,2,-1.0,-1.0,,
ENSG00000130522,2,1,1,0,0,1,116089.30071075787,215157.94798738702,2020-06-24,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,4,JUND,0.09399998,-1.7937,-4.6013,2,-1.0,-1.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000130561,1,1,0,0,0,1,135095.86576106868,254373.32653042395,2020-05-06,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SAG,0.07700002,0.64315,0.61885,2,1.0,0.5,,
ENSG00000130595,1,1,0,0,0,1,41642.5373617829,53449.348719171874,2024-07-19,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TNNT3,0.134,1.0044,-0.30283,1,0.75,0.0,,
ENSG00000130703,1,1,1,0,0,0,150669.89240227733,150669.89240227733,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,OSBPL2,0.533,2.4475,0.81837,1,-1.0,-1.0,Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000130725,1,1,1,0,0,0,188264.63129042363,355284.1215006515,2025-03-06,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,UBE2M,0.728,2.9901,-0.41193,5,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Dectin-1 mediated noncanonical NF-kB signaling;NIK-->noncanonical NF-kB signaling;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-5607761;R-HSA-5676590;R-HSA-597592
ENSG00000130816,1,1,0,0,0,1,40486.1226680631,40486.1226680631,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DNMT1,0.85,7.3454,0.99521,7,-1.0,-1.0,Signal Transduction;Gene expression (Transcription);Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-74160;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-9006934;R-HSA-5663202;R-HSA-597592
ENSG00000130956,1,1,1,0,0,1,367949.31877243903,367949.31877243903,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HABP4,-0.648,-1.7741,-2.1404,1,0.5,-1.0,,
ENSG00000131061,3,1,1,0,0,1,194667.2540182328,521818.7070055739,2023-11-09,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,ZNF341,0.24400002,1.7805,0.47981,0,-1.0,0.0,,
ENSG00000131153,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GINS2,-0.755,-1.4832,-1.5319,1,0.5,0.0,Unwinding of DNA,R-HSA-176974
ENSG00000131355,1,1,0,0,0,1,444537.33605315426,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,ADGRE3,-0.265,1.1043,0.69911,2,0.5,0.5,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000131370,1,1,1,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SH3BP5,0.14999998,0.91281,-1.0446,0,-1.0,-1.0,,
ENSG00000131400,1,1,1,0,1,0,95491.56815792594,95491.56815792594,2023-05-17,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NAPSA,-0.30499995,0.54065,0.82617,1,1.0,0.0,Surfactant metabolism,R-HSA-5683826
ENSG00000131446,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MGAT1,0.361,1.1576,-1.8434,3,-1.0,-1.0,Translation of Structural Proteins_9683701;Disease;Post-translational protein modification,R-HSA-9683701;R-HSA-1643685;R-HSA-597592
ENSG00000131475,1,1,0,0,0,1,59389.77313114188,59389.77313114188,2022-01-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VPS25,-0.023000002,1.6535,-0.36681,2,-1.0,-1.0,Endosomal Sorting Complex Required For Transport (ESCRT);Disease;HCMV Late Events,R-HSA-917729;R-HSA-1643685;R-HSA-9610379
ENSG00000131482,2,1,0,0,1,1,141293.18354755783,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,G6PC1,0.037,1.173,0.89607,3,0.75,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Gluconeogenesis;Glycogen storage diseases;Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-70263;R-HSA-3229121;R-HSA-1643685
ENSG00000131848,1,1,0,0,0,0,41642.5373617829,48135.44521973547,2024-07-19,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ZSCAN5A,0.162,0.33582,-0.53818,0,1.0,-1.0,,
ENSG00000131944,1,1,1,0,0,1,11843.109477001575,11843.109477001575,2024-01-27,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAAP24,-0.33599997,0.97249,0.082129,2,-1.0,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000132003,3,1,1,0,0,0,98271.38571086437,125392.97184483419,2023-01-18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ZSWIM4,0.17000002,2.14,0.058144,0,-1.0,0.0,,
ENSG00000132155,1,1,0,0,0,1,203321.91836345146,203321.91836345146,2020-04-15,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,RAF1,0.647,3.4281,0.38152,17,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Stimuli-sensing channels;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-2672351;R-HSA-5663202
ENSG00000132259,1,1,1,0,0,1,63195.354172698775,63195.354172698775,2024-07-19,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CNGA4,0.075999975,0.85851,0.8375,2,0.75,0.5,VxPx cargo-targeting to cilium;Olfactory Signaling Pathway;Cargo trafficking to the periciliary membrane,R-HSA-5620916;R-HSA-381753;R-HSA-5620920
ENSG00000132359,1,1,0,0,0,1,136856.22408102124,136856.22408102124,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RAP1GAP2,0.56700003,1.8735,-0.098538,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000132383,14,1,0,0,1,1,8824.300529178303,406587.2658730814,2023-01-18,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,RPA1,0.18199998,1.1976,0.38357,30,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;Gap-filling DNA repair synthesis and ligation in TC-NER;Formation of Incision Complex in GG-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Post-translational protein modification,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-6782210;R-HSA-5696395;R-HSA-6782135;R-HSA-6781827;R-HSA-597592
ENSG00000132405,1,1,1,0,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,3,TBC1D14,0.56799996,1.9089,-0.6061,1,-1.0,-1.0,TBC/RABGAPs;Rab regulation of trafficking,R-HSA-8854214;R-HSA-9007101
ENSG00000132671,3,1,0,0,0,1,42398.05428047667,109001.36551434857,2022-10-12,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SSTR4,,-1.9447,-1.0277,2,,,Signal Transduction,R-HSA-162582
ENSG00000132763,1,1,0,0,0,0,108816.31098183901,108816.31098183901,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,MMACHC,-0.16199994,-0.13096,-0.047631,3,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000132773,1,1,0,0,0,1,143413.24457139417,143413.24457139417,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TOE1,-0.22500002,2.0223,1.3915,0,-1.0,-1.0,,
ENSG00000132824,1,1,0,0,0,1,28923.750134754748,28923.750134754748,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SERINC3,0.36699998,0.37401,-0.24704,1,-1.0,-1.0,Serine metabolism,R-HSA-977347
ENSG00000132842,2,1,1,0,0,1,260210.21963428933,1424218.0900670097,2023-01-18,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,AP3B1,0.41000003,2.0333,1.2309,2,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000132938,2,1,0,0,0,0,3750.4,7987.2,2023-10-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MTUS2,0.49800003,0.32656,-0.1587,0,1.0,0.0,,
ENSG00000132958,1,1,0,0,0,1,3308.5637733742674,3308.5637733742674,2024-01-10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TPTE2,0.04000002,1.6733,1.1637,1,1.0,1.0,Synthesis of PIPs at the Golgi membrane,R-HSA-1660514
ENSG00000132963,1,1,0,0,0,1,66736.09970493254,66736.09970493254,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,POMP,-0.19099998,0.84049,0.44952,1,-1.0,-1.0,Metabolism of nucleotides;Post-translational protein modification,R-HSA-15869;R-HSA-597592
ENSG00000132964,1,1,0,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CDK8,0.35399997,2.9169,1.1465,9,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-2173796;R-HSA-2173793
ENSG00000132975,2,1,0,0,0,1,19008.705439555517,160010.51072069994,2011-02-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,0,0,0,12,GPR12,0.32999998,2.1748,-0.10453,0,0.5,0.5,,
ENSG00000133027,1,1,0,0,0,1,116566.20935579021,116566.20935579021,2023-01-18,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PEMT,-0.30999994,-0.065971,-0.18976,1,0.5,-1.0,,
ENSG00000133065,1,1,0,0,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC41A1,0.413,2.8301,0.19139,1,0.5,-1.0,,
ENSG00000133083,1,1,1,0,0,1,28292.123952140868,28292.123952140868,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DCLK1,0.69,4.3006,0.30248,0,0.5,0.0,,
ENSG00000133116,2,1,0,0,1,1,46730.28130799027,1424218.0900670097,2017-09-04,0,0,0,0,0,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,KL,0.083000004,0.81065,0.084156,12,0.75,0.0,Signal Transduction;Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202
ENSG00000133422,1,1,1,0,0,1,63389.5809755003,63389.5809755003,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MORC2,0.7,4.4514,1.6753,2,-1.0,-1.0,Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex;Gene expression (Transcription);Fatty acyl-CoA biosynthesis,R-HSA-9843970;R-HSA-74160;R-HSA-75105
ENSG00000133561,1,1,0,0,1,1,169088.90478978804,169088.90478978804,2019-03-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GIMAP6,-0.38900006,0.73893,0.078153,0,0.5,0.0,,
ENSG00000133661,1,1,1,1,1,1,17601.10520641419,165324.69367515197,2023-05-17,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SFTPD,0.22000003,1.0053,1.1748,10,1.0,0.0,Immune System;Disease;Surfactant metabolism,R-HSA-168256;R-HSA-1643685;R-HSA-5683826
ENSG00000133704,1,1,0,0,0,1,278498.5074409075,278498.5074409075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,IPO8,0.425,2.2699,0.21695,1,-1.0,-1.0,Gene expression (Transcription);Transcriptional regulation by small RNAs;Gene Silencing by RNA,R-HSA-74160;R-HSA-5578749;R-HSA-211000
ENSG00000133710,2,1,1,0,1,1,115338.82014347943,144127.33793912127,2024-07-19,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SPINK5,0.09200001,1.5699,1.1534,2,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000133816,1,1,0,0,0,1,36494.548446257475,36494.548446257475,2024-01-03,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MICAL2,0.28500003,1.3594,0.22538,0,1.0,-1.0,,
ENSG00000133872,1,1,0,0,0,1,2324.6716622691292,2324.6716622691292,2023-04-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SARAF,0.153,0.64218,-0.26663,0,-1.0,-1.0,,
ENSG00000133895,2,1,1,0,1,1,3019.871771386701,104168.97660865163,2020-04-01,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,7,MEN1,0.794,4.2012,0.29313,7,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Formation of the beta-catenin:TCF transactivating complex;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-2173796;R-HSA-2173793;R-HSA-201722;R-HSA-597592
ENSG00000133943,1,1,0,0,0,1,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,DGLUCY,-0.21500003,0.53603,0.080174,0,0.5,-1.0,,
ENSG00000133962,1,1,1,0,0,1,100083.61852522385,168116.01355658393,2019-11-01,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CATSPERB,0.065,1.5479,1.5455,1,1.0,0.5,Fertilization,R-HSA-1187000
ENSG00000134030,1,1,0,0,0,1,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CTIF,0.513,1.1112,-0.31373,0,-1.0,-1.0,,
ENSG00000134058,1,1,0,0,1,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CDK7,0.22600001,0.83974,0.82553,34,-1.0,-1.0,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;RNA Pol II CTD phosphorylation and interaction with CE;mRNA Capping;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;Generic Transcription Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;Cyclin A/B1/B2 associated events during G2/M transition;Formation of TC-NER Pre-Incision Complex;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;RNA Polymerase I Transcription Initiation;Gap-filling DNA repair synthesis and ligation in TC-NER;Formation of Incision Complex in GG-NER;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;RNA polymerase II transcribes snRNA genes;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-167160;R-HSA-77075;R-HSA-72086;R-HSA-113418;R-HSA-167158;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-212436;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-73863;R-HSA-69273;R-HSA-6781823;R-HSA-74160;R-HSA-73772;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-73762;R-HSA-6782210;R-HSA-5696395;R-HSA-73864;R-HSA-73854;R-HSA-6807505;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-6781827
ENSG00000134247,2,1,1,0,1,0,195005.6685718255,1424218.0900670097,2018-10-08,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,PTGFRN,0.44700003,1.4936,-0.45512,0,-1.0,0.0,,
ENSG00000134265,1,1,0,0,0,1,155552.2805078301,155552.2805078301,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NAPG,0.15600002,0.039868,-0.80012,5,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Post-translational protein modification,R-HSA-8856688;R-HSA-6811434;R-HSA-597592
ENSG00000134283,1,1,1,0,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,PPHLN1,0.20200002,0.18444,0.047968,1,-1.0,-1.0,Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex;Gene expression (Transcription),R-HSA-9843970;R-HSA-74160
ENSG00000134452,1,1,1,0,0,0,322220.1169395476,322220.1169395476,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,FBH1,0.551,3.789,0.095445,0,-1.0,-1.0,,
ENSG00000134470,1,1,0,0,0,1,69922.35818009122,69922.35818009122,2015-10-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IL15RA,-0.46000004,-0.12447,-0.95736,1,-1.0,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000134490,1,1,1,0,0,0,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM241,-0.17299998,0.45767,0.85508,0,-1.0,0.0,,
ENSG00000134504,4,1,1,0,0,1,54580.46858134564,141076.9910731678,2020-05-18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,KCTD1,0.394,1.8148,-1.0445,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8864260
ENSG00000134594,2,1,0,0,0,1,106674.19403831073,106674.19403831073,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RAB33A,,,,2,0.5,0.0,TBC/RABGAPs;Rab regulation of trafficking;Post-translational protein modification,R-HSA-8854214;R-HSA-9007101;R-HSA-597592
ENSG00000134597,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RBMX2,,,,1,-1.0,-1.0,,
ENSG00000134758,1,1,1,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RNF138,0.09899998,0.94609,-1.5669,1,0.5,-1.0,Immune System,R-HSA-168256
ENSG00000134769,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DTNA,0.477,2.2978,0.48659,1,0.75,0.0,,
ENSG00000134775,2,1,1,0,1,0,5495.191484272216,21781.337520231158,2021-01-25,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,FHOD3,0.40499997,0.99942,-0.059675,0,0.5,0.0,,
ENSG00000134779,3,1,1,0,0,1,5495.191484272216,203090.6413944402,2021-01-25,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,TPGS2,-0.08800006,0.62123,0.63286,1,0.5,-1.0,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000134899,1,1,1,0,0,1,134159.95265752633,178948.78717378277,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,ERCC5,0.23400003,1.1266,0.22724,3,-1.0,-1.0,Formation of Incision Complex in GG-NER;Dual incision in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-5696395;R-HSA-6782135;R-HSA-6781827
ENSG00000134900,1,1,0,0,0,1,303059.79257468163,645988.1975077938,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TPP2,0.71000004,4.5833,0.6433,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000135045,2,1,1,0,0,1,37912.391866997306,130441.30248818289,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,4,C9orf40,-0.41799998,-1.3288,-1.4962,0,-1.0,0.0,,
ENSG00000135046,1,1,0,0,0,1,35311.70306864786,35311.70306864786,2023-09-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ANXA1,-0.18200004,-0.17361,0.36932,6,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000135063,1,1,0,0,0,1,4917.108320036471,4917.108320036471,2018-03-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ENTREP1,0.052999973,1.0055,0.7264,0,0.5,0.0,,
ENSG00000135093,1,1,0,0,0,1,41139.695927855006,41139.695927855006,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,USP30,0.24299997,1.8904,0.94287,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000135374,1,1,1,0,0,1,17601.10520641419,165324.69367515197,2022-03-07,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,ELF5,-0.06400001,0.48334,-0.12721,0,0.75,0.0,,
ENSG00000135406,2,1,1,0,0,1,27990.711152144155,29677.839493664225,2021-07-21,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PRPH,-0.16100001,0.80514,0.45523,0,0.5,0.0,,
ENSG00000135519,1,1,0,0,1,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KCNH3,0.481,4.1042,0.46593,1,0.75,0.0,,
ENSG00000135605,1,1,0,0,0,1,68837.80679818468,124837.11004999638,2022-11-04,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,TEC,0.110000014,2.0469,0.46873,3,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-9006934
ENSG00000135622,1,1,0,0,0,1,23238.11336553945,23238.11336553945,2020-01-31,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SEMA4F,0.17500001,1.1996,-0.045963,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000135638,1,1,1,0,0,1,103877.27822338727,323648.5577791949,2017-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,5,EMX1,-0.324,-2.0683,-4.2275,0,0.75,0.5,,
ENSG00000135679,1,1,0,0,0,1,20810.981317003367,20810.981317003367,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MDM2,0.675,2.585,0.57931,15,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);SUMOylation of ubiquitinylation proteins;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-3232142;R-HSA-1643685;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000135773,1,1,0,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CAPN9,-0.036000013,0.64619,1.1801,1,0.5,0.5,,
ENSG00000135828,1,1,1,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RNASEL,0.17000002,1.122,0.69045,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000135845,1,1,0,0,0,1,99788.44320353035,99788.44320353035,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PIGC,0.004000008,1.1713,0.77236,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000135940,1,1,0,0,0,1,258213.8601133611,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,COX5B,0.23400003,0.018853,-0.060372,5,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Complex IV assembly,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9864848
ENSG00000135966,1,1,1,0,0,1,151416.12986435954,151416.12986435954,2023-10-16,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TGFBRAP1,0.65400004,1.9843,1.4073,0,-1.0,-1.0,,
ENSG00000135968,1,1,1,0,0,0,10261.413828663603,10261.413828663603,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,GCC2,0.374,-0.098401,-0.24103,2,-1.0,-1.0,Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-1643685;R-HSA-5663202
ENSG00000136026,1,1,0,0,0,1,160062.83409140486,160062.83409140486,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,CKAP4,-0.37699997,-0.093835,-1.1347,6,-1.0,-1.0,Signal Transduction;Immune System;Surfactant metabolism;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-5683826;R-HSA-597592
ENSG00000136048,1,1,0,0,0,1,4451.852673267326,50072.877304794354,2012-12-27,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,DRAM1,-0.13399994,0.23624,-0.58374,0,0.5,-1.0,,
ENSG00000136147,1,1,1,0,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PHF11,-0.931,-0.82487,-1.5033,0,-1.0,-1.0,,
ENSG00000136159,2,1,0,0,1,1,658.0459016393443,658.0459016393443,2018-06-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NUDT15,-0.36399996,-0.5866,-0.97541,2,-1.0,-1.0,Azathioprine ADME;Purine catabolism;Metabolism of nucleotides,R-HSA-9748787;R-HSA-74259;R-HSA-15869
ENSG00000136160,1,1,0,0,0,1,82912.80518893801,82912.80518893801,2019-05-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EDNRB,0.41500002,1.8888,-0.093661,3,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000136238,1,1,1,0,0,1,70321.24039683424,70321.24039683424,2019-06-07,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RAC1,0.75,3.941,0.24835,45,-1.0,-1.0,Signal Transduction;Ephrin signaling;Immune System;Killing mechanisms;WNT5:FZD7-mediated leishmania damping;Developmental Biology;Azathioprine ADME;Activation of RAC1;Activated NTRK2 signals through FYN;Disease;RHO GTPases activate KTN1;Sema4D mediated inhibition of cell attachment and migration;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-3928664;R-HSA-168256;R-HSA-9664420;R-HSA-9673324;R-HSA-1266738;R-HSA-9748787;R-HSA-428540;R-HSA-9032500;R-HSA-1643685;R-HSA-5625970;R-HSA-416550;R-HSA-3928665;R-HSA-9006934;R-HSA-5663202
ENSG00000136243,1,1,1,0,0,1,159189.58506586426,159189.58506586426,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,NUP42,-0.526,-0.37732,-0.13534,28,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000136295,1,1,0,0,0,0,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TTYH3,0.31599998,-2.2583,-2.7625,1,0.5,-1.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000136297,1,1,0,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MMD2,-0.352,-1.2961,-0.65419,0,0.5,0.5,,
ENSG00000136371,1,1,1,0,0,1,58331.23271678036,58331.23271678036,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,MTHFS,0.008000016,-0.015753,-0.55237,1,1.0,-1.0,Metabolism of folate and pterines,R-HSA-196757
ENSG00000136527,1,1,0,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TRA2B,0.472,4.2143,0.41653,4,-1.0,-1.0,Signal Transduction;RHOBTB1 GTPase cycle;RHOBTB GTPase Cycle,R-HSA-162582;R-HSA-9013422;R-HSA-9706574
ENSG00000136536,1,1,0,0,0,1,83653.82242730272,116089.30071075787,2020-06-24,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MARCHF7,0.612,0.59459,0.014616,0,-1.0,-1.0,,
ENSG00000136546,1,1,0,0,0,1,1492.3520749665329,1492.3520749665329,2022-04-02,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SCN7A,-0.12399995,-0.46348,-1.0313,2,0.5,0.0,Developmental Biology;Interaction between L1 and Ankyrins,R-HSA-1266738;R-HSA-445095
ENSG00000136827,1,1,1,0,0,1,220837.49604317299,406587.2658730814,2021-01-04,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TOR1A,0.16000003,0.96185,-0.034383,1,-1.0,-1.0,,
ENSG00000136935,1,1,0,0,0,1,155552.2805078301,155552.2805078301,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GOLGA1,0.31300002,0.80662,0.72692,1,-1.0,-1.0,,
ENSG00000137168,1,1,0,0,0,1,298779.4231289572,298779.4231289572,2020-03-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PPIL1,-0.072999954,0.88875,0.3446,1,-1.0,-1.0,,
ENSG00000137193,1,1,1,0,0,1,220837.49604317299,521818.7070055739,2023-11-09,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PIM1,0.561,2.8522,-0.40928,3,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-6785807
ENSG00000137204,1,1,1,0,0,1,337860.4854363166,337860.4854363166,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC22A7,0.010999978,1.7811,1.2587,2,1.0,0.5,Aspirin ADME,R-HSA-9749641
ENSG00000137261,1,1,0,0,1,0,24267.559108327496,24267.559108327496,2011-11-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KIAA0319,0.11400002,1.6877,1.1225,2,0.5,0.5,,
ENSG00000137269,1,1,0,0,1,1,765591.3646788632,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,LRRC1,0.357,1.0586,0.52743,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000137392,1,1,0,0,0,1,20302.198506576402,20302.198506576402,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CLPS,-0.42299998,0.14973,-0.324,2,1.0,0.0,Digestion and absorption;Digestion,R-HSA-8963743;R-HSA-8935690
ENSG00000137409,1,1,0,0,0,0,197485.87952538437,197485.87952538437,2023-06-05,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MTCH1,0.274,1.1658,-1.5797,0,-1.0,-1.0,,
ENSG00000137513,1,1,1,0,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NARS2,-0.25300002,0.13303,0.2588,1,-1.0,-1.0,tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-379726;R-HSA-72766
ENSG00000137648,1,1,0,0,1,0,28839.897986861684,28839.897986861684,2023-02-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMPRSS4,0.060000002,0.56131,0.53818,0,0.5,0.0,,
ENSG00000137699,1,1,0,0,0,1,2314.313784461153,2314.313784461153,2022-11-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,TRIM29,-0.15400004,0.4741,0.066058,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000137731,1,1,1,0,0,1,765591.3646788632,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FXYD2,-0.23899996,-0.31803,-1.4293,3,1.0,0.0,Disease,R-HSA-1643685
ENSG00000137776,1,1,0,0,0,1,73527.97151319332,73527.97151319332,2021-03-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLTM,0.55700004,2.848,0.88416,0,-1.0,-1.0,,
ENSG00000137807,1,1,0,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,KIF23,0.72099996,3.2844,1.2425,4,0.5,0.0,Immune System;Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-168256;R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000137815,1,1,1,0,0,0,295550.4496098593,295550.4496098593,2020-04-15,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,RTF1,0.777,4.6583,-0.10094,4,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-73857;R-HSA-74160;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000137936,1,1,1,0,0,1,107949.90929360976,143413.24457139417,2023-06-29,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,BCAR3,0.416,1.3766,1.2116,0,-1.0,-1.0,,
ENSG00000137948,1,1,0,0,0,1,314481.0395324854,314481.0395324854,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BRDT,0.199,1.2182,0.88983,0,1.0,0.5,,
ENSG00000137965,1,1,0,0,0,1,14577.354388342934,14577.354388342934,2011-12-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,IFI44,-0.19000006,-1.1664,-0.5616,1,0.5,-1.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000137968,1,1,0,0,0,0,296732.5758623771,296732.5758623771,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,SLC44A5,0.13499999,1.1758,1.2093,2,0.5,0.0,,
ENSG00000138030,1,1,1,1,1,0,338763.57771536184,415452.66715166246,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,KHK,-0.362,0.12947,0.27901,2,0.75,0.0,Disease,R-HSA-1643685
ENSG00000138050,1,1,0,0,0,1,13219.952617929488,13219.952617929488,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,THUMPD2,-0.39600003,-1.8286,-1.3545,0,-1.0,0.0,,
ENSG00000138079,1,1,0,0,0,1,134159.95265752633,134159.95265752633,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SLC3A1,-0.531,-3.2401,-2.0652,3,0.5,0.5,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000138315,1,1,1,0,0,1,394357.452283155,394357.452283155,2020-10-05,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OIT3,0.069000006,1.4033,1.4826,0,1.0,0.5,,
ENSG00000138316,1,1,1,0,0,1,73985.70318108075,187674.40497870417,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,ADAMTS14,0.03399998,0.80769,-0.21842,3,0.5,0.5,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000138326,1,1,1,0,0,1,13785.673050095118,521818.7070055739,2019-09-27,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,RPS24,0.818,1.6762,-1.1998,18,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000138430,1,1,1,0,0,0,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,OLA1,0.50600004,1.7533,0.3842,1,-1.0,-1.0,,
ENSG00000138448,1,1,1,1,0,0,160010.51072069994,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ITGAV,0.19300002,1.3825,-0.090957,14,-1.0,-1.0,Signal Transduction;Immune System;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-9006934
ENSG00000138449,1,1,1,0,0,1,286746.1002745869,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,SLC40A1,0.555,2.5155,0.71154,5,-1.0,-1.0,Disease;Iron uptake and transport,R-HSA-1643685;R-HSA-917937
ENSG00000138614,1,1,0,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,INTS14,0.38,2.0082,1.5288,1,-1.0,-1.0,,
ENSG00000138629,2,1,0,0,0,1,5414.650230111769,5414.650230111769,2017-02-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,UBL7,0.24900001,1.3746,1.3202,0,-1.0,-1.0,,
ENSG00000138685,1,1,0,0,0,1,116566.20935579021,205433.03502595585,2023-01-18,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FGF2,-0.16400003,1.0959,-0.53836,48,-1.0,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202;R-HSA-6785807
ENSG00000138709,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LARP1B,0.065,0.97685,0.65048,0,-1.0,-1.0,,
ENSG00000138760,1,1,0,0,0,1,8034.4390243902435,8034.4390243902435,2021-03-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SCARB2,0.31699997,1.6403,0.84096,2,-1.0,-1.0,,
ENSG00000138780,2,1,0,0,1,1,298504.9722193353,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,3,GSTCD,0.17000002,0.52881,-0.054821,0,-1.0,-1.0,,
ENSG00000138792,3,1,1,1,1,1,45372.42965956089,427337.4491868293,2018-08-13,0,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,ENPEP,-0.026000023,0.09047,0.42069,1,0.5,0.0,Metabolism of Angiotensinogen to Angiotensins,R-HSA-2022377
ENSG00000139146,1,1,0,0,0,1,38886.589732507324,765591.3646788632,2016-01-28,0,0,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,SINHCAF,0.58599997,2.7068,0.7411,0,-1.0,-1.0,,
ENSG00000139154,3,1,0,0,0,1,62762.391330626975,151416.12986435954,2017-12-06,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,AEBP2,0.53900003,-0.66969,-3.1671,2,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000139163,2,1,0,0,0,1,1122672.658801146,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ETNK1,0.63100004,1.6046,0.20677,1,-1.0,-1.0,,
ENSG00000139187,1,1,1,0,0,1,56716.257154516876,56716.257154516876,2025-01-01,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KLRG1,-0.25300002,1.2206,0.68397,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000139218,1,1,1,0,1,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SCAF11,0.588,1.3557,1.1624,0,-1.0,-1.0,,
ENSG00000139220,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PPFIA2,0.638,3.1945,-1.2939,6,0.75,0.0,Acetylcholine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Receptor-type tyrosine-protein phosphatases;Neurotransmitter release cycle,R-HSA-264642;R-HSA-210500;R-HSA-212676;R-HSA-181429;R-HSA-388844;R-HSA-112310
ENSG00000139372,2,1,0,0,0,1,49742.651617673284,109001.36551434857,2022-10-12,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TDG,0.18900001,2.4962,1.3202,5,-1.0,-1.0,"Depyrimidination;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Post-translational protein modification",R-HSA-73928;R-HSA-110328;R-HSA-110329;R-HSA-73929;R-HSA-74160;R-HSA-597592
ENSG00000139514,1,1,0,0,0,1,252346.18526092035,427337.4491868293,2018-08-13,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SLC7A1,0.647,3.9694,0.19422,1,0.5,-1.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000139547,1,1,0,0,0,1,97623.65810915266,129885.88722731256,2024-07-19,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,RDH16,-0.46599996,0.06207,0.81982,2,1.0,0.5,Signal Transduction;The canonical retinoid cycle in rods (twilight vision),R-HSA-162582;R-HSA-2453902
ENSG00000139631,1,1,1,0,0,0,34187.366287406,34187.366287406,2023-05-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CSAD,0.027999997,0.78081,0.58992,1,-1.0,-1.0,,
ENSG00000139767,1,1,0,0,0,1,87545.45580019058,87545.45580019058,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SRRM4,0.34600002,0.049601,-0.16458,0,0.75,0.5,,
ENSG00000139835,1,1,0,0,0,1,6375.838537521578,6375.838537521578,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,GRTP1,-0.661,-0.69559,-0.9846,0,0.5,-1.0,,
ENSG00000139921,2,1,0,0,0,1,1225.1182294700059,1225.1182294700059,2017-01-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TMX1,-0.00999999,0.1202,-0.48165,0,-1.0,-1.0,,
ENSG00000139970,1,1,1,0,0,0,131525.74533408263,131525.74533408263,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,RTN1,0.379,-0.28263,-1.6205,0,1.0,0.0,,
ENSG00000140025,2,1,0,0,0,1,1080.7549234135668,1544.1474358974358,2019-10-11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,EFCAB11,-0.059999943,0.25871,0.29529,0,0.5,-1.0,,
ENSG00000140044,2,1,1,0,0,1,66575.78981395929,189557.6027707886,2019-06-07,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,JDP2,0.07499999,1.0203,-0.55126,0,-1.0,-1.0,,
ENSG00000140093,1,1,0,0,1,1,99788.44320353035,99788.44320353035,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SERPINA10,-0.13100004,0.71741,0.33722,2,1.0,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000140153,1,1,0,0,0,1,94870.11495236546,384314.83364002535,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,WDR20,0.802,2.7784,0.12284,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000140279,1,1,1,0,1,1,15266.472690749142,198317.64799485338,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,6,DUOX2,-0.16499996,0.033927,0.40724,1,0.5,0.0,Metabolism of amine-derived hormones,R-HSA-209776
ENSG00000140481,1,1,0,0,0,0,65182.54129071259,65182.54129071259,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CCDC33,-0.16999996,0.24435,-0.35007,0,0.75,0.5,,
ENSG00000140525,1,1,1,0,1,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,FANCI,0.04100001,-0.69162,-0.80126,2,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000140553,1,1,1,0,0,0,254373.32653042395,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UNC45A,0.11500001,0.75097,0.7617,0,-1.0,-1.0,,
ENSG00000140830,1,1,1,0,0,1,221681.9613153083,221681.9613153083,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TXNL4B,-0.53499997,-0.89193,0.10563,0,-1.0,-1.0,,
ENSG00000140988,1,1,1,0,0,1,232656.1405260205,303059.79257468163,2018-06-11,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RPS2,0.50699997,2.7522,-1.6814,22,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Post-translational protein modification,R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956;R-HSA-597592
ENSG00000141013,3,1,1,0,0,1,28863.30790298137,224333.96758339784,2020-09-04,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DRC4,-0.41199994,-0.81574,-0.39061,1,-1.0,-1.0,,
ENSG00000141027,1,1,1,0,0,1,444537.33605315426,444537.33605315426,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,NCOR1,0.708,4.4457,1.5691,23,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-9006934;R-HSA-5663202;R-HSA-2173793
ENSG00000141068,1,1,1,0,0,1,32254.717802479194,78751.06843456876,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,KSR1,0.519,2.0031,-0.31637,9,0.5,-1.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000141098,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,GFOD2,0.38700002,1.1221,0.76618,0,0.5,-1.0,,
ENSG00000141258,1,1,0,0,0,1,23616.32506644606,23616.32506644606,2023-01-18,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SGSM2,0.14899999,0.16493,-0.76441,0,-1.0,-1.0,,
ENSG00000141380,1,1,1,0,0,1,116089.30071075787,116089.30071075787,2020-06-24,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SS18,0.526,0.12413,-0.269,6,-1.0,-1.0,Developmental Biology;Gene expression (Transcription);Formation of the non-canonical BAF (ncBAF) complex,R-HSA-1266738;R-HSA-74160;R-HSA-9933947
ENSG00000141433,1,1,1,0,0,1,286746.1002745869,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ADCYAP1,0.13599998,-1.5094,-1.3513,3,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000141504,1,1,1,0,0,1,116037.50172934511,116037.50172934511,2024-07-19,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SAT2,-0.072999954,0.75478,0.34642,0,-1.0,-1.0,,
ENSG00000141562,1,1,0,0,0,1,12410.70681955995,39350.931204693305,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,NARF,-0.08099997,-0.025638,0.74104,0,-1.0,-1.0,,
ENSG00000141639,1,1,0,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MAPK4,0.24800003,0.68105,-1.2258,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000141699,1,1,0,0,0,0,15223.454539395489,15223.454539395489,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RETREG3,0.329,0.98246,-0.012598,0,-1.0,-1.0,,
ENSG00000141905,1,1,1,0,0,1,42362.45324254164,42362.45324254164,2024-08-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NFIC,0.601,1.806,-0.26863,2,1.0,-1.0,Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000142046,2,1,1,0,0,1,135357.37232135262,280228.4034560385,2020-05-29,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TMEM91,0.144,1.0685,0.99213,0,0.5,-1.0,,
ENSG00000142166,1,1,1,0,0,1,22669.576834673207,22669.576834673207,2023-05-15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,IFNAR1,-0.73,0.36819,-0.1494,5,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Disease,R-HSA-1280215;R-HSA-168256;R-HSA-1643685
ENSG00000142186,1,1,1,0,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SCYL1,-0.15799999,1.0959,-0.84595,0,-1.0,-1.0,,
ENSG00000142208,1,1,1,0,0,1,100075.58738100652,112184.2204720767,2024-04-26,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,AKT1,0.526,4.2239,0.10641,42,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9006934;R-HSA-5663202
ENSG00000142484,1,1,0,0,0,1,269602.2657190595,269602.2657190595,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,TM4SF5,-0.12399995,0.70457,0.20966,0,0.75,0.5,,
ENSG00000142541,1,1,0,0,0,1,71913.46219676935,144712.0807038357,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,RPL13A,0.697,1.5593,-0.5872,13,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000142552,1,1,0,0,0,1,183579.49764748462,183579.49764748462,2022-08-20,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RCN3,-0.748,-0.68795,-0.67495,0,-1.0,-1.0,,
ENSG00000142583,1,1,1,0,0,1,95491.56815792594,95491.56815792594,2023-05-17,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC2A5,-0.45099998,1.2642,0.31912,2,0.5,0.0,Immune System;Digestion and absorption,R-HSA-168256;R-HSA-8963743
ENSG00000142615,1,1,0,0,1,1,19069.86518571448,19069.86518571448,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CELA2A,-0.16100001,0.6172,0.19245,2,1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000142623,1,1,1,0,0,0,112345.61202884468,112345.61202884468,2021-01-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PADI1,-0.08700001,-0.70657,-0.90572,1,1.0,0.5,,
ENSG00000142698,1,1,0,0,0,1,5685.699118970653,5685.699118970653,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,C1orf94,-0.021999955,0.19196,0.15327,0,1.0,1.0,,
ENSG00000142765,1,1,1,0,0,1,173193.7688415446,173193.7688415446,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SYTL1,-0.04700005,-0.52271,-1.3462,1,0.5,0.0,TBC/RABGAPs;Rab regulation of trafficking,R-HSA-8854214;R-HSA-9007101
ENSG00000142920,1,1,0,0,0,1,135108.48254553688,135108.48254553688,2025-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,AZIN2,0.20300001,1.0415,0.98863,1,0.75,0.0,Metabolism of polyamines,R-HSA-351202
ENSG00000143190,1,1,0,0,0,1,278190.43024910334,521818.7070055739,2023-08-23,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,POU2F1,0.74399996,2.7297,0.364,5,-1.0,-1.0,Signal Transduction;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter;Cytokine Signaling in Immune system;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription;RNA polymerase II transcribes snRNA genes;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-76046;R-HSA-76071;R-HSA-1280215;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147;R-HSA-749476;R-HSA-74158;R-HSA-6807505;R-HSA-6785807
ENSG00000143199,1,1,0,0,0,1,97822.37358221927,109001.36551434857,2022-10-12,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ADCY10,0.07800001,2.3147,1.3027,1,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000143363,1,1,0,0,0,1,46601.3671671619,46601.3671671619,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PRUNE1,0.09799999,1.7048,0.69498,0,-1.0,-1.0,,
ENSG00000143367,1,1,1,0,0,1,322107.4898639223,322107.4898639223,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TUFT1,0.009000003,0.38719,0.28327,0,0.5,-1.0,,
ENSG00000143368,1,1,0,1,0,0,515513.2178404211,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SF3B4,0.741,4.1898,-0.38135,2,-1.0,-1.0,mRNA Splicing - Minor Pathway,R-HSA-72165
ENSG00000143369,1,1,0,0,0,1,103877.27822338727,103877.27822338727,2017-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ECM1,-0.051,1.0007,1.1884,1,0.5,0.0,,
ENSG00000143409,2,1,0,1,1,0,260210.21963428933,1424218.0900670097,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,MINDY1,-0.123000026,1.6725,0.40904,0,-1.0,-1.0,,
ENSG00000143412,1,1,0,0,0,1,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ANXA9,-0.09099996,1.458,0.99487,0,-1.0,0.0,,
ENSG00000143416,1,1,1,0,0,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SELENBP1,-0.39900005,0.94559,-0.78759,0,0.5,-1.0,,
ENSG00000143434,1,1,0,0,0,1,155496.87140784386,205433.03502595585,2025-04-01,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SEMA6C,0.34399998,-0.36656,-1.9164,0,0.5,-1.0,,
ENSG00000143476,1,1,0,0,0,1,196178.71491042234,196178.71491042234,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DTL,0.365,2.0335,0.66447,2,0.75,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000143512,2,1,1,0,1,1,89519.16315227402,180344.38517486732,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,HHIPL2,-0.16299999,0.87043,0.96158,0,0.5,0.5,,
ENSG00000143554,2,1,0,0,1,1,51249.742722210474,192594.63282947522,2023-01-18,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,3,SLC27A3,-0.365,-2.6892,-2.1883,1,-1.0,0.0,Synthesis of very long-chain fatty acyl-CoAs;Fatty acyl-CoA biosynthesis,R-HSA-75876;R-HSA-75105
ENSG00000143569,2,1,0,0,0,1,207220.14223281175,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,UBAP2L,0.841,4.1467,1.3375,0,-1.0,-1.0,,
ENSG00000143575,1,1,0,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HAX1,-0.13199997,0.35869,0.58872,0,-1.0,-1.0,,
ENSG00000143742,1,1,1,0,0,1,1470466.6505612188,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SRP9,0.376,1.5834,0.87542,1,-1.0,-1.0,Translation;SRP-dependent cotranslational protein targeting to membrane,R-HSA-72766;R-HSA-1799339
ENSG00000143819,1,1,1,0,0,1,598869.4096893278,598869.4096893278,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,EPHX1,-0.100000024,0.73864,0.62354,1,0.5,-1.0,,
ENSG00000144036,1,1,0,0,0,1,8483.157855275489,8483.157855275489,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,EXOC6B,0.31199998,2.1536,0.030279,0,0.5,-1.0,,
ENSG00000144057,1,1,0,0,0,1,1470466.6505612188,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ST6GAL2,0.022000015,-0.37688,-0.47591,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000144130,1,1,0,0,0,1,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NT5DC4,-0.809,-0.1078,0.092634,0,0.5,0.5,,
ENSG00000144136,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC20A1,0.366,2.5891,0.45719,1,-1.0,-1.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000144290,1,1,0,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SLC4A10,0.597,4.0273,-0.27025,1,0.75,0.5,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000144381,1,1,0,0,0,0,114817.16866287061,131525.74533408263,2019-07-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,HSPD1,0.815,2.9068,0.4087,4,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8864260
ENSG00000144455,1,1,0,0,0,1,298504.9722193353,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,SUMF1,-0.25399995,-1.3757,-1.7124,2,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000144597,1,1,0,0,0,0,197485.87952538437,197485.87952538437,2023-06-05,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EAF1,-0.011999965,1.6177,0.98495,3,0.5,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation,R-HSA-73857;R-HSA-74160;R-HSA-674695;R-HSA-112382;R-HSA-75955
ENSG00000144645,1,1,1,0,0,0,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,OSBPL10,0.245,0.7253,-1.2393,1,-1.0,-1.0,Acyl chain remodelling of PS,R-HSA-1482801
ENSG00000144741,1,1,1,0,0,0,232656.1405260205,303059.79257468163,2018-06-11,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC25A26,-0.10899997,-1.2033,-0.2792,1,-1.0,-1.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000144821,2,1,0,0,0,1,521433.73994041845,1122672.658801146,2019-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,MYH15,-0.01999998,0.83847,0.85227,0,0.5,0.5,,
ENSG00000144824,2,1,1,0,0,1,57060.02774555957,645988.1975077938,2018-06-11,0,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,PHLDB2,0.283,1.1438,0.4092,0,-1.0,0.0,,
ENSG00000144843,1,1,0,0,0,1,1455.4894671623297,1455.4894671623297,2012-05-06,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ADPRH,-0.16499996,0.8275,0.58153,0,-1.0,-1.0,,
ENSG00000144847,2,1,0,0,0,1,225895.43837715342,225895.43837715342,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,IGSF11,0.18599999,1.4231,-0.31528,0,0.5,0.0,,
ENSG00000144891,1,1,0,0,0,0,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,AGTR1,-0.113000035,1.3757,0.47344,4,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000144959,1,1,0,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NCEH1,0.47100002,1.9608,0.39572,1,-1.0,-1.0,,
ENSG00000145020,1,1,0,0,0,0,539013.8231881644,539013.8231881644,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,AMT,0.195,1.0014,0.52741,1,0.5,-1.0,,
ENSG00000145050,2,1,0,0,0,1,225895.43837715342,225895.43837715342,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MANF,0.051,-0.25626,-0.42081,1,-1.0,-1.0,,
ENSG00000145284,1,1,1,0,0,0,227570.98695011192,1424218.0900670097,2018-07-27,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,SCD5,0.092999995,1.4285,0.47225,3,0.5,-1.0,Developmental Biology;Gene expression (Transcription);Fatty acyl-CoA biosynthesis,R-HSA-1266738;R-HSA-74160;R-HSA-75105
ENSG00000145331,1,1,0,0,0,1,109409.27518493953,172076.47010352428,2024-07-19,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TRMT10A,-0.181,0.59725,1.6943,1,-1.0,0.0,,
ENSG00000145362,1,1,0,0,0,1,5665.868171146231,5665.868171146231,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ANK2,0.729,4.2752,1.3951,2,0.5,0.0,Developmental Biology;Interaction between L1 and Ankyrins;Post-translational protein modification,R-HSA-1266738;R-HSA-445095;R-HSA-597592
ENSG00000145375,1,1,0,0,0,1,16032.459098045585,16032.459098045585,2020-10-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,AFG2A,0.123000026,1.2154,0.8442,0,-1.0,0.0,,
ENSG00000145384,3,1,0,0,1,1,2324.6716622691292,279825.00883385167,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,FABP2,-0.34099996,-0.069702,0.30276,1,1.0,0.5,,
ENSG00000145416,1,1,0,0,0,0,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,MARCHF1,0.13300002,1.3993,0.37784,0,0.5,0.0,,
ENSG00000145423,1,1,0,0,0,1,14790.180826912794,14790.180826912794,2021-11-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SFRP2,0.116,1.2435,-0.010762,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000145451,1,1,0,0,0,1,38819.168478218926,38819.168478218926,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GLRA3,-0.24300003,0.85695,-1.0573,1,0.75,0.5,,
ENSG00000145476,4,1,1,0,0,1,60085.7648087202,502231.5406594711,2022-10-12,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,CYP4V2,-0.12600005,-0.13305,-0.27138,2,0.5,-1.0,The canonical retinoid cycle in rods (twilight vision),R-HSA-2453902
ENSG00000145526,1,1,0,0,0,1,5002.767245657568,5002.767245657568,2015-02-02,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CDH18,0.263,1.4106,0.099417,1,0.5,0.5,,
ENSG00000145626,2,1,0,0,1,1,13658.782960109247,13756.062794259458,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,UGT3A1,-0.25199997,0.31168,-0.42085,2,0.75,0.5,Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000145642,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SHISAL2B,-0.39600003,-0.21066,-0.018499,0,0.75,0.5,,
ENSG00000145681,1,1,0,0,0,1,5123.498352010547,5123.498352010547,2011-12-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,HAPLN1,0.36,0.74534,-0.93002,1,1.0,0.5,,
ENSG00000145808,1,1,0,0,0,1,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ADAMTS19,0.17000002,-0.38527,-2.1041,2,0.75,0.5,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000145817,2,1,0,0,0,1,112218.78632625614,756470.9740366563,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,YIPF5,0.536,0.72561,0.48574,0,-1.0,-1.0,,
ENSG00000145888,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GLRA1,0.024999976,2.4146,1.0141,1,1.0,1.0,,
ENSG00000145920,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CPLX2,0.31699997,1.0402,-0.84944,0,0.75,0.5,,
ENSG00000145979,1,1,1,0,0,1,72148.96319633072,72148.96319633072,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TBC1D7,-0.431,0.098045,0.062574,1,-1.0,-1.0,TBC/RABGAPs;Rab regulation of trafficking,R-HSA-8854214;R-HSA-9007101
ENSG00000146090,1,1,1,0,0,1,1321.7688442211056,340825.7076940272,2022-04-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,RASGEF1C,0.384,1.424,0.025483,0,1.0,0.5,,
ENSG00000146233,1,1,0,0,0,0,367949.31877243903,367949.31877243903,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CYP39A1,-0.09399998,0.48762,-0.67599,2,1.0,0.0,Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-193775;R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000146352,1,1,0,0,1,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CLVS2,0.032000005,2.2517,-0.088953,1,0.75,0.5,Lysosome Vesicle Biogenesis,R-HSA-432720
ENSG00000146410,2,1,0,0,0,1,41961.55659579268,143413.24457139417,2018-06-11,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,MTFR2,-0.454,0.41041,0.48342,0,0.5,0.5,,
ENSG00000146433,2,1,1,0,0,1,29803.01405728205,143413.24457139417,2018-06-11,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,TMEM181,0.34100002,0.037125,-0.47105,0,-1.0,-1.0,,
ENSG00000146469,1,1,0,0,0,1,158370.2523752734,158370.2523752734,2025-04-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VIP,-0.46800005,0.26004,-0.20379,2,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000146842,1,1,1,0,0,1,8069.303371808205,8069.303371808205,2022-07-14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM209,-0.12399995,1.1456,0.18334,0,-1.0,-1.0,,
ENSG00000146872,1,1,0,0,0,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TLK2,0.897,6.5465,1.4815,0,-1.0,-1.0,,
ENSG00000146904,2,1,1,1,0,1,1321.7688442211056,340825.7076940272,2013-10-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,8,EPHA1,0.010999978,1.2079,0.92924,4,0.75,0.0,Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-1266738;R-HSA-3928665
ENSG00000146909,1,1,0,0,0,1,254373.32653042395,275021.63051358337,2020-05-06,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NOM1,0.038999975,-1.1472,-1.0957,0,-1.0,-1.0,,
ENSG00000147059,1,1,0,0,0,1,118492.7744519305,294387.2978738704,2019-02-04,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SPIN2A,,,,0,-1.0,0.0,,
ENSG00000147117,1,1,0,0,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,ZNF157,,,,1,-1.0,0.5,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000147145,1,1,1,0,0,1,11056.124104522269,11056.124104522269,2021-09-30,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,LPAR4,,,,2,0.5,0.5,Signal Transduction;P2Y receptors;Nucleotide-like (purinergic) receptors,R-HSA-162582;R-HSA-417957;R-HSA-418038
ENSG00000147202,1,1,1,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DIAPH2,,,,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000147251,1,1,0,0,1,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DOCK11,,,,3,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000147256,1,1,0,0,0,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ARHGAP36,,,,0,0.75,0.5,,
ENSG00000147416,1,1,0,0,0,0,299999.7750406064,299999.7750406064,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ATP6V1B2,0.543,2.5286,-1.4319,6,-1.0,-1.0,Signal Transduction;Transferrin endocytosis and recycling;Immune System;Developmental Biology;Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy;Iron uptake and transport;Amino acids regulate mTORC1;Cellular response to starvation;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-917977;R-HSA-168256;R-HSA-1266738;R-HSA-9857377;R-HSA-917937;R-HSA-9639288;R-HSA-9711097;R-HSA-9006934
ENSG00000147437,1,1,0,0,1,1,69915.00897904889,69915.00897904889,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GNRH1,-0.22000003,-0.26033,0.48608,2,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000147439,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BIN3,-0.45000005,-0.68717,-0.9618,0,-1.0,-1.0,,
ENSG00000147526,1,1,1,0,0,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TACC1,0.24199998,0.75876,0.38281,0,-1.0,-1.0,,
ENSG00000147536,1,1,0,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GINS4,0.007000029,0.67205,0.62382,1,0.5,0.0,Unwinding of DNA,R-HSA-176974
ENSG00000147679,16,1,1,0,1,1,1848.986479177934,473900.221403792,2008-03-30,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,UTP23,0.116,0.35896,-0.23759,0,-1.0,-1.0,,
ENSG00000147689,1,1,1,0,1,0,23467.651805886748,23467.651805886748,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM83A,-0.25300002,-0.76558,-0.86234,1,0.75,0.5,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000147724,1,1,0,0,0,0,58995.33218928629,58995.33218928629,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM135B,0.556,1.6099,0.55559,0,0.75,0.5,,
ENSG00000147813,1,1,1,0,0,0,114817.16866287061,114817.16866287061,2019-07-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NAPRT,-0.48599994,-1.8516,-2.827,2,0.5,0.0,Immune System,R-HSA-168256
ENSG00000148019,1,1,0,0,0,1,12485.034492356272,12485.034492356272,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CEP78,-0.531,-1.0296,-0.17322,7,-1.0,-1.0,,
ENSG00000148384,3,1,1,0,0,1,64245.57828610605,249965.96240703977,2024-01-05,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,INPP5E,-0.17900002,-1.9305,-2.7371,2,-1.0,-1.0,Synthesis of PIPs at the Golgi membrane;Cargo trafficking to the periciliary membrane,R-HSA-1660514;R-HSA-5620920
ENSG00000148426,1,1,1,0,0,1,33623.31330993628,33623.31330993628,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,PROSER2,-0.81500006,-4.6514,-4.598,0,0.5,0.0,,
ENSG00000148482,1,1,0,0,0,1,28863.30790298137,28863.30790298137,2022-12-10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC39A12,-0.110000014,-0.52511,-1.1851,0,1.0,0.5,,
ENSG00000148735,1,1,1,0,0,1,124531.34246675359,124531.34246675359,2021-02-24,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PLEKHS1,-0.41999996,0.75363,0.051394,0,0.75,0.0,,
ENSG00000148834,1,1,1,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GSTO1,-0.694,0.7611,0.070979,4,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Glutathione conjugation;Signaling by Interleukins;Phase II - Conjugation of compounds,R-HSA-1280215;R-HSA-168256;R-HSA-156590;R-HSA-449147;R-HSA-156580
ENSG00000148843,1,1,1,0,1,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PDCD11,0.427,2.0955,0.88243,2,-1.0,-1.0,rRNA processing,R-HSA-72312
ENSG00000148848,1,1,0,0,0,1,4300.504144527099,4300.504144527099,2017-07-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ADAM12,0.18199998,1.7643,0.35412,2,1.0,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000148950,1,1,0,0,0,1,294763.3750742061,294763.3750742061,2021-02-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,IMMP1L,-0.781,-0.085562,0.42971,0,-1.0,-1.0,,
ENSG00000149090,1,1,0,0,0,1,135095.86576106868,135095.86576106868,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PAMR1,-0.27400005,0.43199,0.75017,0,-1.0,0.0,,
ENSG00000149201,1,1,0,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CCDC81,-0.125,0.44868,1.3268,0,0.5,0.5,,
ENSG00000149218,1,1,0,0,0,1,381165.6245253304,381165.6245253304,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ENDOD1,-0.84300005,-0.46117,-0.41788,1,-1.0,-1.0,,
ENSG00000149262,1,1,0,0,0,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,INTS4,0.269,2.4895,2.152,1,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000149292,3,1,1,0,0,1,208836.15741332836,399832.86333511875,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,TTC12,0.065999985,0.59965,0.73059,0,0.5,-1.0,,
ENSG00000149346,1,1,0,0,0,1,242123.900206037,242123.900206037,2024-11-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLX4IP,-0.12899995,0.95125,0.27236,0,-1.0,0.0,,
ENSG00000149403,1,1,0,0,0,0,13169.593884199616,13169.593884199616,2023-01-18,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GRIK4,0.413,1.9989,0.51244,1,0.5,0.5,Activation of Ca-permeable Kainate Receptor;Ionotropic activity of kainate receptors;Activation of kainate receptors upon glutamate binding,R-HSA-451308;R-HSA-451306;R-HSA-451326
ENSG00000149452,1,1,0,0,0,1,97257.17815683526,97257.17815683526,2024-03-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC22A8,-0.003000021,1.4998,0.90463,2,0.75,0.5,,
ENSG00000149506,1,1,0,0,0,1,21724.94108458234,21724.94108458234,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZP1,-0.026000023,0.96554,0.51549,1,,,Interaction With Cumulus Cells And The Zona Pellucida;Fertilization,R-HSA-2534343;R-HSA-1187000
ENSG00000149516,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MS4A3,-0.14999998,-0.3422,0.94835,1,1.0,0.5,Immune System,R-HSA-168256
ENSG00000149557,1,1,1,0,0,0,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FEZ1,0.342,1.2465,1.067,0,1.0,0.0,,
ENSG00000149573,2,1,1,0,0,0,37477.37186170532,136665.8227530756,2017-06-12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MPZL2,-0.70299995,-0.39418,0.8346,0,0.5,0.0,,
ENSG00000149591,1,1,1,0,0,1,183579.49764748462,215157.94798738702,2022-08-20,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TAGLN,-0.062000036,0.51516,0.071551,0,0.5,-1.0,,
ENSG00000150054,1,1,1,0,0,1,48183.776809827345,48183.776809827345,2021-02-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,MPP7,0.031000018,1.1689,0.0088181,6,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000150456,1,1,0,0,0,0,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EEF1AKMT1,-0.16900003,0.57948,-0.42324,1,-1.0,-1.0,,
ENSG00000150477,3,1,0,0,0,1,5495.191484272216,203090.6413944402,2021-01-25,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,KIAA1328,-0.08899999,0.25177,0.52035,0,-1.0,-1.0,,
ENSG00000150593,1,1,0,0,0,1,254373.32653042395,1424218.0900670097,2020-05-06,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PDCD4,-0.671,0.85002,0.035687,1,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000150625,1,1,1,0,0,1,55416.28042655659,323648.5577791949,2014-07-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,10,GPM6A,0.638,2.2032,0.052559,0,1.0,0.0,,
ENSG00000150760,1,1,0,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,DOCK1,0.36299998,3.3656,-0.27116,9,-1.0,0.0,Signal Transduction;Immune System;Developmental Biology;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-9006934
ENSG00000150764,1,1,0,0,0,0,338763.57771536184,338763.57771536184,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,DIXDC1,0.21700001,1.0106,1.1188,0,-1.0,0.0,,
ENSG00000151247,1,1,0,0,0,1,26857.199410645524,26857.199410645524,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,EIF4E,0.90999997,3.4842,1.0918,13,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;mTORC1-mediated signalling;Immune System;Deadenylation of mRNA;Developmental Biology;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Translation;MTOR signalling;Transport of Mature Transcript to Cytoplasm;ISG15 antiviral mechanism,R-HSA-162582;R-HSA-1280215;R-HSA-166208;R-HSA-168256;R-HSA-429947;R-HSA-1266738;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-72766;R-HSA-165159;R-HSA-72202;R-HSA-1169408
ENSG00000151292,1,1,0,0,0,1,242123.900206037,242123.900206037,2024-11-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CSNK1G3,0.385,2.16,0.28924,0,-1.0,-1.0,,
ENSG00000151360,1,1,0,0,0,0,13253.540201005026,13253.540201005026,2019-09-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,ALLC,-0.14400005,0.061653,0.13863,0,1.0,1.0,,
ENSG00000151364,1,1,0,0,0,1,256118.22261250683,256118.22261250683,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KCTD14,-0.93499994,-0.019323,-0.18394,0,-1.0,0.0,,
ENSG00000151461,1,1,0,0,0,1,135095.86576106868,135095.86576106868,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UPF2,0.841,3.7645,-0.58185,2,-1.0,-1.0,Developmental Biology;Regulation of expression of SLITs and ROBOs,R-HSA-1266738;R-HSA-9010553
ENSG00000151468,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CCDC3,-0.78999996,-1.8514,-1.6252,0,0.5,0.0,,
ENSG00000151640,1,1,1,0,0,1,346772.3766627423,351924.78376246523,2019-06-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,2,DPYSL4,0.11400002,1.2338,-0.4872,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000151693,1,1,1,0,0,1,60111.20110003438,123127.18790121445,2019-02-25,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,3,ASAP2,0.53499997,2.5779,-0.103,0,0.5,0.0,,
ENSG00000151715,3,1,0,0,0,1,22345.675520395987,88186.71873814042,2013-04-01,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,TMEM45B,-0.44700003,-0.037171,-0.32873,0,0.5,0.0,,
ENSG00000151779,2,1,1,0,0,1,100946.28889691093,433862.5685735124,2018-04-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,NBAS,0.23900002,0.22195,-0.76212,1,-1.0,-1.0,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic,R-HSA-8856688;R-HSA-6811434
ENSG00000151834,1,1,0,0,0,0,113567.57166187582,113567.57166187582,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,GABRA2,0.51,3.4103,0.24708,1,1.0,0.5,,
ENSG00000152078,2,1,0,0,0,1,49367.473680139236,323648.5577791949,2021-01-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,TLCD4,0.473,1.0257,0.16195,0,1.0,-1.0,,
ENSG00000152133,1,1,0,0,1,0,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,GPATCH11,-0.008000016,-0.080825,0.54458,0,-1.0,0.0,,
ENSG00000152193,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OBI1,-0.17200005,0.004153,0.16846,1,-1.0,-1.0,Cyclin A/B1/B2 associated events during G2/M transition,R-HSA-69273
ENSG00000152253,1,1,1,0,0,0,28744.184957426678,28744.184957426678,2021-01-26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,SPC25,-0.153,0.37221,-0.25962,6,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000152484,1,1,0,0,0,1,160010.51072069994,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,USP12,0.39999998,3.4935,0.021381,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000152580,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,IGSF10,-0.06799996,0.18836,0.4693,0,0.5,0.0,,
ENSG00000152818,1,1,0,0,0,1,70918.12845178662,323648.5577791949,2021-08-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,UTRN,0.33499998,1.619,0.67836,2,-1.0,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000152953,1,1,0,0,0,1,5344.438356164384,5344.438356164384,2016-10-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,STK32B,-0.05700004,-1.0672,-0.98538,0,0.5,0.0,,
ENSG00000153060,1,1,1,0,0,1,328052.24452619,328052.24452619,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TEKT5,-0.319,-2.2863,-1.1915,0,1.0,1.0,,
ENSG00000153066,1,1,1,0,1,1,68837.80679818468,124837.11004999638,2020-12-11,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,TXNDC11,-0.204,-1.8503,-2.1464,0,-1.0,-1.0,,
ENSG00000153157,1,1,0,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SYCP2L,0.060000002,1.3936,0.8797,0,1.0,0.5,,
ENSG00000153179,1,1,1,0,0,1,232586.34864014547,521818.7070055739,2021-01-04,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,RASSF3,-0.645,-0.38374,-0.43315,0,0.5,-1.0,,
ENSG00000153201,1,1,0,0,0,1,112068.90873552008,112068.90873552008,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RANBP2,0.769,3.8313,2.071,35,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-5663202;R-HSA-597592
ENSG00000153294,2,1,0,0,0,1,115338.82014347943,144127.33793912127,2024-07-19,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ADGRF4,-0.36,-0.56252,-0.12191,0,0.5,0.5,,
ENSG00000153303,1,1,1,0,0,1,39954.52446604414,39954.52446604414,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,FRMD1,-0.23699999,-0.15802,-1.2527,0,0.5,0.5,,
ENSG00000153495,1,1,1,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,TEX29,-0.804,0.63337,-0.14343,0,1.0,0.5,,
ENSG00000153558,1,1,1,0,0,1,226155.40757232966,226155.40757232966,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FBXL2,0.30699998,2.7965,0.74923,0,0.5,0.0,,
ENSG00000153563,1,1,1,0,0,1,3328.0781640536243,3328.0781640536243,2011-06-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CD8A,-0.49600005,-1.2645,-1.3864,1,1.0,0.0,Immune System,R-HSA-168256
ENSG00000153786,1,1,1,0,0,1,220837.49604317299,521818.7070055739,2023-11-09,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,ZDHHC7,0.472,0.66647,-0.90991,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000153827,1,1,1,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRIP12,0.855,6.366,0.061642,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000154016,1,1,1,0,0,0,131525.74533408263,131525.74533408263,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,GRAP,-0.35099995,0.88241,-0.63049,1,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000154040,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CABYR,-0.17499995,0.88931,1.0664,0,1.0,0.0,,
ENSG00000154114,1,1,0,0,0,0,67187.8770182068,551389.5206213495,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,TBCEL,0.487,3.2846,0.99003,0,-1.0,-1.0,,
ENSG00000154265,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ABCA5,0.029999971,0.33724,0.22679,1,-1.0,-1.0,,
ENSG00000154269,2,1,0,0,0,1,195005.6685718255,260210.21963428933,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ENPP3,-0.21099997,0.51033,-0.46983,1,0.5,0.0,Vitamin B5 (pantothenate) metabolism,R-HSA-199220
ENSG00000154274,1,1,0,0,0,1,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PGCKA1,-0.65999997,1.1893,1.4958,0,0.5,0.0,,
ENSG00000154309,1,1,0,0,0,1,54391.03477538057,54391.03477538057,2021-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DISP1,-0.027999997,3.0938,1.8912,0,-1.0,0.0,,
ENSG00000154310,1,1,0,0,0,0,3442.049438202247,3442.049438202247,2017-02-28,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TNIK,0.662,4.5944,0.18218,1,0.5,0.0,,
ENSG00000154328,2,1,1,0,0,1,2954.9908814589667,134159.95265752633,2015-08-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,6,NEIL2,-0.56500006,-2.7828,-2.3386,3,-1.0,-1.0,"Depyrimidination;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine;Base-Excision Repair, AP Site Formation",R-HSA-73928;R-HSA-110328;R-HSA-110329;R-HSA-73929
ENSG00000154359,1,1,1,0,0,1,44692.894702471654,1424218.0900670097,2020-06-15,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,LONRF1,0.34500003,-2.4724,-5.2277,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000154380,1,1,1,0,0,0,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ENAH,0.577,1.727,0.41234,2,-1.0,0.0,Immune System;Developmental Biology,R-HSA-168256;R-HSA-1266738
ENSG00000154415,1,1,0,0,0,1,5586.666666666667,5586.666666666667,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PPP1R3A,0.13999999,0.06153,-0.25761,0,0.75,0.5,,
ENSG00000154493,1,1,0,0,1,0,404399.6052088398,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,C10orf90,-0.031999946,0.10194,-0.11527,0,1.0,0.5,,
ENSG00000154511,1,1,0,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,DIPK1A,-0.24399996,1.3213,-0.23859,0,-1.0,-1.0,,
ENSG00000154553,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PDLIM3,-0.07099998,0.74665,0.54754,0,0.75,0.0,,
ENSG00000154654,1,1,0,0,0,1,171880.2916512608,323648.5577791949,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,NCAM2,0.587,2.1207,0.078847,0,0.5,0.0,,
ENSG00000154655,1,1,0,0,0,1,4447.295196209435,4447.295196209435,2024-07-19,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,L3MBTL4,0.20700002,0.83712,-0.11238,0,-1.0,0.0,,
ENSG00000154997,1,1,0,0,0,1,765591.3646788632,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SEPTIN14,-0.804,-0.26967,0.60244,0,1.0,0.0,,
ENSG00000155858,2,1,0,0,0,1,225895.43837715342,225895.43837715342,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LSM11,0.06999999,-1.5192,-1.806,3,-1.0,0.0,RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-73857;R-HSA-74160
ENSG00000155876,2,1,0,0,0,1,23951.9807071219,406587.2658730814,2022-10-12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,RRAGA,0.16299999,3.8089,-0.61114,8,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;mTORC1-mediated signalling;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;Amino acids regulate mTORC1;MTOR signalling;Cellular response to starvation;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-166208;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-9639288;R-HSA-165159;R-HSA-9711097;R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000155886,1,1,0,0,0,1,101825.50588235294,101825.50588235294,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC24A2,0.273,0.0093266,-1.5497,1,0.5,0.5,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000155893,1,1,1,0,0,1,44660.84794838759,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PXYLP1,0.361,1.9058,0.86056,0,0.5,-1.0,Glycosaminoglycan-protein linkage region biosynthesis,R-HSA-1971475
ENSG00000156026,1,1,0,0,0,0,9104.827151577183,9104.827151577183,2021-04-08,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MCU,0.56,1.6871,-0.37143,2,0.5,-1.0,Mitochondrial calcium ion transport,R-HSA-8949215
ENSG00000156052,1,1,1,0,0,1,67142.73298165268,67142.73298165268,2023-11-30,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GNAQ,0.18199998,2.6607,0.12522,11,-1.0,-1.0,Signal Transduction;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Thromboxane signalling through TP receptor;Free fatty acids regulate insulin secretion;Acetylcholine regulates insulin secretion;ADP signalling through P2Y purinoceptor 1;Signal amplification;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,R-HSA-162582;R-HSA-434316;R-HSA-428930;R-HSA-400451;R-HSA-399997;R-HSA-418592;R-HSA-392518;R-HSA-202040;R-HSA-6814122
ENSG00000156206,1,1,0,0,0,1,394357.452283155,394357.452283155,2020-10-05,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CFAP161,-0.029000044,0.21932,1.0332,0,0.75,0.5,,
ENSG00000156239,1,1,0,0,0,1,19257.690392998462,19257.690392998462,2024-07-19,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HEMK2,-0.91499996,-1.6313,-0.97472,2,-1.0,0.0,,
ENSG00000156374,2,1,0,0,0,1,197775.78125685986,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PCGF6,-0.011999965,0.41874,-1.1016,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8953750
ENSG00000156504,1,1,0,0,0,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PABIR2,,,,0,-1.0,-1.0,,
ENSG00000156575,1,1,0,0,0,1,21724.94108458234,21724.94108458234,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PRG3,-0.39100003,-0.19624,-0.47775,1,1.0,0.5,Immune System,R-HSA-168256
ENSG00000156639,1,1,0,0,0,1,17534.246691821227,17534.246691821227,2011-12-11,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZFAND3,0.25800002,0.55912,-0.71704,0,-1.0,-1.0,,
ENSG00000156642,1,1,0,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NPTN,0.712,3.5629,0.67096,1,-1.0,-1.0,,
ENSG00000156787,1,1,1,0,0,0,409691.21276290494,409691.21276290494,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TBC1D31,0.120000005,1.4369,0.70395,0,0.5,-1.0,,
ENSG00000156831,1,1,0,0,0,1,51573.04760983911,51573.04760983911,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NSMCE2,-0.113000035,0.84778,0.2781,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000156885,1,1,1,0,0,1,23381.922398514344,23381.922398514344,2019-04-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,COX6A2,-0.913,-2.7303,-2.2093,4,0.75,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Complex IV assembly,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9864848
ENSG00000156958,1,1,1,0,0,0,39707.309018073414,39707.309018073414,2019-07-17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GALK2,-0.004999995,-0.059053,1.0078,0,-1.0,-1.0,,
ENSG00000157045,1,1,1,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,NTAN1,-0.633,0.70606,0.1579,0,-1.0,0.0,,
ENSG00000157064,1,1,0,0,0,1,26873.80285776456,26873.80285776456,2017-07-17,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,NMNAT2,0.50600004,2.0389,0.36057,1,1.0,0.0,,
ENSG00000157107,1,1,1,0,0,0,28863.30790298137,28863.30790298137,2022-12-10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FCHO2,0.45099998,1.3523,-0.0055201,2,-1.0,-1.0,,
ENSG00000157214,1,1,1,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STEAP2,0.15899998,1.4289,1.2153,0,1.0,0.0,,
ENSG00000157219,1,1,0,0,0,1,4958.457273834881,4958.457273834881,2021-11-04,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HTR5A,-0.19700003,-0.0627,-1.7061,2,1.0,1.0,Signal Transduction;Serotonin receptors;Amine ligand-binding receptors,R-HSA-162582;R-HSA-390666;R-HSA-375280
ENSG00000157343,1,1,0,0,0,1,19008.705439555517,87248.80974040499,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,ARMC12,0.120000005,1.0766,0.7311,0,1.0,0.0,,
ENSG00000157625,1,1,0,0,0,1,232586.34864014547,232586.34864014547,2021-01-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TAB3,,,,14,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Alpha-protein kinase 1 signaling pathway;IRAK2 mediated activation of TAK1 complex;Disease;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-9645460;R-HSA-937042;R-HSA-1643685;R-HSA-449147
ENSG00000157881,1,1,1,0,0,0,58331.23271678036,58331.23271678036,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PANK4,0.33999997,1.4025,-1.6574,1,-1.0,0.0,Vitamin B5 (pantothenate) metabolism,R-HSA-199220
ENSG00000157954,1,1,0,0,0,1,78751.06843456876,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,WIPI2,0.23000002,1.2729,-0.82078,1,-1.0,-1.0,,
ENSG00000157978,1,1,0,0,0,1,34004.8644513982,78751.06843456876,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,LDLRAP1,-0.082999945,0.4898,0.39274,6,0.5,-1.0,Transport of RCbl within the body;Vitamin D (calciferol) metabolism;Metabolism of steroids,R-HSA-9758890;R-HSA-196791;R-HSA-8957322
ENSG00000158022,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRIM63,-0.329,-0.08117,-0.1552,2,1.0,0.0,Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160
ENSG00000158062,1,1,0,0,0,0,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,UBXN11,0.051,0.17079,-0.77131,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000158156,1,1,1,0,0,1,2201.586503948313,2201.586503948313,2017-12-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,XKR8,-0.43400002,1.0341,0.42362,0,-1.0,-1.0,,
ENSG00000158195,1,1,1,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,WASF2,0.536,2.756,1.2319,7,-1.0,-1.0,Signal Transduction;Immune System;Disease;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9006934
ENSG00000158315,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RHBDL2,-0.20000005,0.58368,0.50866,0,0.5,0.0,,
ENSG00000158352,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,SHROOM4,,,,0,-1.0,0.0,,
ENSG00000158423,1,1,1,0,0,0,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RIBC1,,,,0,0.75,0.0,,
ENSG00000158485,1,1,0,0,0,1,95905.57783546533,95905.57783546533,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,CD1B,-0.334,-1.2773,-1.3704,1,1.0,0.5,Immune System,R-HSA-168256
ENSG00000158516,1,1,0,0,0,1,205425.60717824215,205425.60717824215,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CPA2,-0.28199995,0.41436,0.28018,1,1.0,0.0,,
ENSG00000158560,6,1,0,0,0,1,97181.90375256384,1990918.947961699,2019-01-21,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,9,DYNC1I1,0.353,2.6579,1.0835,12,0.5,0.0,Signal Transduction;Immune System;Disease;Aggrephagy;Golgi-to-ER retrograde transport;Post-translational protein modification,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-9646399;R-HSA-8856688;R-HSA-597592
ENSG00000158571,1,1,0,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PFKFB1,,,,3,0.75,0.5,,
ENSG00000158769,2,1,1,0,0,0,30178.248376775256,30178.248376775256,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,F11R,0.100000024,1.078,1.0077,4,-1.0,-1.0,Signal Transduction;Tight junction interactions,R-HSA-162582;R-HSA-420029
ENSG00000158816,1,1,0,0,0,1,254373.32653042395,765591.3646788632,2020-05-06,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,VWA5B1,-0.17999995,-0.004398,-0.57794,0,1.0,0.5,,
ENSG00000158859,1,1,1,0,0,1,93079.77148598975,157378.92113144128,2016-05-16,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,3,ADAMTS4,0.268,1.3266,1.2761,3,0.5,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000158863,1,1,1,0,0,1,133918.94977035935,133918.94977035935,2020-04-27,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FHIP2B,-0.17299998,-0.32336,-2.1949,0,-1.0,-1.0,,
ENSG00000158864,1,1,1,0,0,0,199181.4939619243,199181.4939619243,2022-10-12,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NDUFS2,0.31,2.2634,1.0532,2,0.5,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000158966,2,1,0,0,0,0,46536.46918214105,62043.890063935265,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,CACHD1,0.36699998,2.3429,0.65239,0,-1.0,0.0,,
ENSG00000159214,1,1,1,0,0,0,167455.33102651383,167455.33102651383,2023-10-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CCDC24,-0.553,-0.7371,-1.0272,0,-1.0,0.0,,
ENSG00000159256,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MORC3,0.63,3.1002,0.038819,0,-1.0,0.0,,
ENSG00000159259,1,1,1,0,0,1,69761.9825146311,69761.9825146311,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,CHAF1B,0.73,2.1559,0.42414,0,0.5,0.0,,
ENSG00000159433,2,1,0,0,0,1,49367.473680139236,150669.89240227733,2019-05-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,STARD9,0.09100002,0.41785,0.50216,0,-1.0,0.0,,
ENSG00000159648,1,1,0,0,0,0,123127.18790121445,123127.18790121445,2019-02-25,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,SPMIP8,-0.18700004,-0.29932,-0.17601,0,1.0,0.5,,
ENSG00000159921,1,1,0,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,GNE,0.17900002,4.0011,2.2136,2,0.75,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000160179,1,1,0,0,0,0,220320.9576294899,220320.9576294899,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ABCG1,0.427,2.327,0.44173,3,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000160190,1,1,0,0,0,1,5785.292188770647,5785.292188770647,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,SLC37A1,0.18300003,2.0032,0.78747,1,0.5,-1.0,Gluconeogenesis,R-HSA-70263
ENSG00000160191,1,1,1,0,0,1,286746.1002745869,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PDE9A,-0.09200001,1.2785,0.52261,1,0.5,0.0,,
ENSG00000160207,1,1,1,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HSF2BP,-0.25699997,0.24622,0.5452,0,1.0,0.5,,
ENSG00000160208,1,1,1,0,0,0,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RRP1B,0.037,1.3241,0.036262,0,-1.0,-1.0,,
ENSG00000160218,1,1,1,0,0,0,78751.06843456876,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TRAPPC10,0.727,2.2794,0.53093,2,-1.0,-1.0,Rab regulation of trafficking;Post-translational protein modification,R-HSA-9007101;R-HSA-597592
ENSG00000160219,1,1,0,0,0,1,16417.447913521348,16417.447913521348,2009-05-10,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GAB3,,,,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000160223,1,1,0,0,0,1,71117.27631467933,71117.27631467933,2025-01-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ICOSLG,,,,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000160294,2,1,1,0,0,1,3288.4396493594068,17115.61307125707,2013-05-12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MCM3AP,0.231,0.60762,0.21947,0,-1.0,-1.0,,
ENSG00000160588,3,1,1,0,0,1,37477.37186170532,136665.8227530756,2017-06-12,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,MPZL3,-0.176,0.38676,0.6489,0,0.5,0.0,,
ENSG00000160688,1,1,1,0,0,0,306980.8575290048,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,FLAD1,0.19099998,1.3376,1.4764,1,-1.0,-1.0,,
ENSG00000160716,1,1,1,0,0,1,251325.91086204,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CHRNB2,-0.116000056,1.0117,-1.3278,3,0.75,0.5,,
ENSG00000160796,2,1,1,0,0,1,195005.6685718255,260210.21963428933,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NBEAL2,0.35900003,2.8794,0.33512,1,-1.0,0.0,Immune System,R-HSA-168256
ENSG00000160813,1,1,0,0,0,1,41299.82664585649,41299.82664585649,2022-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PPP1R35,-0.91199994,-3.1649,-3.5029,0,0.5,-1.0,,
ENSG00000160838,1,1,1,0,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LRRC71,-0.08700001,-0.73402,-1.2724,0,0.75,0.5,,
ENSG00000160951,4,1,1,0,0,1,37609.999325948724,183761.6081180644,2019-11-15,0,0,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,13,PTGER1,-0.88900006,-2.8795,-4.7606,2,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000161011,1,1,1,0,0,1,356440.71671986027,356440.71671986027,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SQSTM1,-0.13,-0.37187,-1.9944,10,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-5663202;R-HSA-597592
ENSG00000161249,1,1,1,0,0,0,11231.262381898725,11231.262381898725,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DMKN,-0.04400003,0.22976,-0.07095,1,1.0,0.0,,
ENSG00000161328,1,1,1,0,1,0,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,LRRC56,-0.22500002,-1.3762,-2.6181,0,0.5,0.0,,
ENSG00000161640,1,1,0,0,1,1,71913.46219676935,104168.97660865163,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,SIGLEC11,-0.291,1.2915,0.78801,1,0.75,0.0,Immune System,R-HSA-168256
ENSG00000161671,1,1,0,0,0,0,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,EMC10,-0.60599995,-1.7206,-1.6357,0,0.5,-1.0,,
ENSG00000161682,1,1,0,0,0,1,332375.5317723021,332375.5317723021,2021-09-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FAM171A2,0.40100002,-0.96293,-1.8851,0,0.5,0.0,,
ENSG00000161791,1,1,1,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FMNL3,0.425,3.0647,0.77596,5,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000161944,1,1,0,1,0,0,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ASGR2,-0.365,0.28737,0.5279,1,1.0,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000161980,1,1,0,0,0,1,5432.315492957747,5432.315492957747,2023-01-05,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,POLR3K,-0.30400002,0.19365,-0.20187,7,-1.0,-1.0,RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;Immune System;RNA Polymerase III Chain Elongation;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription,R-HSA-76046;R-HSA-76071;R-HSA-76061;R-HSA-76066;R-HSA-168256;R-HSA-73780;R-HSA-74160;R-HSA-749476;R-HSA-74158
ENSG00000161996,1,1,1,0,1,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,WDR90,-0.48099995,-3.4119,-4.6843,0,0.5,-1.0,,
ENSG00000162032,1,1,0,0,1,1,303059.79257468163,303059.79257468163,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPSB3,0.07499999,-0.59284,-3.2202,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000162298,1,1,1,0,0,0,40455.65678857565,40455.65678857565,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SYVN1,0.575,2.4085,-0.16608,4,-1.0,-1.0,Signal Transduction;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Disease;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Hh mutants abrogate ligand secretion;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification,R-HSA-162582;R-HSA-901032;R-HSA-901042;R-HSA-532668;R-HSA-1643685;R-HSA-5358346;R-HSA-5362768;R-HSA-5387390;R-HSA-5663202;R-HSA-597592
ENSG00000162413,2,1,0,0,0,1,403949.6773304188,403949.6773304188,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,KLHL21,-0.64699996,-2.4672,-5.1422,2,0.5,-1.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000162433,1,1,1,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,AK4,0.058000028,1.7549,0.62759,1,0.5,-1.0,Interconversion of nucleotide di- and triphosphates;Metabolism of nucleotides,R-HSA-499943;R-HSA-15869
ENSG00000162438,4,1,1,1,1,1,2130.048309178744,33144.02982075252,2017-07-28,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,CTRC,-0.14699996,1.0022,1.5618,1,1.0,0.0,,
ENSG00000162494,1,1,0,0,0,1,79108.36533319818,79108.36533319818,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,LRRC38,0.388,1.2106,0.13081,0,0.75,0.5,,
ENSG00000162522,1,1,1,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NHSL3,0.231,-0.99557,-1.7796,0,-1.0,-1.0,,
ENSG00000162571,1,1,1,0,1,1,192594.63282947522,192594.63282947522,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,TTLL10,-0.24300003,-1.1388,-1.3192,1,0.75,0.5,Carboxyterminal post-translational modifications of tubulin;Post-translational protein modification,R-HSA-8955332;R-HSA-597592
ENSG00000162600,1,1,1,0,0,1,145320.08042080907,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,OMA1,,,,3,-1.0,-1.0,,
ENSG00000162624,1,1,0,0,0,1,512656.0695323204,512656.0695323204,2023-03-27,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,LHX8,0.481,1.8239,-0.33537,0,0.5,0.5,,
ENSG00000162627,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SNX7,0.007000029,0.27249,0.52471,0,-1.0,0.0,,
ENSG00000162642,1,1,0,0,0,1,7810.293083348673,7810.293083348673,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,C1orf52,0.385,0.0028737,-0.86345,0,-1.0,-1.0,,
ENSG00000162688,1,1,0,0,0,0,6799.125508168573,6799.125508168573,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,AGL,0.27999997,0.87709,0.98736,2,0.75,-1.0,Immune System,R-HSA-168256
ENSG00000162695,1,1,1,0,0,1,24739.63081777544,24739.63081777544,2011-08-11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,SLC30A7,-0.116000056,-0.087579,0.56249,0,-1.0,-1.0,,
ENSG00000162769,1,1,0,0,0,1,53369.71648873449,53369.71648873449,2019-03-28,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,FLVCR1,-0.013000011,-0.1071,-0.5358,2,0.5,0.0,Heme biosynthesis;Iron uptake and transport,R-HSA-189451;R-HSA-917937
ENSG00000162775,1,1,1,0,0,1,278498.5074409075,278498.5074409075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RBM15,0.792,2.1069,-1.712,0,0.5,-1.0,,
ENSG00000162814,2,1,0,0,0,1,1987.3402746340728,645988.1975077938,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SPATA17,-0.32000005,-0.27064,0.29126,0,0.5,0.5,,
ENSG00000162881,1,1,0,0,0,1,382631.1172224132,382631.1172224132,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,OXER1,-0.913,-0.3952,-0.21946,2,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000162889,1,1,0,0,0,1,309838.540915932,360605.992793193,2021-07-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MAPKAPK2,0.697,2.9972,-0.25425,10,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;CREB phosphorylation;p38MAPK events;Synthesis of Leukotrienes (LT) and Eoxins (EX);Signaling by Interleukins;Arachidonate metabolism;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-199920;R-HSA-171007;R-HSA-2142691;R-HSA-449147;R-HSA-2142753;R-HSA-9006934
ENSG00000162951,1,1,0,0,0,0,94665.79117035728,94665.79117035728,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LRRTM1,0.61,2.3596,0.26023,1,0.75,0.5,,
ENSG00000162972,3,1,1,0,0,1,15866.724081734988,1778690.168860174,2013-08-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,8,MAIP1,-0.39900005,0.47308,-0.12241,1,-1.0,-1.0,,
ENSG00000163012,2,1,0,0,0,1,47408.95172709719,160010.51072069994,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,ZSWIM2,-0.055999994,-0.34361,1.0038,0,1.0,1.0,,
ENSG00000163046,1,1,0,0,0,1,7121.683239145682,7121.683239145682,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ANKRD30BL,-0.929,-0.35129,0.22331,0,1.0,1.0,,
ENSG00000163154,2,1,0,1,0,0,98271.38571086437,105759.0908630975,2023-01-18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TNFAIP8L2,0.171,0.84402,0.77701,1,0.5,0.0,,
ENSG00000163161,1,1,1,0,0,0,62629.11170662631,62629.11170662631,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,ERCC3,0.20300001,2.079,0.88741,29,-1.0,-1.0,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;RNA Pol II CTD phosphorylation and interaction with CE;mRNA Capping;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;Generic Transcription Pathway;Formation of HIV elongation complex in the absence of HIV Tat;Tat-mediated elongation of the HIV-1 transcript;HIV Transcription Elongation;Formation of HIV-1 elongation complex containing HIV-1 Tat;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;Formation of TC-NER Pre-Incision Complex;Gene expression (Transcription);RNA Polymerase I Promoter Escape;Disease;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex;RNA Polymerase II Transcription Elongation;Transcription of the HIV genome;RNA Polymerase I Transcription Initiation;Gap-filling DNA repair synthesis and ligation in TC-NER;Formation of Incision Complex in GG-NER;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-167160;R-HSA-77075;R-HSA-72086;R-HSA-113418;R-HSA-167158;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-212436;R-HSA-167152;R-HSA-167246;R-HSA-167169;R-HSA-167200;R-HSA-73857;R-HSA-73863;R-HSA-6781823;R-HSA-74160;R-HSA-73772;R-HSA-1643685;R-HSA-5250941;R-HSA-427413;R-HSA-674695;R-HSA-112382;R-HSA-75955;R-HSA-167172;R-HSA-73762;R-HSA-6782210;R-HSA-5696395;R-HSA-73864;R-HSA-73854;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-6781827
ENSG00000163207,1,1,0,0,0,1,44660.84794838759,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,IVL,-0.87899995,-1.8407,0.12629,2,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000163286,1,1,0,0,0,1,13219.952617929488,13219.952617929488,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,ALPG,-0.103000045,0.7993,-0.098256,1,,,Post-translational protein modification,R-HSA-597592
ENSG00000163288,1,1,0,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,GABRB1,0.435,3.0113,-0.4715,2,0.5,0.5,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000163312,1,1,1,0,1,1,6686.38618705036,6686.38618705036,2011-03-17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HELQ,0.25800002,0.93332,0.83145,0,-1.0,-1.0,,
ENSG00000163320,1,1,1,0,0,0,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CGGBP1,0.23299998,1.932,0.16849,0,-1.0,-1.0,,
ENSG00000163331,1,1,0,0,0,1,53549.870129555784,53549.870129555784,2023-03-16,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DAPL1,-0.834,-1.1303,-0.51406,0,0.5,0.0,,
ENSG00000163352,1,1,0,0,0,1,44660.84794838759,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LENEP,-0.59800005,0.71154,0.51016,0,,,,
ENSG00000163359,2,1,1,1,0,1,99445.63572998076,394357.452283155,2020-10-05,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,COL6A3,0.436,2.1118,1.0404,8,0.5,0.0,Signal Transduction;Developmental Biology;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-1266738;R-HSA-9006934
ENSG00000163377,1,1,1,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TAFA4,-0.334,-0.53546,0.0012328,0,0.75,0.5,,
ENSG00000163435,2,1,0,0,0,1,32134.383869398138,57035.41574163062,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,ELF3,0.32200003,2.0139,0.51184,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000163472,1,1,1,0,0,0,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM79,-0.30200005,0.3934,0.68541,0,0.5,0.0,,
ENSG00000163507,1,1,1,0,0,0,143585.2019681512,143585.2019681512,2024-07-19,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CIP2A,-0.05700004,-0.61038,-0.64762,0,-1.0,0.0,,
ENSG00000163534,1,1,1,1,0,1,17820.993879369486,17820.993879369486,2021-09-30,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FCRL1,0.18699998,0.43964,-0.07252,0,0.75,0.5,,
ENSG00000163590,1,1,0,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PPM1L,0.376,2.5325,0.14026,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000163625,1,1,0,0,0,0,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,WDFY3,0.8,7.7015,1.068,0,-1.0,-1.0,,
ENSG00000163636,2,1,1,0,0,1,17534.246691821227,294387.2978738704,2011-12-11,0,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,PSMD6,0.673,1.2153,-0.37192,62,0.5,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Regulation of expression of SLITs and ROBOs;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Dectin-1 mediated noncanonical NF-kB signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-9010553;R-HSA-350562;R-HSA-351202;R-HSA-5607761;R-HSA-450408;R-HSA-5358346;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-5663202;R-HSA-597592;R-HSA-8878159
ENSG00000163644,1,1,1,0,0,1,21939.796916619583,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,22,0,0,0,0,0,0,0,0,0,0,22,PPM1K,0.181,2.0017,0.51721,2,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000163686,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ABHD6,-0.06700003,1.0868,0.99014,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000163689,1,1,0,0,0,1,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,CFAP20DC,0.106000006,0.36661,0.18946,0,0.75,0.5,,
ENSG00000163728,2,1,0,0,0,1,197775.78125685986,323648.5577791949,2022-10-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,TTC14,0.0,0.30862,-0.55975,0,-1.0,-1.0,,
ENSG00000163810,1,1,0,0,0,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TGM4,0.032000005,1.117,0.30774,0,1.0,0.5,,
ENSG00000163872,1,1,0,0,0,0,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,YEATS2,0.448,2.0378,0.68463,2,-1.0,-1.0,Gene expression (Transcription),R-HSA-74160
ENSG00000163873,1,1,0,0,0,1,684816.7338614308,1122672.658801146,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,GRIK3,0.604,3.6053,0.31807,2,0.5,0.0,Activation of Ca-permeable Kainate Receptor;Ionotropic activity of kainate receptors;Presynaptic function of Kainate receptors;Activation of kainate receptors upon glutamate binding,R-HSA-451308;R-HSA-451306;R-HSA-500657;R-HSA-451326
ENSG00000163879,1,1,1,0,1,0,11815.066044029352,11815.066044029352,2015-01-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DNALI1,-0.20200002,0.71393,0.89449,0,0.5,0.0,,
ENSG00000163900,1,1,1,0,0,1,355284.1215006515,355284.1215006515,2025-03-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM41A,-0.18299997,0.30361,0.19972,0,-1.0,-1.0,,
ENSG00000163964,1,1,1,0,0,1,360837.067725683,360837.067725683,2017-10-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,PIGX,-0.737,0.053128,0.3617,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000164010,1,1,1,0,0,0,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ERMAP,0.08700001,0.95549,1.0903,0,-1.0,-1.0,,
ENSG00000164032,1,1,1,0,0,1,86992.9057658324,143413.24457139417,2023-06-29,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,H2AZ1,0.6,3.1198,-0.4835,1,0.5,-1.0,,
ENSG00000164040,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PGRMC2,0.15200001,-0.075626,-1.9004,6,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000164045,2,1,1,0,0,1,122069.83349127392,427337.4491868293,2017-12-06,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,CDC25A,0.51100004,2.283,0.090419,10,0.5,0.0,Cyclin A/B1/B2 associated events during G2/M transition;G1/S-Specific Transcription;Disease;Post-translational protein modification,R-HSA-69273;R-HSA-69205;R-HSA-1643685;R-HSA-597592
ENSG00000164047,1,1,0,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CAMP,-0.204,0.4209,0.14486,2,1.0,0.0,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000164080,1,1,0,0,0,0,444537.33605315426,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,RAD54L2,0.735,4.3338,1.9672,0,-1.0,-1.0,,
ENSG00000164087,1,1,0,0,0,0,66821.18426408028,66821.18426408028,2023-10-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,POC1A,0.012000024,1.266,1.6162,0,0.5,0.0,,
ENSG00000164099,2,1,0,0,1,1,433862.5685735124,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PRSS12,0.035000026,0.13242,-0.90479,0,0.5,0.0,,
ENSG00000164123,1,1,0,0,0,1,56594.692589330625,56594.692589330625,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SPMIP2,-0.79499996,0.025609,0.5233,0,1.0,1.0,,
ENSG00000164176,3,1,0,0,0,1,8884.208806670556,8884.208806670556,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EDIL3,0.29500002,1.2321,0.30849,1,1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000164188,1,1,0,0,0,0,254373.32653042395,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RANBP3L,-0.20500004,0.43641,0.95283,0,0.5,0.0,,
ENSG00000164236,1,1,0,0,0,1,843.0351232524823,843.0351232524823,2022-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ANKRD33B,0.31800002,-0.42512,-1.091,0,1.0,0.0,,
ENSG00000164244,1,1,0,0,0,0,11786.661185394927,11786.661185394927,2024-07-19,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PRRC1,-0.13900006,0.1153,1.1007,0,-1.0,-1.0,,
ENSG00000164270,1,1,1,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,HTR4,0.31,1.2909,0.25553,2,0.75,0.5,Signal Transduction;Serotonin receptors;Amine ligand-binding receptors,R-HSA-162582;R-HSA-390666;R-HSA-375280
ENSG00000164283,1,1,0,0,0,1,5173.800802905755,5173.800802905755,2019-07-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ESM1,0.13800001,1.27,0.12903,0,0.5,0.0,,
ENSG00000164303,2,1,0,0,0,1,12151.673297069092,141293.18354755783,2021-06-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,ENPP6,0.003000021,0.64076,0.63996,1,0.75,0.0,,
ENSG00000164334,1,1,0,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM170A,-0.07000005,-0.30977,-0.24045,0,1.0,1.0,,
ENSG00000164363,7,1,0,0,1,1,17702.698630315714,473900.221403792,2023-01-18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,SLC6A18,-0.143,0.7107,-0.36833,4,1.0,1.0,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000164399,2,1,0,0,1,1,63475.2016898578,116566.20935579021,2023-01-18,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,IL3,-0.42999995,1.0355,0.47818,4,,,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147
ENSG00000164411,1,1,1,0,0,0,228220.5662976458,545988.1005477115,2018-07-30,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GJB7,-0.967,0.38607,0.74144,1,0.75,0.5,Gap junction assembly;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-190861;R-HSA-157858;R-HSA-190828
ENSG00000164438,1,1,0,0,0,1,433862.5685735124,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TLX3,-0.0039999485,0.045814,-1.9912,0,1.0,1.0,,
ENSG00000164483,1,1,0,0,0,1,1076472.0138856068,1076472.0138856068,2023-07-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SAMD3,-0.29200006,0.72645,-0.21853,0,0.5,0.0,,
ENSG00000164494,1,1,0,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PDSS2,0.18199998,1.0961,1.0621,1,-1.0,-1.0,,
ENSG00000164508,1,1,0,0,0,1,45809.99756555466,45809.99756555466,2021-11-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,H2AC1,-0.697,-0.95968,-4.5939,8,1.0,1.0,Disease;HCMV Late Events;Post-translational protein modification,R-HSA-1643685;R-HSA-9610379;R-HSA-597592
ENSG00000164548,1,1,1,0,0,1,83086.61719470083,83086.61719470083,2023-03-13,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TRA2A,0.021000028,1.6331,0.047632,0,-1.0,-1.0,,
ENSG00000164600,1,1,0,0,0,1,155552.2805078301,155552.2805078301,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NEUROD6,0.587,1.8775,-0.82789,0,1.0,1.0,,
ENSG00000164620,1,1,1,0,0,0,207220.14223281175,207220.14223281175,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,RELL2,0.08099997,0.84195,0.059371,0,0.5,0.0,,
ENSG00000164627,1,1,1,0,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KIF6,-0.13199997,0.96484,0.21481,2,0.5,0.5,Golgi-to-ER retrograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Kinesins,R-HSA-8856688;R-HSA-6811434;R-HSA-983189
ENSG00000164647,1,1,1,0,0,1,130268.25219927442,1424218.0900670097,2020-06-08,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,STEAP1,-0.05400002,1.361,0.85402,0,0.5,0.0,,
ENSG00000164663,1,1,0,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,USP49,0.42400002,2.1336,-0.83157,1,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000164687,1,1,0,0,0,1,636.1886490807354,636.1886490807354,2012-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,FABP5,0.16100001,0.54026,0.60909,4,0.5,-1.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000164713,1,1,1,0,0,0,360605.992793193,360605.992793193,2023-02-20,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BRI3,-0.32599998,0.011469,-2.3588,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000164751,2,1,0,0,0,1,383158.3001114715,645988.1975077938,2023-01-18,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PEX2,-0.05700004,0.43329,-0.25363,3,-1.0,-1.0,Class I peroxisomal membrane protein import;Peroxisomal protein import;E3 ubiquitin ligases ubiquitinate target proteins;Protein ubiquitination;Post-translational protein modification,R-HSA-9603798;R-HSA-9033241;R-HSA-8866654;R-HSA-8852135;R-HSA-597592
ENSG00000164754,1,1,0,0,0,1,17227.359990886307,17227.359990886307,2015-05-20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RAD21,0.65900004,3.6539,0.34228,7,-1.0,-1.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000164764,1,1,1,0,0,1,414433.58532016096,414433.58532016096,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SBSPON,-0.18799996,-0.27826,-0.079063,2,-1.0,0.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000164815,1,1,0,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ORC5,0.25300002,0.12279,-0.7708,7,-1.0,-1.0,E2F-enabled inhibition of pre-replication complex formation;Assembly of the ORC complex at the origin of replication;E2F mediated regulation of DNA replication,R-HSA-113507;R-HSA-68616;R-HSA-113510
ENSG00000164823,1,1,0,0,0,1,32254.717802479194,32254.717802479194,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,OSGIN2,0.546,2.0881,0.61817,0,-1.0,-1.0,,
ENSG00000164825,1,1,0,0,0,1,50728.57547498233,50728.57547498233,2022-09-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DEFB1,-0.969,-3.2863,-2.5456,2,0.75,0.0,Immune System;Defensins;Antimicrobial peptides,R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000164828,3,1,1,0,1,1,138890.6106237268,645988.1975077938,2023-01-18,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,SUN1,0.288,0.045491,-1.3493,1,-1.0,-1.0,,
ENSG00000164830,1,1,1,0,0,0,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,OXR1,0.518,0.47797,1.0934,0,-1.0,-1.0,,
ENSG00000164849,1,1,0,0,0,1,254380.61820530874,254380.61820530874,2023-05-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,GPR146,,,,0,0.5,-1.0,,
ENSG00000164855,1,1,0,0,1,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TMEM184A,-0.34599996,-0.74024,-1.0278,0,0.5,0.0,,
ENSG00000164877,1,1,0,0,0,1,145320.08042080907,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,MICALL2,-0.67499995,-4.6301,-5.2003,0,-1.0,0.0,,
ENSG00000165097,2,1,1,0,0,1,125894.9248389576,645988.1975077938,2018-06-11,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,KDM1B,0.23900002,3.1432,0.72507,3,-1.0,-1.0,Signal Transduction;Developmental Biology;Post-translational protein modification,R-HSA-162582;R-HSA-1266738;R-HSA-597592
ENSG00000165140,1,1,1,0,0,1,195666.44200393453,195666.44200393453,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FBP1,-0.15600002,1.9532,0.34439,1,0.5,0.0,Gluconeogenesis,R-HSA-70263
ENSG00000165186,2,1,0,0,0,1,25001.14127082048,65437.677265089216,2020-06-08,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PTCHD1,,,,0,0.5,0.5,,
ENSG00000165269,1,1,0,0,0,1,44431.11621006824,50175.980946411786,2024-10-04,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,AQP7,-0.24000001,0.89601,0.62293,2,0.5,0.0,Passive transport by Aquaporins,R-HSA-432047
ENSG00000165349,2,1,1,0,0,1,74806.7436355004,87037.83598345588,2014-09-14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC7A3,,,,1,0.5,0.5,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000165417,1,1,0,0,0,1,143413.24457139417,143413.24457139417,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GTF2A1,0.575,1.201,0.68915,10,-1.0,-1.0,Signal Transduction;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;RNA Polymerase II Pre-transcription Events;Transcription of the HIV genome;RNA polymerase II transcribes snRNA genes;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-162582;R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-674695;R-HSA-167172;R-HSA-6807505;R-HSA-162587;R-HSA-162599
ENSG00000165449,1,1,1,0,0,1,16386.12478006288,384314.83364002535,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,0,22,0,0,0,0,0,0,0,0,0,0,22,SLC16A9,0.3,0.84794,0.16899,0,0.5,0.0,,
ENSG00000165474,2,1,0,0,1,1,162367.55694122918,396735.32121509424,2022-06-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,GJB2,-0.96500003,0.4439,0.11027,4,0.5,0.0,Gap junction assembly;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-190861;R-HSA-157858;R-HSA-190828
ENSG00000165475,1,1,0,0,0,1,220320.9576294899,220320.9576294899,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CRYL1,-0.29700005,0.094265,0.21331,1,0.5,-1.0,,
ENSG00000165512,1,1,0,0,1,1,278190.43024910334,278190.43024910334,2023-08-23,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF22,-0.21599996,0.39612,0.70007,0,-1.0,-1.0,,
ENSG00000165521,1,1,0,0,0,0,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EML5,0.435,3.0963,0.66253,0,0.5,0.0,,
ENSG00000165617,2,1,0,0,0,1,124801.11117486731,124801.11117486731,2018-12-03,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DACT1,0.297,-0.78096,-1.5465,1,0.5,-1.0,Signal Transduction;Degradation of DVL,R-HSA-162582;R-HSA-4641258
ENSG00000165632,1,1,0,0,0,0,53015.41625594971,53015.41625594971,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,TAF3,0.876,2.094,-0.28927,9,-1.0,-1.0,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;HIV Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase II Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;RNA Polymerase II Pre-transcription Events;Transcription of the HIV genome;HIV Life Cycle;Late Phase of HIV Life Cycle,R-HSA-73779;R-HSA-167161;R-HSA-76042;R-HSA-75953;R-HSA-167162;R-HSA-73776;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-674695;R-HSA-167172;R-HSA-162587;R-HSA-162599
ENSG00000165732,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,DDX21,0.71000004,3.6297,1.2183,2,-1.0,-1.0,Gene expression (Transcription);rRNA processing,R-HSA-74160;R-HSA-72312
ENSG00000165801,1,1,0,0,0,1,76632.8325989884,76632.8325989884,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ARHGEF40,0.278,1.2775,0.38596,4,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000165805,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,C12orf50,0.20300001,0.74036,-0.47617,0,1.0,1.0,,
ENSG00000165914,1,1,0,0,0,1,184666.1521051339,323648.5577791949,2020-11-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,TTC7B,0.597,2.2958,0.63988,0,0.5,-1.0,,
ENSG00000165934,1,1,1,0,0,1,63200.72664467542,63200.72664467542,2022-07-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,CPSF2,0.34899998,3.4283,1.2443,5,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription);Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature Transcript to Cytoplasm,R-HSA-73857;R-HSA-74160;R-HSA-159231;R-HSA-159234;R-HSA-72202
ENSG00000166002,1,1,0,0,0,1,45087.14211417935,45087.14211417935,2024-01-05,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SMCO4,-0.901,0.46471,-0.032569,0,0.5,-1.0,,
ENSG00000166145,1,1,0,0,0,0,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SPINT1,0.111,1.0735,0.3577,2,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000166169,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,POLL,0.037,1.6218,0.21551,1,-1.0,-1.0,,
ENSG00000166224,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SGPL1,0.29000002,2.035,0.67278,1,-1.0,-1.0,,
ENSG00000166228,1,1,1,1,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PCBD1,-0.68499994,1.5951,-0.01246,1,0.5,-1.0,,
ENSG00000166250,1,1,0,0,0,1,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CLMP,0.208,1.1001,0.49878,0,0.5,0.0,,
ENSG00000166260,5,1,1,0,0,0,22345.675520395987,236661.2413729175,2013-04-01,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,COX11,0.20999998,1.0335,0.064349,1,-1.0,-1.0,Complex IV assembly,R-HSA-9864848
ENSG00000166268,2,1,1,0,0,1,598869.4096893278,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,MYRFL,0.089999974,0.87644,0.91376,0,1.0,0.5,,
ENSG00000166295,1,1,0,0,0,0,89519.16315227402,89519.16315227402,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ANAPC16,0.153,0.66443,-0.072598,17,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000166321,1,1,0,0,0,0,756470.9740366563,756470.9740366563,2025-04-07,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NUDT13,-0.25100005,0.82997,0.70757,1,-1.0,0.0,Interconversion of nucleotide di- and triphosphates;Metabolism of nucleotides,R-HSA-499943;R-HSA-15869
ENSG00000166347,2,1,0,0,0,1,18059.189624550825,18572.706211153127,2023-01-18,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CYB5A,-0.19799995,0.33298,0.0027757,2,0.5,-1.0,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,R-HSA-9609523
ENSG00000166478,1,1,1,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ZNF143,0.195,2.4574,-0.2177,3,-1.0,-1.0,RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription;RNA polymerase II transcribes snRNA genes,R-HSA-76046;R-HSA-76071;R-HSA-73857;R-HSA-74160;R-HSA-749476;R-HSA-74158;R-HSA-6807505
ENSG00000166482,2,1,0,1,0,1,156470.480665571,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,MFAP4,0.096000016,1.312,-0.47882,1,-1.0,-1.0,,
ENSG00000166507,1,1,1,0,0,1,433862.5685735124,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NDST2,0.521,2.5469,1.2777,1,-1.0,-1.0,HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-2022928;R-HSA-1638091
ENSG00000166532,1,1,1,0,0,0,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RIMKLB,0.555,3.2008,0.83201,1,-1.0,-1.0,,
ENSG00000166558,1,1,0,0,0,1,6149.559264013693,6149.559264013693,2018-10-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC38A8,-0.676,-6.0508,-6.5948,0,0.5,1.0,,
ENSG00000166598,1,1,1,0,0,1,97822.37358221927,109001.36551434857,2022-10-12,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HSP90B1,0.674,3.5915,1.3844,6,-1.0,-1.0,Cytokine Signaling in Immune system;ATF6 (ATF6-alpha) activates chaperone genes;ATF6 (ATF6-alpha) activates chaperones;Immune System;Signaling by Interleukins;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling,R-HSA-1280215;R-HSA-381183;R-HSA-381033;R-HSA-168256;R-HSA-449147;R-HSA-597592;R-HSA-6785807
ENSG00000166670,1,1,0,1,0,1,3534.485612498504,3534.485612498504,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MMP10,-0.25600004,-0.36898,-0.59018,4,1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000166676,1,1,0,0,0,1,53369.71648873449,53369.71648873449,2019-03-28,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,TVP23A,0.046000004,-0.5352,-0.45331,0,0.5,0.0,,
ENSG00000166750,1,1,1,0,1,1,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,SLFN5,0.11199999,1.3117,0.78332,0,-1.0,-1.0,,
ENSG00000166793,1,1,1,0,0,0,105453.60460439936,105453.60460439936,2022-10-12,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,YPEL4,0.388,1.1204,-0.23725,0,1.0,0.0,,
ENSG00000166839,1,1,0,0,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ANKDD1A,-0.13699996,0.57476,0.15788,0,0.5,0.0,,
ENSG00000166840,1,1,0,0,0,1,21724.94108458234,21724.94108458234,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GLYATL1,-0.06799996,0.1075,-0.51686,3,0.75,0.0,Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156580;R-HSA-9749641
ENSG00000166862,1,1,0,0,0,1,208254.04981354356,208254.04981354356,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,CACNG2,0.729,2.013,0.69033,3,1.0,0.5,LGI-ADAM interactions;Presynaptic depolarization and calcium channel opening;Developmental Biology,R-HSA-5682910;R-HSA-112308;R-HSA-1266738
ENSG00000166926,1,1,1,0,0,1,46668.53011336361,46668.53011336361,2013-10-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MS4A6E,-0.052999973,0.075275,-0.040802,0,1.0,0.5,,
ENSG00000166987,1,1,0,0,1,1,180344.38517486732,180344.38517486732,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MBD6,0.5,-0.36557,-0.09053,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000167037,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SGSM1,0.32700002,2.6249,0.59979,0,0.5,0.0,,
ENSG00000167094,1,1,1,0,1,0,232586.34864014547,232586.34864014547,2021-01-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TTC16,-0.003000021,0.6784,0.69983,0,0.75,0.5,,
ENSG00000167098,1,1,0,0,0,1,205425.60717824215,205425.60717824215,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SUN5,-0.14600003,0.6399,0.20943,0,1.0,1.0,,
ENSG00000167104,2,1,0,0,0,1,64245.57828610605,249965.96240703977,2024-01-05,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,BPIFB6,-0.06799996,-0.19878,-0.51486,1,1.0,1.0,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000167106,1,1,0,0,0,1,221280.45048451523,384314.83364002535,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,4,EEIG1,0.24000001,1.4945,-0.88604,0,-1.0,-1.0,,
ENSG00000167182,1,1,0,0,0,1,28863.30790298137,28863.30790298137,2022-12-10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SP2,0.686,3.1432,0.76204,0,-1.0,-1.0,,
ENSG00000167281,1,1,0,0,0,1,87545.45580019058,87545.45580019058,2016-05-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RBFOX3,0.39499998,1.1108,-0.70058,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000167291,1,1,0,0,0,0,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TBC1D16,-0.039000034,0.39881,-0.89289,1,-1.0,0.0,TBC/RABGAPs;Rab regulation of trafficking,R-HSA-8854214;R-HSA-9007101
ENSG00000167315,1,1,0,0,0,1,122069.83349127392,122069.83349127392,2017-12-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ACAA2,-0.148,0.4051,1.0751,1,0.5,-1.0,,
ENSG00000167360,2,1,0,0,1,1,307.7185080928923,898.4958904109589,2020-07-31,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,OR51Q1,-0.936,-1.5161,-1.2385,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000167397,1,1,1,0,0,1,240639.50239824195,240639.50239824195,2021-10-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,VKORC1,-0.17200005,-0.10044,-0.17353,1,0.5,-1.0,,
ENSG00000167461,1,1,0,0,0,1,100358.73833384078,100358.73833384078,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,RAB8A,0.65999997,2.2716,-0.53476,7,-1.0,-1.0,VxPx cargo-targeting to cilium;TBC/RABGAPs;Rab regulation of trafficking;Cargo trafficking to the periciliary membrane;Post-translational protein modification,R-HSA-5620916;R-HSA-8854214;R-HSA-9007101;R-HSA-5620920;R-HSA-597592
ENSG00000167508,1,1,0,0,0,1,15223.454539395489,15223.454539395489,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MVD,-0.706,-2.2325,-2.4407,3,-1.0,-1.0,Cholesterol biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Post-translational protein modification,R-HSA-191273;R-HSA-8957322;R-HSA-1655829;R-HSA-597592
ENSG00000167562,1,1,1,0,0,1,2324.6716622691292,2324.6716622691292,2023-04-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF701,-0.89199996,0.30505,0.97703,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000167608,1,1,1,0,0,1,1899.55472404116,1899.55472404116,2015-10-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMC4,-0.052000046,0.11201,-1.1715,0,0.5,0.0,,
ENSG00000167614,1,1,0,0,0,1,2042.6733870967741,2042.6733870967741,2017-10-20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TTYH1,0.14600003,-0.043422,-1.9511,1,1.0,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000167642,1,1,0,1,0,1,406587.2658730814,521818.7070055739,2023-11-09,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,SPINT2,0.065,1.1142,-0.14935,2,-1.0,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000167656,3,1,1,1,1,1,119459.84213494582,442877.006007271,2024-07-19,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,LY6D,-0.923,0.45126,-0.35205,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000167674,1,1,0,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,HDGFL2,0.265,-1.5301,-3.0421,0,-1.0,-1.0,,
ENSG00000167703,1,1,1,0,0,1,275021.63051358337,1424218.0900670097,2023-01-18,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLC43A2,0.148,1.1653,-0.11908,1,0.5,-1.0,Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
ENSG00000167716,1,1,1,0,0,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,WDR81,0.18300003,0.73653,-0.55275,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000167748,3,1,0,1,0,0,37609.999325948724,143209.11815732162,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,KLK1,-0.26,1.0243,0.19871,2,0.75,0.0,,
ENSG00000167751,1,1,1,0,0,1,21263.406987557013,42061.79578384488,2020-09-04,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,KLK2,-0.12199998,0.13149,-0.37066,3,1.0,0.5,Signal Transduction;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,R-HSA-162582;R-HSA-5625886
ENSG00000167755,1,1,1,1,0,1,144127.33793912127,144127.33793912127,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KLK6,-0.024999976,0.93716,0.52312,0,1.0,0.0,,
ENSG00000167757,1,1,0,1,0,0,118061.55082048493,118061.55082048493,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,KLK11,0.050000012,0.75962,-0.11175,0,0.5,0.0,,
ENSG00000167880,1,1,0,0,1,0,58331.23271678036,160010.51072069994,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,EVPL,0.0009999871,0.2514,-0.47106,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000167984,1,1,1,0,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NLRC3,-0.38600004,-2.3217,-2.2004,1,0.5,0.0,Immune System;IRF3-mediated induction of type I IFN,R-HSA-168256;R-HSA-3270619
ENSG00000167994,2,1,1,0,0,1,360605.992793193,427337.4491868293,2022-02-03,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RAB3IL1,-0.153,-0.22033,0.036509,1,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000168003,1,1,1,0,0,0,112237.0074902361,112237.0074902361,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SLC3A2,0.092999995,1.268,0.4696,4,-1.0,-1.0,Disease;Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-1643685;R-HSA-425393
ENSG00000168060,1,1,1,0,1,1,21939.796916619583,40455.65678857565,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,NAALADL1,-0.08000004,0.22631,1.2697,0,1.0,-1.0,,
ENSG00000168066,1,1,1,0,0,1,221280.45048451523,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,SF1,0.78,3.5272,-2.3781,1,-1.0,-1.0,,
ENSG00000168081,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PNOC,-0.10699999,0.24413,-0.36404,2,0.75,0.5,Signal Transduction,R-HSA-162582
ENSG00000168092,1,1,0,0,0,1,66438.21345734232,66438.21345734232,2021-12-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PAFAH1B2,0.329,1.6935,0.071541,2,-1.0,-1.0,Immune System;Golgi-to-ER retrograde transport,R-HSA-168256;R-HSA-8856688
ENSG00000168137,1,1,1,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SETD5,0.624,2.0399,-0.83183,0,-1.0,-1.0,,
ENSG00000168143,1,1,0,0,0,1,221280.45048451523,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,FAM83B,0.08499998,0.086918,0.5859,4,0.5,0.0,Signal Transduction;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-9006934
ENSG00000168159,1,1,1,0,0,1,9990.13125608735,9990.13125608735,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RNF187,-0.75699997,-1.9835,-2.4621,0,-1.0,-1.0,,
ENSG00000168175,1,1,1,0,0,0,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MAPK1IP1L,0.24800003,1.3901,0.20291,0,-1.0,-1.0,,
ENSG00000168214,1,1,0,0,0,1,2209.8301559792026,58392.07057732553,2013-12-25,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,RBPJ,0.73300004,3.9052,0.27833,12,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Disease;Diseases of signal transduction by growth factor receptors and second messengers;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-5663202;R-HSA-8878159
ENSG00000168243,1,1,1,0,0,1,68837.80679818468,68837.80679818468,2022-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,GNG4,-0.896,0.029689,0.17294,29,0.5,0.0,"Signal Transduction;Presynaptic function of Kainate receptors;ADP signalling through P2Y purinoceptor 12;Thromboxane signalling through TP receptor;G beta:gamma signalling through PLC beta;Prostacyclin signalling through prostacyclin receptor;G beta:gamma signalling through BTK;ADP signalling through P2Y purinoceptor 1;G beta:gamma signalling through PI3Kgamma;Signal amplification;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Disease;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Activation of kainate receptors upon glutamate binding;Adrenaline,noradrenaline inhibits insulin secretion;G-protein beta:gamma signalling;Inwardly rectifying K+ channels",R-HSA-162582;R-HSA-500657;R-HSA-392170;R-HSA-428930;R-HSA-418217;R-HSA-392851;R-HSA-8964315;R-HSA-418592;R-HSA-392451;R-HSA-392518;R-HSA-202040;R-HSA-6814122;R-HSA-1643685;R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-451326;R-HSA-400042;R-HSA-397795;R-HSA-1296065
ENSG00000168275,2,1,0,0,0,1,37323.99073154585,270756.050710225,2018-08-13,0,0,0,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,COA6,-0.06500006,-1.1036,-0.79233,1,-1.0,-1.0,,
ENSG00000168300,2,1,1,0,0,1,6216.448089338684,40553.36956362069,2012-08-26,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,PCMTD1,0.55700004,3.2236,1.2741,0,-1.0,-1.0,,
ENSG00000168301,1,1,0,0,0,1,13219.952617929488,13219.952617929488,2015-10-26,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,KCTD6,0.22100002,2.8697,1.2552,4,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 regulates estrogen receptor mediated transcription;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-8931987;R-HSA-597592
ENSG00000168329,2,1,0,0,0,1,116089.30071075787,215157.94798738702,2020-06-24,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,3,CX3CR1,-0.38100004,1.5925,0.81404,4,0.5,0.0,Signal Transduction;Disease,R-HSA-162582;R-HSA-1643685
ENSG00000168334,1,1,0,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,XIRP1,,0.38316,-0.12182,0,0.75,0.0,,
ENSG00000168348,1,1,0,0,0,1,196178.71491042234,196178.71491042234,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,INSM2,0.204,-0.69078,-2.3046,0,0.5,0.5,,
ENSG00000168350,1,1,1,0,0,1,170842.91114447502,170842.91114447502,2024-07-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,DEGS2,-0.125,1.0305,0.046767,1,0.5,0.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000168411,3,1,1,0,1,0,1500.8351648351647,42362.45324254164,2013-05-12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,RFWD3,0.069000006,-0.99238,-1.6524,0,0.5,-1.0,,
ENSG00000168447,2,1,0,0,0,1,157277.57551067916,183761.6081180644,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,SCNN1B,0.19,1.5213,-0.029999,2,0.5,0.0,Stimuli-sensing channels,R-HSA-2672351
ENSG00000168453,1,1,0,0,0,1,58331.23271678036,58331.23271678036,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,HR,0.15200001,0.15368,-1.2055,0,0.5,0.0,,
ENSG00000168454,1,1,0,0,0,0,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TXNDC2,-0.903,1.0658,1.3272,0,1.0,1.0,,
ENSG00000168481,1,1,1,0,0,1,134703.04231665854,134703.04231665854,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LGI3,-0.06700003,1.1584,-0.088976,1,1.0,0.0,LGI-ADAM interactions;Developmental Biology,R-HSA-5682910;R-HSA-1266738
ENSG00000168509,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HJV,-0.148,0.30504,0.35339,1,0.75,0.5,,
ENSG00000168538,1,1,0,0,0,1,2240.9147424511543,2240.9147424511543,2018-03-01,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,TRAPPC11,0.18400002,1.17,0.66465,1,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000168591,1,1,1,0,0,0,91613.68494311013,91613.68494311013,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TMUB2,-0.268,0.083406,-0.43117,0,-1.0,-1.0,,
ENSG00000168675,1,1,1,0,0,1,515513.2178404211,515513.2178404211,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LDLRAD4,0.334,1.8097,0.48405,0,0.5,0.0,,
ENSG00000168765,1,1,1,0,0,1,278498.5074409075,278498.5074409075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GSTM4,-0.21399999,0.88994,0.17593,2,0.5,-1.0,Glutathione conjugation;Phase II - Conjugation of compounds,R-HSA-156590;R-HSA-156580
ENSG00000168813,1,1,0,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ZNF507,0.538,1.0208,-0.53644,0,-1.0,-1.0,,
ENSG00000168899,1,1,1,0,0,1,186139.38238354117,186139.38238354117,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VAMP5,-0.668,0.73359,0.14391,0,-1.0,-1.0,,
ENSG00000168961,1,1,0,0,0,1,8249.958661373992,8249.958661373992,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LGALS9,-0.018000007,1.4536,0.97673,1,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000169019,1,1,0,0,0,1,219437.49527928562,219437.49527928562,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,COMMD8,-0.36899996,-0.30695,-0.87027,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000169105,1,1,0,0,0,1,135095.86576106868,135095.86576106868,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CHST14,0.083000004,0.41448,-0.76813,2,-1.0,-1.0,DS-GAG biosynthesis;Disease,R-HSA-2022923;R-HSA-1643685
ENSG00000169122,1,1,0,0,0,1,138626.81357188412,138626.81357188412,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FAM110B,0.43400002,1.4138,0.016217,0,-1.0,-1.0,,
ENSG00000169169,1,1,1,0,0,1,54703.55383629191,215157.94798738702,2018-08-13,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,5,CPT1C,0.222,1.1543,-0.35016,0,0.5,0.0,,
ENSG00000169241,1,1,1,0,0,0,125299.9543761523,263416.51565448404,2019-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,SLC50A1,-0.07099998,1.1891,1.1263,1,-1.0,-1.0,Cellular hexose transport,R-HSA-189200
ENSG00000169327,1,1,0,0,0,1,286746.1002745869,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,OR5AU1,-0.87600005,-0.38518,-0.33475,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000169330,1,1,0,0,0,1,433862.5685735124,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MINAR1,0.23799998,0.85711,-0.18431,0,0.5,0.5,,
ENSG00000169432,2,1,1,0,0,1,2762.5939615736506,197485.87952538437,2023-06-05,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SCN9A,0.14499998,1.2545,0.22219,3,0.5,0.0,Developmental Biology;Interaction between L1 and Ankyrins,R-HSA-1266738;R-HSA-445095
ENSG00000169562,1,1,0,0,0,1,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,GJB1,,,,4,0.75,0.0,Developmental Biology;Gap junction assembly;Gap junction trafficking and regulation;Gap junction trafficking,R-HSA-1266738;R-HSA-190861;R-HSA-157858;R-HSA-190828
ENSG00000169607,1,1,1,0,1,0,5404.47527601613,5404.47527601613,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CKAP2L,0.27999997,-0.018164,0.18536,0,0.75,0.5,,
ENSG00000169609,1,1,1,0,1,0,150669.89240227733,150669.89240227733,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,C15orf40,-0.07000005,-0.71198,-1.4389,0,-1.0,-1.0,,
ENSG00000169696,2,1,1,1,1,1,286746.1002745869,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,ASPSCR1,-0.051,-0.33034,-1.1042,1,-1.0,-1.0,,
ENSG00000169710,1,1,1,0,0,1,263416.51565448404,263416.51565448404,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,FASN,0.71599996,1.9674,-5.4169,5,0.5,-1.0,Signal Transduction;Vitamin B5 (pantothenate) metabolism;Fatty acyl-CoA biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-162582;R-HSA-199220;R-HSA-75105;R-HSA-8957322;R-HSA-1655829
ENSG00000169756,1,1,1,0,0,1,10101.607968694414,10101.607968694414,2018-06-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LIMS1,0.13300002,2.6695,0.83876,2,-1.0,-1.0,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,R-HSA-446388
ENSG00000169908,1,1,1,0,0,1,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TM4SF1,-0.19099998,0.12585,-0.37471,0,-1.0,-1.0,,
ENSG00000169933,2,1,0,0,0,1,37673.655583024774,37673.655583024774,2021-01-19,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,FRMPD4,,,,0,0.75,0.5,,
ENSG00000169967,1,1,1,0,0,1,39979.04830391424,49338.897692059916,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,MAP3K2,0.39999998,1.077,-0.17683,0,-1.0,-1.0,,
ENSG00000170166,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,HOXD4,0.021000028,0.20341,-0.48132,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000170180,1,1,0,0,0,1,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GYPA,-0.717,0.20424,-0.40475,1,1.0,0.5,,
ENSG00000170262,1,1,1,0,0,1,358386.30063935445,427337.4491868293,2021-11-04,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MRAP,-0.44000006,-0.18356,0.29908,0,0.75,0.0,,
ENSG00000170275,1,1,0,0,0,0,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CRTAP,-0.25100005,-2.2798,-1.8719,1,-1.0,-1.0,,
ENSG00000170289,1,1,0,0,0,0,37221.07677995828,86869.04450932604,2018-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,CNGB3,-0.04400003,-0.15051,0.31226,0,0.5,0.5,,
ENSG00000170290,1,1,0,0,0,1,66203.96786022185,66203.96786022185,2011-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLN,-0.63399994,0.2475,-0.49651,2,0.75,0.0,,
ENSG00000170312,1,1,0,0,0,1,23238.11336553945,23238.11336553945,2020-01-31,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CDK1,0.435,2.2306,0.30875,36,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;E2F-enabled inhibition of pre-replication complex formation;Generic Transcription Pathway;Immune System;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;E2F mediated regulation of DNA replication;RNA Polymerase II Transcription;Cyclin A/B1/B2 associated events during G2/M transition;Gene expression (Transcription);G1/S-Specific Transcription;MASTL Facilitates Mitotic Progression;Condensation of Prophase Chromosomes;Depolymerization of the Nuclear Lamina;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;Post-translational protein modification,R-HSA-162582;R-HSA-1280215;R-HSA-113507;R-HSA-212436;R-HSA-168256;R-HSA-1362300;R-HSA-113510;R-HSA-73857;R-HSA-69273;R-HSA-74160;R-HSA-69205;R-HSA-2465910;R-HSA-2299718;R-HSA-4419969;R-HSA-75035;R-HSA-597592
ENSG00000170345,2,1,1,0,0,1,19965.24128263536,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,7,FOS,0.41900003,1.4397,-0.068801,10,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Interleukins;Activation of the AP-1 family of transcription factors;Signaling by Receptor Tyrosine Kinases;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-449147;R-HSA-450341;R-HSA-9006934;R-HSA-6785807
ENSG00000170385,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC30A1,0.59099996,3.3578,0.20313,1,0.5,-1.0,,
ENSG00000170476,1,1,0,1,0,0,5495.191484272216,21724.94108458234,2021-01-25,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,MZB1,-0.33599997,-0.86844,-0.83895,0,0.5,0.0,,
ENSG00000170477,1,1,0,0,0,0,45017.54457704817,45017.54457704817,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KRT4,-0.08899999,0.56154,0.49641,2,1.0,0.0,Developmental Biology,R-HSA-1266738
ENSG00000170683,1,1,0,0,0,1,4970.162871968654,41398.32424291887,2012-10-07,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,OR10A3,-0.571,-0.20005,0.24117,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000170788,1,1,1,0,0,0,100711.28404230655,100711.28404230655,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DYDC1,-0.059999943,0.25532,-0.11978,0,1.0,0.5,,
ENSG00000170836,1,1,0,0,0,1,286678.73247515375,286678.73247515375,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,PPM1D,-0.18299997,2.7759,0.0022131,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000170860,4,1,0,0,0,1,6576.606876790831,756470.9740366563,2021-01-25,0,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,LSM3,-0.849,1.3496,0.31725,2,-1.0,-1.0,,
ENSG00000170871,1,1,0,0,0,0,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KIAA0232,0.7,1.4848,0.016231,0,-1.0,-1.0,,
ENSG00000170876,1,1,0,0,0,1,180344.38517486732,180344.38517486732,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TMEM43,-0.13,0.13944,0.73212,0,-1.0,-1.0,,
ENSG00000170889,1,1,1,0,0,1,19965.24128263536,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,RPS9,0.735,3.1167,0.30778,19,-1.0,-1.0,Developmental Biology;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-1266738;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956
ENSG00000170955,2,1,1,0,0,1,286746.1002745869,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,CAVIN3,-0.95799994,-2.2938,-2.7508,0,-1.0,0.0,,
ENSG00000170989,1,1,0,0,0,1,2828.4945776739683,2828.4945776739683,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,S1PR1,0.678,3.0495,0.16892,3,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Disease;Signaling by Interleukins;Lysosphingolipid and LPA receptors;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1643685;R-HSA-449147;R-HSA-419408;R-HSA-6785807
ENSG00000171017,1,1,0,0,0,0,254373.32653042395,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LRRC8E,-0.906,0.35981,0.012121,1,-1.0,0.0,Miscellaneous transport and binding events,R-HSA-5223345
ENSG00000171060,1,1,0,0,0,0,104995.5848091724,104995.5848091724,2023-01-18,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,C8orf74,-0.85800004,-2.9924,-4.0403,0,1.0,1.0,,
ENSG00000171119,1,1,0,0,0,1,134159.95265752633,134159.95265752633,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,NRTN,-0.14499998,-2.4302,-3.1139,3,0.5,0.0,Signal Transduction;Developmental Biology,R-HSA-162582;R-HSA-1266738
ENSG00000171234,1,1,0,0,1,1,112345.61202884468,112345.61202884468,2021-01-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,UGT2B7,-0.20299995,-1.1785,-0.27691,3,0.75,0.0,Prednisone ADME;Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-9757110;R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000171246,1,1,1,1,1,1,353105.3286394775,353105.3286394775,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NPTX1,0.48000002,1.6082,-0.81528,0,1.0,0.0,,
ENSG00000171403,1,1,0,0,0,1,15223.454539395489,15223.454539395489,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KRT9,0.12699997,0.73017,0.12932,2,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000171469,1,1,0,0,0,1,25778.35048791522,25778.35048791522,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZNF561,-0.32500005,0.21686,0.29096,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000171532,1,1,0,0,0,1,197775.78125685986,197775.78125685986,2022-10-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NEUROD2,0.102999985,1.888,-1.4123,0,1.0,1.0,,
ENSG00000171551,1,1,0,0,0,1,43732.839609234245,43732.839609234245,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,ECEL1,-0.09899998,-0.41176,-1.9969,0,0.75,0.0,,
ENSG00000171564,1,1,0,0,1,1,97822.37358221927,97822.37358221927,2022-10-12,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FGB,0.338,1.2427,0.23421,18,1.0,0.5,Signal Transduction;Immune System;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-168256;R-HSA-1643685;R-HSA-5663202
ENSG00000171608,1,1,1,0,0,1,17115.61307125707,17115.61307125707,2017-06-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PIK3CD,0.77,6.3956,0.49645,14,0.75,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Disease;Signaling by Interleukins;Regulation of signaling by CBL;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-449147;R-HSA-912631;R-HSA-5663202
ENSG00000171812,2,1,1,0,0,1,56101.88409046092,100711.28404230655,2021-02-24,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,COL8A2,-0.13900006,0.29122,-2.323,5,-1.0,0.0,,
ENSG00000171867,2,1,1,0,1,1,350.33688165309957,12618.041744442558,2008-12-11,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,PRNP,-0.036000013,1.4439,0.37349,2,0.5,-1.0,Developmental Biology;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,R-HSA-1266738;R-HSA-9609523
ENSG00000171962,1,1,0,0,1,0,131525.74533408263,131525.74533408263,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,DRC3,-0.055999994,0.53783,0.71236,0,0.5,0.0,,
ENSG00000172009,1,1,1,0,0,1,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,THOP1,0.12400001,1.4988,-0.19712,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000172113,1,1,1,0,0,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NME6,-0.16199994,0.52319,1.7449,0,-1.0,-1.0,,
ENSG00000172156,3,1,0,0,0,1,21897.542503344637,160010.51072069994,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,5,CCL11,-0.742,-0.63377,-1.6864,2,0.5,0.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-449147;R-HSA-6785807
ENSG00000172159,1,1,0,0,0,1,2208.584112906379,2208.584112906379,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,FRMD3,0.43699998,1.3304,-0.049251,0,0.5,0.0,,
ENSG00000172172,1,1,0,0,0,0,1571.446153846154,4368.573359840954,2013-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,MRPL13,-0.842,-0.29656,-0.51069,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000172175,1,1,1,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,MALT1,0.42000002,2.3096,-0.3102,5,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000172208,1,1,0,0,0,1,11798.46653227782,11798.46653227782,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,OR4X2,-0.89199996,-3.2466,-2.7059,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000172247,1,1,0,0,0,1,105453.60460439936,105453.60460439936,2022-10-12,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,C1QTNF4,-0.78400004,-2.0297,-2.3432,0,1.0,0.0,,
ENSG00000172270,1,1,1,0,0,0,143284.77790855977,143284.77790855977,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BSG,-0.25399995,-1.2919,-3.2729,6,-1.0,-1.0,Disease;Aspirin ADME,R-HSA-1643685;R-HSA-9749641
ENSG00000172292,1,1,1,0,0,1,294387.2978738704,294387.2978738704,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CERS6,0.407,1.1612,0.9004,1,-1.0,-1.0,Sphingolipid de novo biosynthesis,R-HSA-1660661
ENSG00000172318,1,1,0,0,0,1,727796.3668420183,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,B3GALT1,0.29000002,2.2874,-0.28512,1,0.5,0.5,,
ENSG00000172349,1,1,1,1,1,0,3511.742535866615,3511.742535866615,2017-04-20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IL16,0.22500002,1.5885,-0.10929,1,0.5,0.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000172362,1,1,0,0,0,1,64507.782812759775,105453.60460439936,2022-10-12,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,OR5B12,,-0.37955,-0.51489,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000172399,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MYOZ2,-0.032999992,1.3051,1.1101,0,0.5,0.5,,
ENSG00000172457,2,1,0,0,1,1,105281.95721639719,105281.95721639719,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,OR9G4,-0.59000003,-0.68068,-1.2286,0,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000172534,1,1,1,0,0,0,29858.247282295106,29858.247282295106,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,HCFC1,,,,4,-1.0,-1.0,Gene expression (Transcription);Post-translational protein modification,R-HSA-74160;R-HSA-597592
ENSG00000172548,1,1,1,0,0,1,185805.42963097955,185805.42963097955,2021-11-04,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,NIPAL4,-0.03699994,1.1053,1.4834,1,0.5,0.0,Miscellaneous transport and binding events,R-HSA-5223345
ENSG00000172602,1,1,0,0,0,1,191895.42310022408,191895.42310022408,2023-11-02,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,RND1,0.439,1.0021,0.36146,4,0.5,0.0,Signal Transduction;Developmental Biology;Sema4D mediated inhibition of cell attachment and migration,R-HSA-162582;R-HSA-1266738;R-HSA-416550
ENSG00000172640,1,1,1,0,1,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR10AD1,,,,1,0.5,1.0,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000172667,1,1,1,0,0,1,125392.97184483419,125392.97184483419,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZMAT3,0.241,0.9061,0.94798,0,-1.0,-1.0,,
ENSG00000172757,1,1,1,0,0,1,75978.4105377159,75978.4105377159,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CFL1,0.592,3.3773,-1.4342,6,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;Developmental Biology;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-449147
ENSG00000172771,1,1,0,0,1,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,EFCAB12,-0.06099999,1.1101,0.47095,0,0.5,0.0,,
ENSG00000172817,5,1,1,0,0,0,195666.44200393453,1122672.658801146,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,9,CYP7B1,0.111,-0.54362,-0.67992,5,0.5,0.0,Disease;Synthesis of bile acids and bile salts;Metabolism of steroids;Bile acid and bile salt metabolism,R-HSA-1643685;R-HSA-192105;R-HSA-8957322;R-HSA-194068
ENSG00000172830,1,1,1,0,0,1,1470466.6505612188,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,SSH3,-0.069000006,0.84091,1.1751,0,-1.0,-1.0,,
ENSG00000172893,1,1,1,0,0,1,376845.12303102604,376845.12303102604,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DHCR7,-0.08700001,0.76289,-0.74898,3,0.5,-1.0,Cholesterol biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-191273;R-HSA-8957322;R-HSA-1655829
ENSG00000172901,3,1,1,0,1,1,64327.12811839673,1470466.6505612188,2021-08-24,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,6,LVRN,-0.102,-1.763,-0.49867,0,0.75,0.5,,
ENSG00000173041,1,1,0,0,0,1,298504.9722193353,298504.9722193353,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF680,0.013000011,1.1238,1.2965,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of endogenous retroelements by KRAB-ZFP proteins,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9843940
ENSG00000173085,1,1,1,0,0,1,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,COQ2,-0.031999946,-1.2344,-1.5699,2,0.5,-1.0,,
ENSG00000173214,1,1,1,0,0,1,11052.199934661876,28923.750134754748,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,MFSD4B,-0.577,1.084,0.80738,1,-1.0,0.0,Cellular hexose transport,R-HSA-189200
ENSG00000173276,1,1,1,0,0,1,124837.11004999638,124837.11004999638,2022-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ZBTB21,0.524,1.1064,-0.37955,0,0.5,-1.0,,
ENSG00000173436,1,1,0,0,0,1,18319.91238877481,18319.91238877481,2024-09-13,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MICOS10,-0.398,-1.1478,-0.77146,1,-1.0,-1.0,Cristae formation,R-HSA-8949613
ENSG00000173467,3,1,0,0,0,1,19046.182555669562,194667.2540182328,2015-08-03,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,AGR3,-0.93200004,-0.43599,-0.31183,0,0.5,0.0,,
ENSG00000173480,1,1,0,0,1,0,205739.47405036874,205739.47405036874,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ZNF417,-0.46800005,2.9854,2.5617,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000173530,1,1,0,0,1,1,111599.28184123649,111599.28184123649,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TNFRSF10D,0.083000004,0.043234,0.40065,3,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000173548,1,1,0,0,0,1,254373.32653042395,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SNX33,0.269,1.8783,1.5373,0,-1.0,0.0,,
ENSG00000173559,1,1,0,0,0,1,2567.3265040255237,2567.3265040255237,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,NABP1,-0.52900004,0.17953,0.91542,1,0.5,0.0,RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes,R-HSA-73857;R-HSA-74160;R-HSA-6807505
ENSG00000173572,1,1,0,0,0,1,7437.959517966932,7437.959517966932,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,NLRP13,-0.019000053,-1.3348,-1.5147,0,0.5,1.0,,
ENSG00000173627,1,1,0,0,0,1,23238.11336553945,23238.11336553945,2020-01-31,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,APOBEC4,-0.41199994,1.5505,0.96266,2,0.75,0.5,,
ENSG00000173681,1,1,1,0,0,0,396735.32121509424,396735.32121509424,2022-06-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,BCLAF3,,,,0,-1.0,-1.0,,
ENSG00000173698,1,1,0,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ADGRG2,,,,0,1.0,0.0,,
ENSG00000173705,1,1,0,0,0,1,3078.048383450147,3078.048383450147,2024-01-10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SUSD5,-0.604,0.50121,0.59306,0,-1.0,0.0,,
ENSG00000173706,2,1,1,0,0,0,260210.21963428933,294387.2978738704,2021-09-30,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,HEG1,0.35500002,1.2682,0.42367,0,-1.0,-1.0,,
ENSG00000173838,1,1,0,0,0,1,16409.925988616185,16409.925988616185,2024-07-24,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MARCHF10,0.06800002,1.563,1.0889,0,1.0,0.5,,
ENSG00000173852,1,1,0,0,0,1,6240.257224606581,6240.257224606581,2018-08-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,DPY19L1,0.36699998,1.7514,0.88278,0,-1.0,-1.0,,
ENSG00000173889,1,1,1,0,0,1,220837.49604317299,521818.7070055739,2023-11-09,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PHC3,0.815,2.793,-0.12057,9,0.5,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);SUMOylation of RNA binding proteins;Transcriptional Regulation by E2F6;Post-translational protein modification,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-4570464;R-HSA-8953750;R-HSA-597592
ENSG00000173905,1,1,0,0,0,1,515513.2178404211,1424218.0900670097,2020-06-15,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,GOLIM4,0.22799999,0.56538,-0.16341,1,-1.0,-1.0,,
ENSG00000173908,1,1,0,0,0,1,21897.542503344637,21897.542503344637,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KRT28,-0.19700003,0.52273,0.36042,2,1.0,1.0,Developmental Biology,R-HSA-1266738
ENSG00000173915,1,1,1,0,0,0,3479.8716981132075,3479.8716981132075,2015-11-25,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,ATP5MK,-0.615,0.46164,-0.50339,2,-1.0,-1.0,Formation of ATP by chemiosmotic coupling;Cristae formation,R-HSA-163210;R-HSA-8949613
ENSG00000174151,1,1,1,0,0,1,197775.78125685986,197775.78125685986,2022-10-20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CYB561D1,-0.18599999,-0.25228,-0.94613,0,-1.0,-1.0,,
ENSG00000174206,1,1,0,0,0,1,155552.2805078301,155552.2805078301,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KICS2,0.38099998,1.8197,0.75665,1,-1.0,-1.0,Amino acids regulate mTORC1;Cellular response to starvation,R-HSA-9639288;R-HSA-9711097
ENSG00000174226,1,1,1,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SNX31,-0.097,0.4662,0.54983,0,0.5,0.5,,
ENSG00000174238,1,1,0,0,0,1,100711.28404230655,100711.28404230655,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PITPNA,0.519,2.5244,0.077043,2,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Developmental Biology;Role of second messengers in netrin-1 signaling;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-1266738;R-HSA-418890;R-HSA-449147
ENSG00000174373,1,1,1,0,0,1,565426.5954047199,565426.5954047199,2024-07-19,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,RALGAPA1,0.708,5.3669,2.2842,1,-1.0,-1.0,Signal Transduction,R-HSA-162582
ENSG00000174453,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,VWC2L,0.259,1.7488,0.1557,0,0.75,0.5,,
ENSG00000174460,1,1,0,0,0,1,135095.86576106868,135095.86576106868,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZCCHC12,,,,0,0.75,0.0,,
ENSG00000174672,1,1,0,0,0,1,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,BRSK2,0.639,2.1289,-2.7854,0,0.75,0.0,,
ENSG00000174788,1,1,1,0,0,1,455.18696069031637,455.18696069031637,2018-06-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,PCP2,-0.93299997,-1.234,-1.7409,1,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000174827,1,1,1,0,0,1,16386.12478006288,384314.83364002535,2021-04-08,0,0,0,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,11,PDZK1,-0.39100003,1.6942,1.9849,0,1.0,0.0,,
ENSG00000174928,1,1,0,0,0,1,182720.23308494932,182720.23308494932,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,C3orf33,-0.38199997,-0.52659,-1.3046,0,-1.0,-1.0,,
ENSG00000174937,1,1,0,0,0,1,109001.36551434857,109001.36551434857,2022-10-12,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR5M3,-0.85099995,-0.45328,-0.34753,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000175048,1,1,0,0,0,1,100369.06546210802,100369.06546210802,2019-10-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ZDHHC14,0.486,1.9242,-0.6819,0,-1.0,0.0,,
ENSG00000175084,1,1,1,0,0,1,78398.053695655,78398.053695655,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DES,0.19,0.37093,-0.53628,1,0.5,0.0,,
ENSG00000175087,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PDIK1L,0.44599998,3.8488,0.86991,0,-1.0,0.0,,
ENSG00000175121,1,1,1,0,0,0,62627.34914844415,62627.34914844415,2024-01-05,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,WFDC5,-0.462,0.23284,0.28161,0,1.0,0.5,,
ENSG00000175203,1,1,0,0,0,1,1129585.974638378,1129585.974638378,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,DCTN2,0.45999998,1.4422,0.34289,11,-1.0,-1.0,Immune System;Golgi-to-ER retrograde transport;Post-translational protein modification,R-HSA-168256;R-HSA-8856688;R-HSA-597592
ENSG00000175206,1,1,1,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NPPA,-0.301,-0.2232,-0.071433,3,1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000175224,1,1,0,0,0,0,4891.641745028519,4891.641745028519,2016-10-10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ATG13,0.527,2.0011,0.24754,1,-1.0,-1.0,,
ENSG00000175309,1,1,0,0,0,0,87248.80974040499,87248.80974040499,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PHYKPL,-0.01999998,-0.68471,-0.70821,2,-1.0,-1.0,,
ENSG00000175356,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SCUBE2,-0.0010000467,1.4101,1.3812,1,0.5,0.0,Signal Transduction;Release of Hh-Np from the secreting cell;Hedgehog ligand biogenesis,R-HSA-162582;R-HSA-5362798;R-HSA-5358346
ENSG00000175513,1,1,1,0,1,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,TSGA10IP,-0.30499995,0.085967,-0.9945,0,1.0,1.0,,
ENSG00000175619,1,1,0,0,0,1,252346.18526092035,252346.18526092035,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR4B1,-0.94299996,-2.4067,-2.0891,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000175646,2,1,0,0,0,1,32254.717802479194,160010.51072069994,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,4,PRM1,-0.638,-0.34856,-0.58775,1,1.0,0.0,Replacement of protamines by nucleosomes in the male pronucleus;Developmental Biology,R-HSA-9821993;R-HSA-1266738
ENSG00000175782,1,1,0,0,0,1,355284.1215006515,355284.1215006515,2025-03-06,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SLC35E3,-0.26600003,0.32785,0.47694,0,-1.0,0.5,,
ENSG00000175832,1,1,0,0,0,1,105821.21679070941,105821.21679070941,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,ETV4,0.17900002,0.89876,0.84645,1,-1.0,0.0,Signal Transduction,R-HSA-162582
ENSG00000175894,1,1,0,0,0,0,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TSPEAR,-0.16100001,-0.73843,-0.27028,0,0.5,0.5,,
ENSG00000175985,1,1,0,0,0,1,16534.94713490521,16534.94713490521,2024-11-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PLEKHD1,0.08899999,1.169,0.5811,0,0.5,0.5,,
ENSG00000176155,1,1,1,0,0,1,125821.84557838629,125821.84557838629,2023-03-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CCDC57,-0.26,-0.37485,-0.37786,0,-1.0,0.0,,
ENSG00000176177,1,1,0,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ENTHD1,0.07200003,1.3001,1.234,0,1.0,0.5,,
ENSG00000176208,1,1,0,0,0,0,397765.9672627851,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ATAD5,0.583,2.4753,1.2732,0,0.5,0.0,,
ENSG00000176294,1,1,0,0,0,1,4294.233261840138,4294.233261840138,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR4N2,-0.888,0.56829,-0.87028,1,1.0,1.0,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000176371,1,1,1,0,0,1,1470466.6505612188,1470466.6505612188,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ZSCAN2,0.26099998,1.2155,-0.015945,0,-1.0,-1.0,,
ENSG00000176533,1,1,0,0,0,0,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,GNG7,0.13099998,0.56644,-0.10791,29,1.0,-1.0,"Signal Transduction;Presynaptic function of Kainate receptors;ADP signalling through P2Y purinoceptor 12;Thromboxane signalling through TP receptor;G beta:gamma signalling through PLC beta;Prostacyclin signalling through prostacyclin receptor;G beta:gamma signalling through BTK;ADP signalling through P2Y purinoceptor 1;G beta:gamma signalling through PI3Kgamma;Signal amplification;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Disease;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Activation of kainate receptors upon glutamate binding;Adrenaline,noradrenaline inhibits insulin secretion;G-protein beta:gamma signalling;Inwardly rectifying K+ channels",R-HSA-162582;R-HSA-500657;R-HSA-392170;R-HSA-428930;R-HSA-418217;R-HSA-392851;R-HSA-8964315;R-HSA-418592;R-HSA-392451;R-HSA-392518;R-HSA-202040;R-HSA-6814122;R-HSA-1643685;R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-451326;R-HSA-400042;R-HSA-397795;R-HSA-1296065
ENSG00000176542,1,1,0,0,1,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,USF3,0.742,2.7954,1.6608,0,-1.0,-1.0,,
ENSG00000176871,1,1,0,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,WSB2,0.63699996,3.4035,0.82737,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000176927,1,1,1,0,1,0,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,EFCAB5,0.09200001,0.8436,0.92352,0,1.0,0.5,,
ENSG00000176946,1,1,1,0,0,1,260631.24114204012,269829.0934099178,2024-07-19,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,THAP4,0.41500002,1.5952,-0.57339,0,-1.0,-1.0,,
ENSG00000176986,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SEC24C,0.725,2.5192,0.994,6,-1.0,-1.0,Immune System;Disease;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Post-translational protein modification,R-HSA-168256;R-HSA-1643685;R-HSA-8957322;R-HSA-1655829;R-HSA-597592
ENSG00000177042,1,1,1,0,0,0,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,TMEM80,-0.696,0.54823,0.026224,0,-1.0,-1.0,,
ENSG00000177191,1,1,1,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,B3GNT8,-0.855,0.49204,-0.66704,1,0.5,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000177272,1,1,0,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,KCNA3,0.222,2.8482,0.73433,1,0.5,0.5,,
ENSG00000177302,1,1,1,0,0,1,13298.635084734673,13298.635084734673,2016-06-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,TOP3A,0.263,2.2407,0.29703,16,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Disease,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1643685
ENSG00000177535,1,1,0,0,0,1,74722.59037384245,100358.73833384078,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,OR2B11,,-0.12351,-0.81269,2,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000177606,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,JUN,0.28399998,1.2855,-1.4455,13,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Killing mechanisms;WNT5:FZD7-mediated leishmania damping;Developmental Biology;Gene expression (Transcription);Disease;Signaling by Interleukins;Activation of the AP-1 family of transcription factors;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-9664420;R-HSA-9673324;R-HSA-1266738;R-HSA-74160;R-HSA-1643685;R-HSA-449147;R-HSA-450341;R-HSA-5663202
ENSG00000177613,1,1,0,0,0,1,155552.2805078301,197485.87952538437,2023-01-18,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CSTF2T,0.353,1.9959,0.14985,4,-1.0,-1.0,RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-73857;R-HSA-74160
ENSG00000177666,1,1,1,0,0,1,1161.9711129991504,1161.9711129991504,2019-12-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PNPLA2,-0.22099996,-2.1674,-3.6758,4,0.5,-1.0,Gene expression (Transcription);Post-translational protein modification;Acyl chain remodeling of DAG and TAG,R-HSA-74160;R-HSA-597592;R-HSA-1482883
ENSG00000177791,1,1,0,0,0,1,228220.5662976458,228220.5662976458,2018-07-30,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MYOZ1,0.004000008,0.405,0.47287,0,0.75,0.0,,
ENSG00000177917,1,1,1,0,0,0,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ARL6IP6,-0.42999995,-1.5381,-1.7446,0,0.5,-1.0,,
ENSG00000178026,2,1,1,0,0,1,77164.05844515702,105873.71696731678,2023-11-30,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,LRRC75B,-0.725,0.20597,-0.46372,0,0.5,0.0,,
ENSG00000178163,1,1,1,0,1,1,7972.656478133315,230312.26972227366,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,0,0,0,0,14,ZNF518B,0.449,-1.1656,-0.86261,0,-1.0,-1.0,,
ENSG00000178233,1,1,0,0,0,1,14639.784588829983,58392.07057732553,2013-12-25,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,5,TMEM151B,0.013999999,0.35249,-1.6456,0,1.0,0.5,,
ENSG00000178381,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZFAND2A,-0.94000006,-1.0172,-2.0024,0,-1.0,-1.0,,
ENSG00000178695,2,1,0,0,0,1,24013.64248317128,42879.69557188197,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,KCTD12,-0.51,-0.70801,-3.0465,0,-1.0,-1.0,,
ENSG00000178750,1,1,0,0,0,1,56614.28807963426,56614.28807963426,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,STX19,-0.41900003,-0.39466,-0.19652,0,0.5,0.0,,
ENSG00000178764,1,1,1,0,0,1,58995.33218928629,521818.7070055739,2023-11-09,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,ZHX2,0.48299998,2.5944,0.66294,0,-1.0,-1.0,,
ENSG00000178809,1,1,1,0,0,1,85474.33432267047,118061.55082048493,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,2,TRIM73,0.551,3.237,2.7875,0,-1.0,-1.0,,
ENSG00000179059,1,1,0,0,0,1,17115.61307125707,17115.61307125707,2017-06-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZFP42,-0.94000006,-0.7098,-0.86477,0,0.5,1.0,,
ENSG00000179133,1,1,0,0,0,1,135095.86576106868,1424218.0900670097,2021-09-30,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,C10orf67,-0.88699996,-0.96286,-0.90465,0,0.5,0.5,,
ENSG00000179241,1,1,0,0,0,1,130268.53228984597,130268.53228984597,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LDLRAD3,-0.032999992,0.91757,1.7399,0,0.5,-1.0,,
ENSG00000179284,1,1,0,0,0,1,1122672.658801146,1122672.658801146,2024-01-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,DAND5,-0.521,0.19988,0.49685,2,0.5,0.5,Developmental Biology;Regulation of signaling by NODAL,R-HSA-1266738;R-HSA-1433617
ENSG00000179299,1,1,0,0,0,1,29713.571045654095,29713.571045654095,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NSUN7,-0.245,1.1076,1.1104,0,0.5,0.0,,
ENSG00000179361,1,1,0,0,0,1,2560.851236868858,2560.851236868858,2016-02-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ARID3B,0.668,3.1154,2.3663,0,0.5,-1.0,,
ENSG00000179627,2,1,0,0,1,1,51573.04760983911,521818.7070055739,2023-11-09,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,ZBTB42,-0.63100004,0.32755,-0.26803,0,-1.0,0.0,,
ENSG00000179639,1,1,1,1,0,0,157563.09954473734,157563.09954473734,2023-07-10,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FCER1A,-0.42499995,-0.041667,-0.25878,5,0.5,0.0,Immune System,R-HSA-168256
ENSG00000179695,1,1,0,0,1,1,112068.90873552008,112068.90873552008,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR6C2,-0.87,-0.90756,-0.15532,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000179761,2,1,0,0,0,1,521433.73994041845,1122672.658801146,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,6,PIPOX,-0.10800004,0.95307,1.255,2,0.75,0.0,Peroxisomal protein import,R-HSA-9033241
ENSG00000179774,2,1,1,0,0,1,101825.50588235294,414433.58532016096,2024-07-19,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,ATOH7,-0.758,-1.2184,-0.7952,0,0.75,0.5,,
ENSG00000179914,2,1,1,0,1,1,7741.739669934235,160010.51072069994,2008-06-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,4,ITLN1,-0.029000044,1.1905,0.48645,1,0.75,0.0,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000179965,1,1,0,0,0,1,135108.48254553688,135108.48254553688,2025-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZNF771,-0.46000004,-2.34,-4.9232,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000180071,1,1,0,0,0,1,19517.853653856917,19517.853653856917,2023-01-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ANKRD18A,0.12800002,1.4941,1.8375,0,0.5,0.5,,
ENSG00000180479,1,1,1,0,1,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF571,-0.15699995,0.79859,-0.2171,1,0.5,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000180613,2,1,1,0,0,1,107949.90929360976,414433.58532016096,2023-06-29,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,GSX2,-0.278,-0.96202,-1.5261,0,,,,
ENSG00000180694,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,TMEM64,-0.35300004,-0.28688,-1.8422,0,1.0,-1.0,,
ENSG00000180758,1,1,1,0,0,1,43608.44695309091,43608.44695309091,2022-10-12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPR157,-0.16400003,0.20798,0.36285,0,0.5,0.0,,
ENSG00000180818,2,1,0,0,0,1,138890.6106237268,203090.6413944402,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HOXC10,0.12800002,0.53323,0.15996,0,1.0,0.0,,
ENSG00000180871,2,1,1,0,0,1,19974.136110585117,160010.51072069994,2011-02-06,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,5,CXCR2,-0.15400004,1.9458,-0.13824,3,0.5,0.0,Signal Transduction;Immune System,R-HSA-162582;R-HSA-168256
ENSG00000180872,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DEFB112,-0.95500004,-0.74095,-0.66829,2,1.0,1.0,Immune System;Defensins;Antimicrobial peptides,R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000180878,1,1,0,0,0,1,105873.71696731678,105873.71696731678,2023-11-30,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,C11orf42,-0.222,-0.27508,0.17775,0,1.0,0.5,,
ENSG00000180900,1,1,1,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SCRIB,0.31599998,-3.2663,-6.7775,6,-1.0,0.0,Signal Transduction;Asymmetric localization of PCP proteins,R-HSA-162582;R-HSA-4608870
ENSG00000180917,1,1,0,0,1,0,227752.06557835746,227752.06557835746,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CMTR2,-0.008999944,0.45164,0.25427,0,-1.0,-1.0,,
ENSG00000181090,1,1,0,0,0,1,10149.473055056984,10149.473055056984,2021-06-02,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EHMT1,0.841,1.9902,-1.2016,6,-1.0,-1.0,Generic Transcription Pathway;Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6,R-HSA-212436;R-HSA-9843970;R-HSA-73857;R-HSA-74160;R-HSA-8953750
ENSG00000181195,1,1,0,1,0,1,765591.3646788632,1424218.0900670097,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PENK,-0.388,0.01407,0.17338,4,0.75,0.0,Signal Transduction;Post-translational protein modification,R-HSA-162582;R-HSA-597592
ENSG00000181322,1,1,0,0,0,1,461914.58891516324,461914.58891516324,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NME9,-0.393,1.3376,0.84243,0,0.5,0.0,,
ENSG00000181450,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF678,-0.919,0.33523,-0.65101,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000181458,1,1,0,0,0,0,96212.56699204071,96212.56699204071,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TMEM45A,-0.069000006,0.77913,-0.061842,0,1.0,-1.0,,
ENSG00000181609,1,1,0,0,0,1,221280.45048451523,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,OR52D1,-0.86600006,-0.20218,-0.74238,1,1.0,1.0,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000181649,1,1,0,0,0,1,19257.690392998462,19257.690392998462,2024-07-19,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PHLDA2,-0.681,0.05464,-0.48444,0,0.5,0.0,,
ENSG00000181656,1,1,0,0,0,1,56101.88409046092,56101.88409046092,2021-02-24,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPR88,-0.77,-0.88276,-3.674,0,1.0,0.5,,
ENSG00000181778,1,1,0,0,0,1,10970.164490603047,10970.164490603047,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM252,-0.357,0.22188,0.075085,0,0.75,0.0,,
ENSG00000181803,1,1,0,0,0,1,2324.6716622691292,2324.6716622691292,2023-04-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR6S1,-0.867,-0.40987,-0.24051,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000181867,1,1,0,0,0,1,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,FTMT,-0.15699995,-1.4465,-1.5653,1,1.0,1.0,Iron uptake and transport,R-HSA-917937
ENSG00000181929,1,1,0,0,1,0,125558.52890364222,125558.52890364222,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,PRKAG1,0.265,2.3686,1.1452,8,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Energy dependent regulation of mTOR by LKB1-AMPK;MTOR signalling,R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-380972;R-HSA-165159
ENSG00000182108,1,1,1,0,0,1,125821.84557838629,125821.84557838629,2023-03-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DEXI,-0.82299995,0.57455,-0.44493,0,-1.0,-1.0,,
ENSG00000182141,1,1,1,0,0,1,135095.86576106868,254373.32653042395,2020-05-06,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ZNF708,-0.30400002,1.1614,0.74318,2,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of endogenous retroelements by KRAB-ZFP proteins,R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9843940
ENSG00000182261,1,1,0,0,1,1,9432.693221905714,244820.6919736302,2020-06-08,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,NLRP10,-0.25800002,0.015839,-0.24941,0,0.75,0.5,,
ENSG00000182272,1,1,1,0,0,1,960369.5592648841,960369.5592648841,2021-05-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,B4GALNT4,-0.059000015,-2.7678,-5.2468,0,0.5,0.0,,
ENSG00000182307,1,1,0,0,0,1,13917.844188444842,13917.844188444842,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,C8orf33,-0.449,-1.1507,-1.3404,0,-1.0,-1.0,,
ENSG00000182534,1,1,1,0,0,1,278498.5074409075,278498.5074409075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MXRA7,-0.824,0.13184,0.18187,0,-1.0,-1.0,,
ENSG00000182557,1,1,1,0,0,1,21014.7618737575,21014.7618737575,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SPNS3,-0.24399996,0.0053777,-0.45887,0,1.0,0.5,,
ENSG00000182718,1,1,1,0,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ANXA2,0.014999986,0.55835,-0.52465,6,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000182759,1,1,0,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MAFA,,-4.3036,-3.9335,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000182782,2,1,0,0,0,1,442877.006007271,442877.006007271,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HCAR2,-0.87100005,1.6877,0.65984,3,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000182858,1,1,1,0,1,1,356440.71671986027,356440.71671986027,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ALG12,0.035000026,0.93748,-0.60642,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000182885,1,1,1,0,0,1,406587.2658730814,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ADGRG3,0.06999999,0.80219,-0.33433,1,1.0,0.0,Immune System,R-HSA-168256
ENSG00000183020,1,1,0,0,0,0,178948.78717378277,178948.78717378277,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,AP2A2,0.56299996,3.0643,-0.84762,15,0.5,0.0,Signal Transduction;Immune System;Developmental Biology;Disease;WNT5A-dependent internalization of FZD4;Recycling pathway of L1;EPH-ephrin mediated repulsion of cells;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1266738;R-HSA-1643685;R-HSA-5099900;R-HSA-437239;R-HSA-3928665;R-HSA-9006934
ENSG00000183092,1,1,0,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,BEGAIN,0.038999975,-1.0672,-3.5593,1,0.75,0.0,,
ENSG00000183150,1,1,0,0,0,1,4451.852673267326,4451.852673267326,2012-12-27,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,GPR19,0.264,1.9479,0.95139,0,0.5,0.5,,
ENSG00000183273,1,1,0,0,0,1,195005.6685718255,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCDC60,-0.062999964,0.92724,1.2962,0,0.5,0.0,,
ENSG00000183347,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GBP6,-0.051,0.55708,1.0926,1,1.0,0.5,Cytokine Signaling in Immune system;Immune System,R-HSA-1280215;R-HSA-168256
ENSG00000183397,2,1,0,0,0,1,22667.68960369517,125392.97184483419,2023-01-18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,TEKTIP1,-0.86,-3.269,-2.9864,0,0.5,0.0,,
ENSG00000183401,1,1,0,0,0,0,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCDC159,-0.110000014,-0.35993,-1.3379,0,-1.0,-1.0,,
ENSG00000183426,1,1,1,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NPIPA1,0.39,2.4421,1.9407,0,0.5,0.0,,
ENSG00000183486,3,1,1,0,0,1,8198.377278833237,133918.94977035935,2011-10-09,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,MX2,0.176,1.4482,-0.32743,2,0.5,0.0,Cytokine Signaling in Immune system;Immune System;ISG15 antiviral mechanism,R-HSA-1280215;R-HSA-168256;R-HSA-1169408
ENSG00000183580,1,1,0,0,0,1,672632.4785173276,672632.4785173276,2021-04-22,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FBXL7,0.458,1.6713,0.078243,3,-1.0,0.0,Immune System;Post-translational protein modification,R-HSA-168256;R-HSA-597592
ENSG00000183638,1,1,0,0,0,0,195005.6685718255,195005.6685718255,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RP1L1,-0.944,-10.89,-7.6836,0,1.0,1.0,,
ENSG00000183644,1,1,0,0,0,1,75978.4105377159,75978.4105377159,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HOATZ,-0.37199998,-0.38233,0.086605,0,0.75,0.5,,
ENSG00000183654,5,1,0,0,0,1,33670.70607708678,141076.9910731678,2015-04-01,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,MARCHF11,-0.25100005,-0.33561,-1.8442,0,1.0,0.5,,
ENSG00000183665,1,1,0,0,0,1,13686.45239978903,58995.33218928629,2023-11-09,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TRMT12,0.16399997,1.4246,1.0951,1,-1.0,-1.0,,
ENSG00000183709,1,1,0,0,0,1,78728.4671948324,78728.4671948324,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,IFNL2,-0.36099994,0.6312,0.79106,1,,,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000183726,1,1,1,0,0,1,576.1087314662274,576.1087314662274,2022-03-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,TMEM50A,0.24699998,0.45939,0.13061,0,-1.0,-1.0,,
ENSG00000183734,1,1,0,0,0,1,18531.1622981202,18531.1622981202,2023-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ASCL2,-0.962,-3.9503,-4.0218,0,0.5,0.0,,
ENSG00000183735,1,1,1,0,1,1,61743.30847289418,95413.07358079177,2018-03-21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,TBK1,0.495,2.5679,0.88329,19,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Immune System;IRF3-mediated induction of type I IFN;Disease;Signaling by Interleukins,R-HSA-162582;R-HSA-1280215;R-HSA-168256;R-HSA-3270619;R-HSA-1643685;R-HSA-449147
ENSG00000183780,2,1,0,0,0,0,37323.99073154585,270756.050710225,2018-08-13,0,0,0,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,SLC35F3,0.30299997,1.9445,0.022773,0,1.0,0.5,,
ENSG00000183798,1,1,1,0,1,1,684816.7338614308,715125.8126650311,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,EMILIN3,-0.12699997,0.57544,-0.089223,1,1.0,0.0,,
ENSG00000183833,1,1,0,0,0,1,183579.49764748462,183579.49764748462,2022-08-20,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CFAP91,-0.12899995,0.12954,0.39761,0,0.5,0.0,,
ENSG00000183853,1,1,0,0,0,0,63200.72664467542,63200.72664467542,2022-07-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KIRREL1,0.588,2.8072,0.99098,1,-1.0,0.0,,
ENSG00000183943,1,1,1,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PRKX,,,,4,0.5,-1.0,Signal Transduction;CREB1 phosphorylation through the activation of Adenylate Cyclase;Disease,R-HSA-162582;R-HSA-442720;R-HSA-1643685
ENSG00000184014,1,1,1,0,0,1,196178.71491042234,196178.71491042234,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DENND5A,0.426,3.2048,0.41433,1,-1.0,-1.0,Rab regulation of trafficking,R-HSA-9007101
ENSG00000184276,1,1,0,0,1,1,3979.099342105263,3979.099342105263,2023-06-20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DEFB108B,-0.849,-0.74093,0.01028,2,1.0,1.0,Immune System;Defensins;Antimicrobial peptides,R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000184330,1,1,0,0,0,1,155496.87140784386,205433.03502595585,2025-04-01,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,S100A7A,-0.78199995,-0.9536,-0.25103,1,0.75,0.5,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000184428,1,1,1,0,0,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TOP1MT,-0.26600003,-0.0039567,-0.17301,0,-1.0,-1.0,,
ENSG00000184502,3,1,0,0,0,1,45589.72605179723,196816.54442141854,2021-02-19,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,GAST,-0.288,0.29492,0.07934,2,1.0,0.5,Signal Transduction;Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-162582;R-HSA-881907
ENSG00000184508,1,1,1,0,0,1,254373.32653042395,254373.32653042395,2020-05-06,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HDDC3,-0.48599994,-0.73107,-0.75079,0,-1.0,-1.0,,
ENSG00000184517,1,1,1,0,0,1,251325.91086204,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZFP1,-0.06099999,-1.8013,-2.7254,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000184564,1,1,0,0,0,1,40611.41370106059,97181.90375256384,2021-09-30,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,SLITRK6,0.18800002,0.68303,-0.30982,1,0.5,0.0,Receptor-type tyrosine-protein phosphatases,R-HSA-388844
ENSG00000184599,1,1,0,0,0,1,3466.7409637187616,3466.7409637187616,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TAFA3,-0.24600005,0.15929,0.14591,0,0.5,0.5,,
ENSG00000184602,1,1,0,0,0,1,107273.75397646755,112218.78632625614,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SNN,-0.753,0.070795,-0.94818,0,0.5,-1.0,,
ENSG00000184828,1,1,0,0,0,1,101603.42051482818,101603.42051482818,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ZBTB7C,0.371,-0.15921,-1.4241,0,0.5,0.0,,
ENSG00000184845,1,1,0,0,0,1,7219.303318490829,7219.303318490829,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,DRD1,0.748,3.2072,0.70565,2,0.75,0.5,Signal Transduction;Amine ligand-binding receptors,R-HSA-162582;R-HSA-375280
ENSG00000184916,1,1,1,0,1,1,97181.90375256384,97181.90375256384,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,JAG2,0.505,1.7314,-3.2819,7,-1.0,0.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000184924,2,1,1,0,0,1,156470.480665571,251325.91086204,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,PTRHD1,-0.33200002,-0.18679,0.01353,0,-1.0,-1.0,,
ENSG00000184985,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SORCS2,0.023000002,-1.7338,-3.4718,0,0.5,0.0,,
ENSG00000184990,1,1,1,0,0,1,190279.23963861223,190279.23963861223,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SIVA1,0.027999997,-0.014672,-1.1806,0,-1.0,-1.0,,
ENSG00000185010,1,1,0,0,1,0,99788.44320353035,99788.44320353035,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,F8,,,,15,0.5,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000185028,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LRRC14B,-0.946,-1.8726,-1.8814,0,0.75,0.5,,
ENSG00000185115,1,1,0,0,0,1,61406.63987179962,61406.63987179962,2023-01-18,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NSMCE3,,-1.0683,-1.6078,1,-1.0,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000185189,1,1,0,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NRBP2,0.086000025,0.40534,-2.0229,0,0.5,-1.0,,
ENSG00000185236,1,1,1,0,0,0,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RAB11B,0.343,2.4822,-0.46368,2,-1.0,-1.0,TBC/RABGAPs;Rab regulation of trafficking;Post-translational protein modification,R-HSA-8854214;R-HSA-9007101;R-HSA-597592
ENSG00000185261,1,1,0,0,0,0,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KIAA0825,0.05699998,1.4988,1.4152,0,-1.0,0.0,,
ENSG00000185271,1,1,1,0,0,1,1380.9855975087582,1380.9855975087582,2018-11-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,KLHL33,-0.047999978,-1.0409,-0.48866,0,0.75,0.5,,
ENSG00000185278,2,1,1,0,0,0,323648.5577791949,1076472.0138856068,2023-07-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ZBTB37,0.417,2.244,0.059805,0,-1.0,0.0,,
ENSG00000185515,1,1,0,0,0,1,100083.61852522385,100083.61852522385,2019-11-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BRCC3,,,,5,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000185518,1,1,0,0,0,1,575147.0632428399,575147.0632428399,2024-07-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SV2B,0.32,1.7201,0.52646,4,0.75,0.5,Neurotoxicity of clostridium toxins;Disease,R-HSA-168799;R-HSA-1643685
ENSG00000185669,1,1,0,0,0,1,15223.454539395489,42939.405891994706,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,SNAI3,-0.75100005,-0.86119,-0.94779,0,1.0,0.0,,
ENSG00000185842,1,1,0,0,1,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DNAH14,0.031000018,2.63,2.902,0,0.5,0.0,,
ENSG00000185862,1,1,1,0,0,1,515513.2178404211,765591.3646788632,2020-06-15,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,EVI2B,-0.18700004,0.98613,0.64568,0,0.5,-1.0,,
ENSG00000185946,1,1,0,0,0,1,256331.89034791503,256331.89034791503,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RNPC3,-0.04100001,-0.088168,-0.36034,1,-1.0,-1.0,mRNA Splicing - Minor Pathway,R-HSA-72165
ENSG00000186086,1,1,0,0,0,1,215157.94798738702,215157.94798738702,2024-07-27,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NBPF6,-0.35399997,1.5107,1.7803,0,0.5,0.5,,
ENSG00000186105,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LRRC70,0.061999977,1.3185,0.20097,0,-1.0,0.0,,
ENSG00000186191,1,1,0,0,0,1,77544.39441764928,77544.39441764928,2022-12-10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,BPIFB4,-0.08200002,0.43012,0.4649,1,1.0,1.0,Immune System;Antimicrobial peptides,R-HSA-168256;R-HSA-6803157
ENSG00000186212,2,1,0,0,0,1,58967.99229610608,521818.7070055739,2023-01-18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,SOWAHB,-0.342,-1.7164,-2.1282,0,0.5,0.0,,
ENSG00000186431,3,1,1,0,0,1,29997.958300125974,87248.80974040499,2012-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,FCAR,-0.123000026,-0.56699,0.36967,1,0.5,0.5,Immune System,R-HSA-168256
ENSG00000186432,1,1,0,0,0,1,383158.3001114715,383158.3001114715,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KPNA4,0.703,2.1151,-0.20023,2,0.5,-1.0,Cytokine Signaling in Immune system;Immune System;NS1 Mediated Effects on Host Pathways;Disease;ISG15 antiviral mechanism,R-HSA-1280215;R-HSA-168256;R-HSA-168276;R-HSA-1643685;R-HSA-1169408
ENSG00000186442,2,1,1,0,0,1,23467.651805886748,59773.57464796038,2024-07-19,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,KRT3,0.004000008,0.10923,-0.9648,2,0.75,0.5,Developmental Biology,R-HSA-1266738
ENSG00000186468,2,1,1,0,0,1,33670.70607708678,141076.9910731678,2015-04-01,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,RPS23,0.816,2.9522,-0.21889,19,-1.0,-1.0,Developmental Biology;Protein hydroxylation;Disease;Translation;rRNA processing;Regulation of expression of SLITs and ROBOs;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Post-translational protein modification,R-HSA-1266738;R-HSA-9629569;R-HSA-1643685;R-HSA-72766;R-HSA-72312;R-HSA-9010553;R-HSA-9711097;R-HSA-168273;R-HSA-1799339;R-HSA-975956;R-HSA-597592
ENSG00000186469,1,1,0,0,0,1,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,GNG2,-0.41999996,1.0524,0.48231,29,0.5,-1.0,"Signal Transduction;Presynaptic function of Kainate receptors;ADP signalling through P2Y purinoceptor 12;Thromboxane signalling through TP receptor;G beta:gamma signalling through PLC beta;Prostacyclin signalling through prostacyclin receptor;G beta:gamma signalling through BTK;ADP signalling through P2Y purinoceptor 1;G beta:gamma signalling through PI3Kgamma;Signal amplification;G-protein activation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Disease;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;Activation of kainate receptors upon glutamate binding;Adrenaline,noradrenaline inhibits insulin secretion;G-protein beta:gamma signalling;Inwardly rectifying K+ channels",R-HSA-162582;R-HSA-500657;R-HSA-392170;R-HSA-428930;R-HSA-418217;R-HSA-392851;R-HSA-8964315;R-HSA-418592;R-HSA-392451;R-HSA-392518;R-HSA-202040;R-HSA-6814122;R-HSA-1643685;R-HSA-1296041;R-HSA-1296059;R-HSA-997272;R-HSA-451326;R-HSA-400042;R-HSA-397795;R-HSA-1296065
ENSG00000186479,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RGS7BP,0.40499997,0.92187,0.66743,0,0.5,0.0,,
ENSG00000186566,1,1,0,0,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,GPATCH8,0.747,1.4905,0.87041,0,-1.0,0.0,,
ENSG00000186787,1,1,0,0,0,1,135095.86576106868,135095.86576106868,2021-09-30,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPIN2B,,,,0,-1.0,-1.0,,
ENSG00000186803,1,1,0,0,1,1,21020.801882160395,95491.56815792594,2022-03-07,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,IFNA10,-0.93799996,-0.91304,-1.0239,6,,,Cytokine Signaling in Immune system;Immune System;Disease,R-HSA-1280215;R-HSA-168256;R-HSA-1643685
ENSG00000186907,1,1,0,0,0,1,21724.94108458234,21724.94108458234,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RTN4RL2,0.245,0.96612,-1.3229,1,0.75,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000186918,1,1,0,0,0,0,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZNF395,0.45999998,0.75733,-0.74287,0,-1.0,-1.0,,
ENSG00000186952,1,1,0,0,0,0,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM232,-0.29999995,-1.4763,-1.2803,0,0.75,0.0,,
ENSG00000187017,1,1,0,0,0,0,38092.548464040476,38092.548464040476,2019-09-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,ESPN,-0.30700004,-1.0887,-0.50083,2,0.5,0.0,,
ENSG00000187210,1,1,1,0,0,1,414433.58532016096,414433.58532016096,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GCNT1,0.17299998,1.1896,0.8515,1,0.75,0.0,Post-translational protein modification,R-HSA-597592
ENSG00000187231,1,1,0,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SESTD1,0.44,2.0441,0.19965,0,-1.0,-1.0,,
ENSG00000187535,1,1,1,0,0,0,156470.480665571,156470.480665571,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,IFT140,0.027999997,-0.37778,-0.65847,2,-1.0,-1.0,Signal Transduction;Intraflagellar transport,R-HSA-162582;R-HSA-5620924
ENSG00000187689,1,1,0,0,0,1,188264.63129042363,355284.1215006515,2025-03-06,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,AMTN,-0.656,0.31853,0.93186,2,0.5,0.5,Post-translational protein modification,R-HSA-597592
ENSG00000187715,1,1,0,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KBTBD12,-0.16999996,0.99081,1.3135,0,0.5,0.5,,
ENSG00000187764,1,1,1,0,0,0,13959.203480505423,13959.203480505423,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SEMA4D,0.546,2.3194,0.90908,3,0.5,-1.0,Developmental Biology;Sema4D mediated inhibition of cell attachment and migration,R-HSA-1266738;R-HSA-416550
ENSG00000187778,1,1,0,0,0,1,252346.18526092035,252346.18526092035,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MCRS1,0.496,2.2157,-0.29532,4,-1.0,-1.0,Gene expression (Transcription);Post-translational protein modification,R-HSA-74160;R-HSA-597592
ENSG00000187783,1,1,0,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TMEM72,-0.08099997,0.4637,-0.39013,0,0.75,0.5,,
ENSG00000187871,1,1,0,0,0,1,40455.65678857565,40455.65678857565,2022-10-12,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,GFRAL,-0.20500004,-0.17449,0.23147,0,,,,
ENSG00000188021,1,1,0,0,0,0,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UBQLN2,,,,1,-1.0,-1.0,,
ENSG00000188167,1,1,0,0,0,1,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,TMPPE,-0.049999952,1.3076,0.62192,0,0.5,0.5,,
ENSG00000188191,1,1,1,0,0,0,45352.660307535756,45352.660307535756,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PRKAR1B,0.314,1.3997,-1.3707,12,1.0,-1.0,Signal Transduction;CREB1 phosphorylation through the activation of Adenylate Cyclase;Disease,R-HSA-162582;R-HSA-442720;R-HSA-1643685
ENSG00000188211,1,1,1,1,0,1,448058.917711015,448058.917711015,2023-11-10,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NCR3LG1,-0.27699995,0.74566,0.85963,1,0.5,0.0,Immune System,R-HSA-168256
ENSG00000188322,1,1,0,0,0,1,135108.48254553688,135108.48254553688,2025-02-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SBK1,-0.13999999,-0.022608,-3.4245,0,0.75,0.0,,
ENSG00000188375,1,1,0,0,0,1,2282.7743876235495,2282.7743876235495,2019-11-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,H3-5,-0.69299996,0.41412,-0.31348,0,1.0,0.5,,
ENSG00000188536,1,1,0,0,0,1,48276.34365519406,48276.34365519406,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,HBA2,-0.91499996,0.68074,1.4325,5,1.0,-1.0,,
ENSG00000188549,2,1,1,0,0,1,118492.7744519305,1424218.0900670097,2019-02-04,0,0,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,CCDC9B,-0.16400003,-0.53948,0.18957,0,0.5,-1.0,,
ENSG00000188580,2,1,0,0,0,1,1076472.0138856068,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,NKAIN2,0.096000016,0.89113,0.64394,0,1.0,0.5,,
ENSG00000188603,1,1,1,0,0,0,19965.24128263536,19965.24128263536,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,CLN3,-0.021999955,0.97718,0.039355,1,-1.0,-1.0,,
ENSG00000188610,5,1,1,0,0,0,22345.675520395987,141076.9910731678,2013-04-01,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,FAM72B,-0.153,1.2014,1.7974,0,0.5,0.5,,
ENSG00000188626,1,1,1,0,0,1,72148.96319633072,85928.28663449686,2024-07-19,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,GOLGA8M,0.0009999871,-0.16926,0.1783,0,0.5,0.0,,
ENSG00000188785,1,1,1,0,0,1,286746.1002745869,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ZNF548,-0.653,1.227,0.58837,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000188827,1,1,1,0,0,1,254373.32653042395,765591.3646788632,2020-05-06,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SLX4,0.10399997,-0.74532,-0.64029,2,0.5,0.0,,
ENSG00000188848,2,1,0,0,0,1,376787.4157813613,715125.8126650311,2019-02-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,BEND4,0.24400002,-1.0549,-1.983,0,0.5,0.5,,
ENSG00000188878,1,1,1,0,1,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FBF1,-0.13300002,-0.4429,-0.8984,1,0.5,-1.0,,
ENSG00000188917,1,1,0,0,0,1,286678.73247515375,286678.73247515375,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,TRMT2B,,,,0,-1.0,-1.0,,
ENSG00000188976,1,1,1,0,0,1,20981.396731054978,20981.396731054978,2018-02-08,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NOC2L,-0.34399998,-1.349,-3.5324,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000189057,1,1,0,0,0,0,38851.92581543917,521818.7070055739,2023-08-23,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,FAM111B,-0.81700003,0.53467,0.6153,0,0.5,0.0,,
ENSG00000189067,4,1,1,0,0,1,19965.24128263536,178948.78717378277,2017-01-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,9,LITAF,-0.01699996,0.46996,-0.30082,0,-1.0,-1.0,,
ENSG00000189108,1,1,0,0,0,1,112237.0074902361,112237.0074902361,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,IL1RAPL2,,,,1,0.5,1.0,Receptor-type tyrosine-protein phosphatases,R-HSA-388844
ENSG00000189139,1,1,0,0,0,1,47336.27089212796,47336.27089212796,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,FSCB,-0.816,-0.044564,0.38176,0,1.0,1.0,,
ENSG00000189157,1,1,1,0,0,1,12283.42801815431,263416.51565448404,2011-06-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,7,FAM47E,-0.17200005,0.67084,-0.11864,0,-1.0,0.0,,
ENSG00000189184,1,1,0,0,0,1,252346.18526092035,427337.4491868293,2018-08-13,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,PCDH18,0.32700002,1.1534,-0.76533,0,-1.0,0.0,,
ENSG00000189233,1,1,0,0,1,1,99227.16426999423,102866.95819249244,2019-08-16,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,NUGGC,0.236,0.45045,-0.14992,0,0.75,0.5,,
ENSG00000189308,1,1,1,0,0,1,545988.1005477115,545988.1005477115,2023-01-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,LIN54,0.796,4.0765,1.6656,7,-1.0,0.0,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G1/S-Specific Transcription,R-HSA-1362300;R-HSA-69205
ENSG00000189357,1,1,0,0,0,1,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,SPATA31D4,-0.93799996,2.2029,2.0133,0,1.0,1.0,,
ENSG00000189367,1,1,0,0,1,1,197485.87952538437,197485.87952538437,2023-06-05,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,KIAA0408,0.010999978,1.0697,-0.18704,0,0.5,0.0,,
ENSG00000196136,1,1,0,1,0,1,406587.2658730814,521818.7070055739,2023-11-09,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,SERPINA3,-0.51600003,-1.3611,-1.3023,2,0.75,0.0,Immune System,R-HSA-168256
ENSG00000196305,1,1,0,0,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,IARS1,0.08899999,1.005,0.5377,3,-1.0,-1.0,tRNA Aminoacylation;Developmental Biology;Cytosolic tRNA aminoacylation;Translation,R-HSA-379724;R-HSA-1266738;R-HSA-379716;R-HSA-72766
ENSG00000196313,1,1,1,0,0,0,384314.83364002535,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,POM121,0.36699998,1.4401,0.94049,29,-1.0,-1.0,Cytokine Signaling in Immune system;Immune System;Postmitotic nuclear pore complex (NPC) reformation;Gene expression (Transcription);Transport of the SLBP independent Mature mRNA;SUMOylation of DNA replication proteins;Interactions of Rev with host cellular proteins;Rev-mediated nuclear export of HIV RNA;Transport of the SLBP Dependant Mature mRNA;SUMOylation of ubiquitinylation proteins;Viral Messenger RNA Synthesis;SUMOylation of SUMOylation proteins;NEP/NS2 Interacts with the Cellular Export Machinery;Export of Viral Ribonucleoproteins from Nucleus;Nuclear import of Rev protein;Transport of Ribonucleoproteins into the Host Nucleus;Transport of Mature mRNA Derived from an Intronless Transcript;NS1 Mediated Effects on Host Pathways;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Interactions of Vpr with host cellular proteins;SUMOylation of RNA binding proteins;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Transcriptional regulation by small RNAs;Gene Silencing by RNA;HIV Life Cycle;Late Phase of HIV Life Cycle;Influenza Viral RNA Transcription and Replication;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;tRNA processing in the nucleus;HCMV Late Events;ISG15 antiviral mechanism;Post-translational protein modification,R-HSA-1280215;R-HSA-168256;R-HSA-9615933;R-HSA-74160;R-HSA-159227;R-HSA-4615885;R-HSA-177243;R-HSA-165054;R-HSA-159230;R-HSA-3232142;R-HSA-168325;R-HSA-4085377;R-HSA-168333;R-HSA-168274;R-HSA-180746;R-HSA-168271;R-HSA-159231;R-HSA-168276;R-HSA-159234;R-HSA-1643685;R-HSA-176033;R-HSA-4570464;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-5578749;R-HSA-211000;R-HSA-162587;R-HSA-162599;R-HSA-168273;R-HSA-159236;R-HSA-72202;R-HSA-6784531;R-HSA-9610379;R-HSA-1169408;R-HSA-597592
ENSG00000196368,2,1,1,0,0,1,3747.57310565635,232586.34864014547,2008-02-10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,NUDT11,,,,1,0.5,0.0,,
ENSG00000196371,1,1,0,0,0,0,258213.8601133611,258213.8601133611,2023-01-18,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FUT4,-0.21599996,-2.8379,-3.2682,1,1.0,0.0,,
ENSG00000196376,1,1,0,0,0,1,70512.90422707179,645988.1975077938,2017-04-17,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,SLC35F1,0.525,1.5723,0.31548,0,0.75,0.0,,
ENSG00000196417,1,1,1,0,1,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF765,-0.074,0.66944,0.55063,1,-1.0,-1.0,Gene expression (Transcription);Regulation of endogenous retroelements by KRAB-ZFP proteins,R-HSA-74160;R-HSA-9843940
ENSG00000196433,1,1,0,0,0,1,27332.684639212748,27332.684639212748,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ASMT,,,,1,1.0,0.5,Metabolism of amine-derived hormones,R-HSA-209776
ENSG00000196449,1,1,1,0,0,1,2209.8301559792026,124837.11004999638,2018-11-13,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,YRDC,-0.25899994,-1.219,-2.3477,0,0.5,-1.0,,
ENSG00000196455,1,1,0,0,0,1,40153.0728800662,433862.5685735124,2017-11-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,PIK3R4,0.638,3.1013,0.53341,11,-1.0,-1.0,Signal Transduction;Immune System;Synthesis of PIPs at the Golgi membrane;Disease;Translation of Replicase and Assembly of the Replication Transcription Complex_9679504;Translation of Replicase and Assembly of the Replication Transcription Complex_9694676;Signaling by Receptor Tyrosine Kinases,R-HSA-162582;R-HSA-168256;R-HSA-1660514;R-HSA-1643685;R-HSA-9679504;R-HSA-9694676;R-HSA-9006934
ENSG00000196468,2,1,0,0,0,1,42193.37905314073,58392.07057732553,2013-12-25,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,FGF16,,,,27,1.0,1.0,Signal Transduction;Disease;SHC-mediated cascade:FGFR4;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5654719;R-HSA-9006934;R-HSA-5663202
ENSG00000196517,1,1,0,0,0,0,33773.41415717191,33773.41415717191,2021-01-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SLC6A9,0.45599997,3.1143,1.4057,1,0.5,0.0,,
ENSG00000196553,1,1,0,0,0,1,606.6666666666666,606.6666666666666,2020-12-11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CCDC196,,,,0,1.0,1.0,,
ENSG00000196715,1,1,0,0,0,1,2324.6716622691292,2324.6716622691292,2023-04-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VKORC1L1,0.435,1.2311,-1.1144,1,-1.0,-1.0,,
ENSG00000196730,2,1,1,0,0,1,42362.45324254164,301203.06999851385,2023-10-16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,DAPK1,0.617,3.997,1.4632,1,-1.0,-1.0,,
ENSG00000196734,1,1,0,0,0,1,44660.84794838759,44660.84794838759,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,LCE1B,-0.878,-0.092655,0.11403,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000196767,1,1,0,0,0,0,34705.12345097053,34705.12345097053,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,POU3F4,,,,0,1.0,0.5,,
ENSG00000196776,1,1,1,0,0,1,54892.674160393246,54892.674160393246,2020-12-02,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CD47,0.27499998,0.94521,-0.78932,4,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000196805,1,1,0,0,0,1,67703.54580567603,67703.54580567603,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SPRR2B,-0.92999995,1.1425,0.039079,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000196814,1,1,1,0,0,0,64507.782812759775,64507.782812759775,2022-10-12,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,MVB12B,0.49199998,1.9216,0.43711,5,1.0,-1.0,Endosomal Sorting Complex Required For Transport (ESCRT);Budding and maturation of HIV virion;Disease;Late endosomal microautophagy;HIV Life Cycle;Late Phase of HIV Life Cycle;HCMV Late Events,R-HSA-917729;R-HSA-162588;R-HSA-1643685;R-HSA-9615710;R-HSA-162587;R-HSA-162599;R-HSA-9610379
ENSG00000196839,1,1,1,1,0,1,62627.34914844415,62627.34914844415,2024-01-05,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ADA,-0.18400002,0.4697,0.3029,3,0.75,0.0,Disease,R-HSA-1643685
ENSG00000196917,1,1,1,0,0,1,306980.8575290048,306980.8575290048,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,HCAR1,-0.775,0.43432,0.29303,2,0.75,0.0,Signal Transduction,R-HSA-162582
ENSG00000196975,1,1,1,0,1,1,55315.825152625155,303059.79257468163,2017-04-17,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,ANXA4,-0.07700002,1.1245,1.0409,0,0.5,-1.0,,
ENSG00000197093,1,1,1,0,0,0,41299.82664585649,41299.82664585649,2022-11-04,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,GAL3ST4,-0.28400004,0.25107,0.63258,0,0.5,0.0,,
ENSG00000197110,1,1,0,0,1,1,9964.719723813545,9964.719723813545,2021-09-30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IFNL3,-0.47399998,-0.11583,-0.13056,1,,,Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins,R-HSA-1280215;R-HSA-168256;R-HSA-449147
ENSG00000197123,1,1,0,0,1,1,2010.4597478176527,2010.4597478176527,2019-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ZNF679,-0.37699997,-0.67685,-0.27885,1,1.0,1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000197142,1,1,1,0,0,1,62297.43658685334,65215.33040479902,2020-09-23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ACSL5,0.29799998,1.2545,1.1304,1,0.5,-1.0,Synthesis of very long-chain fatty acyl-CoAs;Fatty acyl-CoA biosynthesis,R-HSA-75876;R-HSA-75105
ENSG00000197253,1,1,1,1,0,1,33910.05821821659,157563.09954473734,2023-01-18,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,TPSB2,-0.803,-0.66698,-0.27576,0,-1.0,0.0,,
ENSG00000197296,1,1,0,0,0,1,17534.246691821227,294387.2978738704,2011-12-11,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,FITM2,0.010999978,1.4098,0.75744,1,1.0,-1.0,,
ENSG00000197385,1,1,1,0,0,1,131525.74533408263,323648.5577791949,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ZNF860,-0.89199996,1.7792,1.7381,1,0.5,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000197406,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,DIO3,0.463,1.7147,0.018537,1,0.5,0.0,Metabolism of amine-derived hormones,R-HSA-209776
ENSG00000197506,2,1,0,0,0,1,59922.028203228016,59922.028203228016,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SLC28A3,0.07200003,2.0796,1.5055,3,0.5,0.0,"Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane;Azathioprine ADME;Transport of vitamins, nucleosides, and related molecules",R-HSA-83936;R-HSA-9748787;R-HSA-425397
ENSG00000197712,2,1,0,0,0,1,80033.9345349278,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,FAM114A1,-0.14900005,0.8711,0.39131,0,-1.0,-1.0,,
ENSG00000197786,1,1,0,0,1,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR5B17,,-0.86497,-0.22162,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000197893,1,1,1,0,1,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NRAP,-0.044999957,0.26323,1.0498,0,0.75,0.5,,
ENSG00000197894,1,1,0,0,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,ADH5,-0.19099998,1.5936,1.3038,1,-1.0,-1.0,,
ENSG00000197901,1,1,0,0,0,1,466632.7979326389,466632.7979326389,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,SLC22A6,0.065999985,1.643,0.37126,1,1.0,0.5,,
ENSG00000198018,2,1,0,0,0,0,13658.782960109247,13756.062794259458,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,ENTPD7,0.18699998,1.87,1.1702,1,0.5,0.0,Metabolism of nucleotides,R-HSA-15869
ENSG00000198055,1,1,0,0,0,1,3638.1832995745694,3638.1832995745694,2024-07-19,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GRK6,0.39600003,3.0908,0.90668,1,0.5,-1.0,Signal Transduction,R-HSA-162582
ENSG00000198074,1,1,1,0,0,1,358386.30063935445,358386.30063935445,2021-11-04,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,AKR1B10,-0.324,0.41846,-0.39434,1,0.5,0.0,,
ENSG00000198087,3,1,1,1,0,1,1321.7688442211056,340825.7076940272,2013-10-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,9,CD2AP,0.185,-0.16853,0.2598,1,-1.0,-1.0,,
ENSG00000198105,1,1,0,0,0,1,656.3454061796604,656.3454061796604,2018-01-29,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ZNF248,0.36900002,0.81765,0.6233,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000198160,2,1,1,0,0,1,49724.14538298504,71117.27631467933,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,MIER1,0.15499997,1.2773,-0.16078,0,0.5,-1.0,,
ENSG00000198208,1,1,1,0,1,1,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RPS6KL1,0.022000015,0.27297,0.65537,0,0.5,0.0,,
ENSG00000198225,1,1,0,0,0,1,14424.741402471152,14424.741402471152,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,FKBP1C,-0.84000003,-0.029997,-0.057947,0,-1.0,0.5,,
ENSG00000198283,1,1,0,0,0,1,85474.33432267047,118061.55082048493,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,2,OR5B21,-0.72300005,0.44069,0.016536,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000198300,1,1,0,0,0,1,12683.307098418409,12683.307098418409,2023-01-18,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PEG3,0.13200003,1.0189,0.5507,0,0.5,0.0,,
ENSG00000198342,1,1,0,0,0,1,298878.49542603496,298878.49542603496,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF442,0.037,1.2575,1.3727,1,-1.0,0.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000198570,3,1,0,0,0,1,225895.43837715342,399832.86333511875,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,RD3,-0.116000056,-0.001529,-0.0026796,0,1.0,0.5,,
ENSG00000198742,2,1,1,0,0,1,2587.3692643845593,160010.51072069994,2010-03-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,5,SMURF1,0.39600003,2.9845,-0.5745,8,-1.0,0.0,Signal Transduction;Generic Transcription Pathway;Immune System;RNA Polymerase II Transcription;Gene expression (Transcription);Asymmetric localization of PCP proteins;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-212436;R-HSA-168256;R-HSA-73857;R-HSA-74160;R-HSA-4608870;R-HSA-8878159
ENSG00000198753,1,1,1,0,1,0,201549.9575922349,219437.49527928562,2023-01-18,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,PLXNB3,,,,1,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000198824,1,1,0,0,0,1,448058.917711015,448058.917711015,2023-11-10,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CHAMP1,0.84000003,0.31653,-0.18076,0,-1.0,-1.0,,
ENSG00000198830,2,1,1,0,0,1,208763.74686288778,461914.58891516324,2024-07-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,HMGN2,0.11400002,0.049712,-0.21647,0,-1.0,-1.0,,
ENSG00000198844,1,1,1,0,1,1,74207.71608321255,111599.28184123649,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,ARHGEF15,0.083000004,0.94848,0.21854,5,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000198865,2,1,1,0,0,1,138890.6106237268,203090.6413944402,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,CCDC152,-0.87100005,0.26587,-0.24095,0,1.0,0.0,,
ENSG00000198889,1,1,0,0,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,DCAF12L1,,,,0,0.5,0.5,,
ENSG00000198910,1,1,1,0,0,0,376569.5597064443,376569.5597064443,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,L1CAM,,,,5,0.5,0.0,Developmental Biology;Interaction between L1 and Ankyrins;Recycling pathway of L1,R-HSA-1266738;R-HSA-445095;R-HSA-437239
ENSG00000198911,1,1,0,0,0,1,187674.40497870417,187674.40497870417,2022-03-24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SREBF2,0.407,1.4232,0.29607,6,-1.0,-1.0,Developmental Biology;Cholesterol biosynthesis;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-1266738;R-HSA-191273;R-HSA-8957322;R-HSA-1655829
ENSG00000198915,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,RASGEF1A,0.49800003,2.9422,-0.060286,1,0.5,0.0,Signal Transduction,R-HSA-162582
ENSG00000198917,1,1,1,0,0,1,207220.14223281175,207220.14223281175,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,SPOUT1,0.023000002,0.88443,0.047707,0,-1.0,-1.0,,
ENSG00000198919,1,1,1,0,0,0,183579.49764748462,183579.49764748462,2022-08-20,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,DZIP3,0.21899998,1.3337,0.89336,1,-1.0,-1.0,Immune System,R-HSA-168256
ENSG00000198920,1,1,1,0,1,0,383158.3001114715,427337.4491868293,2023-01-18,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,KIAA0753,-0.07099998,0.4674,0.59694,0,-1.0,-1.0,,
ENSG00000198933,1,1,1,0,0,0,215157.94798738702,215157.94798738702,2024-07-27,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TBKBP1,-0.10699999,-1.4087,-2.3275,0,-1.0,-1.0,,
ENSG00000198948,1,1,1,0,0,1,1122672.658801146,1122672.658801146,2024-01-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MFAP3L,0.42299998,2.2782,0.22257,0,0.5,0.0,,
ENSG00000203685,1,1,0,0,0,1,171880.2916512608,171880.2916512608,2022-04-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,STUM,-0.059999943,0.96029,-0.41045,0,0.75,0.0,,
ENSG00000203733,1,1,0,0,0,0,196178.71491042234,196178.71491042234,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GJE1,,,,0,,,,
ENSG00000204007,1,1,0,0,0,1,876.7362549800797,876.7362549800797,2009-11-06,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GLT6D1,-0.36300004,0.15976,0.26356,0,1.0,1.0,,
ENSG00000204104,1,1,1,0,1,0,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,TRAF3IP1,0.277,0.61972,0.095069,1,-1.0,-1.0,Intraflagellar transport,R-HSA-5620924
ENSG00000204193,1,1,0,0,0,1,427337.4491868293,427337.4491868293,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TXNDC8,-0.745,-0.23517,-0.44781,0,1.0,1.0,,
ENSG00000204271,1,1,0,0,0,1,50072.877304794354,50072.877304794354,2020-12-03,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,SPIN3,,,,0,-1.0,0.0,,
ENSG00000204406,1,1,0,0,0,1,545988.1005477115,645988.1975077938,2023-01-19,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MBD5,0.839,2.3668,1.4944,1,-1.0,-1.0,Post-translational protein modification,R-HSA-597592
ENSG00000204442,2,1,0,0,0,1,21235.516789523306,270756.050710225,2017-06-06,0,0,0,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,NALF1,0.803,0.59454,-0.48807,0,0.5,0.5,,
ENSG00000204571,1,1,1,0,0,1,105845.44891077634,105845.44891077634,2018-08-13,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,KRTAP5-11,-0.923,-0.14264,-0.81653,1,1.0,1.0,Developmental Biology,R-HSA-1266738
ENSG00000204577,1,1,1,0,0,1,9770.187636657778,78751.06843456876,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,5,LILRB3,0.17199999,1.4575,1.5944,2,0.5,0.0,Immune System,R-HSA-168256
ENSG00000204673,1,1,0,0,0,1,147105.90765133628,230312.26972227366,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,3,AKT1S1,-0.49,-1.5434,-2.1608,5,-1.0,-1.0,Signal Transduction;Disease;MTOR signalling;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-165159;R-HSA-5663202
ENSG00000204767,1,1,0,0,0,1,150669.89240227733,150669.89240227733,2021-05-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,INSYN2B,0.436,0.93609,0.42257,0,0.5,0.5,,
ENSG00000204856,1,1,1,0,0,0,116547.04276487474,116547.04276487474,2018-10-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,FAM216A,-0.153,-0.55439,0.022671,0,0.75,-1.0,,
ENSG00000204882,1,1,0,0,0,1,155552.2805078301,155552.2805078301,2023-01-18,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,GPR20,,0.418,-0.17861,1,-1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000204919,1,1,0,0,0,1,260210.21963428933,260210.21963428933,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PRR20A,,,,0,,,,
ENSG00000204967,1,1,0,0,1,0,131525.74533408263,131525.74533408263,2019-11-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PCDHA4,0.023999989,0.42582,-0.47063,0,0.5,0.5,,
ENSG00000204978,1,1,1,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ERICH4,-0.89,-1.0563,-1.5385,0,0.75,0.5,,
ENSG00000205030,1,1,0,0,0,1,21724.94108458234,21724.94108458234,2025-02-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR5L2,,-0.94661,-0.99572,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000205038,1,1,0,0,1,0,54878.03815912465,151015.87282657062,2023-01-18,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,PKHD1L1,-0.05400002,0.16407,0.18732,0,0.5,0.0,,
ENSG00000205143,1,1,0,0,0,1,72982.48880358285,72982.48880358285,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ARID3C,-0.71599996,-1.272,-0.09603,0,1.0,1.0,,
ENSG00000205302,1,1,0,0,0,1,48439.20423385324,48439.20423385324,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SNX2,0.47899997,1.5559,-0.4773,1,-1.0,-1.0,,
ENSG00000205356,1,1,1,0,0,1,220837.49604317299,521818.7070055739,2023-11-09,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,TECPR1,-0.049999952,0.41963,-0.7264,0,1.0,-1.0,,
ENSG00000205363,2,1,1,0,0,1,960369.5592648841,1778690.168860174,2021-05-27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,INSYN1,0.273,1.6086,0.15757,0,0.5,0.0,,
ENSG00000205581,2,1,1,0,0,1,714039.8414241908,714039.8414241908,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,HMGN1,0.106000006,-1.073,-0.94736,0,-1.0,-1.0,,
ENSG00000205702,2,1,0,0,0,1,15866.724081734988,15866.724081734988,2017-05-22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CYP2D7,,-0.37881,0.19864,0,,,,
ENSG00000205704,1,1,1,0,0,0,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,SMIM45,,,,0,1.0,0.5,,
ENSG00000205869,1,1,0,0,0,1,141293.18354755783,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,KRTAP5-1,-0.88199997,0.60618,0.94922,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000205981,2,1,0,0,0,1,55416.28042655659,1778690.168860174,2017-10-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,9,DNAJC19,-0.54700005,1.0653,0.058354,1,-1.0,-1.0,,
ENSG00000206047,1,1,0,1,0,1,4293.955119214586,5055.931872674659,2011-12-25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,DEFA1,,,,3,1.0,0.0,Alpha-defensins;Immune System;Defensins;Antimicrobial peptides,R-HSA-1462054;R-HSA-168256;R-HSA-1461973;R-HSA-6803157
ENSG00000206260,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,PRR23A,-0.924,-0.26196,-0.28697,0,1.0,1.0,,
ENSG00000206418,1,1,0,0,0,0,16461.04650907092,16461.04650907092,2015-01-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,RAB12,-0.17999995,1.3038,-1.0811,2,0.5,-1.0,Rab regulation of trafficking;Post-translational protein modification,R-HSA-9007101;R-HSA-597592
ENSG00000206561,2,1,0,0,0,0,10933.133329312666,270756.050710225,2017-06-06,0,0,0,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,COLQ,0.09799999,-0.16893,-0.011855,0,0.5,0.0,,
ENSG00000206562,1,1,0,0,0,1,197485.87952538437,197485.87952538437,2023-06-05,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,METTL6,-0.11099994,0.7641,0.68402,0,-1.0,-1.0,,
ENSG00000211455,1,1,0,0,0,1,1999.872,1999.872,2019-02-04,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STK38L,0.31699997,3.5652,0.44662,0,-1.0,-1.0,,
ENSG00000213171,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,LINGO4,-0.13699996,0.77671,1.0107,0,0.75,0.5,,
ENSG00000213463,1,1,1,0,0,0,521818.7070055739,521818.7070055739,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SYNJ2BP,-0.03999996,0.7392,1.0142,0,-1.0,-1.0,,
ENSG00000213523,1,1,1,0,0,0,433862.5685735124,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SRA1,-0.518,-0.18504,0.46245,0,-1.0,-1.0,,
ENSG00000213533,1,1,1,0,0,0,88632.90640619362,88632.90640619362,2024-06-13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,STIMATE,0.34500003,1.3858,-0.37969,0,-1.0,-1.0,,
ENSG00000213614,1,1,1,0,0,1,200944.0765227402,200944.0765227402,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HEXA,0.052999973,0.45674,1.1646,5,-1.0,-1.0,Hyaluronan degradation;Disease,R-HSA-2160916;R-HSA-1643685
ENSG00000213901,1,1,0,0,0,0,306980.8575290048,397765.9672627851,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,SLC23A3,0.20999998,1.5107,1.1614,0,0.75,0.0,,
ENSG00000213930,1,1,0,0,0,1,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,GALT,0.065,1.8721,1.498,2,0.5,-1.0,Disease,R-HSA-1643685
ENSG00000214063,1,1,1,0,0,1,143413.24457139417,143413.24457139417,2023-06-29,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,TSPAN4,-0.61600006,-0.11712,-1.6816,0,-1.0,-1.0,,
ENSG00000214128,2,1,1,0,1,1,337860.4854363166,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,4,TMEM213,-0.454,0.10472,-0.39999,0,0.75,0.5,,
ENSG00000214216,1,1,0,0,0,1,1173.5007132667617,1173.5007132667617,2022-07-22,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,IQCJ,-0.32000005,-0.41455,0.021584,0,,,,
ENSG00000214336,1,1,0,0,0,1,6021.72810122829,7731.604602670207,2018-01-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,2,FOXI3,0.26999998,0.38054,-0.3275,0,0.75,0.5,,
ENSG00000214357,1,1,0,0,0,1,406587.2658730814,406587.2658730814,2023-11-09,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NEURL1B,-0.047999978,-3.493,-4.9309,6,-1.0,0.0,Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers,R-HSA-162582;R-HSA-1643685;R-HSA-5663202
ENSG00000214376,1,1,0,0,0,0,45087.14211417935,45087.14211417935,2024-01-05,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VSTM5,-0.431,0.90466,0.33454,0,0.5,0.5,,
ENSG00000214415,1,1,0,0,0,1,39406.19595155135,39406.19595155135,2023-12-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,3,GNAT3,-0.008999944,0.4077,0.57265,10,1.0,1.0,Signal Transduction;ADP signalling through P2Y purinoceptor 12;Signal amplification;Disease,R-HSA-162582;R-HSA-392170;R-HSA-392518;R-HSA-1643685
ENSG00000214511,1,1,1,0,0,1,645988.1975077938,645988.1975077938,2025-03-06,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,HIGD1C,-0.81500006,0.17588,0.52177,3,,,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000214575,1,1,0,0,1,0,116547.04276487474,116547.04276487474,2018-10-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CPEB1,0.823,2.6847,0.31055,0,0.5,0.0,Developmental Biology,R-HSA-1266738
ENSG00000214941,1,1,1,0,0,1,562534.7696387965,562534.7696387965,2022-10-12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,ZSWIM7,-0.60300004,-0.70557,0.060986,0,-1.0,-1.0,,
ENSG00000215183,1,1,1,0,0,1,433862.5685735124,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MSMP,0.04000002,0.35326,0.28218,0,0.5,0.5,,
ENSG00000215421,1,1,0,0,0,1,7893.538738412709,7893.538738412709,2018-08-13,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF407,0.774,1.6037,-0.9034,0,-1.0,-1.0,,
ENSG00000215440,1,1,1,0,0,1,5026.948157648103,5026.948157648103,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,NPEPL1,-0.28699994,-1.1412,-2.4355,0,-1.0,-1.0,,
ENSG00000215474,1,1,0,0,0,1,309838.540915932,360605.992793193,2021-07-22,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,SKOR2,-0.23000002,-3.7199,-5.5078,0,,,,
ENSG00000215704,1,1,0,0,0,1,112184.2204720767,112184.2204720767,2024-04-26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CELA2B,0.013000011,0.45277,0.47561,0,1.0,0.0,,
ENSG00000215853,1,1,0,0,0,1,15015.241596403896,15015.241596403896,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RPTN,-0.811,1.061,1.0404,1,0.5,0.5,Developmental Biology,R-HSA-1266738
ENSG00000215915,1,1,1,0,0,1,21897.542503344637,21897.542503344637,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,ATAD3C,-0.14999998,-0.36375,-0.1434,0,-1.0,0.0,,
ENSG00000218336,1,1,0,0,0,1,4622.58832282007,4622.58832282007,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,TENM3,0.695,3.8447,0.76415,0,0.5,0.0,,
ENSG00000221878,2,1,0,0,0,1,37099.31252818776,42341.12463940832,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,PSG7,-0.58500004,-4.5367,-3.967,1,0.75,0.5,,
ENSG00000221890,1,1,1,1,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,NPTXR,0.185,-0.97573,-2.199,0,1.0,0.0,,
ENSG00000221968,2,1,1,0,0,1,78751.06843456876,160010.51072069994,2023-05-08,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,FADS3,0.273,2.0028,-0.18471,0,-1.0,-1.0,,
ENSG00000221983,1,1,1,0,0,1,279791.86865066044,279791.86865066044,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,UBA52,0.707,2.4402,0.78531,200,-1.0,-1.0,Signal Transduction;Cytokine Signaling in Immune system;Generic Transcription Pathway;ER Quality Control Compartment (ERQC);Endosomal Sorting Complex Required For Transport (ESCRT);Calnexin/calreticulin cycle;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Glycogen metabolism;Immune System;Budding and maturation of HIV virion;RNA Polymerase II Transcription;IRAK1 recruits IKK complex;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;Formation of TC-NER Pre-Incision Complex;Developmental Biology;Gene expression (Transcription);Glycogen storage diseases;Glycogen synthesis;Alpha-protein kinase 1 signaling pathway;IRAK2 mediated activation of TAK1 complex;Translation of Structural Proteins_9683701;Disease;Late endosomal microautophagy;Downregulation of ERBB4 signaling;Response of Mtb to phagocytosis;Aggrephagy;Signaling by Interleukins;IKK complex recruitment mediated by RIP1;Regulation of pyruvate metabolism;Suppression of phagosomal maturation;Infection with Mycobacterium tuberculosis;Regulation of signaling by CBL;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Chaperone Mediated Autophagy;Translation;Iron uptake and transport;Gap-filling DNA repair synthesis and ligation in TC-NER;Formation of Incision Complex in GG-NER;Pyruvate metabolism;rRNA processing;Regulation of expression of SLITs and ROBOs;Dual incision in TC-NER;HIV Life Cycle;Late Phase of HIV Life Cycle;Cellular response to starvation;Influenza Viral RNA Transcription and Replication;Stimuli-sensing channels;SRP-dependent cotranslational protein targeting to membrane;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Peroxisomal protein import;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Dectin-1 mediated noncanonical NF-kB signaling;ISG15 antiviral mechanism;E3 ubiquitin ligases ubiquitinate target proteins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Hedgehog ligand biogenesis;Protein ubiquitination;Hh mutants are degraded by ERAD;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Hh mutants abrogate ligand secretion;Asymmetric localization of PCP proteins;NIK-->noncanonical NF-kB signaling;Degradation of DVL;Signaling by Receptor Tyrosine Kinases;Diseases of signal transduction by growth factor receptors and second messengers;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Post-translational protein modification;Transcriptional regulation by RUNX3,R-HSA-162582;R-HSA-1280215;R-HSA-212436;R-HSA-901032;R-HSA-917729;R-HSA-901042;R-HSA-532668;R-HSA-8982491;R-HSA-168256;R-HSA-162588;R-HSA-73857;R-HSA-937039;R-HSA-975144;R-HSA-6781823;R-HSA-1266738;R-HSA-74160;R-HSA-3229121;R-HSA-3322077;R-HSA-9645460;R-HSA-937042;R-HSA-9683701;R-HSA-1643685;R-HSA-9615710;R-HSA-1253288;R-HSA-9637690;R-HSA-9646399;R-HSA-449147;R-HSA-937041;R-HSA-9861718;R-HSA-9637687;R-HSA-9635486;R-HSA-912631;R-HSA-8866652;R-HSA-9613829;R-HSA-72766;R-HSA-917937;R-HSA-6782210;R-HSA-5696395;R-HSA-70268;R-HSA-72312;R-HSA-9010553;R-HSA-6782135;R-HSA-162587;R-HSA-162599;R-HSA-9711097;R-HSA-168273;R-HSA-2672351;R-HSA-1799339;R-HSA-6781827;R-HSA-9033241;R-HSA-975956;R-HSA-5607761;R-HSA-1169408;R-HSA-8866654;R-HSA-450408;R-HSA-5358346;R-HSA-8852135;R-HSA-5362768;R-HSA-1234176;R-HSA-5387390;R-HSA-4608870;R-HSA-5676590;R-HSA-4641258;R-HSA-9006934;R-HSA-5663202;R-HSA-2173796;R-HSA-2173793;R-HSA-597592;R-HSA-8878159
ENSG00000224877,1,1,1,0,0,1,118061.55082048493,118061.55082048493,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,NDUFAF8,-0.82500005,-1.1955,-1.5994,1,-1.0,-1.0,Complex I biogenesis,R-HSA-6799198
ENSG00000225526,1,1,1,0,0,1,83896.55822718568,83896.55822718568,2023-02-07,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,MKRN2OS,-0.32599998,-0.95728,-0.45827,0,0.5,0.0,,
ENSG00000225997,2,1,0,0,0,1,168116.01355658393,358386.30063935445,2021-11-04,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,OR4A8,,,,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000228049,1,1,1,0,0,0,243159.30781957568,270756.050710225,2024-07-19,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,POLR2J2,,,,0,-1.0,-1.0,,
ENSG00000229474,1,1,0,0,0,1,207220.14223281175,207220.14223281175,2023-01-18,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,PATL2,-0.16299999,0.71254,-0.069713,0,0.5,0.0,,
ENSG00000229937,1,1,0,0,0,1,46282.676044693806,356440.71671986027,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,PRPS1L1,-0.16900003,0.11738,-0.17884,1,1.0,1.0,,
ENSG00000229972,1,1,0,0,0,1,1778690.168860174,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,IQCF3,-0.86300004,0.32101,-0.37363,0,1.0,1.0,,
ENSG00000232948,2,1,0,0,0,1,105281.95721639719,105281.95721639719,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,DEFB130A,,,,2,1.0,1.0,,
ENSG00000233974,1,1,0,0,0,1,3389.0621947248455,3389.0621947248455,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,ENSG00000233974,,,,0,,,,
ENSG00000234719,1,1,1,0,0,1,3664.4295302013425,3664.4295302013425,2020-05-20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NPIPB2,-0.31799996,-0.54951,-0.36125,0,-1.0,-1.0,,
ENSG00000235750,3,1,1,0,1,1,309838.540915932,574261.7466389402,2021-07-22,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,KIAA0040,-0.883,0.89453,-0.48586,0,0.5,-1.0,,
ENSG00000239306,2,1,0,0,0,1,714039.8414241908,714039.8414241908,2025-04-09,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,RBM14,0.804,2.0677,0.29246,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000240403,1,1,0,0,0,1,14890.356226921785,14890.356226921785,2019-03-12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,KIR3DL2,-0.283,-2.2607,-0.48289,1,0.5,1.0,Immune System,R-HSA-168256
ENSG00000240764,2,1,0,0,0,1,138890.6106237268,138890.6106237268,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PCDHGC5,0.436,2.1462,2.43,0,1.0,0.5,,
ENSG00000241119,1,1,0,0,0,1,301203.06999851385,301203.06999851385,2023-10-16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,UGT1A9,0.0009999871,0.10591,-0.46431,4,0.75,0.5,Glucuronidation;Phase II - Conjugation of compounds;Aspirin ADME,R-HSA-156588;R-HSA-156580;R-HSA-9749641
ENSG00000241356,1,1,0,0,0,1,168116.01355658393,168116.01355658393,2024-05-27,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR5G3,,,,1,0.75,0.5,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000241852,1,1,1,0,0,1,263416.51565448404,263416.51565448404,2023-12-28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,C8orf58,-0.12100005,-1.1602,-1.3312,0,-1.0,-1.0,,
ENSG00000242372,1,1,0,0,0,1,179853.90625477568,179853.90625477568,2021-07-21,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EIF6,0.37699997,1.5989,0.35195,0,-1.0,-1.0,,
ENSG00000242515,1,1,1,0,0,0,41642.5373617829,41642.5373617829,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,UGT1A10,-0.29400003,-0.70331,-0.7612,2,0.5,0.5,Glucuronidation;Phase II - Conjugation of compounds,R-HSA-156588;R-HSA-156580
ENSG00000243364,1,1,0,1,0,0,116388.33957200912,116388.33957200912,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,EFNA4,-0.33200002,-0.14398,-0.35222,3,0.5,0.0,Developmental Biology;EPH-ephrin mediated repulsion of cells,R-HSA-1266738;R-HSA-3928665
ENSG00000243789,1,1,1,0,0,1,1424218.0900670097,1424218.0900670097,2024-02-19,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,JMJD7,-0.38399994,-1.2069,-1.3657,1,-1.0,-1.0,Protein hydroxylation;Post-translational protein modification,R-HSA-9629569;R-HSA-597592
ENSG00000244057,1,1,1,0,0,0,6131.4565483476135,135108.48254553688,2010-10-17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,LCE3C,,,,1,1.0,0.5,Developmental Biology,R-HSA-1266738
ENSG00000244623,1,1,1,0,0,1,88632.90640619362,88632.90640619362,2024-06-13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR2AE1,-0.905,0.31073,0.18319,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000246705,1,1,1,0,0,1,521818.7070055739,521818.7070055739,2023-11-09,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,H2AJ,0.11500001,1.5679,-0.30122,38,0.5,-1.0,"Signal Transduction;Generic Transcription Pathway;Assembly of the ORC complex at the origin of replication;Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex;SIRT1 negatively regulates rRNA expression;RNA Polymerase II Transcription;Developmental Biology;Depyrimidination;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine;Base-Excision Repair, AP Site Formation;Inhibition of DNA recombination at telomere;Gene expression (Transcription);ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin modifications during the maternal to zygotic transition (MZT);RNA Polymerase I Promoter Escape;Condensation of Prophase Chromosomes;Regulation of endogenous retroelements by KRAB-ZFP proteins;Disease;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Negative epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;RNA Polymerase I Promoter Opening;Transcriptional regulation by small RNAs;Gene Silencing by RNA;RNA Polymerase I Transcription;RNA Polymerase I Promoter Clearance;Formation of the beta-catenin:TCF transactivating complex",R-HSA-162582;R-HSA-212436;R-HSA-68616;R-HSA-9843970;R-HSA-427359;R-HSA-73857;R-HSA-1266738;R-HSA-73928;R-HSA-110328;R-HSA-110329;R-HSA-73929;R-HSA-9670095;R-HSA-74160;R-HSA-427389;R-HSA-9821002;R-HSA-73772;R-HSA-2299718;R-HSA-9843940;R-HSA-1643685;R-HSA-5625886;R-HSA-5250941;R-HSA-427413;R-HSA-73728;R-HSA-5578749;R-HSA-211000;R-HSA-73864;R-HSA-73854;R-HSA-201722
ENSG00000247595,1,1,1,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MISFA,,,,0,1.0,0.0,,
ENSG00000248383,1,1,1,0,1,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,PCDHAC1,0.13099998,1.3194,1.3722,0,1.0,0.5,,
ENSG00000248485,1,1,0,0,0,1,56614.28807963426,56614.28807963426,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,PCP4L1,-0.83800006,-0.043394,-0.33385,0,0.5,0.0,,
ENSG00000249467,1,1,0,0,0,1,145320.08042080907,145320.08042080907,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,H2AL1Q,,,,0,1.0,1.0,,
ENSG00000249581,2,1,0,0,1,1,157962.97296027775,404399.6052088398,2021-06-09,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,7,CLRN2,-0.19000006,0.51185,-0.29384,0,,,,
ENSG00000249751,1,1,0,0,0,1,249965.96240703977,249965.96240703977,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ECSCR,-0.26999998,-0.28863,-0.18032,0,-1.0,0.0,,
ENSG00000249992,1,1,0,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TMEM158,-0.96599996,-3.5919,-4.0727,0,0.5,0.0,,
ENSG00000250067,1,1,1,0,0,0,60313.16706022933,60313.16706022933,2024-04-17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,YJEFN3,-0.44700003,-1.0975,-1.8193,0,1.0,0.5,,
ENSG00000250298,1,1,0,0,0,1,180089.50342935527,180089.50342935527,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,3,GIMD1,-0.49300003,-0.25158,0.050368,0,1.0,0.5,,
ENSG00000250673,1,1,0,0,0,1,286746.1002745869,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,REELD1,,,,0,-1.0,0.5,,
ENSG00000250821,1,1,0,0,0,1,200944.0765227402,200944.0765227402,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,EXOC1L,,,,0,,,,
ENSG00000253148,2,1,0,0,0,1,46064.07771265517,46064.07771265517,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,RGS21,-0.862,-0.035267,0.58497,2,,,Signal Transduction,R-HSA-162582
ENSG00000253250,1,1,1,0,0,1,338763.57771536184,338763.57771536184,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,C8orf88,-0.90900004,0.2232,0.17056,0,0.5,0.0,,
ENSG00000253710,2,1,1,0,0,0,106674.19403831073,106674.19403831073,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,ALG11,0.09200001,1.1209,0.94046,2,-1.0,-1.0,Disease;Post-translational protein modification,R-HSA-1643685;R-HSA-597592
ENSG00000253719,1,1,0,0,0,1,23238.11336553945,23238.11336553945,2020-01-31,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ATXN7L3B,-0.663,-0.27213,-1.3871,0,-1.0,-1.0,,
ENSG00000254004,1,1,1,0,0,1,1129585.974638378,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ZNF260,0.03399998,0.82002,0.46211,0,-1.0,-1.0,,
ENSG00000254709,1,1,0,0,0,1,237176.1991038335,237176.1991038335,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,IGLL5,-0.92200005,-4.8852,-4.7387,0,0.5,0.0,,
ENSG00000255151,2,1,0,0,0,1,72098.8014618248,521818.7070055739,2023-01-18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,GLYATL1B,,,,0,0.75,0.5,,
ENSG00000255582,2,1,0,0,0,1,7692.3985437154915,7692.3985437154915,2024-07-19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,OR10G2,-0.79999995,-0.26055,0.65084,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000256223,1,1,1,0,0,1,765591.3646788632,765591.3646788632,2020-06-15,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ZNF10,-0.204,1.5038,0.40464,1,-1.0,-1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000256574,1,1,0,0,0,1,278190.43024910334,278190.43024910334,2023-08-23,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR13A1,-0.883,-1.1725,-2.0696,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000258890,1,1,1,0,0,0,203321.91836345146,203321.91836345146,2020-04-15,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,CEP95,-0.06099999,-0.35046,0.63001,0,-1.0,-1.0,,
ENSG00000259330,1,1,1,0,0,1,38886.589732507324,294387.2978738704,2016-01-28,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,INAFM2,-0.755,0.22361,-0.64494,0,-1.0,-1.0,,
ENSG00000259494,1,1,0,0,0,1,250700.11896068082,250700.11896068082,2023-02-07,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,MRPL46,-0.13,-0.73933,-0.45311,3,-1.0,-1.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000259956,2,1,1,0,0,1,142744.17442731425,171699.39272110126,2018-07-16,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,RBM15B,0.606,0.25471,-3.0272,0,-1.0,-1.0,,
ENSG00000265241,1,1,0,0,0,1,141076.9910731678,141076.9910731678,2020-05-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,RBM8A,0.454,3.0397,1.0186,6,-1.0,-1.0,RNA Polymerase II Transcription;Developmental Biology;Gene expression (Transcription);Regulation of expression of SLITs and ROBOs;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm,R-HSA-73857;R-HSA-1266738;R-HSA-74160;R-HSA-9010553;R-HSA-159236;R-HSA-72202
ENSG00000266200,1,1,0,0,0,0,718784.6890415357,718784.6890415357,2022-08-01,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PNLIPRP2,-0.26,-0.35652,-0.66047,2,1.0,0.5,Digestion and absorption;Digestion,R-HSA-8963743;R-HSA-8935690
ENSG00000267467,1,1,0,0,1,0,340825.7076940272,340825.7076940272,2023-05-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,APOC4,-0.81700003,0.011471,0.64591,3,1.0,0.5,Signal Transduction,R-HSA-162582
ENSG00000268696,1,1,0,0,0,1,464892.4593283075,464892.4593283075,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ZNF723,,0.44163,-0.68127,0,1.0,1.0,,
ENSG00000269964,1,1,0,0,0,1,40089.29506875466,40089.29506875466,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,MEI4,-0.34099996,1.6818,1.2794,0,0.5,0.5,,
ENSG00000271425,1,1,0,0,0,1,141076.9910731678,141076.9910731678,2020-05-18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NBPF10,-0.96599996,-2.4808,-1.5516,0,-1.0,0.0,,
ENSG00000272398,1,1,0,0,0,1,275021.63051358337,275021.63051358337,2023-01-18,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,CD24,-0.89100003,0.14252,0.11115,1,0.5,-1.0,Developmental Biology,R-HSA-1266738
ENSG00000273604,1,1,0,0,1,1,123127.18790121445,123127.18790121445,2019-02-25,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,EPOP,-0.896,-2.1295,-2.4603,0,0.5,0.0,,
ENSG00000274209,1,1,0,0,0,1,65127.395275883,65127.395275883,2021-09-30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ANTXRL,-0.0039999485,0.044136,-1.5604,0,1.0,0.5,,
ENSG00000274286,1,1,0,0,0,1,3182.5825880914163,3182.5825880914163,2022-01-31,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ADRA2B,-0.556,0.30931,0.89245,4,-1.0,0.0,Signal Transduction;Adrenoceptors;Amine ligand-binding receptors,R-HSA-162582;R-HSA-390696;R-HSA-375280
ENSG00000274391,1,1,0,0,0,1,28923.750134754748,28923.750134754748,2012-12-01,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,TPTE,-0.388,0.91685,0.30609,1,1.0,1.0,Synthesis of PIPs at the Golgi membrane,R-HSA-1660514
ENSG00000275052,2,1,1,0,0,1,116089.30071075787,215157.94798738702,2020-06-24,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PPP4R3B,0.19700003,0.55173,-1.4595,0,-1.0,-1.0,,
ENSG00000275572,1,1,0,0,0,1,252346.18526092035,448058.917711015,2018-08-13,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,GRIFIN,-0.89100003,-0.69148,-1.5317,0,,,,
ENSG00000276293,1,1,0,0,0,1,252346.18526092035,252346.18526092035,2018-08-13,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,PIP4K2B,0.776,3.1373,0.24175,4,-1.0,-1.0,Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-162582;R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000278522,1,1,0,0,0,1,10268.412527615117,10268.412527615117,2023-01-18,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,POTEB3,0.7,4.2008,3.4365,0,1.0,1.0,,
ENSG00000278535,1,1,1,0,0,0,240639.50239824195,240639.50239824195,2021-10-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,DHRS11,0.092999995,0.48131,0.27025,0,1.0,-1.0,,
ENSG00000278570,1,1,0,0,0,1,414433.58532016096,414433.58532016096,2024-07-19,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NR2E3,-0.47000003,-0.87685,-1.136,1,1.0,1.0,Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription),R-HSA-212436;R-HSA-73857;R-HSA-74160
ENSG00000278845,1,1,0,0,0,1,278190.43024910334,278190.43024910334,2023-08-23,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,MRPL45,0.19300002,1.1926,1.2109,0,-1.0,0.0,Translation;Mitochondrial translation termination;Mitochondrial translation initiation;Mitochondrial translation elongation;Mitochondrial translation;Mitochondrial ribosome-associated quality control,R-HSA-72766;R-HSA-5419276;R-HSA-5368286;R-HSA-5389840;R-HSA-5368287;R-HSA-9937383
ENSG00000279000,1,1,0,0,0,1,21082.402979080252,21082.402979080252,2024-07-19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,OR10A6,-0.41799998,-1.8928,-1.05,2,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000279116,1,1,0,0,0,1,113567.57166187582,113567.57166187582,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,OR8D2,,0.58908,-0.41483,1,,,Expression and translocation of olfactory receptors;Olfactory Signaling Pathway,R-HSA-9752946;R-HSA-381753
ENSG00000280165,2,1,0,0,0,1,433862.5685735124,1778690.168860174,2022-07-14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,3,PCDH20,0.306,0.58998,-0.53633,0,0.5,0.5,,
ENSG00000282815,1,1,0,0,0,1,286746.1002745869,286746.1002745869,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,TEX13C,,,,0,1.0,1.0,,
ENSG00000283039,1,1,0,0,0,1,286746.1002745869,286746.1002745869,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,KLF18,,,,0,,,,
ENSG00000283288,1,1,0,0,1,1,194667.2540182328,194667.2540182328,2024-07-19,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,SMIM33,,,,0,0.5,0.5,,
ENSG00000283755,1,1,0,0,0,1,36102.10446378434,36102.10446378434,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,CPHXL,,,,0,,,,
ENSG00000283787,1,1,0,0,0,1,22345.675520395987,33670.70607708678,2013-04-01,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PRR33,,,,0,0.5,0.0,,
ENSG00000284629,1,1,0,0,0,1,323648.5577791949,323648.5577791949,2025-01-03,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,SCYGR1,,,,0,,,,
ENSG00000285480,1,1,1,0,0,1,200944.0765227402,200944.0765227402,2023-01-18,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,H2BK1,-0.768,0.55227,-0.83589,0,0.5,0.5,,
ENSG00000286105,2,1,0,0,0,0,15186.98390755667,33403.07824371935,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,TMEM217B,,-0.03599,1.1048,0,1.0,1.0,,
ENSG00000288636,1,1,0,0,0,1,15223.454539395489,141293.18354755783,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2,ENSG00000288636,-0.29999995,0.16578,0.095566,0,0.5,0.5,,
ENSG00000288701,1,1,1,0,0,1,286678.73247515375,384314.83364002535,2024-10-15,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,2,PRRC2B,0.662,1.1633,-0.52168,0,-1.0,-1.0,,
ENSG00000288867,1,1,0,0,0,1,155496.87140784386,205433.03502595585,2025-04-01,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,PPIAL4C,-0.83500004,1.2173,1.2009,0,0.5,0.5,,
ENSG00000289710,1,1,0,0,0,1,286746.1002745869,433862.5685735124,2024-06-05,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,ENSG00000289710,,,,0,,,,
ENSG00000291315,1,1,0,0,0,0,376569.5597064443,376569.5597064443,2023-01-18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,ENSG00000291315,,,,0,1.0,0.5,,
ENSG00000293137,1,1,0,0,0,0,292977.1806919819,292977.1806919819,2021-11-04,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,MSL3B,,,,0,,,,
ENSG00000300293,1,1,0,0,0,1,360605.992793193,360605.992793193,2022-02-03,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,ENSG00000300293,,,,0,,,,
